,title,publish_time,journal,url,abstract,doi,cord_uid,words
74,MIMOX: a web tool for phage display based epitope mapping,2006-10-12,BMC Bioinformatics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1618411/,"BACKGROUND: Phage display is widely used in basic research such as the exploration of protein-protein interaction sites and networks, and applied research such as the development of new drugs, vaccines, and diagnostics. It has also become a promising method for epitope mapping. Research on new algorithms that assist and automate phage display based epitope mapping has attracted many groups. Most of the existing tools have not been implemented as an online service until now however, making it less convenient for the community to access, utilize, and evaluate them. RESULTS: We present MIMOX, a free web tool that helps to map the native epitope of an antibody based on one or more user supplied mimotopes and the antigen structure. MIMOX was coded in Perl using modules from the Bioperl project. It has two sections. In the first section, MIMOX provides a simple interface for ClustalW to align a set of mimotopes. It also provides a simple statistical method to derive the consensus sequence and embeds JalView as a Java applet to view and manage the alignment. In the second section, MIMOX can map a single mimotope or a consensus sequence of a set of mimotopes, on to the corresponding antigen structure and search for all of the clusters of residues that could represent the native epitope. NACCESS is used to evaluate the surface accessibility of the candidate clusters; and Jmol is embedded to view them interactively in their 3D context. Initial case studies show that MIMOX can reproduce mappings from existing tools such as FINDMAP and 3DEX, as well as providing novel, rational results. CONCLUSION: A web-based tool called MIMOX has been developed for phage display based epitope mapping. As a publicly available online service in this area, it is convenient for the community to access, utilize, and evaluate, complementing other existing programs. MIMOX is freely available at .",10.1186/1471-2105-7-451,1ypgij14,"['BACKGROUND', 'Phage', 'display', 'is', 'widely', 'used', 'in', 'basic', 'research', 'such', 'as', 'the', 'exploration', 'of', 'protein', 'protein', 'interaction', 'sites', 'and', 'networks', 'and', 'applied', 'research', 'such', 'as', 'the', 'development', 'of', 'new', 'drugs', 'vaccines', 'and', 'diagnostics', 'It', 'has', 'also', 'become', 'a', 'promising', 'method', 'for', 'epitope', 'mapping', 'Research', 'on', 'new', 'algorithms', 'that', 'assist', 'and', 'automate', 'phage', 'display', 'based', 'epitope', 'mapping', 'has', 'attracted', 'many', 'groups', 'Most', 'of', 'the', 'existing', 'tools', 'have', 'not', 'been', 'implemented', 'as', 'an', 'online', 'service', 'until', 'now', 'however', 'making', 'it', 'less', 'convenient', 'for', 'the', 'community', 'to', 'access', 'utilize', 'and', 'evaluate', 'them', 'RESULTS', 'We', 'present', 'MIMOX', 'a', 'free', 'web', 'tool', 'that', 'helps', 'to', 'map', 'the', 'native', 'epitope', 'of', 'an', 'antibody', 'based', 'on', 'one', 'or', 'more', 'user', 'supplied', 'mimotopes', 'and', 'the', 'antigen', 'structure', 'MIMOX', 'was', 'coded', 'in', 'Perl', 'using', 'modules', 'from', 'the', 'Bioperl', 'project', 'It', 'has', 'two', 'sections', 'In', 'the', 'first', 'section', 'MIMOX', 'provides', 'a', 'simple', 'interface', 'for', 'ClustalW', 'to', 'align', 'a', 'set', 'of', 'mimotopes', 'It', 'also', 'provides', 'a', 'simple', 'statistical', 'method', 'to', 'derive', 'the', 'consensus', 'sequence', 'and', 'embeds', 'JalView', 'as', 'a', 'Java', 'applet', 'to', 'view', 'and', 'manage', 'the', 'alignment', 'In', 'the', 'second', 'section', 'MIMOX', 'can', 'map', 'a', 'single', 'mimotope', 'or', 'a', 'consensus', 'sequence', 'of', 'a', 'set', 'of', 'mimotopes', 'on', 'to', 'the', 'corresponding', 'antigen', 'structure', 'and', 'search', 'for', 'all', 'of', 'the', 'clusters', 'of', 'residues', 'that', 'could', 'represent', 'the', 'native', 'epitope', 'NACCESS', 'is', 'used', 'to', 'evaluate', 'the', 'surface', 'accessibility', 'of', 'the', 'candidate', 'clusters', 'and', 'Jmol', 'is', 'embedded', 'to', 'view', 'them', 'interactively', 'in', 'their', '3D', 'context', 'Initial', 'case', 'studies', 'show', 'that', 'MIMOX', 'can', 'reproduce', 'mappings', 'from', 'existing', 'tools', 'such', 'as', 'FINDMAP', 'and', '3DEX', 'as', 'well', 'as', 'providing', 'novel', 'rational', 'results', 'CONCLUSION', 'A', 'web', 'based', 'tool', 'called', 'MIMOX', 'has', 'been', 'developed', 'for', 'phage', 'display', 'based', 'epitope', 'mapping', 'As', 'a', 'publicly', 'available', 'online', 'service', 'in', 'this', 'area', 'it', 'is', 'convenient', 'for', 'the', 'community', 'to', 'access', 'utilize', 'and', 'evaluate', 'complementing', 'other', 'existing', 'programs', 'MIMOX', 'is', 'freely', 'available', 'at', '']"
292,Emerging Technologies for the Detection of Rabies Virus: Challenges and Hopes in the 21st Century,2009-09-29,PLoS Negl Trop Dis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745658/,"The diagnosis of rabies is routinely based on clinical and epidemiological information, especially when exposures are reported in rabies-endemic countries. Diagnostic tests using conventional assays that appear to be negative, even when undertaken late in the disease and despite the clinical diagnosis, have a tendency, at times, to be unreliable. These tests are rarely optimal and entirely dependent on the nature and quality of the sample supplied. In the course of the past three decades, the application of molecular biology has aided in the development of tests that result in a more rapid detection of rabies virus. These tests enable viral strain identification from clinical specimens. Currently, there are a number of molecular tests that can be used to complement conventional tests in rabies diagnosis. Indeed the challenges in the 21st century for the development of rabies diagnostics are not of a technical nature; these tests are available now. The challenges in the 21st century for diagnostic test developers are two-fold: firstly, to achieve internationally accepted validation of a test that will then lead to its acceptance by organisations globally. Secondly, the areas of the world where such tests are needed are mainly in developing regions where financial and logistical barriers prevent their implementation. Although developing countries with a poor healthcare infrastructure recognise that molecular-based diagnostic assays will be unaffordable for routine use, the cost/benefit ratio should still be measured. Adoption of rapid and affordable rabies diagnostic tests for use in developing countries highlights the importance of sharing and transferring technology through laboratory twinning between the developed and the developing countries. Importantly for developing countries, the benefit of molecular methods as tools is the capability for a differential diagnosis of human diseases that present with similar clinical symptoms. Antemortem testing for human rabies is now possible using molecular techniques. These barriers are not insurmountable and it is our expectation that if such tests are accepted and implemented where they are most needed, they will provide substantial improvements for rabies diagnosis and surveillance. The advent of molecular biology and new technological initiatives that combine advances in biology with other disciplines will support the development of techniques capable of high throughput testing with a low turnaround time for rabies diagnosis.",10.1371/journal.pntd.0000530,d0eur1hq,"['The', 'diagnosis', 'of', 'rabies', 'is', 'routinely', 'based', 'on', 'clinical', 'and', 'epidemiological', 'information', 'especially', 'when', 'exposures', 'are', 'reported', 'in', 'rabies', 'endemic', 'countries', 'Diagnostic', 'tests', 'using', 'conventional', 'assays', 'that', 'appear', 'to', 'be', 'negative', 'even', 'when', 'undertaken', 'late', 'in', 'the', 'disease', 'and', 'despite', 'the', 'clinical', 'diagnosis', 'have', 'a', 'tendency', 'at', 'times', 'to', 'be', 'unreliable', 'These', 'tests', 'are', 'rarely', 'optimal', 'and', 'entirely', 'dependent', 'on', 'the', 'nature', 'and', 'quality', 'of', 'the', 'sample', 'supplied', 'In', 'the', 'course', 'of', 'the', 'past', 'three', 'decades', 'the', 'application', 'of', 'molecular', 'biology', 'has', 'aided', 'in', 'the', 'development', 'of', 'tests', 'that', 'result', 'in', 'a', 'more', 'rapid', 'detection', 'of', 'rabies', 'virus', 'These', 'tests', 'enable', 'viral', 'strain', 'identification', 'from', 'clinical', 'specimens', 'Currently', 'there', 'are', 'a', 'number', 'of', 'molecular', 'tests', 'that', 'can', 'be', 'used', 'to', 'complement', 'conventional', 'tests', 'in', 'rabies', 'diagnosis', 'Indeed', 'the', 'challenges', 'in', 'the', '21st', 'century', 'for', 'the', 'development', 'of', 'rabies', 'diagnostics', 'are', 'not', 'of', 'a', 'technical', 'nature', 'these', 'tests', 'are', 'available', 'now', 'The', 'challenges', 'in', 'the', '21st', 'century', 'for', 'diagnostic', 'test', 'developers', 'are', 'two', 'fold', 'firstly', 'to', 'achieve', 'internationally', 'accepted', 'validation', 'of', 'a', 'test', 'that', 'will', 'then', 'lead', 'to', 'its', 'acceptance', 'by', 'organisations', 'globally', 'Secondly', 'the', 'areas', 'of', 'the', 'world', 'where', 'such', 'tests', 'are', 'needed', 'are', 'mainly', 'in', 'developing', 'regions', 'where', 'financial', 'and', 'logistical', 'barriers', 'prevent', 'their', 'implementation', 'Although', 'developing', 'countries', 'with', 'a', 'poor', 'healthcare', 'infrastructure', 'recognise', 'that', 'molecular', 'based', 'diagnostic', 'assays', 'will', 'be', 'unaffordable', 'for', 'routine', 'use', 'the', 'cost', 'benefit', 'ratio', 'should', 'still', 'be', 'measured', 'Adoption', 'of', 'rapid', 'and', 'affordable', 'rabies', 'diagnostic', 'tests', 'for', 'use', 'in', 'developing', 'countries', 'highlights', 'the', 'importance', 'of', 'sharing', 'and', 'transferring', 'technology', 'through', 'laboratory', 'twinning', 'between', 'the', 'developed', 'and', 'the', 'developing', 'countries', 'Importantly', 'for', 'developing', 'countries', 'the', 'benefit', 'of', 'molecular', 'methods', 'as', 'tools', 'is', 'the', 'capability', 'for', 'a', 'differential', 'diagnosis', 'of', 'human', 'diseases', 'that', 'present', 'with', 'similar', 'clinical', 'symptoms', 'Antemortem', 'testing', 'for', 'human', 'rabies', 'is', 'now', 'possible', 'using', 'molecular', 'techniques', 'These', 'barriers', 'are', 'not', 'insurmountable', 'and', 'it', 'is', 'our', 'expectation', 'that', 'if', 'such', 'tests', 'are', 'accepted', 'and', 'implemented', 'where', 'they', 'are', 'most', 'needed', 'they', 'will', 'provide', 'substantial', 'improvements', 'for', 'rabies', 'diagnosis', 'and', 'surveillance', 'The', 'advent', 'of', 'molecular', 'biology', 'and', 'new', 'technological', 'initiatives', 'that', 'combine', 'advances', 'in', 'biology', 'with', 'other', 'disciplines', 'will', 'support', 'the', 'development', 'of', 'techniques', 'capable', 'of', 'high', 'throughput', 'testing', 'with', 'a', 'low', 'turnaround', 'time', 'for', 'rabies', 'diagnosis', '']"
507,Avipoxviruses: infection biology and their use as vaccine vectors,2011-02-03,Virol J,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042955/,"Avipoxviruses (APVs) belong to the Chordopoxvirinae subfamily of the Poxviridae family. APVs are distributed worldwide and cause disease in domestic, pet and wild birds of many species. APVs are transmitted by aerosols and biting insects, particularly mosquitoes and arthropods and are usually named after the bird species from which they were originally isolated. The virus species Fowlpox virus (FWPV) causes disease in poultry and associated mortality is usually low, but in flocks under stress (other diseases, high production) mortality can reach up to 50%. APVs are also major players in viral vaccine vector development for diseases in human and veterinary medicine. Abortive infection in mammalian cells (no production of progeny viruses) and their ability to accommodate multiple gene inserts are some of the characteristics that make APVs promising vaccine vectors. Although abortive infection in mammalian cells conceivably represents a major vaccine bio-safety advantage, molecular mechanisms restricting APVs to certain hosts are not yet fully understood. This review summarizes the current knowledge relating to APVs, including classification, morphogenesis, host-virus interactions, diagnostics and disease, and also highlights the use of APVs as recombinant vaccine vectors.",10.1186/1743-422x-8-49,ussnj6ux,"['Avipoxviruses', 'APVs', 'belong', 'to', 'the', 'Chordopoxvirinae', 'subfamily', 'of', 'the', 'Poxviridae', 'family', 'APVs', 'are', 'distributed', 'worldwide', 'and', 'cause', 'disease', 'in', 'domestic', 'pet', 'and', 'wild', 'birds', 'of', 'many', 'species', 'APVs', 'are', 'transmitted', 'by', 'aerosols', 'and', 'biting', 'insects', 'particularly', 'mosquitoes', 'and', 'arthropods', 'and', 'are', 'usually', 'named', 'after', 'the', 'bird', 'species', 'from', 'which', 'they', 'were', 'originally', 'isolated', 'The', 'virus', 'species', 'Fowlpox', 'virus', 'FWPV', 'causes', 'disease', 'in', 'poultry', 'and', 'associated', 'mortality', 'is', 'usually', 'low', 'but', 'in', 'flocks', 'under', 'stress', 'other', 'diseases', 'high', 'production', 'mortality', 'can', 'reach', 'up', 'to', '50', 'APVs', 'are', 'also', 'major', 'players', 'in', 'viral', 'vaccine', 'vector', 'development', 'for', 'diseases', 'in', 'human', 'and', 'veterinary', 'medicine', 'Abortive', 'infection', 'in', 'mammalian', 'cells', 'no', 'production', 'of', 'progeny', 'viruses', 'and', 'their', 'ability', 'to', 'accommodate', 'multiple', 'gene', 'inserts', 'are', 'some', 'of', 'the', 'characteristics', 'that', 'make', 'APVs', 'promising', 'vaccine', 'vectors', 'Although', 'abortive', 'infection', 'in', 'mammalian', 'cells', 'conceivably', 'represents', 'a', 'major', 'vaccine', 'bio', 'safety', 'advantage', 'molecular', 'mechanisms', 'restricting', 'APVs', 'to', 'certain', 'hosts', 'are', 'not', 'yet', 'fully', 'understood', 'This', 'review', 'summarizes', 'the', 'current', 'knowledge', 'relating', 'to', 'APVs', 'including', 'classification', 'morphogenesis', 'host', 'virus', 'interactions', 'diagnostics', 'and', 'disease', 'and', 'also', 'highlights', 'the', 'use', 'of', 'APVs', 'as', 'recombinant', 'vaccine', 'vectors', '']"
559,"A Simple, Inexpensive Device for Nucleic Acid Amplification without Electricity—Toward Instrument-Free Molecular Diagnostics in Low-Resource Settings",2011-05-09,PLoS One,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090398/,"BACKGROUND: Molecular assays targeted to nucleic acid (NA) markers are becoming increasingly important to medical diagnostics. However, these are typically confined to wealthy, developed countries; or, to the national reference laboratories of developing-world countries. There are many infectious diseases that are endemic in low-resource settings (LRS) where the lack of simple, instrument-free, NA diagnostic tests is a critical barrier to timely treatment. One of the primary barriers to the practicality and availability of NA assays in LRS has been the complexity and power requirements of polymerase chain reaction (PCR) instrumentation (another is sample preparation). METHODOLOGY/PRINCIPAL FINDINGS: In this article, we investigate the hypothesis that an electricity-free heater based on exothermic chemical reactions and engineered phase change materials can successfully incubate isothermal NA amplification assays. We assess the heater's equivalence to commercially available PCR instruments through the characterization of the temperature profiles produced, and a minimal method comparison. Versions of the prototype for several different isothermal techniques are presented. CONCLUSIONS/SIGNIFICANCE: We demonstrate that an electricity-free heater based on exothermic chemical reactions and engineered phase change materials can successfully incubate isothermal NA amplification assays, and that the results of those assays are not significantly different from ones incubated in parallel in commercially available PCR instruments. These results clearly suggest the potential of the non-instrumented nucleic acid amplification (NINA) heater for molecular diagnostics in LRS. When combined with other innovations in development that eliminate power requirements for sample preparation, cold reagent storage, and readout, the NINA heater will comprise part of a kit that should enable electricity-free NA testing for many important analytes.",10.1371/journal.pone.0019738,qol5poan,"['BACKGROUND', 'Molecular', 'assays', 'targeted', 'to', 'nucleic', 'acid', 'NA', 'markers', 'are', 'becoming', 'increasingly', 'important', 'to', 'medical', 'diagnostics', 'However', 'these', 'are', 'typically', 'confined', 'to', 'wealthy', 'developed', 'countries', 'or', 'to', 'the', 'national', 'reference', 'laboratories', 'of', 'developing', 'world', 'countries', 'There', 'are', 'many', 'infectious', 'diseases', 'that', 'are', 'endemic', 'in', 'low', 'resource', 'settings', 'LRS', 'where', 'the', 'lack', 'of', 'simple', 'instrument', 'free', 'NA', 'diagnostic', 'tests', 'is', 'a', 'critical', 'barrier', 'to', 'timely', 'treatment', 'One', 'of', 'the', 'primary', 'barriers', 'to', 'the', 'practicality', 'and', 'availability', 'of', 'NA', 'assays', 'in', 'LRS', 'has', 'been', 'the', 'complexity', 'and', 'power', 'requirements', 'of', 'polymerase', 'chain', 'reaction', 'PCR', 'instrumentation', 'another', 'is', 'sample', 'preparation', 'METHODOLOGY', 'PRINCIPAL', 'FINDINGS', 'In', 'this', 'article', 'we', 'investigate', 'the', 'hypothesis', 'that', 'an', 'electricity', 'free', 'heater', 'based', 'on', 'exothermic', 'chemical', 'reactions', 'and', 'engineered', 'phase', 'change', 'materials', 'can', 'successfully', 'incubate', 'isothermal', 'NA', 'amplification', 'assays', 'We', 'assess', 'the', 'heater', 's', 'equivalence', 'to', 'commercially', 'available', 'PCR', 'instruments', 'through', 'the', 'characterization', 'of', 'the', 'temperature', 'profiles', 'produced', 'and', 'a', 'minimal', 'method', 'comparison', 'Versions', 'of', 'the', 'prototype', 'for', 'several', 'different', 'isothermal', 'techniques', 'are', 'presented', 'CONCLUSIONS', 'SIGNIFICANCE', 'We', 'demonstrate', 'that', 'an', 'electricity', 'free', 'heater', 'based', 'on', 'exothermic', 'chemical', 'reactions', 'and', 'engineered', 'phase', 'change', 'materials', 'can', 'successfully', 'incubate', 'isothermal', 'NA', 'amplification', 'assays', 'and', 'that', 'the', 'results', 'of', 'those', 'assays', 'are', 'not', 'significantly', 'different', 'from', 'ones', 'incubated', 'in', 'parallel', 'in', 'commercially', 'available', 'PCR', 'instruments', 'These', 'results', 'clearly', 'suggest', 'the', 'potential', 'of', 'the', 'non', 'instrumented', 'nucleic', 'acid', 'amplification', 'NINA', 'heater', 'for', 'molecular', 'diagnostics', 'in', 'LRS', 'When', 'combined', 'with', 'other', 'innovations', 'in', 'development', 'that', 'eliminate', 'power', 'requirements', 'for', 'sample', 'preparation', 'cold', 'reagent', 'storage', 'and', 'readout', 'the', 'NINA', 'heater', 'will', 'comprise', 'part', 'of', 'a', 'kit', 'that', 'should', 'enable', 'electricity', 'free', 'NA', 'testing', 'for', 'many', 'important', 'analytes', '']"
788,Use and Evaluation of Molecular Diagnostics for Pneumonia Etiology Studies,2012-03-08,Clinical Infectious Diseases,https://academic.oup.com/cid/article-pdf/54/suppl_2/S153/20938419/cir1060.pdf,"Comprehensive microbiological testing will be a core function of the Pneumonia Etiology Research for Child Health (PERCH) project. The development stage of PERCH provided the time and resources necessary for us to conduct a comprehensive review of the current state of respiratory diagnostics. These efforts allowed us to articulate the unique requirements of PERCH, establish that molecular methods would be central to our testing strategy, and focus on a short list of candidate platforms. This process also highlighted critical challenges in the general design and interpretation of diagnostic evaluation studies, particularly in the field of respiratory infections. Although our final molecular diagnostic platform was ultimately selected on the basis of operational and strategic considerations determined by the specific context of PERCH, our review highlighted several conceptual and practical challenges in respiratory diagnostics that have broader relevance for the performance and interpretation of pneumonia research studies.",10.1093/cid/cir1060,z5p3a64x,"['Comprehensive', 'microbiological', 'testing', 'will', 'be', 'a', 'core', 'function', 'of', 'the', 'Pneumonia', 'Etiology', 'Research', 'for', 'Child', 'Health', 'PERCH', 'project', 'The', 'development', 'stage', 'of', 'PERCH', 'provided', 'the', 'time', 'and', 'resources', 'necessary', 'for', 'us', 'to', 'conduct', 'a', 'comprehensive', 'review', 'of', 'the', 'current', 'state', 'of', 'respiratory', 'diagnostics', 'These', 'efforts', 'allowed', 'us', 'to', 'articulate', 'the', 'unique', 'requirements', 'of', 'PERCH', 'establish', 'that', 'molecular', 'methods', 'would', 'be', 'central', 'to', 'our', 'testing', 'strategy', 'and', 'focus', 'on', 'a', 'short', 'list', 'of', 'candidate', 'platforms', 'This', 'process', 'also', 'highlighted', 'critical', 'challenges', 'in', 'the', 'general', 'design', 'and', 'interpretation', 'of', 'diagnostic', 'evaluation', 'studies', 'particularly', 'in', 'the', 'field', 'of', 'respiratory', 'infections', 'Although', 'our', 'final', 'molecular', 'diagnostic', 'platform', 'was', 'ultimately', 'selected', 'on', 'the', 'basis', 'of', 'operational', 'and', 'strategic', 'considerations', 'determined', 'by', 'the', 'specific', 'context', 'of', 'PERCH', 'our', 'review', 'highlighted', 'several', 'conceptual', 'and', 'practical', 'challenges', 'in', 'respiratory', 'diagnostics', 'that', 'have', 'broader', 'relevance', 'for', 'the', 'performance', 'and', 'interpretation', 'of', 'pneumonia', 'research', 'studies', '']"
1221,Expression of Recombinant Antibodies,2013-07-29,Front Immunol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725456/,"Recombinant antibodies are highly specific detection probes in research, diagnostics, and have emerged over the last two decades as the fastest growing class of therapeutic proteins. Antibody generation has been dramatically accelerated by in vitro selection systems, particularly phage display. An increasing variety of recombinant production systems have been developed, ranging from Gram-negative and positive bacteria, yeasts and filamentous fungi, insect cell lines, mammalian cells to transgenic plants and animals. Currently, almost all therapeutic antibodies are still produced in mammalian cell lines in order to reduce the risk of immunogenicity due to altered, non-human glycosylation patterns. However, recent developments of glycosylation-engineered yeast, insect cell lines, and transgenic plants are promising to obtain antibodies with “human-like” post-translational modifications. Furthermore, smaller antibody fragments including bispecific antibodies without any glycosylation are successfully produced in bacteria and have advanced to clinical testing. The first therapeutic antibody products from a non-mammalian source can be expected in coming next years. In this review, we focus on current antibody production systems including their usability for different applications.",10.3389/fimmu.2013.00217,06o7pa3d,"['Recombinant', 'antibodies', 'are', 'highly', 'specific', 'detection', 'probes', 'in', 'research', 'diagnostics', 'and', 'have', 'emerged', 'over', 'the', 'last', 'two', 'decades', 'as', 'the', 'fastest', 'growing', 'class', 'of', 'therapeutic', 'proteins', 'Antibody', 'generation', 'has', 'been', 'dramatically', 'accelerated', 'by', 'in', 'vitro', 'selection', 'systems', 'particularly', 'phage', 'display', 'An', 'increasing', 'variety', 'of', 'recombinant', 'production', 'systems', 'have', 'been', 'developed', 'ranging', 'from', 'Gram', 'negative', 'and', 'positive', 'bacteria', 'yeasts', 'and', 'filamentous', 'fungi', 'insect', 'cell', 'lines', 'mammalian', 'cells', 'to', 'transgenic', 'plants', 'and', 'animals', 'Currently', 'almost', 'all', 'therapeutic', 'antibodies', 'are', 'still', 'produced', 'in', 'mammalian', 'cell', 'lines', 'in', 'order', 'to', 'reduce', 'the', 'risk', 'of', 'immunogenicity', 'due', 'to', 'altered', 'non', 'human', 'glycosylation', 'patterns', 'However', 'recent', 'developments', 'of', 'glycosylation', 'engineered', 'yeast', 'insect', 'cell', 'lines', 'and', 'transgenic', 'plants', 'are', 'promising', 'to', 'obtain', 'antibodies', 'with', 'human', 'like', 'post', 'translational', 'modifications', 'Furthermore', 'smaller', 'antibody', 'fragments', 'including', 'bispecific', 'antibodies', 'without', 'any', 'glycosylation', 'are', 'successfully', 'produced', 'in', 'bacteria', 'and', 'have', 'advanced', 'to', 'clinical', 'testing', 'The', 'first', 'therapeutic', 'antibody', 'products', 'from', 'a', 'non', 'mammalian', 'source', 'can', 'be', 'expected', 'in', 'coming', 'next', 'years', 'In', 'this', 'review', 'we', 'focus', 'on', 'current', 'antibody', 'production', 'systems', 'including', 'their', 'usability', 'for', 'different', 'applications', '']"
1592,Multiplex isothermal solid-phase recombinase polymerase amplification for the specific and fast DNA-based detection of three bacterial pathogens,2014-02-18,Mikrochim Acta,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167443/,"We report on the development of an on-chip RPA (recombinase polymerase amplification) with simultaneous multiplex isothermal amplification and detection on a solid surface. The isothermal RPA was applied to amplify specific target sequences from the pathogens Neisseria gonorrhoeae, Salmonella enterica and methicillin-resistant Staphylococcus aureus (MRSA) using genomic DNA. Additionally, a positive plasmid control was established as an internal control. The four targets were amplified simultaneously in a quadruplex reaction. The amplicon is labeled during on-chip RPA by reverse oligonucleotide primers coupled to a fluorophore. Both amplification and spatially resolved signal generation take place on immobilized forward primers bount to expoxy-silanized glass surfaces in a pump-driven hybridization chamber. The combination of microarray technology and sensitive isothermal nucleic acid amplification at 38 °C allows for a multiparameter analysis on a rather small area. The on-chip RPA was characterized in terms of reaction time, sensitivity and inhibitory conditions. A successful enzymatic reaction is completed in <20 min and results in detection limits of 10 colony-forming units for methicillin-resistant Staphylococcus aureus and Salmonella enterica and 100 colony-forming units for Neisseria gonorrhoeae. The results show this method to be useful with respect to point-of-care testing and to enable simplified and miniaturized nucleic acid-based diagnostics. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00604-014-1198-5) contains supplementary material, which is available to authorized users.",10.1007/s00604-014-1198-5,huz0tpmi,"['We', 'report', 'on', 'the', 'development', 'of', 'an', 'on', 'chip', 'RPA', 'recombinase', 'polymerase', 'amplification', 'with', 'simultaneous', 'multiplex', 'isothermal', 'amplification', 'and', 'detection', 'on', 'a', 'solid', 'surface', 'The', 'isothermal', 'RPA', 'was', 'applied', 'to', 'amplify', 'specific', 'target', 'sequences', 'from', 'the', 'pathogens', 'Neisseria', 'gonorrhoeae', 'Salmonella', 'enterica', 'and', 'methicillin', 'resistant', 'Staphylococcus', 'aureus', 'MRSA', 'using', 'genomic', 'DNA', 'Additionally', 'a', 'positive', 'plasmid', 'control', 'was', 'established', 'as', 'an', 'internal', 'control', 'The', 'four', 'targets', 'were', 'amplified', 'simultaneously', 'in', 'a', 'quadruplex', 'reaction', 'The', 'amplicon', 'is', 'labeled', 'during', 'on', 'chip', 'RPA', 'by', 'reverse', 'oligonucleotide', 'primers', 'coupled', 'to', 'a', 'fluorophore', 'Both', 'amplification', 'and', 'spatially', 'resolved', 'signal', 'generation', 'take', 'place', 'on', 'immobilized', 'forward', 'primers', 'bount', 'to', 'expoxy', 'silanized', 'glass', 'surfaces', 'in', 'a', 'pump', 'driven', 'hybridization', 'chamber', 'The', 'combination', 'of', 'microarray', 'technology', 'and', 'sensitive', 'isothermal', 'nucleic', 'acid', 'amplification', 'at', '38', 'C', 'allows', 'for', 'a', 'multiparameter', 'analysis', 'on', 'a', 'rather', 'small', 'area', 'The', 'on', 'chip', 'RPA', 'was', 'characterized', 'in', 'terms', 'of', 'reaction', 'time', 'sensitivity', 'and', 'inhibitory', 'conditions', 'A', 'successful', 'enzymatic', 'reaction', 'is', 'completed', 'in', '20', 'min', 'and', 'results', 'in', 'detection', 'limits', 'of', '10', 'colony', 'forming', 'units', 'for', 'methicillin', 'resistant', 'Staphylococcus', 'aureus', 'and', 'Salmonella', 'enterica', 'and', '100', 'colony', 'forming', 'units', 'for', 'Neisseria', 'gonorrhoeae', 'The', 'results', 'show', 'this', 'method', 'to', 'be', 'useful', 'with', 'respect', 'to', 'point', 'of', 'care', 'testing', 'and', 'to', 'enable', 'simplified', 'and', 'miniaturized', 'nucleic', 'acid', 'based', 'diagnostics', 'Figure', 'see', 'text', 'ELECTRONIC', 'SUPPLEMENTARY', 'MATERIAL', 'The', 'online', 'version', 'of', 'this', 'article', 'doi', '10', '1007', 's00604', '014', '1198', '5', 'contains', 'supplementary', 'material', 'which', 'is', 'available', 'to', 'authorized', 'users', '']"
1998,Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein,2015-10-21,PLoS One,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619498/,"BACKGROUND: Current Ebola virus (EBOV) detection methods are costly and impractical for epidemic scenarios. Different immune-based assays have been reported for the detection and quantification of Ebola virus (EBOV) proteins. In particular, several monoclonal antibodies (mAbs) have been described that bind the capsid glycoprotein (GP) of EBOV GP. However, the currently available platforms for the design and production of full-length mAbs are cumbersome and costly. The use of antibody fragments, rather than full-length antibodies, might represent a cost-effective alternative for the development of diagnostic and possibly even therapeutic alternatives for EBOV. METHODS/PRINCIPAL FINDINGS: We report the design and expression of three recombinant anti-GP mAb fragments in Escherichia coli cultures. These fragments contained the heavy and light variable portions of the three well-studied anti-GP full-length mAbs 13C6, 13F6, and KZ52, and are consequently named scFv-13C6, scFv-13F6, and Fab-KZ52, respectively. All three fragments exhibited specific anti-GP binding activity in ELISA experiments comparable to that of full-length anti-GP antibodies (i.e., the same order of magnitude) and they are easily and economically produced in bacterial cultures. CONCLUSION/SIGNIFICANCE: Antibody fragments might represent a useful, effective, and low cost alternative to full-length antibodies in Ebola related capture and diagnostics applications.",10.1371/journal.pone.0135859,m31mb2kr,"['BACKGROUND', 'Current', 'Ebola', 'virus', 'EBOV', 'detection', 'methods', 'are', 'costly', 'and', 'impractical', 'for', 'epidemic', 'scenarios', 'Different', 'immune', 'based', 'assays', 'have', 'been', 'reported', 'for', 'the', 'detection', 'and', 'quantification', 'of', 'Ebola', 'virus', 'EBOV', 'proteins', 'In', 'particular', 'several', 'monoclonal', 'antibodies', 'mAbs', 'have', 'been', 'described', 'that', 'bind', 'the', 'capsid', 'glycoprotein', 'GP', 'of', 'EBOV', 'GP', 'However', 'the', 'currently', 'available', 'platforms', 'for', 'the', 'design', 'and', 'production', 'of', 'full', 'length', 'mAbs', 'are', 'cumbersome', 'and', 'costly', 'The', 'use', 'of', 'antibody', 'fragments', 'rather', 'than', 'full', 'length', 'antibodies', 'might', 'represent', 'a', 'cost', 'effective', 'alternative', 'for', 'the', 'development', 'of', 'diagnostic', 'and', 'possibly', 'even', 'therapeutic', 'alternatives', 'for', 'EBOV', 'METHODS', 'PRINCIPAL', 'FINDINGS', 'We', 'report', 'the', 'design', 'and', 'expression', 'of', 'three', 'recombinant', 'anti', 'GP', 'mAb', 'fragments', 'in', 'Escherichia', 'coli', 'cultures', 'These', 'fragments', 'contained', 'the', 'heavy', 'and', 'light', 'variable', 'portions', 'of', 'the', 'three', 'well', 'studied', 'anti', 'GP', 'full', 'length', 'mAbs', '13C6', '13F6', 'and', 'KZ52', 'and', 'are', 'consequently', 'named', 'scFv', '13C6', 'scFv', '13F6', 'and', 'Fab', 'KZ52', 'respectively', 'All', 'three', 'fragments', 'exhibited', 'specific', 'anti', 'GP', 'binding', 'activity', 'in', 'ELISA', 'experiments', 'comparable', 'to', 'that', 'of', 'full', 'length', 'anti', 'GP', 'antibodies', 'i', 'e', 'the', 'same', 'order', 'of', 'magnitude', 'and', 'they', 'are', 'easily', 'and', 'economically', 'produced', 'in', 'bacterial', 'cultures', 'CONCLUSION', 'SIGNIFICANCE', 'Antibody', 'fragments', 'might', 'represent', 'a', 'useful', 'effective', 'and', 'low', 'cost', 'alternative', 'to', 'full', 'length', 'antibodies', 'in', 'Ebola', 'related', 'capture', 'and', 'diagnostics', 'applications', '']"
2096,Real-Time Reverse Transcription PCR Assay for Detection of Senecavirus A in Swine Vesicular Diagnostic Specimens,2016-01-12,PLoS One,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710529/,"Senecavirus A (SV-A), formerly, Seneca Valley virus (SVV), has been detected in swine with vesicular lesions and is thought to be associated with swine idiopathic vesicular disease (SIVD), a vesicular disease syndrome that lacks a defined causative agent. The clinical presentation of SIVD resembles that of other more contagious and economically devastating vesicular diseases, such as foot-and-mouth disease (FMD), swine vesicular disease (SVD), and vesicular stomatitis (VS), that typically require immediate rule out diagnostics to lift restrictions on animal quarantine, movement, and trade. This study presents the development of a sensitive, SYBR Green RT-qPCR assay suitable for detection of SV-A in diagnostic swine specimens. After testing 50 pigs with clinical signs consistent with vesicular disease, 44 (88%) were found to be positive for SV-A by RT-qPCR as compared to none from a negative cohort of 35 animals without vesicular disease, indicating that the assay is able to successfully detect the virus in an endemic population. SV-A RNA was also detectable at a low level in sera from a subset of pigs that presented with (18%) or without (6%) vesicular signs. In 2015, there has been an increase in the occurrence of SV-A in the US, and over 200 specimens submitted to our laboratory for vesicular investigation have tested positive for the virus using this method. SV-A RNA was detectable in all common types of vesicular specimens including swabs and tissue from hoof lesions, oral and snout epithelium, oral swabs, scabs, and internal organ tissues such as liver and lymph node. Genome sequencing analysis from recent virus isolates was performed to confirm target amplicon specificity and was aligned to previous isolates.",10.1371/journal.pone.0146211,bzwfs0i5,"['Senecavirus', 'A', 'SV', 'A', 'formerly', 'Seneca', 'Valley', 'virus', 'SVV', 'has', 'been', 'detected', 'in', 'swine', 'with', 'vesicular', 'lesions', 'and', 'is', 'thought', 'to', 'be', 'associated', 'with', 'swine', 'idiopathic', 'vesicular', 'disease', 'SIVD', 'a', 'vesicular', 'disease', 'syndrome', 'that', 'lacks', 'a', 'defined', 'causative', 'agent', 'The', 'clinical', 'presentation', 'of', 'SIVD', 'resembles', 'that', 'of', 'other', 'more', 'contagious', 'and', 'economically', 'devastating', 'vesicular', 'diseases', 'such', 'as', 'foot', 'and', 'mouth', 'disease', 'FMD', 'swine', 'vesicular', 'disease', 'SVD', 'and', 'vesicular', 'stomatitis', 'VS', 'that', 'typically', 'require', 'immediate', 'rule', 'out', 'diagnostics', 'to', 'lift', 'restrictions', 'on', 'animal', 'quarantine', 'movement', 'and', 'trade', 'This', 'study', 'presents', 'the', 'development', 'of', 'a', 'sensitive', 'SYBR', 'Green', 'RT', 'qPCR', 'assay', 'suitable', 'for', 'detection', 'of', 'SV', 'A', 'in', 'diagnostic', 'swine', 'specimens', 'After', 'testing', '50', 'pigs', 'with', 'clinical', 'signs', 'consistent', 'with', 'vesicular', 'disease', '44', '88', 'were', 'found', 'to', 'be', 'positive', 'for', 'SV', 'A', 'by', 'RT', 'qPCR', 'as', 'compared', 'to', 'none', 'from', 'a', 'negative', 'cohort', 'of', '35', 'animals', 'without', 'vesicular', 'disease', 'indicating', 'that', 'the', 'assay', 'is', 'able', 'to', 'successfully', 'detect', 'the', 'virus', 'in', 'an', 'endemic', 'population', 'SV', 'A', 'RNA', 'was', 'also', 'detectable', 'at', 'a', 'low', 'level', 'in', 'sera', 'from', 'a', 'subset', 'of', 'pigs', 'that', 'presented', 'with', '18', 'or', 'without', '6', 'vesicular', 'signs', 'In', '2015', 'there', 'has', 'been', 'an', 'increase', 'in', 'the', 'occurrence', 'of', 'SV', 'A', 'in', 'the', 'US', 'and', 'over', '200', 'specimens', 'submitted', 'to', 'our', 'laboratory', 'for', 'vesicular', 'investigation', 'have', 'tested', 'positive', 'for', 'the', 'virus', 'using', 'this', 'method', 'SV', 'A', 'RNA', 'was', 'detectable', 'in', 'all', 'common', 'types', 'of', 'vesicular', 'specimens', 'including', 'swabs', 'and', 'tissue', 'from', 'hoof', 'lesions', 'oral', 'and', 'snout', 'epithelium', 'oral', 'swabs', 'scabs', 'and', 'internal', 'organ', 'tissues', 'such', 'as', 'liver', 'and', 'lymph', 'node', 'Genome', 'sequencing', 'analysis', 'from', 'recent', 'virus', 'isolates', 'was', 'performed', 'to', 'confirm', 'target', 'amplicon', 'specificity', 'and', 'was', 'aligned', 'to', 'previous', 'isolates', '']"
2336,"Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC 2015): Jeddah, Kingdom of Saudi Arabia. 30 November - 3 December 2015",2016-07-20,BMC Genomics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959372/,"O1 Regulation of genes by telomere length over long distances Jerry W. Shay O2 The microtubule destabilizer KIF2A regulates the postnatal establishment of neuronal circuits in addition to prenatal cell survival, cell migration, and axon elongation, and its loss leading to malformation of cortical development and severe epilepsy Noriko Homma, Ruyun Zhou, Muhammad Imran Naseer, Adeel G. Chaudhary, Mohammed Al-Qahtani, Nobutaka Hirokawa O3 Integration of metagenomics and metabolomics in gut microbiome research Maryam Goudarzi, Albert J. Fornace Jr. O4 A unique integrated system to discern pathogenesis of central nervous system tumors Saleh Baeesa, Deema Hussain, Mohammed Bangash, Fahad Alghamdi, Hans-Juergen Schulten, Angel Carracedo, Ishaq Khan, Hanadi Qashqari, Nawal Madkhali, Mohamad Saka, Kulvinder S. Saini, Awatif Jamal, Jaudah Al-Maghrabi, Adel Abuzenadah, Adeel Chaudhary, Mohammed Al Qahtani, Ghazi Damanhouri O5 RPL27A is a target of miR-595 and deficiency contributes to ribosomal dysgenesis Heba Alkhatabi O6 Next generation DNA sequencing panels for haemostatic and platelet disorders and for Fanconi anaemia in routine diagnostic service Anne Goodeve, Laura Crookes, Nikolas Niksic, Nicholas Beauchamp O7 Targeted sequencing panels and their utilization in personalized medicine Adel M. Abuzenadah O8 International biobanking in the era of precision medicine Jim Vaught O9 Biobank and biodata for clinical and forensic applications Bruce Budowle, Mourad Assidi, Abdelbaset Buhmeida O10 Tissue microarray technique: a powerful adjunct tool for molecular profiling of solid tumors Jaudah Al-Maghrabi O11 The CEGMR biobanking unit: achievements, challenges and future plans Abdelbaset Buhmeida, Mourad Assidi, Leena Merdad O12 Phylomedicine of tumors Sudhir Kumar, Sayaka Miura, Karen Gomez O13 Clinical implementation of pharmacogenomics for colorectal cancer treatment Angel Carracedo, Mahmood Rasool O14 From association to causality: translation of GWAS findings for genomic medicine Ahmed Rebai O15 E-GRASP: an interactive database and web application for efficient analysis of disease-associated genetic information Sajjad Karim, Hend F Nour Eldin, Heba Abusamra, Elham M Alhathli, Nada Salem, Mohammed H Al-Qahtani, Sudhir Kumar O16 The supercomputer facility “AZIZ” at KAU: utility and future prospects Hossam Faheem O17 New research into the causes of male infertility Ashok Agarwa O18 The Klinefelter syndrome: recent progress in pathophysiology and management Eberhard Nieschlag, Joachim Wistuba, Oliver S. Damm, Mohd A. Beg, Taha A. Abdel-Meguid, Hisham A. Mosli, Osama S. Bajouh, Adel M. Abuzenadah, Mohammed H. Al-Qahtani O19 A new look to reproductive medicine in the era of genomics Serdar Coskun P1 Wnt signalling receptors expression in Saudi breast cancer patients Muhammad Abu-Elmagd, Abdelbaset Buhmeida, Ashraf Dallol, Jaudah Al-Maghrabi, Sahar Hakamy, Wejdan Al-Qahtani, Asia Al-Harbi, Shireen Hussain, Mourad Assidi, Mohammed Al-Qahtani, Adel Abuzenadah P2 Analysis of oxidative stress interactome during spermatogenesis: a systems biology approach to reproduction Burak Ozkosem, Rick DuBois P3 Interleukin-18 gene variants are strongly associated with idiopathic recurrent pregnancy loss. Safia S Messaoudi, Maryam T Dandana, Touhami Mahjoub, Wassim Y Almawi P4 Effect of environmental factors on gene-gene and gene-environment reactions: model and theoretical study applied to environmental interventions using genotype S. Abdalla, M. Nabil Al-Aama P5 Genomics and transcriptomic analysis of imatinib resistance in gastrointestinal stromal tumor Asmaa Elzawahry, Tsuyoshi Takahashi, Sachiyo Mimaki, Eisaku Furukawa, Rie Nakatsuka, Isao Kurosaka, Takahiko Nishigaki, Hiromi Nakamura, Satoshi Serada, Tetsuji Naka, Seiichi Hirota, Tatsuhiro Shibata, Katsuya Tsuchihara, Toshirou Nishida, Mamoru Kato P6 In-Silico analysis of putative HCV epitopes against Pakistani human leukocyte antigen background: an approach towards development of future vaccines for Pakistani population Sajid Mehmood, Naeem Mahmood Ashraf, Awais Asif, Muhammad Bilal, Malik Siddique Mehmood, Aadil Hussain P7 Inhibition of AChE and BuChE with the natural compounds of Bacopa monerri for the treatment of Alzheimer’s disease: a bioinformatics approach Qazi Mohammad Sajid Jamal, Mughees Uddin Siddiqui, Mohammad A. Alzohairy, Mohammad A. Al Karaawi P8 Her2 expression in urothelial cell carcinoma of the bladder in Saudi Arabia Taoufik Nedjadi, Jaudah Al-Maghrabi, Mourad Assidi, Heba Al-Khattabi, Adel Al-Ammari, Ahmed Al-Sayyad, Abdelbaset Buhmeida, Mohammed Al-Qahtani P9 Association of angiotensinogen single nucleotide polymorphisms with Preeclampsia in patients from North Africa Hédia Zitouni, Nozha Raguema, Marwa Ben Ali, Wided Malah, Raja Lfalah, Wassim Almawi, Touhami Mahjoub P10 Systems biology analysis reveals relations between normal skin, benign nevi and malignant melanoma Mohammed Elanbari, Andrey Ptitsyn P11 The apoptotic effect of thymoquinone in Jurkat cells Sana Mahjoub, Rabeb El Ghali, Bechir Achour, Nidhal Ben Amor, Mourad Assidi, Brahim N'siri, Hamid Morjani P12 Sonic hedgehog contributes in bladder cancer invasion in Saudi Arabia Taoufik Nedjadi, Adel Al-Ammari, Ahmed Al-Sayyad, Nada Salem, Esam Azhar, Jaudah Al-Maghrabi P13 Association of Interleukin 18 gene promoter polymorphisms - 607A/C and -137 G/C with colorectal cancer onset in a sample of Tunisian population Vera Chayeb, Maryam Dendena, Hedia Zitouni, Khedija Zouari-Limayem, Touhami Mahjoub P14 Pathological expression of interleukin-6, -11, leukemia inhibitory factor and their receptors in tubal gestation with and without tubal cytomegalovirus infection Bassem Refaat, Ahmed M Ashshi, Sarah A Batwa P15 Phenotypic and genetic profiling of avian pathogenic and human diarrhegenic Escherichia coli in Egypt Hazem Ramadan, Amal Awad, Ahmed Ateya P16 Cancer-targeting dual gene virotherapy as a promising therapeutic strategy for treatment of hepatocellular carcinoma Adel Galal Ahmed El-Shemi, Ahmad Ashshi, Mohammed Basalamah, Youjin Na, Chae-Ok YUN P17 Cancer dual gene therapy with oncolytic adenoviruses expressing TRAIL and IL-12 transgenes markedly eradicated human hepatocellular carcinoma both in vitro and in vivo Adel Galal Ahmed El-Shemi, Ahmad Ashshi, Mohammed Basalamah, Youjin Na, Chae-Ok Yun P18 Therapy with paricalcitol attenuates tumor growth and augments tumoricidal and anti-oncogenic effects of 5-fluorouracil on animal model of colon cancer Adel Galal El-Shemi, Bassem Refaat, Osama Kensara, Amr Abdelfattah P19 The effects of Rubus idaeus extract on normal human lymphocytes and cancer cell line Batol Imran Dheeb, Mohammed M. F. Al-Halbosiy, Rghad Kadhim Al lihabi, Basim Mohammed Khashman P20 Etanercept, a TNF-alpha inhibitor, alleviates mechanical hypersensitivity and spontaneous pain in a rat model of chemotherapy-induced neuropathic pain Djouhri, Laiche, Chaudhary Adeel, Nedjadi, Taoufik P21 Sleeping beauty mutagenesis system identified genes and neuronal transcription factor network involved in pediatric solid tumour (medulloblastoma) Hani Al-Afghani, Maria Łastowska, Haya H Al-Balool, Harsh Sheth, Emma Mercer, Jonathan M Coxhead, Chris PF Redfern, Heiko Peters, Alastair D Burt, Mauro Santibanez-Koref, Chris M Bacon, Louis Chesler, Alistair G Rust, David J Adams, Daniel Williamson, Steven C Clifford, Michael S Jackson P22 Involvement of interleukin-1 in vitiligo pathogenesis Mala Singh, Mohmmad Shoab Mansuri, Shahnawaz D. Jadeja, Hima Patel, Yogesh S. Marfatia, Rasheedunnisa Begum P23 Cytogenetics abnormalities in 12,884 referred population for chromosomal analysis and the role of FISH in refining the diagnosis (cytogenetic experience 2004-2013) Amal M Mohamed, Alaa K Kamel, Nivin A Helmy, Sayda A Hammad, Hesham F Kayed, Marwa I Shehab, Assad El Gerzawy, Maha M. Ead, Ola M Ead, Mona Mekkawy, Innas Mazen, Mona El-Ruby P24 Analysis of binding properties of angiotensin-converting enzyme 2 through in silico method S. M. A. Shahid, Qazi Mohammad Sajid Jamal, J. M. Arif, Mohtashim Lohani P25 Relationship of genetics markers cis and trans to the β-S globin gene with fetal hemoglobin expression in Tunisian sickle cell patients Moumni Imen, Chaouch Leila, Ouragini Houyem, Douzi Kais, Chaouachi Dorra Mellouli Fethi, Bejaoui Mohamed, Abbes Salem P26 Analysis of estrogen receptor alpha gene polymorphisms in breast cancer: link to genetic predisposition in Sudanese women Areeg Faggad, Amanuel T Gebreslasie, Hani Y Zaki, Badreldin E Abdalla P27 KCNQI gene polymorphism and its association with CVD and T2DM in the Saudi population Maha S AlShammari, Rhaya Al-Ali, Nader Al-Balawi , Mansour Al-Enazi, Ali Al-Muraikhi, Fadi Busaleh, Ali Al-Sahwan, Francis Borgio, Abdulazeez Sayyed, Amein Al-Ali, Sadananda Acharya P28 Clinical, neuroimaging and cytogenetic study of a patient with microcephaly capillary malformation syndrome Maha S. Zaki, Hala T. El-Bassyouni, Marwa I. Shehab P29 Altered expression of CD200R1 on dendritic cells of patients with inflammatory bowel diseases: in silico investigations and clinical evaluations Mohammed F. Elshal, Kaleemuddin M., Alia M. Aldahlawi, Omar Saadah, J. Philip McCoy P30 Development of real time PCR diagnostic protocol specific for the Saudi Arabian H1N1 viral strains Adel E El-Tarras, Nabil S Awad, Abdulla A Alharthi, Mohamed M M Ibrahim P31 Identification of novel genetic variations affecting Osteoarthritis patients Haneen S Alsehli, Ashraf Dallol, Abdullah M Gari, Mohammed M Abbas, Roaa A Kadam, Mazen M. Gari, Mohmmed H Alkaff, Adel M Abuzenadah, Mamdooh A Gari P32 An integrated database of GWAS SNVs and their evolutionary properties Heba Abusamra, Sajjad Karim, Hend F Nour eldin, Elham M Alhathli, Nada Salem, Sudhir Kumar, Mohammed H Al-Qahtani P33 Familial hypercholesterolemia in Saudi Arabia: prime time for a national registry and genetic analysis Fatima A. Moradi, Omran M. Rashidi, Zuhier A. Awan P34 Comparative genomics and network-based analyses of early hepatocellular carcinoma Ibrahim Hamza Kaya, Olfat Al-Harazi, Dilek Colak P35 A TALEN-based oncolytic viral vector approach to knock out ABCB1 gene mediated chemoresistance in cancer stem cells Nabila A Alkousi, Takis Athanasopoulos P36 Cartilage differentiation and gene expression of synovial fluid mesenchymal stem cells derived from osteoarthritis patients Afnan O Bahmaid, Etimad A Alhwait, Mamdooh A Gari, Haneen S Alsehli, Mohammed M Abbas, Mohammed H Alkaf, Roaa Kadam, Ashraf Dallol, Gauthaman Kalamegam P37 E-GRASP: Adding an evolutionary component to the genome-wide repository of associations (GRASP) resource Hend F Nour Eldin, Sajjad Karim, Heba Abusamra, Elham Alhathli, Nada Salem, Mohammed H Al-Qahtani, Sudhir Kumar P38 Screening of AGL gene mutation in Saudi family with glycogen storage disease Type III Salma N Alsayed, Fawziah H Aljohani, Samaher M Habeeb, Rawan A Almashali, Sulman Basit, Samia M Ahmed P39 High throughput proteomic data suggest modulation of cAMP dependent protein kinase A and mitochondrial function in infertile patients with varicocele Rakesh Sharma, Ashok Agarwal, Damayanthi Durairajanayagam, Luna Samanta, Muhammad Abu-Elmagd, Adel M. Abuzenadah, Edmund S. Sabanegh, Mourad Assidi, Mohammed Al-Qahtani P40 Significant protein profile alterations in men with primary and secondary infertility Ashok Agarwal, Rakesh Sharma, Luna Samanta, Damayanthi Durairajanayagam, Mourad Assidi, Muhammad Abu-Elmagd, Mohammed Al-Qahtani, Adel M. Abuzenadah, Edmund S. Sabanegh P41 Spermatozoa maturation in infertile patients involves compromised expression of heat shock proteins Luna Samanta, Ashok Agarwal, Rakesh Sharma, Zhihong Cui, Mourad Assidi, Adel M. Abuzenadah, Muhammad Abu-Elmagd, Mohammed Al-Qahtani P42 Array comparative genomic hybridization approach to search genomic answers for spontaneous recurrent abortion in Saudi Arabia Alaa A Alboogmi, Nuha A Alansari, Maha M Al-Quaiti, Fai T Ashgan, Afnan Bandah, Hasan S Jamal, Abdullraheem Rozi(,) Zeenat Mirza, Adel M Abuzenadah, Sajjad Karim, Mohammed H Al-Qahtani P43 Global gene expression profiling of Saudi kidney cancer patients Sajjad Karim, Hans-Juergen Schulten, Ahmad J Al Sayyad, Hasan MA Farsi, Jaudah A Al-Maghrabi, Zeenat Mirza, Reem Alotibi, Alaa Al-Ahmadi, Nuha A Alansari, Alaa A Albogmi, Maha M Al-Quaiti, Fai T Ashgan, Afnan Bandah, Mohammed H Al-Qahtani P44 Downregulated StAR gene and male reproductive dysfunction caused by nifedipine and ethosuximide Rasha A Ebiya, Samia M Darwish, Metwally M. Montaser P45 Clustering based gene expression feature selection method: A computational approach to enrich the classifier efficiency of differentially expressed genes Heba Abusamra, Vladimir B. Bajic P46 Prognostic significance of Osteopontin expression profile in colorectal carcinoma Jaudah Al-Maghrabi, Wafaey Gomaa, Mehenaz Hanbazazh, Mahmoud Al-Ahwal, Asia Al-Harbi, Wejdan Al-Qahtani, Saher Hakamy, Ghali Baba, Abdelbaset Buhmeida, Mohammed Al-Qahtani P47 High Glypican-3 expression pattern predicts longer disease-specific survival in colorectal carcinoma Jaudah Al-Maghrabi, Abdullah Al-Harbi, Mahmoud Al-Ahwal, Asia Al-Harbi, Wejdan Al-Qahtani, Sahar Hakamy, Ghalia Baba, Abdelbaset Buhmeida, Mohammed Al-Qahtani P48 An evolutionary re-assessment of GWAS single nucleotide variants implicated in the Cholesterol traits Elham M Alhathli, Sajjad Karim, Nada Salem, Hend Nour Eldin, Heba Abusamra, Sudhir Kumar, Mohammed H Al-Qahtani P49 Derivation and characterization of human Wharton’s jelly stem cells (hWJSCs) in vitro for future therapeutic applications Aisha A Alyamani, Gauthaman Kalamegam, Etimad A Alhwait, Mamdooh A Gari, Mohammed M Abbas, Mohammed H Alkaf, Haneen S Alsehli, Roaa A Kadam, Mohammed Al-Qahtani P50 Attitudes of healthcare students toward biomedical research in the post-genomic era Rawan Gadi, Abdelbaset Buhmeida, Mourad Assidi , Adeel Chaudhary, Leena Merdad P51 Evaluation of the immunomodulatory effects of thymoquinone on human bone marrow mesenchymal stem cells (BM-MSCs) from osteoarthritic patients Saadiah M Alfakeeh, Etimad A Alhwait, Mamdooh A Gari, Mohammed M Abbas, Mohammed H Alkaf, Haneen S Alsehli, Roaa Kadam, Gauthaman Kalamegam P52 Implication of IL-10 and IL-28 polymorphism with successful anti-HCV therapy and viral clearance Rubi Ghazala, Shilu Mathew, M.Haroon Hamed, Mourad Assidi, Mohammed Al-Qahtani, Ishtiaq Qadri P53 Selection of flavonoids against obesity protein (FTO) using in silico and in vitro approaches Shilu Mathew, Lobna Mira, Manal Shaabad, Shireen Hussain, Mourad Assidi, Muhammad Abu-Elmagd, Mohammed Al-Qahtani P54 Computational selection and in vitro validation of flavonoids as new antidepressant agents Shilu Mathew, Manal Shaabad, Lobna Mira, Shireen Hussain, Mourad Assidi, Muhammad Abu-Elmagd, Mohammed Al-Qahtani P55 In Silico prediction and prioritization of aging candidate genes associated with progressive telomere shortening Ahmed Rebai, Mourad Assidi, Abdelbaset Buhmeida, Muhammad Abu-Elmagd, Ashraf Dallol, Jerry W Shay P56 Identification of new cancer testis antigen genes in diverse types of malignant human tumour cells Mikhlid H Almutairi P57 More comprehensive forensic genetic marker analyses for accurate human remains identification using massively parallel sequencing (MPS) Angie Ambers, Jennifer Churchill, Jonathan King, Monika Stoljarova, Harrell Gill-King, Mourad Assidi, Muhammad Abu-Elmagd, Abdelbaset Buhmeida, Muhammad Al-Qatani, Bruce Budowle P58 Flow cytometry approach towards treatment men infertility in Saudi Arabia Muhammad Abu-Elmagd, Farid Ahmed, Ashraf Dallol, Mourad Assidi, Taha Abo Almagd, Sahar Hakamy, Ashok Agarwal, Muhammad Al-Qahtani, Adel Abuzenadah P59 Tissue microarray based validation of CyclinD1 expression in renal cell carcinoma of Saudi kidney patients Sajjad Karim, Hans-Juergen Schulten, Ahmad J Al Sayyad, Hasan MA Farsi, Jaudah A Al-Maghrabi, Abdelbaset Buhmaida, Zeenat Mirza, Reem Alotibi, Alaa Al-Ahmadi, Nuha A Alansari, Alaa A Albogmi, Maha M Al-Quaiti, Fai T Ashgan, Afnan Bandah, Mohammed H Al-Qahtani P60 Assessment of gold nanoparticles in molecular diagnostics and DNA damage studies Rukhsana Satar, Mahmood Rasool, Waseem Ahmad, Nazia Nazam, Mohamad I Lone, Muhammad I Naseer, Mohammad S Jamal, Syed K Zaidi, Peter N Pushparaj, Mohammad A Jafri, Shakeel A Ansari, Mohammed H Alqahtani P61 Surfing the biospecimen management and processing workflow at CEGMR Biobank Hanan Bashier, Abrar Al Qahtani, Shilu Mathew, Amal M. Nour, Heba Alkhatabi, Adel M. Abu Zenadah, Abdelbaset Buhmeida, Mourad Assidi, Muhammed Al Qahtani P62 Autism Spectrum Disorder: knowledge, attitude and awareness in Jeddah, Kingdom of Saudi Arabia Muhammad Faheem, Shilu Mathew, Shiny Mathew, Peter Natesan Pushparaj, Mohammad H. Al-Qahtani P63 Simultaneous genetic screening of the coagulation pathway genes using the Thromboscan targeted sequencing panel Hani A. Alhadrami, Ashraf Dallol, Adel Abuzenadah P64 Genome wide array comparative genomic hybridization analysis in patients with syndromic congenital heart defects Ibtessam R. Hussein, Adeel G. Chaudhary, Rima S Bader, Randa Bassiouni, Maha Alquaiti, Fai Ashgan, Hans Schulten, Mohamed Nabil Alama, Mohammad H. Al Qahtani P65 Toxocogenetic evaluation of 1, 2-Dichloroethane in bone marrow, blood and cells of immune system using conventional, molecular and flowcytometric approaches Mohammad I Lone, Nazia Nizam, Waseem Ahmad, Mohammad A Jafri, Mahmood Rasool, Shakeel A Ansari, Muhammed H Al-Qahtani P66 Molecular cytogenetic diagnosis of sexual development disorders in newborn: A case of ambiguous genitalia Eradah Alshihri, Muhammad Abu-Elmagd, Lina Alharbi, Mourad Assidi, Mohammed Al-Qahtani P67 Identification of disease specific gene expression clusters and pathways in hepatocellular carcinoma using In Silico methodologies Shilu Mathew, Peter Pushparaj Natesan, Muhammed Al Qahtani P68 Human Wharton’s Jelly stem cell conditioned medium inhibits primary ovarian cancer cells in vitro: Identification of probable targets and mechanisms using systems biology Gauthaman Kalamegam, Peter Natesan Pushparaj, Fazal Khan, Roaa Kadam, Farid Ahmed, Mourad Assidi, Khalid Hussain Wali Sait, Nisreen Anfinan, Mohammed Al Qahtani P69 Mutation spectrum of ASPM (Abnormal Spindle-like, Microcephaly-associated) gene in Saudi Arabian population Muhammad I Naseer, Adeel G Chaudhary, Mohammad S Jamal, Shilu Mathew, Lobna S Mira, Peter N Pushparaj, Shakeel A Ansari, Mahmood Rasool, Mohammed H AlQahtani P70 Identification and characterization of novel genes and mutations of primary microcephaly in Saudi Arabian population Muhammad I Naseer, Adeel G Chaudhary, Shilu Mathew, Lobna S Mira, Mohammad S Jamal, Sameera Sogaty, Randa I Bassiouni, Mahmood Rasool, Mohammed H AlQahtani P71 Molecular genetic analysis of hereditary nonpolyposis colorectal cancer (Lynch Syndrome) in Saudi Arabian population Mahmood Rasool, Shakeel A Ansari, Mohammad S Jamal, Peter N Pushparaj, Abdulrahman MS Sibiani, Waseem Ahmad, Abdelbaset Buhmeida, Mohammad A Jafri, Mohiuddin K Warsi, Muhammad I Naseer, Mohammed H Al-Qahtani P72 Function predication of hypothetical proteins from genome database of chlamydia trachomatis Rubi, Kundan Kumar, Ahmad AT Naqvi, Faizan Ahmad, Md I Hassan, Mohammad S Jamal, Mahmood Rasool, Mohammed H AlQahtani P73 Transcription factors as novel molecular targets for skin cancer Ashraf Ali, Jummanah Jarullah, Mahmood Rasool, Abdelbasit Buhmeida, Shahida Khan, Ghufrana Abdussami, Maryam Mahfooz, Mohammad A Kamal, Ghazi A Damanhouri, Mohammad S Jamal P74 An In Silico analysis of Plumbagin binding to apoptosis executioner: Caspase-3 and Caspase-7 Bushra Jarullah, Jummanah Jarullah, Mohammad SS Jarullah, Ashraf Ali, Mahmood Rasool, Mohammad S Jamal P75 Single cell genomics applications for preimplantation genetic screening optimization: Comparative analysis of whole genome amplification technologies Mourad Assidi, Muhammad Abu-Elmagd, Osama Bajouh, Peter Natesan Pushparaj, Mohammed Al-Qahtani, Adel Abuzenadah P76 ZFP36 regulates miRs-34a in anti-IgM triggered immature B cells Mohammad S Jamal, Jummanah Jarullah, Abdulah EA Mathkoor, Hashim MA Alsalmi, Anas MM Oun, Ghazi A Damanhauri, Mahmood Rasool, Mohammed H AlQahtani P77 Identification of a novel mutation in the STAMBP gene in a family with microcephaly-capillary malformation syndrome Muhammad I. Naseer, Mahmood Rasool, Sameera Sogaty, Adeel G. Chudhary, Yousif A. Abutalib, Daniele Merico, Susan Walker, Christian R. Marshall, Mehdi Zarrei, Stephen W. Scherer, Mohammad H. Al-Qahtani P78 Copy number variations in Saudi patients with intellectual disability and epilepsy Muhammad I. Naseer, Muhammad Faheem, Adeel G. Chaudhary, Mahmood Rasool, Gauthaman Kalamegam, Fai Talal Ashgan, Mourad Assidi, Farid Ahmed, Syed Kashif Zaidi, Mohammed M. Jan, Mohammad H. Al-Qahtani P79 Prognostic significance of CD44 expression profile in colorectal carcinoma Maryam Al-Zahrani, Sahira Lary, Sahar Hakamy, Ashraf Dallol, Mahmoud Al-Ahwal, Jaudah Al-Maghrabi, Emmanuel Dermitzakis, Adel Abuzenadah, Abdelbaset Buhmeida, Mohammed Al-Qahtani P80 Association of the endothelial nitric oxide synthase (eNOS) gene G894T polymorphism with hypertension risk and complications Abeer A Al-refai, Mona Saleh, Rehab I Yassien, Mahmmoud Kamel, Rabab M Habeb P81 SNPs array to screen genetic variation among diabetic patients Najlaa Filimban, Ashraf Dallol, Nadia Ghannam, Mohammed Al-Qahtani, Adel Mohammed Abuzenadah P82 Detection and genotyping of Helicobacter pylori among gastric cancer patients from Saudi Arabian population Fehmida Bibi, Sana Akhtar, Esam I. Azhar, Muhammad Yasir, Muhammad I. Nasser, Asif A. Jiman-Fatani, Ali Sawan P83 Antimicrobial drug resistance and molecular detection of susceptibility to Fluoroquinolones among clinical isolates of Salmonella species from Jeddah-Saudi Arabia Ruaa A Lahzah, Asho Ali P84 Identification of the toxic and virulence nature of MAP1138c protein of Mycobacterium avium subsp. paratuberculosis Syed A Hassan, Seyed E Hasnain, Iftikhar A Tayubi, Hamza A Abujabal, Alaa O Magrabi P85 In vitro and in silico evaluation of miR137 in human breast cancer Fazal Khan, Gauthaman Kalamegam, Peter Natesan Pushparaj, Adel Abuzenada, Taha Abduallah Kumosani, Elie Barbour, Mohammed Al-Qahtani P86 Auruka gene is over-expressed in Saudi breast cancer Manal Shabaad, Shilu Mathew, Ashraf Dallol, Adnan Merdad, Abdelbaset Buhmeida, Mohammed Al-Qahtani P87 The potential of immunogenomics in personalized healthcare Mourad Assidi, Muhammad Abu-Elmagd, Kalamegam Gauthaman, Mamdooh Gari, Adeel Chaudhary, Adel Abuzenadah, Peter Natesan Pushparaj, Mohammed Al-Qahtani P88 In Silico physiochemical and structural characterization of a putative ORF MAP0591 and its implication in the pathogenesis of Mycobacterium paratuberculosis in ruminants and humans Syed A Hassan, Iftikhar A Tayubi, Hani MA Aljahdali P89 Effects of heat shock on human bone marrow mesenchymal stem cells (BM-MSCs): Implications in regenerative medicine Reham Al Nono, Mamdooh Gari, Haneen Alsehli, Farid Ahmed, Mohammed Abbas, Gauthaman Kalamegam, Mohammed Al-Qahtani P90 In Silico analyses of the molecular targets of Resveratrol unravels its importance in mast cell mediated allergic responses Shilu Mathew, Fazal Khan, Mahmood Rasool, Mohammed Sarwar Jamal, Muhammad Imran Naseer, Zeenat Mirza, Sajjad Karim, Shakeel Ansari, Mourad Assidi, Gauthaman Kalamegam, Mamdooh Gari, Adeel Chaudhary, Adel Abuzenadah, Peter Natesan Pushparaj, Mohammed Al-Qahtani P91 Effects of environmental particulate matter on bone-marrow mesenchymal stem cells Muhammad Abu-Elmagd, Gauthaman Kalamegam, Roaa Kadam, Mansour A Alghamdi, Magdy Shamy, Max Costa, Mamdouh I Khoder, Mourad Assidi, Peter Natesan Pushparaj, Mamdooh Gari, Mohammed Al-Qahtani P92 Distinctive charge clusters in human virus proteomes Najla Kharrat, Sabrine Belmabrouk, Rania Abdelhedi, Riadh Benmarzoug, Mourad Assidi, Mohammed H. Al Qahtani, Ahmed Rebai P93 In vitro experimental model and approach in identification of new biomarkers of inflammatory forms of arthritis Ghazi Dhamanhouri, Peter Natesan Pushparaj, Abdelwahab Noorwali, Mohammad Khalid Alwasiyah, Afnan Bahamaid, Saadiah Alfakeeh, Aisha Alyamani, Haneen Alsehli, Mohammed Abbas, Mamdooh Gari, Ali Mobasheri, Gauthaman Kalamegam, Mohammed Al-Qahtani P94 Molecular docking of GABA(A) receptor subunit γ-2 with novel anti-epileptic compounds Muhammad Faheem, Shilu Mathew, Peter Natesan Pushparaj, Mohammad H. Al-Qahtani P95 Breast cancer knowledge, awareness, and practices among Saudi females residing in Jeddah Shilu Mathew, Muhammad Faheem, Shiny Mathew, Peter Natesan Pushparaj, Mohammad H. Al-Qahtani P96 Anti-inflammatory role of Sesamin by Attenuation of Iba1/TNF-α/ICAM-1/iNOS signaling in Diabetic Retinopathy Mohammad Sarwar Jamal, Syed Kashif Zaidi, Raziuddin Khan, Kanchan Bhatia, Mohammed H. Al-Qahtani, Saif Ahmad P97 Identification of drug lead molecule against vp35 protein of Ebola virus: An In-Silico approach Iftikhar AslamTayubi, Manish Tripathi, Syed Asif Hassan, Rahul Shrivastava P98 An approach to personalized medicine from SNP-calling through disease analysis using whole exome-sequencing of three sub-continental populations Iftikhar A Tayubi, Syed Hassan, Hamza A.S Abujabal P99 Low versus high frequency of Glucose –6 – Phosphate Dehydrogenase (G6PD) deficiency in urban against tribal population of Gujarat – A signal to natural selection Ishani Shah, Bushra Jarullah, Mohammad S Jamal, Jummanah Jarullah P100 Spontaneous preterm birth and single nucleotide gene polymorphisms: a recent update Ishfaq A Sheikh, Ejaz Ahmad, Mohammad S Jamal, Mohd Rehan, Muhammad Abu-Elmagd, Iftikhar A Tayubi, Samera F AlBasri, Osama S Bajouh, Rola F Turki, Adel M Abuzenadah, Ghazi A Damanhouri, Mohd A Beg, Mohammed Al-Qahtani P101 Prevalence of congenital heart diseases among Down syndrome cases in Saudi Arabia: role of molecular genetics in the pathogenesis Sahar AF Hammoudah, Khalid M AlHarbi, Lama M El-Attar, Ahmed MZ Darwish P102 Combinatorial efficacy of specific pathway inhibitors in breast cancer cells Sara M Ibrahim, Ashraf Dallol(,) Hani Choudhry, Adel Abuzenadah, Jalaludden Awlia, Adeel Chaudhary, Farid Ahmed, Mohammed Al-Qahtani P103 MiR-143 and miR-145 cluster as potential replacement medicine for the treatment of cancer Mohammad A Jafri, Muhammad Abu-Elmagd, Mourad Assidi, Mohammed Al-Qahtani P104 Metagenomic profile of gut microbiota during pregnancy in Saudi population Imran khan, Muhammad Yasir, Esam I. Azhar, Sameera Al-basri, Elie Barbour, Taha Kumosani P105 Exploration of anticancer targets of selected metabolites of Phoenix dactylifera L. using systems biological approaches Fazal Khan, Gauthaman Kalamegam, Peter Natesan Pushparaj, Adel Abuzenada, Taha Abduallah Kumosani, Elie Barbour P106 CD226 and CD40 gene polymorphism in susceptibility to Juvenile rheumatoid arthritis in Egyptian patients Heba M. EL Sayed, Eman A. Hafez P107 Paediatric exome sequencing in autism spectrum disorder ascertained in Saudi families Hans-Juergen Schulten, Aisha Hassan Elaimi, Ibtessam R Hussein, Randa Ibrahim Bassiouni, Mohammad Khalid Alwasiyah, Richard F Wintle, Adeel Chaudhary, Stephen W Scherer, Mohammed Al-Qahtani P108 Crystal structure of the complex formed between Phospholipase A(2) and the central core hydrophobic fragment of Alzheimer’s β- amyloid peptide: a reductionist approach Zeenat Mirza, Vikram Gopalakrishna Pillai, Sajjad Karim, Sujata Sharma, Punit Kaur, Alagiri Srinivasan, Tej P Singh, Mohammed Al-Qahtani P109 Differential expression profiling between meningiomas from female and male patients Reem Alotibi, Alaa Al-Ahmadi, Fatima Al-Adwani, Deema Hussein, Sajjad Karim, Mona Al-Sharif, Awatif Jamal, Fahad Al-Ghamdi, Jaudah Al-Maghrabi, Saleh S Baeesa, Mohammed Bangash, Adeel Chaudhary, Hans-Juergen Schulten, Mohammed Al-Qahtani P110 Neurospheres as models of early brain development and therapeutics Muhammad Faheem, Peter Natesan Pushparaj, Shilu Mathew, Taha Abdullah Kumosani, Gauthaman Kalamegam, Mohammed Al-Qahtani P111 Identification of a recurrent causative missense mutation p.(W577C) at the LDLR exon 12 in familial hypercholesterolemia affected Saudi families Faisal A Al-Allaf, Zainularifeen Abduljaleel, Abdullah Alashwal, Mohiuddin M. Taher, Abdellatif Bouazzaoui, Halah Abalkhail, Faisal A. Ba-Hammam, Mohammad Athar P112 Epithelial ovarian carcinoma (EOC): Systems oncological approach to identify diagnostic, prognostic and therapeutic biomarkers Gauthaman Kalamegam, Peter Natesan Pushparaj, Muhammad Abu-Elmagd, Farid Ahmed Khalid HussainWali Sait, Nisreen Anfinan, Mamdooh Gari, Adeel Chaudhary, Adel Abuzenadah, Mourad Assidi, Mohammed Al-Qahtani P113 Crohn’s disease phenotype in northern Tunisian population Naira Ben Mami, Yosr Z Haffani, Mouna Medhioub, Lamine Hamzaoui, Ameur Cherif, Msadok Azouz P114 Establishment of In Silico approaches to decipher the potential toxicity and mechanism of action of drug candidates and environmental agents Gauthaman Kalamegam, Fazal Khan, Shilu Mathew, Mohammed Imran Nasser, Mahmood Rasool, Farid Ahmed, Peter Natesan Pushparaj, Mohammed Al-Qahtani P115 1q Gain predicts poor prognosis marker for young breast cancer patients Shereen A Turkistany, Lina M Al-harbi, Ashraf Dallol, Jamal Sabir, Adeel Chaudhary, Adel Abuzenadah P116 Disorders of sex chromosomes in a diagnostic genomic medicine unit in Saudi Arabia: Prevalence, diagnosis and future guidelines Basmah Al-Madoudi, Bayan Al-Aslani, Khulud Al-Harbi, Rwan Al-Jahdali, Hanadi Qudaih, Emad Al Hamzy, Mourad Assidi, Mohammed Al Qahtani P117 Combination of WYE354 and Sunitinib demonstrate synergistic inhibition of acute myeloid leukemia in vitro Asad M Ilyas, Youssri Ahmed, Mamdooh Gari, Farid Ahmed, Mohammed Alqahtani P118 Integrated use of evolutionary information in GWAS reveals important SNPs in Asthma Nada Salem, Sajjad Karim, Elham M Alhathli, Heba Abusamra, Hend F Nour Eldin, Mohammed H Al-Qahtani, Sudhir Kumar P119 Assessment of BRAF, IDH1, IDH2, and EGFR mutations in a series of primary brain tumors Fatima Al-Adwani, Deema Hussein, Mona Al-Sharif, Awatif Jamal, Fahad Al-Ghamdi, Jaudah Al-Maghrabi, Saleh S Baeesa, Mohammed Bangash, Adeel Chaudhary, Mohammed Al-Qahtani, Hans-Juergen Schulten P120 Expression profiles distinguish oligodendrogliomas from glioblastoma multiformes with or without oligodendroglioma component Alaa Alamandi, Reem Alotibi, Deema Hussein, Sajjad Karim, Jaudah Al-Maghrabi, Fahad Al-Ghamdi, Awatif Jamal, Saleh S Baeesa, Mohammed Bangash, Adeel Chaudhary, Hans-Juergen Schulten, Mohammed Al-Qahtani P121 Hierarchical clustering in thyroid goiters and hyperplastic lesions Ohoud Subhi, Nadia Bagatian, Sajjad Karim, Adel Al-Johari, Osman Abdel Al-Hamour, Hosam Al-Aradati, Abdulmonem Al-Mutawa, Faisal Al-Mashat, Jaudah Al-Maghrabi, Hans-Juergen Schulten, Mohammad Al-Qahtani P122 Differential expression analysis in thyroiditis and papillary thyroid carcinomas with or without coexisting thyroiditis Nadia Bagatian, Ohoud Subhi, Sajjad Karim, Adel Al-Johari, Osman Abdel Al-Hamour, Abdulmonem Al-Mutawa, Hosam Al-Aradati, Faisal Al-Mashat, Mohammad Al-Qahtani, Hans-Juergen Schulten, Jaudah Al-Maghrabi P123 Metagenomic analysis of waste water microbiome in Sausdi Arabia Muhammad W shah, Muhammad Yasir, Esam I Azhar, Saad Al-Masoodi P124 Molecular characterization of Helicobacter pylori from faecal samples of Tunisian patients with gastric cancer Yosr Z Haffani, Msadok Azouz, Emna Khamla, Chaima Jlassi, Ahmed S. Masmoudi, Ameur Cherif, Lassaad Belbahri P125 Diagnostic application of the oncoscan(©) panel for the identification of hereditary cancer syndrome Shadi Al-Khayyat, Roba Attas, Atlal Abu-Sanad, Mohammed Abuzinadah, Adnan MerdadAshraf Dallol, Adeel Chaudhary, Mohammed Al-Qahtani, Adel Abuzenadah P126 Characterization of clinical and neurocognitive features in a family with a novel OGT gene missense mutation c. 1193G > A/ (p. Ala319Thr) Habib Bouazzi, Carlos Trujillo, Mohammad Khalid Alwasiyah, Mohammed Al-Qahtani P127 Case report: a rare homozygous deletion mutation of TMEM70 gene associated with 3-Methylglutaconic Aciduria and cataract in a Saudi patient Maha Alotaibi, Rami Nassir P128 Isolation and purification of antimicrobial milk proteins Ishfaq A Sheikh, Mohammad A Kamal, Essam H Jiffri, Ghulam M Ashraf, Mohd A Beg P129 Integrated analysis reveals association of ATP8B1 gene with colorectal cancer Mohammad A Aziz, Rizwan Ali, Mahmood Rasool, Mohammad S Jamal, Nusaibah samman, Ghufrana Abdussami, Sathish Periyasamy, Mohiuddin K Warsi, Mohammed Aldress, Majed Al Otaibi, Zeyad Al Yousef, Mohamed Boudjelal, Abdelbasit Buhmeida, Mohammed H Al-Qahtani, Ibrahim AlAbdulkarim P130 Implication of IL-10 and IL-28 polymorphism with successful anti-HCV therapy and viral clearance Rubi Ghazala, Shilu Mathew, M. Haroon Hamed, Mourad Assidi, Mohammed Al-Qahtani, Ishtiaq Qadri P131 Interactions of endocrine disruptor di-(2-ethylhexyl) phthalate (DEHP) and its metabolite mono-2-ethylhexyl phthalate (MEHP) with progesterone receptor Ishfaq A Sheikh, Muhammad Abu-Elmagd, Rola F Turki, Ghazi A Damanhouri, Mohd A. Beg P132 Association of HCV nucleotide polymorphism in the development of hepatocellular carcinoma Mohd Suhail, Abid Qureshi, Adil Jamal, Peter Natesan Pushparaj, Mohammad Al-Qahtani, Ishtiaq Qadri P133 Gene expression profiling by DNA microarrays in colon cancer treated with chelidonine alkaloid Mahmoud Z El-Readi, Safaa Y Eid, Michael Wink P134 Successful in vitro fertilization after eight failed trials Ahmed M. Isa, Lulu Alnuaim, Johara Almutawa, Basim Abu-Rafae, Saleh Alasiri, Saleh Binsaleh P135 Genetic sensitivity analysis using SCGE, cell cycle and mitochondrial membrane potential in OPs stressed leukocytes in Rattus norvegicus through flow cytometric input Nazia Nazam, Mohamad I Lone, Waseem Ahmad, Shakeel A Ansari, Mohamed H Alqahtani",10.1186/s12864-016-2858-0,pd1g119c,"['O1', 'Regulation', 'of', 'genes', 'by', 'telomere', 'length', 'over', 'long', 'distances', 'Jerry', 'W', 'Shay', 'O2', 'The', 'microtubule', 'destabilizer', 'KIF2A', 'regulates', 'the', 'postnatal', 'establishment', 'of', 'neuronal', 'circuits', 'in', 'addition', 'to', 'prenatal', 'cell', 'survival', 'cell', 'migration', 'and', 'axon', 'elongation', 'and', 'its', 'loss', 'leading', 'to', 'malformation', 'of', 'cortical', 'development', 'and', 'severe', 'epilepsy', 'Noriko', 'Homma', 'Ruyun', 'Zhou', 'Muhammad', 'Imran', 'Naseer', 'Adeel', 'G', 'Chaudhary', 'Mohammed', 'Al', 'Qahtani', 'Nobutaka', 'Hirokawa', 'O3', 'Integration', 'of', 'metagenomics', 'and', 'metabolomics', 'in', 'gut', 'microbiome', 'research', 'Maryam', 'Goudarzi', 'Albert', 'J', 'Fornace', 'Jr', 'O4', 'A', 'unique', 'integrated', 'system', 'to', 'discern', 'pathogenesis', 'of', 'central', 'nervous', 'system', 'tumors', 'Saleh', 'Baeesa', 'Deema', 'Hussain', 'Mohammed', 'Bangash', 'Fahad', 'Alghamdi', 'Hans', 'Juergen', 'Schulten', 'Angel', 'Carracedo', 'Ishaq', 'Khan', 'Hanadi', 'Qashqari', 'Nawal', 'Madkhali', 'Mohamad', 'Saka', 'Kulvinder', 'S', 'Saini', 'Awatif', 'Jamal', 'Jaudah', 'Al', 'Maghrabi', 'Adel', 'Abuzenadah', 'Adeel', 'Chaudhary', 'Mohammed', 'Al', 'Qahtani', 'Ghazi', 'Damanhouri', 'O5', 'RPL27A', 'is', 'a', 'target', 'of', 'miR', '595', 'and', 'deficiency', 'contributes', 'to', 'ribosomal', 'dysgenesis', 'Heba', 'Alkhatabi', 'O6', 'Next', 'generation', 'DNA', 'sequencing', 'panels', 'for', 'haemostatic', 'and', 'platelet', 'disorders', 'and', 'for', 'Fanconi', 'anaemia', 'in', 'routine', 'diagnostic', 'service', 'Anne', 'Goodeve', 'Laura', 'Crookes', 'Nikolas', 'Niksic', 'Nicholas', 'Beauchamp', 'O7', 'Targeted', 'sequencing', 'panels', 'and', 'their', 'utilization', 'in', 'personalized', 'medicine', 'Adel', 'M', 'Abuzenadah', 'O8', 'International', 'biobanking', 'in', 'the', 'era', 'of', 'precision', 'medicine', 'Jim', 'Vaught', 'O9', 'Biobank', 'and', 'biodata', 'for', 'clinical', 'and', 'forensic', 'applications', 'Bruce', 'Budowle', 'Mourad', 'Assidi', 'Abdelbaset', 'Buhmeida', 'O10', 'Tissue', 'microarray', 'technique', 'a', 'powerful', 'adjunct', 'tool', 'for', 'molecular', 'profiling', 'of', 'solid', 'tumors', 'Jaudah', 'Al', 'Maghrabi', 'O11', 'The', 'CEGMR', 'biobanking', 'unit', 'achievements', 'challenges', 'and', 'future', 'plans', 'Abdelbaset', 'Buhmeida', 'Mourad', 'Assidi', 'Leena', 'Merdad', 'O12', 'Phylomedicine', 'of', 'tumors', 'Sudhir', 'Kumar', 'Sayaka', 'Miura', 'Karen', 'Gomez', 'O13', 'Clinical', 'implementation', 'of', 'pharmacogenomics', 'for', 'colorectal', 'cancer', 'treatment', 'Angel', 'Carracedo', 'Mahmood', 'Rasool', 'O14', 'From', 'association', 'to', 'causality', 'translation', 'of', 'GWAS', 'findings', 'for', 'genomic', 'medicine', 'Ahmed', 'Rebai', 'O15', 'E', 'GRASP', 'an', 'interactive', 'database', 'and', 'web', 'application', 'for', 'efficient', 'analysis', 'of', 'disease', 'associated', 'genetic', 'information', 'Sajjad', 'Karim', 'Hend', 'F', 'Nour', 'Eldin', 'Heba', 'Abusamra', 'Elham', 'M', 'Alhathli', 'Nada', 'Salem', 'Mohammed', 'H', 'Al', 'Qahtani', 'Sudhir', 'Kumar', 'O16', 'The', 'supercomputer', 'facility', 'AZIZ', 'at', 'KAU', 'utility', 'and', 'future', 'prospects', 'Hossam', 'Faheem', 'O17', 'New', 'research', 'into', 'the', 'causes', 'of', 'male', 'infertility', 'Ashok', 'Agarwa', 'O18', 'The', 'Klinefelter', 'syndrome', 'recent', 'progress', 'in', 'pathophysiology', 'and', 'management', 'Eberhard', 'Nieschlag', 'Joachim', 'Wistuba', 'Oliver', 'S', 'Damm', 'Mohd', 'A', 'Beg', 'Taha', 'A', 'Abdel', 'Meguid', 'Hisham', 'A', 'Mosli', 'Osama', 'S', 'Bajouh', 'Adel', 'M', 'Abuzenadah', 'Mohammed', 'H', 'Al', 'Qahtani', 'O19', 'A', 'new', 'look', 'to', 'reproductive', 'medicine', 'in', 'the', 'era', 'of', 'genomics', 'Serdar', 'Coskun', 'P1', 'Wnt', 'signalling', 'receptors', 'expression', 'in', 'Saudi', 'breast', 'cancer', 'patients', 'Muhammad', 'Abu', 'Elmagd', 'Abdelbaset', 'Buhmeida', 'Ashraf', 'Dallol', 'Jaudah', 'Al', 'Maghrabi', 'Sahar', 'Hakamy', 'Wejdan', 'Al', 'Qahtani', 'Asia', 'Al', 'Harbi', 'Shireen', 'Hussain', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'Adel', 'Abuzenadah', 'P2', 'Analysis', 'of', 'oxidative', 'stress', 'interactome', 'during', 'spermatogenesis', 'a', 'systems', 'biology', 'approach', 'to', 'reproduction', 'Burak', 'Ozkosem', 'Rick', 'DuBois', 'P3', 'Interleukin', '18', 'gene', 'variants', 'are', 'strongly', 'associated', 'with', 'idiopathic', 'recurrent', 'pregnancy', 'loss', 'Safia', 'S', 'Messaoudi', 'Maryam', 'T', 'Dandana', 'Touhami', 'Mahjoub', 'Wassim', 'Y', 'Almawi', 'P4', 'Effect', 'of', 'environmental', 'factors', 'on', 'gene', 'gene', 'and', 'gene', 'environment', 'reactions', 'model', 'and', 'theoretical', 'study', 'applied', 'to', 'environmental', 'interventions', 'using', 'genotype', 'S', 'Abdalla', 'M', 'Nabil', 'Al', 'Aama', 'P5', 'Genomics', 'and', 'transcriptomic', 'analysis', 'of', 'imatinib', 'resistance', 'in', 'gastrointestinal', 'stromal', 'tumor', 'Asmaa', 'Elzawahry', 'Tsuyoshi', 'Takahashi', 'Sachiyo', 'Mimaki', 'Eisaku', 'Furukawa', 'Rie', 'Nakatsuka', 'Isao', 'Kurosaka', 'Takahiko', 'Nishigaki', 'Hiromi', 'Nakamura', 'Satoshi', 'Serada', 'Tetsuji', 'Naka', 'Seiichi', 'Hirota', 'Tatsuhiro', 'Shibata', 'Katsuya', 'Tsuchihara', 'Toshirou', 'Nishida', 'Mamoru', 'Kato', 'P6', 'In', 'Silico', 'analysis', 'of', 'putative', 'HCV', 'epitopes', 'against', 'Pakistani', 'human', 'leukocyte', 'antigen', 'background', 'an', 'approach', 'towards', 'development', 'of', 'future', 'vaccines', 'for', 'Pakistani', 'population', 'Sajid', 'Mehmood', 'Naeem', 'Mahmood', 'Ashraf', 'Awais', 'Asif', 'Muhammad', 'Bilal', 'Malik', 'Siddique', 'Mehmood', 'Aadil', 'Hussain', 'P7', 'Inhibition', 'of', 'AChE', 'and', 'BuChE', 'with', 'the', 'natural', 'compounds', 'of', 'Bacopa', 'monerri', 'for', 'the', 'treatment', 'of', 'Alzheimer', 's', 'disease', 'a', 'bioinformatics', 'approach', 'Qazi', 'Mohammad', 'Sajid', 'Jamal', 'Mughees', 'Uddin', 'Siddiqui', 'Mohammad', 'A', 'Alzohairy', 'Mohammad', 'A', 'Al', 'Karaawi', 'P8', 'Her2', 'expression', 'in', 'urothelial', 'cell', 'carcinoma', 'of', 'the', 'bladder', 'in', 'Saudi', 'Arabia', 'Taoufik', 'Nedjadi', 'Jaudah', 'Al', 'Maghrabi', 'Mourad', 'Assidi', 'Heba', 'Al', 'Khattabi', 'Adel', 'Al', 'Ammari', 'Ahmed', 'Al', 'Sayyad', 'Abdelbaset', 'Buhmeida', 'Mohammed', 'Al', 'Qahtani', 'P9', 'Association', 'of', 'angiotensinogen', 'single', 'nucleotide', 'polymorphisms', 'with', 'Preeclampsia', 'in', 'patients', 'from', 'North', 'Africa', 'Hédia', 'Zitouni', 'Nozha', 'Raguema', 'Marwa', 'Ben', 'Ali', 'Wided', 'Malah', 'Raja', 'Lfalah', 'Wassim', 'Almawi', 'Touhami', 'Mahjoub', 'P10', 'Systems', 'biology', 'analysis', 'reveals', 'relations', 'between', 'normal', 'skin', 'benign', 'nevi', 'and', 'malignant', 'melanoma', 'Mohammed', 'Elanbari', 'Andrey', 'Ptitsyn', 'P11', 'The', 'apoptotic', 'effect', 'of', 'thymoquinone', 'in', 'Jurkat', 'cells', 'Sana', 'Mahjoub', 'Rabeb', 'El', 'Ghali', 'Bechir', 'Achour', 'Nidhal', 'Ben', 'Amor', 'Mourad', 'Assidi', 'Brahim', 'N', 'siri', 'Hamid', 'Morjani', 'P12', 'Sonic', 'hedgehog', 'contributes', 'in', 'bladder', 'cancer', 'invasion', 'in', 'Saudi', 'Arabia', 'Taoufik', 'Nedjadi', 'Adel', 'Al', 'Ammari', 'Ahmed', 'Al', 'Sayyad', 'Nada', 'Salem', 'Esam', 'Azhar', 'Jaudah', 'Al', 'Maghrabi', 'P13', 'Association', 'of', 'Interleukin', '18', 'gene', 'promoter', 'polymorphisms', '607A', 'C', 'and', '137', 'G', 'C', 'with', 'colorectal', 'cancer', 'onset', 'in', 'a', 'sample', 'of', 'Tunisian', 'population', 'Vera', 'Chayeb', 'Maryam', 'Dendena', 'Hedia', 'Zitouni', 'Khedija', 'Zouari', 'Limayem', 'Touhami', 'Mahjoub', 'P14', 'Pathological', 'expression', 'of', 'interleukin', '6', '11', 'leukemia', 'inhibitory', 'factor', 'and', 'their', 'receptors', 'in', 'tubal', 'gestation', 'with', 'and', 'without', 'tubal', 'cytomegalovirus', 'infection', 'Bassem', 'Refaat', 'Ahmed', 'M', 'Ashshi', 'Sarah', 'A', 'Batwa', 'P15', 'Phenotypic', 'and', 'genetic', 'profiling', 'of', 'avian', 'pathogenic', 'and', 'human', 'diarrhegenic', 'Escherichia', 'coli', 'in', 'Egypt', 'Hazem', 'Ramadan', 'Amal', 'Awad', 'Ahmed', 'Ateya', 'P16', 'Cancer', 'targeting', 'dual', 'gene', 'virotherapy', 'as', 'a', 'promising', 'therapeutic', 'strategy', 'for', 'treatment', 'of', 'hepatocellular', 'carcinoma', 'Adel', 'Galal', 'Ahmed', 'El', 'Shemi', 'Ahmad', 'Ashshi', 'Mohammed', 'Basalamah', 'Youjin', 'Na', 'Chae', 'Ok', 'YUN', 'P17', 'Cancer', 'dual', 'gene', 'therapy', 'with', 'oncolytic', 'adenoviruses', 'expressing', 'TRAIL', 'and', 'IL', '12', 'transgenes', 'markedly', 'eradicated', 'human', 'hepatocellular', 'carcinoma', 'both', 'in', 'vitro', 'and', 'in', 'vivo', 'Adel', 'Galal', 'Ahmed', 'El', 'Shemi', 'Ahmad', 'Ashshi', 'Mohammed', 'Basalamah', 'Youjin', 'Na', 'Chae', 'Ok', 'Yun', 'P18', 'Therapy', 'with', 'paricalcitol', 'attenuates', 'tumor', 'growth', 'and', 'augments', 'tumoricidal', 'and', 'anti', 'oncogenic', 'effects', 'of', '5', 'fluorouracil', 'on', 'animal', 'model', 'of', 'colon', 'cancer', 'Adel', 'Galal', 'El', 'Shemi', 'Bassem', 'Refaat', 'Osama', 'Kensara', 'Amr', 'Abdelfattah', 'P19', 'The', 'effects', 'of', 'Rubus', 'idaeus', 'extract', 'on', 'normal', 'human', 'lymphocytes', 'and', 'cancer', 'cell', 'line', 'Batol', 'Imran', 'Dheeb', 'Mohammed', 'M', 'F', 'Al', 'Halbosiy', 'Rghad', 'Kadhim', 'Al', 'lihabi', 'Basim', 'Mohammed', 'Khashman', 'P20', 'Etanercept', 'a', 'TNF', 'alpha', 'inhibitor', 'alleviates', 'mechanical', 'hypersensitivity', 'and', 'spontaneous', 'pain', 'in', 'a', 'rat', 'model', 'of', 'chemotherapy', 'induced', 'neuropathic', 'pain', 'Djouhri', 'Laiche', 'Chaudhary', 'Adeel', 'Nedjadi', 'Taoufik', 'P21', 'Sleeping', 'beauty', 'mutagenesis', 'system', 'identified', 'genes', 'and', 'neuronal', 'transcription', 'factor', 'network', 'involved', 'in', 'pediatric', 'solid', 'tumour', 'medulloblastoma', 'Hani', 'Al', 'Afghani', 'Maria', 'Łastowska', 'Haya', 'H', 'Al', 'Balool', 'Harsh', 'Sheth', 'Emma', 'Mercer', 'Jonathan', 'M', 'Coxhead', 'Chris', 'PF', 'Redfern', 'Heiko', 'Peters', 'Alastair', 'D', 'Burt', 'Mauro', 'Santibanez', 'Koref', 'Chris', 'M', 'Bacon', 'Louis', 'Chesler', 'Alistair', 'G', 'Rust', 'David', 'J', 'Adams', 'Daniel', 'Williamson', 'Steven', 'C', 'Clifford', 'Michael', 'S', 'Jackson', 'P22', 'Involvement', 'of', 'interleukin', '1', 'in', 'vitiligo', 'pathogenesis', 'Mala', 'Singh', 'Mohmmad', 'Shoab', 'Mansuri', 'Shahnawaz', 'D', 'Jadeja', 'Hima', 'Patel', 'Yogesh', 'S', 'Marfatia', 'Rasheedunnisa', 'Begum', 'P23', 'Cytogenetics', 'abnormalities', 'in', '12', '884', 'referred', 'population', 'for', 'chromosomal', 'analysis', 'and', 'the', 'role', 'of', 'FISH', 'in', 'refining', 'the', 'diagnosis', 'cytogenetic', 'experience', '2004', '2013', 'Amal', 'M', 'Mohamed', 'Alaa', 'K', 'Kamel', 'Nivin', 'A', 'Helmy', 'Sayda', 'A', 'Hammad', 'Hesham', 'F', 'Kayed', 'Marwa', 'I', 'Shehab', 'Assad', 'El', 'Gerzawy', 'Maha', 'M', 'Ead', 'Ola', 'M', 'Ead', 'Mona', 'Mekkawy', 'Innas', 'Mazen', 'Mona', 'El', 'Ruby', 'P24', 'Analysis', 'of', 'binding', 'properties', 'of', 'angiotensin', 'converting', 'enzyme', '2', 'through', 'in', 'silico', 'method', 'S', 'M', 'A', 'Shahid', 'Qazi', 'Mohammad', 'Sajid', 'Jamal', 'J', 'M', 'Arif', 'Mohtashim', 'Lohani', 'P25', 'Relationship', 'of', 'genetics', 'markers', 'cis', 'and', 'trans', 'to', 'the', 'β', 'S', 'globin', 'gene', 'with', 'fetal', 'hemoglobin', 'expression', 'in', 'Tunisian', 'sickle', 'cell', 'patients', 'Moumni', 'Imen', 'Chaouch', 'Leila', 'Ouragini', 'Houyem', 'Douzi', 'Kais', 'Chaouachi', 'Dorra', 'Mellouli', 'Fethi', 'Bejaoui', 'Mohamed', 'Abbes', 'Salem', 'P26', 'Analysis', 'of', 'estrogen', 'receptor', 'alpha', 'gene', 'polymorphisms', 'in', 'breast', 'cancer', 'link', 'to', 'genetic', 'predisposition', 'in', 'Sudanese', 'women', 'Areeg', 'Faggad', 'Amanuel', 'T', 'Gebreslasie', 'Hani', 'Y', 'Zaki', 'Badreldin', 'E', 'Abdalla', 'P27', 'KCNQI', 'gene', 'polymorphism', 'and', 'its', 'association', 'with', 'CVD', 'and', 'T2DM', 'in', 'the', 'Saudi', 'population', 'Maha', 'S', 'AlShammari', 'Rhaya', 'Al', 'Ali', 'Nader', 'Al', 'Balawi', 'Mansour', 'Al', 'Enazi', 'Ali', 'Al', 'Muraikhi', 'Fadi', 'Busaleh', 'Ali', 'Al', 'Sahwan', 'Francis', 'Borgio', 'Abdulazeez', 'Sayyed', 'Amein', 'Al', 'Ali', 'Sadananda', 'Acharya', 'P28', 'Clinical', 'neuroimaging', 'and', 'cytogenetic', 'study', 'of', 'a', 'patient', 'with', 'microcephaly', 'capillary', 'malformation', 'syndrome', 'Maha', 'S', 'Zaki', 'Hala', 'T', 'El', 'Bassyouni', 'Marwa', 'I', 'Shehab', 'P29', 'Altered', 'expression', 'of', 'CD200R1', 'on', 'dendritic', 'cells', 'of', 'patients', 'with', 'inflammatory', 'bowel', 'diseases', 'in', 'silico', 'investigations', 'and', 'clinical', 'evaluations', 'Mohammed', 'F', 'Elshal', 'Kaleemuddin', 'M', 'Alia', 'M', 'Aldahlawi', 'Omar', 'Saadah', 'J', 'Philip', 'McCoy', 'P30', 'Development', 'of', 'real', 'time', 'PCR', 'diagnostic', 'protocol', 'specific', 'for', 'the', 'Saudi', 'Arabian', 'H1N1', 'viral', 'strains', 'Adel', 'E', 'El', 'Tarras', 'Nabil', 'S', 'Awad', 'Abdulla', 'A', 'Alharthi', 'Mohamed', 'M', 'M', 'Ibrahim', 'P31', 'Identification', 'of', 'novel', 'genetic', 'variations', 'affecting', 'Osteoarthritis', 'patients', 'Haneen', 'S', 'Alsehli', 'Ashraf', 'Dallol', 'Abdullah', 'M', 'Gari', 'Mohammed', 'M', 'Abbas', 'Roaa', 'A', 'Kadam', 'Mazen', 'M', 'Gari', 'Mohmmed', 'H', 'Alkaff', 'Adel', 'M', 'Abuzenadah', 'Mamdooh', 'A', 'Gari', 'P32', 'An', 'integrated', 'database', 'of', 'GWAS', 'SNVs', 'and', 'their', 'evolutionary', 'properties', 'Heba', 'Abusamra', 'Sajjad', 'Karim', 'Hend', 'F', 'Nour', 'eldin', 'Elham', 'M', 'Alhathli', 'Nada', 'Salem', 'Sudhir', 'Kumar', 'Mohammed', 'H', 'Al', 'Qahtani', 'P33', 'Familial', 'hypercholesterolemia', 'in', 'Saudi', 'Arabia', 'prime', 'time', 'for', 'a', 'national', 'registry', 'and', 'genetic', 'analysis', 'Fatima', 'A', 'Moradi', 'Omran', 'M', 'Rashidi', 'Zuhier', 'A', 'Awan', 'P34', 'Comparative', 'genomics', 'and', 'network', 'based', 'analyses', 'of', 'early', 'hepatocellular', 'carcinoma', 'Ibrahim', 'Hamza', 'Kaya', 'Olfat', 'Al', 'Harazi', 'Dilek', 'Colak', 'P35', 'A', 'TALEN', 'based', 'oncolytic', 'viral', 'vector', 'approach', 'to', 'knock', 'out', 'ABCB1', 'gene', 'mediated', 'chemoresistance', 'in', 'cancer', 'stem', 'cells', 'Nabila', 'A', 'Alkousi', 'Takis', 'Athanasopoulos', 'P36', 'Cartilage', 'differentiation', 'and', 'gene', 'expression', 'of', 'synovial', 'fluid', 'mesenchymal', 'stem', 'cells', 'derived', 'from', 'osteoarthritis', 'patients', 'Afnan', 'O', 'Bahmaid', 'Etimad', 'A', 'Alhwait', 'Mamdooh', 'A', 'Gari', 'Haneen', 'S', 'Alsehli', 'Mohammed', 'M', 'Abbas', 'Mohammed', 'H', 'Alkaf', 'Roaa', 'Kadam', 'Ashraf', 'Dallol', 'Gauthaman', 'Kalamegam', 'P37', 'E', 'GRASP', 'Adding', 'an', 'evolutionary', 'component', 'to', 'the', 'genome', 'wide', 'repository', 'of', 'associations', 'GRASP', 'resource', 'Hend', 'F', 'Nour', 'Eldin', 'Sajjad', 'Karim', 'Heba', 'Abusamra', 'Elham', 'Alhathli', 'Nada', 'Salem', 'Mohammed', 'H', 'Al', 'Qahtani', 'Sudhir', 'Kumar', 'P38', 'Screening', 'of', 'AGL', 'gene', 'mutation', 'in', 'Saudi', 'family', 'with', 'glycogen', 'storage', 'disease', 'Type', 'III', 'Salma', 'N', 'Alsayed', 'Fawziah', 'H', 'Aljohani', 'Samaher', 'M', 'Habeeb', 'Rawan', 'A', 'Almashali', 'Sulman', 'Basit', 'Samia', 'M', 'Ahmed', 'P39', 'High', 'throughput', 'proteomic', 'data', 'suggest', 'modulation', 'of', 'cAMP', 'dependent', 'protein', 'kinase', 'A', 'and', 'mitochondrial', 'function', 'in', 'infertile', 'patients', 'with', 'varicocele', 'Rakesh', 'Sharma', 'Ashok', 'Agarwal', 'Damayanthi', 'Durairajanayagam', 'Luna', 'Samanta', 'Muhammad', 'Abu', 'Elmagd', 'Adel', 'M', 'Abuzenadah', 'Edmund', 'S', 'Sabanegh', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'P40', 'Significant', 'protein', 'profile', 'alterations', 'in', 'men', 'with', 'primary', 'and', 'secondary', 'infertility', 'Ashok', 'Agarwal', 'Rakesh', 'Sharma', 'Luna', 'Samanta', 'Damayanthi', 'Durairajanayagam', 'Mourad', 'Assidi', 'Muhammad', 'Abu', 'Elmagd', 'Mohammed', 'Al', 'Qahtani', 'Adel', 'M', 'Abuzenadah', 'Edmund', 'S', 'Sabanegh', 'P41', 'Spermatozoa', 'maturation', 'in', 'infertile', 'patients', 'involves', 'compromised', 'expression', 'of', 'heat', 'shock', 'proteins', 'Luna', 'Samanta', 'Ashok', 'Agarwal', 'Rakesh', 'Sharma', 'Zhihong', 'Cui', 'Mourad', 'Assidi', 'Adel', 'M', 'Abuzenadah', 'Muhammad', 'Abu', 'Elmagd', 'Mohammed', 'Al', 'Qahtani', 'P42', 'Array', 'comparative', 'genomic', 'hybridization', 'approach', 'to', 'search', 'genomic', 'answers', 'for', 'spontaneous', 'recurrent', 'abortion', 'in', 'Saudi', 'Arabia', 'Alaa', 'A', 'Alboogmi', 'Nuha', 'A', 'Alansari', 'Maha', 'M', 'Al', 'Quaiti', 'Fai', 'T', 'Ashgan', 'Afnan', 'Bandah', 'Hasan', 'S', 'Jamal', 'Abdullraheem', 'Rozi', 'Zeenat', 'Mirza', 'Adel', 'M', 'Abuzenadah', 'Sajjad', 'Karim', 'Mohammed', 'H', 'Al', 'Qahtani', 'P43', 'Global', 'gene', 'expression', 'profiling', 'of', 'Saudi', 'kidney', 'cancer', 'patients', 'Sajjad', 'Karim', 'Hans', 'Juergen', 'Schulten', 'Ahmad', 'J', 'Al', 'Sayyad', 'Hasan', 'MA', 'Farsi', 'Jaudah', 'A', 'Al', 'Maghrabi', 'Zeenat', 'Mirza', 'Reem', 'Alotibi', 'Alaa', 'Al', 'Ahmadi', 'Nuha', 'A', 'Alansari', 'Alaa', 'A', 'Albogmi', 'Maha', 'M', 'Al', 'Quaiti', 'Fai', 'T', 'Ashgan', 'Afnan', 'Bandah', 'Mohammed', 'H', 'Al', 'Qahtani', 'P44', 'Downregulated', 'StAR', 'gene', 'and', 'male', 'reproductive', 'dysfunction', 'caused', 'by', 'nifedipine', 'and', 'ethosuximide', 'Rasha', 'A', 'Ebiya', 'Samia', 'M', 'Darwish', 'Metwally', 'M', 'Montaser', 'P45', 'Clustering', 'based', 'gene', 'expression', 'feature', 'selection', 'method', 'A', 'computational', 'approach', 'to', 'enrich', 'the', 'classifier', 'efficiency', 'of', 'differentially', 'expressed', 'genes', 'Heba', 'Abusamra', 'Vladimir', 'B', 'Bajic', 'P46', 'Prognostic', 'significance', 'of', 'Osteopontin', 'expression', 'profile', 'in', 'colorectal', 'carcinoma', 'Jaudah', 'Al', 'Maghrabi', 'Wafaey', 'Gomaa', 'Mehenaz', 'Hanbazazh', 'Mahmoud', 'Al', 'Ahwal', 'Asia', 'Al', 'Harbi', 'Wejdan', 'Al', 'Qahtani', 'Saher', 'Hakamy', 'Ghali', 'Baba', 'Abdelbaset', 'Buhmeida', 'Mohammed', 'Al', 'Qahtani', 'P47', 'High', 'Glypican', '3', 'expression', 'pattern', 'predicts', 'longer', 'disease', 'specific', 'survival', 'in', 'colorectal', 'carcinoma', 'Jaudah', 'Al', 'Maghrabi', 'Abdullah', 'Al', 'Harbi', 'Mahmoud', 'Al', 'Ahwal', 'Asia', 'Al', 'Harbi', 'Wejdan', 'Al', 'Qahtani', 'Sahar', 'Hakamy', 'Ghalia', 'Baba', 'Abdelbaset', 'Buhmeida', 'Mohammed', 'Al', 'Qahtani', 'P48', 'An', 'evolutionary', 're', 'assessment', 'of', 'GWAS', 'single', 'nucleotide', 'variants', 'implicated', 'in', 'the', 'Cholesterol', 'traits', 'Elham', 'M', 'Alhathli', 'Sajjad', 'Karim', 'Nada', 'Salem', 'Hend', 'Nour', 'Eldin', 'Heba', 'Abusamra', 'Sudhir', 'Kumar', 'Mohammed', 'H', 'Al', 'Qahtani', 'P49', 'Derivation', 'and', 'characterization', 'of', 'human', 'Wharton', 's', 'jelly', 'stem', 'cells', 'hWJSCs', 'in', 'vitro', 'for', 'future', 'therapeutic', 'applications', 'Aisha', 'A', 'Alyamani', 'Gauthaman', 'Kalamegam', 'Etimad', 'A', 'Alhwait', 'Mamdooh', 'A', 'Gari', 'Mohammed', 'M', 'Abbas', 'Mohammed', 'H', 'Alkaf', 'Haneen', 'S', 'Alsehli', 'Roaa', 'A', 'Kadam', 'Mohammed', 'Al', 'Qahtani', 'P50', 'Attitudes', 'of', 'healthcare', 'students', 'toward', 'biomedical', 'research', 'in', 'the', 'post', 'genomic', 'era', 'Rawan', 'Gadi', 'Abdelbaset', 'Buhmeida', 'Mourad', 'Assidi', 'Adeel', 'Chaudhary', 'Leena', 'Merdad', 'P51', 'Evaluation', 'of', 'the', 'immunomodulatory', 'effects', 'of', 'thymoquinone', 'on', 'human', 'bone', 'marrow', 'mesenchymal', 'stem', 'cells', 'BM', 'MSCs', 'from', 'osteoarthritic', 'patients', 'Saadiah', 'M', 'Alfakeeh', 'Etimad', 'A', 'Alhwait', 'Mamdooh', 'A', 'Gari', 'Mohammed', 'M', 'Abbas', 'Mohammed', 'H', 'Alkaf', 'Haneen', 'S', 'Alsehli', 'Roaa', 'Kadam', 'Gauthaman', 'Kalamegam', 'P52', 'Implication', 'of', 'IL', '10', 'and', 'IL', '28', 'polymorphism', 'with', 'successful', 'anti', 'HCV', 'therapy', 'and', 'viral', 'clearance', 'Rubi', 'Ghazala', 'Shilu', 'Mathew', 'M', 'Haroon', 'Hamed', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'Ishtiaq', 'Qadri', 'P53', 'Selection', 'of', 'flavonoids', 'against', 'obesity', 'protein', 'FTO', 'using', 'in', 'silico', 'and', 'in', 'vitro', 'approaches', 'Shilu', 'Mathew', 'Lobna', 'Mira', 'Manal', 'Shaabad', 'Shireen', 'Hussain', 'Mourad', 'Assidi', 'Muhammad', 'Abu', 'Elmagd', 'Mohammed', 'Al', 'Qahtani', 'P54', 'Computational', 'selection', 'and', 'in', 'vitro', 'validation', 'of', 'flavonoids', 'as', 'new', 'antidepressant', 'agents', 'Shilu', 'Mathew', 'Manal', 'Shaabad', 'Lobna', 'Mira', 'Shireen', 'Hussain', 'Mourad', 'Assidi', 'Muhammad', 'Abu', 'Elmagd', 'Mohammed', 'Al', 'Qahtani', 'P55', 'In', 'Silico', 'prediction', 'and', 'prioritization', 'of', 'aging', 'candidate', 'genes', 'associated', 'with', 'progressive', 'telomere', 'shortening', 'Ahmed', 'Rebai', 'Mourad', 'Assidi', 'Abdelbaset', 'Buhmeida', 'Muhammad', 'Abu', 'Elmagd', 'Ashraf', 'Dallol', 'Jerry', 'W', 'Shay', 'P56', 'Identification', 'of', 'new', 'cancer', 'testis', 'antigen', 'genes', 'in', 'diverse', 'types', 'of', 'malignant', 'human', 'tumour', 'cells', 'Mikhlid', 'H', 'Almutairi', 'P57', 'More', 'comprehensive', 'forensic', 'genetic', 'marker', 'analyses', 'for', 'accurate', 'human', 'remains', 'identification', 'using', 'massively', 'parallel', 'sequencing', 'MPS', 'Angie', 'Ambers', 'Jennifer', 'Churchill', 'Jonathan', 'King', 'Monika', 'Stoljarova', 'Harrell', 'Gill', 'King', 'Mourad', 'Assidi', 'Muhammad', 'Abu', 'Elmagd', 'Abdelbaset', 'Buhmeida', 'Muhammad', 'Al', 'Qatani', 'Bruce', 'Budowle', 'P58', 'Flow', 'cytometry', 'approach', 'towards', 'treatment', 'men', 'infertility', 'in', 'Saudi', 'Arabia', 'Muhammad', 'Abu', 'Elmagd', 'Farid', 'Ahmed', 'Ashraf', 'Dallol', 'Mourad', 'Assidi', 'Taha', 'Abo', 'Almagd', 'Sahar', 'Hakamy', 'Ashok', 'Agarwal', 'Muhammad', 'Al', 'Qahtani', 'Adel', 'Abuzenadah', 'P59', 'Tissue', 'microarray', 'based', 'validation', 'of', 'CyclinD1', 'expression', 'in', 'renal', 'cell', 'carcinoma', 'of', 'Saudi', 'kidney', 'patients', 'Sajjad', 'Karim', 'Hans', 'Juergen', 'Schulten', 'Ahmad', 'J', 'Al', 'Sayyad', 'Hasan', 'MA', 'Farsi', 'Jaudah', 'A', 'Al', 'Maghrabi', 'Abdelbaset', 'Buhmaida', 'Zeenat', 'Mirza', 'Reem', 'Alotibi', 'Alaa', 'Al', 'Ahmadi', 'Nuha', 'A', 'Alansari', 'Alaa', 'A', 'Albogmi', 'Maha', 'M', 'Al', 'Quaiti', 'Fai', 'T', 'Ashgan', 'Afnan', 'Bandah', 'Mohammed', 'H', 'Al', 'Qahtani', 'P60', 'Assessment', 'of', 'gold', 'nanoparticles', 'in', 'molecular', 'diagnostics', 'and', 'DNA', 'damage', 'studies', 'Rukhsana', 'Satar', 'Mahmood', 'Rasool', 'Waseem', 'Ahmad', 'Nazia', 'Nazam', 'Mohamad', 'I', 'Lone', 'Muhammad', 'I', 'Naseer', 'Mohammad', 'S', 'Jamal', 'Syed', 'K', 'Zaidi', 'Peter', 'N', 'Pushparaj', 'Mohammad', 'A', 'Jafri', 'Shakeel', 'A', 'Ansari', 'Mohammed', 'H', 'Alqahtani', 'P61', 'Surfing', 'the', 'biospecimen', 'management', 'and', 'processing', 'workflow', 'at', 'CEGMR', 'Biobank', 'Hanan', 'Bashier', 'Abrar', 'Al', 'Qahtani', 'Shilu', 'Mathew', 'Amal', 'M', 'Nour', 'Heba', 'Alkhatabi', 'Adel', 'M', 'Abu', 'Zenadah', 'Abdelbaset', 'Buhmeida', 'Mourad', 'Assidi', 'Muhammed', 'Al', 'Qahtani', 'P62', 'Autism', 'Spectrum', 'Disorder', 'knowledge', 'attitude', 'and', 'awareness', 'in', 'Jeddah', 'Kingdom', 'of', 'Saudi', 'Arabia', 'Muhammad', 'Faheem', 'Shilu', 'Mathew', 'Shiny', 'Mathew', 'Peter', 'Natesan', 'Pushparaj', 'Mohammad', 'H', 'Al', 'Qahtani', 'P63', 'Simultaneous', 'genetic', 'screening', 'of', 'the', 'coagulation', 'pathway', 'genes', 'using', 'the', 'Thromboscan', 'targeted', 'sequencing', 'panel', 'Hani', 'A', 'Alhadrami', 'Ashraf', 'Dallol', 'Adel', 'Abuzenadah', 'P64', 'Genome', 'wide', 'array', 'comparative', 'genomic', 'hybridization', 'analysis', 'in', 'patients', 'with', 'syndromic', 'congenital', 'heart', 'defects', 'Ibtessam', 'R', 'Hussein', 'Adeel', 'G', 'Chaudhary', 'Rima', 'S', 'Bader', 'Randa', 'Bassiouni', 'Maha', 'Alquaiti', 'Fai', 'Ashgan', 'Hans', 'Schulten', 'Mohamed', 'Nabil', 'Alama', 'Mohammad', 'H', 'Al', 'Qahtani', 'P65', 'Toxocogenetic', 'evaluation', 'of', '1', '2', 'Dichloroethane', 'in', 'bone', 'marrow', 'blood', 'and', 'cells', 'of', 'immune', 'system', 'using', 'conventional', 'molecular', 'and', 'flowcytometric', 'approaches', 'Mohammad', 'I', 'Lone', 'Nazia', 'Nizam', 'Waseem', 'Ahmad', 'Mohammad', 'A', 'Jafri', 'Mahmood', 'Rasool', 'Shakeel', 'A', 'Ansari', 'Muhammed', 'H', 'Al', 'Qahtani', 'P66', 'Molecular', 'cytogenetic', 'diagnosis', 'of', 'sexual', 'development', 'disorders', 'in', 'newborn', 'A', 'case', 'of', 'ambiguous', 'genitalia', 'Eradah', 'Alshihri', 'Muhammad', 'Abu', 'Elmagd', 'Lina', 'Alharbi', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'P67', 'Identification', 'of', 'disease', 'specific', 'gene', 'expression', 'clusters', 'and', 'pathways', 'in', 'hepatocellular', 'carcinoma', 'using', 'In', 'Silico', 'methodologies', 'Shilu', 'Mathew', 'Peter', 'Pushparaj', 'Natesan', 'Muhammed', 'Al', 'Qahtani', 'P68', 'Human', 'Wharton', 's', 'Jelly', 'stem', 'cell', 'conditioned', 'medium', 'inhibits', 'primary', 'ovarian', 'cancer', 'cells', 'in', 'vitro', 'Identification', 'of', 'probable', 'targets', 'and', 'mechanisms', 'using', 'systems', 'biology', 'Gauthaman', 'Kalamegam', 'Peter', 'Natesan', 'Pushparaj', 'Fazal', 'Khan', 'Roaa', 'Kadam', 'Farid', 'Ahmed', 'Mourad', 'Assidi', 'Khalid', 'Hussain', 'Wali', 'Sait', 'Nisreen', 'Anfinan', 'Mohammed', 'Al', 'Qahtani', 'P69', 'Mutation', 'spectrum', 'of', 'ASPM', 'Abnormal', 'Spindle', 'like', 'Microcephaly', 'associated', 'gene', 'in', 'Saudi', 'Arabian', 'population', 'Muhammad', 'I', 'Naseer', 'Adeel', 'G', 'Chaudhary', 'Mohammad', 'S', 'Jamal', 'Shilu', 'Mathew', 'Lobna', 'S', 'Mira', 'Peter', 'N', 'Pushparaj', 'Shakeel', 'A', 'Ansari', 'Mahmood', 'Rasool', 'Mohammed', 'H', 'AlQahtani', 'P70', 'Identification', 'and', 'characterization', 'of', 'novel', 'genes', 'and', 'mutations', 'of', 'primary', 'microcephaly', 'in', 'Saudi', 'Arabian', 'population', 'Muhammad', 'I', 'Naseer', 'Adeel', 'G', 'Chaudhary', 'Shilu', 'Mathew', 'Lobna', 'S', 'Mira', 'Mohammad', 'S', 'Jamal', 'Sameera', 'Sogaty', 'Randa', 'I', 'Bassiouni', 'Mahmood', 'Rasool', 'Mohammed', 'H', 'AlQahtani', 'P71', 'Molecular', 'genetic', 'analysis', 'of', 'hereditary', 'nonpolyposis', 'colorectal', 'cancer', 'Lynch', 'Syndrome', 'in', 'Saudi', 'Arabian', 'population', 'Mahmood', 'Rasool', 'Shakeel', 'A', 'Ansari', 'Mohammad', 'S', 'Jamal', 'Peter', 'N', 'Pushparaj', 'Abdulrahman', 'MS', 'Sibiani', 'Waseem', 'Ahmad', 'Abdelbaset', 'Buhmeida', 'Mohammad', 'A', 'Jafri', 'Mohiuddin', 'K', 'Warsi', 'Muhammad', 'I', 'Naseer', 'Mohammed', 'H', 'Al', 'Qahtani', 'P72', 'Function', 'predication', 'of', 'hypothetical', 'proteins', 'from', 'genome', 'database', 'of', 'chlamydia', 'trachomatis', 'Rubi', 'Kundan', 'Kumar', 'Ahmad', 'AT', 'Naqvi', 'Faizan', 'Ahmad', 'Md', 'I', 'Hassan', 'Mohammad', 'S', 'Jamal', 'Mahmood', 'Rasool', 'Mohammed', 'H', 'AlQahtani', 'P73', 'Transcription', 'factors', 'as', 'novel', 'molecular', 'targets', 'for', 'skin', 'cancer', 'Ashraf', 'Ali', 'Jummanah', 'Jarullah', 'Mahmood', 'Rasool', 'Abdelbasit', 'Buhmeida', 'Shahida', 'Khan', 'Ghufrana', 'Abdussami', 'Maryam', 'Mahfooz', 'Mohammad', 'A', 'Kamal', 'Ghazi', 'A', 'Damanhouri', 'Mohammad', 'S', 'Jamal', 'P74', 'An', 'In', 'Silico', 'analysis', 'of', 'Plumbagin', 'binding', 'to', 'apoptosis', 'executioner', 'Caspase', '3', 'and', 'Caspase', '7', 'Bushra', 'Jarullah', 'Jummanah', 'Jarullah', 'Mohammad', 'SS', 'Jarullah', 'Ashraf', 'Ali', 'Mahmood', 'Rasool', 'Mohammad', 'S', 'Jamal', 'P75', 'Single', 'cell', 'genomics', 'applications', 'for', 'preimplantation', 'genetic', 'screening', 'optimization', 'Comparative', 'analysis', 'of', 'whole', 'genome', 'amplification', 'technologies', 'Mourad', 'Assidi', 'Muhammad', 'Abu', 'Elmagd', 'Osama', 'Bajouh', 'Peter', 'Natesan', 'Pushparaj', 'Mohammed', 'Al', 'Qahtani', 'Adel', 'Abuzenadah', 'P76', 'ZFP36', 'regulates', 'miRs', '34a', 'in', 'anti', 'IgM', 'triggered', 'immature', 'B', 'cells', 'Mohammad', 'S', 'Jamal', 'Jummanah', 'Jarullah', 'Abdulah', 'EA', 'Mathkoor', 'Hashim', 'MA', 'Alsalmi', 'Anas', 'MM', 'Oun', 'Ghazi', 'A', 'Damanhauri', 'Mahmood', 'Rasool', 'Mohammed', 'H', 'AlQahtani', 'P77', 'Identification', 'of', 'a', 'novel', 'mutation', 'in', 'the', 'STAMBP', 'gene', 'in', 'a', 'family', 'with', 'microcephaly', 'capillary', 'malformation', 'syndrome', 'Muhammad', 'I', 'Naseer', 'Mahmood', 'Rasool', 'Sameera', 'Sogaty', 'Adeel', 'G', 'Chudhary', 'Yousif', 'A', 'Abutalib', 'Daniele', 'Merico', 'Susan', 'Walker', 'Christian', 'R', 'Marshall', 'Mehdi', 'Zarrei', 'Stephen', 'W', 'Scherer', 'Mohammad', 'H', 'Al', 'Qahtani', 'P78', 'Copy', 'number', 'variations', 'in', 'Saudi', 'patients', 'with', 'intellectual', 'disability', 'and', 'epilepsy', 'Muhammad', 'I', 'Naseer', 'Muhammad', 'Faheem', 'Adeel', 'G', 'Chaudhary', 'Mahmood', 'Rasool', 'Gauthaman', 'Kalamegam', 'Fai', 'Talal', 'Ashgan', 'Mourad', 'Assidi', 'Farid', 'Ahmed', 'Syed', 'Kashif', 'Zaidi', 'Mohammed', 'M', 'Jan', 'Mohammad', 'H', 'Al', 'Qahtani', 'P79', 'Prognostic', 'significance', 'of', 'CD44', 'expression', 'profile', 'in', 'colorectal', 'carcinoma', 'Maryam', 'Al', 'Zahrani', 'Sahira', 'Lary', 'Sahar', 'Hakamy', 'Ashraf', 'Dallol', 'Mahmoud', 'Al', 'Ahwal', 'Jaudah', 'Al', 'Maghrabi', 'Emmanuel', 'Dermitzakis', 'Adel', 'Abuzenadah', 'Abdelbaset', 'Buhmeida', 'Mohammed', 'Al', 'Qahtani', 'P80', 'Association', 'of', 'the', 'endothelial', 'nitric', 'oxide', 'synthase', 'eNOS', 'gene', 'G894T', 'polymorphism', 'with', 'hypertension', 'risk', 'and', 'complications', 'Abeer', 'A', 'Al', 'refai', 'Mona', 'Saleh', 'Rehab', 'I', 'Yassien', 'Mahmmoud', 'Kamel', 'Rabab', 'M', 'Habeb', 'P81', 'SNPs', 'array', 'to', 'screen', 'genetic', 'variation', 'among', 'diabetic', 'patients', 'Najlaa', 'Filimban', 'Ashraf', 'Dallol', 'Nadia', 'Ghannam', 'Mohammed', 'Al', 'Qahtani', 'Adel', 'Mohammed', 'Abuzenadah', 'P82', 'Detection', 'and', 'genotyping', 'of', 'Helicobacter', 'pylori', 'among', 'gastric', 'cancer', 'patients', 'from', 'Saudi', 'Arabian', 'population', 'Fehmida', 'Bibi', 'Sana', 'Akhtar', 'Esam', 'I', 'Azhar', 'Muhammad', 'Yasir', 'Muhammad', 'I', 'Nasser', 'Asif', 'A', 'Jiman', 'Fatani', 'Ali', 'Sawan', 'P83', 'Antimicrobial', 'drug', 'resistance', 'and', 'molecular', 'detection', 'of', 'susceptibility', 'to', 'Fluoroquinolones', 'among', 'clinical', 'isolates', 'of', 'Salmonella', 'species', 'from', 'Jeddah', 'Saudi', 'Arabia', 'Ruaa', 'A', 'Lahzah', 'Asho', 'Ali', 'P84', 'Identification', 'of', 'the', 'toxic', 'and', 'virulence', 'nature', 'of', 'MAP1138c', 'protein', 'of', 'Mycobacterium', 'avium', 'subsp', 'paratuberculosis', 'Syed', 'A', 'Hassan', 'Seyed', 'E', 'Hasnain', 'Iftikhar', 'A', 'Tayubi', 'Hamza', 'A', 'Abujabal', 'Alaa', 'O', 'Magrabi', 'P85', 'In', 'vitro', 'and', 'in', 'silico', 'evaluation', 'of', 'miR137', 'in', 'human', 'breast', 'cancer', 'Fazal', 'Khan', 'Gauthaman', 'Kalamegam', 'Peter', 'Natesan', 'Pushparaj', 'Adel', 'Abuzenada', 'Taha', 'Abduallah', 'Kumosani', 'Elie', 'Barbour', 'Mohammed', 'Al', 'Qahtani', 'P86', 'Auruka', 'gene', 'is', 'over', 'expressed', 'in', 'Saudi', 'breast', 'cancer', 'Manal', 'Shabaad', 'Shilu', 'Mathew', 'Ashraf', 'Dallol', 'Adnan', 'Merdad', 'Abdelbaset', 'Buhmeida', 'Mohammed', 'Al', 'Qahtani', 'P87', 'The', 'potential', 'of', 'immunogenomics', 'in', 'personalized', 'healthcare', 'Mourad', 'Assidi', 'Muhammad', 'Abu', 'Elmagd', 'Kalamegam', 'Gauthaman', 'Mamdooh', 'Gari', 'Adeel', 'Chaudhary', 'Adel', 'Abuzenadah', 'Peter', 'Natesan', 'Pushparaj', 'Mohammed', 'Al', 'Qahtani', 'P88', 'In', 'Silico', 'physiochemical', 'and', 'structural', 'characterization', 'of', 'a', 'putative', 'ORF', 'MAP0591', 'and', 'its', 'implication', 'in', 'the', 'pathogenesis', 'of', 'Mycobacterium', 'paratuberculosis', 'in', 'ruminants', 'and', 'humans', 'Syed', 'A', 'Hassan', 'Iftikhar', 'A', 'Tayubi', 'Hani', 'MA', 'Aljahdali', 'P89', 'Effects', 'of', 'heat', 'shock', 'on', 'human', 'bone', 'marrow', 'mesenchymal', 'stem', 'cells', 'BM', 'MSCs', 'Implications', 'in', 'regenerative', 'medicine', 'Reham', 'Al', 'Nono', 'Mamdooh', 'Gari', 'Haneen', 'Alsehli', 'Farid', 'Ahmed', 'Mohammed', 'Abbas', 'Gauthaman', 'Kalamegam', 'Mohammed', 'Al', 'Qahtani', 'P90', 'In', 'Silico', 'analyses', 'of', 'the', 'molecular', 'targets', 'of', 'Resveratrol', 'unravels', 'its', 'importance', 'in', 'mast', 'cell', 'mediated', 'allergic', 'responses', 'Shilu', 'Mathew', 'Fazal', 'Khan', 'Mahmood', 'Rasool', 'Mohammed', 'Sarwar', 'Jamal', 'Muhammad', 'Imran', 'Naseer', 'Zeenat', 'Mirza', 'Sajjad', 'Karim', 'Shakeel', 'Ansari', 'Mourad', 'Assidi', 'Gauthaman', 'Kalamegam', 'Mamdooh', 'Gari', 'Adeel', 'Chaudhary', 'Adel', 'Abuzenadah', 'Peter', 'Natesan', 'Pushparaj', 'Mohammed', 'Al', 'Qahtani', 'P91', 'Effects', 'of', 'environmental', 'particulate', 'matter', 'on', 'bone', 'marrow', 'mesenchymal', 'stem', 'cells', 'Muhammad', 'Abu', 'Elmagd', 'Gauthaman', 'Kalamegam', 'Roaa', 'Kadam', 'Mansour', 'A', 'Alghamdi', 'Magdy', 'Shamy', 'Max', 'Costa', 'Mamdouh', 'I', 'Khoder', 'Mourad', 'Assidi', 'Peter', 'Natesan', 'Pushparaj', 'Mamdooh', 'Gari', 'Mohammed', 'Al', 'Qahtani', 'P92', 'Distinctive', 'charge', 'clusters', 'in', 'human', 'virus', 'proteomes', 'Najla', 'Kharrat', 'Sabrine', 'Belmabrouk', 'Rania', 'Abdelhedi', 'Riadh', 'Benmarzoug', 'Mourad', 'Assidi', 'Mohammed', 'H', 'Al', 'Qahtani', 'Ahmed', 'Rebai', 'P93', 'In', 'vitro', 'experimental', 'model', 'and', 'approach', 'in', 'identification', 'of', 'new', 'biomarkers', 'of', 'inflammatory', 'forms', 'of', 'arthritis', 'Ghazi', 'Dhamanhouri', 'Peter', 'Natesan', 'Pushparaj', 'Abdelwahab', 'Noorwali', 'Mohammad', 'Khalid', 'Alwasiyah', 'Afnan', 'Bahamaid', 'Saadiah', 'Alfakeeh', 'Aisha', 'Alyamani', 'Haneen', 'Alsehli', 'Mohammed', 'Abbas', 'Mamdooh', 'Gari', 'Ali', 'Mobasheri', 'Gauthaman', 'Kalamegam', 'Mohammed', 'Al', 'Qahtani', 'P94', 'Molecular', 'docking', 'of', 'GABA', 'A', 'receptor', 'subunit', 'γ', '2', 'with', 'novel', 'anti', 'epileptic', 'compounds', 'Muhammad', 'Faheem', 'Shilu', 'Mathew', 'Peter', 'Natesan', 'Pushparaj', 'Mohammad', 'H', 'Al', 'Qahtani', 'P95', 'Breast', 'cancer', 'knowledge', 'awareness', 'and', 'practices', 'among', 'Saudi', 'females', 'residing', 'in', 'Jeddah', 'Shilu', 'Mathew', 'Muhammad', 'Faheem', 'Shiny', 'Mathew', 'Peter', 'Natesan', 'Pushparaj', 'Mohammad', 'H', 'Al', 'Qahtani', 'P96', 'Anti', 'inflammatory', 'role', 'of', 'Sesamin', 'by', 'Attenuation', 'of', 'Iba1', 'TNF', 'α', 'ICAM', '1', 'iNOS', 'signaling', 'in', 'Diabetic', 'Retinopathy', 'Mohammad', 'Sarwar', 'Jamal', 'Syed', 'Kashif', 'Zaidi', 'Raziuddin', 'Khan', 'Kanchan', 'Bhatia', 'Mohammed', 'H', 'Al', 'Qahtani', 'Saif', 'Ahmad', 'P97', 'Identification', 'of', 'drug', 'lead', 'molecule', 'against', 'vp35', 'protein', 'of', 'Ebola', 'virus', 'An', 'In', 'Silico', 'approach', 'Iftikhar', 'AslamTayubi', 'Manish', 'Tripathi', 'Syed', 'Asif', 'Hassan', 'Rahul', 'Shrivastava', 'P98', 'An', 'approach', 'to', 'personalized', 'medicine', 'from', 'SNP', 'calling', 'through', 'disease', 'analysis', 'using', 'whole', 'exome', 'sequencing', 'of', 'three', 'sub', 'continental', 'populations', 'Iftikhar', 'A', 'Tayubi', 'Syed', 'Hassan', 'Hamza', 'A', 'S', 'Abujabal', 'P99', 'Low', 'versus', 'high', 'frequency', 'of', 'Glucose', '6', 'Phosphate', 'Dehydrogenase', 'G6PD', 'deficiency', 'in', 'urban', 'against', 'tribal', 'population', 'of', 'Gujarat', 'A', 'signal', 'to', 'natural', 'selection', 'Ishani', 'Shah', 'Bushra', 'Jarullah', 'Mohammad', 'S', 'Jamal', 'Jummanah', 'Jarullah', 'P100', 'Spontaneous', 'preterm', 'birth', 'and', 'single', 'nucleotide', 'gene', 'polymorphisms', 'a', 'recent', 'update', 'Ishfaq', 'A', 'Sheikh', 'Ejaz', 'Ahmad', 'Mohammad', 'S', 'Jamal', 'Mohd', 'Rehan', 'Muhammad', 'Abu', 'Elmagd', 'Iftikhar', 'A', 'Tayubi', 'Samera', 'F', 'AlBasri', 'Osama', 'S', 'Bajouh', 'Rola', 'F', 'Turki', 'Adel', 'M', 'Abuzenadah', 'Ghazi', 'A', 'Damanhouri', 'Mohd', 'A', 'Beg', 'Mohammed', 'Al', 'Qahtani', 'P101', 'Prevalence', 'of', 'congenital', 'heart', 'diseases', 'among', 'Down', 'syndrome', 'cases', 'in', 'Saudi', 'Arabia', 'role', 'of', 'molecular', 'genetics', 'in', 'the', 'pathogenesis', 'Sahar', 'AF', 'Hammoudah', 'Khalid', 'M', 'AlHarbi', 'Lama', 'M', 'El', 'Attar', 'Ahmed', 'MZ', 'Darwish', 'P102', 'Combinatorial', 'efficacy', 'of', 'specific', 'pathway', 'inhibitors', 'in', 'breast', 'cancer', 'cells', 'Sara', 'M', 'Ibrahim', 'Ashraf', 'Dallol', 'Hani', 'Choudhry', 'Adel', 'Abuzenadah', 'Jalaludden', 'Awlia', 'Adeel', 'Chaudhary', 'Farid', 'Ahmed', 'Mohammed', 'Al', 'Qahtani', 'P103', 'MiR', '143', 'and', 'miR', '145', 'cluster', 'as', 'potential', 'replacement', 'medicine', 'for', 'the', 'treatment', 'of', 'cancer', 'Mohammad', 'A', 'Jafri', 'Muhammad', 'Abu', 'Elmagd', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'P104', 'Metagenomic', 'profile', 'of', 'gut', 'microbiota', 'during', 'pregnancy', 'in', 'Saudi', 'population', 'Imran', 'khan', 'Muhammad', 'Yasir', 'Esam', 'I', 'Azhar', 'Sameera', 'Al', 'basri', 'Elie', 'Barbour', 'Taha', 'Kumosani', 'P105', 'Exploration', 'of', 'anticancer', 'targets', 'of', 'selected', 'metabolites', 'of', 'Phoenix', 'dactylifera', 'L', 'using', 'systems', 'biological', 'approaches', 'Fazal', 'Khan', 'Gauthaman', 'Kalamegam', 'Peter', 'Natesan', 'Pushparaj', 'Adel', 'Abuzenada', 'Taha', 'Abduallah', 'Kumosani', 'Elie', 'Barbour', 'P106', 'CD226', 'and', 'CD40', 'gene', 'polymorphism', 'in', 'susceptibility', 'to', 'Juvenile', 'rheumatoid', 'arthritis', 'in', 'Egyptian', 'patients', 'Heba', 'M', 'EL', 'Sayed', 'Eman', 'A', 'Hafez', 'P107', 'Paediatric', 'exome', 'sequencing', 'in', 'autism', 'spectrum', 'disorder', 'ascertained', 'in', 'Saudi', 'families', 'Hans', 'Juergen', 'Schulten', 'Aisha', 'Hassan', 'Elaimi', 'Ibtessam', 'R', 'Hussein', 'Randa', 'Ibrahim', 'Bassiouni', 'Mohammad', 'Khalid', 'Alwasiyah', 'Richard', 'F', 'Wintle', 'Adeel', 'Chaudhary', 'Stephen', 'W', 'Scherer', 'Mohammed', 'Al', 'Qahtani', 'P108', 'Crystal', 'structure', 'of', 'the', 'complex', 'formed', 'between', 'Phospholipase', 'A', '2', 'and', 'the', 'central', 'core', 'hydrophobic', 'fragment', 'of', 'Alzheimer', 's', 'β', 'amyloid', 'peptide', 'a', 'reductionist', 'approach', 'Zeenat', 'Mirza', 'Vikram', 'Gopalakrishna', 'Pillai', 'Sajjad', 'Karim', 'Sujata', 'Sharma', 'Punit', 'Kaur', 'Alagiri', 'Srinivasan', 'Tej', 'P', 'Singh', 'Mohammed', 'Al', 'Qahtani', 'P109', 'Differential', 'expression', 'profiling', 'between', 'meningiomas', 'from', 'female', 'and', 'male', 'patients', 'Reem', 'Alotibi', 'Alaa', 'Al', 'Ahmadi', 'Fatima', 'Al', 'Adwani', 'Deema', 'Hussein', 'Sajjad', 'Karim', 'Mona', 'Al', 'Sharif', 'Awatif', 'Jamal', 'Fahad', 'Al', 'Ghamdi', 'Jaudah', 'Al', 'Maghrabi', 'Saleh', 'S', 'Baeesa', 'Mohammed', 'Bangash', 'Adeel', 'Chaudhary', 'Hans', 'Juergen', 'Schulten', 'Mohammed', 'Al', 'Qahtani', 'P110', 'Neurospheres', 'as', 'models', 'of', 'early', 'brain', 'development', 'and', 'therapeutics', 'Muhammad', 'Faheem', 'Peter', 'Natesan', 'Pushparaj', 'Shilu', 'Mathew', 'Taha', 'Abdullah', 'Kumosani', 'Gauthaman', 'Kalamegam', 'Mohammed', 'Al', 'Qahtani', 'P111', 'Identification', 'of', 'a', 'recurrent', 'causative', 'missense', 'mutation', 'p', 'W577C', 'at', 'the', 'LDLR', 'exon', '12', 'in', 'familial', 'hypercholesterolemia', 'affected', 'Saudi', 'families', 'Faisal', 'A', 'Al', 'Allaf', 'Zainularifeen', 'Abduljaleel', 'Abdullah', 'Alashwal', 'Mohiuddin', 'M', 'Taher', 'Abdellatif', 'Bouazzaoui', 'Halah', 'Abalkhail', 'Faisal', 'A', 'Ba', 'Hammam', 'Mohammad', 'Athar', 'P112', 'Epithelial', 'ovarian', 'carcinoma', 'EOC', 'Systems', 'oncological', 'approach', 'to', 'identify', 'diagnostic', 'prognostic', 'and', 'therapeutic', 'biomarkers', 'Gauthaman', 'Kalamegam', 'Peter', 'Natesan', 'Pushparaj', 'Muhammad', 'Abu', 'Elmagd', 'Farid', 'Ahmed', 'Khalid', 'HussainWali', 'Sait', 'Nisreen', 'Anfinan', 'Mamdooh', 'Gari', 'Adeel', 'Chaudhary', 'Adel', 'Abuzenadah', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'P113', 'Crohn', 's', 'disease', 'phenotype', 'in', 'northern', 'Tunisian', 'population', 'Naira', 'Ben', 'Mami', 'Yosr', 'Z', 'Haffani', 'Mouna', 'Medhioub', 'Lamine', 'Hamzaoui', 'Ameur', 'Cherif', 'Msadok', 'Azouz', 'P114', 'Establishment', 'of', 'In', 'Silico', 'approaches', 'to', 'decipher', 'the', 'potential', 'toxicity', 'and', 'mechanism', 'of', 'action', 'of', 'drug', 'candidates', 'and', 'environmental', 'agents', 'Gauthaman', 'Kalamegam', 'Fazal', 'Khan', 'Shilu', 'Mathew', 'Mohammed', 'Imran', 'Nasser', 'Mahmood', 'Rasool', 'Farid', 'Ahmed', 'Peter', 'Natesan', 'Pushparaj', 'Mohammed', 'Al', 'Qahtani', 'P115', '1q', 'Gain', 'predicts', 'poor', 'prognosis', 'marker', 'for', 'young', 'breast', 'cancer', 'patients', 'Shereen', 'A', 'Turkistany', 'Lina', 'M', 'Al', 'harbi', 'Ashraf', 'Dallol', 'Jamal', 'Sabir', 'Adeel', 'Chaudhary', 'Adel', 'Abuzenadah', 'P116', 'Disorders', 'of', 'sex', 'chromosomes', 'in', 'a', 'diagnostic', 'genomic', 'medicine', 'unit', 'in', 'Saudi', 'Arabia', 'Prevalence', 'diagnosis', 'and', 'future', 'guidelines', 'Basmah', 'Al', 'Madoudi', 'Bayan', 'Al', 'Aslani', 'Khulud', 'Al', 'Harbi', 'Rwan', 'Al', 'Jahdali', 'Hanadi', 'Qudaih', 'Emad', 'Al', 'Hamzy', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'P117', 'Combination', 'of', 'WYE354', 'and', 'Sunitinib', 'demonstrate', 'synergistic', 'inhibition', 'of', 'acute', 'myeloid', 'leukemia', 'in', 'vitro', 'Asad', 'M', 'Ilyas', 'Youssri', 'Ahmed', 'Mamdooh', 'Gari', 'Farid', 'Ahmed', 'Mohammed', 'Alqahtani', 'P118', 'Integrated', 'use', 'of', 'evolutionary', 'information', 'in', 'GWAS', 'reveals', 'important', 'SNPs', 'in', 'Asthma', 'Nada', 'Salem', 'Sajjad', 'Karim', 'Elham', 'M', 'Alhathli', 'Heba', 'Abusamra', 'Hend', 'F', 'Nour', 'Eldin', 'Mohammed', 'H', 'Al', 'Qahtani', 'Sudhir', 'Kumar', 'P119', 'Assessment', 'of', 'BRAF', 'IDH1', 'IDH2', 'and', 'EGFR', 'mutations', 'in', 'a', 'series', 'of', 'primary', 'brain', 'tumors', 'Fatima', 'Al', 'Adwani', 'Deema', 'Hussein', 'Mona', 'Al', 'Sharif', 'Awatif', 'Jamal', 'Fahad', 'Al', 'Ghamdi', 'Jaudah', 'Al', 'Maghrabi', 'Saleh', 'S', 'Baeesa', 'Mohammed', 'Bangash', 'Adeel', 'Chaudhary', 'Mohammed', 'Al', 'Qahtani', 'Hans', 'Juergen', 'Schulten', 'P120', 'Expression', 'profiles', 'distinguish', 'oligodendrogliomas', 'from', 'glioblastoma', 'multiformes', 'with', 'or', 'without', 'oligodendroglioma', 'component', 'Alaa', 'Alamandi', 'Reem', 'Alotibi', 'Deema', 'Hussein', 'Sajjad', 'Karim', 'Jaudah', 'Al', 'Maghrabi', 'Fahad', 'Al', 'Ghamdi', 'Awatif', 'Jamal', 'Saleh', 'S', 'Baeesa', 'Mohammed', 'Bangash', 'Adeel', 'Chaudhary', 'Hans', 'Juergen', 'Schulten', 'Mohammed', 'Al', 'Qahtani', 'P121', 'Hierarchical', 'clustering', 'in', 'thyroid', 'goiters', 'and', 'hyperplastic', 'lesions', 'Ohoud', 'Subhi', 'Nadia', 'Bagatian', 'Sajjad', 'Karim', 'Adel', 'Al', 'Johari', 'Osman', 'Abdel', 'Al', 'Hamour', 'Hosam', 'Al', 'Aradati', 'Abdulmonem', 'Al', 'Mutawa', 'Faisal', 'Al', 'Mashat', 'Jaudah', 'Al', 'Maghrabi', 'Hans', 'Juergen', 'Schulten', 'Mohammad', 'Al', 'Qahtani', 'P122', 'Differential', 'expression', 'analysis', 'in', 'thyroiditis', 'and', 'papillary', 'thyroid', 'carcinomas', 'with', 'or', 'without', 'coexisting', 'thyroiditis', 'Nadia', 'Bagatian', 'Ohoud', 'Subhi', 'Sajjad', 'Karim', 'Adel', 'Al', 'Johari', 'Osman', 'Abdel', 'Al', 'Hamour', 'Abdulmonem', 'Al', 'Mutawa', 'Hosam', 'Al', 'Aradati', 'Faisal', 'Al', 'Mashat', 'Mohammad', 'Al', 'Qahtani', 'Hans', 'Juergen', 'Schulten', 'Jaudah', 'Al', 'Maghrabi', 'P123', 'Metagenomic', 'analysis', 'of', 'waste', 'water', 'microbiome', 'in', 'Sausdi', 'Arabia', 'Muhammad', 'W', 'shah', 'Muhammad', 'Yasir', 'Esam', 'I', 'Azhar', 'Saad', 'Al', 'Masoodi', 'P124', 'Molecular', 'characterization', 'of', 'Helicobacter', 'pylori', 'from', 'faecal', 'samples', 'of', 'Tunisian', 'patients', 'with', 'gastric', 'cancer', 'Yosr', 'Z', 'Haffani', 'Msadok', 'Azouz', 'Emna', 'Khamla', 'Chaima', 'Jlassi', 'Ahmed', 'S', 'Masmoudi', 'Ameur', 'Cherif', 'Lassaad', 'Belbahri', 'P125', 'Diagnostic', 'application', 'of', 'the', 'oncoscan', 'panel', 'for', 'the', 'identification', 'of', 'hereditary', 'cancer', 'syndrome', 'Shadi', 'Al', 'Khayyat', 'Roba', 'Attas', 'Atlal', 'Abu', 'Sanad', 'Mohammed', 'Abuzinadah', 'Adnan', 'MerdadAshraf', 'Dallol', 'Adeel', 'Chaudhary', 'Mohammed', 'Al', 'Qahtani', 'Adel', 'Abuzenadah', 'P126', 'Characterization', 'of', 'clinical', 'and', 'neurocognitive', 'features', 'in', 'a', 'family', 'with', 'a', 'novel', 'OGT', 'gene', 'missense', 'mutation', 'c', '1193G', 'A', 'p', 'Ala319Thr', 'Habib', 'Bouazzi', 'Carlos', 'Trujillo', 'Mohammad', 'Khalid', 'Alwasiyah', 'Mohammed', 'Al', 'Qahtani', 'P127', 'Case', 'report', 'a', 'rare', 'homozygous', 'deletion', 'mutation', 'of', 'TMEM70', 'gene', 'associated', 'with', '3', 'Methylglutaconic', 'Aciduria', 'and', 'cataract', 'in', 'a', 'Saudi', 'patient', 'Maha', 'Alotaibi', 'Rami', 'Nassir', 'P128', 'Isolation', 'and', 'purification', 'of', 'antimicrobial', 'milk', 'proteins', 'Ishfaq', 'A', 'Sheikh', 'Mohammad', 'A', 'Kamal', 'Essam', 'H', 'Jiffri', 'Ghulam', 'M', 'Ashraf', 'Mohd', 'A', 'Beg', 'P129', 'Integrated', 'analysis', 'reveals', 'association', 'of', 'ATP8B1', 'gene', 'with', 'colorectal', 'cancer', 'Mohammad', 'A', 'Aziz', 'Rizwan', 'Ali', 'Mahmood', 'Rasool', 'Mohammad', 'S', 'Jamal', 'Nusaibah', 'samman', 'Ghufrana', 'Abdussami', 'Sathish', 'Periyasamy', 'Mohiuddin', 'K', 'Warsi', 'Mohammed', 'Aldress', 'Majed', 'Al', 'Otaibi', 'Zeyad', 'Al', 'Yousef', 'Mohamed', 'Boudjelal', 'Abdelbasit', 'Buhmeida', 'Mohammed', 'H', 'Al', 'Qahtani', 'Ibrahim', 'AlAbdulkarim', 'P130', 'Implication', 'of', 'IL', '10', 'and', 'IL', '28', 'polymorphism', 'with', 'successful', 'anti', 'HCV', 'therapy', 'and', 'viral', 'clearance', 'Rubi', 'Ghazala', 'Shilu', 'Mathew', 'M', 'Haroon', 'Hamed', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'Ishtiaq', 'Qadri', 'P131', 'Interactions', 'of', 'endocrine', 'disruptor', 'di', '2', 'ethylhexyl', 'phthalate', 'DEHP', 'and', 'its', 'metabolite', 'mono', '2', 'ethylhexyl', 'phthalate', 'MEHP', 'with', 'progesterone', 'receptor', 'Ishfaq', 'A', 'Sheikh', 'Muhammad', 'Abu', 'Elmagd', 'Rola', 'F', 'Turki', 'Ghazi', 'A', 'Damanhouri', 'Mohd', 'A', 'Beg', 'P132', 'Association', 'of', 'HCV', 'nucleotide', 'polymorphism', 'in', 'the', 'development', 'of', 'hepatocellular', 'carcinoma', 'Mohd', 'Suhail', 'Abid', 'Qureshi', 'Adil', 'Jamal', 'Peter', 'Natesan', 'Pushparaj', 'Mohammad', 'Al', 'Qahtani', 'Ishtiaq', 'Qadri', 'P133', 'Gene', 'expression', 'profiling', 'by', 'DNA', 'microarrays', 'in', 'colon', 'cancer', 'treated', 'with', 'chelidonine', 'alkaloid', 'Mahmoud', 'Z', 'El', 'Readi', 'Safaa', 'Y', 'Eid', 'Michael', 'Wink', 'P134', 'Successful', 'in', 'vitro', 'fertilization', 'after', 'eight', 'failed', 'trials', 'Ahmed', 'M', 'Isa', 'Lulu', 'Alnuaim', 'Johara', 'Almutawa', 'Basim', 'Abu', 'Rafae', 'Saleh', 'Alasiri', 'Saleh', 'Binsaleh', 'P135', 'Genetic', 'sensitivity', 'analysis', 'using', 'SCGE', 'cell', 'cycle', 'and', 'mitochondrial', 'membrane', 'potential', 'in', 'OPs', 'stressed', 'leukocytes', 'in', 'Rattus', 'norvegicus', 'through', 'flow', 'cytometric', 'input', 'Nazia', 'Nazam', 'Mohamad', 'I', 'Lone', 'Waseem', 'Ahmad', 'Shakeel', 'A', 'Ansari', 'Mohamed', 'H', 'Alqahtani']"
2655,Antibody Engineering for Pursuing a Healthier Future,2017-03-28,Front Microbiol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368232/,"Since the development of antibody-production techniques, a number of immunoglobulins have been developed on a large scale using conventional methods. Hybridoma technology opened a new horizon in the production of antibodies against target antigens of infectious pathogens, malignant diseases including autoimmune disorders, and numerous potent toxins. However, these clinical humanized or chimeric murine antibodies have several limitations and complexities. Therefore, to overcome these difficulties, recent advances in genetic engineering techniques and phage display technique have allowed the production of highly specific recombinant antibodies. These engineered antibodies have been constructed in the hunt for novel therapeutic drugs equipped with enhanced immunoprotective abilities, such as engaging immune effector functions, effective development of fusion proteins, efficient tumor and tissue penetration, and high-affinity antibodies directed against conserved targets. Advanced antibody engineering techniques have extensive applications in the fields of immunology, biotechnology, diagnostics, and therapeutic medicines. However, there is limited knowledge regarding dynamic antibody development approaches. Therefore, this review extends beyond our understanding of conventional polyclonal and monoclonal antibodies. Furthermore, recent advances in antibody engineering techniques together with antibody fragments, display technologies, immunomodulation, and broad applications of antibodies are discussed to enhance innovative antibody production in pursuit of a healthier future for humans.",10.3389/fmicb.2017.00495,0fegsm1v,"['Since', 'the', 'development', 'of', 'antibody', 'production', 'techniques', 'a', 'number', 'of', 'immunoglobulins', 'have', 'been', 'developed', 'on', 'a', 'large', 'scale', 'using', 'conventional', 'methods', 'Hybridoma', 'technology', 'opened', 'a', 'new', 'horizon', 'in', 'the', 'production', 'of', 'antibodies', 'against', 'target', 'antigens', 'of', 'infectious', 'pathogens', 'malignant', 'diseases', 'including', 'autoimmune', 'disorders', 'and', 'numerous', 'potent', 'toxins', 'However', 'these', 'clinical', 'humanized', 'or', 'chimeric', 'murine', 'antibodies', 'have', 'several', 'limitations', 'and', 'complexities', 'Therefore', 'to', 'overcome', 'these', 'difficulties', 'recent', 'advances', 'in', 'genetic', 'engineering', 'techniques', 'and', 'phage', 'display', 'technique', 'have', 'allowed', 'the', 'production', 'of', 'highly', 'specific', 'recombinant', 'antibodies', 'These', 'engineered', 'antibodies', 'have', 'been', 'constructed', 'in', 'the', 'hunt', 'for', 'novel', 'therapeutic', 'drugs', 'equipped', 'with', 'enhanced', 'immunoprotective', 'abilities', 'such', 'as', 'engaging', 'immune', 'effector', 'functions', 'effective', 'development', 'of', 'fusion', 'proteins', 'efficient', 'tumor', 'and', 'tissue', 'penetration', 'and', 'high', 'affinity', 'antibodies', 'directed', 'against', 'conserved', 'targets', 'Advanced', 'antibody', 'engineering', 'techniques', 'have', 'extensive', 'applications', 'in', 'the', 'fields', 'of', 'immunology', 'biotechnology', 'diagnostics', 'and', 'therapeutic', 'medicines', 'However', 'there', 'is', 'limited', 'knowledge', 'regarding', 'dynamic', 'antibody', 'development', 'approaches', 'Therefore', 'this', 'review', 'extends', 'beyond', 'our', 'understanding', 'of', 'conventional', 'polyclonal', 'and', 'monoclonal', 'antibodies', 'Furthermore', 'recent', 'advances', 'in', 'antibody', 'engineering', 'techniques', 'together', 'with', 'antibody', 'fragments', 'display', 'technologies', 'immunomodulation', 'and', 'broad', 'applications', 'of', 'antibodies', 'are', 'discussed', 'to', 'enhance', 'innovative', 'antibody', 'production', 'in', 'pursuit', 'of', 'a', 'healthier', 'future', 'for', 'humans', '']"
2785,"36th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium. 15-18 March 2016",2016-04-20,Crit Care,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493079/,"P001 - Sepsis impairs the capillary response within hypoxic capillaries and decreases erythrocyte oxygen-dependent ATP efflux R. M. Bateman, M. D. Sharpe, J. E. Jagger, C. G. Ellis P002 - Lower serum immunoglobulin G2 level does not predispose to severe flu. J. Solé-Violán, M. López-Rodríguez, E. Herrera-Ramos, J. Ruíz-Hernández, L. Borderías, J. Horcajada, N. González-Quevedo, O. Rajas, M. Briones, F. Rodríguez de Castro, C. Rodríguez Gallego P003 - Brain protective effects of intravenous immunoglobulin through inhibition of complement activation and apoptosis in a rat model of sepsis F. Esen, G. Orhun, P. Ergin Ozcan, E. Senturk, C. Ugur Yilmaz, N. Orhan, N. Arican, M. Kaya, M. Kucukerden, M. Giris, U. Akcan, S. Bilgic Gazioglu, E. Tuzun P004 - Adenosine a1 receptor dysfunction is associated with leukopenia: A possible mechanism for sepsis-induced leukopenia R. Riff, O. Naamani, A. Douvdevani P005 - Analysis of neutrophil by hyper spectral imaging - A preliminary report R. Takegawa, H. Yoshida, T. Hirose, N. Yamamoto, H. Hagiya, M. Ojima, Y. Akeda, O. Tasaki, K. Tomono, T. Shimazu P006 - Chemiluminescent intensity assessed by eaa predicts the incidence of postoperative infectious complications following gastrointestinal surgery S. Ono, T. Kubo, S. Suda, T. Ueno, T. Ikeda P007 - Serial change of c1 inhibitor in patients with sepsis – A prospective observational study T. Hirose, H. Ogura, H. Takahashi, M. Ojima, J. Kang, Y. Nakamura, T. Kojima, T. Shimazu P008 - Comparison of bacteremia and sepsis on sepsis related biomarkers T. Ikeda, S. Suda, Y. Izutani, T. Ueno, S. Ono P009 - The changes of procalcitonin levels in critical patients with abdominal septic shock during blood purification T. Taniguchi, M. O P010 - Validation of a new sensitive point of care device for rapid measurement of procalcitonin C. Dinter, J. Lotz, B. Eilers, C. Wissmann, R. Lott P011 - Infection biomarkers in primary care patients with acute respiratory tract infections – Comparison of procalcitonin and C-reactive protein M. M. Meili, P. S. Schuetz P012 - Do we need a lower procalcitonin cut off? H. Hawa, M. Sharshir, M. Aburageila, N. Salahuddin P013 - The predictive role of C-reactive protein and procalcitonin biomarkers in central nervous system infections with extensively drug resistant bacteria V. Chantziara, S. Georgiou, A. Tsimogianni, P. Alexandropoulos, A. Vassi, F. Lagiou, M. Valta, G. Micha, E. Chinou, G. Michaloudis P014 - Changes in endotoxin activity assay and procalcitonin levels after direct hemoperfusion with polymyxin-b immobilized fiber A. Kodaira, T. Ikeda, S. Ono, T. Ueno, S. Suda, Y. Izutani, H. Imaizumi P015 - Diagnostic usefullness of combination biomarkers on ICU admission M. V. De la Torre-Prados, A. Garcia-De la Torre, A. Enguix-Armada, A. Puerto-Morlan, V. Perez-Valero, A. Garcia-Alcantara P016 - Platelet function analysis utilising the PFA-100 does not predict infection, bacteraemia, sepsis or outcome in critically ill patients N. Bolton, J. Dudziak, S. Bonney, A. Tridente, P. Nee P017 - Extracellular histone H3 levels are inversely correlated with antithrombin levels and platelet counts and are associated with mortality in sepsis patients G. Nicolaes, M. Wiewel, M. Schultz, K. Wildhagen, J. Horn, R. Schrijver, T. Van der Poll, C. Reutelingsperger P018 - Il-8: is this a more reliable biomarker for sepsis severity than CRP, Procalcitonin, E-selectin, IL-6 and TNF-[alpha] S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P019 - Relation between adrenomedullin and short-term outcome in ICU patients: Results from the frog ICU study E. G. Gayat, J. Struck, A. Cariou, N. Deye, B. Guidet, S. Jabert, J. Launay, M. Legrand, M. Léone, M. Resche-Rigon, E. Vicaut, A. Vieillard-Baron, A. Mebazaa P020 - Impact of disease severity assessment on performance of heparin-binding protein for the prediction of septic shock R. Arnold, M. Capan, A. Linder, P. Akesson P021 - Kinetics and prognostic value of presepsin (sCD14) in septic patients. A pilot study M. Popescu, D. Tomescu P022 - Comparison of CD64 levels performed by the facs and accellix systems C. L. Sprung, R. Calderon Morales, G. Munteanu, E. Orenbuch-Harroch, P. Levin, H. Kasdan, A. Reiter, T. Volker, Y. Himmel, Y. Cohen, J. Meissonnier P023 - Diagnosing sepsis in 5 minutes: Nanofluidic technology study with pancreatic-stone protein (PSP/ reg) L. Girard, F. Rebeaud P024 - How nanotechnology-based approaches could contribute to sepsis prevention, diagnosis and treatment I. Herrmann P025 - Il7r transcriptional expression analysis during septic shock B. Delwarde, E. Peronnet, E. Cerrato, F. Venet, A. Lepape, T. Rimmelé, G. Monneret, J. Textoris P026 - Disbalance of microbial metabolites of aromatic acids affects the severity in critically ill patients N. Beloborodova, V. Moroz, A. Osipov, A. Bedova, Y. Sarshor, A. Pautova, A. Sergeev, E. Chernevskaya P027 - Copeptin predicts 10-year all-cause mortality in community patients J. Odermatt, R. Bolliger, L. Hersberger, M. Ottiger, M. Christ-Crain, B. Mueller, P. Schuetz P028 - Identification of differential proteomic response in septic patients secondary to community and hospital acquired pneumonia N. K. Sharma, A. K. Tashima, M. K. Brunialti, F. R. Machado, M. Assuncao, O. Rigato, R. Salomao P029 - Monocyte HLA-DR expression in community-acquired bacteremic sepsis - dynamics associated to aetiology and prediction of secondary sepsis S. C. Cajander, G. Rasmussen, E. Tina, B. Söderquist, J. Källman, K. Strålin P030 - Soluble B- and T-lymphocyte attenuator: A possible prognostic marker in sepsis A. L. Lange, J. S. Sundén-Cullberg, A. M. Magnuson, O. H. Hultgren P031 - Fractal dimension: A new biomarker for quantifying clot microstructure in patients across the sepsis spectrum G. Davies, S. Pillai, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P032 - Comparison between the new biomarker for coagulation, clot microstructure (Df) with rotational thromboelastometry (ROTEM) in patients across the sepsis spectrum S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P033 - Changes in fibrinolysis across the sepsis spectrum: The use of rotational thromboelastometry (ROTEM) lysis index (LI60) and D-Dimer concentration S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P034 - The intensive care infection score – a promising marker for the prediction of infection and its severity. P. Van der Geest, M. Mohseni, J. Linssen, R. De Jonge, S. Duran, J. Groeneveld P035 - Challenges in the clinical diagnosis of sepsis R. Miller III, B. K. Lopansri, L. C. McHugh, A. Seldon, J. P. Burke P036 - Does zero heat flux thermometry more accurately identify sepsis on intensive care? J. Johnston, R. Reece-Anthony, A. Bond, A. Molokhia P037 - Advancing quality (AQ) sepsis programme: Improving early identification & treatment of sepsis in North West England. C. Mcgrath, E. Nsutebu P038 - Prehospital transport of acute septic patients P. Bank Pedersen, D. Pilsgaard Henriksen, S. Mikkelsen, A. Touborg Lassen P039 - Vasodilatory plant extracts gel as an alternative treatment for fever in critically ill patients R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P040 - Host response and outcome of hypothermic sepsis M. A. Wiewel, M. B. Harmon, L. A. Van Vught, B. P. Scicluna, A. J. Hoogendijk, J. Horn, A. H. Zwinderman, O. L. Cremer, M. J. Bonten, M. J. Schultz, T. Van der Poll, N. P. Juffermans, W. J. Wiersinga P041 - Septic shock alert over SIRS criteria has an impact on outcome but needs to be revised G. Eren, Y Tekdos, M. Dogan, O. Acicbe, E. Kaya, O. Hergunsel P042 - Association between previous prescription of βblockers and mortality rate among septic patients: A retrospective observational study S. Alsolamy, G. Ghamdi, L. Alswaidan, S. Alharbi, F. Alenezi, Y. Arabi P043 - Recognition and treatment of sepsis on labour ward– teaching & information resources can improve knowledge J. Heaton, A. Boyce, L. Nolan, J. Johnston, A. Dukoff-Gordon, A. Dean, A. Molokhia P044 - Culture negative sepsis in the ICU – what is unique to this patient population? T. Mann Ben Yehudah P045 - Organ dysfunction in severe sepsis patients identified in administrative data in Germany, 2007-2013 C. Fleischmann, D. Thomas-Rueddel, C. Haas, U. Dennler, K. Reinhart P046 - A comparison of residents’ knowledge regarding; the Surviving Sepsis Campaign 2012 guideline O. Suntornlohanakul, B. Khwannimit P047 - Effectiveness of a septic shock bundle to improve outcomes in the ICU F. Breckenridge, A. Puxty P048 - Dose of norepinephrine in the first 24 hours as a parameter evaluating the effectiveness of treatment in patients with severe sepsis and septic shock P. Szturz, P. Folwarzcny, J. Svancara, R. Kula, P. Sevcik P049 - Norepinephrine or vasopressin + norepinephrine in septic shock. A retrospective series of 39 patients L. Caneva, A. Casazza, E. Bellazzi, S. Marra, L. Pagani, M. Vetere, R. Vanzino, D. Ciprandi, R. Preda, R. Boschi, L. Carnevale P050 - Methylene blue effectiveness as contributory treatment in patients with septic shock V. Lopez, M. Aguilar Arzapalo, L. Barradas, A. Escalante, J. Gongora, M. Cetina P051 - Coagulation disorders in patients with severe sepsis and DIC evaluated with thromboelastometry. B Adamik, D Jakubczyk, A Kübler P052 - Frequency and outcome of early sepsis-associated coagulopathy A. Radford, T. Lee, J. Singer, J. Boyd, D. Fineberg, M. Williams, J. Russell P053 - Assessment of coagulopathy in cancer patients with severe sepsis or septic shock. A case-control pilot study E. Scarlatescu, D. Tomescu, G. Droc, S. Arama P054 - Thromboelastometry in critically ill patients with disseminated intravascular coagulation M. Müller, M. Straat, S. S. Zeerleder, N. P. Juffermans P055 - Cessation of a preexisting chronic antiplatelet therapy is associated with increased mortality rates in severe sepsis and septic shock C. F. Fuchs, C. S. Scheer, S. W. Wauschkuhn, M. V. Vollmer, K. M. Meissner, S. K. Kuhn, K. H. Hahnenkamp, S. R. Rehberg, M. G. Gründling P056 - Neutrophil Extracellular Traps (NETs) production under hypoxic condition N. Yamamoto, M. Ojima, S. Hamaguchi, T. Hirose, Y. Akeda, R. Takegawa, O. Tasaki, T. Shimazu, K. Tomono P057 - Impact of ultraviolet air sterilizer in intensive care unit room, and clinical outcomes of patients E. Gómez-Sánchez, M. Heredia-Rodríguez, E. Álvarez-Fuente, M. Lorenzo-López, E. Gómez-Pesquera, M. Aragón-Camino, P. Liu-Zhu, A. Sánchez-López, A. Hernández-Lozano, M. T. Peláez-Jareño, E. Tamayo P058 - Focus of infection in severe sepsis - comparison of administrative data and prospective cohorts from Germany D. O. Thomas-Rüddel, C. Fleischmann, C. Haas, U. Dennler, K. Reinhart P059 - “Zero CLABSI” – can we get there? Obstacles on the 4 year journey and our strategies to overcome them – experience from an Indian ICU V. Adora, A. Kar, A. Chakraborty, S. Roy, A. Bandyopadhyay, M. Das P060 - Novel molecular techniques to identify central venous catheter (CVC) associated blood stream infections (BSIs) T. Mann Ben Yehudah, G. Ben Yehudah, M. Salim, N. Kumar, L. Arabi, T. Burger, P. Lephart, E. Toth-martin P061 - Zero clabsi” – can we get there? Obstacles on the 4 year journey and our strategies to overcome them – experience from an Indian ICU R. Rao, A. Kar, A. Chakraborty P062 - Prevention of central line-associated bloodstream infections in intensive care units: An international online survey C. Valencia, N. Hammami, S. Blot, J. L. Vincent, M. L. Lambert P063 - 30 days antimicrobial efficacy of non-leaching central venous catheters J. Brunke, T. Riemann, I. Roschke P064 - Efficacy of noble metal alloy-coated catheter in prevention of bacteriuria R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P065 - Predicting bacteremic urinary tract infection in community setting: A prospective observational study S. Nimitvilai, K. Jintanapramote, S. Jarupongprapa P066 - Eight-year analysis of acinetobacter spp. monobacteremia in surgical and medical intensive care units at university hospital in Lithuania D. Adukauskiene, D. Valanciene P067 - Group A and group B streptococcal infections in intensive care unit – our experience in a tertiary centre G. Bose, V. Lostarakos, B. Carr P068 - Improved detection of spontaneous bacterial peritonitis by uritop + tm strip test and inoculation of blood culture bottles with ascitic fluid S. Khedher, A. Maaoui, A. Ezzamouri, M. Salem P069 - Increased risk of cellulitis in patients with congestive heart failure: a population based cohort study J. Chen P070 - Outcomes of severe cellulitis and necrotizing fasciitis in the critically ill D. R. Cranendonk, L. A. Van Vught, M. A. Wiewel, O. L. Cremer, J. Horn, M. J. Bonten, M. J. Schultz, T. Van der Poll, W. J. Wiersinga P071 - Botulism outbreak associated with people who inject drugs (PWIDs) in Scotland. M. Day, G. Penrice, K. Roy, P. Robertson, G. Godbole, B. Jones, M. Booth, L. Donaldson P072 - Surveillance of ESBL-producing enterobacteriaceae fecal carriers in the ICU Y. Kawano, H. Ishikura P073 - Prevalence of ESBL and carbapenemase producing uropathogens in a newly opened hospital in south India S. Sreevidya, N. Brahmananda Reddy, P. Muraray Govind, R. Pratheema, J. Devachandran Apollo Speciality Hospital - OMR, Chennai, India P074 - Prevalence, risk factors and outcomes of methicillin-resistant staphylococcus aureus nasal colonization in critically ill patients H. Al-Dorzi, M. Almutairi, B. Alhamadi, A. Crizaldo Toledo, R. Khan, B. Al Raiy, Y. Arabi P075 - Multidrug-resistant Acinetobacter baumannii infection in intensive care unit patients in a hospital with building construction: Is there an association? H. Talaie P076 - Multidrug-resistant organisms in a Dutch ICU J. A. Van Oers, A. Harts, E. Nieuwkoop, P. Vos P077 - Epidemiology and risk factors of ICU acquired infections caused by multidrug-resistant gram negative bacilli Y. Boussarsar, F. Boutouta, S. Kamoun, I. Mezghani, S. Koubaji, A. Ben Souissi, A. Riahi, M. S. Mebazaa P078 - Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins E. Giamarellos-Bourboulis, N. Tziolos, C. Routsi, C. Katsenos, I. Tsangaris, I. Pneumatikos, G. Vlachogiannis, V. Theodorou, A. Prekates, E. Antypa, V. Koulouras, N. Kapravelos, C. Gogos, E. Antoniadou, K. Mandragos, A. Armaganidis P079 - Must change the medical practice in ICU? A. R. Robles Caballero, B. Civantos, J. C. Figueira, J. López P080 - Mediterranean spotted fever in an infectious diseases intensive care unit A. Silva-Pinto, F. Ceia, A. Sarmento, L. Santos P081 - Clinical features and outcomes of patients with Middle East respiratory syndrome requiring admission to a saudi intensive care unit: A retrospective analysis of 31 cases G. Almekhlafi, Y. Sakr P082 - The ICU response to a hospital outbreak of Middle East respiratory syndrome coronavirus infection H. Al-Dorzi, R. Khan, S. Baharoon, A. Aldawood, A. Matroud, J. Alchin, S. Al Johani, H. Balkhy, Y. Arabi P083 - Middle East respiratory syndrome: Surveillance data analysis S. Alsolamy, S. Y. Yousif, B. O. Alotabi, A. S. Alsaawi P085 - Use of Taqman array card molecular diagnostics in severe pneumonia: A case series J. Ang, MD Curran, D. Enoch, V. Navapurkar, A. Conway Morris P086 - ‘BUNS’: An investigation protocol improves the ICU management of pneumonia R. Sharvill, J. Astin P087 - Pneumonia in patients following secondary peritonitis: epidemiological features and impact on mortality M. Heredia-Rodríguez, E. Gómez-Sánchez, M. T. Peláez-Jareño, E. Gómez-Pesquera, M. Lorenzo-López, P. Liu-Zhu, M. Aragón-Camino, A. Hernández-Lozano, A. Sánchez-López, E. Álvarez-Fuente, E. Tamayo P088 - The use of the “CURB-65 score” by emergency room clinicians in a large teaching hospital J. Patel, C. Kruger P089 - Incidence of community acquired pneumonia with viral infection in mechanically ventilated patients in the medical intensive care unit J. O’Neal, H. Rhodes, J. Jancik P090 - The SAATELLITE Study: Prevention of S aureus Nosocomial Pneumonia (NP) with MEDI4893, a Human Monoclonal Antibody (mAb) Against S aureus B. François, P. F. Laterre, P. Eggimann, A. Torres, M. Sánchez, P. F. Dequin, G. L. Bassi, J. Chastre, H. S. Jafri P091 - Risk factors and microbiological profile for nosocomial infections in trauma patients M. Ben Romdhane, Z. Douira, S. Kamoun, M. Bousselmi, A. Ben Souissi, Y. Boussarsar, A. Riahi, M.S. Mebazaa P092 - Correlation between percentages of ventilated patients developed vap and use of antimicrobial agents in ICU patients. A. Vakalos, V. Avramidis P093 - A comparison of two ventilator associated pneumonia surveillance techniques T. H. Craven, G. Wojcik, K. Kefala, J. McCoubrey, J. Reilly, R. Paterson, D. Inverarity, I. Laurenson, T. S. Walsh P094 - Lung ultrasound before and after fiberbronchoscopy - modifications may improve ventilator-associated pneumonia diagnosis S. Mongodi, B. Bouhemad, A. Orlando, A. Stella, G. Via, G. Iotti, A. Braschi, F. Mojoli P095 - Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia M. Haliloglu, B. Bilgili, U. Kasapoglu, I. Sayan, M. Süzer Aslan, A. Yalcın, I. Cinel P096 - Impact of pRBCs transfusion on percentage of ventilated patients developed VAP in ICU patients A. Vakalos, V. Avramidis P097 - The impact of a series of interventions on the rate of ventilator associated pneumonia in a large teaching hospital H. E. Ellis, K. Bauchmuller, D. Miller, A Temple P098 - The EVADE study: Prevention of Nosocomial Pneumonia (NP) caused by P aeruginosa with MEDI3902, a Novel Bispecific Monoclonal Antibody, against P aeruginosa virulence factors J. Chastre, B. François, A. Torres, C. E. Luyt, M. Sánchez, M. Singer, H. S. Jafri P099 - Short-term inhaled colistin adjunctive therapy for ventilator-associated pneumonia Y. Nassar, M. S. Ayad P100 - Effect of aerosolised colistin on weaning from mechanical ventilation A. Trifi, S. Abdellatif, F. Daly, R. Nasri, S. Ben Lakhal P101 - Septic shock is an independent risk factor for colistin-induced severe acute kidney injury: a retrospective cohort study B. Bilgili, M. Haliloglu, F. Gul, I. Cinel P102 - Nosocomial pneumonia - emphasis on inhaled tobramycin A. Kuzovlev, A. Shabanov, S. Polovnikov, V. Moroz P103 - In vitro evaluation of amikacin inhale and commercial nebulizers in a mechanical ventilator N. Kadrichu, T. Dang, K. Corkery, P. Challoner P104 - The effects of nebulized amikacin/fosfomycin and systemic meropenem on severe amikacin-resistant meropenem-susceptible P.aeruginosa pneumonia G. Li Bassi, E. Aguilera, C. Chiurazzi, C. Travierso, A. Motos, L. Fernandez, R. Amaro, T. Senussi, F. Idone, J. Bobi, M. Rigol, A. Torres P105 - Optimization of gentamicin peak concentrations in critically ill patients C. J. Hodiamont, N. P. Juffermans, J. M. Janssen, C. S. Bouman, R. A. Mathôt, M. D. De Jong, R. M. Van Hest P106 - Systematic review of cefepime induced neurotoxicity L. Payne, G. L. Fraser P107 - Unasyn® causes QT prolongation during treatment of intensive care patients B. Tudor, M. Lahner, G. Roth, C. Krenn P108 - Comparative study between teicoplanin and vancomycin in methicillin-resistant staphylococcus aureus (mrsa) infectious of toxicological intensive care unit (ticu) patients – Tehran, Iran H. Talaie P109 - Phage therapy against antimicrobial resistance, design of the first clinical study phagoburn P. Jault, J. Gabard, T. Leclerc, S. Jennes, Y. Que, A. Rousseau, F. Ravat P110 - Antibiotic dosing errors in critically ill patients with severe sepsis or septic shock H. Al-Dorzi, A. Eissa, S. Al-Harbi, T. Aldabbagh, R. Khan, Y. Arabi P111 - Does empiric antifungal therapy improve survival in septic critically ill patients? (immunocompromised excluded) A. Trifi, S. Abdellatif, F. Daly, R. Nasri, S. Ben Lakhal P112 - Neurocysticercosis-Qatar experience F. Paramba, N. Purayil, V. Naushad, O. Mohammad, V. Negi, P. Chandra P113 - Early indicators in acute haemorrhagic shock A. Kleinsasser P114 - Filtering of red blood cells reduces the inflammatory response of pulmonary cells in an in vitro model of mechanical ventilation M. R. Witrz, J. F. Buchner-Doeven, A. M. Tuip-de Boer, J. C. Goslings, N. P. Juffermans P115 - Microparticles from red blood cell transfusion induce a pro-coagulant and pro-inflammatory endothelial cell response M. Van Hezel, M. Straat, A Boing, R Van Bruggen, N Juffermans P116 - The contribution of cytokines on thrombosis development during hospitalization in ICU D. Markopoulou, K. Venetsanou, V. Kaldis, D. Koutete, D. Chroni, I. Alamanos P117 - Prophylactic enoxaparin dosing and adjustment through anti-xa monitoring in an inpatient burn unit L. Koch, J. Jancik, H. Rhodes, E. Walter P118 - Determination of optimal cut-off values of haemoglobin, platelet count and fibrinogen at 24 hours after injury associated with mortality in trauma patients K. Maekawa, M. Hayakawa, S. Kushimoto, A. Shiraishi, H. Kato, J. Sasaki, H. Ogura, T. Matauoka, T. Uejima, N. Morimura, H. Ishikura, A. Hagiwara, M. Takeda P119 - Trauma-induced coagulopathy - prothrombin complex concentrate vs fresh frozen plasma O. Tarabrin, S. Shcherbakow, D. Gavrychenko, G. Mazurenko, V. Ivanova, O. Chystikov P120 - First study to prove the superiority of prothrombin complex concentrates on mortality rate over fresh frozen plasma in patients with acute bleeding C. Plourde, J. Lessard, J. Chauny, R. Daoust P121 - Prothrombin complex concentrate vs fresh frozen plasma in obstetric massive bleeding S. Shcherbakow, O. Tarabrin, D. Gavrychenko, G. Mazurenko, O. Chystikov P122 - Impact of FFP transfusion on VAP in ICU patients A. Vakalos, V. Avramidis P123 - Preoperative platelet function test and the thrombin generation assay are predictive for blood loss after cardiac surgery L. Kropman, L. In het Panhuis, J. Konings, D. Huskens, E. Schurgers, M. Roest, B. De Laat, M. Lance P124 - Rotational thromboelastometry versus standard coagulation tests before surgical interventions M. Durila, P. Lukas, M. Astraverkhava, J. Jonas P125 - Correction of impaired clot quality and stability by fibrinogen and activated prothrombin complex concentrate in a model of severe thrombocytopenia I. Budnik, B. Shenkman P126 - Assessment of point-of-care prothrombin time analyzer as a monitor after cardiopulmonary bypass H. Hayami, Y. Koide, T. Goto P127 - Disseminated intravascular coagulation (dic) is underdiagnosed in critically ill patients: do we need d-dimer measurements? R. Iqbal, Y. Alhamdi, N. Venugopal, S. Abrams, C. Downey, C. H. Toh, I. D. Welters P128 - Validity of the age-adjusted d-dimer cutoff in patients with COPD B. Bombay, J. M. Chauny, R. D. Daoust, J. L. Lessard, M. M. Marquis, J. P. Paquet P129 - A scoping review of strategies for prevention and management of bleeding following paediatric cardiopulmonary bypass surgery K. Siemens, D. Sangaran, B. J. Hunt, A. Durward, A. Nyman, I. A. Murdoch, S. M. Tibby P130 - Nadir hemoglobulin during cardiopulmonary bypass: impact on postoperative morbidity and mortality F. Ampatzidou, D. Moisidou, E. Dalampini, M. Nastou, E. Vasilarou, V. Kalaizi, H. Chatzikostenoglou, G. Drossos P131 - Red blood cell transfusion do not influence the prognostic value of RDW in critically ill patients S. Spadaro, A. Fogagnolo, T. Fiore, A. Schiavi, V. Fontana, F. Taccone, C. Volta P132 - Reasons for admission in the paediatric intensive care unit and the need for blood and blood products transfusions E. Chochliourou, E. Volakli, A. Violaki, E. Samkinidou, G. Evlavis, V. Panagiotidou, M. Sdougka P133 - The implementation of a massive haemorrhage protocol (mhp) for the management of major trauma: a ten year, single-centre study R. Mothukuri, C. Battle, K. Guy, G. Mills, P. Evans P134 - An integrated major haemorrhage protocol for pre-hospital and retrieval medical teams J. Wijesuriya, S. Keogh P135 - The impact of transfusion thresholds on mortality and cardiovascular events in patients with cardiovascular disease (non-cardiac surgery): a systematic review and meta-analysis A. Docherty, R. O’Donnell, S. Brunskill, M. Trivella, C. Doree, L. Holst, M. Parker, M. Gregersen, J. Almeida, T. Walsh, S. Stanworth P136 - The relationship between poor pre-operative immune status and outcome from cardiac surgery is specific to the peri-operative antigenic threat S. Moravcova, J. Mansell, A. Rogers, R. A. Smith, C. Hamilton-Davies P137 - Impact of simple clinical practice guidelines for reducing post-operative atrial fibrillation after cardiac surgery. A. Omar, M. Allam, O. Bilala, A. Kindawi, H. Ewila P138 - Dexamethasone administration during cardiopulmonary bypass has no beneficial effects on elective postoperative cardiac surgery patients F. Ampatzidou, D. Moisidou, M. Nastou, E. Dalampini, A. Malamas, E. Vasilarou, G. Drossos P139 - Intra-aortic balloon counterpulsation in patients undergoing cardiac surgery (IABCS): preliminary results G. Ferreira, J. Caldas, J. Fukushima, E. A. Osawa, E. Arita, L. Camara, S. Zeferino, J. Jardim, F. Gaioto, L. Dallan, F. B. Jatene, R. Kalil Filho, .F Galas, L. A. Hajjar P140 - Effects of low-dose atrial natriuretic peptide infusion on cardiac surgery-associated acute kidney injury C. Mitaka, T. Ohnuma, T. Murayama, F. Kunimoto, M. Nagashima, T. Takei, M. Tomita P141 - Acute kidney injury influence on high sensitive troponin measurements after cardiac surgery A. Omar, K. Mahmoud, S. Hanoura, S. Sudarsanan, P. Sivadasan, H. Othamn, Y. Shouman, R. Singh, A. Al Khulaifi P142 - Complex evaluation of endothelial dysfunction markers for prognosis of outcomes in patients undergoing cardiac surgery I. Mandel, S. Mikheev, I. Suhodolo, V. Kiselev, Y. Svirko, Y. Podoksenov P143 - New-onset atrial fibrillation in intensive care: incidence, management and outcome S. A. Jenkins, R. Griffin P144 - One single spot measurement of the sublingual microcirculation during acute pulmonary hypertension in a pig model of shock M. S. Tovar Doncel, A. Lima, C. Aldecoa, C. Ince P145 - Assessment of levosimendan as a therapeutic option to recruit the microcirculation in cardiogenic shock – initial experience in cardiac ICU A. Taha, A. Shafie, M. Mostafa, N. Syed, H. Hon P146 - Terlipressin vs. norepinephrine in the Potential Multiorgan Donor(PMD) F. Righetti, E. Colombaroli, G. Castellano P147 - Echocardiography in the potential heart donor exposed to substitution hormonotherapy F. Righetti, E. Colombaroli P148 - Machine learning can reduce rate of monitor alarms M. Hravnak, L. C. Chen, A. D. Dubrawski, G. C. Clermont, M. R. Pinsky P149 - Peripherally inserted central catheters placed in the ICU S. Gonzalez, D. Macias, J. Acosta, P. Jimenez, A. Loza, A. Lesmes, F. Lucena, C. Leon P150 - Recordings of abnormal central venous pressure waveform morphology during an episode of pulmonary hypertension in a porcine shock model M. S. Tovar Doncel, C. Ince, C. Aldecoa, A. Lima P151 - Ultrasound guided central venous access technique among French intensivists M. Bastide, J. Richecoeur, E. Frenoy, C. Lemaire, B. Sauneuf, F. Tamion, S. Nseir, D. Du Cheyron, H. Dupont, J. Maizel P152 - Predictive ability of the Pv-aCO2 gap in patients with shock M. Shaban, R. Kolko, N. Salahuddin, M. Sharshir, M. AbuRageila, A. AlHussain P153 - Comparison of echocardiography and pulmonary artery catheter measurements of hemodynamic parameters in critical ill patients P. Mercado, J. Maizel, L. Kontar, D. Titeca, F. Brazier, A. Riviere, M. Joris, T. Soupison, B. De Cagny, M. Slama P154 - The volume clamp method for noninvasive cardiac output measurement in postoperative cardiothoracic surgery patients: a comparison with intermittent pulmonary artery thermodilution J. Wagner, A. Körner, M. Kubik, S. Kluge, D. Reuter, B. Saugel P155 - Hemodynamic monitoring in patients with septic shock (SS) – CPCCO (continuous pulse contour cardiac output) vs. TEE (transesophageal echocardiography) E. Colombaroli, F. Righetti, G. Castellano P156 - Cardiac output measurement with transthoracic echocardiography in critically ill patients: a pragmatic clinical study T. Tran, D. De Bels, A. Cudia, M. Strachinaru, P. Ghottignies, J. Devriendt, C. Pierrakos P157 - Left ventricular outflow tract velocity time integral correlates with stroke volume index in mechanically ventilated patients Ó. Martínez González, R. Blancas, J. Luján, D. Ballesteros, C. Martínez Díaz, A. Núñez, C. Martín Parra, B. López Matamala, M. Alonso Fernández, M. Chana P158 - Transpulmonary thermodilution (TPTD) derived from femoral vs. jugular central venous catheter: validation of a previously published correction formula and a proprietary correction formula for global end-diastolic volume index (GEDVI) W. Huber, M. Eckmann, F. Elkmann, A. Gruber, I. Klein, R. M. Schmid, T. Lahmer P160 - Dynamic arterial elastance calculated with lidcoplus monitor does not predict changes in arterial pressure after a fluid challenge in postsurgical patients D. Bastoni, H. Aya, L. Toscani, L. Pigozzi, A. Rhodes, M. Cecconi P159 - Venous return driving pressure and resistance in acute blood volume changes P. W. Moller, S. Sondergaard, S. M. Jakob, J. Takala, D. Berger P160 - Dynamic arterial elastance calculated with lidcoplus monitor does not predict changes in arterial pressure after a fluid challenge in postsurgical patients D. Bastoni, H. Aya, L. Toscani, L. Pigozzi, A. Rhodes, M. Cecconi P161 - Analysis of duration of post-operative goal-directed therapy protocol C. Ostrowska, H. Aya, A. Abbas, J. Mellinghoff, C. Ryan, D. Dawson, A. Rhodes, M. Cecconi P162 - Hemodynamic optimization – back to square one? M. Cronhjort, O. Wall, E. Nyberg, R. Zeng, C. Svensen, J. Mårtensson, E. Joelsson-Alm P163 - Effectiveness of fluid thoracic content measurement by bioimpedance guiding intravascular volume optimization in patients with septic shock M. Aguilar Arzapalo, L. Barradas, V. Lopez, M. Cetina P164 - A systematic review on the role of internal jugular vein ultrasound measurements in assessment of volume status in critical shock patients N. Parenti, C. Palazzi, L. A. Amidei, F. B. Borrelli, S. C. Campanale, F. T. Tagliazucchi, G. S. Sedoni, D. L. Lucchesi, E. C. Carella, A. L Luciani P165 - Importance of recognizing dehydration in medical Intensive Care Unit M. Mackovic, N. Maric, M. Bakula P166 - Effect of volume for a fluid challenge in septic patients H. Aya, A. Rhodes, R. M. Grounds, N. Fletcher, M. Cecconi P167 - Fluid bolus practices in a large Australian intensive care unit B. Avard, P. Zhang P168 - Liberal late fluid management is associated with longer ventilation duration and worst outcome in severe trauma patients: a retrospective cohort of 294 patients M. Mezidi, J. Charbit, M. Ould-Chikh, P. Deras, C. Maury, O. Martinez, X. Capdevila P169 - Association of fluids and outcomes in emergency department patients hospitalized with community-acquired pneumonia P. Hou, W. Z. Linde-Zwirble, I. D. Douglas, N. S. Shapiro P170 - Association of positive fluid balance with poor outcome in medicosurgical ICU patients A. Ben Souissi, I. Mezghani, Y. Ben Aicha, S. Kamoun, B. Laribi, B. Jeribi, A. Riahi, M. S. Mebazaa P171 - Impact of fluid balance to organ dysfunction in critically ill patients C. Pereira, R. Marinho, R. Antunes, A. Marinho P172 - Volume bolus in ICU patients: do we need to balance our crystalloids? M. Crivits, M. Raes, J. Decruyenaere, E. Hoste P173 - The use of 6 % HES solution do not reduce total fluid requirement in the therapy of patients with burn shock V. Bagin, V. Rudnov, A. Savitsky, M. Astafyeva, I. Korobko, V. Vein P174 - Electron microscopic assessment of acute kidney injury in septic sheep resuscitated with crystalloids or different colloids T. Kampmeier , P. Arnemann, M. Hessler, A. Wald, K. Bockbreder, A. Morelli, H. Van Aken, S. Rehberg, C. Ertmer P175 - Alterations of conjunctival microcirculation in a sheep model of haemorrhagic shock and resuscitation with 0.9 % saline or balanced tetrastarch P. Arnemann, M. Hessler, T. Kampmeier, S. Rehberg, H. Van Aken, C. Ince, C. Ertmer P176 - A single centre nested pilot study investigating the effect of using 0.9 % saline or Plasma-Lyte 148 ® as crystalloid fluid therapy on gastrointestinal feeding intolerance in mechanically ventilated patients receiving nasogastric enteral nutrition S. Reddy, M. Bailey, R. Beasley, R. Bellomo, D. Mackle, A. Psirides, P. Young P177 - A single centre nested pilot study investigating the effect on post-operative bleeding of using 0.9 % saline or Plasma-Lyte® 148 as crystalloid fluid therapy in adults in ICU after heart surgery S. Reddy, M. Bailey, R. Beasley, R. Bellomo, D. Mackle, P. Young P178 - Extreme hypernatremia and sepsis in a patient with Huntington’s dementia: a conundrum in fluid management H. Venkatesh, S. Ramachandran, A. Basu, H. Nair P179 - Diagnosis and management of severe hypernatraemia in the critical care setting S. Egan, J. Bates P180 - Correlation between arterial blood gas and electrolyte disturbances during hospitalization and outcome in critically ill patients S. Oliveira, N. R. Rangel Neto, F. Q. Reis P181 - Missing the “I” in MUDPILES – a rare cause of high anion gap metabolic acidosis (HAGMA) C. P. Lee, X. L. Lin, C. Choong , K. M. Eu, W. Y. Sim , K. S. Tee, J. Pau , J. Abisheganaden P182 - Plasma NGAL and urinary output: potential parameters for early initiation of renal replacement therapy K. Maas, H. De Geus P183 - Renal replacement therapy for critically ill patients: an intermittent continuity E. Lafuente, R. Marinho, J. Moura, R. Antunes, A. Marinho P184 - A survey of practices related to renal replacement therapy in critically ill patients in the north of England. T. E. Doris, D. Monkhouse, T. Shipley, S. Kardasz, I Gonzalez P185 - High initiation creatinine associated with lower 28-day mortality in critically ill patients necessitating continuous renal replacement therapy S. Stads, A. J. Groeneveld P186 - The impact of Karnofsky performance scale on outcomes in acute kidney injury patients receiving renal replacement therapy on the intensive care unit I. Elsayed, N. Ward, A. Tridente, A. Raithatha P187 - Severe hypophosphatemia during citrate-anticoagulated CRRT A. Steuber, C. Pelletier, S. Schroeder, E. Michael, T. Slowinski, D. Kindgen-Milles P188 - Citrate regional anticoagulation for post dilution continuous renal replacement therapy S. Ghabina P189 - Citrate 18 mmol/l improves anticoagulation during RRT with adsorbing filters F. Turani, A. Belli, S. Busatti, G. Barettin, F. Candidi, F. Gargano, R. Barchetta, M. Falco P190 - Calcium gluconate instead of calcium chloride in citrate-anticoagulated CVVHD O. Demirkiran, M. Kosuk, S. Bozbay P191 - Enhanced clearance of interleukin-6 with continuous veno-venous haemodialysis (CVVHD) using Ultraflux EMiC2 vs. Ultraflux AV1000S V. Weber, J. Hartmann, S. Harm, I. Linsberger, T. Eichhorn, G. Valicek, G. Miestinger, C. Hoermann P192 - Removal of bilirubin with a new adsorbent system: in vitro kinetics S. Faenza, D. Ricci, E. Mancini, C. Gemelli, A. Cuoghi, S. Magnani, M. Atti P193 - Case series of patients with severe sepsis and septic shock treated with a new extracorporeal sorbent T. Laddomada, A. Doronzio, B. Balicco P194 - In vitro adsorption of a broad spectrum of inflammatory mediators with CytoSorb® hemoadsorbent polymer beads M. C. Gruda, P. O’Sullivan, V. P. Dan, T. Guliashvili, A. Scheirer, T. D. Golobish, V. J. Capponi, P. P. Chan P195 - Observations in early vs. late use of cytosorb therapy in critically ill patients K. Kogelmann, M. Drüner, D. Jarczak P196 - Oxiris membrane decreases endotoxin during rrt in septic patients with basal EAA > 0,6 F. Turani, A. B. Belli, S. M. Martni, V. C. Cotticelli, F. Mounajergi, R. Barchetta P197 - An observational prospective study on the onset of augmented renal clearance: the first report S. Morimoto, H. Ishikura P198 - An ultrasound- guided algorithm for the management of oliguria in severe sepsis I. Hussain, N. Salahuddin, A. Nadeem, K. Ghorab, K. Maghrabi P199 - Ultrasound in acute kidney injury (aki). First findings of farius, an education-programme in structural ultrasonography S. K. Kloesel, C. Goldfuss, A. Stieglitz, A. S. Stieglitz, L. Krstevska, G. Albuszies P200 - Effectiveness of renal angina index score predicting acute kidney injury on critically ill patients M. Aguilar Arzapalo, L. Barradas, V. Lopez, A. Escalante, G. Jimmy, M. Cetina P201 - Time length below blood pressure thresholds and progression of acute kidney injury in critically ill patients with or without sepsis: a retrospective, exploratory cohort study J. Izawa, T. Iwami, S. Uchino, M. Takinami, T. Kitamura, T. Kawamura P202 - Anaemia does not affect renal recovery in acute kidney injury J. G. Powell-Tuck, S. Crichton, M. Raimundo, L. Camporota, D. Wyncoll, M. Ostermann P203 - Estimated glomerular filtration rate based on serum creatinine: actual practice in Dutch ICU’s A. Hana, H. R. De Geus P204 - Comparison of estimated glomerular filtration rate calculated by mdrd, ckd-epi-serum-creatinine and ckd-epi-cystatin-c in adult critically ill patients H. R. De Geus, A. Hana P205 - Early diagnosis of septic acute kidney injury in medical critical care patients with a urine cell cycle arrest marker: insulin like growth factor binding protein-7 (IGFBP-7) M. Aydogdu, N. Boyaci, S. Yuksel, G. Gursel, A. B. Cayci Sivri P206 - Urinary neutrophil gelatinase-associated lipocalin as early biomarker of severe acute kidney injury in intensive care J. Meza-Márquez, J. Nava-López, R. Carrillo-Esper P207 - Shrunken pore syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting A. Dardashti, A. Grubb P208 - The biomarker nephrocheck™ can discriminate the septic shock patients with an akin 1 or 2 acute renal failure who will not progress toward the akin 3 level J. Maizel, M. Wetzstein, D. Titeca, L. Kontar, F. Brazier, B. De Cagny, A. Riviere, T. Soupison, M. Joris, M. Slama P209 - A worldwide multicentre evaluation of acute kidney injury in septic and non-septic critically ill patients: the intensive care over nations (icon) audit E. Peters, H. Njimi, P. Pickkers, J. L. Vincent P210 - Does enhanced recovery after surgery reduce the incidence of acute kidney injury in those undergoing major gynae-oncological surgery? M. Waraich , J. Doyle, T. Samuels, L. Forni P211 - Identification of risk factors for the development of acute kidney injury after lower limb arthroplasty N. Desai, R. Baumber, P. Gunning, A. Sell P212 - Incidences and associations of acute kidney injury after major trauma S. Lin, H. Torrence, M. O’Dwyer, C. Kirwan, J. Prowle P213 - Acute kidney injury of major trauma patients T Kim P214 - Trajectory of serum creatinine after major surgery and the diagnosis of acute kidney injury M. E. O’Connor, R. W. Hewson, C. J. Kirwan, R. M. Pearse, J. Prowle P215 - Epidemiology of acute kidney injury after cardiac surgery. A single center retrospective study S. Hanoura , A. Omar, H. Othamn, S. Sudarsanan , M. Allam, M. Maksoud, R. Singh, A. Al Khulaifi P216 - Post-operative acute kidney injury after major non-cardiac surgery and its association with death in the following year M. E. O’Connor, R. W. Hewson, C. J. Kirwan, R. M. Pearse, J. Prowle P217 - Factors affecting acute renal failure in intensive care unit and effect of these factors on mortality O. Uzundere, D. Memis , M. Ýnal, A. , N. Turan P218 - Results of the live kidney transplantations according to national data of turkish organ and tissue information system M. A. Aydin, H. Basar, I. Sencan, A. Kapuagasi, M. Ozturk, Z. Uzundurukan, D. Gokmen, A. Ozcan, C. Kaymak P219 - Anaesthesia procedure and intensive therapy in patients with neck phlegmon V. A. Artemenko, A. Budnyuk P220 - Nasal high flow oygen for acute respiratory failure: a systematic review R. Pugh , S. Bhandari P221 - Setting optimal flow rate during high flow nasal cannula support: preliminary results T. Mauri, C. Turrini, T. Langer, P. Taccone, C. A. Volta, C. Marenghi, L. Gattinoni, A. Pesenti P222 - Dose to dose consistency across two different gas flow rates using cystic fibrosis and normal adult breathing profiles during nasal high flow oxygen therapy L. Sweeney, A . O’ Sullivan, P. Kelly, E. Mukeria, R. MacLoughlin P223 - Final results of an evaluation of airway medix closed suction system compared to a standard closed suction system M. Pfeffer, J. T. Thomas, G. B. Bregman, G. K. Karp, E. K. Kishinevsky, D. S. Stavi, N. A. Adi P224 - Different cuff materials and different leak tests - one size does not fit all T. Poropat, R. Knafelj P225 - Observational study on the value of the cuff-leak test and the onset of upper airway obstruction after extubation E. Llopart, M. Batlle, C. De Haro, J. Mesquida, A. Artigas P226 - A device for emergency transtracheal lung ventilation D. Pavlovic, L. Lewerentz, A. Spassov, R. Schneider P227 - Long-term outcome and health-related quality of life in patients discharged from the intensive care unit with a tracheostomy and with or without prolonged mechanical ventilation S. De Smet, S. De Raedt, E. Derom, P Depuydt, S. Oeyen, D. Benoit, J. Decruyenaere P228 - Ultrasound-guided percutaneous dilational tracheostomy versus bronchoscopy-guided percutaneous dilational tracheostomy in critically ill patients (trachus): a randomized clinical trial A. Gobatto, B. Bese, P. Tierno, L. Melro, P. Mendes, F. Cadamuro, M. Park, L. M. Malbouisson P229 - Is it safe to discharge patients with tracheostomy from the ICU to the ward? B. C. Civanto, J. L. Lopez, A. Robles, J. Figueira, S. Yus, A. Garcia P230 - The application of tracheostomy in children in ICU A. Oglinda, G. Ciobanu, C. Oglinda, L. Schirca, T. Sertinean, V. Lupu P231 - The impact of passive humidifiers on aerosol drug delivery during mechanical ventilation P. Kelly, A. O’Sullivan, L. Sweeney, R. MacLoughlin P232 - Evaluation of vibrating mesh and jet nebuliser performance at two different attachment setups in line with a humidifier nebuliser system A. O’Sullivan, P. Kelly, L. Sweeney, E. Mukeria, M. Wolny , R. MacLoughlin P233 - Psv-niv versus cpap in the treatment of acute cardiogenic pulmonary edema A. Pagano, F. Numis, G. Vison, L. Saldamarco, T. Russo, G. Porta, F. Paladino P234 - Noninvasive ventilation in patients with haematologic malignancy: a retrospective review C. Bell, J. Liu, J. Debacker, C. Lee, E. Tamberg, V. Campbell, S. Mehta P235 - Use of non-invasive ventilation in infectious diseases besides classical indications A. Silva-Pinto, A. Sarmento, L. Santos P236 - The impact of fragility on noninvasive mechanical ventilation application and results in the ICU Ý. Kara, F. Yýldýrým, A. Zerman, Z. Güllü, N. Boyacý, B. Basarýk Aydogan, Ü. Gaygýsýz, K. Gönderen, G. Arýk, M. Turkoglu, M. Aydogdu, G. Aygencel, Z. Ülger, G. Gursel P237 - Effects of metabolic alkalosis on noninvasive ventilation success and ICU outcome in patients with hypercapnic respiratory failure N. Boyacý, Z. Isýkdogan, Ö. Özdedeoglu, Z. Güllü, M. Badoglu, U. Gaygýsýz, M. Aydogdu, G. Gursel P238 - Asynchrony index and breathing patterns of acute exacerbation copd patients assisted with noninvasive pressure support ventilation and neurally adjusted ventilatory assist N. Kongpolprom, C. Sittipunt P239 - High frequency jet ventilation for severe acute hypoxemia A. Eden, Y. Kokhanovsky, S. Bursztein – De Myttenaere, R. Pizov P240 - HFOV revisited: a 7 year retrospective analysis of patients receiving HFOV who met oscillate trial entry criteria L. Neilans, N. MacIntyre P241 - Implementation of a goal-directed mechanical ventilation order set driven by respiratory therapists can improve compliance with best practices for mechanical ventilation M. Radosevich, B. Wanta, V. Weber, T. Meyer, N. Smischney, D. Brown, D. Diedrich P242 - A reduction in tidal volumes for ventilated patients on ICU calculated from IBW. can it minimise mortality in comparison to traditional strategies? A . Fuller, P. McLindon, K. Sim P243 - Predictive value of lung aeration scoring using lung ultrasound in weaning failure M. Shoaeir, K. Noeam, A. Mahrous, R. Matsa, A. Ali P244 - Conventional versus automated weaning from mechanical ventilation using SmartCare™ C. Dridi, S. Koubaji, S. Kamoun, F. Haddad, A. Ben Souissi, B. Laribi, A. Riahi, M. S. Mebazaa P245 - Ultrasonographic evaluation protocol for weaning from mechanichal ventilation A. Pérez-Calatayud, R. Carrillo-Esper, A. Zepeda-Mendoza, M. Diaz-Carrillo, E. Arch-Tirado P246 - Diaphragm ultrasonography: a method for weaning patients from mechanical ventilation S. Carbognin, L. Pelacani, F. Zannoni, A. Agnoli, G. Gagliardi P247 - Dorsal diaphragmatic excursion tracks transpulmonary pressure in ventilated ARDS patients: a potential non-invasive indicator of lung recruitment? R. Cho, A. Adams , S. Lunos, S. Ambur, R. Shapiro, M. Prekker P248 - Pulse oximetry in the icu patient: is the perfusion index of any value? M. Thijssen, L. Janssen, N. Foudraine P249 - Ventilation is a better assessment of respiratory status than EtCO2 C. J. Voscopoulos, J. Freeman P250 - Evaluation of the relationship between non-invasive minute ventilation and end-tidal CO2 in patients undergoing general vs spinal anesthesia C. J. Voscopoulos, J. Freeman, E. George P251 - Respiratory volume monitoring provides early warning of respiratory depression and can be used to reduce false alarms in non-intubated patients C. J. Voscopoulos, D. Eversole, J. Freeman, E. George P252 - P/i index: a predictive edi-derived weaning index during nava S. Muttini, R. Bigi, G. Villani, N. Patroniti P253 - Adequacy of ventilation in patients receiving opioids in the post anesthesia care unit: minute ventilation versus respiratory rate G. Williams, C. J. Voscopoulos, J. Freeman, E. George P254 - Comparison of regional and global expiratory time constants measured by electrical impedance tomography (EIT) A. Waldmann, S. Böhm, W. Windisch, S. Strassmann, C. Karagiannidis P255 - Electrical impedance tomography: robustness of a new pixel wise regional expiratory time constant calculation A. Waldmann, S. Böhm, W. Windisch, S. Strassmann, C. Karagiannidis P256 - Validation of regional and global expiratory time constant measurement by electrical impedance tomography in ards and obstructive pulmonary diseases C. K. Karagiannidis, A. W. Waldmann, S. B. Böhm, S. Strassmann, W. W. Windisch P257 - Transpulmonary pressure in a model with elastic recoiling lung and expanding chest wall P. Persson, S. Lundin, O. Stenqvist P258 - Lactate in pleural and abdominal effusion G. Porta, F. Numis, C. S. Serra, A. P. Pagano, M. M. Masarone, L. R. Rinaldi, A. A. Amelia, M. F. Fascione, L. A. Adinolfi, E. R. Ruggiero P259 - Outcome of patients admitted to the intensive care with pulmonary fibrosis F. Asota, K. O’Rourke, S. Ranjan, P. Morgan P260 - Sedation and analgesia practice in extra-corporeal membrane oxygenation (ECMO)-treated patients with acute respiratory distress syndrome (ARDS): a retrospective study J. W. DeBacker, E. Tamberg, L. O’Neill, L. Munshi, L. Burry, E. Fan, S. Mehta P261 - Characteristics and outcomes of patients deemed not eligible when referred for veno-venous extracorporeal membrane oxygenation (vv-ECMO) S. Poo, K. Mahendran, J. Fowles, C. Gerrard, A. Vuylsteke P262 - The SAVE SMR for veno-arterial ECMO R. Loveridge, C. Chaddock, S. Patel, V. Kakar, C. Willars, T. Hurst, C. Park, T. Best, A. Vercueil, G. Auzinger P263 - A simplified score to predict early (48 h) mortality in patients being considered for VA-ECMO A. Borgman, A. G. Proudfoot, E. Grins, K. E. Emiley, J. Schuitema, S. J. Fitch, G. Marco, J. Sturgill, M. G. Dickinson, M. Strueber, A. Khaghani, P. Wilton, S. M. Jovinge P264 - Lung function six months post extra corporeal membrane oxygenation (ECMO) for severe acute respiratory failure in adult survivors C. Sampson, S. Harris-Fox P265 - Bicarbonate dialysis removes carbon dioxide in hypoventilated rodents. M. E. Cove, L. H. Vu, A. Sen, W. J. Federspiel, J. A. Kellum P266 - Procalcitonin as predictor of primary graft dysfunction and mortality in post-lung transplantation C. Mazo Torre, J. Riera, S. Ramirez, B. Borgatta, L. Lagunes, J. Rello P267 - New molecular biomarkers of acute respiratory distress syndrome in abdominal sepsis A. K. Kuzovlev, V. Moroz, A. Goloubev, S. Polovnikov, S. Nenchuk P268 - Tight junction’s proteins claudin -5 and regulation by tnf in experimental murine lung injury model of ali/ards V. Karavana, C. Glynos, A. Asimakos, K. Pappas, C. Vrettou, M. Magkou, E. Ischaki, G. Stathopoulos, S. Zakynthinos P269 - Cell counts in endobronchial aspirate to assess airway inflammation in ARDS patients: a pilot study S. Spadaro, I. Kozhevnikova, F. Dalla Corte, S. Grasso, P. Casolari, G. Caramori, C. Volta P270 - Epidemiological and clinical profile of patients with acute respiratory distress syndrome in the surgical intensive care unit surgical, hospital JRA, Antananarivo T. Andrianjafiarinoa, T. Randriamandrato, T. Rajaonera P271 - Effect of high PEEP after recruitment maneuver on right ventricular function in ARDS. Is it good for the lung and for the heart? S. El-Dash, ELV Costa, MR Tucci, F Leleu, L Kontar, B. De Cagny, F. Brazier, D. Titeca, G. Bacari-Risal, J. Maizel, M. Amato, M. Slama P272 - Effect of recruitment maneuver on left ventricular systolic strain P. Mercado, J. Maizel, L. Kontar, D. Titeca, F. Brazier, A. Riviere, M. Joris, T. Soupison, B. De Cagny, S. El Dash, M. Slama P273 - Inhaled nitric oxide – is switching supplier cost effective? Remmington, A. Fischer, S. Squire, M. Boichat P274 - Epidemiological study of severe acute pancreatitis in Japan, comparison of the etiology and the patient outcomes on 1159 patients. H. Honzawa, H. Yasuda, T. Adati, S. Suzaki, M. Horibe, M. Sasaki, M. Sanui P275 - Extracorporeal liver support therapy. Experience in an intensive care unit R. Marinho, J. Daniel, H. Miranda, A. Marinho P276 - Accuracy of mortality prediction models in acute versus acute-on-chronic liver failure in the intensive care setting K. Milinis, M. Cooper, G. R. Williams, E. McCarron, S. Simants, I. Patanwala, I. Welters P277 - Risk of coronary artery disease in patients with chronic liver disease: a population based cohort study Y. Su P278 - 20 years of liver transplantation in Santiago de Compostela (Spain). Experience review J. Fernández Villanueva, R. Fernández Garda, A. López Lago, E. Rodríguez Ruíz, R. Hernández Vaquero, S. Tomé Martínez de Rituerto, E. Varo Pérez P279 - Diarrhea is a risk factor for liver injury and may lead to intestinal failure associated liver disease in critical illness N. Lefel, F. Schaap, D. Bergmans, S. Olde Damink, M. Van de Poll P280 - Bowel care on the intensive care unit: constipation guideline compliance and complications K. Tizard, C. Lister, L. Poole P281 - Malnutrition assessed by phase angle determines outcomes in low risk cardiac surgery patients D. Ringaitiene, D. Gineityte, V. Vicka, I. Norkiene, J. Sipylaite P282 - Preoperative fasting times in an irish hospital A. O’Loughlin, V. Maraj, J. Dowling P283 - Costs and final outcome of early x delayed feeding in a private Brazil ICU M. B. Velasco, D. M. Dalcomune, E. B. Dias, S. L. Fernandes P284 - Can ventilator derived energy expenditure measurements replace indirect calorimetry? T. Oshima, S. Graf, C. Heidegger, L. Genton, V. Karsegard, Y. Dupertuis, C. Pichard P285 - Revisiting the refeeding syndrome: results of a systematic review N. Friedli, Z. Stanga, B. Mueller, P. Schuetz P286 - Compliance with the new protocol for parenteral nutrition in our ICU L. Vandersteen, B. Stessel, S. Evers, A. Van Assche, L. Jamaer, J. Dubois P287 - Nutrition may be another treatment in the intensive care unit where less is more? R. Marinho, H. Castro, J. Moura, J. Valente, P. Martins, P. Casteloes, C. Magalhaes, S. Cabral, M. Santos, B. Oliveira, A. Salgueiro, A. Marinho P288 - Should we provide more protein to critically ill patients? R. Marinho, M. Santos, E. Lafuente, H. Castro, S. Cabral, J. Moura, P. Martins, B. Oliveira, A. Salgueiro, S. Duarte, S. Castro, M. Melo, P. Casteloes, A. Marinho P289 Protein provision in an adult intensive care unit S. Gray P290 - Prevalence and clinical outcomes of vitamin d deficiency in the medical critically ill patients in Songklanagarind hospital K. Maipang, R. Bhurayanontachai P291 - Vitamin d deficiency strongly predicts adverse medical outcome across different medical inpatient populations: results from a prospective study L. G. Grädel, P. Schütz P292 - Omega-3 fatty acids in patients undergoing cardiac surgery: a systematic review and meta-analysis P. Langlois, W. Manzanares P293 - Can 5-hydroxytriptophan prevent post-traumatic stress disorder in critically ill patients? R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P294 - Parenteral selenium in the critically ill: an updated systematic review and meta-analysis W. Manzanares, P. Langlois, M. Lemieux, G. Elke, F. Bloos, K. Reinhart, D. Heyland P295 - Probiotics in the critically ill: an updated systematic review and meta-analysis P. Langlois, M. Lemieux, I. Aramendi, D. Heyland, W. Manzanares P296 - Diabetes with hyperglycemic crisis episodes may be associated with higher risk of pancreatic cancer: a population-based cohort study Y. Su P297 - Incidence of hypoglycemia in an intensive care unit depending on insulin protocol R. Marinho, N. Babo, A. Marinho P298 - Severity of the diseases is two-dimensionally correlated to blood glucose, including blood glucose variability, especially in moderately to severely ill patients with glucose intolerance. M. Hoshino, Y. Haraguchi, S. Kajiwara, T. Mitsuhashi, T. Tsubata, M. Aida P299 - A study of glycemic control by subcutaneous glargine injection transition from continuous regular insulin infusion in critically ill patients T. Rattanapraphat, R. Bhurayanontachai, C. Kongkamol, B. Khwannimit P300 - Glycemic control in Portuguese intensive care unit R. Marinho, M. Santos, H. Castro, E. Lafuente, A. Salgueiro, S. Cabral, P. Martins, J. Moura, B. Oliveira, M. Melo, B. Xavier, J. Valente, C. Magalhaes, P. Casteloes, A. Marinho P301 - Impact of hyperglycemia duration on the day of operation on short-term outcome of cardiac surgery patients D. Moisidou, F. Ampatzidou, C. Koutsogiannidis, M. Moschopoulou, G. Drossos P302 - Lactate levels in diabetic ketoacidosis patients at ICU admissions G. Taskin, M. Çakir, AK Güler, A. Taskin, N. Öcal, S. Özer, L. Yamanel P303 - Intensive care implications of merging heart attack centre units in London J. M. Wong, C. Fitton, S. Anwar, S. Stacey P304 - Special characteristics of in-hospital cardiac arrests M. Aggou, B. Fyntanidou, S. Patsatzakis, E. Oloktsidou, K. Lolakos, E. Papapostolou, V. Grosomanidis P305 - Clinical evaluation of ICU-admitted patients who were resuscitated in the general medicine ward S. Suda , T. Ikeda, S. Ono, T. Ueno, Y. Izutani P306 - Serious game evaluation of a one-hour training basic life support session for secondary school students: new tools for future bystanders S. Gaudry, V. Desailly, P. Pasquier, PB Brun, AT Tesnieres, JD Ricard, D. Dreyfuss, A. Mignon P307 - Public and clinical staff perceptions and knowledge of CPR compared to local and national data J. C White, A. Molokhia, A. Dean, A. Stilwell, G. Friedlaender P308 Dispatcher-assisted telephone cardiopulmonary resuscitation using a French-language compression-ventilation pediatric protocol M. Peters, S. Stipulante, A. Delfosse, AF Donneau, A. Ghuysen P309 Dantrolene versus amiodarone for resuscitation – an experimental study C. Feldmann, D. Freitag, W. Dersch, M. Irqsusi, D. Eschbach, T. Steinfeldt, H. Wulf, T. Wiesmann P310 Long term survival and functional neurological outcome in comatose survivors undergoing therapeutic hypothermia N. Kongpolprom, J. Cholkraisuwat P311 Impact of kidney disease on mortality and neurological outcome in out-of-hospital cardiac arrest: a prospective observational study S. Beitland , E. Nakstad, H. Stær-Jensen , T. Drægni , G. Andersen , D. Jacobsen , C. Brunborg, B. Waldum-Grevbo , K. Sunde P312 ICU dependency of patients admitted after primary percutaneous coronary intervention (PPCI) following out of the hospital cardiac arrest K. Hoyland, D. Pandit P313 Prognostic indicators and outcome prediction model for patients with return of spontaneous circulation from cardiopulmonary arrest: comprehensive registry of in-hospital intensive care on OHCA survival (critical) study in Osaka, Japan K. Hayakawa P314 Cerebral oxygen saturation during resuscitation in a porcine model of cardiac arrest E. Oloktsidou, K. Kotzampassi, B. Fyntanidou, S. Patsatzakis, L. Loukipoudi, E. Doumaki, V. Grosomanidis P315 Presumption of cardiopulmonary resuscitation for sustaining cerebral oxidation using regional cerebral saturation of oxygen: observational cohort study (press study) H. Yasuda P316 EEG reactivity in patients after cardiac arrest: a close look at stimuli MM Admiraal, M. Van Assen, MJ Van Putten, M. Tjepkema-Cloostermans, AF Van Rootselaar, J. Horn P317 Prognostic value of neuron-specific enolase after cardiac arrest F. Ragusa, A. Marudi , S. Baroni, A. Gaspari, E. Bertellini P318 Correlation between electroencephalographic findings and serum neuron specific enolase with outcome of post cardiac arrest patients A. Taha, T. Abdullah, S. Abdel Monem P319 Introduction of a targeted temperature management strategy following cardiac arrest in a district general hospital intensive care unit. S. Alcorn, S. McNeill, S. Russell P320 The evolution of cerebral oxygen saturation in post-cardiac arrest patients treated with therapeutic hypothermia W. Eertmans, C. Genbrugge, I. Meex, J. Dens, F. Jans, C. De Deyne P321 Prognostic factors and neurological outcomes of therapeutic hypothermia in comatose survivors from cardiac arrest: 8-year single center experience J. Cholkraisuwat, N. Kongpolprom P322 Adherence to targeted temperature management after out of hospital cardiac arrest B. Avard, R. Burns P323 Implementation of a therapeutic hypothermia protocol for comatose survivors of out-of-hospital cardiac arrest. A. Patarchi, T. Spina P324 Factors associated with ventilator weaning after targeted temperature management for cardiac arrest patients in japan H. Tanaka, N. Otani, S. Ode, S. Ishimatsu P325 Differential activation of c-fos in paraventricular nuclei of the hypothalamus and thalamus of the rat following myocardial infarction J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin, M. H. Won P326 Monitoring of cTroponin I in patients with acute ischemic stroke - predictor of inhospital mortality S. Dakova, Z. Ramsheva, K. Ramshev P327 Hyperthermic preconditioning severely accelerates neuronal damage in the gerbil ischemic hippocampal dentate gyrus via decreasing sods expressions J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin P328 Failure in neuroprotection of remote limb ischemic post conditioning in the hippocampus of a gerbil model of transient cerebral ischemia J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin P329 Brain death and admission diagnosis in neurologic intensive care unit, a correlation? A Marudi, S Baroni, A Gaspari, E Bertellini P330 Brain magnetic resonance imaging findings in patients with septic shock G. Orhun, E. Senturk, P. E. Ozcan, S. Sencer, C. Ulusoy, E. Tuzun, F . Esen P331 Benefits of L-carnitine in valproic acid induced encephalopathy R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P332Automatic analysis of EEG reactivity in comatose patients M. Van Assen, M. M. Admiraal, M. J. Van Putten, M. Tjepkema-Cloostermans, A. F. Van Rootselaar, J. Horn P333 Usefulness of common ICU severity scoring systems in predicting outcome after spontaneous intracerebral hemorrhage M. Fallenius, M. B. Skrifvars, M. Reinikainen, S. Bendel, R. Raj P334 Evalution of patients with suspected subarachnoid haemorrhage and negative ct imaging M. Abu-Habsa, C. Hymers, A. Borowska, H. Sivadhas, S. Sahiba, S. Perkins P335 Timing of endovascular and surgical treatment for aneurysmal subarachnoid haemorrhage: early but not so fast. J. Rubio, J. A. Rubio, R. Sierra P336 Red blood cell transfusion in aneurysmal subarachnoid hemorrhage – the Sahara cohort study S. English, M. Chasse, A. Turgeon, F. Lauzier, D. Griesdale, A. Garland, D. Fergusson, R. Zarychanski, A. Tinmouth, C. Van Walraven, K. Montroy, J. Ziegler, R. Dupont Chouinard, R. Carignan, A. Dhaliwal, C. Lum, J. Sinclair, G. Pagliarello, L. McIntyre P337 - Aneurysmal subarachnoid hemorrhage and anemia: a canadian multi-centre retrospective cohort study S. English, M. Chasse, A. Turgeon, F. Lauzier, D. Griesdale, A. Garland, D. Fergusson, R. Zarychanski, A. Tinmouth, C. Van Walraven, K. Montroy, J. Ziegler, R. Dupont Chouinard, R. Carignan, A. Dhaliwal, C. Lum, J. Sinclair, G. Pagliarello, L. McIntyre P338 - Does the neutrophil-to-lymphocyte (NLR) ratio predict symptomatic vasospasm or delayed cerebral ischemia (DCI) after aneurysmal subarachnoid haemorrhage (SAH)? T. Groza, N. Moreau, D. Castanares-Zapatero, P. Hantson P339 - ICU-acquired infections in aneurysmal subarachnoid hemorrhage patients: impact on ICU and hospital length of stay M. Carbonara , F. Ortolano, T. Zoerle, S. Magnoni, S. Pifferi, V. Conte, N. Stocchetti P340 - Cerebral metabolic effects of normobaric hyperoxia during the acute phase of aneurysmal subarachnoid hemorrhage L. Carteron, T. Suys, C. Patet, H. Quintard, M. Oddo P341 - Postoperative care for elective craniotomy: where is best done? J. A. Rubio, J. Rubio, R. Sierra P342 - 5-year follow-up of patients after transplantation of organs from donors from neurocritical care V. Spatenkova, E. Pokorna, P. Suchomel P343 - Evaluation of levetiracetam pharmacokinetics after severe traumatic brain injury in neurocritical care patients at a level one trauma center N. Ebert, J. Jancik, H. Rhodes P344 - Model based time series cluster analysis to determine unique patient states in traumatic brain injury T. Bylinski, C. Hawthorne, M. Shaw, I. Piper, J. Kinsella P345 - Brain compartment monitoring capabilities from ICP to BI (bioimpedance) during HS (hypertonic saline) administration. State of art simulation outcome depending on brain swelling type A. K. Kink , I. R. Rätsep P346 - Transfusion of red blood cells in patients with traumatic brain injury admitted to Canadian trauma health centers: a multicenter cohort study A. Boutin, L. Moore, M. Chasse, R. Zarychanski, F. Lauzier, S. English, L. McIntyre, J. Lacroix, D. Griesdale, P. Lessard-Bonaventure, A. F. Turgeon P347 - Hemoglobin thresholds and red blood cell transfusions in adult patients with moderate or severe traumatic brain injury: a retrospective cohort study A. Boutin, L. Moore, R. Green, P. Lessard-Bonaventure, M. Erdogan, M. Butler, F. Lauzier, M. Chasse, S. English, L. McIntyre, R. Zarychanski, J. Lacroix, D. Griesdale, P. Desjardins, D. A. Fergusson, A. F. Turgeon P348 - Characteristics of patients with gunshot wounds to the head - an observational Brazilian study B. Goncalves, B. Vidal, C. Valdez, A. C. Rodrigues, L. Miguez, G. Moralez P349 - Base excess as predictor for ICU admission and the injury severity in blunt trauma patients T. Hong P350 - Enhancement of usual emergency department care with proadrenomedullin to improve outcome prediction - Results from the multi-national, prospective, observational TRIAGE study A. Kutz, P. Hausfater, D. Amin, T. Struja, S. Haubitz, A. Huber, B. Mueller, P. Schuetz P351 - Developing an innovative emergency medicine point-of-care simulation programme T. Brown, J. Collinson, C. Pritchett, T. Slade P352 - The InSim program: an in situ simulation program for junior trainees in intensive care M. Le Guen, S. Hellings, R. Ramsaran P353 - Impact of excessive and inappropriate troponin testing in the emergency setting how good are we A. Alsheikhly P354 - The development of time tracking monitor at emergency department T. Abe P355 - Role of focussed echocardiography in emergency assessment of syncope L. Kanapeckaite, M. Abu-Habsa, R. Bahl P356 - Insertion of an open-ended 14-gauge catheter through the chest wall causes a significant pneumothorax in a self-ventilating swine model M. Q Russell, K. J. Real, M. Abu-Habsa , R. M. Lyon, N. P. Oveland P357 - Ez-io® intraosseous access teaching in the workplace using a mobile ‘tea trolley’ training method J. Penketh, M. Mcdonald, F. Kelly P358 - Black widow envenomation in Saudi Arabia: a prospective observational case series M. Alfafi, S. Alsolamy, W. Almutairi, B. Alotaibi P359 - Mechanical ventilation in patients with overdose not yet intubated on icu admission A. E. Van den Berg, Y. Schriel, L. Dawson, I. A. Meynaar P360 - Central nervous system depressants poisoning and ventilator associated pneumonia: an underrated risk factor in toxicological intensive care unit H. Talaie P361 - Acute barium intoxication treated with hemodiafiltration D. Silva, S. Fernandes, J. Gouveia, J. Santos Silva P362 - Major trauma presenting to the emergency department. the spectrum of cycling injuries in Ireland J. Foley, A. Kaskovagheorgescu, D. Evoy, J. Cronin, J. Ryan P363 - Burns from French military operations: a 14-year retrospective observational analysis. M. Huck, C. Hoffmann, J. Renner, P. Laitselart, N. Donat, A. Cirodde, J. V. Schaal, Y. Masson, A. Nau, T. Leclerc P364 - A comparison of mortality scores in burns patients on the intensive care unit. O. Howarth, K. Davenport, P. Jeanrenaud, S. Raftery P365 - Clasification of pain and its treatment and an intensive care rehabiliation clinic P. MacTavish, H. Devine, J. McPeake, M. Daniel, J. Kinsella, T. Quasim P366 - Pain management adequacy in critical care areas ,the process and the barriers perceived by critical care nurses S. Alrabiee, A. Alrashid , S. Alsolamy P367 - Pain assessment in critically ill adult patients: validation of the Turkish version of the critical-care pain observation tool O. Gundogan, C. Bor, E. Akýn Korhan, K. Demirag , M. Uyar P368 - An audit of pain and sedation assessments in the intensive care unit: recommendations for clinical practice F. Frame, C. Ashton, L. Bergstrom Niska P369 - Impact of pharmaceutical care on treatment of pain and agitation in medical intensive care unit P. Dilokpattanamongkol, T. Suansanae, C. Suthisisang, S. Morakul, C. Karnjanarachata, V. Tangsujaritvijit P370 - Agitation in trauma ICU, prevention and outcome S. Mahmood, H. Al Thani, A. Almenyar P371 Correlation between percentages of ventilated patients developed vap and use of sedative agents in icu patients. A. Vakalos , V. Avramidis P372 - Improving recording of sedation events in the Emergency Department: The implementation of the SIVA International Taskforce adverse event reporting tool for procedural sedation R. Sharvill, J. Penketh P373 - Impact of sedative drug use on the length of mechanical ventilation S. E. Morton, Y. S. Chiew, C. Pretty, J. G. Chase, G. M. Shaw P374 - Co-administration of nitric oxide and sevoflurane using anaconda R. Knafelj, P. Kordis P375 - A retrospective study of the use of Dexmedetomidine in an oncological critical care setting S. Patel, V. Grover P376 - Dexmedetomidine and posttraumatic stress disorder incidence in alcohol withdrawal icu patients I. Kuchyn, K. Bielka P377 - Hemodynamic effects of dexmedetomidine in a porcine model of septic shock Z. Aidoni, V. Grosomanidis, K. Kotzampassi, G. Stavrou, B. Fyntanidou, S. Patsatzakis, C. Skourtis P378 - Ketamine for analgosedation in severe hypoxic respiratory failure S. D. Lee, K. Williams, I. D. Weltes P379 - Madness from the moon? lunar cycle and the incidence of delirium on the intensive care unit S. Berhane, C. Arrowsmith, C. Peters, S. Robert P380 - Impaired dynamic cerebral autoregulation after coronary artery bypass grafting and association with postoperative delirium J. Caldas, R. B. Panerai, T. G. Robinson, L. Camara, G. Ferreira, E. Borg-Seng-Shu, M. De Lima Oliveira, N. C. Mian, L. Santos, R. Nogueira, S. P. Zeferino, M. Jacobsen Teixeira, F. Galas, L. A. Hajjar P381 - Risk factors predicting prolonged intensive care unit length of stay after major elective surgery. P. Killeen, M. McPhail, W. Bernal, J. Maggs, J. Wendon, T. Hughes P382 - Systemic inflammatory response syndrome criteria and hospital mortality prediction in a brazilian cohort of critically ill patients L. U. Taniguchi, E. M. Siqueira, J. M. Vieira Jr, L. C. Azevedo P383 - Evaluating the efficacy of a risk predictor panel in identifying patients at elevated risk of morbidity following emergency admission A. N. Ahmad, M. Abu-Habsa, R. Bahl, E. Helme, S. Hadfield, R. Loveridge P384 - A retrospective comparison of outcomes for elective surgical patients admitted post-operatively to the critical care unit or general ward J. Shak, C. Senver, R. Howard-Griffin P385 - Effect of obesity on mortality in surgical critically ill patients. P. Wacharasint, P. Fuengfoo, N. Sukcharoen, R. Rangsin P386 - The national early warning score (news) reliably improves adverse clinical outcome prediction in community-acquired pneumonia - results from a 6 year follow-up D. Sbiti-Rohr, P. Schuetz P387 - Clinical usefulness of the charlson¡¯s weighted index of comorbidities _as prognostic factor in patients with prolonged acute mechanical ventilation H. Na, S. Song, S. Lee, E. Jeong, K. Lee P388 - Comparison of mortality prediction scoring systems in patients with cirrhosis admitted to general intensive care unit M. Cooper, K. Milinis, G. Williams, E. McCarron, S. Simants, I. Patanwala, I. D. Welters P389 - Impact of admission source and time of admission on outcome of pediatric intensive care patients: retrospective 15 years study E. Zoumpelouli, EA Volakli, V. Chrysohoidou, S. Georgiou, K. Charisopoulou, E. Kotzapanagiotou, V. Panagiotidou, K. Manavidou, Z. Stathi, M. Sdougka P390 - Heart rate variability and outcomes prediction in critical illness N. Salahuddin, B. AlGhamdi, Q. Marashly, K. Zaza, M. Sharshir, M. Khurshid, Z. Ali, M. Malgapo, M. Jamil, A. Shafquat, M. Shoukri, M. Hijazi P391 - The incidence and outcome of hyperlactatemia in the post anaesthesia care unit T. Abe, S. Uchino, M. Takinami P392 - Correlation between arterial blood gas disturbances and arterial lactate levels during hospitalization and outcome in critically septic patients N. R. Rangel Neto, S. Oliveira, F. Q. Reis, F. A. Rocha P393 - External validation of saps 3 and mpm iii scores in 48,816 patients from 72 brazilian icus G. Moralez, K. Ebecken, L. S. Rabello, M. F. Lima, R. Hatum, F. V. De Marco, A. Alves, J. E. Pinto, M. Godoy, P. E. Brasil, F. A. Bozza, J. I. Salluh, M. Soares P394 - The frailty penalty: pre-admission functional status confounds mortality prediction models in critically ill patients J. Krinsley, G. Kang P395 - ‘sooner rather than later”: how delayed discharge from critical care leads to increased out of hours discharges and subsequent increase in in-hospital mortality. J. Perry, H. Hines P396 - Identifying poor outcome patient groups in a resource-constrained critical care unit K. M. Wilkinson, C. Tordoff, B. Sloan, M. C. Bellamy P397 - Effects of icu weekend admission and discharge on mortality. E. Moreira, F. Verga, M. Barbato, G. Burghi P398 - Organizational factors, outcomes and resource use in 9,946 cancer patients admitted to 70 ICUs M Soares, U. V. Silva, L. C. Azevedo, A. P. Torelly, J. M. Kahn, D. C. Angus, M. F. Knibel, P. E. Brasil, F. A. Bozza, J. I. Salluh P399 - Evaluation of oncological critically ill patients, severity score and outcome compared to not oncological in a particular hospital cti. M. B. Velasco, D. M. Dalcomune P400 - Outcomes of patients admitted to a large uk critical care department with palliative oncological diagnoses R. Marshall, T. Gilpin, A. Tridente, A. Raithatha P401 - Predictors of mortality in febrile neutropenic patients with haematological malignancies admitted to an intensive care unit of a cancer center D. Mota, B. Loureiro, J. Dias, O. Afonso, F. Coelho, A. Martins, F. Faria P402 - Patients with hematologic malignancies requiring invasive mechanical ventilation: characteristics and predictors of mortality H. Al-Dorzi, H. Al Orainni , F. AlEid, H. Tlaygeh, A. Itani, A. Hejazi, Y. Arabi P403 - Patient-important outcomes in randomized controlled trials in critically ill patients: a systematic review S. Gaudry, J. Messika, J. D. Ricard, S. Guillo, B. Pasquet, E. Dubief, D. Dreyfuss, F. Tubach P404 - Alopecia in survivors of critical illness: a qualitative study C . Battle, K. James, P. Temblett P405 - The impact of mental health on icu admission L. Davies, C. Battle, C. Lynch P406 - Cognitive impairment 5 years after ICU discharge S. Pereira, S. Cavaco, J. Fernandes, I. Moreira, E. Almeida, F. Seabra Pereira, M. Malheiro, F. Cardoso, I. Aragão, T. Cardoso P407 - Apache ii versus apache iv for octagenerians in medical icu M. Fister, R. Knafelj P408 - Outcomes of octagenarians in an indian icu P. Muraray Govind, N. Brahmananda Reddy, R. Pratheema, E. D. Arul, J. Devachandran P409 - Mortality and outcomes in elderly patients 80 years of age or older admitted to the icu M. B. Velasco , D. M. Dalcomune P410 - Octagenerians in medical icu - adding days to life or life to days? R. Knafelj, M. Fister P411 - The very elderly admitted to intensive care unit: outcomes and economic evaluation N. Chin-Yee, G. D’Egidio, K. Thavorn, D. Heyland, K. Kyeremanteng P412 - The very elderly in intensive care: relationship between acuity of illness and long-term mortality A. G. Murchison, K. Swalwell, J. Mandeville, D. Stott P413 - Acquired weakness in an oncological intensive care unit I. Guerreiro P414 - Musculoskeletal problems in intensive care unit (ICU) patients post-discharge H. Devine, P. MacTavish, J. McPeake, T. Quasim, J. Kinsella, M. Daniel P415 - Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness C. Goossens M. B. Marques, S. Derde, S. Vander Perre, T. Dufour, S. E. Thiessen, F. Güiza, T. Janssens, G. Hermans, I. Vanhorebeek, K. De Bock, G. Van den Berghe, L. Langouche P416 - Physical outcome measures for critical care patients following intensive care unit (icu) discharge H. Devine, P. MacTavish, T. Quasim, J. Kinsella, M. Daniel, J. McPeake P417 - Improving active mobilisation in a general intensive care unit B. Miles , S. Madden, H. Devine P418 - Mobilization in patients on vasoactive drugs use – a pilot study. M. Weiler, P. Marques, C. Rodrigues, M. Boeira, K. Brenner, C. Leães, A. Machado, R. Townsend, J. Andrade P419 - Pharmacy intervention at an intensive care rehabilitation clinic P. MacTavish, J. McPeake, H. Devine, J. Kinsella, M. Daniel, R. Kishore, C. Fenlon, T. Quasim P420 - Interactive gaming is feasible and potentially increases icu patients’ motivation to be engaged in rehabilitation programs T. Fiks, A. Ruijter, M. Te Raa, P. Spronk P421 - Simulation-based design of a robust stopping rule to ensure patient safety Y. S. Chiew, P. Docherty, J. Dickson, E. Moltchanova, C. Scarrot, C. Pretty, G. M. Shaw, J. G. Chase P422 - Are daily blood tests on the intensive care unit necessary? T. Hall, W. C. Ngu, J. M. Jack, P. Morgan P423 - Measuring urine output in ward patients: is it helpful? B. Avard, A. Pavli, X. Gee P424 - The incidence of pressure ulcers in an adult mixed intensive care unit in turkey C . Bor, E. Akin Korhan, K. Demirag, M. Uyar P425 - Intensivist/patient ratios in closed ICUs in Alexandria, Egypt; an overview M. Shirazy, A. Fayed P426 - Eicu (electronic intensive care unit): impact on ALOS (average length of stay) in a developing country like India S. Gupta, A. Kaushal, S. Dewan, A. Varma P427 - Predicting deterioration in general ward using early deterioration indicator E. Ghosh, L. Yang, L. Eshelman, B. Lord, E. Carlson P428 - High impact enhanced critical care outreach - the imobile service: making a difference E. Helme, R. Broderick, S. Hadfield, R. Loveridge P429 - Impact of bed availability and cognitive load on intensive care unit (ICU) bed allocation: a vignette-based trial J. Ramos, D. Forte P430 - Characteristics of critically ill patients admitted through the emergency department F. Yang, P. Hou P431 - Admission to critical care: the quantification of functional reserve J. Dudziak, J. Feeney, K. Wilkinson, K. Bauchmuller, K. Shuker, M. Faulds, A. Raithatha, D. Bryden, L. England, N. Bolton, A. Tridente P432 - Admission to critical care: the importance of frailty K. Bauchmuller, K Shuker, A Tridente, M Faulds, A Matheson, J. Gaynor, D Bryden, S South Yorkshire Hospitals Research Collaboration P433 - Development of an instrument to aid triage decisions for intensive care unit admission J. Ramos, B. Peroni, R. Daglius-Dias, L. Miranda, C. Cohen, C. Carvalho, I . Velasco, D. Forte P434 - Using selective serotonin re-uptake inhibitors and serotonin-norepinephrine re-uptake inhibitors in critical care: a systematic review of the evidence for benefit or harm J. M. Kelly, A. Neill, G. Rubenfeld, N. Masson, A. Min P435 - Measuring adaptive coping of hospitalized patients with a severe medical condition:the sickness insight in coping questionnaire (sicq) E. Boezeman, J. Hofhuis , A. Hovingh, R. De Vries, P. Spronk P436 - Results of a national survey regarding intensive care medicine training G. Cabral-Campello, I. Aragão, T. Cardoso P437 - Work engagement among healthcare professionals in the intensive care unit M. Van Mol, M. Nijkamp, E . Kompanje P438 - Empowering the intensive care practitioners. is it a burnout ameliorating intervention? P. Ostrowski, A. Omar P439 - Icu patients suffer from circadian rhythm desynchronisation K. Kiss , B. Köves, V. Csernus, Z. Molnár P440 - Noise reduction in the ICU: feasible ? Y. Hoydonckx, S. Vanwing, B. Stessel, A. Van Assche, L. Jamaer, J. Dubois P441 - Accidental removal of invasive devices in the critical patient into the bed-washing. does the presence of professional nurse modify his incidence? V. Medo, R. Galvez, J. P. Miranda P442 - Deprivation of liberty safeguards (dols): audit of compliance in a of a 16-bed specialist cancer critical care unit. C. Stone, T. Wigmore P443 - Use of a modified cristal score to predict futility of critical care in the elderly Y. Arunan, A. Wheeler, K. Bauchmuller, D. Bryden P444 - Improvement of Referral Rate to Palliative Care for Patients with Poor Prognosis in Neurosurgical Intensive Care Unit Y. Wong, C. Poi, C. Gu P445 - Factors associated with limitation of life supporting care (lsc) in a medico-surgical intermediate care unit, and outcome of patients with lsc limitation: a monocentric, six-month study. P. Molmy, N. Van Grunderbeeck, O. Nigeon, M. Lemyze, D. Thevenin, J. Mallat P446 - Palliative care consultation and intensive care unit admission request: a cohort study J. Ramos, M. Correa, R. T. Carvalho, D. Forte P447 - Nursing and medicine together in postsurgical intensive care unit: situations of prognostic conflict at the end of life. our critical care nurses suffer with our medical activism? A. Fernandez, C. McBride P448 - End of life who may decide E. Koonthalloor, C. Walsh P449 - Correctly diagnosing death A. Webber, M. Ashe, K. Smith, P. Jeanrenaud P450 - Skin procurement performed by intensive care physicians: yes, we can. A. Marudi , S. Baroni, F. Ragusa, E. Bertellini P451 - Death analysis in pediatric intensive care patients E. A. Volakli , E. Chochliourou, M. Dimitriadou, A. Violaki, P. Mantzafleri, E. Samkinidou, O. Vrani, A. Arbouti, T. Varsami, M. Sdougka P452 - The potential impact of euthanasia on organ donation: analysis of data from belgium J. A. Bollen, T. C. Van Smaalen, W. C. De Jongh, M. M. Ten Hoopen, D. Ysebaert, L. W. Van Heurn, W. N. Van Mook P453 - Communication within an intensive care setting K. Sim, A. Fuller P454 - Development and implementation of a longitudinal communication curriculum for critical care medicine fellows A. Roze des Ordons, P. Couillard, C. Doig P455 - Staff-family conflict in a multi-ethnic intensive care unit R. V. Van Keer, R. D. Deschepper, A. F. Francke, L. H. Huyghens, J. B. Bilsen P456 - Does the source of admission to critical care affect family satisfaction? B. Nyamaizi, C. Dalrymple, A. Molokhia, A. Dobru P457 - A simple alternative to the family satisfaction survey (fs-icu) E. Marrinan, A. Ankuli, A. Molokhia P458 - A study to explore the experiences of patient and family volunteers in a critical care environment: a phenomenological analysis J. McPeake, R. Struthers, R. Crawford , H. Devine , P. Mactavish , T. Quasim P459 - Prevalence and risk factors of anxiety and depression in relatives of burn patients. P. Morelli, M. Degiovanangelo, F. Lemos, V. MArtinez, F. Verga, J. Cabrera, G. Burghi P460 - Guidance of visiting children at an adult intensive care unit (icu) A. Rutten , S. Van Ieperen, S. De Geer, M. Van Vugt, E. Der Kinderen P461 - Visiting policies in Italian pediatric ICUs: an update A. Giannini, G Miccinesi, T Marchesi, E Prandi",10.1186/s13054-016-1208-6,1vimqhdp,"['P001', 'Sepsis', 'impairs', 'the', 'capillary', 'response', 'within', 'hypoxic', 'capillaries', 'and', 'decreases', 'erythrocyte', 'oxygen', 'dependent', 'ATP', 'efflux', 'R', 'M', 'Bateman', 'M', 'D', 'Sharpe', 'J', 'E', 'Jagger', 'C', 'G', 'Ellis', 'P002', 'Lower', 'serum', 'immunoglobulin', 'G2', 'level', 'does', 'not', 'predispose', 'to', 'severe', 'flu', 'J', 'Solé', 'Violán', 'M', 'López', 'Rodríguez', 'E', 'Herrera', 'Ramos', 'J', 'Ruíz', 'Hernández', 'L', 'Borderías', 'J', 'Horcajada', 'N', 'González', 'Quevedo', 'O', 'Rajas', 'M', 'Briones', 'F', 'Rodríguez', 'de', 'Castro', 'C', 'Rodríguez', 'Gallego', 'P003', 'Brain', 'protective', 'effects', 'of', 'intravenous', 'immunoglobulin', 'through', 'inhibition', 'of', 'complement', 'activation', 'and', 'apoptosis', 'in', 'a', 'rat', 'model', 'of', 'sepsis', 'F', 'Esen', 'G', 'Orhun', 'P', 'Ergin', 'Ozcan', 'E', 'Senturk', 'C', 'Ugur', 'Yilmaz', 'N', 'Orhan', 'N', 'Arican', 'M', 'Kaya', 'M', 'Kucukerden', 'M', 'Giris', 'U', 'Akcan', 'S', 'Bilgic', 'Gazioglu', 'E', 'Tuzun', 'P004', 'Adenosine', 'a1', 'receptor', 'dysfunction', 'is', 'associated', 'with', 'leukopenia', 'A', 'possible', 'mechanism', 'for', 'sepsis', 'induced', 'leukopenia', 'R', 'Riff', 'O', 'Naamani', 'A', 'Douvdevani', 'P005', 'Analysis', 'of', 'neutrophil', 'by', 'hyper', 'spectral', 'imaging', 'A', 'preliminary', 'report', 'R', 'Takegawa', 'H', 'Yoshida', 'T', 'Hirose', 'N', 'Yamamoto', 'H', 'Hagiya', 'M', 'Ojima', 'Y', 'Akeda', 'O', 'Tasaki', 'K', 'Tomono', 'T', 'Shimazu', 'P006', 'Chemiluminescent', 'intensity', 'assessed', 'by', 'eaa', 'predicts', 'the', 'incidence', 'of', 'postoperative', 'infectious', 'complications', 'following', 'gastrointestinal', 'surgery', 'S', 'Ono', 'T', 'Kubo', 'S', 'Suda', 'T', 'Ueno', 'T', 'Ikeda', 'P007', 'Serial', 'change', 'of', 'c1', 'inhibitor', 'in', 'patients', 'with', 'sepsis', 'A', 'prospective', 'observational', 'study', 'T', 'Hirose', 'H', 'Ogura', 'H', 'Takahashi', 'M', 'Ojima', 'J', 'Kang', 'Y', 'Nakamura', 'T', 'Kojima', 'T', 'Shimazu', 'P008', 'Comparison', 'of', 'bacteremia', 'and', 'sepsis', 'on', 'sepsis', 'related', 'biomarkers', 'T', 'Ikeda', 'S', 'Suda', 'Y', 'Izutani', 'T', 'Ueno', 'S', 'Ono', 'P009', 'The', 'changes', 'of', 'procalcitonin', 'levels', 'in', 'critical', 'patients', 'with', 'abdominal', 'septic', 'shock', 'during', 'blood', 'purification', 'T', 'Taniguchi', 'M', 'O', 'P010', 'Validation', 'of', 'a', 'new', 'sensitive', 'point', 'of', 'care', 'device', 'for', 'rapid', 'measurement', 'of', 'procalcitonin', 'C', 'Dinter', 'J', 'Lotz', 'B', 'Eilers', 'C', 'Wissmann', 'R', 'Lott', 'P011', 'Infection', 'biomarkers', 'in', 'primary', 'care', 'patients', 'with', 'acute', 'respiratory', 'tract', 'infections', 'Comparison', 'of', 'procalcitonin', 'and', 'C', 'reactive', 'protein', 'M', 'M', 'Meili', 'P', 'S', 'Schuetz', 'P012', 'Do', 'we', 'need', 'a', 'lower', 'procalcitonin', 'cut', 'off', 'H', 'Hawa', 'M', 'Sharshir', 'M', 'Aburageila', 'N', 'Salahuddin', 'P013', 'The', 'predictive', 'role', 'of', 'C', 'reactive', 'protein', 'and', 'procalcitonin', 'biomarkers', 'in', 'central', 'nervous', 'system', 'infections', 'with', 'extensively', 'drug', 'resistant', 'bacteria', 'V', 'Chantziara', 'S', 'Georgiou', 'A', 'Tsimogianni', 'P', 'Alexandropoulos', 'A', 'Vassi', 'F', 'Lagiou', 'M', 'Valta', 'G', 'Micha', 'E', 'Chinou', 'G', 'Michaloudis', 'P014', 'Changes', 'in', 'endotoxin', 'activity', 'assay', 'and', 'procalcitonin', 'levels', 'after', 'direct', 'hemoperfusion', 'with', 'polymyxin', 'b', 'immobilized', 'fiber', 'A', 'Kodaira', 'T', 'Ikeda', 'S', 'Ono', 'T', 'Ueno', 'S', 'Suda', 'Y', 'Izutani', 'H', 'Imaizumi', 'P015', 'Diagnostic', 'usefullness', 'of', 'combination', 'biomarkers', 'on', 'ICU', 'admission', 'M', 'V', 'De', 'la', 'Torre', 'Prados', 'A', 'Garcia', 'De', 'la', 'Torre', 'A', 'Enguix', 'Armada', 'A', 'Puerto', 'Morlan', 'V', 'Perez', 'Valero', 'A', 'Garcia', 'Alcantara', 'P016', 'Platelet', 'function', 'analysis', 'utilising', 'the', 'PFA', '100', 'does', 'not', 'predict', 'infection', 'bacteraemia', 'sepsis', 'or', 'outcome', 'in', 'critically', 'ill', 'patients', 'N', 'Bolton', 'J', 'Dudziak', 'S', 'Bonney', 'A', 'Tridente', 'P', 'Nee', 'P017', 'Extracellular', 'histone', 'H3', 'levels', 'are', 'inversely', 'correlated', 'with', 'antithrombin', 'levels', 'and', 'platelet', 'counts', 'and', 'are', 'associated', 'with', 'mortality', 'in', 'sepsis', 'patients', 'G', 'Nicolaes', 'M', 'Wiewel', 'M', 'Schultz', 'K', 'Wildhagen', 'J', 'Horn', 'R', 'Schrijver', 'T', 'Van', 'der', 'Poll', 'C', 'Reutelingsperger', 'P018', 'Il', '8', 'is', 'this', 'a', 'more', 'reliable', 'biomarker', 'for', 'sepsis', 'severity', 'than', 'CRP', 'Procalcitonin', 'E', 'selectin', 'IL', '6', 'and', 'TNF', 'alpha', 'S', 'Pillai', 'G', 'Davies', 'G', 'Mills', 'R', 'Aubrey', 'K', 'Morris', 'P', 'Williams', 'P', 'Evans', 'P019', 'Relation', 'between', 'adrenomedullin', 'and', 'short', 'term', 'outcome', 'in', 'ICU', 'patients', 'Results', 'from', 'the', 'frog', 'ICU', 'study', 'E', 'G', 'Gayat', 'J', 'Struck', 'A', 'Cariou', 'N', 'Deye', 'B', 'Guidet', 'S', 'Jabert', 'J', 'Launay', 'M', 'Legrand', 'M', 'Léone', 'M', 'Resche', 'Rigon', 'E', 'Vicaut', 'A', 'Vieillard', 'Baron', 'A', 'Mebazaa', 'P020', 'Impact', 'of', 'disease', 'severity', 'assessment', 'on', 'performance', 'of', 'heparin', 'binding', 'protein', 'for', 'the', 'prediction', 'of', 'septic', 'shock', 'R', 'Arnold', 'M', 'Capan', 'A', 'Linder', 'P', 'Akesson', 'P021', 'Kinetics', 'and', 'prognostic', 'value', 'of', 'presepsin', 'sCD14', 'in', 'septic', 'patients', 'A', 'pilot', 'study', 'M', 'Popescu', 'D', 'Tomescu', 'P022', 'Comparison', 'of', 'CD64', 'levels', 'performed', 'by', 'the', 'facs', 'and', 'accellix', 'systems', 'C', 'L', 'Sprung', 'R', 'Calderon', 'Morales', 'G', 'Munteanu', 'E', 'Orenbuch', 'Harroch', 'P', 'Levin', 'H', 'Kasdan', 'A', 'Reiter', 'T', 'Volker', 'Y', 'Himmel', 'Y', 'Cohen', 'J', 'Meissonnier', 'P023', 'Diagnosing', 'sepsis', 'in', '5', 'minutes', 'Nanofluidic', 'technology', 'study', 'with', 'pancreatic', 'stone', 'protein', 'PSP', 'reg', 'L', 'Girard', 'F', 'Rebeaud', 'P024', 'How', 'nanotechnology', 'based', 'approaches', 'could', 'contribute', 'to', 'sepsis', 'prevention', 'diagnosis', 'and', 'treatment', 'I', 'Herrmann', 'P025', 'Il7r', 'transcriptional', 'expression', 'analysis', 'during', 'septic', 'shock', 'B', 'Delwarde', 'E', 'Peronnet', 'E', 'Cerrato', 'F', 'Venet', 'A', 'Lepape', 'T', 'Rimmelé', 'G', 'Monneret', 'J', 'Textoris', 'P026', 'Disbalance', 'of', 'microbial', 'metabolites', 'of', 'aromatic', 'acids', 'affects', 'the', 'severity', 'in', 'critically', 'ill', 'patients', 'N', 'Beloborodova', 'V', 'Moroz', 'A', 'Osipov', 'A', 'Bedova', 'Y', 'Sarshor', 'A', 'Pautova', 'A', 'Sergeev', 'E', 'Chernevskaya', 'P027', 'Copeptin', 'predicts', '10', 'year', 'all', 'cause', 'mortality', 'in', 'community', 'patients', 'J', 'Odermatt', 'R', 'Bolliger', 'L', 'Hersberger', 'M', 'Ottiger', 'M', 'Christ', 'Crain', 'B', 'Mueller', 'P', 'Schuetz', 'P028', 'Identification', 'of', 'differential', 'proteomic', 'response', 'in', 'septic', 'patients', 'secondary', 'to', 'community', 'and', 'hospital', 'acquired', 'pneumonia', 'N', 'K', 'Sharma', 'A', 'K', 'Tashima', 'M', 'K', 'Brunialti', 'F', 'R', 'Machado', 'M', 'Assuncao', 'O', 'Rigato', 'R', 'Salomao', 'P029', 'Monocyte', 'HLA', 'DR', 'expression', 'in', 'community', 'acquired', 'bacteremic', 'sepsis', 'dynamics', 'associated', 'to', 'aetiology', 'and', 'prediction', 'of', 'secondary', 'sepsis', 'S', 'C', 'Cajander', 'G', 'Rasmussen', 'E', 'Tina', 'B', 'Söderquist', 'J', 'Källman', 'K', 'Strålin', 'P030', 'Soluble', 'B', 'and', 'T', 'lymphocyte', 'attenuator', 'A', 'possible', 'prognostic', 'marker', 'in', 'sepsis', 'A', 'L', 'Lange', 'J', 'S', 'Sundén', 'Cullberg', 'A', 'M', 'Magnuson', 'O', 'H', 'Hultgren', 'P031', 'Fractal', 'dimension', 'A', 'new', 'biomarker', 'for', 'quantifying', 'clot', 'microstructure', 'in', 'patients', 'across', 'the', 'sepsis', 'spectrum', 'G', 'Davies', 'S', 'Pillai', 'G', 'Mills', 'R', 'Aubrey', 'K', 'Morris', 'P', 'Williams', 'P', 'Evans', 'P032', 'Comparison', 'between', 'the', 'new', 'biomarker', 'for', 'coagulation', 'clot', 'microstructure', 'Df', 'with', 'rotational', 'thromboelastometry', 'ROTEM', 'in', 'patients', 'across', 'the', 'sepsis', 'spectrum', 'S', 'Pillai', 'G', 'Davies', 'G', 'Mills', 'R', 'Aubrey', 'K', 'Morris', 'P', 'Williams', 'P', 'Evans', 'P033', 'Changes', 'in', 'fibrinolysis', 'across', 'the', 'sepsis', 'spectrum', 'The', 'use', 'of', 'rotational', 'thromboelastometry', 'ROTEM', 'lysis', 'index', 'LI60', 'and', 'D', 'Dimer', 'concentration', 'S', 'Pillai', 'G', 'Davies', 'G', 'Mills', 'R', 'Aubrey', 'K', 'Morris', 'P', 'Williams', 'P', 'Evans', 'P034', 'The', 'intensive', 'care', 'infection', 'score', 'a', 'promising', 'marker', 'for', 'the', 'prediction', 'of', 'infection', 'and', 'its', 'severity', 'P', 'Van', 'der', 'Geest', 'M', 'Mohseni', 'J', 'Linssen', 'R', 'De', 'Jonge', 'S', 'Duran', 'J', 'Groeneveld', 'P035', 'Challenges', 'in', 'the', 'clinical', 'diagnosis', 'of', 'sepsis', 'R', 'Miller', 'III', 'B', 'K', 'Lopansri', 'L', 'C', 'McHugh', 'A', 'Seldon', 'J', 'P', 'Burke', 'P036', 'Does', 'zero', 'heat', 'flux', 'thermometry', 'more', 'accurately', 'identify', 'sepsis', 'on', 'intensive', 'care', 'J', 'Johnston', 'R', 'Reece', 'Anthony', 'A', 'Bond', 'A', 'Molokhia', 'P037', 'Advancing', 'quality', 'AQ', 'sepsis', 'programme', 'Improving', 'early', 'identification', 'treatment', 'of', 'sepsis', 'in', 'North', 'West', 'England', 'C', 'Mcgrath', 'E', 'Nsutebu', 'P038', 'Prehospital', 'transport', 'of', 'acute', 'septic', 'patients', 'P', 'Bank', 'Pedersen', 'D', 'Pilsgaard', 'Henriksen', 'S', 'Mikkelsen', 'A', 'Touborg', 'Lassen', 'P039', 'Vasodilatory', 'plant', 'extracts', 'gel', 'as', 'an', 'alternative', 'treatment', 'for', 'fever', 'in', 'critically', 'ill', 'patients', 'R', 'Tincu', 'C', 'Cobilinschi', 'D', 'Tomescu', 'Z', 'Ghiorghiu', 'R', 'Macovei', 'P040', 'Host', 'response', 'and', 'outcome', 'of', 'hypothermic', 'sepsis', 'M', 'A', 'Wiewel', 'M', 'B', 'Harmon', 'L', 'A', 'Van', 'Vught', 'B', 'P', 'Scicluna', 'A', 'J', 'Hoogendijk', 'J', 'Horn', 'A', 'H', 'Zwinderman', 'O', 'L', 'Cremer', 'M', 'J', 'Bonten', 'M', 'J', 'Schultz', 'T', 'Van', 'der', 'Poll', 'N', 'P', 'Juffermans', 'W', 'J', 'Wiersinga', 'P041', 'Septic', 'shock', 'alert', 'over', 'SIRS', 'criteria', 'has', 'an', 'impact', 'on', 'outcome', 'but', 'needs', 'to', 'be', 'revised', 'G', 'Eren', 'Y', 'Tekdos', 'M', 'Dogan', 'O', 'Acicbe', 'E', 'Kaya', 'O', 'Hergunsel', 'P042', 'Association', 'between', 'previous', 'prescription', 'of', 'βblockers', 'and', 'mortality', 'rate', 'among', 'septic', 'patients', 'A', 'retrospective', 'observational', 'study', 'S', 'Alsolamy', 'G', 'Ghamdi', 'L', 'Alswaidan', 'S', 'Alharbi', 'F', 'Alenezi', 'Y', 'Arabi', 'P043', 'Recognition', 'and', 'treatment', 'of', 'sepsis', 'on', 'labour', 'ward', 'teaching', 'information', 'resources', 'can', 'improve', 'knowledge', 'J', 'Heaton', 'A', 'Boyce', 'L', 'Nolan', 'J', 'Johnston', 'A', 'Dukoff', 'Gordon', 'A', 'Dean', 'A', 'Molokhia', 'P044', 'Culture', 'negative', 'sepsis', 'in', 'the', 'ICU', 'what', 'is', 'unique', 'to', 'this', 'patient', 'population', 'T', 'Mann', 'Ben', 'Yehudah', 'P045', 'Organ', 'dysfunction', 'in', 'severe', 'sepsis', 'patients', 'identified', 'in', 'administrative', 'data', 'in', 'Germany', '2007', '2013', 'C', 'Fleischmann', 'D', 'Thomas', 'Rueddel', 'C', 'Haas', 'U', 'Dennler', 'K', 'Reinhart', 'P046', 'A', 'comparison', 'of', 'residents', 'knowledge', 'regarding', 'the', 'Surviving', 'Sepsis', 'Campaign', '2012', 'guideline', 'O', 'Suntornlohanakul', 'B', 'Khwannimit', 'P047', 'Effectiveness', 'of', 'a', 'septic', 'shock', 'bundle', 'to', 'improve', 'outcomes', 'in', 'the', 'ICU', 'F', 'Breckenridge', 'A', 'Puxty', 'P048', 'Dose', 'of', 'norepinephrine', 'in', 'the', 'first', '24', 'hours', 'as', 'a', 'parameter', 'evaluating', 'the', 'effectiveness', 'of', 'treatment', 'in', 'patients', 'with', 'severe', 'sepsis', 'and', 'septic', 'shock', 'P', 'Szturz', 'P', 'Folwarzcny', 'J', 'Svancara', 'R', 'Kula', 'P', 'Sevcik', 'P049', 'Norepinephrine', 'or', 'vasopressin', 'norepinephrine', 'in', 'septic', 'shock', 'A', 'retrospective', 'series', 'of', '39', 'patients', 'L', 'Caneva', 'A', 'Casazza', 'E', 'Bellazzi', 'S', 'Marra', 'L', 'Pagani', 'M', 'Vetere', 'R', 'Vanzino', 'D', 'Ciprandi', 'R', 'Preda', 'R', 'Boschi', 'L', 'Carnevale', 'P050', 'Methylene', 'blue', 'effectiveness', 'as', 'contributory', 'treatment', 'in', 'patients', 'with', 'septic', 'shock', 'V', 'Lopez', 'M', 'Aguilar', 'Arzapalo', 'L', 'Barradas', 'A', 'Escalante', 'J', 'Gongora', 'M', 'Cetina', 'P051', 'Coagulation', 'disorders', 'in', 'patients', 'with', 'severe', 'sepsis', 'and', 'DIC', 'evaluated', 'with', 'thromboelastometry', 'B', 'Adamik', 'D', 'Jakubczyk', 'A', 'Kübler', 'P052', 'Frequency', 'and', 'outcome', 'of', 'early', 'sepsis', 'associated', 'coagulopathy', 'A', 'Radford', 'T', 'Lee', 'J', 'Singer', 'J', 'Boyd', 'D', 'Fineberg', 'M', 'Williams', 'J', 'Russell', 'P053', 'Assessment', 'of', 'coagulopathy', 'in', 'cancer', 'patients', 'with', 'severe', 'sepsis', 'or', 'septic', 'shock', 'A', 'case', 'control', 'pilot', 'study', 'E', 'Scarlatescu', 'D', 'Tomescu', 'G', 'Droc', 'S', 'Arama', 'P054', 'Thromboelastometry', 'in', 'critically', 'ill', 'patients', 'with', 'disseminated', 'intravascular', 'coagulation', 'M', 'Müller', 'M', 'Straat', 'S', 'S', 'Zeerleder', 'N', 'P', 'Juffermans', 'P055', 'Cessation', 'of', 'a', 'preexisting', 'chronic', 'antiplatelet', 'therapy', 'is', 'associated', 'with', 'increased', 'mortality', 'rates', 'in', 'severe', 'sepsis', 'and', 'septic', 'shock', 'C', 'F', 'Fuchs', 'C', 'S', 'Scheer', 'S', 'W', 'Wauschkuhn', 'M', 'V', 'Vollmer', 'K', 'M', 'Meissner', 'S', 'K', 'Kuhn', 'K', 'H', 'Hahnenkamp', 'S', 'R', 'Rehberg', 'M', 'G', 'Gründling', 'P056', 'Neutrophil', 'Extracellular', 'Traps', 'NETs', 'production', 'under', 'hypoxic', 'condition', 'N', 'Yamamoto', 'M', 'Ojima', 'S', 'Hamaguchi', 'T', 'Hirose', 'Y', 'Akeda', 'R', 'Takegawa', 'O', 'Tasaki', 'T', 'Shimazu', 'K', 'Tomono', 'P057', 'Impact', 'of', 'ultraviolet', 'air', 'sterilizer', 'in', 'intensive', 'care', 'unit', 'room', 'and', 'clinical', 'outcomes', 'of', 'patients', 'E', 'Gómez', 'Sánchez', 'M', 'Heredia', 'Rodríguez', 'E', 'Álvarez', 'Fuente', 'M', 'Lorenzo', 'López', 'E', 'Gómez', 'Pesquera', 'M', 'Aragón', 'Camino', 'P', 'Liu', 'Zhu', 'A', 'Sánchez', 'López', 'A', 'Hernández', 'Lozano', 'M', 'T', 'Peláez', 'Jareño', 'E', 'Tamayo', 'P058', 'Focus', 'of', 'infection', 'in', 'severe', 'sepsis', 'comparison', 'of', 'administrative', 'data', 'and', 'prospective', 'cohorts', 'from', 'Germany', 'D', 'O', 'Thomas', 'Rüddel', 'C', 'Fleischmann', 'C', 'Haas', 'U', 'Dennler', 'K', 'Reinhart', 'P059', 'Zero', 'CLABSI', 'can', 'we', 'get', 'there', 'Obstacles', 'on', 'the', '4', 'year', 'journey', 'and', 'our', 'strategies', 'to', 'overcome', 'them', 'experience', 'from', 'an', 'Indian', 'ICU', 'V', 'Adora', 'A', 'Kar', 'A', 'Chakraborty', 'S', 'Roy', 'A', 'Bandyopadhyay', 'M', 'Das', 'P060', 'Novel', 'molecular', 'techniques', 'to', 'identify', 'central', 'venous', 'catheter', 'CVC', 'associated', 'blood', 'stream', 'infections', 'BSIs', 'T', 'Mann', 'Ben', 'Yehudah', 'G', 'Ben', 'Yehudah', 'M', 'Salim', 'N', 'Kumar', 'L', 'Arabi', 'T', 'Burger', 'P', 'Lephart', 'E', 'Toth', 'martin', 'P061', 'Zero', 'clabsi', 'can', 'we', 'get', 'there', 'Obstacles', 'on', 'the', '4', 'year', 'journey', 'and', 'our', 'strategies', 'to', 'overcome', 'them', 'experience', 'from', 'an', 'Indian', 'ICU', 'R', 'Rao', 'A', 'Kar', 'A', 'Chakraborty', 'P062', 'Prevention', 'of', 'central', 'line', 'associated', 'bloodstream', 'infections', 'in', 'intensive', 'care', 'units', 'An', 'international', 'online', 'survey', 'C', 'Valencia', 'N', 'Hammami', 'S', 'Blot', 'J', 'L', 'Vincent', 'M', 'L', 'Lambert', 'P063', '30', 'days', 'antimicrobial', 'efficacy', 'of', 'non', 'leaching', 'central', 'venous', 'catheters', 'J', 'Brunke', 'T', 'Riemann', 'I', 'Roschke', 'P064', 'Efficacy', 'of', 'noble', 'metal', 'alloy', 'coated', 'catheter', 'in', 'prevention', 'of', 'bacteriuria', 'R', 'Tincu', 'C', 'Cobilinschi', 'D', 'Tomescu', 'Z', 'Ghiorghiu', 'R', 'Macovei', 'P065', 'Predicting', 'bacteremic', 'urinary', 'tract', 'infection', 'in', 'community', 'setting', 'A', 'prospective', 'observational', 'study', 'S', 'Nimitvilai', 'K', 'Jintanapramote', 'S', 'Jarupongprapa', 'P066', 'Eight', 'year', 'analysis', 'of', 'acinetobacter', 'spp', 'monobacteremia', 'in', 'surgical', 'and', 'medical', 'intensive', 'care', 'units', 'at', 'university', 'hospital', 'in', 'Lithuania', 'D', 'Adukauskiene', 'D', 'Valanciene', 'P067', 'Group', 'A', 'and', 'group', 'B', 'streptococcal', 'infections', 'in', 'intensive', 'care', 'unit', 'our', 'experience', 'in', 'a', 'tertiary', 'centre', 'G', 'Bose', 'V', 'Lostarakos', 'B', 'Carr', 'P068', 'Improved', 'detection', 'of', 'spontaneous', 'bacterial', 'peritonitis', 'by', 'uritop', 'tm', 'strip', 'test', 'and', 'inoculation', 'of', 'blood', 'culture', 'bottles', 'with', 'ascitic', 'fluid', 'S', 'Khedher', 'A', 'Maaoui', 'A', 'Ezzamouri', 'M', 'Salem', 'P069', 'Increased', 'risk', 'of', 'cellulitis', 'in', 'patients', 'with', 'congestive', 'heart', 'failure', 'a', 'population', 'based', 'cohort', 'study', 'J', 'Chen', 'P070', 'Outcomes', 'of', 'severe', 'cellulitis', 'and', 'necrotizing', 'fasciitis', 'in', 'the', 'critically', 'ill', 'D', 'R', 'Cranendonk', 'L', 'A', 'Van', 'Vught', 'M', 'A', 'Wiewel', 'O', 'L', 'Cremer', 'J', 'Horn', 'M', 'J', 'Bonten', 'M', 'J', 'Schultz', 'T', 'Van', 'der', 'Poll', 'W', 'J', 'Wiersinga', 'P071', 'Botulism', 'outbreak', 'associated', 'with', 'people', 'who', 'inject', 'drugs', 'PWIDs', 'in', 'Scotland', 'M', 'Day', 'G', 'Penrice', 'K', 'Roy', 'P', 'Robertson', 'G', 'Godbole', 'B', 'Jones', 'M', 'Booth', 'L', 'Donaldson', 'P072', 'Surveillance', 'of', 'ESBL', 'producing', 'enterobacteriaceae', 'fecal', 'carriers', 'in', 'the', 'ICU', 'Y', 'Kawano', 'H', 'Ishikura', 'P073', 'Prevalence', 'of', 'ESBL', 'and', 'carbapenemase', 'producing', 'uropathogens', 'in', 'a', 'newly', 'opened', 'hospital', 'in', 'south', 'India', 'S', 'Sreevidya', 'N', 'Brahmananda', 'Reddy', 'P', 'Muraray', 'Govind', 'R', 'Pratheema', 'J', 'Devachandran', 'Apollo', 'Speciality', 'Hospital', 'OMR', 'Chennai', 'India', 'P074', 'Prevalence', 'risk', 'factors', 'and', 'outcomes', 'of', 'methicillin', 'resistant', 'staphylococcus', 'aureus', 'nasal', 'colonization', 'in', 'critically', 'ill', 'patients', 'H', 'Al', 'Dorzi', 'M', 'Almutairi', 'B', 'Alhamadi', 'A', 'Crizaldo', 'Toledo', 'R', 'Khan', 'B', 'Al', 'Raiy', 'Y', 'Arabi', 'P075', 'Multidrug', 'resistant', 'Acinetobacter', 'baumannii', 'infection', 'in', 'intensive', 'care', 'unit', 'patients', 'in', 'a', 'hospital', 'with', 'building', 'construction', 'Is', 'there', 'an', 'association', 'H', 'Talaie', 'P076', 'Multidrug', 'resistant', 'organisms', 'in', 'a', 'Dutch', 'ICU', 'J', 'A', 'Van', 'Oers', 'A', 'Harts', 'E', 'Nieuwkoop', 'P', 'Vos', 'P077', 'Epidemiology', 'and', 'risk', 'factors', 'of', 'ICU', 'acquired', 'infections', 'caused', 'by', 'multidrug', 'resistant', 'gram', 'negative', 'bacilli', 'Y', 'Boussarsar', 'F', 'Boutouta', 'S', 'Kamoun', 'I', 'Mezghani', 'S', 'Koubaji', 'A', 'Ben', 'Souissi', 'A', 'Riahi', 'M', 'S', 'Mebazaa', 'P078', 'Improving', 'outcomes', 'of', 'severe', 'infections', 'by', 'multidrug', 'resistant', 'pathogens', 'with', 'polyclonal', 'IgM', 'enriched', 'immunoglobulins', 'E', 'Giamarellos', 'Bourboulis', 'N', 'Tziolos', 'C', 'Routsi', 'C', 'Katsenos', 'I', 'Tsangaris', 'I', 'Pneumatikos', 'G', 'Vlachogiannis', 'V', 'Theodorou', 'A', 'Prekates', 'E', 'Antypa', 'V', 'Koulouras', 'N', 'Kapravelos', 'C', 'Gogos', 'E', 'Antoniadou', 'K', 'Mandragos', 'A', 'Armaganidis', 'P079', 'Must', 'change', 'the', 'medical', 'practice', 'in', 'ICU', 'A', 'R', 'Robles', 'Caballero', 'B', 'Civantos', 'J', 'C', 'Figueira', 'J', 'López', 'P080', 'Mediterranean', 'spotted', 'fever', 'in', 'an', 'infectious', 'diseases', 'intensive', 'care', 'unit', 'A', 'Silva', 'Pinto', 'F', 'Ceia', 'A', 'Sarmento', 'L', 'Santos', 'P081', 'Clinical', 'features', 'and', 'outcomes', 'of', 'patients', 'with', 'Middle', 'East', 'respiratory', 'syndrome', 'requiring', 'admission', 'to', 'a', 'saudi', 'intensive', 'care', 'unit', 'A', 'retrospective', 'analysis', 'of', '31', 'cases', 'G', 'Almekhlafi', 'Y', 'Sakr', 'P082', 'The', 'ICU', 'response', 'to', 'a', 'hospital', 'outbreak', 'of', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'infection', 'H', 'Al', 'Dorzi', 'R', 'Khan', 'S', 'Baharoon', 'A', 'Aldawood', 'A', 'Matroud', 'J', 'Alchin', 'S', 'Al', 'Johani', 'H', 'Balkhy', 'Y', 'Arabi', 'P083', 'Middle', 'East', 'respiratory', 'syndrome', 'Surveillance', 'data', 'analysis', 'S', 'Alsolamy', 'S', 'Y', 'Yousif', 'B', 'O', 'Alotabi', 'A', 'S', 'Alsaawi', 'P085', 'Use', 'of', 'Taqman', 'array', 'card', 'molecular', 'diagnostics', 'in', 'severe', 'pneumonia', 'A', 'case', 'series', 'J', 'Ang', 'MD', 'Curran', 'D', 'Enoch', 'V', 'Navapurkar', 'A', 'Conway', 'Morris', 'P086', 'BUNS', 'An', 'investigation', 'protocol', 'improves', 'the', 'ICU', 'management', 'of', 'pneumonia', 'R', 'Sharvill', 'J', 'Astin', 'P087', 'Pneumonia', 'in', 'patients', 'following', 'secondary', 'peritonitis', 'epidemiological', 'features', 'and', 'impact', 'on', 'mortality', 'M', 'Heredia', 'Rodríguez', 'E', 'Gómez', 'Sánchez', 'M', 'T', 'Peláez', 'Jareño', 'E', 'Gómez', 'Pesquera', 'M', 'Lorenzo', 'López', 'P', 'Liu', 'Zhu', 'M', 'Aragón', 'Camino', 'A', 'Hernández', 'Lozano', 'A', 'Sánchez', 'López', 'E', 'Álvarez', 'Fuente', 'E', 'Tamayo', 'P088', 'The', 'use', 'of', 'the', 'CURB', '65', 'score', 'by', 'emergency', 'room', 'clinicians', 'in', 'a', 'large', 'teaching', 'hospital', 'J', 'Patel', 'C', 'Kruger', 'P089', 'Incidence', 'of', 'community', 'acquired', 'pneumonia', 'with', 'viral', 'infection', 'in', 'mechanically', 'ventilated', 'patients', 'in', 'the', 'medical', 'intensive', 'care', 'unit', 'J', 'O', 'Neal', 'H', 'Rhodes', 'J', 'Jancik', 'P090', 'The', 'SAATELLITE', 'Study', 'Prevention', 'of', 'S', 'aureus', 'Nosocomial', 'Pneumonia', 'NP', 'with', 'MEDI4893', 'a', 'Human', 'Monoclonal', 'Antibody', 'mAb', 'Against', 'S', 'aureus', 'B', 'François', 'P', 'F', 'Laterre', 'P', 'Eggimann', 'A', 'Torres', 'M', 'Sánchez', 'P', 'F', 'Dequin', 'G', 'L', 'Bassi', 'J', 'Chastre', 'H', 'S', 'Jafri', 'P091', 'Risk', 'factors', 'and', 'microbiological', 'profile', 'for', 'nosocomial', 'infections', 'in', 'trauma', 'patients', 'M', 'Ben', 'Romdhane', 'Z', 'Douira', 'S', 'Kamoun', 'M', 'Bousselmi', 'A', 'Ben', 'Souissi', 'Y', 'Boussarsar', 'A', 'Riahi', 'M', 'S', 'Mebazaa', 'P092', 'Correlation', 'between', 'percentages', 'of', 'ventilated', 'patients', 'developed', 'vap', 'and', 'use', 'of', 'antimicrobial', 'agents', 'in', 'ICU', 'patients', 'A', 'Vakalos', 'V', 'Avramidis', 'P093', 'A', 'comparison', 'of', 'two', 'ventilator', 'associated', 'pneumonia', 'surveillance', 'techniques', 'T', 'H', 'Craven', 'G', 'Wojcik', 'K', 'Kefala', 'J', 'McCoubrey', 'J', 'Reilly', 'R', 'Paterson', 'D', 'Inverarity', 'I', 'Laurenson', 'T', 'S', 'Walsh', 'P094', 'Lung', 'ultrasound', 'before', 'and', 'after', 'fiberbronchoscopy', 'modifications', 'may', 'improve', 'ventilator', 'associated', 'pneumonia', 'diagnosis', 'S', 'Mongodi', 'B', 'Bouhemad', 'A', 'Orlando', 'A', 'Stella', 'G', 'Via', 'G', 'Iotti', 'A', 'Braschi', 'F', 'Mojoli', 'P095', 'Comparing', 'the', 'accuracy', 'of', 'predictors', 'of', 'mortality', 'in', 'ventilator', 'associated', 'pneumonia', 'M', 'Haliloglu', 'B', 'Bilgili', 'U', 'Kasapoglu', 'I', 'Sayan', 'M', 'Süzer', 'Aslan', 'A', 'Yalcın', 'I', 'Cinel', 'P096', 'Impact', 'of', 'pRBCs', 'transfusion', 'on', 'percentage', 'of', 'ventilated', 'patients', 'developed', 'VAP', 'in', 'ICU', 'patients', 'A', 'Vakalos', 'V', 'Avramidis', 'P097', 'The', 'impact', 'of', 'a', 'series', 'of', 'interventions', 'on', 'the', 'rate', 'of', 'ventilator', 'associated', 'pneumonia', 'in', 'a', 'large', 'teaching', 'hospital', 'H', 'E', 'Ellis', 'K', 'Bauchmuller', 'D', 'Miller', 'A', 'Temple', 'P098', 'The', 'EVADE', 'study', 'Prevention', 'of', 'Nosocomial', 'Pneumonia', 'NP', 'caused', 'by', 'P', 'aeruginosa', 'with', 'MEDI3902', 'a', 'Novel', 'Bispecific', 'Monoclonal', 'Antibody', 'against', 'P', 'aeruginosa', 'virulence', 'factors', 'J', 'Chastre', 'B', 'François', 'A', 'Torres', 'C', 'E', 'Luyt', 'M', 'Sánchez', 'M', 'Singer', 'H', 'S', 'Jafri', 'P099', 'Short', 'term', 'inhaled', 'colistin', 'adjunctive', 'therapy', 'for', 'ventilator', 'associated', 'pneumonia', 'Y', 'Nassar', 'M', 'S', 'Ayad', 'P100', 'Effect', 'of', 'aerosolised', 'colistin', 'on', 'weaning', 'from', 'mechanical', 'ventilation', 'A', 'Trifi', 'S', 'Abdellatif', 'F', 'Daly', 'R', 'Nasri', 'S', 'Ben', 'Lakhal', 'P101', 'Septic', 'shock', 'is', 'an', 'independent', 'risk', 'factor', 'for', 'colistin', 'induced', 'severe', 'acute', 'kidney', 'injury', 'a', 'retrospective', 'cohort', 'study', 'B', 'Bilgili', 'M', 'Haliloglu', 'F', 'Gul', 'I', 'Cinel', 'P102', 'Nosocomial', 'pneumonia', 'emphasis', 'on', 'inhaled', 'tobramycin', 'A', 'Kuzovlev', 'A', 'Shabanov', 'S', 'Polovnikov', 'V', 'Moroz', 'P103', 'In', 'vitro', 'evaluation', 'of', 'amikacin', 'inhale', 'and', 'commercial', 'nebulizers', 'in', 'a', 'mechanical', 'ventilator', 'N', 'Kadrichu', 'T', 'Dang', 'K', 'Corkery', 'P', 'Challoner', 'P104', 'The', 'effects', 'of', 'nebulized', 'amikacin', 'fosfomycin', 'and', 'systemic', 'meropenem', 'on', 'severe', 'amikacin', 'resistant', 'meropenem', 'susceptible', 'P', 'aeruginosa', 'pneumonia', 'G', 'Li', 'Bassi', 'E', 'Aguilera', 'C', 'Chiurazzi', 'C', 'Travierso', 'A', 'Motos', 'L', 'Fernandez', 'R', 'Amaro', 'T', 'Senussi', 'F', 'Idone', 'J', 'Bobi', 'M', 'Rigol', 'A', 'Torres', 'P105', 'Optimization', 'of', 'gentamicin', 'peak', 'concentrations', 'in', 'critically', 'ill', 'patients', 'C', 'J', 'Hodiamont', 'N', 'P', 'Juffermans', 'J', 'M', 'Janssen', 'C', 'S', 'Bouman', 'R', 'A', 'Mathôt', 'M', 'D', 'De', 'Jong', 'R', 'M', 'Van', 'Hest', 'P106', 'Systematic', 'review', 'of', 'cefepime', 'induced', 'neurotoxicity', 'L', 'Payne', 'G', 'L', 'Fraser', 'P107', 'Unasyn', 'causes', 'QT', 'prolongation', 'during', 'treatment', 'of', 'intensive', 'care', 'patients', 'B', 'Tudor', 'M', 'Lahner', 'G', 'Roth', 'C', 'Krenn', 'P108', 'Comparative', 'study', 'between', 'teicoplanin', 'and', 'vancomycin', 'in', 'methicillin', 'resistant', 'staphylococcus', 'aureus', 'mrsa', 'infectious', 'of', 'toxicological', 'intensive', 'care', 'unit', 'ticu', 'patients', 'Tehran', 'Iran', 'H', 'Talaie', 'P109', 'Phage', 'therapy', 'against', 'antimicrobial', 'resistance', 'design', 'of', 'the', 'first', 'clinical', 'study', 'phagoburn', 'P', 'Jault', 'J', 'Gabard', 'T', 'Leclerc', 'S', 'Jennes', 'Y', 'Que', 'A', 'Rousseau', 'F', 'Ravat', 'P110', 'Antibiotic', 'dosing', 'errors', 'in', 'critically', 'ill', 'patients', 'with', 'severe', 'sepsis', 'or', 'septic', 'shock', 'H', 'Al', 'Dorzi', 'A', 'Eissa', 'S', 'Al', 'Harbi', 'T', 'Aldabbagh', 'R', 'Khan', 'Y', 'Arabi', 'P111', 'Does', 'empiric', 'antifungal', 'therapy', 'improve', 'survival', 'in', 'septic', 'critically', 'ill', 'patients', 'immunocompromised', 'excluded', 'A', 'Trifi', 'S', 'Abdellatif', 'F', 'Daly', 'R', 'Nasri', 'S', 'Ben', 'Lakhal', 'P112', 'Neurocysticercosis', 'Qatar', 'experience', 'F', 'Paramba', 'N', 'Purayil', 'V', 'Naushad', 'O', 'Mohammad', 'V', 'Negi', 'P', 'Chandra', 'P113', 'Early', 'indicators', 'in', 'acute', 'haemorrhagic', 'shock', 'A', 'Kleinsasser', 'P114', 'Filtering', 'of', 'red', 'blood', 'cells', 'reduces', 'the', 'inflammatory', 'response', 'of', 'pulmonary', 'cells', 'in', 'an', 'in', 'vitro', 'model', 'of', 'mechanical', 'ventilation', 'M', 'R', 'Witrz', 'J', 'F', 'Buchner', 'Doeven', 'A', 'M', 'Tuip', 'de', 'Boer', 'J', 'C', 'Goslings', 'N', 'P', 'Juffermans', 'P115', 'Microparticles', 'from', 'red', 'blood', 'cell', 'transfusion', 'induce', 'a', 'pro', 'coagulant', 'and', 'pro', 'inflammatory', 'endothelial', 'cell', 'response', 'M', 'Van', 'Hezel', 'M', 'Straat', 'A', 'Boing', 'R', 'Van', 'Bruggen', 'N', 'Juffermans', 'P116', 'The', 'contribution', 'of', 'cytokines', 'on', 'thrombosis', 'development', 'during', 'hospitalization', 'in', 'ICU', 'D', 'Markopoulou', 'K', 'Venetsanou', 'V', 'Kaldis', 'D', 'Koutete', 'D', 'Chroni', 'I', 'Alamanos', 'P117', 'Prophylactic', 'enoxaparin', 'dosing', 'and', 'adjustment', 'through', 'anti', 'xa', 'monitoring', 'in', 'an', 'inpatient', 'burn', 'unit', 'L', 'Koch', 'J', 'Jancik', 'H', 'Rhodes', 'E', 'Walter', 'P118', 'Determination', 'of', 'optimal', 'cut', 'off', 'values', 'of', 'haemoglobin', 'platelet', 'count', 'and', 'fibrinogen', 'at', '24', 'hours', 'after', 'injury', 'associated', 'with', 'mortality', 'in', 'trauma', 'patients', 'K', 'Maekawa', 'M', 'Hayakawa', 'S', 'Kushimoto', 'A', 'Shiraishi', 'H', 'Kato', 'J', 'Sasaki', 'H', 'Ogura', 'T', 'Matauoka', 'T', 'Uejima', 'N', 'Morimura', 'H', 'Ishikura', 'A', 'Hagiwara', 'M', 'Takeda', 'P119', 'Trauma', 'induced', 'coagulopathy', 'prothrombin', 'complex', 'concentrate', 'vs', 'fresh', 'frozen', 'plasma', 'O', 'Tarabrin', 'S', 'Shcherbakow', 'D', 'Gavrychenko', 'G', 'Mazurenko', 'V', 'Ivanova', 'O', 'Chystikov', 'P120', 'First', 'study', 'to', 'prove', 'the', 'superiority', 'of', 'prothrombin', 'complex', 'concentrates', 'on', 'mortality', 'rate', 'over', 'fresh', 'frozen', 'plasma', 'in', 'patients', 'with', 'acute', 'bleeding', 'C', 'Plourde', 'J', 'Lessard', 'J', 'Chauny', 'R', 'Daoust', 'P121', 'Prothrombin', 'complex', 'concentrate', 'vs', 'fresh', 'frozen', 'plasma', 'in', 'obstetric', 'massive', 'bleeding', 'S', 'Shcherbakow', 'O', 'Tarabrin', 'D', 'Gavrychenko', 'G', 'Mazurenko', 'O', 'Chystikov', 'P122', 'Impact', 'of', 'FFP', 'transfusion', 'on', 'VAP', 'in', 'ICU', 'patients', 'A', 'Vakalos', 'V', 'Avramidis', 'P123', 'Preoperative', 'platelet', 'function', 'test', 'and', 'the', 'thrombin', 'generation', 'assay', 'are', 'predictive', 'for', 'blood', 'loss', 'after', 'cardiac', 'surgery', 'L', 'Kropman', 'L', 'In', 'het', 'Panhuis', 'J', 'Konings', 'D', 'Huskens', 'E', 'Schurgers', 'M', 'Roest', 'B', 'De', 'Laat', 'M', 'Lance', 'P124', 'Rotational', 'thromboelastometry', 'versus', 'standard', 'coagulation', 'tests', 'before', 'surgical', 'interventions', 'M', 'Durila', 'P', 'Lukas', 'M', 'Astraverkhava', 'J', 'Jonas', 'P125', 'Correction', 'of', 'impaired', 'clot', 'quality', 'and', 'stability', 'by', 'fibrinogen', 'and', 'activated', 'prothrombin', 'complex', 'concentrate', 'in', 'a', 'model', 'of', 'severe', 'thrombocytopenia', 'I', 'Budnik', 'B', 'Shenkman', 'P126', 'Assessment', 'of', 'point', 'of', 'care', 'prothrombin', 'time', 'analyzer', 'as', 'a', 'monitor', 'after', 'cardiopulmonary', 'bypass', 'H', 'Hayami', 'Y', 'Koide', 'T', 'Goto', 'P127', 'Disseminated', 'intravascular', 'coagulation', 'dic', 'is', 'underdiagnosed', 'in', 'critically', 'ill', 'patients', 'do', 'we', 'need', 'd', 'dimer', 'measurements', 'R', 'Iqbal', 'Y', 'Alhamdi', 'N', 'Venugopal', 'S', 'Abrams', 'C', 'Downey', 'C', 'H', 'Toh', 'I', 'D', 'Welters', 'P128', 'Validity', 'of', 'the', 'age', 'adjusted', 'd', 'dimer', 'cutoff', 'in', 'patients', 'with', 'COPD', 'B', 'Bombay', 'J', 'M', 'Chauny', 'R', 'D', 'Daoust', 'J', 'L', 'Lessard', 'M', 'M', 'Marquis', 'J', 'P', 'Paquet', 'P129', 'A', 'scoping', 'review', 'of', 'strategies', 'for', 'prevention', 'and', 'management', 'of', 'bleeding', 'following', 'paediatric', 'cardiopulmonary', 'bypass', 'surgery', 'K', 'Siemens', 'D', 'Sangaran', 'B', 'J', 'Hunt', 'A', 'Durward', 'A', 'Nyman', 'I', 'A', 'Murdoch', 'S', 'M', 'Tibby', 'P130', 'Nadir', 'hemoglobulin', 'during', 'cardiopulmonary', 'bypass', 'impact', 'on', 'postoperative', 'morbidity', 'and', 'mortality', 'F', 'Ampatzidou', 'D', 'Moisidou', 'E', 'Dalampini', 'M', 'Nastou', 'E', 'Vasilarou', 'V', 'Kalaizi', 'H', 'Chatzikostenoglou', 'G', 'Drossos', 'P131', 'Red', 'blood', 'cell', 'transfusion', 'do', 'not', 'influence', 'the', 'prognostic', 'value', 'of', 'RDW', 'in', 'critically', 'ill', 'patients', 'S', 'Spadaro', 'A', 'Fogagnolo', 'T', 'Fiore', 'A', 'Schiavi', 'V', 'Fontana', 'F', 'Taccone', 'C', 'Volta', 'P132', 'Reasons', 'for', 'admission', 'in', 'the', 'paediatric', 'intensive', 'care', 'unit', 'and', 'the', 'need', 'for', 'blood', 'and', 'blood', 'products', 'transfusions', 'E', 'Chochliourou', 'E', 'Volakli', 'A', 'Violaki', 'E', 'Samkinidou', 'G', 'Evlavis', 'V', 'Panagiotidou', 'M', 'Sdougka', 'P133', 'The', 'implementation', 'of', 'a', 'massive', 'haemorrhage', 'protocol', 'mhp', 'for', 'the', 'management', 'of', 'major', 'trauma', 'a', 'ten', 'year', 'single', 'centre', 'study', 'R', 'Mothukuri', 'C', 'Battle', 'K', 'Guy', 'G', 'Mills', 'P', 'Evans', 'P134', 'An', 'integrated', 'major', 'haemorrhage', 'protocol', 'for', 'pre', 'hospital', 'and', 'retrieval', 'medical', 'teams', 'J', 'Wijesuriya', 'S', 'Keogh', 'P135', 'The', 'impact', 'of', 'transfusion', 'thresholds', 'on', 'mortality', 'and', 'cardiovascular', 'events', 'in', 'patients', 'with', 'cardiovascular', 'disease', 'non', 'cardiac', 'surgery', 'a', 'systematic', 'review', 'and', 'meta', 'analysis', 'A', 'Docherty', 'R', 'O', 'Donnell', 'S', 'Brunskill', 'M', 'Trivella', 'C', 'Doree', 'L', 'Holst', 'M', 'Parker', 'M', 'Gregersen', 'J', 'Almeida', 'T', 'Walsh', 'S', 'Stanworth', 'P136', 'The', 'relationship', 'between', 'poor', 'pre', 'operative', 'immune', 'status', 'and', 'outcome', 'from', 'cardiac', 'surgery', 'is', 'specific', 'to', 'the', 'peri', 'operative', 'antigenic', 'threat', 'S', 'Moravcova', 'J', 'Mansell', 'A', 'Rogers', 'R', 'A', 'Smith', 'C', 'Hamilton', 'Davies', 'P137', 'Impact', 'of', 'simple', 'clinical', 'practice', 'guidelines', 'for', 'reducing', 'post', 'operative', 'atrial', 'fibrillation', 'after', 'cardiac', 'surgery', 'A', 'Omar', 'M', 'Allam', 'O', 'Bilala', 'A', 'Kindawi', 'H', 'Ewila', 'P138', 'Dexamethasone', 'administration', 'during', 'cardiopulmonary', 'bypass', 'has', 'no', 'beneficial', 'effects', 'on', 'elective', 'postoperative', 'cardiac', 'surgery', 'patients', 'F', 'Ampatzidou', 'D', 'Moisidou', 'M', 'Nastou', 'E', 'Dalampini', 'A', 'Malamas', 'E', 'Vasilarou', 'G', 'Drossos', 'P139', 'Intra', 'aortic', 'balloon', 'counterpulsation', 'in', 'patients', 'undergoing', 'cardiac', 'surgery', 'IABCS', 'preliminary', 'results', 'G', 'Ferreira', 'J', 'Caldas', 'J', 'Fukushima', 'E', 'A', 'Osawa', 'E', 'Arita', 'L', 'Camara', 'S', 'Zeferino', 'J', 'Jardim', 'F', 'Gaioto', 'L', 'Dallan', 'F', 'B', 'Jatene', 'R', 'Kalil', 'Filho', 'F', 'Galas', 'L', 'A', 'Hajjar', 'P140', 'Effects', 'of', 'low', 'dose', 'atrial', 'natriuretic', 'peptide', 'infusion', 'on', 'cardiac', 'surgery', 'associated', 'acute', 'kidney', 'injury', 'C', 'Mitaka', 'T', 'Ohnuma', 'T', 'Murayama', 'F', 'Kunimoto', 'M', 'Nagashima', 'T', 'Takei', 'M', 'Tomita', 'P141', 'Acute', 'kidney', 'injury', 'influence', 'on', 'high', 'sensitive', 'troponin', 'measurements', 'after', 'cardiac', 'surgery', 'A', 'Omar', 'K', 'Mahmoud', 'S', 'Hanoura', 'S', 'Sudarsanan', 'P', 'Sivadasan', 'H', 'Othamn', 'Y', 'Shouman', 'R', 'Singh', 'A', 'Al', 'Khulaifi', 'P142', 'Complex', 'evaluation', 'of', 'endothelial', 'dysfunction', 'markers', 'for', 'prognosis', 'of', 'outcomes', 'in', 'patients', 'undergoing', 'cardiac', 'surgery', 'I', 'Mandel', 'S', 'Mikheev', 'I', 'Suhodolo', 'V', 'Kiselev', 'Y', 'Svirko', 'Y', 'Podoksenov', 'P143', 'New', 'onset', 'atrial', 'fibrillation', 'in', 'intensive', 'care', 'incidence', 'management', 'and', 'outcome', 'S', 'A', 'Jenkins', 'R', 'Griffin', 'P144', 'One', 'single', 'spot', 'measurement', 'of', 'the', 'sublingual', 'microcirculation', 'during', 'acute', 'pulmonary', 'hypertension', 'in', 'a', 'pig', 'model', 'of', 'shock', 'M', 'S', 'Tovar', 'Doncel', 'A', 'Lima', 'C', 'Aldecoa', 'C', 'Ince', 'P145', 'Assessment', 'of', 'levosimendan', 'as', 'a', 'therapeutic', 'option', 'to', 'recruit', 'the', 'microcirculation', 'in', 'cardiogenic', 'shock', 'initial', 'experience', 'in', 'cardiac', 'ICU', 'A', 'Taha', 'A', 'Shafie', 'M', 'Mostafa', 'N', 'Syed', 'H', 'Hon', 'P146', 'Terlipressin', 'vs', 'norepinephrine', 'in', 'the', 'Potential', 'Multiorgan', 'Donor', 'PMD', 'F', 'Righetti', 'E', 'Colombaroli', 'G', 'Castellano', 'P147', 'Echocardiography', 'in', 'the', 'potential', 'heart', 'donor', 'exposed', 'to', 'substitution', 'hormonotherapy', 'F', 'Righetti', 'E', 'Colombaroli', 'P148', 'Machine', 'learning', 'can', 'reduce', 'rate', 'of', 'monitor', 'alarms', 'M', 'Hravnak', 'L', 'C', 'Chen', 'A', 'D', 'Dubrawski', 'G', 'C', 'Clermont', 'M', 'R', 'Pinsky', 'P149', 'Peripherally', 'inserted', 'central', 'catheters', 'placed', 'in', 'the', 'ICU', 'S', 'Gonzalez', 'D', 'Macias', 'J', 'Acosta', 'P', 'Jimenez', 'A', 'Loza', 'A', 'Lesmes', 'F', 'Lucena', 'C', 'Leon', 'P150', 'Recordings', 'of', 'abnormal', 'central', 'venous', 'pressure', 'waveform', 'morphology', 'during', 'an', 'episode', 'of', 'pulmonary', 'hypertension', 'in', 'a', 'porcine', 'shock', 'model', 'M', 'S', 'Tovar', 'Doncel', 'C', 'Ince', 'C', 'Aldecoa', 'A', 'Lima', 'P151', 'Ultrasound', 'guided', 'central', 'venous', 'access', 'technique', 'among', 'French', 'intensivists', 'M', 'Bastide', 'J', 'Richecoeur', 'E', 'Frenoy', 'C', 'Lemaire', 'B', 'Sauneuf', 'F', 'Tamion', 'S', 'Nseir', 'D', 'Du', 'Cheyron', 'H', 'Dupont', 'J', 'Maizel', 'P152', 'Predictive', 'ability', 'of', 'the', 'Pv', 'aCO2', 'gap', 'in', 'patients', 'with', 'shock', 'M', 'Shaban', 'R', 'Kolko', 'N', 'Salahuddin', 'M', 'Sharshir', 'M', 'AbuRageila', 'A', 'AlHussain', 'P153', 'Comparison', 'of', 'echocardiography', 'and', 'pulmonary', 'artery', 'catheter', 'measurements', 'of', 'hemodynamic', 'parameters', 'in', 'critical', 'ill', 'patients', 'P', 'Mercado', 'J', 'Maizel', 'L', 'Kontar', 'D', 'Titeca', 'F', 'Brazier', 'A', 'Riviere', 'M', 'Joris', 'T', 'Soupison', 'B', 'De', 'Cagny', 'M', 'Slama', 'P154', 'The', 'volume', 'clamp', 'method', 'for', 'noninvasive', 'cardiac', 'output', 'measurement', 'in', 'postoperative', 'cardiothoracic', 'surgery', 'patients', 'a', 'comparison', 'with', 'intermittent', 'pulmonary', 'artery', 'thermodilution', 'J', 'Wagner', 'A', 'Körner', 'M', 'Kubik', 'S', 'Kluge', 'D', 'Reuter', 'B', 'Saugel', 'P155', 'Hemodynamic', 'monitoring', 'in', 'patients', 'with', 'septic', 'shock', 'SS', 'CPCCO', 'continuous', 'pulse', 'contour', 'cardiac', 'output', 'vs', 'TEE', 'transesophageal', 'echocardiography', 'E', 'Colombaroli', 'F', 'Righetti', 'G', 'Castellano', 'P156', 'Cardiac', 'output', 'measurement', 'with', 'transthoracic', 'echocardiography', 'in', 'critically', 'ill', 'patients', 'a', 'pragmatic', 'clinical', 'study', 'T', 'Tran', 'D', 'De', 'Bels', 'A', 'Cudia', 'M', 'Strachinaru', 'P', 'Ghottignies', 'J', 'Devriendt', 'C', 'Pierrakos', 'P157', 'Left', 'ventricular', 'outflow', 'tract', 'velocity', 'time', 'integral', 'correlates', 'with', 'stroke', 'volume', 'index', 'in', 'mechanically', 'ventilated', 'patients', 'Ó', 'Martínez', 'González', 'R', 'Blancas', 'J', 'Luján', 'D', 'Ballesteros', 'C', 'Martínez', 'Díaz', 'A', 'Núñez', 'C', 'Martín', 'Parra', 'B', 'López', 'Matamala', 'M', 'Alonso', 'Fernández', 'M', 'Chana', 'P158', 'Transpulmonary', 'thermodilution', 'TPTD', 'derived', 'from', 'femoral', 'vs', 'jugular', 'central', 'venous', 'catheter', 'validation', 'of', 'a', 'previously', 'published', 'correction', 'formula', 'and', 'a', 'proprietary', 'correction', 'formula', 'for', 'global', 'end', 'diastolic', 'volume', 'index', 'GEDVI', 'W', 'Huber', 'M', 'Eckmann', 'F', 'Elkmann', 'A', 'Gruber', 'I', 'Klein', 'R', 'M', 'Schmid', 'T', 'Lahmer', 'P160', 'Dynamic', 'arterial', 'elastance', 'calculated', 'with', 'lidcoplus', 'monitor', 'does', 'not', 'predict', 'changes', 'in', 'arterial', 'pressure', 'after', 'a', 'fluid', 'challenge', 'in', 'postsurgical', 'patients', 'D', 'Bastoni', 'H', 'Aya', 'L', 'Toscani', 'L', 'Pigozzi', 'A', 'Rhodes', 'M', 'Cecconi', 'P159', 'Venous', 'return', 'driving', 'pressure', 'and', 'resistance', 'in', 'acute', 'blood', 'volume', 'changes', 'P', 'W', 'Moller', 'S', 'Sondergaard', 'S', 'M', 'Jakob', 'J', 'Takala', 'D', 'Berger', 'P160', 'Dynamic', 'arterial', 'elastance', 'calculated', 'with', 'lidcoplus', 'monitor', 'does', 'not', 'predict', 'changes', 'in', 'arterial', 'pressure', 'after', 'a', 'fluid', 'challenge', 'in', 'postsurgical', 'patients', 'D', 'Bastoni', 'H', 'Aya', 'L', 'Toscani', 'L', 'Pigozzi', 'A', 'Rhodes', 'M', 'Cecconi', 'P161', 'Analysis', 'of', 'duration', 'of', 'post', 'operative', 'goal', 'directed', 'therapy', 'protocol', 'C', 'Ostrowska', 'H', 'Aya', 'A', 'Abbas', 'J', 'Mellinghoff', 'C', 'Ryan', 'D', 'Dawson', 'A', 'Rhodes', 'M', 'Cecconi', 'P162', 'Hemodynamic', 'optimization', 'back', 'to', 'square', 'one', 'M', 'Cronhjort', 'O', 'Wall', 'E', 'Nyberg', 'R', 'Zeng', 'C', 'Svensen', 'J', 'Mårtensson', 'E', 'Joelsson', 'Alm', 'P163', 'Effectiveness', 'of', 'fluid', 'thoracic', 'content', 'measurement', 'by', 'bioimpedance', 'guiding', 'intravascular', 'volume', 'optimization', 'in', 'patients', 'with', 'septic', 'shock', 'M', 'Aguilar', 'Arzapalo', 'L', 'Barradas', 'V', 'Lopez', 'M', 'Cetina', 'P164', 'A', 'systematic', 'review', 'on', 'the', 'role', 'of', 'internal', 'jugular', 'vein', 'ultrasound', 'measurements', 'in', 'assessment', 'of', 'volume', 'status', 'in', 'critical', 'shock', 'patients', 'N', 'Parenti', 'C', 'Palazzi', 'L', 'A', 'Amidei', 'F', 'B', 'Borrelli', 'S', 'C', 'Campanale', 'F', 'T', 'Tagliazucchi', 'G', 'S', 'Sedoni', 'D', 'L', 'Lucchesi', 'E', 'C', 'Carella', 'A', 'L', 'Luciani', 'P165', 'Importance', 'of', 'recognizing', 'dehydration', 'in', 'medical', 'Intensive', 'Care', 'Unit', 'M', 'Mackovic', 'N', 'Maric', 'M', 'Bakula', 'P166', 'Effect', 'of', 'volume', 'for', 'a', 'fluid', 'challenge', 'in', 'septic', 'patients', 'H', 'Aya', 'A', 'Rhodes', 'R', 'M', 'Grounds', 'N', 'Fletcher', 'M', 'Cecconi', 'P167', 'Fluid', 'bolus', 'practices', 'in', 'a', 'large', 'Australian', 'intensive', 'care', 'unit', 'B', 'Avard', 'P', 'Zhang', 'P168', 'Liberal', 'late', 'fluid', 'management', 'is', 'associated', 'with', 'longer', 'ventilation', 'duration', 'and', 'worst', 'outcome', 'in', 'severe', 'trauma', 'patients', 'a', 'retrospective', 'cohort', 'of', '294', 'patients', 'M', 'Mezidi', 'J', 'Charbit', 'M', 'Ould', 'Chikh', 'P', 'Deras', 'C', 'Maury', 'O', 'Martinez', 'X', 'Capdevila', 'P169', 'Association', 'of', 'fluids', 'and', 'outcomes', 'in', 'emergency', 'department', 'patients', 'hospitalized', 'with', 'community', 'acquired', 'pneumonia', 'P', 'Hou', 'W', 'Z', 'Linde', 'Zwirble', 'I', 'D', 'Douglas', 'N', 'S', 'Shapiro', 'P170', 'Association', 'of', 'positive', 'fluid', 'balance', 'with', 'poor', 'outcome', 'in', 'medicosurgical', 'ICU', 'patients', 'A', 'Ben', 'Souissi', 'I', 'Mezghani', 'Y', 'Ben', 'Aicha', 'S', 'Kamoun', 'B', 'Laribi', 'B', 'Jeribi', 'A', 'Riahi', 'M', 'S', 'Mebazaa', 'P171', 'Impact', 'of', 'fluid', 'balance', 'to', 'organ', 'dysfunction', 'in', 'critically', 'ill', 'patients', 'C', 'Pereira', 'R', 'Marinho', 'R', 'Antunes', 'A', 'Marinho', 'P172', 'Volume', 'bolus', 'in', 'ICU', 'patients', 'do', 'we', 'need', 'to', 'balance', 'our', 'crystalloids', 'M', 'Crivits', 'M', 'Raes', 'J', 'Decruyenaere', 'E', 'Hoste', 'P173', 'The', 'use', 'of', '6', 'HES', 'solution', 'do', 'not', 'reduce', 'total', 'fluid', 'requirement', 'in', 'the', 'therapy', 'of', 'patients', 'with', 'burn', 'shock', 'V', 'Bagin', 'V', 'Rudnov', 'A', 'Savitsky', 'M', 'Astafyeva', 'I', 'Korobko', 'V', 'Vein', 'P174', 'Electron', 'microscopic', 'assessment', 'of', 'acute', 'kidney', 'injury', 'in', 'septic', 'sheep', 'resuscitated', 'with', 'crystalloids', 'or', 'different', 'colloids', 'T', 'Kampmeier', 'P', 'Arnemann', 'M', 'Hessler', 'A', 'Wald', 'K', 'Bockbreder', 'A', 'Morelli', 'H', 'Van', 'Aken', 'S', 'Rehberg', 'C', 'Ertmer', 'P175', 'Alterations', 'of', 'conjunctival', 'microcirculation', 'in', 'a', 'sheep', 'model', 'of', 'haemorrhagic', 'shock', 'and', 'resuscitation', 'with', '0', '9', 'saline', 'or', 'balanced', 'tetrastarch', 'P', 'Arnemann', 'M', 'Hessler', 'T', 'Kampmeier', 'S', 'Rehberg', 'H', 'Van', 'Aken', 'C', 'Ince', 'C', 'Ertmer', 'P176', 'A', 'single', 'centre', 'nested', 'pilot', 'study', 'investigating', 'the', 'effect', 'of', 'using', '0', '9', 'saline', 'or', 'Plasma', 'Lyte', '148', 'as', 'crystalloid', 'fluid', 'therapy', 'on', 'gastrointestinal', 'feeding', 'intolerance', 'in', 'mechanically', 'ventilated', 'patients', 'receiving', 'nasogastric', 'enteral', 'nutrition', 'S', 'Reddy', 'M', 'Bailey', 'R', 'Beasley', 'R', 'Bellomo', 'D', 'Mackle', 'A', 'Psirides', 'P', 'Young', 'P177', 'A', 'single', 'centre', 'nested', 'pilot', 'study', 'investigating', 'the', 'effect', 'on', 'post', 'operative', 'bleeding', 'of', 'using', '0', '9', 'saline', 'or', 'Plasma', 'Lyte', '148', 'as', 'crystalloid', 'fluid', 'therapy', 'in', 'adults', 'in', 'ICU', 'after', 'heart', 'surgery', 'S', 'Reddy', 'M', 'Bailey', 'R', 'Beasley', 'R', 'Bellomo', 'D', 'Mackle', 'P', 'Young', 'P178', 'Extreme', 'hypernatremia', 'and', 'sepsis', 'in', 'a', 'patient', 'with', 'Huntington', 's', 'dementia', 'a', 'conundrum', 'in', 'fluid', 'management', 'H', 'Venkatesh', 'S', 'Ramachandran', 'A', 'Basu', 'H', 'Nair', 'P179', 'Diagnosis', 'and', 'management', 'of', 'severe', 'hypernatraemia', 'in', 'the', 'critical', 'care', 'setting', 'S', 'Egan', 'J', 'Bates', 'P180', 'Correlation', 'between', 'arterial', 'blood', 'gas', 'and', 'electrolyte', 'disturbances', 'during', 'hospitalization', 'and', 'outcome', 'in', 'critically', 'ill', 'patients', 'S', 'Oliveira', 'N', 'R', 'Rangel', 'Neto', 'F', 'Q', 'Reis', 'P181', 'Missing', 'the', 'I', 'in', 'MUDPILES', 'a', 'rare', 'cause', 'of', 'high', 'anion', 'gap', 'metabolic', 'acidosis', 'HAGMA', 'C', 'P', 'Lee', 'X', 'L', 'Lin', 'C', 'Choong', 'K', 'M', 'Eu', 'W', 'Y', 'Sim', 'K', 'S', 'Tee', 'J', 'Pau', 'J', 'Abisheganaden', 'P182', 'Plasma', 'NGAL', 'and', 'urinary', 'output', 'potential', 'parameters', 'for', 'early', 'initiation', 'of', 'renal', 'replacement', 'therapy', 'K', 'Maas', 'H', 'De', 'Geus', 'P183', 'Renal', 'replacement', 'therapy', 'for', 'critically', 'ill', 'patients', 'an', 'intermittent', 'continuity', 'E', 'Lafuente', 'R', 'Marinho', 'J', 'Moura', 'R', 'Antunes', 'A', 'Marinho', 'P184', 'A', 'survey', 'of', 'practices', 'related', 'to', 'renal', 'replacement', 'therapy', 'in', 'critically', 'ill', 'patients', 'in', 'the', 'north', 'of', 'England', 'T', 'E', 'Doris', 'D', 'Monkhouse', 'T', 'Shipley', 'S', 'Kardasz', 'I', 'Gonzalez', 'P185', 'High', 'initiation', 'creatinine', 'associated', 'with', 'lower', '28', 'day', 'mortality', 'in', 'critically', 'ill', 'patients', 'necessitating', 'continuous', 'renal', 'replacement', 'therapy', 'S', 'Stads', 'A', 'J', 'Groeneveld', 'P186', 'The', 'impact', 'of', 'Karnofsky', 'performance', 'scale', 'on', 'outcomes', 'in', 'acute', 'kidney', 'injury', 'patients', 'receiving', 'renal', 'replacement', 'therapy', 'on', 'the', 'intensive', 'care', 'unit', 'I', 'Elsayed', 'N', 'Ward', 'A', 'Tridente', 'A', 'Raithatha', 'P187', 'Severe', 'hypophosphatemia', 'during', 'citrate', 'anticoagulated', 'CRRT', 'A', 'Steuber', 'C', 'Pelletier', 'S', 'Schroeder', 'E', 'Michael', 'T', 'Slowinski', 'D', 'Kindgen', 'Milles', 'P188', 'Citrate', 'regional', 'anticoagulation', 'for', 'post', 'dilution', 'continuous', 'renal', 'replacement', 'therapy', 'S', 'Ghabina', 'P189', 'Citrate', '18', 'mmol', 'l', 'improves', 'anticoagulation', 'during', 'RRT', 'with', 'adsorbing', 'filters', 'F', 'Turani', 'A', 'Belli', 'S', 'Busatti', 'G', 'Barettin', 'F', 'Candidi', 'F', 'Gargano', 'R', 'Barchetta', 'M', 'Falco', 'P190', 'Calcium', 'gluconate', 'instead', 'of', 'calcium', 'chloride', 'in', 'citrate', 'anticoagulated', 'CVVHD', 'O', 'Demirkiran', 'M', 'Kosuk', 'S', 'Bozbay', 'P191', 'Enhanced', 'clearance', 'of', 'interleukin', '6', 'with', 'continuous', 'veno', 'venous', 'haemodialysis', 'CVVHD', 'using', 'Ultraflux', 'EMiC2', 'vs', 'Ultraflux', 'AV1000S', 'V', 'Weber', 'J', 'Hartmann', 'S', 'Harm', 'I', 'Linsberger', 'T', 'Eichhorn', 'G', 'Valicek', 'G', 'Miestinger', 'C', 'Hoermann', 'P192', 'Removal', 'of', 'bilirubin', 'with', 'a', 'new', 'adsorbent', 'system', 'in', 'vitro', 'kinetics', 'S', 'Faenza', 'D', 'Ricci', 'E', 'Mancini', 'C', 'Gemelli', 'A', 'Cuoghi', 'S', 'Magnani', 'M', 'Atti', 'P193', 'Case', 'series', 'of', 'patients', 'with', 'severe', 'sepsis', 'and', 'septic', 'shock', 'treated', 'with', 'a', 'new', 'extracorporeal', 'sorbent', 'T', 'Laddomada', 'A', 'Doronzio', 'B', 'Balicco', 'P194', 'In', 'vitro', 'adsorption', 'of', 'a', 'broad', 'spectrum', 'of', 'inflammatory', 'mediators', 'with', 'CytoSorb', 'hemoadsorbent', 'polymer', 'beads', 'M', 'C', 'Gruda', 'P', 'O', 'Sullivan', 'V', 'P', 'Dan', 'T', 'Guliashvili', 'A', 'Scheirer', 'T', 'D', 'Golobish', 'V', 'J', 'Capponi', 'P', 'P', 'Chan', 'P195', 'Observations', 'in', 'early', 'vs', 'late', 'use', 'of', 'cytosorb', 'therapy', 'in', 'critically', 'ill', 'patients', 'K', 'Kogelmann', 'M', 'Drüner', 'D', 'Jarczak', 'P196', 'Oxiris', 'membrane', 'decreases', 'endotoxin', 'during', 'rrt', 'in', 'septic', 'patients', 'with', 'basal', 'EAA', '0', '6', 'F', 'Turani', 'A', 'B', 'Belli', 'S', 'M', 'Martni', 'V', 'C', 'Cotticelli', 'F', 'Mounajergi', 'R', 'Barchetta', 'P197', 'An', 'observational', 'prospective', 'study', 'on', 'the', 'onset', 'of', 'augmented', 'renal', 'clearance', 'the', 'first', 'report', 'S', 'Morimoto', 'H', 'Ishikura', 'P198', 'An', 'ultrasound', 'guided', 'algorithm', 'for', 'the', 'management', 'of', 'oliguria', 'in', 'severe', 'sepsis', 'I', 'Hussain', 'N', 'Salahuddin', 'A', 'Nadeem', 'K', 'Ghorab', 'K', 'Maghrabi', 'P199', 'Ultrasound', 'in', 'acute', 'kidney', 'injury', 'aki', 'First', 'findings', 'of', 'farius', 'an', 'education', 'programme', 'in', 'structural', 'ultrasonography', 'S', 'K', 'Kloesel', 'C', 'Goldfuss', 'A', 'Stieglitz', 'A', 'S', 'Stieglitz', 'L', 'Krstevska', 'G', 'Albuszies', 'P200', 'Effectiveness', 'of', 'renal', 'angina', 'index', 'score', 'predicting', 'acute', 'kidney', 'injury', 'on', 'critically', 'ill', 'patients', 'M', 'Aguilar', 'Arzapalo', 'L', 'Barradas', 'V', 'Lopez', 'A', 'Escalante', 'G', 'Jimmy', 'M', 'Cetina', 'P201', 'Time', 'length', 'below', 'blood', 'pressure', 'thresholds', 'and', 'progression', 'of', 'acute', 'kidney', 'injury', 'in', 'critically', 'ill', 'patients', 'with', 'or', 'without', 'sepsis', 'a', 'retrospective', 'exploratory', 'cohort', 'study', 'J', 'Izawa', 'T', 'Iwami', 'S', 'Uchino', 'M', 'Takinami', 'T', 'Kitamura', 'T', 'Kawamura', 'P202', 'Anaemia', 'does', 'not', 'affect', 'renal', 'recovery', 'in', 'acute', 'kidney', 'injury', 'J', 'G', 'Powell', 'Tuck', 'S', 'Crichton', 'M', 'Raimundo', 'L', 'Camporota', 'D', 'Wyncoll', 'M', 'Ostermann', 'P203', 'Estimated', 'glomerular', 'filtration', 'rate', 'based', 'on', 'serum', 'creatinine', 'actual', 'practice', 'in', 'Dutch', 'ICU', 's', 'A', 'Hana', 'H', 'R', 'De', 'Geus', 'P204', 'Comparison', 'of', 'estimated', 'glomerular', 'filtration', 'rate', 'calculated', 'by', 'mdrd', 'ckd', 'epi', 'serum', 'creatinine', 'and', 'ckd', 'epi', 'cystatin', 'c', 'in', 'adult', 'critically', 'ill', 'patients', 'H', 'R', 'De', 'Geus', 'A', 'Hana', 'P205', 'Early', 'diagnosis', 'of', 'septic', 'acute', 'kidney', 'injury', 'in', 'medical', 'critical', 'care', 'patients', 'with', 'a', 'urine', 'cell', 'cycle', 'arrest', 'marker', 'insulin', 'like', 'growth', 'factor', 'binding', 'protein', '7', 'IGFBP', '7', 'M', 'Aydogdu', 'N', 'Boyaci', 'S', 'Yuksel', 'G', 'Gursel', 'A', 'B', 'Cayci', 'Sivri', 'P206', 'Urinary', 'neutrophil', 'gelatinase', 'associated', 'lipocalin', 'as', 'early', 'biomarker', 'of', 'severe', 'acute', 'kidney', 'injury', 'in', 'intensive', 'care', 'J', 'Meza', 'Márquez', 'J', 'Nava', 'López', 'R', 'Carrillo', 'Esper', 'P207', 'Shrunken', 'pore', 'syndrome', 'is', 'associated', 'with', 'a', 'sharp', 'rise', 'in', 'mortality', 'in', 'patients', 'undergoing', 'elective', 'coronary', 'artery', 'bypass', 'grafting', 'A', 'Dardashti', 'A', 'Grubb', 'P208', 'The', 'biomarker', 'nephrocheck', 'can', 'discriminate', 'the', 'septic', 'shock', 'patients', 'with', 'an', 'akin', '1', 'or', '2', 'acute', 'renal', 'failure', 'who', 'will', 'not', 'progress', 'toward', 'the', 'akin', '3', 'level', 'J', 'Maizel', 'M', 'Wetzstein', 'D', 'Titeca', 'L', 'Kontar', 'F', 'Brazier', 'B', 'De', 'Cagny', 'A', 'Riviere', 'T', 'Soupison', 'M', 'Joris', 'M', 'Slama', 'P209', 'A', 'worldwide', 'multicentre', 'evaluation', 'of', 'acute', 'kidney', 'injury', 'in', 'septic', 'and', 'non', 'septic', 'critically', 'ill', 'patients', 'the', 'intensive', 'care', 'over', 'nations', 'icon', 'audit', 'E', 'Peters', 'H', 'Njimi', 'P', 'Pickkers', 'J', 'L', 'Vincent', 'P210', 'Does', 'enhanced', 'recovery', 'after', 'surgery', 'reduce', 'the', 'incidence', 'of', 'acute', 'kidney', 'injury', 'in', 'those', 'undergoing', 'major', 'gynae', 'oncological', 'surgery', 'M', 'Waraich', 'J', 'Doyle', 'T', 'Samuels', 'L', 'Forni', 'P211', 'Identification', 'of', 'risk', 'factors', 'for', 'the', 'development', 'of', 'acute', 'kidney', 'injury', 'after', 'lower', 'limb', 'arthroplasty', 'N', 'Desai', 'R', 'Baumber', 'P', 'Gunning', 'A', 'Sell', 'P212', 'Incidences', 'and', 'associations', 'of', 'acute', 'kidney', 'injury', 'after', 'major', 'trauma', 'S', 'Lin', 'H', 'Torrence', 'M', 'O', 'Dwyer', 'C', 'Kirwan', 'J', 'Prowle', 'P213', 'Acute', 'kidney', 'injury', 'of', 'major', 'trauma', 'patients', 'T', 'Kim', 'P214', 'Trajectory', 'of', 'serum', 'creatinine', 'after', 'major', 'surgery', 'and', 'the', 'diagnosis', 'of', 'acute', 'kidney', 'injury', 'M', 'E', 'O', 'Connor', 'R', 'W', 'Hewson', 'C', 'J', 'Kirwan', 'R', 'M', 'Pearse', 'J', 'Prowle', 'P215', 'Epidemiology', 'of', 'acute', 'kidney', 'injury', 'after', 'cardiac', 'surgery', 'A', 'single', 'center', 'retrospective', 'study', 'S', 'Hanoura', 'A', 'Omar', 'H', 'Othamn', 'S', 'Sudarsanan', 'M', 'Allam', 'M', 'Maksoud', 'R', 'Singh', 'A', 'Al', 'Khulaifi', 'P216', 'Post', 'operative', 'acute', 'kidney', 'injury', 'after', 'major', 'non', 'cardiac', 'surgery', 'and', 'its', 'association', 'with', 'death', 'in', 'the', 'following', 'year', 'M', 'E', 'O', 'Connor', 'R', 'W', 'Hewson', 'C', 'J', 'Kirwan', 'R', 'M', 'Pearse', 'J', 'Prowle', 'P217', 'Factors', 'affecting', 'acute', 'renal', 'failure', 'in', 'intensive', 'care', 'unit', 'and', 'effect', 'of', 'these', 'factors', 'on', 'mortality', 'O', 'Uzundere', 'D', 'Memis', 'M', 'Ýnal', 'A', 'N', 'Turan', 'P218', 'Results', 'of', 'the', 'live', 'kidney', 'transplantations', 'according', 'to', 'national', 'data', 'of', 'turkish', 'organ', 'and', 'tissue', 'information', 'system', 'M', 'A', 'Aydin', 'H', 'Basar', 'I', 'Sencan', 'A', 'Kapuagasi', 'M', 'Ozturk', 'Z', 'Uzundurukan', 'D', 'Gokmen', 'A', 'Ozcan', 'C', 'Kaymak', 'P219', 'Anaesthesia', 'procedure', 'and', 'intensive', 'therapy', 'in', 'patients', 'with', 'neck', 'phlegmon', 'V', 'A', 'Artemenko', 'A', 'Budnyuk', 'P220', 'Nasal', 'high', 'flow', 'oygen', 'for', 'acute', 'respiratory', 'failure', 'a', 'systematic', 'review', 'R', 'Pugh', 'S', 'Bhandari', 'P221', 'Setting', 'optimal', 'flow', 'rate', 'during', 'high', 'flow', 'nasal', 'cannula', 'support', 'preliminary', 'results', 'T', 'Mauri', 'C', 'Turrini', 'T', 'Langer', 'P', 'Taccone', 'C', 'A', 'Volta', 'C', 'Marenghi', 'L', 'Gattinoni', 'A', 'Pesenti', 'P222', 'Dose', 'to', 'dose', 'consistency', 'across', 'two', 'different', 'gas', 'flow', 'rates', 'using', 'cystic', 'fibrosis', 'and', 'normal', 'adult', 'breathing', 'profiles', 'during', 'nasal', 'high', 'flow', 'oxygen', 'therapy', 'L', 'Sweeney', 'A', 'O', 'Sullivan', 'P', 'Kelly', 'E', 'Mukeria', 'R', 'MacLoughlin', 'P223', 'Final', 'results', 'of', 'an', 'evaluation', 'of', 'airway', 'medix', 'closed', 'suction', 'system', 'compared', 'to', 'a', 'standard', 'closed', 'suction', 'system', 'M', 'Pfeffer', 'J', 'T', 'Thomas', 'G', 'B', 'Bregman', 'G', 'K', 'Karp', 'E', 'K', 'Kishinevsky', 'D', 'S', 'Stavi', 'N', 'A', 'Adi', 'P224', 'Different', 'cuff', 'materials', 'and', 'different', 'leak', 'tests', 'one', 'size', 'does', 'not', 'fit', 'all', 'T', 'Poropat', 'R', 'Knafelj', 'P225', 'Observational', 'study', 'on', 'the', 'value', 'of', 'the', 'cuff', 'leak', 'test', 'and', 'the', 'onset', 'of', 'upper', 'airway', 'obstruction', 'after', 'extubation', 'E', 'Llopart', 'M', 'Batlle', 'C', 'De', 'Haro', 'J', 'Mesquida', 'A', 'Artigas', 'P226', 'A', 'device', 'for', 'emergency', 'transtracheal', 'lung', 'ventilation', 'D', 'Pavlovic', 'L', 'Lewerentz', 'A', 'Spassov', 'R', 'Schneider', 'P227', 'Long', 'term', 'outcome', 'and', 'health', 'related', 'quality', 'of', 'life', 'in', 'patients', 'discharged', 'from', 'the', 'intensive', 'care', 'unit', 'with', 'a', 'tracheostomy', 'and', 'with', 'or', 'without', 'prolonged', 'mechanical', 'ventilation', 'S', 'De', 'Smet', 'S', 'De', 'Raedt', 'E', 'Derom', 'P', 'Depuydt', 'S', 'Oeyen', 'D', 'Benoit', 'J', 'Decruyenaere', 'P228', 'Ultrasound', 'guided', 'percutaneous', 'dilational', 'tracheostomy', 'versus', 'bronchoscopy', 'guided', 'percutaneous', 'dilational', 'tracheostomy', 'in', 'critically', 'ill', 'patients', 'trachus', 'a', 'randomized', 'clinical', 'trial', 'A', 'Gobatto', 'B', 'Bese', 'P', 'Tierno', 'L', 'Melro', 'P', 'Mendes', 'F', 'Cadamuro', 'M', 'Park', 'L', 'M', 'Malbouisson', 'P229', 'Is', 'it', 'safe', 'to', 'discharge', 'patients', 'with', 'tracheostomy', 'from', 'the', 'ICU', 'to', 'the', 'ward', 'B', 'C', 'Civanto', 'J', 'L', 'Lopez', 'A', 'Robles', 'J', 'Figueira', 'S', 'Yus', 'A', 'Garcia', 'P230', 'The', 'application', 'of', 'tracheostomy', 'in', 'children', 'in', 'ICU', 'A', 'Oglinda', 'G', 'Ciobanu', 'C', 'Oglinda', 'L', 'Schirca', 'T', 'Sertinean', 'V', 'Lupu', 'P231', 'The', 'impact', 'of', 'passive', 'humidifiers', 'on', 'aerosol', 'drug', 'delivery', 'during', 'mechanical', 'ventilation', 'P', 'Kelly', 'A', 'O', 'Sullivan', 'L', 'Sweeney', 'R', 'MacLoughlin', 'P232', 'Evaluation', 'of', 'vibrating', 'mesh', 'and', 'jet', 'nebuliser', 'performance', 'at', 'two', 'different', 'attachment', 'setups', 'in', 'line', 'with', 'a', 'humidifier', 'nebuliser', 'system', 'A', 'O', 'Sullivan', 'P', 'Kelly', 'L', 'Sweeney', 'E', 'Mukeria', 'M', 'Wolny', 'R', 'MacLoughlin', 'P233', 'Psv', 'niv', 'versus', 'cpap', 'in', 'the', 'treatment', 'of', 'acute', 'cardiogenic', 'pulmonary', 'edema', 'A', 'Pagano', 'F', 'Numis', 'G', 'Vison', 'L', 'Saldamarco', 'T', 'Russo', 'G', 'Porta', 'F', 'Paladino', 'P234', 'Noninvasive', 'ventilation', 'in', 'patients', 'with', 'haematologic', 'malignancy', 'a', 'retrospective', 'review', 'C', 'Bell', 'J', 'Liu', 'J', 'Debacker', 'C', 'Lee', 'E', 'Tamberg', 'V', 'Campbell', 'S', 'Mehta', 'P235', 'Use', 'of', 'non', 'invasive', 'ventilation', 'in', 'infectious', 'diseases', 'besides', 'classical', 'indications', 'A', 'Silva', 'Pinto', 'A', 'Sarmento', 'L', 'Santos', 'P236', 'The', 'impact', 'of', 'fragility', 'on', 'noninvasive', 'mechanical', 'ventilation', 'application', 'and', 'results', 'in', 'the', 'ICU', 'Ý', 'Kara', 'F', 'Yýldýrým', 'A', 'Zerman', 'Z', 'Güllü', 'N', 'Boyacý', 'B', 'Basarýk', 'Aydogan', 'Ü', 'Gaygýsýz', 'K', 'Gönderen', 'G', 'Arýk', 'M', 'Turkoglu', 'M', 'Aydogdu', 'G', 'Aygencel', 'Z', 'Ülger', 'G', 'Gursel', 'P237', 'Effects', 'of', 'metabolic', 'alkalosis', 'on', 'noninvasive', 'ventilation', 'success', 'and', 'ICU', 'outcome', 'in', 'patients', 'with', 'hypercapnic', 'respiratory', 'failure', 'N', 'Boyacý', 'Z', 'Isýkdogan', 'Ö', 'Özdedeoglu', 'Z', 'Güllü', 'M', 'Badoglu', 'U', 'Gaygýsýz', 'M', 'Aydogdu', 'G', 'Gursel', 'P238', 'Asynchrony', 'index', 'and', 'breathing', 'patterns', 'of', 'acute', 'exacerbation', 'copd', 'patients', 'assisted', 'with', 'noninvasive', 'pressure', 'support', 'ventilation', 'and', 'neurally', 'adjusted', 'ventilatory', 'assist', 'N', 'Kongpolprom', 'C', 'Sittipunt', 'P239', 'High', 'frequency', 'jet', 'ventilation', 'for', 'severe', 'acute', 'hypoxemia', 'A', 'Eden', 'Y', 'Kokhanovsky', 'S', 'Bursztein', 'De', 'Myttenaere', 'R', 'Pizov', 'P240', 'HFOV', 'revisited', 'a', '7', 'year', 'retrospective', 'analysis', 'of', 'patients', 'receiving', 'HFOV', 'who', 'met', 'oscillate', 'trial', 'entry', 'criteria', 'L', 'Neilans', 'N', 'MacIntyre', 'P241', 'Implementation', 'of', 'a', 'goal', 'directed', 'mechanical', 'ventilation', 'order', 'set', 'driven', 'by', 'respiratory', 'therapists', 'can', 'improve', 'compliance', 'with', 'best', 'practices', 'for', 'mechanical', 'ventilation', 'M', 'Radosevich', 'B', 'Wanta', 'V', 'Weber', 'T', 'Meyer', 'N', 'Smischney', 'D', 'Brown', 'D', 'Diedrich', 'P242', 'A', 'reduction', 'in', 'tidal', 'volumes', 'for', 'ventilated', 'patients', 'on', 'ICU', 'calculated', 'from', 'IBW', 'can', 'it', 'minimise', 'mortality', 'in', 'comparison', 'to', 'traditional', 'strategies', 'A', 'Fuller', 'P', 'McLindon', 'K', 'Sim', 'P243', 'Predictive', 'value', 'of', 'lung', 'aeration', 'scoring', 'using', 'lung', 'ultrasound', 'in', 'weaning', 'failure', 'M', 'Shoaeir', 'K', 'Noeam', 'A', 'Mahrous', 'R', 'Matsa', 'A', 'Ali', 'P244', 'Conventional', 'versus', 'automated', 'weaning', 'from', 'mechanical', 'ventilation', 'using', 'SmartCare', 'C', 'Dridi', 'S', 'Koubaji', 'S', 'Kamoun', 'F', 'Haddad', 'A', 'Ben', 'Souissi', 'B', 'Laribi', 'A', 'Riahi', 'M', 'S', 'Mebazaa', 'P245', 'Ultrasonographic', 'evaluation', 'protocol', 'for', 'weaning', 'from', 'mechanichal', 'ventilation', 'A', 'Pérez', 'Calatayud', 'R', 'Carrillo', 'Esper', 'A', 'Zepeda', 'Mendoza', 'M', 'Diaz', 'Carrillo', 'E', 'Arch', 'Tirado', 'P246', 'Diaphragm', 'ultrasonography', 'a', 'method', 'for', 'weaning', 'patients', 'from', 'mechanical', 'ventilation', 'S', 'Carbognin', 'L', 'Pelacani', 'F', 'Zannoni', 'A', 'Agnoli', 'G', 'Gagliardi', 'P247', 'Dorsal', 'diaphragmatic', 'excursion', 'tracks', 'transpulmonary', 'pressure', 'in', 'ventilated', 'ARDS', 'patients', 'a', 'potential', 'non', 'invasive', 'indicator', 'of', 'lung', 'recruitment', 'R', 'Cho', 'A', 'Adams', 'S', 'Lunos', 'S', 'Ambur', 'R', 'Shapiro', 'M', 'Prekker', 'P248', 'Pulse', 'oximetry', 'in', 'the', 'icu', 'patient', 'is', 'the', 'perfusion', 'index', 'of', 'any', 'value', 'M', 'Thijssen', 'L', 'Janssen', 'N', 'Foudraine', 'P249', 'Ventilation', 'is', 'a', 'better', 'assessment', 'of', 'respiratory', 'status', 'than', 'EtCO2', 'C', 'J', 'Voscopoulos', 'J', 'Freeman', 'P250', 'Evaluation', 'of', 'the', 'relationship', 'between', 'non', 'invasive', 'minute', 'ventilation', 'and', 'end', 'tidal', 'CO2', 'in', 'patients', 'undergoing', 'general', 'vs', 'spinal', 'anesthesia', 'C', 'J', 'Voscopoulos', 'J', 'Freeman', 'E', 'George', 'P251', 'Respiratory', 'volume', 'monitoring', 'provides', 'early', 'warning', 'of', 'respiratory', 'depression', 'and', 'can', 'be', 'used', 'to', 'reduce', 'false', 'alarms', 'in', 'non', 'intubated', 'patients', 'C', 'J', 'Voscopoulos', 'D', 'Eversole', 'J', 'Freeman', 'E', 'George', 'P252', 'P', 'i', 'index', 'a', 'predictive', 'edi', 'derived', 'weaning', 'index', 'during', 'nava', 'S', 'Muttini', 'R', 'Bigi', 'G', 'Villani', 'N', 'Patroniti', 'P253', 'Adequacy', 'of', 'ventilation', 'in', 'patients', 'receiving', 'opioids', 'in', 'the', 'post', 'anesthesia', 'care', 'unit', 'minute', 'ventilation', 'versus', 'respiratory', 'rate', 'G', 'Williams', 'C', 'J', 'Voscopoulos', 'J', 'Freeman', 'E', 'George', 'P254', 'Comparison', 'of', 'regional', 'and', 'global', 'expiratory', 'time', 'constants', 'measured', 'by', 'electrical', 'impedance', 'tomography', 'EIT', 'A', 'Waldmann', 'S', 'Böhm', 'W', 'Windisch', 'S', 'Strassmann', 'C', 'Karagiannidis', 'P255', 'Electrical', 'impedance', 'tomography', 'robustness', 'of', 'a', 'new', 'pixel', 'wise', 'regional', 'expiratory', 'time', 'constant', 'calculation', 'A', 'Waldmann', 'S', 'Böhm', 'W', 'Windisch', 'S', 'Strassmann', 'C', 'Karagiannidis', 'P256', 'Validation', 'of', 'regional', 'and', 'global', 'expiratory', 'time', 'constant', 'measurement', 'by', 'electrical', 'impedance', 'tomography', 'in', 'ards', 'and', 'obstructive', 'pulmonary', 'diseases', 'C', 'K', 'Karagiannidis', 'A', 'W', 'Waldmann', 'S', 'B', 'Böhm', 'S', 'Strassmann', 'W', 'W', 'Windisch', 'P257', 'Transpulmonary', 'pressure', 'in', 'a', 'model', 'with', 'elastic', 'recoiling', 'lung', 'and', 'expanding', 'chest', 'wall', 'P', 'Persson', 'S', 'Lundin', 'O', 'Stenqvist', 'P258', 'Lactate', 'in', 'pleural', 'and', 'abdominal', 'effusion', 'G', 'Porta', 'F', 'Numis', 'C', 'S', 'Serra', 'A', 'P', 'Pagano', 'M', 'M', 'Masarone', 'L', 'R', 'Rinaldi', 'A', 'A', 'Amelia', 'M', 'F', 'Fascione', 'L', 'A', 'Adinolfi', 'E', 'R', 'Ruggiero', 'P259', 'Outcome', 'of', 'patients', 'admitted', 'to', 'the', 'intensive', 'care', 'with', 'pulmonary', 'fibrosis', 'F', 'Asota', 'K', 'O', 'Rourke', 'S', 'Ranjan', 'P', 'Morgan', 'P260', 'Sedation', 'and', 'analgesia', 'practice', 'in', 'extra', 'corporeal', 'membrane', 'oxygenation', 'ECMO', 'treated', 'patients', 'with', 'acute', 'respiratory', 'distress', 'syndrome', 'ARDS', 'a', 'retrospective', 'study', 'J', 'W', 'DeBacker', 'E', 'Tamberg', 'L', 'O', 'Neill', 'L', 'Munshi', 'L', 'Burry', 'E', 'Fan', 'S', 'Mehta', 'P261', 'Characteristics', 'and', 'outcomes', 'of', 'patients', 'deemed', 'not', 'eligible', 'when', 'referred', 'for', 'veno', 'venous', 'extracorporeal', 'membrane', 'oxygenation', 'vv', 'ECMO', 'S', 'Poo', 'K', 'Mahendran', 'J', 'Fowles', 'C', 'Gerrard', 'A', 'Vuylsteke', 'P262', 'The', 'SAVE', 'SMR', 'for', 'veno', 'arterial', 'ECMO', 'R', 'Loveridge', 'C', 'Chaddock', 'S', 'Patel', 'V', 'Kakar', 'C', 'Willars', 'T', 'Hurst', 'C', 'Park', 'T', 'Best', 'A', 'Vercueil', 'G', 'Auzinger', 'P263', 'A', 'simplified', 'score', 'to', 'predict', 'early', '48', 'h', 'mortality', 'in', 'patients', 'being', 'considered', 'for', 'VA', 'ECMO', 'A', 'Borgman', 'A', 'G', 'Proudfoot', 'E', 'Grins', 'K', 'E', 'Emiley', 'J', 'Schuitema', 'S', 'J', 'Fitch', 'G', 'Marco', 'J', 'Sturgill', 'M', 'G', 'Dickinson', 'M', 'Strueber', 'A', 'Khaghani', 'P', 'Wilton', 'S', 'M', 'Jovinge', 'P264', 'Lung', 'function', 'six', 'months', 'post', 'extra', 'corporeal', 'membrane', 'oxygenation', 'ECMO', 'for', 'severe', 'acute', 'respiratory', 'failure', 'in', 'adult', 'survivors', 'C', 'Sampson', 'S', 'Harris', 'Fox', 'P265', 'Bicarbonate', 'dialysis', 'removes', 'carbon', 'dioxide', 'in', 'hypoventilated', 'rodents', 'M', 'E', 'Cove', 'L', 'H', 'Vu', 'A', 'Sen', 'W', 'J', 'Federspiel', 'J', 'A', 'Kellum', 'P266', 'Procalcitonin', 'as', 'predictor', 'of', 'primary', 'graft', 'dysfunction', 'and', 'mortality', 'in', 'post', 'lung', 'transplantation', 'C', 'Mazo', 'Torre', 'J', 'Riera', 'S', 'Ramirez', 'B', 'Borgatta', 'L', 'Lagunes', 'J', 'Rello', 'P267', 'New', 'molecular', 'biomarkers', 'of', 'acute', 'respiratory', 'distress', 'syndrome', 'in', 'abdominal', 'sepsis', 'A', 'K', 'Kuzovlev', 'V', 'Moroz', 'A', 'Goloubev', 'S', 'Polovnikov', 'S', 'Nenchuk', 'P268', 'Tight', 'junction', 's', 'proteins', 'claudin', '5', 'and', 'regulation', 'by', 'tnf', 'in', 'experimental', 'murine', 'lung', 'injury', 'model', 'of', 'ali', 'ards', 'V', 'Karavana', 'C', 'Glynos', 'A', 'Asimakos', 'K', 'Pappas', 'C', 'Vrettou', 'M', 'Magkou', 'E', 'Ischaki', 'G', 'Stathopoulos', 'S', 'Zakynthinos', 'P269', 'Cell', 'counts', 'in', 'endobronchial', 'aspirate', 'to', 'assess', 'airway', 'inflammation', 'in', 'ARDS', 'patients', 'a', 'pilot', 'study', 'S', 'Spadaro', 'I', 'Kozhevnikova', 'F', 'Dalla', 'Corte', 'S', 'Grasso', 'P', 'Casolari', 'G', 'Caramori', 'C', 'Volta', 'P270', 'Epidemiological', 'and', 'clinical', 'profile', 'of', 'patients', 'with', 'acute', 'respiratory', 'distress', 'syndrome', 'in', 'the', 'surgical', 'intensive', 'care', 'unit', 'surgical', 'hospital', 'JRA', 'Antananarivo', 'T', 'Andrianjafiarinoa', 'T', 'Randriamandrato', 'T', 'Rajaonera', 'P271', 'Effect', 'of', 'high', 'PEEP', 'after', 'recruitment', 'maneuver', 'on', 'right', 'ventricular', 'function', 'in', 'ARDS', 'Is', 'it', 'good', 'for', 'the', 'lung', 'and', 'for', 'the', 'heart', 'S', 'El', 'Dash', 'ELV', 'Costa', 'MR', 'Tucci', 'F', 'Leleu', 'L', 'Kontar', 'B', 'De', 'Cagny', 'F', 'Brazier', 'D', 'Titeca', 'G', 'Bacari', 'Risal', 'J', 'Maizel', 'M', 'Amato', 'M', 'Slama', 'P272', 'Effect', 'of', 'recruitment', 'maneuver', 'on', 'left', 'ventricular', 'systolic', 'strain', 'P', 'Mercado', 'J', 'Maizel', 'L', 'Kontar', 'D', 'Titeca', 'F', 'Brazier', 'A', 'Riviere', 'M', 'Joris', 'T', 'Soupison', 'B', 'De', 'Cagny', 'S', 'El', 'Dash', 'M', 'Slama', 'P273', 'Inhaled', 'nitric', 'oxide', 'is', 'switching', 'supplier', 'cost', 'effective', 'Remmington', 'A', 'Fischer', 'S', 'Squire', 'M', 'Boichat', 'P274', 'Epidemiological', 'study', 'of', 'severe', 'acute', 'pancreatitis', 'in', 'Japan', 'comparison', 'of', 'the', 'etiology', 'and', 'the', 'patient', 'outcomes', 'on', '1159', 'patients', 'H', 'Honzawa', 'H', 'Yasuda', 'T', 'Adati', 'S', 'Suzaki', 'M', 'Horibe', 'M', 'Sasaki', 'M', 'Sanui', 'P275', 'Extracorporeal', 'liver', 'support', 'therapy', 'Experience', 'in', 'an', 'intensive', 'care', 'unit', 'R', 'Marinho', 'J', 'Daniel', 'H', 'Miranda', 'A', 'Marinho', 'P276', 'Accuracy', 'of', 'mortality', 'prediction', 'models', 'in', 'acute', 'versus', 'acute', 'on', 'chronic', 'liver', 'failure', 'in', 'the', 'intensive', 'care', 'setting', 'K', 'Milinis', 'M', 'Cooper', 'G', 'R', 'Williams', 'E', 'McCarron', 'S', 'Simants', 'I', 'Patanwala', 'I', 'Welters', 'P277', 'Risk', 'of', 'coronary', 'artery', 'disease', 'in', 'patients', 'with', 'chronic', 'liver', 'disease', 'a', 'population', 'based', 'cohort', 'study', 'Y', 'Su', 'P278', '20', 'years', 'of', 'liver', 'transplantation', 'in', 'Santiago', 'de', 'Compostela', 'Spain', 'Experience', 'review', 'J', 'Fernández', 'Villanueva', 'R', 'Fernández', 'Garda', 'A', 'López', 'Lago', 'E', 'Rodríguez', 'Ruíz', 'R', 'Hernández', 'Vaquero', 'S', 'Tomé', 'Martínez', 'de', 'Rituerto', 'E', 'Varo', 'Pérez', 'P279', 'Diarrhea', 'is', 'a', 'risk', 'factor', 'for', 'liver', 'injury', 'and', 'may', 'lead', 'to', 'intestinal', 'failure', 'associated', 'liver', 'disease', 'in', 'critical', 'illness', 'N', 'Lefel', 'F', 'Schaap', 'D', 'Bergmans', 'S', 'Olde', 'Damink', 'M', 'Van', 'de', 'Poll', 'P280', 'Bowel', 'care', 'on', 'the', 'intensive', 'care', 'unit', 'constipation', 'guideline', 'compliance', 'and', 'complications', 'K', 'Tizard', 'C', 'Lister', 'L', 'Poole', 'P281', 'Malnutrition', 'assessed', 'by', 'phase', 'angle', 'determines', 'outcomes', 'in', 'low', 'risk', 'cardiac', 'surgery', 'patients', 'D', 'Ringaitiene', 'D', 'Gineityte', 'V', 'Vicka', 'I', 'Norkiene', 'J', 'Sipylaite', 'P282', 'Preoperative', 'fasting', 'times', 'in', 'an', 'irish', 'hospital', 'A', 'O', 'Loughlin', 'V', 'Maraj', 'J', 'Dowling', 'P283', 'Costs', 'and', 'final', 'outcome', 'of', 'early', 'x', 'delayed', 'feeding', 'in', 'a', 'private', 'Brazil', 'ICU', 'M', 'B', 'Velasco', 'D', 'M', 'Dalcomune', 'E', 'B', 'Dias', 'S', 'L', 'Fernandes', 'P284', 'Can', 'ventilator', 'derived', 'energy', 'expenditure', 'measurements', 'replace', 'indirect', 'calorimetry', 'T', 'Oshima', 'S', 'Graf', 'C', 'Heidegger', 'L', 'Genton', 'V', 'Karsegard', 'Y', 'Dupertuis', 'C', 'Pichard', 'P285', 'Revisiting', 'the', 'refeeding', 'syndrome', 'results', 'of', 'a', 'systematic', 'review', 'N', 'Friedli', 'Z', 'Stanga', 'B', 'Mueller', 'P', 'Schuetz', 'P286', 'Compliance', 'with', 'the', 'new', 'protocol', 'for', 'parenteral', 'nutrition', 'in', 'our', 'ICU', 'L', 'Vandersteen', 'B', 'Stessel', 'S', 'Evers', 'A', 'Van', 'Assche', 'L', 'Jamaer', 'J', 'Dubois', 'P287', 'Nutrition', 'may', 'be', 'another', 'treatment', 'in', 'the', 'intensive', 'care', 'unit', 'where', 'less', 'is', 'more', 'R', 'Marinho', 'H', 'Castro', 'J', 'Moura', 'J', 'Valente', 'P', 'Martins', 'P', 'Casteloes', 'C', 'Magalhaes', 'S', 'Cabral', 'M', 'Santos', 'B', 'Oliveira', 'A', 'Salgueiro', 'A', 'Marinho', 'P288', 'Should', 'we', 'provide', 'more', 'protein', 'to', 'critically', 'ill', 'patients', 'R', 'Marinho', 'M', 'Santos', 'E', 'Lafuente', 'H', 'Castro', 'S', 'Cabral', 'J', 'Moura', 'P', 'Martins', 'B', 'Oliveira', 'A', 'Salgueiro', 'S', 'Duarte', 'S', 'Castro', 'M', 'Melo', 'P', 'Casteloes', 'A', 'Marinho', 'P289', 'Protein', 'provision', 'in', 'an', 'adult', 'intensive', 'care', 'unit', 'S', 'Gray', 'P290', 'Prevalence', 'and', 'clinical', 'outcomes', 'of', 'vitamin', 'd', 'deficiency', 'in', 'the', 'medical', 'critically', 'ill', 'patients', 'in', 'Songklanagarind', 'hospital', 'K', 'Maipang', 'R', 'Bhurayanontachai', 'P291', 'Vitamin', 'd', 'deficiency', 'strongly', 'predicts', 'adverse', 'medical', 'outcome', 'across', 'different', 'medical', 'inpatient', 'populations', 'results', 'from', 'a', 'prospective', 'study', 'L', 'G', 'Grädel', 'P', 'Schütz', 'P292', 'Omega', '3', 'fatty', 'acids', 'in', 'patients', 'undergoing', 'cardiac', 'surgery', 'a', 'systematic', 'review', 'and', 'meta', 'analysis', 'P', 'Langlois', 'W', 'Manzanares', 'P293', 'Can', '5', 'hydroxytriptophan', 'prevent', 'post', 'traumatic', 'stress', 'disorder', 'in', 'critically', 'ill', 'patients', 'R', 'Tincu', 'C', 'Cobilinschi', 'D', 'Tomescu', 'Z', 'Ghiorghiu', 'R', 'Macovei', 'P294', 'Parenteral', 'selenium', 'in', 'the', 'critically', 'ill', 'an', 'updated', 'systematic', 'review', 'and', 'meta', 'analysis', 'W', 'Manzanares', 'P', 'Langlois', 'M', 'Lemieux', 'G', 'Elke', 'F', 'Bloos', 'K', 'Reinhart', 'D', 'Heyland', 'P295', 'Probiotics', 'in', 'the', 'critically', 'ill', 'an', 'updated', 'systematic', 'review', 'and', 'meta', 'analysis', 'P', 'Langlois', 'M', 'Lemieux', 'I', 'Aramendi', 'D', 'Heyland', 'W', 'Manzanares', 'P296', 'Diabetes', 'with', 'hyperglycemic', 'crisis', 'episodes', 'may', 'be', 'associated', 'with', 'higher', 'risk', 'of', 'pancreatic', 'cancer', 'a', 'population', 'based', 'cohort', 'study', 'Y', 'Su', 'P297', 'Incidence', 'of', 'hypoglycemia', 'in', 'an', 'intensive', 'care', 'unit', 'depending', 'on', 'insulin', 'protocol', 'R', 'Marinho', 'N', 'Babo', 'A', 'Marinho', 'P298', 'Severity', 'of', 'the', 'diseases', 'is', 'two', 'dimensionally', 'correlated', 'to', 'blood', 'glucose', 'including', 'blood', 'glucose', 'variability', 'especially', 'in', 'moderately', 'to', 'severely', 'ill', 'patients', 'with', 'glucose', 'intolerance', 'M', 'Hoshino', 'Y', 'Haraguchi', 'S', 'Kajiwara', 'T', 'Mitsuhashi', 'T', 'Tsubata', 'M', 'Aida', 'P299', 'A', 'study', 'of', 'glycemic', 'control', 'by', 'subcutaneous', 'glargine', 'injection', 'transition', 'from', 'continuous', 'regular', 'insulin', 'infusion', 'in', 'critically', 'ill', 'patients', 'T', 'Rattanapraphat', 'R', 'Bhurayanontachai', 'C', 'Kongkamol', 'B', 'Khwannimit', 'P300', 'Glycemic', 'control', 'in', 'Portuguese', 'intensive', 'care', 'unit', 'R', 'Marinho', 'M', 'Santos', 'H', 'Castro', 'E', 'Lafuente', 'A', 'Salgueiro', 'S', 'Cabral', 'P', 'Martins', 'J', 'Moura', 'B', 'Oliveira', 'M', 'Melo', 'B', 'Xavier', 'J', 'Valente', 'C', 'Magalhaes', 'P', 'Casteloes', 'A', 'Marinho', 'P301', 'Impact', 'of', 'hyperglycemia', 'duration', 'on', 'the', 'day', 'of', 'operation', 'on', 'short', 'term', 'outcome', 'of', 'cardiac', 'surgery', 'patients', 'D', 'Moisidou', 'F', 'Ampatzidou', 'C', 'Koutsogiannidis', 'M', 'Moschopoulou', 'G', 'Drossos', 'P302', 'Lactate', 'levels', 'in', 'diabetic', 'ketoacidosis', 'patients', 'at', 'ICU', 'admissions', 'G', 'Taskin', 'M', 'Çakir', 'AK', 'Güler', 'A', 'Taskin', 'N', 'Öcal', 'S', 'Özer', 'L', 'Yamanel', 'P303', 'Intensive', 'care', 'implications', 'of', 'merging', 'heart', 'attack', 'centre', 'units', 'in', 'London', 'J', 'M', 'Wong', 'C', 'Fitton', 'S', 'Anwar', 'S', 'Stacey', 'P304', 'Special', 'characteristics', 'of', 'in', 'hospital', 'cardiac', 'arrests', 'M', 'Aggou', 'B', 'Fyntanidou', 'S', 'Patsatzakis', 'E', 'Oloktsidou', 'K', 'Lolakos', 'E', 'Papapostolou', 'V', 'Grosomanidis', 'P305', 'Clinical', 'evaluation', 'of', 'ICU', 'admitted', 'patients', 'who', 'were', 'resuscitated', 'in', 'the', 'general', 'medicine', 'ward', 'S', 'Suda', 'T', 'Ikeda', 'S', 'Ono', 'T', 'Ueno', 'Y', 'Izutani', 'P306', 'Serious', 'game', 'evaluation', 'of', 'a', 'one', 'hour', 'training', 'basic', 'life', 'support', 'session', 'for', 'secondary', 'school', 'students', 'new', 'tools', 'for', 'future', 'bystanders', 'S', 'Gaudry', 'V', 'Desailly', 'P', 'Pasquier', 'PB', 'Brun', 'AT', 'Tesnieres', 'JD', 'Ricard', 'D', 'Dreyfuss', 'A', 'Mignon', 'P307', 'Public', 'and', 'clinical', 'staff', 'perceptions', 'and', 'knowledge', 'of', 'CPR', 'compared', 'to', 'local', 'and', 'national', 'data', 'J', 'C', 'White', 'A', 'Molokhia', 'A', 'Dean', 'A', 'Stilwell', 'G', 'Friedlaender', 'P308', 'Dispatcher', 'assisted', 'telephone', 'cardiopulmonary', 'resuscitation', 'using', 'a', 'French', 'language', 'compression', 'ventilation', 'pediatric', 'protocol', 'M', 'Peters', 'S', 'Stipulante', 'A', 'Delfosse', 'AF', 'Donneau', 'A', 'Ghuysen', 'P309', 'Dantrolene', 'versus', 'amiodarone', 'for', 'resuscitation', 'an', 'experimental', 'study', 'C', 'Feldmann', 'D', 'Freitag', 'W', 'Dersch', 'M', 'Irqsusi', 'D', 'Eschbach', 'T', 'Steinfeldt', 'H', 'Wulf', 'T', 'Wiesmann', 'P310', 'Long', 'term', 'survival', 'and', 'functional', 'neurological', 'outcome', 'in', 'comatose', 'survivors', 'undergoing', 'therapeutic', 'hypothermia', 'N', 'Kongpolprom', 'J', 'Cholkraisuwat', 'P311', 'Impact', 'of', 'kidney', 'disease', 'on', 'mortality', 'and', 'neurological', 'outcome', 'in', 'out', 'of', 'hospital', 'cardiac', 'arrest', 'a', 'prospective', 'observational', 'study', 'S', 'Beitland', 'E', 'Nakstad', 'H', 'Stær', 'Jensen', 'T', 'Drægni', 'G', 'Andersen', 'D', 'Jacobsen', 'C', 'Brunborg', 'B', 'Waldum', 'Grevbo', 'K', 'Sunde', 'P312', 'ICU', 'dependency', 'of', 'patients', 'admitted', 'after', 'primary', 'percutaneous', 'coronary', 'intervention', 'PPCI', 'following', 'out', 'of', 'the', 'hospital', 'cardiac', 'arrest', 'K', 'Hoyland', 'D', 'Pandit', 'P313', 'Prognostic', 'indicators', 'and', 'outcome', 'prediction', 'model', 'for', 'patients', 'with', 'return', 'of', 'spontaneous', 'circulation', 'from', 'cardiopulmonary', 'arrest', 'comprehensive', 'registry', 'of', 'in', 'hospital', 'intensive', 'care', 'on', 'OHCA', 'survival', 'critical', 'study', 'in', 'Osaka', 'Japan', 'K', 'Hayakawa', 'P314', 'Cerebral', 'oxygen', 'saturation', 'during', 'resuscitation', 'in', 'a', 'porcine', 'model', 'of', 'cardiac', 'arrest', 'E', 'Oloktsidou', 'K', 'Kotzampassi', 'B', 'Fyntanidou', 'S', 'Patsatzakis', 'L', 'Loukipoudi', 'E', 'Doumaki', 'V', 'Grosomanidis', 'P315', 'Presumption', 'of', 'cardiopulmonary', 'resuscitation', 'for', 'sustaining', 'cerebral', 'oxidation', 'using', 'regional', 'cerebral', 'saturation', 'of', 'oxygen', 'observational', 'cohort', 'study', 'press', 'study', 'H', 'Yasuda', 'P316', 'EEG', 'reactivity', 'in', 'patients', 'after', 'cardiac', 'arrest', 'a', 'close', 'look', 'at', 'stimuli', 'MM', 'Admiraal', 'M', 'Van', 'Assen', 'MJ', 'Van', 'Putten', 'M', 'Tjepkema', 'Cloostermans', 'AF', 'Van', 'Rootselaar', 'J', 'Horn', 'P317', 'Prognostic', 'value', 'of', 'neuron', 'specific', 'enolase', 'after', 'cardiac', 'arrest', 'F', 'Ragusa', 'A', 'Marudi', 'S', 'Baroni', 'A', 'Gaspari', 'E', 'Bertellini', 'P318', 'Correlation', 'between', 'electroencephalographic', 'findings', 'and', 'serum', 'neuron', 'specific', 'enolase', 'with', 'outcome', 'of', 'post', 'cardiac', 'arrest', 'patients', 'A', 'Taha', 'T', 'Abdullah', 'S', 'Abdel', 'Monem', 'P319', 'Introduction', 'of', 'a', 'targeted', 'temperature', 'management', 'strategy', 'following', 'cardiac', 'arrest', 'in', 'a', 'district', 'general', 'hospital', 'intensive', 'care', 'unit', 'S', 'Alcorn', 'S', 'McNeill', 'S', 'Russell', 'P320', 'The', 'evolution', 'of', 'cerebral', 'oxygen', 'saturation', 'in', 'post', 'cardiac', 'arrest', 'patients', 'treated', 'with', 'therapeutic', 'hypothermia', 'W', 'Eertmans', 'C', 'Genbrugge', 'I', 'Meex', 'J', 'Dens', 'F', 'Jans', 'C', 'De', 'Deyne', 'P321', 'Prognostic', 'factors', 'and', 'neurological', 'outcomes', 'of', 'therapeutic', 'hypothermia', 'in', 'comatose', 'survivors', 'from', 'cardiac', 'arrest', '8', 'year', 'single', 'center', 'experience', 'J', 'Cholkraisuwat', 'N', 'Kongpolprom', 'P322', 'Adherence', 'to', 'targeted', 'temperature', 'management', 'after', 'out', 'of', 'hospital', 'cardiac', 'arrest', 'B', 'Avard', 'R', 'Burns', 'P323', 'Implementation', 'of', 'a', 'therapeutic', 'hypothermia', 'protocol', 'for', 'comatose', 'survivors', 'of', 'out', 'of', 'hospital', 'cardiac', 'arrest', 'A', 'Patarchi', 'T', 'Spina', 'P324', 'Factors', 'associated', 'with', 'ventilator', 'weaning', 'after', 'targeted', 'temperature', 'management', 'for', 'cardiac', 'arrest', 'patients', 'in', 'japan', 'H', 'Tanaka', 'N', 'Otani', 'S', 'Ode', 'S', 'Ishimatsu', 'P325', 'Differential', 'activation', 'of', 'c', 'fos', 'in', 'paraventricular', 'nuclei', 'of', 'the', 'hypothalamus', 'and', 'thalamus', 'of', 'the', 'rat', 'following', 'myocardial', 'infarction', 'J', 'Cho', 'J', 'B', 'Moon', 'C', 'W', 'Park', 'T', 'G', 'Ohk', 'M', 'C', 'Shin', 'M', 'H', 'Won', 'P326', 'Monitoring', 'of', 'cTroponin', 'I', 'in', 'patients', 'with', 'acute', 'ischemic', 'stroke', 'predictor', 'of', 'inhospital', 'mortality', 'S', 'Dakova', 'Z', 'Ramsheva', 'K', 'Ramshev', 'P327', 'Hyperthermic', 'preconditioning', 'severely', 'accelerates', 'neuronal', 'damage', 'in', 'the', 'gerbil', 'ischemic', 'hippocampal', 'dentate', 'gyrus', 'via', 'decreasing', 'sods', 'expressions', 'J', 'Cho', 'J', 'B', 'Moon', 'C', 'W', 'Park', 'T', 'G', 'Ohk', 'M', 'C', 'Shin', 'P328', 'Failure', 'in', 'neuroprotection', 'of', 'remote', 'limb', 'ischemic', 'post', 'conditioning', 'in', 'the', 'hippocampus', 'of', 'a', 'gerbil', 'model', 'of', 'transient', 'cerebral', 'ischemia', 'J', 'Cho', 'J', 'B', 'Moon', 'C', 'W', 'Park', 'T', 'G', 'Ohk', 'M', 'C', 'Shin', 'P329', 'Brain', 'death', 'and', 'admission', 'diagnosis', 'in', 'neurologic', 'intensive', 'care', 'unit', 'a', 'correlation', 'A', 'Marudi', 'S', 'Baroni', 'A', 'Gaspari', 'E', 'Bertellini', 'P330', 'Brain', 'magnetic', 'resonance', 'imaging', 'findings', 'in', 'patients', 'with', 'septic', 'shock', 'G', 'Orhun', 'E', 'Senturk', 'P', 'E', 'Ozcan', 'S', 'Sencer', 'C', 'Ulusoy', 'E', 'Tuzun', 'F', 'Esen', 'P331', 'Benefits', 'of', 'L', 'carnitine', 'in', 'valproic', 'acid', 'induced', 'encephalopathy', 'R', 'Tincu', 'C', 'Cobilinschi', 'D', 'Tomescu', 'Z', 'Ghiorghiu', 'R', 'Macovei', 'P332Automatic', 'analysis', 'of', 'EEG', 'reactivity', 'in', 'comatose', 'patients', 'M', 'Van', 'Assen', 'M', 'M', 'Admiraal', 'M', 'J', 'Van', 'Putten', 'M', 'Tjepkema', 'Cloostermans', 'A', 'F', 'Van', 'Rootselaar', 'J', 'Horn', 'P333', 'Usefulness', 'of', 'common', 'ICU', 'severity', 'scoring', 'systems', 'in', 'predicting', 'outcome', 'after', 'spontaneous', 'intracerebral', 'hemorrhage', 'M', 'Fallenius', 'M', 'B', 'Skrifvars', 'M', 'Reinikainen', 'S', 'Bendel', 'R', 'Raj', 'P334', 'Evalution', 'of', 'patients', 'with', 'suspected', 'subarachnoid', 'haemorrhage', 'and', 'negative', 'ct', 'imaging', 'M', 'Abu', 'Habsa', 'C', 'Hymers', 'A', 'Borowska', 'H', 'Sivadhas', 'S', 'Sahiba', 'S', 'Perkins', 'P335', 'Timing', 'of', 'endovascular', 'and', 'surgical', 'treatment', 'for', 'aneurysmal', 'subarachnoid', 'haemorrhage', 'early', 'but', 'not', 'so', 'fast', 'J', 'Rubio', 'J', 'A', 'Rubio', 'R', 'Sierra', 'P336', 'Red', 'blood', 'cell', 'transfusion', 'in', 'aneurysmal', 'subarachnoid', 'hemorrhage', 'the', 'Sahara', 'cohort', 'study', 'S', 'English', 'M', 'Chasse', 'A', 'Turgeon', 'F', 'Lauzier', 'D', 'Griesdale', 'A', 'Garland', 'D', 'Fergusson', 'R', 'Zarychanski', 'A', 'Tinmouth', 'C', 'Van', 'Walraven', 'K', 'Montroy', 'J', 'Ziegler', 'R', 'Dupont', 'Chouinard', 'R', 'Carignan', 'A', 'Dhaliwal', 'C', 'Lum', 'J', 'Sinclair', 'G', 'Pagliarello', 'L', 'McIntyre', 'P337', 'Aneurysmal', 'subarachnoid', 'hemorrhage', 'and', 'anemia', 'a', 'canadian', 'multi', 'centre', 'retrospective', 'cohort', 'study', 'S', 'English', 'M', 'Chasse', 'A', 'Turgeon', 'F', 'Lauzier', 'D', 'Griesdale', 'A', 'Garland', 'D', 'Fergusson', 'R', 'Zarychanski', 'A', 'Tinmouth', 'C', 'Van', 'Walraven', 'K', 'Montroy', 'J', 'Ziegler', 'R', 'Dupont', 'Chouinard', 'R', 'Carignan', 'A', 'Dhaliwal', 'C', 'Lum', 'J', 'Sinclair', 'G', 'Pagliarello', 'L', 'McIntyre', 'P338', 'Does', 'the', 'neutrophil', 'to', 'lymphocyte', 'NLR', 'ratio', 'predict', 'symptomatic', 'vasospasm', 'or', 'delayed', 'cerebral', 'ischemia', 'DCI', 'after', 'aneurysmal', 'subarachnoid', 'haemorrhage', 'SAH', 'T', 'Groza', 'N', 'Moreau', 'D', 'Castanares', 'Zapatero', 'P', 'Hantson', 'P339', 'ICU', 'acquired', 'infections', 'in', 'aneurysmal', 'subarachnoid', 'hemorrhage', 'patients', 'impact', 'on', 'ICU', 'and', 'hospital', 'length', 'of', 'stay', 'M', 'Carbonara', 'F', 'Ortolano', 'T', 'Zoerle', 'S', 'Magnoni', 'S', 'Pifferi', 'V', 'Conte', 'N', 'Stocchetti', 'P340', 'Cerebral', 'metabolic', 'effects', 'of', 'normobaric', 'hyperoxia', 'during', 'the', 'acute', 'phase', 'of', 'aneurysmal', 'subarachnoid', 'hemorrhage', 'L', 'Carteron', 'T', 'Suys', 'C', 'Patet', 'H', 'Quintard', 'M', 'Oddo', 'P341', 'Postoperative', 'care', 'for', 'elective', 'craniotomy', 'where', 'is', 'best', 'done', 'J', 'A', 'Rubio', 'J', 'Rubio', 'R', 'Sierra', 'P342', '5', 'year', 'follow', 'up', 'of', 'patients', 'after', 'transplantation', 'of', 'organs', 'from', 'donors', 'from', 'neurocritical', 'care', 'V', 'Spatenkova', 'E', 'Pokorna', 'P', 'Suchomel', 'P343', 'Evaluation', 'of', 'levetiracetam', 'pharmacokinetics', 'after', 'severe', 'traumatic', 'brain', 'injury', 'in', 'neurocritical', 'care', 'patients', 'at', 'a', 'level', 'one', 'trauma', 'center', 'N', 'Ebert', 'J', 'Jancik', 'H', 'Rhodes', 'P344', 'Model', 'based', 'time', 'series', 'cluster', 'analysis', 'to', 'determine', 'unique', 'patient', 'states', 'in', 'traumatic', 'brain', 'injury', 'T', 'Bylinski', 'C', 'Hawthorne', 'M', 'Shaw', 'I', 'Piper', 'J', 'Kinsella', 'P345', 'Brain', 'compartment', 'monitoring', 'capabilities', 'from', 'ICP', 'to', 'BI', 'bioimpedance', 'during', 'HS', 'hypertonic', 'saline', 'administration', 'State', 'of', 'art', 'simulation', 'outcome', 'depending', 'on', 'brain', 'swelling', 'type', 'A', 'K', 'Kink', 'I', 'R', 'Rätsep', 'P346', 'Transfusion', 'of', 'red', 'blood', 'cells', 'in', 'patients', 'with', 'traumatic', 'brain', 'injury', 'admitted', 'to', 'Canadian', 'trauma', 'health', 'centers', 'a', 'multicenter', 'cohort', 'study', 'A', 'Boutin', 'L', 'Moore', 'M', 'Chasse', 'R', 'Zarychanski', 'F', 'Lauzier', 'S', 'English', 'L', 'McIntyre', 'J', 'Lacroix', 'D', 'Griesdale', 'P', 'Lessard', 'Bonaventure', 'A', 'F', 'Turgeon', 'P347', 'Hemoglobin', 'thresholds', 'and', 'red', 'blood', 'cell', 'transfusions', 'in', 'adult', 'patients', 'with', 'moderate', 'or', 'severe', 'traumatic', 'brain', 'injury', 'a', 'retrospective', 'cohort', 'study', 'A', 'Boutin', 'L', 'Moore', 'R', 'Green', 'P', 'Lessard', 'Bonaventure', 'M', 'Erdogan', 'M', 'Butler', 'F', 'Lauzier', 'M', 'Chasse', 'S', 'English', 'L', 'McIntyre', 'R', 'Zarychanski', 'J', 'Lacroix', 'D', 'Griesdale', 'P', 'Desjardins', 'D', 'A', 'Fergusson', 'A', 'F', 'Turgeon', 'P348', 'Characteristics', 'of', 'patients', 'with', 'gunshot', 'wounds', 'to', 'the', 'head', 'an', 'observational', 'Brazilian', 'study', 'B', 'Goncalves', 'B', 'Vidal', 'C', 'Valdez', 'A', 'C', 'Rodrigues', 'L', 'Miguez', 'G', 'Moralez', 'P349', 'Base', 'excess', 'as', 'predictor', 'for', 'ICU', 'admission', 'and', 'the', 'injury', 'severity', 'in', 'blunt', 'trauma', 'patients', 'T', 'Hong', 'P350', 'Enhancement', 'of', 'usual', 'emergency', 'department', 'care', 'with', 'proadrenomedullin', 'to', 'improve', 'outcome', 'prediction', 'Results', 'from', 'the', 'multi', 'national', 'prospective', 'observational', 'TRIAGE', 'study', 'A', 'Kutz', 'P', 'Hausfater', 'D', 'Amin', 'T', 'Struja', 'S', 'Haubitz', 'A', 'Huber', 'B', 'Mueller', 'P', 'Schuetz', 'P351', 'Developing', 'an', 'innovative', 'emergency', 'medicine', 'point', 'of', 'care', 'simulation', 'programme', 'T', 'Brown', 'J', 'Collinson', 'C', 'Pritchett', 'T', 'Slade', 'P352', 'The', 'InSim', 'program', 'an', 'in', 'situ', 'simulation', 'program', 'for', 'junior', 'trainees', 'in', 'intensive', 'care', 'M', 'Le', 'Guen', 'S', 'Hellings', 'R', 'Ramsaran', 'P353', 'Impact', 'of', 'excessive', 'and', 'inappropriate', 'troponin', 'testing', 'in', 'the', 'emergency', 'setting', 'how', 'good', 'are', 'we', 'A', 'Alsheikhly', 'P354', 'The', 'development', 'of', 'time', 'tracking', 'monitor', 'at', 'emergency', 'department', 'T', 'Abe', 'P355', 'Role', 'of', 'focussed', 'echocardiography', 'in', 'emergency', 'assessment', 'of', 'syncope', 'L', 'Kanapeckaite', 'M', 'Abu', 'Habsa', 'R', 'Bahl', 'P356', 'Insertion', 'of', 'an', 'open', 'ended', '14', 'gauge', 'catheter', 'through', 'the', 'chest', 'wall', 'causes', 'a', 'significant', 'pneumothorax', 'in', 'a', 'self', 'ventilating', 'swine', 'model', 'M', 'Q', 'Russell', 'K', 'J', 'Real', 'M', 'Abu', 'Habsa', 'R', 'M', 'Lyon', 'N', 'P', 'Oveland', 'P357', 'Ez', 'io', 'intraosseous', 'access', 'teaching', 'in', 'the', 'workplace', 'using', 'a', 'mobile', 'tea', 'trolley', 'training', 'method', 'J', 'Penketh', 'M', 'Mcdonald', 'F', 'Kelly', 'P358', 'Black', 'widow', 'envenomation', 'in', 'Saudi', 'Arabia', 'a', 'prospective', 'observational', 'case', 'series', 'M', 'Alfafi', 'S', 'Alsolamy', 'W', 'Almutairi', 'B', 'Alotaibi', 'P359', 'Mechanical', 'ventilation', 'in', 'patients', 'with', 'overdose', 'not', 'yet', 'intubated', 'on', 'icu', 'admission', 'A', 'E', 'Van', 'den', 'Berg', 'Y', 'Schriel', 'L', 'Dawson', 'I', 'A', 'Meynaar', 'P360', 'Central', 'nervous', 'system', 'depressants', 'poisoning', 'and', 'ventilator', 'associated', 'pneumonia', 'an', 'underrated', 'risk', 'factor', 'in', 'toxicological', 'intensive', 'care', 'unit', 'H', 'Talaie', 'P361', 'Acute', 'barium', 'intoxication', 'treated', 'with', 'hemodiafiltration', 'D', 'Silva', 'S', 'Fernandes', 'J', 'Gouveia', 'J', 'Santos', 'Silva', 'P362', 'Major', 'trauma', 'presenting', 'to', 'the', 'emergency', 'department', 'the', 'spectrum', 'of', 'cycling', 'injuries', 'in', 'Ireland', 'J', 'Foley', 'A', 'Kaskovagheorgescu', 'D', 'Evoy', 'J', 'Cronin', 'J', 'Ryan', 'P363', 'Burns', 'from', 'French', 'military', 'operations', 'a', '14', 'year', 'retrospective', 'observational', 'analysis', 'M', 'Huck', 'C', 'Hoffmann', 'J', 'Renner', 'P', 'Laitselart', 'N', 'Donat', 'A', 'Cirodde', 'J', 'V', 'Schaal', 'Y', 'Masson', 'A', 'Nau', 'T', 'Leclerc', 'P364', 'A', 'comparison', 'of', 'mortality', 'scores', 'in', 'burns', 'patients', 'on', 'the', 'intensive', 'care', 'unit', 'O', 'Howarth', 'K', 'Davenport', 'P', 'Jeanrenaud', 'S', 'Raftery', 'P365', 'Clasification', 'of', 'pain', 'and', 'its', 'treatment', 'and', 'an', 'intensive', 'care', 'rehabiliation', 'clinic', 'P', 'MacTavish', 'H', 'Devine', 'J', 'McPeake', 'M', 'Daniel', 'J', 'Kinsella', 'T', 'Quasim', 'P366', 'Pain', 'management', 'adequacy', 'in', 'critical', 'care', 'areas', 'the', 'process', 'and', 'the', 'barriers', 'perceived', 'by', 'critical', 'care', 'nurses', 'S', 'Alrabiee', 'A', 'Alrashid', 'S', 'Alsolamy', 'P367', 'Pain', 'assessment', 'in', 'critically', 'ill', 'adult', 'patients', 'validation', 'of', 'the', 'Turkish', 'version', 'of', 'the', 'critical', 'care', 'pain', 'observation', 'tool', 'O', 'Gundogan', 'C', 'Bor', 'E', 'Akýn', 'Korhan', 'K', 'Demirag', 'M', 'Uyar', 'P368', 'An', 'audit', 'of', 'pain', 'and', 'sedation', 'assessments', 'in', 'the', 'intensive', 'care', 'unit', 'recommendations', 'for', 'clinical', 'practice', 'F', 'Frame', 'C', 'Ashton', 'L', 'Bergstrom', 'Niska', 'P369', 'Impact', 'of', 'pharmaceutical', 'care', 'on', 'treatment', 'of', 'pain', 'and', 'agitation', 'in', 'medical', 'intensive', 'care', 'unit', 'P', 'Dilokpattanamongkol', 'T', 'Suansanae', 'C', 'Suthisisang', 'S', 'Morakul', 'C', 'Karnjanarachata', 'V', 'Tangsujaritvijit', 'P370', 'Agitation', 'in', 'trauma', 'ICU', 'prevention', 'and', 'outcome', 'S', 'Mahmood', 'H', 'Al', 'Thani', 'A', 'Almenyar', 'P371', 'Correlation', 'between', 'percentages', 'of', 'ventilated', 'patients', 'developed', 'vap', 'and', 'use', 'of', 'sedative', 'agents', 'in', 'icu', 'patients', 'A', 'Vakalos', 'V', 'Avramidis', 'P372', 'Improving', 'recording', 'of', 'sedation', 'events', 'in', 'the', 'Emergency', 'Department', 'The', 'implementation', 'of', 'the', 'SIVA', 'International', 'Taskforce', 'adverse', 'event', 'reporting', 'tool', 'for', 'procedural', 'sedation', 'R', 'Sharvill', 'J', 'Penketh', 'P373', 'Impact', 'of', 'sedative', 'drug', 'use', 'on', 'the', 'length', 'of', 'mechanical', 'ventilation', 'S', 'E', 'Morton', 'Y', 'S', 'Chiew', 'C', 'Pretty', 'J', 'G', 'Chase', 'G', 'M', 'Shaw', 'P374', 'Co', 'administration', 'of', 'nitric', 'oxide', 'and', 'sevoflurane', 'using', 'anaconda', 'R', 'Knafelj', 'P', 'Kordis', 'P375', 'A', 'retrospective', 'study', 'of', 'the', 'use', 'of', 'Dexmedetomidine', 'in', 'an', 'oncological', 'critical', 'care', 'setting', 'S', 'Patel', 'V', 'Grover', 'P376', 'Dexmedetomidine', 'and', 'posttraumatic', 'stress', 'disorder', 'incidence', 'in', 'alcohol', 'withdrawal', 'icu', 'patients', 'I', 'Kuchyn', 'K', 'Bielka', 'P377', 'Hemodynamic', 'effects', 'of', 'dexmedetomidine', 'in', 'a', 'porcine', 'model', 'of', 'septic', 'shock', 'Z', 'Aidoni', 'V', 'Grosomanidis', 'K', 'Kotzampassi', 'G', 'Stavrou', 'B', 'Fyntanidou', 'S', 'Patsatzakis', 'C', 'Skourtis', 'P378', 'Ketamine', 'for', 'analgosedation', 'in', 'severe', 'hypoxic', 'respiratory', 'failure', 'S', 'D', 'Lee', 'K', 'Williams', 'I', 'D', 'Weltes', 'P379', 'Madness', 'from', 'the', 'moon', 'lunar', 'cycle', 'and', 'the', 'incidence', 'of', 'delirium', 'on', 'the', 'intensive', 'care', 'unit', 'S', 'Berhane', 'C', 'Arrowsmith', 'C', 'Peters', 'S', 'Robert', 'P380', 'Impaired', 'dynamic', 'cerebral', 'autoregulation', 'after', 'coronary', 'artery', 'bypass', 'grafting', 'and', 'association', 'with', 'postoperative', 'delirium', 'J', 'Caldas', 'R', 'B', 'Panerai', 'T', 'G', 'Robinson', 'L', 'Camara', 'G', 'Ferreira', 'E', 'Borg', 'Seng', 'Shu', 'M', 'De', 'Lima', 'Oliveira', 'N', 'C', 'Mian', 'L', 'Santos', 'R', 'Nogueira', 'S', 'P', 'Zeferino', 'M', 'Jacobsen', 'Teixeira', 'F', 'Galas', 'L', 'A', 'Hajjar', 'P381', 'Risk', 'factors', 'predicting', 'prolonged', 'intensive', 'care', 'unit', 'length', 'of', 'stay', 'after', 'major', 'elective', 'surgery', 'P', 'Killeen', 'M', 'McPhail', 'W', 'Bernal', 'J', 'Maggs', 'J', 'Wendon', 'T', 'Hughes', 'P382', 'Systemic', 'inflammatory', 'response', 'syndrome', 'criteria', 'and', 'hospital', 'mortality', 'prediction', 'in', 'a', 'brazilian', 'cohort', 'of', 'critically', 'ill', 'patients', 'L', 'U', 'Taniguchi', 'E', 'M', 'Siqueira', 'J', 'M', 'Vieira', 'Jr', 'L', 'C', 'Azevedo', 'P383', 'Evaluating', 'the', 'efficacy', 'of', 'a', 'risk', 'predictor', 'panel', 'in', 'identifying', 'patients', 'at', 'elevated', 'risk', 'of', 'morbidity', 'following', 'emergency', 'admission', 'A', 'N', 'Ahmad', 'M', 'Abu', 'Habsa', 'R', 'Bahl', 'E', 'Helme', 'S', 'Hadfield', 'R', 'Loveridge', 'P384', 'A', 'retrospective', 'comparison', 'of', 'outcomes', 'for', 'elective', 'surgical', 'patients', 'admitted', 'post', 'operatively', 'to', 'the', 'critical', 'care', 'unit', 'or', 'general', 'ward', 'J', 'Shak', 'C', 'Senver', 'R', 'Howard', 'Griffin', 'P385', 'Effect', 'of', 'obesity', 'on', 'mortality', 'in', 'surgical', 'critically', 'ill', 'patients', 'P', 'Wacharasint', 'P', 'Fuengfoo', 'N', 'Sukcharoen', 'R', 'Rangsin', 'P386', 'The', 'national', 'early', 'warning', 'score', 'news', 'reliably', 'improves', 'adverse', 'clinical', 'outcome', 'prediction', 'in', 'community', 'acquired', 'pneumonia', 'results', 'from', 'a', '6', 'year', 'follow', 'up', 'D', 'Sbiti', 'Rohr', 'P', 'Schuetz', 'P387', 'Clinical', 'usefulness', 'of', 'the', 'charlson', 's', 'weighted', 'index', 'of', 'comorbidities', 'as', 'prognostic', 'factor', 'in', 'patients', 'with', 'prolonged', 'acute', 'mechanical', 'ventilation', 'H', 'Na', 'S', 'Song', 'S', 'Lee', 'E', 'Jeong', 'K', 'Lee', 'P388', 'Comparison', 'of', 'mortality', 'prediction', 'scoring', 'systems', 'in', 'patients', 'with', 'cirrhosis', 'admitted', 'to', 'general', 'intensive', 'care', 'unit', 'M', 'Cooper', 'K', 'Milinis', 'G', 'Williams', 'E', 'McCarron', 'S', 'Simants', 'I', 'Patanwala', 'I', 'D', 'Welters', 'P389', 'Impact', 'of', 'admission', 'source', 'and', 'time', 'of', 'admission', 'on', 'outcome', 'of', 'pediatric', 'intensive', 'care', 'patients', 'retrospective', '15', 'years', 'study', 'E', 'Zoumpelouli', 'EA', 'Volakli', 'V', 'Chrysohoidou', 'S', 'Georgiou', 'K', 'Charisopoulou', 'E', 'Kotzapanagiotou', 'V', 'Panagiotidou', 'K', 'Manavidou', 'Z', 'Stathi', 'M', 'Sdougka', 'P390', 'Heart', 'rate', 'variability', 'and', 'outcomes', 'prediction', 'in', 'critical', 'illness', 'N', 'Salahuddin', 'B', 'AlGhamdi', 'Q', 'Marashly', 'K', 'Zaza', 'M', 'Sharshir', 'M', 'Khurshid', 'Z', 'Ali', 'M', 'Malgapo', 'M', 'Jamil', 'A', 'Shafquat', 'M', 'Shoukri', 'M', 'Hijazi', 'P391', 'The', 'incidence', 'and', 'outcome', 'of', 'hyperlactatemia', 'in', 'the', 'post', 'anaesthesia', 'care', 'unit', 'T', 'Abe', 'S', 'Uchino', 'M', 'Takinami', 'P392', 'Correlation', 'between', 'arterial', 'blood', 'gas', 'disturbances', 'and', 'arterial', 'lactate', 'levels', 'during', 'hospitalization', 'and', 'outcome', 'in', 'critically', 'septic', 'patients', 'N', 'R', 'Rangel', 'Neto', 'S', 'Oliveira', 'F', 'Q', 'Reis', 'F', 'A', 'Rocha', 'P393', 'External', 'validation', 'of', 'saps', '3', 'and', 'mpm', 'iii', 'scores', 'in', '48', '816', 'patients', 'from', '72', 'brazilian', 'icus', 'G', 'Moralez', 'K', 'Ebecken', 'L', 'S', 'Rabello', 'M', 'F', 'Lima', 'R', 'Hatum', 'F', 'V', 'De', 'Marco', 'A', 'Alves', 'J', 'E', 'Pinto', 'M', 'Godoy', 'P', 'E', 'Brasil', 'F', 'A', 'Bozza', 'J', 'I', 'Salluh', 'M', 'Soares', 'P394', 'The', 'frailty', 'penalty', 'pre', 'admission', 'functional', 'status', 'confounds', 'mortality', 'prediction', 'models', 'in', 'critically', 'ill', 'patients', 'J', 'Krinsley', 'G', 'Kang', 'P395', 'sooner', 'rather', 'than', 'later', 'how', 'delayed', 'discharge', 'from', 'critical', 'care', 'leads', 'to', 'increased', 'out', 'of', 'hours', 'discharges', 'and', 'subsequent', 'increase', 'in', 'in', 'hospital', 'mortality', 'J', 'Perry', 'H', 'Hines', 'P396', 'Identifying', 'poor', 'outcome', 'patient', 'groups', 'in', 'a', 'resource', 'constrained', 'critical', 'care', 'unit', 'K', 'M', 'Wilkinson', 'C', 'Tordoff', 'B', 'Sloan', 'M', 'C', 'Bellamy', 'P397', 'Effects', 'of', 'icu', 'weekend', 'admission', 'and', 'discharge', 'on', 'mortality', 'E', 'Moreira', 'F', 'Verga', 'M', 'Barbato', 'G', 'Burghi', 'P398', 'Organizational', 'factors', 'outcomes', 'and', 'resource', 'use', 'in', '9', '946', 'cancer', 'patients', 'admitted', 'to', '70', 'ICUs', 'M', 'Soares', 'U', 'V', 'Silva', 'L', 'C', 'Azevedo', 'A', 'P', 'Torelly', 'J', 'M', 'Kahn', 'D', 'C', 'Angus', 'M', 'F', 'Knibel', 'P', 'E', 'Brasil', 'F', 'A', 'Bozza', 'J', 'I', 'Salluh', 'P399', 'Evaluation', 'of', 'oncological', 'critically', 'ill', 'patients', 'severity', 'score', 'and', 'outcome', 'compared', 'to', 'not', 'oncological', 'in', 'a', 'particular', 'hospital', 'cti', 'M', 'B', 'Velasco', 'D', 'M', 'Dalcomune', 'P400', 'Outcomes', 'of', 'patients', 'admitted', 'to', 'a', 'large', 'uk', 'critical', 'care', 'department', 'with', 'palliative', 'oncological', 'diagnoses', 'R', 'Marshall', 'T', 'Gilpin', 'A', 'Tridente', 'A', 'Raithatha', 'P401', 'Predictors', 'of', 'mortality', 'in', 'febrile', 'neutropenic', 'patients', 'with', 'haematological', 'malignancies', 'admitted', 'to', 'an', 'intensive', 'care', 'unit', 'of', 'a', 'cancer', 'center', 'D', 'Mota', 'B', 'Loureiro', 'J', 'Dias', 'O', 'Afonso', 'F', 'Coelho', 'A', 'Martins', 'F', 'Faria', 'P402', 'Patients', 'with', 'hematologic', 'malignancies', 'requiring', 'invasive', 'mechanical', 'ventilation', 'characteristics', 'and', 'predictors', 'of', 'mortality', 'H', 'Al', 'Dorzi', 'H', 'Al', 'Orainni', 'F', 'AlEid', 'H', 'Tlaygeh', 'A', 'Itani', 'A', 'Hejazi', 'Y', 'Arabi', 'P403', 'Patient', 'important', 'outcomes', 'in', 'randomized', 'controlled', 'trials', 'in', 'critically', 'ill', 'patients', 'a', 'systematic', 'review', 'S', 'Gaudry', 'J', 'Messika', 'J', 'D', 'Ricard', 'S', 'Guillo', 'B', 'Pasquet', 'E', 'Dubief', 'D', 'Dreyfuss', 'F', 'Tubach', 'P404', 'Alopecia', 'in', 'survivors', 'of', 'critical', 'illness', 'a', 'qualitative', 'study', 'C', 'Battle', 'K', 'James', 'P', 'Temblett', 'P405', 'The', 'impact', 'of', 'mental', 'health', 'on', 'icu', 'admission', 'L', 'Davies', 'C', 'Battle', 'C', 'Lynch', 'P406', 'Cognitive', 'impairment', '5', 'years', 'after', 'ICU', 'discharge', 'S', 'Pereira', 'S', 'Cavaco', 'J', 'Fernandes', 'I', 'Moreira', 'E', 'Almeida', 'F', 'Seabra', 'Pereira', 'M', 'Malheiro', 'F', 'Cardoso', 'I', 'Aragão', 'T', 'Cardoso', 'P407', 'Apache', 'ii', 'versus', 'apache', 'iv', 'for', 'octagenerians', 'in', 'medical', 'icu', 'M', 'Fister', 'R', 'Knafelj', 'P408', 'Outcomes', 'of', 'octagenarians', 'in', 'an', 'indian', 'icu', 'P', 'Muraray', 'Govind', 'N', 'Brahmananda', 'Reddy', 'R', 'Pratheema', 'E', 'D', 'Arul', 'J', 'Devachandran', 'P409', 'Mortality', 'and', 'outcomes', 'in', 'elderly', 'patients', '80', 'years', 'of', 'age', 'or', 'older', 'admitted', 'to', 'the', 'icu', 'M', 'B', 'Velasco', 'D', 'M', 'Dalcomune', 'P410', 'Octagenerians', 'in', 'medical', 'icu', 'adding', 'days', 'to', 'life', 'or', 'life', 'to', 'days', 'R', 'Knafelj', 'M', 'Fister', 'P411', 'The', 'very', 'elderly', 'admitted', 'to', 'intensive', 'care', 'unit', 'outcomes', 'and', 'economic', 'evaluation', 'N', 'Chin', 'Yee', 'G', 'D', 'Egidio', 'K', 'Thavorn', 'D', 'Heyland', 'K', 'Kyeremanteng', 'P412', 'The', 'very', 'elderly', 'in', 'intensive', 'care', 'relationship', 'between', 'acuity', 'of', 'illness', 'and', 'long', 'term', 'mortality', 'A', 'G', 'Murchison', 'K', 'Swalwell', 'J', 'Mandeville', 'D', 'Stott', 'P413', 'Acquired', 'weakness', 'in', 'an', 'oncological', 'intensive', 'care', 'unit', 'I', 'Guerreiro', 'P414', 'Musculoskeletal', 'problems', 'in', 'intensive', 'care', 'unit', 'ICU', 'patients', 'post', 'discharge', 'H', 'Devine', 'P', 'MacTavish', 'J', 'McPeake', 'T', 'Quasim', 'J', 'Kinsella', 'M', 'Daniel', 'P415', 'Premorbid', 'obesity', 'but', 'not', 'nutrition', 'prevents', 'critical', 'illness', 'induced', 'muscle', 'wasting', 'and', 'weakness', 'C', 'Goossens', 'M', 'B', 'Marques', 'S', 'Derde', 'S', 'Vander', 'Perre', 'T', 'Dufour', 'S', 'E', 'Thiessen', 'F', 'Güiza', 'T', 'Janssens', 'G', 'Hermans', 'I', 'Vanhorebeek', 'K', 'De', 'Bock', 'G', 'Van', 'den', 'Berghe', 'L', 'Langouche', 'P416', 'Physical', 'outcome', 'measures', 'for', 'critical', 'care', 'patients', 'following', 'intensive', 'care', 'unit', 'icu', 'discharge', 'H', 'Devine', 'P', 'MacTavish', 'T', 'Quasim', 'J', 'Kinsella', 'M', 'Daniel', 'J', 'McPeake', 'P417', 'Improving', 'active', 'mobilisation', 'in', 'a', 'general', 'intensive', 'care', 'unit', 'B', 'Miles', 'S', 'Madden', 'H', 'Devine', 'P418', 'Mobilization', 'in', 'patients', 'on', 'vasoactive', 'drugs', 'use', 'a', 'pilot', 'study', 'M', 'Weiler', 'P', 'Marques', 'C', 'Rodrigues', 'M', 'Boeira', 'K', 'Brenner', 'C', 'Leães', 'A', 'Machado', 'R', 'Townsend', 'J', 'Andrade', 'P419', 'Pharmacy', 'intervention', 'at', 'an', 'intensive', 'care', 'rehabilitation', 'clinic', 'P', 'MacTavish', 'J', 'McPeake', 'H', 'Devine', 'J', 'Kinsella', 'M', 'Daniel', 'R', 'Kishore', 'C', 'Fenlon', 'T', 'Quasim', 'P420', 'Interactive', 'gaming', 'is', 'feasible', 'and', 'potentially', 'increases', 'icu', 'patients', 'motivation', 'to', 'be', 'engaged', 'in', 'rehabilitation', 'programs', 'T', 'Fiks', 'A', 'Ruijter', 'M', 'Te', 'Raa', 'P', 'Spronk', 'P421', 'Simulation', 'based', 'design', 'of', 'a', 'robust', 'stopping', 'rule', 'to', 'ensure', 'patient', 'safety', 'Y', 'S', 'Chiew', 'P', 'Docherty', 'J', 'Dickson', 'E', 'Moltchanova', 'C', 'Scarrot', 'C', 'Pretty', 'G', 'M', 'Shaw', 'J', 'G', 'Chase', 'P422', 'Are', 'daily', 'blood', 'tests', 'on', 'the', 'intensive', 'care', 'unit', 'necessary', 'T', 'Hall', 'W', 'C', 'Ngu', 'J', 'M', 'Jack', 'P', 'Morgan', 'P423', 'Measuring', 'urine', 'output', 'in', 'ward', 'patients', 'is', 'it', 'helpful', 'B', 'Avard', 'A', 'Pavli', 'X', 'Gee', 'P424', 'The', 'incidence', 'of', 'pressure', 'ulcers', 'in', 'an', 'adult', 'mixed', 'intensive', 'care', 'unit', 'in', 'turkey', 'C', 'Bor', 'E', 'Akin', 'Korhan', 'K', 'Demirag', 'M', 'Uyar', 'P425', 'Intensivist', 'patient', 'ratios', 'in', 'closed', 'ICUs', 'in', 'Alexandria', 'Egypt', 'an', 'overview', 'M', 'Shirazy', 'A', 'Fayed', 'P426', 'Eicu', 'electronic', 'intensive', 'care', 'unit', 'impact', 'on', 'ALOS', 'average', 'length', 'of', 'stay', 'in', 'a', 'developing', 'country', 'like', 'India', 'S', 'Gupta', 'A', 'Kaushal', 'S', 'Dewan', 'A', 'Varma', 'P427', 'Predicting', 'deterioration', 'in', 'general', 'ward', 'using', 'early', 'deterioration', 'indicator', 'E', 'Ghosh', 'L', 'Yang', 'L', 'Eshelman', 'B', 'Lord', 'E', 'Carlson', 'P428', 'High', 'impact', 'enhanced', 'critical', 'care', 'outreach', 'the', 'imobile', 'service', 'making', 'a', 'difference', 'E', 'Helme', 'R', 'Broderick', 'S', 'Hadfield', 'R', 'Loveridge', 'P429', 'Impact', 'of', 'bed', 'availability', 'and', 'cognitive', 'load', 'on', 'intensive', 'care', 'unit', 'ICU', 'bed', 'allocation', 'a', 'vignette', 'based', 'trial', 'J', 'Ramos', 'D', 'Forte', 'P430', 'Characteristics', 'of', 'critically', 'ill', 'patients', 'admitted', 'through', 'the', 'emergency', 'department', 'F', 'Yang', 'P', 'Hou', 'P431', 'Admission', 'to', 'critical', 'care', 'the', 'quantification', 'of', 'functional', 'reserve', 'J', 'Dudziak', 'J', 'Feeney', 'K', 'Wilkinson', 'K', 'Bauchmuller', 'K', 'Shuker', 'M', 'Faulds', 'A', 'Raithatha', 'D', 'Bryden', 'L', 'England', 'N', 'Bolton', 'A', 'Tridente', 'P432', 'Admission', 'to', 'critical', 'care', 'the', 'importance', 'of', 'frailty', 'K', 'Bauchmuller', 'K', 'Shuker', 'A', 'Tridente', 'M', 'Faulds', 'A', 'Matheson', 'J', 'Gaynor', 'D', 'Bryden', 'S', 'South', 'Yorkshire', 'Hospitals', 'Research', 'Collaboration', 'P433', 'Development', 'of', 'an', 'instrument', 'to', 'aid', 'triage', 'decisions', 'for', 'intensive', 'care', 'unit', 'admission', 'J', 'Ramos', 'B', 'Peroni', 'R', 'Daglius', 'Dias', 'L', 'Miranda', 'C', 'Cohen', 'C', 'Carvalho', 'I', 'Velasco', 'D', 'Forte', 'P434', 'Using', 'selective', 'serotonin', 're', 'uptake', 'inhibitors', 'and', 'serotonin', 'norepinephrine', 're', 'uptake', 'inhibitors', 'in', 'critical', 'care', 'a', 'systematic', 'review', 'of', 'the', 'evidence', 'for', 'benefit', 'or', 'harm', 'J', 'M', 'Kelly', 'A', 'Neill', 'G', 'Rubenfeld', 'N', 'Masson', 'A', 'Min', 'P435', 'Measuring', 'adaptive', 'coping', 'of', 'hospitalized', 'patients', 'with', 'a', 'severe', 'medical', 'condition', 'the', 'sickness', 'insight', 'in', 'coping', 'questionnaire', 'sicq', 'E', 'Boezeman', 'J', 'Hofhuis', 'A', 'Hovingh', 'R', 'De', 'Vries', 'P', 'Spronk', 'P436', 'Results', 'of', 'a', 'national', 'survey', 'regarding', 'intensive', 'care', 'medicine', 'training', 'G', 'Cabral', 'Campello', 'I', 'Aragão', 'T', 'Cardoso', 'P437', 'Work', 'engagement', 'among', 'healthcare', 'professionals', 'in', 'the', 'intensive', 'care', 'unit', 'M', 'Van', 'Mol', 'M', 'Nijkamp', 'E', 'Kompanje', 'P438', 'Empowering', 'the', 'intensive', 'care', 'practitioners', 'is', 'it', 'a', 'burnout', 'ameliorating', 'intervention', 'P', 'Ostrowski', 'A', 'Omar', 'P439', 'Icu', 'patients', 'suffer', 'from', 'circadian', 'rhythm', 'desynchronisation', 'K', 'Kiss', 'B', 'Köves', 'V', 'Csernus', 'Z', 'Molnár', 'P440', 'Noise', 'reduction', 'in', 'the', 'ICU', 'feasible', 'Y', 'Hoydonckx', 'S', 'Vanwing', 'B', 'Stessel', 'A', 'Van', 'Assche', 'L', 'Jamaer', 'J', 'Dubois', 'P441', 'Accidental', 'removal', 'of', 'invasive', 'devices', 'in', 'the', 'critical', 'patient', 'into', 'the', 'bed', 'washing', 'does', 'the', 'presence', 'of', 'professional', 'nurse', 'modify', 'his', 'incidence', 'V', 'Medo', 'R', 'Galvez', 'J', 'P', 'Miranda', 'P442', 'Deprivation', 'of', 'liberty', 'safeguards', 'dols', 'audit', 'of', 'compliance', 'in', 'a', 'of', 'a', '16', 'bed', 'specialist', 'cancer', 'critical', 'care', 'unit', 'C', 'Stone', 'T', 'Wigmore', 'P443', 'Use', 'of', 'a', 'modified', 'cristal', 'score', 'to', 'predict', 'futility', 'of', 'critical', 'care', 'in', 'the', 'elderly', 'Y', 'Arunan', 'A', 'Wheeler', 'K', 'Bauchmuller', 'D', 'Bryden', 'P444', 'Improvement', 'of', 'Referral', 'Rate', 'to', 'Palliative', 'Care', 'for', 'Patients', 'with', 'Poor', 'Prognosis', 'in', 'Neurosurgical', 'Intensive', 'Care', 'Unit', 'Y', 'Wong', 'C', 'Poi', 'C', 'Gu', 'P445', 'Factors', 'associated', 'with', 'limitation', 'of', 'life', 'supporting', 'care', 'lsc', 'in', 'a', 'medico', 'surgical', 'intermediate', 'care', 'unit', 'and', 'outcome', 'of', 'patients', 'with', 'lsc', 'limitation', 'a', 'monocentric', 'six', 'month', 'study', 'P', 'Molmy', 'N', 'Van', 'Grunderbeeck', 'O', 'Nigeon', 'M', 'Lemyze', 'D', 'Thevenin', 'J', 'Mallat', 'P446', 'Palliative', 'care', 'consultation', 'and', 'intensive', 'care', 'unit', 'admission', 'request', 'a', 'cohort', 'study', 'J', 'Ramos', 'M', 'Correa', 'R', 'T', 'Carvalho', 'D', 'Forte', 'P447', 'Nursing', 'and', 'medicine', 'together', 'in', 'postsurgical', 'intensive', 'care', 'unit', 'situations', 'of', 'prognostic', 'conflict', 'at', 'the', 'end', 'of', 'life', 'our', 'critical', 'care', 'nurses', 'suffer', 'with', 'our', 'medical', 'activism', 'A', 'Fernandez', 'C', 'McBride', 'P448', 'End', 'of', 'life', 'who', 'may', 'decide', 'E', 'Koonthalloor', 'C', 'Walsh', 'P449', 'Correctly', 'diagnosing', 'death', 'A', 'Webber', 'M', 'Ashe', 'K', 'Smith', 'P', 'Jeanrenaud', 'P450', 'Skin', 'procurement', 'performed', 'by', 'intensive', 'care', 'physicians', 'yes', 'we', 'can', 'A', 'Marudi', 'S', 'Baroni', 'F', 'Ragusa', 'E', 'Bertellini', 'P451', 'Death', 'analysis', 'in', 'pediatric', 'intensive', 'care', 'patients', 'E', 'A', 'Volakli', 'E', 'Chochliourou', 'M', 'Dimitriadou', 'A', 'Violaki', 'P', 'Mantzafleri', 'E', 'Samkinidou', 'O', 'Vrani', 'A', 'Arbouti', 'T', 'Varsami', 'M', 'Sdougka', 'P452', 'The', 'potential', 'impact', 'of', 'euthanasia', 'on', 'organ', 'donation', 'analysis', 'of', 'data', 'from', 'belgium', 'J', 'A', 'Bollen', 'T', 'C', 'Van', 'Smaalen', 'W', 'C', 'De', 'Jongh', 'M', 'M', 'Ten', 'Hoopen', 'D', 'Ysebaert', 'L', 'W', 'Van', 'Heurn', 'W', 'N', 'Van', 'Mook', 'P453', 'Communication', 'within', 'an', 'intensive', 'care', 'setting', 'K', 'Sim', 'A', 'Fuller', 'P454', 'Development', 'and', 'implementation', 'of', 'a', 'longitudinal', 'communication', 'curriculum', 'for', 'critical', 'care', 'medicine', 'fellows', 'A', 'Roze', 'des', 'Ordons', 'P', 'Couillard', 'C', 'Doig', 'P455', 'Staff', 'family', 'conflict', 'in', 'a', 'multi', 'ethnic', 'intensive', 'care', 'unit', 'R', 'V', 'Van', 'Keer', 'R', 'D', 'Deschepper', 'A', 'F', 'Francke', 'L', 'H', 'Huyghens', 'J', 'B', 'Bilsen', 'P456', 'Does', 'the', 'source', 'of', 'admission', 'to', 'critical', 'care', 'affect', 'family', 'satisfaction', 'B', 'Nyamaizi', 'C', 'Dalrymple', 'A', 'Molokhia', 'A', 'Dobru', 'P457', 'A', 'simple', 'alternative', 'to', 'the', 'family', 'satisfaction', 'survey', 'fs', 'icu', 'E', 'Marrinan', 'A', 'Ankuli', 'A', 'Molokhia', 'P458', 'A', 'study', 'to', 'explore', 'the', 'experiences', 'of', 'patient', 'and', 'family', 'volunteers', 'in', 'a', 'critical', 'care', 'environment', 'a', 'phenomenological', 'analysis', 'J', 'McPeake', 'R', 'Struthers', 'R', 'Crawford', 'H', 'Devine', 'P', 'Mactavish', 'T', 'Quasim', 'P459', 'Prevalence', 'and', 'risk', 'factors', 'of', 'anxiety', 'and', 'depression', 'in', 'relatives', 'of', 'burn', 'patients', 'P', 'Morelli', 'M', 'Degiovanangelo', 'F', 'Lemos', 'V', 'MArtinez', 'F', 'Verga', 'J', 'Cabrera', 'G', 'Burghi', 'P460', 'Guidance', 'of', 'visiting', 'children', 'at', 'an', 'adult', 'intensive', 'care', 'unit', 'icu', 'A', 'Rutten', 'S', 'Van', 'Ieperen', 'S', 'De', 'Geer', 'M', 'Van', 'Vugt', 'E', 'Der', 'Kinderen', 'P461', 'Visiting', 'policies', 'in', 'Italian', 'pediatric', 'ICUs', 'an', 'update', 'A', 'Giannini', 'G', 'Miccinesi', 'T', 'Marchesi', 'E', 'Prandi']"
2861,A novel quantitative PCR mediated by high-fidelity DNA polymerase,2017-09-04,Sci Rep,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583327/,"The biggest challenge for accurate diagnosis of viral infectious disease is the high genetic variability of involved viruses, which affects amplification efficiency and results in low sensitivity and narrow spectrum. Here, we developed a new simple qPCR mediated by high-fidelity (HF) DNA polymerase. The new method utilizes an HFman probe and one primer. Fluorescent signal was generated from the 3′–5′ hydrolysis of HFman probe by HF DNA polymerase before elongation initiation. Mismatches between probe/primer and template have less influence on the amplification efficiency of the new method. The new qPCR exhibited higher sensitivity and better adaptability to sequence variable templates than the conventional TaqMan probe based-qPCR in quantification of HIV-1 viral load. Further comparison with COBAS TaqMan HIV-1 Test (v2.0) showed a good correlation coefficient (R(2) = 0.79) between both methods in quantification of HIV-1 viral load among 21 clinical samples. The characteristics of tolerance to variable templates and one probe-one primer system imply that the probe/primer design for the new method will be easier and more flexible than the conventional method for highly heterogeneous viruses. Therefore, the HF DNA polymerase-mediated qPCR method is a simple, sensitive and promising approach for the development of diagnostics for viral infectious diseases.",10.1038/s41598-017-10782-4,chnaum4b,"['The', 'biggest', 'challenge', 'for', 'accurate', 'diagnosis', 'of', 'viral', 'infectious', 'disease', 'is', 'the', 'high', 'genetic', 'variability', 'of', 'involved', 'viruses', 'which', 'affects', 'amplification', 'efficiency', 'and', 'results', 'in', 'low', 'sensitivity', 'and', 'narrow', 'spectrum', 'Here', 'we', 'developed', 'a', 'new', 'simple', 'qPCR', 'mediated', 'by', 'high', 'fidelity', 'HF', 'DNA', 'polymerase', 'The', 'new', 'method', 'utilizes', 'an', 'HFman', 'probe', 'and', 'one', 'primer', 'Fluorescent', 'signal', 'was', 'generated', 'from', 'the', '3', '5', 'hydrolysis', 'of', 'HFman', 'probe', 'by', 'HF', 'DNA', 'polymerase', 'before', 'elongation', 'initiation', 'Mismatches', 'between', 'probe', 'primer', 'and', 'template', 'have', 'less', 'influence', 'on', 'the', 'amplification', 'efficiency', 'of', 'the', 'new', 'method', 'The', 'new', 'qPCR', 'exhibited', 'higher', 'sensitivity', 'and', 'better', 'adaptability', 'to', 'sequence', 'variable', 'templates', 'than', 'the', 'conventional', 'TaqMan', 'probe', 'based', 'qPCR', 'in', 'quantification', 'of', 'HIV', '1', 'viral', 'load', 'Further', 'comparison', 'with', 'COBAS', 'TaqMan', 'HIV', '1', 'Test', 'v2', '0', 'showed', 'a', 'good', 'correlation', 'coefficient', 'R', '2', '0', '79', 'between', 'both', 'methods', 'in', 'quantification', 'of', 'HIV', '1', 'viral', 'load', 'among', '21', 'clinical', 'samples', 'The', 'characteristics', 'of', 'tolerance', 'to', 'variable', 'templates', 'and', 'one', 'probe', 'one', 'primer', 'system', 'imply', 'that', 'the', 'probe', 'primer', 'design', 'for', 'the', 'new', 'method', 'will', 'be', 'easier', 'and', 'more', 'flexible', 'than', 'the', 'conventional', 'method', 'for', 'highly', 'heterogeneous', 'viruses', 'Therefore', 'the', 'HF', 'DNA', 'polymerase', 'mediated', 'qPCR', 'method', 'is', 'a', 'simple', 'sensitive', 'and', 'promising', 'approach', 'for', 'the', 'development', 'of', 'diagnostics', 'for', 'viral', 'infectious', 'diseases', '']"
2882,Advancing Point-of-Care (PoC) Testing Using Human Saliva as Liquid Biopsy,2017-07-04,Diagnostics (Basel),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617939/,"Salivary diagnostics is an emerging field for the encroachment of point of care technology (PoCT). The necessity of the development of point-of-care (PoC) technology, the potential of saliva, identification and validation of biomarkers through salivary diagnostic toolboxes, and a broad overview of emerging technologies is discussed in this review. Furthermore, novel advanced techniques incorporated in devices for the early detection and diagnosis of several oral and systemic diseases in a non-invasive, easily-monitored, less time consuming, and in a personalised way is explicated. The latest technology detection systems and clinical utilities of saliva as a liquid biopsy, electric field-induced release and measurement (EFIRM), biosensors, smartphone technology, microfluidics, paper-based technology, and how their futuristic perspectives can improve salivary diagnostics and reduce hospital stays by replacing it with chairside screening is also highlighted.",10.3390/diagnostics7030039,agzklj3p,"['Salivary', 'diagnostics', 'is', 'an', 'emerging', 'field', 'for', 'the', 'encroachment', 'of', 'point', 'of', 'care', 'technology', 'PoCT', 'The', 'necessity', 'of', 'the', 'development', 'of', 'point', 'of', 'care', 'PoC', 'technology', 'the', 'potential', 'of', 'saliva', 'identification', 'and', 'validation', 'of', 'biomarkers', 'through', 'salivary', 'diagnostic', 'toolboxes', 'and', 'a', 'broad', 'overview', 'of', 'emerging', 'technologies', 'is', 'discussed', 'in', 'this', 'review', 'Furthermore', 'novel', 'advanced', 'techniques', 'incorporated', 'in', 'devices', 'for', 'the', 'early', 'detection', 'and', 'diagnosis', 'of', 'several', 'oral', 'and', 'systemic', 'diseases', 'in', 'a', 'non', 'invasive', 'easily', 'monitored', 'less', 'time', 'consuming', 'and', 'in', 'a', 'personalised', 'way', 'is', 'explicated', 'The', 'latest', 'technology', 'detection', 'systems', 'and', 'clinical', 'utilities', 'of', 'saliva', 'as', 'a', 'liquid', 'biopsy', 'electric', 'field', 'induced', 'release', 'and', 'measurement', 'EFIRM', 'biosensors', 'smartphone', 'technology', 'microfluidics', 'paper', 'based', 'technology', 'and', 'how', 'their', 'futuristic', 'perspectives', 'can', 'improve', 'salivary', 'diagnostics', 'and', 'reduce', 'hospital', 'stays', 'by', 'replacing', 'it', 'with', 'chairside', 'screening', 'is', 'also', 'highlighted', '']"
3108,Translating Lung Microbiome Profiles into the Next-Generation Diagnostic Gold Standard for Pneumonia: a Clinical Investigator’s Perspective,2018-03-13,mSystems,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850077/,"Severe bacterial pneumonia is a major global cause of morbidity and mortality, yet current diagnostic approaches rely on identification of causative pathogens by cultures, which require extended incubation periods and often fail to detect relevant pathogens. Consequently, patients are prescribed broad-spectrum antibiotics in a “one-size-fits-all” manner, which may be inappropriate for their individual needs and promote antibiotic resistance. My research focuses on leveraging next-generation sequencing of microbial DNA directly from patient samples for the development of new, culture-independent definitions of pneumonia. In this perspective article, I discuss the current state of the field and focus on the conceptual and research design challenges for clinical translation. With ongoing technological advancements and application of computational biology methods for assessing clinical validity and utility, I anticipate that sequencing-based diagnostics will soon be able to positively disrupt the way we think about, diagnose, and treat pulmonary infections.",10.1128/msystems.00153-17,betpeary,"['Severe', 'bacterial', 'pneumonia', 'is', 'a', 'major', 'global', 'cause', 'of', 'morbidity', 'and', 'mortality', 'yet', 'current', 'diagnostic', 'approaches', 'rely', 'on', 'identification', 'of', 'causative', 'pathogens', 'by', 'cultures', 'which', 'require', 'extended', 'incubation', 'periods', 'and', 'often', 'fail', 'to', 'detect', 'relevant', 'pathogens', 'Consequently', 'patients', 'are', 'prescribed', 'broad', 'spectrum', 'antibiotics', 'in', 'a', 'one', 'size', 'fits', 'all', 'manner', 'which', 'may', 'be', 'inappropriate', 'for', 'their', 'individual', 'needs', 'and', 'promote', 'antibiotic', 'resistance', 'My', 'research', 'focuses', 'on', 'leveraging', 'next', 'generation', 'sequencing', 'of', 'microbial', 'DNA', 'directly', 'from', 'patient', 'samples', 'for', 'the', 'development', 'of', 'new', 'culture', 'independent', 'definitions', 'of', 'pneumonia', 'In', 'this', 'perspective', 'article', 'I', 'discuss', 'the', 'current', 'state', 'of', 'the', 'field', 'and', 'focus', 'on', 'the', 'conceptual', 'and', 'research', 'design', 'challenges', 'for', 'clinical', 'translation', 'With', 'ongoing', 'technological', 'advancements', 'and', 'application', 'of', 'computational', 'biology', 'methods', 'for', 'assessing', 'clinical', 'validity', 'and', 'utility', 'I', 'anticipate', 'that', 'sequencing', 'based', 'diagnostics', 'will', 'soon', 'be', 'able', 'to', 'positively', 'disrupt', 'the', 'way', 'we', 'think', 'about', 'diagnose', 'and', 'treat', 'pulmonary', 'infections', '']"
3193,Overview of Virus Metagenomic Classification Methods and Their Biological Applications,2018-04-23,Front Microbiol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924777/,"Metagenomics poses opportunities for clinical and public health virology applications by offering a way to assess complete taxonomic composition of a clinical sample in an unbiased way. However, the techniques required are complicated and analysis standards have yet to develop. This, together with the wealth of different tools and workflows that have been proposed, poses a barrier for new users. We evaluated 49 published computational classification workflows for virus metagenomics in a literature review. To this end, we described the methods of existing workflows by breaking them up into five general steps and assessed their ease-of-use and validation experiments. Performance scores of previous benchmarks were summarized and correlations between methods and performance were investigated. We indicate the potential suitability of the different workflows for (1) time-constrained diagnostics, (2) surveillance and outbreak source tracing, (3) detection of remote homologies (discovery), and (4) biodiversity studies. We provide two decision trees for virologists to help select a workflow for medical or biodiversity studies, as well as directions for future developments in clinical viral metagenomics.",10.3389/fmicb.2018.00749,s5k59eq8,"['Metagenomics', 'poses', 'opportunities', 'for', 'clinical', 'and', 'public', 'health', 'virology', 'applications', 'by', 'offering', 'a', 'way', 'to', 'assess', 'complete', 'taxonomic', 'composition', 'of', 'a', 'clinical', 'sample', 'in', 'an', 'unbiased', 'way', 'However', 'the', 'techniques', 'required', 'are', 'complicated', 'and', 'analysis', 'standards', 'have', 'yet', 'to', 'develop', 'This', 'together', 'with', 'the', 'wealth', 'of', 'different', 'tools', 'and', 'workflows', 'that', 'have', 'been', 'proposed', 'poses', 'a', 'barrier', 'for', 'new', 'users', 'We', 'evaluated', '49', 'published', 'computational', 'classification', 'workflows', 'for', 'virus', 'metagenomics', 'in', 'a', 'literature', 'review', 'To', 'this', 'end', 'we', 'described', 'the', 'methods', 'of', 'existing', 'workflows', 'by', 'breaking', 'them', 'up', 'into', 'five', 'general', 'steps', 'and', 'assessed', 'their', 'ease', 'of', 'use', 'and', 'validation', 'experiments', 'Performance', 'scores', 'of', 'previous', 'benchmarks', 'were', 'summarized', 'and', 'correlations', 'between', 'methods', 'and', 'performance', 'were', 'investigated', 'We', 'indicate', 'the', 'potential', 'suitability', 'of', 'the', 'different', 'workflows', 'for', '1', 'time', 'constrained', 'diagnostics', '2', 'surveillance', 'and', 'outbreak', 'source', 'tracing', '3', 'detection', 'of', 'remote', 'homologies', 'discovery', 'and', '4', 'biodiversity', 'studies', 'We', 'provide', 'two', 'decision', 'trees', 'for', 'virologists', 'to', 'help', 'select', 'a', 'workflow', 'for', 'medical', 'or', 'biodiversity', 'studies', 'as', 'well', 'as', 'directions', 'for', 'future', 'developments', 'in', 'clinical', 'viral', 'metagenomics', '']"
3605,Assay Challenges for Emerging Infectious Diseases: The Zika Experience,2018-10-02,Vaccines (Basel),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313918/,"From the perspective of vaccine development, it is imperative to accurately diagnose target infections in order to exclude subjects with prior exposure from evaluations of vaccine effectiveness, to track incident infection during the course of a clinical trial and to differentiate immune reactions due to natural infections from responses that are vaccine related. When vaccine development is accelerated to a rapid pace in response to emerging infectious disease threats, the challenges to develop such diagnostic tools is even greater. This was observed through the recent expansion of Zika virus infections into the Western Hemisphere in 2014–2017. When initial Zika vaccine clinical trials were being designed and launched in response to the outbreak, there were no standardized sets of viral and immunological assays, and no approved diagnostic tests for Zika virus infection. The diagnosis of Zika virus infection is still an area of active research and development on many fronts. Here we review emerging infectious disease vaccine clinical assay development and trial execution with a special focus on the state of Zika virus clinical assays and diagnostics.",10.3390/vaccines6040070,ypefqm71,"['From', 'the', 'perspective', 'of', 'vaccine', 'development', 'it', 'is', 'imperative', 'to', 'accurately', 'diagnose', 'target', 'infections', 'in', 'order', 'to', 'exclude', 'subjects', 'with', 'prior', 'exposure', 'from', 'evaluations', 'of', 'vaccine', 'effectiveness', 'to', 'track', 'incident', 'infection', 'during', 'the', 'course', 'of', 'a', 'clinical', 'trial', 'and', 'to', 'differentiate', 'immune', 'reactions', 'due', 'to', 'natural', 'infections', 'from', 'responses', 'that', 'are', 'vaccine', 'related', 'When', 'vaccine', 'development', 'is', 'accelerated', 'to', 'a', 'rapid', 'pace', 'in', 'response', 'to', 'emerging', 'infectious', 'disease', 'threats', 'the', 'challenges', 'to', 'develop', 'such', 'diagnostic', 'tools', 'is', 'even', 'greater', 'This', 'was', 'observed', 'through', 'the', 'recent', 'expansion', 'of', 'Zika', 'virus', 'infections', 'into', 'the', 'Western', 'Hemisphere', 'in', '2014', '2017', 'When', 'initial', 'Zika', 'vaccine', 'clinical', 'trials', 'were', 'being', 'designed', 'and', 'launched', 'in', 'response', 'to', 'the', 'outbreak', 'there', 'were', 'no', 'standardized', 'sets', 'of', 'viral', 'and', 'immunological', 'assays', 'and', 'no', 'approved', 'diagnostic', 'tests', 'for', 'Zika', 'virus', 'infection', 'The', 'diagnosis', 'of', 'Zika', 'virus', 'infection', 'is', 'still', 'an', 'area', 'of', 'active', 'research', 'and', 'development', 'on', 'many', 'fronts', 'Here', 'we', 'review', 'emerging', 'infectious', 'disease', 'vaccine', 'clinical', 'assay', 'development', 'and', 'trial', 'execution', 'with', 'a', 'special', 'focus', 'on', 'the', 'state', 'of', 'Zika', 'virus', 'clinical', 'assays', 'and', 'diagnostics', '']"
3715,Diagnostic tests for Crimean-Congo haemorrhagic fever: a widespread tickborne disease,2019-02-20,BMJ Glob Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407549/,"Crimean-Congo haemorrhagic fever (CCHF) is a widespread tickborne disease that circulates in wild and domestic animal hosts, and causes severe and often fatal haemorrhagic fever in infected humans. Due to the lack of treatment options or vaccines, and a high fatality rate, CCHF virus (CCHFV) is considered a high-priority pathogen according to the WHO R&D Blueprint. Several commercial reverse transcriptase PCR (RT-PCR) and serological diagnostic assays for CCHFV are already available, including febrile agent panels to distinguish CCHFV from other viral haemorrhagic fever agents; however, the majority of international laboratories use inhouse assays. As CCHFV has numerous amplifying animal hosts, a cross-sectoral ‘One Health’ approach to outbreak prevention is recommended to enhance notifications and enable early warning for genetic and epidemiological shifts in the human, animal and tick populations. However, a lack of guidance for surveillance in animals, harmonisation of case identification and validated serodiagnostic kits for animal testing hinders efforts to strengthen surveillance systems. Additionally, as RT-PCR tests tend to be lineage-specific for regional circulating strains, there is a need for pan-lineage sensitive diagnostics. Adaptation of existing tests to point-of-care molecular diagnostic platforms that can be implemented in clinic or field-based settings would be of value given the potential for CCHFV outbreaks in remote or low-resource areas. Finally, improved access to clinical specimens for validation of diagnostics would help to accelerate development of new tests. These gaps should be addressed by updated target product profiles for CCHFV diagnostics.",10.1136/bmjgh-2018-001114,u5tvbej3,"['Crimean', 'Congo', 'haemorrhagic', 'fever', 'CCHF', 'is', 'a', 'widespread', 'tickborne', 'disease', 'that', 'circulates', 'in', 'wild', 'and', 'domestic', 'animal', 'hosts', 'and', 'causes', 'severe', 'and', 'often', 'fatal', 'haemorrhagic', 'fever', 'in', 'infected', 'humans', 'Due', 'to', 'the', 'lack', 'of', 'treatment', 'options', 'or', 'vaccines', 'and', 'a', 'high', 'fatality', 'rate', 'CCHF', 'virus', 'CCHFV', 'is', 'considered', 'a', 'high', 'priority', 'pathogen', 'according', 'to', 'the', 'WHO', 'R', 'D', 'Blueprint', 'Several', 'commercial', 'reverse', 'transcriptase', 'PCR', 'RT', 'PCR', 'and', 'serological', 'diagnostic', 'assays', 'for', 'CCHFV', 'are', 'already', 'available', 'including', 'febrile', 'agent', 'panels', 'to', 'distinguish', 'CCHFV', 'from', 'other', 'viral', 'haemorrhagic', 'fever', 'agents', 'however', 'the', 'majority', 'of', 'international', 'laboratories', 'use', 'inhouse', 'assays', 'As', 'CCHFV', 'has', 'numerous', 'amplifying', 'animal', 'hosts', 'a', 'cross', 'sectoral', 'One', 'Health', 'approach', 'to', 'outbreak', 'prevention', 'is', 'recommended', 'to', 'enhance', 'notifications', 'and', 'enable', 'early', 'warning', 'for', 'genetic', 'and', 'epidemiological', 'shifts', 'in', 'the', 'human', 'animal', 'and', 'tick', 'populations', 'However', 'a', 'lack', 'of', 'guidance', 'for', 'surveillance', 'in', 'animals', 'harmonisation', 'of', 'case', 'identification', 'and', 'validated', 'serodiagnostic', 'kits', 'for', 'animal', 'testing', 'hinders', 'efforts', 'to', 'strengthen', 'surveillance', 'systems', 'Additionally', 'as', 'RT', 'PCR', 'tests', 'tend', 'to', 'be', 'lineage', 'specific', 'for', 'regional', 'circulating', 'strains', 'there', 'is', 'a', 'need', 'for', 'pan', 'lineage', 'sensitive', 'diagnostics', 'Adaptation', 'of', 'existing', 'tests', 'to', 'point', 'of', 'care', 'molecular', 'diagnostic', 'platforms', 'that', 'can', 'be', 'implemented', 'in', 'clinic', 'or', 'field', 'based', 'settings', 'would', 'be', 'of', 'value', 'given', 'the', 'potential', 'for', 'CCHFV', 'outbreaks', 'in', 'remote', 'or', 'low', 'resource', 'areas', 'Finally', 'improved', 'access', 'to', 'clinical', 'specimens', 'for', 'validation', 'of', 'diagnostics', 'would', 'help', 'to', 'accelerate', 'development', 'of', 'new', 'tests', 'These', 'gaps', 'should', 'be', 'addressed', 'by', 'updated', 'target', 'product', 'profiles', 'for', 'CCHFV', 'diagnostics', '']"
4486,Qualitative Research: Institutional Preparedness During Threats of Infectious Disease Outbreaks,2020-01-23,Biomed Res Int,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998699/,"BACKGROUND: As demonstrated during the global Ebola crisis of 2014–2016, healthcare institutions in high resource settings need support concerning preparedness during threats of infectious disease outbreaks. This study aimed to exploratively develop a standardized preparedness system to use during unfolding threats of severe infectious diseases. METHODS: A qualitative three-step study among infectious disease prevention and control experts was performed. First, interviews (n = 5) were conducted to identify which factors trigger preparedness activities during an unfolding threat. Second, these triggers informed the design of a phased preparedness system which was tested in a focus group discussion (n = 5) were conducted to identify which factors trigger preparedness activities during an unfolding threat. Second, these triggers informed the design of a phased preparedness system which was tested in a focus group discussion (n = 5) were conducted to identify which factors trigger preparedness activities during an unfolding threat. Second, these triggers informed the design of a phased preparedness system which was tested in a focus group discussion ( RESULTS: Four preparedness phases were identified: preparedness phase green is a situation without the presence of the infectious disease threat that requires centralized care, anywhere in the world. Phase yellow is an outbreak in the world with some likelihood of imported cases. Phase orange is a realistic chance of an unexpected case within the country, or unrest developing among population or staff; phase red is cases admitted to hospitals in the country, potentially causing a shortage of resources. Specific preparedness activities included infection prevention, diagnostics, patient care, staff, and communication. Consensus was reached on the need for the development of a preparedness system and national coordination during threats. CONCLUSIONS: In this study, we developed a standardized system to support institutional preparedness during an increasing threat. Use of this system by both curative healthcare institutions and the (municipal) public health service, could help to effectively communicate and align preparedness activities during future threats of severe infectious diseases.",10.1155/2020/5861894,g6ki6vyy,"['BACKGROUND', 'As', 'demonstrated', 'during', 'the', 'global', 'Ebola', 'crisis', 'of', '2014', '2016', 'healthcare', 'institutions', 'in', 'high', 'resource', 'settings', 'need', 'support', 'concerning', 'preparedness', 'during', 'threats', 'of', 'infectious', 'disease', 'outbreaks', 'This', 'study', 'aimed', 'to', 'exploratively', 'develop', 'a', 'standardized', 'preparedness', 'system', 'to', 'use', 'during', 'unfolding', 'threats', 'of', 'severe', 'infectious', 'diseases', 'METHODS', 'A', 'qualitative', 'three', 'step', 'study', 'among', 'infectious', 'disease', 'prevention', 'and', 'control', 'experts', 'was', 'performed', 'First', 'interviews', 'n', '5', 'were', 'conducted', 'to', 'identify', 'which', 'factors', 'trigger', 'preparedness', 'activities', 'during', 'an', 'unfolding', 'threat', 'Second', 'these', 'triggers', 'informed', 'the', 'design', 'of', 'a', 'phased', 'preparedness', 'system', 'which', 'was', 'tested', 'in', 'a', 'focus', 'group', 'discussion', 'n', '5', 'were', 'conducted', 'to', 'identify', 'which', 'factors', 'trigger', 'preparedness', 'activities', 'during', 'an', 'unfolding', 'threat', 'Second', 'these', 'triggers', 'informed', 'the', 'design', 'of', 'a', 'phased', 'preparedness', 'system', 'which', 'was', 'tested', 'in', 'a', 'focus', 'group', 'discussion', 'n', '5', 'were', 'conducted', 'to', 'identify', 'which', 'factors', 'trigger', 'preparedness', 'activities', 'during', 'an', 'unfolding', 'threat', 'Second', 'these', 'triggers', 'informed', 'the', 'design', 'of', 'a', 'phased', 'preparedness', 'system', 'which', 'was', 'tested', 'in', 'a', 'focus', 'group', 'discussion', 'RESULTS', 'Four', 'preparedness', 'phases', 'were', 'identified', 'preparedness', 'phase', 'green', 'is', 'a', 'situation', 'without', 'the', 'presence', 'of', 'the', 'infectious', 'disease', 'threat', 'that', 'requires', 'centralized', 'care', 'anywhere', 'in', 'the', 'world', 'Phase', 'yellow', 'is', 'an', 'outbreak', 'in', 'the', 'world', 'with', 'some', 'likelihood', 'of', 'imported', 'cases', 'Phase', 'orange', 'is', 'a', 'realistic', 'chance', 'of', 'an', 'unexpected', 'case', 'within', 'the', 'country', 'or', 'unrest', 'developing', 'among', 'population', 'or', 'staff', 'phase', 'red', 'is', 'cases', 'admitted', 'to', 'hospitals', 'in', 'the', 'country', 'potentially', 'causing', 'a', 'shortage', 'of', 'resources', 'Specific', 'preparedness', 'activities', 'included', 'infection', 'prevention', 'diagnostics', 'patient', 'care', 'staff', 'and', 'communication', 'Consensus', 'was', 'reached', 'on', 'the', 'need', 'for', 'the', 'development', 'of', 'a', 'preparedness', 'system', 'and', 'national', 'coordination', 'during', 'threats', 'CONCLUSIONS', 'In', 'this', 'study', 'we', 'developed', 'a', 'standardized', 'system', 'to', 'support', 'institutional', 'preparedness', 'during', 'an', 'increasing', 'threat', 'Use', 'of', 'this', 'system', 'by', 'both', 'curative', 'healthcare', 'institutions', 'and', 'the', 'municipal', 'public', 'health', 'service', 'could', 'help', 'to', 'effectively', 'communicate', 'and', 'align', 'preparedness', 'activities', 'during', 'future', 'threats', 'of', 'severe', 'infectious', 'diseases', '']"
4553,Loop-Mediated Isothermal Amplification (LAMP) for the Diagnosis of Zika Virus: A Review,2019-12-23,Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019470/,"The recent outbreak of Zika virus (ZIKV) in the Americas and its devastating developmental and neurological manifestations has prompted the development of field-based diagnostics that are rapid, reliable, handheld, specific, sensitive, and inexpensive. The gold standard molecular method for lab-based diagnosis of ZIKV, from either patient samples or insect vectors, is reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The method, however, is costly and requires lab-based equipment and expertise, which severely limits its use as a point-of-care (POC) tool in resource-poor settings. Moreover, given the lack of antivirals or approved vaccines for ZIKV infection, a POC diagnostic test is urgently needed for the early detection of new outbreaks and to adequately manage patients. Loop-mediated isothermal amplification (LAMP) is a compelling alternative to RT-qPCR for ZIKV and other arboviruses. This low-cost molecular system can be freeze-dried for distribution and exhibits high specificity, sensitivity, and efficiency. A growing body of evidence suggests that LAMP assays can provide greater accessibility to much-needed diagnostics for ZIKV infections, especially in developing countries where the ZIKV is now endemic. This review summarizes the different LAMP methods that have been developed for the virus and summarizes their features, advantages, and limitations.",10.3390/v12010019,yxuyhc7p,"['The', 'recent', 'outbreak', 'of', 'Zika', 'virus', 'ZIKV', 'in', 'the', 'Americas', 'and', 'its', 'devastating', 'developmental', 'and', 'neurological', 'manifestations', 'has', 'prompted', 'the', 'development', 'of', 'field', 'based', 'diagnostics', 'that', 'are', 'rapid', 'reliable', 'handheld', 'specific', 'sensitive', 'and', 'inexpensive', 'The', 'gold', 'standard', 'molecular', 'method', 'for', 'lab', 'based', 'diagnosis', 'of', 'ZIKV', 'from', 'either', 'patient', 'samples', 'or', 'insect', 'vectors', 'is', 'reverse', 'transcription', 'quantitative', 'polymerase', 'chain', 'reaction', 'RT', 'qPCR', 'The', 'method', 'however', 'is', 'costly', 'and', 'requires', 'lab', 'based', 'equipment', 'and', 'expertise', 'which', 'severely', 'limits', 'its', 'use', 'as', 'a', 'point', 'of', 'care', 'POC', 'tool', 'in', 'resource', 'poor', 'settings', 'Moreover', 'given', 'the', 'lack', 'of', 'antivirals', 'or', 'approved', 'vaccines', 'for', 'ZIKV', 'infection', 'a', 'POC', 'diagnostic', 'test', 'is', 'urgently', 'needed', 'for', 'the', 'early', 'detection', 'of', 'new', 'outbreaks', 'and', 'to', 'adequately', 'manage', 'patients', 'Loop', 'mediated', 'isothermal', 'amplification', 'LAMP', 'is', 'a', 'compelling', 'alternative', 'to', 'RT', 'qPCR', 'for', 'ZIKV', 'and', 'other', 'arboviruses', 'This', 'low', 'cost', 'molecular', 'system', 'can', 'be', 'freeze', 'dried', 'for', 'distribution', 'and', 'exhibits', 'high', 'specificity', 'sensitivity', 'and', 'efficiency', 'A', 'growing', 'body', 'of', 'evidence', 'suggests', 'that', 'LAMP', 'assays', 'can', 'provide', 'greater', 'accessibility', 'to', 'much', 'needed', 'diagnostics', 'for', 'ZIKV', 'infections', 'especially', 'in', 'developing', 'countries', 'where', 'the', 'ZIKV', 'is', 'now', 'endemic', 'This', 'review', 'summarizes', 'the', 'different', 'LAMP', 'methods', 'that', 'have', 'been', 'developed', 'for', 'the', 'virus', 'and', 'summarizes', 'their', 'features', 'advantages', 'and', 'limitations', '']"
4784,Microfluidics in macro-biomolecules analysis: macro inside in a nano world,2010-06-13,Anal Bioanal Chem,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079953/,"Use of microfluidic devices in the life sciences and medicine has created the possibility of performing investigations at the molecular level. Moreover, microfluidic devices are also part of the technological framework that has enabled a new type of scientific information to be revealed, i.e. that based on intensive screening of complete sets of gene and protein sequences. A deeper bioanalytical perspective may provide quantitative and qualitative tools, enabling study of various diseases and, eventually, may offer support for the development of accurate and reliable methods for clinical assessment. This would open the way to molecule-based diagnostics, i.e. establish accurate diagnosis and disease prognosis based on identification and/or quantification of biomacromolecules, for example proteins or nucleic acids. Finally, the development of disposable and portable devices for molecule-based diagnosis would provide the perfect translation of the science behind life-science research into practical applications dedicated to patients and health practitioners. This review provides an analytical perspective of the impact of microfluidics on the detection and characterization of bio-macromolecules involved in pathological processes. The main features of molecule-based diagnostics and the specific requirements for the diagnostic devices are discussed. Further, the techniques currently used for testing bio-macromolecules for potential diagnostic purposes are identified, emphasizing the newest developments. Subsequently, the challenges of this type of application and the status of commercially available devices are highlighted, and future trends are noted.",10.1007/s00216-010-3857-7,ale7xhcf,"['Use', 'of', 'microfluidic', 'devices', 'in', 'the', 'life', 'sciences', 'and', 'medicine', 'has', 'created', 'the', 'possibility', 'of', 'performing', 'investigations', 'at', 'the', 'molecular', 'level', 'Moreover', 'microfluidic', 'devices', 'are', 'also', 'part', 'of', 'the', 'technological', 'framework', 'that', 'has', 'enabled', 'a', 'new', 'type', 'of', 'scientific', 'information', 'to', 'be', 'revealed', 'i', 'e', 'that', 'based', 'on', 'intensive', 'screening', 'of', 'complete', 'sets', 'of', 'gene', 'and', 'protein', 'sequences', 'A', 'deeper', 'bioanalytical', 'perspective', 'may', 'provide', 'quantitative', 'and', 'qualitative', 'tools', 'enabling', 'study', 'of', 'various', 'diseases', 'and', 'eventually', 'may', 'offer', 'support', 'for', 'the', 'development', 'of', 'accurate', 'and', 'reliable', 'methods', 'for', 'clinical', 'assessment', 'This', 'would', 'open', 'the', 'way', 'to', 'molecule', 'based', 'diagnostics', 'i', 'e', 'establish', 'accurate', 'diagnosis', 'and', 'disease', 'prognosis', 'based', 'on', 'identification', 'and', 'or', 'quantification', 'of', 'biomacromolecules', 'for', 'example', 'proteins', 'or', 'nucleic', 'acids', 'Finally', 'the', 'development', 'of', 'disposable', 'and', 'portable', 'devices', 'for', 'molecule', 'based', 'diagnosis', 'would', 'provide', 'the', 'perfect', 'translation', 'of', 'the', 'science', 'behind', 'life', 'science', 'research', 'into', 'practical', 'applications', 'dedicated', 'to', 'patients', 'and', 'health', 'practitioners', 'This', 'review', 'provides', 'an', 'analytical', 'perspective', 'of', 'the', 'impact', 'of', 'microfluidics', 'on', 'the', 'detection', 'and', 'characterization', 'of', 'bio', 'macromolecules', 'involved', 'in', 'pathological', 'processes', 'The', 'main', 'features', 'of', 'molecule', 'based', 'diagnostics', 'and', 'the', 'specific', 'requirements', 'for', 'the', 'diagnostic', 'devices', 'are', 'discussed', 'Further', 'the', 'techniques', 'currently', 'used', 'for', 'testing', 'bio', 'macromolecules', 'for', 'potential', 'diagnostic', 'purposes', 'are', 'identified', 'emphasizing', 'the', 'newest', 'developments', 'Subsequently', 'the', 'challenges', 'of', 'this', 'type', 'of', 'application', 'and', 'the', 'status', 'of', 'commercially', 'available', 'devices', 'are', 'highlighted', 'and', 'future', 'trends', 'are', 'noted', '']"
4851,Gedanken zur Differentialdiagnostik*,2003,Med Klin (Munich),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080171/,"Referring to H. E. Bock’s famous lectures on differential diagnostics, some recent developments are discussed. Topical remarks are given concerning modern differential diagnostics. In general, they have changed from the diagnostic of the phenotype to the detection of the pathogenesis.",10.1007/s00063-003-1312-7,uocadc35,"['Referring', 'to', 'H', 'E', 'Bock', 's', 'famous', 'lectures', 'on', 'differential', 'diagnostics', 'some', 'recent', 'developments', 'are', 'discussed', 'Topical', 'remarks', 'are', 'given', 'concerning', 'modern', 'differential', 'diagnostics', 'In', 'general', 'they', 'have', 'changed', 'from', 'the', 'diagnostic', 'of', 'the', 'phenotype', 'to', 'the', 'detection', 'of', 'the', 'pathogenesis', '']"
5357,The use of loop-mediated isothermal DNA amplification for the detection and identification of the anthrax pathogen,2017-09-20,Mol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088587/,The results of detection and identification of Bacillus anthracis strains in loop-mediated isothermal DNA amplification (LAMP) reaction performed under optimized conditions with original primers and thermostable DNA polymerase are presented. Reproducible LAMP-based detection of chromosomal and plasmid DNA targets specific for B. anthracis strains has been demonstrated. No cross reactions with DNA from bacterial strains of other species of the B. cereus group were detected. The development of tests for anthrax-pathogen detection based on the optimized reaction of loop isothermal DNA amplification is planned. These tests will be convenient for clinical studies and field diagnostics due to the absence of requirements for sophisticated equipment.,10.3103/s0891416817020094,7rdvjylx,"['The', 'results', 'of', 'detection', 'and', 'identification', 'of', 'Bacillus', 'anthracis', 'strains', 'in', 'loop', 'mediated', 'isothermal', 'DNA', 'amplification', 'LAMP', 'reaction', 'performed', 'under', 'optimized', 'conditions', 'with', 'original', 'primers', 'and', 'thermostable', 'DNA', 'polymerase', 'are', 'presented', 'Reproducible', 'LAMP', 'based', 'detection', 'of', 'chromosomal', 'and', 'plasmid', 'DNA', 'targets', 'specific', 'for', 'B', 'anthracis', 'strains', 'has', 'been', 'demonstrated', 'No', 'cross', 'reactions', 'with', 'DNA', 'from', 'bacterial', 'strains', 'of', 'other', 'species', 'of', 'the', 'B', 'cereus', 'group', 'were', 'detected', 'The', 'development', 'of', 'tests', 'for', 'anthrax', 'pathogen', 'detection', 'based', 'on', 'the', 'optimized', 'reaction', 'of', 'loop', 'isothermal', 'DNA', 'amplification', 'is', 'planned', 'These', 'tests', 'will', 'be', 'convenient', 'for', 'clinical', 'studies', 'and', 'field', 'diagnostics', 'due', 'to', 'the', 'absence', 'of', 'requirements', 'for', 'sophisticated', 'equipment', '']"
5601,Detection of human viral RNA via a combined fluorescence and SERS molecular beacon assay,2007-05-03,Nanobiotechnology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091242/,"A dual-mode molecular beacon on a multiplexed substrate has been developed and applied to the measurement of unlabeled human viral RNA. The detection system is based on a combined surface-enhanced Raman scattering (SERS) and fluorescent molecular beacon assay that is assembled on Nanobarcodes™ particles. In this assay, a molecular beacon probe terminated with a fluorescent Raman label dye is conjugated to the metallic Nanobarcodes™ particles. The molecular beacon probe is a single-stranded oligonucleotide that has been designed with a hairpin structure that holds the dye at 3′-end close to the particle surface when the probe is attached through a 5′-thiol group. In this configuration, the SERS spectrum of the label was obtained and its fluorescence quenched because the dye is in very close proximity to a noble metal surface with nanoscale features (Nanobarcodes™ particles). The SERS signal decreased and the fluorescence signal increased when target viral RNA was captured by this molecular beacon probe. In addition, a hepatitis C virus reverse transcriptase-polymerase chain reaction (HCV RT-PCR) product was detected using this dual-mode beacon. The development of a multiplexed, label-free assay system with the reassurance offered by detection of two distinctly separate signals offers significant benefits for rapid molecular diagnostics.",10.1007/s12030-007-0003-5,mkiz23c4,"['A', 'dual', 'mode', 'molecular', 'beacon', 'on', 'a', 'multiplexed', 'substrate', 'has', 'been', 'developed', 'and', 'applied', 'to', 'the', 'measurement', 'of', 'unlabeled', 'human', 'viral', 'RNA', 'The', 'detection', 'system', 'is', 'based', 'on', 'a', 'combined', 'surface', 'enhanced', 'Raman', 'scattering', 'SERS', 'and', 'fluorescent', 'molecular', 'beacon', 'assay', 'that', 'is', 'assembled', 'on', 'Nanobarcodes', 'particles', 'In', 'this', 'assay', 'a', 'molecular', 'beacon', 'probe', 'terminated', 'with', 'a', 'fluorescent', 'Raman', 'label', 'dye', 'is', 'conjugated', 'to', 'the', 'metallic', 'Nanobarcodes', 'particles', 'The', 'molecular', 'beacon', 'probe', 'is', 'a', 'single', 'stranded', 'oligonucleotide', 'that', 'has', 'been', 'designed', 'with', 'a', 'hairpin', 'structure', 'that', 'holds', 'the', 'dye', 'at', '3', 'end', 'close', 'to', 'the', 'particle', 'surface', 'when', 'the', 'probe', 'is', 'attached', 'through', 'a', '5', 'thiol', 'group', 'In', 'this', 'configuration', 'the', 'SERS', 'spectrum', 'of', 'the', 'label', 'was', 'obtained', 'and', 'its', 'fluorescence', 'quenched', 'because', 'the', 'dye', 'is', 'in', 'very', 'close', 'proximity', 'to', 'a', 'noble', 'metal', 'surface', 'with', 'nanoscale', 'features', 'Nanobarcodes', 'particles', 'The', 'SERS', 'signal', 'decreased', 'and', 'the', 'fluorescence', 'signal', 'increased', 'when', 'target', 'viral', 'RNA', 'was', 'captured', 'by', 'this', 'molecular', 'beacon', 'probe', 'In', 'addition', 'a', 'hepatitis', 'C', 'virus', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'HCV', 'RT', 'PCR', 'product', 'was', 'detected', 'using', 'this', 'dual', 'mode', 'beacon', 'The', 'development', 'of', 'a', 'multiplexed', 'label', 'free', 'assay', 'system', 'with', 'the', 'reassurance', 'offered', 'by', 'detection', 'of', 'two', 'distinctly', 'separate', 'signals', 'offers', 'significant', 'benefits', 'for', 'rapid', 'molecular', 'diagnostics', '']"
6369,Non-invasive lung disease diagnostics from exhaled microdroplets of lung fluid: perspectives and technical challenges,2018-01-01,J Breath Res,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099678/,"The combination of ultra-sensitive assay techniques and recent improvements in the instrumentation used to collect microdroplets of lung fluid (MLF) from exhaled breath has enabled the development of non-invasive lung disease diagnostics that are based on MLF analysis. In one example of this approach, electrospun nylon filters were used to collect MLFs from patients with pulmonary tuberculosis. The filters were washed to obtain liquid probes, which were then tested for human immunoglobulin A (h-IgA) and fractions of h-IgA specific to ESAT-6 and Psts-1, two antigens secreted by Mycobacterium tuberculosis. Probes collected for 10 min contained 100–1500 fg of h-IgA and, in patients with pulmonary tuberculosis, a portion of these h-IgA molecules showed specificity to the secreted antigens. Separate MLFs and their dry residues were successfully collected using an electrostatic collector and impactor developed especially for this purpose. Visualization of MLF dry residues by atomic force microscopy made it possible to estimate the lipid content in each MLF and revealed mucin molecules in some MLFs. This exciting new approach will likely make it possible to detect biomarkers in individual MLFs. MLFs emerging from an infection site (‘hot’ microdroplets) are expected to be enriched with infection biomarkers. This paper discusses possible experimental approaches to detecting biomarkers in single MLFs, as well as certain technological problems that need to be resolved in order to develop new non-invasive diagnostics based on analysing biomarkers in separate MLFs.",10.1088/1752-7163/aa88e4,n6jsx47v,"['The', 'combination', 'of', 'ultra', 'sensitive', 'assay', 'techniques', 'and', 'recent', 'improvements', 'in', 'the', 'instrumentation', 'used', 'to', 'collect', 'microdroplets', 'of', 'lung', 'fluid', 'MLF', 'from', 'exhaled', 'breath', 'has', 'enabled', 'the', 'development', 'of', 'non', 'invasive', 'lung', 'disease', 'diagnostics', 'that', 'are', 'based', 'on', 'MLF', 'analysis', 'In', 'one', 'example', 'of', 'this', 'approach', 'electrospun', 'nylon', 'filters', 'were', 'used', 'to', 'collect', 'MLFs', 'from', 'patients', 'with', 'pulmonary', 'tuberculosis', 'The', 'filters', 'were', 'washed', 'to', 'obtain', 'liquid', 'probes', 'which', 'were', 'then', 'tested', 'for', 'human', 'immunoglobulin', 'A', 'h', 'IgA', 'and', 'fractions', 'of', 'h', 'IgA', 'specific', 'to', 'ESAT', '6', 'and', 'Psts', '1', 'two', 'antigens', 'secreted', 'by', 'Mycobacterium', 'tuberculosis', 'Probes', 'collected', 'for', '10', 'min', 'contained', '100', '1500', 'fg', 'of', 'h', 'IgA', 'and', 'in', 'patients', 'with', 'pulmonary', 'tuberculosis', 'a', 'portion', 'of', 'these', 'h', 'IgA', 'molecules', 'showed', 'specificity', 'to', 'the', 'secreted', 'antigens', 'Separate', 'MLFs', 'and', 'their', 'dry', 'residues', 'were', 'successfully', 'collected', 'using', 'an', 'electrostatic', 'collector', 'and', 'impactor', 'developed', 'especially', 'for', 'this', 'purpose', 'Visualization', 'of', 'MLF', 'dry', 'residues', 'by', 'atomic', 'force', 'microscopy', 'made', 'it', 'possible', 'to', 'estimate', 'the', 'lipid', 'content', 'in', 'each', 'MLF', 'and', 'revealed', 'mucin', 'molecules', 'in', 'some', 'MLFs', 'This', 'exciting', 'new', 'approach', 'will', 'likely', 'make', 'it', 'possible', 'to', 'detect', 'biomarkers', 'in', 'individual', 'MLFs', 'MLFs', 'emerging', 'from', 'an', 'infection', 'site', 'hot', 'microdroplets', 'are', 'expected', 'to', 'be', 'enriched', 'with', 'infection', 'biomarkers', 'This', 'paper', 'discusses', 'possible', 'experimental', 'approaches', 'to', 'detecting', 'biomarkers', 'in', 'single', 'MLFs', 'as', 'well', 'as', 'certain', 'technological', 'problems', 'that', 'need', 'to', 'be', 'resolved', 'in', 'order', 'to', 'develop', 'new', 'non', 'invasive', 'diagnostics', 'based', 'on', 'analysing', 'biomarkers', 'in', 'separate', 'MLFs', '']"
7020,Endemic Mycoses: What’s New About Old Diseases?,2016-03-18,Curr Clin Microbiol Rep,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102464/,"Infections with geographically constrained dimorphic fungi cause the endemic mycoses, which include blastomycosis, coccidioidomycosis, emmonsiosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and penicilliosis. In the last 5 years, our understanding of the epidemiology, diagnostics, and to a lesser extent management of these diseases has advanced. Specifically, the application of molecular techniques for genotyping fungal pathogens has resulted in the recognition of cryptic species within several genera, including Blastomyces, and Paracoccidioides; the reclassification of Penicillium marneffei, the agent of penicilliosis, to the genus Talaromyces; and the global emergence of dimorphic fungi of the genus Emmonsia, cause disease in immunocompromised persons. New and refined diagnostic tests are available based on the detection of circulating antigens and antibodies, mass spectrometry, and targeted gene amplification. In contrast, the development of new therapeutic options remains stalled, although isavuconazole may hold promise. Finally, advances have been made in the prospect of viable vaccines for preventing animal and human disease.",10.1007/s40588-016-0034-6,hrsk5l73,"['Infections', 'with', 'geographically', 'constrained', 'dimorphic', 'fungi', 'cause', 'the', 'endemic', 'mycoses', 'which', 'include', 'blastomycosis', 'coccidioidomycosis', 'emmonsiosis', 'histoplasmosis', 'paracoccidioidomycosis', 'sporotrichosis', 'and', 'penicilliosis', 'In', 'the', 'last', '5', 'years', 'our', 'understanding', 'of', 'the', 'epidemiology', 'diagnostics', 'and', 'to', 'a', 'lesser', 'extent', 'management', 'of', 'these', 'diseases', 'has', 'advanced', 'Specifically', 'the', 'application', 'of', 'molecular', 'techniques', 'for', 'genotyping', 'fungal', 'pathogens', 'has', 'resulted', 'in', 'the', 'recognition', 'of', 'cryptic', 'species', 'within', 'several', 'genera', 'including', 'Blastomyces', 'and', 'Paracoccidioides', 'the', 'reclassification', 'of', 'Penicillium', 'marneffei', 'the', 'agent', 'of', 'penicilliosis', 'to', 'the', 'genus', 'Talaromyces', 'and', 'the', 'global', 'emergence', 'of', 'dimorphic', 'fungi', 'of', 'the', 'genus', 'Emmonsia', 'cause', 'disease', 'in', 'immunocompromised', 'persons', 'New', 'and', 'refined', 'diagnostic', 'tests', 'are', 'available', 'based', 'on', 'the', 'detection', 'of', 'circulating', 'antigens', 'and', 'antibodies', 'mass', 'spectrometry', 'and', 'targeted', 'gene', 'amplification', 'In', 'contrast', 'the', 'development', 'of', 'new', 'therapeutic', 'options', 'remains', 'stalled', 'although', 'isavuconazole', 'may', 'hold', 'promise', 'Finally', 'advances', 'have', 'been', 'made', 'in', 'the', 'prospect', 'of', 'viable', 'vaccines', 'for', 'preventing', 'animal', 'and', 'human', 'disease', '']"
7462,A Recently Identified Rhinovirus Genotype Is Associated with Severe Respiratory-Tract Infection in Children in Germany,2007-12-15,J Infect Dis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109967/,"Acute respiratory infection is a significant cause of morbidity and mortality in children worldwide. Accurate identification of causative agents is critical to case management and to prioritization in vaccine development. Sensitive multiplex diagnostics provide us with an opportunity to investigate the relative contributions of individual agents andmayalso facilitate the discovery of new pathogens. Recently, application of MassTag polymerase chain reaction (PCR) to undiagnosed infuenza-like illness in New York State led to the discovery of a novel rhinovirus genotype. Here we report the investigation, by MassTag PCR, of pediatric respiratory-tract infections in Germany, studying 97 cases for which no pathogen was identified through routine laboratory evaluation. Respiratory viruses were identified in 49 cases (51%); of the 55 identified viruses, 41 (75%) were rhinoviruses. The novel genotype represented 73% of rhinoviruses and 55% of all identified viruses. Infections with the novel genotype were associated with upper-respiratory-tract symptoms but, more frequently, with bronchitis, bronchiolitis, and pneumonia.",10.1086/524312,hcpa8ej5,"['Acute', 'respiratory', 'infection', 'is', 'a', 'significant', 'cause', 'of', 'morbidity', 'and', 'mortality', 'in', 'children', 'worldwide', 'Accurate', 'identification', 'of', 'causative', 'agents', 'is', 'critical', 'to', 'case', 'management', 'and', 'to', 'prioritization', 'in', 'vaccine', 'development', 'Sensitive', 'multiplex', 'diagnostics', 'provide', 'us', 'with', 'an', 'opportunity', 'to', 'investigate', 'the', 'relative', 'contributions', 'of', 'individual', 'agents', 'andmayalso', 'facilitate', 'the', 'discovery', 'of', 'new', 'pathogens', 'Recently', 'application', 'of', 'MassTag', 'polymerase', 'chain', 'reaction', 'PCR', 'to', 'undiagnosed', 'infuenza', 'like', 'illness', 'in', 'New', 'York', 'State', 'led', 'to', 'the', 'discovery', 'of', 'a', 'novel', 'rhinovirus', 'genotype', 'Here', 'we', 'report', 'the', 'investigation', 'by', 'MassTag', 'PCR', 'of', 'pediatric', 'respiratory', 'tract', 'infections', 'in', 'Germany', 'studying', '97', 'cases', 'for', 'which', 'no', 'pathogen', 'was', 'identified', 'through', 'routine', 'laboratory', 'evaluation', 'Respiratory', 'viruses', 'were', 'identified', 'in', '49', 'cases', '51', 'of', 'the', '55', 'identified', 'viruses', '41', '75', 'were', 'rhinoviruses', 'The', 'novel', 'genotype', 'represented', '73', 'of', 'rhinoviruses', 'and', '55', 'of', 'all', 'identified', 'viruses', 'Infections', 'with', 'the', 'novel', 'genotype', 'were', 'associated', 'with', 'upper', 'respiratory', 'tract', 'symptoms', 'but', 'more', 'frequently', 'with', 'bronchitis', 'bronchiolitis', 'and', 'pneumonia', '']"
7657,Development and Evaluation of a One-Step Quantitative RT-PCR Assay for Detection of Lassa Virus,2019-06-03,J Virol Methods,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113850/,"Lassa fever is a severe viral hemorrhagic illness caused by Lassa virus. Based on estimates, the number of LASV infections ranges from 300,000 to 500,000 cases in endemic areas with a fatality rate of 1%. Development of fast and sensitive tools for the control and prevention of Lassa virus infection as well as for clinical diagnostics of Lassa fever are crucial. Here we reported development and evaluation of a one-step quantitative RT-qPCR assay for the Lassa virus detection – LASV-Fl. This assay is suitable for the detection of lineages I-IV of Lassa virus. The limit of detection of the assay ranged from 10(3) copies/ml to 10(5) copies/ml and has 96.4% diagnostic sensitivity, whereas analytical and diagnostic specificities both were 100%. Serum, whole blood and tissue are suitable for use with the assay. The assay contains all the necessary components to perform the analysis, including an armored positive control (ARC+) and an armored internal control (IC). The study was done during the mission of specialized anti-epidemic team of the Russian Federation (SAET) in the Republic of Guinea in 2015-2018. Based on sequencing data, LASV-specific assay was developed using synthetic MS2-phage-based armored RNA particles, RNA from Lassa virus strain Josiah, and further, evaluated in field conditions using samples from patients and Mastomys natalensis rodents.",10.1016/j.jviromet.2019.113674,iqwojhq2,"['Lassa', 'fever', 'is', 'a', 'severe', 'viral', 'hemorrhagic', 'illness', 'caused', 'by', 'Lassa', 'virus', 'Based', 'on', 'estimates', 'the', 'number', 'of', 'LASV', 'infections', 'ranges', 'from', '300', '000', 'to', '500', '000', 'cases', 'in', 'endemic', 'areas', 'with', 'a', 'fatality', 'rate', 'of', '1', 'Development', 'of', 'fast', 'and', 'sensitive', 'tools', 'for', 'the', 'control', 'and', 'prevention', 'of', 'Lassa', 'virus', 'infection', 'as', 'well', 'as', 'for', 'clinical', 'diagnostics', 'of', 'Lassa', 'fever', 'are', 'crucial', 'Here', 'we', 'reported', 'development', 'and', 'evaluation', 'of', 'a', 'one', 'step', 'quantitative', 'RT', 'qPCR', 'assay', 'for', 'the', 'Lassa', 'virus', 'detection', 'LASV', 'Fl', 'This', 'assay', 'is', 'suitable', 'for', 'the', 'detection', 'of', 'lineages', 'I', 'IV', 'of', 'Lassa', 'virus', 'The', 'limit', 'of', 'detection', 'of', 'the', 'assay', 'ranged', 'from', '10', '3', 'copies', 'ml', 'to', '10', '5', 'copies', 'ml', 'and', 'has', '96', '4', 'diagnostic', 'sensitivity', 'whereas', 'analytical', 'and', 'diagnostic', 'specificities', 'both', 'were', '100', 'Serum', 'whole', 'blood', 'and', 'tissue', 'are', 'suitable', 'for', 'use', 'with', 'the', 'assay', 'The', 'assay', 'contains', 'all', 'the', 'necessary', 'components', 'to', 'perform', 'the', 'analysis', 'including', 'an', 'armored', 'positive', 'control', 'ARC', 'and', 'an', 'armored', 'internal', 'control', 'IC', 'The', 'study', 'was', 'done', 'during', 'the', 'mission', 'of', 'specialized', 'anti', 'epidemic', 'team', 'of', 'the', 'Russian', 'Federation', 'SAET', 'in', 'the', 'Republic', 'of', 'Guinea', 'in', '2015', '2018', 'Based', 'on', 'sequencing', 'data', 'LASV', 'specific', 'assay', 'was', 'developed', 'using', 'synthetic', 'MS2', 'phage', 'based', 'armored', 'RNA', 'particles', 'RNA', 'from', 'Lassa', 'virus', 'strain', 'Josiah', 'and', 'further', 'evaluated', 'in', 'field', 'conditions', 'using', 'samples', 'from', 'patients', 'and', 'Mastomys', 'natalensis', 'rodents', '']"
8803,Application of monoclonal antibodies in animal production: A review,2003-10-02,Livest,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131807/,"The hybridoma technology for production of monoclonal antibodies circumvents many of the constraints associated with the use of conventional antisera, and consequently broadens the areas of application of antibodies in animal sciences. In the present review, the potential usefulness of monoclonal antibodies in animal production - with emphasis on reproduction - is discussed, including the inherent limitations of the current technology and the improvements that can be foreseen within the next few years. Because of their unique specificity and the fact that they can be produced in virtually unlimited quantities, monoclonal antibodies are an important tool in diagnostics. However, the use of these antibodies does not always guarantee absolute specificity, and the low affinity of many monoclonal antibodies will impose a number of limitations on their use. Monoclonal antibodies can also be used to optimize physiological processes such as growth and reproduction. For this, homologous antibodies will probably offer several advantages over their murine counterparts in terms of effectiveness for passive immunization. Some success has already been achieved in the development of monoclonal antibodies from livestock species. Finally, it is shown that monoclonal antibodies are becoming extremely powerful research tools.",10.1016/0301-6226(88)90032-2,ye0tvnnf,"['The', 'hybridoma', 'technology', 'for', 'production', 'of', 'monoclonal', 'antibodies', 'circumvents', 'many', 'of', 'the', 'constraints', 'associated', 'with', 'the', 'use', 'of', 'conventional', 'antisera', 'and', 'consequently', 'broadens', 'the', 'areas', 'of', 'application', 'of', 'antibodies', 'in', 'animal', 'sciences', 'In', 'the', 'present', 'review', 'the', 'potential', 'usefulness', 'of', 'monoclonal', 'antibodies', 'in', 'animal', 'production', 'with', 'emphasis', 'on', 'reproduction', 'is', 'discussed', 'including', 'the', 'inherent', 'limitations', 'of', 'the', 'current', 'technology', 'and', 'the', 'improvements', 'that', 'can', 'be', 'foreseen', 'within', 'the', 'next', 'few', 'years', 'Because', 'of', 'their', 'unique', 'specificity', 'and', 'the', 'fact', 'that', 'they', 'can', 'be', 'produced', 'in', 'virtually', 'unlimited', 'quantities', 'monoclonal', 'antibodies', 'are', 'an', 'important', 'tool', 'in', 'diagnostics', 'However', 'the', 'use', 'of', 'these', 'antibodies', 'does', 'not', 'always', 'guarantee', 'absolute', 'specificity', 'and', 'the', 'low', 'affinity', 'of', 'many', 'monoclonal', 'antibodies', 'will', 'impose', 'a', 'number', 'of', 'limitations', 'on', 'their', 'use', 'Monoclonal', 'antibodies', 'can', 'also', 'be', 'used', 'to', 'optimize', 'physiological', 'processes', 'such', 'as', 'growth', 'and', 'reproduction', 'For', 'this', 'homologous', 'antibodies', 'will', 'probably', 'offer', 'several', 'advantages', 'over', 'their', 'murine', 'counterparts', 'in', 'terms', 'of', 'effectiveness', 'for', 'passive', 'immunization', 'Some', 'success', 'has', 'already', 'been', 'achieved', 'in', 'the', 'development', 'of', 'monoclonal', 'antibodies', 'from', 'livestock', 'species', 'Finally', 'it', 'is', 'shown', 'that', 'monoclonal', 'antibodies', 'are', 'becoming', 'extremely', 'powerful', 'research', 'tools', '']"
9563,Real-time kinetics and high-resolution melt curves in single-molecule digital LAMP to differentiate and study specific and non-specific amplification,2020-04-17,Nucleic Acids Res,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144905/,"Isothermal amplification assays, such as loop-mediated isothermal amplification (LAMP), show great utility for the development of rapid diagnostics for infectious diseases because they have high sensitivity, pathogen-specificity and potential for implementation at the point of care. However, elimination of non-specific amplification remains a key challenge for the optimization of LAMP assays. Here, using chlamydia DNA as a clinically relevant target and high-throughput sequencing as an analytical tool, we investigate a potential mechanism of non-specific amplification. We then develop a real-time digital LAMP (dLAMP) with high-resolution melting temperature (HRM) analysis and use this single-molecule approach to analyze approximately 1.2 million amplification events. We show that single-molecule HRM provides insight into specific and non-specific amplification in LAMP that are difficult to deduce from bulk measurements. We use real-time dLAMP with HRM to evaluate differences between polymerase enzymes, the impact of assay parameters (e.g. time, rate or florescence intensity), and the effect background human DNA. By differentiating true and false positives, HRM enables determination of the optimal assay and analysis parameters that leads to the lowest limit of detection (LOD) in a digital isothermal amplification assay.",10.1093/nar/gkaa099,zt1o1bcz,"['Isothermal', 'amplification', 'assays', 'such', 'as', 'loop', 'mediated', 'isothermal', 'amplification', 'LAMP', 'show', 'great', 'utility', 'for', 'the', 'development', 'of', 'rapid', 'diagnostics', 'for', 'infectious', 'diseases', 'because', 'they', 'have', 'high', 'sensitivity', 'pathogen', 'specificity', 'and', 'potential', 'for', 'implementation', 'at', 'the', 'point', 'of', 'care', 'However', 'elimination', 'of', 'non', 'specific', 'amplification', 'remains', 'a', 'key', 'challenge', 'for', 'the', 'optimization', 'of', 'LAMP', 'assays', 'Here', 'using', 'chlamydia', 'DNA', 'as', 'a', 'clinically', 'relevant', 'target', 'and', 'high', 'throughput', 'sequencing', 'as', 'an', 'analytical', 'tool', 'we', 'investigate', 'a', 'potential', 'mechanism', 'of', 'non', 'specific', 'amplification', 'We', 'then', 'develop', 'a', 'real', 'time', 'digital', 'LAMP', 'dLAMP', 'with', 'high', 'resolution', 'melting', 'temperature', 'HRM', 'analysis', 'and', 'use', 'this', 'single', 'molecule', 'approach', 'to', 'analyze', 'approximately', '1', '2', 'million', 'amplification', 'events', 'We', 'show', 'that', 'single', 'molecule', 'HRM', 'provides', 'insight', 'into', 'specific', 'and', 'non', 'specific', 'amplification', 'in', 'LAMP', 'that', 'are', 'difficult', 'to', 'deduce', 'from', 'bulk', 'measurements', 'We', 'use', 'real', 'time', 'dLAMP', 'with', 'HRM', 'to', 'evaluate', 'differences', 'between', 'polymerase', 'enzymes', 'the', 'impact', 'of', 'assay', 'parameters', 'e', 'g', 'time', 'rate', 'or', 'florescence', 'intensity', 'and', 'the', 'effect', 'background', 'human', 'DNA', 'By', 'differentiating', 'true', 'and', 'false', 'positives', 'HRM', 'enables', 'determination', 'of', 'the', 'optimal', 'assay', 'and', 'analysis', 'parameters', 'that', 'leads', 'to', 'the', 'lowest', 'limit', 'of', 'detection', 'LOD', 'in', 'a', 'digital', 'isothermal', 'amplification', 'assay', '']"
9967,"Late‐onset Pneumocystis jirovecii pneumonia post–fludarabine, cyclophosphamide and rituximab: implications for prophylaxis",2013-06-15,Eur J Haematol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163499/,"OBJECTIVE: Fludarabine, cyclophosphamide and rituximab (FCR) therapy for lymphoid malignancies has historically been associated with a low reported incidence of Pneumocystis jirovecii pneumonia (PJP). However, prophylaxis was routinely used in early studies, and molecular diagnostic tools were not employed. The objective of this study was to review the incidence of PJP during and post‐FCR in the era of highly sensitive molecular diagnostics and (18)F‐fluorodeoxyglucose (FDG) positron emission tomography (PET)–computerised tomography (CT). METHODS: All patients treated with standard FCR at the Peter MacCallum Cancer Centre (March 2009 to June 2012) were identified from a medications management database. Laboratory‐confirmed PJP cases during this time were identified from an electronic database. RESULTS: Overall, 66 patients were treated with a median of 5.5 FCR cycles. Eight PJP cases were identified, 6 of whom had received chemotherapy prior to FCR. In 5 cases, (18)F‐FDG PET demonstrated bilateral ground‐glass infiltrates. Median CD4(+) lymphocyte counts at time of PJP diagnosis and 9–12 months following FCR were 123 and 400 cells/μL, respectively. In patients receiving no prophylaxis, 9.1% developed PJP during FCR. The rate following FCR was 18.4%, with median onset at 6 months (2.4–24 months). CONCLUSION: Given the high rate of late‐onset PJP, consideration should be given for extended PJP prophylaxis for up to 12 months post‐FCR, particularly in pretreated patients. Further evaluation of the role of CD4(+) monitoring is warranted to quantify risk of disease development and to guide duration of prophylaxis.",10.1111/ejh.12135,000ajevz,"['OBJECTIVE', 'Fludarabine', 'cyclophosphamide', 'and', 'rituximab', 'FCR', 'therapy', 'for', 'lymphoid', 'malignancies', 'has', 'historically', 'been', 'associated', 'with', 'a', 'low', 'reported', 'incidence', 'of', 'Pneumocystis', 'jirovecii', 'pneumonia', 'PJP', 'However', 'prophylaxis', 'was', 'routinely', 'used', 'in', 'early', 'studies', 'and', 'molecular', 'diagnostic', 'tools', 'were', 'not', 'employed', 'The', 'objective', 'of', 'this', 'study', 'was', 'to', 'review', 'the', 'incidence', 'of', 'PJP', 'during', 'and', 'post', 'FCR', 'in', 'the', 'era', 'of', 'highly', 'sensitive', 'molecular', 'diagnostics', 'and', '18', 'F', 'fluorodeoxyglucose', 'FDG', 'positron', 'emission', 'tomography', 'PET', 'computerised', 'tomography', 'CT', 'METHODS', 'All', 'patients', 'treated', 'with', 'standard', 'FCR', 'at', 'the', 'Peter', 'MacCallum', 'Cancer', 'Centre', 'March', '2009', 'to', 'June', '2012', 'were', 'identified', 'from', 'a', 'medications', 'management', 'database', 'Laboratory', 'confirmed', 'PJP', 'cases', 'during', 'this', 'time', 'were', 'identified', 'from', 'an', 'electronic', 'database', 'RESULTS', 'Overall', '66', 'patients', 'were', 'treated', 'with', 'a', 'median', 'of', '5', '5', 'FCR', 'cycles', 'Eight', 'PJP', 'cases', 'were', 'identified', '6', 'of', 'whom', 'had', 'received', 'chemotherapy', 'prior', 'to', 'FCR', 'In', '5', 'cases', '18', 'F', 'FDG', 'PET', 'demonstrated', 'bilateral', 'ground', 'glass', 'infiltrates', 'Median', 'CD4', 'lymphocyte', 'counts', 'at', 'time', 'of', 'PJP', 'diagnosis', 'and', '9', '12', 'months', 'following', 'FCR', 'were', '123', 'and', '400', 'cells', 'μL', 'respectively', 'In', 'patients', 'receiving', 'no', 'prophylaxis', '9', '1', 'developed', 'PJP', 'during', 'FCR', 'The', 'rate', 'following', 'FCR', 'was', '18', '4', 'with', 'median', 'onset', 'at', '6', 'months', '2', '4', '24', 'months', 'CONCLUSION', 'Given', 'the', 'high', 'rate', 'of', 'late', 'onset', 'PJP', 'consideration', 'should', 'be', 'given', 'for', 'extended', 'PJP', 'prophylaxis', 'for', 'up', 'to', '12', 'months', 'post', 'FCR', 'particularly', 'in', 'pretreated', 'patients', 'Further', 'evaluation', 'of', 'the', 'role', 'of', 'CD4', 'monitoring', 'is', 'warranted', 'to', 'quantify', 'risk', 'of', 'disease', 'development', 'and', 'to', 'guide', 'duration', 'of', 'prophylaxis', '']"
10034,Medical Devices for Low- and Middle-Income Countries: A Review and Directions for Development,2020-03-01,J Med Device,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164506/,"The development of diagnostics and medical devices has historically been concentrated in high-income countries, despite a significant need to expand healthcare services to low- and middle-income countries (LMIC). Poor quality healthcare extends beyond LMIC to underserved communities in developed countries. This paper reviews diseases and conditions that have not received much attention in the past despite imposing a significant burden on healthcare systems in these circumstances. We review the underlying mechanism of action of these conditions and current technology in use for diagnosis or surgical intervention. We aim to identify areas for technological development and review policy considerations that will enable real-world adoption. Specifically, this review focuses on diseases prevalent in sub-Saharan Africa and south Asia: melioidosis, infant and maternal mortality, schistosomiasis, and heavy metal and pesticide poisoning. Our aim with this review is to identify problems facing the world that require the attention of the medical device community and provide recommendations for research directions for groups interested in this field.",10.1115/1.4045910,v20r44lr,"['The', 'development', 'of', 'diagnostics', 'and', 'medical', 'devices', 'has', 'historically', 'been', 'concentrated', 'in', 'high', 'income', 'countries', 'despite', 'a', 'significant', 'need', 'to', 'expand', 'healthcare', 'services', 'to', 'low', 'and', 'middle', 'income', 'countries', 'LMIC', 'Poor', 'quality', 'healthcare', 'extends', 'beyond', 'LMIC', 'to', 'underserved', 'communities', 'in', 'developed', 'countries', 'This', 'paper', 'reviews', 'diseases', 'and', 'conditions', 'that', 'have', 'not', 'received', 'much', 'attention', 'in', 'the', 'past', 'despite', 'imposing', 'a', 'significant', 'burden', 'on', 'healthcare', 'systems', 'in', 'these', 'circumstances', 'We', 'review', 'the', 'underlying', 'mechanism', 'of', 'action', 'of', 'these', 'conditions', 'and', 'current', 'technology', 'in', 'use', 'for', 'diagnosis', 'or', 'surgical', 'intervention', 'We', 'aim', 'to', 'identify', 'areas', 'for', 'technological', 'development', 'and', 'review', 'policy', 'considerations', 'that', 'will', 'enable', 'real', 'world', 'adoption', 'Specifically', 'this', 'review', 'focuses', 'on', 'diseases', 'prevalent', 'in', 'sub', 'Saharan', 'Africa', 'and', 'south', 'Asia', 'melioidosis', 'infant', 'and', 'maternal', 'mortality', 'schistosomiasis', 'and', 'heavy', 'metal', 'and', 'pesticide', 'poisoning', 'Our', 'aim', 'with', 'this', 'review', 'is', 'to', 'identify', 'problems', 'facing', 'the', 'world', 'that', 'require', 'the', 'attention', 'of', 'the', 'medical', 'device', 'community', 'and', 'provide', 'recommendations', 'for', 'research', 'directions', 'for', 'groups', 'interested', 'in', 'this', 'field', '']"
10037,Diagnostics as the Key to Advances in Global Health: Proposed Methods for Making Reliable Diagnostics Widely Available,2020-03-01,J Med Device,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164509/,"This paper proposes a structure and method for the development of an AI diagnostic system as a highly leveraged step toward improvements in delivery of healthcare in underserved regions. First, the paper provides a high-level, general review of the current efforts to provide healthcare services in underserved areas and the many efforts being made to impact health outcomes by various international, governmental, and NGO entities. We also very briefly review university programs and research institutions that have specific technical and institutional assets with significant potential to carry out research or to partially implement such a plan. Our review uses weighted values in a decision-system that takes in a variety of assets we consider fundamental to successful engagement in delivery of new, innovative, technology-enabled healthcare systems for under-resourced settings. We then review nine factors that hinder the advancement in healthcare in under-resourced settings, some of which are well described in current literature and some that may bring new perspectives. The paper then attempts to review how a proposed system can manage to operate successfully within the context of the nine named hindrance factors. The primary focus of the paper is in the description of a system which can increase the availability of diagnostics through technology-enabled systems. Such a system would impact the outcomes of persons in underserved regions. The paper then describes why making diagnostics available is a critical priority among efforts for improvements in global health.",10.1115/1.4046046,1amynkqd,"['This', 'paper', 'proposes', 'a', 'structure', 'and', 'method', 'for', 'the', 'development', 'of', 'an', 'AI', 'diagnostic', 'system', 'as', 'a', 'highly', 'leveraged', 'step', 'toward', 'improvements', 'in', 'delivery', 'of', 'healthcare', 'in', 'underserved', 'regions', 'First', 'the', 'paper', 'provides', 'a', 'high', 'level', 'general', 'review', 'of', 'the', 'current', 'efforts', 'to', 'provide', 'healthcare', 'services', 'in', 'underserved', 'areas', 'and', 'the', 'many', 'efforts', 'being', 'made', 'to', 'impact', 'health', 'outcomes', 'by', 'various', 'international', 'governmental', 'and', 'NGO', 'entities', 'We', 'also', 'very', 'briefly', 'review', 'university', 'programs', 'and', 'research', 'institutions', 'that', 'have', 'specific', 'technical', 'and', 'institutional', 'assets', 'with', 'significant', 'potential', 'to', 'carry', 'out', 'research', 'or', 'to', 'partially', 'implement', 'such', 'a', 'plan', 'Our', 'review', 'uses', 'weighted', 'values', 'in', 'a', 'decision', 'system', 'that', 'takes', 'in', 'a', 'variety', 'of', 'assets', 'we', 'consider', 'fundamental', 'to', 'successful', 'engagement', 'in', 'delivery', 'of', 'new', 'innovative', 'technology', 'enabled', 'healthcare', 'systems', 'for', 'under', 'resourced', 'settings', 'We', 'then', 'review', 'nine', 'factors', 'that', 'hinder', 'the', 'advancement', 'in', 'healthcare', 'in', 'under', 'resourced', 'settings', 'some', 'of', 'which', 'are', 'well', 'described', 'in', 'current', 'literature', 'and', 'some', 'that', 'may', 'bring', 'new', 'perspectives', 'The', 'paper', 'then', 'attempts', 'to', 'review', 'how', 'a', 'proposed', 'system', 'can', 'manage', 'to', 'operate', 'successfully', 'within', 'the', 'context', 'of', 'the', 'nine', 'named', 'hindrance', 'factors', 'The', 'primary', 'focus', 'of', 'the', 'paper', 'is', 'in', 'the', 'description', 'of', 'a', 'system', 'which', 'can', 'increase', 'the', 'availability', 'of', 'diagnostics', 'through', 'technology', 'enabled', 'systems', 'Such', 'a', 'system', 'would', 'impact', 'the', 'outcomes', 'of', 'persons', 'in', 'underserved', 'regions', 'The', 'paper', 'then', 'describes', 'why', 'making', 'diagnostics', 'available', 'is', 'a', 'critical', 'priority', 'among', 'efforts', 'for', 'improvements', 'in', 'global', 'health', '']"
10422,Parainfluenza Virus Infection,2016-08-31,Semin Respir Crit Care Med,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171724/,"Human parainfluenza viruses (HPIVs) are single-stranded, enveloped RNA viruses of the Paramyoviridaie family. There are four serotypes which cause respiratory illnesses in children and adults. HPIVs bind and replicate in the ciliated epithelial cells of the upper and lower respiratory tract and the extent of the infection correlates with the location involved. Seasonal HPIV epidemics result in a significant burden of disease in children and account for 40% of pediatric hospitalizations for lower respiratory tract illnesses (LRTIs) and 75% of croup cases. Parainfluenza viruses are associated with a wide spectrum of illnesses which include otitis media, pharyngitis, conjunctivitis, croup, tracheobronchitis, and pneumonia. Uncommon respiratory manifestations include apnea, bradycardia, parotitis, and respiratory distress syndrome and rarely disseminated infection. Immunity resulting from disease in childhood is incomplete and reinfection with HPIV accounts for 15% of respiratory illnesses in adults. Severe disease and fatal pneumonia may occur in elderly and immunocompromised adults. HPIV pneumonia in recipients of hematopoietic stem cell transplant (HSCT) is associated with 50% acute mortality and 75% mortality at 6 months. Though sensitive molecular diagnostics are available to rapidly diagnose HPIV infection, effective antiviral therapies are not available. Currently, treatment for HPIV infection is supportive with the exception of croup where the use of corticosteroids has been found to be beneficial. Several novel drugs including DAS181 appear promising in efforts to treat severe disease in immunocompromised patients, and vaccines to decrease the burden of disease in young children are in development.",10.1055/s-0036-1584798,f6mpdo1o,"['Human', 'parainfluenza', 'viruses', 'HPIVs', 'are', 'single', 'stranded', 'enveloped', 'RNA', 'viruses', 'of', 'the', 'Paramyoviridaie', 'family', 'There', 'are', 'four', 'serotypes', 'which', 'cause', 'respiratory', 'illnesses', 'in', 'children', 'and', 'adults', 'HPIVs', 'bind', 'and', 'replicate', 'in', 'the', 'ciliated', 'epithelial', 'cells', 'of', 'the', 'upper', 'and', 'lower', 'respiratory', 'tract', 'and', 'the', 'extent', 'of', 'the', 'infection', 'correlates', 'with', 'the', 'location', 'involved', 'Seasonal', 'HPIV', 'epidemics', 'result', 'in', 'a', 'significant', 'burden', 'of', 'disease', 'in', 'children', 'and', 'account', 'for', '40', 'of', 'pediatric', 'hospitalizations', 'for', 'lower', 'respiratory', 'tract', 'illnesses', 'LRTIs', 'and', '75', 'of', 'croup', 'cases', 'Parainfluenza', 'viruses', 'are', 'associated', 'with', 'a', 'wide', 'spectrum', 'of', 'illnesses', 'which', 'include', 'otitis', 'media', 'pharyngitis', 'conjunctivitis', 'croup', 'tracheobronchitis', 'and', 'pneumonia', 'Uncommon', 'respiratory', 'manifestations', 'include', 'apnea', 'bradycardia', 'parotitis', 'and', 'respiratory', 'distress', 'syndrome', 'and', 'rarely', 'disseminated', 'infection', 'Immunity', 'resulting', 'from', 'disease', 'in', 'childhood', 'is', 'incomplete', 'and', 'reinfection', 'with', 'HPIV', 'accounts', 'for', '15', 'of', 'respiratory', 'illnesses', 'in', 'adults', 'Severe', 'disease', 'and', 'fatal', 'pneumonia', 'may', 'occur', 'in', 'elderly', 'and', 'immunocompromised', 'adults', 'HPIV', 'pneumonia', 'in', 'recipients', 'of', 'hematopoietic', 'stem', 'cell', 'transplant', 'HSCT', 'is', 'associated', 'with', '50', 'acute', 'mortality', 'and', '75', 'mortality', 'at', '6', 'months', 'Though', 'sensitive', 'molecular', 'diagnostics', 'are', 'available', 'to', 'rapidly', 'diagnose', 'HPIV', 'infection', 'effective', 'antiviral', 'therapies', 'are', 'not', 'available', 'Currently', 'treatment', 'for', 'HPIV', 'infection', 'is', 'supportive', 'with', 'the', 'exception', 'of', 'croup', 'where', 'the', 'use', 'of', 'corticosteroids', 'has', 'been', 'found', 'to', 'be', 'beneficial', 'Several', 'novel', 'drugs', 'including', 'DAS181', 'appear', 'promising', 'in', 'efforts', 'to', 'treat', 'severe', 'disease', 'in', 'immunocompromised', 'patients', 'and', 'vaccines', 'to', 'decrease', 'the', 'burden', 'of', 'disease', 'in', 'young', 'children', 'are', 'in', 'development', '']"
10786,Point-of-Care Technologies for Health Care,2011-03-10,IEEE Trans Biomed Eng,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192160/,"The increasingly global focus on health care issues continues to underline the importance of point-of-care technologies and their ability to provide cost-effective solutions that address many unmet health care needs. Further, the current crisis in health care costs has critically underscored the need for research and development into highly effective, but low cost means of delivering health care. With a focus on providing clinically actionable information at or near the patient, point-of-care devices provide clinicians with information that is critical to the management of patient care while they are still with the patient. Rapid information results in various advantages for POC testing in different kinds of health care settings. In primary care settings in developed countries, the shortened timeline between testing and availability of results reduces the need for extra office visits or follow-up phone calls to convey testing results and adjust clinical intervention. This strategy can reduce cost and increase access of otherwise underserved populations to medical care. For diseases that are infectious, such as sexually transmitted infections or respiratory diseases, POC testing can facilitate treatment modalities quickly, thus preventing further spread of the infection for better and timely clinical management. In acute care settings, timely access to diagnostic information is most critical for providing an effective medical response. In disaster settings, POC diagnostics can speed triage and enable rapid establishment and delivery of medical services.",10.1109/tbme.2011.2109251,c5j0cd3u,"['The', 'increasingly', 'global', 'focus', 'on', 'health', 'care', 'issues', 'continues', 'to', 'underline', 'the', 'importance', 'of', 'point', 'of', 'care', 'technologies', 'and', 'their', 'ability', 'to', 'provide', 'cost', 'effective', 'solutions', 'that', 'address', 'many', 'unmet', 'health', 'care', 'needs', 'Further', 'the', 'current', 'crisis', 'in', 'health', 'care', 'costs', 'has', 'critically', 'underscored', 'the', 'need', 'for', 'research', 'and', 'development', 'into', 'highly', 'effective', 'but', 'low', 'cost', 'means', 'of', 'delivering', 'health', 'care', 'With', 'a', 'focus', 'on', 'providing', 'clinically', 'actionable', 'information', 'at', 'or', 'near', 'the', 'patient', 'point', 'of', 'care', 'devices', 'provide', 'clinicians', 'with', 'information', 'that', 'is', 'critical', 'to', 'the', 'management', 'of', 'patient', 'care', 'while', 'they', 'are', 'still', 'with', 'the', 'patient', 'Rapid', 'information', 'results', 'in', 'various', 'advantages', 'for', 'POC', 'testing', 'in', 'different', 'kinds', 'of', 'health', 'care', 'settings', 'In', 'primary', 'care', 'settings', 'in', 'developed', 'countries', 'the', 'shortened', 'timeline', 'between', 'testing', 'and', 'availability', 'of', 'results', 'reduces', 'the', 'need', 'for', 'extra', 'office', 'visits', 'or', 'follow', 'up', 'phone', 'calls', 'to', 'convey', 'testing', 'results', 'and', 'adjust', 'clinical', 'intervention', 'This', 'strategy', 'can', 'reduce', 'cost', 'and', 'increase', 'access', 'of', 'otherwise', 'underserved', 'populations', 'to', 'medical', 'care', 'For', 'diseases', 'that', 'are', 'infectious', 'such', 'as', 'sexually', 'transmitted', 'infections', 'or', 'respiratory', 'diseases', 'POC', 'testing', 'can', 'facilitate', 'treatment', 'modalities', 'quickly', 'thus', 'preventing', 'further', 'spread', 'of', 'the', 'infection', 'for', 'better', 'and', 'timely', 'clinical', 'management', 'In', 'acute', 'care', 'settings', 'timely', 'access', 'to', 'diagnostic', 'information', 'is', 'most', 'critical', 'for', 'providing', 'an', 'effective', 'medical', 'response', 'In', 'disaster', 'settings', 'POC', 'diagnostics', 'can', 'speed', 'triage', 'and', 'enable', 'rapid', 'establishment', 'and', 'delivery', 'of', 'medical', 'services', '']"
11088,Pulmonary non-tuberculous mycobacterial infections: current state and future management,2019-12-18,Eur J Clin Microbiol Infect Dis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222044/,"Currently, there is a trend of increasing incidence in pulmonary non-tuberculous mycobacterial infections (PNTM) together with a decrease in tuberculosis (TB) incidence, particularly in developed countries. The prevalence of PNTM in underdeveloped and developing countries remains unclear as there is still a lack of detection methods that could clearly diagnose PNTM applicable in these low-resource settings. Since non-tuberculous mycobacteria (NTM) are environmental pathogens, the vicinity favouring host-pathogen interactions is known as important predisposing factor for PNTM. The ongoing changes in world population, as well as socio-political and economic factors, are linked to the rise in the incidence of PNTM. Development is an important factor for the improvement of population well-being, but it has also been linked, in general, to detrimental environmental consequences, including the rise of emergent (usually neglected) infectious diseases, such as PNTM. The rise of neglected PNTM infections requires the expansion of the current efforts on the development of diagnostics, therapies and vaccines for mycobacterial diseases, which at present, are mainly focused on TB. This review discuss the current situation of PNTM and its predisposing factors, as well as the efforts and challenges for their control.",10.1007/s10096-019-03771-0,yh4pe5t3,"['Currently', 'there', 'is', 'a', 'trend', 'of', 'increasing', 'incidence', 'in', 'pulmonary', 'non', 'tuberculous', 'mycobacterial', 'infections', 'PNTM', 'together', 'with', 'a', 'decrease', 'in', 'tuberculosis', 'TB', 'incidence', 'particularly', 'in', 'developed', 'countries', 'The', 'prevalence', 'of', 'PNTM', 'in', 'underdeveloped', 'and', 'developing', 'countries', 'remains', 'unclear', 'as', 'there', 'is', 'still', 'a', 'lack', 'of', 'detection', 'methods', 'that', 'could', 'clearly', 'diagnose', 'PNTM', 'applicable', 'in', 'these', 'low', 'resource', 'settings', 'Since', 'non', 'tuberculous', 'mycobacteria', 'NTM', 'are', 'environmental', 'pathogens', 'the', 'vicinity', 'favouring', 'host', 'pathogen', 'interactions', 'is', 'known', 'as', 'important', 'predisposing', 'factor', 'for', 'PNTM', 'The', 'ongoing', 'changes', 'in', 'world', 'population', 'as', 'well', 'as', 'socio', 'political', 'and', 'economic', 'factors', 'are', 'linked', 'to', 'the', 'rise', 'in', 'the', 'incidence', 'of', 'PNTM', 'Development', 'is', 'an', 'important', 'factor', 'for', 'the', 'improvement', 'of', 'population', 'well', 'being', 'but', 'it', 'has', 'also', 'been', 'linked', 'in', 'general', 'to', 'detrimental', 'environmental', 'consequences', 'including', 'the', 'rise', 'of', 'emergent', 'usually', 'neglected', 'infectious', 'diseases', 'such', 'as', 'PNTM', 'The', 'rise', 'of', 'neglected', 'PNTM', 'infections', 'requires', 'the', 'expansion', 'of', 'the', 'current', 'efforts', 'on', 'the', 'development', 'of', 'diagnostics', 'therapies', 'and', 'vaccines', 'for', 'mycobacterial', 'diseases', 'which', 'at', 'present', 'are', 'mainly', 'focused', 'on', 'TB', 'This', 'review', 'discuss', 'the', 'current', 'situation', 'of', 'PNTM', 'and', 'its', 'predisposing', 'factors', 'as', 'well', 'as', 'the', 'efforts', 'and', 'challenges', 'for', 'their', 'control', '']"
11096,Neue Impfstoffe gegen Tuberkulose,2019-11-29,Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222064/,"With about 10 million active disease cases and 1.5 million deaths in 2018, tuberculosis (TB) remains one of the most threatening infectious diseases. Yet, the World Health Organization (WHO) aims to reduce morbidity and mortality by 90 and 95%, respectively, between 2015 and 2035. Although diagnostics, therapeutics, and a vaccine are available, it is beyond doubt that better intervention measures are needed to accomplish this ambitious goal. The vaccine bacille Calmette-Guérin (BCG) partially protects infants against TB, but it is virtually ineffective against pulmonary TB in adolescents and adults. The efficacy of this vaccine, however, has not yet been fully exploited. In addition, new vaccine candidates are currently being assessed in clinical trials. Because a quarter of all people are latently infected with Mycobacterium tuberculosis (Mtb), new vaccines must be applied not only prior to infection (pre-exposure vaccination) but also after infection (postexposure vaccination). Prevention of infection, prevention of disease, and prevention of recurrence are currently assessed as clinical endpoints. Because protection against TB is primarily mediated by T lymphocytes, TB vaccine development focuses on protective T cell responses. Protein adjuvant formulations, viral vectors, and killed and live bacterial vaccines are currently being assessed in clinical trials. Moreover, therapeutic vaccination is clinically tested, notably in adjunct to canonical drug therapy to multiresistant TB. It is likely that a single vaccine cannot accomplish the various indications and that different vaccination strategies are required.",10.1007/s00103-019-03065-y,bgehvxo7,"['With', 'about', '10', 'million', 'active', 'disease', 'cases', 'and', '1', '5', 'million', 'deaths', 'in', '2018', 'tuberculosis', 'TB', 'remains', 'one', 'of', 'the', 'most', 'threatening', 'infectious', 'diseases', 'Yet', 'the', 'World', 'Health', 'Organization', 'WHO', 'aims', 'to', 'reduce', 'morbidity', 'and', 'mortality', 'by', '90', 'and', '95', 'respectively', 'between', '2015', 'and', '2035', 'Although', 'diagnostics', 'therapeutics', 'and', 'a', 'vaccine', 'are', 'available', 'it', 'is', 'beyond', 'doubt', 'that', 'better', 'intervention', 'measures', 'are', 'needed', 'to', 'accomplish', 'this', 'ambitious', 'goal', 'The', 'vaccine', 'bacille', 'Calmette', 'Guérin', 'BCG', 'partially', 'protects', 'infants', 'against', 'TB', 'but', 'it', 'is', 'virtually', 'ineffective', 'against', 'pulmonary', 'TB', 'in', 'adolescents', 'and', 'adults', 'The', 'efficacy', 'of', 'this', 'vaccine', 'however', 'has', 'not', 'yet', 'been', 'fully', 'exploited', 'In', 'addition', 'new', 'vaccine', 'candidates', 'are', 'currently', 'being', 'assessed', 'in', 'clinical', 'trials', 'Because', 'a', 'quarter', 'of', 'all', 'people', 'are', 'latently', 'infected', 'with', 'Mycobacterium', 'tuberculosis', 'Mtb', 'new', 'vaccines', 'must', 'be', 'applied', 'not', 'only', 'prior', 'to', 'infection', 'pre', 'exposure', 'vaccination', 'but', 'also', 'after', 'infection', 'postexposure', 'vaccination', 'Prevention', 'of', 'infection', 'prevention', 'of', 'disease', 'and', 'prevention', 'of', 'recurrence', 'are', 'currently', 'assessed', 'as', 'clinical', 'endpoints', 'Because', 'protection', 'against', 'TB', 'is', 'primarily', 'mediated', 'by', 'T', 'lymphocytes', 'TB', 'vaccine', 'development', 'focuses', 'on', 'protective', 'T', 'cell', 'responses', 'Protein', 'adjuvant', 'formulations', 'viral', 'vectors', 'and', 'killed', 'and', 'live', 'bacterial', 'vaccines', 'are', 'currently', 'being', 'assessed', 'in', 'clinical', 'trials', 'Moreover', 'therapeutic', 'vaccination', 'is', 'clinically', 'tested', 'notably', 'in', 'adjunct', 'to', 'canonical', 'drug', 'therapy', 'to', 'multiresistant', 'TB', 'It', 'is', 'likely', 'that', 'a', 'single', 'vaccine', 'cannot', 'accomplish', 'the', 'various', 'indications', 'and', 'that', 'different', 'vaccination', 'strategies', 'are', 'required', '']"
11173,Molecular Modelling and Insilico Engineering of PapMV-CP Towards Display and Development of Capripox Viral Like Particles Based on Immunogenic P32 Envelop Protein is the Homologous of the Vaccinia-Viral H3L Gene: An Insilico Approach,2020-01-06,Int J Pept Res Ther,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222904/,"Viral-like particles are assembled from capsid protein structural subunits of different viruses and have ability to establish research in biomedicals, like construction of novel safety vaccines, gene therapy vectors by delivering systems for nucleic acids, small biomolecules and diagnostics. Papaya Mosaic Viral nanoparticals can provide as a vaccine candidate helps to increase the immunity by fusing the epitope based peptide antigen. Capripox viruses are the genus comprises Lymphy skin-disease, Sheep and Goat pox Viruses are notified by The World Animal Health Organization (OIE) based on their economic impotence act as a transboundary animal diseases viruses of sheep, goat, and cattle’s respectively. Plant viral based innovative vaccines have been emerged ineffective vaccine development. This research describes the engineering and development of a new vaccine candidate by display immunogenic peptide using the carrier capsid protein of Papaya Mosaic Virus. The Capripox virus P32 immunogenic protein is homologous of the vaccinia virus H3L gene displayed PapMV CP. The antigenicity of P32 protein epitope lowest score among epitopes C-terminally docked epitopes are EP6 > EP3 > EP8 as well the lowest score among epitopes N-terminally docked epitopes are EP8 > EP3 > EP6 presented on the N-terminus of PMV CP region which are found to be suitable for epitope display. And these modelled immunogenic peptide could be used to develop a viral like particles. Epitope based Antibody developed against immunogenic epitopic regions can contribute to a novel and robust protection from infection. As well might be used for developing cost effective detection kits for Transboundary animal disease viruses.",10.1007/s10989-019-10007-4,zqvv0ecj,"['Viral', 'like', 'particles', 'are', 'assembled', 'from', 'capsid', 'protein', 'structural', 'subunits', 'of', 'different', 'viruses', 'and', 'have', 'ability', 'to', 'establish', 'research', 'in', 'biomedicals', 'like', 'construction', 'of', 'novel', 'safety', 'vaccines', 'gene', 'therapy', 'vectors', 'by', 'delivering', 'systems', 'for', 'nucleic', 'acids', 'small', 'biomolecules', 'and', 'diagnostics', 'Papaya', 'Mosaic', 'Viral', 'nanoparticals', 'can', 'provide', 'as', 'a', 'vaccine', 'candidate', 'helps', 'to', 'increase', 'the', 'immunity', 'by', 'fusing', 'the', 'epitope', 'based', 'peptide', 'antigen', 'Capripox', 'viruses', 'are', 'the', 'genus', 'comprises', 'Lymphy', 'skin', 'disease', 'Sheep', 'and', 'Goat', 'pox', 'Viruses', 'are', 'notified', 'by', 'The', 'World', 'Animal', 'Health', 'Organization', 'OIE', 'based', 'on', 'their', 'economic', 'impotence', 'act', 'as', 'a', 'transboundary', 'animal', 'diseases', 'viruses', 'of', 'sheep', 'goat', 'and', 'cattle', 's', 'respectively', 'Plant', 'viral', 'based', 'innovative', 'vaccines', 'have', 'been', 'emerged', 'ineffective', 'vaccine', 'development', 'This', 'research', 'describes', 'the', 'engineering', 'and', 'development', 'of', 'a', 'new', 'vaccine', 'candidate', 'by', 'display', 'immunogenic', 'peptide', 'using', 'the', 'carrier', 'capsid', 'protein', 'of', 'Papaya', 'Mosaic', 'Virus', 'The', 'Capripox', 'virus', 'P32', 'immunogenic', 'protein', 'is', 'homologous', 'of', 'the', 'vaccinia', 'virus', 'H3L', 'gene', 'displayed', 'PapMV', 'CP', 'The', 'antigenicity', 'of', 'P32', 'protein', 'epitope', 'lowest', 'score', 'among', 'epitopes', 'C', 'terminally', 'docked', 'epitopes', 'are', 'EP6', 'EP3', 'EP8', 'as', 'well', 'the', 'lowest', 'score', 'among', 'epitopes', 'N', 'terminally', 'docked', 'epitopes', 'are', 'EP8', 'EP3', 'EP6', 'presented', 'on', 'the', 'N', 'terminus', 'of', 'PMV', 'CP', 'region', 'which', 'are', 'found', 'to', 'be', 'suitable', 'for', 'epitope', 'display', 'And', 'these', 'modelled', 'immunogenic', 'peptide', 'could', 'be', 'used', 'to', 'develop', 'a', 'viral', 'like', 'particles', 'Epitope', 'based', 'Antibody', 'developed', 'against', 'immunogenic', 'epitopic', 'regions', 'can', 'contribute', 'to', 'a', 'novel', 'and', 'robust', 'protection', 'from', 'infection', 'As', 'well', 'might', 'be', 'used', 'for', 'developing', 'cost', 'effective', 'detection', 'kits', 'for', 'Transboundary', 'animal', 'disease', 'viruses', '']"
11228,Treatment of Ebola-related critical illness,2020-02-13,Intensive Care Med,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223059/,"PURPOSE: To explore contemporary clincial case management of patients with Ebola virus disease. METHODS: A narrative review from a clinical perspective of clinical features, diagnostic tests, treatments and outcomes of patients with Ebola virus disease. RESULTS: Substantial advances have been made in the care of patients with Ebola virus disease (EVD), precipitated by the unprecedented extent of the 2014–2016 outbreak. There has been improved point-of-care diagnostics, improved characterization of the clinical course of EVD, improved patient-optimized standards of care, evaluation of effective anti-Ebola therapies, administration of effective vaccines, and development of innovative Ebola treatment units. A better understanding of the Ebola virus disease clinical syndrome has led to the appreciation of a central role for critical care clinicians—over 50% of patients have life-threatening complications, including hypotension, severe electrolyte imbalance, acute kidney injury, metabolic acidosis and respiratory failure. Accordingly, patients often require critical care interventions such as monitoring of vital signs, intravenous fluid resuscitation, intravenous vasoactive medications, frequent diagnostic laboratory testing, renal replacement therapy, oxygen and occasionally mechanical ventilation. CONCLUSION: With advanced training and adherence to infection prevention and control practices, clinical interventions, including critical care, are feasible and safe to perform in critically ill patients. With specific anti-Ebola medications, most patients can survive Ebola virus infection.",10.1007/s00134-020-05949-z,fvg4thmr,"['PURPOSE', 'To', 'explore', 'contemporary', 'clincial', 'case', 'management', 'of', 'patients', 'with', 'Ebola', 'virus', 'disease', 'METHODS', 'A', 'narrative', 'review', 'from', 'a', 'clinical', 'perspective', 'of', 'clinical', 'features', 'diagnostic', 'tests', 'treatments', 'and', 'outcomes', 'of', 'patients', 'with', 'Ebola', 'virus', 'disease', 'RESULTS', 'Substantial', 'advances', 'have', 'been', 'made', 'in', 'the', 'care', 'of', 'patients', 'with', 'Ebola', 'virus', 'disease', 'EVD', 'precipitated', 'by', 'the', 'unprecedented', 'extent', 'of', 'the', '2014', '2016', 'outbreak', 'There', 'has', 'been', 'improved', 'point', 'of', 'care', 'diagnostics', 'improved', 'characterization', 'of', 'the', 'clinical', 'course', 'of', 'EVD', 'improved', 'patient', 'optimized', 'standards', 'of', 'care', 'evaluation', 'of', 'effective', 'anti', 'Ebola', 'therapies', 'administration', 'of', 'effective', 'vaccines', 'and', 'development', 'of', 'innovative', 'Ebola', 'treatment', 'units', 'A', 'better', 'understanding', 'of', 'the', 'Ebola', 'virus', 'disease', 'clinical', 'syndrome', 'has', 'led', 'to', 'the', 'appreciation', 'of', 'a', 'central', 'role', 'for', 'critical', 'care', 'clinicians', 'over', '50', 'of', 'patients', 'have', 'life', 'threatening', 'complications', 'including', 'hypotension', 'severe', 'electrolyte', 'imbalance', 'acute', 'kidney', 'injury', 'metabolic', 'acidosis', 'and', 'respiratory', 'failure', 'Accordingly', 'patients', 'often', 'require', 'critical', 'care', 'interventions', 'such', 'as', 'monitoring', 'of', 'vital', 'signs', 'intravenous', 'fluid', 'resuscitation', 'intravenous', 'vasoactive', 'medications', 'frequent', 'diagnostic', 'laboratory', 'testing', 'renal', 'replacement', 'therapy', 'oxygen', 'and', 'occasionally', 'mechanical', 'ventilation', 'CONCLUSION', 'With', 'advanced', 'training', 'and', 'adherence', 'to', 'infection', 'prevention', 'and', 'control', 'practices', 'clinical', 'interventions', 'including', 'critical', 'care', 'are', 'feasible', 'and', 'safe', 'to', 'perform', 'in', 'critically', 'ill', 'patients', 'With', 'specific', 'anti', 'Ebola', 'medications', 'most', 'patients', 'can', 'survive', 'Ebola', 'virus', 'infection', '']"
11448,Clinical decision-making on spinal cord injury-associated pneumonia: a nationwide survey in Germany,2020-02-18,Spinal Cord,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223654/,"STUDY DESIGN: Survey study. OBJECTIVES: Spinal cord injury (SCI)-associated pneumonia (SCI-AP) is associated with poor functional recovery and a major cause of death after SCI. Better tackling SCI-AP requires a common understanding on how SCI-AP is defined. This survey examines clinical algorithms relevant for diagnosis and treatment of SCI-AP. SETTING: All departments for SCI-care in Germany. METHODS: The clinical decision-making on SCI-AP and the utility of the Centers for Disease Control and Prevention (CDC) criteria for diagnosis of ‘clinically defined pneumonia’ were assessed by means of a standardized questionnaire including eight case vignettes of suspected SCI-AP. The diagnostic decisions based on the case information were analysed using classification and regression trees (CART). RESULTS: The majority of responding departments were aware of the CDC-criteria (88%). In the clinical vignettes, 38–81% of the departments diagnosed SCI-AP in accordance with the CDC-criteria and 7–41% diagnosed SCI-AP in deviation from the CDC-criteria. The diagnostic agreement was not associated with the availability of standard operating procedures for SCI-AP management in the departments. CART analysis identified radiological findings, fever, and worsened gas exchange as most important for the decision on SCI-AP. Frequently requested supplementary diagnostics were microbiological analyses, C-reactive protein, and procalcitonin. For empirical antibiotic therapy, the departments used (acyl-)aminopenicillins/β-lactamase inhibitors, cephalosporins, or combinations of (acyl-)aminopenicillins/β-lactamase inhibitors with fluoroquinolones or carbapenems. CONCLUSIONS: This survey reveals a diagnostic ambiguity regarding SCI-AP despite the awareness of CDC-criteria and established SOPs. Heterogeneous clinical practice is encouraging the development of disease-specific guidelines for diagnosis and management of SCI-AP.",10.1038/s41393-020-0435-5,ngri5gk5,"['STUDY', 'DESIGN', 'Survey', 'study', 'OBJECTIVES', 'Spinal', 'cord', 'injury', 'SCI', 'associated', 'pneumonia', 'SCI', 'AP', 'is', 'associated', 'with', 'poor', 'functional', 'recovery', 'and', 'a', 'major', 'cause', 'of', 'death', 'after', 'SCI', 'Better', 'tackling', 'SCI', 'AP', 'requires', 'a', 'common', 'understanding', 'on', 'how', 'SCI', 'AP', 'is', 'defined', 'This', 'survey', 'examines', 'clinical', 'algorithms', 'relevant', 'for', 'diagnosis', 'and', 'treatment', 'of', 'SCI', 'AP', 'SETTING', 'All', 'departments', 'for', 'SCI', 'care', 'in', 'Germany', 'METHODS', 'The', 'clinical', 'decision', 'making', 'on', 'SCI', 'AP', 'and', 'the', 'utility', 'of', 'the', 'Centers', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'criteria', 'for', 'diagnosis', 'of', 'clinically', 'defined', 'pneumonia', 'were', 'assessed', 'by', 'means', 'of', 'a', 'standardized', 'questionnaire', 'including', 'eight', 'case', 'vignettes', 'of', 'suspected', 'SCI', 'AP', 'The', 'diagnostic', 'decisions', 'based', 'on', 'the', 'case', 'information', 'were', 'analysed', 'using', 'classification', 'and', 'regression', 'trees', 'CART', 'RESULTS', 'The', 'majority', 'of', 'responding', 'departments', 'were', 'aware', 'of', 'the', 'CDC', 'criteria', '88', 'In', 'the', 'clinical', 'vignettes', '38', '81', 'of', 'the', 'departments', 'diagnosed', 'SCI', 'AP', 'in', 'accordance', 'with', 'the', 'CDC', 'criteria', 'and', '7', '41', 'diagnosed', 'SCI', 'AP', 'in', 'deviation', 'from', 'the', 'CDC', 'criteria', 'The', 'diagnostic', 'agreement', 'was', 'not', 'associated', 'with', 'the', 'availability', 'of', 'standard', 'operating', 'procedures', 'for', 'SCI', 'AP', 'management', 'in', 'the', 'departments', 'CART', 'analysis', 'identified', 'radiological', 'findings', 'fever', 'and', 'worsened', 'gas', 'exchange', 'as', 'most', 'important', 'for', 'the', 'decision', 'on', 'SCI', 'AP', 'Frequently', 'requested', 'supplementary', 'diagnostics', 'were', 'microbiological', 'analyses', 'C', 'reactive', 'protein', 'and', 'procalcitonin', 'For', 'empirical', 'antibiotic', 'therapy', 'the', 'departments', 'used', 'acyl', 'aminopenicillins', 'β', 'lactamase', 'inhibitors', 'cephalosporins', 'or', 'combinations', 'of', 'acyl', 'aminopenicillins', 'β', 'lactamase', 'inhibitors', 'with', 'fluoroquinolones', 'or', 'carbapenems', 'CONCLUSIONS', 'This', 'survey', 'reveals', 'a', 'diagnostic', 'ambiguity', 'regarding', 'SCI', 'AP', 'despite', 'the', 'awareness', 'of', 'CDC', 'criteria', 'and', 'established', 'SOPs', 'Heterogeneous', 'clinical', 'practice', 'is', 'encouraging', 'the', 'development', 'of', 'disease', 'specific', 'guidelines', 'for', 'diagnosis', 'and', 'management', 'of', 'SCI', 'AP', '']"
11873,Developments of Riboswitches and Toehold Switches for Molecular Detection—Biosensing and Molecular Diagnostics,2020-04-30,Int J Mol Sci,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247568/,"Riboswitches and toehold switches are considered to have potential for implementation in various fields, i.e., biosensing, metabolic engineering, and molecular diagnostics. The specific binding, programmability, and manipulability of these RNA-based molecules enable their intensive deployments in molecular detection as biosensors for regulating gene expressions, tracking metabolites, or detecting RNA sequences of pathogenic microorganisms. In this review, we will focus on the development of riboswitches and toehold switches in biosensing and molecular diagnostics. This review introduces the operating principles and the notable design features of riboswitches as well as toehold switches. Moreover, we will describe the advances and future directions of riboswitches and toehold switches in biosensing and molecular diagnostics.",10.3390/ijms21093192,6c8zr745,"['Riboswitches', 'and', 'toehold', 'switches', 'are', 'considered', 'to', 'have', 'potential', 'for', 'implementation', 'in', 'various', 'fields', 'i', 'e', 'biosensing', 'metabolic', 'engineering', 'and', 'molecular', 'diagnostics', 'The', 'specific', 'binding', 'programmability', 'and', 'manipulability', 'of', 'these', 'RNA', 'based', 'molecules', 'enable', 'their', 'intensive', 'deployments', 'in', 'molecular', 'detection', 'as', 'biosensors', 'for', 'regulating', 'gene', 'expressions', 'tracking', 'metabolites', 'or', 'detecting', 'RNA', 'sequences', 'of', 'pathogenic', 'microorganisms', 'In', 'this', 'review', 'we', 'will', 'focus', 'on', 'the', 'development', 'of', 'riboswitches', 'and', 'toehold', 'switches', 'in', 'biosensing', 'and', 'molecular', 'diagnostics', 'This', 'review', 'introduces', 'the', 'operating', 'principles', 'and', 'the', 'notable', 'design', 'features', 'of', 'riboswitches', 'as', 'well', 'as', 'toehold', 'switches', 'Moreover', 'we', 'will', 'describe', 'the', 'advances', 'and', 'future', 'directions', 'of', 'riboswitches', 'and', 'toehold', 'switches', 'in', 'biosensing', 'and', 'molecular', 'diagnostics', '']"
12815,Advances in molecular phytodiagnostics – new solutions for old problems,2006-07-13,Eur J Plant Pathol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087944/,"In the last decade, developments in molecular (nucleic acid-based) diagnostic methods have made significant improvements in the detection of plant pathogens. By using methods such as the polymerase chain reaction (PCR), the range of targets that can now be reliably diagnosed has grown to the extent that there are now extremely few, known pathogens that cannot be identified accurately by using laboratory-based diagnostics. However, while the detection of pathogens in individual, infected samples is becoming simpler, there are still many scenarios that present a major challenge to diagnosticians and plant pathologists. Amongst these are the detection of pathogens in soil or viruses in their vectors, high throughput testing and the development of generic methods, that allow samples to be simultaneously screened for large numbers of pathogens. Another major challenge is to develop robust technologies that avoid the reliance on well-equipped central laboratories and making reliable diagnostics available to pathologists in the field or in less-developed countries. In recent years, much of the research carried out on phytodiagnostics has focussed in these areas and as a result many novel, routine diagnostic tests are becoming available. This has been possible due to the introduction of new molecular technologies such real-time PCR and microarrays. These advances have been complemented by the development of new nucleic acid extraction methods, increased automation, reliable internal controls, assay multiplexing and generic amplification methods. With developments in new hardware, field-portable real-time PCR is now also a reality and offers the prospect of ultra-rapid, on-site molecular diagnostics for the first time. In this paper, the development and implementation of new diagnostic methods based upon novel molecular techniques is presented, with specific examples given to demonstrate how these new methods can be used to overcome some long-standing problems.",10.1007/s10658-006-9037-0,mfc3rdov,"['In', 'the', 'last', 'decade', 'developments', 'in', 'molecular', 'nucleic', 'acid', 'based', 'diagnostic', 'methods', 'have', 'made', 'significant', 'improvements', 'in', 'the', 'detection', 'of', 'plant', 'pathogens', 'By', 'using', 'methods', 'such', 'as', 'the', 'polymerase', 'chain', 'reaction', 'PCR', 'the', 'range', 'of', 'targets', 'that', 'can', 'now', 'be', 'reliably', 'diagnosed', 'has', 'grown', 'to', 'the', 'extent', 'that', 'there', 'are', 'now', 'extremely', 'few', 'known', 'pathogens', 'that', 'cannot', 'be', 'identified', 'accurately', 'by', 'using', 'laboratory', 'based', 'diagnostics', 'However', 'while', 'the', 'detection', 'of', 'pathogens', 'in', 'individual', 'infected', 'samples', 'is', 'becoming', 'simpler', 'there', 'are', 'still', 'many', 'scenarios', 'that', 'present', 'a', 'major', 'challenge', 'to', 'diagnosticians', 'and', 'plant', 'pathologists', 'Amongst', 'these', 'are', 'the', 'detection', 'of', 'pathogens', 'in', 'soil', 'or', 'viruses', 'in', 'their', 'vectors', 'high', 'throughput', 'testing', 'and', 'the', 'development', 'of', 'generic', 'methods', 'that', 'allow', 'samples', 'to', 'be', 'simultaneously', 'screened', 'for', 'large', 'numbers', 'of', 'pathogens', 'Another', 'major', 'challenge', 'is', 'to', 'develop', 'robust', 'technologies', 'that', 'avoid', 'the', 'reliance', 'on', 'well', 'equipped', 'central', 'laboratories', 'and', 'making', 'reliable', 'diagnostics', 'available', 'to', 'pathologists', 'in', 'the', 'field', 'or', 'in', 'less', 'developed', 'countries', 'In', 'recent', 'years', 'much', 'of', 'the', 'research', 'carried', 'out', 'on', 'phytodiagnostics', 'has', 'focussed', 'in', 'these', 'areas', 'and', 'as', 'a', 'result', 'many', 'novel', 'routine', 'diagnostic', 'tests', 'are', 'becoming', 'available', 'This', 'has', 'been', 'possible', 'due', 'to', 'the', 'introduction', 'of', 'new', 'molecular', 'technologies', 'such', 'real', 'time', 'PCR', 'and', 'microarrays', 'These', 'advances', 'have', 'been', 'complemented', 'by', 'the', 'development', 'of', 'new', 'nucleic', 'acid', 'extraction', 'methods', 'increased', 'automation', 'reliable', 'internal', 'controls', 'assay', 'multiplexing', 'and', 'generic', 'amplification', 'methods', 'With', 'developments', 'in', 'new', 'hardware', 'field', 'portable', 'real', 'time', 'PCR', 'is', 'now', 'also', 'a', 'reality', 'and', 'offers', 'the', 'prospect', 'of', 'ultra', 'rapid', 'on', 'site', 'molecular', 'diagnostics', 'for', 'the', 'first', 'time', 'In', 'this', 'paper', 'the', 'development', 'and', 'implementation', 'of', 'new', 'diagnostic', 'methods', 'based', 'upon', 'novel', 'molecular', 'techniques', 'is', 'presented', 'with', 'specific', 'examples', 'given', 'to', 'demonstrate', 'how', 'these', 'new', 'methods', 'can', 'be', 'used', 'to', 'overcome', 'some', 'long', 'standing', 'problems', '']"
12835,Das neue Verständnis pulmonaler Infektionen,2019-12-10,Pneumologe (Berl),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088196/,"Epidemiological data on the distribution of mostly bacterial pathogens are still the basis for empirical treatment recommendations on respiratory infections. Because of the dynamic technological developments in molecular multiplexing and sequencing procedures, the spectrum of potential pathogens is increased and challenges the current dogma of virulence and pathogenicity of certain pathogens. Classical pathogens of the lungs are thereby not questioned but are increasingly placed in a context that reflects co-infections with viruses and changes of the local microbiome in more depth. Recent data indicate that integration of this novel information is required for a better understanding of the seasonal differences in the frequency of particular lung infections and to find new approaches to risk stratification of patients. This becomes most obvious in the subgroup of immunosuppressed patients who are at risk of severe courses of diseases with higher morbidity and mortality from infections with viruses and facultative pathogens, such as nontuberculous mycobacteria (NTM). Based on the fundamental knowledge on the spectrum of pathogens of community-acquired and nosocomial lung infections, novel approaches in pathogen diagnostics and lung microbiome analytics are discussed and the applicability with respect to the current clinical routine is questioned.",10.1007/s10405-019-00291-8,0dhzv75e,"['Epidemiological', 'data', 'on', 'the', 'distribution', 'of', 'mostly', 'bacterial', 'pathogens', 'are', 'still', 'the', 'basis', 'for', 'empirical', 'treatment', 'recommendations', 'on', 'respiratory', 'infections', 'Because', 'of', 'the', 'dynamic', 'technological', 'developments', 'in', 'molecular', 'multiplexing', 'and', 'sequencing', 'procedures', 'the', 'spectrum', 'of', 'potential', 'pathogens', 'is', 'increased', 'and', 'challenges', 'the', 'current', 'dogma', 'of', 'virulence', 'and', 'pathogenicity', 'of', 'certain', 'pathogens', 'Classical', 'pathogens', 'of', 'the', 'lungs', 'are', 'thereby', 'not', 'questioned', 'but', 'are', 'increasingly', 'placed', 'in', 'a', 'context', 'that', 'reflects', 'co', 'infections', 'with', 'viruses', 'and', 'changes', 'of', 'the', 'local', 'microbiome', 'in', 'more', 'depth', 'Recent', 'data', 'indicate', 'that', 'integration', 'of', 'this', 'novel', 'information', 'is', 'required', 'for', 'a', 'better', 'understanding', 'of', 'the', 'seasonal', 'differences', 'in', 'the', 'frequency', 'of', 'particular', 'lung', 'infections', 'and', 'to', 'find', 'new', 'approaches', 'to', 'risk', 'stratification', 'of', 'patients', 'This', 'becomes', 'most', 'obvious', 'in', 'the', 'subgroup', 'of', 'immunosuppressed', 'patients', 'who', 'are', 'at', 'risk', 'of', 'severe', 'courses', 'of', 'diseases', 'with', 'higher', 'morbidity', 'and', 'mortality', 'from', 'infections', 'with', 'viruses', 'and', 'facultative', 'pathogens', 'such', 'as', 'nontuberculous', 'mycobacteria', 'NTM', 'Based', 'on', 'the', 'fundamental', 'knowledge', 'on', 'the', 'spectrum', 'of', 'pathogens', 'of', 'community', 'acquired', 'and', 'nosocomial', 'lung', 'infections', 'novel', 'approaches', 'in', 'pathogen', 'diagnostics', 'and', 'lung', 'microbiome', 'analytics', 'are', 'discussed', 'and', 'the', 'applicability', 'with', 'respect', 'to', 'the', 'current', 'clinical', 'routine', 'is', 'questioned', '']"
12966,Plasmonic molecular assays: Recent advances and applications for mobile health,2018-06-05,Nano Res,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091255/,"Plasmonics-based biosensing assays have been extensively employed for biomedical applications. Significant advancements in use of plasmonic assays for the construction of point-of-care (POC) diagnostic methods have been made to provide effective and urgent health care of patients, especially in resourcelimited settings. This rapidly progressive research area, centered on the unique surface plasmon resonance (SPR) properties of metallic nanostructures with exceptional absorption and scattering abilities, has greatly facilitated the development of cost-effective, sensitive, and rapid strategies for disease diagnostics and improving patient healthcare in both developed and developing worlds. This review highlights the recent advances and applications of plasmonic technologies for highly sensitive protein and nucleic acid biomarker detection. In particular, we focus on the implementation and penetration of various plasmonic technologies in conventional molecular diagnostic assays, and discuss how such modification has resulted in simpler, faster, and more sensitive alternatives that are suited for point-of-use. Finally, integration of plasmonic molecular assays with various portable POC platforms for mobile health applications are highlighted.",10.1007/s12274-018-2094-9,ym8sydbz,"['Plasmonics', 'based', 'biosensing', 'assays', 'have', 'been', 'extensively', 'employed', 'for', 'biomedical', 'applications', 'Significant', 'advancements', 'in', 'use', 'of', 'plasmonic', 'assays', 'for', 'the', 'construction', 'of', 'point', 'of', 'care', 'POC', 'diagnostic', 'methods', 'have', 'been', 'made', 'to', 'provide', 'effective', 'and', 'urgent', 'health', 'care', 'of', 'patients', 'especially', 'in', 'resourcelimited', 'settings', 'This', 'rapidly', 'progressive', 'research', 'area', 'centered', 'on', 'the', 'unique', 'surface', 'plasmon', 'resonance', 'SPR', 'properties', 'of', 'metallic', 'nanostructures', 'with', 'exceptional', 'absorption', 'and', 'scattering', 'abilities', 'has', 'greatly', 'facilitated', 'the', 'development', 'of', 'cost', 'effective', 'sensitive', 'and', 'rapid', 'strategies', 'for', 'disease', 'diagnostics', 'and', 'improving', 'patient', 'healthcare', 'in', 'both', 'developed', 'and', 'developing', 'worlds', 'This', 'review', 'highlights', 'the', 'recent', 'advances', 'and', 'applications', 'of', 'plasmonic', 'technologies', 'for', 'highly', 'sensitive', 'protein', 'and', 'nucleic', 'acid', 'biomarker', 'detection', 'In', 'particular', 'we', 'focus', 'on', 'the', 'implementation', 'and', 'penetration', 'of', 'various', 'plasmonic', 'technologies', 'in', 'conventional', 'molecular', 'diagnostic', 'assays', 'and', 'discuss', 'how', 'such', 'modification', 'has', 'resulted', 'in', 'simpler', 'faster', 'and', 'more', 'sensitive', 'alternatives', 'that', 'are', 'suited', 'for', 'point', 'of', 'use', 'Finally', 'integration', 'of', 'plasmonic', 'molecular', 'assays', 'with', 'various', 'portable', 'POC', 'platforms', 'for', 'mobile', 'health', 'applications', 'are', 'highlighted', '']"
13706,Viral Diagnostics,2018-12-08,Principles and Practice of Transplant Infectious Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115029/,"This chapter discusses recent developments in diagnostics for cytomegalovirus (CMV), Epstein-Barr virus (EBV), BK virus (BKV), community respiratory viruses (CRVs), parvovirus, hepatitis viruses, HIV, and other viral agents of importance in solid organ and hematopoietic stem cell transplantation.",10.1007/978-1-4939-9034-4_49,3tpq5zar,"['This', 'chapter', 'discusses', 'recent', 'developments', 'in', 'diagnostics', 'for', 'cytomegalovirus', 'CMV', 'Epstein', 'Barr', 'virus', 'EBV', 'BK', 'virus', 'BKV', 'community', 'respiratory', 'viruses', 'CRVs', 'parvovirus', 'hepatitis', 'viruses', 'HIV', 'and', 'other', 'viral', 'agents', 'of', 'importance', 'in', 'solid', 'organ', 'and', 'hematopoietic', 'stem', 'cell', 'transplantation', '']"
13900,An Introduction to Biotechnology,2016-10-23,Basic and Applied Aspects of Biotechnology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119977/,"Biotechnology is multidisciplinary field which has major impact on our lives. The technology is known since years which involves working with cells or cell-derived molecules for various applications. It has wide range of uses and is termed “technology of hope” which impact human health, well being of other life forms and our environment. It has revolutionized diagnostics and therapeutics; however, the major challenges to the human beings have been threats posed by deadly virus infections as avian flu, Chikungunya, Ebola, Influenza A, SARS, West Nile, and the latest Zika virus. Personalized medicine is increasingly recognized in healthcare system. In this chapter, the readers would understand the applications of biotechnology in human health care system. It has also impacted the environment which is loaded by toxic compounds due to human industrialization and urbanization. Bioremediation process utilizes use of natural or recombinant organisms for the cleanup of environmental toxic pollutants. The development of insect and pest resistant crops and herbicide tolerant crops has greatly reduced the environmental load of toxic insecticides and pesticides. The increase in crop productivity for solving world food and feed problem is addressed in agricultural biotechnology. The technological advancements have focused on development of alternate, renewable, and sustainable energy sources for production of biofuels. Marine biotechnology explores the products which can be obtained from aquatic organisms. As with every research area, the field of biotechnology is associated with many ethical issues and unseen fears. These are important in defining laws governing the feasibility and approval for the conduct of particular research.",10.1007/978-981-10-0875-7_1,qt0keeow,"['Biotechnology', 'is', 'multidisciplinary', 'field', 'which', 'has', 'major', 'impact', 'on', 'our', 'lives', 'The', 'technology', 'is', 'known', 'since', 'years', 'which', 'involves', 'working', 'with', 'cells', 'or', 'cell', 'derived', 'molecules', 'for', 'various', 'applications', 'It', 'has', 'wide', 'range', 'of', 'uses', 'and', 'is', 'termed', 'technology', 'of', 'hope', 'which', 'impact', 'human', 'health', 'well', 'being', 'of', 'other', 'life', 'forms', 'and', 'our', 'environment', 'It', 'has', 'revolutionized', 'diagnostics', 'and', 'therapeutics', 'however', 'the', 'major', 'challenges', 'to', 'the', 'human', 'beings', 'have', 'been', 'threats', 'posed', 'by', 'deadly', 'virus', 'infections', 'as', 'avian', 'flu', 'Chikungunya', 'Ebola', 'Influenza', 'A', 'SARS', 'West', 'Nile', 'and', 'the', 'latest', 'Zika', 'virus', 'Personalized', 'medicine', 'is', 'increasingly', 'recognized', 'in', 'healthcare', 'system', 'In', 'this', 'chapter', 'the', 'readers', 'would', 'understand', 'the', 'applications', 'of', 'biotechnology', 'in', 'human', 'health', 'care', 'system', 'It', 'has', 'also', 'impacted', 'the', 'environment', 'which', 'is', 'loaded', 'by', 'toxic', 'compounds', 'due', 'to', 'human', 'industrialization', 'and', 'urbanization', 'Bioremediation', 'process', 'utilizes', 'use', 'of', 'natural', 'or', 'recombinant', 'organisms', 'for', 'the', 'cleanup', 'of', 'environmental', 'toxic', 'pollutants', 'The', 'development', 'of', 'insect', 'and', 'pest', 'resistant', 'crops', 'and', 'herbicide', 'tolerant', 'crops', 'has', 'greatly', 'reduced', 'the', 'environmental', 'load', 'of', 'toxic', 'insecticides', 'and', 'pesticides', 'The', 'increase', 'in', 'crop', 'productivity', 'for', 'solving', 'world', 'food', 'and', 'feed', 'problem', 'is', 'addressed', 'in', 'agricultural', 'biotechnology', 'The', 'technological', 'advancements', 'have', 'focused', 'on', 'development', 'of', 'alternate', 'renewable', 'and', 'sustainable', 'energy', 'sources', 'for', 'production', 'of', 'biofuels', 'Marine', 'biotechnology', 'explores', 'the', 'products', 'which', 'can', 'be', 'obtained', 'from', 'aquatic', 'organisms', 'As', 'with', 'every', 'research', 'area', 'the', 'field', 'of', 'biotechnology', 'is', 'associated', 'with', 'many', 'ethical', 'issues', 'and', 'unseen', 'fears', 'These', 'are', 'important', 'in', 'defining', 'laws', 'governing', 'the', 'feasibility', 'and', 'approval', 'for', 'the', 'conduct', 'of', 'particular', 'research', '']"
13938,Emerging Plant Viruses: a Diversity of Mechanisms and Opportunities,2008,Plant Virus Evolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120024/,"Although emerging plant viruses receive much less publicity than their animal- or human-infecting cousins, they pose a serious threat to worldwide agricultural production. These viruses can be new (i.e., not previously known) or already known; however, they share the common characteristic of occupying and spreading within new niches. Factors driving the emergence of plant viruses include genetic variability in the virus, changes in agricultural practices, increases in the population and/or distribution of insect vectors and long-distance transport of plant materials. In recent years, individual as well as entire groups of viruses have emerged, and this has involved a variety of mechanism(s), depending on the virus and the environment. Here, we will discuss some of these viruses, and highlight the mechanisms that have mediated their emergence. Special emphasis is placed upon the whiteflytransmitted geminiviruses (begomoviruses) and the thrips-transmitted tosposviruses, which have emerged as major threats to crop production throughout the world. Other examples include the recent emergence of novel viruslike agents, the acquisition and role of satellite DNA or RNA molecules in emergence of plant viruses, and cases where emerging viruses have had only a transient impact. It seems clear that global movement of plant materials, expansion of agriculture and large-scale monoculture will continue to favor emergence of plant viruses. However, improved diagnostics should allow for rapid identification of emerging viruses and better understanding of viral biology. This information can be used in the development of effective management strategies, which will hopefully minimize impact on agricultural production.",10.1007/978-3-540-75763-4_3,u21znpyz,"['Although', 'emerging', 'plant', 'viruses', 'receive', 'much', 'less', 'publicity', 'than', 'their', 'animal', 'or', 'human', 'infecting', 'cousins', 'they', 'pose', 'a', 'serious', 'threat', 'to', 'worldwide', 'agricultural', 'production', 'These', 'viruses', 'can', 'be', 'new', 'i', 'e', 'not', 'previously', 'known', 'or', 'already', 'known', 'however', 'they', 'share', 'the', 'common', 'characteristic', 'of', 'occupying', 'and', 'spreading', 'within', 'new', 'niches', 'Factors', 'driving', 'the', 'emergence', 'of', 'plant', 'viruses', 'include', 'genetic', 'variability', 'in', 'the', 'virus', 'changes', 'in', 'agricultural', 'practices', 'increases', 'in', 'the', 'population', 'and', 'or', 'distribution', 'of', 'insect', 'vectors', 'and', 'long', 'distance', 'transport', 'of', 'plant', 'materials', 'In', 'recent', 'years', 'individual', 'as', 'well', 'as', 'entire', 'groups', 'of', 'viruses', 'have', 'emerged', 'and', 'this', 'has', 'involved', 'a', 'variety', 'of', 'mechanism', 's', 'depending', 'on', 'the', 'virus', 'and', 'the', 'environment', 'Here', 'we', 'will', 'discuss', 'some', 'of', 'these', 'viruses', 'and', 'highlight', 'the', 'mechanisms', 'that', 'have', 'mediated', 'their', 'emergence', 'Special', 'emphasis', 'is', 'placed', 'upon', 'the', 'whiteflytransmitted', 'geminiviruses', 'begomoviruses', 'and', 'the', 'thrips', 'transmitted', 'tosposviruses', 'which', 'have', 'emerged', 'as', 'major', 'threats', 'to', 'crop', 'production', 'throughout', 'the', 'world', 'Other', 'examples', 'include', 'the', 'recent', 'emergence', 'of', 'novel', 'viruslike', 'agents', 'the', 'acquisition', 'and', 'role', 'of', 'satellite', 'DNA', 'or', 'RNA', 'molecules', 'in', 'emergence', 'of', 'plant', 'viruses', 'and', 'cases', 'where', 'emerging', 'viruses', 'have', 'had', 'only', 'a', 'transient', 'impact', 'It', 'seems', 'clear', 'that', 'global', 'movement', 'of', 'plant', 'materials', 'expansion', 'of', 'agriculture', 'and', 'large', 'scale', 'monoculture', 'will', 'continue', 'to', 'favor', 'emergence', 'of', 'plant', 'viruses', 'However', 'improved', 'diagnostics', 'should', 'allow', 'for', 'rapid', 'identification', 'of', 'emerging', 'viruses', 'and', 'better', 'understanding', 'of', 'viral', 'biology', 'This', 'information', 'can', 'be', 'used', 'in', 'the', 'development', 'of', 'effective', 'management', 'strategies', 'which', 'will', 'hopefully', 'minimize', 'impact', 'on', 'agricultural', 'production', '']"
14092,Recent Advances in Veterinary Diagnostic Virology: Report from a Collaborating Centre of the World Organization for Animal Health (OIE),2012-04-05,Advanced Techniques in Diagnostic Microbiology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120236/,"Infectious diseases have a very high impact on animal and human health and welfare today, despite of strong efforts and good results in diagnostics, vaccine developments and control measures, including the early warning systems. There are many reasons, which have to be considered as supporting factors for the spread of infectious diseases, such as the open borders of the European Union, allowing rather free movement of animals over a whole continent, the globalization, the released and accelerated international and national trade and animal transfer. Simultaneously, the emergence and re-emergence of new or already known pathogens is a various serious issue in veterinary and in human medicine. This scenario is clearly illustrated by the regular occurrence of transboundary animal diseases (TADs), such as foot-and-mouth disease (FMD), classical swine fever (CSF), African swine fever (ASF), among others. The recent occurrence of African swine fever in the Caucasus region and the spread afterwards to large territories of Russia clearly illustrates that our health authorities require a very strong preparedness, including prompt and powerful diagnosis, for the successful fight against the novel scenarios.",10.1007/978-1-4614-3970-7_36,uhei3bvr,"['Infectious', 'diseases', 'have', 'a', 'very', 'high', 'impact', 'on', 'animal', 'and', 'human', 'health', 'and', 'welfare', 'today', 'despite', 'of', 'strong', 'efforts', 'and', 'good', 'results', 'in', 'diagnostics', 'vaccine', 'developments', 'and', 'control', 'measures', 'including', 'the', 'early', 'warning', 'systems', 'There', 'are', 'many', 'reasons', 'which', 'have', 'to', 'be', 'considered', 'as', 'supporting', 'factors', 'for', 'the', 'spread', 'of', 'infectious', 'diseases', 'such', 'as', 'the', 'open', 'borders', 'of', 'the', 'European', 'Union', 'allowing', 'rather', 'free', 'movement', 'of', 'animals', 'over', 'a', 'whole', 'continent', 'the', 'globalization', 'the', 'released', 'and', 'accelerated', 'international', 'and', 'national', 'trade', 'and', 'animal', 'transfer', 'Simultaneously', 'the', 'emergence', 'and', 're', 'emergence', 'of', 'new', 'or', 'already', 'known', 'pathogens', 'is', 'a', 'various', 'serious', 'issue', 'in', 'veterinary', 'and', 'in', 'human', 'medicine', 'This', 'scenario', 'is', 'clearly', 'illustrated', 'by', 'the', 'regular', 'occurrence', 'of', 'transboundary', 'animal', 'diseases', 'TADs', 'such', 'as', 'foot', 'and', 'mouth', 'disease', 'FMD', 'classical', 'swine', 'fever', 'CSF', 'African', 'swine', 'fever', 'ASF', 'among', 'others', 'The', 'recent', 'occurrence', 'of', 'African', 'swine', 'fever', 'in', 'the', 'Caucasus', 'region', 'and', 'the', 'spread', 'afterwards', 'to', 'large', 'territories', 'of', 'Russia', 'clearly', 'illustrates', 'that', 'our', 'health', 'authorities', 'require', 'a', 'very', 'strong', 'preparedness', 'including', 'prompt', 'and', 'powerful', 'diagnosis', 'for', 'the', 'successful', 'fight', 'against', 'the', 'novel', 'scenarios', '']"
14163,Novel Molecular Diagnostics and Therapeutic Tools for Livestock Diseases,2018-04-26,Advances in Animal Biotechnology and its Applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120337/,"Recent novelties in diverse diagnostics and therapeutic tools in animal health sector have paved a brighter and clearer way ahead. These are proved to be better in detection, management, control and eradication of animal sufferings caused by various infectious and non-infectious diseases. These innovations have potential impact that extends beyond the animal health and welfare. The advancements have significantly contributed towards improvement in the economy of the country as well as food security. In the present competitive era of evolution, the organisms have inculcated a number of new strategies for survival and spread. Therefore, science needs to continuously evolve more sensitive, specific and high-throughput tools to overcome pathogen cleverness to escape from host immune surveillance. For visible or remarkable changes, it is necessary to use full potential of these advanced molecular techniques into current animal health standards and practices. Under ‘One Health’ concept, the health of animals and humans has to be taken care simultaneously. At present, these advanced molecular diagnostic methods play a significant role in the detection of new and emerging pathogens of livestock. The acquired information also helps to study the interrelationships of pathogens, their hosts and their surroundings. Additionally new vaccines bridging human and animal health development may be discovered. Latest developments in the field of diagnostics and vaccine design through genomics approach have also laid the foundation to enhance the diagnosis and surveillance and in turn helped in the control of infectious diseases. Latest high-throughput DNA sequencing platforms are currently being used for identification and detailed analysis of both disease pathogen and host genomes. The high-throughput data generated using these platforms need to be analysed adopting the bioinformatics and computational genomics that have taken a very high pace nowadays. In the context of animal health, the data analysis may provide some key opportunities for the development of better diagnostic and therapeutic tools for emerging or re-emerging diseases. Such novel and potent technologies put forward a significantly new scenario of disease knowledge, which enables more accurate predictions leading to faster and greater management responses to combat potentially devastating disease crises.",10.1007/978-981-10-4702-2_14,280kwlev,"['Recent', 'novelties', 'in', 'diverse', 'diagnostics', 'and', 'therapeutic', 'tools', 'in', 'animal', 'health', 'sector', 'have', 'paved', 'a', 'brighter', 'and', 'clearer', 'way', 'ahead', 'These', 'are', 'proved', 'to', 'be', 'better', 'in', 'detection', 'management', 'control', 'and', 'eradication', 'of', 'animal', 'sufferings', 'caused', 'by', 'various', 'infectious', 'and', 'non', 'infectious', 'diseases', 'These', 'innovations', 'have', 'potential', 'impact', 'that', 'extends', 'beyond', 'the', 'animal', 'health', 'and', 'welfare', 'The', 'advancements', 'have', 'significantly', 'contributed', 'towards', 'improvement', 'in', 'the', 'economy', 'of', 'the', 'country', 'as', 'well', 'as', 'food', 'security', 'In', 'the', 'present', 'competitive', 'era', 'of', 'evolution', 'the', 'organisms', 'have', 'inculcated', 'a', 'number', 'of', 'new', 'strategies', 'for', 'survival', 'and', 'spread', 'Therefore', 'science', 'needs', 'to', 'continuously', 'evolve', 'more', 'sensitive', 'specific', 'and', 'high', 'throughput', 'tools', 'to', 'overcome', 'pathogen', 'cleverness', 'to', 'escape', 'from', 'host', 'immune', 'surveillance', 'For', 'visible', 'or', 'remarkable', 'changes', 'it', 'is', 'necessary', 'to', 'use', 'full', 'potential', 'of', 'these', 'advanced', 'molecular', 'techniques', 'into', 'current', 'animal', 'health', 'standards', 'and', 'practices', 'Under', 'One', 'Health', 'concept', 'the', 'health', 'of', 'animals', 'and', 'humans', 'has', 'to', 'be', 'taken', 'care', 'simultaneously', 'At', 'present', 'these', 'advanced', 'molecular', 'diagnostic', 'methods', 'play', 'a', 'significant', 'role', 'in', 'the', 'detection', 'of', 'new', 'and', 'emerging', 'pathogens', 'of', 'livestock', 'The', 'acquired', 'information', 'also', 'helps', 'to', 'study', 'the', 'interrelationships', 'of', 'pathogens', 'their', 'hosts', 'and', 'their', 'surroundings', 'Additionally', 'new', 'vaccines', 'bridging', 'human', 'and', 'animal', 'health', 'development', 'may', 'be', 'discovered', 'Latest', 'developments', 'in', 'the', 'field', 'of', 'diagnostics', 'and', 'vaccine', 'design', 'through', 'genomics', 'approach', 'have', 'also', 'laid', 'the', 'foundation', 'to', 'enhance', 'the', 'diagnosis', 'and', 'surveillance', 'and', 'in', 'turn', 'helped', 'in', 'the', 'control', 'of', 'infectious', 'diseases', 'Latest', 'high', 'throughput', 'DNA', 'sequencing', 'platforms', 'are', 'currently', 'being', 'used', 'for', 'identification', 'and', 'detailed', 'analysis', 'of', 'both', 'disease', 'pathogen', 'and', 'host', 'genomes', 'The', 'high', 'throughput', 'data', 'generated', 'using', 'these', 'platforms', 'need', 'to', 'be', 'analysed', 'adopting', 'the', 'bioinformatics', 'and', 'computational', 'genomics', 'that', 'have', 'taken', 'a', 'very', 'high', 'pace', 'nowadays', 'In', 'the', 'context', 'of', 'animal', 'health', 'the', 'data', 'analysis', 'may', 'provide', 'some', 'key', 'opportunities', 'for', 'the', 'development', 'of', 'better', 'diagnostic', 'and', 'therapeutic', 'tools', 'for', 'emerging', 'or', 're', 'emerging', 'diseases', 'Such', 'novel', 'and', 'potent', 'technologies', 'put', 'forward', 'a', 'significantly', 'new', 'scenario', 'of', 'disease', 'knowledge', 'which', 'enables', 'more', 'accurate', 'predictions', 'leading', 'to', 'faster', 'and', 'greater', 'management', 'responses', 'to', 'combat', 'potentially', 'devastating', 'disease', 'crises', '']"
14383,"The Domestic Cat, Felis catus, as a Model of Hereditary and Infectious Disease",2008,Sourcebook of Models for Biomedical Research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120622/,"The domestic cat, currently the most frequent of companion animals, has enjoyed a medical surveillance, as a nonprimate species, second only to the dog. With over 200 hereditary disease pathologies reported in the cat, the clinical and physiological study of these feline hereditary diseases provides a strong comparative medicine opportunity for prevention, diagnostics, and treatment studies in a laboratory setting. Causal mutations have been characterized in 19 felid genes, with the largest representation from lysosomal storage enzyme disorders. Corrective therapeutic strategies for several disorders have been proposed and examined in the cat, including enzyme replacement, heterologous bone marrow transplantation, and substrate reduction therapy. Genomics tools developed in the cat, including the recent completion of the 2-fold whole genome sequence of the cat and genome browser, radiation hybrid map of 1793 integrated coding and microsatellite loci, a 5-cM genetic linkage map, arrayed BAC libraries, and flow sorted chromosomes, are providing resources that are being utilized in mapping and characterization of genes of interest. A recent report of the mapping and characterization of a novel causative gene for feline spinal muscular atrophy marked the first identification of a disease gene purely from positional reasoning. With the development of genomic resources in the cat and the application of complementary comparative tools developed in other species, the domestic cat is emerging as a promising resource of phenotypically defined genetic variation of biomedical significance. Additionally, the cat has provided several useful models for infectious disease. These include feline leukemia and feline sarcoma virus, feline coronavirus, and Type C retroviruses that interact with cellular oncogenes to induce leukemia, lymphoma, and sarcoma.",10.1007/978-1-59745-285-4_25,80l5mua2,"['The', 'domestic', 'cat', 'currently', 'the', 'most', 'frequent', 'of', 'companion', 'animals', 'has', 'enjoyed', 'a', 'medical', 'surveillance', 'as', 'a', 'nonprimate', 'species', 'second', 'only', 'to', 'the', 'dog', 'With', 'over', '200', 'hereditary', 'disease', 'pathologies', 'reported', 'in', 'the', 'cat', 'the', 'clinical', 'and', 'physiological', 'study', 'of', 'these', 'feline', 'hereditary', 'diseases', 'provides', 'a', 'strong', 'comparative', 'medicine', 'opportunity', 'for', 'prevention', 'diagnostics', 'and', 'treatment', 'studies', 'in', 'a', 'laboratory', 'setting', 'Causal', 'mutations', 'have', 'been', 'characterized', 'in', '19', 'felid', 'genes', 'with', 'the', 'largest', 'representation', 'from', 'lysosomal', 'storage', 'enzyme', 'disorders', 'Corrective', 'therapeutic', 'strategies', 'for', 'several', 'disorders', 'have', 'been', 'proposed', 'and', 'examined', 'in', 'the', 'cat', 'including', 'enzyme', 'replacement', 'heterologous', 'bone', 'marrow', 'transplantation', 'and', 'substrate', 'reduction', 'therapy', 'Genomics', 'tools', 'developed', 'in', 'the', 'cat', 'including', 'the', 'recent', 'completion', 'of', 'the', '2', 'fold', 'whole', 'genome', 'sequence', 'of', 'the', 'cat', 'and', 'genome', 'browser', 'radiation', 'hybrid', 'map', 'of', '1793', 'integrated', 'coding', 'and', 'microsatellite', 'loci', 'a', '5', 'cM', 'genetic', 'linkage', 'map', 'arrayed', 'BAC', 'libraries', 'and', 'flow', 'sorted', 'chromosomes', 'are', 'providing', 'resources', 'that', 'are', 'being', 'utilized', 'in', 'mapping', 'and', 'characterization', 'of', 'genes', 'of', 'interest', 'A', 'recent', 'report', 'of', 'the', 'mapping', 'and', 'characterization', 'of', 'a', 'novel', 'causative', 'gene', 'for', 'feline', 'spinal', 'muscular', 'atrophy', 'marked', 'the', 'first', 'identification', 'of', 'a', 'disease', 'gene', 'purely', 'from', 'positional', 'reasoning', 'With', 'the', 'development', 'of', 'genomic', 'resources', 'in', 'the', 'cat', 'and', 'the', 'application', 'of', 'complementary', 'comparative', 'tools', 'developed', 'in', 'other', 'species', 'the', 'domestic', 'cat', 'is', 'emerging', 'as', 'a', 'promising', 'resource', 'of', 'phenotypically', 'defined', 'genetic', 'variation', 'of', 'biomedical', 'significance', 'Additionally', 'the', 'cat', 'has', 'provided', 'several', 'useful', 'models', 'for', 'infectious', 'disease', 'These', 'include', 'feline', 'leukemia', 'and', 'feline', 'sarcoma', 'virus', 'feline', 'coronavirus', 'and', 'Type', 'C', 'retroviruses', 'that', 'interact', 'with', 'cellular', 'oncogenes', 'to', 'induce', 'leukemia', 'lymphoma', 'and', 'sarcoma', '']"
14541,Diagnosis of Viral Infections,2017-05-05,"Viral Infections in Children, Volume I",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120824/,"Accurate diagnosis of viral infections enhances the ability of the clinician to make decisions on appropriate treatment of patients, evaluate disease progression and prevent misuse of antibiotics. Knowledge of the pathogen involved also allow implementation of infection control and monitoring of success of antiviral treatments that may affect the prognosis of patients. Epidemiological data collected through accurate diagnostics play an important role in public health through identification and control of outbreaks, implementation of appropriate diagnostic tests, vaccination programs and treatment but also to recognize common and emerging pathogens in a community. It is key that the clinician have an understanding of appropriate specimens to send to the laboratory and the value of specific nucleic acid and serological testing for different viral pathogens. Molecular techniques have revolutionized viral diagnoses over the past decade and enhanced both the sensitivity and specificity of tests and the speed by which a diagnosis can be made and new tests be developed. The continued use of serology for viruses with a short viremia, or for chronic infections should however complement these tests. This chapter aims to provide an overview of the available tests, the principles of testing and appropriate tests to select for different viruses and syndromes. Also provided is a glimpse of new developments in diagnostics that may further enhance the capacity to make a conclusive diagnosis in the near future.",10.1007/978-3-319-54033-7_6,z31g3mr5,"['Accurate', 'diagnosis', 'of', 'viral', 'infections', 'enhances', 'the', 'ability', 'of', 'the', 'clinician', 'to', 'make', 'decisions', 'on', 'appropriate', 'treatment', 'of', 'patients', 'evaluate', 'disease', 'progression', 'and', 'prevent', 'misuse', 'of', 'antibiotics', 'Knowledge', 'of', 'the', 'pathogen', 'involved', 'also', 'allow', 'implementation', 'of', 'infection', 'control', 'and', 'monitoring', 'of', 'success', 'of', 'antiviral', 'treatments', 'that', 'may', 'affect', 'the', 'prognosis', 'of', 'patients', 'Epidemiological', 'data', 'collected', 'through', 'accurate', 'diagnostics', 'play', 'an', 'important', 'role', 'in', 'public', 'health', 'through', 'identification', 'and', 'control', 'of', 'outbreaks', 'implementation', 'of', 'appropriate', 'diagnostic', 'tests', 'vaccination', 'programs', 'and', 'treatment', 'but', 'also', 'to', 'recognize', 'common', 'and', 'emerging', 'pathogens', 'in', 'a', 'community', 'It', 'is', 'key', 'that', 'the', 'clinician', 'have', 'an', 'understanding', 'of', 'appropriate', 'specimens', 'to', 'send', 'to', 'the', 'laboratory', 'and', 'the', 'value', 'of', 'specific', 'nucleic', 'acid', 'and', 'serological', 'testing', 'for', 'different', 'viral', 'pathogens', 'Molecular', 'techniques', 'have', 'revolutionized', 'viral', 'diagnoses', 'over', 'the', 'past', 'decade', 'and', 'enhanced', 'both', 'the', 'sensitivity', 'and', 'specificity', 'of', 'tests', 'and', 'the', 'speed', 'by', 'which', 'a', 'diagnosis', 'can', 'be', 'made', 'and', 'new', 'tests', 'be', 'developed', 'The', 'continued', 'use', 'of', 'serology', 'for', 'viruses', 'with', 'a', 'short', 'viremia', 'or', 'for', 'chronic', 'infections', 'should', 'however', 'complement', 'these', 'tests', 'This', 'chapter', 'aims', 'to', 'provide', 'an', 'overview', 'of', 'the', 'available', 'tests', 'the', 'principles', 'of', 'testing', 'and', 'appropriate', 'tests', 'to', 'select', 'for', 'different', 'viruses', 'and', 'syndromes', 'Also', 'provided', 'is', 'a', 'glimpse', 'of', 'new', 'developments', 'in', 'diagnostics', 'that', 'may', 'further', 'enhance', 'the', 'capacity', 'to', 'make', 'a', 'conclusive', 'diagnosis', 'in', 'the', 'near', 'future', '']"
14715,Nanomicrobiology,2017-03-21,The Handbook of Nanomedicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121058/,"Microbiology plays an important role in practice of medicine. Nanodiagnostics have refined the detection of infectious diseases and many new nanotechnology-based therapies, particularly of viral diseases, are in development.",10.1007/978-1-4939-6966-1_14,c7b76q54,"['Microbiology', 'plays', 'an', 'important', 'role', 'in', 'practice', 'of', 'medicine', 'Nanodiagnostics', 'have', 'refined', 'the', 'detection', 'of', 'infectious', 'diseases', 'and', 'many', 'new', 'nanotechnology', 'based', 'therapies', 'particularly', 'of', 'viral', 'diseases', 'are', 'in', 'development', '']"
15131,Biosafety and Bioethics,2016-10-23,Basic and Applied Aspects of Biotechnology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121592/,"The advancement in technology is likely to tame several life forms present on earth. Microorganisms are posing a big challenge due to difficulties encountered to control the diseases caused by them. Working with deadly disease-causing microorganisms for their characterization, diagnostics or therapeutics and vaccine development purposes are posing increasingly potential biosafety problems for laboratory workers. Thus, an appropriate biosafe working environment may protect workers from laboratory-induced infections. Biotechnology has the ability to solve the upcoming problems of the world’s increasing population. However, there is often reluctance among the public to accept and support biotechnological products in medicine, industry, or agriculture. There are many safety and ethical issues raised for GM crops and human cloning. Raising transgenic animals and plants has fueled ethical concerns, and the scientists have faced a lot of resistance where genetically modified crop plants or reproductive cloning research of human beings is involved. Thus, biosafety and bioethics are continuously being expanded to combine the rationale of ever-increasing scientific knowledge in biotechnology that is often in conflict with the long-standing social and moral value system of our society.",10.1007/978-981-10-0875-7_24,5men6dfk,"['The', 'advancement', 'in', 'technology', 'is', 'likely', 'to', 'tame', 'several', 'life', 'forms', 'present', 'on', 'earth', 'Microorganisms', 'are', 'posing', 'a', 'big', 'challenge', 'due', 'to', 'difficulties', 'encountered', 'to', 'control', 'the', 'diseases', 'caused', 'by', 'them', 'Working', 'with', 'deadly', 'disease', 'causing', 'microorganisms', 'for', 'their', 'characterization', 'diagnostics', 'or', 'therapeutics', 'and', 'vaccine', 'development', 'purposes', 'are', 'posing', 'increasingly', 'potential', 'biosafety', 'problems', 'for', 'laboratory', 'workers', 'Thus', 'an', 'appropriate', 'biosafe', 'working', 'environment', 'may', 'protect', 'workers', 'from', 'laboratory', 'induced', 'infections', 'Biotechnology', 'has', 'the', 'ability', 'to', 'solve', 'the', 'upcoming', 'problems', 'of', 'the', 'world', 's', 'increasing', 'population', 'However', 'there', 'is', 'often', 'reluctance', 'among', 'the', 'public', 'to', 'accept', 'and', 'support', 'biotechnological', 'products', 'in', 'medicine', 'industry', 'or', 'agriculture', 'There', 'are', 'many', 'safety', 'and', 'ethical', 'issues', 'raised', 'for', 'GM', 'crops', 'and', 'human', 'cloning', 'Raising', 'transgenic', 'animals', 'and', 'plants', 'has', 'fueled', 'ethical', 'concerns', 'and', 'the', 'scientists', 'have', 'faced', 'a', 'lot', 'of', 'resistance', 'where', 'genetically', 'modified', 'crop', 'plants', 'or', 'reproductive', 'cloning', 'research', 'of', 'human', 'beings', 'is', 'involved', 'Thus', 'biosafety', 'and', 'bioethics', 'are', 'continuously', 'being', 'expanded', 'to', 'combine', 'the', 'rationale', 'of', 'ever', 'increasing', 'scientific', 'knowledge', 'in', 'biotechnology', 'that', 'is', 'often', 'in', 'conflict', 'with', 'the', 'long', 'standing', 'social', 'and', 'moral', 'value', 'system', 'of', 'our', 'society', '']"
15232,Infections in Allogeneic Stem Cell Transplantation,2018-12-08,Principles and Practice of Transplant Infectious Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121717/,"Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has become a widely used modality of therapy for a variety of malignant and nonmalignant diseases. Despite advances in pharmacotherapy and transplantation techniques, infection remains one of the most severe and frequently encountered complications of allo-HSCT. This chapter will address the risk factors for development of infection following allo-HSCT, including those related to the host, the conditioning regimen, and the graft, as well as the timing of opportunistic infections after allo-HSCT. The most common bacterial, viral, fungal, and parasitic infections, as well as issues surrounding their diagnostics and treatment, will be discussed. Finally, this chapter will address vaccination and other preventative strategies to be utilized when caring for patients undergoing allo-HSCT.",10.1007/978-1-4939-9034-4_11,wuxkhh7k,"['Allogeneic', 'hematopoietic', 'stem', 'cell', 'transplantation', 'allo', 'HSCT', 'has', 'become', 'a', 'widely', 'used', 'modality', 'of', 'therapy', 'for', 'a', 'variety', 'of', 'malignant', 'and', 'nonmalignant', 'diseases', 'Despite', 'advances', 'in', 'pharmacotherapy', 'and', 'transplantation', 'techniques', 'infection', 'remains', 'one', 'of', 'the', 'most', 'severe', 'and', 'frequently', 'encountered', 'complications', 'of', 'allo', 'HSCT', 'This', 'chapter', 'will', 'address', 'the', 'risk', 'factors', 'for', 'development', 'of', 'infection', 'following', 'allo', 'HSCT', 'including', 'those', 'related', 'to', 'the', 'host', 'the', 'conditioning', 'regimen', 'and', 'the', 'graft', 'as', 'well', 'as', 'the', 'timing', 'of', 'opportunistic', 'infections', 'after', 'allo', 'HSCT', 'The', 'most', 'common', 'bacterial', 'viral', 'fungal', 'and', 'parasitic', 'infections', 'as', 'well', 'as', 'issues', 'surrounding', 'their', 'diagnostics', 'and', 'treatment', 'will', 'be', 'discussed', 'Finally', 'this', 'chapter', 'will', 'address', 'vaccination', 'and', 'other', 'preventative', 'strategies', 'to', 'be', 'utilized', 'when', 'caring', 'for', 'patients', 'undergoing', 'allo', 'HSCT', '']"
15427,Point-of-Care Diagnostics,2014-12-04,Holographic Sensors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121962/,"Rapid tests that are low-cost and portable are the first line of defence in healthcare systems. Dipstick and lateral-flow are the two universal assay formats as they are lightweight and compact, and provide qualitative results without external instrumentation. However, existing formats have limitations in the quantification of analyte concentrations. Hence, the demand for sample preparation, improved sensitivity and user-interface has challenged the commercial products. Recently, capabilities, sensors and readout devices were expanded to multiplexable assays platforms, which might transcend the capabilities of existing design format of diagnostic tests. This chapter outlines the evolution of diagnostic devices and current trends in the development of qualitative and quantitative sensing devices for applications in healthcare, veterinary medicine, environmental monitoring and food safety. The chapter also discusses design parameters for diagnostics, their functionalisation to increase the capabilities and the performance, emerging sensing platforms and readout technologies. The factors which limit the emerging rapid diagnostics to become commercial products are also discussed.",10.1007/978-3-319-13584-7_1,4lavnvgo,"['Rapid', 'tests', 'that', 'are', 'low', 'cost', 'and', 'portable', 'are', 'the', 'first', 'line', 'of', 'defence', 'in', 'healthcare', 'systems', 'Dipstick', 'and', 'lateral', 'flow', 'are', 'the', 'two', 'universal', 'assay', 'formats', 'as', 'they', 'are', 'lightweight', 'and', 'compact', 'and', 'provide', 'qualitative', 'results', 'without', 'external', 'instrumentation', 'However', 'existing', 'formats', 'have', 'limitations', 'in', 'the', 'quantification', 'of', 'analyte', 'concentrations', 'Hence', 'the', 'demand', 'for', 'sample', 'preparation', 'improved', 'sensitivity', 'and', 'user', 'interface', 'has', 'challenged', 'the', 'commercial', 'products', 'Recently', 'capabilities', 'sensors', 'and', 'readout', 'devices', 'were', 'expanded', 'to', 'multiplexable', 'assays', 'platforms', 'which', 'might', 'transcend', 'the', 'capabilities', 'of', 'existing', 'design', 'format', 'of', 'diagnostic', 'tests', 'This', 'chapter', 'outlines', 'the', 'evolution', 'of', 'diagnostic', 'devices', 'and', 'current', 'trends', 'in', 'the', 'development', 'of', 'qualitative', 'and', 'quantitative', 'sensing', 'devices', 'for', 'applications', 'in', 'healthcare', 'veterinary', 'medicine', 'environmental', 'monitoring', 'and', 'food', 'safety', 'The', 'chapter', 'also', 'discusses', 'design', 'parameters', 'for', 'diagnostics', 'their', 'functionalisation', 'to', 'increase', 'the', 'capabilities', 'and', 'the', 'performance', 'emerging', 'sensing', 'platforms', 'and', 'readout', 'technologies', 'The', 'factors', 'which', 'limit', 'the', 'emerging', 'rapid', 'diagnostics', 'to', 'become', 'commercial', 'products', 'are', 'also', 'discussed', '']"
15733,Diagnosis of Tuberculosis: Nanodiagnostics Approaches,2019-09-25,NanoBioMedicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122355/,"Tuberculosis (TB) remains one of the most devastating infectious diseases worldwide. The burden of TB is alarmingly high in developing countries, where diagnosis latent TB infection (LTBI), Extra-pulmonary tuberculosis (EPTB), drug-resistant tuberculosis (DR-TB), HIV-associated TB, and paediatric TB is still a challenge. This is mainly due to delayed or misdiagnosis of TB, which continues to fuel its worldwide epidemic. The ideal diagnostic test is still unavailable, and conventional methods remain a necessity for TB diagnosis, though with poor diagnostic ability. The nanoparticles have shown potential for the improvement of drug delivery, reducing treatment frequency and diagnosis of various diseases. The engineering of antigens/antibody nanocarriers represents an exciting front in the field of diagnostics, potentially flagging the way toward development of better diagnostics for TB. This chapter discusses the presently available tests for TB diagnostics and also highlights the recent advancement in the nanotechnology-based detection tests for M. tuberculosis.",10.1007/978-981-32-9898-9_11,suavsu0x,"['Tuberculosis', 'TB', 'remains', 'one', 'of', 'the', 'most', 'devastating', 'infectious', 'diseases', 'worldwide', 'The', 'burden', 'of', 'TB', 'is', 'alarmingly', 'high', 'in', 'developing', 'countries', 'where', 'diagnosis', 'latent', 'TB', 'infection', 'LTBI', 'Extra', 'pulmonary', 'tuberculosis', 'EPTB', 'drug', 'resistant', 'tuberculosis', 'DR', 'TB', 'HIV', 'associated', 'TB', 'and', 'paediatric', 'TB', 'is', 'still', 'a', 'challenge', 'This', 'is', 'mainly', 'due', 'to', 'delayed', 'or', 'misdiagnosis', 'of', 'TB', 'which', 'continues', 'to', 'fuel', 'its', 'worldwide', 'epidemic', 'The', 'ideal', 'diagnostic', 'test', 'is', 'still', 'unavailable', 'and', 'conventional', 'methods', 'remain', 'a', 'necessity', 'for', 'TB', 'diagnosis', 'though', 'with', 'poor', 'diagnostic', 'ability', 'The', 'nanoparticles', 'have', 'shown', 'potential', 'for', 'the', 'improvement', 'of', 'drug', 'delivery', 'reducing', 'treatment', 'frequency', 'and', 'diagnosis', 'of', 'various', 'diseases', 'The', 'engineering', 'of', 'antigens', 'antibody', 'nanocarriers', 'represents', 'an', 'exciting', 'front', 'in', 'the', 'field', 'of', 'diagnostics', 'potentially', 'flagging', 'the', 'way', 'toward', 'development', 'of', 'better', 'diagnostics', 'for', 'TB', 'This', 'chapter', 'discusses', 'the', 'presently', 'available', 'tests', 'for', 'TB', 'diagnostics', 'and', 'also', 'highlights', 'the', 'recent', 'advancement', 'in', 'the', 'nanotechnology', 'based', 'detection', 'tests', 'for', 'M', 'tuberculosis', '']"
15784,"Genomics, Other “Omic” Technologies, Personalized Medicine, and Additional Biotechnology-Related Techniques",2013-08-27,Pharmaceutical Biotechnology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122419/,"The products resulting for biotechnologies continue to grow at an exponential rate, and the expectations are that an even greater percentage of drug development will be in the area of the biologics. In 2011, worldwide there were over 800 new biotech drugs and treatments in development including 23 antisense, 64 cell therapy, 50 gene therapy, 300 monoclonal antibodies, 78 recombinant proteins, and 298 vaccines (PhRMA 2012). Pharmaceutical biotechnology techniques are at the core of most methodologies used today for drug discovery and development of both biologics and small molecules. While recombinant DNA technology and hybridoma techniques were the major methods utilized in pharmaceutical biotechnology through most of its historical timeline, our ever-widening understanding of human cellular function and disease processes and a wealth of additional and innovative biotechnologies have been, and will continue to be, developed in order to harvest the information found in the human genome. These technological advances will provide a better understanding of the relationship between genetics and biological function, unravel the underlying causes of disease, explore the association of genomic variation and drug response, enhance pharmaceutical research, and fuel the discovery and development of new and novel biopharmaceuticals. These revolutionary technologies and additional biotechnology-related techniques are improving the very competitive and costly process of drug development of new medicinal agents, diagnostics, and medical devices. Some of the technologies and techniques described in this chapter are both well established and commonly used applications of biotechnology producing potential therapeutic products now in development including clinical trials. New techniques are emerging at a rapid and unprecedented pace and their full impact on the future of molecular medicine has yet to be imagined.",10.1007/978-1-4614-6486-0_8,j8bdb3qy,"['The', 'products', 'resulting', 'for', 'biotechnologies', 'continue', 'to', 'grow', 'at', 'an', 'exponential', 'rate', 'and', 'the', 'expectations', 'are', 'that', 'an', 'even', 'greater', 'percentage', 'of', 'drug', 'development', 'will', 'be', 'in', 'the', 'area', 'of', 'the', 'biologics', 'In', '2011', 'worldwide', 'there', 'were', 'over', '800', 'new', 'biotech', 'drugs', 'and', 'treatments', 'in', 'development', 'including', '23', 'antisense', '64', 'cell', 'therapy', '50', 'gene', 'therapy', '300', 'monoclonal', 'antibodies', '78', 'recombinant', 'proteins', 'and', '298', 'vaccines', 'PhRMA', '2012', 'Pharmaceutical', 'biotechnology', 'techniques', 'are', 'at', 'the', 'core', 'of', 'most', 'methodologies', 'used', 'today', 'for', 'drug', 'discovery', 'and', 'development', 'of', 'both', 'biologics', 'and', 'small', 'molecules', 'While', 'recombinant', 'DNA', 'technology', 'and', 'hybridoma', 'techniques', 'were', 'the', 'major', 'methods', 'utilized', 'in', 'pharmaceutical', 'biotechnology', 'through', 'most', 'of', 'its', 'historical', 'timeline', 'our', 'ever', 'widening', 'understanding', 'of', 'human', 'cellular', 'function', 'and', 'disease', 'processes', 'and', 'a', 'wealth', 'of', 'additional', 'and', 'innovative', 'biotechnologies', 'have', 'been', 'and', 'will', 'continue', 'to', 'be', 'developed', 'in', 'order', 'to', 'harvest', 'the', 'information', 'found', 'in', 'the', 'human', 'genome', 'These', 'technological', 'advances', 'will', 'provide', 'a', 'better', 'understanding', 'of', 'the', 'relationship', 'between', 'genetics', 'and', 'biological', 'function', 'unravel', 'the', 'underlying', 'causes', 'of', 'disease', 'explore', 'the', 'association', 'of', 'genomic', 'variation', 'and', 'drug', 'response', 'enhance', 'pharmaceutical', 'research', 'and', 'fuel', 'the', 'discovery', 'and', 'development', 'of', 'new', 'and', 'novel', 'biopharmaceuticals', 'These', 'revolutionary', 'technologies', 'and', 'additional', 'biotechnology', 'related', 'techniques', 'are', 'improving', 'the', 'very', 'competitive', 'and', 'costly', 'process', 'of', 'drug', 'development', 'of', 'new', 'medicinal', 'agents', 'diagnostics', 'and', 'medical', 'devices', 'Some', 'of', 'the', 'technologies', 'and', 'techniques', 'described', 'in', 'this', 'chapter', 'are', 'both', 'well', 'established', 'and', 'commonly', 'used', 'applications', 'of', 'biotechnology', 'producing', 'potential', 'therapeutic', 'products', 'now', 'in', 'development', 'including', 'clinical', 'trials', 'New', 'techniques', 'are', 'emerging', 'at', 'a', 'rapid', 'and', 'unprecedented', 'pace', 'and', 'their', 'full', 'impact', 'on', 'the', 'future', 'of', 'molecular', 'medicine', 'has', 'yet', 'to', 'be', 'imagined', '']"
15978,"Diagnosis, Discovery and Dissection of Viral Diseases",2014-02-27,Viral Infections of Humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122662/,"Only a few years ago, viral diagnosis was largely an exercise for academic researchers and public health practitioners with focus on epidemiologic analyses and outbreak prevention, detection, and control. Opportunities for therapeutic intervention were limited to only a few applications such as herpesvirus infections, influenza, and HIV/AIDS; hence, once a bacterial or fungal infection was excluded, clinicians were limited to providing supportive care for what was presumed to be a viral syndrome. Public health organizations tracked the incidence of viral infections and the development of resistance to the few antiviral drugs in use and provided input to governments and the pharmaceutical industry regarding selection of vaccine targets. More recently, interest in viral diagnostics has burgeoned with the advent of new tools for detection and discovery, global recognition of pandemic risk, high-throughput drug screening, rational drug design, and immunotherapeutics. An additional impetus has been the implication of viruses in chronic illnesses not previously attributed to infection. The objective of this chapter is to review the factors responsible for the rise in awareness of viral infections, methods for diagnosis and monitoring viral infections, and future prospects for improvements in discovery, detection, and response to the challenges of clinical virology.",10.1007/978-1-4899-7448-8_2,g0nf1iwm,"['Only', 'a', 'few', 'years', 'ago', 'viral', 'diagnosis', 'was', 'largely', 'an', 'exercise', 'for', 'academic', 'researchers', 'and', 'public', 'health', 'practitioners', 'with', 'focus', 'on', 'epidemiologic', 'analyses', 'and', 'outbreak', 'prevention', 'detection', 'and', 'control', 'Opportunities', 'for', 'therapeutic', 'intervention', 'were', 'limited', 'to', 'only', 'a', 'few', 'applications', 'such', 'as', 'herpesvirus', 'infections', 'influenza', 'and', 'HIV', 'AIDS', 'hence', 'once', 'a', 'bacterial', 'or', 'fungal', 'infection', 'was', 'excluded', 'clinicians', 'were', 'limited', 'to', 'providing', 'supportive', 'care', 'for', 'what', 'was', 'presumed', 'to', 'be', 'a', 'viral', 'syndrome', 'Public', 'health', 'organizations', 'tracked', 'the', 'incidence', 'of', 'viral', 'infections', 'and', 'the', 'development', 'of', 'resistance', 'to', 'the', 'few', 'antiviral', 'drugs', 'in', 'use', 'and', 'provided', 'input', 'to', 'governments', 'and', 'the', 'pharmaceutical', 'industry', 'regarding', 'selection', 'of', 'vaccine', 'targets', 'More', 'recently', 'interest', 'in', 'viral', 'diagnostics', 'has', 'burgeoned', 'with', 'the', 'advent', 'of', 'new', 'tools', 'for', 'detection', 'and', 'discovery', 'global', 'recognition', 'of', 'pandemic', 'risk', 'high', 'throughput', 'drug', 'screening', 'rational', 'drug', 'design', 'and', 'immunotherapeutics', 'An', 'additional', 'impetus', 'has', 'been', 'the', 'implication', 'of', 'viruses', 'in', 'chronic', 'illnesses', 'not', 'previously', 'attributed', 'to', 'infection', 'The', 'objective', 'of', 'this', 'chapter', 'is', 'to', 'review', 'the', 'factors', 'responsible', 'for', 'the', 'rise', 'in', 'awareness', 'of', 'viral', 'infections', 'methods', 'for', 'diagnosis', 'and', 'monitoring', 'viral', 'infections', 'and', 'future', 'prospects', 'for', 'improvements', 'in', 'discovery', 'detection', 'and', 'response', 'to', 'the', 'challenges', 'of', 'clinical', 'virology', '']"
16217,Gold Nanoparticles for DNA/RNA-Based Diagnostics,2015-08-07,Handbook of Nanoparticles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123017/,"The remarkable physicochemical properties of gold nanoparticles (AuNPs) have prompted development in exploring biomolecular interactions with AuNPs-containing systems, pursuing biomedical applications in diagnostics. Among these applications, AuNPs have been remarkably useful for the development of DNA/RNA detection and characterization systems for diagnostics, including systems suitable for point of need. Here, emphasis will be on available molecular detection schemes of relevant pathogens and their molecular characterization, genomic sequences associated with medical conditions (including cancer), mutation and polymorphism identification, and the quantification of gene expression.",10.1007/978-3-319-15338-4_31,unvsfyr9,"['The', 'remarkable', 'physicochemical', 'properties', 'of', 'gold', 'nanoparticles', 'AuNPs', 'have', 'prompted', 'development', 'in', 'exploring', 'biomolecular', 'interactions', 'with', 'AuNPs', 'containing', 'systems', 'pursuing', 'biomedical', 'applications', 'in', 'diagnostics', 'Among', 'these', 'applications', 'AuNPs', 'have', 'been', 'remarkably', 'useful', 'for', 'the', 'development', 'of', 'DNA', 'RNA', 'detection', 'and', 'characterization', 'systems', 'for', 'diagnostics', 'including', 'systems', 'suitable', 'for', 'point', 'of', 'need', 'Here', 'emphasis', 'will', 'be', 'on', 'available', 'molecular', 'detection', 'schemes', 'of', 'relevant', 'pathogens', 'and', 'their', 'molecular', 'characterization', 'genomic', 'sequences', 'associated', 'with', 'medical', 'conditions', 'including', 'cancer', 'mutation', 'and', 'polymorphism', 'identification', 'and', 'the', 'quantification', 'of', 'gene', 'expression', '']"
16359,Biochip Platforms for DNA Diagnostics,2009,Microarrays,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123192/,"This chapter looks at the use of microlithographically fabricated biochip platforms for DNA diagnostics and prognostics, although protein and RNA biochips are also briefly considered. Biodetection methods such as ion-selective electrodes (ISEs), microelectromechanical systems (MEMS) devices such as microcantilevers, optical, piezoelectric-based acoustic wave, and mass spectrometry are briefly discussed. Emphasis is given to label-free electrochemical (impedimetric, voltammet-ric, and amperometric) detection. The production of DNA biochips is highlighted as are the operation and design of the experiments to reveal gene expression and SNP data. Applications discussed include the monitoring of microbes, cancer classification studies, and patient stratification in drug development. Finally, challenges and issues facing the development of diagnostic and prognostic biochips are discussed in detail.",10.1007/978-0-387-72719-6_14,8hasilvh,"['This', 'chapter', 'looks', 'at', 'the', 'use', 'of', 'microlithographically', 'fabricated', 'biochip', 'platforms', 'for', 'DNA', 'diagnostics', 'and', 'prognostics', 'although', 'protein', 'and', 'RNA', 'biochips', 'are', 'also', 'briefly', 'considered', 'Biodetection', 'methods', 'such', 'as', 'ion', 'selective', 'electrodes', 'ISEs', 'microelectromechanical', 'systems', 'MEMS', 'devices', 'such', 'as', 'microcantilevers', 'optical', 'piezoelectric', 'based', 'acoustic', 'wave', 'and', 'mass', 'spectrometry', 'are', 'briefly', 'discussed', 'Emphasis', 'is', 'given', 'to', 'label', 'free', 'electrochemical', 'impedimetric', 'voltammet', 'ric', 'and', 'amperometric', 'detection', 'The', 'production', 'of', 'DNA', 'biochips', 'is', 'highlighted', 'as', 'are', 'the', 'operation', 'and', 'design', 'of', 'the', 'experiments', 'to', 'reveal', 'gene', 'expression', 'and', 'SNP', 'data', 'Applications', 'discussed', 'include', 'the', 'monitoring', 'of', 'microbes', 'cancer', 'classification', 'studies', 'and', 'patient', 'stratification', 'in', 'drug', 'development', 'Finally', 'challenges', 'and', 'issues', 'facing', 'the', 'development', 'of', 'diagnostic', 'and', 'prognostic', 'biochips', 'are', 'discussed', 'in', 'detail', '']"
16372,Laboratory Methods for Detecting Viral Infections,2013-08-12,Molecular Virology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123206/,"The first methods for detection of bacterial infections were available around 1880. After staining, bacterial pathogens were recognized in the light microscope because of their size and could be cultivated in culture media. Viruses evaded this approach, as they are significantly smaller, and as obligate parasites are not able to multiply in cell culture media. Although some viral infections could be associated with specific cellular changes and certain depositions in the infected tissue around the turn of the century, e.g. Negri inclusion bodies in nerve cells during rabies, a specific diagnosis was only possible through the development of cell culture methods and modern molecular biology. Today, viral infections can be detected directly by determining the agents, individual viral proteins, or their genetic information, or other materials in the blood of infected people or animals by using appropriate methods. Direct detection of viruses is possible, with the exception of latent or persistent infection forms, only during the acute phase of the disease. In some cases, the pathogens are present in the infected organism only before the symptomatic phase, so the direct detection of the virus is frequently not successful. Therefore, infections or contact with pathogens is usually demonstrated in virus diagnostics indirectly by characterization of the developing specific immune response.",10.1007/978-3-642-20718-1_13,26o3c7ps,"['The', 'first', 'methods', 'for', 'detection', 'of', 'bacterial', 'infections', 'were', 'available', 'around', '1880', 'After', 'staining', 'bacterial', 'pathogens', 'were', 'recognized', 'in', 'the', 'light', 'microscope', 'because', 'of', 'their', 'size', 'and', 'could', 'be', 'cultivated', 'in', 'culture', 'media', 'Viruses', 'evaded', 'this', 'approach', 'as', 'they', 'are', 'significantly', 'smaller', 'and', 'as', 'obligate', 'parasites', 'are', 'not', 'able', 'to', 'multiply', 'in', 'cell', 'culture', 'media', 'Although', 'some', 'viral', 'infections', 'could', 'be', 'associated', 'with', 'specific', 'cellular', 'changes', 'and', 'certain', 'depositions', 'in', 'the', 'infected', 'tissue', 'around', 'the', 'turn', 'of', 'the', 'century', 'e', 'g', 'Negri', 'inclusion', 'bodies', 'in', 'nerve', 'cells', 'during', 'rabies', 'a', 'specific', 'diagnosis', 'was', 'only', 'possible', 'through', 'the', 'development', 'of', 'cell', 'culture', 'methods', 'and', 'modern', 'molecular', 'biology', 'Today', 'viral', 'infections', 'can', 'be', 'detected', 'directly', 'by', 'determining', 'the', 'agents', 'individual', 'viral', 'proteins', 'or', 'their', 'genetic', 'information', 'or', 'other', 'materials', 'in', 'the', 'blood', 'of', 'infected', 'people', 'or', 'animals', 'by', 'using', 'appropriate', 'methods', 'Direct', 'detection', 'of', 'viruses', 'is', 'possible', 'with', 'the', 'exception', 'of', 'latent', 'or', 'persistent', 'infection', 'forms', 'only', 'during', 'the', 'acute', 'phase', 'of', 'the', 'disease', 'In', 'some', 'cases', 'the', 'pathogens', 'are', 'present', 'in', 'the', 'infected', 'organism', 'only', 'before', 'the', 'symptomatic', 'phase', 'so', 'the', 'direct', 'detection', 'of', 'the', 'virus', 'is', 'frequently', 'not', 'successful', 'Therefore', 'infections', 'or', 'contact', 'with', 'pathogens', 'is', 'usually', 'demonstrated', 'in', 'virus', 'diagnostics', 'indirectly', 'by', 'characterization', 'of', 'the', 'developing', 'specific', 'immune', 'response', '']"
17006,Nanomicrobiology,2012-06-12,The Handbook of Nanomedicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124020/,"Microbiology plays an important role in practice of medicine. Nanodiagnostics have refined the detection of infectious diseases and many new nanotechnology-based therapies, particularly of viral diseases, are in development.",10.1007/978-1-61779-983-9_14,h1c3hoz9,"['Microbiology', 'plays', 'an', 'important', 'role', 'in', 'practice', 'of', 'medicine', 'Nanodiagnostics', 'have', 'refined', 'the', 'detection', 'of', 'infectious', 'diseases', 'and', 'many', 'new', 'nanotechnology', 'based', 'therapies', 'particularly', 'of', 'viral', 'diseases', 'are', 'in', 'development', '']"
17093,Introduction to In Vitro Diagnostic Devices,2015-07-17,In-Vitro Diagnostic Devices,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124134/,"Healthcare investment keeps on increasing substantially in recent years. Such investment has also focused on fighting major diseases, enabled by the novel invention of cost-effective and valid drug development for treatment and side effect reduction, along with improved vector control. In addition, the demand for diagnostics that is essential in determining prognosis, identifying disease stages, monitoring treatment, and assessing the spreading as health services has expanded. Molecular-based diagnostics is critical for prevention, identification, and treatment of disease. Current laboratory analyses support correct diagnosis in over 70 % of all diseases and can be used to aid the continuous monitoring of drug therapy. However, classic diagnostic technologies are not completely well suited to meeting the expanded testing requirement because they rely on complicated sample purification and sophisticated instruments which are labor-intensive, timely, and expensive and require well-trained operators. One of the main challenges for industry is to develop fast, relatively accurate, easy-to-use, and inexpensive devices. In addition to the improved efficiency in laboratory diagnostics, there has been a trend toward a more decentralized diagnostics which occurs directly at patients’ bedside, in outpatient clinics, or at the sites of accidents, so-called point-of-care (POC) systems. The concept of POC testing is mainly for the patient, so short turnaround time, minimum sample preparation, reagent storage and transferring, user-friendly analytical instruments, and digital or visible quantitative or semiquantitative single readout are required. POC test is a great option of potential in vitro diagnostics (IVD) for resource-limited settings. It is clear that on-site or minimum sample preparation and on-chip storage limit the delays that caused by transport and preparation of clinical samples. Shorter turnaround time leads to rapid clinical decision-making and may save fatal consequences. No previous knowledge in sample analysis should be required, so elders can perform the tests at home with minimum training to improve health outcome. Lateral-flow immunoassay (LFIA) devices, for example, which were originally proposed in the 1980s, remain popular largely because of their design simplicity. The purpose of this article is to introduce readers with basic information regarding the LFIA approach that we think the most representative product of IVD test for solving global health issues.",10.1007/978-3-319-19737-1_1,u6m7vy6l,"['Healthcare', 'investment', 'keeps', 'on', 'increasing', 'substantially', 'in', 'recent', 'years', 'Such', 'investment', 'has', 'also', 'focused', 'on', 'fighting', 'major', 'diseases', 'enabled', 'by', 'the', 'novel', 'invention', 'of', 'cost', 'effective', 'and', 'valid', 'drug', 'development', 'for', 'treatment', 'and', 'side', 'effect', 'reduction', 'along', 'with', 'improved', 'vector', 'control', 'In', 'addition', 'the', 'demand', 'for', 'diagnostics', 'that', 'is', 'essential', 'in', 'determining', 'prognosis', 'identifying', 'disease', 'stages', 'monitoring', 'treatment', 'and', 'assessing', 'the', 'spreading', 'as', 'health', 'services', 'has', 'expanded', 'Molecular', 'based', 'diagnostics', 'is', 'critical', 'for', 'prevention', 'identification', 'and', 'treatment', 'of', 'disease', 'Current', 'laboratory', 'analyses', 'support', 'correct', 'diagnosis', 'in', 'over', '70', 'of', 'all', 'diseases', 'and', 'can', 'be', 'used', 'to', 'aid', 'the', 'continuous', 'monitoring', 'of', 'drug', 'therapy', 'However', 'classic', 'diagnostic', 'technologies', 'are', 'not', 'completely', 'well', 'suited', 'to', 'meeting', 'the', 'expanded', 'testing', 'requirement', 'because', 'they', 'rely', 'on', 'complicated', 'sample', 'purification', 'and', 'sophisticated', 'instruments', 'which', 'are', 'labor', 'intensive', 'timely', 'and', 'expensive', 'and', 'require', 'well', 'trained', 'operators', 'One', 'of', 'the', 'main', 'challenges', 'for', 'industry', 'is', 'to', 'develop', 'fast', 'relatively', 'accurate', 'easy', 'to', 'use', 'and', 'inexpensive', 'devices', 'In', 'addition', 'to', 'the', 'improved', 'efficiency', 'in', 'laboratory', 'diagnostics', 'there', 'has', 'been', 'a', 'trend', 'toward', 'a', 'more', 'decentralized', 'diagnostics', 'which', 'occurs', 'directly', 'at', 'patients', 'bedside', 'in', 'outpatient', 'clinics', 'or', 'at', 'the', 'sites', 'of', 'accidents', 'so', 'called', 'point', 'of', 'care', 'POC', 'systems', 'The', 'concept', 'of', 'POC', 'testing', 'is', 'mainly', 'for', 'the', 'patient', 'so', 'short', 'turnaround', 'time', 'minimum', 'sample', 'preparation', 'reagent', 'storage', 'and', 'transferring', 'user', 'friendly', 'analytical', 'instruments', 'and', 'digital', 'or', 'visible', 'quantitative', 'or', 'semiquantitative', 'single', 'readout', 'are', 'required', 'POC', 'test', 'is', 'a', 'great', 'option', 'of', 'potential', 'in', 'vitro', 'diagnostics', 'IVD', 'for', 'resource', 'limited', 'settings', 'It', 'is', 'clear', 'that', 'on', 'site', 'or', 'minimum', 'sample', 'preparation', 'and', 'on', 'chip', 'storage', 'limit', 'the', 'delays', 'that', 'caused', 'by', 'transport', 'and', 'preparation', 'of', 'clinical', 'samples', 'Shorter', 'turnaround', 'time', 'leads', 'to', 'rapid', 'clinical', 'decision', 'making', 'and', 'may', 'save', 'fatal', 'consequences', 'No', 'previous', 'knowledge', 'in', 'sample', 'analysis', 'should', 'be', 'required', 'so', 'elders', 'can', 'perform', 'the', 'tests', 'at', 'home', 'with', 'minimum', 'training', 'to', 'improve', 'health', 'outcome', 'Lateral', 'flow', 'immunoassay', 'LFIA', 'devices', 'for', 'example', 'which', 'were', 'originally', 'proposed', 'in', 'the', '1980s', 'remain', 'popular', 'largely', 'because', 'of', 'their', 'design', 'simplicity', 'The', 'purpose', 'of', 'this', 'article', 'is', 'to', 'introduce', 'readers', 'with', 'basic', 'information', 'regarding', 'the', 'LFIA', 'approach', 'that', 'we', 'think', 'the', 'most', 'representative', 'product', 'of', 'IVD', 'test', 'for', 'solving', 'global', 'health', 'issues', '']"
20084,Microbiology,2019-05-28,Hunter's Tropical Medicine and Emerging Infectious Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152427/,"The management and containment of many treatable and preventable infectious diseases in resource-poor countries is limited by the failure to make an accurate diagnosis. Most of the world's population lacks access to accurate, affordable, easy-to-use, quality-assured, reliable, and accessible diagnostic tests and misdiagnosis of infectious diseases is common and compromises patient care. Laboratory diagnostics are also needed for the detection and surveillance of the increasing levels of antimicrobial resistance. Accurate clinical diagnosis in resource-poor settings relies strongly on the laboratory service, and the need to support the development of a quality-assured laboratory service in such settings is increasingly recognized. International organizations are actively working with local and national providers to improve laboratory services. The development of laboratory services will contribute to improved health for the local population, protection against emerging pathogens, and ensure better use of scarce health care resources.",10.1016/b978-0-323-55512-8.00021-1,soqeje4z,"['The', 'management', 'and', 'containment', 'of', 'many', 'treatable', 'and', 'preventable', 'infectious', 'diseases', 'in', 'resource', 'poor', 'countries', 'is', 'limited', 'by', 'the', 'failure', 'to', 'make', 'an', 'accurate', 'diagnosis', 'Most', 'of', 'the', 'world', 's', 'population', 'lacks', 'access', 'to', 'accurate', 'affordable', 'easy', 'to', 'use', 'quality', 'assured', 'reliable', 'and', 'accessible', 'diagnostic', 'tests', 'and', 'misdiagnosis', 'of', 'infectious', 'diseases', 'is', 'common', 'and', 'compromises', 'patient', 'care', 'Laboratory', 'diagnostics', 'are', 'also', 'needed', 'for', 'the', 'detection', 'and', 'surveillance', 'of', 'the', 'increasing', 'levels', 'of', 'antimicrobial', 'resistance', 'Accurate', 'clinical', 'diagnosis', 'in', 'resource', 'poor', 'settings', 'relies', 'strongly', 'on', 'the', 'laboratory', 'service', 'and', 'the', 'need', 'to', 'support', 'the', 'development', 'of', 'a', 'quality', 'assured', 'laboratory', 'service', 'in', 'such', 'settings', 'is', 'increasingly', 'recognized', 'International', 'organizations', 'are', 'actively', 'working', 'with', 'local', 'and', 'national', 'providers', 'to', 'improve', 'laboratory', 'services', 'The', 'development', 'of', 'laboratory', 'services', 'will', 'contribute', 'to', 'improved', 'health', 'for', 'the', 'local', 'population', 'protection', 'against', 'emerging', 'pathogens', 'and', 'ensure', 'better', 'use', 'of', 'scarce', 'health', 'care', 'resources', '']"
20170,Global Microbial Identifier,2017-01-24,Applied Genomics of Foodborne Pathogens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153444/,"Human and animal populations are increasingly confronted with emerging and re-emerging infections and often such infections are exchanged between these populations, e.g. through food. A more effective and uniform approach to the prevention of these microbial threats is essential. The technological advances in the next generation sequencing field and decreasing costs of these tests provide novel opportunities in understanding the dynamics of infection—even in real time—through the analysis of microbial genome diversity. The projected significant increase in whole (microbial) genome sequencing (WGS) will likely also enable a much better understanding of the pathogenesis of the infection and the molecular basis of the host response to infection. But the full potential of these advances will only transpire if the data in this area become transferable and thereby comparable, preferably in open-source systems. There is therefore an obvious need to develop a global system of whole microbial genome databases to aggregate, share, mine and use microbiological genomic data, to address global public health and clinical challenges, and most importantly to identify and diagnose infectious diseases. The global microbial identifier (GMI) initiative, aims to build a database of whole microbial genome sequencing data linked to relevant metadata, which can be used to identify microorganisms, their communities and the diseases they cause. It would be a platform for storing whole genome sequencing (WGS) data of microorganisms, for the identification of relevant genes and for the comparison of genomes to detect outbreaks and emerging pathogens. To harness the full potential of WGS, a shared global database of genomes linked to relevant metadata and the necessary software tools needs to be generated, hence the global microbial identifier (GMI) initiative. This tool will ideally be used in amongst others in the diagnosis of infectious diseases in humans and animals, in the identification of microorganisms in food and environment, and to track and trace microbial agents in all arenas globally. This will require standardization and extensive investments in computational analytical tools. In addition, the wider introduction of WGS in clinical diagnostics can accelerate developments in health care in many poor countries. This overview describes the growing network of stakeholders behind GMI, the contours of the database, and the IT structures needed to serve the GMI user community. It discusses what essentially can be done by a global GMI tool and how the GMI organization could help achieve these goals.",10.1007/978-3-319-43751-4_2,lkw7ony8,"['Human', 'and', 'animal', 'populations', 'are', 'increasingly', 'confronted', 'with', 'emerging', 'and', 're', 'emerging', 'infections', 'and', 'often', 'such', 'infections', 'are', 'exchanged', 'between', 'these', 'populations', 'e', 'g', 'through', 'food', 'A', 'more', 'effective', 'and', 'uniform', 'approach', 'to', 'the', 'prevention', 'of', 'these', 'microbial', 'threats', 'is', 'essential', 'The', 'technological', 'advances', 'in', 'the', 'next', 'generation', 'sequencing', 'field', 'and', 'decreasing', 'costs', 'of', 'these', 'tests', 'provide', 'novel', 'opportunities', 'in', 'understanding', 'the', 'dynamics', 'of', 'infection', 'even', 'in', 'real', 'time', 'through', 'the', 'analysis', 'of', 'microbial', 'genome', 'diversity', 'The', 'projected', 'significant', 'increase', 'in', 'whole', 'microbial', 'genome', 'sequencing', 'WGS', 'will', 'likely', 'also', 'enable', 'a', 'much', 'better', 'understanding', 'of', 'the', 'pathogenesis', 'of', 'the', 'infection', 'and', 'the', 'molecular', 'basis', 'of', 'the', 'host', 'response', 'to', 'infection', 'But', 'the', 'full', 'potential', 'of', 'these', 'advances', 'will', 'only', 'transpire', 'if', 'the', 'data', 'in', 'this', 'area', 'become', 'transferable', 'and', 'thereby', 'comparable', 'preferably', 'in', 'open', 'source', 'systems', 'There', 'is', 'therefore', 'an', 'obvious', 'need', 'to', 'develop', 'a', 'global', 'system', 'of', 'whole', 'microbial', 'genome', 'databases', 'to', 'aggregate', 'share', 'mine', 'and', 'use', 'microbiological', 'genomic', 'data', 'to', 'address', 'global', 'public', 'health', 'and', 'clinical', 'challenges', 'and', 'most', 'importantly', 'to', 'identify', 'and', 'diagnose', 'infectious', 'diseases', 'The', 'global', 'microbial', 'identifier', 'GMI', 'initiative', 'aims', 'to', 'build', 'a', 'database', 'of', 'whole', 'microbial', 'genome', 'sequencing', 'data', 'linked', 'to', 'relevant', 'metadata', 'which', 'can', 'be', 'used', 'to', 'identify', 'microorganisms', 'their', 'communities', 'and', 'the', 'diseases', 'they', 'cause', 'It', 'would', 'be', 'a', 'platform', 'for', 'storing', 'whole', 'genome', 'sequencing', 'WGS', 'data', 'of', 'microorganisms', 'for', 'the', 'identification', 'of', 'relevant', 'genes', 'and', 'for', 'the', 'comparison', 'of', 'genomes', 'to', 'detect', 'outbreaks', 'and', 'emerging', 'pathogens', 'To', 'harness', 'the', 'full', 'potential', 'of', 'WGS', 'a', 'shared', 'global', 'database', 'of', 'genomes', 'linked', 'to', 'relevant', 'metadata', 'and', 'the', 'necessary', 'software', 'tools', 'needs', 'to', 'be', 'generated', 'hence', 'the', 'global', 'microbial', 'identifier', 'GMI', 'initiative', 'This', 'tool', 'will', 'ideally', 'be', 'used', 'in', 'amongst', 'others', 'in', 'the', 'diagnosis', 'of', 'infectious', 'diseases', 'in', 'humans', 'and', 'animals', 'in', 'the', 'identification', 'of', 'microorganisms', 'in', 'food', 'and', 'environment', 'and', 'to', 'track', 'and', 'trace', 'microbial', 'agents', 'in', 'all', 'arenas', 'globally', 'This', 'will', 'require', 'standardization', 'and', 'extensive', 'investments', 'in', 'computational', 'analytical', 'tools', 'In', 'addition', 'the', 'wider', 'introduction', 'of', 'WGS', 'in', 'clinical', 'diagnostics', 'can', 'accelerate', 'developments', 'in', 'health', 'care', 'in', 'many', 'poor', 'countries', 'This', 'overview', 'describes', 'the', 'growing', 'network', 'of', 'stakeholders', 'behind', 'GMI', 'the', 'contours', 'of', 'the', 'database', 'and', 'the', 'IT', 'structures', 'needed', 'to', 'serve', 'the', 'GMI', 'user', 'community', 'It', 'discusses', 'what', 'essentially', 'can', 'be', 'done', 'by', 'a', 'global', 'GMI', 'tool', 'and', 'how', 'the', 'GMI', 'organization', 'could', 'help', 'achieve', 'these', 'goals', '']"
20244,Current and Future Applications of Monoclonal Antibodies against Bacteria in Veterinary Medicine,2014-06-27,Monoclonal Antibodies Against Bacteria,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155467/,"This chapter discusses the current and future applications of monoclonal antibodies against bacteria in veterinary medicine. It discusses the existing applications of monoclonal antibodies, including the use of pilus-specific monoclonal antibodies for passive immunization of calves and piglets against enteropathogenic E. coli (EPEC) infections as well as the development of rapid diagnostic test kits for field diagnosis of EPEC infections. The potential applications of monoclonal antibodies for passive immunization against a variety of veterinary pathogens are passive immunization against Moraxella bovis (pinkeye), Bacteroides nodosus (foot rot), EPEC enterotoxin (enteric colibacillosis), Pasteurella haemolytica (pneumonic pasteurellosis), and Streptococcus equi (strangles). Three main areas of application for monoclonal antibodies against bacterial antigens in veterinary medicine are passive immunization, improved immunodiagnostics, and immunotherapy. Monoclonal antibodies, because of their specificity, unlimited availability, and high titer, represent excellent passive immunizing agents. However, their potential usefulness in preventing infection must be evaluated on a case-by-case basis.",10.1016/b978-0-12-463003-1.50018-6,hxph2xid,"['This', 'chapter', 'discusses', 'the', 'current', 'and', 'future', 'applications', 'of', 'monoclonal', 'antibodies', 'against', 'bacteria', 'in', 'veterinary', 'medicine', 'It', 'discusses', 'the', 'existing', 'applications', 'of', 'monoclonal', 'antibodies', 'including', 'the', 'use', 'of', 'pilus', 'specific', 'monoclonal', 'antibodies', 'for', 'passive', 'immunization', 'of', 'calves', 'and', 'piglets', 'against', 'enteropathogenic', 'E', 'coli', 'EPEC', 'infections', 'as', 'well', 'as', 'the', 'development', 'of', 'rapid', 'diagnostic', 'test', 'kits', 'for', 'field', 'diagnosis', 'of', 'EPEC', 'infections', 'The', 'potential', 'applications', 'of', 'monoclonal', 'antibodies', 'for', 'passive', 'immunization', 'against', 'a', 'variety', 'of', 'veterinary', 'pathogens', 'are', 'passive', 'immunization', 'against', 'Moraxella', 'bovis', 'pinkeye', 'Bacteroides', 'nodosus', 'foot', 'rot', 'EPEC', 'enterotoxin', 'enteric', 'colibacillosis', 'Pasteurella', 'haemolytica', 'pneumonic', 'pasteurellosis', 'and', 'Streptococcus', 'equi', 'strangles', 'Three', 'main', 'areas', 'of', 'application', 'for', 'monoclonal', 'antibodies', 'against', 'bacterial', 'antigens', 'in', 'veterinary', 'medicine', 'are', 'passive', 'immunization', 'improved', 'immunodiagnostics', 'and', 'immunotherapy', 'Monoclonal', 'antibodies', 'because', 'of', 'their', 'specificity', 'unlimited', 'availability', 'and', 'high', 'titer', 'represent', 'excellent', 'passive', 'immunizing', 'agents', 'However', 'their', 'potential', 'usefulness', 'in', 'preventing', 'infection', 'must', 'be', 'evaluated', 'on', 'a', 'case', 'by', 'case', 'basis', '']"
22063,A Fast and Sensitive Integrated Young Interferometer Biosensor,2009-05-14,Advanced Photonic Structures for Biological and Chemical Detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187954/,"We have developed an ultrasensitive biosensor based on an integrated optical Young interferometer. Key features of this sensor are that it is very compact, extremely sensitive, label free, and very fast. Therefore the Young interferometer has significant potential to be developed into a handheld, point-of-care device. In this chapter we review the progress that has been made on the development of integrated Young interferometer sensors. The sensor developed in our lab is discussed in detail. We demonstrate various applications of the current sensor. Special attention is paid to the detection of viruses. Finally a discussion on future prospects of this sensor for diagnostics is given.",10.1007/978-0-387-98063-8_10,gbksid8n,"['We', 'have', 'developed', 'an', 'ultrasensitive', 'biosensor', 'based', 'on', 'an', 'integrated', 'optical', 'Young', 'interferometer', 'Key', 'features', 'of', 'this', 'sensor', 'are', 'that', 'it', 'is', 'very', 'compact', 'extremely', 'sensitive', 'label', 'free', 'and', 'very', 'fast', 'Therefore', 'the', 'Young', 'interferometer', 'has', 'significant', 'potential', 'to', 'be', 'developed', 'into', 'a', 'handheld', 'point', 'of', 'care', 'device', 'In', 'this', 'chapter', 'we', 'review', 'the', 'progress', 'that', 'has', 'been', 'made', 'on', 'the', 'development', 'of', 'integrated', 'Young', 'interferometer', 'sensors', 'The', 'sensor', 'developed', 'in', 'our', 'lab', 'is', 'discussed', 'in', 'detail', 'We', 'demonstrate', 'various', 'applications', 'of', 'the', 'current', 'sensor', 'Special', 'attention', 'is', 'paid', 'to', 'the', 'detection', 'of', 'viruses', 'Finally', 'a', 'discussion', 'on', 'future', 'prospects', 'of', 'this', 'sensor', 'for', 'diagnostics', 'is', 'given', '']"
23785,Method for the elucidation of LAMP products captured on lateral flow strips in a point of care test for HPV 16,2020-06-03,Anal Bioanal Chem,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266737/,"Loop-mediated amplification (LAMP) is an isothermal amplification technique favored in diagnostics and point-of-care work due to its high sensitivity and ability to run in isothermal conditions. In addition, a visual readout by lateral flow strips (LFS) can be used in conjunction with LAMP, making the assay accessible at the point-of-care. However, the amplicons resulting from a LAMP reaction varied in length and shape, making them undiscernible on a double-stranded DNA intercalating dye stained gel. Standard characterization techniques also do not identify which amplicons specifically bind to the LFS, which generate the visual readout. We aimed to standardize our characterization of LAMP products during assay development by using fluorescein amidite (FAM) and biotin-tagged loop forward and backward primers during assay development. A pvuII restriction enzyme digest is applied to the LAMP products. FAM-tagged bands are directly correlated with the LFS visual readout. We applied this assay development workflow for an HPV 16 assay using both plasmid DNA and clinical samples to demonstrate proof of concept for generalized assay development work. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00216-020-02702-9) contains supplementary material, which is available to authorized users.",10.1007/s00216-020-02702-9,g9uxb6xw,"['Loop', 'mediated', 'amplification', 'LAMP', 'is', 'an', 'isothermal', 'amplification', 'technique', 'favored', 'in', 'diagnostics', 'and', 'point', 'of', 'care', 'work', 'due', 'to', 'its', 'high', 'sensitivity', 'and', 'ability', 'to', 'run', 'in', 'isothermal', 'conditions', 'In', 'addition', 'a', 'visual', 'readout', 'by', 'lateral', 'flow', 'strips', 'LFS', 'can', 'be', 'used', 'in', 'conjunction', 'with', 'LAMP', 'making', 'the', 'assay', 'accessible', 'at', 'the', 'point', 'of', 'care', 'However', 'the', 'amplicons', 'resulting', 'from', 'a', 'LAMP', 'reaction', 'varied', 'in', 'length', 'and', 'shape', 'making', 'them', 'undiscernible', 'on', 'a', 'double', 'stranded', 'DNA', 'intercalating', 'dye', 'stained', 'gel', 'Standard', 'characterization', 'techniques', 'also', 'do', 'not', 'identify', 'which', 'amplicons', 'specifically', 'bind', 'to', 'the', 'LFS', 'which', 'generate', 'the', 'visual', 'readout', 'We', 'aimed', 'to', 'standardize', 'our', 'characterization', 'of', 'LAMP', 'products', 'during', 'assay', 'development', 'by', 'using', 'fluorescein', 'amidite', 'FAM', 'and', 'biotin', 'tagged', 'loop', 'forward', 'and', 'backward', 'primers', 'during', 'assay', 'development', 'A', 'pvuII', 'restriction', 'enzyme', 'digest', 'is', 'applied', 'to', 'the', 'LAMP', 'products', 'FAM', 'tagged', 'bands', 'are', 'directly', 'correlated', 'with', 'the', 'LFS', 'visual', 'readout', 'We', 'applied', 'this', 'assay', 'development', 'workflow', 'for', 'an', 'HPV', '16', 'assay', 'using', 'both', 'plasmid', 'DNA', 'and', 'clinical', 'samples', 'to', 'demonstrate', 'proof', 'of', 'concept', 'for', 'generalized', 'assay', 'development', 'work', 'ELECTRONIC', 'SUPPLEMENTARY', 'MATERIAL', 'The', 'online', 'version', 'of', 'this', 'article', '10', '1007', 's00216', '020', '02702', '9', 'contains', 'supplementary', 'material', 'which', 'is', 'available', 'to', 'authorized', 'users', '']"
23820,"Molecular Pathology Economics 101: an Overview of Molecular Diagnostics Coding, Coverage and Reimbursement",2020-06-03,J Mol Diagn,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267794/,"Widespread indications for use of molecular diagnostics in various aspects of clinical medicine have driven proliferation of testing. The rapid adoption and continuous technological evolution of molecular diagnostics have often strained the development and maintenance of a functional underlying framework of coding, coverage, and reimbursement policies, thereby presenting challenges to various stakeholders including molecular professionals, payers, and patients. A multidisciplinary working group convened by the Association for Molecular Pathology Economic Affairs Committee was tasked to describe the complex landscape of molecular pathology economics and highlight opportunities for member engagement. In this manuscript, on the basis of review and synthesis of government regulations and procedures, published payer policy documents, peer-reviewed literature, and expert consensus, the Working Group navigates the ecosystem of molecular pathology economics in terms of stakeholders, coding systems and processes, coverage policy determination, and pricing mechanisms. The composition and interrelatedness of various working groups and committees are emphasized in order to highlight the functional underpinnings of the system. Molecular professionals must be conversant in the language and complex inner workings of molecular pathology economics in order to lead successful, viable laboratories and advocate effectively for policy development on their behalf. This overview is provided to be a resource to molecular professionals as they navigate the reimbursement landscape.",10.1016/j.jmoldx.2020.05.008,72gr3hv3,"['Widespread', 'indications', 'for', 'use', 'of', 'molecular', 'diagnostics', 'in', 'various', 'aspects', 'of', 'clinical', 'medicine', 'have', 'driven', 'proliferation', 'of', 'testing', 'The', 'rapid', 'adoption', 'and', 'continuous', 'technological', 'evolution', 'of', 'molecular', 'diagnostics', 'have', 'often', 'strained', 'the', 'development', 'and', 'maintenance', 'of', 'a', 'functional', 'underlying', 'framework', 'of', 'coding', 'coverage', 'and', 'reimbursement', 'policies', 'thereby', 'presenting', 'challenges', 'to', 'various', 'stakeholders', 'including', 'molecular', 'professionals', 'payers', 'and', 'patients', 'A', 'multidisciplinary', 'working', 'group', 'convened', 'by', 'the', 'Association', 'for', 'Molecular', 'Pathology', 'Economic', 'Affairs', 'Committee', 'was', 'tasked', 'to', 'describe', 'the', 'complex', 'landscape', 'of', 'molecular', 'pathology', 'economics', 'and', 'highlight', 'opportunities', 'for', 'member', 'engagement', 'In', 'this', 'manuscript', 'on', 'the', 'basis', 'of', 'review', 'and', 'synthesis', 'of', 'government', 'regulations', 'and', 'procedures', 'published', 'payer', 'policy', 'documents', 'peer', 'reviewed', 'literature', 'and', 'expert', 'consensus', 'the', 'Working', 'Group', 'navigates', 'the', 'ecosystem', 'of', 'molecular', 'pathology', 'economics', 'in', 'terms', 'of', 'stakeholders', 'coding', 'systems', 'and', 'processes', 'coverage', 'policy', 'determination', 'and', 'pricing', 'mechanisms', 'The', 'composition', 'and', 'interrelatedness', 'of', 'various', 'working', 'groups', 'and', 'committees', 'are', 'emphasized', 'in', 'order', 'to', 'highlight', 'the', 'functional', 'underpinnings', 'of', 'the', 'system', 'Molecular', 'professionals', 'must', 'be', 'conversant', 'in', 'the', 'language', 'and', 'complex', 'inner', 'workings', 'of', 'molecular', 'pathology', 'economics', 'in', 'order', 'to', 'lead', 'successful', 'viable', 'laboratories', 'and', 'advocate', 'effectively', 'for', 'policy', 'development', 'on', 'their', 'behalf', 'This', 'overview', 'is', 'provided', 'to', 'be', 'a', 'resource', 'to', 'molecular', 'professionals', 'as', 'they', 'navigate', 'the', 'reimbursement', 'landscape', '']"
27701,Current Applications for Nuclear Medicine Imaging in Pulmonary Disease,2020-07-22,Curr Pulmonol Rep,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374080/,"PURPOSE OF REVIEW: The main goal of the article is to familiarize the reader with commonly and uncommonly used nuclear medicine procedures that can significantly contribute to improved patient care. The article presents examples of specific modality utilization in the chest including assessment of lung ventilation and perfusion, imaging options for broad range of infectious and inflammatory processes, and selected aspects of oncologic imaging. In addition, rapidly developing new techniques utilizing molecular imaging are discussed. RECENT FINDINGS: The article describes nuclear medicine imaging modalities including gamma camera, SPECT, PET, and hybrid imaging (SPECT/CT, PET/CT, and PET/MR) in the context of established and emerging clinical applications. Areas of potential future development in nuclear medicine are discussed with emphasis on molecular imaging and implementation of new targeted tracers used in diagnostics and therapeutics (theranostics). SUMMARY: Nuclear medicine and molecular imaging provide many unique and novel options for the diagnosis and treatment of pulmonary diseases. This article reviews current applications for nuclear medicine and molecular imaging and selected future applications for radiopharmaceuticals and targeted molecular imaging techniques.",10.1007/s13665-020-00251-1,qndb0zno,"['PURPOSE', 'OF', 'REVIEW', 'The', 'main', 'goal', 'of', 'the', 'article', 'is', 'to', 'familiarize', 'the', 'reader', 'with', 'commonly', 'and', 'uncommonly', 'used', 'nuclear', 'medicine', 'procedures', 'that', 'can', 'significantly', 'contribute', 'to', 'improved', 'patient', 'care', 'The', 'article', 'presents', 'examples', 'of', 'specific', 'modality', 'utilization', 'in', 'the', 'chest', 'including', 'assessment', 'of', 'lung', 'ventilation', 'and', 'perfusion', 'imaging', 'options', 'for', 'broad', 'range', 'of', 'infectious', 'and', 'inflammatory', 'processes', 'and', 'selected', 'aspects', 'of', 'oncologic', 'imaging', 'In', 'addition', 'rapidly', 'developing', 'new', 'techniques', 'utilizing', 'molecular', 'imaging', 'are', 'discussed', 'RECENT', 'FINDINGS', 'The', 'article', 'describes', 'nuclear', 'medicine', 'imaging', 'modalities', 'including', 'gamma', 'camera', 'SPECT', 'PET', 'and', 'hybrid', 'imaging', 'SPECT', 'CT', 'PET', 'CT', 'and', 'PET', 'MR', 'in', 'the', 'context', 'of', 'established', 'and', 'emerging', 'clinical', 'applications', 'Areas', 'of', 'potential', 'future', 'development', 'in', 'nuclear', 'medicine', 'are', 'discussed', 'with', 'emphasis', 'on', 'molecular', 'imaging', 'and', 'implementation', 'of', 'new', 'targeted', 'tracers', 'used', 'in', 'diagnostics', 'and', 'therapeutics', 'theranostics', 'SUMMARY', 'Nuclear', 'medicine', 'and', 'molecular', 'imaging', 'provide', 'many', 'unique', 'and', 'novel', 'options', 'for', 'the', 'diagnosis', 'and', 'treatment', 'of', 'pulmonary', 'diseases', 'This', 'article', 'reviews', 'current', 'applications', 'for', 'nuclear', 'medicine', 'and', 'molecular', 'imaging', 'and', 'selected', 'future', 'applications', 'for', 'radiopharmaceuticals', 'and', 'targeted', 'molecular', 'imaging', 'techniques', '']"
28537,Improvements in Patient Monitoring for the Intensive Care Unit: Survey Study.,2020-05-13,Journal of medical Internet research,https://doi.org/10.2196/19091; https://www.ncbi.nlm.nih.gov/pubmed/32459655/,"BACKGROUND Due to demographic change and, more recently, the Coronavirus Disease 2019 (COVID-19), the importance of modern intensive care units (ICU) is becoming apparent. One of the key components of an ICU is the continuous monitoring of patients' vital parameters. However, existing advances in informatics, signal processing, or engineering that could alleviate the burden on ICUs have not yet been applied. This could be related to the lack of user involvement in research and development. OBJECTIVE This study focused on satisfaction of ICU staff with the current patient monitoring and their suggestions for future improvements. We aimed to identify aspects disturbing patient care, display devices for remote monitoring, use cases for artificial intelligence (AI), and whether ICU staff is willing to improve their digital literacy or contribute to the improvement of patient monitoring. We further desired to uncover differences in the responses of the professional groups. METHODS This survey study was realized with ICU staff from four ICUs of a German university hospital between November 2019 and January 2020. We developed a web-based 36-item survey questionnaire by analyzing a preceding qualitative interview study with ICU staff about clinical requirements of future patient monitoring. Statistical analyses of questionnaire results included median values with their bootstrapped 95% confidence intervals, and Chi-square tests to compare the distributions of item responses of the professional groups. RESULTS Eighty-six of the 270 ICU physicians and nurses completed the survey questionnaire. The majority stated to feel confident using the patient monitoring, but high rates of false positive alarms and the many sensor cables were considered to disturb patient care. Wireless sensors, reduction of false positive alarms and hospital standard operating procedures (SOP) for alarm management were demanded. Responses to the display devices proposed for remote patient monitoring were split. Regarding its use, most respondents indicated responsibility for multiple wards or earlier alerting. AI for ICUs would be useful for early detection of complications and increased risk of mortality, as well as to have guidelines for therapy and diagnostics proposed. Transparency, interoperability, usability, and staff training were essential to promote usage of an AI. The majority wanted to learn more about new technologies for ICU and desired more time for it. Physicians had fewer reservations than nurses about using mobile phones for remote monitoring, and AI-based intelligent alarm management. CONCLUSIONS This survey study among ICU staff revealed key improvements for patient monitoring in intensive care medicine. Hospital providers and medical device manufacturers should focus on reducing false alarms, implementing hospital alarm SOPs, introducing wireless sensors, preparing for the use of AI, and enhancing digital literacy of ICU staff. Our results may contribute to the user-centered transfer of digital technologies into practice to alleviate challenges in intensive care medicine. CLINICALTRIAL ClinicalTrials.gov NCT03514173; https://clinicaltrials.gov/ct2/show/NCT03514173.",10.2196/19091,kml27hvb,"['BACKGROUND', 'Due', 'to', 'demographic', 'change', 'and', 'more', 'recently', 'the', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'the', 'importance', 'of', 'modern', 'intensive', 'care', 'units', 'ICU', 'is', 'becoming', 'apparent', 'One', 'of', 'the', 'key', 'components', 'of', 'an', 'ICU', 'is', 'the', 'continuous', 'monitoring', 'of', 'patients', 'vital', 'parameters', 'However', 'existing', 'advances', 'in', 'informatics', 'signal', 'processing', 'or', 'engineering', 'that', 'could', 'alleviate', 'the', 'burden', 'on', 'ICUs', 'have', 'not', 'yet', 'been', 'applied', 'This', 'could', 'be', 'related', 'to', 'the', 'lack', 'of', 'user', 'involvement', 'in', 'research', 'and', 'development', 'OBJECTIVE', 'This', 'study', 'focused', 'on', 'satisfaction', 'of', 'ICU', 'staff', 'with', 'the', 'current', 'patient', 'monitoring', 'and', 'their', 'suggestions', 'for', 'future', 'improvements', 'We', 'aimed', 'to', 'identify', 'aspects', 'disturbing', 'patient', 'care', 'display', 'devices', 'for', 'remote', 'monitoring', 'use', 'cases', 'for', 'artificial', 'intelligence', 'AI', 'and', 'whether', 'ICU', 'staff', 'is', 'willing', 'to', 'improve', 'their', 'digital', 'literacy', 'or', 'contribute', 'to', 'the', 'improvement', 'of', 'patient', 'monitoring', 'We', 'further', 'desired', 'to', 'uncover', 'differences', 'in', 'the', 'responses', 'of', 'the', 'professional', 'groups', 'METHODS', 'This', 'survey', 'study', 'was', 'realized', 'with', 'ICU', 'staff', 'from', 'four', 'ICUs', 'of', 'a', 'German', 'university', 'hospital', 'between', 'November', '2019', 'and', 'January', '2020', 'We', 'developed', 'a', 'web', 'based', '36', 'item', 'survey', 'questionnaire', 'by', 'analyzing', 'a', 'preceding', 'qualitative', 'interview', 'study', 'with', 'ICU', 'staff', 'about', 'clinical', 'requirements', 'of', 'future', 'patient', 'monitoring', 'Statistical', 'analyses', 'of', 'questionnaire', 'results', 'included', 'median', 'values', 'with', 'their', 'bootstrapped', '95', 'confidence', 'intervals', 'and', 'Chi', 'square', 'tests', 'to', 'compare', 'the', 'distributions', 'of', 'item', 'responses', 'of', 'the', 'professional', 'groups', 'RESULTS', 'Eighty', 'six', 'of', 'the', '270', 'ICU', 'physicians', 'and', 'nurses', 'completed', 'the', 'survey', 'questionnaire', 'The', 'majority', 'stated', 'to', 'feel', 'confident', 'using', 'the', 'patient', 'monitoring', 'but', 'high', 'rates', 'of', 'false', 'positive', 'alarms', 'and', 'the', 'many', 'sensor', 'cables', 'were', 'considered', 'to', 'disturb', 'patient', 'care', 'Wireless', 'sensors', 'reduction', 'of', 'false', 'positive', 'alarms', 'and', 'hospital', 'standard', 'operating', 'procedures', 'SOP', 'for', 'alarm', 'management', 'were', 'demanded', 'Responses', 'to', 'the', 'display', 'devices', 'proposed', 'for', 'remote', 'patient', 'monitoring', 'were', 'split', 'Regarding', 'its', 'use', 'most', 'respondents', 'indicated', 'responsibility', 'for', 'multiple', 'wards', 'or', 'earlier', 'alerting', 'AI', 'for', 'ICUs', 'would', 'be', 'useful', 'for', 'early', 'detection', 'of', 'complications', 'and', 'increased', 'risk', 'of', 'mortality', 'as', 'well', 'as', 'to', 'have', 'guidelines', 'for', 'therapy', 'and', 'diagnostics', 'proposed', 'Transparency', 'interoperability', 'usability', 'and', 'staff', 'training', 'were', 'essential', 'to', 'promote', 'usage', 'of', 'an', 'AI', 'The', 'majority', 'wanted', 'to', 'learn', 'more', 'about', 'new', 'technologies', 'for', 'ICU', 'and', 'desired', 'more', 'time', 'for', 'it', 'Physicians', 'had', 'fewer', 'reservations', 'than', 'nurses', 'about', 'using', 'mobile', 'phones', 'for', 'remote', 'monitoring', 'and', 'AI', 'based', 'intelligent', 'alarm', 'management', 'CONCLUSIONS', 'This', 'survey', 'study', 'among', 'ICU', 'staff', 'revealed', 'key', 'improvements', 'for', 'patient', 'monitoring', 'in', 'intensive', 'care', 'medicine', 'Hospital', 'providers', 'and', 'medical', 'device', 'manufacturers', 'should', 'focus', 'on', 'reducing', 'false', 'alarms', 'implementing', 'hospital', 'alarm', 'SOPs', 'introducing', 'wireless', 'sensors', 'preparing', 'for', 'the', 'use', 'of', 'AI', 'and', 'enhancing', 'digital', 'literacy', 'of', 'ICU', 'staff', 'Our', 'results', 'may', 'contribute', 'to', 'the', 'user', 'centered', 'transfer', 'of', 'digital', 'technologies', 'into', 'practice', 'to', 'alleviate', 'challenges', 'in', 'intensive', 'care', 'medicine', 'CLINICALTRIAL', 'ClinicalTrials', 'gov', 'NCT03514173', 'https', 'clinicaltrials', 'gov', 'ct2', 'show', 'NCT03514173', '']"
28613,Paper-based microfluidic point-of-care diagnostic devices.,2013,Lab on a chip,https://doi.org/10.1039/c3lc50169h; https://www.ncbi.nlm.nih.gov/pubmed/23652632/,"Dipstick and lateral-flow formats have dominated rapid diagnostics over the last three decades. These formats gained popularity in the consumer markets due to their compactness, portability and facile interpretation without external instrumentation. However, lack of quantitation in measurements has challenged the demand of existing assay formats in consumer markets. Recently, paper-based microfluidics has emerged as a multiplexable point-of-care platform which might transcend the capabilities of existing assays in resource-limited settings. However, paper-based microfluidics can enable fluid handling and quantitative analysis for potential applications in healthcare, veterinary medicine, environmental monitoring and food safety. Currently, in its early development stages, paper-based microfluidics is considered a low-cost, lightweight, and disposable technology. The aim of this review is to discuss: (1) fabrication of paper-based microfluidic devices, (2) functionalisation of microfluidic components to increase the capabilities and the performance, (3) introduction of existing detection techniques to the paper platform and (4) exploration of extracting quantitative readouts via handheld devices and camera phones. Additionally, this review includes challenges to scaling up, commercialisation and regulatory issues. The factors which limit paper-based microfluidic devices to become real world products and future directions are also identified.",10.1039/c3lc50169h,zqwkyqbj,"['Dipstick', 'and', 'lateral', 'flow', 'formats', 'have', 'dominated', 'rapid', 'diagnostics', 'over', 'the', 'last', 'three', 'decades', 'These', 'formats', 'gained', 'popularity', 'in', 'the', 'consumer', 'markets', 'due', 'to', 'their', 'compactness', 'portability', 'and', 'facile', 'interpretation', 'without', 'external', 'instrumentation', 'However', 'lack', 'of', 'quantitation', 'in', 'measurements', 'has', 'challenged', 'the', 'demand', 'of', 'existing', 'assay', 'formats', 'in', 'consumer', 'markets', 'Recently', 'paper', 'based', 'microfluidics', 'has', 'emerged', 'as', 'a', 'multiplexable', 'point', 'of', 'care', 'platform', 'which', 'might', 'transcend', 'the', 'capabilities', 'of', 'existing', 'assays', 'in', 'resource', 'limited', 'settings', 'However', 'paper', 'based', 'microfluidics', 'can', 'enable', 'fluid', 'handling', 'and', 'quantitative', 'analysis', 'for', 'potential', 'applications', 'in', 'healthcare', 'veterinary', 'medicine', 'environmental', 'monitoring', 'and', 'food', 'safety', 'Currently', 'in', 'its', 'early', 'development', 'stages', 'paper', 'based', 'microfluidics', 'is', 'considered', 'a', 'low', 'cost', 'lightweight', 'and', 'disposable', 'technology', 'The', 'aim', 'of', 'this', 'review', 'is', 'to', 'discuss', '1', 'fabrication', 'of', 'paper', 'based', 'microfluidic', 'devices', '2', 'functionalisation', 'of', 'microfluidic', 'components', 'to', 'increase', 'the', 'capabilities', 'and', 'the', 'performance', '3', 'introduction', 'of', 'existing', 'detection', 'techniques', 'to', 'the', 'paper', 'platform', 'and', '4', 'exploration', 'of', 'extracting', 'quantitative', 'readouts', 'via', 'handheld', 'devices', 'and', 'camera', 'phones', 'Additionally', 'this', 'review', 'includes', 'challenges', 'to', 'scaling', 'up', 'commercialisation', 'and', 'regulatory', 'issues', 'The', 'factors', 'which', 'limit', 'paper', 'based', 'microfluidic', 'devices', 'to', 'become', 'real', 'world', 'products', 'and', 'future', 'directions', 'are', 'also', 'identified', '']"
28983,Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.,2020-07-23,Science,https://doi.org/10.1126/science.abd0826; https://www.ncbi.nlm.nih.gov/pubmed/32703906/,"The COVID-19 pandemic has led to accelerated efforts to develop therapeutics and vaccines. A key target of these efforts is the spike (S) protein, which is metastable and difficult to produce recombinantly. Here, we characterized 100 structure-guided spike designs and identified 26 individual substitutions that increased protein yields and stability. Testing combinations of beneficial substitutions resulted in the identification of HexaPro, a variant with six beneficial proline substitutions exhibiting ~10-fold higher expression than its parental construct and the ability to withstand heat stress, storage at room temperature, and three freeze-thaw cycles. A 3.2 Å-resolution cryo-EM structure of HexaPro confirmed that it retains the prefusion spike conformation. High-yield production of a stabilized prefusion spike protein will accelerate the development of vaccines and serological diagnostics for SARS-CoV-2.",10.1126/science.abd0826,titu9lm4,"['The', 'COVID', '19', 'pandemic', 'has', 'led', 'to', 'accelerated', 'efforts', 'to', 'develop', 'therapeutics', 'and', 'vaccines', 'A', 'key', 'target', 'of', 'these', 'efforts', 'is', 'the', 'spike', 'S', 'protein', 'which', 'is', 'metastable', 'and', 'difficult', 'to', 'produce', 'recombinantly', 'Here', 'we', 'characterized', '100', 'structure', 'guided', 'spike', 'designs', 'and', 'identified', '26', 'individual', 'substitutions', 'that', 'increased', 'protein', 'yields', 'and', 'stability', 'Testing', 'combinations', 'of', 'beneficial', 'substitutions', 'resulted', 'in', 'the', 'identification', 'of', 'HexaPro', 'a', 'variant', 'with', 'six', 'beneficial', 'proline', 'substitutions', 'exhibiting', '10', 'fold', 'higher', 'expression', 'than', 'its', 'parental', 'construct', 'and', 'the', 'ability', 'to', 'withstand', 'heat', 'stress', 'storage', 'at', 'room', 'temperature', 'and', 'three', 'freeze', 'thaw', 'cycles', 'A', '3', '2', 'Å', 'resolution', 'cryo', 'EM', 'structure', 'of', 'HexaPro', 'confirmed', 'that', 'it', 'retains', 'the', 'prefusion', 'spike', 'conformation', 'High', 'yield', 'production', 'of', 'a', 'stabilized', 'prefusion', 'spike', 'protein', 'will', 'accelerate', 'the', 'development', 'of', 'vaccines', 'and', 'serological', 'diagnostics', 'for', 'SARS', 'CoV', '2', '']"
29355,Companion diagnostics: emerging strategies and issues in pharmaceutical development.,2012,Expert review of molecular diagnostics,https://doi.org/10.1586/erm.12.49; https://www.ncbi.nlm.nih.gov/pubmed/22845476/,"This article summarizes the broad messages from pharmaceutical and diagnostic companies on the collaborations required to support companion diagnostics. Since the groundbreaking herceptin HER2 diagnostic model in 1998, it has taken until 2011 for the US FDA to issue a draft guidance document, which was then immediately followed with approvals for two new drugs and their companion diagnostics. This conference summarized the current state of thinking in new projects and innovative technologies in pharmaceutical and diagnostic codevelopment. Attitudes are slowly changing and collaborations are rapidly ensuing, although the alignment between pharmaceutical and diagnostic understanding of value, timelines, outcomes and impact is difficult and remains a contentious area. The value of this conference has been to address these issues.",10.1586/erm.12.49,mwzhy7lb,"['This', 'article', 'summarizes', 'the', 'broad', 'messages', 'from', 'pharmaceutical', 'and', 'diagnostic', 'companies', 'on', 'the', 'collaborations', 'required', 'to', 'support', 'companion', 'diagnostics', 'Since', 'the', 'groundbreaking', 'herceptin', 'HER2', 'diagnostic', 'model', 'in', '1998', 'it', 'has', 'taken', 'until', '2011', 'for', 'the', 'US', 'FDA', 'to', 'issue', 'a', 'draft', 'guidance', 'document', 'which', 'was', 'then', 'immediately', 'followed', 'with', 'approvals', 'for', 'two', 'new', 'drugs', 'and', 'their', 'companion', 'diagnostics', 'This', 'conference', 'summarized', 'the', 'current', 'state', 'of', 'thinking', 'in', 'new', 'projects', 'and', 'innovative', 'technologies', 'in', 'pharmaceutical', 'and', 'diagnostic', 'codevelopment', 'Attitudes', 'are', 'slowly', 'changing', 'and', 'collaborations', 'are', 'rapidly', 'ensuing', 'although', 'the', 'alignment', 'between', 'pharmaceutical', 'and', 'diagnostic', 'understanding', 'of', 'value', 'timelines', 'outcomes', 'and', 'impact', 'is', 'difficult', 'and', 'remains', 'a', 'contentious', 'area', 'The', 'value', 'of', 'this', 'conference', 'has', 'been', 'to', 'address', 'these', 'issues', '']"
29529,Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus.,2015,Cell,https://doi.org/10.1016/j.cell.2015.07.020; https://www.ncbi.nlm.nih.gov/pubmed/26276630/,"The 2013-2015 West African epidemic of Ebola virus disease (EVD) reminds us of how little is known about biosafety level 4 viruses. Like Ebola virus, Lassa virus (LASV) can cause hemorrhagic fever with high case fatality rates. We generated a genomic catalog of almost 200 LASV sequences from clinical and rodent reservoir samples. We show that whereas the 2013-2015 EVD epidemic is fueled by human-to-human transmissions, LASV infections mainly result from reservoir-to-human infections. We elucidated the spread of LASV across West Africa and show that this migration was accompanied by changes in LASV genome abundance, fatality rates, codon adaptation, and translational efficiency. By investigating intrahost evolution, we found that mutations accumulate in epitopes of viral surface proteins, suggesting selection for immune escape. This catalog will serve as a foundation for the development of vaccines and diagnostics. VIDEO ABSTRACT.",10.1016/j.cell.2015.07.020,7z22a2lc,"['The', '2013', '2015', 'West', 'African', 'epidemic', 'of', 'Ebola', 'virus', 'disease', 'EVD', 'reminds', 'us', 'of', 'how', 'little', 'is', 'known', 'about', 'biosafety', 'level', '4', 'viruses', 'Like', 'Ebola', 'virus', 'Lassa', 'virus', 'LASV', 'can', 'cause', 'hemorrhagic', 'fever', 'with', 'high', 'case', 'fatality', 'rates', 'We', 'generated', 'a', 'genomic', 'catalog', 'of', 'almost', '200', 'LASV', 'sequences', 'from', 'clinical', 'and', 'rodent', 'reservoir', 'samples', 'We', 'show', 'that', 'whereas', 'the', '2013', '2015', 'EVD', 'epidemic', 'is', 'fueled', 'by', 'human', 'to', 'human', 'transmissions', 'LASV', 'infections', 'mainly', 'result', 'from', 'reservoir', 'to', 'human', 'infections', 'We', 'elucidated', 'the', 'spread', 'of', 'LASV', 'across', 'West', 'Africa', 'and', 'show', 'that', 'this', 'migration', 'was', 'accompanied', 'by', 'changes', 'in', 'LASV', 'genome', 'abundance', 'fatality', 'rates', 'codon', 'adaptation', 'and', 'translational', 'efficiency', 'By', 'investigating', 'intrahost', 'evolution', 'we', 'found', 'that', 'mutations', 'accumulate', 'in', 'epitopes', 'of', 'viral', 'surface', 'proteins', 'suggesting', 'selection', 'for', 'immune', 'escape', 'This', 'catalog', 'will', 'serve', 'as', 'a', 'foundation', 'for', 'the', 'development', 'of', 'vaccines', 'and', 'diagnostics', 'VIDEO', 'ABSTRACT', '']"
30979,The role of rhinovirus infections in the development of early childhood asthma.,2010,Current opinion in allergy and clinical immunology,https://doi.org/10.1097/aci.0b013e3283352f7c; https://www.ncbi.nlm.nih.gov/pubmed/19996738/,"PURPOSE OF REVIEW To discuss the role of human rhinoviruses (HRVs) in early childhood wheezing illnesses and how HRVs contribute to the development of childhood asthma. RECENT FINDINGS Advanced molecular diagnostics have identified HRVs as pathogens frequently causing wheezing illnesses in infants and young children. Wheezing during HRV infection in early life identifies children at particularly high-risk of asthma development. Plausible mechanisms by which HRV could cause airway damage, promote airway remodeling, and lead to asthma development have recently been identified. SUMMARY HRV is a significant source of morbidity in infants and young children. The present review identifies mechanisms by which HRV lower respiratory tract infection, particularly in a susceptible host, could promote the development of childhood asthma. Further studies are needed to elucidate the mechanisms underlying the link between HRV wheezing in early childhood and subsequent asthma development, with the critical goal of identifying novel therapeutic and prevention strategies for both early childhood wheezing and asthma.",10.1097/aci.0b013e3283352f7c,4nfnnv5a,"['PURPOSE', 'OF', 'REVIEW', 'To', 'discuss', 'the', 'role', 'of', 'human', 'rhinoviruses', 'HRVs', 'in', 'early', 'childhood', 'wheezing', 'illnesses', 'and', 'how', 'HRVs', 'contribute', 'to', 'the', 'development', 'of', 'childhood', 'asthma', 'RECENT', 'FINDINGS', 'Advanced', 'molecular', 'diagnostics', 'have', 'identified', 'HRVs', 'as', 'pathogens', 'frequently', 'causing', 'wheezing', 'illnesses', 'in', 'infants', 'and', 'young', 'children', 'Wheezing', 'during', 'HRV', 'infection', 'in', 'early', 'life', 'identifies', 'children', 'at', 'particularly', 'high', 'risk', 'of', 'asthma', 'development', 'Plausible', 'mechanisms', 'by', 'which', 'HRV', 'could', 'cause', 'airway', 'damage', 'promote', 'airway', 'remodeling', 'and', 'lead', 'to', 'asthma', 'development', 'have', 'recently', 'been', 'identified', 'SUMMARY', 'HRV', 'is', 'a', 'significant', 'source', 'of', 'morbidity', 'in', 'infants', 'and', 'young', 'children', 'The', 'present', 'review', 'identifies', 'mechanisms', 'by', 'which', 'HRV', 'lower', 'respiratory', 'tract', 'infection', 'particularly', 'in', 'a', 'susceptible', 'host', 'could', 'promote', 'the', 'development', 'of', 'childhood', 'asthma', 'Further', 'studies', 'are', 'needed', 'to', 'elucidate', 'the', 'mechanisms', 'underlying', 'the', 'link', 'between', 'HRV', 'wheezing', 'in', 'early', 'childhood', 'and', 'subsequent', 'asthma', 'development', 'with', 'the', 'critical', 'goal', 'of', 'identifying', 'novel', 'therapeutic', 'and', 'prevention', 'strategies', 'for', 'both', 'early', 'childhood', 'wheezing', 'and', 'asthma', '']"
32096,Avian rotavirus enteritis - an updated review.,2015,The Veterinary quarterly,https://doi.org/10.1080/01652176.2015.1046014; https://www.ncbi.nlm.nih.gov/pubmed/25917772/,"Rotaviruses (RVs) are among the leading causes of enteritis and diarrhea in a number of mammalian and avian species, and impose colossal loss to livestock and poultry industry globally. Subsequent to detection of rotavirus in mammalian hosts in 1973, avian rotavirus (AvRV) was first reported in turkey poults in USA during 1977 and since then RVs of group A (RVA), D (RVD), F (RVF) and G (RVG) have been identified around the globe. Besides RVA, other AvRV groups (RVD, RVF and RVG) may also contribute to disease. However, their significance has yet to be unraveled. Under field conditions, co-infection of AvRVs occurs with other infectious agents such as astroviruses, enteroviruses, reoviruses, paramyxovirus, adenovirus, Salmonella, Escherichia coli, cryptosporidium and Eimeria species prospering severity of disease outcome. Birds surviving to RV disease predominantly succumb to secondary bacterial infections, mostly E. coli and Salmonella spp. Recent developments in molecular tools including state-of-the-art diagnostics and vaccine development have led to advances in our understanding towards AvRVs. Development of new generation vaccines using immunogenic antigens of AvRV has to be explored and given due importance. Till now, no effective vaccines are available. Although specific as well as sensitive approaches are available to identify and characterize AvRVs, there is still need to have point-of-care detection assays to review disease burden, contemplate new directions for adopting vaccination and follow improvements in public health measures. This review discusses AvRVs, their epidemiology, pathology and pathogenesis, immunity, recent trends in diagnostics, vaccines, therapeutics as well as appropriate prevention and control strategies.",10.1080/01652176.2015.1046014,mb6bik7h,"['Rotaviruses', 'RVs', 'are', 'among', 'the', 'leading', 'causes', 'of', 'enteritis', 'and', 'diarrhea', 'in', 'a', 'number', 'of', 'mammalian', 'and', 'avian', 'species', 'and', 'impose', 'colossal', 'loss', 'to', 'livestock', 'and', 'poultry', 'industry', 'globally', 'Subsequent', 'to', 'detection', 'of', 'rotavirus', 'in', 'mammalian', 'hosts', 'in', '1973', 'avian', 'rotavirus', 'AvRV', 'was', 'first', 'reported', 'in', 'turkey', 'poults', 'in', 'USA', 'during', '1977', 'and', 'since', 'then', 'RVs', 'of', 'group', 'A', 'RVA', 'D', 'RVD', 'F', 'RVF', 'and', 'G', 'RVG', 'have', 'been', 'identified', 'around', 'the', 'globe', 'Besides', 'RVA', 'other', 'AvRV', 'groups', 'RVD', 'RVF', 'and', 'RVG', 'may', 'also', 'contribute', 'to', 'disease', 'However', 'their', 'significance', 'has', 'yet', 'to', 'be', 'unraveled', 'Under', 'field', 'conditions', 'co', 'infection', 'of', 'AvRVs', 'occurs', 'with', 'other', 'infectious', 'agents', 'such', 'as', 'astroviruses', 'enteroviruses', 'reoviruses', 'paramyxovirus', 'adenovirus', 'Salmonella', 'Escherichia', 'coli', 'cryptosporidium', 'and', 'Eimeria', 'species', 'prospering', 'severity', 'of', 'disease', 'outcome', 'Birds', 'surviving', 'to', 'RV', 'disease', 'predominantly', 'succumb', 'to', 'secondary', 'bacterial', 'infections', 'mostly', 'E', 'coli', 'and', 'Salmonella', 'spp', 'Recent', 'developments', 'in', 'molecular', 'tools', 'including', 'state', 'of', 'the', 'art', 'diagnostics', 'and', 'vaccine', 'development', 'have', 'led', 'to', 'advances', 'in', 'our', 'understanding', 'towards', 'AvRVs', 'Development', 'of', 'new', 'generation', 'vaccines', 'using', 'immunogenic', 'antigens', 'of', 'AvRV', 'has', 'to', 'be', 'explored', 'and', 'given', 'due', 'importance', 'Till', 'now', 'no', 'effective', 'vaccines', 'are', 'available', 'Although', 'specific', 'as', 'well', 'as', 'sensitive', 'approaches', 'are', 'available', 'to', 'identify', 'and', 'characterize', 'AvRVs', 'there', 'is', 'still', 'need', 'to', 'have', 'point', 'of', 'care', 'detection', 'assays', 'to', 'review', 'disease', 'burden', 'contemplate', 'new', 'directions', 'for', 'adopting', 'vaccination', 'and', 'follow', 'improvements', 'in', 'public', 'health', 'measures', 'This', 'review', 'discusses', 'AvRVs', 'their', 'epidemiology', 'pathology', 'and', 'pathogenesis', 'immunity', 'recent', 'trends', 'in', 'diagnostics', 'vaccines', 'therapeutics', 'as', 'well', 'as', 'appropriate', 'prevention', 'and', 'control', 'strategies', '']"
33239,"2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness.",2020-01-31,Journal of infection in developing countries,https://doi.org/10.3855/jidc.12425; https://www.ncbi.nlm.nih.gov/pubmed/32088679/,"On 31 December 2019 the Wuhan Health Commission reported a cluster of atypical pneumonia cases that was linked to a wet market in the city of Wuhan, China. The first patients began experiencing symptoms of illness in mid-December 2019. Clinical isolates were found to contain a novel coronavirus with similarity to bat coronaviruses. As of 28 January 2020, there are in excess of 4,500 laboratory-confirmed cases, with > 100 known deaths. As with the SARS-CoV, infections in children appear to be rare. Travel-related cases have been confirmed in multiple countries and regions outside mainland China including Germany, France, Thailand, Japan, South Korea, Vietnam, Canada, and the United States, as well as Hong Kong and Taiwan. Domestically in China, the virus has also been noted in several cities and provinces with cases in all but one provinence. While zoonotic transmission appears to be the original source of infections, the most alarming development is that human-to-human transmission is now prevelant. Of particular concern is that many healthcare workers have been infected in the current epidemic. There are several critical clinical questions that need to be resolved, including how efficient is human-to-human transmission? What is the animal reservoir? Is there an intermediate animal reservoir? Do the vaccines generated to the SARS-CoV or MERS-CoV or their proteins offer protection against 2019-nCoV? We offer a research perspective on the next steps for the generation of vaccines. We also present data on the use of in silico docking in gaining insight into 2019-nCoV Spike-receptor binding to aid in therapeutic development. Diagnostic PCR protocols can be found at https://www.who.int/health-topics/coronavirus/laboratory-diagnostics-for-novel-coronavirus.",10.3855/jidc.12425,rxrlbw60,"['On', '31', 'December', '2019', 'the', 'Wuhan', 'Health', 'Commission', 'reported', 'a', 'cluster', 'of', 'atypical', 'pneumonia', 'cases', 'that', 'was', 'linked', 'to', 'a', 'wet', 'market', 'in', 'the', 'city', 'of', 'Wuhan', 'China', 'The', 'first', 'patients', 'began', 'experiencing', 'symptoms', 'of', 'illness', 'in', 'mid', 'December', '2019', 'Clinical', 'isolates', 'were', 'found', 'to', 'contain', 'a', 'novel', 'coronavirus', 'with', 'similarity', 'to', 'bat', 'coronaviruses', 'As', 'of', '28', 'January', '2020', 'there', 'are', 'in', 'excess', 'of', '4', '500', 'laboratory', 'confirmed', 'cases', 'with', '100', 'known', 'deaths', 'As', 'with', 'the', 'SARS', 'CoV', 'infections', 'in', 'children', 'appear', 'to', 'be', 'rare', 'Travel', 'related', 'cases', 'have', 'been', 'confirmed', 'in', 'multiple', 'countries', 'and', 'regions', 'outside', 'mainland', 'China', 'including', 'Germany', 'France', 'Thailand', 'Japan', 'South', 'Korea', 'Vietnam', 'Canada', 'and', 'the', 'United', 'States', 'as', 'well', 'as', 'Hong', 'Kong', 'and', 'Taiwan', 'Domestically', 'in', 'China', 'the', 'virus', 'has', 'also', 'been', 'noted', 'in', 'several', 'cities', 'and', 'provinces', 'with', 'cases', 'in', 'all', 'but', 'one', 'provinence', 'While', 'zoonotic', 'transmission', 'appears', 'to', 'be', 'the', 'original', 'source', 'of', 'infections', 'the', 'most', 'alarming', 'development', 'is', 'that', 'human', 'to', 'human', 'transmission', 'is', 'now', 'prevelant', 'Of', 'particular', 'concern', 'is', 'that', 'many', 'healthcare', 'workers', 'have', 'been', 'infected', 'in', 'the', 'current', 'epidemic', 'There', 'are', 'several', 'critical', 'clinical', 'questions', 'that', 'need', 'to', 'be', 'resolved', 'including', 'how', 'efficient', 'is', 'human', 'to', 'human', 'transmission', 'What', 'is', 'the', 'animal', 'reservoir', 'Is', 'there', 'an', 'intermediate', 'animal', 'reservoir', 'Do', 'the', 'vaccines', 'generated', 'to', 'the', 'SARS', 'CoV', 'or', 'MERS', 'CoV', 'or', 'their', 'proteins', 'offer', 'protection', 'against', '2019', 'nCoV', 'We', 'offer', 'a', 'research', 'perspective', 'on', 'the', 'next', 'steps', 'for', 'the', 'generation', 'of', 'vaccines', 'We', 'also', 'present', 'data', 'on', 'the', 'use', 'of', 'in', 'silico', 'docking', 'in', 'gaining', 'insight', 'into', '2019', 'nCoV', 'Spike', 'receptor', 'binding', 'to', 'aid', 'in', 'therapeutic', 'development', 'Diagnostic', 'PCR', 'protocols', 'can', 'be', 'found', 'at', 'https', 'www', 'who', 'int', 'health', 'topics', 'coronavirus', 'laboratory', 'diagnostics', 'for', 'novel', 'coronavirus', '']"
33778,Replication of SARS-CoV-2 in human respiratory epithelium.,2020-05-20,Journal of virology,https://doi.org/10.1128/jvi.00957-20; https://www.ncbi.nlm.nih.gov/pubmed/32434888/,"Currently, there are four seasonal coronaviruses associated with relatively mild respiratory tract disease in humans. However, there are also a plethora of animal coronaviruses, which have the potential to cross the species border. This regularly results in the emergence of new viruses in humans. In 2002 SARS-CoV emerged, to rapidly disappear in May 2003. In 2012 MERS-CoV was identified as a possible threat to humans, but its pandemic potential so far is minimal, as the human-to-human transmission is ineffective. The end of 2019 brought us information about the SARS-CoV-2 emergence, and the virus rapidly spread in 2020 causing an unprecedented pandemic.At present, the studies on the virus are carried out using a surrogate system based on the immortalized simian Vero E6 cell line. This model is convenient for diagnostics, but it has serious limitations and does not allow for the understanding of virus biology and evolution.Here we show that fully differentiated human airway epithelium cultures constitute an excellent model to study the infection with the novel human coronavirus SARS-CoV-2. We observed an efficient replication of the virus in the tissue, with the maximal replication at 2 days post-infection. The virus replicated in ciliated cells and was released apically.IMPORTANCE SARS-CoV-2 emerged by the end of 2019 to rapidly spread in 2020. At present, it is of utmost importance to understand the virus biology and to rapidly assess the potential of existing drugs and develop new active compounds. While some animal models for such studies are under development, most of the research is carried out in the Vero E6 cells. Here, we propose fully differentiated human airway epithelium cultures as a model for studies on the SARS-CoV-2.",10.1128/jvi.00957-20,4v42ezk8,"['Currently', 'there', 'are', 'four', 'seasonal', 'coronaviruses', 'associated', 'with', 'relatively', 'mild', 'respiratory', 'tract', 'disease', 'in', 'humans', 'However', 'there', 'are', 'also', 'a', 'plethora', 'of', 'animal', 'coronaviruses', 'which', 'have', 'the', 'potential', 'to', 'cross', 'the', 'species', 'border', 'This', 'regularly', 'results', 'in', 'the', 'emergence', 'of', 'new', 'viruses', 'in', 'humans', 'In', '2002', 'SARS', 'CoV', 'emerged', 'to', 'rapidly', 'disappear', 'in', 'May', '2003', 'In', '2012', 'MERS', 'CoV', 'was', 'identified', 'as', 'a', 'possible', 'threat', 'to', 'humans', 'but', 'its', 'pandemic', 'potential', 'so', 'far', 'is', 'minimal', 'as', 'the', 'human', 'to', 'human', 'transmission', 'is', 'ineffective', 'The', 'end', 'of', '2019', 'brought', 'us', 'information', 'about', 'the', 'SARS', 'CoV', '2', 'emergence', 'and', 'the', 'virus', 'rapidly', 'spread', 'in', '2020', 'causing', 'an', 'unprecedented', 'pandemic', 'At', 'present', 'the', 'studies', 'on', 'the', 'virus', 'are', 'carried', 'out', 'using', 'a', 'surrogate', 'system', 'based', 'on', 'the', 'immortalized', 'simian', 'Vero', 'E6', 'cell', 'line', 'This', 'model', 'is', 'convenient', 'for', 'diagnostics', 'but', 'it', 'has', 'serious', 'limitations', 'and', 'does', 'not', 'allow', 'for', 'the', 'understanding', 'of', 'virus', 'biology', 'and', 'evolution', 'Here', 'we', 'show', 'that', 'fully', 'differentiated', 'human', 'airway', 'epithelium', 'cultures', 'constitute', 'an', 'excellent', 'model', 'to', 'study', 'the', 'infection', 'with', 'the', 'novel', 'human', 'coronavirus', 'SARS', 'CoV', '2', 'We', 'observed', 'an', 'efficient', 'replication', 'of', 'the', 'virus', 'in', 'the', 'tissue', 'with', 'the', 'maximal', 'replication', 'at', '2', 'days', 'post', 'infection', 'The', 'virus', 'replicated', 'in', 'ciliated', 'cells', 'and', 'was', 'released', 'apically', 'IMPORTANCE', 'SARS', 'CoV', '2', 'emerged', 'by', 'the', 'end', 'of', '2019', 'to', 'rapidly', 'spread', 'in', '2020', 'At', 'present', 'it', 'is', 'of', 'utmost', 'importance', 'to', 'understand', 'the', 'virus', 'biology', 'and', 'to', 'rapidly', 'assess', 'the', 'potential', 'of', 'existing', 'drugs', 'and', 'develop', 'new', 'active', 'compounds', 'While', 'some', 'animal', 'models', 'for', 'such', 'studies', 'are', 'under', 'development', 'most', 'of', 'the', 'research', 'is', 'carried', 'out', 'in', 'the', 'Vero', 'E6', 'cells', 'Here', 'we', 'propose', 'fully', 'differentiated', 'human', 'airway', 'epithelium', 'cultures', 'as', 'a', 'model', 'for', 'studies', 'on', 'the', 'SARS', 'CoV', '2', '']"
34391,Autoantibodies in cancer: prognostic biomarkers and immune activation.,2011,Expert review of proteomics,https://doi.org/10.1586/epr.11.48; https://www.ncbi.nlm.nih.gov/pubmed/21999829/,"The development of proteomic technologies that display a wide variety of antigenic structures has led to the identification of autoantibodies to cancer-derived tumor antigens. These autoantibodies have been detected in sera from patients with multiple cancer types, and are being evaluated as biomarkers for early cancer detection. It is not known whether these antibodies also contribute to active immune surveillance or even tumorigenicity of developing tumors. Here, we review which tumor antigen-specific antibodies are prognostic biomarkers of cancer outcome, and emerging proteomic methods for the isolation and cloning of these antibodies for potential molecular diagnostics and therapeutics.",10.1586/epr.11.48,5oldlm6t,"['The', 'development', 'of', 'proteomic', 'technologies', 'that', 'display', 'a', 'wide', 'variety', 'of', 'antigenic', 'structures', 'has', 'led', 'to', 'the', 'identification', 'of', 'autoantibodies', 'to', 'cancer', 'derived', 'tumor', 'antigens', 'These', 'autoantibodies', 'have', 'been', 'detected', 'in', 'sera', 'from', 'patients', 'with', 'multiple', 'cancer', 'types', 'and', 'are', 'being', 'evaluated', 'as', 'biomarkers', 'for', 'early', 'cancer', 'detection', 'It', 'is', 'not', 'known', 'whether', 'these', 'antibodies', 'also', 'contribute', 'to', 'active', 'immune', 'surveillance', 'or', 'even', 'tumorigenicity', 'of', 'developing', 'tumors', 'Here', 'we', 'review', 'which', 'tumor', 'antigen', 'specific', 'antibodies', 'are', 'prognostic', 'biomarkers', 'of', 'cancer', 'outcome', 'and', 'emerging', 'proteomic', 'methods', 'for', 'the', 'isolation', 'and', 'cloning', 'of', 'these', 'antibodies', 'for', 'potential', 'molecular', 'diagnostics', 'and', 'therapeutics', '']"
35548,Emerging technologies for diagnostics and drug delivery in the fight against COVID-19 and other pandemics.,2020-07-17,Expert review of medical devices,https://doi.org/10.1080/17434440.2020.1792287; https://www.ncbi.nlm.nih.gov/pubmed/32674622/,"INTRODUCTION A pandemic is the worst-case scenario in the field of infectious diseases. Innovative technologies have the potential to address the challenges associated with the manufacture of personalized drug delivery systems, biosensors, and medical devices during a pandemic. 3D-Printing, microfluidics, and Microelectromechanical systems (MEMS) can provide an important part on this fight, as are cheap, easy to be operated, capable to provide rapid detection and monitoring of a disease, and deliver medicines. AREAS COVERED This manuscript answers the question of how these emerging technologies can save lives during a pandemic by avoiding supply chain delays and also by providing rapid diagnostics, disease monitoring, or by offering personalized treatments. The manuscript covers recent approaches in the topic with a focus in manuscripts published in the last year and by emphasising recent regulatory considerations by regulatory agencies in the manufacturing of 3DP systems or other medical devices during COVID. EXPERT OPINION New manufacturing techniques are emerging with the ability to address the challenges associated with the development of medical devices or diagnostics, during a pandemic. Are many challenges in order to achieve this and especially in short times that are required under a pandemic attack, which will also be covered in this manuscript.",10.1080/17434440.2020.1792287,lmku7l88,"['INTRODUCTION', 'A', 'pandemic', 'is', 'the', 'worst', 'case', 'scenario', 'in', 'the', 'field', 'of', 'infectious', 'diseases', 'Innovative', 'technologies', 'have', 'the', 'potential', 'to', 'address', 'the', 'challenges', 'associated', 'with', 'the', 'manufacture', 'of', 'personalized', 'drug', 'delivery', 'systems', 'biosensors', 'and', 'medical', 'devices', 'during', 'a', 'pandemic', '3D', 'Printing', 'microfluidics', 'and', 'Microelectromechanical', 'systems', 'MEMS', 'can', 'provide', 'an', 'important', 'part', 'on', 'this', 'fight', 'as', 'are', 'cheap', 'easy', 'to', 'be', 'operated', 'capable', 'to', 'provide', 'rapid', 'detection', 'and', 'monitoring', 'of', 'a', 'disease', 'and', 'deliver', 'medicines', 'AREAS', 'COVERED', 'This', 'manuscript', 'answers', 'the', 'question', 'of', 'how', 'these', 'emerging', 'technologies', 'can', 'save', 'lives', 'during', 'a', 'pandemic', 'by', 'avoiding', 'supply', 'chain', 'delays', 'and', 'also', 'by', 'providing', 'rapid', 'diagnostics', 'disease', 'monitoring', 'or', 'by', 'offering', 'personalized', 'treatments', 'The', 'manuscript', 'covers', 'recent', 'approaches', 'in', 'the', 'topic', 'with', 'a', 'focus', 'in', 'manuscripts', 'published', 'in', 'the', 'last', 'year', 'and', 'by', 'emphasising', 'recent', 'regulatory', 'considerations', 'by', 'regulatory', 'agencies', 'in', 'the', 'manufacturing', 'of', '3DP', 'systems', 'or', 'other', 'medical', 'devices', 'during', 'COVID', 'EXPERT', 'OPINION', 'New', 'manufacturing', 'techniques', 'are', 'emerging', 'with', 'the', 'ability', 'to', 'address', 'the', 'challenges', 'associated', 'with', 'the', 'development', 'of', 'medical', 'devices', 'or', 'diagnostics', 'during', 'a', 'pandemic', 'Are', 'many', 'challenges', 'in', 'order', 'to', 'achieve', 'this', 'and', 'especially', 'in', 'short', 'times', 'that', 'are', 'required', 'under', 'a', 'pandemic', 'attack', 'which', 'will', 'also', 'be', 'covered', 'in', 'this', 'manuscript', '']"
35731,Microfluidic designs and techniques using lab-on-a-chip devices for pathogen detection for point-of-care diagnostics.,2012,Lab on a chip,https://doi.org/10.1039/c2lc40630f; https://www.ncbi.nlm.nih.gov/pubmed/22859057/,"Effective pathogen detection is an essential prerequisite for the prevention and treatment of infectious diseases. Despite recent advances in biosensors, infectious diseases remain a major cause of illnesses and mortality throughout the world. For instance in developing countries, infectious diseases account for over half of the mortality rate. Pathogen detection platforms provide a fundamental tool in different fields including clinical diagnostics, pathology, drug discovery, clinical research, disease outbreaks, and food safety. Microfluidic lab-on-a-chip (LOC) devices offer many advantages for pathogen detection such as miniaturization, small sample volume, portability, rapid detection time and point-of-care diagnosis. This review paper outlines recent microfluidic based devices and LOC design strategies for pathogen detection with the main focus on the integration of different techniques that led to the development of sample-to-result devices. Several examples of recently developed devices are presented along with respective advantages and limitations of each design. Progresses made in biomarkers, sample preparation, amplification and fluid handling techniques using microfluidic platforms are also covered and strategies for multiplexing and high-throughput analysis, as well as point-of-care diagnosis, are discussed.",10.1039/c2lc40630f,dlsrw6kb,"['Effective', 'pathogen', 'detection', 'is', 'an', 'essential', 'prerequisite', 'for', 'the', 'prevention', 'and', 'treatment', 'of', 'infectious', 'diseases', 'Despite', 'recent', 'advances', 'in', 'biosensors', 'infectious', 'diseases', 'remain', 'a', 'major', 'cause', 'of', 'illnesses', 'and', 'mortality', 'throughout', 'the', 'world', 'For', 'instance', 'in', 'developing', 'countries', 'infectious', 'diseases', 'account', 'for', 'over', 'half', 'of', 'the', 'mortality', 'rate', 'Pathogen', 'detection', 'platforms', 'provide', 'a', 'fundamental', 'tool', 'in', 'different', 'fields', 'including', 'clinical', 'diagnostics', 'pathology', 'drug', 'discovery', 'clinical', 'research', 'disease', 'outbreaks', 'and', 'food', 'safety', 'Microfluidic', 'lab', 'on', 'a', 'chip', 'LOC', 'devices', 'offer', 'many', 'advantages', 'for', 'pathogen', 'detection', 'such', 'as', 'miniaturization', 'small', 'sample', 'volume', 'portability', 'rapid', 'detection', 'time', 'and', 'point', 'of', 'care', 'diagnosis', 'This', 'review', 'paper', 'outlines', 'recent', 'microfluidic', 'based', 'devices', 'and', 'LOC', 'design', 'strategies', 'for', 'pathogen', 'detection', 'with', 'the', 'main', 'focus', 'on', 'the', 'integration', 'of', 'different', 'techniques', 'that', 'led', 'to', 'the', 'development', 'of', 'sample', 'to', 'result', 'devices', 'Several', 'examples', 'of', 'recently', 'developed', 'devices', 'are', 'presented', 'along', 'with', 'respective', 'advantages', 'and', 'limitations', 'of', 'each', 'design', 'Progresses', 'made', 'in', 'biomarkers', 'sample', 'preparation', 'amplification', 'and', 'fluid', 'handling', 'techniques', 'using', 'microfluidic', 'platforms', 'are', 'also', 'covered', 'and', 'strategies', 'for', 'multiplexing', 'and', 'high', 'throughput', 'analysis', 'as', 'well', 'as', 'point', 'of', 'care', 'diagnosis', 'are', 'discussed', '']"
35921,Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.,2020-05-26,Viruses,https://doi.org/10.3390/v12060582; https://www.ncbi.nlm.nih.gov/pubmed/32466458/,"The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, clinical treatment, and development of vaccines, is urgently needed to win the battle against COVID-19. The past three unprecedented outbreaks of emerging human coronavirus infections at the beginning of the 21st century have highlighted the importance of readily available, accurate, and rapid diagnostic technologies to contain emerging and re-emerging pandemics. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) based assays performed on respiratory specimens remain the gold standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging with high sensitivity and specificity as well. Even though excellent techniques are available for the diagnosis of symptomatic patients with COVID-19 in well-equipped laboratories; critical gaps still remain in screening asymptomatic people who are in the incubation phase of the virus, as well as in the accurate determination of live viral shedding during convalescence to inform decisions for ending isolation. This review article aims to discuss the currently available laboratory methods and surveillance technologies available for the detection of COVID-19, their performance characteristics and highlight the gaps in current diagnostic capacity, and finally, propose potential solutions. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of COVID-19.",10.3390/v12060582,h2mloxuh,"['The', 'recent', 'outbreak', 'of', 'the', 'Coronavirus', 'disease', '2019', 'COVID', '19', 'has', 'quickly', 'spread', 'worldwide', 'since', 'its', 'discovery', 'in', 'Wuhan', 'city', 'China', 'in', 'December', '2019', 'A', 'comprehensive', 'strategy', 'including', 'surveillance', 'diagnostics', 'research', 'clinical', 'treatment', 'and', 'development', 'of', 'vaccines', 'is', 'urgently', 'needed', 'to', 'win', 'the', 'battle', 'against', 'COVID', '19', 'The', 'past', 'three', 'unprecedented', 'outbreaks', 'of', 'emerging', 'human', 'coronavirus', 'infections', 'at', 'the', 'beginning', 'of', 'the', '21st', 'century', 'have', 'highlighted', 'the', 'importance', 'of', 'readily', 'available', 'accurate', 'and', 'rapid', 'diagnostic', 'technologies', 'to', 'contain', 'emerging', 'and', 're', 'emerging', 'pandemics', 'Real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'rRT', 'PCR', 'based', 'assays', 'performed', 'on', 'respiratory', 'specimens', 'remain', 'the', 'gold', 'standard', 'for', 'COVID', '19', 'diagnostics', 'However', 'point', 'of', 'care', 'technologies', 'and', 'serologic', 'immunoassays', 'are', 'rapidly', 'emerging', 'with', 'high', 'sensitivity', 'and', 'specificity', 'as', 'well', 'Even', 'though', 'excellent', 'techniques', 'are', 'available', 'for', 'the', 'diagnosis', 'of', 'symptomatic', 'patients', 'with', 'COVID', '19', 'in', 'well', 'equipped', 'laboratories', 'critical', 'gaps', 'still', 'remain', 'in', 'screening', 'asymptomatic', 'people', 'who', 'are', 'in', 'the', 'incubation', 'phase', 'of', 'the', 'virus', 'as', 'well', 'as', 'in', 'the', 'accurate', 'determination', 'of', 'live', 'viral', 'shedding', 'during', 'convalescence', 'to', 'inform', 'decisions', 'for', 'ending', 'isolation', 'This', 'review', 'article', 'aims', 'to', 'discuss', 'the', 'currently', 'available', 'laboratory', 'methods', 'and', 'surveillance', 'technologies', 'available', 'for', 'the', 'detection', 'of', 'COVID', '19', 'their', 'performance', 'characteristics', 'and', 'highlight', 'the', 'gaps', 'in', 'current', 'diagnostic', 'capacity', 'and', 'finally', 'propose', 'potential', 'solutions', 'We', 'also', 'summarize', 'the', 'specifications', 'of', 'the', 'majority', 'of', 'the', 'available', 'commercial', 'kits', 'PCR', 'EIA', 'and', 'POC', 'for', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
36832,Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests.,2020-07-06,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,https://doi.org/10.1016/j.jcv.2020.104544; https://www.ncbi.nlm.nih.gov/pubmed/32663788/,"The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) has been followed by the rapid development of antibody tests. To assess the utility of the tests for clinical use and seroepidemiologic studies, we examined the sensitivity of commercial antibody tests from Roche, Abbott, Novatec, Virotech Siemens, Euroimmun, and Mediagnost in a prospective diagnostic study. The tests were evaluated with 73 sera from SARS CoV-2 RNA positive individuals with mild to moderate disease or asymptomatic infection. Sera were obtained at 2-3 weeks (N = 25) or > 4 weeks (N = 48) after symptom onset and viral RNA test. The overall sensitivity of the tests ranged from 64.4-93.2%. The most sensitive assays recognized 95.8-100 % of the sera obtained after 4 weeks or later. Sera drawn at 2-3 weeks were recognized with lower sensitivity indicating that the optimal time point for serologic testing is later than 3 weeks after onset of the disease. Nucleoprotein- and glycoproteinbased assays had similar sensitivity indicating that tests with both antigens are suitable for serological diagnostics. Breakdown of the test results showed that nucleoprotein- and glycoprotein-based tests of comparable sensitivity reacted with different sets of sera. The observation indicates that a combination of nucleoprotein- and glycoprotein-based tests would increase the percentage of positive results.",10.1016/j.jcv.2020.104544,555g14yx,"['The', 'emergence', 'of', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'been', 'followed', 'by', 'the', 'rapid', 'development', 'of', 'antibody', 'tests', 'To', 'assess', 'the', 'utility', 'of', 'the', 'tests', 'for', 'clinical', 'use', 'and', 'seroepidemiologic', 'studies', 'we', 'examined', 'the', 'sensitivity', 'of', 'commercial', 'antibody', 'tests', 'from', 'Roche', 'Abbott', 'Novatec', 'Virotech', 'Siemens', 'Euroimmun', 'and', 'Mediagnost', 'in', 'a', 'prospective', 'diagnostic', 'study', 'The', 'tests', 'were', 'evaluated', 'with', '73', 'sera', 'from', 'SARS', 'CoV', '2', 'RNA', 'positive', 'individuals', 'with', 'mild', 'to', 'moderate', 'disease', 'or', 'asymptomatic', 'infection', 'Sera', 'were', 'obtained', 'at', '2', '3', 'weeks', 'N', '25', 'or', '4', 'weeks', 'N', '48', 'after', 'symptom', 'onset', 'and', 'viral', 'RNA', 'test', 'The', 'overall', 'sensitivity', 'of', 'the', 'tests', 'ranged', 'from', '64', '4', '93', '2', 'The', 'most', 'sensitive', 'assays', 'recognized', '95', '8', '100', 'of', 'the', 'sera', 'obtained', 'after', '4', 'weeks', 'or', 'later', 'Sera', 'drawn', 'at', '2', '3', 'weeks', 'were', 'recognized', 'with', 'lower', 'sensitivity', 'indicating', 'that', 'the', 'optimal', 'time', 'point', 'for', 'serologic', 'testing', 'is', 'later', 'than', '3', 'weeks', 'after', 'onset', 'of', 'the', 'disease', 'Nucleoprotein', 'and', 'glycoproteinbased', 'assays', 'had', 'similar', 'sensitivity', 'indicating', 'that', 'tests', 'with', 'both', 'antigens', 'are', 'suitable', 'for', 'serological', 'diagnostics', 'Breakdown', 'of', 'the', 'test', 'results', 'showed', 'that', 'nucleoprotein', 'and', 'glycoprotein', 'based', 'tests', 'of', 'comparable', 'sensitivity', 'reacted', 'with', 'different', 'sets', 'of', 'sera', 'The', 'observation', 'indicates', 'that', 'a', 'combination', 'of', 'nucleoprotein', 'and', 'glycoprotein', 'based', 'tests', 'would', 'increase', 'the', 'percentage', 'of', 'positive', 'results', '']"
38170,Application of resequencing microarrays in microbial detection and characterization.,2012,Future microbiology,https://doi.org/10.2217/fmb.12.30; https://www.ncbi.nlm.nih.gov/pubmed/22568717/,"Microarrays are powerful, highly parallel assays that are transforming microbiological diagnostics and research. The adaptation of microarray-based resequencing technology for microbial detection and characterization resulted in the development of a number assays that have unique advantages over other existing technologies. This technological platform seems to be especially useful for sensitive and high-resolution multiplexed diagnostics for clinical syndromes with similar symptoms, screening environmental samples for biothreat agents, as well as genotyping and whole-genome analysis of single pathogens.",10.2217/fmb.12.30,pthoazqw,"['Microarrays', 'are', 'powerful', 'highly', 'parallel', 'assays', 'that', 'are', 'transforming', 'microbiological', 'diagnostics', 'and', 'research', 'The', 'adaptation', 'of', 'microarray', 'based', 'resequencing', 'technology', 'for', 'microbial', 'detection', 'and', 'characterization', 'resulted', 'in', 'the', 'development', 'of', 'a', 'number', 'assays', 'that', 'have', 'unique', 'advantages', 'over', 'other', 'existing', 'technologies', 'This', 'technological', 'platform', 'seems', 'to', 'be', 'especially', 'useful', 'for', 'sensitive', 'and', 'high', 'resolution', 'multiplexed', 'diagnostics', 'for', 'clinical', 'syndromes', 'with', 'similar', 'symptoms', 'screening', 'environmental', 'samples', 'for', 'biothreat', 'agents', 'as', 'well', 'as', 'genotyping', 'and', 'whole', 'genome', 'analysis', 'of', 'single', 'pathogens', '']"
38556,A bead-based suspension array for the multiplexed detection of begomoviruses and their whitefly vectors.,2014,Journal of virological methods,https://doi.org/10.1016/j.jviromet.2013.12.014; https://www.ncbi.nlm.nih.gov/pubmed/24388931/,"Bead-based suspension array systems enable simultaneous fluorescence-based identification of multiple nucleic acid targets in a single reaction. This study describes the development of a novel approach to plant virus and vector diagnostics, a multiplexed 7-plex array that comprises a hierarchical set of assays for the simultaneous detection of begomoviruses and Bemisia tabaci, from both plant and whitefly samples. The multiplexed array incorporates genus, species and strain-specific assays, offering a unique approach for identifying both known and unknown viruses and B. tabaci species. When tested against a large panel of sequence-characterized begomovirus and whitefly samples, the array was shown to be 100% specific to the homologous target. Additionally, the multiplexed array was highly sensitive, efficiently and concurrently determining both virus and whitefly identity from single viruliferous whitefly samples. The detection limit for one assay within the multiplexed array that specifically detects Tomato yellow leaf curl virus-Israel (TYLCV-IL) was quantified as 200fg of TYLCV-IL DNA, directly equivalent to that of TYLCV-specific qPCR. Highly reproducible results were obtained over multiple tests. The flexible multiplexed array described in this study has great potential for use in plant quarantine, biosecurity and disease management programs worldwide.",10.1016/j.jviromet.2013.12.014,r6sdf6xa,"['Bead', 'based', 'suspension', 'array', 'systems', 'enable', 'simultaneous', 'fluorescence', 'based', 'identification', 'of', 'multiple', 'nucleic', 'acid', 'targets', 'in', 'a', 'single', 'reaction', 'This', 'study', 'describes', 'the', 'development', 'of', 'a', 'novel', 'approach', 'to', 'plant', 'virus', 'and', 'vector', 'diagnostics', 'a', 'multiplexed', '7', 'plex', 'array', 'that', 'comprises', 'a', 'hierarchical', 'set', 'of', 'assays', 'for', 'the', 'simultaneous', 'detection', 'of', 'begomoviruses', 'and', 'Bemisia', 'tabaci', 'from', 'both', 'plant', 'and', 'whitefly', 'samples', 'The', 'multiplexed', 'array', 'incorporates', 'genus', 'species', 'and', 'strain', 'specific', 'assays', 'offering', 'a', 'unique', 'approach', 'for', 'identifying', 'both', 'known', 'and', 'unknown', 'viruses', 'and', 'B', 'tabaci', 'species', 'When', 'tested', 'against', 'a', 'large', 'panel', 'of', 'sequence', 'characterized', 'begomovirus', 'and', 'whitefly', 'samples', 'the', 'array', 'was', 'shown', 'to', 'be', '100', 'specific', 'to', 'the', 'homologous', 'target', 'Additionally', 'the', 'multiplexed', 'array', 'was', 'highly', 'sensitive', 'efficiently', 'and', 'concurrently', 'determining', 'both', 'virus', 'and', 'whitefly', 'identity', 'from', 'single', 'viruliferous', 'whitefly', 'samples', 'The', 'detection', 'limit', 'for', 'one', 'assay', 'within', 'the', 'multiplexed', 'array', 'that', 'specifically', 'detects', 'Tomato', 'yellow', 'leaf', 'curl', 'virus', 'Israel', 'TYLCV', 'IL', 'was', 'quantified', 'as', '200fg', 'of', 'TYLCV', 'IL', 'DNA', 'directly', 'equivalent', 'to', 'that', 'of', 'TYLCV', 'specific', 'qPCR', 'Highly', 'reproducible', 'results', 'were', 'obtained', 'over', 'multiple', 'tests', 'The', 'flexible', 'multiplexed', 'array', 'described', 'in', 'this', 'study', 'has', 'great', 'potential', 'for', 'use', 'in', 'plant', 'quarantine', 'biosecurity', 'and', 'disease', 'management', 'programs', 'worldwide', '']"
39008,Under the microscope: From pathogens to probiotics and back.,2015,Bioengineered,https://doi.org/10.1080/21655979.2015.1089368; https://www.ncbi.nlm.nih.gov/pubmed/26339986/,"The review centers on the human gastrointestinal tract; focusing first on the bacterial stress responses needed to overcome the physiochemical defenses of the host, specifically how these stress survival strategies can be used as targets for alternative infection control strategies. The concluding section focuses on recent developments in molecular diagnostics; centring on the shifting paradigm from culture to molecular based diagnostics.",10.1080/21655979.2015.1089368,jw9uyzdu,"['The', 'review', 'centers', 'on', 'the', 'human', 'gastrointestinal', 'tract', 'focusing', 'first', 'on', 'the', 'bacterial', 'stress', 'responses', 'needed', 'to', 'overcome', 'the', 'physiochemical', 'defenses', 'of', 'the', 'host', 'specifically', 'how', 'these', 'stress', 'survival', 'strategies', 'can', 'be', 'used', 'as', 'targets', 'for', 'alternative', 'infection', 'control', 'strategies', 'The', 'concluding', 'section', 'focuses', 'on', 'recent', 'developments', 'in', 'molecular', 'diagnostics', 'centring', 'on', 'the', 'shifting', 'paradigm', 'from', 'culture', 'to', 'molecular', 'based', 'diagnostics', '']"
39523,Periprosthetic joint infection: what is on the horizon?,2012,The International journal of artificial organs,https://doi.org/10.5301/ijao.5000145; https://www.ncbi.nlm.nih.gov/pubmed/23371923/,"Periprosthetic joint infection (PJI) will emerge as one of the most important issues for both orthopedic surgeons and researchers active in the field over the coming decades. Although the rate of PJI has not changed significantly over the past decade, the affected patients (hosts) being treated often present with more comorbidities than in the past, and the organisms responsible for these infections are evolving to become more difficult to treat. Fortunately, though, major strides in basic, translational, and clinical research have occurred in recent years that have armed the clinician with an armamentarium of techniques and technologies to better diagnose, prevent, and treat PJI. Advances in diagnostics, including refinements in established biomarkers, the introduction of point of service tests, developments in molecular techniques, and new techniques in advanced imaging will allow us to correctly identify the infecting pathogens and their virulence factors. Utilizing developed risk indexes to stratify and medically optimize our patients, modifying implants to incorporate antimicrobial and anti-biofilm properties, and developing clinically applicable vaccines and biofilm inhibiting enzymes will address our struggles in preventing PJI. Success of our future treatment strategies will hinge on refining the indications and technique of our current surgical procedures as well as the rational use of biofilm disrupting technologies and photodynamic therapy. Finally, the field of metabolomics, though still relatively in its infancy, likely holds the key to a novel diagnostic and treatment approach to infection and a more profound understanding of the pathophysiology of PJI on the human body.",10.5301/ijao.5000145,t9rsm119,"['Periprosthetic', 'joint', 'infection', 'PJI', 'will', 'emerge', 'as', 'one', 'of', 'the', 'most', 'important', 'issues', 'for', 'both', 'orthopedic', 'surgeons', 'and', 'researchers', 'active', 'in', 'the', 'field', 'over', 'the', 'coming', 'decades', 'Although', 'the', 'rate', 'of', 'PJI', 'has', 'not', 'changed', 'significantly', 'over', 'the', 'past', 'decade', 'the', 'affected', 'patients', 'hosts', 'being', 'treated', 'often', 'present', 'with', 'more', 'comorbidities', 'than', 'in', 'the', 'past', 'and', 'the', 'organisms', 'responsible', 'for', 'these', 'infections', 'are', 'evolving', 'to', 'become', 'more', 'difficult', 'to', 'treat', 'Fortunately', 'though', 'major', 'strides', 'in', 'basic', 'translational', 'and', 'clinical', 'research', 'have', 'occurred', 'in', 'recent', 'years', 'that', 'have', 'armed', 'the', 'clinician', 'with', 'an', 'armamentarium', 'of', 'techniques', 'and', 'technologies', 'to', 'better', 'diagnose', 'prevent', 'and', 'treat', 'PJI', 'Advances', 'in', 'diagnostics', 'including', 'refinements', 'in', 'established', 'biomarkers', 'the', 'introduction', 'of', 'point', 'of', 'service', 'tests', 'developments', 'in', 'molecular', 'techniques', 'and', 'new', 'techniques', 'in', 'advanced', 'imaging', 'will', 'allow', 'us', 'to', 'correctly', 'identify', 'the', 'infecting', 'pathogens', 'and', 'their', 'virulence', 'factors', 'Utilizing', 'developed', 'risk', 'indexes', 'to', 'stratify', 'and', 'medically', 'optimize', 'our', 'patients', 'modifying', 'implants', 'to', 'incorporate', 'antimicrobial', 'and', 'anti', 'biofilm', 'properties', 'and', 'developing', 'clinically', 'applicable', 'vaccines', 'and', 'biofilm', 'inhibiting', 'enzymes', 'will', 'address', 'our', 'struggles', 'in', 'preventing', 'PJI', 'Success', 'of', 'our', 'future', 'treatment', 'strategies', 'will', 'hinge', 'on', 'refining', 'the', 'indications', 'and', 'technique', 'of', 'our', 'current', 'surgical', 'procedures', 'as', 'well', 'as', 'the', 'rational', 'use', 'of', 'biofilm', 'disrupting', 'technologies', 'and', 'photodynamic', 'therapy', 'Finally', 'the', 'field', 'of', 'metabolomics', 'though', 'still', 'relatively', 'in', 'its', 'infancy', 'likely', 'holds', 'the', 'key', 'to', 'a', 'novel', 'diagnostic', 'and', 'treatment', 'approach', 'to', 'infection', 'and', 'a', 'more', 'profound', 'understanding', 'of', 'the', 'pathophysiology', 'of', 'PJI', 'on', 'the', 'human', 'body', '']"
39800,Suture materials - Current and emerging trends.,2016,Journal of biomedical materials research. Part A,https://doi.org/10.1002/jbm.a.35683; https://www.ncbi.nlm.nih.gov/pubmed/26860644/,"Surgical sutures are used to facilitate closure and healing of surgical- or trauma-induced wounds by upholding tissues together to facilitate healing process. There is a wide range of suture materials for medical purpose and the main types include absorbable and nonabsorbable. Recently, there is a growth in the development of classes of suture materials based on their properties and capabilities to improve tissue approximation and wound closure. This review outlines and discusses the current and emerging trends in suture technology including knotless barbed sutures, antimicrobial sutures, bio-active sutures such as drug-eluting and stem cells seeded sutures, and smart sutures including elastic, and electronic sutures. These newer strategies expand the versatility of sutures from being used as just a physical entity approximating opposing tissues to a more biologically active component enabling delivery of drugs and cells to the desired site with immense application potential in both therapeutics and diagnostics. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1544-1559, 2016.",10.1002/jbm.a.35683,mfwds2at,"['Surgical', 'sutures', 'are', 'used', 'to', 'facilitate', 'closure', 'and', 'healing', 'of', 'surgical', 'or', 'trauma', 'induced', 'wounds', 'by', 'upholding', 'tissues', 'together', 'to', 'facilitate', 'healing', 'process', 'There', 'is', 'a', 'wide', 'range', 'of', 'suture', 'materials', 'for', 'medical', 'purpose', 'and', 'the', 'main', 'types', 'include', 'absorbable', 'and', 'nonabsorbable', 'Recently', 'there', 'is', 'a', 'growth', 'in', 'the', 'development', 'of', 'classes', 'of', 'suture', 'materials', 'based', 'on', 'their', 'properties', 'and', 'capabilities', 'to', 'improve', 'tissue', 'approximation', 'and', 'wound', 'closure', 'This', 'review', 'outlines', 'and', 'discusses', 'the', 'current', 'and', 'emerging', 'trends', 'in', 'suture', 'technology', 'including', 'knotless', 'barbed', 'sutures', 'antimicrobial', 'sutures', 'bio', 'active', 'sutures', 'such', 'as', 'drug', 'eluting', 'and', 'stem', 'cells', 'seeded', 'sutures', 'and', 'smart', 'sutures', 'including', 'elastic', 'and', 'electronic', 'sutures', 'These', 'newer', 'strategies', 'expand', 'the', 'versatility', 'of', 'sutures', 'from', 'being', 'used', 'as', 'just', 'a', 'physical', 'entity', 'approximating', 'opposing', 'tissues', 'to', 'a', 'more', 'biologically', 'active', 'component', 'enabling', 'delivery', 'of', 'drugs', 'and', 'cells', 'to', 'the', 'desired', 'site', 'with', 'immense', 'application', 'potential', 'in', 'both', 'therapeutics', 'and', 'diagnostics', '2016', 'Wiley', 'Periodicals', 'Inc', 'J', 'Biomed', 'Mater', 'Res', 'Part', 'A', '104A', '1544', '1559', '2016', '']"
40201,Technology-driven diagnostics: From smart doctor to smartphone.,2016,Critical reviews in clinical laboratory sciences,https://doi.org/10.3109/10408363.2016.1149689; https://www.ncbi.nlm.nih.gov/pubmed/26857116/,"This review explores recent innovations in four seemingly unrelated areas of medical diagnostics, which, when used concurrently, promise to revolutionize the future of medicine. Novel microfluidics and microelectronics, combined with smartphones, allow individuals to test themselves at anytime and anywhere, thus providing instant health information. An emerging development is the availability of genomic testing directly to consumers for assessing disease predisposition. Some organizations have opened diagnostic laboratories in pharmacies and other public outlets, are encouraging consumers to test themselves, and claim that by doing so consumers will be empowered to diagnose the early disease that could be effectively treated or prevented. Another recent development is the initiation of large studies that aim to better understand wellness and disease processes, through the frequent and sometimes continuous monitoring of hundreds or thousands of parameters. These are then analyzed by health coaches who advise participants on follow-up steps to correct the abnormalities and return to wellness. A number of these approaches have now entered the health market and the services can be purchased. It is highly likely that further technological innovations will contribute to the popularity of these approaches among millions of health-conscious consumers. However, the evidence for the effectiveness of these strategies to prevent or detect early disease, or to promote wellness, does not yet exist. We here analyze the perceived benefits and (neglected) harms of these approaches, in an effort to balance the optimism about their utility, until the evidence for their benefit is clearly demonstrated.",10.3109/10408363.2016.1149689,hquyuclf,"['This', 'review', 'explores', 'recent', 'innovations', 'in', 'four', 'seemingly', 'unrelated', 'areas', 'of', 'medical', 'diagnostics', 'which', 'when', 'used', 'concurrently', 'promise', 'to', 'revolutionize', 'the', 'future', 'of', 'medicine', 'Novel', 'microfluidics', 'and', 'microelectronics', 'combined', 'with', 'smartphones', 'allow', 'individuals', 'to', 'test', 'themselves', 'at', 'anytime', 'and', 'anywhere', 'thus', 'providing', 'instant', 'health', 'information', 'An', 'emerging', 'development', 'is', 'the', 'availability', 'of', 'genomic', 'testing', 'directly', 'to', 'consumers', 'for', 'assessing', 'disease', 'predisposition', 'Some', 'organizations', 'have', 'opened', 'diagnostic', 'laboratories', 'in', 'pharmacies', 'and', 'other', 'public', 'outlets', 'are', 'encouraging', 'consumers', 'to', 'test', 'themselves', 'and', 'claim', 'that', 'by', 'doing', 'so', 'consumers', 'will', 'be', 'empowered', 'to', 'diagnose', 'the', 'early', 'disease', 'that', 'could', 'be', 'effectively', 'treated', 'or', 'prevented', 'Another', 'recent', 'development', 'is', 'the', 'initiation', 'of', 'large', 'studies', 'that', 'aim', 'to', 'better', 'understand', 'wellness', 'and', 'disease', 'processes', 'through', 'the', 'frequent', 'and', 'sometimes', 'continuous', 'monitoring', 'of', 'hundreds', 'or', 'thousands', 'of', 'parameters', 'These', 'are', 'then', 'analyzed', 'by', 'health', 'coaches', 'who', 'advise', 'participants', 'on', 'follow', 'up', 'steps', 'to', 'correct', 'the', 'abnormalities', 'and', 'return', 'to', 'wellness', 'A', 'number', 'of', 'these', 'approaches', 'have', 'now', 'entered', 'the', 'health', 'market', 'and', 'the', 'services', 'can', 'be', 'purchased', 'It', 'is', 'highly', 'likely', 'that', 'further', 'technological', 'innovations', 'will', 'contribute', 'to', 'the', 'popularity', 'of', 'these', 'approaches', 'among', 'millions', 'of', 'health', 'conscious', 'consumers', 'However', 'the', 'evidence', 'for', 'the', 'effectiveness', 'of', 'these', 'strategies', 'to', 'prevent', 'or', 'detect', 'early', 'disease', 'or', 'to', 'promote', 'wellness', 'does', 'not', 'yet', 'exist', 'We', 'here', 'analyze', 'the', 'perceived', 'benefits', 'and', 'neglected', 'harms', 'of', 'these', 'approaches', 'in', 'an', 'effort', 'to', 'balance', 'the', 'optimism', 'about', 'their', 'utility', 'until', 'the', 'evidence', 'for', 'their', 'benefit', 'is', 'clearly', 'demonstrated', '']"
40502,Application of mass spectrometry to molecular diagnostics of viral infections.,2013,Expert review of molecular diagnostics,https://doi.org/10.1586/erm.13.24; https://www.ncbi.nlm.nih.gov/pubmed/23638820/,"Mass spectrometry (MS) has found numerous applications in life sciences. It has high accuracy, sensitivity and wide dynamic range in addition to medium- to high-throughput capabilities. These features make MS a superior platform for analysis of various biomolecules including proteins, lipids, nucleic acids and carbohydrates. Until recently, MS was applied for protein detection and characterization. During the last decade, however, MS has successfully been used for molecular diagnostics of microbial and viral infections with the most notable applications being identification of pathogens, genomic sequencing, mutation detection, DNA methylation analysis, tracking of transmissions, and characterization of genetic heterogeneity. These new developments vastly expand the MS application from experimental research to public health and clinical fields. Matching of molecular techniques with specific requirements of the major MS platforms has produced powerful technologies for molecular diagnostics, which will further benefit from coupling with computational tools for extracting clinical information from MS-derived data.",10.1586/erm.13.24,qh2kuzdc,"['Mass', 'spectrometry', 'MS', 'has', 'found', 'numerous', 'applications', 'in', 'life', 'sciences', 'It', 'has', 'high', 'accuracy', 'sensitivity', 'and', 'wide', 'dynamic', 'range', 'in', 'addition', 'to', 'medium', 'to', 'high', 'throughput', 'capabilities', 'These', 'features', 'make', 'MS', 'a', 'superior', 'platform', 'for', 'analysis', 'of', 'various', 'biomolecules', 'including', 'proteins', 'lipids', 'nucleic', 'acids', 'and', 'carbohydrates', 'Until', 'recently', 'MS', 'was', 'applied', 'for', 'protein', 'detection', 'and', 'characterization', 'During', 'the', 'last', 'decade', 'however', 'MS', 'has', 'successfully', 'been', 'used', 'for', 'molecular', 'diagnostics', 'of', 'microbial', 'and', 'viral', 'infections', 'with', 'the', 'most', 'notable', 'applications', 'being', 'identification', 'of', 'pathogens', 'genomic', 'sequencing', 'mutation', 'detection', 'DNA', 'methylation', 'analysis', 'tracking', 'of', 'transmissions', 'and', 'characterization', 'of', 'genetic', 'heterogeneity', 'These', 'new', 'developments', 'vastly', 'expand', 'the', 'MS', 'application', 'from', 'experimental', 'research', 'to', 'public', 'health', 'and', 'clinical', 'fields', 'Matching', 'of', 'molecular', 'techniques', 'with', 'specific', 'requirements', 'of', 'the', 'major', 'MS', 'platforms', 'has', 'produced', 'powerful', 'technologies', 'for', 'molecular', 'diagnostics', 'which', 'will', 'further', 'benefit', 'from', 'coupling', 'with', 'computational', 'tools', 'for', 'extracting', 'clinical', 'information', 'from', 'MS', 'derived', 'data', '']"
42049,Rhinovirus and the initiation of asthma.,2009,Current opinion in allergy and clinical immunology,https://doi.org/10.1097/aci.0b013e32831f8f1b; https://www.ncbi.nlm.nih.gov/pubmed/19532096/,"PURPOSE OF REVIEW Virus-induced wheezing in infancy is a risk factor for asthma, and recent studies have highlighted the role of rhinoviruses in causing acute illnesses and as a possible contributing factor to chronic asthma. RECENT FINDINGS Human rhinoviruses (HRVs) have long been known as the most common cause of common cold in infants and children. Recent developments in molecular diagnostics have led to the discovery of new viruses and have also provided data to implicate HRV as an important cause of lower respiratory infections and acute virus-induced wheezing in preschool children. In addition, HRV-induced wheezing episodes appear to identify children who are at increased risk for the subsequent development of childhood asthma. SUMMARY Collectively, these findings raise the possibility that lower respiratory infections with pathogens such as HRV and respiratory syncytial virus could participate in the causation of asthma, especially in children with suboptimal antiviral defenses. A variety of experimental models and clinical studies have been used to identify possible mechanisms related to the infection and the ensuing host response that could disturb normal lung and immunologic development to promote asthma. Defining these relationships could lead to new therapeutic and preventive approaches to common forms of childhood asthma.",10.1097/aci.0b013e32831f8f1b,yq7y5y65,"['PURPOSE', 'OF', 'REVIEW', 'Virus', 'induced', 'wheezing', 'in', 'infancy', 'is', 'a', 'risk', 'factor', 'for', 'asthma', 'and', 'recent', 'studies', 'have', 'highlighted', 'the', 'role', 'of', 'rhinoviruses', 'in', 'causing', 'acute', 'illnesses', 'and', 'as', 'a', 'possible', 'contributing', 'factor', 'to', 'chronic', 'asthma', 'RECENT', 'FINDINGS', 'Human', 'rhinoviruses', 'HRVs', 'have', 'long', 'been', 'known', 'as', 'the', 'most', 'common', 'cause', 'of', 'common', 'cold', 'in', 'infants', 'and', 'children', 'Recent', 'developments', 'in', 'molecular', 'diagnostics', 'have', 'led', 'to', 'the', 'discovery', 'of', 'new', 'viruses', 'and', 'have', 'also', 'provided', 'data', 'to', 'implicate', 'HRV', 'as', 'an', 'important', 'cause', 'of', 'lower', 'respiratory', 'infections', 'and', 'acute', 'virus', 'induced', 'wheezing', 'in', 'preschool', 'children', 'In', 'addition', 'HRV', 'induced', 'wheezing', 'episodes', 'appear', 'to', 'identify', 'children', 'who', 'are', 'at', 'increased', 'risk', 'for', 'the', 'subsequent', 'development', 'of', 'childhood', 'asthma', 'SUMMARY', 'Collectively', 'these', 'findings', 'raise', 'the', 'possibility', 'that', 'lower', 'respiratory', 'infections', 'with', 'pathogens', 'such', 'as', 'HRV', 'and', 'respiratory', 'syncytial', 'virus', 'could', 'participate', 'in', 'the', 'causation', 'of', 'asthma', 'especially', 'in', 'children', 'with', 'suboptimal', 'antiviral', 'defenses', 'A', 'variety', 'of', 'experimental', 'models', 'and', 'clinical', 'studies', 'have', 'been', 'used', 'to', 'identify', 'possible', 'mechanisms', 'related', 'to', 'the', 'infection', 'and', 'the', 'ensuing', 'host', 'response', 'that', 'could', 'disturb', 'normal', 'lung', 'and', 'immunologic', 'development', 'to', 'promote', 'asthma', 'Defining', 'these', 'relationships', 'could', 'lead', 'to', 'new', 'therapeutic', 'and', 'preventive', 'approaches', 'to', 'common', 'forms', 'of', 'childhood', 'asthma', '']"
42051,History and Practice: Antibodies in Infectious Diseases.,2015,Microbiology spectrum,https://doi.org/10.1128/microbiolspec.aid-0026-2014; https://www.ncbi.nlm.nih.gov/pubmed/26104697/,"Antibodies and passive antibody therapy in the treatment of infectious diseases is the story of a treatment concept which dates back more than 120 years, to the 1890s, when the use of serum from immunized animals provided the first effective treatment options against infections with Clostridium tetani and Corynebacterium diphtheriae. However, after the discovery of penicillin by Fleming in 1928, and the subsequent introduction of the much cheaper and safer antibiotics in the 1930s, serum therapy was largely abandoned. However, the broad and general use of antibiotics in human and veterinary medicine has resulted in the development of multi-resistant strains of bacteria with limited to no response to existing treatments and the need for alternative treatment options. The combined specificity and flexibility of antibody-based treatments makes them very valuable tools for designing specific antibody treatments to infectious agents. These attributes have already caused a revolution in new antibody-based treatments in oncology and inflammatory diseases, with many approved products. However, only one monoclonal antibody, palivizumab, for the prevention and treatment of respiratory syncytial virus, is approved for infectious diseases. The high cost of monoclonal antibody therapies, the need for parallel development of diagnostics, and the relatively small markets are major barriers for their development in the presence of cheap antibiotics. It is time to take a new and revised look into the future to find appropriate niches in infectious diseases where new antibody-based treatments or combinations with existing antibiotics, could prove their value and serve as stepping stones for broader acceptance of the potential for and value of these treatments.",10.1128/microbiolspec.aid-0026-2014,l6eq4bzb,"['Antibodies', 'and', 'passive', 'antibody', 'therapy', 'in', 'the', 'treatment', 'of', 'infectious', 'diseases', 'is', 'the', 'story', 'of', 'a', 'treatment', 'concept', 'which', 'dates', 'back', 'more', 'than', '120', 'years', 'to', 'the', '1890s', 'when', 'the', 'use', 'of', 'serum', 'from', 'immunized', 'animals', 'provided', 'the', 'first', 'effective', 'treatment', 'options', 'against', 'infections', 'with', 'Clostridium', 'tetani', 'and', 'Corynebacterium', 'diphtheriae', 'However', 'after', 'the', 'discovery', 'of', 'penicillin', 'by', 'Fleming', 'in', '1928', 'and', 'the', 'subsequent', 'introduction', 'of', 'the', 'much', 'cheaper', 'and', 'safer', 'antibiotics', 'in', 'the', '1930s', 'serum', 'therapy', 'was', 'largely', 'abandoned', 'However', 'the', 'broad', 'and', 'general', 'use', 'of', 'antibiotics', 'in', 'human', 'and', 'veterinary', 'medicine', 'has', 'resulted', 'in', 'the', 'development', 'of', 'multi', 'resistant', 'strains', 'of', 'bacteria', 'with', 'limited', 'to', 'no', 'response', 'to', 'existing', 'treatments', 'and', 'the', 'need', 'for', 'alternative', 'treatment', 'options', 'The', 'combined', 'specificity', 'and', 'flexibility', 'of', 'antibody', 'based', 'treatments', 'makes', 'them', 'very', 'valuable', 'tools', 'for', 'designing', 'specific', 'antibody', 'treatments', 'to', 'infectious', 'agents', 'These', 'attributes', 'have', 'already', 'caused', 'a', 'revolution', 'in', 'new', 'antibody', 'based', 'treatments', 'in', 'oncology', 'and', 'inflammatory', 'diseases', 'with', 'many', 'approved', 'products', 'However', 'only', 'one', 'monoclonal', 'antibody', 'palivizumab', 'for', 'the', 'prevention', 'and', 'treatment', 'of', 'respiratory', 'syncytial', 'virus', 'is', 'approved', 'for', 'infectious', 'diseases', 'The', 'high', 'cost', 'of', 'monoclonal', 'antibody', 'therapies', 'the', 'need', 'for', 'parallel', 'development', 'of', 'diagnostics', 'and', 'the', 'relatively', 'small', 'markets', 'are', 'major', 'barriers', 'for', 'their', 'development', 'in', 'the', 'presence', 'of', 'cheap', 'antibiotics', 'It', 'is', 'time', 'to', 'take', 'a', 'new', 'and', 'revised', 'look', 'into', 'the', 'future', 'to', 'find', 'appropriate', 'niches', 'in', 'infectious', 'diseases', 'where', 'new', 'antibody', 'based', 'treatments', 'or', 'combinations', 'with', 'existing', 'antibiotics', 'could', 'prove', 'their', 'value', 'and', 'serve', 'as', 'stepping', 'stones', 'for', 'broader', 'acceptance', 'of', 'the', 'potential', 'for', 'and', 'value', 'of', 'these', 'treatments', '']"
42446,Glycan-based high-affinity ligands for toxins and pathogen receptors.,2010,Medicinal research reviews,https://doi.org/10.1002/med.20196; https://www.ncbi.nlm.nih.gov/pubmed/20135686/,"Glycans decorate over 95% of the mammalian cell surface in the form of glycolipids and glycoproteins. Several toxins and pathogens bind to these glycans to enter the cells. Understanding the fundamentals of the complex interplay between microbial pathogens and their glycan receptors at the molecular level could lead to the development of novel therapeutics and diagnostics. Using Shiga toxin and influenza virus as examples, we describe the complex biological interface between host glycans and these infectious agents, and recent strategies to develop glycan-based high-affinity ligands. These molecules are expected to ultimately be incorporated into diagnostics and therapeutics, and can be used as probes to study important biological processes. Additionally, by focusing on the specific glycans that microbial pathogens target, we can begin to decipher the ""glycocode"" and how these glycans participate in normal and aberrant cellular communication.",10.1002/med.20196,2adlx919,"['Glycans', 'decorate', 'over', '95', 'of', 'the', 'mammalian', 'cell', 'surface', 'in', 'the', 'form', 'of', 'glycolipids', 'and', 'glycoproteins', 'Several', 'toxins', 'and', 'pathogens', 'bind', 'to', 'these', 'glycans', 'to', 'enter', 'the', 'cells', 'Understanding', 'the', 'fundamentals', 'of', 'the', 'complex', 'interplay', 'between', 'microbial', 'pathogens', 'and', 'their', 'glycan', 'receptors', 'at', 'the', 'molecular', 'level', 'could', 'lead', 'to', 'the', 'development', 'of', 'novel', 'therapeutics', 'and', 'diagnostics', 'Using', 'Shiga', 'toxin', 'and', 'influenza', 'virus', 'as', 'examples', 'we', 'describe', 'the', 'complex', 'biological', 'interface', 'between', 'host', 'glycans', 'and', 'these', 'infectious', 'agents', 'and', 'recent', 'strategies', 'to', 'develop', 'glycan', 'based', 'high', 'affinity', 'ligands', 'These', 'molecules', 'are', 'expected', 'to', 'ultimately', 'be', 'incorporated', 'into', 'diagnostics', 'and', 'therapeutics', 'and', 'can', 'be', 'used', 'as', 'probes', 'to', 'study', 'important', 'biological', 'processes', 'Additionally', 'by', 'focusing', 'on', 'the', 'specific', 'glycans', 'that', 'microbial', 'pathogens', 'target', 'we', 'can', 'begin', 'to', 'decipher', 'the', 'glycocode', 'and', 'how', 'these', 'glycans', 'participate', 'in', 'normal', 'and', 'aberrant', 'cellular', 'communication', '']"
43280,Trends and innovations in biosensors for COVID-19 mass testing.,2020-05-04,Chembiochem : a European journal of chemical biology,https://doi.org/10.1002/cbic.202000250; https://www.ncbi.nlm.nih.gov/pubmed/32367615/,"Fast and widespread diagnosis is crucial to fight against the outbreak of COVID-19. The present work surveys the landscape of available and emerging biosensor technologies for COVID-19 testing. Molecular diagnostic assays based on quantitative Reverse Transcription Polymerase Chain Reaction are used in most clinical laboratories. The COVID-19 pandemic has overwhelmed the testing capacity and motivated the development of fast point-of-care tests and the adoption of isothermal DNA amplification. Antigenic and serological rapid tests based on lateral flow immunoassays suffer from low sensitivity. Advanced digital systems enhance the performance at the expense of speed and large equipment requirement. Emerging technologies, including CRISPR gene-editing tools, benefit from high sensitivity and selectivity of molecular diagnostics and the easy use of lateral flow assays. DNA sequencing and sample pooling strategies are highlighted to bring out the full capacity of the available biosensor technologies and accelerate mass testing.",10.1002/cbic.202000250,nswmhpzf,"['Fast', 'and', 'widespread', 'diagnosis', 'is', 'crucial', 'to', 'fight', 'against', 'the', 'outbreak', 'of', 'COVID', '19', 'The', 'present', 'work', 'surveys', 'the', 'landscape', 'of', 'available', 'and', 'emerging', 'biosensor', 'technologies', 'for', 'COVID', '19', 'testing', 'Molecular', 'diagnostic', 'assays', 'based', 'on', 'quantitative', 'Reverse', 'Transcription', 'Polymerase', 'Chain', 'Reaction', 'are', 'used', 'in', 'most', 'clinical', 'laboratories', 'The', 'COVID', '19', 'pandemic', 'has', 'overwhelmed', 'the', 'testing', 'capacity', 'and', 'motivated', 'the', 'development', 'of', 'fast', 'point', 'of', 'care', 'tests', 'and', 'the', 'adoption', 'of', 'isothermal', 'DNA', 'amplification', 'Antigenic', 'and', 'serological', 'rapid', 'tests', 'based', 'on', 'lateral', 'flow', 'immunoassays', 'suffer', 'from', 'low', 'sensitivity', 'Advanced', 'digital', 'systems', 'enhance', 'the', 'performance', 'at', 'the', 'expense', 'of', 'speed', 'and', 'large', 'equipment', 'requirement', 'Emerging', 'technologies', 'including', 'CRISPR', 'gene', 'editing', 'tools', 'benefit', 'from', 'high', 'sensitivity', 'and', 'selectivity', 'of', 'molecular', 'diagnostics', 'and', 'the', 'easy', 'use', 'of', 'lateral', 'flow', 'assays', 'DNA', 'sequencing', 'and', 'sample', 'pooling', 'strategies', 'are', 'highlighted', 'to', 'bring', 'out', 'the', 'full', 'capacity', 'of', 'the', 'available', 'biosensor', 'technologies', 'and', 'accelerate', 'mass', 'testing', '']"
44398,Syndromic Panel-Based Testing in Clinical Microbiology.,2018,Clinical microbiology reviews,https://doi.org/10.1128/cmr.00024-17; https://www.ncbi.nlm.nih.gov/pubmed/29142077/,"The recent development of commercial panel-based molecular diagnostics for the rapid detection of pathogens in positive blood culture bottles, respiratory specimens, stool, and cerebrospinal fluid has resulted in a paradigm shift in clinical microbiology and clinical practice. This review focuses on U.S. Food and Drug Administration (FDA)-approved/cleared multiplex molecular panels with more than five targets designed to assist in the diagnosis of bloodstream, respiratory tract, gastrointestinal, or central nervous system infections. While these panel-based assays have the clear advantages of a rapid turnaround time and the detection of a large number of microorganisms and promise to improve health care, they present certain challenges, including cost and the definition of ideal test utilization strategies (i.e., optimal ordering) and test interpretation.",10.1128/cmr.00024-17,gsprsbug,"['The', 'recent', 'development', 'of', 'commercial', 'panel', 'based', 'molecular', 'diagnostics', 'for', 'the', 'rapid', 'detection', 'of', 'pathogens', 'in', 'positive', 'blood', 'culture', 'bottles', 'respiratory', 'specimens', 'stool', 'and', 'cerebrospinal', 'fluid', 'has', 'resulted', 'in', 'a', 'paradigm', 'shift', 'in', 'clinical', 'microbiology', 'and', 'clinical', 'practice', 'This', 'review', 'focuses', 'on', 'U', 'S', 'Food', 'and', 'Drug', 'Administration', 'FDA', 'approved', 'cleared', 'multiplex', 'molecular', 'panels', 'with', 'more', 'than', 'five', 'targets', 'designed', 'to', 'assist', 'in', 'the', 'diagnosis', 'of', 'bloodstream', 'respiratory', 'tract', 'gastrointestinal', 'or', 'central', 'nervous', 'system', 'infections', 'While', 'these', 'panel', 'based', 'assays', 'have', 'the', 'clear', 'advantages', 'of', 'a', 'rapid', 'turnaround', 'time', 'and', 'the', 'detection', 'of', 'a', 'large', 'number', 'of', 'microorganisms', 'and', 'promise', 'to', 'improve', 'health', 'care', 'they', 'present', 'certain', 'challenges', 'including', 'cost', 'and', 'the', 'definition', 'of', 'ideal', 'test', 'utilization', 'strategies', 'i', 'e', 'optimal', 'ordering', 'and', 'test', 'interpretation', '']"
46002,Label-free biological and chemical sensors.,2010,Nanoscale,https://doi.org/10.1039/c0nr00201a; https://www.ncbi.nlm.nih.gov/pubmed/20820687/,"Highly sensitive, label-free biodetection methods have applications in both the fundamental research and healthcare diagnostics arenas. Therefore, the development of new transduction methods and the improvement of the existing methods will significantly impact these areas. A brief overview of the different types of biosensors and the critical parameters governing their performance will be given. Additionally, a more in-depth discussion of optical devices, surface functionalization methods to increase device specificity, and fluidic techniques to improve sample delivery will be reviewed.",10.1039/c0nr00201a,cgp2ht15,"['Highly', 'sensitive', 'label', 'free', 'biodetection', 'methods', 'have', 'applications', 'in', 'both', 'the', 'fundamental', 'research', 'and', 'healthcare', 'diagnostics', 'arenas', 'Therefore', 'the', 'development', 'of', 'new', 'transduction', 'methods', 'and', 'the', 'improvement', 'of', 'the', 'existing', 'methods', 'will', 'significantly', 'impact', 'these', 'areas', 'A', 'brief', 'overview', 'of', 'the', 'different', 'types', 'of', 'biosensors', 'and', 'the', 'critical', 'parameters', 'governing', 'their', 'performance', 'will', 'be', 'given', 'Additionally', 'a', 'more', 'in', 'depth', 'discussion', 'of', 'optical', 'devices', 'surface', 'functionalization', 'methods', 'to', 'increase', 'device', 'specificity', 'and', 'fluidic', 'techniques', 'to', 'improve', 'sample', 'delivery', 'will', 'be', 'reviewed', '']"
47640,Recombinant protein-based viral disease diagnostics in veterinary medicine.,2010,Expert review of molecular diagnostics,https://doi.org/10.1586/erm.10.61; https://www.ncbi.nlm.nih.gov/pubmed/20843198/,"Identification of pathogens or antibody response to pathogens in human and animals modulates the treatment strategies for naive population and subsequent infections. Diseases can be controlled and even eradicated based on the epidemiology and effective prophylaxis, which often depends on development of efficient diagnostics. In addition, combating newly emerging diseases in human as well as animal healthcare is challenging and is dependent on developing safe and efficient diagnostics. Detection of antibodies directed against specific antigens has been the method of choice for documenting prior infection. Other than zoonosis, development of inexpensive vaccines and diagnostics is a unique problem in animal healthcare. The advent of recombinant DNA technology and its application in the biotechnology industry has revolutionized animal healthcare. The use of recombinant DNA technology in animal disease diagnosis has improved the rapidity, specificity and sensitivity of various diagnostic assays. This is because of the absence of host cellular proteins in the recombinant derived antigen preparations that dramatically decrease the rate of false-positive reactions. Various recombinant products are used for disease diagnosis in veterinary medicine and this article discusses recombinant-based viral disease diagnostics currently used for detection of pathogens in livestock and poultry.",10.1586/erm.10.61,ierl283y,"['Identification', 'of', 'pathogens', 'or', 'antibody', 'response', 'to', 'pathogens', 'in', 'human', 'and', 'animals', 'modulates', 'the', 'treatment', 'strategies', 'for', 'naive', 'population', 'and', 'subsequent', 'infections', 'Diseases', 'can', 'be', 'controlled', 'and', 'even', 'eradicated', 'based', 'on', 'the', 'epidemiology', 'and', 'effective', 'prophylaxis', 'which', 'often', 'depends', 'on', 'development', 'of', 'efficient', 'diagnostics', 'In', 'addition', 'combating', 'newly', 'emerging', 'diseases', 'in', 'human', 'as', 'well', 'as', 'animal', 'healthcare', 'is', 'challenging', 'and', 'is', 'dependent', 'on', 'developing', 'safe', 'and', 'efficient', 'diagnostics', 'Detection', 'of', 'antibodies', 'directed', 'against', 'specific', 'antigens', 'has', 'been', 'the', 'method', 'of', 'choice', 'for', 'documenting', 'prior', 'infection', 'Other', 'than', 'zoonosis', 'development', 'of', 'inexpensive', 'vaccines', 'and', 'diagnostics', 'is', 'a', 'unique', 'problem', 'in', 'animal', 'healthcare', 'The', 'advent', 'of', 'recombinant', 'DNA', 'technology', 'and', 'its', 'application', 'in', 'the', 'biotechnology', 'industry', 'has', 'revolutionized', 'animal', 'healthcare', 'The', 'use', 'of', 'recombinant', 'DNA', 'technology', 'in', 'animal', 'disease', 'diagnosis', 'has', 'improved', 'the', 'rapidity', 'specificity', 'and', 'sensitivity', 'of', 'various', 'diagnostic', 'assays', 'This', 'is', 'because', 'of', 'the', 'absence', 'of', 'host', 'cellular', 'proteins', 'in', 'the', 'recombinant', 'derived', 'antigen', 'preparations', 'that', 'dramatically', 'decrease', 'the', 'rate', 'of', 'false', 'positive', 'reactions', 'Various', 'recombinant', 'products', 'are', 'used', 'for', 'disease', 'diagnosis', 'in', 'veterinary', 'medicine', 'and', 'this', 'article', 'discusses', 'recombinant', 'based', 'viral', 'disease', 'diagnostics', 'currently', 'used', 'for', 'detection', 'of', 'pathogens', 'in', 'livestock', 'and', 'poultry', '']"
48535,Culture-Independent Diagnostics for Health Security.,2016,Health security,https://doi.org/10.1089/hs.2015.0074; https://www.ncbi.nlm.nih.gov/pubmed/27314653/,"The past decade has seen considerable development in the diagnostic application of nonculture methods, including nucleic acid amplification-based methods and mass spectrometry, for the diagnosis of infectious diseases. The implications of these new culture-independent diagnostic tests (CIDTs) include bypassing the need to culture organisms, thus potentially affecting public health surveillance systems, which continue to use isolates as the basis of their surveillance programs and to assess phenotypic resistance to antimicrobial agents. CIDTs may also affect the way public health practitioners detect and respond to a bioterrorism event. In response to a request from the Department of Homeland Security, Los Alamos National Laboratory and the Centers for Disease Control and Prevention cosponsored a workshop to review the impact of CIDTs on the rapid detection and identification of biothreat agents. Four panel discussions were held that covered nucleic acid amplification-based diagnostics, mass spectrometry, antibody-based diagnostics, and next-generation sequencing. Exploiting the extensive expertise available at this workshop, we identified the key features, benefits, and limitations of the various CIDT methods for providing rapid pathogen identification that are critical to the response and mitigation of a bioterrorism event. After the workshop we conducted a thorough review of the literature, investigating the current state of these 4 culture-independent diagnostic methods. This article combines information from the literature review and the insights obtained at the workshop.",10.1089/hs.2015.0074,5r6kl6tk,"['The', 'past', 'decade', 'has', 'seen', 'considerable', 'development', 'in', 'the', 'diagnostic', 'application', 'of', 'nonculture', 'methods', 'including', 'nucleic', 'acid', 'amplification', 'based', 'methods', 'and', 'mass', 'spectrometry', 'for', 'the', 'diagnosis', 'of', 'infectious', 'diseases', 'The', 'implications', 'of', 'these', 'new', 'culture', 'independent', 'diagnostic', 'tests', 'CIDTs', 'include', 'bypassing', 'the', 'need', 'to', 'culture', 'organisms', 'thus', 'potentially', 'affecting', 'public', 'health', 'surveillance', 'systems', 'which', 'continue', 'to', 'use', 'isolates', 'as', 'the', 'basis', 'of', 'their', 'surveillance', 'programs', 'and', 'to', 'assess', 'phenotypic', 'resistance', 'to', 'antimicrobial', 'agents', 'CIDTs', 'may', 'also', 'affect', 'the', 'way', 'public', 'health', 'practitioners', 'detect', 'and', 'respond', 'to', 'a', 'bioterrorism', 'event', 'In', 'response', 'to', 'a', 'request', 'from', 'the', 'Department', 'of', 'Homeland', 'Security', 'Los', 'Alamos', 'National', 'Laboratory', 'and', 'the', 'Centers', 'for', 'Disease', 'Control', 'and', 'Prevention', 'cosponsored', 'a', 'workshop', 'to', 'review', 'the', 'impact', 'of', 'CIDTs', 'on', 'the', 'rapid', 'detection', 'and', 'identification', 'of', 'biothreat', 'agents', 'Four', 'panel', 'discussions', 'were', 'held', 'that', 'covered', 'nucleic', 'acid', 'amplification', 'based', 'diagnostics', 'mass', 'spectrometry', 'antibody', 'based', 'diagnostics', 'and', 'next', 'generation', 'sequencing', 'Exploiting', 'the', 'extensive', 'expertise', 'available', 'at', 'this', 'workshop', 'we', 'identified', 'the', 'key', 'features', 'benefits', 'and', 'limitations', 'of', 'the', 'various', 'CIDT', 'methods', 'for', 'providing', 'rapid', 'pathogen', 'identification', 'that', 'are', 'critical', 'to', 'the', 'response', 'and', 'mitigation', 'of', 'a', 'bioterrorism', 'event', 'After', 'the', 'workshop', 'we', 'conducted', 'a', 'thorough', 'review', 'of', 'the', 'literature', 'investigating', 'the', 'current', 'state', 'of', 'these', '4', 'culture', 'independent', 'diagnostic', 'methods', 'This', 'article', 'combines', 'information', 'from', 'the', 'literature', 'review', 'and', 'the', 'insights', 'obtained', 'at', 'the', 'workshop', '']"
48579,Tissue classification by rapid evaporative ionization mass spectrometry (REIMS): comparison between a diathermic knife and CO2 laser sampling on classification performance.,2019-11-11,Analytical and bioanalytical chemistry,https://doi.org/10.1007/s00216-019-02148-8; https://www.ncbi.nlm.nih.gov/pubmed/31713015/,"The increasing need for rapid, in situ, and robust tissue profiling approaches in the context of intraoperative diagnostics has led to the development of a large number of ambient ionization-based surface sampling strategies. This paper compares the performances of a diathermic knife and a CO2 laser handpiece, both clinically approved, coupled to a rapid evaporative ionization mass spectrometry (REIMS) source for quasi-instantaneous tissue classification. Several fresh meat samples (muscle, liver, bone, bone marrow, cartilage, skin, fat) were obtained from different animals. Overall, the laser produced cleaner cuts and more reproducible and higher spectral quality signals when compared with the diathermic knife (CV laser = 9-12%, CV diathermic = 14-23%). The molecular profiles were subsequently entered into a database and PCA/LDA classification/prediction models were built to assess if the data generated with one sampling modality can be employed to classify the data generated with the other handpiece. We demonstrate that the correct classification rate of the models increases (+ 25%) with the introduction of a model based on peak lists that are tissue-specific and common to the two handpieces, compared with considering solely the whole molecular profile. This renders it possible to use a unique and universal database for quasi-instantaneous tissue recognition which would provide similar classification results independent of the handpiece used. Furthermore, the laser was able to generate aerosols rich in lipids from hard tissues such as bone, bone marrow, and cartilage. Combined, these results demonstrate that REIMS is a valuable and versatile tool for instantaneous identification/classification of hard tissue and coupling to different aerosol-generating handpieces expands its field of application. Graphical abstract.",10.1007/s00216-019-02148-8,w6qlswqc,"['The', 'increasing', 'need', 'for', 'rapid', 'in', 'situ', 'and', 'robust', 'tissue', 'profiling', 'approaches', 'in', 'the', 'context', 'of', 'intraoperative', 'diagnostics', 'has', 'led', 'to', 'the', 'development', 'of', 'a', 'large', 'number', 'of', 'ambient', 'ionization', 'based', 'surface', 'sampling', 'strategies', 'This', 'paper', 'compares', 'the', 'performances', 'of', 'a', 'diathermic', 'knife', 'and', 'a', 'CO2', 'laser', 'handpiece', 'both', 'clinically', 'approved', 'coupled', 'to', 'a', 'rapid', 'evaporative', 'ionization', 'mass', 'spectrometry', 'REIMS', 'source', 'for', 'quasi', 'instantaneous', 'tissue', 'classification', 'Several', 'fresh', 'meat', 'samples', 'muscle', 'liver', 'bone', 'bone', 'marrow', 'cartilage', 'skin', 'fat', 'were', 'obtained', 'from', 'different', 'animals', 'Overall', 'the', 'laser', 'produced', 'cleaner', 'cuts', 'and', 'more', 'reproducible', 'and', 'higher', 'spectral', 'quality', 'signals', 'when', 'compared', 'with', 'the', 'diathermic', 'knife', 'CV', 'laser', '9', '12', 'CV', 'diathermic', '14', '23', 'The', 'molecular', 'profiles', 'were', 'subsequently', 'entered', 'into', 'a', 'database', 'and', 'PCA', 'LDA', 'classification', 'prediction', 'models', 'were', 'built', 'to', 'assess', 'if', 'the', 'data', 'generated', 'with', 'one', 'sampling', 'modality', 'can', 'be', 'employed', 'to', 'classify', 'the', 'data', 'generated', 'with', 'the', 'other', 'handpiece', 'We', 'demonstrate', 'that', 'the', 'correct', 'classification', 'rate', 'of', 'the', 'models', 'increases', '25', 'with', 'the', 'introduction', 'of', 'a', 'model', 'based', 'on', 'peak', 'lists', 'that', 'are', 'tissue', 'specific', 'and', 'common', 'to', 'the', 'two', 'handpieces', 'compared', 'with', 'considering', 'solely', 'the', 'whole', 'molecular', 'profile', 'This', 'renders', 'it', 'possible', 'to', 'use', 'a', 'unique', 'and', 'universal', 'database', 'for', 'quasi', 'instantaneous', 'tissue', 'recognition', 'which', 'would', 'provide', 'similar', 'classification', 'results', 'independent', 'of', 'the', 'handpiece', 'used', 'Furthermore', 'the', 'laser', 'was', 'able', 'to', 'generate', 'aerosols', 'rich', 'in', 'lipids', 'from', 'hard', 'tissues', 'such', 'as', 'bone', 'bone', 'marrow', 'and', 'cartilage', 'Combined', 'these', 'results', 'demonstrate', 'that', 'REIMS', 'is', 'a', 'valuable', 'and', 'versatile', 'tool', 'for', 'instantaneous', 'identification', 'classification', 'of', 'hard', 'tissue', 'and', 'coupling', 'to', 'different', 'aerosol', 'generating', 'handpieces', 'expands', 'its', 'field', 'of', 'application', 'Graphical', 'abstract', '']"
49643,Molecular Diagnostics and In Utero Therapeutics for Orofacial Clefts.,2020-07-01,Journal of dental research,https://doi.org/10.1177/0022034520936245; https://www.ncbi.nlm.nih.gov/pubmed/32609569/,"Orofacial clefts and their management impose a substantial burden on patients, on their families, and on the health system. Under the current standard of care, affected patients are subjected to a lifelong journey of corrective surgeries and multidisciplinary management to replace bone and soft tissues, as well as restore esthetics and physiologic functions while restoring self-esteem and psychological health. Hence, a better understanding of the dynamic interplay of molecular signaling pathways at critical phases of palate development is necessary to pioneer novel prenatal interventions. Such pathways include transforming growth factor-β (Tgfβ), sonic hedgehog (Shh), wingless-integrated site (Wnt)/β-catenin, bone morphogenetic protein (Bmp), and fibroblast growth factor (Fgf) and its associated receptors, among others. Here, we summarize commonly used surgical methods used to correct cleft defects postnatally. We also review the advances made in prenatal diagnostics of clefts through imaging and genomics and the various in utero surgical corrections that have been attempted thus far. An overview of how key mediators of signaling that drive palatogenesis are emphasized in the context of the framework and rationale for the development and testing of therapeutics in animal model systems and in humans is provided. The pros and cons of in utero therapies that can potentially restore molecular homeostasis needed for the proper growth and fusion of palatal shelves are presented. The theme advanced throughout this review is the need to develop preclinical molecular therapies that could ultimately be translated into human trials that can correct orofacial clefts at earlier stages of development.",10.1177/0022034520936245,to4qy8nm,"['Orofacial', 'clefts', 'and', 'their', 'management', 'impose', 'a', 'substantial', 'burden', 'on', 'patients', 'on', 'their', 'families', 'and', 'on', 'the', 'health', 'system', 'Under', 'the', 'current', 'standard', 'of', 'care', 'affected', 'patients', 'are', 'subjected', 'to', 'a', 'lifelong', 'journey', 'of', 'corrective', 'surgeries', 'and', 'multidisciplinary', 'management', 'to', 'replace', 'bone', 'and', 'soft', 'tissues', 'as', 'well', 'as', 'restore', 'esthetics', 'and', 'physiologic', 'functions', 'while', 'restoring', 'self', 'esteem', 'and', 'psychological', 'health', 'Hence', 'a', 'better', 'understanding', 'of', 'the', 'dynamic', 'interplay', 'of', 'molecular', 'signaling', 'pathways', 'at', 'critical', 'phases', 'of', 'palate', 'development', 'is', 'necessary', 'to', 'pioneer', 'novel', 'prenatal', 'interventions', 'Such', 'pathways', 'include', 'transforming', 'growth', 'factor', 'β', 'Tgfβ', 'sonic', 'hedgehog', 'Shh', 'wingless', 'integrated', 'site', 'Wnt', 'β', 'catenin', 'bone', 'morphogenetic', 'protein', 'Bmp', 'and', 'fibroblast', 'growth', 'factor', 'Fgf', 'and', 'its', 'associated', 'receptors', 'among', 'others', 'Here', 'we', 'summarize', 'commonly', 'used', 'surgical', 'methods', 'used', 'to', 'correct', 'cleft', 'defects', 'postnatally', 'We', 'also', 'review', 'the', 'advances', 'made', 'in', 'prenatal', 'diagnostics', 'of', 'clefts', 'through', 'imaging', 'and', 'genomics', 'and', 'the', 'various', 'in', 'utero', 'surgical', 'corrections', 'that', 'have', 'been', 'attempted', 'thus', 'far', 'An', 'overview', 'of', 'how', 'key', 'mediators', 'of', 'signaling', 'that', 'drive', 'palatogenesis', 'are', 'emphasized', 'in', 'the', 'context', 'of', 'the', 'framework', 'and', 'rationale', 'for', 'the', 'development', 'and', 'testing', 'of', 'therapeutics', 'in', 'animal', 'model', 'systems', 'and', 'in', 'humans', 'is', 'provided', 'The', 'pros', 'and', 'cons', 'of', 'in', 'utero', 'therapies', 'that', 'can', 'potentially', 'restore', 'molecular', 'homeostasis', 'needed', 'for', 'the', 'proper', 'growth', 'and', 'fusion', 'of', 'palatal', 'shelves', 'are', 'presented', 'The', 'theme', 'advanced', 'throughout', 'this', 'review', 'is', 'the', 'need', 'to', 'develop', 'preclinical', 'molecular', 'therapies', 'that', 'could', 'ultimately', 'be', 'translated', 'into', 'human', 'trials', 'that', 'can', 'correct', 'orofacial', 'clefts', 'at', 'earlier', 'stages', 'of', 'development', '']"
49675,A Prospective One-Year Microbiologic Survey of Combined Pneumonia and Respiratory Failure.,2017,Surgical infections,https://doi.org/10.1089/sur.2017.111; https://www.ncbi.nlm.nih.gov/pubmed/28880805/,"BACKGROUND Pneumonia and respiratory failure are common problems in the intensive care unit (ICU) setting, often occurring together. The relative prevalence of pneumonia types (community acquired, hospital acquired, ventilator associated) and causative pathogens is not well described in patients with respiratory failure. METHODS This was a prospective observational cohort study conducted in the medical ICU (34 beds) of Barnes-Jewish Hospital, an academic referral center of 1,300 beds from January 2016-December 2016. All patients who were prospectively adjudicated to have respiratory failure and pneumonia (RFP) regardless of pneumonia type were classified into one of four microbiologic categories: pathogen negative, antibiotic-susceptible pathogen (according to ceftriaxone susceptibility), antibiotic-resistant pathogen, and viruses. The primary outcomes assessed were the hospital mortality rate and inappropriate initial antibiotic therapy (IIAT) for non-viral pathogens. RESULTS Among 364 consecutive patients with RFP, 63 (17.3%) had organisms that were antibiotic susceptible, 104 (28.6%) had antibiotic-resistant organisms, 118 (32.4%) were pathogen negative, and 79 (21.7%) had viral infections. For these categories, IIAT occurred in 3.2%, 21.2%, 0.8%, and 0, respectively (p < 0.001). Vasopressor-requiring shock was present in 61.9%, 72.1%, 68.6%, and 67.1%, respectively (p = 0.585), and the hospital mortality rates were 27.0%, 48.1%, 31.4%, and 36.7%, respectively (p = 0.020). Multivariable logistic regression analysis identified IIAT as an independent predictor of in-hospital death (adjusted odds ratio 5.28; 95% confidence interval 2.72-10.22; p = 0.012). Male gender, increasing Acute Physiology and Chronic Health Evaluation (APACHE) II scores, greater age, and the presence of shock also predicted death. CONCLUSIONS Microbiologic categorization of patients with RFP suggests that antibiotic-resistant pathogens and viruses are associated with the highest mortality rates. Vasopressor-requiring shock was common regardless of the microbiologic categorization of RFP. Future development and use of rapid diagnostics and novel therapeutics targeting specific RFP pathogens may allow more timely administration of appropriate antimicrobial therapy and enhance antibiotic stewardship practices.",10.1089/sur.2017.111,sg34z82q,"['BACKGROUND', 'Pneumonia', 'and', 'respiratory', 'failure', 'are', 'common', 'problems', 'in', 'the', 'intensive', 'care', 'unit', 'ICU', 'setting', 'often', 'occurring', 'together', 'The', 'relative', 'prevalence', 'of', 'pneumonia', 'types', 'community', 'acquired', 'hospital', 'acquired', 'ventilator', 'associated', 'and', 'causative', 'pathogens', 'is', 'not', 'well', 'described', 'in', 'patients', 'with', 'respiratory', 'failure', 'METHODS', 'This', 'was', 'a', 'prospective', 'observational', 'cohort', 'study', 'conducted', 'in', 'the', 'medical', 'ICU', '34', 'beds', 'of', 'Barnes', 'Jewish', 'Hospital', 'an', 'academic', 'referral', 'center', 'of', '1', '300', 'beds', 'from', 'January', '2016', 'December', '2016', 'All', 'patients', 'who', 'were', 'prospectively', 'adjudicated', 'to', 'have', 'respiratory', 'failure', 'and', 'pneumonia', 'RFP', 'regardless', 'of', 'pneumonia', 'type', 'were', 'classified', 'into', 'one', 'of', 'four', 'microbiologic', 'categories', 'pathogen', 'negative', 'antibiotic', 'susceptible', 'pathogen', 'according', 'to', 'ceftriaxone', 'susceptibility', 'antibiotic', 'resistant', 'pathogen', 'and', 'viruses', 'The', 'primary', 'outcomes', 'assessed', 'were', 'the', 'hospital', 'mortality', 'rate', 'and', 'inappropriate', 'initial', 'antibiotic', 'therapy', 'IIAT', 'for', 'non', 'viral', 'pathogens', 'RESULTS', 'Among', '364', 'consecutive', 'patients', 'with', 'RFP', '63', '17', '3', 'had', 'organisms', 'that', 'were', 'antibiotic', 'susceptible', '104', '28', '6', 'had', 'antibiotic', 'resistant', 'organisms', '118', '32', '4', 'were', 'pathogen', 'negative', 'and', '79', '21', '7', 'had', 'viral', 'infections', 'For', 'these', 'categories', 'IIAT', 'occurred', 'in', '3', '2', '21', '2', '0', '8', 'and', '0', 'respectively', 'p', '0', '001', 'Vasopressor', 'requiring', 'shock', 'was', 'present', 'in', '61', '9', '72', '1', '68', '6', 'and', '67', '1', 'respectively', 'p', '0', '585', 'and', 'the', 'hospital', 'mortality', 'rates', 'were', '27', '0', '48', '1', '31', '4', 'and', '36', '7', 'respectively', 'p', '0', '020', 'Multivariable', 'logistic', 'regression', 'analysis', 'identified', 'IIAT', 'as', 'an', 'independent', 'predictor', 'of', 'in', 'hospital', 'death', 'adjusted', 'odds', 'ratio', '5', '28', '95', 'confidence', 'interval', '2', '72', '10', '22', 'p', '0', '012', 'Male', 'gender', 'increasing', 'Acute', 'Physiology', 'and', 'Chronic', 'Health', 'Evaluation', 'APACHE', 'II', 'scores', 'greater', 'age', 'and', 'the', 'presence', 'of', 'shock', 'also', 'predicted', 'death', 'CONCLUSIONS', 'Microbiologic', 'categorization', 'of', 'patients', 'with', 'RFP', 'suggests', 'that', 'antibiotic', 'resistant', 'pathogens', 'and', 'viruses', 'are', 'associated', 'with', 'the', 'highest', 'mortality', 'rates', 'Vasopressor', 'requiring', 'shock', 'was', 'common', 'regardless', 'of', 'the', 'microbiologic', 'categorization', 'of', 'RFP', 'Future', 'development', 'and', 'use', 'of', 'rapid', 'diagnostics', 'and', 'novel', 'therapeutics', 'targeting', 'specific', 'RFP', 'pathogens', 'may', 'allow', 'more', 'timely', 'administration', 'of', 'appropriate', 'antimicrobial', 'therapy', 'and', 'enhance', 'antibiotic', 'stewardship', 'practices', '']"
52209,The role of disposable inhalers in pulmonary drug delivery.,2015,Expert opinion on drug delivery,https://doi.org/10.1517/17425247.2014.952626; https://www.ncbi.nlm.nih.gov/pubmed/25374325/,"INTRODUCTION There is increasing interest in the pulmonary route for both local and systemically acting drugs, vaccines and diagnostics and new applications may require new inhaler technology to obtain the most therapeutically and/or cost-effective administration. Some of these new applications can benefit from the use of disposable inhalers. AREAS COVERED Current trends in pulmonary drug delivery are presented in this review as well as the possible contribution of disposable inhalers to the improvement of pulmonary administration therein. Arguments in favour of disposable inhalers and the starting points for development of devices and their formulations are discussed. Also, a brief review of the state of the art regarding current disposable inhaler development is given. EXPERT OPINION Prerequisites for the use of disposable inhalers, particularly dry powder inhalers, in applications such as childhood vaccination and for preventing or stopping pandemic outbreaks of highly infectious diseases (like influenza, bird flu, SARS) are that they are simple, cheap and effective. Not only do the devices have to be simple in design, but the drug formulations should also be cheap. This may require a different approach as the formulation may not need to be adapted to improve the inhaler must be designed to enhance formulation dispersion.",10.1517/17425247.2014.952626,v8cnofdh,"['INTRODUCTION', 'There', 'is', 'increasing', 'interest', 'in', 'the', 'pulmonary', 'route', 'for', 'both', 'local', 'and', 'systemically', 'acting', 'drugs', 'vaccines', 'and', 'diagnostics', 'and', 'new', 'applications', 'may', 'require', 'new', 'inhaler', 'technology', 'to', 'obtain', 'the', 'most', 'therapeutically', 'and', 'or', 'cost', 'effective', 'administration', 'Some', 'of', 'these', 'new', 'applications', 'can', 'benefit', 'from', 'the', 'use', 'of', 'disposable', 'inhalers', 'AREAS', 'COVERED', 'Current', 'trends', 'in', 'pulmonary', 'drug', 'delivery', 'are', 'presented', 'in', 'this', 'review', 'as', 'well', 'as', 'the', 'possible', 'contribution', 'of', 'disposable', 'inhalers', 'to', 'the', 'improvement', 'of', 'pulmonary', 'administration', 'therein', 'Arguments', 'in', 'favour', 'of', 'disposable', 'inhalers', 'and', 'the', 'starting', 'points', 'for', 'development', 'of', 'devices', 'and', 'their', 'formulations', 'are', 'discussed', 'Also', 'a', 'brief', 'review', 'of', 'the', 'state', 'of', 'the', 'art', 'regarding', 'current', 'disposable', 'inhaler', 'development', 'is', 'given', 'EXPERT', 'OPINION', 'Prerequisites', 'for', 'the', 'use', 'of', 'disposable', 'inhalers', 'particularly', 'dry', 'powder', 'inhalers', 'in', 'applications', 'such', 'as', 'childhood', 'vaccination', 'and', 'for', 'preventing', 'or', 'stopping', 'pandemic', 'outbreaks', 'of', 'highly', 'infectious', 'diseases', 'like', 'influenza', 'bird', 'flu', 'SARS', 'are', 'that', 'they', 'are', 'simple', 'cheap', 'and', 'effective', 'Not', 'only', 'do', 'the', 'devices', 'have', 'to', 'be', 'simple', 'in', 'design', 'but', 'the', 'drug', 'formulations', 'should', 'also', 'be', 'cheap', 'This', 'may', 'require', 'a', 'different', 'approach', 'as', 'the', 'formulation', 'may', 'not', 'need', 'to', 'be', 'adapted', 'to', 'improve', 'the', 'inhaler', 'must', 'be', 'designed', 'to', 'enhance', 'formulation', 'dispersion', '']"
52641,"Pertussis: Microbiology, Disease, Treatment, and Prevention.",2016,Clinical microbiology reviews,https://doi.org/10.1128/cmr.00083-15; https://www.ncbi.nlm.nih.gov/pubmed/27029594/,"Pertussis is a severe respiratory infection caused by Bordetella pertussis, and in 2008, pertussis was associated with an estimated 16 million cases and 195,000 deaths globally. Sizeable outbreaks of pertussis have been reported over the past 5 years, and disease reemergence has been the focus of international attention to develop a deeper understanding of pathogen virulence and genetic evolution of B. pertussis strains. During the past 20 years, the scientific community has recognized pertussis among adults as well as infants and children. Increased recognition that older children and adolescents are at risk for disease and may transmit B. pertussis to younger siblings has underscored the need to better understand the role of innate, humoral, and cell-mediated immunity, including the role of waning immunity. Although recognition of adult pertussis has increased in tandem with a better understanding of B. pertussis pathogenesis, pertussis in neonates and adults can manifest with atypical clinical presentations. Such disease patterns make pertussis recognition difficult and lead to delays in treatment. Ongoing research using newer tools for molecular analysis holds promise for improved understanding of pertussis epidemiology, bacterial pathogenesis, bioinformatics, and immunology. Together, these advances provide a foundation for the development of new-generation diagnostics, therapeutics, and vaccines.",10.1128/cmr.00083-15,h0vqeiyg,"['Pertussis', 'is', 'a', 'severe', 'respiratory', 'infection', 'caused', 'by', 'Bordetella', 'pertussis', 'and', 'in', '2008', 'pertussis', 'was', 'associated', 'with', 'an', 'estimated', '16', 'million', 'cases', 'and', '195', '000', 'deaths', 'globally', 'Sizeable', 'outbreaks', 'of', 'pertussis', 'have', 'been', 'reported', 'over', 'the', 'past', '5', 'years', 'and', 'disease', 'reemergence', 'has', 'been', 'the', 'focus', 'of', 'international', 'attention', 'to', 'develop', 'a', 'deeper', 'understanding', 'of', 'pathogen', 'virulence', 'and', 'genetic', 'evolution', 'of', 'B', 'pertussis', 'strains', 'During', 'the', 'past', '20', 'years', 'the', 'scientific', 'community', 'has', 'recognized', 'pertussis', 'among', 'adults', 'as', 'well', 'as', 'infants', 'and', 'children', 'Increased', 'recognition', 'that', 'older', 'children', 'and', 'adolescents', 'are', 'at', 'risk', 'for', 'disease', 'and', 'may', 'transmit', 'B', 'pertussis', 'to', 'younger', 'siblings', 'has', 'underscored', 'the', 'need', 'to', 'better', 'understand', 'the', 'role', 'of', 'innate', 'humoral', 'and', 'cell', 'mediated', 'immunity', 'including', 'the', 'role', 'of', 'waning', 'immunity', 'Although', 'recognition', 'of', 'adult', 'pertussis', 'has', 'increased', 'in', 'tandem', 'with', 'a', 'better', 'understanding', 'of', 'B', 'pertussis', 'pathogenesis', 'pertussis', 'in', 'neonates', 'and', 'adults', 'can', 'manifest', 'with', 'atypical', 'clinical', 'presentations', 'Such', 'disease', 'patterns', 'make', 'pertussis', 'recognition', 'difficult', 'and', 'lead', 'to', 'delays', 'in', 'treatment', 'Ongoing', 'research', 'using', 'newer', 'tools', 'for', 'molecular', 'analysis', 'holds', 'promise', 'for', 'improved', 'understanding', 'of', 'pertussis', 'epidemiology', 'bacterial', 'pathogenesis', 'bioinformatics', 'and', 'immunology', 'Together', 'these', 'advances', 'provide', 'a', 'foundation', 'for', 'the', 'development', 'of', 'new', 'generation', 'diagnostics', 'therapeutics', 'and', 'vaccines', '']"
53263,Genome-wide study of Pseudomonas aeruginosa outer membrane protein immunogenicity using self-assembling protein microarrays.,2009,Infection and immunity,https://doi.org/10.1128/iai.00698-09; https://www.ncbi.nlm.nih.gov/pubmed/19737893/,"Pseudomonas aeruginosa is responsible for potentially life-threatening infections in individuals with compromised defense mechanisms and those with cystic fibrosis. P. aeruginosa infection is notable for the appearance of a humoral response to some known antigens, such as flagellin C, elastase, alkaline protease, and others. Although a number of immunogenic proteins are known, no effective vaccine has been approved yet. Here, we report a comprehensive study of all 262 outer membrane and exported P. aeruginosa PAO1 proteins by a modified protein microarray methodology called the nucleic acid-programmable protein array. From this study, it was possible to identify 12 proteins that trigger an adaptive immune response in cystic fibrosis and acutely infected patients, providing valuable information about which bacterial proteins are actually recognized by the immune system in vivo during the natural course of infection. The differential detections of these proteins in patients and controls proved to be statistically significant (P<0.01). The study provides a list of potential candidates for the improvement of serological diagnostics and the development of vaccines.",10.1128/iai.00698-09,zmr3slhg,"['Pseudomonas', 'aeruginosa', 'is', 'responsible', 'for', 'potentially', 'life', 'threatening', 'infections', 'in', 'individuals', 'with', 'compromised', 'defense', 'mechanisms', 'and', 'those', 'with', 'cystic', 'fibrosis', 'P', 'aeruginosa', 'infection', 'is', 'notable', 'for', 'the', 'appearance', 'of', 'a', 'humoral', 'response', 'to', 'some', 'known', 'antigens', 'such', 'as', 'flagellin', 'C', 'elastase', 'alkaline', 'protease', 'and', 'others', 'Although', 'a', 'number', 'of', 'immunogenic', 'proteins', 'are', 'known', 'no', 'effective', 'vaccine', 'has', 'been', 'approved', 'yet', 'Here', 'we', 'report', 'a', 'comprehensive', 'study', 'of', 'all', '262', 'outer', 'membrane', 'and', 'exported', 'P', 'aeruginosa', 'PAO1', 'proteins', 'by', 'a', 'modified', 'protein', 'microarray', 'methodology', 'called', 'the', 'nucleic', 'acid', 'programmable', 'protein', 'array', 'From', 'this', 'study', 'it', 'was', 'possible', 'to', 'identify', '12', 'proteins', 'that', 'trigger', 'an', 'adaptive', 'immune', 'response', 'in', 'cystic', 'fibrosis', 'and', 'acutely', 'infected', 'patients', 'providing', 'valuable', 'information', 'about', 'which', 'bacterial', 'proteins', 'are', 'actually', 'recognized', 'by', 'the', 'immune', 'system', 'in', 'vivo', 'during', 'the', 'natural', 'course', 'of', 'infection', 'The', 'differential', 'detections', 'of', 'these', 'proteins', 'in', 'patients', 'and', 'controls', 'proved', 'to', 'be', 'statistically', 'significant', 'P', '0', '01', 'The', 'study', 'provides', 'a', 'list', 'of', 'potential', 'candidates', 'for', 'the', 'improvement', 'of', 'serological', 'diagnostics', 'and', 'the', 'development', 'of', 'vaccines', '']"
53529,[Cell-free synthetic biology: an emerging strategy torevolutionize the biomedical industry].,2019-12-25,Sheng wu gong cheng xue bao = Chinese journal of biotechnology,https://doi.org/10.13345/j.cjb.190271; https://www.ncbi.nlm.nih.gov/pubmed/31880135/,"Cell-free synthetic biology system can perform biological transcription and translation process in vitro. Because of its advanced features, such as flexible openness, easy control, short expression time and high tolerance to cytotoxicity, this systemhas been successfully used to synthesize proteins that are difficult to express in cells. With the continuous development of cell-free biosensing technology and the lyophilization technology, its applications have widely expanded into many biomedical fields. This review discusses the current research progress of cell-free synthetic biology system in on-demand biopharmaceutical synthesis, portable diagnostics, and others. Further development of the system can lead to even more complicated synthesis of therapeutic proteins with post-translational modifications and evolution of different cell-free biosensors with high sensitivity. Cell-free synthetic biology as an emerging engineering strategy can be a better means applied to high-throughput screening of pharmaceutical proteins, detection of new pathogens, and other important health-care fields in the future.",10.13345/j.cjb.190271,eopnw88o,"['Cell', 'free', 'synthetic', 'biology', 'system', 'can', 'perform', 'biological', 'transcription', 'and', 'translation', 'process', 'in', 'vitro', 'Because', 'of', 'its', 'advanced', 'features', 'such', 'as', 'flexible', 'openness', 'easy', 'control', 'short', 'expression', 'time', 'and', 'high', 'tolerance', 'to', 'cytotoxicity', 'this', 'systemhas', 'been', 'successfully', 'used', 'to', 'synthesize', 'proteins', 'that', 'are', 'difficult', 'to', 'express', 'in', 'cells', 'With', 'the', 'continuous', 'development', 'of', 'cell', 'free', 'biosensing', 'technology', 'and', 'the', 'lyophilization', 'technology', 'its', 'applications', 'have', 'widely', 'expanded', 'into', 'many', 'biomedical', 'fields', 'This', 'review', 'discusses', 'the', 'current', 'research', 'progress', 'of', 'cell', 'free', 'synthetic', 'biology', 'system', 'in', 'on', 'demand', 'biopharmaceutical', 'synthesis', 'portable', 'diagnostics', 'and', 'others', 'Further', 'development', 'of', 'the', 'system', 'can', 'lead', 'to', 'even', 'more', 'complicated', 'synthesis', 'of', 'therapeutic', 'proteins', 'with', 'post', 'translational', 'modifications', 'and', 'evolution', 'of', 'different', 'cell', 'free', 'biosensors', 'with', 'high', 'sensitivity', 'Cell', 'free', 'synthetic', 'biology', 'as', 'an', 'emerging', 'engineering', 'strategy', 'can', 'be', 'a', 'better', 'means', 'applied', 'to', 'high', 'throughput', 'screening', 'of', 'pharmaceutical', 'proteins', 'detection', 'of', 'new', 'pathogens', 'and', 'other', 'important', 'health', 'care', 'fields', 'in', 'the', 'future', '']"
53702,Advances in Telemedicine in Ophthalmology.,2020-07-09,Seminars in ophthalmology,https://doi.org/10.1080/08820538.2020.1789675; https://www.ncbi.nlm.nih.gov/pubmed/32644878/,"Telemedicine is the provision of healthcare-related services from a distance and is poised to move healthcare from the physician's office back into the patient's home. The field of ophthalmology is often at the forefront of technological advances in medicine including telemedicine and the use of artificial intelligence. Multiple studies have demonstrated the reliability of tele-ophthalmology for use in screening and diagnostics and have demonstrated benefits to patients, physicians, as well as payors. There remain obstacles to widespread implementation, but recent legislation and regulation passed due to the devastating COVID-19 pandemic have helped to reduce some of these barriers. This review describes the current status of tele-ophthalmology in the United States including benefits, hurdles, current programs, technology, and developments in artificial intelligence. With ongoing advances patients may benefit from improved detection and earlier treatment of eye diseases, resulting in better care and improved visual outcomes.",10.1080/08820538.2020.1789675,22eneg79,"['Telemedicine', 'is', 'the', 'provision', 'of', 'healthcare', 'related', 'services', 'from', 'a', 'distance', 'and', 'is', 'poised', 'to', 'move', 'healthcare', 'from', 'the', 'physician', 's', 'office', 'back', 'into', 'the', 'patient', 's', 'home', 'The', 'field', 'of', 'ophthalmology', 'is', 'often', 'at', 'the', 'forefront', 'of', 'technological', 'advances', 'in', 'medicine', 'including', 'telemedicine', 'and', 'the', 'use', 'of', 'artificial', 'intelligence', 'Multiple', 'studies', 'have', 'demonstrated', 'the', 'reliability', 'of', 'tele', 'ophthalmology', 'for', 'use', 'in', 'screening', 'and', 'diagnostics', 'and', 'have', 'demonstrated', 'benefits', 'to', 'patients', 'physicians', 'as', 'well', 'as', 'payors', 'There', 'remain', 'obstacles', 'to', 'widespread', 'implementation', 'but', 'recent', 'legislation', 'and', 'regulation', 'passed', 'due', 'to', 'the', 'devastating', 'COVID', '19', 'pandemic', 'have', 'helped', 'to', 'reduce', 'some', 'of', 'these', 'barriers', 'This', 'review', 'describes', 'the', 'current', 'status', 'of', 'tele', 'ophthalmology', 'in', 'the', 'United', 'States', 'including', 'benefits', 'hurdles', 'current', 'programs', 'technology', 'and', 'developments', 'in', 'artificial', 'intelligence', 'With', 'ongoing', 'advances', 'patients', 'may', 'benefit', 'from', 'improved', 'detection', 'and', 'earlier', 'treatment', 'of', 'eye', 'diseases', 'resulting', 'in', 'better', 'care', 'and', 'improved', 'visual', 'outcomes', '']"
53737,Scientific Advances in Thoracic Oncology 2016.,2017,Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,https://doi.org/10.1016/j.jtho.2017.05.019; https://www.ncbi.nlm.nih.gov/pubmed/28579481/,"Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.",10.1016/j.jtho.2017.05.019,jhfg6d3f,"['Lung', 'cancer', 'care', 'is', 'rapidly', 'changing', 'with', 'advances', 'in', 'genomic', 'testing', 'the', 'development', 'of', 'next', 'generation', 'targeted', 'kinase', 'inhibitors', 'and', 'the', 'continued', 'broad', 'study', 'of', 'immunotherapy', 'in', 'new', 'settings', 'and', 'potential', 'combinations', 'The', 'International', 'Association', 'for', 'the', 'Study', 'of', 'Lung', 'Cancer', 'and', 'the', 'Journal', 'of', 'Thoracic', 'Oncology', 'publish', 'this', 'annual', 'update', 'to', 'help', 'readers', 'keep', 'pace', 'with', 'these', 'important', 'developments', 'Experts', 'in', 'thoracic', 'cancer', 'and', 'care', 'provide', 'focused', 'updates', 'across', 'multiple', 'areas', 'including', 'prevention', 'and', 'early', 'detection', 'molecular', 'diagnostics', 'pathology', 'and', 'staging', 'surgery', 'adjuvant', 'therapy', 'radiotherapy', 'molecular', 'targeted', 'therapy', 'and', 'immunotherapy', 'for', 'NSCLC', 'SCLC', 'and', 'mesothelioma', 'Quality', 'and', 'value', 'of', 'care', 'and', 'perspectives', 'on', 'the', 'future', 'of', 'lung', 'cancer', 'research', 'and', 'treatment', 'have', 'also', 'been', 'included', 'in', 'this', 'concise', 'review', '']"
54905,New respiratory viral infections.,2012,Current opinion in pulmonary medicine,https://doi.org/10.1097/mcp.0b013e328351f8d4; https://www.ncbi.nlm.nih.gov/pubmed/22366993/,"PURPOSE OF REVIEW The first era in the discoveries of respiratory viruses occured between 1933 and 1965 when influenza virus, enteroviruses, adenovirus, respiratory syncytial virus, rhinovirus, parainfluenza virus and coronavirus (CoV) were found by virus culture. In the 1990s, the development of high throughput viral detection and diagnostics instruments increased diagnostic sensitivity and enabled the search for new viruses. This article briefly reviews the clinical significance of newly discovered respiratory viruses. RECENT FINDINGS In 2001, the second era in the discoveries of respiratory viruses began, and several new respiratory viruses and their subgroups have been found: human metapneumovirus, CoVs NL63 and HKU1, human bocavirus and human rhinovirus C and D groups. SUMMARY Currently, a viral cause of pediatric respiratory illness is identifiable in up to 95% of cases, but the detection rates decrease steadily by age, to 30-40% in the elderly. The new viruses cause respiratory illnesses such as common cold, bronchitis, bronchiolitis, exacerbations of asthma and chronic obstructive pulmonary disease and pneumonia. Rarely, acute respiratory failure may occur. The clinical role of other new viruses, KI and WU polyomaviruses and the torque teno virus, as respiratory pathogens is not clear.",10.1097/mcp.0b013e328351f8d4,trhok8y8,"['PURPOSE', 'OF', 'REVIEW', 'The', 'first', 'era', 'in', 'the', 'discoveries', 'of', 'respiratory', 'viruses', 'occured', 'between', '1933', 'and', '1965', 'when', 'influenza', 'virus', 'enteroviruses', 'adenovirus', 'respiratory', 'syncytial', 'virus', 'rhinovirus', 'parainfluenza', 'virus', 'and', 'coronavirus', 'CoV', 'were', 'found', 'by', 'virus', 'culture', 'In', 'the', '1990s', 'the', 'development', 'of', 'high', 'throughput', 'viral', 'detection', 'and', 'diagnostics', 'instruments', 'increased', 'diagnostic', 'sensitivity', 'and', 'enabled', 'the', 'search', 'for', 'new', 'viruses', 'This', 'article', 'briefly', 'reviews', 'the', 'clinical', 'significance', 'of', 'newly', 'discovered', 'respiratory', 'viruses', 'RECENT', 'FINDINGS', 'In', '2001', 'the', 'second', 'era', 'in', 'the', 'discoveries', 'of', 'respiratory', 'viruses', 'began', 'and', 'several', 'new', 'respiratory', 'viruses', 'and', 'their', 'subgroups', 'have', 'been', 'found', 'human', 'metapneumovirus', 'CoVs', 'NL63', 'and', 'HKU1', 'human', 'bocavirus', 'and', 'human', 'rhinovirus', 'C', 'and', 'D', 'groups', 'SUMMARY', 'Currently', 'a', 'viral', 'cause', 'of', 'pediatric', 'respiratory', 'illness', 'is', 'identifiable', 'in', 'up', 'to', '95', 'of', 'cases', 'but', 'the', 'detection', 'rates', 'decrease', 'steadily', 'by', 'age', 'to', '30', '40', 'in', 'the', 'elderly', 'The', 'new', 'viruses', 'cause', 'respiratory', 'illnesses', 'such', 'as', 'common', 'cold', 'bronchitis', 'bronchiolitis', 'exacerbations', 'of', 'asthma', 'and', 'chronic', 'obstructive', 'pulmonary', 'disease', 'and', 'pneumonia', 'Rarely', 'acute', 'respiratory', 'failure', 'may', 'occur', 'The', 'clinical', 'role', 'of', 'other', 'new', 'viruses', 'KI', 'and', 'WU', 'polyomaviruses', 'and', 'the', 'torque', 'teno', 'virus', 'as', 'respiratory', 'pathogens', 'is', 'not', 'clear', '']"
56177,Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.,2015,mAbs,https://doi.org/10.1080/19420862.2015.1088618; https://www.ncbi.nlm.nih.gov/pubmed/26337947/,"Phage-display technology facilitates rapid selection of antigen-specific single-chain variable fragment (scFv) antibodies from large recombinant libraries. ScFv antibodies, composed of a VH and VL domain, are readily engineered into multimeric formats for the development of diagnostics and targeted therapies. However, the recombinant nature of the selection strategy can result in VH and VL domains with sub-optimal biophysical properties, such as reduced thermodynamic stability and enhanced aggregation propensity, which lead to poor production and limited application. We found that the C10 anti-epidermal growth factor receptor (EGFR) scFv, and its affinity mutant, P2224, exhibit weak production from E. coli. Interestingly, these scFv contain a fusion of lambda3 and lambda1 V-region (LV3 and LV1) genes, most likely the result of a PCR aberration during library construction. To enhance the biophysical properties of these scFvs, we utilized a structure-based approach to replace and redesign the pre-existing framework of the VL domain to one that best pairs with the existing VH. We describe a method to exchange lambda sequences with a more stable kappa3 framework (KV3) within the VL domain that incorporates the original lambda DE-loop. The resulting scFvs, C10KV3_LV1DE and P2224KV3_LV1DE, are more thermodynamically stable and easier to produce from bacterial culture. Additionally, C10KV3_LV1DE and P2224KV3_LV1DE retain binding affinity to EGFR, suggesting that such a dramatic framework swap does not significantly affect scFv binding. We provide here a novel strategy for redesigning the light chain of problematic scFvs to enhance their stability and therapeutic applicability.",10.1080/19420862.2015.1088618,6lsageb9,"['Phage', 'display', 'technology', 'facilitates', 'rapid', 'selection', 'of', 'antigen', 'specific', 'single', 'chain', 'variable', 'fragment', 'scFv', 'antibodies', 'from', 'large', 'recombinant', 'libraries', 'ScFv', 'antibodies', 'composed', 'of', 'a', 'VH', 'and', 'VL', 'domain', 'are', 'readily', 'engineered', 'into', 'multimeric', 'formats', 'for', 'the', 'development', 'of', 'diagnostics', 'and', 'targeted', 'therapies', 'However', 'the', 'recombinant', 'nature', 'of', 'the', 'selection', 'strategy', 'can', 'result', 'in', 'VH', 'and', 'VL', 'domains', 'with', 'sub', 'optimal', 'biophysical', 'properties', 'such', 'as', 'reduced', 'thermodynamic', 'stability', 'and', 'enhanced', 'aggregation', 'propensity', 'which', 'lead', 'to', 'poor', 'production', 'and', 'limited', 'application', 'We', 'found', 'that', 'the', 'C10', 'anti', 'epidermal', 'growth', 'factor', 'receptor', 'EGFR', 'scFv', 'and', 'its', 'affinity', 'mutant', 'P2224', 'exhibit', 'weak', 'production', 'from', 'E', 'coli', 'Interestingly', 'these', 'scFv', 'contain', 'a', 'fusion', 'of', 'lambda3', 'and', 'lambda1', 'V', 'region', 'LV3', 'and', 'LV1', 'genes', 'most', 'likely', 'the', 'result', 'of', 'a', 'PCR', 'aberration', 'during', 'library', 'construction', 'To', 'enhance', 'the', 'biophysical', 'properties', 'of', 'these', 'scFvs', 'we', 'utilized', 'a', 'structure', 'based', 'approach', 'to', 'replace', 'and', 'redesign', 'the', 'pre', 'existing', 'framework', 'of', 'the', 'VL', 'domain', 'to', 'one', 'that', 'best', 'pairs', 'with', 'the', 'existing', 'VH', 'We', 'describe', 'a', 'method', 'to', 'exchange', 'lambda', 'sequences', 'with', 'a', 'more', 'stable', 'kappa3', 'framework', 'KV3', 'within', 'the', 'VL', 'domain', 'that', 'incorporates', 'the', 'original', 'lambda', 'DE', 'loop', 'The', 'resulting', 'scFvs', 'C10KV3', 'LV1DE', 'and', 'P2224KV3', 'LV1DE', 'are', 'more', 'thermodynamically', 'stable', 'and', 'easier', 'to', 'produce', 'from', 'bacterial', 'culture', 'Additionally', 'C10KV3', 'LV1DE', 'and', 'P2224KV3', 'LV1DE', 'retain', 'binding', 'affinity', 'to', 'EGFR', 'suggesting', 'that', 'such', 'a', 'dramatic', 'framework', 'swap', 'does', 'not', 'significantly', 'affect', 'scFv', 'binding', 'We', 'provide', 'here', 'a', 'novel', 'strategy', 'for', 'redesigning', 'the', 'light', 'chain', 'of', 'problematic', 'scFvs', 'to', 'enhance', 'their', 'stability', 'and', 'therapeutic', 'applicability', '']"
57150,New approaches to sepsis: molecular diagnostics and biomarkers.,2012,Clinical microbiology reviews,https://doi.org/10.1128/cmr.00016-12; https://www.ncbi.nlm.nih.gov/pubmed/23034322/,"Sepsis is among the most common causes of death in hospitals. It arises from the host response to infection. Currently, diagnosis relies on nonspecific physiological criteria and culture-based pathogen detection. This results in diagnostic uncertainty, therapeutic delays, the mis- and overuse of antibiotics, and the failure to identify patients who might benefit from immunomodulatory therapies. There is a need for new sepsis biomarkers that can aid in therapeutic decision making and add information about screening, diagnosis, risk stratification, and monitoring of the response to therapy. The host response involves hundreds of mediators and single molecules, many of which have been proposed as biomarkers. It is, however, unlikely that one single biomarker is able to satisfy all the needs and expectations for sepsis research and management. Among biomarkers that are measurable by assays approved for clinical use, procalcitonin (PCT) has shown some usefulness as an infection marker and for antibiotic stewardship. Other possible new approaches consist of molecular strategies to improve pathogen detection and molecular diagnostics and prognostics based on transcriptomic, proteomic, or metabolic profiling. Novel approaches to sepsis promise to transform sepsis from a physiologic syndrome into a group of distinct biochemical disorders and help in the development of better diagnostic tools and effective adjunctive sepsis therapies.",10.1128/cmr.00016-12,jymfbfau,"['Sepsis', 'is', 'among', 'the', 'most', 'common', 'causes', 'of', 'death', 'in', 'hospitals', 'It', 'arises', 'from', 'the', 'host', 'response', 'to', 'infection', 'Currently', 'diagnosis', 'relies', 'on', 'nonspecific', 'physiological', 'criteria', 'and', 'culture', 'based', 'pathogen', 'detection', 'This', 'results', 'in', 'diagnostic', 'uncertainty', 'therapeutic', 'delays', 'the', 'mis', 'and', 'overuse', 'of', 'antibiotics', 'and', 'the', 'failure', 'to', 'identify', 'patients', 'who', 'might', 'benefit', 'from', 'immunomodulatory', 'therapies', 'There', 'is', 'a', 'need', 'for', 'new', 'sepsis', 'biomarkers', 'that', 'can', 'aid', 'in', 'therapeutic', 'decision', 'making', 'and', 'add', 'information', 'about', 'screening', 'diagnosis', 'risk', 'stratification', 'and', 'monitoring', 'of', 'the', 'response', 'to', 'therapy', 'The', 'host', 'response', 'involves', 'hundreds', 'of', 'mediators', 'and', 'single', 'molecules', 'many', 'of', 'which', 'have', 'been', 'proposed', 'as', 'biomarkers', 'It', 'is', 'however', 'unlikely', 'that', 'one', 'single', 'biomarker', 'is', 'able', 'to', 'satisfy', 'all', 'the', 'needs', 'and', 'expectations', 'for', 'sepsis', 'research', 'and', 'management', 'Among', 'biomarkers', 'that', 'are', 'measurable', 'by', 'assays', 'approved', 'for', 'clinical', 'use', 'procalcitonin', 'PCT', 'has', 'shown', 'some', 'usefulness', 'as', 'an', 'infection', 'marker', 'and', 'for', 'antibiotic', 'stewardship', 'Other', 'possible', 'new', 'approaches', 'consist', 'of', 'molecular', 'strategies', 'to', 'improve', 'pathogen', 'detection', 'and', 'molecular', 'diagnostics', 'and', 'prognostics', 'based', 'on', 'transcriptomic', 'proteomic', 'or', 'metabolic', 'profiling', 'Novel', 'approaches', 'to', 'sepsis', 'promise', 'to', 'transform', 'sepsis', 'from', 'a', 'physiologic', 'syndrome', 'into', 'a', 'group', 'of', 'distinct', 'biochemical', 'disorders', 'and', 'help', 'in', 'the', 'development', 'of', 'better', 'diagnostic', 'tools', 'and', 'effective', 'adjunctive', 'sepsis', 'therapies', '']"
57892,Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response.,2017,The Journal of general virology,https://doi.org/10.1099/jgv.0.000758; https://www.ncbi.nlm.nih.gov/pubmed/28555543/,"Our previous screening of 50 240 structurally diverse compounds led to the identification of 39 influenza A virus infection inhibitors (Kao R.Y., Yang D., Lau L.S., Tsui W.H., Hu L. et al. Nat Biotechnol 2010;28:600-605). Further screening of these compounds against common respiratory viruses led to the discovery of compound FA-613. This inhibitor exhibited low micromolar antiviral activity against various influenza A and B virus strains, including the highly pathogenic influenza A strains H5N1 and H7N9, enterovirus A71, respiratory syncytial virus, human rhinovirus A, SARS- and MERS-coronavirus. No significant cellular toxicity was observed at the effective concentrations. Animal studies showed an improved survival rate in BALB/c mice that received intranasal FA-613 treatments against a lethal dose infection of A/HK/415742Md/2009 (H1N1). Further cell-based assays indicated that FA-613 interfer with the de novo pyrimidine biosynthesis pathway by targeting the dihydroorotate dehydrogenase. Surprisingly, FA-613 lost its antiviral potency in the interferon-deficient Vero cell line, while maintaining its inhibitory activity in an interferon-competent cell line which showed elevated expression of host antiviral genes when infected in the presence of FA-613. Further investigation of the specific connection between pyrimidine synthesis inhibition and the induction of host innate immunity might aid clinical development of this type of drug in antiviral therapies. Therefore, in acute cases of respiratory tract infections, when rapid diagnostics of the causative agent are not readily available, an antiviral drug with properties like FA-613 could prove to be very valuable.",10.1099/jgv.0.000758,g4oku7wp,"['Our', 'previous', 'screening', 'of', '50', '240', 'structurally', 'diverse', 'compounds', 'led', 'to', 'the', 'identification', 'of', '39', 'influenza', 'A', 'virus', 'infection', 'inhibitors', 'Kao', 'R', 'Y', 'Yang', 'D', 'Lau', 'L', 'S', 'Tsui', 'W', 'H', 'Hu', 'L', 'et', 'al', 'Nat', 'Biotechnol', '2010', '28', '600', '605', 'Further', 'screening', 'of', 'these', 'compounds', 'against', 'common', 'respiratory', 'viruses', 'led', 'to', 'the', 'discovery', 'of', 'compound', 'FA', '613', 'This', 'inhibitor', 'exhibited', 'low', 'micromolar', 'antiviral', 'activity', 'against', 'various', 'influenza', 'A', 'and', 'B', 'virus', 'strains', 'including', 'the', 'highly', 'pathogenic', 'influenza', 'A', 'strains', 'H5N1', 'and', 'H7N9', 'enterovirus', 'A71', 'respiratory', 'syncytial', 'virus', 'human', 'rhinovirus', 'A', 'SARS', 'and', 'MERS', 'coronavirus', 'No', 'significant', 'cellular', 'toxicity', 'was', 'observed', 'at', 'the', 'effective', 'concentrations', 'Animal', 'studies', 'showed', 'an', 'improved', 'survival', 'rate', 'in', 'BALB', 'c', 'mice', 'that', 'received', 'intranasal', 'FA', '613', 'treatments', 'against', 'a', 'lethal', 'dose', 'infection', 'of', 'A', 'HK', '415742Md', '2009', 'H1N1', 'Further', 'cell', 'based', 'assays', 'indicated', 'that', 'FA', '613', 'interfer', 'with', 'the', 'de', 'novo', 'pyrimidine', 'biosynthesis', 'pathway', 'by', 'targeting', 'the', 'dihydroorotate', 'dehydrogenase', 'Surprisingly', 'FA', '613', 'lost', 'its', 'antiviral', 'potency', 'in', 'the', 'interferon', 'deficient', 'Vero', 'cell', 'line', 'while', 'maintaining', 'its', 'inhibitory', 'activity', 'in', 'an', 'interferon', 'competent', 'cell', 'line', 'which', 'showed', 'elevated', 'expression', 'of', 'host', 'antiviral', 'genes', 'when', 'infected', 'in', 'the', 'presence', 'of', 'FA', '613', 'Further', 'investigation', 'of', 'the', 'specific', 'connection', 'between', 'pyrimidine', 'synthesis', 'inhibition', 'and', 'the', 'induction', 'of', 'host', 'innate', 'immunity', 'might', 'aid', 'clinical', 'development', 'of', 'this', 'type', 'of', 'drug', 'in', 'antiviral', 'therapies', 'Therefore', 'in', 'acute', 'cases', 'of', 'respiratory', 'tract', 'infections', 'when', 'rapid', 'diagnostics', 'of', 'the', 'causative', 'agent', 'are', 'not', 'readily', 'available', 'an', 'antiviral', 'drug', 'with', 'properties', 'like', 'FA', '613', 'could', 'prove', 'to', 'be', 'very', 'valuable', '']"
58205,"Ebola from emergence to epidemic: the virus and the disease, global preparedness and perspectives.",2015,Journal of infection in developing countries,https://doi.org/10.3855/jidc.6197; https://www.ncbi.nlm.nih.gov/pubmed/25989163/,"Humans constantly encounter threats from many infectious, zoonotic, and devastating pathogens. Outbreaks of severe acute respiratory syndrome (SARS), bird flu, and swine flu posing pandemic threats have compelled health agencies to follow global preparedness for combating the emerging deadly pathogens. The outbreak in West Africa of highly contagious Ebola viral disease (EVD) that started in Guinea in December 2013, assumed global proportions to become the largest outbreak of EVD and the most prominent international health concern. With fatality rates of nearly 50%-90%, it has claimed, as of 11 April 2015, 10,619 human lives out of a total of 25,626 cases reported worldwide. Ebola virus (EBOV), a member of Filoviridae family, is associated with severe, often lethal, hemorrhagic fever disease in humans and animals. The animal hosts, including non-human primates and reservoir hosts (fruit bats), play a significant role in transmission and maintenance of EBOV in nature. Although no approved vaccine for the prevention of EVD currently exists, disease control can be greatly enhanced by timely laboratory confirmation through blood tests using enzyme-linked immunosorbent assay (ELISA) and reverse transcription polymerase chain reaction (RT-PCR). Adherence to strict sanitary and hygienic measures, monitoring and surveillance of EBOV, as well as quarantine checks on international trade, transport, and visitors from affected countries are mandatory to prevent and control the spread of EVD. This review describes the salient properties of EBOV and the development of novel diagnostics, vaccines, and control strategies for this emerging disease of high public health concern and international emergency.",10.3855/jidc.6197,2l7f22fl,"['Humans', 'constantly', 'encounter', 'threats', 'from', 'many', 'infectious', 'zoonotic', 'and', 'devastating', 'pathogens', 'Outbreaks', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'bird', 'flu', 'and', 'swine', 'flu', 'posing', 'pandemic', 'threats', 'have', 'compelled', 'health', 'agencies', 'to', 'follow', 'global', 'preparedness', 'for', 'combating', 'the', 'emerging', 'deadly', 'pathogens', 'The', 'outbreak', 'in', 'West', 'Africa', 'of', 'highly', 'contagious', 'Ebola', 'viral', 'disease', 'EVD', 'that', 'started', 'in', 'Guinea', 'in', 'December', '2013', 'assumed', 'global', 'proportions', 'to', 'become', 'the', 'largest', 'outbreak', 'of', 'EVD', 'and', 'the', 'most', 'prominent', 'international', 'health', 'concern', 'With', 'fatality', 'rates', 'of', 'nearly', '50', '90', 'it', 'has', 'claimed', 'as', 'of', '11', 'April', '2015', '10', '619', 'human', 'lives', 'out', 'of', 'a', 'total', 'of', '25', '626', 'cases', 'reported', 'worldwide', 'Ebola', 'virus', 'EBOV', 'a', 'member', 'of', 'Filoviridae', 'family', 'is', 'associated', 'with', 'severe', 'often', 'lethal', 'hemorrhagic', 'fever', 'disease', 'in', 'humans', 'and', 'animals', 'The', 'animal', 'hosts', 'including', 'non', 'human', 'primates', 'and', 'reservoir', 'hosts', 'fruit', 'bats', 'play', 'a', 'significant', 'role', 'in', 'transmission', 'and', 'maintenance', 'of', 'EBOV', 'in', 'nature', 'Although', 'no', 'approved', 'vaccine', 'for', 'the', 'prevention', 'of', 'EVD', 'currently', 'exists', 'disease', 'control', 'can', 'be', 'greatly', 'enhanced', 'by', 'timely', 'laboratory', 'confirmation', 'through', 'blood', 'tests', 'using', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'and', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'Adherence', 'to', 'strict', 'sanitary', 'and', 'hygienic', 'measures', 'monitoring', 'and', 'surveillance', 'of', 'EBOV', 'as', 'well', 'as', 'quarantine', 'checks', 'on', 'international', 'trade', 'transport', 'and', 'visitors', 'from', 'affected', 'countries', 'are', 'mandatory', 'to', 'prevent', 'and', 'control', 'the', 'spread', 'of', 'EVD', 'This', 'review', 'describes', 'the', 'salient', 'properties', 'of', 'EBOV', 'and', 'the', 'development', 'of', 'novel', 'diagnostics', 'vaccines', 'and', 'control', 'strategies', 'for', 'this', 'emerging', 'disease', 'of', 'high', 'public', 'health', 'concern', 'and', 'international', 'emergency', '']"
58670,An update on the status of COVID-19: a comprehensive review.,2020-04-01,European review for medical and pharmacological sciences,https://doi.org/10.26355/eurrev_202004_21046; https://www.ncbi.nlm.nih.gov/pubmed/32374000/,"The last two decades have witnessed two large-scale pandemics caused by coronaviruses, including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). At the end of 2019, another novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hit Wuhan, a city in the center of China, and subsequently spread rapidly to the whole world. Latest reports revealed that more than 800 thousand people in over 200 countries are involved in the epidemic disease by SARS-CoV-2. Due to the high mortality rate and the lack of optimum therapeutics, it is crucial to understand the biological characteristics of the virus and its possible pathogenesis to respond to the SARS-CoV-2. Rapid diagnostics and effective therapeutics are also important interventions for the management of infection control. However, the rapid evolution of SARS-CoV-2 exerted tremendous challenges on its diagnostics and therapeutics. Therefore, there is an urgent need to summarize the existing research results to guide decision-making on the prioritization of resources for research and development. In this review, we focus on our current understanding of epidemiology, pathogenesis, diagnostics and therapeutics of coronavirus disease 2019 (COVID-19).",10.26355/eurrev_202004_21046,irqcpi6g,"['The', 'last', 'two', 'decades', 'have', 'witnessed', 'two', 'large', 'scale', 'pandemics', 'caused', 'by', 'coronaviruses', 'including', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'and', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'MERS', 'At', 'the', 'end', 'of', '2019', 'another', 'novel', 'coronavirus', 'designated', 'as', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'hit', 'Wuhan', 'a', 'city', 'in', 'the', 'center', 'of', 'China', 'and', 'subsequently', 'spread', 'rapidly', 'to', 'the', 'whole', 'world', 'Latest', 'reports', 'revealed', 'that', 'more', 'than', '800', 'thousand', 'people', 'in', 'over', '200', 'countries', 'are', 'involved', 'in', 'the', 'epidemic', 'disease', 'by', 'SARS', 'CoV', '2', 'Due', 'to', 'the', 'high', 'mortality', 'rate', 'and', 'the', 'lack', 'of', 'optimum', 'therapeutics', 'it', 'is', 'crucial', 'to', 'understand', 'the', 'biological', 'characteristics', 'of', 'the', 'virus', 'and', 'its', 'possible', 'pathogenesis', 'to', 'respond', 'to', 'the', 'SARS', 'CoV', '2', 'Rapid', 'diagnostics', 'and', 'effective', 'therapeutics', 'are', 'also', 'important', 'interventions', 'for', 'the', 'management', 'of', 'infection', 'control', 'However', 'the', 'rapid', 'evolution', 'of', 'SARS', 'CoV', '2', 'exerted', 'tremendous', 'challenges', 'on', 'its', 'diagnostics', 'and', 'therapeutics', 'Therefore', 'there', 'is', 'an', 'urgent', 'need', 'to', 'summarize', 'the', 'existing', 'research', 'results', 'to', 'guide', 'decision', 'making', 'on', 'the', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'In', 'this', 'review', 'we', 'focus', 'on', 'our', 'current', 'understanding', 'of', 'epidemiology', 'pathogenesis', 'diagnostics', 'and', 'therapeutics', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', '']"
59350,Community-acquired respiratory viral infections in lung transplant recipients.,2013,Current opinion in infectious diseases,https://doi.org/10.1097/qco.0b013e3283630e85; https://www.ncbi.nlm.nih.gov/pubmed/23806892/,"PURPOSE OF REVIEW Community-acquired respiratory virus (CARV) infections are a significant cause of morbidity and sometimes mortality in lung transplant recipients (LTRs); this review will focus on the most recent advances in this field. RECENT FINDINGS Recent advancements in molecular diagnostics have resulted in the detection of higher rates of CARVs in LTRs. Persistence of rhinovirus has been implicated in the development of acute and chronic rejection, whereas the role of bocavirus remains uncertain. The data on the association of CARV infections with acute or chronic rejection remain less. A recent systematic review failed to show an association between CARV infections and acute or chronic rejection. Different routes of administration of antiviral medications, vaccines and newer promising antiviral medications are being evaluated to assess efficacy and safety. Similarly, newer strategies of vaccination may potentiate the immune response in these patients. SUMMARY With current advanced investigating tools, the full impact of CARV infections in LTR is increasingly coming to realization. Research for novel effective treatments and improved responses to current and new vaccines is ongoing; they would provide great benefit in solving this complex and ever-evolving problem.",10.1097/qco.0b013e3283630e85,jog6f7pe,"['PURPOSE', 'OF', 'REVIEW', 'Community', 'acquired', 'respiratory', 'virus', 'CARV', 'infections', 'are', 'a', 'significant', 'cause', 'of', 'morbidity', 'and', 'sometimes', 'mortality', 'in', 'lung', 'transplant', 'recipients', 'LTRs', 'this', 'review', 'will', 'focus', 'on', 'the', 'most', 'recent', 'advances', 'in', 'this', 'field', 'RECENT', 'FINDINGS', 'Recent', 'advancements', 'in', 'molecular', 'diagnostics', 'have', 'resulted', 'in', 'the', 'detection', 'of', 'higher', 'rates', 'of', 'CARVs', 'in', 'LTRs', 'Persistence', 'of', 'rhinovirus', 'has', 'been', 'implicated', 'in', 'the', 'development', 'of', 'acute', 'and', 'chronic', 'rejection', 'whereas', 'the', 'role', 'of', 'bocavirus', 'remains', 'uncertain', 'The', 'data', 'on', 'the', 'association', 'of', 'CARV', 'infections', 'with', 'acute', 'or', 'chronic', 'rejection', 'remain', 'less', 'A', 'recent', 'systematic', 'review', 'failed', 'to', 'show', 'an', 'association', 'between', 'CARV', 'infections', 'and', 'acute', 'or', 'chronic', 'rejection', 'Different', 'routes', 'of', 'administration', 'of', 'antiviral', 'medications', 'vaccines', 'and', 'newer', 'promising', 'antiviral', 'medications', 'are', 'being', 'evaluated', 'to', 'assess', 'efficacy', 'and', 'safety', 'Similarly', 'newer', 'strategies', 'of', 'vaccination', 'may', 'potentiate', 'the', 'immune', 'response', 'in', 'these', 'patients', 'SUMMARY', 'With', 'current', 'advanced', 'investigating', 'tools', 'the', 'full', 'impact', 'of', 'CARV', 'infections', 'in', 'LTR', 'is', 'increasingly', 'coming', 'to', 'realization', 'Research', 'for', 'novel', 'effective', 'treatments', 'and', 'improved', 'responses', 'to', 'current', 'and', 'new', 'vaccines', 'is', 'ongoing', 'they', 'would', 'provide', 'great', 'benefit', 'in', 'solving', 'this', 'complex', 'and', 'ever', 'evolving', 'problem', '']"
60925,Recent advances in vaccines and diagnostics against Middle East respiratory syndrome coronavirus.,2020,Acta virologica,https://doi.org/10.4149/av_2020_208; https://www.ncbi.nlm.nih.gov/pubmed/32551793/,"Middle East respiratory syndrome coronavirus (MERS-CoV) is an RNA virus that causes severe respiratory disease. Since it was identified in 2012, approximately 2500 MERS cases with high mortality have been confirmed in 27 countries. Although most cases have occurred in the Middle East, an outbreak in South Korea in 2015 showed that MERS could be a global threat via human-to-human transmission. There is no licensed vaccine against MERS. Thus, early detection is the best way to limit the spread of this fatal disease. In this review, we focus on transmission, the infection process, and scientific efforts in vaccine development and diagnostics for MERS-CoV. Keywords: Middle East respiratory syndrome coronavirus; epidemiology; virology; vaccine; diagnostics.",10.4149/av_2020_208,5z6w3zfk,"['Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'is', 'an', 'RNA', 'virus', 'that', 'causes', 'severe', 'respiratory', 'disease', 'Since', 'it', 'was', 'identified', 'in', '2012', 'approximately', '2500', 'MERS', 'cases', 'with', 'high', 'mortality', 'have', 'been', 'confirmed', 'in', '27', 'countries', 'Although', 'most', 'cases', 'have', 'occurred', 'in', 'the', 'Middle', 'East', 'an', 'outbreak', 'in', 'South', 'Korea', 'in', '2015', 'showed', 'that', 'MERS', 'could', 'be', 'a', 'global', 'threat', 'via', 'human', 'to', 'human', 'transmission', 'There', 'is', 'no', 'licensed', 'vaccine', 'against', 'MERS', 'Thus', 'early', 'detection', 'is', 'the', 'best', 'way', 'to', 'limit', 'the', 'spread', 'of', 'this', 'fatal', 'disease', 'In', 'this', 'review', 'we', 'focus', 'on', 'transmission', 'the', 'infection', 'process', 'and', 'scientific', 'efforts', 'in', 'vaccine', 'development', 'and', 'diagnostics', 'for', 'MERS', 'CoV', 'Keywords', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'epidemiology', 'virology', 'vaccine', 'diagnostics', '']"
61011,RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look.,2020-05-12,RNA,https://doi.org/10.1261/rna.076141.120; https://www.ncbi.nlm.nih.gov/pubmed/32398273/,"As the COVID-19 outbreak spreads, there is a growing need for a compilation of conserved RNA genome regions in the SARS-CoV-2 virus along with their structural propensities to guide development of antivirals and diagnostics. Here we present a first look at RNA sequence conservation and structural propensities in the SARS-CoV-2 genome. Using sequence alignments spanning a range of betacoronaviruses, we rank genomic regions by RNA sequence conservation, identifying 79 regions of length at least 15 nucleotides as exactly conserved over SARS-related complete genome sequences available near the beginning of the COVID-19 outbreak. We then confirm the conservation of the majority of these genome regions across 739 SARS-CoV-2 sequences subsequently reported from the COVID-19 outbreak, and we present a curated list of 30 'SARS-related-conserved' regions. We find that known RNA structured elements curated as Rfam families and in prior literature are enriched in these conserved genome regions, and we predict additional conserved, stable secondary structures across the viral genome. We provide 106 'SARS-CoV-2-conserved-structured' regions as potential targets for antivirals that bind to structured RNA. We further provide detailed secondary structure models for the extended 5' UTR, frame-shifting element, and 3' UTR. Last, we predict regions of the SARS-CoV-2 viral genome that have low propensity for RNA secondary structure and are conserved within SARS-CoV-2 strains. These 59 'SARS-CoV-2-conserved-unstructured' genomic regions may be most easily targeted in primer-based diagnostic and oligonucleotide-based therapeutic strategies.",10.1261/rna.076141.120,16swzibp,"['As', 'the', 'COVID', '19', 'outbreak', 'spreads', 'there', 'is', 'a', 'growing', 'need', 'for', 'a', 'compilation', 'of', 'conserved', 'RNA', 'genome', 'regions', 'in', 'the', 'SARS', 'CoV', '2', 'virus', 'along', 'with', 'their', 'structural', 'propensities', 'to', 'guide', 'development', 'of', 'antivirals', 'and', 'diagnostics', 'Here', 'we', 'present', 'a', 'first', 'look', 'at', 'RNA', 'sequence', 'conservation', 'and', 'structural', 'propensities', 'in', 'the', 'SARS', 'CoV', '2', 'genome', 'Using', 'sequence', 'alignments', 'spanning', 'a', 'range', 'of', 'betacoronaviruses', 'we', 'rank', 'genomic', 'regions', 'by', 'RNA', 'sequence', 'conservation', 'identifying', '79', 'regions', 'of', 'length', 'at', 'least', '15', 'nucleotides', 'as', 'exactly', 'conserved', 'over', 'SARS', 'related', 'complete', 'genome', 'sequences', 'available', 'near', 'the', 'beginning', 'of', 'the', 'COVID', '19', 'outbreak', 'We', 'then', 'confirm', 'the', 'conservation', 'of', 'the', 'majority', 'of', 'these', 'genome', 'regions', 'across', '739', 'SARS', 'CoV', '2', 'sequences', 'subsequently', 'reported', 'from', 'the', 'COVID', '19', 'outbreak', 'and', 'we', 'present', 'a', 'curated', 'list', 'of', '30', 'SARS', 'related', 'conserved', 'regions', 'We', 'find', 'that', 'known', 'RNA', 'structured', 'elements', 'curated', 'as', 'Rfam', 'families', 'and', 'in', 'prior', 'literature', 'are', 'enriched', 'in', 'these', 'conserved', 'genome', 'regions', 'and', 'we', 'predict', 'additional', 'conserved', 'stable', 'secondary', 'structures', 'across', 'the', 'viral', 'genome', 'We', 'provide', '106', 'SARS', 'CoV', '2', 'conserved', 'structured', 'regions', 'as', 'potential', 'targets', 'for', 'antivirals', 'that', 'bind', 'to', 'structured', 'RNA', 'We', 'further', 'provide', 'detailed', 'secondary', 'structure', 'models', 'for', 'the', 'extended', '5', 'UTR', 'frame', 'shifting', 'element', 'and', '3', 'UTR', 'Last', 'we', 'predict', 'regions', 'of', 'the', 'SARS', 'CoV', '2', 'viral', 'genome', 'that', 'have', 'low', 'propensity', 'for', 'RNA', 'secondary', 'structure', 'and', 'are', 'conserved', 'within', 'SARS', 'CoV', '2', 'strains', 'These', '59', 'SARS', 'CoV', '2', 'conserved', 'unstructured', 'genomic', 'regions', 'may', 'be', 'most', 'easily', 'targeted', 'in', 'primer', 'based', 'diagnostic', 'and', 'oligonucleotide', 'based', 'therapeutic', 'strategies', '']"
61130,What we know so far: COVID-19 current clinical knowledge and research.,2020-03-05,Clinical medicine,https://doi.org/10.7861/clinmed.2019-coron; https://www.ncbi.nlm.nih.gov/pubmed/32139372/,"In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features.",10.7861/clinmed.2019-coron,sn72mkzq,"['In', 'December', '2019', 'health', 'authorities', 'in', 'Wuhan', 'China', 'identified', 'a', 'cluster', 'of', 'pneumonia', 'cases', 'of', 'unknown', 'aetiology', 'linked', 'to', 'the', 'city', 's', 'South', 'China', 'Seafood', 'Market', 'Subsequent', 'investigations', 'revealed', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'as', 'the', 'causative', 'agent', 'now', 'at', 'the', 'heart', 'of', 'a', 'major', 'outbreak', 'The', 'rising', 'case', 'numbers', 'have', 'been', 'accompanied', 'by', 'unprecedented', 'public', 'health', 'action', 'including', 'the', 'wholesale', 'isolation', 'of', 'Wuhan', 'Alongside', 'this', 'has', 'been', 'a', 'robust', 'scientific', 'response', 'including', 'early', 'publication', 'of', 'the', 'pathogen', 'genome', 'and', 'rapid', 'development', 'of', 'highly', 'specific', 'diagnostics', 'This', 'article', 'will', 'review', 'the', 'new', 'knowledge', 'of', 'SARS', 'CoV', '2', 'COVID', '19', 'acute', 'respiratory', 'disease', 'and', 'summarise', 'its', 'clinical', 'features', '']"
61215,[Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic].,2020-05-04,Kardiologiia,https://doi.org/10.18087/cardio.2020.5.n1130; https://www.ncbi.nlm.nih.gov/pubmed/32515698/,"The beginning of 2020 was characterized by the development of a new coronavirus pandemic (COVID-19). Information about the epidemiology, etiology, pathogenesis, clinical and laboratory diagnostics, as well as prevention and therapy for this disease is constantly being expanded and reviewed. The COVID-19 pandemic creates the need for the emergence of new conditions of specialized care for patients with heart rhythm and conduction disorders [1]. These recommendations are intended for general practitioners, internists, cardiologists, electrophysiologists/arrhythmologists, cardiovascular surgeons, functional diagnostics doctors, anesthesiologists-resuscitators, laboratory diagnostics specialists, health care organizers in the system of organizations and healthcare institutions that provide specialized care to patients with heart rhythm and conduction disorders.",10.18087/cardio.2020.5.n1130,oaxn8my7,"['The', 'beginning', 'of', '2020', 'was', 'characterized', 'by', 'the', 'development', 'of', 'a', 'new', 'coronavirus', 'pandemic', 'COVID', '19', 'Information', 'about', 'the', 'epidemiology', 'etiology', 'pathogenesis', 'clinical', 'and', 'laboratory', 'diagnostics', 'as', 'well', 'as', 'prevention', 'and', 'therapy', 'for', 'this', 'disease', 'is', 'constantly', 'being', 'expanded', 'and', 'reviewed', 'The', 'COVID', '19', 'pandemic', 'creates', 'the', 'need', 'for', 'the', 'emergence', 'of', 'new', 'conditions', 'of', 'specialized', 'care', 'for', 'patients', 'with', 'heart', 'rhythm', 'and', 'conduction', 'disorders', '1', 'These', 'recommendations', 'are', 'intended', 'for', 'general', 'practitioners', 'internists', 'cardiologists', 'electrophysiologists', 'arrhythmologists', 'cardiovascular', 'surgeons', 'functional', 'diagnostics', 'doctors', 'anesthesiologists', 'resuscitators', 'laboratory', 'diagnostics', 'specialists', 'health', 'care', 'organizers', 'in', 'the', 'system', 'of', 'organizations', 'and', 'healthcare', 'institutions', 'that', 'provide', 'specialized', 'care', 'to', 'patients', 'with', 'heart', 'rhythm', 'and', 'conduction', 'disorders', '']"
63839,Turning the Page: Advancing Paper-Based Microfluidics for Broad Diagnostic Application.,2017,Chemical reviews,https://doi.org/10.1021/acs.chemrev.7b00024; https://www.ncbi.nlm.nih.gov/pubmed/28627178/,"Infectious diseases are a major global health issue. Diagnosis is a critical first step in effectively managing their spread. Paper-based microfluidic diagnostics first emerged in 2007 as a low-cost alternative to conventional laboratory testing, with the goal of improving accessibility to medical diagnostics in developing countries. In this review, we examine the advances in paper-based microfluidic diagnostics for medical diagnosis in the context of global health from 2007 to 2016. The theory of fluid transport in paper is first presented. The next section examines the strategies that have been employed to control fluid and analyte transport in paper-based assays. Tasks such as mixing, timing, and sequential fluid delivery have been achieved in paper and have enabled analytical capabilities comparable to those of conventional laboratory methods. The following section examines paper-based sample processing and analysis. The most impactful advancement here has been the translation of nucleic acid analysis to a paper-based format. Smartphone-based analysis is another exciting development with potential for wide dissemination. The last core section of the review highlights emerging health applications, such as male fertility testing and wearable diagnostics. We conclude the review with the future outlook, remaining challenges, and emerging opportunities.",10.1021/acs.chemrev.7b00024,u9rytelh,"['Infectious', 'diseases', 'are', 'a', 'major', 'global', 'health', 'issue', 'Diagnosis', 'is', 'a', 'critical', 'first', 'step', 'in', 'effectively', 'managing', 'their', 'spread', 'Paper', 'based', 'microfluidic', 'diagnostics', 'first', 'emerged', 'in', '2007', 'as', 'a', 'low', 'cost', 'alternative', 'to', 'conventional', 'laboratory', 'testing', 'with', 'the', 'goal', 'of', 'improving', 'accessibility', 'to', 'medical', 'diagnostics', 'in', 'developing', 'countries', 'In', 'this', 'review', 'we', 'examine', 'the', 'advances', 'in', 'paper', 'based', 'microfluidic', 'diagnostics', 'for', 'medical', 'diagnosis', 'in', 'the', 'context', 'of', 'global', 'health', 'from', '2007', 'to', '2016', 'The', 'theory', 'of', 'fluid', 'transport', 'in', 'paper', 'is', 'first', 'presented', 'The', 'next', 'section', 'examines', 'the', 'strategies', 'that', 'have', 'been', 'employed', 'to', 'control', 'fluid', 'and', 'analyte', 'transport', 'in', 'paper', 'based', 'assays', 'Tasks', 'such', 'as', 'mixing', 'timing', 'and', 'sequential', 'fluid', 'delivery', 'have', 'been', 'achieved', 'in', 'paper', 'and', 'have', 'enabled', 'analytical', 'capabilities', 'comparable', 'to', 'those', 'of', 'conventional', 'laboratory', 'methods', 'The', 'following', 'section', 'examines', 'paper', 'based', 'sample', 'processing', 'and', 'analysis', 'The', 'most', 'impactful', 'advancement', 'here', 'has', 'been', 'the', 'translation', 'of', 'nucleic', 'acid', 'analysis', 'to', 'a', 'paper', 'based', 'format', 'Smartphone', 'based', 'analysis', 'is', 'another', 'exciting', 'development', 'with', 'potential', 'for', 'wide', 'dissemination', 'The', 'last', 'core', 'section', 'of', 'the', 'review', 'highlights', 'emerging', 'health', 'applications', 'such', 'as', 'male', 'fertility', 'testing', 'and', 'wearable', 'diagnostics', 'We', 'conclude', 'the', 'review', 'with', 'the', 'future', 'outlook', 'remaining', 'challenges', 'and', 'emerging', 'opportunities', '']"
64554,Neglected and endemic zoonoses.,2009,"Philosophical transactions of the Royal Society of London. Series B, Biological sciences",https://doi.org/10.1098/rstb.2009.0067; https://www.ncbi.nlm.nih.gov/pubmed/19687045/,"Endemic zoonoses are found throughout the developing world, wherever people live in close proximity to their animals, affecting not only the health of poor people but often also their livelihoods through the health of their livestock. Unlike newly emerging zoonoses that attract the attention of the developed world, these endemic zoonoses are by comparison neglected. This is, in part, a consequence of under-reporting, resulting in underestimation of their global burden, which in turn artificially downgrades their importance in the eyes of administrators and funding agencies. The development of cheap and effective vaccines is no guarantee that these endemic diseases will be eliminated in the near future. However, simply increasing awareness about their causes and how they may be prevented-often with very simple technologies-could reduce the incidence of many endemic zoonoses. Sustainable control of zoonoses is reliant on surveillance, but, as with other public-sector animal health services, this is rarely implemented in the developing world, not least because of the lack of sufficiently cheap diagnostics. Public-private partnerships have already provided advocacy for human disease control and could be equally effective in addressing endemic zoonoses.",10.1098/rstb.2009.0067,93nqe0h4,"['Endemic', 'zoonoses', 'are', 'found', 'throughout', 'the', 'developing', 'world', 'wherever', 'people', 'live', 'in', 'close', 'proximity', 'to', 'their', 'animals', 'affecting', 'not', 'only', 'the', 'health', 'of', 'poor', 'people', 'but', 'often', 'also', 'their', 'livelihoods', 'through', 'the', 'health', 'of', 'their', 'livestock', 'Unlike', 'newly', 'emerging', 'zoonoses', 'that', 'attract', 'the', 'attention', 'of', 'the', 'developed', 'world', 'these', 'endemic', 'zoonoses', 'are', 'by', 'comparison', 'neglected', 'This', 'is', 'in', 'part', 'a', 'consequence', 'of', 'under', 'reporting', 'resulting', 'in', 'underestimation', 'of', 'their', 'global', 'burden', 'which', 'in', 'turn', 'artificially', 'downgrades', 'their', 'importance', 'in', 'the', 'eyes', 'of', 'administrators', 'and', 'funding', 'agencies', 'The', 'development', 'of', 'cheap', 'and', 'effective', 'vaccines', 'is', 'no', 'guarantee', 'that', 'these', 'endemic', 'diseases', 'will', 'be', 'eliminated', 'in', 'the', 'near', 'future', 'However', 'simply', 'increasing', 'awareness', 'about', 'their', 'causes', 'and', 'how', 'they', 'may', 'be', 'prevented', 'often', 'with', 'very', 'simple', 'technologies', 'could', 'reduce', 'the', 'incidence', 'of', 'many', 'endemic', 'zoonoses', 'Sustainable', 'control', 'of', 'zoonoses', 'is', 'reliant', 'on', 'surveillance', 'but', 'as', 'with', 'other', 'public', 'sector', 'animal', 'health', 'services', 'this', 'is', 'rarely', 'implemented', 'in', 'the', 'developing', 'world', 'not', 'least', 'because', 'of', 'the', 'lack', 'of', 'sufficiently', 'cheap', 'diagnostics', 'Public', 'private', 'partnerships', 'have', 'already', 'provided', 'advocacy', 'for', 'human', 'disease', 'control', 'and', 'could', 'be', 'equally', 'effective', 'in', 'addressing', 'endemic', 'zoonoses', '']"
64942,Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification.,2013,PloS one,https://doi.org/10.1371/journal.pone.0062791; https://www.ncbi.nlm.nih.gov/pubmed/23675426/,"The HER3 receptor is implicated in the progression of various cancers as well as in resistance to several currently used drugs, and is hence a potential target for development of new therapies. We have previously generated Affibody molecules that inhibit heregulin-induced signaling of the HER3 pathways. The aim of this study was to improve the affinity of the binders to hopefully increase receptor inhibition efficacy and enable a high receptor-mediated uptake in tumors. We explored a novel strategy for affinity maturation of Affibody molecules that is based on alanine scanning followed by design of library diversification to mimic the result from an error-prone PCR reaction, but with full control over mutated positions and thus less biases. Using bacterial surface display and flow-cytometric sorting of the maturation library, the affinity for HER3 was improved more than 30-fold down to 21 pM. The affinity is among the higher that has been reported for Affibody molecules and we believe that the maturation strategy should be generally applicable for improvement of affinity proteins. The new binders also demonstrated an improved thermal stability as well as complete refolding after denaturation. Moreover, inhibition of ligand-induced proliferation of HER3-positive breast cancer cells was improved more than two orders of magnitude compared to the previously best-performing clone. Radiolabeled Affibody molecules showed specific targeting of a number of HER3-positive cell lines in vitro as well as targeting of HER3 in in vivo mouse models and represent promising candidates for future development of targeted therapies and diagnostics.",10.1371/journal.pone.0062791,3bskw92e,"['The', 'HER3', 'receptor', 'is', 'implicated', 'in', 'the', 'progression', 'of', 'various', 'cancers', 'as', 'well', 'as', 'in', 'resistance', 'to', 'several', 'currently', 'used', 'drugs', 'and', 'is', 'hence', 'a', 'potential', 'target', 'for', 'development', 'of', 'new', 'therapies', 'We', 'have', 'previously', 'generated', 'Affibody', 'molecules', 'that', 'inhibit', 'heregulin', 'induced', 'signaling', 'of', 'the', 'HER3', 'pathways', 'The', 'aim', 'of', 'this', 'study', 'was', 'to', 'improve', 'the', 'affinity', 'of', 'the', 'binders', 'to', 'hopefully', 'increase', 'receptor', 'inhibition', 'efficacy', 'and', 'enable', 'a', 'high', 'receptor', 'mediated', 'uptake', 'in', 'tumors', 'We', 'explored', 'a', 'novel', 'strategy', 'for', 'affinity', 'maturation', 'of', 'Affibody', 'molecules', 'that', 'is', 'based', 'on', 'alanine', 'scanning', 'followed', 'by', 'design', 'of', 'library', 'diversification', 'to', 'mimic', 'the', 'result', 'from', 'an', 'error', 'prone', 'PCR', 'reaction', 'but', 'with', 'full', 'control', 'over', 'mutated', 'positions', 'and', 'thus', 'less', 'biases', 'Using', 'bacterial', 'surface', 'display', 'and', 'flow', 'cytometric', 'sorting', 'of', 'the', 'maturation', 'library', 'the', 'affinity', 'for', 'HER3', 'was', 'improved', 'more', 'than', '30', 'fold', 'down', 'to', '21', 'pM', 'The', 'affinity', 'is', 'among', 'the', 'higher', 'that', 'has', 'been', 'reported', 'for', 'Affibody', 'molecules', 'and', 'we', 'believe', 'that', 'the', 'maturation', 'strategy', 'should', 'be', 'generally', 'applicable', 'for', 'improvement', 'of', 'affinity', 'proteins', 'The', 'new', 'binders', 'also', 'demonstrated', 'an', 'improved', 'thermal', 'stability', 'as', 'well', 'as', 'complete', 'refolding', 'after', 'denaturation', 'Moreover', 'inhibition', 'of', 'ligand', 'induced', 'proliferation', 'of', 'HER3', 'positive', 'breast', 'cancer', 'cells', 'was', 'improved', 'more', 'than', 'two', 'orders', 'of', 'magnitude', 'compared', 'to', 'the', 'previously', 'best', 'performing', 'clone', 'Radiolabeled', 'Affibody', 'molecules', 'showed', 'specific', 'targeting', 'of', 'a', 'number', 'of', 'HER3', 'positive', 'cell', 'lines', 'in', 'vitro', 'as', 'well', 'as', 'targeting', 'of', 'HER3', 'in', 'in', 'vivo', 'mouse', 'models', 'and', 'represent', 'promising', 'candidates', 'for', 'future', 'development', 'of', 'targeted', 'therapies', 'and', 'diagnostics', '']"
64964,Human bocavirus: passenger or pathogen in acute respiratory tract infections?,2008,Clinical microbiology reviews,https://doi.org/10.1128/cmr.00030-07; https://www.ncbi.nlm.nih.gov/pubmed/18400798/,"Human bocavirus (HBoV) is a newly identified virus tentatively assigned to the family Parvoviridae, subfamily Parvovirinae, genus Bocavirus. HBoV was first described in 2005 and has since been detected in respiratory tract secretions worldwide. Herein we review the literature on HBoV and discuss the biology and potential clinical impact of this virus. Most studies have been PCR based and performed on patients with acute respiratory symptoms, from whom HBoV was detected in 2 to 19% of the samples. HBoV-positive samples have been derived mainly from infants and young children. HBoV DNA has also been detected in the blood of patients with respiratory tract infection and in fecal samples of patients with diarrhea with or without concomitant respiratory symptoms. A characteristic feature of HBoV studies is the high frequency of coinciding detections, or codetections, with other viruses. Available data nevertheless indicate a statistical association between HBoV and acute respiratory tract disease. We present a model incorporating these somewhat contradictory findings and suggest that primary HBoV infection causes respiratory tract symptoms which can be followed by prolonged low-level virus shedding in the respiratory tract. Detection of the virus in this phase will be facilitated by other infections, either simply via increased sample cell count or via reactivation of HBoV, leading to an increased detection frequency of HBoV during other virus infections. We conclude that the majority of available HBoV studies are limited by the sole use of PCR diagnostics on respiratory tract secretions, addressing virus prevalence but not disease association. The ability to detect primary infection through the development of improved diagnostic methods will be of great importance for future studies seeking to assign a role for HBoV in causing respiratory illnesses.",10.1128/cmr.00030-07,cvapqip5,"['Human', 'bocavirus', 'HBoV', 'is', 'a', 'newly', 'identified', 'virus', 'tentatively', 'assigned', 'to', 'the', 'family', 'Parvoviridae', 'subfamily', 'Parvovirinae', 'genus', 'Bocavirus', 'HBoV', 'was', 'first', 'described', 'in', '2005', 'and', 'has', 'since', 'been', 'detected', 'in', 'respiratory', 'tract', 'secretions', 'worldwide', 'Herein', 'we', 'review', 'the', 'literature', 'on', 'HBoV', 'and', 'discuss', 'the', 'biology', 'and', 'potential', 'clinical', 'impact', 'of', 'this', 'virus', 'Most', 'studies', 'have', 'been', 'PCR', 'based', 'and', 'performed', 'on', 'patients', 'with', 'acute', 'respiratory', 'symptoms', 'from', 'whom', 'HBoV', 'was', 'detected', 'in', '2', 'to', '19', 'of', 'the', 'samples', 'HBoV', 'positive', 'samples', 'have', 'been', 'derived', 'mainly', 'from', 'infants', 'and', 'young', 'children', 'HBoV', 'DNA', 'has', 'also', 'been', 'detected', 'in', 'the', 'blood', 'of', 'patients', 'with', 'respiratory', 'tract', 'infection', 'and', 'in', 'fecal', 'samples', 'of', 'patients', 'with', 'diarrhea', 'with', 'or', 'without', 'concomitant', 'respiratory', 'symptoms', 'A', 'characteristic', 'feature', 'of', 'HBoV', 'studies', 'is', 'the', 'high', 'frequency', 'of', 'coinciding', 'detections', 'or', 'codetections', 'with', 'other', 'viruses', 'Available', 'data', 'nevertheless', 'indicate', 'a', 'statistical', 'association', 'between', 'HBoV', 'and', 'acute', 'respiratory', 'tract', 'disease', 'We', 'present', 'a', 'model', 'incorporating', 'these', 'somewhat', 'contradictory', 'findings', 'and', 'suggest', 'that', 'primary', 'HBoV', 'infection', 'causes', 'respiratory', 'tract', 'symptoms', 'which', 'can', 'be', 'followed', 'by', 'prolonged', 'low', 'level', 'virus', 'shedding', 'in', 'the', 'respiratory', 'tract', 'Detection', 'of', 'the', 'virus', 'in', 'this', 'phase', 'will', 'be', 'facilitated', 'by', 'other', 'infections', 'either', 'simply', 'via', 'increased', 'sample', 'cell', 'count', 'or', 'via', 'reactivation', 'of', 'HBoV', 'leading', 'to', 'an', 'increased', 'detection', 'frequency', 'of', 'HBoV', 'during', 'other', 'virus', 'infections', 'We', 'conclude', 'that', 'the', 'majority', 'of', 'available', 'HBoV', 'studies', 'are', 'limited', 'by', 'the', 'sole', 'use', 'of', 'PCR', 'diagnostics', 'on', 'respiratory', 'tract', 'secretions', 'addressing', 'virus', 'prevalence', 'but', 'not', 'disease', 'association', 'The', 'ability', 'to', 'detect', 'primary', 'infection', 'through', 'the', 'development', 'of', 'improved', 'diagnostic', 'methods', 'will', 'be', 'of', 'great', 'importance', 'for', 'future', 'studies', 'seeking', 'to', 'assign', 'a', 'role', 'for', 'HBoV', 'in', 'causing', 'respiratory', 'illnesses', '']"
68057,Laboratory methods for determining pneumonia etiology in children.,2012,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,https://doi.org/10.1093/cid/cir1073; https://www.ncbi.nlm.nih.gov/pubmed/22403229/,"Laboratory diagnostics are a core component of any pneumonia etiology study. Recent advances in diagnostic technology have introduced newer methods that have greatly improved the ability to identify respiratory pathogens. However, determining the microbial etiology of pneumonia remains a challenge, especially in children. This is largely because of the inconsistent use of assays between studies, difficulties in specimen collection, and problems in interpreting the presence of pathogens as being causally related to the pneumonia event. The laboratory testing strategy for the Pneumonia Etiology Research for Child Health (PERCH) study aims to incorporate a broad range of diagnostic testing that will be standardized across the 7 participating sites. We describe the current status of laboratory diagnostics for pneumonia and the PERCH approach for specimen testing. Pneumonia diagnostics are evolving, and it is also a priority of PERCH to collect and archive specimens for future testing by promising diagnostic methods that are currently under development.",10.1093/cid/cir1073,n76k4nuh,"['Laboratory', 'diagnostics', 'are', 'a', 'core', 'component', 'of', 'any', 'pneumonia', 'etiology', 'study', 'Recent', 'advances', 'in', 'diagnostic', 'technology', 'have', 'introduced', 'newer', 'methods', 'that', 'have', 'greatly', 'improved', 'the', 'ability', 'to', 'identify', 'respiratory', 'pathogens', 'However', 'determining', 'the', 'microbial', 'etiology', 'of', 'pneumonia', 'remains', 'a', 'challenge', 'especially', 'in', 'children', 'This', 'is', 'largely', 'because', 'of', 'the', 'inconsistent', 'use', 'of', 'assays', 'between', 'studies', 'difficulties', 'in', 'specimen', 'collection', 'and', 'problems', 'in', 'interpreting', 'the', 'presence', 'of', 'pathogens', 'as', 'being', 'causally', 'related', 'to', 'the', 'pneumonia', 'event', 'The', 'laboratory', 'testing', 'strategy', 'for', 'the', 'Pneumonia', 'Etiology', 'Research', 'for', 'Child', 'Health', 'PERCH', 'study', 'aims', 'to', 'incorporate', 'a', 'broad', 'range', 'of', 'diagnostic', 'testing', 'that', 'will', 'be', 'standardized', 'across', 'the', '7', 'participating', 'sites', 'We', 'describe', 'the', 'current', 'status', 'of', 'laboratory', 'diagnostics', 'for', 'pneumonia', 'and', 'the', 'PERCH', 'approach', 'for', 'specimen', 'testing', 'Pneumonia', 'diagnostics', 'are', 'evolving', 'and', 'it', 'is', 'also', 'a', 'priority', 'of', 'PERCH', 'to', 'collect', 'and', 'archive', 'specimens', 'for', 'future', 'testing', 'by', 'promising', 'diagnostic', 'methods', 'that', 'are', 'currently', 'under', 'development', '']"
68762,Evaluation and clinical validation of an alcohol-based transport medium for preservation and inactivation of respiratory viruses.,2011,Journal of clinical microbiology,https://doi.org/10.1128/jcm.00327-11; https://www.ncbi.nlm.nih.gov/pubmed/21508158/,"The clinical and public health importance of influenza and other respiratory viruses has accelerated the development of highly sensitive molecular diagnostics, but data are limited regarding preanalytical stages of diagnostic testing. We evaluated CyMol, an alcohol-based transport medium, for its ability to maintain specimen integrity for up to 21 days of storage at various temperatures; for its ability to inactivate virus; and for its compatibility with antigen- or nucleic acid-based diagnostics for respiratory viruses in clinical samples. In mock-infected samples, both universal transport medium (UTM-RT) and CyMol maintained equivalent viral quantities for at least 14 days at room temperature or colder, whereas a dry swab collection maintained viral quantities only if refrigerated or frozen. CyMol inactivated influenza virus within 5 min of sample immersion. UTM-RT- and CyMol-collected nasal swab specimens from 73 symptomatic students attending a campus health clinic were positive for a respiratory virus in 56.2% of subjects by multiplex PCR testing, including influenza A and B viruses, rhinovirus/enteroviruses, coronaviruses, respiratory syncytial virus, parainfluenza viruses, metapneumovirus, and adenovirus. Detection by PCR was equivalent in UTM-RT- and CyMol-collected specimens and in self- and staff-collected swabs. Direct fluorescent antibody (DFA) testing was substantially less sensitive (23.3%) than multiplex PCR, and DFA testing from UTM-RT-collected swabs was more sensitive than that from CyMol-collected swabs. These data indicate that an alcohol-based transport medium such as CyMol preserves respiratory virus integrity, rapidly inactivates viruses, and is compatible with PCR-based respiratory diagnostics.",10.1128/jcm.00327-11,4cgs2kp5,"['The', 'clinical', 'and', 'public', 'health', 'importance', 'of', 'influenza', 'and', 'other', 'respiratory', 'viruses', 'has', 'accelerated', 'the', 'development', 'of', 'highly', 'sensitive', 'molecular', 'diagnostics', 'but', 'data', 'are', 'limited', 'regarding', 'preanalytical', 'stages', 'of', 'diagnostic', 'testing', 'We', 'evaluated', 'CyMol', 'an', 'alcohol', 'based', 'transport', 'medium', 'for', 'its', 'ability', 'to', 'maintain', 'specimen', 'integrity', 'for', 'up', 'to', '21', 'days', 'of', 'storage', 'at', 'various', 'temperatures', 'for', 'its', 'ability', 'to', 'inactivate', 'virus', 'and', 'for', 'its', 'compatibility', 'with', 'antigen', 'or', 'nucleic', 'acid', 'based', 'diagnostics', 'for', 'respiratory', 'viruses', 'in', 'clinical', 'samples', 'In', 'mock', 'infected', 'samples', 'both', 'universal', 'transport', 'medium', 'UTM', 'RT', 'and', 'CyMol', 'maintained', 'equivalent', 'viral', 'quantities', 'for', 'at', 'least', '14', 'days', 'at', 'room', 'temperature', 'or', 'colder', 'whereas', 'a', 'dry', 'swab', 'collection', 'maintained', 'viral', 'quantities', 'only', 'if', 'refrigerated', 'or', 'frozen', 'CyMol', 'inactivated', 'influenza', 'virus', 'within', '5', 'min', 'of', 'sample', 'immersion', 'UTM', 'RT', 'and', 'CyMol', 'collected', 'nasal', 'swab', 'specimens', 'from', '73', 'symptomatic', 'students', 'attending', 'a', 'campus', 'health', 'clinic', 'were', 'positive', 'for', 'a', 'respiratory', 'virus', 'in', '56', '2', 'of', 'subjects', 'by', 'multiplex', 'PCR', 'testing', 'including', 'influenza', 'A', 'and', 'B', 'viruses', 'rhinovirus', 'enteroviruses', 'coronaviruses', 'respiratory', 'syncytial', 'virus', 'parainfluenza', 'viruses', 'metapneumovirus', 'and', 'adenovirus', 'Detection', 'by', 'PCR', 'was', 'equivalent', 'in', 'UTM', 'RT', 'and', 'CyMol', 'collected', 'specimens', 'and', 'in', 'self', 'and', 'staff', 'collected', 'swabs', 'Direct', 'fluorescent', 'antibody', 'DFA', 'testing', 'was', 'substantially', 'less', 'sensitive', '23', '3', 'than', 'multiplex', 'PCR', 'and', 'DFA', 'testing', 'from', 'UTM', 'RT', 'collected', 'swabs', 'was', 'more', 'sensitive', 'than', 'that', 'from', 'CyMol', 'collected', 'swabs', 'These', 'data', 'indicate', 'that', 'an', 'alcohol', 'based', 'transport', 'medium', 'such', 'as', 'CyMol', 'preserves', 'respiratory', 'virus', 'integrity', 'rapidly', 'inactivates', 'viruses', 'and', 'is', 'compatible', 'with', 'PCR', 'based', 'respiratory', 'diagnostics', '']"
71564,SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies,2020-03-28,bioRxiv,https://doi.org/10.1101/2020.03.27.009480,"In December 2019, an outbreak of atypical pneumonia (Coronavirus disease 2019 - COVID-19) associated with a novel coronavirus (SARS-CoV-2) was reported in Wuhan city, Hubei province, China. The outbreak was traced to a seafood wholesale market and human to human transmission was confirmed. The rapid spread and the death toll of the new epidemic warrants immediate intervention. The intra-host genomic variability of SARS-CoV-2 plays a pivotal role in the development of effective antiviral agents and vaccines, but also in the design of accurate diagnostics. We analyzed NGS data derived from clinical samples of three Chinese patients infected with SARS-CoV-2, in order to identify small- and large-scale intra-host variations in the viral genome. We identified tens of low- or higher-frequency single nucleotide variations (SNVs) with variable density across the viral genome, affecting 7 out of 10 protein-coding viral genes. The majority of these SNVs corresponded to missense changes. The annotation of the identified SNVs but also of all currently circulating strain variations revealed colocalization of intra-host but also strain specific SNVs with primers and probes currently used in molecular diagnostics assays. Moreover, we de-novo assembled the viral genome, in order to isolate and validate intra-host structural variations and recombination breakpoints. The bioinformatics analysis disclosed genomic rearrangements over poly-A / poly-U regions located in ORF1ab and spike (S) gene, including a potential recombination hot-spot within S gene. Our results highlight the intra-host genomic diversity and plasticity of SARS-CoV-2, pointing out genomic regions that are prone to alterations. The isolated SNVs and genomic rearrangements, reflect the intra-patient capacity of the polymorphic quasispecies, which may arise rapidly during the outbreak, allowing immunological escape of the virus, offering resistance to anti-viral drugs and affecting the sensitivity of the molecular diagnostics assays.",10.1101/2020.03.27.009480,jxm69ndw,"['In', 'December', '2019', 'an', 'outbreak', 'of', 'atypical', 'pneumonia', 'Coronavirus', 'disease', '2019', 'COVID', '19', 'associated', 'with', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'was', 'reported', 'in', 'Wuhan', 'city', 'Hubei', 'province', 'China', 'The', 'outbreak', 'was', 'traced', 'to', 'a', 'seafood', 'wholesale', 'market', 'and', 'human', 'to', 'human', 'transmission', 'was', 'confirmed', 'The', 'rapid', 'spread', 'and', 'the', 'death', 'toll', 'of', 'the', 'new', 'epidemic', 'warrants', 'immediate', 'intervention', 'The', 'intra', 'host', 'genomic', 'variability', 'of', 'SARS', 'CoV', '2', 'plays', 'a', 'pivotal', 'role', 'in', 'the', 'development', 'of', 'effective', 'antiviral', 'agents', 'and', 'vaccines', 'but', 'also', 'in', 'the', 'design', 'of', 'accurate', 'diagnostics', 'We', 'analyzed', 'NGS', 'data', 'derived', 'from', 'clinical', 'samples', 'of', 'three', 'Chinese', 'patients', 'infected', 'with', 'SARS', 'CoV', '2', 'in', 'order', 'to', 'identify', 'small', 'and', 'large', 'scale', 'intra', 'host', 'variations', 'in', 'the', 'viral', 'genome', 'We', 'identified', 'tens', 'of', 'low', 'or', 'higher', 'frequency', 'single', 'nucleotide', 'variations', 'SNVs', 'with', 'variable', 'density', 'across', 'the', 'viral', 'genome', 'affecting', '7', 'out', 'of', '10', 'protein', 'coding', 'viral', 'genes', 'The', 'majority', 'of', 'these', 'SNVs', 'corresponded', 'to', 'missense', 'changes', 'The', 'annotation', 'of', 'the', 'identified', 'SNVs', 'but', 'also', 'of', 'all', 'currently', 'circulating', 'strain', 'variations', 'revealed', 'colocalization', 'of', 'intra', 'host', 'but', 'also', 'strain', 'specific', 'SNVs', 'with', 'primers', 'and', 'probes', 'currently', 'used', 'in', 'molecular', 'diagnostics', 'assays', 'Moreover', 'we', 'de', 'novo', 'assembled', 'the', 'viral', 'genome', 'in', 'order', 'to', 'isolate', 'and', 'validate', 'intra', 'host', 'structural', 'variations', 'and', 'recombination', 'breakpoints', 'The', 'bioinformatics', 'analysis', 'disclosed', 'genomic', 'rearrangements', 'over', 'poly', 'A', 'poly', 'U', 'regions', 'located', 'in', 'ORF1ab', 'and', 'spike', 'S', 'gene', 'including', 'a', 'potential', 'recombination', 'hot', 'spot', 'within', 'S', 'gene', 'Our', 'results', 'highlight', 'the', 'intra', 'host', 'genomic', 'diversity', 'and', 'plasticity', 'of', 'SARS', 'CoV', '2', 'pointing', 'out', 'genomic', 'regions', 'that', 'are', 'prone', 'to', 'alterations', 'The', 'isolated', 'SNVs', 'and', 'genomic', 'rearrangements', 'reflect', 'the', 'intra', 'patient', 'capacity', 'of', 'the', 'polymorphic', 'quasispecies', 'which', 'may', 'arise', 'rapidly', 'during', 'the', 'outbreak', 'allowing', 'immunological', 'escape', 'of', 'the', 'virus', 'offering', 'resistance', 'to', 'anti', 'viral', 'drugs', 'and', 'affecting', 'the', 'sensitivity', 'of', 'the', 'molecular', 'diagnostics', 'assays', '']"
71608,Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays,2020-04-20,,https://doi.org/10.1101/2020.04.15.20066407,"Background: The SARS-CoV-2 pandemic caused >1 million infections during January-March 2020. There is an urgent need for robust antibody detection approaches to support diagnostics, vaccine development, safe individual release from quarantine and population lock-down exit strategies. The early promise of lateral flow immunoassay (LFIA) devices has been questioned following concerns about sensitivity and specificity. Methods: We used a panel of plasma samples designated SARS-CoV-2 positive (from SARS-CoV-2 RT-PCR-positive individuals; n=40) and negative (samples banked in the UK prior to December-2019 (n=142)). We tested plasma for SARS-Cov-2 IgM and IgG antibodies by ELISA and using nine different commercially available LFIA devices. Results: ELISA detected SARS-CoV-2 IgM or IgG in 34/40 individuals with an RT-PCR-confirmed diagnosis of SARS-CoV-2 infection (sensitivity 85%, 95%CI 70-94%), vs 0/50 pre-pandemic controls (specificity 100% [95%CI 93-100%]). IgG levels were detected in 31/31 RT-PCR-positive individuals tested ≥10 days after symptom onset (sensitivity 100%, 95%CI 89-100%). IgG titres rose during the 3 weeks post symptom onset and began to fall by 8 weeks, but remained above the detection threshold. Point estimates for the sensitivity of LFIA devices ranged from 55-70% versus RT-PCR and 65-85% versus ELISA, with specificity 95-100% and 93-100% respectively. Within the limits of the study size, the performance of most LFIA devices was similar. Conclusions: The performance of current LFIA devices is inadequate for most individual patient applications. ELISA can be calibrated to be specific for detecting and quantifying SARS-CoV-2 IgM and IgG and is highly sensitive for IgG from 10 days following symptoms onset.",10.1101/2020.04.15.20066407,5trox1i5,"['Background', 'The', 'SARS', 'CoV', '2', 'pandemic', 'caused', '1', 'million', 'infections', 'during', 'January', 'March', '2020', 'There', 'is', 'an', 'urgent', 'need', 'for', 'robust', 'antibody', 'detection', 'approaches', 'to', 'support', 'diagnostics', 'vaccine', 'development', 'safe', 'individual', 'release', 'from', 'quarantine', 'and', 'population', 'lock', 'down', 'exit', 'strategies', 'The', 'early', 'promise', 'of', 'lateral', 'flow', 'immunoassay', 'LFIA', 'devices', 'has', 'been', 'questioned', 'following', 'concerns', 'about', 'sensitivity', 'and', 'specificity', 'Methods', 'We', 'used', 'a', 'panel', 'of', 'plasma', 'samples', 'designated', 'SARS', 'CoV', '2', 'positive', 'from', 'SARS', 'CoV', '2', 'RT', 'PCR', 'positive', 'individuals', 'n', '40', 'and', 'negative', 'samples', 'banked', 'in', 'the', 'UK', 'prior', 'to', 'December', '2019', 'n', '142', 'We', 'tested', 'plasma', 'for', 'SARS', 'Cov', '2', 'IgM', 'and', 'IgG', 'antibodies', 'by', 'ELISA', 'and', 'using', 'nine', 'different', 'commercially', 'available', 'LFIA', 'devices', 'Results', 'ELISA', 'detected', 'SARS', 'CoV', '2', 'IgM', 'or', 'IgG', 'in', '34', '40', 'individuals', 'with', 'an', 'RT', 'PCR', 'confirmed', 'diagnosis', 'of', 'SARS', 'CoV', '2', 'infection', 'sensitivity', '85', '95', 'CI', '70', '94', 'vs', '0', '50', 'pre', 'pandemic', 'controls', 'specificity', '100', '95', 'CI', '93', '100', 'IgG', 'levels', 'were', 'detected', 'in', '31', '31', 'RT', 'PCR', 'positive', 'individuals', 'tested', '10', 'days', 'after', 'symptom', 'onset', 'sensitivity', '100', '95', 'CI', '89', '100', 'IgG', 'titres', 'rose', 'during', 'the', '3', 'weeks', 'post', 'symptom', 'onset', 'and', 'began', 'to', 'fall', 'by', '8', 'weeks', 'but', 'remained', 'above', 'the', 'detection', 'threshold', 'Point', 'estimates', 'for', 'the', 'sensitivity', 'of', 'LFIA', 'devices', 'ranged', 'from', '55', '70', 'versus', 'RT', 'PCR', 'and', '65', '85', 'versus', 'ELISA', 'with', 'specificity', '95', '100', 'and', '93', '100', 'respectively', 'Within', 'the', 'limits', 'of', 'the', 'study', 'size', 'the', 'performance', 'of', 'most', 'LFIA', 'devices', 'was', 'similar', 'Conclusions', 'The', 'performance', 'of', 'current', 'LFIA', 'devices', 'is', 'inadequate', 'for', 'most', 'individual', 'patient', 'applications', 'ELISA', 'can', 'be', 'calibrated', 'to', 'be', 'specific', 'for', 'detecting', 'and', 'quantifying', 'SARS', 'CoV', '2', 'IgM', 'and', 'IgG', 'and', 'is', 'highly', 'sensitive', 'for', 'IgG', 'from', '10', 'days', 'following', 'symptoms', 'onset', '']"
71995,Real-time colorimetric LAMP methodology for quantitative nucleic acids detection at the point-of-care,2020-07-24,bioRxiv,https://doi.org/10.1101/2020.07.22.215251,"Most methods applied to nucleic acids’ detection at the point-of-care require either expensive and mostly bench-top instruments or simpler inexpensive systems providing qualitative results. Truly decentralized approaches to reliable, quantitative and affordable diagnostics are still missing. Here, we report the development of real-time quantitative colorimetric LAMP based on a portable and cost-effective device, the use of which requires minimal training. Main advantages of the method are the rapid analysis time (<30min); quantification over a large dynamic range (9 log units); ability to work with crude samples (saliva, tissue); demonstrated low detection limit (1-10 copies); smartphone-operation and fast prototyping (3D-printing). The system’s broad detection capability is demonstrated during infectious diseases-testing for COVID-19 and pharmacogenetics for BRAF V600E mutation testing. Validation studies showed 97.4% and 100% agreement with qRT-PCR for SARS-CoV-2 RNA detection extracted from positive and negative patients’ samples (89), respectively; and 100% agreement with ddPCR and Sanger sequencing for BRAF V600E mutation detection from 12 clinical biopsy samples. The new methodology provides a needed solution for affordable healthcare at the point-of-care, with emphasis on global diagnostics.",10.1101/2020.07.22.215251,e0krtdfy,"['Most', 'methods', 'applied', 'to', 'nucleic', 'acids', 'detection', 'at', 'the', 'point', 'of', 'care', 'require', 'either', 'expensive', 'and', 'mostly', 'bench', 'top', 'instruments', 'or', 'simpler', 'inexpensive', 'systems', 'providing', 'qualitative', 'results', 'Truly', 'decentralized', 'approaches', 'to', 'reliable', 'quantitative', 'and', 'affordable', 'diagnostics', 'are', 'still', 'missing', 'Here', 'we', 'report', 'the', 'development', 'of', 'real', 'time', 'quantitative', 'colorimetric', 'LAMP', 'based', 'on', 'a', 'portable', 'and', 'cost', 'effective', 'device', 'the', 'use', 'of', 'which', 'requires', 'minimal', 'training', 'Main', 'advantages', 'of', 'the', 'method', 'are', 'the', 'rapid', 'analysis', 'time', '30min', 'quantification', 'over', 'a', 'large', 'dynamic', 'range', '9', 'log', 'units', 'ability', 'to', 'work', 'with', 'crude', 'samples', 'saliva', 'tissue', 'demonstrated', 'low', 'detection', 'limit', '1', '10', 'copies', 'smartphone', 'operation', 'and', 'fast', 'prototyping', '3D', 'printing', 'The', 'system', 's', 'broad', 'detection', 'capability', 'is', 'demonstrated', 'during', 'infectious', 'diseases', 'testing', 'for', 'COVID', '19', 'and', 'pharmacogenetics', 'for', 'BRAF', 'V600E', 'mutation', 'testing', 'Validation', 'studies', 'showed', '97', '4', 'and', '100', 'agreement', 'with', 'qRT', 'PCR', 'for', 'SARS', 'CoV', '2', 'RNA', 'detection', 'extracted', 'from', 'positive', 'and', 'negative', 'patients', 'samples', '89', 'respectively', 'and', '100', 'agreement', 'with', 'ddPCR', 'and', 'Sanger', 'sequencing', 'for', 'BRAF', 'V600E', 'mutation', 'detection', 'from', '12', 'clinical', 'biopsy', 'samples', 'The', 'new', 'methodology', 'provides', 'a', 'needed', 'solution', 'for', 'affordable', 'healthcare', 'at', 'the', 'point', 'of', 'care', 'with', 'emphasis', 'on', 'global', 'diagnostics', '']"
72341,"Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration",2020-05-05,,http://medrxiv.org/cgi/content/short/2020.04.29.20082099v1?rss=1,"In January, Mologic, embarked on a product development pathway for COVID-19 diagnostics focusing on ELISA and rapid diagnostic tests (RDTs), with anticipated funding from Wellcome Trust and DFID. 755 clinical samples from known COVID-19 patients and hospital negative controls were tested on Mologics IgG ELISA. The reported sensitivity on 191 SGUL prospectively enrolled patients was 95% on day 7 or more post diagnosis, and 97% 10 days or more post-diagnosis. A specificity panel comprising 564 samples pre-December 2019 were tested to include most common respiratory pathogens, other types of coronavirus, and flaviviruses. Specificity in this panel was 97%. This is the first in a series of Mologic products for COVID-19, which will be deployed for COVID-19 diagnosis, contact tracing and sero-epidemiological studies to estimate disease burden and transmission with a focus on ensuring access, affordability, and availability to lowest resource settings.",10.1101/2020.04.29.20082099,nol2n8fo,"['In', 'January', 'Mologic', 'embarked', 'on', 'a', 'product', 'development', 'pathway', 'for', 'COVID', '19', 'diagnostics', 'focusing', 'on', 'ELISA', 'and', 'rapid', 'diagnostic', 'tests', 'RDTs', 'with', 'anticipated', 'funding', 'from', 'Wellcome', 'Trust', 'and', 'DFID', '755', 'clinical', 'samples', 'from', 'known', 'COVID', '19', 'patients', 'and', 'hospital', 'negative', 'controls', 'were', 'tested', 'on', 'Mologics', 'IgG', 'ELISA', 'The', 'reported', 'sensitivity', 'on', '191', 'SGUL', 'prospectively', 'enrolled', 'patients', 'was', '95', 'on', 'day', '7', 'or', 'more', 'post', 'diagnosis', 'and', '97', '10', 'days', 'or', 'more', 'post', 'diagnosis', 'A', 'specificity', 'panel', 'comprising', '564', 'samples', 'pre', 'December', '2019', 'were', 'tested', 'to', 'include', 'most', 'common', 'respiratory', 'pathogens', 'other', 'types', 'of', 'coronavirus', 'and', 'flaviviruses', 'Specificity', 'in', 'this', 'panel', 'was', '97', 'This', 'is', 'the', 'first', 'in', 'a', 'series', 'of', 'Mologic', 'products', 'for', 'COVID', '19', 'which', 'will', 'be', 'deployed', 'for', 'COVID', '19', 'diagnosis', 'contact', 'tracing', 'and', 'sero', 'epidemiological', 'studies', 'to', 'estimate', 'disease', 'burden', 'and', 'transmission', 'with', 'a', 'focus', 'on', 'ensuring', 'access', 'affordability', 'and', 'availability', 'to', 'lowest', 'resource', 'settings', '']"
72632,"Diagnostic technology for COVID-19: comparative evaluation of antigen and serology-based SARS-CoV-2 immunoassays, and contact tracing solutions for potential use as at-home products",2020-06-29,,http://medrxiv.org/cgi/content/short/2020.06.25.20140236v1?rss=1,"As the United States prepares to return to work and open up the economy in the midst of the COVID-19 pandemic without an available vaccine or effective therapy, testing and contact tracing are essential to contain and limit the spread of the COVID-19 virus. In response to the urgent public health need for accurate, effective, low-cost, and scalable COVID-19 testing technology, we evaluated and identified diagnostic solutions with potential for use as an at-home product. We conducted a deep horizon scan for antigen and serology-based diagnostics and down-selected to the most promising technologies. A total of 303 candidate products (138 antibody and 44 antigen tests) were identified. Product evaluations were based entirely on company-provided data. 73 serology-based antibody tests passing an initial scoring algorithm based on specificity and sensitivity data were then further evaluated using a second scoring algorithm. This second algorithm included a review of additional technical specifications of the devices, an analysis of supply chain, manufacturing, and distribution capacity of each vendor. 24 potential antibody products met the selection criteria for further direct laboratory evaluation. The performance metrics for selection of these 24 products are currently being evaluated in a Mass General Brigham laboratory. Testing alone might not be sufficient to prevent the spread of a highly contagious disease like COVID-19. Manual contact tracing could complement testing, but it is likely to fail in identifying many individuals who were in contact with a given COVID patient. The proliferation of smartphones in the population has enabled the development of solutions that can provide public health officials with valuable information for rapid and accurate contact tracing. Besides, electronic-based contact tracing solutions can be augmented by symptom self-reports gathered using electronic patient reported outcome (ePRO) platforms and by physiological data collected using wearable sensors. We performed a detailed assessment of 12 ePRO solutions, 27 wearable sensors, and 44 electronic-based contact tracing solutions. These technologies were evaluated using criteria developed to assess their suitability to address the COVID-19 pandemic. We identified a number of solutions that could augment if not provide a more effective alternative to manual contact tracing. Finally, we propose a theoretical framework in which ePRO platforms, wearable sensors, and electronic-based contact tracing solutions would be utilized in combination with molecular and serological tests to identify and isolate COVID-19 cases rapidly.",10.1101/2020.06.25.20140236,hz3z6xkk,"['As', 'the', 'United', 'States', 'prepares', 'to', 'return', 'to', 'work', 'and', 'open', 'up', 'the', 'economy', 'in', 'the', 'midst', 'of', 'the', 'COVID', '19', 'pandemic', 'without', 'an', 'available', 'vaccine', 'or', 'effective', 'therapy', 'testing', 'and', 'contact', 'tracing', 'are', 'essential', 'to', 'contain', 'and', 'limit', 'the', 'spread', 'of', 'the', 'COVID', '19', 'virus', 'In', 'response', 'to', 'the', 'urgent', 'public', 'health', 'need', 'for', 'accurate', 'effective', 'low', 'cost', 'and', 'scalable', 'COVID', '19', 'testing', 'technology', 'we', 'evaluated', 'and', 'identified', 'diagnostic', 'solutions', 'with', 'potential', 'for', 'use', 'as', 'an', 'at', 'home', 'product', 'We', 'conducted', 'a', 'deep', 'horizon', 'scan', 'for', 'antigen', 'and', 'serology', 'based', 'diagnostics', 'and', 'down', 'selected', 'to', 'the', 'most', 'promising', 'technologies', 'A', 'total', 'of', '303', 'candidate', 'products', '138', 'antibody', 'and', '44', 'antigen', 'tests', 'were', 'identified', 'Product', 'evaluations', 'were', 'based', 'entirely', 'on', 'company', 'provided', 'data', '73', 'serology', 'based', 'antibody', 'tests', 'passing', 'an', 'initial', 'scoring', 'algorithm', 'based', 'on', 'specificity', 'and', 'sensitivity', 'data', 'were', 'then', 'further', 'evaluated', 'using', 'a', 'second', 'scoring', 'algorithm', 'This', 'second', 'algorithm', 'included', 'a', 'review', 'of', 'additional', 'technical', 'specifications', 'of', 'the', 'devices', 'an', 'analysis', 'of', 'supply', 'chain', 'manufacturing', 'and', 'distribution', 'capacity', 'of', 'each', 'vendor', '24', 'potential', 'antibody', 'products', 'met', 'the', 'selection', 'criteria', 'for', 'further', 'direct', 'laboratory', 'evaluation', 'The', 'performance', 'metrics', 'for', 'selection', 'of', 'these', '24', 'products', 'are', 'currently', 'being', 'evaluated', 'in', 'a', 'Mass', 'General', 'Brigham', 'laboratory', 'Testing', 'alone', 'might', 'not', 'be', 'sufficient', 'to', 'prevent', 'the', 'spread', 'of', 'a', 'highly', 'contagious', 'disease', 'like', 'COVID', '19', 'Manual', 'contact', 'tracing', 'could', 'complement', 'testing', 'but', 'it', 'is', 'likely', 'to', 'fail', 'in', 'identifying', 'many', 'individuals', 'who', 'were', 'in', 'contact', 'with', 'a', 'given', 'COVID', 'patient', 'The', 'proliferation', 'of', 'smartphones', 'in', 'the', 'population', 'has', 'enabled', 'the', 'development', 'of', 'solutions', 'that', 'can', 'provide', 'public', 'health', 'officials', 'with', 'valuable', 'information', 'for', 'rapid', 'and', 'accurate', 'contact', 'tracing', 'Besides', 'electronic', 'based', 'contact', 'tracing', 'solutions', 'can', 'be', 'augmented', 'by', 'symptom', 'self', 'reports', 'gathered', 'using', 'electronic', 'patient', 'reported', 'outcome', 'ePRO', 'platforms', 'and', 'by', 'physiological', 'data', 'collected', 'using', 'wearable', 'sensors', 'We', 'performed', 'a', 'detailed', 'assessment', 'of', '12', 'ePRO', 'solutions', '27', 'wearable', 'sensors', 'and', '44', 'electronic', 'based', 'contact', 'tracing', 'solutions', 'These', 'technologies', 'were', 'evaluated', 'using', 'criteria', 'developed', 'to', 'assess', 'their', 'suitability', 'to', 'address', 'the', 'COVID', '19', 'pandemic', 'We', 'identified', 'a', 'number', 'of', 'solutions', 'that', 'could', 'augment', 'if', 'not', 'provide', 'a', 'more', 'effective', 'alternative', 'to', 'manual', 'contact', 'tracing', 'Finally', 'we', 'propose', 'a', 'theoretical', 'framework', 'in', 'which', 'ePRO', 'platforms', 'wearable', 'sensors', 'and', 'electronic', 'based', 'contact', 'tracing', 'solutions', 'would', 'be', 'utilized', 'in', 'combination', 'with', 'molecular', 'and', 'serological', 'tests', 'to', 'identify', 'and', 'isolate', 'COVID', '19', 'cases', 'rapidly', '']"
72984,A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19,2020,Cureus,https://doi.org/10.7759/cureus.7708,"Saliva is an exocrine secretion produced from the salivary glands and has numerous functions, such as cleansing and protection of the oral cavity, antimicrobial effects and aids in digestion Due to the speedy development in the field of salivaomics, saliva is now well accepted as a pool of biological markers that vary from changes in biochemicals, nucleic acids and proteins to the microflora Saliva has an immense potential as a diagnostic fluid and offers an edge over other biological fluids as its collection method does not require invasive procedure, economical and is useful for monitoring systemic health Development of sensitive and precise salivary diagnostic tools and the formulation of defined guidelines following meticulous testing will allow salivary diagnostics to be utilised as chair side tests for various oral and systemic diseases in the near future The coronavirus disease (Covid-19) pandemic is the biggest challenge and global health crisis for the world since World War Two Rapid and accurate diagnosis of Covid-19 is crucial in controlling the outbreak in the community and in hospitals Nasopharyngeal and oropharyngeal swabs are the recommended specimen types for Covid-19 diagnostic testing The collection of these specimen types requires close contact between healthcare workers and patients and poses a risk of transmission of the virus, causes discomfort and may cause bleeding, especially in patients with condition such as thrombocytopenia Hence, nasopharyngeal or oropharyngeal swabs are not desirable for sequential monitoring of viral load Saliva specimens can be obtained easily as the patient is asked to spit into a sterile bottle The collection of saliva is non-invasive and greatly minimizes the exposure of healthcare workers to Covid-19 Saliva has a high consistency rate of greater than 90% with nasopharyngeal specimens in the detection of respiratory viruses, including coronaviruses Saliva has also been used in screening respiratory viruses among hospitalized patients without pyrexia or respiratory symptoms SARS-CoV can be detected in saliva at high titers Salivary diagnostics is a dynamic field that is being incorporated as part of disease diagnosis, clinical monitoring of systemic health and to make significant clinical decisions for patient care More research is required to analyze the potential diagnostic of Covid-19 in saliva to develop rapid chair side tests for the detection of Covid-19 and it is also pivotal to improve and develop successful strategies for prevention, especially for dentists and healthcare professionals who are involved in performing aerosol-generating procedures",10.7759/cureus.7708,awy3aans,"['Saliva', 'is', 'an', 'exocrine', 'secretion', 'produced', 'from', 'the', 'salivary', 'glands', 'and', 'has', 'numerous', 'functions', 'such', 'as', 'cleansing', 'and', 'protection', 'of', 'the', 'oral', 'cavity', 'antimicrobial', 'effects', 'and', 'aids', 'in', 'digestion', 'Due', 'to', 'the', 'speedy', 'development', 'in', 'the', 'field', 'of', 'salivaomics', 'saliva', 'is', 'now', 'well', 'accepted', 'as', 'a', 'pool', 'of', 'biological', 'markers', 'that', 'vary', 'from', 'changes', 'in', 'biochemicals', 'nucleic', 'acids', 'and', 'proteins', 'to', 'the', 'microflora', 'Saliva', 'has', 'an', 'immense', 'potential', 'as', 'a', 'diagnostic', 'fluid', 'and', 'offers', 'an', 'edge', 'over', 'other', 'biological', 'fluids', 'as', 'its', 'collection', 'method', 'does', 'not', 'require', 'invasive', 'procedure', 'economical', 'and', 'is', 'useful', 'for', 'monitoring', 'systemic', 'health', 'Development', 'of', 'sensitive', 'and', 'precise', 'salivary', 'diagnostic', 'tools', 'and', 'the', 'formulation', 'of', 'defined', 'guidelines', 'following', 'meticulous', 'testing', 'will', 'allow', 'salivary', 'diagnostics', 'to', 'be', 'utilised', 'as', 'chair', 'side', 'tests', 'for', 'various', 'oral', 'and', 'systemic', 'diseases', 'in', 'the', 'near', 'future', 'The', 'coronavirus', 'disease', 'Covid', '19', 'pandemic', 'is', 'the', 'biggest', 'challenge', 'and', 'global', 'health', 'crisis', 'for', 'the', 'world', 'since', 'World', 'War', 'Two', 'Rapid', 'and', 'accurate', 'diagnosis', 'of', 'Covid', '19', 'is', 'crucial', 'in', 'controlling', 'the', 'outbreak', 'in', 'the', 'community', 'and', 'in', 'hospitals', 'Nasopharyngeal', 'and', 'oropharyngeal', 'swabs', 'are', 'the', 'recommended', 'specimen', 'types', 'for', 'Covid', '19', 'diagnostic', 'testing', 'The', 'collection', 'of', 'these', 'specimen', 'types', 'requires', 'close', 'contact', 'between', 'healthcare', 'workers', 'and', 'patients', 'and', 'poses', 'a', 'risk', 'of', 'transmission', 'of', 'the', 'virus', 'causes', 'discomfort', 'and', 'may', 'cause', 'bleeding', 'especially', 'in', 'patients', 'with', 'condition', 'such', 'as', 'thrombocytopenia', 'Hence', 'nasopharyngeal', 'or', 'oropharyngeal', 'swabs', 'are', 'not', 'desirable', 'for', 'sequential', 'monitoring', 'of', 'viral', 'load', 'Saliva', 'specimens', 'can', 'be', 'obtained', 'easily', 'as', 'the', 'patient', 'is', 'asked', 'to', 'spit', 'into', 'a', 'sterile', 'bottle', 'The', 'collection', 'of', 'saliva', 'is', 'non', 'invasive', 'and', 'greatly', 'minimizes', 'the', 'exposure', 'of', 'healthcare', 'workers', 'to', 'Covid', '19', 'Saliva', 'has', 'a', 'high', 'consistency', 'rate', 'of', 'greater', 'than', '90', 'with', 'nasopharyngeal', 'specimens', 'in', 'the', 'detection', 'of', 'respiratory', 'viruses', 'including', 'coronaviruses', 'Saliva', 'has', 'also', 'been', 'used', 'in', 'screening', 'respiratory', 'viruses', 'among', 'hospitalized', 'patients', 'without', 'pyrexia', 'or', 'respiratory', 'symptoms', 'SARS', 'CoV', 'can', 'be', 'detected', 'in', 'saliva', 'at', 'high', 'titers', 'Salivary', 'diagnostics', 'is', 'a', 'dynamic', 'field', 'that', 'is', 'being', 'incorporated', 'as', 'part', 'of', 'disease', 'diagnosis', 'clinical', 'monitoring', 'of', 'systemic', 'health', 'and', 'to', 'make', 'significant', 'clinical', 'decisions', 'for', 'patient', 'care', 'More', 'research', 'is', 'required', 'to', 'analyze', 'the', 'potential', 'diagnostic', 'of', 'Covid', '19', 'in', 'saliva', 'to', 'develop', 'rapid', 'chair', 'side', 'tests', 'for', 'the', 'detection', 'of', 'Covid', '19', 'and', 'it', 'is', 'also', 'pivotal', 'to', 'improve', 'and', 'develop', 'successful', 'strategies', 'for', 'prevention', 'especially', 'for', 'dentists', 'and', 'healthcare', 'professionals', 'who', 'are', 'involved', 'in', 'performing', 'aerosol', 'generating', 'procedures']"
73021,The UCSC SARS-CoV-2 Genome Browser,2020-05-04,bioRxiv,https://doi.org/10.1101/2020.05.04.075945,"Background Researchers are generating molecular data pertaining to the SARS-CoV-2 RNA genome and its proteins at an unprecedented rate during the COVID-19 pandemic. As a result, there is a critical need for rapid and continuously updated access to the latest molecular data in a format in which all data can be quickly cross-referenced and compared. We adapted our genome browser visualization tool to the viral genome for this purpose. Molecular data, curated from published studies or from database submissions, are mapped to the viral genome and grouped together into “annotation tracks” where they can be visualized along the linear map of the viral genome sequence and programmatically downloaded in standard format for analysis. Results The UCSC Genome Browser for SARS-CoV-2 (https://genome.ucsc.edu/covid19.html) provides continuously updated access to the mutations in the many thousands of SARS-CoV-2 genomes deposited in GISAID and the international nucleotide sequencing databases, displayed alongside phylogenetic trees. These data are augmented with alignments of bat, pangolin, and other animal and human coronavirus genomes, including per-base evolutionary rate analysis. All available annotations are cross-referenced on the virus genome, including those from major databases (PDB, RFAM, IEDB, UniProt) as well as up-to-date individual results from preprints. Annotated data include predicted and validated immune epitopes, promising antibodies, RT-PCR and sequencing primers, CRISPR guides (from research, diagnostics, vaccines, and therapies), and points of interaction between human and viral genes. As a community resource, any user can add manual annotations which are quality checked and shared publicly on the browser the next day. Conclusions We invite all investigators to contribute additional data and annotations to this resource to accelerate research and development activities globally. Contact us at genome-www@soe.ucsc.edu with data suggestions or requests for support for adding data. Rapid sharing of data will accelerate SARS-CoV-2 research, especially when researchers take time to integrate their data with those from other labs on a widely-used community browser platform with standardized machine-readable data formats, such as the SARS-CoV-2 Genome Browser.",10.1101/2020.05.04.075945,gmk4qo4i,"['Background', 'Researchers', 'are', 'generating', 'molecular', 'data', 'pertaining', 'to', 'the', 'SARS', 'CoV', '2', 'RNA', 'genome', 'and', 'its', 'proteins', 'at', 'an', 'unprecedented', 'rate', 'during', 'the', 'COVID', '19', 'pandemic', 'As', 'a', 'result', 'there', 'is', 'a', 'critical', 'need', 'for', 'rapid', 'and', 'continuously', 'updated', 'access', 'to', 'the', 'latest', 'molecular', 'data', 'in', 'a', 'format', 'in', 'which', 'all', 'data', 'can', 'be', 'quickly', 'cross', 'referenced', 'and', 'compared', 'We', 'adapted', 'our', 'genome', 'browser', 'visualization', 'tool', 'to', 'the', 'viral', 'genome', 'for', 'this', 'purpose', 'Molecular', 'data', 'curated', 'from', 'published', 'studies', 'or', 'from', 'database', 'submissions', 'are', 'mapped', 'to', 'the', 'viral', 'genome', 'and', 'grouped', 'together', 'into', 'annotation', 'tracks', 'where', 'they', 'can', 'be', 'visualized', 'along', 'the', 'linear', 'map', 'of', 'the', 'viral', 'genome', 'sequence', 'and', 'programmatically', 'downloaded', 'in', 'standard', 'format', 'for', 'analysis', 'Results', 'The', 'UCSC', 'Genome', 'Browser', 'for', 'SARS', 'CoV', '2', 'https', 'genome', 'ucsc', 'edu', 'covid19', 'html', 'provides', 'continuously', 'updated', 'access', 'to', 'the', 'mutations', 'in', 'the', 'many', 'thousands', 'of', 'SARS', 'CoV', '2', 'genomes', 'deposited', 'in', 'GISAID', 'and', 'the', 'international', 'nucleotide', 'sequencing', 'databases', 'displayed', 'alongside', 'phylogenetic', 'trees', 'These', 'data', 'are', 'augmented', 'with', 'alignments', 'of', 'bat', 'pangolin', 'and', 'other', 'animal', 'and', 'human', 'coronavirus', 'genomes', 'including', 'per', 'base', 'evolutionary', 'rate', 'analysis', 'All', 'available', 'annotations', 'are', 'cross', 'referenced', 'on', 'the', 'virus', 'genome', 'including', 'those', 'from', 'major', 'databases', 'PDB', 'RFAM', 'IEDB', 'UniProt', 'as', 'well', 'as', 'up', 'to', 'date', 'individual', 'results', 'from', 'preprints', 'Annotated', 'data', 'include', 'predicted', 'and', 'validated', 'immune', 'epitopes', 'promising', 'antibodies', 'RT', 'PCR', 'and', 'sequencing', 'primers', 'CRISPR', 'guides', 'from', 'research', 'diagnostics', 'vaccines', 'and', 'therapies', 'and', 'points', 'of', 'interaction', 'between', 'human', 'and', 'viral', 'genes', 'As', 'a', 'community', 'resource', 'any', 'user', 'can', 'add', 'manual', 'annotations', 'which', 'are', 'quality', 'checked', 'and', 'shared', 'publicly', 'on', 'the', 'browser', 'the', 'next', 'day', 'Conclusions', 'We', 'invite', 'all', 'investigators', 'to', 'contribute', 'additional', 'data', 'and', 'annotations', 'to', 'this', 'resource', 'to', 'accelerate', 'research', 'and', 'development', 'activities', 'globally', 'Contact', 'us', 'at', 'genome', 'www', 'soe', 'ucsc', 'edu', 'with', 'data', 'suggestions', 'or', 'requests', 'for', 'support', 'for', 'adding', 'data', 'Rapid', 'sharing', 'of', 'data', 'will', 'accelerate', 'SARS', 'CoV', '2', 'research', 'especially', 'when', 'researchers', 'take', 'time', 'to', 'integrate', 'their', 'data', 'with', 'those', 'from', 'other', 'labs', 'on', 'a', 'widely', 'used', 'community', 'browser', 'platform', 'with', 'standardized', 'machine', 'readable', 'data', 'formats', 'such', 'as', 'the', 'SARS', 'CoV', '2', 'Genome', 'Browser', '']"
73247,Identifying Key Determinants of SARS-CoV-2/ACE2 Tight Interaction,2020-07-13,bioRxiv,https://doi.org/10.1101/2020.07.13.199562,"SARS-CoV-2 virus, the causative agent of Covid-19, has fired up a global pandemic. The virus interacts with the human receptor angiotensin-converting enzyme 2 (ACE2) for invasion via receptor binding domain (RBD) on its spike protein. To provide a deeper understanding of this interaction, we performed microsecond simulations of the RBD-ACE2 complex for SARS- CoV-2 and compared it with the closely related SARS-CoV discovered in 2003. We show residues in the RBD of SARS-CoV-2 that were mutated from SARS-CoV, collectively help make RBD anchor much stronger to the N-terminal part of ACE2 than the corresponding residues on RBD of SARS-CoV. This would result in reduced dissociation rate of SARS-CoV-2 from human recep- tor protein compared to SARS-CoV. This phenomenon was consistently observed in simulations beyond 500 ns and was reproducible across different force fields. Altogether, our study shed light on the key residues and their dynamics at the virus spike and human receptor binding interface and advance our knowledge for the development of diagnostics and therapeutics to combat the pandemic efficiently.",10.1101/2020.07.13.199562,w2gdbm42,"['SARS', 'CoV', '2', 'virus', 'the', 'causative', 'agent', 'of', 'Covid', '19', 'has', 'fired', 'up', 'a', 'global', 'pandemic', 'The', 'virus', 'interacts', 'with', 'the', 'human', 'receptor', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'for', 'invasion', 'via', 'receptor', 'binding', 'domain', 'RBD', 'on', 'its', 'spike', 'protein', 'To', 'provide', 'a', 'deeper', 'understanding', 'of', 'this', 'interaction', 'we', 'performed', 'microsecond', 'simulations', 'of', 'the', 'RBD', 'ACE2', 'complex', 'for', 'SARS', 'CoV', '2', 'and', 'compared', 'it', 'with', 'the', 'closely', 'related', 'SARS', 'CoV', 'discovered', 'in', '2003', 'We', 'show', 'residues', 'in', 'the', 'RBD', 'of', 'SARS', 'CoV', '2', 'that', 'were', 'mutated', 'from', 'SARS', 'CoV', 'collectively', 'help', 'make', 'RBD', 'anchor', 'much', 'stronger', 'to', 'the', 'N', 'terminal', 'part', 'of', 'ACE2', 'than', 'the', 'corresponding', 'residues', 'on', 'RBD', 'of', 'SARS', 'CoV', 'This', 'would', 'result', 'in', 'reduced', 'dissociation', 'rate', 'of', 'SARS', 'CoV', '2', 'from', 'human', 'recep', 'tor', 'protein', 'compared', 'to', 'SARS', 'CoV', 'This', 'phenomenon', 'was', 'consistently', 'observed', 'in', 'simulations', 'beyond', '500', 'ns', 'and', 'was', 'reproducible', 'across', 'different', 'force', 'fields', 'Altogether', 'our', 'study', 'shed', 'light', 'on', 'the', 'key', 'residues', 'and', 'their', 'dynamics', 'at', 'the', 'virus', 'spike', 'and', 'human', 'receptor', 'binding', 'interface', 'and', 'advance', 'our', 'knowledge', 'for', 'the', 'development', 'of', 'diagnostics', 'and', 'therapeutics', 'to', 'combat', 'the', 'pandemic', 'efficiently', '']"
73676,Stabilizing the Closed SARS-CoV-2 Spike Trimer,2020-07-10,bioRxiv,https://doi.org/10.1101/2020.07.10.197814,"The trimeric spike (S) protein of SARS-CoV-2 is the primary focus of most vaccine design and development efforts. Due to intrinsic instability typical of class I fusion proteins, S tends to prematurely refold to the post-fusion conformation, compromising immunogenic properties and prefusion trimer yields. To support ongoing vaccine development efforts, we report the structure-based design of soluble S trimers, with increased yields and stabilities, based on introduction of single point mutations and disulfide-bridges. We identify two regions in the S-protein critical for the protein’s stability: the heptad repeat region 1 of the S2 subunit and subunit domain 1 at the interface with S2. We combined a minimal selection of mostly interprotomeric mutations to create a stable S-closed variant with a 6.4-fold higher expression than the parental construct while no longer containing a heterologous trimerization domain. The cryo-EM structure reveals a correctly folded, predominantly closed pre-fusion conformation. Highly stable and well producing S protein and the increased understanding of S protein structure will support vaccine development and serological diagnostics.",10.1101/2020.07.10.197814,h90c721k,"['The', 'trimeric', 'spike', 'S', 'protein', 'of', 'SARS', 'CoV', '2', 'is', 'the', 'primary', 'focus', 'of', 'most', 'vaccine', 'design', 'and', 'development', 'efforts', 'Due', 'to', 'intrinsic', 'instability', 'typical', 'of', 'class', 'I', 'fusion', 'proteins', 'S', 'tends', 'to', 'prematurely', 'refold', 'to', 'the', 'post', 'fusion', 'conformation', 'compromising', 'immunogenic', 'properties', 'and', 'prefusion', 'trimer', 'yields', 'To', 'support', 'ongoing', 'vaccine', 'development', 'efforts', 'we', 'report', 'the', 'structure', 'based', 'design', 'of', 'soluble', 'S', 'trimers', 'with', 'increased', 'yields', 'and', 'stabilities', 'based', 'on', 'introduction', 'of', 'single', 'point', 'mutations', 'and', 'disulfide', 'bridges', 'We', 'identify', 'two', 'regions', 'in', 'the', 'S', 'protein', 'critical', 'for', 'the', 'protein', 's', 'stability', 'the', 'heptad', 'repeat', 'region', '1', 'of', 'the', 'S2', 'subunit', 'and', 'subunit', 'domain', '1', 'at', 'the', 'interface', 'with', 'S2', 'We', 'combined', 'a', 'minimal', 'selection', 'of', 'mostly', 'interprotomeric', 'mutations', 'to', 'create', 'a', 'stable', 'S', 'closed', 'variant', 'with', 'a', '6', '4', 'fold', 'higher', 'expression', 'than', 'the', 'parental', 'construct', 'while', 'no', 'longer', 'containing', 'a', 'heterologous', 'trimerization', 'domain', 'The', 'cryo', 'EM', 'structure', 'reveals', 'a', 'correctly', 'folded', 'predominantly', 'closed', 'pre', 'fusion', 'conformation', 'Highly', 'stable', 'and', 'well', 'producing', 'S', 'protein', 'and', 'the', 'increased', 'understanding', 'of', 'S', 'protein', 'structure', 'will', 'support', 'vaccine', 'development', 'and', 'serological', 'diagnostics', '']"
74792,Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus,2020-02-23,,https://doi.org/10.1101/2020.02.22.20025460,"Background: The recent outbreak of infections by the 2019 novel coronavirus (2019-nCoV), the third zoonotic CoV has raised great public health concern. The demand for rapid and accurate diagnosis of this novel pathogen brought significant clinical and technological challenges. Currently, metagenomic next-generation sequencing (mNGS) and reverse-transcription PCR (RT-PCR) are the most widely used molecular diagnostics. Methods: 2019-nCoV infections were confirmed in 52 specimens by mNGS. Genomic information was analyzed and used for the design and development of an isothermal, CRISPR-based diagnostic for this novel virus. The diagnostic performance of CRISPR-nCoV was assessed and compared across three technology platforms (mNGS, RT-PCR and CRISPR). Results: 2019-nCoVs sequenced in our study were conserved with the Wuhan strain, and shared certain genetic similarity with SARS-CoV. A high degree of variation in the level of viral RNA was observed in clinical specimens. CRISPR-nCoV demonstrated a near single-copy sensitivity and great clinical sensitivity with a shorter turn-around time than RT-PCR. Conclusion: CRISPR-nCoV presents as a promising diagnostic option for the emerging pathogen.",10.1101/2020.02.22.20025460,hth8f5sn,"['Background', 'The', 'recent', 'outbreak', 'of', 'infections', 'by', 'the', '2019', 'novel', 'coronavirus', '2019', 'nCoV', 'the', 'third', 'zoonotic', 'CoV', 'has', 'raised', 'great', 'public', 'health', 'concern', 'The', 'demand', 'for', 'rapid', 'and', 'accurate', 'diagnosis', 'of', 'this', 'novel', 'pathogen', 'brought', 'significant', 'clinical', 'and', 'technological', 'challenges', 'Currently', 'metagenomic', 'next', 'generation', 'sequencing', 'mNGS', 'and', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'are', 'the', 'most', 'widely', 'used', 'molecular', 'diagnostics', 'Methods', '2019', 'nCoV', 'infections', 'were', 'confirmed', 'in', '52', 'specimens', 'by', 'mNGS', 'Genomic', 'information', 'was', 'analyzed', 'and', 'used', 'for', 'the', 'design', 'and', 'development', 'of', 'an', 'isothermal', 'CRISPR', 'based', 'diagnostic', 'for', 'this', 'novel', 'virus', 'The', 'diagnostic', 'performance', 'of', 'CRISPR', 'nCoV', 'was', 'assessed', 'and', 'compared', 'across', 'three', 'technology', 'platforms', 'mNGS', 'RT', 'PCR', 'and', 'CRISPR', 'Results', '2019', 'nCoVs', 'sequenced', 'in', 'our', 'study', 'were', 'conserved', 'with', 'the', 'Wuhan', 'strain', 'and', 'shared', 'certain', 'genetic', 'similarity', 'with', 'SARS', 'CoV', 'A', 'high', 'degree', 'of', 'variation', 'in', 'the', 'level', 'of', 'viral', 'RNA', 'was', 'observed', 'in', 'clinical', 'specimens', 'CRISPR', 'nCoV', 'demonstrated', 'a', 'near', 'single', 'copy', 'sensitivity', 'and', 'great', 'clinical', 'sensitivity', 'with', 'a', 'shorter', 'turn', 'around', 'time', 'than', 'RT', 'PCR', 'Conclusion', 'CRISPR', 'nCoV', 'presents', 'as', 'a', 'promising', 'diagnostic', 'option', 'for', 'the', 'emerging', 'pathogen', '']"
75239,In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19,2020-06-02,bioRxiv,https://doi.org/10.1101/2020.05.22.111526,"Rapid generation of diagnostics is paramount to understand epidemiology and to control the spread of emerging infectious diseases such as COVID-19. Computational methods to predict serodiagnostic epitopes that are specific for the pathogen could help accelerate the development of new diagnostics. A systematic survey of 27 SARS-CoV-2 proteins was conducted to assess whether existing B-cell epitope prediction methods, combined with comprehensive mining of sequence databases and structural data, could predict whether a particular protein would be suitable for serodiagnosis. Nine of the predictions were validated with recombinant SARS-CoV-2 proteins in the ELISA format using plasma and sera from patients with SARS-CoV-2 infection, and a further 11 predictions were compared to the recent literature. Results appeared to be in agreement with 12 of the predictions, in disagreement with 3, while a further 5 were deemed inconclusive. We showed that two of our top five candidates, the N-terminal fragment of the nucleoprotein and the receptor-binding domain of the spike protein, have the highest sensitivity and specificity and signal-to-noise ratio for detecting COVID-19 sera/plasma by ELISA. Mixing the two antigens together for coating ELISA plates led to a sensitivity of 94% (N=80 samples from persons with RT-PCR confirmed SARS-CoV2 infection), and a specificity of 97.2% (N=106 control samples).",10.1101/2020.05.22.111526,90a9rhsh,"['Rapid', 'generation', 'of', 'diagnostics', 'is', 'paramount', 'to', 'understand', 'epidemiology', 'and', 'to', 'control', 'the', 'spread', 'of', 'emerging', 'infectious', 'diseases', 'such', 'as', 'COVID', '19', 'Computational', 'methods', 'to', 'predict', 'serodiagnostic', 'epitopes', 'that', 'are', 'specific', 'for', 'the', 'pathogen', 'could', 'help', 'accelerate', 'the', 'development', 'of', 'new', 'diagnostics', 'A', 'systematic', 'survey', 'of', '27', 'SARS', 'CoV', '2', 'proteins', 'was', 'conducted', 'to', 'assess', 'whether', 'existing', 'B', 'cell', 'epitope', 'prediction', 'methods', 'combined', 'with', 'comprehensive', 'mining', 'of', 'sequence', 'databases', 'and', 'structural', 'data', 'could', 'predict', 'whether', 'a', 'particular', 'protein', 'would', 'be', 'suitable', 'for', 'serodiagnosis', 'Nine', 'of', 'the', 'predictions', 'were', 'validated', 'with', 'recombinant', 'SARS', 'CoV', '2', 'proteins', 'in', 'the', 'ELISA', 'format', 'using', 'plasma', 'and', 'sera', 'from', 'patients', 'with', 'SARS', 'CoV', '2', 'infection', 'and', 'a', 'further', '11', 'predictions', 'were', 'compared', 'to', 'the', 'recent', 'literature', 'Results', 'appeared', 'to', 'be', 'in', 'agreement', 'with', '12', 'of', 'the', 'predictions', 'in', 'disagreement', 'with', '3', 'while', 'a', 'further', '5', 'were', 'deemed', 'inconclusive', 'We', 'showed', 'that', 'two', 'of', 'our', 'top', 'five', 'candidates', 'the', 'N', 'terminal', 'fragment', 'of', 'the', 'nucleoprotein', 'and', 'the', 'receptor', 'binding', 'domain', 'of', 'the', 'spike', 'protein', 'have', 'the', 'highest', 'sensitivity', 'and', 'specificity', 'and', 'signal', 'to', 'noise', 'ratio', 'for', 'detecting', 'COVID', '19', 'sera', 'plasma', 'by', 'ELISA', 'Mixing', 'the', 'two', 'antigens', 'together', 'for', 'coating', 'ELISA', 'plates', 'led', 'to', 'a', 'sensitivity', 'of', '94', 'N', '80', 'samples', 'from', 'persons', 'with', 'RT', 'PCR', 'confirmed', 'SARS', 'CoV2', 'infection', 'and', 'a', 'specificity', 'of', '97', '2', 'N', '106', 'control', 'samples', '']"
75708,SARS-CoV-2 assays to detect functional antibody responses that block ACE2 recognition in vaccinated animals and infected patients,2020-06-18,bioRxiv,https://doi.org/10.1101/2020.06.17.158527,"SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) has caused a global pandemic of COVID-19 resulting in cases of mild to severe respiratory distress and significant mortality. The global outbreak of this novel coronavirus has now infected >8 million people worldwide with >2 million cases in the US (June 17th, 2020). There is an urgent need for vaccines and therapeutics to combat the spread of this coronavirus. Similarly, the development of diagnostic and research tools to determine infection and vaccine efficacy are critically needed. Molecular assays have been developed to determine viral genetic material present in patients. Serological assays have been developed to determine humoral responses to the spike protein or receptor binding domain (RBD). Detection of functional antibodies can be accomplished through neutralization of live SARS-CoV2 virus, but requires significant expertise, an infectible stable cell line, a specialized BioSafety Level 3 (BSL-3) facility. As large numbers of people return from quarantine, it is critical to have rapid diagnostics that can be widely adopted and employed to assess functional antibody levels in the returning workforce. This type of surrogate neutralization diagnostic can also be used to assess humoral immune responses induced in patients from the large number of vaccine and immunotherapy trials currently on-going. Here we describe a rapid serological diagnostic assay for determining antibody receptor blocking and demonstrate the broad utility of the assay by measuring the antibody functionality of sera from small animals and non-human primates immunized with an experimental SARS-CoV-2 vaccine and using sera from infected patients.",10.1101/2020.06.17.158527,qpbgq5d8,"['SARS', 'CoV', '2', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'Coronavirus', '2', 'has', 'caused', 'a', 'global', 'pandemic', 'of', 'COVID', '19', 'resulting', 'in', 'cases', 'of', 'mild', 'to', 'severe', 'respiratory', 'distress', 'and', 'significant', 'mortality', 'The', 'global', 'outbreak', 'of', 'this', 'novel', 'coronavirus', 'has', 'now', 'infected', '8', 'million', 'people', 'worldwide', 'with', '2', 'million', 'cases', 'in', 'the', 'US', 'June', '17th', '2020', 'There', 'is', 'an', 'urgent', 'need', 'for', 'vaccines', 'and', 'therapeutics', 'to', 'combat', 'the', 'spread', 'of', 'this', 'coronavirus', 'Similarly', 'the', 'development', 'of', 'diagnostic', 'and', 'research', 'tools', 'to', 'determine', 'infection', 'and', 'vaccine', 'efficacy', 'are', 'critically', 'needed', 'Molecular', 'assays', 'have', 'been', 'developed', 'to', 'determine', 'viral', 'genetic', 'material', 'present', 'in', 'patients', 'Serological', 'assays', 'have', 'been', 'developed', 'to', 'determine', 'humoral', 'responses', 'to', 'the', 'spike', 'protein', 'or', 'receptor', 'binding', 'domain', 'RBD', 'Detection', 'of', 'functional', 'antibodies', 'can', 'be', 'accomplished', 'through', 'neutralization', 'of', 'live', 'SARS', 'CoV2', 'virus', 'but', 'requires', 'significant', 'expertise', 'an', 'infectible', 'stable', 'cell', 'line', 'a', 'specialized', 'BioSafety', 'Level', '3', 'BSL', '3', 'facility', 'As', 'large', 'numbers', 'of', 'people', 'return', 'from', 'quarantine', 'it', 'is', 'critical', 'to', 'have', 'rapid', 'diagnostics', 'that', 'can', 'be', 'widely', 'adopted', 'and', 'employed', 'to', 'assess', 'functional', 'antibody', 'levels', 'in', 'the', 'returning', 'workforce', 'This', 'type', 'of', 'surrogate', 'neutralization', 'diagnostic', 'can', 'also', 'be', 'used', 'to', 'assess', 'humoral', 'immune', 'responses', 'induced', 'in', 'patients', 'from', 'the', 'large', 'number', 'of', 'vaccine', 'and', 'immunotherapy', 'trials', 'currently', 'on', 'going', 'Here', 'we', 'describe', 'a', 'rapid', 'serological', 'diagnostic', 'assay', 'for', 'determining', 'antibody', 'receptor', 'blocking', 'and', 'demonstrate', 'the', 'broad', 'utility', 'of', 'the', 'assay', 'by', 'measuring', 'the', 'antibody', 'functionality', 'of', 'sera', 'from', 'small', 'animals', 'and', 'non', 'human', 'primates', 'immunized', 'with', 'an', 'experimental', 'SARS', 'CoV', '2', 'vaccine', 'and', 'using', 'sera', 'from', 'infected', 'patients', '']"
76158,Multi-site Validation of a SARS-CoV-2 IgG/IgM Rapid Antibody Detection Kit,2020-05-26,,http://medrxiv.org/cgi/content/short/2020.05.25.20112227v1?rss=1,"Deaths from coronavirus disease (COVID-19) have exceeded 300,000 persons globally, calling for rapid development of mobile diagnostics that can assay widespread prevalence and infection rates. Data provided in this study supports the utility of a newly-designed lateral flow immunoassay (LFA) for detecting SARS-CoV-2 IgM and IgG antibodies. We employed a clinical cohort of 1,892 SARS-CoV-2 patients and controls, including individuals diagnosed by RT-qPCR at Yale New Haven Hospital, The First Affiliated Hospital of Anhui Medical University, the Chinese Center for Disease Control and Prevention of Hefei City (Hefei CDC), Anhui Province (Anhui Province CDC), and Fuyang City (Fuyang CDC). The LFA studied here detects SARS-CoV-2 IgM and IgG antibodies with a specificity of 97.9-100% for IgM, 99.7-100% for IgG, and sensitivities ranging from 94.1-100% for patients >14-days post symptom onset. Sensitivity decreases in patients <14-days post symptom onset, which is likely due to lower IgG/IgM antibody levels in this population. Finally, we developed a visual intensity reporting system that we believe will be suitable for laboratory and point-of-care settings, and will provide granular information about antibody levels. Overall our results support the widespread utility of this and other LFAs in assessing population-level epidemiological statistics.",10.1101/2020.05.25.20112227,lqed8b0b,"['Deaths', 'from', 'coronavirus', 'disease', 'COVID', '19', 'have', 'exceeded', '300', '000', 'persons', 'globally', 'calling', 'for', 'rapid', 'development', 'of', 'mobile', 'diagnostics', 'that', 'can', 'assay', 'widespread', 'prevalence', 'and', 'infection', 'rates', 'Data', 'provided', 'in', 'this', 'study', 'supports', 'the', 'utility', 'of', 'a', 'newly', 'designed', 'lateral', 'flow', 'immunoassay', 'LFA', 'for', 'detecting', 'SARS', 'CoV', '2', 'IgM', 'and', 'IgG', 'antibodies', 'We', 'employed', 'a', 'clinical', 'cohort', 'of', '1', '892', 'SARS', 'CoV', '2', 'patients', 'and', 'controls', 'including', 'individuals', 'diagnosed', 'by', 'RT', 'qPCR', 'at', 'Yale', 'New', 'Haven', 'Hospital', 'The', 'First', 'Affiliated', 'Hospital', 'of', 'Anhui', 'Medical', 'University', 'the', 'Chinese', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'of', 'Hefei', 'City', 'Hefei', 'CDC', 'Anhui', 'Province', 'Anhui', 'Province', 'CDC', 'and', 'Fuyang', 'City', 'Fuyang', 'CDC', 'The', 'LFA', 'studied', 'here', 'detects', 'SARS', 'CoV', '2', 'IgM', 'and', 'IgG', 'antibodies', 'with', 'a', 'specificity', 'of', '97', '9', '100', 'for', 'IgM', '99', '7', '100', 'for', 'IgG', 'and', 'sensitivities', 'ranging', 'from', '94', '1', '100', 'for', 'patients', '14', 'days', 'post', 'symptom', 'onset', 'Sensitivity', 'decreases', 'in', 'patients', '14', 'days', 'post', 'symptom', 'onset', 'which', 'is', 'likely', 'due', 'to', 'lower', 'IgG', 'IgM', 'antibody', 'levels', 'in', 'this', 'population', 'Finally', 'we', 'developed', 'a', 'visual', 'intensity', 'reporting', 'system', 'that', 'we', 'believe', 'will', 'be', 'suitable', 'for', 'laboratory', 'and', 'point', 'of', 'care', 'settings', 'and', 'will', 'provide', 'granular', 'information', 'about', 'antibody', 'levels', 'Overall', 'our', 'results', 'support', 'the', 'widespread', 'utility', 'of', 'this', 'and', 'other', 'LFAs', 'in', 'assessing', 'population', 'level', 'epidemiological', 'statistics', '']"
76529,A handheld point-of-care system for rapid detection of SARS-CoV-2 in under 20 minutes,2020-06-30,,http://medrxiv.org/cgi/content/short/2020.06.29.20142349v1?rss=1,"The COVID-19 pandemic is a global health emergency characterized by the high rate of transmission and ongoing increase of cases globally. Rapid point-of-care (PoC) diagnostics to detect the causative virus, SARS-CoV-2, are urgently needed to identify and isolate patients, contain its spread and guide clinical management. In this work, we report the development of a rapid PoC diagnostic test (< 20 min) based on reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) and semiconductor technology for the detection of SARS-CoV-2 from extracted RNA samples. The developed LAMP assay was tested on a real-time benchtop instrument (RT-qLAMP) showing a lower limit of detection of 10 RNA copies per reaction. It was validated against 183 clinical samples including 127 positive samples (screened by the CDC RT-qPCR assay). Results showed 90.55% sensitivity and 100% specificity when compared to RT-qPCR and average positive detection times of 15.45 {+/-} 4.43 min. For validating the incorporation of the RT-LAMP assay onto our PoC platform (RT-eLAMP), a subset of samples was tested (n=40), showing average detection times of 12.89 {+/-} 2.59 min for positive samples (n=34), demonstrating a comparable performance to a benchtop commercial instrument. Paired with a smartphone for results visualization and geo-localization, this portable diagnostic platform with secure cloud connectivity will enable real-time case identification and epidemiological surveillance.",10.1101/2020.06.29.20142349,m9l8ntur,"['The', 'COVID', '19', 'pandemic', 'is', 'a', 'global', 'health', 'emergency', 'characterized', 'by', 'the', 'high', 'rate', 'of', 'transmission', 'and', 'ongoing', 'increase', 'of', 'cases', 'globally', 'Rapid', 'point', 'of', 'care', 'PoC', 'diagnostics', 'to', 'detect', 'the', 'causative', 'virus', 'SARS', 'CoV', '2', 'are', 'urgently', 'needed', 'to', 'identify', 'and', 'isolate', 'patients', 'contain', 'its', 'spread', 'and', 'guide', 'clinical', 'management', 'In', 'this', 'work', 'we', 'report', 'the', 'development', 'of', 'a', 'rapid', 'PoC', 'diagnostic', 'test', '20', 'min', 'based', 'on', 'reverse', 'transcriptase', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'and', 'semiconductor', 'technology', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'from', 'extracted', 'RNA', 'samples', 'The', 'developed', 'LAMP', 'assay', 'was', 'tested', 'on', 'a', 'real', 'time', 'benchtop', 'instrument', 'RT', 'qLAMP', 'showing', 'a', 'lower', 'limit', 'of', 'detection', 'of', '10', 'RNA', 'copies', 'per', 'reaction', 'It', 'was', 'validated', 'against', '183', 'clinical', 'samples', 'including', '127', 'positive', 'samples', 'screened', 'by', 'the', 'CDC', 'RT', 'qPCR', 'assay', 'Results', 'showed', '90', '55', 'sensitivity', 'and', '100', 'specificity', 'when', 'compared', 'to', 'RT', 'qPCR', 'and', 'average', 'positive', 'detection', 'times', 'of', '15', '45', '4', '43', 'min', 'For', 'validating', 'the', 'incorporation', 'of', 'the', 'RT', 'LAMP', 'assay', 'onto', 'our', 'PoC', 'platform', 'RT', 'eLAMP', 'a', 'subset', 'of', 'samples', 'was', 'tested', 'n', '40', 'showing', 'average', 'detection', 'times', 'of', '12', '89', '2', '59', 'min', 'for', 'positive', 'samples', 'n', '34', 'demonstrating', 'a', 'comparable', 'performance', 'to', 'a', 'benchtop', 'commercial', 'instrument', 'Paired', 'with', 'a', 'smartphone', 'for', 'results', 'visualization', 'and', 'geo', 'localization', 'this', 'portable', 'diagnostic', 'platform', 'with', 'secure', 'cloud', 'connectivity', 'will', 'enable', 'real', 'time', 'case', 'identification', 'and', 'epidemiological', 'surveillance', '']"
77611,BioLaboro: A bioinformatics system for detecting molecular assay signature erosion and designing new assays in response to emerging and reemerging pathogens,2020-04-10,bioRxiv,https://doi.org/10.1101/2020.04.08.031963,"Background Emerging and reemerging infectious diseases such as the novel Coronavirus disease, COVID-19 and Ebola pose a significant threat to global society and test the public health community’s preparedness to rapidly respond to an outbreak with effective diagnostics and therapeutics. Recent advances in next generation sequencing technologies enable rapid generation of pathogen genome sequence data, within 24 hours of obtaining a sample in some instances. With these data, one can quickly evaluate the effectiveness of existing diagnostics and therapeutics using in silico approaches. The propensity of some viruses to rapidly accumulate mutations can lead to the failure of molecular detection assays creating the need for redesigned or newly designed assays. Results Here we describe a bioinformatics system named BioLaboro to identify signature regions in a given pathogen genome, design PCR assays targeting those regions, and then test the PCR assays in silico to determine their sensitivity and specificity. We demonstrate BioLaboro with two use cases: Bombali Ebolavirus (BOMV) and the novel Coronavirus 2019 (SARS-CoV-2). For the BOMV, we analyzed 30 currently available real-time reverse transcription-PCR assays against the three available complete genome sequences of BOMV. Only two met our in silico criteria for successful detection and neither had perfect matches to the primer/probe sequences. We designed five new primer sets against BOMV signatures and all had true positive hits to the three BOMV genomes and no false positive hits to any other sequence. Four assays are closely clustered in the nucleoprotein gene and one is located in the glycoprotein gene. Similarly, for the SARS-CoV-2, we designed five highly specific primer sets that hit all 145 whole genomes (available as of February 28, 2020) and none of the near neighbors. Conclusions Here we applied BioLaboro in two real-world use cases to demonstrate its capability; 1) to identify signature regions, 2) to assess the efficacy of existing PCR assays to detect pathogens as they evolve over time, and 3) to design new assays with perfect in silico detection accuracy, all within hours, for further development and deployment. BioLaboro is designed with a user-friendly graphical user interface for biologists with limited bioinformatics experience.",10.1101/2020.04.08.031963,eifrg2fe,"['Background', 'Emerging', 'and', 'reemerging', 'infectious', 'diseases', 'such', 'as', 'the', 'novel', 'Coronavirus', 'disease', 'COVID', '19', 'and', 'Ebola', 'pose', 'a', 'significant', 'threat', 'to', 'global', 'society', 'and', 'test', 'the', 'public', 'health', 'community', 's', 'preparedness', 'to', 'rapidly', 'respond', 'to', 'an', 'outbreak', 'with', 'effective', 'diagnostics', 'and', 'therapeutics', 'Recent', 'advances', 'in', 'next', 'generation', 'sequencing', 'technologies', 'enable', 'rapid', 'generation', 'of', 'pathogen', 'genome', 'sequence', 'data', 'within', '24', 'hours', 'of', 'obtaining', 'a', 'sample', 'in', 'some', 'instances', 'With', 'these', 'data', 'one', 'can', 'quickly', 'evaluate', 'the', 'effectiveness', 'of', 'existing', 'diagnostics', 'and', 'therapeutics', 'using', 'in', 'silico', 'approaches', 'The', 'propensity', 'of', 'some', 'viruses', 'to', 'rapidly', 'accumulate', 'mutations', 'can', 'lead', 'to', 'the', 'failure', 'of', 'molecular', 'detection', 'assays', 'creating', 'the', 'need', 'for', 'redesigned', 'or', 'newly', 'designed', 'assays', 'Results', 'Here', 'we', 'describe', 'a', 'bioinformatics', 'system', 'named', 'BioLaboro', 'to', 'identify', 'signature', 'regions', 'in', 'a', 'given', 'pathogen', 'genome', 'design', 'PCR', 'assays', 'targeting', 'those', 'regions', 'and', 'then', 'test', 'the', 'PCR', 'assays', 'in', 'silico', 'to', 'determine', 'their', 'sensitivity', 'and', 'specificity', 'We', 'demonstrate', 'BioLaboro', 'with', 'two', 'use', 'cases', 'Bombali', 'Ebolavirus', 'BOMV', 'and', 'the', 'novel', 'Coronavirus', '2019', 'SARS', 'CoV', '2', 'For', 'the', 'BOMV', 'we', 'analyzed', '30', 'currently', 'available', 'real', 'time', 'reverse', 'transcription', 'PCR', 'assays', 'against', 'the', 'three', 'available', 'complete', 'genome', 'sequences', 'of', 'BOMV', 'Only', 'two', 'met', 'our', 'in', 'silico', 'criteria', 'for', 'successful', 'detection', 'and', 'neither', 'had', 'perfect', 'matches', 'to', 'the', 'primer', 'probe', 'sequences', 'We', 'designed', 'five', 'new', 'primer', 'sets', 'against', 'BOMV', 'signatures', 'and', 'all', 'had', 'true', 'positive', 'hits', 'to', 'the', 'three', 'BOMV', 'genomes', 'and', 'no', 'false', 'positive', 'hits', 'to', 'any', 'other', 'sequence', 'Four', 'assays', 'are', 'closely', 'clustered', 'in', 'the', 'nucleoprotein', 'gene', 'and', 'one', 'is', 'located', 'in', 'the', 'glycoprotein', 'gene', 'Similarly', 'for', 'the', 'SARS', 'CoV', '2', 'we', 'designed', 'five', 'highly', 'specific', 'primer', 'sets', 'that', 'hit', 'all', '145', 'whole', 'genomes', 'available', 'as', 'of', 'February', '28', '2020', 'and', 'none', 'of', 'the', 'near', 'neighbors', 'Conclusions', 'Here', 'we', 'applied', 'BioLaboro', 'in', 'two', 'real', 'world', 'use', 'cases', 'to', 'demonstrate', 'its', 'capability', '1', 'to', 'identify', 'signature', 'regions', '2', 'to', 'assess', 'the', 'efficacy', 'of', 'existing', 'PCR', 'assays', 'to', 'detect', 'pathogens', 'as', 'they', 'evolve', 'over', 'time', 'and', '3', 'to', 'design', 'new', 'assays', 'with', 'perfect', 'in', 'silico', 'detection', 'accuracy', 'all', 'within', 'hours', 'for', 'further', 'development', 'and', 'deployment', 'BioLaboro', 'is', 'designed', 'with', 'a', 'user', 'friendly', 'graphical', 'user', 'interface', 'for', 'biologists', 'with', 'limited', 'bioinformatics', 'experience', '']"
77844,Rapid and accurate detection of novel coronavirus SARS-CoV-2 using CRISPR-Cas3,2020-06-02,,http://medrxiv.org/cgi/content/short/2020.06.02.20119875v1?rss=1,"Novel coronavirus SARS-CoV-2 outbreaks have rapidly spread to multiple countries, highlighting the urgent necessity for fast, sensitive, and specific diagnostic tools for virus surveillance. Here, the previously unknown collateral single-stranded DNA cleavage we observed with type I CRISPR-Cas3 highlights its potential for development as a Cas3-mediated rapid (within 40 min), low-cost, instrument-free detection method for SARS-CoV-2. This Cas3-based assay is comparable with Cas12- and real-time reverse-transcriptase PCR-based assays in its speed and sensitivity, but offers greater specificity for single-base-pair discrimination while negating the need for highly trained operators. These findings support the use of CRISPR diagnostics for point-of-care testing in patients with suspected SARS-CoV-2 infections.",10.1101/2020.06.02.20119875,mqvp28h1,"['Novel', 'coronavirus', 'SARS', 'CoV', '2', 'outbreaks', 'have', 'rapidly', 'spread', 'to', 'multiple', 'countries', 'highlighting', 'the', 'urgent', 'necessity', 'for', 'fast', 'sensitive', 'and', 'specific', 'diagnostic', 'tools', 'for', 'virus', 'surveillance', 'Here', 'the', 'previously', 'unknown', 'collateral', 'single', 'stranded', 'DNA', 'cleavage', 'we', 'observed', 'with', 'type', 'I', 'CRISPR', 'Cas3', 'highlights', 'its', 'potential', 'for', 'development', 'as', 'a', 'Cas3', 'mediated', 'rapid', 'within', '40', 'min', 'low', 'cost', 'instrument', 'free', 'detection', 'method', 'for', 'SARS', 'CoV', '2', 'This', 'Cas3', 'based', 'assay', 'is', 'comparable', 'with', 'Cas12', 'and', 'real', 'time', 'reverse', 'transcriptase', 'PCR', 'based', 'assays', 'in', 'its', 'speed', 'and', 'sensitivity', 'but', 'offers', 'greater', 'specificity', 'for', 'single', 'base', 'pair', 'discrimination', 'while', 'negating', 'the', 'need', 'for', 'highly', 'trained', 'operators', 'These', 'findings', 'support', 'the', 'use', 'of', 'CRISPR', 'diagnostics', 'for', 'point', 'of', 'care', 'testing', 'in', 'patients', 'with', 'suspected', 'SARS', 'CoV', '2', 'infections', '']"
78208,"Controlling the SARS-CoV-2 outbreak, insights from large scale whole genome sequences generated across the world",2020-05-26,bioRxiv,https://doi.org/10.1101/2020.04.28.066977,"Background SARS-CoV-2 most likely evolved from a bat beta-coronavirus and started infecting humans in December 2019. Since then it has rapidly infected people around the world, with more than 4.5 million confirmed cases by the middle of May 2020. Early genome sequencing of the virus has enabled the development of molecular diagnostics and the commencement of therapy and vaccine development. The analysis of the early sequences showed relatively few evolutionary selection pressures. However, with the rapid worldwide expansion into diverse human populations, significant genetic variations are becoming increasingly likely. The current limitations on social movement between countries also offers the opportunity for these viral variants to become distinct strains with potential implications for diagnostics, therapies and vaccines. Methods We used the current sequencing archives (NCBI and GISAID) to investigate 15,487 whole genomes, looking for evidence of strain diversification and selective pressure. Results We used 6,294 SNPs to build a phylogenetic tree of SARS-CoV-2 diversity and noted strong evidence for the existence of two major clades and six sub-clades, unevenly distributed across the world. We also noted that convergent evolution has potentially occurred across several locations in the genome, showing selection pressures, including on the spike glycoprotein where we noted a potentially critical mutation that could affect its binding to the ACE2 receptor. We also report on mutations that could prevent current molecular diagnostics from detecting some of the sub-clades. Conclusion The worldwide whole genome sequencing effort is revealing the challenge of developing SARS-CoV-2 containment tools suitable for everyone and the need for data to be continually evaluated to ensure accuracy in outbreak estimations.",10.1101/2020.04.28.066977,tutit2bc,"['Background', 'SARS', 'CoV', '2', 'most', 'likely', 'evolved', 'from', 'a', 'bat', 'beta', 'coronavirus', 'and', 'started', 'infecting', 'humans', 'in', 'December', '2019', 'Since', 'then', 'it', 'has', 'rapidly', 'infected', 'people', 'around', 'the', 'world', 'with', 'more', 'than', '4', '5', 'million', 'confirmed', 'cases', 'by', 'the', 'middle', 'of', 'May', '2020', 'Early', 'genome', 'sequencing', 'of', 'the', 'virus', 'has', 'enabled', 'the', 'development', 'of', 'molecular', 'diagnostics', 'and', 'the', 'commencement', 'of', 'therapy', 'and', 'vaccine', 'development', 'The', 'analysis', 'of', 'the', 'early', 'sequences', 'showed', 'relatively', 'few', 'evolutionary', 'selection', 'pressures', 'However', 'with', 'the', 'rapid', 'worldwide', 'expansion', 'into', 'diverse', 'human', 'populations', 'significant', 'genetic', 'variations', 'are', 'becoming', 'increasingly', 'likely', 'The', 'current', 'limitations', 'on', 'social', 'movement', 'between', 'countries', 'also', 'offers', 'the', 'opportunity', 'for', 'these', 'viral', 'variants', 'to', 'become', 'distinct', 'strains', 'with', 'potential', 'implications', 'for', 'diagnostics', 'therapies', 'and', 'vaccines', 'Methods', 'We', 'used', 'the', 'current', 'sequencing', 'archives', 'NCBI', 'and', 'GISAID', 'to', 'investigate', '15', '487', 'whole', 'genomes', 'looking', 'for', 'evidence', 'of', 'strain', 'diversification', 'and', 'selective', 'pressure', 'Results', 'We', 'used', '6', '294', 'SNPs', 'to', 'build', 'a', 'phylogenetic', 'tree', 'of', 'SARS', 'CoV', '2', 'diversity', 'and', 'noted', 'strong', 'evidence', 'for', 'the', 'existence', 'of', 'two', 'major', 'clades', 'and', 'six', 'sub', 'clades', 'unevenly', 'distributed', 'across', 'the', 'world', 'We', 'also', 'noted', 'that', 'convergent', 'evolution', 'has', 'potentially', 'occurred', 'across', 'several', 'locations', 'in', 'the', 'genome', 'showing', 'selection', 'pressures', 'including', 'on', 'the', 'spike', 'glycoprotein', 'where', 'we', 'noted', 'a', 'potentially', 'critical', 'mutation', 'that', 'could', 'affect', 'its', 'binding', 'to', 'the', 'ACE2', 'receptor', 'We', 'also', 'report', 'on', 'mutations', 'that', 'could', 'prevent', 'current', 'molecular', 'diagnostics', 'from', 'detecting', 'some', 'of', 'the', 'sub', 'clades', 'Conclusion', 'The', 'worldwide', 'whole', 'genome', 'sequencing', 'effort', 'is', 'revealing', 'the', 'challenge', 'of', 'developing', 'SARS', 'CoV', '2', 'containment', 'tools', 'suitable', 'for', 'everyone', 'and', 'the', 'need', 'for', 'data', 'to', 'be', 'continually', 'evaluated', 'to', 'ensure', 'accuracy', 'in', 'outbreak', 'estimations', '']"
78281,An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection,2020-06-15,bioRxiv,https://doi.org/10.1101/2020.06.14.150862,"SARS-CoV-2 is a novel pandemic coronavirus that caused a global health and economic crisis. The development of efficient drugs and vaccines against COVID-19 requires detailed knowledge about SARS-CoV-2 biology. Several techniques to detect SARS-CoV-2 infection have been established, mainly based on counting infected cells by staining plaques or foci, or by quantifying the viral genome by PCR. These methods are laborious, time-consuming and expensive and therefore not suitable for a high sample throughput or rapid diagnostics. We here report a novel enzyme-based immunodetection assay that directly quantifies the amount of de novo synthesized viral spike protein within fixed and permeabilized cells. This in-cell ELISA enables a rapid and quantitative detection of SARS-CoV-2 infection in microtiter format, regardless of the virus isolate or target cell culture. It follows the established method of performing ELISA assays and does not require expensive instrumentation. Utilization of the in-cell ELISA allows to e.g. determine TCID50 of virus stocks, antiviral efficiencies (IC50 values) of drugs or neutralizing activity of sera. Thus, the in-cell spike ELISA represents a promising alternative to study SARS-CoV-2 infection and inhibition and may facilitate future research. Highlights Determination of SARS-CoV-2 infection by enzymatically quantifying the expression of viral spike protein in bulk cell cultures Targeting a highly conserved region in the S2 subunit of the S protein allows broad detection of several SARS-CoV-2 isolates in different cell lines Screening of antivirals in microtiter format and determining the antiviral activity as inhibitory concentrations 50 (IC50)",10.1101/2020.06.14.150862,ew78trl9,"['SARS', 'CoV', '2', 'is', 'a', 'novel', 'pandemic', 'coronavirus', 'that', 'caused', 'a', 'global', 'health', 'and', 'economic', 'crisis', 'The', 'development', 'of', 'efficient', 'drugs', 'and', 'vaccines', 'against', 'COVID', '19', 'requires', 'detailed', 'knowledge', 'about', 'SARS', 'CoV', '2', 'biology', 'Several', 'techniques', 'to', 'detect', 'SARS', 'CoV', '2', 'infection', 'have', 'been', 'established', 'mainly', 'based', 'on', 'counting', 'infected', 'cells', 'by', 'staining', 'plaques', 'or', 'foci', 'or', 'by', 'quantifying', 'the', 'viral', 'genome', 'by', 'PCR', 'These', 'methods', 'are', 'laborious', 'time', 'consuming', 'and', 'expensive', 'and', 'therefore', 'not', 'suitable', 'for', 'a', 'high', 'sample', 'throughput', 'or', 'rapid', 'diagnostics', 'We', 'here', 'report', 'a', 'novel', 'enzyme', 'based', 'immunodetection', 'assay', 'that', 'directly', 'quantifies', 'the', 'amount', 'of', 'de', 'novo', 'synthesized', 'viral', 'spike', 'protein', 'within', 'fixed', 'and', 'permeabilized', 'cells', 'This', 'in', 'cell', 'ELISA', 'enables', 'a', 'rapid', 'and', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'infection', 'in', 'microtiter', 'format', 'regardless', 'of', 'the', 'virus', 'isolate', 'or', 'target', 'cell', 'culture', 'It', 'follows', 'the', 'established', 'method', 'of', 'performing', 'ELISA', 'assays', 'and', 'does', 'not', 'require', 'expensive', 'instrumentation', 'Utilization', 'of', 'the', 'in', 'cell', 'ELISA', 'allows', 'to', 'e', 'g', 'determine', 'TCID50', 'of', 'virus', 'stocks', 'antiviral', 'efficiencies', 'IC50', 'values', 'of', 'drugs', 'or', 'neutralizing', 'activity', 'of', 'sera', 'Thus', 'the', 'in', 'cell', 'spike', 'ELISA', 'represents', 'a', 'promising', 'alternative', 'to', 'study', 'SARS', 'CoV', '2', 'infection', 'and', 'inhibition', 'and', 'may', 'facilitate', 'future', 'research', 'Highlights', 'Determination', 'of', 'SARS', 'CoV', '2', 'infection', 'by', 'enzymatically', 'quantifying', 'the', 'expression', 'of', 'viral', 'spike', 'protein', 'in', 'bulk', 'cell', 'cultures', 'Targeting', 'a', 'highly', 'conserved', 'region', 'in', 'the', 'S2', 'subunit', 'of', 'the', 'S', 'protein', 'allows', 'broad', 'detection', 'of', 'several', 'SARS', 'CoV', '2', 'isolates', 'in', 'different', 'cell', 'lines', 'Screening', 'of', 'antivirals', 'in', 'microtiter', 'format', 'and', 'determining', 'the', 'antiviral', 'activity', 'as', 'inhibitory', 'concentrations', '50', 'IC50', '']"
78961,Fighting COVID-19: Integrated Micro- and Nanosystems for Viral Infection Diagnostics,2020,Matter,https://doi.org/10.1016/j.matt.2020.06.015,"SummaryThe pandemic of coronavirus disease 2019 (COVID-19) highlights the importance of rapid and sensitive diagnostics of viral infection that enables the efficient tracing of cases and the implementation of public health measures for disease containment The immediate actions from both academia and industry have led to the development of many COVID-19 diagnostic systems that have secured fast-track regulatory approvals and have been serving our healthcare frontlines since the early stage of the pandemic On diagnostic technologies, many of these clinically validated systems have significantly benefited from the recent advances in micro- and nanotechnologies in terms of platform design, analytical method, and system integration and miniaturization The continued development of new diagnostic platforms integrating micro- and nanocomponents will address some of the shortcomings we have witnessed in the existing COVID-19 diagnostic systems This Perspective reviews the previous and ongoing research efforts on developing integrated micro- and nanosystems for nucleic acid-based virus detection, and highlights promising technologies that could provide better solutions for the diagnosis of COVID-19 and other viral infectious diseases With the summary and outlook of this rapidly evolving research field, we hope to inspire more research and development activities to better prepare our society for future public health crises",10.1016/j.matt.2020.06.015,7v6rj65a,"['SummaryThe', 'pandemic', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'highlights', 'the', 'importance', 'of', 'rapid', 'and', 'sensitive', 'diagnostics', 'of', 'viral', 'infection', 'that', 'enables', 'the', 'efficient', 'tracing', 'of', 'cases', 'and', 'the', 'implementation', 'of', 'public', 'health', 'measures', 'for', 'disease', 'containment', 'The', 'immediate', 'actions', 'from', 'both', 'academia', 'and', 'industry', 'have', 'led', 'to', 'the', 'development', 'of', 'many', 'COVID', '19', 'diagnostic', 'systems', 'that', 'have', 'secured', 'fast', 'track', 'regulatory', 'approvals', 'and', 'have', 'been', 'serving', 'our', 'healthcare', 'frontlines', 'since', 'the', 'early', 'stage', 'of', 'the', 'pandemic', 'On', 'diagnostic', 'technologies', 'many', 'of', 'these', 'clinically', 'validated', 'systems', 'have', 'significantly', 'benefited', 'from', 'the', 'recent', 'advances', 'in', 'micro', 'and', 'nanotechnologies', 'in', 'terms', 'of', 'platform', 'design', 'analytical', 'method', 'and', 'system', 'integration', 'and', 'miniaturization', 'The', 'continued', 'development', 'of', 'new', 'diagnostic', 'platforms', 'integrating', 'micro', 'and', 'nanocomponents', 'will', 'address', 'some', 'of', 'the', 'shortcomings', 'we', 'have', 'witnessed', 'in', 'the', 'existing', 'COVID', '19', 'diagnostic', 'systems', 'This', 'Perspective', 'reviews', 'the', 'previous', 'and', 'ongoing', 'research', 'efforts', 'on', 'developing', 'integrated', 'micro', 'and', 'nanosystems', 'for', 'nucleic', 'acid', 'based', 'virus', 'detection', 'and', 'highlights', 'promising', 'technologies', 'that', 'could', 'provide', 'better', 'solutions', 'for', 'the', 'diagnosis', 'of', 'COVID', '19', 'and', 'other', 'viral', 'infectious', 'diseases', 'With', 'the', 'summary', 'and', 'outlook', 'of', 'this', 'rapidly', 'evolving', 'research', 'field', 'we', 'hope', 'to', 'inspire', 'more', 'research', 'and', 'development', 'activities', 'to', 'better', 'prepare', 'our', 'society', 'for', 'future', 'public', 'health', 'crises']"
79364,"A new role for Biofoundries in rapid prototyping, development, and validation of automated clinical diagnostic tests for SARS-CoV-2",2020-05-06,,http://medrxiv.org/cgi/content/short/2020.05.02.20088344v1?rss=1,"The SARS-CoV-2 pandemic has shown how the rapid rise in demand for patient and community sample testing, required for tracing and containing a highly infectious disease, has quickly overwhelmed testing capability globally. With most diagnostic infrastructure dependent on specialised instruments, their exclusive reagent supplies quickly become bottlenecks in times of peak demand, creating an urgent need for novel approaches to boost testing capacity. We address this challenge by refocusing the full synthetic biology stack available at the London Biofoundry onto the development of alternative patient sample testing pipelines. We present a reagent-agnostic automated SARS-CoV-2 testing platform that can be quickly deployed and scaled, and that accepts a diverse range of reagents. Using an in-house-generated, open-source, MS2-virus-like-particle-SARS-CoV-2 standard, we validate RNA extraction and RT-qPCR workflows as well as two novel detection assays based on CRISPR-Cas and Loop-mediated isothermal Amplification (LAMP) approaches. In collaboration with an NHS diagnostic testing lab, we report the performance of the overall workflow and benchmark SARS-CoV-2 detection in patient samples via RT-qPCR, CRISPR-Cas, and LAMP against clinical test sets. The validated RNA extraction and RT-qPCR platform has been installed in NHS diagnostic labs and now contributes to increased patient sample processing in the UK while we continue to refine and develop novel high-throughput diagnostic methods. Finally, our workflows and protocols can be quickly implemented and adapted by members of the Global Biofoundry Alliance and the wider scientific and medical diagnostics community.",10.1101/2020.05.02.20088344,9h7kulwn,"['The', 'SARS', 'CoV', '2', 'pandemic', 'has', 'shown', 'how', 'the', 'rapid', 'rise', 'in', 'demand', 'for', 'patient', 'and', 'community', 'sample', 'testing', 'required', 'for', 'tracing', 'and', 'containing', 'a', 'highly', 'infectious', 'disease', 'has', 'quickly', 'overwhelmed', 'testing', 'capability', 'globally', 'With', 'most', 'diagnostic', 'infrastructure', 'dependent', 'on', 'specialised', 'instruments', 'their', 'exclusive', 'reagent', 'supplies', 'quickly', 'become', 'bottlenecks', 'in', 'times', 'of', 'peak', 'demand', 'creating', 'an', 'urgent', 'need', 'for', 'novel', 'approaches', 'to', 'boost', 'testing', 'capacity', 'We', 'address', 'this', 'challenge', 'by', 'refocusing', 'the', 'full', 'synthetic', 'biology', 'stack', 'available', 'at', 'the', 'London', 'Biofoundry', 'onto', 'the', 'development', 'of', 'alternative', 'patient', 'sample', 'testing', 'pipelines', 'We', 'present', 'a', 'reagent', 'agnostic', 'automated', 'SARS', 'CoV', '2', 'testing', 'platform', 'that', 'can', 'be', 'quickly', 'deployed', 'and', 'scaled', 'and', 'that', 'accepts', 'a', 'diverse', 'range', 'of', 'reagents', 'Using', 'an', 'in', 'house', 'generated', 'open', 'source', 'MS2', 'virus', 'like', 'particle', 'SARS', 'CoV', '2', 'standard', 'we', 'validate', 'RNA', 'extraction', 'and', 'RT', 'qPCR', 'workflows', 'as', 'well', 'as', 'two', 'novel', 'detection', 'assays', 'based', 'on', 'CRISPR', 'Cas', 'and', 'Loop', 'mediated', 'isothermal', 'Amplification', 'LAMP', 'approaches', 'In', 'collaboration', 'with', 'an', 'NHS', 'diagnostic', 'testing', 'lab', 'we', 'report', 'the', 'performance', 'of', 'the', 'overall', 'workflow', 'and', 'benchmark', 'SARS', 'CoV', '2', 'detection', 'in', 'patient', 'samples', 'via', 'RT', 'qPCR', 'CRISPR', 'Cas', 'and', 'LAMP', 'against', 'clinical', 'test', 'sets', 'The', 'validated', 'RNA', 'extraction', 'and', 'RT', 'qPCR', 'platform', 'has', 'been', 'installed', 'in', 'NHS', 'diagnostic', 'labs', 'and', 'now', 'contributes', 'to', 'increased', 'patient', 'sample', 'processing', 'in', 'the', 'UK', 'while', 'we', 'continue', 'to', 'refine', 'and', 'develop', 'novel', 'high', 'throughput', 'diagnostic', 'methods', 'Finally', 'our', 'workflows', 'and', 'protocols', 'can', 'be', 'quickly', 'implemented', 'and', 'adapted', 'by', 'members', 'of', 'the', 'Global', 'Biofoundry', 'Alliance', 'and', 'the', 'wider', 'scientific', 'and', 'medical', 'diagnostics', 'community', '']"
79738,Scalable Transcriptional Analysis Routine—Multiplexed Quantitative Real-Time Polymerase Chain Reaction Platform for Gene Expression Analysis and Molecular Diagnostics,2005-10-31,The Journal of Molecular Diagnostics,https://api.elsevier.com/content/article/pii/S1525157810605752; https://www.sciencedirect.com/science/article/pii/S1525157810605752,"We report the development of a new technology for simultaneous quantitative detection of multiple targets in a single sample. Scalable transcriptional analysis routine (STAR) represents a novel integration of reverse transcriptase-polymerase chain reaction and capillary electrophoresis that allows detection of dozens of gene transcripts in a multiplexed format using amplicon size as an identifier for each target. STAR demonstrated similar or better sensitivity and precision compared to two commonly used methods, SYBR Green-based and TaqMan probe-based real-time reverse transcriptase-polymerase chain reaction. STAR can be used as a flexible platform for building a variety of applications to monitor gene expression, from single gene assays to assays analyzing the expression level of multiple genes. Using severe acute respiratory syndrome (SARS) corona virus as a model system, STAR technology detected single copies of the viral genome in a two-gene multiplex. Blinded studies using RNA extracted from various tissues of a SARS-infected individual showed that STAR correctly identified all samples containing SARS virus and yielded negative results for non-SARS control samples. Using alternate priming strategies, STAR technology can be adapted to transcriptional profiling studies without requiring a priori sequence information. Thus, STAR technology offers a flexible platform for development of highly multiplexed assays in gene expression analysis and molecular diagnostics.",10.1016/s1525-1578(10)60575-2,qhftb6d7,"['We', 'report', 'the', 'development', 'of', 'a', 'new', 'technology', 'for', 'simultaneous', 'quantitative', 'detection', 'of', 'multiple', 'targets', 'in', 'a', 'single', 'sample', 'Scalable', 'transcriptional', 'analysis', 'routine', 'STAR', 'represents', 'a', 'novel', 'integration', 'of', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'and', 'capillary', 'electrophoresis', 'that', 'allows', 'detection', 'of', 'dozens', 'of', 'gene', 'transcripts', 'in', 'a', 'multiplexed', 'format', 'using', 'amplicon', 'size', 'as', 'an', 'identifier', 'for', 'each', 'target', 'STAR', 'demonstrated', 'similar', 'or', 'better', 'sensitivity', 'and', 'precision', 'compared', 'to', 'two', 'commonly', 'used', 'methods', 'SYBR', 'Green', 'based', 'and', 'TaqMan', 'probe', 'based', 'real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'STAR', 'can', 'be', 'used', 'as', 'a', 'flexible', 'platform', 'for', 'building', 'a', 'variety', 'of', 'applications', 'to', 'monitor', 'gene', 'expression', 'from', 'single', 'gene', 'assays', 'to', 'assays', 'analyzing', 'the', 'expression', 'level', 'of', 'multiple', 'genes', 'Using', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'corona', 'virus', 'as', 'a', 'model', 'system', 'STAR', 'technology', 'detected', 'single', 'copies', 'of', 'the', 'viral', 'genome', 'in', 'a', 'two', 'gene', 'multiplex', 'Blinded', 'studies', 'using', 'RNA', 'extracted', 'from', 'various', 'tissues', 'of', 'a', 'SARS', 'infected', 'individual', 'showed', 'that', 'STAR', 'correctly', 'identified', 'all', 'samples', 'containing', 'SARS', 'virus', 'and', 'yielded', 'negative', 'results', 'for', 'non', 'SARS', 'control', 'samples', 'Using', 'alternate', 'priming', 'strategies', 'STAR', 'technology', 'can', 'be', 'adapted', 'to', 'transcriptional', 'profiling', 'studies', 'without', 'requiring', 'a', 'priori', 'sequence', 'information', 'Thus', 'STAR', 'technology', 'offers', 'a', 'flexible', 'platform', 'for', 'development', 'of', 'highly', 'multiplexed', 'assays', 'in', 'gene', 'expression', 'analysis', 'and', 'molecular', 'diagnostics', '']"
80056,An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets,2020-05-12,bioRxiv,https://doi.org/10.1101/2020.05.11.089409,"Background The COVID-19 pandemic is causing a major global health and socio-economic burden, instigating the mobilisation of resources into the development of control tools, such as diagnostics and vaccines. The poor performance of some diagnostic serological tools has emphasised the need for up to date immune-informatic analyses to inform the selection of viable targets for further study. This requires the integration and analysis of genetic and immunological data for SARS-CoV-2 and its homology with other human coronavirus species to understand cross-reactivity. Methods We have developed an online tool for SARS-CoV-2 research, which combines an extensive epitope mapping and prediction meta-analysis, with an updated variant database (55,944 non-synonymous mutations) based on 16,087 whole genome sequences, and an analysis of human coronavirus homology. To demonstrate its utility, we present an integrated analysis of the SARS-CoV-2 spike and nucleocapsid proteins, which are candidate vaccine and serological diagnostic targets. Results Our analysis reveals that the nucleocapsid protein in its native form appears to be a sub-optimal target for use in serological diagnostic platforms. Whilst, a further analysis suggests that orf3a proteins may be a suitable alternative target for diagnostic assays. Conclusions The tool can be accessed online (http://genomics.lshtm.ac.uk/immuno) and will serve as a useful tool for biological discovery in the fight against SARS-CoV-2. Further, it may be adapted to inform on biological targets in future outbreaks, including new human coronaviruses that spill over from animal hosts.",10.1101/2020.05.11.089409,0kxo3a4q,"['Background', 'The', 'COVID', '19', 'pandemic', 'is', 'causing', 'a', 'major', 'global', 'health', 'and', 'socio', 'economic', 'burden', 'instigating', 'the', 'mobilisation', 'of', 'resources', 'into', 'the', 'development', 'of', 'control', 'tools', 'such', 'as', 'diagnostics', 'and', 'vaccines', 'The', 'poor', 'performance', 'of', 'some', 'diagnostic', 'serological', 'tools', 'has', 'emphasised', 'the', 'need', 'for', 'up', 'to', 'date', 'immune', 'informatic', 'analyses', 'to', 'inform', 'the', 'selection', 'of', 'viable', 'targets', 'for', 'further', 'study', 'This', 'requires', 'the', 'integration', 'and', 'analysis', 'of', 'genetic', 'and', 'immunological', 'data', 'for', 'SARS', 'CoV', '2', 'and', 'its', 'homology', 'with', 'other', 'human', 'coronavirus', 'species', 'to', 'understand', 'cross', 'reactivity', 'Methods', 'We', 'have', 'developed', 'an', 'online', 'tool', 'for', 'SARS', 'CoV', '2', 'research', 'which', 'combines', 'an', 'extensive', 'epitope', 'mapping', 'and', 'prediction', 'meta', 'analysis', 'with', 'an', 'updated', 'variant', 'database', '55', '944', 'non', 'synonymous', 'mutations', 'based', 'on', '16', '087', 'whole', 'genome', 'sequences', 'and', 'an', 'analysis', 'of', 'human', 'coronavirus', 'homology', 'To', 'demonstrate', 'its', 'utility', 'we', 'present', 'an', 'integrated', 'analysis', 'of', 'the', 'SARS', 'CoV', '2', 'spike', 'and', 'nucleocapsid', 'proteins', 'which', 'are', 'candidate', 'vaccine', 'and', 'serological', 'diagnostic', 'targets', 'Results', 'Our', 'analysis', 'reveals', 'that', 'the', 'nucleocapsid', 'protein', 'in', 'its', 'native', 'form', 'appears', 'to', 'be', 'a', 'sub', 'optimal', 'target', 'for', 'use', 'in', 'serological', 'diagnostic', 'platforms', 'Whilst', 'a', 'further', 'analysis', 'suggests', 'that', 'orf3a', 'proteins', 'may', 'be', 'a', 'suitable', 'alternative', 'target', 'for', 'diagnostic', 'assays', 'Conclusions', 'The', 'tool', 'can', 'be', 'accessed', 'online', 'http', 'genomics', 'lshtm', 'ac', 'uk', 'immuno', 'and', 'will', 'serve', 'as', 'a', 'useful', 'tool', 'for', 'biological', 'discovery', 'in', 'the', 'fight', 'against', 'SARS', 'CoV', '2', 'Further', 'it', 'may', 'be', 'adapted', 'to', 'inform', 'on', 'biological', 'targets', 'in', 'future', 'outbreaks', 'including', 'new', 'human', 'coronaviruses', 'that', 'spill', 'over', 'from', 'animal', 'hosts', '']"
80253,Pharma mobilizes to combat the coronavirus,2020,C&amp;EN Global Enterprise,https://doi.org/10.1021/cen-09805-buscon4,"The World Health Organization has declared the fast-moving coronavirus outbreak in China a “public health emergency of international concern,” a measure that can spur coordinated global efforts to combat it With infections steadily rising, major drug companies are mobilizing to develop diagnostics, vaccines, and possible treatments for the virus, 2019-nCoV According to WHO, as of Jan 30 more than 7,800 people worldwide are confirmed to have been infected by the virus, and another 12,000-plus cases are suspected Almost all of the cases are in China, where 170 people have died Although smaller biotech firms were among the first to publicly respond to the outbreak, big pharma firms say they have been quietly working on tests and treatments for several weeks Roche has sent the first commercial diagnostic to China, and Johnson & Johnson says it is using the same technologies deployed for the rapid development of an Ebola vaccine to( )",10.1021/cen-09805-buscon4,0tetqt33,"['The', 'World', 'Health', 'Organization', 'has', 'declared', 'the', 'fast', 'moving', 'coronavirus', 'outbreak', 'in', 'China', 'a', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'a', 'measure', 'that', 'can', 'spur', 'coordinated', 'global', 'efforts', 'to', 'combat', 'it', 'With', 'infections', 'steadily', 'rising', 'major', 'drug', 'companies', 'are', 'mobilizing', 'to', 'develop', 'diagnostics', 'vaccines', 'and', 'possible', 'treatments', 'for', 'the', 'virus', '2019', 'nCoV', 'According', 'to', 'WHO', 'as', 'of', 'Jan', '30', 'more', 'than', '7', '800', 'people', 'worldwide', 'are', 'confirmed', 'to', 'have', 'been', 'infected', 'by', 'the', 'virus', 'and', 'another', '12', '000', 'plus', 'cases', 'are', 'suspected', 'Almost', 'all', 'of', 'the', 'cases', 'are', 'in', 'China', 'where', '170', 'people', 'have', 'died', 'Although', 'smaller', 'biotech', 'firms', 'were', 'among', 'the', 'first', 'to', 'publicly', 'respond', 'to', 'the', 'outbreak', 'big', 'pharma', 'firms', 'say', 'they', 'have', 'been', 'quietly', 'working', 'on', 'tests', 'and', 'treatments', 'for', 'several', 'weeks', 'Roche', 'has', 'sent', 'the', 'first', 'commercial', 'diagnostic', 'to', 'China', 'and', 'Johnson', 'Johnson', 'says', 'it', 'is', 'using', 'the', 'same', 'technologies', 'deployed', 'for', 'the', 'rapid', 'development', 'of', 'an', 'Ebola', 'vaccine', 'to', '']"
80628,Companies are racing to develop COVID-19 tests for the US. Will the tests help?,2020,C&amp;EN Global Enterprise,https://doi.org/10.1021/cen-09814-cover3,"These speed bumps are some of the reasons why many industry watchers and public health officials are praising the development of a 5 min bedside, or point-of-care, test produced by Abbott Laboratories Approved in late March, the test relies on PCR but uses a different method of copying genetic material, allowing it to be done at a constant temperature and quickly Other companies that use this method, called isothermal amplification, for infectious disease diagnostics have developed specialized enzymes that can copy viral RNA without the temperature cycling used in more traditional PCR It’s not clear exactly how Abbott is employing isothermal amplification, but the company says the test can be done in a small, portable machine that many hospitals already use to diagnose other infectious diseases Abbott says this test and another, more traditional PCR diagnostic it developed can perform up to 5 million COVID-19 tests per month total",10.1021/cen-09814-cover3,hboafe4u,"['These', 'speed', 'bumps', 'are', 'some', 'of', 'the', 'reasons', 'why', 'many', 'industry', 'watchers', 'and', 'public', 'health', 'officials', 'are', 'praising', 'the', 'development', 'of', 'a', '5', 'min', 'bedside', 'or', 'point', 'of', 'care', 'test', 'produced', 'by', 'Abbott', 'Laboratories', 'Approved', 'in', 'late', 'March', 'the', 'test', 'relies', 'on', 'PCR', 'but', 'uses', 'a', 'different', 'method', 'of', 'copying', 'genetic', 'material', 'allowing', 'it', 'to', 'be', 'done', 'at', 'a', 'constant', 'temperature', 'and', 'quickly', 'Other', 'companies', 'that', 'use', 'this', 'method', 'called', 'isothermal', 'amplification', 'for', 'infectious', 'disease', 'diagnostics', 'have', 'developed', 'specialized', 'enzymes', 'that', 'can', 'copy', 'viral', 'RNA', 'without', 'the', 'temperature', 'cycling', 'used', 'in', 'more', 'traditional', 'PCR', 'It', 's', 'not', 'clear', 'exactly', 'how', 'Abbott', 'is', 'employing', 'isothermal', 'amplification', 'but', 'the', 'company', 'says', 'the', 'test', 'can', 'be', 'done', 'in', 'a', 'small', 'portable', 'machine', 'that', 'many', 'hospitals', 'already', 'use', 'to', 'diagnose', 'other', 'infectious', 'diseases', 'Abbott', 'says', 'this', 'test', 'and', 'another', 'more', 'traditional', 'PCR', 'diagnostic', 'it', 'developed', 'can', 'perform', 'up', 'to', '5', 'million', 'COVID', '19', 'tests', 'per', 'month', 'total']"
80886,Drugmakers connect with Gates Foundation,2020,C&amp;EN Global Enterprise,https://doi.org/10.1021/cen-09813-buscon14,"Fifteen pharmaceutical and life sciences companies will work with the Bill and Melinda Gates Foundation to accelerate the development of vaccines, diagnostics, and treatments for COVID-19 The group will share proprietary compound libraries, along with safety and activity data, with the COVID-19 Therapeutics Accelerator, an effort the foundation launched last month with Wellcome and Mastercard The 15 firms are also involved in other partnerships to develop COVID-19 therapies",10.1021/cen-09813-buscon14,kqm2h17q,"['Fifteen', 'pharmaceutical', 'and', 'life', 'sciences', 'companies', 'will', 'work', 'with', 'the', 'Bill', 'and', 'Melinda', 'Gates', 'Foundation', 'to', 'accelerate', 'the', 'development', 'of', 'vaccines', 'diagnostics', 'and', 'treatments', 'for', 'COVID', '19', 'The', 'group', 'will', 'share', 'proprietary', 'compound', 'libraries', 'along', 'with', 'safety', 'and', 'activity', 'data', 'with', 'the', 'COVID', '19', 'Therapeutics', 'Accelerator', 'an', 'effort', 'the', 'foundation', 'launched', 'last', 'month', 'with', 'Wellcome', 'and', 'Mastercard', 'The', '15', 'firms', 'are', 'also', 'involved', 'in', 'other', 'partnerships', 'to', 'develop', 'COVID', '19', 'therapies']"
81941,Production systems for recombinant antibodies.,2008,Frontiers in bioscience : a journal and virtual library,https://www.ncbi.nlm.nih.gov/pubmed/18508530/,"Recombinant antibodies are the fastest growing class of therapeutic proteins. Furthermore, antibodies are key detection reagents in research and diagnostics. The increasing demand for antibodies with regards to amount and quality resulted in the development of a variety of recombinant production systems employing gram-negative and gram-positive bacteria, yeast and filamentous fungi, insect cell lines as well as mammalian cell lines. More recently, antibodies were also successfully produced in transgenic plants and animals. Currently, the production of recombinant antibodies for therapy is performed in mammalian cell lines to reduce the risk of immunogenicity caused by non-human post-translational modifications, in particular glycosylation. However, novel strategies already allow human-like glycosylation patterns in yeast, insect cell lines and transgenic plants. Furthermore, therapeutic strategies not requiring glycosylation of the Fc portion have been conceived, most prominently using bispecific antibodies or scFv fusion proteins, which can be produced in bacteria. Here, we review all current antibody production systems considering their advantages and limitations with respect to intended applications.",,a6ewlox0,"['Recombinant', 'antibodies', 'are', 'the', 'fastest', 'growing', 'class', 'of', 'therapeutic', 'proteins', 'Furthermore', 'antibodies', 'are', 'key', 'detection', 'reagents', 'in', 'research', 'and', 'diagnostics', 'The', 'increasing', 'demand', 'for', 'antibodies', 'with', 'regards', 'to', 'amount', 'and', 'quality', 'resulted', 'in', 'the', 'development', 'of', 'a', 'variety', 'of', 'recombinant', 'production', 'systems', 'employing', 'gram', 'negative', 'and', 'gram', 'positive', 'bacteria', 'yeast', 'and', 'filamentous', 'fungi', 'insect', 'cell', 'lines', 'as', 'well', 'as', 'mammalian', 'cell', 'lines', 'More', 'recently', 'antibodies', 'were', 'also', 'successfully', 'produced', 'in', 'transgenic', 'plants', 'and', 'animals', 'Currently', 'the', 'production', 'of', 'recombinant', 'antibodies', 'for', 'therapy', 'is', 'performed', 'in', 'mammalian', 'cell', 'lines', 'to', 'reduce', 'the', 'risk', 'of', 'immunogenicity', 'caused', 'by', 'non', 'human', 'post', 'translational', 'modifications', 'in', 'particular', 'glycosylation', 'However', 'novel', 'strategies', 'already', 'allow', 'human', 'like', 'glycosylation', 'patterns', 'in', 'yeast', 'insect', 'cell', 'lines', 'and', 'transgenic', 'plants', 'Furthermore', 'therapeutic', 'strategies', 'not', 'requiring', 'glycosylation', 'of', 'the', 'Fc', 'portion', 'have', 'been', 'conceived', 'most', 'prominently', 'using', 'bispecific', 'antibodies', 'or', 'scFv', 'fusion', 'proteins', 'which', 'can', 'be', 'produced', 'in', 'bacteria', 'Here', 'we', 'review', 'all', 'current', 'antibody', 'production', 'systems', 'considering', 'their', 'advantages', 'and', 'limitations', 'with', 'respect', 'to', 'intended', 'applications', '']"
82568,A clearing house for diagnostic testing: the solution to ensure access to and use of patented genetic inventions?,2006,Bulletin of the World Health Organization,https://www.ncbi.nlm.nih.gov/pubmed/16710543/,"In genetic diagnostics, the emergence of a so-called ""patent thicket"" is imminent. Such an overlapping set of patent rights may have restrictive effects on further research and development of diagnostic tests, and the provision of clinical diagnostic services. Currently, two models that may facilitate access to and use of patented genetic inventions are attracting much debate in various national and international fora: patent pools and clearing houses. In this article, we explore the concept of clearing houses. Several types of clearing houses are identified. First, we describe and discuss two types that would provide access to information on the patented inventions: the information clearing house and the technology exchange clearing house. Second, three types of clearing houses are analysed that not only offer access to information but also provide an instrument to facilitate the use of the patented inventions: the open access clearing house, the standardized licences clearing house and the royalty collection clearing house. A royalty collection clearing house for genetic diagnostic testing would be the most comprehensive as it would serve several functions: identifying patents and patent claims essential to diagnostic testing, matching licensees with licensors, developing and supplying standardized licences, collecting royalties, monitoring whether users respect licensing conditions, and providing dispute resolution services such as mediation and arbitration. In this way, it might function as an effective model for users to facilitate access to and use of the patented inventions. However, it remains to be seen whether patent holders with a strong patent portfolio will be convinced by the advantages of the royalty collection clearing house and be willing to participate.",,9zffv8o9,"['In', 'genetic', 'diagnostics', 'the', 'emergence', 'of', 'a', 'so', 'called', 'patent', 'thicket', 'is', 'imminent', 'Such', 'an', 'overlapping', 'set', 'of', 'patent', 'rights', 'may', 'have', 'restrictive', 'effects', 'on', 'further', 'research', 'and', 'development', 'of', 'diagnostic', 'tests', 'and', 'the', 'provision', 'of', 'clinical', 'diagnostic', 'services', 'Currently', 'two', 'models', 'that', 'may', 'facilitate', 'access', 'to', 'and', 'use', 'of', 'patented', 'genetic', 'inventions', 'are', 'attracting', 'much', 'debate', 'in', 'various', 'national', 'and', 'international', 'fora', 'patent', 'pools', 'and', 'clearing', 'houses', 'In', 'this', 'article', 'we', 'explore', 'the', 'concept', 'of', 'clearing', 'houses', 'Several', 'types', 'of', 'clearing', 'houses', 'are', 'identified', 'First', 'we', 'describe', 'and', 'discuss', 'two', 'types', 'that', 'would', 'provide', 'access', 'to', 'information', 'on', 'the', 'patented', 'inventions', 'the', 'information', 'clearing', 'house', 'and', 'the', 'technology', 'exchange', 'clearing', 'house', 'Second', 'three', 'types', 'of', 'clearing', 'houses', 'are', 'analysed', 'that', 'not', 'only', 'offer', 'access', 'to', 'information', 'but', 'also', 'provide', 'an', 'instrument', 'to', 'facilitate', 'the', 'use', 'of', 'the', 'patented', 'inventions', 'the', 'open', 'access', 'clearing', 'house', 'the', 'standardized', 'licences', 'clearing', 'house', 'and', 'the', 'royalty', 'collection', 'clearing', 'house', 'A', 'royalty', 'collection', 'clearing', 'house', 'for', 'genetic', 'diagnostic', 'testing', 'would', 'be', 'the', 'most', 'comprehensive', 'as', 'it', 'would', 'serve', 'several', 'functions', 'identifying', 'patents', 'and', 'patent', 'claims', 'essential', 'to', 'diagnostic', 'testing', 'matching', 'licensees', 'with', 'licensors', 'developing', 'and', 'supplying', 'standardized', 'licences', 'collecting', 'royalties', 'monitoring', 'whether', 'users', 'respect', 'licensing', 'conditions', 'and', 'providing', 'dispute', 'resolution', 'services', 'such', 'as', 'mediation', 'and', 'arbitration', 'In', 'this', 'way', 'it', 'might', 'function', 'as', 'an', 'effective', 'model', 'for', 'users', 'to', 'facilitate', 'access', 'to', 'and', 'use', 'of', 'the', 'patented', 'inventions', 'However', 'it', 'remains', 'to', 'be', 'seen', 'whether', 'patent', 'holders', 'with', 'a', 'strong', 'patent', 'portfolio', 'will', 'be', 'convinced', 'by', 'the', 'advantages', 'of', 'the', 'royalty', 'collection', 'clearing', 'house', 'and', 'be', 'willing', 'to', 'participate', '']"
83140,Recent advances in diagnostic technology: applications in autoimmune and infectious diseases.,2008,Clinical and experimental rheumatology,https://www.ncbi.nlm.nih.gov/pubmed/18570756/,"Biomarkers are used ubiquitously as indicators of biological health. The development of genomic and proteomic multiplex technologies have enormously amplified biomarker discovery and application to diagnostic and therapeutic decisions in clinical practice. New technologies are now available that simultaneously identify a wide spectrum of biomarkers and save time and costs. Multiplexed assays can be coupled to other disease specific indicators (i.e., cytokines, single nucleotide polymorphisms) in order to get more powerful information. However, there is an urgent need for validation/standardization of the new assays before they are adopted into clinical diagnostics. It is worthy to note a new assay, T cell interferon gamma release (TIGRAs), which has recently been introduced in the diagnosis of latent tuberculosis infection. It seems to perform better than tuberculin skin test in patients with inflammatory rheumatic diseases. In this review, we focus on advantages and limits of novel approaches to the detection of autoantibody profiles in autoimmune diseases or pathogen signatures in microbiology.",,e102oa18,"['Biomarkers', 'are', 'used', 'ubiquitously', 'as', 'indicators', 'of', 'biological', 'health', 'The', 'development', 'of', 'genomic', 'and', 'proteomic', 'multiplex', 'technologies', 'have', 'enormously', 'amplified', 'biomarker', 'discovery', 'and', 'application', 'to', 'diagnostic', 'and', 'therapeutic', 'decisions', 'in', 'clinical', 'practice', 'New', 'technologies', 'are', 'now', 'available', 'that', 'simultaneously', 'identify', 'a', 'wide', 'spectrum', 'of', 'biomarkers', 'and', 'save', 'time', 'and', 'costs', 'Multiplexed', 'assays', 'can', 'be', 'coupled', 'to', 'other', 'disease', 'specific', 'indicators', 'i', 'e', 'cytokines', 'single', 'nucleotide', 'polymorphisms', 'in', 'order', 'to', 'get', 'more', 'powerful', 'information', 'However', 'there', 'is', 'an', 'urgent', 'need', 'for', 'validation', 'standardization', 'of', 'the', 'new', 'assays', 'before', 'they', 'are', 'adopted', 'into', 'clinical', 'diagnostics', 'It', 'is', 'worthy', 'to', 'note', 'a', 'new', 'assay', 'T', 'cell', 'interferon', 'gamma', 'release', 'TIGRAs', 'which', 'has', 'recently', 'been', 'introduced', 'in', 'the', 'diagnosis', 'of', 'latent', 'tuberculosis', 'infection', 'It', 'seems', 'to', 'perform', 'better', 'than', 'tuberculin', 'skin', 'test', 'in', 'patients', 'with', 'inflammatory', 'rheumatic', 'diseases', 'In', 'this', 'review', 'we', 'focus', 'on', 'advantages', 'and', 'limits', 'of', 'novel', 'approaches', 'to', 'the', 'detection', 'of', 'autoantibody', 'profiles', 'in', 'autoimmune', 'diseases', 'or', 'pathogen', 'signatures', 'in', 'microbiology', '']"
83692,[Construction and screening of SARS-CoV S protein-specific phage displayed antigen library].,2013,Bing du xue bao = Chinese journal of virology,https://www.ncbi.nlm.nih.gov/pubmed/23905471/,"The aim of this study is to construct a SARS-CoV S protein-specific phage displayed antigen library for the epitope characterization of anti-S monoclonal antibodies (mAbs). First, the full-length gene of SARS-S protein was PCR amplified, purified and then digested with DNase I to obtain DNA fragments in the size range of 50-500 bp. The resulting fragments were blunt-end ligated to the modified phage display vector pComb3XSS. The reactions were electrotransformed into XL1-Blue and infected with VCSM13 helper phage. The SARS-CoV S protein-specific phage displayed antigen library was biopanned and screened against two anti-S mAbs, S-M1 and S-M2. The results showed that we successfully constructed the phage displayed antigen library with a size of 5.7 x 10(6). After three-rounds of biopanning, 14 positive phage clones for S-M1 and 15 for S-M2 were respectively identified. Sequence analyses revealed the possible epitopes of two mAbs. Therefore, the S protein-specific phage displayed antigen library provides a crucial platform for the epitope characterization of anti-S antibodies and it is highly valuable for development of SARS vaccines and diagnostics.",,rmjvb8v6,"['The', 'aim', 'of', 'this', 'study', 'is', 'to', 'construct', 'a', 'SARS', 'CoV', 'S', 'protein', 'specific', 'phage', 'displayed', 'antigen', 'library', 'for', 'the', 'epitope', 'characterization', 'of', 'anti', 'S', 'monoclonal', 'antibodies', 'mAbs', 'First', 'the', 'full', 'length', 'gene', 'of', 'SARS', 'S', 'protein', 'was', 'PCR', 'amplified', 'purified', 'and', 'then', 'digested', 'with', 'DNase', 'I', 'to', 'obtain', 'DNA', 'fragments', 'in', 'the', 'size', 'range', 'of', '50', '500', 'bp', 'The', 'resulting', 'fragments', 'were', 'blunt', 'end', 'ligated', 'to', 'the', 'modified', 'phage', 'display', 'vector', 'pComb3XSS', 'The', 'reactions', 'were', 'electrotransformed', 'into', 'XL1', 'Blue', 'and', 'infected', 'with', 'VCSM13', 'helper', 'phage', 'The', 'SARS', 'CoV', 'S', 'protein', 'specific', 'phage', 'displayed', 'antigen', 'library', 'was', 'biopanned', 'and', 'screened', 'against', 'two', 'anti', 'S', 'mAbs', 'S', 'M1', 'and', 'S', 'M2', 'The', 'results', 'showed', 'that', 'we', 'successfully', 'constructed', 'the', 'phage', 'displayed', 'antigen', 'library', 'with', 'a', 'size', 'of', '5', '7', 'x', '10', '6', 'After', 'three', 'rounds', 'of', 'biopanning', '14', 'positive', 'phage', 'clones', 'for', 'S', 'M1', 'and', '15', 'for', 'S', 'M2', 'were', 'respectively', 'identified', 'Sequence', 'analyses', 'revealed', 'the', 'possible', 'epitopes', 'of', 'two', 'mAbs', 'Therefore', 'the', 'S', 'protein', 'specific', 'phage', 'displayed', 'antigen', 'library', 'provides', 'a', 'crucial', 'platform', 'for', 'the', 'epitope', 'characterization', 'of', 'anti', 'S', 'antibodies', 'and', 'it', 'is', 'highly', 'valuable', 'for', 'development', 'of', 'SARS', 'vaccines', 'and', 'diagnostics', '']"
84976,"Laboratory test descriptions for bovine respiratory disease diagnosis and their strengths and weaknesses: gold standards for diagnosis, do they exist?",2012,The Canadian veterinary journal = La revue veterinaire canadienne,https://www.ncbi.nlm.nih.gov/pubmed/23277642/,"The diagnosis of bovine respiratory diseases (BRD) poses significant challenges to the clinician as there are numerous infectious etiologies, operating singly or most often in combination. Clinical signs alone may not be diagnostic and the diagnostic laboratory is often used to assist the clinician. Recently many molecular-based tests have been taken from the research laboratory to the veterinary diagnostic laboratory. This review describes the ""traditional tests"" and several ""molecular tests"" and discusses the benefits and limitations of the tests and their interpretation. Clinicians should consult with their diagnostic laboratory regarding the interpretation of the test results. The rate of development and use of molecular diagnostic tests have outpaced validation, standardization, and standards for interpretation relative to their use in BRD diagnostics.",,e82pjjuu,"['The', 'diagnosis', 'of', 'bovine', 'respiratory', 'diseases', 'BRD', 'poses', 'significant', 'challenges', 'to', 'the', 'clinician', 'as', 'there', 'are', 'numerous', 'infectious', 'etiologies', 'operating', 'singly', 'or', 'most', 'often', 'in', 'combination', 'Clinical', 'signs', 'alone', 'may', 'not', 'be', 'diagnostic', 'and', 'the', 'diagnostic', 'laboratory', 'is', 'often', 'used', 'to', 'assist', 'the', 'clinician', 'Recently', 'many', 'molecular', 'based', 'tests', 'have', 'been', 'taken', 'from', 'the', 'research', 'laboratory', 'to', 'the', 'veterinary', 'diagnostic', 'laboratory', 'This', 'review', 'describes', 'the', 'traditional', 'tests', 'and', 'several', 'molecular', 'tests', 'and', 'discusses', 'the', 'benefits', 'and', 'limitations', 'of', 'the', 'tests', 'and', 'their', 'interpretation', 'Clinicians', 'should', 'consult', 'with', 'their', 'diagnostic', 'laboratory', 'regarding', 'the', 'interpretation', 'of', 'the', 'test', 'results', 'The', 'rate', 'of', 'development', 'and', 'use', 'of', 'molecular', 'diagnostic', 'tests', 'have', 'outpaced', 'validation', 'standardization', 'and', 'standards', 'for', 'interpretation', 'relative', 'to', 'their', 'use', 'in', 'BRD', 'diagnostics', '']"
85080,Evaluation and significance of C-reactive protein in the clinical diagnosis of severe pneumonia.,2015,Experimental and therapeutic medicine,https://www.ncbi.nlm.nih.gov/pubmed/26170931/,"Severe pneumonia is a major cause of mortality in children. The present study evaluated the diagnostic value of serum C-reactive protein (CRP) levels for cases of severe pneumonia. A total of 862 children, hospitalized for acute respiratory tract infections, were evaluated between September 2008 and February 2011; the serum levels of CRP were measured in all the children. Bacterial identification was performed, while polymerase chain reaction was used to detect the 12 respiratory viruses. Multivariate logistic regression analysis was performed with independent [CRP, proportion of neutrophils (NEUT), body temperature, sputum production, age and dyspnea] and dependent (severe and mild pneumonia) variables for clinical diagnosis, which produced three new variables that represented an individual's predictive value: Pre-1, Pre-2 and Pre-3. A receiver operating characteristic (ROC) curve was generated using the new variables to assess their predictive value for severe pneumonia. Of the 862 patients, 108 individuals were diagnosed with severe pneumonia and 754 individuals had mild pneumonia. Increased levels of CRP were associated with severe pneumonia and bacterial infection (P<0.05). Multivariate logistic regression analysis found that severe pneumonia was associated with the levels of CRP, body temperature, expectoration, age, NEUT and dyspnea (P<0.05). The ROC curve of the regression diagnostics model sequentially presented CRP, CRP and the other five correlative variables (NEUT + body temperature + sputum production + age + dyspnea) and the other five correlative variables used to diagnose severe pneumonia. The area under curve values were determined as 0.550 for Pre-1 [95% confidence interval (CI), 0.490-0.609], 0.897 for Pre-2 (95% CI, 0.861-0.932) and 0.893 for Pre-3 (95% CI, 0.855-0.931). The results revealed that the six correlative variables had improved accuracy in the diagnosis of severe pneumonia. The serum levels of CRP were strongly associated with bacterial infection and severe pneumonia. Therefore, the CRP level, along with other parameters, may be used as early indicators of severe pneumonia development. However, the efficiency of the CRP level alone to diagnose severe pneumonia was found to be limited.",,tcszpuqd,"['Severe', 'pneumonia', 'is', 'a', 'major', 'cause', 'of', 'mortality', 'in', 'children', 'The', 'present', 'study', 'evaluated', 'the', 'diagnostic', 'value', 'of', 'serum', 'C', 'reactive', 'protein', 'CRP', 'levels', 'for', 'cases', 'of', 'severe', 'pneumonia', 'A', 'total', 'of', '862', 'children', 'hospitalized', 'for', 'acute', 'respiratory', 'tract', 'infections', 'were', 'evaluated', 'between', 'September', '2008', 'and', 'February', '2011', 'the', 'serum', 'levels', 'of', 'CRP', 'were', 'measured', 'in', 'all', 'the', 'children', 'Bacterial', 'identification', 'was', 'performed', 'while', 'polymerase', 'chain', 'reaction', 'was', 'used', 'to', 'detect', 'the', '12', 'respiratory', 'viruses', 'Multivariate', 'logistic', 'regression', 'analysis', 'was', 'performed', 'with', 'independent', 'CRP', 'proportion', 'of', 'neutrophils', 'NEUT', 'body', 'temperature', 'sputum', 'production', 'age', 'and', 'dyspnea', 'and', 'dependent', 'severe', 'and', 'mild', 'pneumonia', 'variables', 'for', 'clinical', 'diagnosis', 'which', 'produced', 'three', 'new', 'variables', 'that', 'represented', 'an', 'individual', 's', 'predictive', 'value', 'Pre', '1', 'Pre', '2', 'and', 'Pre', '3', 'A', 'receiver', 'operating', 'characteristic', 'ROC', 'curve', 'was', 'generated', 'using', 'the', 'new', 'variables', 'to', 'assess', 'their', 'predictive', 'value', 'for', 'severe', 'pneumonia', 'Of', 'the', '862', 'patients', '108', 'individuals', 'were', 'diagnosed', 'with', 'severe', 'pneumonia', 'and', '754', 'individuals', 'had', 'mild', 'pneumonia', 'Increased', 'levels', 'of', 'CRP', 'were', 'associated', 'with', 'severe', 'pneumonia', 'and', 'bacterial', 'infection', 'P', '0', '05', 'Multivariate', 'logistic', 'regression', 'analysis', 'found', 'that', 'severe', 'pneumonia', 'was', 'associated', 'with', 'the', 'levels', 'of', 'CRP', 'body', 'temperature', 'expectoration', 'age', 'NEUT', 'and', 'dyspnea', 'P', '0', '05', 'The', 'ROC', 'curve', 'of', 'the', 'regression', 'diagnostics', 'model', 'sequentially', 'presented', 'CRP', 'CRP', 'and', 'the', 'other', 'five', 'correlative', 'variables', 'NEUT', 'body', 'temperature', 'sputum', 'production', 'age', 'dyspnea', 'and', 'the', 'other', 'five', 'correlative', 'variables', 'used', 'to', 'diagnose', 'severe', 'pneumonia', 'The', 'area', 'under', 'curve', 'values', 'were', 'determined', 'as', '0', '550', 'for', 'Pre', '1', '95', 'confidence', 'interval', 'CI', '0', '490', '0', '609', '0', '897', 'for', 'Pre', '2', '95', 'CI', '0', '861', '0', '932', 'and', '0', '893', 'for', 'Pre', '3', '95', 'CI', '0', '855', '0', '931', 'The', 'results', 'revealed', 'that', 'the', 'six', 'correlative', 'variables', 'had', 'improved', 'accuracy', 'in', 'the', 'diagnosis', 'of', 'severe', 'pneumonia', 'The', 'serum', 'levels', 'of', 'CRP', 'were', 'strongly', 'associated', 'with', 'bacterial', 'infection', 'and', 'severe', 'pneumonia', 'Therefore', 'the', 'CRP', 'level', 'along', 'with', 'other', 'parameters', 'may', 'be', 'used', 'as', 'early', 'indicators', 'of', 'severe', 'pneumonia', 'development', 'However', 'the', 'efficiency', 'of', 'the', 'CRP', 'level', 'alone', 'to', 'diagnose', 'severe', 'pneumonia', 'was', 'found', 'to', 'be', 'limited', '']"
86712,The laboratory diagnosis of severe acute respiratory syndrome: emerging laboratory tests for an emerging pathogen.,2004,The Clinical biochemist. Reviews,https://www.ncbi.nlm.nih.gov/pubmed/18458711/,"The 2003 pandemic of Severe Acute Respiratory Syndrome (SARS) profiled the ability of modern diagnostic microbiology and molecular biology to identify, isolate and characterize, within weeks, a previously unknown viral infectious pathogen. The culprit, SARS coronavirus (SARS-CoV), was detected in patient specimens by traditional cell culture using an unusual cell line for respiratory viruses, Vero E6, and by reverse transcriptase polymerase chain reaction (RT-PCR) targeting the polymerase 1 B region of the genome. In addition, serologic assays were rapidly developed, and the genome of this large virus was sequenced within one month of its spread to North America. At the present time, diagnostics have progressed to the point that RT-PCR has a sensitivity approaching 80% within the first few days of onset of illness, while serology has a sensitivity close to 100% on convalescent sera taken >21 days after illness onset. Viral culture remains a method confined to biosafety level III laboratories. The specificity of RT-PCR and serology remains to be conclusively defined, but in most studies to date seems to be >90%. Serologic cross-reactivity with human coronaviruses causing the common cold may be a problem with some serologic assays. The early development of SARS-CoV diagnostics is now being replaced by refinement and optimization of these assays. Although at the present time we do not have a test that will definitively rule in or rule out SARS at the time of initial presentation of a patient with a respiratory infection, modifications of existing assays will hopefully result in our ability to make this diagnosis with a high degree of accuracy in the future.",,ycch15k8,"['The', '2003', 'pandemic', 'of', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'SARS', 'profiled', 'the', 'ability', 'of', 'modern', 'diagnostic', 'microbiology', 'and', 'molecular', 'biology', 'to', 'identify', 'isolate', 'and', 'characterize', 'within', 'weeks', 'a', 'previously', 'unknown', 'viral', 'infectious', 'pathogen', 'The', 'culprit', 'SARS', 'coronavirus', 'SARS', 'CoV', 'was', 'detected', 'in', 'patient', 'specimens', 'by', 'traditional', 'cell', 'culture', 'using', 'an', 'unusual', 'cell', 'line', 'for', 'respiratory', 'viruses', 'Vero', 'E6', 'and', 'by', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'targeting', 'the', 'polymerase', '1', 'B', 'region', 'of', 'the', 'genome', 'In', 'addition', 'serologic', 'assays', 'were', 'rapidly', 'developed', 'and', 'the', 'genome', 'of', 'this', 'large', 'virus', 'was', 'sequenced', 'within', 'one', 'month', 'of', 'its', 'spread', 'to', 'North', 'America', 'At', 'the', 'present', 'time', 'diagnostics', 'have', 'progressed', 'to', 'the', 'point', 'that', 'RT', 'PCR', 'has', 'a', 'sensitivity', 'approaching', '80', 'within', 'the', 'first', 'few', 'days', 'of', 'onset', 'of', 'illness', 'while', 'serology', 'has', 'a', 'sensitivity', 'close', 'to', '100', 'on', 'convalescent', 'sera', 'taken', '21', 'days', 'after', 'illness', 'onset', 'Viral', 'culture', 'remains', 'a', 'method', 'confined', 'to', 'biosafety', 'level', 'III', 'laboratories', 'The', 'specificity', 'of', 'RT', 'PCR', 'and', 'serology', 'remains', 'to', 'be', 'conclusively', 'defined', 'but', 'in', 'most', 'studies', 'to', 'date', 'seems', 'to', 'be', '90', 'Serologic', 'cross', 'reactivity', 'with', 'human', 'coronaviruses', 'causing', 'the', 'common', 'cold', 'may', 'be', 'a', 'problem', 'with', 'some', 'serologic', 'assays', 'The', 'early', 'development', 'of', 'SARS', 'CoV', 'diagnostics', 'is', 'now', 'being', 'replaced', 'by', 'refinement', 'and', 'optimization', 'of', 'these', 'assays', 'Although', 'at', 'the', 'present', 'time', 'we', 'do', 'not', 'have', 'a', 'test', 'that', 'will', 'definitively', 'rule', 'in', 'or', 'rule', 'out', 'SARS', 'at', 'the', 'time', 'of', 'initial', 'presentation', 'of', 'a', 'patient', 'with', 'a', 'respiratory', 'infection', 'modifications', 'of', 'existing', 'assays', 'will', 'hopefully', 'result', 'in', 'our', 'ability', 'to', 'make', 'this', 'diagnosis', 'with', 'a', 'high', 'degree', 'of', 'accuracy', 'in', 'the', 'future', '']"
86766,Ultrastructural telepathology--remote EM-diagnostic via Internet.,2001,Ultrastructural pathology,https://www.ncbi.nlm.nih.gov/pubmed/11577775/,"New collaboratory opportunities in ultrastructural research and diagnostics are now available on the Internet through the combination of digital image acquisition, remote operation of modern digitally controlled and automated electron microscopes, and the development of software specifically tailored for collaboratory needs. Remote experts can examine samples directly, and unique instruments can be utilized from anywhere. In the case of diagnostic dilemmas, the second-opinion expert is no longer constrained by problems inherent in the interpretation of preselected images. The remote examiner can independently choose the area of interest on the sample as well as select the appropriate magnification for an accurate diagnosis. With these capabilities and together with teleconferencing tools and securely accessible databases on-line, telepathology can provide increased effectiveness and support for diagnostics, research, and teaching in many areas. The authors report their experience with remote electron microscope diagnoses of pathological samples using two different dynamic imaging systems and discuss the main technical issues encountered. It appears that only minor technical issues need to be resolved before ultrastructural telepathology can be promoted for routine use in areas with high-speed Internet access.",,bdgelrhu,"['New', 'collaboratory', 'opportunities', 'in', 'ultrastructural', 'research', 'and', 'diagnostics', 'are', 'now', 'available', 'on', 'the', 'Internet', 'through', 'the', 'combination', 'of', 'digital', 'image', 'acquisition', 'remote', 'operation', 'of', 'modern', 'digitally', 'controlled', 'and', 'automated', 'electron', 'microscopes', 'and', 'the', 'development', 'of', 'software', 'specifically', 'tailored', 'for', 'collaboratory', 'needs', 'Remote', 'experts', 'can', 'examine', 'samples', 'directly', 'and', 'unique', 'instruments', 'can', 'be', 'utilized', 'from', 'anywhere', 'In', 'the', 'case', 'of', 'diagnostic', 'dilemmas', 'the', 'second', 'opinion', 'expert', 'is', 'no', 'longer', 'constrained', 'by', 'problems', 'inherent', 'in', 'the', 'interpretation', 'of', 'preselected', 'images', 'The', 'remote', 'examiner', 'can', 'independently', 'choose', 'the', 'area', 'of', 'interest', 'on', 'the', 'sample', 'as', 'well', 'as', 'select', 'the', 'appropriate', 'magnification', 'for', 'an', 'accurate', 'diagnosis', 'With', 'these', 'capabilities', 'and', 'together', 'with', 'teleconferencing', 'tools', 'and', 'securely', 'accessible', 'databases', 'on', 'line', 'telepathology', 'can', 'provide', 'increased', 'effectiveness', 'and', 'support', 'for', 'diagnostics', 'research', 'and', 'teaching', 'in', 'many', 'areas', 'The', 'authors', 'report', 'their', 'experience', 'with', 'remote', 'electron', 'microscope', 'diagnoses', 'of', 'pathological', 'samples', 'using', 'two', 'different', 'dynamic', 'imaging', 'systems', 'and', 'discuss', 'the', 'main', 'technical', 'issues', 'encountered', 'It', 'appears', 'that', 'only', 'minor', 'technical', 'issues', 'need', 'to', 'be', 'resolved', 'before', 'ultrastructural', 'telepathology', 'can', 'be', 'promoted', 'for', 'routine', 'use', 'in', 'areas', 'with', 'high', 'speed', 'Internet', 'access', '']"
88281,Examination of animal and zoonotic pathogens using microarrays.,2008,Veterinary research,https://www.ncbi.nlm.nih.gov/pubmed/18073091/,"The advancement in functional genomics, such as DNA microarrays along with the genome availability of important pathogens as well as of human and livestock species has allowed scientists to study the expression of thousands of genes in a single step. In the past decade, DNA arrays have been employed to study infectious processes of pathogens, in diagnostics, and to study host-pathogen interactions. The generation of enormous data sets by microarray experiments also stimulated the growth of a new generation of analytical software. The information provided by microarray experiments has been useful in generating new hypotheses for future research. The concept of DNA array technology has been utilized in the development of novel diagnostic methods. This review highlights the application of microarrays in the field of veterinary research.",,av2oyf60,"['The', 'advancement', 'in', 'functional', 'genomics', 'such', 'as', 'DNA', 'microarrays', 'along', 'with', 'the', 'genome', 'availability', 'of', 'important', 'pathogens', 'as', 'well', 'as', 'of', 'human', 'and', 'livestock', 'species', 'has', 'allowed', 'scientists', 'to', 'study', 'the', 'expression', 'of', 'thousands', 'of', 'genes', 'in', 'a', 'single', 'step', 'In', 'the', 'past', 'decade', 'DNA', 'arrays', 'have', 'been', 'employed', 'to', 'study', 'infectious', 'processes', 'of', 'pathogens', 'in', 'diagnostics', 'and', 'to', 'study', 'host', 'pathogen', 'interactions', 'The', 'generation', 'of', 'enormous', 'data', 'sets', 'by', 'microarray', 'experiments', 'also', 'stimulated', 'the', 'growth', 'of', 'a', 'new', 'generation', 'of', 'analytical', 'software', 'The', 'information', 'provided', 'by', 'microarray', 'experiments', 'has', 'been', 'useful', 'in', 'generating', 'new', 'hypotheses', 'for', 'future', 'research', 'The', 'concept', 'of', 'DNA', 'array', 'technology', 'has', 'been', 'utilized', 'in', 'the', 'development', 'of', 'novel', 'diagnostic', 'methods', 'This', 'review', 'highlights', 'the', 'application', 'of', 'microarrays', 'in', 'the', 'field', 'of', 'veterinary', 'research', '']"
90566,SARS: an emerging global microbial threat.,2004,Transactions of the American Clinical and Climatological Association,https://www.ncbi.nlm.nih.gov/pubmed/17060979/,"In March 2003, the Institute of Medicine published an update to its 1992 landmark report on emerging infections. The new report, Microbial Threats to Health: Emergence, Detection, and Response, describes the current spectrum of global microbial threats, factors affecting their emergence or resurgence, and measures that should be undertaken to effectively address them. Coincident with this publication came increasing reports of severe atypical pneumonia of unknown etiology among persons in southeast Asia. This new disease, designated severe acute respiratory syndrome (SARS), spread globally in a matter of weeks, infecting primarily close contacts of index patients (e.g., household members and healthcare workers caring for index patients) but also resulting in community transmission in some areas. An unprecedented worldwide collaborative effort was undertaken to determine the cause of the illness and implement prevention measures. A previously unrecognized coronavirus was identified as the causative agent, and health officials throughout the world struggled to implement measures to contain its spread, including isolation of suspect SARS cases and quarantine of exposed persons. The emergence of SARS is a timely reminder of the need to expect the unexpected and to ensure strong national and global public health partnerships when preparing for and responding to infectious diseases. Effectively addressing the threat of SARS will require enhanced global infectious disease surveillance, the development of rapid diagnostics, new therapies, and vaccines, implementation of aggressive evidence-based infection control strategies, and effective communication.",,pdpg55aq,"['In', 'March', '2003', 'the', 'Institute', 'of', 'Medicine', 'published', 'an', 'update', 'to', 'its', '1992', 'landmark', 'report', 'on', 'emerging', 'infections', 'The', 'new', 'report', 'Microbial', 'Threats', 'to', 'Health', 'Emergence', 'Detection', 'and', 'Response', 'describes', 'the', 'current', 'spectrum', 'of', 'global', 'microbial', 'threats', 'factors', 'affecting', 'their', 'emergence', 'or', 'resurgence', 'and', 'measures', 'that', 'should', 'be', 'undertaken', 'to', 'effectively', 'address', 'them', 'Coincident', 'with', 'this', 'publication', 'came', 'increasing', 'reports', 'of', 'severe', 'atypical', 'pneumonia', 'of', 'unknown', 'etiology', 'among', 'persons', 'in', 'southeast', 'Asia', 'This', 'new', 'disease', 'designated', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'spread', 'globally', 'in', 'a', 'matter', 'of', 'weeks', 'infecting', 'primarily', 'close', 'contacts', 'of', 'index', 'patients', 'e', 'g', 'household', 'members', 'and', 'healthcare', 'workers', 'caring', 'for', 'index', 'patients', 'but', 'also', 'resulting', 'in', 'community', 'transmission', 'in', 'some', 'areas', 'An', 'unprecedented', 'worldwide', 'collaborative', 'effort', 'was', 'undertaken', 'to', 'determine', 'the', 'cause', 'of', 'the', 'illness', 'and', 'implement', 'prevention', 'measures', 'A', 'previously', 'unrecognized', 'coronavirus', 'was', 'identified', 'as', 'the', 'causative', 'agent', 'and', 'health', 'officials', 'throughout', 'the', 'world', 'struggled', 'to', 'implement', 'measures', 'to', 'contain', 'its', 'spread', 'including', 'isolation', 'of', 'suspect', 'SARS', 'cases', 'and', 'quarantine', 'of', 'exposed', 'persons', 'The', 'emergence', 'of', 'SARS', 'is', 'a', 'timely', 'reminder', 'of', 'the', 'need', 'to', 'expect', 'the', 'unexpected', 'and', 'to', 'ensure', 'strong', 'national', 'and', 'global', 'public', 'health', 'partnerships', 'when', 'preparing', 'for', 'and', 'responding', 'to', 'infectious', 'diseases', 'Effectively', 'addressing', 'the', 'threat', 'of', 'SARS', 'will', 'require', 'enhanced', 'global', 'infectious', 'disease', 'surveillance', 'the', 'development', 'of', 'rapid', 'diagnostics', 'new', 'therapies', 'and', 'vaccines', 'implementation', 'of', 'aggressive', 'evidence', 'based', 'infection', 'control', 'strategies', 'and', 'effective', 'communication', '']"
90612,Rapid diagnostic assays in the genomic biology era: detection and identification of infectious disease and biological weapon agents.,2003,BioTechniques,https://www.ncbi.nlm.nih.gov/pubmed/14579750/,"In this special section of BioTechniques, we examine the role of rapid molecular technologies in the detection and identification of agents of infectious disease (ID) and biological weapons (BWs). Besides the threat posed by the global proliferation of BW technologies, there are numerous emerging and reemerging ID agents with significant public health consequences. Further compounding this already complicated situation are the estimated 600 million international tourists annually, many with the potential to the spread disease globally in a matter of hours. While clinical laboratories have key roles in the detection and identification of potential ID/BW agents, most staff are unfamiliar with these agents because of their rarity and the often laborious conventional methodologies needed to identify them. To meet this challenge, a vast array of rapid assay strategies has been developed for use in clinical diagnostics and environmental detection. Technologies have been developed or adapted to the challenges posed by these agents, permitting detection and identification in several minutes to hours. In particular, the development of improved reagents and detection systems has led to dramatic improvements in the sensitivity and specificity of immunological and nucleic acid-based systems, allowing an ever-increasing range of analytes to be identified and quantitated. In the accompanying articles, we have brought together experts from the many overlapping aspects of this arena in order to present a comprehensive and critical analysis of these technologies.",,e91xy4pw,"['In', 'this', 'special', 'section', 'of', 'BioTechniques', 'we', 'examine', 'the', 'role', 'of', 'rapid', 'molecular', 'technologies', 'in', 'the', 'detection', 'and', 'identification', 'of', 'agents', 'of', 'infectious', 'disease', 'ID', 'and', 'biological', 'weapons', 'BWs', 'Besides', 'the', 'threat', 'posed', 'by', 'the', 'global', 'proliferation', 'of', 'BW', 'technologies', 'there', 'are', 'numerous', 'emerging', 'and', 'reemerging', 'ID', 'agents', 'with', 'significant', 'public', 'health', 'consequences', 'Further', 'compounding', 'this', 'already', 'complicated', 'situation', 'are', 'the', 'estimated', '600', 'million', 'international', 'tourists', 'annually', 'many', 'with', 'the', 'potential', 'to', 'the', 'spread', 'disease', 'globally', 'in', 'a', 'matter', 'of', 'hours', 'While', 'clinical', 'laboratories', 'have', 'key', 'roles', 'in', 'the', 'detection', 'and', 'identification', 'of', 'potential', 'ID', 'BW', 'agents', 'most', 'staff', 'are', 'unfamiliar', 'with', 'these', 'agents', 'because', 'of', 'their', 'rarity', 'and', 'the', 'often', 'laborious', 'conventional', 'methodologies', 'needed', 'to', 'identify', 'them', 'To', 'meet', 'this', 'challenge', 'a', 'vast', 'array', 'of', 'rapid', 'assay', 'strategies', 'has', 'been', 'developed', 'for', 'use', 'in', 'clinical', 'diagnostics', 'and', 'environmental', 'detection', 'Technologies', 'have', 'been', 'developed', 'or', 'adapted', 'to', 'the', 'challenges', 'posed', 'by', 'these', 'agents', 'permitting', 'detection', 'and', 'identification', 'in', 'several', 'minutes', 'to', 'hours', 'In', 'particular', 'the', 'development', 'of', 'improved', 'reagents', 'and', 'detection', 'systems', 'has', 'led', 'to', 'dramatic', 'improvements', 'in', 'the', 'sensitivity', 'and', 'specificity', 'of', 'immunological', 'and', 'nucleic', 'acid', 'based', 'systems', 'allowing', 'an', 'ever', 'increasing', 'range', 'of', 'analytes', 'to', 'be', 'identified', 'and', 'quantitated', 'In', 'the', 'accompanying', 'articles', 'we', 'have', 'brought', 'together', 'experts', 'from', 'the', 'many', 'overlapping', 'aspects', 'of', 'this', 'arena', 'in', 'order', 'to', 'present', 'a', 'comprehensive', 'and', 'critical', 'analysis', 'of', 'these', 'technologies', '']"
90714,Synthetic biology for translational research.,2010,American journal of translational research,https://www.ncbi.nlm.nih.gov/pubmed/20733948/,"Synthetic biology involves the engineering of proteins, signaling pathways and even whole organisms using modular designs and formats. A major tool of synthetic biology is artificial gene synthesis, which provides a direct means from a conceptualized DNA sequence to the corresponding physical DNA for the construction of a variety of biological components. To date, synthetic biology has often been used to answer fundamental questions in basic research, but now is poised to greatly enhance translational research. In this review, we discuss several translational applications of synthetic biology including the construction of novel diagnostics and vaccines, development of new synthetic pathways for drug screening and biosynthesis, and the creation of engineered viruses and microbes to fight human disease. Together these and other novel translational applications of artificial gene synthesis and synthetic biology have the opportunity to make major advances for improving human health.",,1pgnmpw0,"['Synthetic', 'biology', 'involves', 'the', 'engineering', 'of', 'proteins', 'signaling', 'pathways', 'and', 'even', 'whole', 'organisms', 'using', 'modular', 'designs', 'and', 'formats', 'A', 'major', 'tool', 'of', 'synthetic', 'biology', 'is', 'artificial', 'gene', 'synthesis', 'which', 'provides', 'a', 'direct', 'means', 'from', 'a', 'conceptualized', 'DNA', 'sequence', 'to', 'the', 'corresponding', 'physical', 'DNA', 'for', 'the', 'construction', 'of', 'a', 'variety', 'of', 'biological', 'components', 'To', 'date', 'synthetic', 'biology', 'has', 'often', 'been', 'used', 'to', 'answer', 'fundamental', 'questions', 'in', 'basic', 'research', 'but', 'now', 'is', 'poised', 'to', 'greatly', 'enhance', 'translational', 'research', 'In', 'this', 'review', 'we', 'discuss', 'several', 'translational', 'applications', 'of', 'synthetic', 'biology', 'including', 'the', 'construction', 'of', 'novel', 'diagnostics', 'and', 'vaccines', 'development', 'of', 'new', 'synthetic', 'pathways', 'for', 'drug', 'screening', 'and', 'biosynthesis', 'and', 'the', 'creation', 'of', 'engineered', 'viruses', 'and', 'microbes', 'to', 'fight', 'human', 'disease', 'Together', 'these', 'and', 'other', 'novel', 'translational', 'applications', 'of', 'artificial', 'gene', 'synthesis', 'and', 'synthetic', 'biology', 'have', 'the', 'opportunity', 'to', 'make', 'major', 'advances', 'for', 'improving', 'human', 'health', '']"
90930,Epidemiology of pandemic influenza: use of surveillance and modeling for pandemic preparedness.,2006,The Journal of infectious diseases,https://www.ncbi.nlm.nih.gov/pubmed/17163395/,"Along with continual enhancement of current influenza surveillance programs, pandemic preparedness also involves application of current surveillance techniques to past pandemics to identify their viruses and patterns, as well as estimation of the potential burden of future pandemics. Although mortality surveillance has been in place in selected locations for more than a century, the recent development of molecular diagnostics has shed new light on the origin and structure of the viruses responsible for the past 3 pandemics, allowing for comparisons with new viruses identified through ongoing viral surveillance. Models previously used to estimate hospitalizations and mortality associated with past epidemics and pandemics have evolved to estimate the burden and required surge capacity of future pandemics of different severities.",,mgsgfi77,"['Along', 'with', 'continual', 'enhancement', 'of', 'current', 'influenza', 'surveillance', 'programs', 'pandemic', 'preparedness', 'also', 'involves', 'application', 'of', 'current', 'surveillance', 'techniques', 'to', 'past', 'pandemics', 'to', 'identify', 'their', 'viruses', 'and', 'patterns', 'as', 'well', 'as', 'estimation', 'of', 'the', 'potential', 'burden', 'of', 'future', 'pandemics', 'Although', 'mortality', 'surveillance', 'has', 'been', 'in', 'place', 'in', 'selected', 'locations', 'for', 'more', 'than', 'a', 'century', 'the', 'recent', 'development', 'of', 'molecular', 'diagnostics', 'has', 'shed', 'new', 'light', 'on', 'the', 'origin', 'and', 'structure', 'of', 'the', 'viruses', 'responsible', 'for', 'the', 'past', '3', 'pandemics', 'allowing', 'for', 'comparisons', 'with', 'new', 'viruses', 'identified', 'through', 'ongoing', 'viral', 'surveillance', 'Models', 'previously', 'used', 'to', 'estimate', 'hospitalizations', 'and', 'mortality', 'associated', 'with', 'past', 'epidemics', 'and', 'pandemics', 'have', 'evolved', 'to', 'estimate', 'the', 'burden', 'and', 'required', 'surge', 'capacity', 'of', 'future', 'pandemics', 'of', 'different', 'severities', '']"
91125,National laboratory surveillance of viral agents of gastroenteritis in Brazil.,1993,Bulletin of the Pan American Health Organization,https://www.ncbi.nlm.nih.gov/pubmed/8220517/,"In 1984 an enzyme immunoassay for rotavirus and adenovirus developed in the Virology Department of the Oswaldo Cruz Foundation was distributed to laboratories in 14 Brazilian states as part of a project to survey viral agents in fecal specimens from children with diarrhea. The ensuing surveillance continued for 3 to 5 years, and in 1991 the results obtained by all laboratories that tested 300 or more fecal specimens were reviewed at a workshop held in Belém. These results showed that rotavirus had been detected in 13% to 20% of the specimens tested, with positive specimens appearing to peak in the May to September ""winter"" or dry season in Brazil's central and southern states but not in the more tropical northern areas. Adenovirus, detected in 0.7% to 5.5% of the specimens tested for it, showed no seasonal variations. Many other viral agents known to cause gastroenteritis (e.g., astrovirus, small round-structured viruses, calcivirus, and group C rotavirus) were detected at centers that used electron microscopy. Picobirnavirus, a novel agent not yet associated with gastroenteritis in humans, was found by polyacrylamide gel electrophoresis in specimens from a number of centers using this technique. Vaccines to prevent rotavirus that are currently under development would be of great use in Brazil, where rotavirus is the most common cause of childhood diarrhea. Improved diagnostics will be required to assess the importance of the other viral agents.",,7jj1lyso,"['In', '1984', 'an', 'enzyme', 'immunoassay', 'for', 'rotavirus', 'and', 'adenovirus', 'developed', 'in', 'the', 'Virology', 'Department', 'of', 'the', 'Oswaldo', 'Cruz', 'Foundation', 'was', 'distributed', 'to', 'laboratories', 'in', '14', 'Brazilian', 'states', 'as', 'part', 'of', 'a', 'project', 'to', 'survey', 'viral', 'agents', 'in', 'fecal', 'specimens', 'from', 'children', 'with', 'diarrhea', 'The', 'ensuing', 'surveillance', 'continued', 'for', '3', 'to', '5', 'years', 'and', 'in', '1991', 'the', 'results', 'obtained', 'by', 'all', 'laboratories', 'that', 'tested', '300', 'or', 'more', 'fecal', 'specimens', 'were', 'reviewed', 'at', 'a', 'workshop', 'held', 'in', 'Belém', 'These', 'results', 'showed', 'that', 'rotavirus', 'had', 'been', 'detected', 'in', '13', 'to', '20', 'of', 'the', 'specimens', 'tested', 'with', 'positive', 'specimens', 'appearing', 'to', 'peak', 'in', 'the', 'May', 'to', 'September', 'winter', 'or', 'dry', 'season', 'in', 'Brazil', 's', 'central', 'and', 'southern', 'states', 'but', 'not', 'in', 'the', 'more', 'tropical', 'northern', 'areas', 'Adenovirus', 'detected', 'in', '0', '7', 'to', '5', '5', 'of', 'the', 'specimens', 'tested', 'for', 'it', 'showed', 'no', 'seasonal', 'variations', 'Many', 'other', 'viral', 'agents', 'known', 'to', 'cause', 'gastroenteritis', 'e', 'g', 'astrovirus', 'small', 'round', 'structured', 'viruses', 'calcivirus', 'and', 'group', 'C', 'rotavirus', 'were', 'detected', 'at', 'centers', 'that', 'used', 'electron', 'microscopy', 'Picobirnavirus', 'a', 'novel', 'agent', 'not', 'yet', 'associated', 'with', 'gastroenteritis', 'in', 'humans', 'was', 'found', 'by', 'polyacrylamide', 'gel', 'electrophoresis', 'in', 'specimens', 'from', 'a', 'number', 'of', 'centers', 'using', 'this', 'technique', 'Vaccines', 'to', 'prevent', 'rotavirus', 'that', 'are', 'currently', 'under', 'development', 'would', 'be', 'of', 'great', 'use', 'in', 'Brazil', 'where', 'rotavirus', 'is', 'the', 'most', 'common', 'cause', 'of', 'childhood', 'diarrhea', 'Improved', 'diagnostics', 'will', 'be', 'required', 'to', 'assess', 'the', 'importance', 'of', 'the', 'other', 'viral', 'agents', '']"
92286,Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis.,2005,Clinical science,https://www.ncbi.nlm.nih.gov/pubmed/16171460/,"qRT-PCR (real-time reverse transcription-PCR) has become the benchmark for the detection and quantification of RNA targets and is being utilized increasingly in novel clinical diagnostic assays. Quantitative results obtained by this technology are not only more informative than qualitative data, but simplify assay standardization and quality management. qRT-PCR assays are most established for the detection of viral load and therapy monitoring, and the development of SARS (severe acute respiratory syndrome)-associated coronavirus qRT-PCR assays provide a textbook example of the value of this technology for clinical diagnostics. The widespread use of qRT-PCR assays for diagnosis and the detection of disease-specific prognostic markers in leukaemia patients provide further examples of their usefulness. Their value for the detection of disease-associated mRNA expressed by circulating tumour cells in patients with solid malignancies is far less apparent, and the clinical significance of results obtained from such tests remains unclear. This is because of conceptual reservations as well as technical limitations that can interfere with the diagnostic specificity of qRT-PCR assays. Therefore, although it is evident that qRT-PCR assay has become a useful and important technology in the clinical diagnostic laboratory, it must be used appropriately and it is essential to be aware of its limitations if it is to fulfil its potential.",,z1d8i5em,"['qRT', 'PCR', 'real', 'time', 'reverse', 'transcription', 'PCR', 'has', 'become', 'the', 'benchmark', 'for', 'the', 'detection', 'and', 'quantification', 'of', 'RNA', 'targets', 'and', 'is', 'being', 'utilized', 'increasingly', 'in', 'novel', 'clinical', 'diagnostic', 'assays', 'Quantitative', 'results', 'obtained', 'by', 'this', 'technology', 'are', 'not', 'only', 'more', 'informative', 'than', 'qualitative', 'data', 'but', 'simplify', 'assay', 'standardization', 'and', 'quality', 'management', 'qRT', 'PCR', 'assays', 'are', 'most', 'established', 'for', 'the', 'detection', 'of', 'viral', 'load', 'and', 'therapy', 'monitoring', 'and', 'the', 'development', 'of', 'SARS', 'severe', 'acute', 'respiratory', 'syndrome', 'associated', 'coronavirus', 'qRT', 'PCR', 'assays', 'provide', 'a', 'textbook', 'example', 'of', 'the', 'value', 'of', 'this', 'technology', 'for', 'clinical', 'diagnostics', 'The', 'widespread', 'use', 'of', 'qRT', 'PCR', 'assays', 'for', 'diagnosis', 'and', 'the', 'detection', 'of', 'disease', 'specific', 'prognostic', 'markers', 'in', 'leukaemia', 'patients', 'provide', 'further', 'examples', 'of', 'their', 'usefulness', 'Their', 'value', 'for', 'the', 'detection', 'of', 'disease', 'associated', 'mRNA', 'expressed', 'by', 'circulating', 'tumour', 'cells', 'in', 'patients', 'with', 'solid', 'malignancies', 'is', 'far', 'less', 'apparent', 'and', 'the', 'clinical', 'significance', 'of', 'results', 'obtained', 'from', 'such', 'tests', 'remains', 'unclear', 'This', 'is', 'because', 'of', 'conceptual', 'reservations', 'as', 'well', 'as', 'technical', 'limitations', 'that', 'can', 'interfere', 'with', 'the', 'diagnostic', 'specificity', 'of', 'qRT', 'PCR', 'assays', 'Therefore', 'although', 'it', 'is', 'evident', 'that', 'qRT', 'PCR', 'assay', 'has', 'become', 'a', 'useful', 'and', 'important', 'technology', 'in', 'the', 'clinical', 'diagnostic', 'laboratory', 'it', 'must', 'be', 'used', 'appropriately', 'and', 'it', 'is', 'essential', 'to', 'be', 'aware', 'of', 'its', 'limitations', 'if', 'it', 'is', 'to', 'fulfil', 'its', 'potential', '']"
93018,Application of microbial genomic science to advanced therapeutics.,2005,Annual review of medicine,https://www.ncbi.nlm.nih.gov/pubmed/15660522/,"Since the publication of the first complete microbial genome sequence of Haemophilus influenzae in 1995, more than 200 additional microbial genome sequences have become available in the public domain. Approximately 40% of these represent important human pathogens. Comparative in silico methods, along with large-scale approaches such as transcriptomics and proteomics, are beginning to reveal insights into new virulence genes, pathogen-host interactions, and the molecular basis of host specificity. Sequence data are also starting to accumulate from multiple isolates or strains of a single pathogen, and this type of data has proven to be quite valuable in providing new insights into the genetic variability that is present in a particular species as well as in facilitating correlations between genotype and phenotype. Ultimately, a major goal of genome-enabled infectious disease research is the development of novel diagnostics, therapeutics, and vaccines.",,z3lui194,"['Since', 'the', 'publication', 'of', 'the', 'first', 'complete', 'microbial', 'genome', 'sequence', 'of', 'Haemophilus', 'influenzae', 'in', '1995', 'more', 'than', '200', 'additional', 'microbial', 'genome', 'sequences', 'have', 'become', 'available', 'in', 'the', 'public', 'domain', 'Approximately', '40', 'of', 'these', 'represent', 'important', 'human', 'pathogens', 'Comparative', 'in', 'silico', 'methods', 'along', 'with', 'large', 'scale', 'approaches', 'such', 'as', 'transcriptomics', 'and', 'proteomics', 'are', 'beginning', 'to', 'reveal', 'insights', 'into', 'new', 'virulence', 'genes', 'pathogen', 'host', 'interactions', 'and', 'the', 'molecular', 'basis', 'of', 'host', 'specificity', 'Sequence', 'data', 'are', 'also', 'starting', 'to', 'accumulate', 'from', 'multiple', 'isolates', 'or', 'strains', 'of', 'a', 'single', 'pathogen', 'and', 'this', 'type', 'of', 'data', 'has', 'proven', 'to', 'be', 'quite', 'valuable', 'in', 'providing', 'new', 'insights', 'into', 'the', 'genetic', 'variability', 'that', 'is', 'present', 'in', 'a', 'particular', 'species', 'as', 'well', 'as', 'in', 'facilitating', 'correlations', 'between', 'genotype', 'and', 'phenotype', 'Ultimately', 'a', 'major', 'goal', 'of', 'genome', 'enabled', 'infectious', 'disease', 'research', 'is', 'the', 'development', 'of', 'novel', 'diagnostics', 'therapeutics', 'and', 'vaccines', '']"
93260,Improvements in Patient Monitoring in the Intensive Care Unit: Survey Study,2020,J Med Internet Res,,"BACKGROUND: Due to demographic change and, more recently, coronavirus disease (COVID-19), the importance of modern intensive care units (ICU) is becoming apparent. One of the key components of an ICU is the continuous monitoring of patients' vital parameters. However, existing advances in informatics, signal processing, or engineering that could alleviate the burden on ICUs have not yet been applied. This could be due to the lack of user involvement in research and development. OBJECTIVE: This study focused on the satisfaction of ICU staff with current patient monitoring and their suggestions for future improvements. We aimed to identify aspects of monitoring that interrupt patient care, display devices for remote monitoring, use cases for artificial intelligence (AI), and whether ICU staff members are willing to improve their digital literacy or contribute to the improvement of patient monitoring. We further aimed to identify differences in the responses of different professional groups. METHODS: This survey study was performed with ICU staff from 4 ICUs of a German university hospital between November 2019 and January 2020. We developed a web-based 36-item survey questionnaire, by analyzing a preceding qualitative interview study with ICU staff, about the clinical requirements of future patient monitoring. Statistical analyses of questionnaire results included median values with their bootstrapped 95% confidence intervals, and chi-square tests to compare the distributions of item responses of the professional groups. RESULTS: In total, 86 of the 270 ICU physicians and nurses completed the survey questionnaire. The majority stated they felt confident using the patient monitoring equipment, but that high rates of false-positive alarms and the many sensor cables interrupted patient care. Regarding future improvements, respondents asked for wireless sensors, a reduction in the number of false-positive alarms, and hospital standard operating procedures for alarm management. Responses to the display devices proposed for remote patient monitoring were divided. Most respondents indicated it would be useful for earlier alerting or when they were responsible for multiple wards. AI for ICUs would be useful for early detection of complications and an increased risk of mortality; in addition, the AI could propose guidelines for therapy and diagnostics. Transparency, interoperability, usability, and staff training were essential to promote the use of AI. The majority wanted to learn more about new technologies for the ICU and required more time for learning. Physicians had fewer reservations than nurses about AI-based intelligent alarm management and using mobile phones for remote monitoring. CONCLUSIONS: This survey study of ICU staff revealed key improvements for patient monitoring in intensive care medicine. Hospital providers and medical device manufacturers should focus on reducing false alarms, implementing hospital alarm standard operating procedures, introducing wireless sensors, preparing for the use of AI, and enhancing the digital literacy of ICU staff. Our results may contribute to the user-centered transfer of digital technologies into practice to alleviate challenges in intensive care medicine. TRIAL REGISTRATION: ClinicalTrials.gov NCT03514173; https://clinicaltrials.gov/ct2/show/NCT03514173.",,vn5boexq,"['BACKGROUND', 'Due', 'to', 'demographic', 'change', 'and', 'more', 'recently', 'coronavirus', 'disease', 'COVID', '19', 'the', 'importance', 'of', 'modern', 'intensive', 'care', 'units', 'ICU', 'is', 'becoming', 'apparent', 'One', 'of', 'the', 'key', 'components', 'of', 'an', 'ICU', 'is', 'the', 'continuous', 'monitoring', 'of', 'patients', 'vital', 'parameters', 'However', 'existing', 'advances', 'in', 'informatics', 'signal', 'processing', 'or', 'engineering', 'that', 'could', 'alleviate', 'the', 'burden', 'on', 'ICUs', 'have', 'not', 'yet', 'been', 'applied', 'This', 'could', 'be', 'due', 'to', 'the', 'lack', 'of', 'user', 'involvement', 'in', 'research', 'and', 'development', 'OBJECTIVE', 'This', 'study', 'focused', 'on', 'the', 'satisfaction', 'of', 'ICU', 'staff', 'with', 'current', 'patient', 'monitoring', 'and', 'their', 'suggestions', 'for', 'future', 'improvements', 'We', 'aimed', 'to', 'identify', 'aspects', 'of', 'monitoring', 'that', 'interrupt', 'patient', 'care', 'display', 'devices', 'for', 'remote', 'monitoring', 'use', 'cases', 'for', 'artificial', 'intelligence', 'AI', 'and', 'whether', 'ICU', 'staff', 'members', 'are', 'willing', 'to', 'improve', 'their', 'digital', 'literacy', 'or', 'contribute', 'to', 'the', 'improvement', 'of', 'patient', 'monitoring', 'We', 'further', 'aimed', 'to', 'identify', 'differences', 'in', 'the', 'responses', 'of', 'different', 'professional', 'groups', 'METHODS', 'This', 'survey', 'study', 'was', 'performed', 'with', 'ICU', 'staff', 'from', '4', 'ICUs', 'of', 'a', 'German', 'university', 'hospital', 'between', 'November', '2019', 'and', 'January', '2020', 'We', 'developed', 'a', 'web', 'based', '36', 'item', 'survey', 'questionnaire', 'by', 'analyzing', 'a', 'preceding', 'qualitative', 'interview', 'study', 'with', 'ICU', 'staff', 'about', 'the', 'clinical', 'requirements', 'of', 'future', 'patient', 'monitoring', 'Statistical', 'analyses', 'of', 'questionnaire', 'results', 'included', 'median', 'values', 'with', 'their', 'bootstrapped', '95', 'confidence', 'intervals', 'and', 'chi', 'square', 'tests', 'to', 'compare', 'the', 'distributions', 'of', 'item', 'responses', 'of', 'the', 'professional', 'groups', 'RESULTS', 'In', 'total', '86', 'of', 'the', '270', 'ICU', 'physicians', 'and', 'nurses', 'completed', 'the', 'survey', 'questionnaire', 'The', 'majority', 'stated', 'they', 'felt', 'confident', 'using', 'the', 'patient', 'monitoring', 'equipment', 'but', 'that', 'high', 'rates', 'of', 'false', 'positive', 'alarms', 'and', 'the', 'many', 'sensor', 'cables', 'interrupted', 'patient', 'care', 'Regarding', 'future', 'improvements', 'respondents', 'asked', 'for', 'wireless', 'sensors', 'a', 'reduction', 'in', 'the', 'number', 'of', 'false', 'positive', 'alarms', 'and', 'hospital', 'standard', 'operating', 'procedures', 'for', 'alarm', 'management', 'Responses', 'to', 'the', 'display', 'devices', 'proposed', 'for', 'remote', 'patient', 'monitoring', 'were', 'divided', 'Most', 'respondents', 'indicated', 'it', 'would', 'be', 'useful', 'for', 'earlier', 'alerting', 'or', 'when', 'they', 'were', 'responsible', 'for', 'multiple', 'wards', 'AI', 'for', 'ICUs', 'would', 'be', 'useful', 'for', 'early', 'detection', 'of', 'complications', 'and', 'an', 'increased', 'risk', 'of', 'mortality', 'in', 'addition', 'the', 'AI', 'could', 'propose', 'guidelines', 'for', 'therapy', 'and', 'diagnostics', 'Transparency', 'interoperability', 'usability', 'and', 'staff', 'training', 'were', 'essential', 'to', 'promote', 'the', 'use', 'of', 'AI', 'The', 'majority', 'wanted', 'to', 'learn', 'more', 'about', 'new', 'technologies', 'for', 'the', 'ICU', 'and', 'required', 'more', 'time', 'for', 'learning', 'Physicians', 'had', 'fewer', 'reservations', 'than', 'nurses', 'about', 'AI', 'based', 'intelligent', 'alarm', 'management', 'and', 'using', 'mobile', 'phones', 'for', 'remote', 'monitoring', 'CONCLUSIONS', 'This', 'survey', 'study', 'of', 'ICU', 'staff', 'revealed', 'key', 'improvements', 'for', 'patient', 'monitoring', 'in', 'intensive', 'care', 'medicine', 'Hospital', 'providers', 'and', 'medical', 'device', 'manufacturers', 'should', 'focus', 'on', 'reducing', 'false', 'alarms', 'implementing', 'hospital', 'alarm', 'standard', 'operating', 'procedures', 'introducing', 'wireless', 'sensors', 'preparing', 'for', 'the', 'use', 'of', 'AI', 'and', 'enhancing', 'the', 'digital', 'literacy', 'of', 'ICU', 'staff', 'Our', 'results', 'may', 'contribute', 'to', 'the', 'user', 'centered', 'transfer', 'of', 'digital', 'technologies', 'into', 'practice', 'to', 'alleviate', 'challenges', 'in', 'intensive', 'care', 'medicine', 'TRIAL', 'REGISTRATION', 'ClinicalTrials', 'gov', 'NCT03514173', 'https', 'clinicaltrials', 'gov', 'ct2', 'show', 'NCT03514173', '']"
93261,Improvements in Patient Monitoring in the Intensive Care Unit: Survey Study,2020,J Med Internet Res,,"BACKGROUND: Due to demographic change and, more recently, coronavirus disease (COVID-19), the importance of modern intensive care units (ICU) is becoming apparent. One of the key components of an ICU is the continuous monitoring of patients' vital parameters. However, existing advances in informatics, signal processing, or engineering that could alleviate the burden on ICUs have not yet been applied. This could be due to the lack of user involvement in research and development. OBJECTIVE: This study focused on the satisfaction of ICU staff with current patient monitoring and their suggestions for future improvements. We aimed to identify aspects of monitoring that interrupt patient care, display devices for remote monitoring, use cases for artificial intelligence (AI), and whether ICU staff members are willing to improve their digital literacy or contribute to the improvement of patient monitoring. We further aimed to identify differences in the responses of different professional groups. METHODS: This survey study was performed with ICU staff from 4 ICUs of a German university hospital between November 2019 and January 2020. We developed a web-based 36-item survey questionnaire, by analyzing a preceding qualitative interview study with ICU staff, about the clinical requirements of future patient monitoring. Statistical analyses of questionnaire results included median values with their bootstrapped 95% confidence intervals, and chi-square tests to compare the distributions of item responses of the professional groups. RESULTS: In total, 86 of the 270 ICU physicians and nurses completed the survey questionnaire. The majority stated they felt confident using the patient monitoring equipment, but that high rates of false-positive alarms and the many sensor cables interrupted patient care. Regarding future improvements, respondents asked for wireless sensors, a reduction in the number of false-positive alarms, and hospital standard operating procedures for alarm management. Responses to the display devices proposed for remote patient monitoring were divided. Most respondents indicated it would be useful for earlier alerting or when they were responsible for multiple wards. AI for ICUs would be useful for early detection of complications and an increased risk of mortality; in addition, the AI could propose guidelines for therapy and diagnostics. Transparency, interoperability, usability, and staff training were essential to promote the use of AI. The majority wanted to learn more about new technologies for the ICU and required more time for learning. Physicians had fewer reservations than nurses about AI-based intelligent alarm management and using mobile phones for remote monitoring. CONCLUSIONS: This survey study of ICU staff revealed key improvements for patient monitoring in intensive care medicine. Hospital providers and medical device manufacturers should focus on reducing false alarms, implementing hospital alarm standard operating procedures, introducing wireless sensors, preparing for the use of AI, and enhancing the digital literacy of ICU staff. Our results may contribute to the user-centered transfer of digital technologies into practice to alleviate challenges in intensive care medicine. TRIAL REGISTRATION: ClinicalTrials.gov NCT03514173; https://clinicaltrials.gov/ct2/show/NCT03514173.",,x065xgd3,"['BACKGROUND', 'Due', 'to', 'demographic', 'change', 'and', 'more', 'recently', 'coronavirus', 'disease', 'COVID', '19', 'the', 'importance', 'of', 'modern', 'intensive', 'care', 'units', 'ICU', 'is', 'becoming', 'apparent', 'One', 'of', 'the', 'key', 'components', 'of', 'an', 'ICU', 'is', 'the', 'continuous', 'monitoring', 'of', 'patients', 'vital', 'parameters', 'However', 'existing', 'advances', 'in', 'informatics', 'signal', 'processing', 'or', 'engineering', 'that', 'could', 'alleviate', 'the', 'burden', 'on', 'ICUs', 'have', 'not', 'yet', 'been', 'applied', 'This', 'could', 'be', 'due', 'to', 'the', 'lack', 'of', 'user', 'involvement', 'in', 'research', 'and', 'development', 'OBJECTIVE', 'This', 'study', 'focused', 'on', 'the', 'satisfaction', 'of', 'ICU', 'staff', 'with', 'current', 'patient', 'monitoring', 'and', 'their', 'suggestions', 'for', 'future', 'improvements', 'We', 'aimed', 'to', 'identify', 'aspects', 'of', 'monitoring', 'that', 'interrupt', 'patient', 'care', 'display', 'devices', 'for', 'remote', 'monitoring', 'use', 'cases', 'for', 'artificial', 'intelligence', 'AI', 'and', 'whether', 'ICU', 'staff', 'members', 'are', 'willing', 'to', 'improve', 'their', 'digital', 'literacy', 'or', 'contribute', 'to', 'the', 'improvement', 'of', 'patient', 'monitoring', 'We', 'further', 'aimed', 'to', 'identify', 'differences', 'in', 'the', 'responses', 'of', 'different', 'professional', 'groups', 'METHODS', 'This', 'survey', 'study', 'was', 'performed', 'with', 'ICU', 'staff', 'from', '4', 'ICUs', 'of', 'a', 'German', 'university', 'hospital', 'between', 'November', '2019', 'and', 'January', '2020', 'We', 'developed', 'a', 'web', 'based', '36', 'item', 'survey', 'questionnaire', 'by', 'analyzing', 'a', 'preceding', 'qualitative', 'interview', 'study', 'with', 'ICU', 'staff', 'about', 'the', 'clinical', 'requirements', 'of', 'future', 'patient', 'monitoring', 'Statistical', 'analyses', 'of', 'questionnaire', 'results', 'included', 'median', 'values', 'with', 'their', 'bootstrapped', '95', 'confidence', 'intervals', 'and', 'chi', 'square', 'tests', 'to', 'compare', 'the', 'distributions', 'of', 'item', 'responses', 'of', 'the', 'professional', 'groups', 'RESULTS', 'In', 'total', '86', 'of', 'the', '270', 'ICU', 'physicians', 'and', 'nurses', 'completed', 'the', 'survey', 'questionnaire', 'The', 'majority', 'stated', 'they', 'felt', 'confident', 'using', 'the', 'patient', 'monitoring', 'equipment', 'but', 'that', 'high', 'rates', 'of', 'false', 'positive', 'alarms', 'and', 'the', 'many', 'sensor', 'cables', 'interrupted', 'patient', 'care', 'Regarding', 'future', 'improvements', 'respondents', 'asked', 'for', 'wireless', 'sensors', 'a', 'reduction', 'in', 'the', 'number', 'of', 'false', 'positive', 'alarms', 'and', 'hospital', 'standard', 'operating', 'procedures', 'for', 'alarm', 'management', 'Responses', 'to', 'the', 'display', 'devices', 'proposed', 'for', 'remote', 'patient', 'monitoring', 'were', 'divided', 'Most', 'respondents', 'indicated', 'it', 'would', 'be', 'useful', 'for', 'earlier', 'alerting', 'or', 'when', 'they', 'were', 'responsible', 'for', 'multiple', 'wards', 'AI', 'for', 'ICUs', 'would', 'be', 'useful', 'for', 'early', 'detection', 'of', 'complications', 'and', 'an', 'increased', 'risk', 'of', 'mortality', 'in', 'addition', 'the', 'AI', 'could', 'propose', 'guidelines', 'for', 'therapy', 'and', 'diagnostics', 'Transparency', 'interoperability', 'usability', 'and', 'staff', 'training', 'were', 'essential', 'to', 'promote', 'the', 'use', 'of', 'AI', 'The', 'majority', 'wanted', 'to', 'learn', 'more', 'about', 'new', 'technologies', 'for', 'the', 'ICU', 'and', 'required', 'more', 'time', 'for', 'learning', 'Physicians', 'had', 'fewer', 'reservations', 'than', 'nurses', 'about', 'AI', 'based', 'intelligent', 'alarm', 'management', 'and', 'using', 'mobile', 'phones', 'for', 'remote', 'monitoring', 'CONCLUSIONS', 'This', 'survey', 'study', 'of', 'ICU', 'staff', 'revealed', 'key', 'improvements', 'for', 'patient', 'monitoring', 'in', 'intensive', 'care', 'medicine', 'Hospital', 'providers', 'and', 'medical', 'device', 'manufacturers', 'should', 'focus', 'on', 'reducing', 'false', 'alarms', 'implementing', 'hospital', 'alarm', 'standard', 'operating', 'procedures', 'introducing', 'wireless', 'sensors', 'preparing', 'for', 'the', 'use', 'of', 'AI', 'and', 'enhancing', 'the', 'digital', 'literacy', 'of', 'ICU', 'staff', 'Our', 'results', 'may', 'contribute', 'to', 'the', 'user', 'centered', 'transfer', 'of', 'digital', 'technologies', 'into', 'practice', 'to', 'alleviate', 'challenges', 'in', 'intensive', 'care', 'medicine', 'TRIAL', 'REGISTRATION', 'ClinicalTrials', 'gov', 'NCT03514173', 'https', 'clinicaltrials', 'gov', 'ct2', 'show', 'NCT03514173', '']"
93262,Improvements in Patient Monitoring in the Intensive Care Unit: Survey Study,2020,J Med Internet Res,,"BACKGROUND: Due to demographic change and, more recently, coronavirus disease (COVID-19), the importance of modern intensive care units (ICU) is becoming apparent. One of the key components of an ICU is the continuous monitoring of patients' vital parameters. However, existing advances in informatics, signal processing, or engineering that could alleviate the burden on ICUs have not yet been applied. This could be due to the lack of user involvement in research and development. OBJECTIVE: This study focused on the satisfaction of ICU staff with current patient monitoring and their suggestions for future improvements. We aimed to identify aspects of monitoring that interrupt patient care, display devices for remote monitoring, use cases for artificial intelligence (AI), and whether ICU staff members are willing to improve their digital literacy or contribute to the improvement of patient monitoring. We further aimed to identify differences in the responses of different professional groups. METHODS: This survey study was performed with ICU staff from 4 ICUs of a German university hospital between November 2019 and January 2020. We developed a web-based 36-item survey questionnaire, by analyzing a preceding qualitative interview study with ICU staff, about the clinical requirements of future patient monitoring. Statistical analyses of questionnaire results included median values with their bootstrapped 95% confidence intervals, and chi-square tests to compare the distributions of item responses of the professional groups. RESULTS: In total, 86 of the 270 ICU physicians and nurses completed the survey questionnaire. The majority stated they felt confident using the patient monitoring equipment, but that high rates of false-positive alarms and the many sensor cables interrupted patient care. Regarding future improvements, respondents asked for wireless sensors, a reduction in the number of false-positive alarms, and hospital standard operating procedures for alarm management. Responses to the display devices proposed for remote patient monitoring were divided. Most respondents indicated it would be useful for earlier alerting or when they were responsible for multiple wards. AI for ICUs would be useful for early detection of complications and an increased risk of mortality; in addition, the AI could propose guidelines for therapy and diagnostics. Transparency, interoperability, usability, and staff training were essential to promote the use of AI. The majority wanted to learn more about new technologies for the ICU and required more time for learning. Physicians had fewer reservations than nurses about AI-based intelligent alarm management and using mobile phones for remote monitoring. CONCLUSIONS: This survey study of ICU staff revealed key improvements for patient monitoring in intensive care medicine. Hospital providers and medical device manufacturers should focus on reducing false alarms, implementing hospital alarm standard operating procedures, introducing wireless sensors, preparing for the use of AI, and enhancing the digital literacy of ICU staff. Our results may contribute to the user-centered transfer of digital technologies into practice to alleviate challenges in intensive care medicine. TRIAL REGISTRATION: ClinicalTrials.gov NCT03514173; https://clinicaltrials.gov/ct2/show/NCT03514173.",,zxr52une,"['BACKGROUND', 'Due', 'to', 'demographic', 'change', 'and', 'more', 'recently', 'coronavirus', 'disease', 'COVID', '19', 'the', 'importance', 'of', 'modern', 'intensive', 'care', 'units', 'ICU', 'is', 'becoming', 'apparent', 'One', 'of', 'the', 'key', 'components', 'of', 'an', 'ICU', 'is', 'the', 'continuous', 'monitoring', 'of', 'patients', 'vital', 'parameters', 'However', 'existing', 'advances', 'in', 'informatics', 'signal', 'processing', 'or', 'engineering', 'that', 'could', 'alleviate', 'the', 'burden', 'on', 'ICUs', 'have', 'not', 'yet', 'been', 'applied', 'This', 'could', 'be', 'due', 'to', 'the', 'lack', 'of', 'user', 'involvement', 'in', 'research', 'and', 'development', 'OBJECTIVE', 'This', 'study', 'focused', 'on', 'the', 'satisfaction', 'of', 'ICU', 'staff', 'with', 'current', 'patient', 'monitoring', 'and', 'their', 'suggestions', 'for', 'future', 'improvements', 'We', 'aimed', 'to', 'identify', 'aspects', 'of', 'monitoring', 'that', 'interrupt', 'patient', 'care', 'display', 'devices', 'for', 'remote', 'monitoring', 'use', 'cases', 'for', 'artificial', 'intelligence', 'AI', 'and', 'whether', 'ICU', 'staff', 'members', 'are', 'willing', 'to', 'improve', 'their', 'digital', 'literacy', 'or', 'contribute', 'to', 'the', 'improvement', 'of', 'patient', 'monitoring', 'We', 'further', 'aimed', 'to', 'identify', 'differences', 'in', 'the', 'responses', 'of', 'different', 'professional', 'groups', 'METHODS', 'This', 'survey', 'study', 'was', 'performed', 'with', 'ICU', 'staff', 'from', '4', 'ICUs', 'of', 'a', 'German', 'university', 'hospital', 'between', 'November', '2019', 'and', 'January', '2020', 'We', 'developed', 'a', 'web', 'based', '36', 'item', 'survey', 'questionnaire', 'by', 'analyzing', 'a', 'preceding', 'qualitative', 'interview', 'study', 'with', 'ICU', 'staff', 'about', 'the', 'clinical', 'requirements', 'of', 'future', 'patient', 'monitoring', 'Statistical', 'analyses', 'of', 'questionnaire', 'results', 'included', 'median', 'values', 'with', 'their', 'bootstrapped', '95', 'confidence', 'intervals', 'and', 'chi', 'square', 'tests', 'to', 'compare', 'the', 'distributions', 'of', 'item', 'responses', 'of', 'the', 'professional', 'groups', 'RESULTS', 'In', 'total', '86', 'of', 'the', '270', 'ICU', 'physicians', 'and', 'nurses', 'completed', 'the', 'survey', 'questionnaire', 'The', 'majority', 'stated', 'they', 'felt', 'confident', 'using', 'the', 'patient', 'monitoring', 'equipment', 'but', 'that', 'high', 'rates', 'of', 'false', 'positive', 'alarms', 'and', 'the', 'many', 'sensor', 'cables', 'interrupted', 'patient', 'care', 'Regarding', 'future', 'improvements', 'respondents', 'asked', 'for', 'wireless', 'sensors', 'a', 'reduction', 'in', 'the', 'number', 'of', 'false', 'positive', 'alarms', 'and', 'hospital', 'standard', 'operating', 'procedures', 'for', 'alarm', 'management', 'Responses', 'to', 'the', 'display', 'devices', 'proposed', 'for', 'remote', 'patient', 'monitoring', 'were', 'divided', 'Most', 'respondents', 'indicated', 'it', 'would', 'be', 'useful', 'for', 'earlier', 'alerting', 'or', 'when', 'they', 'were', 'responsible', 'for', 'multiple', 'wards', 'AI', 'for', 'ICUs', 'would', 'be', 'useful', 'for', 'early', 'detection', 'of', 'complications', 'and', 'an', 'increased', 'risk', 'of', 'mortality', 'in', 'addition', 'the', 'AI', 'could', 'propose', 'guidelines', 'for', 'therapy', 'and', 'diagnostics', 'Transparency', 'interoperability', 'usability', 'and', 'staff', 'training', 'were', 'essential', 'to', 'promote', 'the', 'use', 'of', 'AI', 'The', 'majority', 'wanted', 'to', 'learn', 'more', 'about', 'new', 'technologies', 'for', 'the', 'ICU', 'and', 'required', 'more', 'time', 'for', 'learning', 'Physicians', 'had', 'fewer', 'reservations', 'than', 'nurses', 'about', 'AI', 'based', 'intelligent', 'alarm', 'management', 'and', 'using', 'mobile', 'phones', 'for', 'remote', 'monitoring', 'CONCLUSIONS', 'This', 'survey', 'study', 'of', 'ICU', 'staff', 'revealed', 'key', 'improvements', 'for', 'patient', 'monitoring', 'in', 'intensive', 'care', 'medicine', 'Hospital', 'providers', 'and', 'medical', 'device', 'manufacturers', 'should', 'focus', 'on', 'reducing', 'false', 'alarms', 'implementing', 'hospital', 'alarm', 'standard', 'operating', 'procedures', 'introducing', 'wireless', 'sensors', 'preparing', 'for', 'the', 'use', 'of', 'AI', 'and', 'enhancing', 'the', 'digital', 'literacy', 'of', 'ICU', 'staff', 'Our', 'results', 'may', 'contribute', 'to', 'the', 'user', 'centered', 'transfer', 'of', 'digital', 'technologies', 'into', 'practice', 'to', 'alleviate', 'challenges', 'in', 'intensive', 'care', 'medicine', 'TRIAL', 'REGISTRATION', 'ClinicalTrials', 'gov', 'NCT03514173', 'https', 'clinicaltrials', 'gov', 'ct2', 'show', 'NCT03514173', '']"
97971,"SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions",2020,Viruses,,"The COVID-19 pandemic is due to infection caused by the novel SARS-CoV-2 virus that impacts the lower respiratory tract. The spectrum of symptoms ranges from asymptomatic infections to mild respiratory symptoms to the lethal form of COVID-19 which is associated with severe pneumonia, acute respiratory distress, and fatality. To address this global crisis, up-to-date information on viral genomics and transcriptomics is crucial for understanding the origins and global dispersion of the virus, providing insights into viral pathogenicity, transmission, and epidemiology, and enabling strategies for therapeutic interventions, drug discovery, and vaccine development. Therefore, this review provides a comprehensive overview of COVID-19 epidemiology, genomic etiology, findings from recent transcriptomic map analysis, viral-human protein interactions, molecular diagnostics, and the current status of vaccine and novel therapeutic intervention development. Moreover, we provide an extensive list of resources that will help the scientific community access numerous types of databases related to SARS-CoV-2 OMICs and approaches to therapeutics related to COVID-19 treatment.",,5c2h6e2v,"['The', 'COVID', '19', 'pandemic', 'is', 'due', 'to', 'infection', 'caused', 'by', 'the', 'novel', 'SARS', 'CoV', '2', 'virus', 'that', 'impacts', 'the', 'lower', 'respiratory', 'tract', 'The', 'spectrum', 'of', 'symptoms', 'ranges', 'from', 'asymptomatic', 'infections', 'to', 'mild', 'respiratory', 'symptoms', 'to', 'the', 'lethal', 'form', 'of', 'COVID', '19', 'which', 'is', 'associated', 'with', 'severe', 'pneumonia', 'acute', 'respiratory', 'distress', 'and', 'fatality', 'To', 'address', 'this', 'global', 'crisis', 'up', 'to', 'date', 'information', 'on', 'viral', 'genomics', 'and', 'transcriptomics', 'is', 'crucial', 'for', 'understanding', 'the', 'origins', 'and', 'global', 'dispersion', 'of', 'the', 'virus', 'providing', 'insights', 'into', 'viral', 'pathogenicity', 'transmission', 'and', 'epidemiology', 'and', 'enabling', 'strategies', 'for', 'therapeutic', 'interventions', 'drug', 'discovery', 'and', 'vaccine', 'development', 'Therefore', 'this', 'review', 'provides', 'a', 'comprehensive', 'overview', 'of', 'COVID', '19', 'epidemiology', 'genomic', 'etiology', 'findings', 'from', 'recent', 'transcriptomic', 'map', 'analysis', 'viral', 'human', 'protein', 'interactions', 'molecular', 'diagnostics', 'and', 'the', 'current', 'status', 'of', 'vaccine', 'and', 'novel', 'therapeutic', 'intervention', 'development', 'Moreover', 'we', 'provide', 'an', 'extensive', 'list', 'of', 'resources', 'that', 'will', 'help', 'the', 'scientific', 'community', 'access', 'numerous', 'types', 'of', 'databases', 'related', 'to', 'SARS', 'CoV', '2', 'OMICs', 'and', 'approaches', 'to', 'therapeutics', 'related', 'to', 'COVID', '19', 'treatment', '']"
98381,"2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness",2020,J Infect Dev Ctries,,"On 31 December 2019 the Wuhan Health Commission reported a cluster of atypical pneumonia cases that was linked to a wet market in the city of Wuhan, China. The first patients began experiencing symptoms of illness in mid-December 2019. Clinical isolates were found to contain a novel coronavirus with similarity to bat coronaviruses. As of 28 January 2020, there are in excess of 4,500 laboratory-confirmed cases, with > 100 known deaths. As with the SARS-CoV, infections in children appear to be rare. Travel-related cases have been confirmed in multiple countries and regions outside mainland China including Germany, France, Thailand, Japan, South Korea, Vietnam, Canada, and the United States, as well as Hong Kong and Taiwan. Domestically in China, the virus has also been noted in several cities and provinces with cases in all but one provinence. While zoonotic transmission appears to be the original source of infections, the most alarming development is that human-to-human transmission is now prevelant. Of particular concern is that many healthcare workers have been infected in the current epidemic. There are several critical clinical questions that need to be resolved, including how efficient is human-to-human transmission? What is the animal reservoir? Is there an intermediate animal reservoir? Do the vaccines generated to the SARS-CoV or MERS-CoV or their proteins offer protection against 2019-nCoV? We offer a research perspective on the next steps for the generation of vaccines. We also present data on the use of in silico docking in gaining insight into 2019-nCoV Spike-receptor binding to aid in therapeutic development. Diagnostic PCR protocols can be found at https://www.who.int/health-topics/coronavirus/laboratory-diagnostics-for-novel-coronavirus.",,bu1ib2ul,"['On', '31', 'December', '2019', 'the', 'Wuhan', 'Health', 'Commission', 'reported', 'a', 'cluster', 'of', 'atypical', 'pneumonia', 'cases', 'that', 'was', 'linked', 'to', 'a', 'wet', 'market', 'in', 'the', 'city', 'of', 'Wuhan', 'China', 'The', 'first', 'patients', 'began', 'experiencing', 'symptoms', 'of', 'illness', 'in', 'mid', 'December', '2019', 'Clinical', 'isolates', 'were', 'found', 'to', 'contain', 'a', 'novel', 'coronavirus', 'with', 'similarity', 'to', 'bat', 'coronaviruses', 'As', 'of', '28', 'January', '2020', 'there', 'are', 'in', 'excess', 'of', '4', '500', 'laboratory', 'confirmed', 'cases', 'with', '100', 'known', 'deaths', 'As', 'with', 'the', 'SARS', 'CoV', 'infections', 'in', 'children', 'appear', 'to', 'be', 'rare', 'Travel', 'related', 'cases', 'have', 'been', 'confirmed', 'in', 'multiple', 'countries', 'and', 'regions', 'outside', 'mainland', 'China', 'including', 'Germany', 'France', 'Thailand', 'Japan', 'South', 'Korea', 'Vietnam', 'Canada', 'and', 'the', 'United', 'States', 'as', 'well', 'as', 'Hong', 'Kong', 'and', 'Taiwan', 'Domestically', 'in', 'China', 'the', 'virus', 'has', 'also', 'been', 'noted', 'in', 'several', 'cities', 'and', 'provinces', 'with', 'cases', 'in', 'all', 'but', 'one', 'provinence', 'While', 'zoonotic', 'transmission', 'appears', 'to', 'be', 'the', 'original', 'source', 'of', 'infections', 'the', 'most', 'alarming', 'development', 'is', 'that', 'human', 'to', 'human', 'transmission', 'is', 'now', 'prevelant', 'Of', 'particular', 'concern', 'is', 'that', 'many', 'healthcare', 'workers', 'have', 'been', 'infected', 'in', 'the', 'current', 'epidemic', 'There', 'are', 'several', 'critical', 'clinical', 'questions', 'that', 'need', 'to', 'be', 'resolved', 'including', 'how', 'efficient', 'is', 'human', 'to', 'human', 'transmission', 'What', 'is', 'the', 'animal', 'reservoir', 'Is', 'there', 'an', 'intermediate', 'animal', 'reservoir', 'Do', 'the', 'vaccines', 'generated', 'to', 'the', 'SARS', 'CoV', 'or', 'MERS', 'CoV', 'or', 'their', 'proteins', 'offer', 'protection', 'against', '2019', 'nCoV', 'We', 'offer', 'a', 'research', 'perspective', 'on', 'the', 'next', 'steps', 'for', 'the', 'generation', 'of', 'vaccines', 'We', 'also', 'present', 'data', 'on', 'the', 'use', 'of', 'in', 'silico', 'docking', 'in', 'gaining', 'insight', 'into', '2019', 'nCoV', 'Spike', 'receptor', 'binding', 'to', 'aid', 'in', 'therapeutic', 'development', 'Diagnostic', 'PCR', 'protocols', 'can', 'be', 'found', 'at', 'https', 'www', 'who', 'int', 'health', 'topics', 'coronavirus', 'laboratory', 'diagnostics', 'for', 'novel', 'coronavirus', '']"
98660,Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019-2020,2020,Virusdisease,,"Wuhan, the city in Hubei province in China is in the focus of global community due to the outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), formerly known as 2019-nCoV. The virus emerged in humans from Wuhan seafood market probably via zoonotic transmission. Within a few days the virus spread its tentacles rapidly to neighboring cities in China and to different geographical regions through travelers and to some extent by human to human transmission leading to significant disease burden globally. More than 2,00,000 people (including more than 8000 deaths) have been infected with this respiratory illness across 167 countries and territories worldwide leading to a pandemic. The present review provides an outline about emergence and spread of SARS-CoV-2 from Wuhan, China in 2019-2020. We have also provided information about the classification, genome, proteins, clinical presentation of COVID-19, type of clinical specimens to be collected and diagnostic methods adopted to identify the respiratory illness. In addition we have also provided information about transmission dynamics, prevention measures and treatment options that are available at the present. Subsequently, we have given a comprehensive overview of the spread of this infection from China to the other parts of the globe. Management of the ongoing outbreak of SARS-CoV-2 encompassing surveillance, clinical, immunological, genetic and evolutionary investigations are likely to provide the desired results. Joint efforts of global scientific community are needed at this hour in terms of enhancement of research on development of accurate diagnostics, antiviral therapeutics and finally into formation of an effective vaccine against the emerging novel coronavirus.",,9yenf9w3,"['Wuhan', 'the', 'city', 'in', 'Hubei', 'province', 'in', 'China', 'is', 'in', 'the', 'focus', 'of', 'global', 'community', 'due', 'to', 'the', 'outbreak', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'formerly', 'known', 'as', '2019', 'nCoV', 'The', 'virus', 'emerged', 'in', 'humans', 'from', 'Wuhan', 'seafood', 'market', 'probably', 'via', 'zoonotic', 'transmission', 'Within', 'a', 'few', 'days', 'the', 'virus', 'spread', 'its', 'tentacles', 'rapidly', 'to', 'neighboring', 'cities', 'in', 'China', 'and', 'to', 'different', 'geographical', 'regions', 'through', 'travelers', 'and', 'to', 'some', 'extent', 'by', 'human', 'to', 'human', 'transmission', 'leading', 'to', 'significant', 'disease', 'burden', 'globally', 'More', 'than', '2', '00', '000', 'people', 'including', 'more', 'than', '8000', 'deaths', 'have', 'been', 'infected', 'with', 'this', 'respiratory', 'illness', 'across', '167', 'countries', 'and', 'territories', 'worldwide', 'leading', 'to', 'a', 'pandemic', 'The', 'present', 'review', 'provides', 'an', 'outline', 'about', 'emergence', 'and', 'spread', 'of', 'SARS', 'CoV', '2', 'from', 'Wuhan', 'China', 'in', '2019', '2020', 'We', 'have', 'also', 'provided', 'information', 'about', 'the', 'classification', 'genome', 'proteins', 'clinical', 'presentation', 'of', 'COVID', '19', 'type', 'of', 'clinical', 'specimens', 'to', 'be', 'collected', 'and', 'diagnostic', 'methods', 'adopted', 'to', 'identify', 'the', 'respiratory', 'illness', 'In', 'addition', 'we', 'have', 'also', 'provided', 'information', 'about', 'transmission', 'dynamics', 'prevention', 'measures', 'and', 'treatment', 'options', 'that', 'are', 'available', 'at', 'the', 'present', 'Subsequently', 'we', 'have', 'given', 'a', 'comprehensive', 'overview', 'of', 'the', 'spread', 'of', 'this', 'infection', 'from', 'China', 'to', 'the', 'other', 'parts', 'of', 'the', 'globe', 'Management', 'of', 'the', 'ongoing', 'outbreak', 'of', 'SARS', 'CoV', '2', 'encompassing', 'surveillance', 'clinical', 'immunological', 'genetic', 'and', 'evolutionary', 'investigations', 'are', 'likely', 'to', 'provide', 'the', 'desired', 'results', 'Joint', 'efforts', 'of', 'global', 'scientific', 'community', 'are', 'needed', 'at', 'this', 'hour', 'in', 'terms', 'of', 'enhancement', 'of', 'research', 'on', 'development', 'of', 'accurate', 'diagnostics', 'antiviral', 'therapeutics', 'and', 'finally', 'into', 'formation', 'of', 'an', 'effective', 'vaccine', 'against', 'the', 'emerging', 'novel', 'coronavirus', '']"
100850,Emerging technologies for diagnostics and drug delivery in the fight against COVID-19 and other pandemics,2020,Expert Rev Med Devices,,"INTRODUCTION: A pandemic is the worst-case scenario in the field of infectious diseases. Innovative technologies have the potential to address the challenges associated with the manufacture of personalized drug delivery systems, biosensors, and medical devices during a pandemic. 3D-Printing, microfluidics, and Microelectromechanical systems (MEMS) can provide an important part on this fight, as are cheap, easy to be operated, capable to provide rapid detection and monitoring of a disease, and deliver medicines. AREAS COVERED: This manuscript answers the question of how these emerging technologies can save lives during a pandemic by avoiding supply chain delays and also by providing rapid diagnostics, disease monitoring, or by offering personalized treatments. The manuscript covers recent approaches in the topic with a focus in manuscripts published in the last year and by emphasising recent regulatory considerations by regulatory agencies in the manufacturing of 3DP systems or other medical devices during COVID. EXPERT OPINION: New manufacturing techniques are emerging with the ability to address the challenges associated with the development of medical devices or diagnostics, during a pandemic. Are many challenges in order to achieve this and especially in short times that are required under a pandemic attack, which will also be covered in this manuscript.",,eihyii1k,"['INTRODUCTION', 'A', 'pandemic', 'is', 'the', 'worst', 'case', 'scenario', 'in', 'the', 'field', 'of', 'infectious', 'diseases', 'Innovative', 'technologies', 'have', 'the', 'potential', 'to', 'address', 'the', 'challenges', 'associated', 'with', 'the', 'manufacture', 'of', 'personalized', 'drug', 'delivery', 'systems', 'biosensors', 'and', 'medical', 'devices', 'during', 'a', 'pandemic', '3D', 'Printing', 'microfluidics', 'and', 'Microelectromechanical', 'systems', 'MEMS', 'can', 'provide', 'an', 'important', 'part', 'on', 'this', 'fight', 'as', 'are', 'cheap', 'easy', 'to', 'be', 'operated', 'capable', 'to', 'provide', 'rapid', 'detection', 'and', 'monitoring', 'of', 'a', 'disease', 'and', 'deliver', 'medicines', 'AREAS', 'COVERED', 'This', 'manuscript', 'answers', 'the', 'question', 'of', 'how', 'these', 'emerging', 'technologies', 'can', 'save', 'lives', 'during', 'a', 'pandemic', 'by', 'avoiding', 'supply', 'chain', 'delays', 'and', 'also', 'by', 'providing', 'rapid', 'diagnostics', 'disease', 'monitoring', 'or', 'by', 'offering', 'personalized', 'treatments', 'The', 'manuscript', 'covers', 'recent', 'approaches', 'in', 'the', 'topic', 'with', 'a', 'focus', 'in', 'manuscripts', 'published', 'in', 'the', 'last', 'year', 'and', 'by', 'emphasising', 'recent', 'regulatory', 'considerations', 'by', 'regulatory', 'agencies', 'in', 'the', 'manufacturing', 'of', '3DP', 'systems', 'or', 'other', 'medical', 'devices', 'during', 'COVID', 'EXPERT', 'OPINION', 'New', 'manufacturing', 'techniques', 'are', 'emerging', 'with', 'the', 'ability', 'to', 'address', 'the', 'challenges', 'associated', 'with', 'the', 'development', 'of', 'medical', 'devices', 'or', 'diagnostics', 'during', 'a', 'pandemic', 'Are', 'many', 'challenges', 'in', 'order', 'to', 'achieve', 'this', 'and', 'especially', 'in', 'short', 'times', 'that', 'are', 'required', 'under', 'a', 'pandemic', 'attack', 'which', 'will', 'also', 'be', 'covered', 'in', 'this', 'manuscript', '']"
101264,Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2,2020,Viruses,,"The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, clinical treatment, and development of vaccines, is urgently needed to win the battle against COVID-19. The past three unprecedented outbreaks of emerging human coronavirus infections at the beginning of the 21st century have highlighted the importance of readily available, accurate, and rapid diagnostic technologies to contain emerging and re-emerging pandemics. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) based assays performed on respiratory specimens remain the gold standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging with high sensitivity and specificity as well. Even though excellent techniques are available for the diagnosis of symptomatic patients with COVID-19 in well-equipped laboratories; critical gaps still remain in screening asymptomatic people who are in the incubation phase of the virus, as well as in the accurate determination of live viral shedding during convalescence to inform decisions for ending isolation. This review article aims to discuss the currently available laboratory methods and surveillance technologies available for the detection of COVID-19, their performance characteristics and highlight the gaps in current diagnostic capacity, and finally, propose potential solutions. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of COVID-19.",,nm8a3jxt,"['The', 'recent', 'outbreak', 'of', 'the', 'Coronavirus', 'disease', '2019', 'COVID', '19', 'has', 'quickly', 'spread', 'worldwide', 'since', 'its', 'discovery', 'in', 'Wuhan', 'city', 'China', 'in', 'December', '2019', 'A', 'comprehensive', 'strategy', 'including', 'surveillance', 'diagnostics', 'research', 'clinical', 'treatment', 'and', 'development', 'of', 'vaccines', 'is', 'urgently', 'needed', 'to', 'win', 'the', 'battle', 'against', 'COVID', '19', 'The', 'past', 'three', 'unprecedented', 'outbreaks', 'of', 'emerging', 'human', 'coronavirus', 'infections', 'at', 'the', 'beginning', 'of', 'the', '21st', 'century', 'have', 'highlighted', 'the', 'importance', 'of', 'readily', 'available', 'accurate', 'and', 'rapid', 'diagnostic', 'technologies', 'to', 'contain', 'emerging', 'and', 're', 'emerging', 'pandemics', 'Real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'rRT', 'PCR', 'based', 'assays', 'performed', 'on', 'respiratory', 'specimens', 'remain', 'the', 'gold', 'standard', 'for', 'COVID', '19', 'diagnostics', 'However', 'point', 'of', 'care', 'technologies', 'and', 'serologic', 'immunoassays', 'are', 'rapidly', 'emerging', 'with', 'high', 'sensitivity', 'and', 'specificity', 'as', 'well', 'Even', 'though', 'excellent', 'techniques', 'are', 'available', 'for', 'the', 'diagnosis', 'of', 'symptomatic', 'patients', 'with', 'COVID', '19', 'in', 'well', 'equipped', 'laboratories', 'critical', 'gaps', 'still', 'remain', 'in', 'screening', 'asymptomatic', 'people', 'who', 'are', 'in', 'the', 'incubation', 'phase', 'of', 'the', 'virus', 'as', 'well', 'as', 'in', 'the', 'accurate', 'determination', 'of', 'live', 'viral', 'shedding', 'during', 'convalescence', 'to', 'inform', 'decisions', 'for', 'ending', 'isolation', 'This', 'review', 'article', 'aims', 'to', 'discuss', 'the', 'currently', 'available', 'laboratory', 'methods', 'and', 'surveillance', 'technologies', 'available', 'for', 'the', 'detection', 'of', 'COVID', '19', 'their', 'performance', 'characteristics', 'and', 'highlight', 'the', 'gaps', 'in', 'current', 'diagnostic', 'capacity', 'and', 'finally', 'propose', 'potential', 'solutions', 'We', 'also', 'summarize', 'the', 'specifications', 'of', 'the', 'majority', 'of', 'the', 'available', 'commercial', 'kits', 'PCR', 'EIA', 'and', 'POC', 'for', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
102294,Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests,2020,J Clin Virol,,"The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) has been followed by the rapid development of antibody tests. To assess the utility of the tests for clinical use and seroepidemiologic studies, we examined the sensitivity of commercial antibody tests from Roche, Abbott, Novatec, Virotech Siemens, Euroimmun, and Mediagnost in a prospective diagnostic study. The tests were evaluated with 73 sera from SARS CoV-2 RNA positive individuals with mild to moderate disease or asymptomatic infection. Sera were obtained at 2-3 weeks (Nâ¯=â¯25) or > 4 weeks (Nâ¯=â¯48) after symptom onset and viral RNA test. The overall sensitivity of the tests ranged from 64.4-93.2%. The most sensitive assays recognized 95.8-100 % of the sera obtained after 4 weeks or later. Sera drawn at 2-3 weeks were recognized with lower sensitivity indicating that the optimal time point for serologic testing is later than 3 weeks after onset of the disease. Nucleoprotein- and glycoproteinbased assays had similar sensitivity indicating that tests with both antigens are suitable for serological diagnostics. Breakdown of the test results showed that nucleoprotein- and glycoprotein-based tests of comparable sensitivity reacted with different sets of sera. The observation indicates that a combination of nucleoprotein- and glycoprotein-based tests would increase the percentage of positive results.",,57fkrkiz,"['The', 'emergence', 'of', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'been', 'followed', 'by', 'the', 'rapid', 'development', 'of', 'antibody', 'tests', 'To', 'assess', 'the', 'utility', 'of', 'the', 'tests', 'for', 'clinical', 'use', 'and', 'seroepidemiologic', 'studies', 'we', 'examined', 'the', 'sensitivity', 'of', 'commercial', 'antibody', 'tests', 'from', 'Roche', 'Abbott', 'Novatec', 'Virotech', 'Siemens', 'Euroimmun', 'and', 'Mediagnost', 'in', 'a', 'prospective', 'diagnostic', 'study', 'The', 'tests', 'were', 'evaluated', 'with', '73', 'sera', 'from', 'SARS', 'CoV', '2', 'RNA', 'positive', 'individuals', 'with', 'mild', 'to', 'moderate', 'disease', 'or', 'asymptomatic', 'infection', 'Sera', 'were', 'obtained', 'at', '2', '3', 'weeks', 'Nâ', 'â', '25', 'or', '4', 'weeks', 'Nâ', 'â', '48', 'after', 'symptom', 'onset', 'and', 'viral', 'RNA', 'test', 'The', 'overall', 'sensitivity', 'of', 'the', 'tests', 'ranged', 'from', '64', '4', '93', '2', 'The', 'most', 'sensitive', 'assays', 'recognized', '95', '8', '100', 'of', 'the', 'sera', 'obtained', 'after', '4', 'weeks', 'or', 'later', 'Sera', 'drawn', 'at', '2', '3', 'weeks', 'were', 'recognized', 'with', 'lower', 'sensitivity', 'indicating', 'that', 'the', 'optimal', 'time', 'point', 'for', 'serologic', 'testing', 'is', 'later', 'than', '3', 'weeks', 'after', 'onset', 'of', 'the', 'disease', 'Nucleoprotein', 'and', 'glycoproteinbased', 'assays', 'had', 'similar', 'sensitivity', 'indicating', 'that', 'tests', 'with', 'both', 'antigens', 'are', 'suitable', 'for', 'serological', 'diagnostics', 'Breakdown', 'of', 'the', 'test', 'results', 'showed', 'that', 'nucleoprotein', 'and', 'glycoprotein', 'based', 'tests', 'of', 'comparable', 'sensitivity', 'reacted', 'with', 'different', 'sets', 'of', 'sera', 'The', 'observation', 'indicates', 'that', 'a', 'combination', 'of', 'nucleoprotein', 'and', 'glycoprotein', 'based', 'tests', 'would', 'increase', 'the', 'percentage', 'of', 'positive', 'results', '']"
102425,Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes,2020,Bioinformatics,,"SUMMARY: Genome detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next-generation sequencing datasets. This application allows the identification of phylogenetic clusters and genotypes from assembled genomes in FASTA format. Since its release in 2019, we have produced a number of typing tools for emergent viruses that have caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil. Here, we present the Genome Detective Coronavirus Typing Tool that can accurately identify the novel severe acute respiratory syndrome (SARS)-related coronavirus (SARS-CoV-2) sequences isolated in China and around the world. The tool can accept up to 2000 sequences per submission and the analysis of a new whole-genome sequence will take approximately 1 min. The tool has been tested and validated with hundreds of whole genomes from 10 coronavirus species, and correctly classified all of the SARS-related coronavirus (SARSr-CoV) and all of the available public data for SARS-CoV-2. The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines to stop the COVID-19 disease. AVAILABILITY AND IMPLEMENTATION: https://www.genomedetective.com/app/typingtool/cov. CONTACT: koen@emweb.be or deoliveira@ukzn.ac.za. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.",,88hswyln,"['SUMMARY', 'Genome', 'detective', 'is', 'a', 'web', 'based', 'user', 'friendly', 'software', 'application', 'to', 'quickly', 'and', 'accurately', 'assemble', 'all', 'known', 'virus', 'genomes', 'from', 'next', 'generation', 'sequencing', 'datasets', 'This', 'application', 'allows', 'the', 'identification', 'of', 'phylogenetic', 'clusters', 'and', 'genotypes', 'from', 'assembled', 'genomes', 'in', 'FASTA', 'format', 'Since', 'its', 'release', 'in', '2019', 'we', 'have', 'produced', 'a', 'number', 'of', 'typing', 'tools', 'for', 'emergent', 'viruses', 'that', 'have', 'caused', 'large', 'outbreaks', 'such', 'as', 'Zika', 'and', 'Yellow', 'Fever', 'Virus', 'in', 'Brazil', 'Here', 'we', 'present', 'the', 'Genome', 'Detective', 'Coronavirus', 'Typing', 'Tool', 'that', 'can', 'accurately', 'identify', 'the', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'related', 'coronavirus', 'SARS', 'CoV', '2', 'sequences', 'isolated', 'in', 'China', 'and', 'around', 'the', 'world', 'The', 'tool', 'can', 'accept', 'up', 'to', '2000', 'sequences', 'per', 'submission', 'and', 'the', 'analysis', 'of', 'a', 'new', 'whole', 'genome', 'sequence', 'will', 'take', 'approximately', '1', 'min', 'The', 'tool', 'has', 'been', 'tested', 'and', 'validated', 'with', 'hundreds', 'of', 'whole', 'genomes', 'from', '10', 'coronavirus', 'species', 'and', 'correctly', 'classified', 'all', 'of', 'the', 'SARS', 'related', 'coronavirus', 'SARSr', 'CoV', 'and', 'all', 'of', 'the', 'available', 'public', 'data', 'for', 'SARS', 'CoV', '2', 'The', 'tool', 'also', 'allows', 'tracking', 'of', 'new', 'viral', 'mutations', 'as', 'the', 'outbreak', 'expands', 'globally', 'which', 'may', 'help', 'to', 'accelerate', 'the', 'development', 'of', 'novel', 'diagnostics', 'drugs', 'and', 'vaccines', 'to', 'stop', 'the', 'COVID', '19', 'disease', 'AVAILABILITY', 'AND', 'IMPLEMENTATION', 'https', 'www', 'genomedetective', 'com', 'app', 'typingtool', 'cov', 'CONTACT', 'koen', 'emweb', 'be', 'or', 'deoliveira', 'ukzn', 'ac', 'za', 'SUPPLEMENTARY', 'INFORMATION', 'Supplementary', 'data', 'are', 'available', 'at', 'Bioinformatics', 'online', '']"
102426,Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes,2020,Bioinformatics,,"SUMMARY: Genome detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next-generation sequencing datasets. This application allows the identification of phylogenetic clusters and genotypes from assembled genomes in FASTA format. Since its release in 2019, we have produced a number of typing tools for emergent viruses that have caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil. Here, we present the Genome Detective Coronavirus Typing Tool that can accurately identify the novel severe acute respiratory syndrome (SARS)-related coronavirus (SARS-CoV-2) sequences isolated in China and around the world. The tool can accept up to 2000 sequences per submission and the analysis of a new whole-genome sequence will take approximately 1 min. The tool has been tested and validated with hundreds of whole genomes from 10 coronavirus species, and correctly classified all of the SARS-related coronavirus (SARSr-CoV) and all of the available public data for SARS-CoV-2. The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines to stop the COVID-19 disease. AVAILABILITY AND IMPLEMENTATION: https://www.genomedetective.com/app/typingtool/cov. CONTACT: koen@emweb.be or deoliveira@ukzn.ac.za. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.",,xgpxa84g,"['SUMMARY', 'Genome', 'detective', 'is', 'a', 'web', 'based', 'user', 'friendly', 'software', 'application', 'to', 'quickly', 'and', 'accurately', 'assemble', 'all', 'known', 'virus', 'genomes', 'from', 'next', 'generation', 'sequencing', 'datasets', 'This', 'application', 'allows', 'the', 'identification', 'of', 'phylogenetic', 'clusters', 'and', 'genotypes', 'from', 'assembled', 'genomes', 'in', 'FASTA', 'format', 'Since', 'its', 'release', 'in', '2019', 'we', 'have', 'produced', 'a', 'number', 'of', 'typing', 'tools', 'for', 'emergent', 'viruses', 'that', 'have', 'caused', 'large', 'outbreaks', 'such', 'as', 'Zika', 'and', 'Yellow', 'Fever', 'Virus', 'in', 'Brazil', 'Here', 'we', 'present', 'the', 'Genome', 'Detective', 'Coronavirus', 'Typing', 'Tool', 'that', 'can', 'accurately', 'identify', 'the', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'related', 'coronavirus', 'SARS', 'CoV', '2', 'sequences', 'isolated', 'in', 'China', 'and', 'around', 'the', 'world', 'The', 'tool', 'can', 'accept', 'up', 'to', '2000', 'sequences', 'per', 'submission', 'and', 'the', 'analysis', 'of', 'a', 'new', 'whole', 'genome', 'sequence', 'will', 'take', 'approximately', '1', 'min', 'The', 'tool', 'has', 'been', 'tested', 'and', 'validated', 'with', 'hundreds', 'of', 'whole', 'genomes', 'from', '10', 'coronavirus', 'species', 'and', 'correctly', 'classified', 'all', 'of', 'the', 'SARS', 'related', 'coronavirus', 'SARSr', 'CoV', 'and', 'all', 'of', 'the', 'available', 'public', 'data', 'for', 'SARS', 'CoV', '2', 'The', 'tool', 'also', 'allows', 'tracking', 'of', 'new', 'viral', 'mutations', 'as', 'the', 'outbreak', 'expands', 'globally', 'which', 'may', 'help', 'to', 'accelerate', 'the', 'development', 'of', 'novel', 'diagnostics', 'drugs', 'and', 'vaccines', 'to', 'stop', 'the', 'COVID', '19', 'disease', 'AVAILABILITY', 'AND', 'IMPLEMENTATION', 'https', 'www', 'genomedetective', 'com', 'app', 'typingtool', 'cov', 'CONTACT', 'koen', 'emweb', 'be', 'or', 'deoliveira', 'ukzn', 'ac', 'za', 'SUPPLEMENTARY', 'INFORMATION', 'Supplementary', 'data', 'are', 'available', 'at', 'Bioinformatics', 'online', '']"
103570,Using Artificial Intelligence in Infection Prevention,2020,Curr Treat Options Infect Dis,,"Purpose of Review: Artificial intelligence (AI) offers huge potential in infection prevention and control (IPC). We explore its potential IPC benefits in epidemiology, laboratory infection diagnosis, and hand hygiene. Recent Findings: AI has the potential to detect transmission events during outbreaks or predict high-risk patients, enabling development of tailored IPC interventions. AI offers opportunities to enhance diagnostics with objective pattern recognition, standardize the diagnosis of infections with IPC implications, and facilitate the dissemination of IPC expertise. AI hand hygiene applications can deliver behavior change, though it requires further evaluation in different clinical settings. However, staff can become dependent on automatic reminders, and performance returns to baseline if feedback is removed. Summary: Advantages for IPC include speed, consistency, and capability of handling infinitely large datasets. However, many challenges remain; improving the availability of high-quality representative datasets and consideration of biases within preexisting databases are important challenges for future developments. AI in itself will not improve IPC; this requires culture and behavior change. Most studies to date assess performance retrospectively so there is a need for prospective evaluation in the real-life, often chaotic, clinical setting. Close collaboration with IPC experts to interpret outputs and ensure clinical relevance is essential.",,u743tnug,"['Purpose', 'of', 'Review', 'Artificial', 'intelligence', 'AI', 'offers', 'huge', 'potential', 'in', 'infection', 'prevention', 'and', 'control', 'IPC', 'We', 'explore', 'its', 'potential', 'IPC', 'benefits', 'in', 'epidemiology', 'laboratory', 'infection', 'diagnosis', 'and', 'hand', 'hygiene', 'Recent', 'Findings', 'AI', 'has', 'the', 'potential', 'to', 'detect', 'transmission', 'events', 'during', 'outbreaks', 'or', 'predict', 'high', 'risk', 'patients', 'enabling', 'development', 'of', 'tailored', 'IPC', 'interventions', 'AI', 'offers', 'opportunities', 'to', 'enhance', 'diagnostics', 'with', 'objective', 'pattern', 'recognition', 'standardize', 'the', 'diagnosis', 'of', 'infections', 'with', 'IPC', 'implications', 'and', 'facilitate', 'the', 'dissemination', 'of', 'IPC', 'expertise', 'AI', 'hand', 'hygiene', 'applications', 'can', 'deliver', 'behavior', 'change', 'though', 'it', 'requires', 'further', 'evaluation', 'in', 'different', 'clinical', 'settings', 'However', 'staff', 'can', 'become', 'dependent', 'on', 'automatic', 'reminders', 'and', 'performance', 'returns', 'to', 'baseline', 'if', 'feedback', 'is', 'removed', 'Summary', 'Advantages', 'for', 'IPC', 'include', 'speed', 'consistency', 'and', 'capability', 'of', 'handling', 'infinitely', 'large', 'datasets', 'However', 'many', 'challenges', 'remain', 'improving', 'the', 'availability', 'of', 'high', 'quality', 'representative', 'datasets', 'and', 'consideration', 'of', 'biases', 'within', 'preexisting', 'databases', 'are', 'important', 'challenges', 'for', 'future', 'developments', 'AI', 'in', 'itself', 'will', 'not', 'improve', 'IPC', 'this', 'requires', 'culture', 'and', 'behavior', 'change', 'Most', 'studies', 'to', 'date', 'assess', 'performance', 'retrospectively', 'so', 'there', 'is', 'a', 'need', 'for', 'prospective', 'evaluation', 'in', 'the', 'real', 'life', 'often', 'chaotic', 'clinical', 'setting', 'Close', 'collaboration', 'with', 'IPC', 'experts', 'to', 'interpret', 'outputs', 'and', 'ensure', 'clinical', 'relevance', 'is', 'essential', '']"
104372,Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks,2020,Tissue Eng Part A,,"In light of the current novel coronavirus (COVID-19) pandemic, as well as other viral outbreaks in the 21st century, there is a dire need for new diagnostic and therapeutic strategies to combat infectious diseases worldwide. As a convergence science, tissue engineering has traditionally focused on the application of engineering principles to biological systems, collaboration across disciplines, and rapid translation of technologies from the benchtop to the bedside. Given these strengths, tissue engineers are particularly well suited to apply their skill set to the current crisis and viral outbreaks in general. This work introduces the basics of virology and epidemiology for tissue engineers, and highlights important developments in the field of tissue engineering relevant to the current pandemic, including in vitro model systems, vaccine technology, and small-molecule drug delivery. COVID-19 serves as a call to arms for scientists across all disciplines, and tissue engineers are well trained to be leaders and contributors in this time of need. Impact statement Given the steep mortality caused by the recent novel coronavirus (COVID-19) pandemic, there is clear need for advances in diagnostics and therapeutics for viral outbreaks. Tissue engineering has the potential for critical impact on clinical outcomes in viral outbreaks. Tissue engineers, if mobilized, could play key roles as leaders in the outbreak, given their ability to apply engineering principles to biological processes, experience in collaborative environments, and penchant for technological translation from benchtop to bedside. In this work, three areas pioneered by tissue engineers that could be applied to the current COVID-19 crisis and future viral outbreaks are highlighted.",,pt2pokvt,"['In', 'light', 'of', 'the', 'current', 'novel', 'coronavirus', 'COVID', '19', 'pandemic', 'as', 'well', 'as', 'other', 'viral', 'outbreaks', 'in', 'the', '21st', 'century', 'there', 'is', 'a', 'dire', 'need', 'for', 'new', 'diagnostic', 'and', 'therapeutic', 'strategies', 'to', 'combat', 'infectious', 'diseases', 'worldwide', 'As', 'a', 'convergence', 'science', 'tissue', 'engineering', 'has', 'traditionally', 'focused', 'on', 'the', 'application', 'of', 'engineering', 'principles', 'to', 'biological', 'systems', 'collaboration', 'across', 'disciplines', 'and', 'rapid', 'translation', 'of', 'technologies', 'from', 'the', 'benchtop', 'to', 'the', 'bedside', 'Given', 'these', 'strengths', 'tissue', 'engineers', 'are', 'particularly', 'well', 'suited', 'to', 'apply', 'their', 'skill', 'set', 'to', 'the', 'current', 'crisis', 'and', 'viral', 'outbreaks', 'in', 'general', 'This', 'work', 'introduces', 'the', 'basics', 'of', 'virology', 'and', 'epidemiology', 'for', 'tissue', 'engineers', 'and', 'highlights', 'important', 'developments', 'in', 'the', 'field', 'of', 'tissue', 'engineering', 'relevant', 'to', 'the', 'current', 'pandemic', 'including', 'in', 'vitro', 'model', 'systems', 'vaccine', 'technology', 'and', 'small', 'molecule', 'drug', 'delivery', 'COVID', '19', 'serves', 'as', 'a', 'call', 'to', 'arms', 'for', 'scientists', 'across', 'all', 'disciplines', 'and', 'tissue', 'engineers', 'are', 'well', 'trained', 'to', 'be', 'leaders', 'and', 'contributors', 'in', 'this', 'time', 'of', 'need', 'Impact', 'statement', 'Given', 'the', 'steep', 'mortality', 'caused', 'by', 'the', 'recent', 'novel', 'coronavirus', 'COVID', '19', 'pandemic', 'there', 'is', 'clear', 'need', 'for', 'advances', 'in', 'diagnostics', 'and', 'therapeutics', 'for', 'viral', 'outbreaks', 'Tissue', 'engineering', 'has', 'the', 'potential', 'for', 'critical', 'impact', 'on', 'clinical', 'outcomes', 'in', 'viral', 'outbreaks', 'Tissue', 'engineers', 'if', 'mobilized', 'could', 'play', 'key', 'roles', 'as', 'leaders', 'in', 'the', 'outbreak', 'given', 'their', 'ability', 'to', 'apply', 'engineering', 'principles', 'to', 'biological', 'processes', 'experience', 'in', 'collaborative', 'environments', 'and', 'penchant', 'for', 'technological', 'translation', 'from', 'benchtop', 'to', 'bedside', 'In', 'this', 'work', 'three', 'areas', 'pioneered', 'by', 'tissue', 'engineers', 'that', 'could', 'be', 'applied', 'to', 'the', 'current', 'COVID', '19', 'crisis', 'and', 'future', 'viral', 'outbreaks', 'are', 'highlighted', '']"
104373,Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks,2020,Tissue Eng Part A,,"In light of the current novel coronavirus (COVID-19) pandemic, as well as other viral outbreaks in the 21st century, there is a dire need for new diagnostic and therapeutic strategies to combat infectious diseases worldwide. As a convergence science, tissue engineering has traditionally focused on the application of engineering principles to biological systems, collaboration across disciplines, and rapid translation of technologies from the benchtop to the bedside. Given these strengths, tissue engineers are particularly well suited to apply their skill set to the current crisis and viral outbreaks in general. This work introduces the basics of virology and epidemiology for tissue engineers, and highlights important developments in the field of tissue engineering relevant to the current pandemic, including in vitro model systems, vaccine technology, and small-molecule drug delivery. COVID-19 serves as a call to arms for scientists across all disciplines, and tissue engineers are well trained to be leaders and contributors in this time of need. Impact statement Given the steep mortality caused by the recent novel coronavirus (COVID-19) pandemic, there is clear need for advances in diagnostics and therapeutics for viral outbreaks. Tissue engineering has the potential for critical impact on clinical outcomes in viral outbreaks. Tissue engineers, if mobilized, could play key roles as leaders in the outbreak, given their ability to apply engineering principles to biological processes, experience in collaborative environments, and penchant for technological translation from benchtop to bedside. In this work, three areas pioneered by tissue engineers that could be applied to the current COVID-19 crisis and future viral outbreaks are highlighted.",,anyvz7bo,"['In', 'light', 'of', 'the', 'current', 'novel', 'coronavirus', 'COVID', '19', 'pandemic', 'as', 'well', 'as', 'other', 'viral', 'outbreaks', 'in', 'the', '21st', 'century', 'there', 'is', 'a', 'dire', 'need', 'for', 'new', 'diagnostic', 'and', 'therapeutic', 'strategies', 'to', 'combat', 'infectious', 'diseases', 'worldwide', 'As', 'a', 'convergence', 'science', 'tissue', 'engineering', 'has', 'traditionally', 'focused', 'on', 'the', 'application', 'of', 'engineering', 'principles', 'to', 'biological', 'systems', 'collaboration', 'across', 'disciplines', 'and', 'rapid', 'translation', 'of', 'technologies', 'from', 'the', 'benchtop', 'to', 'the', 'bedside', 'Given', 'these', 'strengths', 'tissue', 'engineers', 'are', 'particularly', 'well', 'suited', 'to', 'apply', 'their', 'skill', 'set', 'to', 'the', 'current', 'crisis', 'and', 'viral', 'outbreaks', 'in', 'general', 'This', 'work', 'introduces', 'the', 'basics', 'of', 'virology', 'and', 'epidemiology', 'for', 'tissue', 'engineers', 'and', 'highlights', 'important', 'developments', 'in', 'the', 'field', 'of', 'tissue', 'engineering', 'relevant', 'to', 'the', 'current', 'pandemic', 'including', 'in', 'vitro', 'model', 'systems', 'vaccine', 'technology', 'and', 'small', 'molecule', 'drug', 'delivery', 'COVID', '19', 'serves', 'as', 'a', 'call', 'to', 'arms', 'for', 'scientists', 'across', 'all', 'disciplines', 'and', 'tissue', 'engineers', 'are', 'well', 'trained', 'to', 'be', 'leaders', 'and', 'contributors', 'in', 'this', 'time', 'of', 'need', 'Impact', 'statement', 'Given', 'the', 'steep', 'mortality', 'caused', 'by', 'the', 'recent', 'novel', 'coronavirus', 'COVID', '19', 'pandemic', 'there', 'is', 'clear', 'need', 'for', 'advances', 'in', 'diagnostics', 'and', 'therapeutics', 'for', 'viral', 'outbreaks', 'Tissue', 'engineering', 'has', 'the', 'potential', 'for', 'critical', 'impact', 'on', 'clinical', 'outcomes', 'in', 'viral', 'outbreaks', 'Tissue', 'engineers', 'if', 'mobilized', 'could', 'play', 'key', 'roles', 'as', 'leaders', 'in', 'the', 'outbreak', 'given', 'their', 'ability', 'to', 'apply', 'engineering', 'principles', 'to', 'biological', 'processes', 'experience', 'in', 'collaborative', 'environments', 'and', 'penchant', 'for', 'technological', 'translation', 'from', 'benchtop', 'to', 'bedside', 'In', 'this', 'work', 'three', 'areas', 'pioneered', 'by', 'tissue', 'engineers', 'that', 'could', 'be', 'applied', 'to', 'the', 'current', 'COVID', '19', 'crisis', 'and', 'future', 'viral', 'outbreaks', 'are', 'highlighted', '']"
104699,"Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines",2020,Biomed. j. (Mumbai.Online),,"The coronavirus disease 2019 (COVID-19) pandemic caused by a novel coronavirus, SARS-CoV-2, has infected more than 4.9 million individuals and resulted in over 300,000 deaths globally. The rapid spread of the virus and the precipitously increasing numbers of cases necessitate the urgent development of accurate diagnostic methods, effective treatments, and vaccines. Here, we review the progress of developing diagnostic methods, therapies, and vaccines for SARS-CoV-2 with a focus on current clinical trials and their challenges. For diagnosis, nucleic acid amplification tests remain the mainstay diagnostics for laboratory confirmation of SARS-CoV-2 infection, while serological antibody tests are used to aid contact tracing, epidemiological, and vaccine evaluation studies. Viral isolation is not recommended for routine diagnostic procedures due to safety concerns. Currently, no single effective drug or specific vaccine is available against SARS-CoV-2. Some candidate drugs targeting different levels and stages of human responses against COVID-19 such as cell membrane fusion, RNA-dependent RNA polymerase, viral protease inhibitor, interleukin 6 blocker, and convalescent plasma may improve the clinical outcomes of critical COVID-19 patients. Other supportive care measures for critical patients are still necessary. Advances in genetic sequencing and other technological developments have sped up the establishment of a variety of vaccine platforms. Accordingly, numerous vaccines are under development. Vaccine candidates against SARS-CoV-2 are mainly based upon the viral spike protein due to its vital role in viral infectivity, and most of these candidates have recently moved into clinical trials. Before the efficacy of such vaccines in humans is demonstrated, strong international coordination and collaboration among studies, pharmaceutical companies, regulators, and governments are needed to limit further damage due the emerging SARS-CoV-2 virus.",,2vevp0fg,"['The', 'coronavirus', 'disease', '2019', 'COVID', '19', 'pandemic', 'caused', 'by', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'has', 'infected', 'more', 'than', '4', '9', 'million', 'individuals', 'and', 'resulted', 'in', 'over', '300', '000', 'deaths', 'globally', 'The', 'rapid', 'spread', 'of', 'the', 'virus', 'and', 'the', 'precipitously', 'increasing', 'numbers', 'of', 'cases', 'necessitate', 'the', 'urgent', 'development', 'of', 'accurate', 'diagnostic', 'methods', 'effective', 'treatments', 'and', 'vaccines', 'Here', 'we', 'review', 'the', 'progress', 'of', 'developing', 'diagnostic', 'methods', 'therapies', 'and', 'vaccines', 'for', 'SARS', 'CoV', '2', 'with', 'a', 'focus', 'on', 'current', 'clinical', 'trials', 'and', 'their', 'challenges', 'For', 'diagnosis', 'nucleic', 'acid', 'amplification', 'tests', 'remain', 'the', 'mainstay', 'diagnostics', 'for', 'laboratory', 'confirmation', 'of', 'SARS', 'CoV', '2', 'infection', 'while', 'serological', 'antibody', 'tests', 'are', 'used', 'to', 'aid', 'contact', 'tracing', 'epidemiological', 'and', 'vaccine', 'evaluation', 'studies', 'Viral', 'isolation', 'is', 'not', 'recommended', 'for', 'routine', 'diagnostic', 'procedures', 'due', 'to', 'safety', 'concerns', 'Currently', 'no', 'single', 'effective', 'drug', 'or', 'specific', 'vaccine', 'is', 'available', 'against', 'SARS', 'CoV', '2', 'Some', 'candidate', 'drugs', 'targeting', 'different', 'levels', 'and', 'stages', 'of', 'human', 'responses', 'against', 'COVID', '19', 'such', 'as', 'cell', 'membrane', 'fusion', 'RNA', 'dependent', 'RNA', 'polymerase', 'viral', 'protease', 'inhibitor', 'interleukin', '6', 'blocker', 'and', 'convalescent', 'plasma', 'may', 'improve', 'the', 'clinical', 'outcomes', 'of', 'critical', 'COVID', '19', 'patients', 'Other', 'supportive', 'care', 'measures', 'for', 'critical', 'patients', 'are', 'still', 'necessary', 'Advances', 'in', 'genetic', 'sequencing', 'and', 'other', 'technological', 'developments', 'have', 'sped', 'up', 'the', 'establishment', 'of', 'a', 'variety', 'of', 'vaccine', 'platforms', 'Accordingly', 'numerous', 'vaccines', 'are', 'under', 'development', 'Vaccine', 'candidates', 'against', 'SARS', 'CoV', '2', 'are', 'mainly', 'based', 'upon', 'the', 'viral', 'spike', 'protein', 'due', 'to', 'its', 'vital', 'role', 'in', 'viral', 'infectivity', 'and', 'most', 'of', 'these', 'candidates', 'have', 'recently', 'moved', 'into', 'clinical', 'trials', 'Before', 'the', 'efficacy', 'of', 'such', 'vaccines', 'in', 'humans', 'is', 'demonstrated', 'strong', 'international', 'coordination', 'and', 'collaboration', 'among', 'studies', 'pharmaceutical', 'companies', 'regulators', 'and', 'governments', 'are', 'needed', 'to', 'limit', 'further', 'damage', 'due', 'the', 'emerging', 'SARS', 'CoV', '2', 'virus', '']"
106203,COVID-19 pandemic-a focused review for clinicians,2020,Clin Microbiol Infect,,"BACKGROUND: The COVID-19 pandemic caused by SARS-CoV-2 remains a significant issue for global health, economics and society. A wealth of data has been generated since its emergence in December 2019, and it is vital for clinicians to keep up with this data from across the world at a time of uncertainty and constantly evolving guidelines and clinical practice. OBJECTIVES: Here we provide an update for clinicians on the recent developments in the virology, diagnostics, clinical presentation, viral shedding, and treatment options for COVID-19 based on current literature. SOURCES: We considered published peer-reviewed papers and non-peer-reviewed pre-print manuscripts on COVID19 and related aspects with an emphasis on clinical management aspects. CONTENT: We describe the virological characteristics of SARS-CoV-2 and the clinical course of COVID-19 with an emphasis on diagnostic challenges, duration of viral shedding, severity markers and current treatment options. IMPLICATIONS: The key challenge in managing COVID-19 remains patient density. However, accurate diagnosis as well as early identification and management of high-risk severe cases are important for many clinicians. For improved management of cases, there is a need to understand test probability of serology, qRT-PCR and radiological testing, and the efficacy of available treatment options that could be used in severe cases with a high risk of mortality.",,f33f0868,"['BACKGROUND', 'The', 'COVID', '19', 'pandemic', 'caused', 'by', 'SARS', 'CoV', '2', 'remains', 'a', 'significant', 'issue', 'for', 'global', 'health', 'economics', 'and', 'society', 'A', 'wealth', 'of', 'data', 'has', 'been', 'generated', 'since', 'its', 'emergence', 'in', 'December', '2019', 'and', 'it', 'is', 'vital', 'for', 'clinicians', 'to', 'keep', 'up', 'with', 'this', 'data', 'from', 'across', 'the', 'world', 'at', 'a', 'time', 'of', 'uncertainty', 'and', 'constantly', 'evolving', 'guidelines', 'and', 'clinical', 'practice', 'OBJECTIVES', 'Here', 'we', 'provide', 'an', 'update', 'for', 'clinicians', 'on', 'the', 'recent', 'developments', 'in', 'the', 'virology', 'diagnostics', 'clinical', 'presentation', 'viral', 'shedding', 'and', 'treatment', 'options', 'for', 'COVID', '19', 'based', 'on', 'current', 'literature', 'SOURCES', 'We', 'considered', 'published', 'peer', 'reviewed', 'papers', 'and', 'non', 'peer', 'reviewed', 'pre', 'print', 'manuscripts', 'on', 'COVID19', 'and', 'related', 'aspects', 'with', 'an', 'emphasis', 'on', 'clinical', 'management', 'aspects', 'CONTENT', 'We', 'describe', 'the', 'virological', 'characteristics', 'of', 'SARS', 'CoV', '2', 'and', 'the', 'clinical', 'course', 'of', 'COVID', '19', 'with', 'an', 'emphasis', 'on', 'diagnostic', 'challenges', 'duration', 'of', 'viral', 'shedding', 'severity', 'markers', 'and', 'current', 'treatment', 'options', 'IMPLICATIONS', 'The', 'key', 'challenge', 'in', 'managing', 'COVID', '19', 'remains', 'patient', 'density', 'However', 'accurate', 'diagnosis', 'as', 'well', 'as', 'early', 'identification', 'and', 'management', 'of', 'high', 'risk', 'severe', 'cases', 'are', 'important', 'for', 'many', 'clinicians', 'For', 'improved', 'management', 'of', 'cases', 'there', 'is', 'a', 'need', 'to', 'understand', 'test', 'probability', 'of', 'serology', 'qRT', 'PCR', 'and', 'radiological', 'testing', 'and', 'the', 'efficacy', 'of', 'available', 'treatment', 'options', 'that', 'could', 'be', 'used', 'in', 'severe', 'cases', 'with', 'a', 'high', 'risk', 'of', 'mortality', '']"
106232,SARS-CoV-2 antibody testing-questions to be asked,2020,J Allergy Clin Immunol,,"Severe acute respiratory syndrome coronavirus 2 infection and development of coronavirus disease 2019 presents a major health care challenge of global dimensions. Laboratory diagnostics of infected patients, and the assessment of immunity against severe acute respiratory syndrome coronavirus 2, presents a major cornerstone in handling the pandemic. Currently, there is an increase in demand for antibody testing and a large number of tests are already marketed or are in the late stage of development. However, the interpretation of test results depends on many variables and factors, including sensitivity, specificity, potential cross-reactivity and cross-protectivity, the diagnostic value of antibodies of different isotypes, and the use of antibody testing in identification of acutely ill patients or in epidemiological settings. In this article, the recently established COVID-19 Task Force of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) addresses these issues on the basis of currently available data sets in this rapidly moving field.",,laobflfb,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'infection', 'and', 'development', 'of', 'coronavirus', 'disease', '2019', 'presents', 'a', 'major', 'health', 'care', 'challenge', 'of', 'global', 'dimensions', 'Laboratory', 'diagnostics', 'of', 'infected', 'patients', 'and', 'the', 'assessment', 'of', 'immunity', 'against', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'presents', 'a', 'major', 'cornerstone', 'in', 'handling', 'the', 'pandemic', 'Currently', 'there', 'is', 'an', 'increase', 'in', 'demand', 'for', 'antibody', 'testing', 'and', 'a', 'large', 'number', 'of', 'tests', 'are', 'already', 'marketed', 'or', 'are', 'in', 'the', 'late', 'stage', 'of', 'development', 'However', 'the', 'interpretation', 'of', 'test', 'results', 'depends', 'on', 'many', 'variables', 'and', 'factors', 'including', 'sensitivity', 'specificity', 'potential', 'cross', 'reactivity', 'and', 'cross', 'protectivity', 'the', 'diagnostic', 'value', 'of', 'antibodies', 'of', 'different', 'isotypes', 'and', 'the', 'use', 'of', 'antibody', 'testing', 'in', 'identification', 'of', 'acutely', 'ill', 'patients', 'or', 'in', 'epidemiological', 'settings', 'In', 'this', 'article', 'the', 'recently', 'established', 'COVID', '19', 'Task', 'Force', 'of', 'the', 'German', 'Society', 'for', 'Clinical', 'Chemistry', 'and', 'Laboratory', 'Medicine', 'DGKL', 'addresses', 'these', 'issues', 'on', 'the', 'basis', 'of', 'currently', 'available', 'data', 'sets', 'in', 'this', 'rapidly', 'moving', 'field', '']"
107580,Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients,2020,Nat Commun,,"Given the ongoing SARS-CoV-2 pandemic, identification of immunogenic targets against the coronavirus spike glycoprotein will provide crucial advances towards the development of sensitive diagnostic tools and potential vaccine candidate targets. In this study, using pools of overlapping linear B-cell peptides, we report two IgG immunodominant regions on SARS-CoV-2 spike glycoprotein that are recognised by sera from COVID-19 convalescent patients. Notably, one is specific to SARS-CoV-2, which is located in close proximity to the receptor binding domain. The other region, which is localised at the fusion peptide, could potentially function as a pan-SARS target. Functionally, antibody depletion assays demonstrate that antibodies targeting these immunodominant regions significantly alter virus neutralisation capacities. Taken together, identification and validation of these neutralising B-cell epitopes will provide insights towards the design of diagnostics and vaccine candidates against this high priority coronavirus.",,budjcbej,"['Given', 'the', 'ongoing', 'SARS', 'CoV', '2', 'pandemic', 'identification', 'of', 'immunogenic', 'targets', 'against', 'the', 'coronavirus', 'spike', 'glycoprotein', 'will', 'provide', 'crucial', 'advances', 'towards', 'the', 'development', 'of', 'sensitive', 'diagnostic', 'tools', 'and', 'potential', 'vaccine', 'candidate', 'targets', 'In', 'this', 'study', 'using', 'pools', 'of', 'overlapping', 'linear', 'B', 'cell', 'peptides', 'we', 'report', 'two', 'IgG', 'immunodominant', 'regions', 'on', 'SARS', 'CoV', '2', 'spike', 'glycoprotein', 'that', 'are', 'recognised', 'by', 'sera', 'from', 'COVID', '19', 'convalescent', 'patients', 'Notably', 'one', 'is', 'specific', 'to', 'SARS', 'CoV', '2', 'which', 'is', 'located', 'in', 'close', 'proximity', 'to', 'the', 'receptor', 'binding', 'domain', 'The', 'other', 'region', 'which', 'is', 'localised', 'at', 'the', 'fusion', 'peptide', 'could', 'potentially', 'function', 'as', 'a', 'pan', 'SARS', 'target', 'Functionally', 'antibody', 'depletion', 'assays', 'demonstrate', 'that', 'antibodies', 'targeting', 'these', 'immunodominant', 'regions', 'significantly', 'alter', 'virus', 'neutralisation', 'capacities', 'Taken', 'together', 'identification', 'and', 'validation', 'of', 'these', 'neutralising', 'B', 'cell', 'epitopes', 'will', 'provide', 'insights', 'towards', 'the', 'design', 'of', 'diagnostics', 'and', 'vaccine', 'candidates', 'against', 'this', 'high', 'priority', 'coronavirus', '']"
109581,Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?,2020,Cell Immunol,,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a severe acute respiratory syndrome that is called COVID-19. Clinical manifestations of COVID-19 include diarrhea, pneumonia, lymphopenia, exhausted lymphocytes, and pro-inflammatory cytokine production. Immunology is part of the process of clinical evolution, but there are some questions around immunity-based protection: (1) why some infected people have only mild symptoms of the disease or are asymptomatic; (2) why delayed and weak antibody responses are associated with severe outcomes; and (3) why positivity in molecular tests does not represent protective antibody IgG. Perhaps T cell responses may be the key to solving those questions. SARS-CoV-2-specific memory T cells persist in peripheral blood and may be capable of providing effective information about protective immunity. The T cells studies can be helpful in elucidating the pathways for development of vaccines, therapies, and diagnostics for COVID-19 and for filling these immunology knowledge gaps.",,rs79r7kc,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'induces', 'a', 'severe', 'acute', 'respiratory', 'syndrome', 'that', 'is', 'called', 'COVID', '19', 'Clinical', 'manifestations', 'of', 'COVID', '19', 'include', 'diarrhea', 'pneumonia', 'lymphopenia', 'exhausted', 'lymphocytes', 'and', 'pro', 'inflammatory', 'cytokine', 'production', 'Immunology', 'is', 'part', 'of', 'the', 'process', 'of', 'clinical', 'evolution', 'but', 'there', 'are', 'some', 'questions', 'around', 'immunity', 'based', 'protection', '1', 'why', 'some', 'infected', 'people', 'have', 'only', 'mild', 'symptoms', 'of', 'the', 'disease', 'or', 'are', 'asymptomatic', '2', 'why', 'delayed', 'and', 'weak', 'antibody', 'responses', 'are', 'associated', 'with', 'severe', 'outcomes', 'and', '3', 'why', 'positivity', 'in', 'molecular', 'tests', 'does', 'not', 'represent', 'protective', 'antibody', 'IgG', 'Perhaps', 'T', 'cell', 'responses', 'may', 'be', 'the', 'key', 'to', 'solving', 'those', 'questions', 'SARS', 'CoV', '2', 'specific', 'memory', 'T', 'cells', 'persist', 'in', 'peripheral', 'blood', 'and', 'may', 'be', 'capable', 'of', 'providing', 'effective', 'information', 'about', 'protective', 'immunity', 'The', 'T', 'cells', 'studies', 'can', 'be', 'helpful', 'in', 'elucidating', 'the', 'pathways', 'for', 'development', 'of', 'vaccines', 'therapies', 'and', 'diagnostics', 'for', 'COVID', '19', 'and', 'for', 'filling', 'these', 'immunology', 'knowledge', 'gaps', '']"
109624,Trends and Innovations in Biosensors for COVID-19 Mass Testing,2020,Chembiochem,,"Fast and widespread diagnosis is crucial to fighting against the outbreak of COVID-19. This work surveys the landscape of available and emerging biosensor technologies for COVID-19 testing. Molecular diagnostic assays based on quantitative reverse transcription polymerase chain reaction are used in most clinical laboratories. However, the COVID-19 pandemic has overwhelmed testing capacity and motivated the development of fast point-of-care tests and the adoption of isothermal DNA amplification. Antigenic and serological rapid tests based on lateral-flow immunoassays suffer from low sensitivity. Advanced digital systems enhance performance at the expense of speed and the need for large equipment. Emerging technologies, including CRISPR gene-editing tools, benefit from high sensitivity and specificity of molecular diagnostics and the easy use of lateral-flow assays. DNA sequencing and sample pooling strategies are highlighted to bring out the full capacity of the available biosensor technologies and accelerate mass testing.",,d5d10lwr,"['Fast', 'and', 'widespread', 'diagnosis', 'is', 'crucial', 'to', 'fighting', 'against', 'the', 'outbreak', 'of', 'COVID', '19', 'This', 'work', 'surveys', 'the', 'landscape', 'of', 'available', 'and', 'emerging', 'biosensor', 'technologies', 'for', 'COVID', '19', 'testing', 'Molecular', 'diagnostic', 'assays', 'based', 'on', 'quantitative', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'are', 'used', 'in', 'most', 'clinical', 'laboratories', 'However', 'the', 'COVID', '19', 'pandemic', 'has', 'overwhelmed', 'testing', 'capacity', 'and', 'motivated', 'the', 'development', 'of', 'fast', 'point', 'of', 'care', 'tests', 'and', 'the', 'adoption', 'of', 'isothermal', 'DNA', 'amplification', 'Antigenic', 'and', 'serological', 'rapid', 'tests', 'based', 'on', 'lateral', 'flow', 'immunoassays', 'suffer', 'from', 'low', 'sensitivity', 'Advanced', 'digital', 'systems', 'enhance', 'performance', 'at', 'the', 'expense', 'of', 'speed', 'and', 'the', 'need', 'for', 'large', 'equipment', 'Emerging', 'technologies', 'including', 'CRISPR', 'gene', 'editing', 'tools', 'benefit', 'from', 'high', 'sensitivity', 'and', 'specificity', 'of', 'molecular', 'diagnostics', 'and', 'the', 'easy', 'use', 'of', 'lateral', 'flow', 'assays', 'DNA', 'sequencing', 'and', 'sample', 'pooling', 'strategies', 'are', 'highlighted', 'to', 'bring', 'out', 'the', 'full', 'capacity', 'of', 'the', 'available', 'biosensor', 'technologies', 'and', 'accelerate', 'mass', 'testing', '']"
113260,Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic,2020,ACS Nano,,"The COVID-19 outbreak has fueled a global demand for effective diagnosis and treatment as well as mitigation of the spread of infection, all through large-scale approaches such as specific alternative antiviral methods and classical disinfection protocols. Based on an abundance of engineered materials identifiable by their useful physicochemical properties through versatile chemical functionalization, nanotechnology offers a number of approaches to cope with this emergency. Here, through a multidisciplinary Perspective encompassing diverse fields such as virology, biology, medicine, engineering, chemistry, materials science, and computational science, we outline how nanotechnology-based strategies can support the fight against COVID-19, as well as infectious diseases in general, including future pandemics. Considering what we know so far about the life cycle of the virus, we envision key steps where nanotechnology could counter the disease. First, nanoparticles (NPs) can offer alternative methods to classical disinfection protocols used in healthcare settings, thanks to their intrinsic antipathogenic properties and/or their ability to inactivate viruses, bacteria, fungi, or yeasts either photothermally or via photocatalysis-induced reactive oxygen species (ROS) generation. Nanotechnology tools to inactivate SARS-CoV-2 in patients could also be explored. In this case, nanomaterials could be used to deliver drugs to the pulmonary system to inhibit interaction between angiotensin-converting enzyme 2 (ACE2) receptors and viral S protein. Moreover, the concept of ""nanoimmunity by design"" can help us to design materials for immune modulation, either stimulating or suppressing the immune response, which would find applications in the context of vaccine development for SARS-CoV-2 or in counteracting the cytokine storm, respectively. In addition to disease prevention and therapeutic potential, nanotechnology has important roles in diagnostics, with potential to support the development of simple, fast, and cost-effective nanotechnology-based assays to monitor the presence of SARS-CoV-2 and related biomarkers. In summary, nanotechnology is critical in counteracting COVID-19 and will be vital when preparing for future pandemics.",,nhhbqw4q,"['The', 'COVID', '19', 'outbreak', 'has', 'fueled', 'a', 'global', 'demand', 'for', 'effective', 'diagnosis', 'and', 'treatment', 'as', 'well', 'as', 'mitigation', 'of', 'the', 'spread', 'of', 'infection', 'all', 'through', 'large', 'scale', 'approaches', 'such', 'as', 'specific', 'alternative', 'antiviral', 'methods', 'and', 'classical', 'disinfection', 'protocols', 'Based', 'on', 'an', 'abundance', 'of', 'engineered', 'materials', 'identifiable', 'by', 'their', 'useful', 'physicochemical', 'properties', 'through', 'versatile', 'chemical', 'functionalization', 'nanotechnology', 'offers', 'a', 'number', 'of', 'approaches', 'to', 'cope', 'with', 'this', 'emergency', 'Here', 'through', 'a', 'multidisciplinary', 'Perspective', 'encompassing', 'diverse', 'fields', 'such', 'as', 'virology', 'biology', 'medicine', 'engineering', 'chemistry', 'materials', 'science', 'and', 'computational', 'science', 'we', 'outline', 'how', 'nanotechnology', 'based', 'strategies', 'can', 'support', 'the', 'fight', 'against', 'COVID', '19', 'as', 'well', 'as', 'infectious', 'diseases', 'in', 'general', 'including', 'future', 'pandemics', 'Considering', 'what', 'we', 'know', 'so', 'far', 'about', 'the', 'life', 'cycle', 'of', 'the', 'virus', 'we', 'envision', 'key', 'steps', 'where', 'nanotechnology', 'could', 'counter', 'the', 'disease', 'First', 'nanoparticles', 'NPs', 'can', 'offer', 'alternative', 'methods', 'to', 'classical', 'disinfection', 'protocols', 'used', 'in', 'healthcare', 'settings', 'thanks', 'to', 'their', 'intrinsic', 'antipathogenic', 'properties', 'and', 'or', 'their', 'ability', 'to', 'inactivate', 'viruses', 'bacteria', 'fungi', 'or', 'yeasts', 'either', 'photothermally', 'or', 'via', 'photocatalysis', 'induced', 'reactive', 'oxygen', 'species', 'ROS', 'generation', 'Nanotechnology', 'tools', 'to', 'inactivate', 'SARS', 'CoV', '2', 'in', 'patients', 'could', 'also', 'be', 'explored', 'In', 'this', 'case', 'nanomaterials', 'could', 'be', 'used', 'to', 'deliver', 'drugs', 'to', 'the', 'pulmonary', 'system', 'to', 'inhibit', 'interaction', 'between', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'receptors', 'and', 'viral', 'S', 'protein', 'Moreover', 'the', 'concept', 'of', 'nanoimmunity', 'by', 'design', 'can', 'help', 'us', 'to', 'design', 'materials', 'for', 'immune', 'modulation', 'either', 'stimulating', 'or', 'suppressing', 'the', 'immune', 'response', 'which', 'would', 'find', 'applications', 'in', 'the', 'context', 'of', 'vaccine', 'development', 'for', 'SARS', 'CoV', '2', 'or', 'in', 'counteracting', 'the', 'cytokine', 'storm', 'respectively', 'In', 'addition', 'to', 'disease', 'prevention', 'and', 'therapeutic', 'potential', 'nanotechnology', 'has', 'important', 'roles', 'in', 'diagnostics', 'with', 'potential', 'to', 'support', 'the', 'development', 'of', 'simple', 'fast', 'and', 'cost', 'effective', 'nanotechnology', 'based', 'assays', 'to', 'monitor', 'the', 'presence', 'of', 'SARS', 'CoV', '2', 'and', 'related', 'biomarkers', 'In', 'summary', 'nanotechnology', 'is', 'critical', 'in', 'counteracting', 'COVID', '19', 'and', 'will', 'be', 'vital', 'when', 'preparing', 'for', 'future', 'pandemics', '']"
113261,Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic,2020,ACS Nano,,"The COVID-19 outbreak has fueled a global demand for effective diagnosis and treatment as well as mitigation of the spread of infection, all through large-scale approaches such as specific alternative antiviral methods and classical disinfection protocols. Based on an abundance of engineered materials identifiable by their useful physicochemical properties through versatile chemical functionalization, nanotechnology offers a number of approaches to cope with this emergency. Here, through a multidisciplinary Perspective encompassing diverse fields such as virology, biology, medicine, engineering, chemistry, materials science, and computational science, we outline how nanotechnology-based strategies can support the fight against COVID-19, as well as infectious diseases in general, including future pandemics. Considering what we know so far about the life cycle of the virus, we envision key steps where nanotechnology could counter the disease. First, nanoparticles (NPs) can offer alternative methods to classical disinfection protocols used in healthcare settings, thanks to their intrinsic antipathogenic properties and/or their ability to inactivate viruses, bacteria, fungi, or yeasts either photothermally or via photocatalysis-induced reactive oxygen species (ROS) generation. Nanotechnology tools to inactivate SARS-CoV-2 in patients could also be explored. In this case, nanomaterials could be used to deliver drugs to the pulmonary system to inhibit interaction between angiotensin-converting enzyme 2 (ACE2) receptors and viral S protein. Moreover, the concept of ""nanoimmunity by design"" can help us to design materials for immune modulation, either stimulating or suppressing the immune response, which would find applications in the context of vaccine development for SARS-CoV-2 or in counteracting the cytokine storm, respectively. In addition to disease prevention and therapeutic potential, nanotechnology has important roles in diagnostics, with potential to support the development of simple, fast, and cost-effective nanotechnology-based assays to monitor the presence of SARS-CoV-2 and related biomarkers. In summary, nanotechnology is critical in counteracting COVID-19 and will be vital when preparing for future pandemics.",,8wf7hu40,"['The', 'COVID', '19', 'outbreak', 'has', 'fueled', 'a', 'global', 'demand', 'for', 'effective', 'diagnosis', 'and', 'treatment', 'as', 'well', 'as', 'mitigation', 'of', 'the', 'spread', 'of', 'infection', 'all', 'through', 'large', 'scale', 'approaches', 'such', 'as', 'specific', 'alternative', 'antiviral', 'methods', 'and', 'classical', 'disinfection', 'protocols', 'Based', 'on', 'an', 'abundance', 'of', 'engineered', 'materials', 'identifiable', 'by', 'their', 'useful', 'physicochemical', 'properties', 'through', 'versatile', 'chemical', 'functionalization', 'nanotechnology', 'offers', 'a', 'number', 'of', 'approaches', 'to', 'cope', 'with', 'this', 'emergency', 'Here', 'through', 'a', 'multidisciplinary', 'Perspective', 'encompassing', 'diverse', 'fields', 'such', 'as', 'virology', 'biology', 'medicine', 'engineering', 'chemistry', 'materials', 'science', 'and', 'computational', 'science', 'we', 'outline', 'how', 'nanotechnology', 'based', 'strategies', 'can', 'support', 'the', 'fight', 'against', 'COVID', '19', 'as', 'well', 'as', 'infectious', 'diseases', 'in', 'general', 'including', 'future', 'pandemics', 'Considering', 'what', 'we', 'know', 'so', 'far', 'about', 'the', 'life', 'cycle', 'of', 'the', 'virus', 'we', 'envision', 'key', 'steps', 'where', 'nanotechnology', 'could', 'counter', 'the', 'disease', 'First', 'nanoparticles', 'NPs', 'can', 'offer', 'alternative', 'methods', 'to', 'classical', 'disinfection', 'protocols', 'used', 'in', 'healthcare', 'settings', 'thanks', 'to', 'their', 'intrinsic', 'antipathogenic', 'properties', 'and', 'or', 'their', 'ability', 'to', 'inactivate', 'viruses', 'bacteria', 'fungi', 'or', 'yeasts', 'either', 'photothermally', 'or', 'via', 'photocatalysis', 'induced', 'reactive', 'oxygen', 'species', 'ROS', 'generation', 'Nanotechnology', 'tools', 'to', 'inactivate', 'SARS', 'CoV', '2', 'in', 'patients', 'could', 'also', 'be', 'explored', 'In', 'this', 'case', 'nanomaterials', 'could', 'be', 'used', 'to', 'deliver', 'drugs', 'to', 'the', 'pulmonary', 'system', 'to', 'inhibit', 'interaction', 'between', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'receptors', 'and', 'viral', 'S', 'protein', 'Moreover', 'the', 'concept', 'of', 'nanoimmunity', 'by', 'design', 'can', 'help', 'us', 'to', 'design', 'materials', 'for', 'immune', 'modulation', 'either', 'stimulating', 'or', 'suppressing', 'the', 'immune', 'response', 'which', 'would', 'find', 'applications', 'in', 'the', 'context', 'of', 'vaccine', 'development', 'for', 'SARS', 'CoV', '2', 'or', 'in', 'counteracting', 'the', 'cytokine', 'storm', 'respectively', 'In', 'addition', 'to', 'disease', 'prevention', 'and', 'therapeutic', 'potential', 'nanotechnology', 'has', 'important', 'roles', 'in', 'diagnostics', 'with', 'potential', 'to', 'support', 'the', 'development', 'of', 'simple', 'fast', 'and', 'cost', 'effective', 'nanotechnology', 'based', 'assays', 'to', 'monitor', 'the', 'presence', 'of', 'SARS', 'CoV', '2', 'and', 'related', 'biomarkers', 'In', 'summary', 'nanotechnology', 'is', 'critical', 'in', 'counteracting', 'COVID', '19', 'and', 'will', 'be', 'vital', 'when', 'preparing', 'for', 'future', 'pandemics', '']"
113701,Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation,2020,Science,,"The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure development, we determined a 3.5-angstrom-resolution cryo-electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also provide biophysical and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S. Additionally, we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs. The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis.",,2b5hue2r,"['The', 'outbreak', 'of', 'a', 'novel', 'coronavirus', '2019', 'nCoV', 'represents', 'a', 'pandemic', 'threat', 'that', 'has', 'been', 'declared', 'a', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'The', 'CoV', 'spike', 'S', 'glycoprotein', 'is', 'a', 'key', 'target', 'for', 'vaccines', 'therapeutic', 'antibodies', 'and', 'diagnostics', 'To', 'facilitate', 'medical', 'countermeasure', 'development', 'we', 'determined', 'a', '3', '5', 'angstrom', 'resolution', 'cryo', 'electron', 'microscopy', 'structure', 'of', 'the', '2019', 'nCoV', 'S', 'trimer', 'in', 'the', 'prefusion', 'conformation', 'The', 'predominant', 'state', 'of', 'the', 'trimer', 'has', 'one', 'of', 'the', 'three', 'receptor', 'binding', 'domains', 'RBDs', 'rotated', 'up', 'in', 'a', 'receptor', 'accessible', 'conformation', 'We', 'also', 'provide', 'biophysical', 'and', 'structural', 'evidence', 'that', 'the', '2019', 'nCoV', 'S', 'protein', 'binds', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'with', 'higher', 'affinity', 'than', 'does', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'S', 'Additionally', 'we', 'tested', 'several', 'published', 'SARS', 'CoV', 'RBD', 'specific', 'monoclonal', 'antibodies', 'and', 'found', 'that', 'they', 'do', 'not', 'have', 'appreciable', 'binding', 'to', '2019', 'nCoV', 'S', 'suggesting', 'that', 'antibody', 'cross', 'reactivity', 'may', 'be', 'limited', 'between', 'the', 'two', 'RBDs', 'The', 'structure', 'of', '2019', 'nCoV', 'S', 'should', 'enable', 'the', 'rapid', 'development', 'and', 'evaluation', 'of', 'medical', 'countermeasures', 'to', 'address', 'the', 'ongoing', 'public', 'health', 'crisis', '']"
113702,Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation,2020,Science,,"The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure development, we determined a 3.5-angstrom-resolution cryo-electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also provide biophysical and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S. Additionally, we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs. The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis.",,sb297tzj,"['The', 'outbreak', 'of', 'a', 'novel', 'coronavirus', '2019', 'nCoV', 'represents', 'a', 'pandemic', 'threat', 'that', 'has', 'been', 'declared', 'a', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'The', 'CoV', 'spike', 'S', 'glycoprotein', 'is', 'a', 'key', 'target', 'for', 'vaccines', 'therapeutic', 'antibodies', 'and', 'diagnostics', 'To', 'facilitate', 'medical', 'countermeasure', 'development', 'we', 'determined', 'a', '3', '5', 'angstrom', 'resolution', 'cryo', 'electron', 'microscopy', 'structure', 'of', 'the', '2019', 'nCoV', 'S', 'trimer', 'in', 'the', 'prefusion', 'conformation', 'The', 'predominant', 'state', 'of', 'the', 'trimer', 'has', 'one', 'of', 'the', 'three', 'receptor', 'binding', 'domains', 'RBDs', 'rotated', 'up', 'in', 'a', 'receptor', 'accessible', 'conformation', 'We', 'also', 'provide', 'biophysical', 'and', 'structural', 'evidence', 'that', 'the', '2019', 'nCoV', 'S', 'protein', 'binds', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'with', 'higher', 'affinity', 'than', 'does', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'S', 'Additionally', 'we', 'tested', 'several', 'published', 'SARS', 'CoV', 'RBD', 'specific', 'monoclonal', 'antibodies', 'and', 'found', 'that', 'they', 'do', 'not', 'have', 'appreciable', 'binding', 'to', '2019', 'nCoV', 'S', 'suggesting', 'that', 'antibody', 'cross', 'reactivity', 'may', 'be', 'limited', 'between', 'the', 'two', 'RBDs', 'The', 'structure', 'of', '2019', 'nCoV', 'S', 'should', 'enable', 'the', 'rapid', 'development', 'and', 'evaluation', 'of', 'medical', 'countermeasures', 'to', 'address', 'the', 'ongoing', 'public', 'health', 'crisis', '']"
114213,Serology testing in the COVID-19 pandemic response,2020,Lancet infect. dis,,"The collapse of global cooperation and a failure of international solidarity have led to many low-income and middle-income countries being denied access to molecular diagnostics in the COVID-19 pandemic response. Yet the scarcity of knowledge on the dynamics of the immune response to infection has led to hesitation on recommending the use of rapid immunodiagnostic tests, even though rapid serology tests are commercially available and scalable. On the basis of our knowledge and understanding of viral infectivity and host response, we urge countries without the capacity to do molecular testing at scale to research the use of serology tests to triage symptomatic patients in community settings, to test contacts of confirmed cases, and in situational analysis and surveillance. The WHO R&D Blue Print expert group identified eight priorities for research and development, of which the highest is to mobilise research on rapid point-of-care diagnostics for use at the community level. This research should inform control programmes of the required performance and utility of rapid serology tests, which, when applied specifically for appropriate public health measures to then be put in place, can make a huge difference.",,rrxloui4,"['The', 'collapse', 'of', 'global', 'cooperation', 'and', 'a', 'failure', 'of', 'international', 'solidarity', 'have', 'led', 'to', 'many', 'low', 'income', 'and', 'middle', 'income', 'countries', 'being', 'denied', 'access', 'to', 'molecular', 'diagnostics', 'in', 'the', 'COVID', '19', 'pandemic', 'response', 'Yet', 'the', 'scarcity', 'of', 'knowledge', 'on', 'the', 'dynamics', 'of', 'the', 'immune', 'response', 'to', 'infection', 'has', 'led', 'to', 'hesitation', 'on', 'recommending', 'the', 'use', 'of', 'rapid', 'immunodiagnostic', 'tests', 'even', 'though', 'rapid', 'serology', 'tests', 'are', 'commercially', 'available', 'and', 'scalable', 'On', 'the', 'basis', 'of', 'our', 'knowledge', 'and', 'understanding', 'of', 'viral', 'infectivity', 'and', 'host', 'response', 'we', 'urge', 'countries', 'without', 'the', 'capacity', 'to', 'do', 'molecular', 'testing', 'at', 'scale', 'to', 'research', 'the', 'use', 'of', 'serology', 'tests', 'to', 'triage', 'symptomatic', 'patients', 'in', 'community', 'settings', 'to', 'test', 'contacts', 'of', 'confirmed', 'cases', 'and', 'in', 'situational', 'analysis', 'and', 'surveillance', 'The', 'WHO', 'R', 'D', 'Blue', 'Print', 'expert', 'group', 'identified', 'eight', 'priorities', 'for', 'research', 'and', 'development', 'of', 'which', 'the', 'highest', 'is', 'to', 'mobilise', 'research', 'on', 'rapid', 'point', 'of', 'care', 'diagnostics', 'for', 'use', 'at', 'the', 'community', 'level', 'This', 'research', 'should', 'inform', 'control', 'programmes', 'of', 'the', 'required', 'performance', 'and', 'utility', 'of', 'rapid', 'serology', 'tests', 'which', 'when', 'applied', 'specifically', 'for', 'appropriate', 'public', 'health', 'measures', 'to', 'then', 'be', 'put', 'in', 'place', 'can', 'make', 'a', 'huge', 'difference', '']"
116949,Molecular Diagnostics and In Utero Therapeutics for Orofacial Clefts,2020,J Dent Res,,"Orofacial clefts and their management impose a substantial burden on patients, on their families, and on the health system. Under the current standard of care, affected patients are subjected to a lifelong journey of corrective surgeries and multidisciplinary management to replace bone and soft tissues, as well as restore esthetics and physiologic functions while restoring self-esteem and psychological health. Hence, a better understanding of the dynamic interplay of molecular signaling pathways at critical phases of palate development is necessary to pioneer novel prenatal interventions. Such pathways include transforming growth factor-ß (Tgfß), sonic hedgehog (Shh), wingless-integrated site (Wnt)/ß-catenin, bone morphogenetic protein (Bmp), and fibroblast growth factor (Fgf) and its associated receptors, among others. Here, we summarize commonly used surgical methods used to correct cleft defects postnatally. We also review the advances made in prenatal diagnostics of clefts through imaging and genomics and the various in utero surgical corrections that have been attempted thus far. An overview of how key mediators of signaling that drive palatogenesis are emphasized in the context of the framework and rationale for the development and testing of therapeutics in animal model systems and in humans is provided. The pros and cons of in utero therapies that can potentially restore molecular homeostasis needed for the proper growth and fusion of palatal shelves are presented. The theme advanced throughout this review is the need to develop preclinical molecular therapies that could ultimately be translated into human trials that can correct orofacial clefts at earlier stages of development.",,p0ak6cnt,"['Orofacial', 'clefts', 'and', 'their', 'management', 'impose', 'a', 'substantial', 'burden', 'on', 'patients', 'on', 'their', 'families', 'and', 'on', 'the', 'health', 'system', 'Under', 'the', 'current', 'standard', 'of', 'care', 'affected', 'patients', 'are', 'subjected', 'to', 'a', 'lifelong', 'journey', 'of', 'corrective', 'surgeries', 'and', 'multidisciplinary', 'management', 'to', 'replace', 'bone', 'and', 'soft', 'tissues', 'as', 'well', 'as', 'restore', 'esthetics', 'and', 'physiologic', 'functions', 'while', 'restoring', 'self', 'esteem', 'and', 'psychological', 'health', 'Hence', 'a', 'better', 'understanding', 'of', 'the', 'dynamic', 'interplay', 'of', 'molecular', 'signaling', 'pathways', 'at', 'critical', 'phases', 'of', 'palate', 'development', 'is', 'necessary', 'to', 'pioneer', 'novel', 'prenatal', 'interventions', 'Such', 'pathways', 'include', 'transforming', 'growth', 'factor', 'ß', 'Tgfß', 'sonic', 'hedgehog', 'Shh', 'wingless', 'integrated', 'site', 'Wnt', 'ß', 'catenin', 'bone', 'morphogenetic', 'protein', 'Bmp', 'and', 'fibroblast', 'growth', 'factor', 'Fgf', 'and', 'its', 'associated', 'receptors', 'among', 'others', 'Here', 'we', 'summarize', 'commonly', 'used', 'surgical', 'methods', 'used', 'to', 'correct', 'cleft', 'defects', 'postnatally', 'We', 'also', 'review', 'the', 'advances', 'made', 'in', 'prenatal', 'diagnostics', 'of', 'clefts', 'through', 'imaging', 'and', 'genomics', 'and', 'the', 'various', 'in', 'utero', 'surgical', 'corrections', 'that', 'have', 'been', 'attempted', 'thus', 'far', 'An', 'overview', 'of', 'how', 'key', 'mediators', 'of', 'signaling', 'that', 'drive', 'palatogenesis', 'are', 'emphasized', 'in', 'the', 'context', 'of', 'the', 'framework', 'and', 'rationale', 'for', 'the', 'development', 'and', 'testing', 'of', 'therapeutics', 'in', 'animal', 'model', 'systems', 'and', 'in', 'humans', 'is', 'provided', 'The', 'pros', 'and', 'cons', 'of', 'in', 'utero', 'therapies', 'that', 'can', 'potentially', 'restore', 'molecular', 'homeostasis', 'needed', 'for', 'the', 'proper', 'growth', 'and', 'fusion', 'of', 'palatal', 'shelves', 'are', 'presented', 'The', 'theme', 'advanced', 'throughout', 'this', 'review', 'is', 'the', 'need', 'to', 'develop', 'preclinical', 'molecular', 'therapies', 'that', 'could', 'ultimately', 'be', 'translated', 'into', 'human', 'trials', 'that', 'can', 'correct', 'orofacial', 'clefts', 'at', 'earlier', 'stages', 'of', 'development', '']"
117369,"COVID-19: Progress in diagnostics, therapy and vaccination",2020,Theranostics,,"Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently become a pandemic. As the sudden emergence and rapid spread of SARS-CoV-2 is endangering global health and the economy, the development of strategies to contain the virus's spread are urgently needed. At present, various diagnostic kits to test for SARS-CoV-2 are available for use to initiate appropriate treatment faster and to limit further spread of the virus. Several drugs have demonstrated in vitro activity against SARS-CoV-2 or potential clinical benefits. In addition, institutions and companies worldwide are working tirelessly to develop treatments and vaccines against COVID-19. However, no drug or vaccine has yet been specifically approved for COVID-19. Given the urgency of the outbreak, we focus here on recent advances in the diagnostics, treatment, and vaccine development for SARS-CoV-2 infection, helping to guide strategies to address the current COVID-19 pandemic.",,l5uf8y58,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'recently', 'become', 'a', 'pandemic', 'As', 'the', 'sudden', 'emergence', 'and', 'rapid', 'spread', 'of', 'SARS', 'CoV', '2', 'is', 'endangering', 'global', 'health', 'and', 'the', 'economy', 'the', 'development', 'of', 'strategies', 'to', 'contain', 'the', 'virus', 's', 'spread', 'are', 'urgently', 'needed', 'At', 'present', 'various', 'diagnostic', 'kits', 'to', 'test', 'for', 'SARS', 'CoV', '2', 'are', 'available', 'for', 'use', 'to', 'initiate', 'appropriate', 'treatment', 'faster', 'and', 'to', 'limit', 'further', 'spread', 'of', 'the', 'virus', 'Several', 'drugs', 'have', 'demonstrated', 'in', 'vitro', 'activity', 'against', 'SARS', 'CoV', '2', 'or', 'potential', 'clinical', 'benefits', 'In', 'addition', 'institutions', 'and', 'companies', 'worldwide', 'are', 'working', 'tirelessly', 'to', 'develop', 'treatments', 'and', 'vaccines', 'against', 'COVID', '19', 'However', 'no', 'drug', 'or', 'vaccine', 'has', 'yet', 'been', 'specifically', 'approved', 'for', 'COVID', '19', 'Given', 'the', 'urgency', 'of', 'the', 'outbreak', 'we', 'focus', 'here', 'on', 'recent', 'advances', 'in', 'the', 'diagnostics', 'treatment', 'and', 'vaccine', 'development', 'for', 'SARS', 'CoV', '2', 'infection', 'helping', 'to', 'guide', 'strategies', 'to', 'address', 'the', 'current', 'COVID', '19', 'pandemic', '']"
121582,Advances in Telemedicine in Ophthalmology,2020,Semin Ophthalmol,,"Telemedicine is the provision of healthcare-related services from a distance and is poised to move healthcare from the physician's office back into the patient's home. The field of ophthalmology is often at the forefront of technological advances in medicine including telemedicine and the use of artificial intelligence. Multiple studies have demonstrated the reliability of tele-ophthalmology for use in screening and diagnostics and have demonstrated benefits to patients, physicians, as well as payors. There remain obstacles to widespread implementation, but recent legislation and regulation passed due to the devastating COVID-19 pandemic have helped to reduce some of these barriers. This review describes the current status of tele-ophthalmology in the United States including benefits, hurdles, current programs, technology, and developments in artificial intelligence. With ongoing advances patients may benefit from improved detection and earlier treatment of eye diseases, resulting in better care and improved visual outcomes.",,ezdeohsj,"['Telemedicine', 'is', 'the', 'provision', 'of', 'healthcare', 'related', 'services', 'from', 'a', 'distance', 'and', 'is', 'poised', 'to', 'move', 'healthcare', 'from', 'the', 'physician', 's', 'office', 'back', 'into', 'the', 'patient', 's', 'home', 'The', 'field', 'of', 'ophthalmology', 'is', 'often', 'at', 'the', 'forefront', 'of', 'technological', 'advances', 'in', 'medicine', 'including', 'telemedicine', 'and', 'the', 'use', 'of', 'artificial', 'intelligence', 'Multiple', 'studies', 'have', 'demonstrated', 'the', 'reliability', 'of', 'tele', 'ophthalmology', 'for', 'use', 'in', 'screening', 'and', 'diagnostics', 'and', 'have', 'demonstrated', 'benefits', 'to', 'patients', 'physicians', 'as', 'well', 'as', 'payors', 'There', 'remain', 'obstacles', 'to', 'widespread', 'implementation', 'but', 'recent', 'legislation', 'and', 'regulation', 'passed', 'due', 'to', 'the', 'devastating', 'COVID', '19', 'pandemic', 'have', 'helped', 'to', 'reduce', 'some', 'of', 'these', 'barriers', 'This', 'review', 'describes', 'the', 'current', 'status', 'of', 'tele', 'ophthalmology', 'in', 'the', 'United', 'States', 'including', 'benefits', 'hurdles', 'current', 'programs', 'technology', 'and', 'developments', 'in', 'artificial', 'intelligence', 'With', 'ongoing', 'advances', 'patients', 'may', 'benefit', 'from', 'improved', 'detection', 'and', 'earlier', 'treatment', 'of', 'eye', 'diseases', 'resulting', 'in', 'better', 'care', 'and', 'improved', 'visual', 'outcomes', '']"
123445,CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia,2020,J Drug Target,,"Emerging infectious diseases, the persistent potential for destabilising pandemics, remain a global threat leading to excessive morbidity and mortality. The current outbreak of pneumonia caused by 2019 novel coronavirus (COVID-19) illustrated difficulties in lack of effective drugs for treatment. Accurate and rapid diagnostic tools are essential for early recognition and treatment of infectious diseases, allowing timely implementation of infection control, improved clinical care and other public health measures to stop the spread of the disease. CRISPR-Cas technology speed up the development of infectious disease diagnostics with high rapid and accurate. In this review, we summarise current advance regarding diverse CRISPR-Cas systems, including CRISPR-Cas9, CRISPR-Cas12 and CRISPR-Cas13, in the development of fast, accurate and portable diagnostic tests and highlight the potential of CRISPR-Cas13 in COVID-19 Pneumonia and other emerging infectious diseases diagnosis.",,5uv9kaxf,"['Emerging', 'infectious', 'diseases', 'the', 'persistent', 'potential', 'for', 'destabilising', 'pandemics', 'remain', 'a', 'global', 'threat', 'leading', 'to', 'excessive', 'morbidity', 'and', 'mortality', 'The', 'current', 'outbreak', 'of', 'pneumonia', 'caused', 'by', '2019', 'novel', 'coronavirus', 'COVID', '19', 'illustrated', 'difficulties', 'in', 'lack', 'of', 'effective', 'drugs', 'for', 'treatment', 'Accurate', 'and', 'rapid', 'diagnostic', 'tools', 'are', 'essential', 'for', 'early', 'recognition', 'and', 'treatment', 'of', 'infectious', 'diseases', 'allowing', 'timely', 'implementation', 'of', 'infection', 'control', 'improved', 'clinical', 'care', 'and', 'other', 'public', 'health', 'measures', 'to', 'stop', 'the', 'spread', 'of', 'the', 'disease', 'CRISPR', 'Cas', 'technology', 'speed', 'up', 'the', 'development', 'of', 'infectious', 'disease', 'diagnostics', 'with', 'high', 'rapid', 'and', 'accurate', 'In', 'this', 'review', 'we', 'summarise', 'current', 'advance', 'regarding', 'diverse', 'CRISPR', 'Cas', 'systems', 'including', 'CRISPR', 'Cas9', 'CRISPR', 'Cas12', 'and', 'CRISPR', 'Cas13', 'in', 'the', 'development', 'of', 'fast', 'accurate', 'and', 'portable', 'diagnostic', 'tests', 'and', 'highlight', 'the', 'potential', 'of', 'CRISPR', 'Cas13', 'in', 'COVID', '19', 'Pneumonia', 'and', 'other', 'emerging', 'infectious', 'diseases', 'diagnosis', '']"
123548,"Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020",2020,MMWR Morb Mortal Wkly Rep,,"An outbreak of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) began in Wuhan, Hubei Province, China in December 2019, and has spread throughout China and to 31 other countries and territories, including the United States (1). As of February 23, 2020, there were 76,936 reported cases in mainland China and 1,875 cases in locations outside mainland China (1). There have been 2,462 associated deaths worldwide; no deaths have been reported in the United States. Fourteen cases have been diagnosed in the United States, and an additional 39 cases have occurred among repatriated persons from high-risk settings, for a current total of 53 cases within the United States. This report summarizes the aggressive measures (2,3) that CDC, state and local health departments, multiple other federal agencies, and other partners are implementing to slow and try to contain transmission of COVID-19 in the United States. These measures require the identification of cases and contacts of persons with COVID-19 in the United States and the recommended assessment, monitoring, and care of travelers arriving from areas with substantial COVID-19 transmission. Although these measures might not prevent widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare state and local health departments, health care systems, businesses, educational organizations, and the general public in the event that widespread transmission occurs; and 3) better characterize COVID-19 to guide public health recommendations and the development and deployment of medical countermeasures, including diagnostics, therapeutics, and vaccines. U.S. public health authorities are monitoring the situation closely, and CDC is coordinating efforts with the World Health Organization (WHO) and other global partners. Interim guidance is available at https://www.cdc.gov/coronavirus/index.html. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC, state and local health departments, health care providers, and communities.",,rlqxmf1l,"['An', 'outbreak', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'the', '2019', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'began', 'in', 'Wuhan', 'Hubei', 'Province', 'China', 'in', 'December', '2019', 'and', 'has', 'spread', 'throughout', 'China', 'and', 'to', '31', 'other', 'countries', 'and', 'territories', 'including', 'the', 'United', 'States', '1', 'As', 'of', 'February', '23', '2020', 'there', 'were', '76', '936', 'reported', 'cases', 'in', 'mainland', 'China', 'and', '1', '875', 'cases', 'in', 'locations', 'outside', 'mainland', 'China', '1', 'There', 'have', 'been', '2', '462', 'associated', 'deaths', 'worldwide', 'no', 'deaths', 'have', 'been', 'reported', 'in', 'the', 'United', 'States', 'Fourteen', 'cases', 'have', 'been', 'diagnosed', 'in', 'the', 'United', 'States', 'and', 'an', 'additional', '39', 'cases', 'have', 'occurred', 'among', 'repatriated', 'persons', 'from', 'high', 'risk', 'settings', 'for', 'a', 'current', 'total', 'of', '53', 'cases', 'within', 'the', 'United', 'States', 'This', 'report', 'summarizes', 'the', 'aggressive', 'measures', '2', '3', 'that', 'CDC', 'state', 'and', 'local', 'health', 'departments', 'multiple', 'other', 'federal', 'agencies', 'and', 'other', 'partners', 'are', 'implementing', 'to', 'slow', 'and', 'try', 'to', 'contain', 'transmission', 'of', 'COVID', '19', 'in', 'the', 'United', 'States', 'These', 'measures', 'require', 'the', 'identification', 'of', 'cases', 'and', 'contacts', 'of', 'persons', 'with', 'COVID', '19', 'in', 'the', 'United', 'States', 'and', 'the', 'recommended', 'assessment', 'monitoring', 'and', 'care', 'of', 'travelers', 'arriving', 'from', 'areas', 'with', 'substantial', 'COVID', '19', 'transmission', 'Although', 'these', 'measures', 'might', 'not', 'prevent', 'widespread', 'transmission', 'of', 'the', 'virus', 'in', 'the', 'United', 'States', 'they', 'are', 'being', 'implemented', 'to', '1', 'slow', 'the', 'spread', 'of', 'illness', '2', 'provide', 'time', 'to', 'better', 'prepare', 'state', 'and', 'local', 'health', 'departments', 'health', 'care', 'systems', 'businesses', 'educational', 'organizations', 'and', 'the', 'general', 'public', 'in', 'the', 'event', 'that', 'widespread', 'transmission', 'occurs', 'and', '3', 'better', 'characterize', 'COVID', '19', 'to', 'guide', 'public', 'health', 'recommendations', 'and', 'the', 'development', 'and', 'deployment', 'of', 'medical', 'countermeasures', 'including', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'U', 'S', 'public', 'health', 'authorities', 'are', 'monitoring', 'the', 'situation', 'closely', 'and', 'CDC', 'is', 'coordinating', 'efforts', 'with', 'the', 'World', 'Health', 'Organization', 'WHO', 'and', 'other', 'global', 'partners', 'Interim', 'guidance', 'is', 'available', 'at', 'https', 'www', 'cdc', 'gov', 'coronavirus', 'index', 'html', 'As', 'more', 'is', 'learned', 'about', 'this', 'novel', 'virus', 'and', 'this', 'outbreak', 'CDC', 'will', 'rapidly', 'incorporate', 'new', 'knowledge', 'into', 'guidance', 'for', 'action', 'by', 'CDC', 'state', 'and', 'local', 'health', 'departments', 'health', 'care', 'providers', 'and', 'communities', '']"
123549,"Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020",2020,MMWR Morb Mortal Wkly Rep,,"An outbreak of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) began in Wuhan, Hubei Province, China in December 2019, and has spread throughout China and to 31 other countries and territories, including the United States (1). As of February 23, 2020, there were 76,936 reported cases in mainland China and 1,875 cases in locations outside mainland China (1). There have been 2,462 associated deaths worldwide; no deaths have been reported in the United States. Fourteen cases have been diagnosed in the United States, and an additional 39 cases have occurred among repatriated persons from high-risk settings, for a current total of 53 cases within the United States. This report summarizes the aggressive measures (2,3) that CDC, state and local health departments, multiple other federal agencies, and other partners are implementing to slow and try to contain transmission of COVID-19 in the United States. These measures require the identification of cases and contacts of persons with COVID-19 in the United States and the recommended assessment, monitoring, and care of travelers arriving from areas with substantial COVID-19 transmission. Although these measures might not prevent widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare state and local health departments, health care systems, businesses, educational organizations, and the general public in the event that widespread transmission occurs; and 3) better characterize COVID-19 to guide public health recommendations and the development and deployment of medical countermeasures, including diagnostics, therapeutics, and vaccines. U.S. public health authorities are monitoring the situation closely, and CDC is coordinating efforts with the World Health Organization (WHO) and other global partners. Interim guidance is available at https://www.cdc.gov/coronavirus/index.html. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC, state and local health departments, health care providers, and communities.",,2ff6qg5g,"['An', 'outbreak', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'the', '2019', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'began', 'in', 'Wuhan', 'Hubei', 'Province', 'China', 'in', 'December', '2019', 'and', 'has', 'spread', 'throughout', 'China', 'and', 'to', '31', 'other', 'countries', 'and', 'territories', 'including', 'the', 'United', 'States', '1', 'As', 'of', 'February', '23', '2020', 'there', 'were', '76', '936', 'reported', 'cases', 'in', 'mainland', 'China', 'and', '1', '875', 'cases', 'in', 'locations', 'outside', 'mainland', 'China', '1', 'There', 'have', 'been', '2', '462', 'associated', 'deaths', 'worldwide', 'no', 'deaths', 'have', 'been', 'reported', 'in', 'the', 'United', 'States', 'Fourteen', 'cases', 'have', 'been', 'diagnosed', 'in', 'the', 'United', 'States', 'and', 'an', 'additional', '39', 'cases', 'have', 'occurred', 'among', 'repatriated', 'persons', 'from', 'high', 'risk', 'settings', 'for', 'a', 'current', 'total', 'of', '53', 'cases', 'within', 'the', 'United', 'States', 'This', 'report', 'summarizes', 'the', 'aggressive', 'measures', '2', '3', 'that', 'CDC', 'state', 'and', 'local', 'health', 'departments', 'multiple', 'other', 'federal', 'agencies', 'and', 'other', 'partners', 'are', 'implementing', 'to', 'slow', 'and', 'try', 'to', 'contain', 'transmission', 'of', 'COVID', '19', 'in', 'the', 'United', 'States', 'These', 'measures', 'require', 'the', 'identification', 'of', 'cases', 'and', 'contacts', 'of', 'persons', 'with', 'COVID', '19', 'in', 'the', 'United', 'States', 'and', 'the', 'recommended', 'assessment', 'monitoring', 'and', 'care', 'of', 'travelers', 'arriving', 'from', 'areas', 'with', 'substantial', 'COVID', '19', 'transmission', 'Although', 'these', 'measures', 'might', 'not', 'prevent', 'widespread', 'transmission', 'of', 'the', 'virus', 'in', 'the', 'United', 'States', 'they', 'are', 'being', 'implemented', 'to', '1', 'slow', 'the', 'spread', 'of', 'illness', '2', 'provide', 'time', 'to', 'better', 'prepare', 'state', 'and', 'local', 'health', 'departments', 'health', 'care', 'systems', 'businesses', 'educational', 'organizations', 'and', 'the', 'general', 'public', 'in', 'the', 'event', 'that', 'widespread', 'transmission', 'occurs', 'and', '3', 'better', 'characterize', 'COVID', '19', 'to', 'guide', 'public', 'health', 'recommendations', 'and', 'the', 'development', 'and', 'deployment', 'of', 'medical', 'countermeasures', 'including', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'U', 'S', 'public', 'health', 'authorities', 'are', 'monitoring', 'the', 'situation', 'closely', 'and', 'CDC', 'is', 'coordinating', 'efforts', 'with', 'the', 'World', 'Health', 'Organization', 'WHO', 'and', 'other', 'global', 'partners', 'Interim', 'guidance', 'is', 'available', 'at', 'https', 'www', 'cdc', 'gov', 'coronavirus', 'index', 'html', 'As', 'more', 'is', 'learned', 'about', 'this', 'novel', 'virus', 'and', 'this', 'outbreak', 'CDC', 'will', 'rapidly', 'incorporate', 'new', 'knowledge', 'into', 'guidance', 'for', 'action', 'by', 'CDC', 'state', 'and', 'local', 'health', 'departments', 'health', 'care', 'providers', 'and', 'communities', '']"
123939,"Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020",2020,MMWR Morb Mortal Wkly Rep,,"On December 31, 2019, Chinese health officials reported a cluster of cases of acute respiratory illness in persons associated with the Hunan seafood and animal market in the city of Wuhan, Hubei Province, in central China. On January 7, 2020, Chinese health officials confirmed that a novel coronavirus (2019-nCoV) was associated with this initial cluster (1). As of February 4, 2020, a total of 20,471 confirmed cases, including 2,788 (13.6%) with severe illness,* and 425 deaths (2.1%) had been reported by the National Health Commission of China (2). Cases have also been reported in 26 locations outside of mainland China, including documentation of some person-to-person transmission and one death (2). As of February 4, 11 cases had been reported in the United States. On January 30, the World Health Organization (WHO) Director-General declared that the 2019-nCoV outbreak constitutes a Public Health Emergency of International Concern. On January 31, the U.S. Department of Health and Human Services (HHS) Secretary declared a U.S. public health emergency to respond to 2019-nCoV.§ Also on January 31, the president of the United States signed a ""Proclamation on Suspension of Entry as Immigrants and Nonimmigrants of Persons who Pose a Risk of Transmitting 2019 Novel Coronavirus,"" which limits entry into the United States of persons who traveled to mainland China to U.S. citizens and lawful permanent residents and their families (3). CDC, multiple other federal agencies, state and local health departments, and other partners are implementing aggressive measures to slow transmission of 2019-nCoV in the United States (4,5). These measures require the identification of cases and their contacts in the United States and the appropriate assessment and care of travelers arriving from mainland China to the United States. These measures are being implemented in anticipation of additional 2019-nCoV cases in the United States. Although these measures might not prevent the eventual establishment of ongoing, widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare health care systems and the general public to be ready if widespread transmission with substantial associated illness occurs; and 3) better characterize 2019-nCoV infection to guide public health recommendations and the development of medical countermeasures including diagnostics, therapeutics, and vaccines. Public health authorities are monitoring the situation closely. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC and state and local health departments.",,emcn4wcj,"['On', 'December', '31', '2019', 'Chinese', 'health', 'officials', 'reported', 'a', 'cluster', 'of', 'cases', 'of', 'acute', 'respiratory', 'illness', 'in', 'persons', 'associated', 'with', 'the', 'Hunan', 'seafood', 'and', 'animal', 'market', 'in', 'the', 'city', 'of', 'Wuhan', 'Hubei', 'Province', 'in', 'central', 'China', 'On', 'January', '7', '2020', 'Chinese', 'health', 'officials', 'confirmed', 'that', 'a', 'novel', 'coronavirus', '2019', 'nCoV', 'was', 'associated', 'with', 'this', 'initial', 'cluster', '1', 'As', 'of', 'February', '4', '2020', 'a', 'total', 'of', '20', '471', 'confirmed', 'cases', 'including', '2', '788', '13', '6', 'with', 'severe', 'illness', 'and', '425', 'deaths', '2', '1', 'had', 'been', 'reported', 'by', 'the', 'National', 'Health', 'Commission', 'of', 'China', '2', 'Cases', 'have', 'also', 'been', 'reported', 'in', '26', 'locations', 'outside', 'of', 'mainland', 'China', 'including', 'documentation', 'of', 'some', 'person', 'to', 'person', 'transmission', 'and', 'one', 'death', '2', 'As', 'of', 'February', '4', '11', 'cases', 'had', 'been', 'reported', 'in', 'the', 'United', 'States', 'On', 'January', '30', 'the', 'World', 'Health', 'Organization', 'WHO', 'Director', 'General', 'declared', 'that', 'the', '2019', 'nCoV', 'outbreak', 'constitutes', 'a', 'Public', 'Health', 'Emergency', 'of', 'International', 'Concern', 'On', 'January', '31', 'the', 'U', 'S', 'Department', 'of', 'Health', 'and', 'Human', 'Services', 'HHS', 'Secretary', 'declared', 'a', 'U', 'S', 'public', 'health', 'emergency', 'to', 'respond', 'to', '2019', 'nCoV', 'Also', 'on', 'January', '31', 'the', 'president', 'of', 'the', 'United', 'States', 'signed', 'a', 'Proclamation', 'on', 'Suspension', 'of', 'Entry', 'as', 'Immigrants', 'and', 'Nonimmigrants', 'of', 'Persons', 'who', 'Pose', 'a', 'Risk', 'of', 'Transmitting', '2019', 'Novel', 'Coronavirus', 'which', 'limits', 'entry', 'into', 'the', 'United', 'States', 'of', 'persons', 'who', 'traveled', 'to', 'mainland', 'China', 'to', 'U', 'S', 'citizens', 'and', 'lawful', 'permanent', 'residents', 'and', 'their', 'families', '3', 'CDC', 'multiple', 'other', 'federal', 'agencies', 'state', 'and', 'local', 'health', 'departments', 'and', 'other', 'partners', 'are', 'implementing', 'aggressive', 'measures', 'to', 'slow', 'transmission', 'of', '2019', 'nCoV', 'in', 'the', 'United', 'States', '4', '5', 'These', 'measures', 'require', 'the', 'identification', 'of', 'cases', 'and', 'their', 'contacts', 'in', 'the', 'United', 'States', 'and', 'the', 'appropriate', 'assessment', 'and', 'care', 'of', 'travelers', 'arriving', 'from', 'mainland', 'China', 'to', 'the', 'United', 'States', 'These', 'measures', 'are', 'being', 'implemented', 'in', 'anticipation', 'of', 'additional', '2019', 'nCoV', 'cases', 'in', 'the', 'United', 'States', 'Although', 'these', 'measures', 'might', 'not', 'prevent', 'the', 'eventual', 'establishment', 'of', 'ongoing', 'widespread', 'transmission', 'of', 'the', 'virus', 'in', 'the', 'United', 'States', 'they', 'are', 'being', 'implemented', 'to', '1', 'slow', 'the', 'spread', 'of', 'illness', '2', 'provide', 'time', 'to', 'better', 'prepare', 'health', 'care', 'systems', 'and', 'the', 'general', 'public', 'to', 'be', 'ready', 'if', 'widespread', 'transmission', 'with', 'substantial', 'associated', 'illness', 'occurs', 'and', '3', 'better', 'characterize', '2019', 'nCoV', 'infection', 'to', 'guide', 'public', 'health', 'recommendations', 'and', 'the', 'development', 'of', 'medical', 'countermeasures', 'including', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'Public', 'health', 'authorities', 'are', 'monitoring', 'the', 'situation', 'closely', 'As', 'more', 'is', 'learned', 'about', 'this', 'novel', 'virus', 'and', 'this', 'outbreak', 'CDC', 'will', 'rapidly', 'incorporate', 'new', 'knowledge', 'into', 'guidance', 'for', 'action', 'by', 'CDC', 'and', 'state', 'and', 'local', 'health', 'departments', '']"
123940,"Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020",2020,MMWR Morb Mortal Wkly Rep,,"On December 31, 2019, Chinese health officials reported a cluster of cases of acute respiratory illness in persons associated with the Hunan seafood and animal market in the city of Wuhan, Hubei Province, in central China. On January 7, 2020, Chinese health officials confirmed that a novel coronavirus (2019-nCoV) was associated with this initial cluster (1). As of February 4, 2020, a total of 20,471 confirmed cases, including 2,788 (13.6%) with severe illness,* and 425 deaths (2.1%) had been reported by the National Health Commission of China (2). Cases have also been reported in 26 locations outside of mainland China, including documentation of some person-to-person transmission and one death (2). As of February 4, 11 cases had been reported in the United States. On January 30, the World Health Organization (WHO) Director-General declared that the 2019-nCoV outbreak constitutes a Public Health Emergency of International Concern. On January 31, the U.S. Department of Health and Human Services (HHS) Secretary declared a U.S. public health emergency to respond to 2019-nCoV.§ Also on January 31, the president of the United States signed a ""Proclamation on Suspension of Entry as Immigrants and Nonimmigrants of Persons who Pose a Risk of Transmitting 2019 Novel Coronavirus,"" which limits entry into the United States of persons who traveled to mainland China to U.S. citizens and lawful permanent residents and their families (3). CDC, multiple other federal agencies, state and local health departments, and other partners are implementing aggressive measures to slow transmission of 2019-nCoV in the United States (4,5). These measures require the identification of cases and their contacts in the United States and the appropriate assessment and care of travelers arriving from mainland China to the United States. These measures are being implemented in anticipation of additional 2019-nCoV cases in the United States. Although these measures might not prevent the eventual establishment of ongoing, widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare health care systems and the general public to be ready if widespread transmission with substantial associated illness occurs; and 3) better characterize 2019-nCoV infection to guide public health recommendations and the development of medical countermeasures including diagnostics, therapeutics, and vaccines. Public health authorities are monitoring the situation closely. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC and state and local health departments.",,2qrxoqmh,"['On', 'December', '31', '2019', 'Chinese', 'health', 'officials', 'reported', 'a', 'cluster', 'of', 'cases', 'of', 'acute', 'respiratory', 'illness', 'in', 'persons', 'associated', 'with', 'the', 'Hunan', 'seafood', 'and', 'animal', 'market', 'in', 'the', 'city', 'of', 'Wuhan', 'Hubei', 'Province', 'in', 'central', 'China', 'On', 'January', '7', '2020', 'Chinese', 'health', 'officials', 'confirmed', 'that', 'a', 'novel', 'coronavirus', '2019', 'nCoV', 'was', 'associated', 'with', 'this', 'initial', 'cluster', '1', 'As', 'of', 'February', '4', '2020', 'a', 'total', 'of', '20', '471', 'confirmed', 'cases', 'including', '2', '788', '13', '6', 'with', 'severe', 'illness', 'and', '425', 'deaths', '2', '1', 'had', 'been', 'reported', 'by', 'the', 'National', 'Health', 'Commission', 'of', 'China', '2', 'Cases', 'have', 'also', 'been', 'reported', 'in', '26', 'locations', 'outside', 'of', 'mainland', 'China', 'including', 'documentation', 'of', 'some', 'person', 'to', 'person', 'transmission', 'and', 'one', 'death', '2', 'As', 'of', 'February', '4', '11', 'cases', 'had', 'been', 'reported', 'in', 'the', 'United', 'States', 'On', 'January', '30', 'the', 'World', 'Health', 'Organization', 'WHO', 'Director', 'General', 'declared', 'that', 'the', '2019', 'nCoV', 'outbreak', 'constitutes', 'a', 'Public', 'Health', 'Emergency', 'of', 'International', 'Concern', 'On', 'January', '31', 'the', 'U', 'S', 'Department', 'of', 'Health', 'and', 'Human', 'Services', 'HHS', 'Secretary', 'declared', 'a', 'U', 'S', 'public', 'health', 'emergency', 'to', 'respond', 'to', '2019', 'nCoV', 'Also', 'on', 'January', '31', 'the', 'president', 'of', 'the', 'United', 'States', 'signed', 'a', 'Proclamation', 'on', 'Suspension', 'of', 'Entry', 'as', 'Immigrants', 'and', 'Nonimmigrants', 'of', 'Persons', 'who', 'Pose', 'a', 'Risk', 'of', 'Transmitting', '2019', 'Novel', 'Coronavirus', 'which', 'limits', 'entry', 'into', 'the', 'United', 'States', 'of', 'persons', 'who', 'traveled', 'to', 'mainland', 'China', 'to', 'U', 'S', 'citizens', 'and', 'lawful', 'permanent', 'residents', 'and', 'their', 'families', '3', 'CDC', 'multiple', 'other', 'federal', 'agencies', 'state', 'and', 'local', 'health', 'departments', 'and', 'other', 'partners', 'are', 'implementing', 'aggressive', 'measures', 'to', 'slow', 'transmission', 'of', '2019', 'nCoV', 'in', 'the', 'United', 'States', '4', '5', 'These', 'measures', 'require', 'the', 'identification', 'of', 'cases', 'and', 'their', 'contacts', 'in', 'the', 'United', 'States', 'and', 'the', 'appropriate', 'assessment', 'and', 'care', 'of', 'travelers', 'arriving', 'from', 'mainland', 'China', 'to', 'the', 'United', 'States', 'These', 'measures', 'are', 'being', 'implemented', 'in', 'anticipation', 'of', 'additional', '2019', 'nCoV', 'cases', 'in', 'the', 'United', 'States', 'Although', 'these', 'measures', 'might', 'not', 'prevent', 'the', 'eventual', 'establishment', 'of', 'ongoing', 'widespread', 'transmission', 'of', 'the', 'virus', 'in', 'the', 'United', 'States', 'they', 'are', 'being', 'implemented', 'to', '1', 'slow', 'the', 'spread', 'of', 'illness', '2', 'provide', 'time', 'to', 'better', 'prepare', 'health', 'care', 'systems', 'and', 'the', 'general', 'public', 'to', 'be', 'ready', 'if', 'widespread', 'transmission', 'with', 'substantial', 'associated', 'illness', 'occurs', 'and', '3', 'better', 'characterize', '2019', 'nCoV', 'infection', 'to', 'guide', 'public', 'health', 'recommendations', 'and', 'the', 'development', 'of', 'medical', 'countermeasures', 'including', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'Public', 'health', 'authorities', 'are', 'monitoring', 'the', 'situation', 'closely', 'As', 'more', 'is', 'learned', 'about', 'this', 'novel', 'virus', 'and', 'this', 'outbreak', 'CDC', 'will', 'rapidly', 'incorporate', 'new', 'knowledge', 'into', 'guidance', 'for', 'action', 'by', 'CDC', 'and', 'state', 'and', 'local', 'health', 'departments', '']"
126361,Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium,2020,J. virol,,"Currently, there are four seasonal coronaviruses associated with relatively mild respiratory tract disease in humans. However, there is also a plethora of animal coronaviruses which have the potential to cross the species border. This regularly results in the emergence of new viruses in humans. In 2002, severe acute respiratory syndrome coronavirus (SARS-CoV) emerged and rapidly disappeared in May 2003. In 2012, Middle East respiratory syndrome coronavirus (MERS-CoV) was identified as a possible threat to humans, but its pandemic potential so far is minimal, as human-to-human transmission is ineffective. The end of 2019 brought us information about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emergence, and the virus rapidly spread in 2020, causing an unprecedented pandemic. At present, studies on the virus are carried out using a surrogate system based on the immortalized simian Vero E6 cell line. This model is convenient for diagnostics, but it has serious limitations and does not allow for understanding of the biology and evolution of the virus. Here, we show that fully differentiated human airway epithelium cultures constitute an excellent model to study infection with the novel human coronavirus SARS-CoV-2. We observed efficient replication of the virus in the tissue, with maximal replication at 2 days postinfection. The virus replicated in ciliated cells and was released apically.IMPORTANCE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged by the end of 2019 and rapidly spread in 2020. At present, it is of utmost importance to understand the biology of the virus, rapidly assess the treatment potential of existing drugs, and develop new active compounds. While some animal models for such studies are under development, most of the research is carried out in Vero E6 cells. Here, we propose fully differentiated human airway epithelium cultures as a model for studies on SARS-CoV-2.",,598n91gb,"['Currently', 'there', 'are', 'four', 'seasonal', 'coronaviruses', 'associated', 'with', 'relatively', 'mild', 'respiratory', 'tract', 'disease', 'in', 'humans', 'However', 'there', 'is', 'also', 'a', 'plethora', 'of', 'animal', 'coronaviruses', 'which', 'have', 'the', 'potential', 'to', 'cross', 'the', 'species', 'border', 'This', 'regularly', 'results', 'in', 'the', 'emergence', 'of', 'new', 'viruses', 'in', 'humans', 'In', '2002', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'SARS', 'CoV', 'emerged', 'and', 'rapidly', 'disappeared', 'in', 'May', '2003', 'In', '2012', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'was', 'identified', 'as', 'a', 'possible', 'threat', 'to', 'humans', 'but', 'its', 'pandemic', 'potential', 'so', 'far', 'is', 'minimal', 'as', 'human', 'to', 'human', 'transmission', 'is', 'ineffective', 'The', 'end', 'of', '2019', 'brought', 'us', 'information', 'about', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'emergence', 'and', 'the', 'virus', 'rapidly', 'spread', 'in', '2020', 'causing', 'an', 'unprecedented', 'pandemic', 'At', 'present', 'studies', 'on', 'the', 'virus', 'are', 'carried', 'out', 'using', 'a', 'surrogate', 'system', 'based', 'on', 'the', 'immortalized', 'simian', 'Vero', 'E6', 'cell', 'line', 'This', 'model', 'is', 'convenient', 'for', 'diagnostics', 'but', 'it', 'has', 'serious', 'limitations', 'and', 'does', 'not', 'allow', 'for', 'understanding', 'of', 'the', 'biology', 'and', 'evolution', 'of', 'the', 'virus', 'Here', 'we', 'show', 'that', 'fully', 'differentiated', 'human', 'airway', 'epithelium', 'cultures', 'constitute', 'an', 'excellent', 'model', 'to', 'study', 'infection', 'with', 'the', 'novel', 'human', 'coronavirus', 'SARS', 'CoV', '2', 'We', 'observed', 'efficient', 'replication', 'of', 'the', 'virus', 'in', 'the', 'tissue', 'with', 'maximal', 'replication', 'at', '2', 'days', 'postinfection', 'The', 'virus', 'replicated', 'in', 'ciliated', 'cells', 'and', 'was', 'released', 'apically', 'IMPORTANCE', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'emerged', 'by', 'the', 'end', 'of', '2019', 'and', 'rapidly', 'spread', 'in', '2020', 'At', 'present', 'it', 'is', 'of', 'utmost', 'importance', 'to', 'understand', 'the', 'biology', 'of', 'the', 'virus', 'rapidly', 'assess', 'the', 'treatment', 'potential', 'of', 'existing', 'drugs', 'and', 'develop', 'new', 'active', 'compounds', 'While', 'some', 'animal', 'models', 'for', 'such', 'studies', 'are', 'under', 'development', 'most', 'of', 'the', 'research', 'is', 'carried', 'out', 'in', 'Vero', 'E6', 'cells', 'Here', 'we', 'propose', 'fully', 'differentiated', 'human', 'airway', 'epithelium', 'cultures', 'as', 'a', 'model', 'for', 'studies', 'on', 'SARS', 'CoV', '2', '']"
127362,An update on the status of COVID-19: a comprehensive review,2020,Eur Rev Med Pharmacol Sci,,"The last two decades have witnessed two large-scale pandemics caused by coronaviruses, including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). At the end of 2019, another novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hit Wuhan, a city in the center of China, and subsequently spread rapidly to the whole world. Latest reports revealed that more than 800 thousand people in over 200 countries are involved in the epidemic disease by SARS-CoV-2. Due to the high mortality rate and the lack of optimum therapeutics, it is crucial to understand the biological characteristics of the virus and its possible pathogenesis to respond to the SARS-CoV-2. Rapid diagnostics and effective therapeutics are also important interventions for the management of infection control. However, the rapid evolution of SARS-CoV-2 exerted tremendous challenges on its diagnostics and therapeutics. Therefore, there is an urgent need to summarize the existing research results to guide decision-making on the prioritization of resources for research and development. In this review, we focus on our current understanding of epidemiology, pathogenesis, diagnostics and therapeutics of coronavirus disease 2019 (COVID-19).",,limug35b,"['The', 'last', 'two', 'decades', 'have', 'witnessed', 'two', 'large', 'scale', 'pandemics', 'caused', 'by', 'coronaviruses', 'including', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'and', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'MERS', 'At', 'the', 'end', 'of', '2019', 'another', 'novel', 'coronavirus', 'designated', 'as', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'hit', 'Wuhan', 'a', 'city', 'in', 'the', 'center', 'of', 'China', 'and', 'subsequently', 'spread', 'rapidly', 'to', 'the', 'whole', 'world', 'Latest', 'reports', 'revealed', 'that', 'more', 'than', '800', 'thousand', 'people', 'in', 'over', '200', 'countries', 'are', 'involved', 'in', 'the', 'epidemic', 'disease', 'by', 'SARS', 'CoV', '2', 'Due', 'to', 'the', 'high', 'mortality', 'rate', 'and', 'the', 'lack', 'of', 'optimum', 'therapeutics', 'it', 'is', 'crucial', 'to', 'understand', 'the', 'biological', 'characteristics', 'of', 'the', 'virus', 'and', 'its', 'possible', 'pathogenesis', 'to', 'respond', 'to', 'the', 'SARS', 'CoV', '2', 'Rapid', 'diagnostics', 'and', 'effective', 'therapeutics', 'are', 'also', 'important', 'interventions', 'for', 'the', 'management', 'of', 'infection', 'control', 'However', 'the', 'rapid', 'evolution', 'of', 'SARS', 'CoV', '2', 'exerted', 'tremendous', 'challenges', 'on', 'its', 'diagnostics', 'and', 'therapeutics', 'Therefore', 'there', 'is', 'an', 'urgent', 'need', 'to', 'summarize', 'the', 'existing', 'research', 'results', 'to', 'guide', 'decision', 'making', 'on', 'the', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'In', 'this', 'review', 'we', 'focus', 'on', 'our', 'current', 'understanding', 'of', 'epidemiology', 'pathogenesis', 'diagnostics', 'and', 'therapeutics', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', '']"
127363,An update on the status of COVID-19: a comprehensive review,2020,Eur Rev Med Pharmacol Sci,,"The last two decades have witnessed two large-scale pandemics caused by coronaviruses, including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). At the end of 2019, another novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hit Wuhan, a city in the center of China, and subsequently spread rapidly to the whole world. Latest reports revealed that more than 800 thousand people in over 200 countries are involved in the epidemic disease by SARS-CoV-2. Due to the high mortality rate and the lack of optimum therapeutics, it is crucial to understand the biological characteristics of the virus and its possible pathogenesis to respond to the SARS-CoV-2. Rapid diagnostics and effective therapeutics are also important interventions for the management of infection control. However, the rapid evolution of SARS-CoV-2 exerted tremendous challenges on its diagnostics and therapeutics. Therefore, there is an urgent need to summarize the existing research results to guide decision-making on the prioritization of resources for research and development. In this review, we focus on our current understanding of epidemiology, pathogenesis, diagnostics and therapeutics of coronavirus disease 2019 (COVID-19).",,gj8ng7xg,"['The', 'last', 'two', 'decades', 'have', 'witnessed', 'two', 'large', 'scale', 'pandemics', 'caused', 'by', 'coronaviruses', 'including', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'and', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'MERS', 'At', 'the', 'end', 'of', '2019', 'another', 'novel', 'coronavirus', 'designated', 'as', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'hit', 'Wuhan', 'a', 'city', 'in', 'the', 'center', 'of', 'China', 'and', 'subsequently', 'spread', 'rapidly', 'to', 'the', 'whole', 'world', 'Latest', 'reports', 'revealed', 'that', 'more', 'than', '800', 'thousand', 'people', 'in', 'over', '200', 'countries', 'are', 'involved', 'in', 'the', 'epidemic', 'disease', 'by', 'SARS', 'CoV', '2', 'Due', 'to', 'the', 'high', 'mortality', 'rate', 'and', 'the', 'lack', 'of', 'optimum', 'therapeutics', 'it', 'is', 'crucial', 'to', 'understand', 'the', 'biological', 'characteristics', 'of', 'the', 'virus', 'and', 'its', 'possible', 'pathogenesis', 'to', 'respond', 'to', 'the', 'SARS', 'CoV', '2', 'Rapid', 'diagnostics', 'and', 'effective', 'therapeutics', 'are', 'also', 'important', 'interventions', 'for', 'the', 'management', 'of', 'infection', 'control', 'However', 'the', 'rapid', 'evolution', 'of', 'SARS', 'CoV', '2', 'exerted', 'tremendous', 'challenges', 'on', 'its', 'diagnostics', 'and', 'therapeutics', 'Therefore', 'there', 'is', 'an', 'urgent', 'need', 'to', 'summarize', 'the', 'existing', 'research', 'results', 'to', 'guide', 'decision', 'making', 'on', 'the', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'In', 'this', 'review', 'we', 'focus', 'on', 'our', 'current', 'understanding', 'of', 'epidemiology', 'pathogenesis', 'diagnostics', 'and', 'therapeutics', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', '']"
129250,Recent advances in lab-on-a-chip technologies for viral diagnosis,2020,Biosens Bioelectron,,"The global risk of viral disease outbreaks emphasizes the need for rapid, accurate, and sensitive detection techniques to speed up diagnostics allowing early intervention. An emerging field of microfluidics also known as the lab-on-a-chip (LOC) or micro total analysis system includes a wide range of diagnostic devices. This review briefly covers both conventional and microfluidics-based techniques for rapid viral detection. We first describe conventional detection methods such as cell culturing, immunofluorescence or enzyme-linked immunosorbent assay (ELISA), or reverse transcription polymerase chain reaction (RT-PCR). These methods often have limited speed, sensitivity, or specificity and are performed with typically bulky equipment. Here, we discuss some of the LOC technologies that can overcome these demerits, highlighting the latest advances in LOC devices for viral disease diagnosis. We also discuss the fabrication of LOC systems to produce devices for performing either individual steps or virus detection in samples with the sample to answer method. The complete system consists of sample preparation, and ELISA and RT-PCR for viral-antibody and nucleic acid detection, respectively. Finally, we formulate our opinions on these areas for the future development of LOC systems for viral diagnostics.",,u9s272m5,"['The', 'global', 'risk', 'of', 'viral', 'disease', 'outbreaks', 'emphasizes', 'the', 'need', 'for', 'rapid', 'accurate', 'and', 'sensitive', 'detection', 'techniques', 'to', 'speed', 'up', 'diagnostics', 'allowing', 'early', 'intervention', 'An', 'emerging', 'field', 'of', 'microfluidics', 'also', 'known', 'as', 'the', 'lab', 'on', 'a', 'chip', 'LOC', 'or', 'micro', 'total', 'analysis', 'system', 'includes', 'a', 'wide', 'range', 'of', 'diagnostic', 'devices', 'This', 'review', 'briefly', 'covers', 'both', 'conventional', 'and', 'microfluidics', 'based', 'techniques', 'for', 'rapid', 'viral', 'detection', 'We', 'first', 'describe', 'conventional', 'detection', 'methods', 'such', 'as', 'cell', 'culturing', 'immunofluorescence', 'or', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'or', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'These', 'methods', 'often', 'have', 'limited', 'speed', 'sensitivity', 'or', 'specificity', 'and', 'are', 'performed', 'with', 'typically', 'bulky', 'equipment', 'Here', 'we', 'discuss', 'some', 'of', 'the', 'LOC', 'technologies', 'that', 'can', 'overcome', 'these', 'demerits', 'highlighting', 'the', 'latest', 'advances', 'in', 'LOC', 'devices', 'for', 'viral', 'disease', 'diagnosis', 'We', 'also', 'discuss', 'the', 'fabrication', 'of', 'LOC', 'systems', 'to', 'produce', 'devices', 'for', 'performing', 'either', 'individual', 'steps', 'or', 'virus', 'detection', 'in', 'samples', 'with', 'the', 'sample', 'to', 'answer', 'method', 'The', 'complete', 'system', 'consists', 'of', 'sample', 'preparation', 'and', 'ELISA', 'and', 'RT', 'PCR', 'for', 'viral', 'antibody', 'and', 'nucleic', 'acid', 'detection', 'respectively', 'Finally', 'we', 'formulate', 'our', 'opinions', 'on', 'these', 'areas', 'for', 'the', 'future', 'development', 'of', 'LOC', 'systems', 'for', 'viral', 'diagnostics', '']"
129977,RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look,2020,RNA,,"As the COVID-19 outbreak spreads, there is a growing need for a compilation of conserved RNA genome regions in the SARS-CoV-2 virus along with their structural propensities to guide development of antivirals and diagnostics. Here we present a first look at RNA sequence conservation and structural propensities in the SARS-CoV-2 genome. Using sequence alignments spanning a range of betacoronaviruses, we rank genomic regions by RNA sequence conservation, identifying 79 regions of length at least 15 nt as exactly conserved over SARS-related complete genome sequences available near the beginning of the COVID-19 outbreak. We then confirm the conservation of the majority of these genome regions across 739 SARS-CoV-2 sequences subsequently reported from the COVID-19 outbreak, and we present a curated list of 30 ""SARS-related-conserved"" regions. We find that known RNA structured elements curated as Rfam families and in prior literature are enriched in these conserved genome regions, and we predict additional conserved, stable secondary structures across the viral genome. We provide 106 ""SARS-CoV-2-conserved-structured"" regions as potential targets for antivirals that bind to structured RNA. We further provide detailed secondary structure models for the extended 5' UTR, frameshifting stimulation element, and 3' UTR. Lastly, we predict regions of the SARS-CoV-2 viral genome that have low propensity for RNA secondary structure and are conserved within SARS-CoV-2 strains. These 59 ""SARS-CoV-2-conserved-unstructured"" genomic regions may be most easily accessible by hybridization in primer-based diagnostic strategies.",,6kv372ue,"['As', 'the', 'COVID', '19', 'outbreak', 'spreads', 'there', 'is', 'a', 'growing', 'need', 'for', 'a', 'compilation', 'of', 'conserved', 'RNA', 'genome', 'regions', 'in', 'the', 'SARS', 'CoV', '2', 'virus', 'along', 'with', 'their', 'structural', 'propensities', 'to', 'guide', 'development', 'of', 'antivirals', 'and', 'diagnostics', 'Here', 'we', 'present', 'a', 'first', 'look', 'at', 'RNA', 'sequence', 'conservation', 'and', 'structural', 'propensities', 'in', 'the', 'SARS', 'CoV', '2', 'genome', 'Using', 'sequence', 'alignments', 'spanning', 'a', 'range', 'of', 'betacoronaviruses', 'we', 'rank', 'genomic', 'regions', 'by', 'RNA', 'sequence', 'conservation', 'identifying', '79', 'regions', 'of', 'length', 'at', 'least', '15', 'nt', 'as', 'exactly', 'conserved', 'over', 'SARS', 'related', 'complete', 'genome', 'sequences', 'available', 'near', 'the', 'beginning', 'of', 'the', 'COVID', '19', 'outbreak', 'We', 'then', 'confirm', 'the', 'conservation', 'of', 'the', 'majority', 'of', 'these', 'genome', 'regions', 'across', '739', 'SARS', 'CoV', '2', 'sequences', 'subsequently', 'reported', 'from', 'the', 'COVID', '19', 'outbreak', 'and', 'we', 'present', 'a', 'curated', 'list', 'of', '30', 'SARS', 'related', 'conserved', 'regions', 'We', 'find', 'that', 'known', 'RNA', 'structured', 'elements', 'curated', 'as', 'Rfam', 'families', 'and', 'in', 'prior', 'literature', 'are', 'enriched', 'in', 'these', 'conserved', 'genome', 'regions', 'and', 'we', 'predict', 'additional', 'conserved', 'stable', 'secondary', 'structures', 'across', 'the', 'viral', 'genome', 'We', 'provide', '106', 'SARS', 'CoV', '2', 'conserved', 'structured', 'regions', 'as', 'potential', 'targets', 'for', 'antivirals', 'that', 'bind', 'to', 'structured', 'RNA', 'We', 'further', 'provide', 'detailed', 'secondary', 'structure', 'models', 'for', 'the', 'extended', '5', 'UTR', 'frameshifting', 'stimulation', 'element', 'and', '3', 'UTR', 'Lastly', 'we', 'predict', 'regions', 'of', 'the', 'SARS', 'CoV', '2', 'viral', 'genome', 'that', 'have', 'low', 'propensity', 'for', 'RNA', 'secondary', 'structure', 'and', 'are', 'conserved', 'within', 'SARS', 'CoV', '2', 'strains', 'These', '59', 'SARS', 'CoV', '2', 'conserved', 'unstructured', 'genomic', 'regions', 'may', 'be', 'most', 'easily', 'accessible', 'by', 'hybridization', 'in', 'primer', 'based', 'diagnostic', 'strategies', '']"
130086,What we know so far: COVID-19 current clinical knowledge and research,2020,Clin Med (Lond),,"In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features.",,3mnmib3o,"['In', 'December', '2019', 'health', 'authorities', 'in', 'Wuhan', 'China', 'identified', 'a', 'cluster', 'of', 'pneumonia', 'cases', 'of', 'unknown', 'aetiology', 'linked', 'to', 'the', 'city', 's', 'South', 'China', 'Seafood', 'Market', 'Subsequent', 'investigations', 'revealed', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'as', 'the', 'causative', 'agent', 'now', 'at', 'the', 'heart', 'of', 'a', 'major', 'outbreak', 'The', 'rising', 'case', 'numbers', 'have', 'been', 'accompanied', 'by', 'unprecedented', 'public', 'health', 'action', 'including', 'the', 'wholesale', 'isolation', 'of', 'Wuhan', 'Alongside', 'this', 'has', 'been', 'a', 'robust', 'scientific', 'response', 'including', 'early', 'publication', 'of', 'the', 'pathogen', 'genome', 'and', 'rapid', 'development', 'of', 'highly', 'specific', 'diagnostics', 'This', 'article', 'will', 'review', 'the', 'new', 'knowledge', 'of', 'SARS', 'CoV', '2', 'COVID', '19', 'acute', 'respiratory', 'disease', 'and', 'summarise', 'its', 'clinical', 'features', '']"
130087,What we know so far: COVID-19 current clinical knowledge and research,2020,Clin Med (Lond),,"In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features.",,os8nw36g,"['In', 'December', '2019', 'health', 'authorities', 'in', 'Wuhan', 'China', 'identified', 'a', 'cluster', 'of', 'pneumonia', 'cases', 'of', 'unknown', 'aetiology', 'linked', 'to', 'the', 'city', 's', 'South', 'China', 'Seafood', 'Market', 'Subsequent', 'investigations', 'revealed', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'as', 'the', 'causative', 'agent', 'now', 'at', 'the', 'heart', 'of', 'a', 'major', 'outbreak', 'The', 'rising', 'case', 'numbers', 'have', 'been', 'accompanied', 'by', 'unprecedented', 'public', 'health', 'action', 'including', 'the', 'wholesale', 'isolation', 'of', 'Wuhan', 'Alongside', 'this', 'has', 'been', 'a', 'robust', 'scientific', 'response', 'including', 'early', 'publication', 'of', 'the', 'pathogen', 'genome', 'and', 'rapid', 'development', 'of', 'highly', 'specific', 'diagnostics', 'This', 'article', 'will', 'review', 'the', 'new', 'knowledge', 'of', 'SARS', 'CoV', '2', 'COVID', '19', 'acute', 'respiratory', 'disease', 'and', 'summarise', 'its', 'clinical', 'features', '']"
130088,What we know so far: COVID-19 current clinical knowledge and research,2020,Clinical Medicine,,"In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features , Copyright Notice (C) 2020 Royal College of Physicians",,9griuata,"['In', 'December', '2019', 'health', 'authorities', 'in', 'Wuhan', 'China', 'identified', 'a', 'cluster', 'of', 'pneumonia', 'cases', 'of', 'unknown', 'aetiology', 'linked', 'to', 'the', 'city', 's', 'South', 'China', 'Seafood', 'Market', 'Subsequent', 'investigations', 'revealed', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'as', 'the', 'causative', 'agent', 'now', 'at', 'the', 'heart', 'of', 'a', 'major', 'outbreak', 'The', 'rising', 'case', 'numbers', 'have', 'been', 'accompanied', 'by', 'unprecedented', 'public', 'health', 'action', 'including', 'the', 'wholesale', 'isolation', 'of', 'Wuhan', 'Alongside', 'this', 'has', 'been', 'a', 'robust', 'scientific', 'response', 'including', 'early', 'publication', 'of', 'the', 'pathogen', 'genome', 'and', 'rapid', 'development', 'of', 'highly', 'specific', 'diagnostics', 'This', 'article', 'will', 'review', 'the', 'new', 'knowledge', 'of', 'SARS', 'CoV', '2', 'COVID', '19', 'acute', 'respiratory', 'disease', 'and', 'summarise', 'its', 'clinical', 'features', 'Copyright', 'Notice', 'C', '2020', 'Royal', 'College', 'of', 'Physicians']"
130183,[Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic],2020,Kardiologiia,,"The beginning of 2020 was characterized by the development of a new coronavirus pandemic (COVID-19). Information about the epidemiology, etiology, pathogenesis, clinical and laboratory diagnostics, as well as prevention and therapy for this disease is constantly being expanded and reviewed. The COVID-19 pandemic creates the need for the emergence of new conditions of specialized care for patients with heart rhythm and conduction disorders [1]. These recommendations are intended for general practitioners, internists, cardiologists, electrophysiologists/arrhythmologists, cardiovascular surgeons, functional diagnostics doctors, anesthesiologists-resuscitators, laboratory diagnostics specialists, health care organizers in the system of organizations and healthcare institutions that provide specialized care to patients with heart rhythm and conduction disorders.",,3n3jjiyl,"['The', 'beginning', 'of', '2020', 'was', 'characterized', 'by', 'the', 'development', 'of', 'a', 'new', 'coronavirus', 'pandemic', 'COVID', '19', 'Information', 'about', 'the', 'epidemiology', 'etiology', 'pathogenesis', 'clinical', 'and', 'laboratory', 'diagnostics', 'as', 'well', 'as', 'prevention', 'and', 'therapy', 'for', 'this', 'disease', 'is', 'constantly', 'being', 'expanded', 'and', 'reviewed', 'The', 'COVID', '19', 'pandemic', 'creates', 'the', 'need', 'for', 'the', 'emergence', 'of', 'new', 'conditions', 'of', 'specialized', 'care', 'for', 'patients', 'with', 'heart', 'rhythm', 'and', 'conduction', 'disorders', '1', 'These', 'recommendations', 'are', 'intended', 'for', 'general', 'practitioners', 'internists', 'cardiologists', 'electrophysiologists', 'arrhythmologists', 'cardiovascular', 'surgeons', 'functional', 'diagnostics', 'doctors', 'anesthesiologists', 'resuscitators', 'laboratory', 'diagnostics', 'specialists', 'health', 'care', 'organizers', 'in', 'the', 'system', 'of', 'organizations', 'and', 'healthcare', 'institutions', 'that', 'provide', 'specialized', 'care', 'to', 'patients', 'with', 'heart', 'rhythm', 'and', 'conduction', 'disorders', '']"
130184,[Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic],2020,Kardiologiia,,"The beginning of 2020 was characterized by the development of a new coronavirus pandemic (COVID-19). Information about the epidemiology, etiology, pathogenesis, clinical and laboratory diagnostics, as well as prevention and therapy for this disease is constantly being expanded and reviewed. The COVID-19 pandemic creates the need for the emergence of new conditions of specialized care for patients with heart rhythm and conduction disorders [1]. These recommendations are intended for general practitioners, internists, cardiologists, electrophysiologists/arrhythmologists, cardiovascular surgeons, functional diagnostics doctors, anesthesiologists-resuscitators, laboratory diagnostics specialists, health care organizers in the system of organizations and healthcare institutions that provide specialized care to patients with heart rhythm and conduction disorders.",,xlyi0qap,"['The', 'beginning', 'of', '2020', 'was', 'characterized', 'by', 'the', 'development', 'of', 'a', 'new', 'coronavirus', 'pandemic', 'COVID', '19', 'Information', 'about', 'the', 'epidemiology', 'etiology', 'pathogenesis', 'clinical', 'and', 'laboratory', 'diagnostics', 'as', 'well', 'as', 'prevention', 'and', 'therapy', 'for', 'this', 'disease', 'is', 'constantly', 'being', 'expanded', 'and', 'reviewed', 'The', 'COVID', '19', 'pandemic', 'creates', 'the', 'need', 'for', 'the', 'emergence', 'of', 'new', 'conditions', 'of', 'specialized', 'care', 'for', 'patients', 'with', 'heart', 'rhythm', 'and', 'conduction', 'disorders', '1', 'These', 'recommendations', 'are', 'intended', 'for', 'general', 'practitioners', 'internists', 'cardiologists', 'electrophysiologists', 'arrhythmologists', 'cardiovascular', 'surgeons', 'functional', 'diagnostics', 'doctors', 'anesthesiologists', 'resuscitators', 'laboratory', 'diagnostics', 'specialists', 'health', 'care', 'organizers', 'in', 'the', 'system', 'of', 'organizations', 'and', 'healthcare', 'institutions', 'that', 'provide', 'specialized', 'care', 'to', 'patients', 'with', 'heart', 'rhythm', 'and', 'conduction', 'disorders', '']"
132059,"An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies",2020,Travel Med Infect Dis,,"Coronavirus Disease 2019 (COVID-19), emerged in early December 2019 in China and became a pandemic situation worldwide by its rapid spread to more than 200 countries or territories. Bats are considered as the reservoir host, and the search of a probable intermediate host is still going on. The severe form of the infection is associated with death is mainly reported in older and immune-compromised patients with pre-existing disease history. Death in severe cases is attributed to respiratory failure associated with hyperinflammation. Cytokine storm syndrome associated with inflammation in response to SARS-CoV-2 infection is considered as the leading cause of mortality in COVID-19 patients. COVID-19 patients have thus higher levels of many proinflammatory cytokines and chemokines. The blood laboratory profile of the COVID-19 patients exhibits lymphopenia, leukopenia, thrombocytopenia, and RNAaemia, along with increased levels of aspartate aminotransferase. SARS-CoV-2 infection in pregnant women does not lead to fetus mortality, unlike other zoonotic coronaviruses such as SARS-CoV and MERS-CoV, and there is, to date, no evidence of intrauterine transmission to neonates. Rapid diagnostics have been developed, and significant efforts are being made to develop effective vaccines and therapeutics. In the absence of any virus-specific therapy, internationally, health care authorities are recommending the adoption of effective community mitigation measures to counter and contain this pandemic virus. This paper is an overview of this virus and the disease with a particular focus on SARS-CoV-2/COVID-19 clinical pathology, pathogenesis, and immunopathology, along with recent research developments.",,uojjp4dd,"['Coronavirus', 'Disease', '2019', 'COVID', '19', 'emerged', 'in', 'early', 'December', '2019', 'in', 'China', 'and', 'became', 'a', 'pandemic', 'situation', 'worldwide', 'by', 'its', 'rapid', 'spread', 'to', 'more', 'than', '200', 'countries', 'or', 'territories', 'Bats', 'are', 'considered', 'as', 'the', 'reservoir', 'host', 'and', 'the', 'search', 'of', 'a', 'probable', 'intermediate', 'host', 'is', 'still', 'going', 'on', 'The', 'severe', 'form', 'of', 'the', 'infection', 'is', 'associated', 'with', 'death', 'is', 'mainly', 'reported', 'in', 'older', 'and', 'immune', 'compromised', 'patients', 'with', 'pre', 'existing', 'disease', 'history', 'Death', 'in', 'severe', 'cases', 'is', 'attributed', 'to', 'respiratory', 'failure', 'associated', 'with', 'hyperinflammation', 'Cytokine', 'storm', 'syndrome', 'associated', 'with', 'inflammation', 'in', 'response', 'to', 'SARS', 'CoV', '2', 'infection', 'is', 'considered', 'as', 'the', 'leading', 'cause', 'of', 'mortality', 'in', 'COVID', '19', 'patients', 'COVID', '19', 'patients', 'have', 'thus', 'higher', 'levels', 'of', 'many', 'proinflammatory', 'cytokines', 'and', 'chemokines', 'The', 'blood', 'laboratory', 'profile', 'of', 'the', 'COVID', '19', 'patients', 'exhibits', 'lymphopenia', 'leukopenia', 'thrombocytopenia', 'and', 'RNAaemia', 'along', 'with', 'increased', 'levels', 'of', 'aspartate', 'aminotransferase', 'SARS', 'CoV', '2', 'infection', 'in', 'pregnant', 'women', 'does', 'not', 'lead', 'to', 'fetus', 'mortality', 'unlike', 'other', 'zoonotic', 'coronaviruses', 'such', 'as', 'SARS', 'CoV', 'and', 'MERS', 'CoV', 'and', 'there', 'is', 'to', 'date', 'no', 'evidence', 'of', 'intrauterine', 'transmission', 'to', 'neonates', 'Rapid', 'diagnostics', 'have', 'been', 'developed', 'and', 'significant', 'efforts', 'are', 'being', 'made', 'to', 'develop', 'effective', 'vaccines', 'and', 'therapeutics', 'In', 'the', 'absence', 'of', 'any', 'virus', 'specific', 'therapy', 'internationally', 'health', 'care', 'authorities', 'are', 'recommending', 'the', 'adoption', 'of', 'effective', 'community', 'mitigation', 'measures', 'to', 'counter', 'and', 'contain', 'this', 'pandemic', 'virus', 'This', 'paper', 'is', 'an', 'overview', 'of', 'this', 'virus', 'and', 'the', 'disease', 'with', 'a', 'particular', 'focus', 'on', 'SARS', 'CoV', '2', 'COVID', '19', 'clinical', 'pathology', 'pathogenesis', 'and', 'immunopathology', 'along', 'with', 'recent', 'research', 'developments', '']"
132896,"COVID-19 Diagnostics, Tools, and Prevention",2020,,,"The Coronavirus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), outbreak from Wuhan City, Hubei province, China in 2019 has become an ongoing global health emergency. The emerging virus, SARS-CoV-2, causes coughing, fever, muscle ache, and shortness of breath or dyspnea in symptomatic patients. The pathogenic particles that are generated by coughing and sneezing remain suspended in the air or attach to a surface to facilitate transmission in an aerosol form. This review focuses on the recent trends in pandemic biology, diagnostics methods, prevention tools, and policies for COVID-19 management. To meet the growing demand for medical supplies during the COVID-19 era, a variety of personal protective equipment (PPE) and ventilators have been developed using do-it-yourself (DIY) manufacturing. COVID-19 diagnosis and the prediction of virus transmission are analyzed by machine learning algorithms, simulations, and digital monitoring. Until the discovery of a clinically approved vaccine for COVID-19, pandemics remain a public concern. Therefore, technological developments, biomedical research, and policy development are needed to decipher the coronavirus mechanism and epidemiological characteristics, prevent transmission, and develop therapeutic drugs.",,bzcl1xgf,"['The', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'caused', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'outbreak', 'from', 'Wuhan', 'City', 'Hubei', 'province', 'China', 'in', '2019', 'has', 'become', 'an', 'ongoing', 'global', 'health', 'emergency', 'The', 'emerging', 'virus', 'SARS', 'CoV', '2', 'causes', 'coughing', 'fever', 'muscle', 'ache', 'and', 'shortness', 'of', 'breath', 'or', 'dyspnea', 'in', 'symptomatic', 'patients', 'The', 'pathogenic', 'particles', 'that', 'are', 'generated', 'by', 'coughing', 'and', 'sneezing', 'remain', 'suspended', 'in', 'the', 'air', 'or', 'attach', 'to', 'a', 'surface', 'to', 'facilitate', 'transmission', 'in', 'an', 'aerosol', 'form', 'This', 'review', 'focuses', 'on', 'the', 'recent', 'trends', 'in', 'pandemic', 'biology', 'diagnostics', 'methods', 'prevention', 'tools', 'and', 'policies', 'for', 'COVID', '19', 'management', 'To', 'meet', 'the', 'growing', 'demand', 'for', 'medical', 'supplies', 'during', 'the', 'COVID', '19', 'era', 'a', 'variety', 'of', 'personal', 'protective', 'equipment', 'PPE', 'and', 'ventilators', 'have', 'been', 'developed', 'using', 'do', 'it', 'yourself', 'DIY', 'manufacturing', 'COVID', '19', 'diagnosis', 'and', 'the', 'prediction', 'of', 'virus', 'transmission', 'are', 'analyzed', 'by', 'machine', 'learning', 'algorithms', 'simulations', 'and', 'digital', 'monitoring', 'Until', 'the', 'discovery', 'of', 'a', 'clinically', 'approved', 'vaccine', 'for', 'COVID', '19', 'pandemics', 'remain', 'a', 'public', 'concern', 'Therefore', 'technological', 'developments', 'biomedical', 'research', 'and', 'policy', 'development', 'are', 'needed', 'to', 'decipher', 'the', 'coronavirus', 'mechanism', 'and', 'epidemiological', 'characteristics', 'prevent', 'transmission', 'and', 'develop', 'therapeutic', 'drugs', '']"
133633,COVID-19 Clinical Diagnostics and Testing Technology,2020,Pharmacotherapy,,"Given the global nature of the COVID-19 pandemic, the need for disease detection and expanding testing capacity remains a critical priority. This review discusses the technological advances in testing capability and methodology that are currently employed or in development for detecting the novel coronavirus. We describe the current clinical diagnostics and technology, including molecular and serological testing approaches, for SARS-CoV-2 testing as well as address their advantages and limitations. Nucleic acid amplification technology for molecular diagnostics remains the gold standard for virus detection. We highlight alternative molecular detection techniques used for developing novel COVID-19 diagnostics on the horizon. Antibody response against SARS-CoV-2 remains poorly understood and proper validation of serology tests is necessary to demonstrate their accuracy and clinical utility. In order to bring the pandemic under control, we must speed up the development of rapid and widespread testing through improvements in clinical diagnostics and testing technology as well as access to these tools.",,afcd4wc9,"['Given', 'the', 'global', 'nature', 'of', 'the', 'COVID', '19', 'pandemic', 'the', 'need', 'for', 'disease', 'detection', 'and', 'expanding', 'testing', 'capacity', 'remains', 'a', 'critical', 'priority', 'This', 'review', 'discusses', 'the', 'technological', 'advances', 'in', 'testing', 'capability', 'and', 'methodology', 'that', 'are', 'currently', 'employed', 'or', 'in', 'development', 'for', 'detecting', 'the', 'novel', 'coronavirus', 'We', 'describe', 'the', 'current', 'clinical', 'diagnostics', 'and', 'technology', 'including', 'molecular', 'and', 'serological', 'testing', 'approaches', 'for', 'SARS', 'CoV', '2', 'testing', 'as', 'well', 'as', 'address', 'their', 'advantages', 'and', 'limitations', 'Nucleic', 'acid', 'amplification', 'technology', 'for', 'molecular', 'diagnostics', 'remains', 'the', 'gold', 'standard', 'for', 'virus', 'detection', 'We', 'highlight', 'alternative', 'molecular', 'detection', 'techniques', 'used', 'for', 'developing', 'novel', 'COVID', '19', 'diagnostics', 'on', 'the', 'horizon', 'Antibody', 'response', 'against', 'SARS', 'CoV', '2', 'remains', 'poorly', 'understood', 'and', 'proper', 'validation', 'of', 'serology', 'tests', 'is', 'necessary', 'to', 'demonstrate', 'their', 'accuracy', 'and', 'clinical', 'utility', 'In', 'order', 'to', 'bring', 'the', 'pandemic', 'under', 'control', 'we', 'must', 'speed', 'up', 'the', 'development', 'of', 'rapid', 'and', 'widespread', 'testing', 'through', 'improvements', 'in', 'clinical', 'diagnostics', 'and', 'testing', 'technology', 'as', 'well', 'as', 'access', 'to', 'these', 'tools', '']"
141010,"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review",2020,,,"Rapid diagnostics, vaccines and therapeutics are important interventions for the management of the 2019 novel coronavirus (2019-nCoV) outbreak. It is timely to systematically review the potential of these interventions, including those for Middle East respiratory syndrome-Coronavirus (MERS-CoV) and severe acute respiratory syndrome (SARS)-CoV, to guide policymakers globally on their prioritization of resources for research and development. A systematic search was carried out in three major electronic databases (PubMed, Embase and Cochrane Library) to identify published studies in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Supplementary strategies through Google Search and personal communications were used. A total of 27 studies fulfilled the criteria for review. Several laboratory protocols for confirmation of suspected 2019-nCoV cases using real-time reverse transcription polymerase chain reaction (RT-PCR) have been published. A commercial RT-PCR kit developed by the Beijing Genomic Institute is currently widely used in China and likely in Asia. However, serological assays as well as point-of-care testing kits have not been developed but are likely in the near future. Several vaccine candidates are in the pipeline. The likely earliest Phase 1 vaccine trial is a synthetic DNA-based candidate. A number of novel compounds as well as therapeutics licensed for other conditions appear to have in vitro efficacy against the 2019-nCoV. Some are being tested in clinical trials against MERS-CoV and SARS-CoV, while others have been listed for clinical trials against 2019-nCoV. However, there are currently no effective specific antivirals or drug combinations supported by high-level evidence.",,m95bmi9t,"['Rapid', 'diagnostics', 'vaccines', 'and', 'therapeutics', 'are', 'important', 'interventions', 'for', 'the', 'management', 'of', 'the', '2019', 'novel', 'coronavirus', '2019', 'nCoV', 'outbreak', 'It', 'is', 'timely', 'to', 'systematically', 'review', 'the', 'potential', 'of', 'these', 'interventions', 'including', 'those', 'for', 'Middle', 'East', 'respiratory', 'syndrome', 'Coronavirus', 'MERS', 'CoV', 'and', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'to', 'guide', 'policymakers', 'globally', 'on', 'their', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'A', 'systematic', 'search', 'was', 'carried', 'out', 'in', 'three', 'major', 'electronic', 'databases', 'PubMed', 'Embase', 'and', 'Cochrane', 'Library', 'to', 'identify', 'published', 'studies', 'in', 'accordance', 'with', 'the', 'Preferred', 'Reporting', 'Items', 'for', 'Systematic', 'Reviews', 'and', 'Meta', 'Analyses', 'PRISMA', 'guidelines', 'Supplementary', 'strategies', 'through', 'Google', 'Search', 'and', 'personal', 'communications', 'were', 'used', 'A', 'total', 'of', '27', 'studies', 'fulfilled', 'the', 'criteria', 'for', 'review', 'Several', 'laboratory', 'protocols', 'for', 'confirmation', 'of', 'suspected', '2019', 'nCoV', 'cases', 'using', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'have', 'been', 'published', 'A', 'commercial', 'RT', 'PCR', 'kit', 'developed', 'by', 'the', 'Beijing', 'Genomic', 'Institute', 'is', 'currently', 'widely', 'used', 'in', 'China', 'and', 'likely', 'in', 'Asia', 'However', 'serological', 'assays', 'as', 'well', 'as', 'point', 'of', 'care', 'testing', 'kits', 'have', 'not', 'been', 'developed', 'but', 'are', 'likely', 'in', 'the', 'near', 'future', 'Several', 'vaccine', 'candidates', 'are', 'in', 'the', 'pipeline', 'The', 'likely', 'earliest', 'Phase', '1', 'vaccine', 'trial', 'is', 'a', 'synthetic', 'DNA', 'based', 'candidate', 'A', 'number', 'of', 'novel', 'compounds', 'as', 'well', 'as', 'therapeutics', 'licensed', 'for', 'other', 'conditions', 'appear', 'to', 'have', 'in', 'vitro', 'efficacy', 'against', 'the', '2019', 'nCoV', 'Some', 'are', 'being', 'tested', 'in', 'clinical', 'trials', 'against', 'MERS', 'CoV', 'and', 'SARS', 'CoV', 'while', 'others', 'have', 'been', 'listed', 'for', 'clinical', 'trials', 'against', '2019', 'nCoV', 'However', 'there', 'are', 'currently', 'no', 'effective', 'specific', 'antivirals', 'or', 'drug', 'combinations', 'supported', 'by', 'high', 'level', 'evidence', '']"
141343,Smart polyhydroxyalkanoate nanobeads by protein based functionalization,2015-02-24,Nanomedicine,https://www.sciencedirect.com/science/article/pii/S1549963415000477; https://api.elsevier.com/content/article/pii/S1549963415000477; https://doi.org/10.1016/j.nano.2015.01.018; https://www.ncbi.nlm.nih.gov/pubmed/25720989/,"The development of innovative medicines and personalized biomedical approaches calls for new generation easily tunable biomaterials that can be manufactured applying straightforward and low-priced technologies. Production of functionalized bacterial polyhydroxyalkanoate (PHA) nanobeads by harnessing their natural carbon-storage granule production system is a thrilling recent development. This branch of nanobiotechnology employs proteins intrinsically binding the PHA granules as tags to immobilize recombinant proteins of interest and design functional nanocarriers for wide range of applications. Additionally, the implementation of new methodological platforms regarding production of endotoxin free PHA nanobeads using Gram-positive bacteria opened new avenues for biomedical applications. This prompts serious considerations of possible exploitation of bacterial cell factories as alternatives to traditional chemical synthesis and sources of novel bioproducts that could dramatically expand possible applications of biopolymers. FROM THE CLINICAL EDITOR: In the 21st century, we are coming into the age of personalized medicine. There is a growing use of biomaterials in the clinical setting. In this review article, the authors describe the use of natural polyhydroxyalkanoate (PHA) nanoparticulates, which are formed within bacterial cells and can be easily functionalized. The potential uses would include high-affinity bioseparation, enzyme immobilization, protein delivery, diagnostics etc. The challenges of this approach remain the possible toxicity from endotoxin and the high cost of production.",10.1016/j.nano.2015.01.018,e63pgcir,"['The', 'development', 'of', 'innovative', 'medicines', 'and', 'personalized', 'biomedical', 'approaches', 'calls', 'for', 'new', 'generation', 'easily', 'tunable', 'biomaterials', 'that', 'can', 'be', 'manufactured', 'applying', 'straightforward', 'and', 'low', 'priced', 'technologies', 'Production', 'of', 'functionalized', 'bacterial', 'polyhydroxyalkanoate', 'PHA', 'nanobeads', 'by', 'harnessing', 'their', 'natural', 'carbon', 'storage', 'granule', 'production', 'system', 'is', 'a', 'thrilling', 'recent', 'development', 'This', 'branch', 'of', 'nanobiotechnology', 'employs', 'proteins', 'intrinsically', 'binding', 'the', 'PHA', 'granules', 'as', 'tags', 'to', 'immobilize', 'recombinant', 'proteins', 'of', 'interest', 'and', 'design', 'functional', 'nanocarriers', 'for', 'wide', 'range', 'of', 'applications', 'Additionally', 'the', 'implementation', 'of', 'new', 'methodological', 'platforms', 'regarding', 'production', 'of', 'endotoxin', 'free', 'PHA', 'nanobeads', 'using', 'Gram', 'positive', 'bacteria', 'opened', 'new', 'avenues', 'for', 'biomedical', 'applications', 'This', 'prompts', 'serious', 'considerations', 'of', 'possible', 'exploitation', 'of', 'bacterial', 'cell', 'factories', 'as', 'alternatives', 'to', 'traditional', 'chemical', 'synthesis', 'and', 'sources', 'of', 'novel', 'bioproducts', 'that', 'could', 'dramatically', 'expand', 'possible', 'applications', 'of', 'biopolymers', 'FROM', 'THE', 'CLINICAL', 'EDITOR', 'In', 'the', '21st', 'century', 'we', 'are', 'coming', 'into', 'the', 'age', 'of', 'personalized', 'medicine', 'There', 'is', 'a', 'growing', 'use', 'of', 'biomaterials', 'in', 'the', 'clinical', 'setting', 'In', 'this', 'review', 'article', 'the', 'authors', 'describe', 'the', 'use', 'of', 'natural', 'polyhydroxyalkanoate', 'PHA', 'nanoparticulates', 'which', 'are', 'formed', 'within', 'bacterial', 'cells', 'and', 'can', 'be', 'easily', 'functionalized', 'The', 'potential', 'uses', 'would', 'include', 'high', 'affinity', 'bioseparation', 'enzyme', 'immobilization', 'protein', 'delivery', 'diagnostics', 'etc', 'The', 'challenges', 'of', 'this', 'approach', 'remain', 'the', 'possible', 'toxicity', 'from', 'endotoxin', 'and', 'the', 'high', 'cost', 'of', 'production', '']"
141361,"Social determinants, ethical issues and future challenge of tuberculosis in a pluralistic society: the example of Israel",2020-04-30,J Prev Med Hyg,https://www.ncbi.nlm.nih.gov/pubmed/32529102/; https://doi.org/10.15167/2421-4248/jpmh2020.61.1s1.1443,"Tuberculosis is a very serious respiratory infectious disease, caused by the bacillus Mycobacterium tuberculosis, which generates a relevant societal and clinical burden. It has always represented a permanent concern and a public health challenge over the course of human history, because of its severe epidemiological, and economic-financial implications. The present review aims at over-viewing the impact of tuberculosis on the Israeli healthcare system, its temporal trend and evolution, stratified according to ethnicities and minorities, the need of establishing new facilities and implementing screening techniques, public health strategies and diagnostic tests, following massive immigration waves from countries characterized by a high incidence rate of tuberculosis during the fifties-sixties until the nineties, and the policies implemented by the Israeli government in the control, management and treatment of tuberculosis, as well as the role played by Israeli prominent scientists in discovering new druggable targets and finding bioactive compounds and bio-molecules in the fight against tuberculosis. Israel represents a unique, living laboratory in which features of developed and developing countries mix together. This country as a case-study of immigrant, pluralistic society underlines the importance of adopting a culturally-sensitive community intervention approach. The understanding of the subtle interplay between race/ethnic host and pathogen factors, including the role of gene variations and polymorphisms can pave the way for a personalized treatment and management of tuberculosis patients, contributing to the development of new tools for targeted tuberculosis therapeutics, immunodiagnostics and vaccination products.",10.15167/2421-4248/jpmh2020.61.1s1.1443,yy3v8sos,"['Tuberculosis', 'is', 'a', 'very', 'serious', 'respiratory', 'infectious', 'disease', 'caused', 'by', 'the', 'bacillus', 'Mycobacterium', 'tuberculosis', 'which', 'generates', 'a', 'relevant', 'societal', 'and', 'clinical', 'burden', 'It', 'has', 'always', 'represented', 'a', 'permanent', 'concern', 'and', 'a', 'public', 'health', 'challenge', 'over', 'the', 'course', 'of', 'human', 'history', 'because', 'of', 'its', 'severe', 'epidemiological', 'and', 'economic', 'financial', 'implications', 'The', 'present', 'review', 'aims', 'at', 'over', 'viewing', 'the', 'impact', 'of', 'tuberculosis', 'on', 'the', 'Israeli', 'healthcare', 'system', 'its', 'temporal', 'trend', 'and', 'evolution', 'stratified', 'according', 'to', 'ethnicities', 'and', 'minorities', 'the', 'need', 'of', 'establishing', 'new', 'facilities', 'and', 'implementing', 'screening', 'techniques', 'public', 'health', 'strategies', 'and', 'diagnostic', 'tests', 'following', 'massive', 'immigration', 'waves', 'from', 'countries', 'characterized', 'by', 'a', 'high', 'incidence', 'rate', 'of', 'tuberculosis', 'during', 'the', 'fifties', 'sixties', 'until', 'the', 'nineties', 'and', 'the', 'policies', 'implemented', 'by', 'the', 'Israeli', 'government', 'in', 'the', 'control', 'management', 'and', 'treatment', 'of', 'tuberculosis', 'as', 'well', 'as', 'the', 'role', 'played', 'by', 'Israeli', 'prominent', 'scientists', 'in', 'discovering', 'new', 'druggable', 'targets', 'and', 'finding', 'bioactive', 'compounds', 'and', 'bio', 'molecules', 'in', 'the', 'fight', 'against', 'tuberculosis', 'Israel', 'represents', 'a', 'unique', 'living', 'laboratory', 'in', 'which', 'features', 'of', 'developed', 'and', 'developing', 'countries', 'mix', 'together', 'This', 'country', 'as', 'a', 'case', 'study', 'of', 'immigrant', 'pluralistic', 'society', 'underlines', 'the', 'importance', 'of', 'adopting', 'a', 'culturally', 'sensitive', 'community', 'intervention', 'approach', 'The', 'understanding', 'of', 'the', 'subtle', 'interplay', 'between', 'race', 'ethnic', 'host', 'and', 'pathogen', 'factors', 'including', 'the', 'role', 'of', 'gene', 'variations', 'and', 'polymorphisms', 'can', 'pave', 'the', 'way', 'for', 'a', 'personalized', 'treatment', 'and', 'management', 'of', 'tuberculosis', 'patients', 'contributing', 'to', 'the', 'development', 'of', 'new', 'tools', 'for', 'targeted', 'tuberculosis', 'therapeutics', 'immunodiagnostics', 'and', 'vaccination', 'products', '']"
142305,Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes,2020-05-30,bioRxiv,https://www.ncbi.nlm.nih.gov/pubmed/32577660/; https://doi.org/10.1101/2020.05.30.125484,"The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 has led to accelerated efforts to develop therapeutics, diagnostics, and vaccines to mitigate this public health emergency. A key target of these efforts is the spike (S) protein, a large trimeric class I fusion protein that is metastable and difficult to produce recombinantly in large quantities. Here, we designed and expressed over 100 structure-guided spike variants based upon a previously determined cryo-EM structure of the prefusion SARS-CoV-2 spike. Biochemical, biophysical and structural characterization of these variants identified numerous individual substitutions that increased protein yields and stability. The best variant, HexaPro, has six beneficial proline substitutions leading to ~10-fold higher expression than its parental construct and is able to withstand heat stress, storage at room temperature, and multiple freeze-thaws. A 3.2 Å-resolution cryo-EM structure of HexaPro confirmed that it retains the prefusion spike conformation. High-yield production of a stabilized prefusion spike protein will accelerate the development of vaccines and serological diagnostics for SARS-CoV-2.",10.1101/2020.05.30.125484,g81ylcxq,"['The', 'COVID', '19', 'pandemic', 'caused', 'by', 'the', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'has', 'led', 'to', 'accelerated', 'efforts', 'to', 'develop', 'therapeutics', 'diagnostics', 'and', 'vaccines', 'to', 'mitigate', 'this', 'public', 'health', 'emergency', 'A', 'key', 'target', 'of', 'these', 'efforts', 'is', 'the', 'spike', 'S', 'protein', 'a', 'large', 'trimeric', 'class', 'I', 'fusion', 'protein', 'that', 'is', 'metastable', 'and', 'difficult', 'to', 'produce', 'recombinantly', 'in', 'large', 'quantities', 'Here', 'we', 'designed', 'and', 'expressed', 'over', '100', 'structure', 'guided', 'spike', 'variants', 'based', 'upon', 'a', 'previously', 'determined', 'cryo', 'EM', 'structure', 'of', 'the', 'prefusion', 'SARS', 'CoV', '2', 'spike', 'Biochemical', 'biophysical', 'and', 'structural', 'characterization', 'of', 'these', 'variants', 'identified', 'numerous', 'individual', 'substitutions', 'that', 'increased', 'protein', 'yields', 'and', 'stability', 'The', 'best', 'variant', 'HexaPro', 'has', 'six', 'beneficial', 'proline', 'substitutions', 'leading', 'to', '10', 'fold', 'higher', 'expression', 'than', 'its', 'parental', 'construct', 'and', 'is', 'able', 'to', 'withstand', 'heat', 'stress', 'storage', 'at', 'room', 'temperature', 'and', 'multiple', 'freeze', 'thaws', 'A', '3', '2', 'Å', 'resolution', 'cryo', 'EM', 'structure', 'of', 'HexaPro', 'confirmed', 'that', 'it', 'retains', 'the', 'prefusion', 'spike', 'conformation', 'High', 'yield', 'production', 'of', 'a', 'stabilized', 'prefusion', 'spike', 'protein', 'will', 'accelerate', 'the', 'development', 'of', 'vaccines', 'and', 'serological', 'diagnostics', 'for', 'SARS', 'CoV', '2', '']"
142818,"A perspective on microarrays: current applications, pitfalls, and potential uses",2007-01-25,Microb Cell Fact,https://www.ncbi.nlm.nih.gov/pubmed/17254338/,"With advances in robotics, computational capabilities, and the fabrication of high quality glass slides coinciding with increased genomic information being available on public databases, microarray technology is increasingly being used in laboratories around the world. In fact, fields as varied as: toxicology, evolutionary biology, drug development and production, disease characterization, diagnostics development, cellular physiology and stress responses, and forensics have benefiting from its use. However, for many researchers not familiar with microarrays, current articles and reviews often address neither the fundamental principles behind the technology nor the proper designing of experiments. Although, microarray technology is relatively simple, conceptually, its practice does require careful planning and detailed understanding of the limitations inherently present. Without these considerations, it can be exceedingly difficult to ascertain valuable information from microarray data. Therefore, this text aims to outline key features in microarray technology, paying particular attention to current applications as outlined in recent publications, experimental design, statistical methods, and potential uses. Furthermore, this review is not meant to be comprehensive, but rather substantive; highlighting important concepts and detailing steps necessary to conduct and interpret microarray experiments. Collectively, the information included in this text will highlight the versatility of microarray technology and provide a glimpse of what the future may hold.",10.1186/1475-2859-6-4,u1y1bznk,"['With', 'advances', 'in', 'robotics', 'computational', 'capabilities', 'and', 'the', 'fabrication', 'of', 'high', 'quality', 'glass', 'slides', 'coinciding', 'with', 'increased', 'genomic', 'information', 'being', 'available', 'on', 'public', 'databases', 'microarray', 'technology', 'is', 'increasingly', 'being', 'used', 'in', 'laboratories', 'around', 'the', 'world', 'In', 'fact', 'fields', 'as', 'varied', 'as', 'toxicology', 'evolutionary', 'biology', 'drug', 'development', 'and', 'production', 'disease', 'characterization', 'diagnostics', 'development', 'cellular', 'physiology', 'and', 'stress', 'responses', 'and', 'forensics', 'have', 'benefiting', 'from', 'its', 'use', 'However', 'for', 'many', 'researchers', 'not', 'familiar', 'with', 'microarrays', 'current', 'articles', 'and', 'reviews', 'often', 'address', 'neither', 'the', 'fundamental', 'principles', 'behind', 'the', 'technology', 'nor', 'the', 'proper', 'designing', 'of', 'experiments', 'Although', 'microarray', 'technology', 'is', 'relatively', 'simple', 'conceptually', 'its', 'practice', 'does', 'require', 'careful', 'planning', 'and', 'detailed', 'understanding', 'of', 'the', 'limitations', 'inherently', 'present', 'Without', 'these', 'considerations', 'it', 'can', 'be', 'exceedingly', 'difficult', 'to', 'ascertain', 'valuable', 'information', 'from', 'microarray', 'data', 'Therefore', 'this', 'text', 'aims', 'to', 'outline', 'key', 'features', 'in', 'microarray', 'technology', 'paying', 'particular', 'attention', 'to', 'current', 'applications', 'as', 'outlined', 'in', 'recent', 'publications', 'experimental', 'design', 'statistical', 'methods', 'and', 'potential', 'uses', 'Furthermore', 'this', 'review', 'is', 'not', 'meant', 'to', 'be', 'comprehensive', 'but', 'rather', 'substantive', 'highlighting', 'important', 'concepts', 'and', 'detailing', 'steps', 'necessary', 'to', 'conduct', 'and', 'interpret', 'microarray', 'experiments', 'Collectively', 'the', 'information', 'included', 'in', 'this', 'text', 'will', 'highlight', 'the', 'versatility', 'of', 'microarray', 'technology', 'and', 'provide', 'a', 'glimpse', 'of', 'what', 'the', 'future', 'may', 'hold', '']"
142834,Emerging Advances in Rapid Diagnostics of Respiratory Infections,2010-09-30,Infectious Disease Clinics of North America,https://api.elsevier.com/content/article/pii/S0891552010000334; https://www.ncbi.nlm.nih.gov/pubmed/20674804/; https://doi.org/10.1016/j.idc.2010.04.006; https://www.sciencedirect.com/science/article/pii/S0891552010000334,"Recent developments in rapid diagnostics for respiratory infections have mostly occurred in the areas of antigen and nucleic acid detection. Nucleic acid amplification tests have improved the ability to identify respiratory viruses in clinical specimens and have played pivotal roles in the rapid characterization of new viral pathogens. Antigen-detection assays in immunochromatographic or similar formats are most easily developed as near-patient tests, although they have been developed commercially only for a limited range of respiratory pathogens. New approaches for respiratory pathogen detection are needed, and breath analysis is an exciting area with enormous potential.",10.1016/j.idc.2010.04.006,bjksz4hf,"['Recent', 'developments', 'in', 'rapid', 'diagnostics', 'for', 'respiratory', 'infections', 'have', 'mostly', 'occurred', 'in', 'the', 'areas', 'of', 'antigen', 'and', 'nucleic', 'acid', 'detection', 'Nucleic', 'acid', 'amplification', 'tests', 'have', 'improved', 'the', 'ability', 'to', 'identify', 'respiratory', 'viruses', 'in', 'clinical', 'specimens', 'and', 'have', 'played', 'pivotal', 'roles', 'in', 'the', 'rapid', 'characterization', 'of', 'new', 'viral', 'pathogens', 'Antigen', 'detection', 'assays', 'in', 'immunochromatographic', 'or', 'similar', 'formats', 'are', 'most', 'easily', 'developed', 'as', 'near', 'patient', 'tests', 'although', 'they', 'have', 'been', 'developed', 'commercially', 'only', 'for', 'a', 'limited', 'range', 'of', 'respiratory', 'pathogens', 'New', 'approaches', 'for', 'respiratory', 'pathogen', 'detection', 'are', 'needed', 'and', 'breath', 'analysis', 'is', 'an', 'exciting', 'area', 'with', 'enormous', 'potential', '']"
143322,CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia,2020-05-26,J Drug Target,https://doi.org/10.1080/1061186x.2020.1769637; https://www.ncbi.nlm.nih.gov/pubmed/32401064/,"Emerging infectious diseases, the persistent potential for destabilising pandemics, remain a global threat leading to excessive morbidity and mortality. The current outbreak of pneumonia caused by 2019 novel coronavirus (COVID-19) illustrated difficulties in lack of effective drugs for treatment. Accurate and rapid diagnostic tools are essential for early recognition and treatment of infectious diseases, allowing timely implementation of infection control, improved clinical care and other public health measures to stop the spread of the disease. CRISPR-Cas technology speed up the development of infectious disease diagnostics with high rapid and accurate. In this review, we summarise current advance regarding diverse CRISPR-Cas systems, including CRISPR-Cas9, CRISPR-Cas12 and CRISPR-Cas13, in the development of fast, accurate and portable diagnostic tests and highlight the potential of CRISPR-Cas13 in COVID-19 Pneumonia and other emerging infectious diseases diagnosis.",10.1080/1061186x.2020.1769637,q52mia0e,"['Emerging', 'infectious', 'diseases', 'the', 'persistent', 'potential', 'for', 'destabilising', 'pandemics', 'remain', 'a', 'global', 'threat', 'leading', 'to', 'excessive', 'morbidity', 'and', 'mortality', 'The', 'current', 'outbreak', 'of', 'pneumonia', 'caused', 'by', '2019', 'novel', 'coronavirus', 'COVID', '19', 'illustrated', 'difficulties', 'in', 'lack', 'of', 'effective', 'drugs', 'for', 'treatment', 'Accurate', 'and', 'rapid', 'diagnostic', 'tools', 'are', 'essential', 'for', 'early', 'recognition', 'and', 'treatment', 'of', 'infectious', 'diseases', 'allowing', 'timely', 'implementation', 'of', 'infection', 'control', 'improved', 'clinical', 'care', 'and', 'other', 'public', 'health', 'measures', 'to', 'stop', 'the', 'spread', 'of', 'the', 'disease', 'CRISPR', 'Cas', 'technology', 'speed', 'up', 'the', 'development', 'of', 'infectious', 'disease', 'diagnostics', 'with', 'high', 'rapid', 'and', 'accurate', 'In', 'this', 'review', 'we', 'summarise', 'current', 'advance', 'regarding', 'diverse', 'CRISPR', 'Cas', 'systems', 'including', 'CRISPR', 'Cas9', 'CRISPR', 'Cas12', 'and', 'CRISPR', 'Cas13', 'in', 'the', 'development', 'of', 'fast', 'accurate', 'and', 'portable', 'diagnostic', 'tests', 'and', 'highlight', 'the', 'potential', 'of', 'CRISPR', 'Cas13', 'in', 'COVID', '19', 'Pneumonia', 'and', 'other', 'emerging', 'infectious', 'diseases', 'diagnosis', '']"
144001,DNA-based bioanalytical microsystems for handheld device applications,2006-01-18,Anal Chim Acta,https://api.elsevier.com/content/article/pii/S0003267005009438; https://www.ncbi.nlm.nih.gov/pubmed/17723328/; https://www.sciencedirect.com/science/article/pii/S0003267005009438,"This article reviews and highlights the current development of DNA-based bioanalytical microsystems for point-of-care diagnostics and on-site monitoring of food and water. Recent progresses in the miniaturization of various biological processing steps for the sample preparation, DNA amplification (polymerase chain reaction), and product detection are delineated in detail. Product detection approaches utilizing “portable” detection signals and electrochemistry-based methods are emphasized in this work. The strategies and challenges for the integration of individual processing module on the same chip are discussed.",10.1016/j.aca.2005.05.075,b6tr2zyx,"['This', 'article', 'reviews', 'and', 'highlights', 'the', 'current', 'development', 'of', 'DNA', 'based', 'bioanalytical', 'microsystems', 'for', 'point', 'of', 'care', 'diagnostics', 'and', 'on', 'site', 'monitoring', 'of', 'food', 'and', 'water', 'Recent', 'progresses', 'in', 'the', 'miniaturization', 'of', 'various', 'biological', 'processing', 'steps', 'for', 'the', 'sample', 'preparation', 'DNA', 'amplification', 'polymerase', 'chain', 'reaction', 'and', 'product', 'detection', 'are', 'delineated', 'in', 'detail', 'Product', 'detection', 'approaches', 'utilizing', 'portable', 'detection', 'signals', 'and', 'electrochemistry', 'based', 'methods', 'are', 'emphasized', 'in', 'this', 'work', 'The', 'strategies', 'and', 'challenges', 'for', 'the', 'integration', 'of', 'individual', 'processing', 'module', 'on', 'the', 'same', 'chip', 'are', 'discussed', '']"
144741,Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children,2019-06-25,Front Pediatr,https://www.ncbi.nlm.nih.gov/pubmed/31294001/; https://doi.org/10.3389/fped.2019.00233,"Millions of children are exposed to tuberculosis (TB) each year, many of which become infected with Mycobacterium tuberculosis. Most children can immunologically contain or eradicate the organism without pathology developing. However, in a minority, the organism overcomes the immunological constraints, proliferates and causes TB disease. Each year a million children develop TB disease, with a quarter dying. While it is known that young children and those with immunodeficiencies are at increased risk of progression from TB infection to TB disease, our understanding of risk factors for this transition is limited. The most immunologically disruptive process that can happen during childhood is infection with another pathogen and yet the impact of co-infections on TB risk is poorly investigated. Many diseases have overlapping geographical distributions to TB and affect similar patient populations. It is therefore likely that infection with viruses, bacteria, fungi and protozoa may impact on the risk of developing TB disease following exposure and infection, although disentangling correlation and causation is challenging. As vaccinations also disrupt immunological pathways, these may also impact on TB risk. In this article we describe the pediatric immune response to M. tuberculosis and then review the existing evidence of the impact of co-infection with other pathogens, as well as vaccination, on the host response to M. tuberculosis. We focus on the impact of other organisms on the risk of TB disease in children, in particularly evaluating if co-infections drive host immune responses in an age-dependent way. We finally propose priorities for future research in this field. An improved understanding of the impact of co-infections on TB could assist in TB control strategies, vaccine development (for TB vaccines or vaccines for other organisms), TB treatment approaches and TB diagnostics.",10.3389/fped.2019.00233,cjs9zust,"['Millions', 'of', 'children', 'are', 'exposed', 'to', 'tuberculosis', 'TB', 'each', 'year', 'many', 'of', 'which', 'become', 'infected', 'with', 'Mycobacterium', 'tuberculosis', 'Most', 'children', 'can', 'immunologically', 'contain', 'or', 'eradicate', 'the', 'organism', 'without', 'pathology', 'developing', 'However', 'in', 'a', 'minority', 'the', 'organism', 'overcomes', 'the', 'immunological', 'constraints', 'proliferates', 'and', 'causes', 'TB', 'disease', 'Each', 'year', 'a', 'million', 'children', 'develop', 'TB', 'disease', 'with', 'a', 'quarter', 'dying', 'While', 'it', 'is', 'known', 'that', 'young', 'children', 'and', 'those', 'with', 'immunodeficiencies', 'are', 'at', 'increased', 'risk', 'of', 'progression', 'from', 'TB', 'infection', 'to', 'TB', 'disease', 'our', 'understanding', 'of', 'risk', 'factors', 'for', 'this', 'transition', 'is', 'limited', 'The', 'most', 'immunologically', 'disruptive', 'process', 'that', 'can', 'happen', 'during', 'childhood', 'is', 'infection', 'with', 'another', 'pathogen', 'and', 'yet', 'the', 'impact', 'of', 'co', 'infections', 'on', 'TB', 'risk', 'is', 'poorly', 'investigated', 'Many', 'diseases', 'have', 'overlapping', 'geographical', 'distributions', 'to', 'TB', 'and', 'affect', 'similar', 'patient', 'populations', 'It', 'is', 'therefore', 'likely', 'that', 'infection', 'with', 'viruses', 'bacteria', 'fungi', 'and', 'protozoa', 'may', 'impact', 'on', 'the', 'risk', 'of', 'developing', 'TB', 'disease', 'following', 'exposure', 'and', 'infection', 'although', 'disentangling', 'correlation', 'and', 'causation', 'is', 'challenging', 'As', 'vaccinations', 'also', 'disrupt', 'immunological', 'pathways', 'these', 'may', 'also', 'impact', 'on', 'TB', 'risk', 'In', 'this', 'article', 'we', 'describe', 'the', 'pediatric', 'immune', 'response', 'to', 'M', 'tuberculosis', 'and', 'then', 'review', 'the', 'existing', 'evidence', 'of', 'the', 'impact', 'of', 'co', 'infection', 'with', 'other', 'pathogens', 'as', 'well', 'as', 'vaccination', 'on', 'the', 'host', 'response', 'to', 'M', 'tuberculosis', 'We', 'focus', 'on', 'the', 'impact', 'of', 'other', 'organisms', 'on', 'the', 'risk', 'of', 'TB', 'disease', 'in', 'children', 'in', 'particularly', 'evaluating', 'if', 'co', 'infections', 'drive', 'host', 'immune', 'responses', 'in', 'an', 'age', 'dependent', 'way', 'We', 'finally', 'propose', 'priorities', 'for', 'future', 'research', 'in', 'this', 'field', 'An', 'improved', 'understanding', 'of', 'the', 'impact', 'of', 'co', 'infections', 'on', 'TB', 'could', 'assist', 'in', 'TB', 'control', 'strategies', 'vaccine', 'development', 'for', 'TB', 'vaccines', 'or', 'vaccines', 'for', 'other', 'organisms', 'TB', 'treatment', 'approaches', 'and', 'TB', 'diagnostics', '']"
144890,Recognizing flu-like symptoms from videos,2014-09-12,BMC Bioinformatics,https://doi.org/10.1186/1471-2105-15-300; https://www.ncbi.nlm.nih.gov/pubmed/25217118/,"BACKGROUND: Vision-based surveillance and monitoring is a potential alternative for early detection of respiratory disease outbreaks in urban areas complementing molecular diagnostics and hospital and doctor visit-based alert systems. Visible actions representing typical flu-like symptoms include sneeze and cough that are associated with changing patterns of hand to head distances, among others. The technical difficulties lie in the high complexity and large variation of those actions as well as numerous similar background actions such as scratching head, cell phone use, eating, drinking and so on. RESULTS: In this paper, we make a first attempt at the challenging problem of recognizing flu-like symptoms from videos. Since there was no related dataset available, we created a new public health dataset for action recognition that includes two major flu-like symptom related actions (sneeze and cough) and a number of background actions. We also developed a suitable novel algorithm by introducing two types of Action Matching Kernels, where both types aim to integrate two aspects of local features, namely the space-time layout and the Bag-of-Words representations. In particular, we show that the Pyramid Match Kernel and Spatial Pyramid Matching are both special cases of our proposed kernels. Besides experimenting on standard testbed, the proposed algorithm is evaluated also on the new sneeze and cough set. Empirically, we observe that our approach achieves competitive performance compared to the state-of-the-arts, while recognition on the new public health dataset is shown to be a non-trivial task even with simple single person unobstructed view. CONCLUSIONS: Our sneeze and cough video dataset and newly developed action recognition algorithm is the first of its kind and aims to kick-start the field of action recognition of flu-like symptoms from videos. It will be challenging but necessary in future developments to consider more complex real-life scenario of detecting these actions simultaneously from multiple persons in possibly crowded environments.",10.1186/1471-2105-15-300,gm1e9j80,"['BACKGROUND', 'Vision', 'based', 'surveillance', 'and', 'monitoring', 'is', 'a', 'potential', 'alternative', 'for', 'early', 'detection', 'of', 'respiratory', 'disease', 'outbreaks', 'in', 'urban', 'areas', 'complementing', 'molecular', 'diagnostics', 'and', 'hospital', 'and', 'doctor', 'visit', 'based', 'alert', 'systems', 'Visible', 'actions', 'representing', 'typical', 'flu', 'like', 'symptoms', 'include', 'sneeze', 'and', 'cough', 'that', 'are', 'associated', 'with', 'changing', 'patterns', 'of', 'hand', 'to', 'head', 'distances', 'among', 'others', 'The', 'technical', 'difficulties', 'lie', 'in', 'the', 'high', 'complexity', 'and', 'large', 'variation', 'of', 'those', 'actions', 'as', 'well', 'as', 'numerous', 'similar', 'background', 'actions', 'such', 'as', 'scratching', 'head', 'cell', 'phone', 'use', 'eating', 'drinking', 'and', 'so', 'on', 'RESULTS', 'In', 'this', 'paper', 'we', 'make', 'a', 'first', 'attempt', 'at', 'the', 'challenging', 'problem', 'of', 'recognizing', 'flu', 'like', 'symptoms', 'from', 'videos', 'Since', 'there', 'was', 'no', 'related', 'dataset', 'available', 'we', 'created', 'a', 'new', 'public', 'health', 'dataset', 'for', 'action', 'recognition', 'that', 'includes', 'two', 'major', 'flu', 'like', 'symptom', 'related', 'actions', 'sneeze', 'and', 'cough', 'and', 'a', 'number', 'of', 'background', 'actions', 'We', 'also', 'developed', 'a', 'suitable', 'novel', 'algorithm', 'by', 'introducing', 'two', 'types', 'of', 'Action', 'Matching', 'Kernels', 'where', 'both', 'types', 'aim', 'to', 'integrate', 'two', 'aspects', 'of', 'local', 'features', 'namely', 'the', 'space', 'time', 'layout', 'and', 'the', 'Bag', 'of', 'Words', 'representations', 'In', 'particular', 'we', 'show', 'that', 'the', 'Pyramid', 'Match', 'Kernel', 'and', 'Spatial', 'Pyramid', 'Matching', 'are', 'both', 'special', 'cases', 'of', 'our', 'proposed', 'kernels', 'Besides', 'experimenting', 'on', 'standard', 'testbed', 'the', 'proposed', 'algorithm', 'is', 'evaluated', 'also', 'on', 'the', 'new', 'sneeze', 'and', 'cough', 'set', 'Empirically', 'we', 'observe', 'that', 'our', 'approach', 'achieves', 'competitive', 'performance', 'compared', 'to', 'the', 'state', 'of', 'the', 'arts', 'while', 'recognition', 'on', 'the', 'new', 'public', 'health', 'dataset', 'is', 'shown', 'to', 'be', 'a', 'non', 'trivial', 'task', 'even', 'with', 'simple', 'single', 'person', 'unobstructed', 'view', 'CONCLUSIONS', 'Our', 'sneeze', 'and', 'cough', 'video', 'dataset', 'and', 'newly', 'developed', 'action', 'recognition', 'algorithm', 'is', 'the', 'first', 'of', 'its', 'kind', 'and', 'aims', 'to', 'kick', 'start', 'the', 'field', 'of', 'action', 'recognition', 'of', 'flu', 'like', 'symptoms', 'from', 'videos', 'It', 'will', 'be', 'challenging', 'but', 'necessary', 'in', 'future', 'developments', 'to', 'consider', 'more', 'complex', 'real', 'life', 'scenario', 'of', 'detecting', 'these', 'actions', 'simultaneously', 'from', 'multiple', 'persons', 'in', 'possibly', 'crowded', 'environments', '']"
145174,Establishment and reinforcement of the national reference centers for human microbiology in Belgium,2012-06-22,Arch Public Health,https://www.ncbi.nlm.nih.gov/pubmed/22958353/; https://doi.org/10.1186/0778-7367-70-16,"BACKGROUND: Microbiology reference laboratories are critical in the development of high-quality clinical and public health services. In Belgium, the reference laboratories performed their activities on a voluntary basis and lacked a legal status. METHODS: Pathogens or groups of pathogens necessitating a national reference center (NRC) were prioritized based on diagnostic and epidemiologic relevance. Terms of reference for each of these pathogens were developed. RESULTS: Recently, 40 NRCs for different pathogens or groups of pathogens have been installed in Belgium to fulfill the following core functions: offering reference diagnostics, collecting reference materials, sharing information and scientific advice, participating in national and international networks, collaborating with research workgroups, and contributing to surveillance activities. CONCLUSIONS: These NRCs are important focal points of the national and international network in public health microbiology.",10.1186/0778-7367-70-16,ttyrvhrh,"['BACKGROUND', 'Microbiology', 'reference', 'laboratories', 'are', 'critical', 'in', 'the', 'development', 'of', 'high', 'quality', 'clinical', 'and', 'public', 'health', 'services', 'In', 'Belgium', 'the', 'reference', 'laboratories', 'performed', 'their', 'activities', 'on', 'a', 'voluntary', 'basis', 'and', 'lacked', 'a', 'legal', 'status', 'METHODS', 'Pathogens', 'or', 'groups', 'of', 'pathogens', 'necessitating', 'a', 'national', 'reference', 'center', 'NRC', 'were', 'prioritized', 'based', 'on', 'diagnostic', 'and', 'epidemiologic', 'relevance', 'Terms', 'of', 'reference', 'for', 'each', 'of', 'these', 'pathogens', 'were', 'developed', 'RESULTS', 'Recently', '40', 'NRCs', 'for', 'different', 'pathogens', 'or', 'groups', 'of', 'pathogens', 'have', 'been', 'installed', 'in', 'Belgium', 'to', 'fulfill', 'the', 'following', 'core', 'functions', 'offering', 'reference', 'diagnostics', 'collecting', 'reference', 'materials', 'sharing', 'information', 'and', 'scientific', 'advice', 'participating', 'in', 'national', 'and', 'international', 'networks', 'collaborating', 'with', 'research', 'workgroups', 'and', 'contributing', 'to', 'surveillance', 'activities', 'CONCLUSIONS', 'These', 'NRCs', 'are', 'important', 'focal', 'points', 'of', 'the', 'national', 'and', 'international', 'network', 'in', 'public', 'health', 'microbiology', '']"
145209,Clinical Chemistry through Clinical Chemistry: A Journal Timeline,2004-12-01,Clin Chem,https://www.ncbi.nlm.nih.gov/pubmed/15563498/,"The establishment of the modern discipline of clinical chemistry was concurrent with the foundation of the journal Clinical Chemistry and that of the American Association for Clinical Chemistry in the late 1940s and early 1950s. To mark the 50th volume of this Journal, I chronicle and highlight scientific milestones, and those within the discipline, as documented in the pages of Clinical Chemistry. Amazing progress has been made in the field of laboratory diagnostics over these five decades, in many cases paralleling—as well as being bolstered by—the rapid pace in the development of computer technologies. Specific areas of laboratory medicine particularly well represented in Clinical Chemistry include lipids, endocrinology, protein markers, quality of laboratory measurements, molecular diagnostics, and general advances in methodology and instrumentation.",10.1373/clinchem.2004.042820,j00jj2og,"['The', 'establishment', 'of', 'the', 'modern', 'discipline', 'of', 'clinical', 'chemistry', 'was', 'concurrent', 'with', 'the', 'foundation', 'of', 'the', 'journal', 'Clinical', 'Chemistry', 'and', 'that', 'of', 'the', 'American', 'Association', 'for', 'Clinical', 'Chemistry', 'in', 'the', 'late', '1940s', 'and', 'early', '1950s', 'To', 'mark', 'the', '50th', 'volume', 'of', 'this', 'Journal', 'I', 'chronicle', 'and', 'highlight', 'scientific', 'milestones', 'and', 'those', 'within', 'the', 'discipline', 'as', 'documented', 'in', 'the', 'pages', 'of', 'Clinical', 'Chemistry', 'Amazing', 'progress', 'has', 'been', 'made', 'in', 'the', 'field', 'of', 'laboratory', 'diagnostics', 'over', 'these', 'five', 'decades', 'in', 'many', 'cases', 'paralleling', 'as', 'well', 'as', 'being', 'bolstered', 'by', 'the', 'rapid', 'pace', 'in', 'the', 'development', 'of', 'computer', 'technologies', 'Specific', 'areas', 'of', 'laboratory', 'medicine', 'particularly', 'well', 'represented', 'in', 'Clinical', 'Chemistry', 'include', 'lipids', 'endocrinology', 'protein', 'markers', 'quality', 'of', 'laboratory', 'measurements', 'molecular', 'diagnostics', 'and', 'general', 'advances', 'in', 'methodology', 'and', 'instrumentation', '']"
145215,Pathogenicity and immunogenicity of a new strain of porcine epidemic diarrhea virus containing a novel deletion in the N gene,2019-11-15,Vet Microbiol,https://www.sciencedirect.com/science/article/pii/S0378113519307497; https://api.elsevier.com/content/article/pii/S0378113519307497; https://www.ncbi.nlm.nih.gov/pubmed/31902508/; https://doi.org/10.1016/j.vetmic.2019.108511,"Since late 2010, highly virulent PEDV G2-genotype strains have emerged globally extracting heavy losses on the pork industries of numerous countries. We investigated the characteristics of a field strain of PEDV (PEDV strain SH) isolated from a piglet with severe diarrhea on a farm in Shanghai China. Whole genome sequencing and analysis revealed that the SH strain belonged to subtype G2b and has a unique 12-aa deletion (aa 399–410) including the antigenic epitope NEP-1C9 (aa 398–406) of the N protein. PEDV SH strain is highly pathogenic to challenged newborn piglets, resulting in 100 % morbidity and mortality. Pathological examination revealed significant villus atrophy in the jejuna of infected piglets. Mice inoculated with inactivated PEDV SH produced antibodies against the N protein, but no antibodies against the deletions. These results illustrated that deletion of the NEP-1C9 epitope had no effect on the immunogenicity or pathogenicity of PEDV, providing evidence of the necessity to monitor the genetic diversity of the virus. Our study also contributes to development of candidate for vaccines and diagnostics that could differentiate pigs seropositive due to vaccination by conventional strains from wild virus infection.",10.1016/j.vetmic.2019.108511,4jrsws4e,"['Since', 'late', '2010', 'highly', 'virulent', 'PEDV', 'G2', 'genotype', 'strains', 'have', 'emerged', 'globally', 'extracting', 'heavy', 'losses', 'on', 'the', 'pork', 'industries', 'of', 'numerous', 'countries', 'We', 'investigated', 'the', 'characteristics', 'of', 'a', 'field', 'strain', 'of', 'PEDV', 'PEDV', 'strain', 'SH', 'isolated', 'from', 'a', 'piglet', 'with', 'severe', 'diarrhea', 'on', 'a', 'farm', 'in', 'Shanghai', 'China', 'Whole', 'genome', 'sequencing', 'and', 'analysis', 'revealed', 'that', 'the', 'SH', 'strain', 'belonged', 'to', 'subtype', 'G2b', 'and', 'has', 'a', 'unique', '12', 'aa', 'deletion', 'aa', '399', '410', 'including', 'the', 'antigenic', 'epitope', 'NEP', '1C9', 'aa', '398', '406', 'of', 'the', 'N', 'protein', 'PEDV', 'SH', 'strain', 'is', 'highly', 'pathogenic', 'to', 'challenged', 'newborn', 'piglets', 'resulting', 'in', '100', 'morbidity', 'and', 'mortality', 'Pathological', 'examination', 'revealed', 'significant', 'villus', 'atrophy', 'in', 'the', 'jejuna', 'of', 'infected', 'piglets', 'Mice', 'inoculated', 'with', 'inactivated', 'PEDV', 'SH', 'produced', 'antibodies', 'against', 'the', 'N', 'protein', 'but', 'no', 'antibodies', 'against', 'the', 'deletions', 'These', 'results', 'illustrated', 'that', 'deletion', 'of', 'the', 'NEP', '1C9', 'epitope', 'had', 'no', 'effect', 'on', 'the', 'immunogenicity', 'or', 'pathogenicity', 'of', 'PEDV', 'providing', 'evidence', 'of', 'the', 'necessity', 'to', 'monitor', 'the', 'genetic', 'diversity', 'of', 'the', 'virus', 'Our', 'study', 'also', 'contributes', 'to', 'development', 'of', 'candidate', 'for', 'vaccines', 'and', 'diagnostics', 'that', 'could', 'differentiate', 'pigs', 'seropositive', 'due', 'to', 'vaccination', 'by', 'conventional', 'strains', 'from', 'wild', 'virus', 'infection', '']"
146632,Super induction of dengue virus NS1 protein in E. coli,2009-07-31,Protein Expression and Purification,https://doi.org/10.1016/j.pep.2009.02.003; https://www.sciencedirect.com/science/article/pii/S1046592809000333; https://api.elsevier.com/content/article/pii/S1046592809000333; https://www.ncbi.nlm.nih.gov/pubmed/19232392/,"Abstract The non-structural protein 1 (NS1) of dengue virus is a useful target for diagnostics of dengue infection since the protein is abundantly circulating in blood during the acute phase of the disease. Prior work has established that secreted NS1 levels in plasma correlates with viremia levels and hence can also be used to diagnose patients at the risk for developing dengue hemorrhagic fever. Thus detection of non-structural dengue antigens may be of benefit for an early rapid diagnosis of dengue infection due to its long half life in the blood. Here we describe a simple and efficient method for the expression of NS1 in Escherichia coli, which could potentially be used to develop monoclonal and bispecific antibodies for point of care diagnostics. E. coli codon optimized synthetic full-length NS1 gene of dengue serotype 1 (DEN-1) was successfully cloned and expressed in very high-level as inclusion bodies. The NS1 protein was successfully affinity purified and refolded as a recombinant NS1 (rNS1) protein in E. coli and yield was 230–250mg/L of bacterial culture. The rNS1 protein was used to immunize mice for hybridoma development. The polyclonal antiserum from animals immunized with this rNS1 protein was found to specifically recognize the rNS1, thus demonstrating the immunogenic nature of the protein. The rNS1 protein purified from E. coli could be useful for developing a sensitive serum diagnostic assay to monitor dengue outbreaks.",10.1016/j.pep.2009.02.003,k8ob9wbe,"['Abstract', 'The', 'non', 'structural', 'protein', '1', 'NS1', 'of', 'dengue', 'virus', 'is', 'a', 'useful', 'target', 'for', 'diagnostics', 'of', 'dengue', 'infection', 'since', 'the', 'protein', 'is', 'abundantly', 'circulating', 'in', 'blood', 'during', 'the', 'acute', 'phase', 'of', 'the', 'disease', 'Prior', 'work', 'has', 'established', 'that', 'secreted', 'NS1', 'levels', 'in', 'plasma', 'correlates', 'with', 'viremia', 'levels', 'and', 'hence', 'can', 'also', 'be', 'used', 'to', 'diagnose', 'patients', 'at', 'the', 'risk', 'for', 'developing', 'dengue', 'hemorrhagic', 'fever', 'Thus', 'detection', 'of', 'non', 'structural', 'dengue', 'antigens', 'may', 'be', 'of', 'benefit', 'for', 'an', 'early', 'rapid', 'diagnosis', 'of', 'dengue', 'infection', 'due', 'to', 'its', 'long', 'half', 'life', 'in', 'the', 'blood', 'Here', 'we', 'describe', 'a', 'simple', 'and', 'efficient', 'method', 'for', 'the', 'expression', 'of', 'NS1', 'in', 'Escherichia', 'coli', 'which', 'could', 'potentially', 'be', 'used', 'to', 'develop', 'monoclonal', 'and', 'bispecific', 'antibodies', 'for', 'point', 'of', 'care', 'diagnostics', 'E', 'coli', 'codon', 'optimized', 'synthetic', 'full', 'length', 'NS1', 'gene', 'of', 'dengue', 'serotype', '1', 'DEN', '1', 'was', 'successfully', 'cloned', 'and', 'expressed', 'in', 'very', 'high', 'level', 'as', 'inclusion', 'bodies', 'The', 'NS1', 'protein', 'was', 'successfully', 'affinity', 'purified', 'and', 'refolded', 'as', 'a', 'recombinant', 'NS1', 'rNS1', 'protein', 'in', 'E', 'coli', 'and', 'yield', 'was', '230', '250mg', 'L', 'of', 'bacterial', 'culture', 'The', 'rNS1', 'protein', 'was', 'used', 'to', 'immunize', 'mice', 'for', 'hybridoma', 'development', 'The', 'polyclonal', 'antiserum', 'from', 'animals', 'immunized', 'with', 'this', 'rNS1', 'protein', 'was', 'found', 'to', 'specifically', 'recognize', 'the', 'rNS1', 'thus', 'demonstrating', 'the', 'immunogenic', 'nature', 'of', 'the', 'protein', 'The', 'rNS1', 'protein', 'purified', 'from', 'E', 'coli', 'could', 'be', 'useful', 'for', 'developing', 'a', 'sensitive', 'serum', 'diagnostic', 'assay', 'to', 'monitor', 'dengue', 'outbreaks', '']"
146672,A practical review of alternatives to the steady pressurisation method for determining building airtightness,2020-10-31,Renewable and Sustainable Energy Reviews,https://www.sciencedirect.com/science/article/pii/S1364032120303403; https://api.elsevier.com/content/article/pii/S1364032120303403,"Abstract As an important indicator of construction quality and envelope integrity of buildings, airtightness is responsible for a considerable amount of energy losses associated with infiltration. It is crucial to understand building airtightness during construction and retrofitting to achieve a suitable envelope airtightness which is essential for obtaining a desirable building energy efficiency, durability and indoor environment. As a convenient means of measurement, the current steady pressurisation method has long been accepted as a standard testing method for measuring building airtightness. It offers an intuitive and robust approach for measuring building airtightness and performing building diagnostics. However, it also has some shortcomings that are mainly related to its high pressure measurement, requirement for skilful operation, long test duration and change to the building envelope. Efforts have been made by manufacturers and researchers to further improve its accuracy and practicality with much progress achieved. Work has also been done to develop alternative methods that can overcome some of the issues. This paper provides a practical review on the incumbent methodology and efforts that have been made over the past decades in research and development of other methods to achieve a similar purpose. It compares them in relation to aspects that are considered important in achieving an accurate, quick and practical measurement of building airtightness and the finding shows other methods such as acoustic and unsteady technique have their own advantages over the steady pressurisation method but also add some of their own restrictions, which therefore makes them suited for different applications.",10.1016/j.rser.2020.110049,ow7gzpyd,"['Abstract', 'As', 'an', 'important', 'indicator', 'of', 'construction', 'quality', 'and', 'envelope', 'integrity', 'of', 'buildings', 'airtightness', 'is', 'responsible', 'for', 'a', 'considerable', 'amount', 'of', 'energy', 'losses', 'associated', 'with', 'infiltration', 'It', 'is', 'crucial', 'to', 'understand', 'building', 'airtightness', 'during', 'construction', 'and', 'retrofitting', 'to', 'achieve', 'a', 'suitable', 'envelope', 'airtightness', 'which', 'is', 'essential', 'for', 'obtaining', 'a', 'desirable', 'building', 'energy', 'efficiency', 'durability', 'and', 'indoor', 'environment', 'As', 'a', 'convenient', 'means', 'of', 'measurement', 'the', 'current', 'steady', 'pressurisation', 'method', 'has', 'long', 'been', 'accepted', 'as', 'a', 'standard', 'testing', 'method', 'for', 'measuring', 'building', 'airtightness', 'It', 'offers', 'an', 'intuitive', 'and', 'robust', 'approach', 'for', 'measuring', 'building', 'airtightness', 'and', 'performing', 'building', 'diagnostics', 'However', 'it', 'also', 'has', 'some', 'shortcomings', 'that', 'are', 'mainly', 'related', 'to', 'its', 'high', 'pressure', 'measurement', 'requirement', 'for', 'skilful', 'operation', 'long', 'test', 'duration', 'and', 'change', 'to', 'the', 'building', 'envelope', 'Efforts', 'have', 'been', 'made', 'by', 'manufacturers', 'and', 'researchers', 'to', 'further', 'improve', 'its', 'accuracy', 'and', 'practicality', 'with', 'much', 'progress', 'achieved', 'Work', 'has', 'also', 'been', 'done', 'to', 'develop', 'alternative', 'methods', 'that', 'can', 'overcome', 'some', 'of', 'the', 'issues', 'This', 'paper', 'provides', 'a', 'practical', 'review', 'on', 'the', 'incumbent', 'methodology', 'and', 'efforts', 'that', 'have', 'been', 'made', 'over', 'the', 'past', 'decades', 'in', 'research', 'and', 'development', 'of', 'other', 'methods', 'to', 'achieve', 'a', 'similar', 'purpose', 'It', 'compares', 'them', 'in', 'relation', 'to', 'aspects', 'that', 'are', 'considered', 'important', 'in', 'achieving', 'an', 'accurate', 'quick', 'and', 'practical', 'measurement', 'of', 'building', 'airtightness', 'and', 'the', 'finding', 'shows', 'other', 'methods', 'such', 'as', 'acoustic', 'and', 'unsteady', 'technique', 'have', 'their', 'own', 'advantages', 'over', 'the', 'steady', 'pressurisation', 'method', 'but', 'also', 'add', 'some', 'of', 'their', 'own', 'restrictions', 'which', 'therefore', 'makes', 'them', 'suited', 'for', 'different', 'applications', '']"
149361,Enteric viral infections in lambs or kids,2015-12-14,Vet Microbiol,https://www.ncbi.nlm.nih.gov/pubmed/26321129/; https://www.sciencedirect.com/science/article/pii/S0378113515003144; https://doi.org/10.1016/j.vetmic.2015.08.006; https://api.elsevier.com/content/article/pii/S0378113515003144,"Diarrhoea in lambs and kids is often a complex, multi-factorial syndrome. Common infectious causes of diarrhoea in lambs and kids during the first month of life are of bacterial or parasite nature. However, despite appreciable improvements in management practices and prevention and treatment strategies over the last decades, diarrhoea is still a common and costly syndrome affecting newborn small ruminants. Recent advances in the diagnostics and metagenomic investigations of the enteric environment have allowed discovering a number of novel viruses, although their pathobiological properties remain largely unknown. Assessing more in depth the impact of these viruses on the health and productions of these livestock animals is necessary and requires the development of accurate diagnostic tools and updating of the diagnostic algorithms of enteric pathological conditions.",10.1016/j.vetmic.2015.08.006,1mdgv8ya,"['Diarrhoea', 'in', 'lambs', 'and', 'kids', 'is', 'often', 'a', 'complex', 'multi', 'factorial', 'syndrome', 'Common', 'infectious', 'causes', 'of', 'diarrhoea', 'in', 'lambs', 'and', 'kids', 'during', 'the', 'first', 'month', 'of', 'life', 'are', 'of', 'bacterial', 'or', 'parasite', 'nature', 'However', 'despite', 'appreciable', 'improvements', 'in', 'management', 'practices', 'and', 'prevention', 'and', 'treatment', 'strategies', 'over', 'the', 'last', 'decades', 'diarrhoea', 'is', 'still', 'a', 'common', 'and', 'costly', 'syndrome', 'affecting', 'newborn', 'small', 'ruminants', 'Recent', 'advances', 'in', 'the', 'diagnostics', 'and', 'metagenomic', 'investigations', 'of', 'the', 'enteric', 'environment', 'have', 'allowed', 'discovering', 'a', 'number', 'of', 'novel', 'viruses', 'although', 'their', 'pathobiological', 'properties', 'remain', 'largely', 'unknown', 'Assessing', 'more', 'in', 'depth', 'the', 'impact', 'of', 'these', 'viruses', 'on', 'the', 'health', 'and', 'productions', 'of', 'these', 'livestock', 'animals', 'is', 'necessary', 'and', 'requires', 'the', 'development', 'of', 'accurate', 'diagnostic', 'tools', 'and', 'updating', 'of', 'the', 'diagnostic', 'algorithms', 'of', 'enteric', 'pathological', 'conditions', '']"
149507,Microparticle encoding technologies for high-throughput multiplexed suspension assays,2009-05-07,Integr Biol (Camb),https://doi.org/10.1039/b905502a; https://www.ncbi.nlm.nih.gov/pubmed/20023742/,"The requirement for analysis of large numbers of biomolecules for drug discovery and clinical diagnostics has driven the development of low-cost, flexible and high-throughput methods for simultaneous detection of multiple molecular targets in a single sample (multiplexed analysis). The technique that seems most likely to satisfy all of these requirements is the multiplexed suspension (bead-based) assay, which offers a number of advantages over alternative approaches such as ELISAs and microarrays. In a bead based assay, different probe molecules are attached to different beads (of a few tens of microns in size), which are then reacted in suspension with the target sample. After reaction, the beads must be identifiable in order to determine the attached probe molecule, and thus each bead must be labelled (encoded) with a unique identifier. A large number of techniques have been proposed for encoding beads. This critical review analyses each technology on the basis of its ability to fulfil the practical requirements of assays, whilst being compatible with low-cost, high-throughput manufacturing processes and high-throughput detection methods. As a result, we identify the most likely candidates to be used for future integrated device development for practical applications.",10.1039/b905502a,hzr4sxtp,"['The', 'requirement', 'for', 'analysis', 'of', 'large', 'numbers', 'of', 'biomolecules', 'for', 'drug', 'discovery', 'and', 'clinical', 'diagnostics', 'has', 'driven', 'the', 'development', 'of', 'low', 'cost', 'flexible', 'and', 'high', 'throughput', 'methods', 'for', 'simultaneous', 'detection', 'of', 'multiple', 'molecular', 'targets', 'in', 'a', 'single', 'sample', 'multiplexed', 'analysis', 'The', 'technique', 'that', 'seems', 'most', 'likely', 'to', 'satisfy', 'all', 'of', 'these', 'requirements', 'is', 'the', 'multiplexed', 'suspension', 'bead', 'based', 'assay', 'which', 'offers', 'a', 'number', 'of', 'advantages', 'over', 'alternative', 'approaches', 'such', 'as', 'ELISAs', 'and', 'microarrays', 'In', 'a', 'bead', 'based', 'assay', 'different', 'probe', 'molecules', 'are', 'attached', 'to', 'different', 'beads', 'of', 'a', 'few', 'tens', 'of', 'microns', 'in', 'size', 'which', 'are', 'then', 'reacted', 'in', 'suspension', 'with', 'the', 'target', 'sample', 'After', 'reaction', 'the', 'beads', 'must', 'be', 'identifiable', 'in', 'order', 'to', 'determine', 'the', 'attached', 'probe', 'molecule', 'and', 'thus', 'each', 'bead', 'must', 'be', 'labelled', 'encoded', 'with', 'a', 'unique', 'identifier', 'A', 'large', 'number', 'of', 'techniques', 'have', 'been', 'proposed', 'for', 'encoding', 'beads', 'This', 'critical', 'review', 'analyses', 'each', 'technology', 'on', 'the', 'basis', 'of', 'its', 'ability', 'to', 'fulfil', 'the', 'practical', 'requirements', 'of', 'assays', 'whilst', 'being', 'compatible', 'with', 'low', 'cost', 'high', 'throughput', 'manufacturing', 'processes', 'and', 'high', 'throughput', 'detection', 'methods', 'As', 'a', 'result', 'we', 'identify', 'the', 'most', 'likely', 'candidates', 'to', 'be', 'used', 'for', 'future', 'integrated', 'device', 'development', 'for', 'practical', 'applications', '']"
149672,Virus Pathogen Database and Analysis Resource (ViPR): A Comprehensive Bioinformatics Database and Analysis Resource for the Coronavirus Research Community,2012-11-19,Viruses,https://www.ncbi.nlm.nih.gov/pubmed/23202522/; https://doi.org/10.3390/v4113209,"Several viruses within the Coronaviridae family have been categorized as either emerging or re-emerging human pathogens, with Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) being the most well known. The NIAID-sponsored Virus Pathogen Database and Analysis Resource (ViPR, www.viprbrc.org) supports bioinformatics workflows for a broad range of human virus pathogens and other related viruses, including the entire Coronaviridae family. ViPR provides access to sequence records, gene and protein annotations, immune epitopes, 3D structures, host factor data, and other data types through an intuitive web-based search interface. Records returned from these queries can then be subjected to web-based analyses including: multiple sequence alignment, phylogenetic inference, sequence variation determination, BLAST comparison, and metadata-driven comparative genomics statistical analysis. Additional tools exist to display multiple sequence alignments, view phylogenetic trees, visualize 3D protein structures, transfer existing reference genome annotations to new genomes, and store or share results from any search or analysis within personal private ‘Workbench’ spaces for future access. All of the data and integrated analysis and visualization tools in ViPR are made available without charge as a service to the Coronaviridae research community to facilitate the research and development of diagnostics, prophylactics, vaccines and therapeutics against these human pathogens.",10.3390/v4113209,facjsy92,"['Several', 'viruses', 'within', 'the', 'Coronaviridae', 'family', 'have', 'been', 'categorized', 'as', 'either', 'emerging', 'or', 're', 'emerging', 'human', 'pathogens', 'with', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'Coronavirus', 'SARS', 'CoV', 'being', 'the', 'most', 'well', 'known', 'The', 'NIAID', 'sponsored', 'Virus', 'Pathogen', 'Database', 'and', 'Analysis', 'Resource', 'ViPR', 'www', 'viprbrc', 'org', 'supports', 'bioinformatics', 'workflows', 'for', 'a', 'broad', 'range', 'of', 'human', 'virus', 'pathogens', 'and', 'other', 'related', 'viruses', 'including', 'the', 'entire', 'Coronaviridae', 'family', 'ViPR', 'provides', 'access', 'to', 'sequence', 'records', 'gene', 'and', 'protein', 'annotations', 'immune', 'epitopes', '3D', 'structures', 'host', 'factor', 'data', 'and', 'other', 'data', 'types', 'through', 'an', 'intuitive', 'web', 'based', 'search', 'interface', 'Records', 'returned', 'from', 'these', 'queries', 'can', 'then', 'be', 'subjected', 'to', 'web', 'based', 'analyses', 'including', 'multiple', 'sequence', 'alignment', 'phylogenetic', 'inference', 'sequence', 'variation', 'determination', 'BLAST', 'comparison', 'and', 'metadata', 'driven', 'comparative', 'genomics', 'statistical', 'analysis', 'Additional', 'tools', 'exist', 'to', 'display', 'multiple', 'sequence', 'alignments', 'view', 'phylogenetic', 'trees', 'visualize', '3D', 'protein', 'structures', 'transfer', 'existing', 'reference', 'genome', 'annotations', 'to', 'new', 'genomes', 'and', 'store', 'or', 'share', 'results', 'from', 'any', 'search', 'or', 'analysis', 'within', 'personal', 'private', 'Workbench', 'spaces', 'for', 'future', 'access', 'All', 'of', 'the', 'data', 'and', 'integrated', 'analysis', 'and', 'visualization', 'tools', 'in', 'ViPR', 'are', 'made', 'available', 'without', 'charge', 'as', 'a', 'service', 'to', 'the', 'Coronaviridae', 'research', 'community', 'to', 'facilitate', 'the', 'research', 'and', 'development', 'of', 'diagnostics', 'prophylactics', 'vaccines', 'and', 'therapeutics', 'against', 'these', 'human', 'pathogens', '']"
150355,"Characterization of a genetically heterogeneous porcine rotavirus C, and other viruses present in the fecal virome of a non-diarrheic Belgian piglet",2016-05-14,Infect Genet Evol,https://doi.org/10.1016/j.meegid.2016.05.018; https://www.sciencedirect.com/science/article/pii/S1567134816301903; https://api.elsevier.com/content/article/pii/S1567134816301903; https://www.ncbi.nlm.nih.gov/pubmed/27184192/,"Next-generation sequencing (NGS) technologies are becoming increasingly accessible, leading to an expanded interest in the composition of the porcine enteric virome. In the present study, the fecal virome of a non-diarrheic Belgian piglet was determined. Although the virome of only a single piglet was analyzed, some interesting data were obtained, including the second complete genome of a pig group C rotavirus (RVC). This Belgian strain was only distantly related to the only other completely characterized pig RVC strain, Cowden. Its relatedness to RVC strains from other host species was also analyzed and the porcine strain found in our study was only distantly related to RVCs detected in humans and cows. The gene encoding the outer capsid protein VP7 belonged to the rare porcine G3 genotype, which might be serologically distinct from most other pig RVC strains. A putative novel RVC VP6 genotype was identified as well. A group A rotavirus strain also present in this fecal sample contained the rare pig genotype combination G11P[27], but was only partially characterized. Typical pig RVA genotypes I5, A8, and T7 were found for the viral proteins VP6, NSP1, and NSP3, respectively. Interestingly, the fecal virome of the piglet also contained an astrovirus and an enterovirus, of which the complete genomes were characterized. Results of the current study indicate that many viruses may be present simultaneously in fecal samples of non-diarrheic piglets. In this study, these viruses could not be directly associated with any disease, but still they might have had a potential subclinical impact on pig growth performance. The fast evolution of NGS will be a powerful tool for future diagnostics in veterinary practice. Its application will certainly lead to better insights into the relevance of many (sub)clinical enteric viral infections, that may have remained unnoticed using traditional diagnostic techniques. This will stimulate the development of new and durable prophylactic measures to improve pig health and production.",10.1016/j.meegid.2016.05.018,i84epslv,"['Next', 'generation', 'sequencing', 'NGS', 'technologies', 'are', 'becoming', 'increasingly', 'accessible', 'leading', 'to', 'an', 'expanded', 'interest', 'in', 'the', 'composition', 'of', 'the', 'porcine', 'enteric', 'virome', 'In', 'the', 'present', 'study', 'the', 'fecal', 'virome', 'of', 'a', 'non', 'diarrheic', 'Belgian', 'piglet', 'was', 'determined', 'Although', 'the', 'virome', 'of', 'only', 'a', 'single', 'piglet', 'was', 'analyzed', 'some', 'interesting', 'data', 'were', 'obtained', 'including', 'the', 'second', 'complete', 'genome', 'of', 'a', 'pig', 'group', 'C', 'rotavirus', 'RVC', 'This', 'Belgian', 'strain', 'was', 'only', 'distantly', 'related', 'to', 'the', 'only', 'other', 'completely', 'characterized', 'pig', 'RVC', 'strain', 'Cowden', 'Its', 'relatedness', 'to', 'RVC', 'strains', 'from', 'other', 'host', 'species', 'was', 'also', 'analyzed', 'and', 'the', 'porcine', 'strain', 'found', 'in', 'our', 'study', 'was', 'only', 'distantly', 'related', 'to', 'RVCs', 'detected', 'in', 'humans', 'and', 'cows', 'The', 'gene', 'encoding', 'the', 'outer', 'capsid', 'protein', 'VP7', 'belonged', 'to', 'the', 'rare', 'porcine', 'G3', 'genotype', 'which', 'might', 'be', 'serologically', 'distinct', 'from', 'most', 'other', 'pig', 'RVC', 'strains', 'A', 'putative', 'novel', 'RVC', 'VP6', 'genotype', 'was', 'identified', 'as', 'well', 'A', 'group', 'A', 'rotavirus', 'strain', 'also', 'present', 'in', 'this', 'fecal', 'sample', 'contained', 'the', 'rare', 'pig', 'genotype', 'combination', 'G11P', '27', 'but', 'was', 'only', 'partially', 'characterized', 'Typical', 'pig', 'RVA', 'genotypes', 'I5', 'A8', 'and', 'T7', 'were', 'found', 'for', 'the', 'viral', 'proteins', 'VP6', 'NSP1', 'and', 'NSP3', 'respectively', 'Interestingly', 'the', 'fecal', 'virome', 'of', 'the', 'piglet', 'also', 'contained', 'an', 'astrovirus', 'and', 'an', 'enterovirus', 'of', 'which', 'the', 'complete', 'genomes', 'were', 'characterized', 'Results', 'of', 'the', 'current', 'study', 'indicate', 'that', 'many', 'viruses', 'may', 'be', 'present', 'simultaneously', 'in', 'fecal', 'samples', 'of', 'non', 'diarrheic', 'piglets', 'In', 'this', 'study', 'these', 'viruses', 'could', 'not', 'be', 'directly', 'associated', 'with', 'any', 'disease', 'but', 'still', 'they', 'might', 'have', 'had', 'a', 'potential', 'subclinical', 'impact', 'on', 'pig', 'growth', 'performance', 'The', 'fast', 'evolution', 'of', 'NGS', 'will', 'be', 'a', 'powerful', 'tool', 'for', 'future', 'diagnostics', 'in', 'veterinary', 'practice', 'Its', 'application', 'will', 'certainly', 'lead', 'to', 'better', 'insights', 'into', 'the', 'relevance', 'of', 'many', 'sub', 'clinical', 'enteric', 'viral', 'infections', 'that', 'may', 'have', 'remained', 'unnoticed', 'using', 'traditional', 'diagnostic', 'techniques', 'This', 'will', 'stimulate', 'the', 'development', 'of', 'new', 'and', 'durable', 'prophylactic', 'measures', 'to', 'improve', 'pig', 'health', 'and', 'production', '']"
150895,Pains and Gains from China's Experiences with Emerging Epidemics: From SARS to H7N9,2016-07-20,Biomed Res Int,https://www.ncbi.nlm.nih.gov/pubmed/27525272/; https://doi.org/10.1155/2016/5717108,"Over the recent decades, China experienced several emerging virus outbreaks including those caused by the severe acute respiratory syndrome- (SARS-) coronavirus (Cov), H5N1 virus, and H7N9 virus. The SARS tragedy revealed faults in China's infectious disease prevention system, propelling the Chinese government to enact reforms that enabled better combating of the subsequent H1N1 and H7N9 avian flu epidemics. The system is buttressed by three fundamental, mutually reinforcing components: (1) enduring government administration reforms, including legislation establishing a unified public health emergency management system; (2) prioritized funding for biotechnology and biomedicine industrialization, especially in the areas of pathogen identification, drug production, and the development of vaccines and diagnostics; and (3) increasing investment for public health and establishment of a rapid-response infectious diseases prevention and control system. China is now using its hard-gained experience to support the fight against Ebola in Africa and the Middle East Respiratory Syndrome in its own country.",10.1155/2016/5717108,zd011ca5,"['Over', 'the', 'recent', 'decades', 'China', 'experienced', 'several', 'emerging', 'virus', 'outbreaks', 'including', 'those', 'caused', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'coronavirus', 'Cov', 'H5N1', 'virus', 'and', 'H7N9', 'virus', 'The', 'SARS', 'tragedy', 'revealed', 'faults', 'in', 'China', 's', 'infectious', 'disease', 'prevention', 'system', 'propelling', 'the', 'Chinese', 'government', 'to', 'enact', 'reforms', 'that', 'enabled', 'better', 'combating', 'of', 'the', 'subsequent', 'H1N1', 'and', 'H7N9', 'avian', 'flu', 'epidemics', 'The', 'system', 'is', 'buttressed', 'by', 'three', 'fundamental', 'mutually', 'reinforcing', 'components', '1', 'enduring', 'government', 'administration', 'reforms', 'including', 'legislation', 'establishing', 'a', 'unified', 'public', 'health', 'emergency', 'management', 'system', '2', 'prioritized', 'funding', 'for', 'biotechnology', 'and', 'biomedicine', 'industrialization', 'especially', 'in', 'the', 'areas', 'of', 'pathogen', 'identification', 'drug', 'production', 'and', 'the', 'development', 'of', 'vaccines', 'and', 'diagnostics', 'and', '3', 'increasing', 'investment', 'for', 'public', 'health', 'and', 'establishment', 'of', 'a', 'rapid', 'response', 'infectious', 'diseases', 'prevention', 'and', 'control', 'system', 'China', 'is', 'now', 'using', 'its', 'hard', 'gained', 'experience', 'to', 'support', 'the', 'fight', 'against', 'Ebola', 'in', 'Africa', 'and', 'the', 'Middle', 'East', 'Respiratory', 'Syndrome', 'in', 'its', 'own', 'country', '']"
151210,Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics,2020-06-26,Diagnostics (Basel),https://doi.org/10.3390/diagnostics10060434; https://www.ncbi.nlm.nih.gov/pubmed/32604919/,"Validated and accurate laboratory testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a crucial part of the timely management of Coronavirus Disease 2019 (COVID-19) disease, supporting the clinical decision-making process for infection control at the healthcare level and detecting asymptomatic cases. This would facilitate an appropriate treatment, a prompt isolation and consequently deceleration of the pandemic. Various laboratory tests can identify the genetic material of SARS-CoV-2 that causes COVID-19 in specimens, or specific anti-viral antibodies in blood/serum. Due to the current pandemic situation, a development of point-of-care diagnostics (POCD) allows us to substantially accelerate taking clinical decisions and implement strategic planning at the national level of preventative measures. This review summarizes and compares the available POCD and those currently under development, including quantitative reverse transcription PCR (RT-qPCR), serology immunoassays (SIAs) and protein microarray method (PMM) designed for standard and rapid COVID-19 diagnosis.",10.3390/diagnostics10060434,tb1zsuw4,"['Validated', 'and', 'accurate', 'laboratory', 'testing', 'for', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'Coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'a', 'crucial', 'part', 'of', 'the', 'timely', 'management', 'of', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'disease', 'supporting', 'the', 'clinical', 'decision', 'making', 'process', 'for', 'infection', 'control', 'at', 'the', 'healthcare', 'level', 'and', 'detecting', 'asymptomatic', 'cases', 'This', 'would', 'facilitate', 'an', 'appropriate', 'treatment', 'a', 'prompt', 'isolation', 'and', 'consequently', 'deceleration', 'of', 'the', 'pandemic', 'Various', 'laboratory', 'tests', 'can', 'identify', 'the', 'genetic', 'material', 'of', 'SARS', 'CoV', '2', 'that', 'causes', 'COVID', '19', 'in', 'specimens', 'or', 'specific', 'anti', 'viral', 'antibodies', 'in', 'blood', 'serum', 'Due', 'to', 'the', 'current', 'pandemic', 'situation', 'a', 'development', 'of', 'point', 'of', 'care', 'diagnostics', 'POCD', 'allows', 'us', 'to', 'substantially', 'accelerate', 'taking', 'clinical', 'decisions', 'and', 'implement', 'strategic', 'planning', 'at', 'the', 'national', 'level', 'of', 'preventative', 'measures', 'This', 'review', 'summarizes', 'and', 'compares', 'the', 'available', 'POCD', 'and', 'those', 'currently', 'under', 'development', 'including', 'quantitative', 'reverse', 'transcription', 'PCR', 'RT', 'qPCR', 'serology', 'immunoassays', 'SIAs', 'and', 'protein', 'microarray', 'method', 'PMM', 'designed', 'for', 'standard', 'and', 'rapid', 'COVID', '19', 'diagnosis', '']"
152320,IoT PCR for pandemic disease detection and its spread monitoring,2020-01-15,Sensors and Actuators B: Chemical,https://doi.org/10.1016/j.snb.2019.127098; https://www.sciencedirect.com/science/article/pii/S0925400519312973; https://www.ncbi.nlm.nih.gov/pubmed/32288256/; https://api.elsevier.com/content/article/pii/S0925400519312973,"Abstract During infectious disease outbreaks, the centers for disease control need to monitor particular areas. Considerable effort has been invested in the development of portable, user-friendly, and cost-effective systems for point-of-care (POC) diagnostics, which could also create an Internet of Things (IoT) for healthcare via a global network. However, at present IoT based on a functional POC instrument is not available. Here we show a fast, user-friendly, and affordable IoT system based on a miniaturized polymerase chain reaction device. We demonstrated the system’s capability by amplification of complementary deoxyribonucleic acid (cDNA) of the dengue fever virus. The resulting data were then automatically uploaded via a Bluetooth interface to an Android-based smartphone and then wirelessly sent to a global network, instantly making the test results available anywhere in the world. The IoT system presented here could become an essential tool for healthcare centers to tackle infectious disease outbreaks identified either by DNA or ribonucleic acid.",10.1016/j.snb.2019.127098,ityhcak7,"['Abstract', 'During', 'infectious', 'disease', 'outbreaks', 'the', 'centers', 'for', 'disease', 'control', 'need', 'to', 'monitor', 'particular', 'areas', 'Considerable', 'effort', 'has', 'been', 'invested', 'in', 'the', 'development', 'of', 'portable', 'user', 'friendly', 'and', 'cost', 'effective', 'systems', 'for', 'point', 'of', 'care', 'POC', 'diagnostics', 'which', 'could', 'also', 'create', 'an', 'Internet', 'of', 'Things', 'IoT', 'for', 'healthcare', 'via', 'a', 'global', 'network', 'However', 'at', 'present', 'IoT', 'based', 'on', 'a', 'functional', 'POC', 'instrument', 'is', 'not', 'available', 'Here', 'we', 'show', 'a', 'fast', 'user', 'friendly', 'and', 'affordable', 'IoT', 'system', 'based', 'on', 'a', 'miniaturized', 'polymerase', 'chain', 'reaction', 'device', 'We', 'demonstrated', 'the', 'system', 's', 'capability', 'by', 'amplification', 'of', 'complementary', 'deoxyribonucleic', 'acid', 'cDNA', 'of', 'the', 'dengue', 'fever', 'virus', 'The', 'resulting', 'data', 'were', 'then', 'automatically', 'uploaded', 'via', 'a', 'Bluetooth', 'interface', 'to', 'an', 'Android', 'based', 'smartphone', 'and', 'then', 'wirelessly', 'sent', 'to', 'a', 'global', 'network', 'instantly', 'making', 'the', 'test', 'results', 'available', 'anywhere', 'in', 'the', 'world', 'The', 'IoT', 'system', 'presented', 'here', 'could', 'become', 'an', 'essential', 'tool', 'for', 'healthcare', 'centers', 'to', 'tackle', 'infectious', 'disease', 'outbreaks', 'identified', 'either', 'by', 'DNA', 'or', 'ribonucleic', 'acid', '']"
152433,Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019–2020,2020-04-08,Virusdisease,https://doi.org/10.1007/s13337-020-00575-1; https://www.ncbi.nlm.nih.gov/pubmed/32292802/,"Wuhan, the city in Hubei province in China is in the focus of global community due to the outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), formerly known as 2019-nCoV. The virus emerged in humans from Wuhan seafood market probably via zoonotic transmission. Within a few days the virus spread its tentacles rapidly to neighboring cities in China and to different geographical regions through travelers and to some extent by human to human transmission leading to significant disease burden globally. More than 2,00,000 people (including more than 8000 deaths) have been infected with this respiratory illness across 167 countries and territories worldwide leading to a pandemic. The present review provides an outline about emergence and spread of SARS-CoV-2 from Wuhan, China in 2019–2020. We have also provided information about the classification, genome, proteins, clinical presentation of COVID-19, type of clinical specimens to be collected and diagnostic methods adopted to identify the respiratory illness. In addition we have also provided information about transmission dynamics, prevention measures and treatment options that are available at the present. Subsequently, we have given a comprehensive overview of the spread of this infection from China to the other parts of the globe. Management of the ongoing outbreak of SARS-CoV-2 encompassing surveillance, clinical, immunological, genetic and evolutionary investigations are likely to provide the desired results. Joint efforts of global scientific community are needed at this hour in terms of enhancement of research on development of accurate diagnostics, antiviral therapeutics and finally into formation of an effective vaccine against the emerging novel coronavirus.",10.1007/s13337-020-00575-1,43gik8e3,"['Wuhan', 'the', 'city', 'in', 'Hubei', 'province', 'in', 'China', 'is', 'in', 'the', 'focus', 'of', 'global', 'community', 'due', 'to', 'the', 'outbreak', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'formerly', 'known', 'as', '2019', 'nCoV', 'The', 'virus', 'emerged', 'in', 'humans', 'from', 'Wuhan', 'seafood', 'market', 'probably', 'via', 'zoonotic', 'transmission', 'Within', 'a', 'few', 'days', 'the', 'virus', 'spread', 'its', 'tentacles', 'rapidly', 'to', 'neighboring', 'cities', 'in', 'China', 'and', 'to', 'different', 'geographical', 'regions', 'through', 'travelers', 'and', 'to', 'some', 'extent', 'by', 'human', 'to', 'human', 'transmission', 'leading', 'to', 'significant', 'disease', 'burden', 'globally', 'More', 'than', '2', '00', '000', 'people', 'including', 'more', 'than', '8000', 'deaths', 'have', 'been', 'infected', 'with', 'this', 'respiratory', 'illness', 'across', '167', 'countries', 'and', 'territories', 'worldwide', 'leading', 'to', 'a', 'pandemic', 'The', 'present', 'review', 'provides', 'an', 'outline', 'about', 'emergence', 'and', 'spread', 'of', 'SARS', 'CoV', '2', 'from', 'Wuhan', 'China', 'in', '2019', '2020', 'We', 'have', 'also', 'provided', 'information', 'about', 'the', 'classification', 'genome', 'proteins', 'clinical', 'presentation', 'of', 'COVID', '19', 'type', 'of', 'clinical', 'specimens', 'to', 'be', 'collected', 'and', 'diagnostic', 'methods', 'adopted', 'to', 'identify', 'the', 'respiratory', 'illness', 'In', 'addition', 'we', 'have', 'also', 'provided', 'information', 'about', 'transmission', 'dynamics', 'prevention', 'measures', 'and', 'treatment', 'options', 'that', 'are', 'available', 'at', 'the', 'present', 'Subsequently', 'we', 'have', 'given', 'a', 'comprehensive', 'overview', 'of', 'the', 'spread', 'of', 'this', 'infection', 'from', 'China', 'to', 'the', 'other', 'parts', 'of', 'the', 'globe', 'Management', 'of', 'the', 'ongoing', 'outbreak', 'of', 'SARS', 'CoV', '2', 'encompassing', 'surveillance', 'clinical', 'immunological', 'genetic', 'and', 'evolutionary', 'investigations', 'are', 'likely', 'to', 'provide', 'the', 'desired', 'results', 'Joint', 'efforts', 'of', 'global', 'scientific', 'community', 'are', 'needed', 'at', 'this', 'hour', 'in', 'terms', 'of', 'enhancement', 'of', 'research', 'on', 'development', 'of', 'accurate', 'diagnostics', 'antiviral', 'therapeutics', 'and', 'finally', 'into', 'formation', 'of', 'an', 'effective', 'vaccine', 'against', 'the', 'emerging', 'novel', 'coronavirus', '']"
152922,How recent advances in molecular tests could impact the diagnosis of pneumonia,2016-03-07,Expert Rev Mol Diagn,https://doi.org/10.1586/14737159.2016.1156536; https://www.ncbi.nlm.nih.gov/pubmed/26891612/,"Molecular diagnostic tests have been the single major development in pneumonia diagnostics over recent years. Nucleic acid detection tests (NATs) have greatly improved the ability to detect respiratory viruses and bacterial pathogens that do not normally colonize the respiratory tract. In contrast, NATs do not yet have an established role for diagnosing pneumonia caused by bacteria that commonly colonize the nasopharynx due to difficulties discriminating between pathogens and coincidental carriage strains. New approaches are needed to distinguish infection from colonization, such as through use of quantitative methods and identification of discriminating cut-off levels. The recent realization that the lung microbiome exists has provided new insights into the pathogenesis of pneumonia involving the interaction between multiple microorganisms. New developments in molecular diagnostics must account for this new paradigm.",10.1586/14737159.2016.1156536,4ivqlsgt,"['Molecular', 'diagnostic', 'tests', 'have', 'been', 'the', 'single', 'major', 'development', 'in', 'pneumonia', 'diagnostics', 'over', 'recent', 'years', 'Nucleic', 'acid', 'detection', 'tests', 'NATs', 'have', 'greatly', 'improved', 'the', 'ability', 'to', 'detect', 'respiratory', 'viruses', 'and', 'bacterial', 'pathogens', 'that', 'do', 'not', 'normally', 'colonize', 'the', 'respiratory', 'tract', 'In', 'contrast', 'NATs', 'do', 'not', 'yet', 'have', 'an', 'established', 'role', 'for', 'diagnosing', 'pneumonia', 'caused', 'by', 'bacteria', 'that', 'commonly', 'colonize', 'the', 'nasopharynx', 'due', 'to', 'difficulties', 'discriminating', 'between', 'pathogens', 'and', 'coincidental', 'carriage', 'strains', 'New', 'approaches', 'are', 'needed', 'to', 'distinguish', 'infection', 'from', 'colonization', 'such', 'as', 'through', 'use', 'of', 'quantitative', 'methods', 'and', 'identification', 'of', 'discriminating', 'cut', 'off', 'levels', 'The', 'recent', 'realization', 'that', 'the', 'lung', 'microbiome', 'exists', 'has', 'provided', 'new', 'insights', 'into', 'the', 'pathogenesis', 'of', 'pneumonia', 'involving', 'the', 'interaction', 'between', 'multiple', 'microorganisms', 'New', 'developments', 'in', 'molecular', 'diagnostics', 'must', 'account', 'for', 'this', 'new', 'paradigm', '']"
153644,Chapter 15 Proteomics of viruses,2008-12-31,Medical Applications of Mass Spectrometry,https://api.elsevier.com/content/article/pii/B9780444519801500173; https://www.sciencedirect.com/science/article/pii/B9780444519801500173,"Publisher Summary Proteomics is a promising approach for the study of viruses allowing a better understanding of disease processes and the development of new biomarkers for diagnosis and early detection of disease, thus accelerating drug development. Viral proteomics has included the analysis of viral particles to determine all proteins that compose the infectious virus, the examination of cellular proteins associated with a single viral protein in the hopes of determining all the functions of that viral protein, or the determination of cellular proteins induced or altered during a particular disease state. Viral particles of human cytomegalovirus (HCMV) and Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) have been recently examined. During the herpesviral replicative cycle, different viral particles are formed. For HCMV, this includes mature, infectious virions, noninfectious enveloped particles, and dense bodies. A proteome database of B-lymphoblastoid cell lines (LCLs), before and after transformation, has been developed to identify the cellular mechanisms of virus-induced immortalization. 2DE is used to first separate proteins based on their relative charge (pI) and then based on their molecular weight. Proteomic analysis has provided a unique tool for the identification of diagnostic biomarkers, evaluation of disease progression, and drug development. It is also an important approach for clinical diagnostics.",10.1016/b978-044451980-1.50017-3,9dyh8bj2,"['Publisher', 'Summary', 'Proteomics', 'is', 'a', 'promising', 'approach', 'for', 'the', 'study', 'of', 'viruses', 'allowing', 'a', 'better', 'understanding', 'of', 'disease', 'processes', 'and', 'the', 'development', 'of', 'new', 'biomarkers', 'for', 'diagnosis', 'and', 'early', 'detection', 'of', 'disease', 'thus', 'accelerating', 'drug', 'development', 'Viral', 'proteomics', 'has', 'included', 'the', 'analysis', 'of', 'viral', 'particles', 'to', 'determine', 'all', 'proteins', 'that', 'compose', 'the', 'infectious', 'virus', 'the', 'examination', 'of', 'cellular', 'proteins', 'associated', 'with', 'a', 'single', 'viral', 'protein', 'in', 'the', 'hopes', 'of', 'determining', 'all', 'the', 'functions', 'of', 'that', 'viral', 'protein', 'or', 'the', 'determination', 'of', 'cellular', 'proteins', 'induced', 'or', 'altered', 'during', 'a', 'particular', 'disease', 'state', 'Viral', 'particles', 'of', 'human', 'cytomegalovirus', 'HCMV', 'and', 'Kaposi', 's', 'sarcoma', 'associated', 'herpesvirus', 'human', 'herpesvirus', '8', 'KSHV', 'HHV', '8', 'have', 'been', 'recently', 'examined', 'During', 'the', 'herpesviral', 'replicative', 'cycle', 'different', 'viral', 'particles', 'are', 'formed', 'For', 'HCMV', 'this', 'includes', 'mature', 'infectious', 'virions', 'noninfectious', 'enveloped', 'particles', 'and', 'dense', 'bodies', 'A', 'proteome', 'database', 'of', 'B', 'lymphoblastoid', 'cell', 'lines', 'LCLs', 'before', 'and', 'after', 'transformation', 'has', 'been', 'developed', 'to', 'identify', 'the', 'cellular', 'mechanisms', 'of', 'virus', 'induced', 'immortalization', '2DE', 'is', 'used', 'to', 'first', 'separate', 'proteins', 'based', 'on', 'their', 'relative', 'charge', 'pI', 'and', 'then', 'based', 'on', 'their', 'molecular', 'weight', 'Proteomic', 'analysis', 'has', 'provided', 'a', 'unique', 'tool', 'for', 'the', 'identification', 'of', 'diagnostic', 'biomarkers', 'evaluation', 'of', 'disease', 'progression', 'and', 'drug', 'development', 'It', 'is', 'also', 'an', 'important', 'approach', 'for', 'clinical', 'diagnostics', '']"
153784,COVID-19 pandemic – A focused review for clinicians,2020-04-25,Clin Microbiol Infect,https://www.ncbi.nlm.nih.gov/pubmed/32344166/; https://www.sciencedirect.com/science/article/pii/S1198743X20302317?v=s5; https://api.elsevier.com/content/article/pii/S1198743X20302317; https://doi.org/10.1016/j.cmi.2020.04.023,"Abstract Background The COVID-19 pandemic caused by SARS-CoV-2 remains a significant issue for global health, economics and society. A wealth of data has been generated since its emergence in December 2019 and it is vital for clinicians to keep up with this data from across the world at a time of uncertainty and constantly evolving guidelines and clinical practice. Objectives Here we provide an update for clinicians on the recent developments about virology, diagnostics, clinical presentation, viral shedding, and treatment options for COVID-19 based on current literature. Sources We considered published peer-reviewed papers and non-peer-reviewed pre-print manuscripts on COVID19 and related aspects with an emphasis on clinical management aspects. Content We describe the virological characteristics of SARS-CoV-2 and clinical course of COVID-19 with an emphasis on diagnostic challenges, duration of viral shedding, severity markers and current treatment options. Implications The key challenge in managing COVID-19 remains the patient density. However, accurate diagnoses as well as early identification and management of high-risk severe cases are important for many clinicians. For improved management of cases, there is a need to understand test probability of serology, qRT-PCR and radiological testing, and the efficacy of available treatment options that could be used in severe cases with a high risk of mortality.",10.1016/j.cmi.2020.04.023,x64tii2t,"['Abstract', 'Background', 'The', 'COVID', '19', 'pandemic', 'caused', 'by', 'SARS', 'CoV', '2', 'remains', 'a', 'significant', 'issue', 'for', 'global', 'health', 'economics', 'and', 'society', 'A', 'wealth', 'of', 'data', 'has', 'been', 'generated', 'since', 'its', 'emergence', 'in', 'December', '2019', 'and', 'it', 'is', 'vital', 'for', 'clinicians', 'to', 'keep', 'up', 'with', 'this', 'data', 'from', 'across', 'the', 'world', 'at', 'a', 'time', 'of', 'uncertainty', 'and', 'constantly', 'evolving', 'guidelines', 'and', 'clinical', 'practice', 'Objectives', 'Here', 'we', 'provide', 'an', 'update', 'for', 'clinicians', 'on', 'the', 'recent', 'developments', 'about', 'virology', 'diagnostics', 'clinical', 'presentation', 'viral', 'shedding', 'and', 'treatment', 'options', 'for', 'COVID', '19', 'based', 'on', 'current', 'literature', 'Sources', 'We', 'considered', 'published', 'peer', 'reviewed', 'papers', 'and', 'non', 'peer', 'reviewed', 'pre', 'print', 'manuscripts', 'on', 'COVID19', 'and', 'related', 'aspects', 'with', 'an', 'emphasis', 'on', 'clinical', 'management', 'aspects', 'Content', 'We', 'describe', 'the', 'virological', 'characteristics', 'of', 'SARS', 'CoV', '2', 'and', 'clinical', 'course', 'of', 'COVID', '19', 'with', 'an', 'emphasis', 'on', 'diagnostic', 'challenges', 'duration', 'of', 'viral', 'shedding', 'severity', 'markers', 'and', 'current', 'treatment', 'options', 'Implications', 'The', 'key', 'challenge', 'in', 'managing', 'COVID', '19', 'remains', 'the', 'patient', 'density', 'However', 'accurate', 'diagnoses', 'as', 'well', 'as', 'early', 'identification', 'and', 'management', 'of', 'high', 'risk', 'severe', 'cases', 'are', 'important', 'for', 'many', 'clinicians', 'For', 'improved', 'management', 'of', 'cases', 'there', 'is', 'a', 'need', 'to', 'understand', 'test', 'probability', 'of', 'serology', 'qRT', 'PCR', 'and', 'radiological', 'testing', 'and', 'the', 'efficacy', 'of', 'available', 'treatment', 'options', 'that', 'could', 'be', 'used', 'in', 'severe', 'cases', 'with', 'a', 'high', 'risk', 'of', 'mortality', '']"
154082,Stable long‐term cultures of self‐renewing B cells and their applications,2016-02-10,Immunol Rev,https://doi.org/10.1111/imr.12395; https://www.ncbi.nlm.nih.gov/pubmed/26864105/,"Monoclonal antibodies are essential therapeutics and diagnostics in a large number of diseases. Moreover, they are essential tools in all sectors of life sciences. Although the great majority of monoclonal antibodies currently in use are of mouse origin, the use of human B cells to generate monoclonal antibodies is increasing as new techniques to tap the human B cell repertoire are rapidly emerging. Cloned lines of immortalized human B cells are ideal sources of monoclonal antibodies. In this review, we summarize our studies to the regulation of the replicative life span, differentiation, and maturation of B cells that led to the development of a platform that uses immortalization of human B cells by in vitro genetic modification for antibody development. We describe a number of human antibodies that were isolated using this platform and the application of the technique in other species. We also discuss the use of immortalized B cells as antigen‐presenting cells for the discovery of tumor neoantigens.",10.1111/imr.12395,g12r2417,"['Monoclonal', 'antibodies', 'are', 'essential', 'therapeutics', 'and', 'diagnostics', 'in', 'a', 'large', 'number', 'of', 'diseases', 'Moreover', 'they', 'are', 'essential', 'tools', 'in', 'all', 'sectors', 'of', 'life', 'sciences', 'Although', 'the', 'great', 'majority', 'of', 'monoclonal', 'antibodies', 'currently', 'in', 'use', 'are', 'of', 'mouse', 'origin', 'the', 'use', 'of', 'human', 'B', 'cells', 'to', 'generate', 'monoclonal', 'antibodies', 'is', 'increasing', 'as', 'new', 'techniques', 'to', 'tap', 'the', 'human', 'B', 'cell', 'repertoire', 'are', 'rapidly', 'emerging', 'Cloned', 'lines', 'of', 'immortalized', 'human', 'B', 'cells', 'are', 'ideal', 'sources', 'of', 'monoclonal', 'antibodies', 'In', 'this', 'review', 'we', 'summarize', 'our', 'studies', 'to', 'the', 'regulation', 'of', 'the', 'replicative', 'life', 'span', 'differentiation', 'and', 'maturation', 'of', 'B', 'cells', 'that', 'led', 'to', 'the', 'development', 'of', 'a', 'platform', 'that', 'uses', 'immortalization', 'of', 'human', 'B', 'cells', 'by', 'in', 'vitro', 'genetic', 'modification', 'for', 'antibody', 'development', 'We', 'describe', 'a', 'number', 'of', 'human', 'antibodies', 'that', 'were', 'isolated', 'using', 'this', 'platform', 'and', 'the', 'application', 'of', 'the', 'technique', 'in', 'other', 'species', 'We', 'also', 'discuss', 'the', 'use', 'of', 'immortalized', 'B', 'cells', 'as', 'antigen', 'presenting', 'cells', 'for', 'the', 'discovery', 'of', 'tumor', 'neoantigens', '']"
154483,SAROTUP: Scanner and Reporter of Target-Unrelated Peptides,2010-03-21,J Biomed Biotechnol,https://doi.org/10.1155/2010/101932; https://www.ncbi.nlm.nih.gov/pubmed/20339521/,"As epitope mimics, mimotopes have been widely utilized in the study of epitope prediction and the development of new diagnostics, therapeutics, and vaccines. Screening the random peptide libraries constructed with phage display or any other surface display technologies provides an efficient and convenient approach to acquire mimotopes. However, target-unrelated peptides creep into mimotopes from time to time through binding to contaminants or other components of the screening system. In this study, we present SAROTUP, a free web tool for scanning, reporting and excluding possible target-unrelated peptides from real mimotopes. Preliminary tests show that SAROTUP is efficient and capable of improving the accuracy of mimotope-based epitope mapping. It is also helpful for the development of mimotope-based diagnostics, therapeutics, and vaccines.",10.1155/2010/101932,hi7z3nob,"['As', 'epitope', 'mimics', 'mimotopes', 'have', 'been', 'widely', 'utilized', 'in', 'the', 'study', 'of', 'epitope', 'prediction', 'and', 'the', 'development', 'of', 'new', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'Screening', 'the', 'random', 'peptide', 'libraries', 'constructed', 'with', 'phage', 'display', 'or', 'any', 'other', 'surface', 'display', 'technologies', 'provides', 'an', 'efficient', 'and', 'convenient', 'approach', 'to', 'acquire', 'mimotopes', 'However', 'target', 'unrelated', 'peptides', 'creep', 'into', 'mimotopes', 'from', 'time', 'to', 'time', 'through', 'binding', 'to', 'contaminants', 'or', 'other', 'components', 'of', 'the', 'screening', 'system', 'In', 'this', 'study', 'we', 'present', 'SAROTUP', 'a', 'free', 'web', 'tool', 'for', 'scanning', 'reporting', 'and', 'excluding', 'possible', 'target', 'unrelated', 'peptides', 'from', 'real', 'mimotopes', 'Preliminary', 'tests', 'show', 'that', 'SAROTUP', 'is', 'efficient', 'and', 'capable', 'of', 'improving', 'the', 'accuracy', 'of', 'mimotope', 'based', 'epitope', 'mapping', 'It', 'is', 'also', 'helpful', 'for', 'the', 'development', 'of', 'mimotope', 'based', 'diagnostics', 'therapeutics', 'and', 'vaccines', '']"
154549,Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation,2020-02-15,bioRxiv,https://doi.org/10.1101/2020.02.11.944462; https://www.ncbi.nlm.nih.gov/pubmed/32511295/,"The outbreak of a novel betacoronavirus (2019-nCov) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for urgently needed vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure (MCM) development we determined a 3.5 Å-resolution cryo-EM structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also show biophysical and structural evidence that the 2019-nCoV S binds ACE2 with higher affinity than SARS-CoV S. Additionally we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to nCoV-2019 S, suggesting antibody cross-reactivity may be limited between the two virus RBDs. The atomic-resolution structure of 2019-nCoV S should enable rapid development and evaluation of MCMs to address the ongoing public health crisis.",10.1101/2020.02.11.944462,prqeufwg,"['The', 'outbreak', 'of', 'a', 'novel', 'betacoronavirus', '2019', 'nCov', 'represents', 'a', 'pandemic', 'threat', 'that', 'has', 'been', 'declared', 'a', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'The', 'CoV', 'spike', 'S', 'glycoprotein', 'is', 'a', 'key', 'target', 'for', 'urgently', 'needed', 'vaccines', 'therapeutic', 'antibodies', 'and', 'diagnostics', 'To', 'facilitate', 'medical', 'countermeasure', 'MCM', 'development', 'we', 'determined', 'a', '3', '5', 'Å', 'resolution', 'cryo', 'EM', 'structure', 'of', 'the', '2019', 'nCoV', 'S', 'trimer', 'in', 'the', 'prefusion', 'conformation', 'The', 'predominant', 'state', 'of', 'the', 'trimer', 'has', 'one', 'of', 'the', 'three', 'receptor', 'binding', 'domains', 'RBDs', 'rotated', 'up', 'in', 'a', 'receptor', 'accessible', 'conformation', 'We', 'also', 'show', 'biophysical', 'and', 'structural', 'evidence', 'that', 'the', '2019', 'nCoV', 'S', 'binds', 'ACE2', 'with', 'higher', 'affinity', 'than', 'SARS', 'CoV', 'S', 'Additionally', 'we', 'tested', 'several', 'published', 'SARS', 'CoV', 'RBD', 'specific', 'monoclonal', 'antibodies', 'and', 'found', 'that', 'they', 'do', 'not', 'have', 'appreciable', 'binding', 'to', 'nCoV', '2019', 'S', 'suggesting', 'antibody', 'cross', 'reactivity', 'may', 'be', 'limited', 'between', 'the', 'two', 'virus', 'RBDs', 'The', 'atomic', 'resolution', 'structure', 'of', '2019', 'nCoV', 'S', 'should', 'enable', 'rapid', 'development', 'and', 'evaluation', 'of', 'MCMs', 'to', 'address', 'the', 'ongoing', 'public', 'health', 'crisis', '']"
154694,Database and Analytical Resources for Viral Research Community,2019-12-31,Reference Module in Life Sciences,https://www.sciencedirect.com/science/article/pii/B9780128096338209953; https://api.elsevier.com/content/article/pii/B9780128096338209953,"Abstract Many public databases and analytical resources are available to facilitate virology research. The Virus Pathogen Database and Analysis Resource (ViPR, see “Relevant Websites section”) and Influenza Research Database (IRD, see “Relevant Websites section”) are comprehensive and highly curated repositories of genome and protein sequence records and annotations, protein structures, immune epitopes, and epidemiological and surveillance data about human and related viral pathogens. These data are acquired from public repositories, direct submissions and in-house bioinformatics analyses. The resources offer seamless integration of data, analytics and visualization, and are freely available without cost or restriction to facilitate diagnostics and therapeutics development for priority pathogens.",10.1016/b978-0-12-809633-8.20995-3,1pau5m3s,"['Abstract', 'Many', 'public', 'databases', 'and', 'analytical', 'resources', 'are', 'available', 'to', 'facilitate', 'virology', 'research', 'The', 'Virus', 'Pathogen', 'Database', 'and', 'Analysis', 'Resource', 'ViPR', 'see', 'Relevant', 'Websites', 'section', 'and', 'Influenza', 'Research', 'Database', 'IRD', 'see', 'Relevant', 'Websites', 'section', 'are', 'comprehensive', 'and', 'highly', 'curated', 'repositories', 'of', 'genome', 'and', 'protein', 'sequence', 'records', 'and', 'annotations', 'protein', 'structures', 'immune', 'epitopes', 'and', 'epidemiological', 'and', 'surveillance', 'data', 'about', 'human', 'and', 'related', 'viral', 'pathogens', 'These', 'data', 'are', 'acquired', 'from', 'public', 'repositories', 'direct', 'submissions', 'and', 'in', 'house', 'bioinformatics', 'analyses', 'The', 'resources', 'offer', 'seamless', 'integration', 'of', 'data', 'analytics', 'and', 'visualization', 'and', 'are', 'freely', 'available', 'without', 'cost', 'or', 'restriction', 'to', 'facilitate', 'diagnostics', 'and', 'therapeutics', 'development', 'for', 'priority', 'pathogens', '']"
155026,Future Veterinary Diagnostics,2010-09-19,J Exot Pet Med,https://api.elsevier.com/content/article/pii/S1557506310000558; https://doi.org/10.1053/j.jepm.2010.05.006; https://www.sciencedirect.com/science/article/pii/S1557506310000558; https://www.ncbi.nlm.nih.gov/pubmed/32288673/,"The development of rapid, accurate, and sensitive diagnostic methods for detecting pathogens is the basis for treating, controlling, and eradicating infectious diseases of veterinary importance. Scientific and technological advancements have revolutionized the field of veterinary diagnostics. Genome sequencing has allowed efficient, sensitive, and specific diagnostic assays to be developed based on the detection of nucleic acids. The integration of advances in biochemistry, proteomics, engineering, and medicine offers enormous potential for the rapid and accurate diagnosis of viral, microbial, genetic, and metabolic disease. In the future, polymerase chain reaction assays, microarray testing, genomic analysis, and metabolic profiling will be accomplished in a rapid, portable, sensitive, and cost-efficient manner.",10.1053/j.jepm.2010.05.006,o976nab9,"['The', 'development', 'of', 'rapid', 'accurate', 'and', 'sensitive', 'diagnostic', 'methods', 'for', 'detecting', 'pathogens', 'is', 'the', 'basis', 'for', 'treating', 'controlling', 'and', 'eradicating', 'infectious', 'diseases', 'of', 'veterinary', 'importance', 'Scientific', 'and', 'technological', 'advancements', 'have', 'revolutionized', 'the', 'field', 'of', 'veterinary', 'diagnostics', 'Genome', 'sequencing', 'has', 'allowed', 'efficient', 'sensitive', 'and', 'specific', 'diagnostic', 'assays', 'to', 'be', 'developed', 'based', 'on', 'the', 'detection', 'of', 'nucleic', 'acids', 'The', 'integration', 'of', 'advances', 'in', 'biochemistry', 'proteomics', 'engineering', 'and', 'medicine', 'offers', 'enormous', 'potential', 'for', 'the', 'rapid', 'and', 'accurate', 'diagnosis', 'of', 'viral', 'microbial', 'genetic', 'and', 'metabolic', 'disease', 'In', 'the', 'future', 'polymerase', 'chain', 'reaction', 'assays', 'microarray', 'testing', 'genomic', 'analysis', 'and', 'metabolic', 'profiling', 'will', 'be', 'accomplished', 'in', 'a', 'rapid', 'portable', 'sensitive', 'and', 'cost', 'efficient', 'manner', '']"
155069,Identification of a Novel Linear B-Cell Epitope on the Nucleocapsid Protein of Porcine Deltacoronavirus,2020-01-19,Int J Mol Sci,https://www.ncbi.nlm.nih.gov/pubmed/31963776/; https://doi.org/10.3390/ijms21020648,"Porcine deltacoronavirus (PDCoV), first identified in 2012, is a swine enteropathogen now found in many countries. The nucleocapsid (N) protein, a core component of PDCoV, is essential for virus replication and is a significant candidate in the development of diagnostics for PDCoV. In this study, monoclonal antibodies (mAbs) were generated and tested for reactivity with three truncations of the full protein (N1, N2, N3) that contained partial overlaps; of the five monoclonals chosen tested, each reacted with only the N3 truncation. The antibody designated 4E88 had highest binding affinity with the N protein and was chosen for in-depth examination. The 4E88 epitope was located to amino acids 308-AKPKQQKKPKK-318 by testing the 4E88 monoclonal for reactivity with a series of N3 truncations, then the minimal epitope, 309-KPKQQKKPK-317 (designated EP-4E88), was pinpointed by testing the 4E88 monoclonal for reactivity with a series of synthetic peptides of this region. Homology analysis showed that the EP-4E88 sequence is highly conserved among PDCoV strains, and also shares high similarity with sparrow coronavirus (HKU17), Asian leopard cat coronavirus (ALCCoV), quail coronavirus (UAE-HKU30), and sparrow deltacoronavirus (SpDCoV). Of note, the PDCoV EP-4E88 sequence shared very low similarity (<22.2%) with other porcine coronaviruses (PEDV, TGEV, PRCV, SADS-CoV, PHEV), demonstrating that it is an epitope that can be used for distinguishing PDCoV and other porcine coronavirus. 3D structural analysis revealed that amino acids of EP-4E88 were in close proximity and may be exposed on the surface of the N protein.",10.3390/ijms21020648,2r101v54,"['Porcine', 'deltacoronavirus', 'PDCoV', 'first', 'identified', 'in', '2012', 'is', 'a', 'swine', 'enteropathogen', 'now', 'found', 'in', 'many', 'countries', 'The', 'nucleocapsid', 'N', 'protein', 'a', 'core', 'component', 'of', 'PDCoV', 'is', 'essential', 'for', 'virus', 'replication', 'and', 'is', 'a', 'significant', 'candidate', 'in', 'the', 'development', 'of', 'diagnostics', 'for', 'PDCoV', 'In', 'this', 'study', 'monoclonal', 'antibodies', 'mAbs', 'were', 'generated', 'and', 'tested', 'for', 'reactivity', 'with', 'three', 'truncations', 'of', 'the', 'full', 'protein', 'N1', 'N2', 'N3', 'that', 'contained', 'partial', 'overlaps', 'of', 'the', 'five', 'monoclonals', 'chosen', 'tested', 'each', 'reacted', 'with', 'only', 'the', 'N3', 'truncation', 'The', 'antibody', 'designated', '4E88', 'had', 'highest', 'binding', 'affinity', 'with', 'the', 'N', 'protein', 'and', 'was', 'chosen', 'for', 'in', 'depth', 'examination', 'The', '4E88', 'epitope', 'was', 'located', 'to', 'amino', 'acids', '308', 'AKPKQQKKPKK', '318', 'by', 'testing', 'the', '4E88', 'monoclonal', 'for', 'reactivity', 'with', 'a', 'series', 'of', 'N3', 'truncations', 'then', 'the', 'minimal', 'epitope', '309', 'KPKQQKKPK', '317', 'designated', 'EP', '4E88', 'was', 'pinpointed', 'by', 'testing', 'the', '4E88', 'monoclonal', 'for', 'reactivity', 'with', 'a', 'series', 'of', 'synthetic', 'peptides', 'of', 'this', 'region', 'Homology', 'analysis', 'showed', 'that', 'the', 'EP', '4E88', 'sequence', 'is', 'highly', 'conserved', 'among', 'PDCoV', 'strains', 'and', 'also', 'shares', 'high', 'similarity', 'with', 'sparrow', 'coronavirus', 'HKU17', 'Asian', 'leopard', 'cat', 'coronavirus', 'ALCCoV', 'quail', 'coronavirus', 'UAE', 'HKU30', 'and', 'sparrow', 'deltacoronavirus', 'SpDCoV', 'Of', 'note', 'the', 'PDCoV', 'EP', '4E88', 'sequence', 'shared', 'very', 'low', 'similarity', '22', '2', 'with', 'other', 'porcine', 'coronaviruses', 'PEDV', 'TGEV', 'PRCV', 'SADS', 'CoV', 'PHEV', 'demonstrating', 'that', 'it', 'is', 'an', 'epitope', 'that', 'can', 'be', 'used', 'for', 'distinguishing', 'PDCoV', 'and', 'other', 'porcine', 'coronavirus', '3D', 'structural', 'analysis', 'revealed', 'that', 'amino', 'acids', 'of', 'EP', '4E88', 'were', 'in', 'close', 'proximity', 'and', 'may', 'be', 'exposed', 'on', 'the', 'surface', 'of', 'the', 'N', 'protein', '']"
155161,Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe,2017-10-31,Journal of Clinical Virology,https://www.sciencedirect.com/science/article/pii/S1386653217302172; https://www.ncbi.nlm.nih.gov/pubmed/28837859/; https://api.elsevier.com/content/article/pii/S1386653217302172; https://doi.org/10.1016/j.jcv.2017.07.019,"Abstract Community-acquired pneumonia (CAP) is an important respiratory disease and the fifth leading cause of mortality in Europe. The development of molecular diagnostic tests has highlighted the contributions of respiratory viruses to the aetiology of CAP, suggesting the incidence of viral pneumonia may have been previously underestimated. We performed a systematic review and meta-analysis to describe the overall identification of respiratory viruses in adult patients with CAP in Europe, following PRISMA guidelines (PROSPERO; CRD42016037233). We searched EMBASE, MEDLINE, CINAHL, WHOLIS, COCHRANE library and grey literature sources for relevant studies, and screened these against protocol eligibility criteria. Two researchers performed data extraction and risk of bias assessments, independently, using a piloted form. Results were synthesised narratively, and random effects meta-analyses performed to calculate pooled estimates of effect; heterogeneity was quantified using I2. Twenty-eight studies met inclusion criteria of which 21 were included in the primary meta-analysis. The pooled proportion of patients with identified respiratory viruses was 22.0% (95% CI: 18.0%–27.0%), rising to 29.0% (25.0%–34.0%) in studies where polymerase chain reaction (PCR) diagnostics were performed. Influenza virus was the most frequently detected virus in 9% (7%–12%) of adults with CAP. Respiratory viruses make a substantial contribution to the aetiology of CAP in adult patients in Europe; one or more respiratory viruses are detected in about one quarter of all cases.",10.1016/j.jcv.2017.07.019,b6mlolpx,"['Abstract', 'Community', 'acquired', 'pneumonia', 'CAP', 'is', 'an', 'important', 'respiratory', 'disease', 'and', 'the', 'fifth', 'leading', 'cause', 'of', 'mortality', 'in', 'Europe', 'The', 'development', 'of', 'molecular', 'diagnostic', 'tests', 'has', 'highlighted', 'the', 'contributions', 'of', 'respiratory', 'viruses', 'to', 'the', 'aetiology', 'of', 'CAP', 'suggesting', 'the', 'incidence', 'of', 'viral', 'pneumonia', 'may', 'have', 'been', 'previously', 'underestimated', 'We', 'performed', 'a', 'systematic', 'review', 'and', 'meta', 'analysis', 'to', 'describe', 'the', 'overall', 'identification', 'of', 'respiratory', 'viruses', 'in', 'adult', 'patients', 'with', 'CAP', 'in', 'Europe', 'following', 'PRISMA', 'guidelines', 'PROSPERO', 'CRD42016037233', 'We', 'searched', 'EMBASE', 'MEDLINE', 'CINAHL', 'WHOLIS', 'COCHRANE', 'library', 'and', 'grey', 'literature', 'sources', 'for', 'relevant', 'studies', 'and', 'screened', 'these', 'against', 'protocol', 'eligibility', 'criteria', 'Two', 'researchers', 'performed', 'data', 'extraction', 'and', 'risk', 'of', 'bias', 'assessments', 'independently', 'using', 'a', 'piloted', 'form', 'Results', 'were', 'synthesised', 'narratively', 'and', 'random', 'effects', 'meta', 'analyses', 'performed', 'to', 'calculate', 'pooled', 'estimates', 'of', 'effect', 'heterogeneity', 'was', 'quantified', 'using', 'I2', 'Twenty', 'eight', 'studies', 'met', 'inclusion', 'criteria', 'of', 'which', '21', 'were', 'included', 'in', 'the', 'primary', 'meta', 'analysis', 'The', 'pooled', 'proportion', 'of', 'patients', 'with', 'identified', 'respiratory', 'viruses', 'was', '22', '0', '95', 'CI', '18', '0', '27', '0', 'rising', 'to', '29', '0', '25', '0', '34', '0', 'in', 'studies', 'where', 'polymerase', 'chain', 'reaction', 'PCR', 'diagnostics', 'were', 'performed', 'Influenza', 'virus', 'was', 'the', 'most', 'frequently', 'detected', 'virus', 'in', '9', '7', '12', 'of', 'adults', 'with', 'CAP', 'Respiratory', 'viruses', 'make', 'a', 'substantial', 'contribution', 'to', 'the', 'aetiology', 'of', 'CAP', 'in', 'adult', 'patients', 'in', 'Europe', 'one', 'or', 'more', 'respiratory', 'viruses', 'are', 'detected', 'in', 'about', 'one', 'quarter', 'of', 'all', 'cases', '']"
155191,Current Status of Point-of-Care Diagnostic Devices in the Indian Healthcare System with an Update on COVID-19 Pandemic,2020-06-09,Sensors International,https://api.elsevier.com/content/article/pii/S2666351120300152; https://doi.org/10.1016/j.sintl.2020.100015; https://www.sciencedirect.com/science/article/pii/S2666351120300152?v=s5,"Abstract Point-of-care (POC) diagnostic device is an instrument that is used to acquire particular clinical information of patients in clinical as well as resource-limited settings. The conventional clinical diagnostic procedure requires high-end and costly instruments, an expert technician for operation and result interpretation, longer time, etc. that ultimately makes it exhausting and expensive. Although there are a lot of improvements in the medical facilities in the Indian healthcare system, the use of POC diagnostic devices is still in its nascent phase. This review illustrates the status of POC diagnostic devices currently used in clinical setups along with constraints in their use. The devices and technologies that are in the research and development phase across the country that has tremendous potential to elevate the clinical diagnostics scenario along with the diagnosis of ongoing COVID-19 pandemic are emphasized. The implications of using POC diagnostic devices and the future objectives for technological advancements that may eventually uplift the status of healthcare and related sectors in India are also discussed here.",10.1016/j.sintl.2020.100015,vrrybxd5,"['Abstract', 'Point', 'of', 'care', 'POC', 'diagnostic', 'device', 'is', 'an', 'instrument', 'that', 'is', 'used', 'to', 'acquire', 'particular', 'clinical', 'information', 'of', 'patients', 'in', 'clinical', 'as', 'well', 'as', 'resource', 'limited', 'settings', 'The', 'conventional', 'clinical', 'diagnostic', 'procedure', 'requires', 'high', 'end', 'and', 'costly', 'instruments', 'an', 'expert', 'technician', 'for', 'operation', 'and', 'result', 'interpretation', 'longer', 'time', 'etc', 'that', 'ultimately', 'makes', 'it', 'exhausting', 'and', 'expensive', 'Although', 'there', 'are', 'a', 'lot', 'of', 'improvements', 'in', 'the', 'medical', 'facilities', 'in', 'the', 'Indian', 'healthcare', 'system', 'the', 'use', 'of', 'POC', 'diagnostic', 'devices', 'is', 'still', 'in', 'its', 'nascent', 'phase', 'This', 'review', 'illustrates', 'the', 'status', 'of', 'POC', 'diagnostic', 'devices', 'currently', 'used', 'in', 'clinical', 'setups', 'along', 'with', 'constraints', 'in', 'their', 'use', 'The', 'devices', 'and', 'technologies', 'that', 'are', 'in', 'the', 'research', 'and', 'development', 'phase', 'across', 'the', 'country', 'that', 'has', 'tremendous', 'potential', 'to', 'elevate', 'the', 'clinical', 'diagnostics', 'scenario', 'along', 'with', 'the', 'diagnosis', 'of', 'ongoing', 'COVID', '19', 'pandemic', 'are', 'emphasized', 'The', 'implications', 'of', 'using', 'POC', 'diagnostic', 'devices', 'and', 'the', 'future', 'objectives', 'for', 'technological', 'advancements', 'that', 'may', 'eventually', 'uplift', 'the', 'status', 'of', 'healthcare', 'and', 'related', 'sectors', 'in', 'India', 'are', 'also', 'discussed', 'here', '']"
155611,Advances in Diagnostic Approaches for Viral Etiologies of Diarrhea: From the Lab to the Field,2019-09-13,Front Microbiol,https://www.ncbi.nlm.nih.gov/pubmed/31608017/; https://doi.org/10.3389/fmicb.2019.01957,"The applications of correct diagnostic approaches play a decisive role in timely containment of infectious diseases spread and mitigation of public health risks. Nevertheless, there is a need to update the diagnostics regularly to capture the new, emergent, and highly divergent viruses. Acute gastroenteritis of viral origin has been identified as a significant cause of mortality across the globe, with the more serious consequences seen at the extremes of age groups (young and elderly) and immune-compromised individuals. Therefore, significant advancements and efforts have been put in the development of enteric virus diagnostics to meet the WHO ASSURED criteria as a benchmark over the years. The Enzyme-Linked Immunosorbent (ELISA) and Polymerase Chain Reaction (PCR) are the basic assays that provided the platform for development of several efficient diagnostics such as real-time RT-PCR, loop-mediated isothermal amplification (LAMP), polymerase spiral reaction (PSR), biosensors, microarrays and next generation sequencing. Herein, we describe and discuss the applications of these advanced technologies in context to enteric virus detection by delineating their features, advantages and limitations.",10.3389/fmicb.2019.01957,h6zdbs28,"['The', 'applications', 'of', 'correct', 'diagnostic', 'approaches', 'play', 'a', 'decisive', 'role', 'in', 'timely', 'containment', 'of', 'infectious', 'diseases', 'spread', 'and', 'mitigation', 'of', 'public', 'health', 'risks', 'Nevertheless', 'there', 'is', 'a', 'need', 'to', 'update', 'the', 'diagnostics', 'regularly', 'to', 'capture', 'the', 'new', 'emergent', 'and', 'highly', 'divergent', 'viruses', 'Acute', 'gastroenteritis', 'of', 'viral', 'origin', 'has', 'been', 'identified', 'as', 'a', 'significant', 'cause', 'of', 'mortality', 'across', 'the', 'globe', 'with', 'the', 'more', 'serious', 'consequences', 'seen', 'at', 'the', 'extremes', 'of', 'age', 'groups', 'young', 'and', 'elderly', 'and', 'immune', 'compromised', 'individuals', 'Therefore', 'significant', 'advancements', 'and', 'efforts', 'have', 'been', 'put', 'in', 'the', 'development', 'of', 'enteric', 'virus', 'diagnostics', 'to', 'meet', 'the', 'WHO', 'ASSURED', 'criteria', 'as', 'a', 'benchmark', 'over', 'the', 'years', 'The', 'Enzyme', 'Linked', 'Immunosorbent', 'ELISA', 'and', 'Polymerase', 'Chain', 'Reaction', 'PCR', 'are', 'the', 'basic', 'assays', 'that', 'provided', 'the', 'platform', 'for', 'development', 'of', 'several', 'efficient', 'diagnostics', 'such', 'as', 'real', 'time', 'RT', 'PCR', 'loop', 'mediated', 'isothermal', 'amplification', 'LAMP', 'polymerase', 'spiral', 'reaction', 'PSR', 'biosensors', 'microarrays', 'and', 'next', 'generation', 'sequencing', 'Herein', 'we', 'describe', 'and', 'discuss', 'the', 'applications', 'of', 'these', 'advanced', 'technologies', 'in', 'context', 'to', 'enteric', 'virus', 'detection', 'by', 'delineating', 'their', 'features', 'advantages', 'and', 'limitations', '']"
155678,Inorganic Complexes and Metal-Based Nanomaterials for Infectious Disease Diagnostics,2018-12-04,Chem Rev,https://www.ncbi.nlm.nih.gov/pubmed/30511833/; https://doi.org/10.1021/acs.chemrev.8b00136,"[Image: see text] Infectious diseases claim millions of lives each year. Robust and accurate diagnostics are essential tools for identifying those who are at risk and in need of treatment in low-resource settings. Inorganic complexes and metal-based nanomaterials continue to drive the development of diagnostic platforms and strategies that enable infectious disease detection in low-resource settings. In this review, we highlight works from the past 20 years in which inorganic chemistry and nanotechnology were implemented in each of the core components that make up a diagnostic test. First, we present how inorganic biomarkers and their properties are leveraged for infectious disease detection. In the following section, we detail metal-based technologies that have been employed for sample preparation and biomarker isolation from sample matrices. We then describe how inorganic- and nanomaterial-based probes have been utilized in point-of-care diagnostics for signal generation. The following section discusses instrumentation for signal readout in resource-limited settings. Next, we highlight the detection of nucleic acids at the point of care as an emerging application of inorganic chemistry. Lastly, we consider the challenges that remain for translation of the aforementioned diagnostic platforms to low-resource settings.",10.1021/acs.chemrev.8b00136,dc90ecfe,"['', 'Image', 'see', 'text', 'Infectious', 'diseases', 'claim', 'millions', 'of', 'lives', 'each', 'year', 'Robust', 'and', 'accurate', 'diagnostics', 'are', 'essential', 'tools', 'for', 'identifying', 'those', 'who', 'are', 'at', 'risk', 'and', 'in', 'need', 'of', 'treatment', 'in', 'low', 'resource', 'settings', 'Inorganic', 'complexes', 'and', 'metal', 'based', 'nanomaterials', 'continue', 'to', 'drive', 'the', 'development', 'of', 'diagnostic', 'platforms', 'and', 'strategies', 'that', 'enable', 'infectious', 'disease', 'detection', 'in', 'low', 'resource', 'settings', 'In', 'this', 'review', 'we', 'highlight', 'works', 'from', 'the', 'past', '20', 'years', 'in', 'which', 'inorganic', 'chemistry', 'and', 'nanotechnology', 'were', 'implemented', 'in', 'each', 'of', 'the', 'core', 'components', 'that', 'make', 'up', 'a', 'diagnostic', 'test', 'First', 'we', 'present', 'how', 'inorganic', 'biomarkers', 'and', 'their', 'properties', 'are', 'leveraged', 'for', 'infectious', 'disease', 'detection', 'In', 'the', 'following', 'section', 'we', 'detail', 'metal', 'based', 'technologies', 'that', 'have', 'been', 'employed', 'for', 'sample', 'preparation', 'and', 'biomarker', 'isolation', 'from', 'sample', 'matrices', 'We', 'then', 'describe', 'how', 'inorganic', 'and', 'nanomaterial', 'based', 'probes', 'have', 'been', 'utilized', 'in', 'point', 'of', 'care', 'diagnostics', 'for', 'signal', 'generation', 'The', 'following', 'section', 'discusses', 'instrumentation', 'for', 'signal', 'readout', 'in', 'resource', 'limited', 'settings', 'Next', 'we', 'highlight', 'the', 'detection', 'of', 'nucleic', 'acids', 'at', 'the', 'point', 'of', 'care', 'as', 'an', 'emerging', 'application', 'of', 'inorganic', 'chemistry', 'Lastly', 'we', 'consider', 'the', 'challenges', 'that', 'remain', 'for', 'translation', 'of', 'the', 'aforementioned', 'diagnostic', 'platforms', 'to', 'low', 'resource', 'settings', '']"
155834,Coronavirus disease pandemic (Covid-19): Challenges and a global perspective,2020,Pathogens,https://www.ncbi.nlm.nih.gov/pubmed/32605194/; https://doi.org/10.3390/pathogens9070519,"The technology-driven world of the 21stcentury is currently confronted with a major threat to humankind, represented by the coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome, coronavirus-2 (SARS-CoV-2). As of now, COVID-19 has affected more than 6 million confirmed cases and took 0.39 million human lives. SARS-CoV-2 spreads much faster than its two ancestors, SARS-CoV and Middle East respiratory syndrome-CoV (MERS-CoV), but has low fatality rates. Our analyses speculate that the efficient replication and transmission of SARS-CoV-2 might be due to the high-density basic amino acid residues, preferably positioned in close proximity at both the furin-like cleavage sites (S1/S2 and S2’) within the spike protein. Given the high genomic similarities of SARS-CoV-2 to bat SARS-like CoVs, it is likely that bats serve as a reservoir host for its progenitor. Women and children are less susceptible to SARS-CoV-2 infection, while the elderly and people with comorbidities are more prone to serious clinical outcomes, which may be associated with acute respiratory distress syndrome (ARDS) and cytokine storm. The cohesive approach amongst researchers across the globe has delivered high-end viral diagnostics. However, home-based point-of-care diagnostics are still under development, which may prove transformative in current COVID-19 pandemic containment. Similarly, vaccines and therapeutics against COVID-19 are currently in the pipeline for clinical trials. In this review, we discuss the noteworthy advancements, focusing on the etiological viral agent, comparative genomic analysis, population susceptibility, disease epidemiology and diagnosis, animal reservoirs, laboratory animal models, disease transmission, therapeutics, vaccine challenges, and disease mitigation measures.",10.3390/pathogens9070519,bsz35lrd,"['The', 'technology', 'driven', 'world', 'of', 'the', '21stcentury', 'is', 'currently', 'confronted', 'with', 'a', 'major', 'threat', 'to', 'humankind', 'represented', 'by', 'the', 'coronavirus', 'disease', 'COVID', '19', 'pandemic', 'caused', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'As', 'of', 'now', 'COVID', '19', 'has', 'affected', 'more', 'than', '6', 'million', 'confirmed', 'cases', 'and', 'took', '0', '39', 'million', 'human', 'lives', 'SARS', 'CoV', '2', 'spreads', 'much', 'faster', 'than', 'its', 'two', 'ancestors', 'SARS', 'CoV', 'and', 'Middle', 'East', 'respiratory', 'syndrome', 'CoV', 'MERS', 'CoV', 'but', 'has', 'low', 'fatality', 'rates', 'Our', 'analyses', 'speculate', 'that', 'the', 'efficient', 'replication', 'and', 'transmission', 'of', 'SARS', 'CoV', '2', 'might', 'be', 'due', 'to', 'the', 'high', 'density', 'basic', 'amino', 'acid', 'residues', 'preferably', 'positioned', 'in', 'close', 'proximity', 'at', 'both', 'the', 'furin', 'like', 'cleavage', 'sites', 'S1', 'S2', 'and', 'S2', 'within', 'the', 'spike', 'protein', 'Given', 'the', 'high', 'genomic', 'similarities', 'of', 'SARS', 'CoV', '2', 'to', 'bat', 'SARS', 'like', 'CoVs', 'it', 'is', 'likely', 'that', 'bats', 'serve', 'as', 'a', 'reservoir', 'host', 'for', 'its', 'progenitor', 'Women', 'and', 'children', 'are', 'less', 'susceptible', 'to', 'SARS', 'CoV', '2', 'infection', 'while', 'the', 'elderly', 'and', 'people', 'with', 'comorbidities', 'are', 'more', 'prone', 'to', 'serious', 'clinical', 'outcomes', 'which', 'may', 'be', 'associated', 'with', 'acute', 'respiratory', 'distress', 'syndrome', 'ARDS', 'and', 'cytokine', 'storm', 'The', 'cohesive', 'approach', 'amongst', 'researchers', 'across', 'the', 'globe', 'has', 'delivered', 'high', 'end', 'viral', 'diagnostics', 'However', 'home', 'based', 'point', 'of', 'care', 'diagnostics', 'are', 'still', 'under', 'development', 'which', 'may', 'prove', 'transformative', 'in', 'current', 'COVID', '19', 'pandemic', 'containment', 'Similarly', 'vaccines', 'and', 'therapeutics', 'against', 'COVID', '19', 'are', 'currently', 'in', 'the', 'pipeline', 'for', 'clinical', 'trials', 'In', 'this', 'review', 'we', 'discuss', 'the', 'noteworthy', 'advancements', 'focusing', 'on', 'the', 'etiological', 'viral', 'agent', 'comparative', 'genomic', 'analysis', 'population', 'susceptibility', 'disease', 'epidemiology', 'and', 'diagnosis', 'animal', 'reservoirs', 'laboratory', 'animal', 'models', 'disease', 'transmission', 'therapeutics', 'vaccine', 'challenges', 'and', 'disease', 'mitigation', 'measures', '']"
156228,Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation,2020-03-13,Science,https://www.ncbi.nlm.nih.gov/pubmed/32075877/; https://doi.org/10.1126/science.abb2507,"The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure development, we determined a 3.5-angstrom-resolution cryo–electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also provide biophysical and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S. Additionally, we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs. The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis.",10.1126/science.abb2507,vp96izcs,"['The', 'outbreak', 'of', 'a', 'novel', 'coronavirus', '2019', 'nCoV', 'represents', 'a', 'pandemic', 'threat', 'that', 'has', 'been', 'declared', 'a', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'The', 'CoV', 'spike', 'S', 'glycoprotein', 'is', 'a', 'key', 'target', 'for', 'vaccines', 'therapeutic', 'antibodies', 'and', 'diagnostics', 'To', 'facilitate', 'medical', 'countermeasure', 'development', 'we', 'determined', 'a', '3', '5', 'angstrom', 'resolution', 'cryo', 'electron', 'microscopy', 'structure', 'of', 'the', '2019', 'nCoV', 'S', 'trimer', 'in', 'the', 'prefusion', 'conformation', 'The', 'predominant', 'state', 'of', 'the', 'trimer', 'has', 'one', 'of', 'the', 'three', 'receptor', 'binding', 'domains', 'RBDs', 'rotated', 'up', 'in', 'a', 'receptor', 'accessible', 'conformation', 'We', 'also', 'provide', 'biophysical', 'and', 'structural', 'evidence', 'that', 'the', '2019', 'nCoV', 'S', 'protein', 'binds', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'with', 'higher', 'affinity', 'than', 'does', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'S', 'Additionally', 'we', 'tested', 'several', 'published', 'SARS', 'CoV', 'RBD', 'specific', 'monoclonal', 'antibodies', 'and', 'found', 'that', 'they', 'do', 'not', 'have', 'appreciable', 'binding', 'to', '2019', 'nCoV', 'S', 'suggesting', 'that', 'antibody', 'cross', 'reactivity', 'may', 'be', 'limited', 'between', 'the', 'two', 'RBDs', 'The', 'structure', 'of', '2019', 'nCoV', 'S', 'should', 'enable', 'the', 'rapid', 'development', 'and', 'evaluation', 'of', 'medical', 'countermeasures', 'to', 'address', 'the', 'ongoing', 'public', 'health', 'crisis', '']"
157745,Optimization and clinical validation of a pathogen detection microarray,2007-05-28,Genome Biol,https://www.ncbi.nlm.nih.gov/pubmed/17531104/,"DNA microarrays used as 'genomic sensors' have great potential in clinical diagnostics. Biases inherent in random PCR-amplification, cross-hybridization effects, and inadequate microarray analysis, however, limit detection sensitivity and specificity. Here, we have studied the relationships between viral amplification efficiency, hybridization signal, and target-probe annealing specificity using a customized microarray platform. Novel features of this platform include the development of a robust algorithm that accurately predicts PCR bias during DNA amplification and can be used to improve PCR primer design, as well as a powerful statistical concept for inferring pathogen identity from probe recognition signatures. Compared to real-time PCR, the microarray platform identified pathogens with 94% accuracy (76% sensitivity and 100% specificity) in a panel of 36 patient specimens. Our findings show that microarrays can be used for the robust and accurate diagnosis of pathogens, and further substantiate the use of microarray technology in clinical diagnostics.",10.1186/gb-2007-8-5-r93,ueyaw8pd,"['DNA', 'microarrays', 'used', 'as', 'genomic', 'sensors', 'have', 'great', 'potential', 'in', 'clinical', 'diagnostics', 'Biases', 'inherent', 'in', 'random', 'PCR', 'amplification', 'cross', 'hybridization', 'effects', 'and', 'inadequate', 'microarray', 'analysis', 'however', 'limit', 'detection', 'sensitivity', 'and', 'specificity', 'Here', 'we', 'have', 'studied', 'the', 'relationships', 'between', 'viral', 'amplification', 'efficiency', 'hybridization', 'signal', 'and', 'target', 'probe', 'annealing', 'specificity', 'using', 'a', 'customized', 'microarray', 'platform', 'Novel', 'features', 'of', 'this', 'platform', 'include', 'the', 'development', 'of', 'a', 'robust', 'algorithm', 'that', 'accurately', 'predicts', 'PCR', 'bias', 'during', 'DNA', 'amplification', 'and', 'can', 'be', 'used', 'to', 'improve', 'PCR', 'primer', 'design', 'as', 'well', 'as', 'a', 'powerful', 'statistical', 'concept', 'for', 'inferring', 'pathogen', 'identity', 'from', 'probe', 'recognition', 'signatures', 'Compared', 'to', 'real', 'time', 'PCR', 'the', 'microarray', 'platform', 'identified', 'pathogens', 'with', '94', 'accuracy', '76', 'sensitivity', 'and', '100', 'specificity', 'in', 'a', 'panel', 'of', '36', 'patient', 'specimens', 'Our', 'findings', 'show', 'that', 'microarrays', 'can', 'be', 'used', 'for', 'the', 'robust', 'and', 'accurate', 'diagnosis', 'of', 'pathogens', 'and', 'further', 'substantiate', 'the', 'use', 'of', 'microarray', 'technology', 'in', 'clinical', 'diagnostics', '']"
157863,"International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19–20 July 2007()",2009-02-05,Vaccine,https://doi.org/10.1016/j.vaccine.2008.11.072; https://www.ncbi.nlm.nih.gov/pubmed/19071179/; https://api.elsevier.com/content/article/pii/S0264410X08015946; https://www.sciencedirect.com/science/article/pii/S0264410X08015946,"An international meeting on Bordetella pertussis assay standardization and harmonization was held at the Centers for Disease Control and Prevention (CDC), Atlanta, GA, 19–20 July 2007. The goal of the meeting was to harmonize the immunoassays used for pertussis diagnostics and vaccine evaluation, as agreed upon by academic and government researchers, regulatory authorities, vaccine manufacturers, and the World Health Organization (WHO). The primary objectives were (1) to provide epidemiologic, laboratory, and statistical background for support of global harmonization; (2) to overview the current status of global epidemiology, pathogenesis and immunology of pertussis; (3) to develop a consensus opinion on existing gaps in understanding standardization of pertussis assays used for serodiagnosis and vaccine evaluation; and (4) to search for a multicenter process for addressing these priority gaps. Presentations and discussions by content experts addressed these objectives. A prioritized list of action items to improve standardization and harmonization of pertussis assays was identified during a group discussion at the end of the meeting. The major items included: (1) to identify a group that will organize, prepare, maintain, and distribute proficiency panels and key reagents such as reference and control sera; (2) to encourage the development and identification of one or more reference laboratories that can serve as an anchor and resource for other laboratories; (3) to define a performance-based assay method that can serve as a reference point for evaluating laboratory differences; (4) to develop guidance on quality of other reagents, e.g., pertussis toxin and other antigens, and methods to demonstrate their suitability; (5) to establish an international working group to harmonize the criteria to evaluate the results obtained on reference and proficiency panel sera; (6) to create an inventory to determine the amount of appropriate and well-characterized sera that are available globally to be used as bridging reagents for vaccine licensure; and (7) to seek specific guidance from regulatory authorities regarding the expectations and requirements for the licensure of new multicomponent pertussis vaccines.",10.1016/j.vaccine.2008.11.072,8ces57rn,"['An', 'international', 'meeting', 'on', 'Bordetella', 'pertussis', 'assay', 'standardization', 'and', 'harmonization', 'was', 'held', 'at', 'the', 'Centers', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'Atlanta', 'GA', '19', '20', 'July', '2007', 'The', 'goal', 'of', 'the', 'meeting', 'was', 'to', 'harmonize', 'the', 'immunoassays', 'used', 'for', 'pertussis', 'diagnostics', 'and', 'vaccine', 'evaluation', 'as', 'agreed', 'upon', 'by', 'academic', 'and', 'government', 'researchers', 'regulatory', 'authorities', 'vaccine', 'manufacturers', 'and', 'the', 'World', 'Health', 'Organization', 'WHO', 'The', 'primary', 'objectives', 'were', '1', 'to', 'provide', 'epidemiologic', 'laboratory', 'and', 'statistical', 'background', 'for', 'support', 'of', 'global', 'harmonization', '2', 'to', 'overview', 'the', 'current', 'status', 'of', 'global', 'epidemiology', 'pathogenesis', 'and', 'immunology', 'of', 'pertussis', '3', 'to', 'develop', 'a', 'consensus', 'opinion', 'on', 'existing', 'gaps', 'in', 'understanding', 'standardization', 'of', 'pertussis', 'assays', 'used', 'for', 'serodiagnosis', 'and', 'vaccine', 'evaluation', 'and', '4', 'to', 'search', 'for', 'a', 'multicenter', 'process', 'for', 'addressing', 'these', 'priority', 'gaps', 'Presentations', 'and', 'discussions', 'by', 'content', 'experts', 'addressed', 'these', 'objectives', 'A', 'prioritized', 'list', 'of', 'action', 'items', 'to', 'improve', 'standardization', 'and', 'harmonization', 'of', 'pertussis', 'assays', 'was', 'identified', 'during', 'a', 'group', 'discussion', 'at', 'the', 'end', 'of', 'the', 'meeting', 'The', 'major', 'items', 'included', '1', 'to', 'identify', 'a', 'group', 'that', 'will', 'organize', 'prepare', 'maintain', 'and', 'distribute', 'proficiency', 'panels', 'and', 'key', 'reagents', 'such', 'as', 'reference', 'and', 'control', 'sera', '2', 'to', 'encourage', 'the', 'development', 'and', 'identification', 'of', 'one', 'or', 'more', 'reference', 'laboratories', 'that', 'can', 'serve', 'as', 'an', 'anchor', 'and', 'resource', 'for', 'other', 'laboratories', '3', 'to', 'define', 'a', 'performance', 'based', 'assay', 'method', 'that', 'can', 'serve', 'as', 'a', 'reference', 'point', 'for', 'evaluating', 'laboratory', 'differences', '4', 'to', 'develop', 'guidance', 'on', 'quality', 'of', 'other', 'reagents', 'e', 'g', 'pertussis', 'toxin', 'and', 'other', 'antigens', 'and', 'methods', 'to', 'demonstrate', 'their', 'suitability', '5', 'to', 'establish', 'an', 'international', 'working', 'group', 'to', 'harmonize', 'the', 'criteria', 'to', 'evaluate', 'the', 'results', 'obtained', 'on', 'reference', 'and', 'proficiency', 'panel', 'sera', '6', 'to', 'create', 'an', 'inventory', 'to', 'determine', 'the', 'amount', 'of', 'appropriate', 'and', 'well', 'characterized', 'sera', 'that', 'are', 'available', 'globally', 'to', 'be', 'used', 'as', 'bridging', 'reagents', 'for', 'vaccine', 'licensure', 'and', '7', 'to', 'seek', 'specific', 'guidance', 'from', 'regulatory', 'authorities', 'regarding', 'the', 'expectations', 'and', 'requirements', 'for', 'the', 'licensure', 'of', 'new', 'multicomponent', 'pertussis', 'vaccines', '']"
157958,"Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects",2014-11-30,The Lancet Infectious Diseases,https://www.sciencedirect.com/science/article/pii/S1473309914708278; https://www.ncbi.nlm.nih.gov/pubmed/25189349/; https://api.elsevier.com/content/article/pii/S1473309914708278; https://doi.org/10.1016/s1473-3099(14)70827-8,"Summary Respiratory tract infections rank second as causes of adult and paediatric morbidity and mortality worldwide. Respiratory tract infections are caused by many different bacteria (including mycobacteria) and viruses, and rapid detection of pathogens in individual cases is crucial in achieving the best clinical management, public health surveillance, and control outcomes. Further challenges in improving management outcomes for respiratory tract infections exist: rapid identification of drug resistant pathogens; more widespread surveillance of infections, locally and internationally; and global responses to infections with pandemic potential. Developments in genome amplification have led to the discovery of several new respiratory pathogens, and sensitive PCR methods for the diagnostic work-up of these are available. Advances in technology have allowed for development of single and multiplexed PCR techniques that provide rapid detection of respiratory viruses in clinical specimens. Microarray-based multiplexing and nucleic-acid-based deep-sequencing methods allow simultaneous detection of pathogen nucleic acid and multiple antibiotic resistance, providing further hope in revolutionising rapid point of care respiratory tract infection diagnostics.",10.1016/s1473-3099(14)70827-8,8ewqubwy,"['Summary', 'Respiratory', 'tract', 'infections', 'rank', 'second', 'as', 'causes', 'of', 'adult', 'and', 'paediatric', 'morbidity', 'and', 'mortality', 'worldwide', 'Respiratory', 'tract', 'infections', 'are', 'caused', 'by', 'many', 'different', 'bacteria', 'including', 'mycobacteria', 'and', 'viruses', 'and', 'rapid', 'detection', 'of', 'pathogens', 'in', 'individual', 'cases', 'is', 'crucial', 'in', 'achieving', 'the', 'best', 'clinical', 'management', 'public', 'health', 'surveillance', 'and', 'control', 'outcomes', 'Further', 'challenges', 'in', 'improving', 'management', 'outcomes', 'for', 'respiratory', 'tract', 'infections', 'exist', 'rapid', 'identification', 'of', 'drug', 'resistant', 'pathogens', 'more', 'widespread', 'surveillance', 'of', 'infections', 'locally', 'and', 'internationally', 'and', 'global', 'responses', 'to', 'infections', 'with', 'pandemic', 'potential', 'Developments', 'in', 'genome', 'amplification', 'have', 'led', 'to', 'the', 'discovery', 'of', 'several', 'new', 'respiratory', 'pathogens', 'and', 'sensitive', 'PCR', 'methods', 'for', 'the', 'diagnostic', 'work', 'up', 'of', 'these', 'are', 'available', 'Advances', 'in', 'technology', 'have', 'allowed', 'for', 'development', 'of', 'single', 'and', 'multiplexed', 'PCR', 'techniques', 'that', 'provide', 'rapid', 'detection', 'of', 'respiratory', 'viruses', 'in', 'clinical', 'specimens', 'Microarray', 'based', 'multiplexing', 'and', 'nucleic', 'acid', 'based', 'deep', 'sequencing', 'methods', 'allow', 'simultaneous', 'detection', 'of', 'pathogen', 'nucleic', 'acid', 'and', 'multiple', 'antibiotic', 'resistance', 'providing', 'further', 'hope', 'in', 'revolutionising', 'rapid', 'point', 'of', 'care', 'respiratory', 'tract', 'infection', 'diagnostics', '']"
158588,Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?,2020-04-28,Cell Immunol,https://doi.org/10.1016/j.cellimm.2020.104114; https://www.ncbi.nlm.nih.gov/pubmed/32361409/; https://www.sciencedirect.com/science/article/pii/S0008874920302501?v=s5; https://api.elsevier.com/content/article/pii/S0008874920302501,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a severe acute respiratory syndrome that is called COVID-19. Clinical manifestations of COVID-19 include diarrhea, pneumonia, lymphopenia, exhausted lymphocytes, and pro-inflammatory cytokine production. Immunology is part of the process of clinical evolution, but there are some questions around immunity-based protection: (1) why some infected people have only mild symptoms of the disease or are asymptomatic; (2) why delayed and weak antibody responses are associated with severe outcomes; and (3) why positivity in molecular tests does not represent protective antibody IgG. Perhaps T cell responses may be the key to solving those questions. SARS-CoV-2-specific memory T cells persist in peripheral blood and may be capable of providing effective information about protective immunity. The T cells studies can be helpful in elucidating the pathways for development of vaccines, therapies, and diagnostics for COVID-19 and for filling these immunology knowledge gaps.",10.1016/j.cellimm.2020.104114,rsz7ch2a,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'induces', 'a', 'severe', 'acute', 'respiratory', 'syndrome', 'that', 'is', 'called', 'COVID', '19', 'Clinical', 'manifestations', 'of', 'COVID', '19', 'include', 'diarrhea', 'pneumonia', 'lymphopenia', 'exhausted', 'lymphocytes', 'and', 'pro', 'inflammatory', 'cytokine', 'production', 'Immunology', 'is', 'part', 'of', 'the', 'process', 'of', 'clinical', 'evolution', 'but', 'there', 'are', 'some', 'questions', 'around', 'immunity', 'based', 'protection', '1', 'why', 'some', 'infected', 'people', 'have', 'only', 'mild', 'symptoms', 'of', 'the', 'disease', 'or', 'are', 'asymptomatic', '2', 'why', 'delayed', 'and', 'weak', 'antibody', 'responses', 'are', 'associated', 'with', 'severe', 'outcomes', 'and', '3', 'why', 'positivity', 'in', 'molecular', 'tests', 'does', 'not', 'represent', 'protective', 'antibody', 'IgG', 'Perhaps', 'T', 'cell', 'responses', 'may', 'be', 'the', 'key', 'to', 'solving', 'those', 'questions', 'SARS', 'CoV', '2', 'specific', 'memory', 'T', 'cells', 'persist', 'in', 'peripheral', 'blood', 'and', 'may', 'be', 'capable', 'of', 'providing', 'effective', 'information', 'about', 'protective', 'immunity', 'The', 'T', 'cells', 'studies', 'can', 'be', 'helpful', 'in', 'elucidating', 'the', 'pathways', 'for', 'development', 'of', 'vaccines', 'therapies', 'and', 'diagnostics', 'for', 'COVID', '19', 'and', 'for', 'filling', 'these', 'immunology', 'knowledge', 'gaps', '']"
158643,"Better Tests, Better Care: Improved Diagnostics for Infectious Diseases",2013-11-06,Clinical Infectious Diseases,https://www.ncbi.nlm.nih.gov/pubmed/24200831/; https://academic.oup.com/cid/article-pdf/57/suppl_3/S139/20911343/cit578.pdf; https://doi.org/10.1093/cid/cit578,"In this IDSA policy paper, we review the current diagnostic landscape, including unmet needs and emerging technologies, and assess the challenges to the development and clinical integration of improved tests. To fulfill the promise of emerging diagnostics, IDSA presents recommendations that address a host of identified barriers. Achieving these goals will require the engagement and coordination of a number of stakeholders, including Congress, funding and regulatory bodies, public health agencies, the diagnostics industry, healthcare systems, professional societies, and individual clinicians.",10.1093/cid/cit578,6x3l453f,"['In', 'this', 'IDSA', 'policy', 'paper', 'we', 'review', 'the', 'current', 'diagnostic', 'landscape', 'including', 'unmet', 'needs', 'and', 'emerging', 'technologies', 'and', 'assess', 'the', 'challenges', 'to', 'the', 'development', 'and', 'clinical', 'integration', 'of', 'improved', 'tests', 'To', 'fulfill', 'the', 'promise', 'of', 'emerging', 'diagnostics', 'IDSA', 'presents', 'recommendations', 'that', 'address', 'a', 'host', 'of', 'identified', 'barriers', 'Achieving', 'these', 'goals', 'will', 'require', 'the', 'engagement', 'and', 'coordination', 'of', 'a', 'number', 'of', 'stakeholders', 'including', 'Congress', 'funding', 'and', 'regulatory', 'bodies', 'public', 'health', 'agencies', 'the', 'diagnostics', 'industry', 'healthcare', 'systems', 'professional', 'societies', 'and', 'individual', 'clinicians', '']"
158790,Mutational patterns correlate with genome organization in SARS and other coronaviruses,2004-03-31,Trends in Genetics,https://www.ncbi.nlm.nih.gov/pubmed/15049309/; https://www.sciencedirect.com/science/article/pii/S0168952504000241; https://api.elsevier.com/content/article/pii/S0168952504000241,"Abstract Focused efforts by several international laboratories have resulted in the sequencing of the genome of the causative agent of severe acute respiratory syndrome (SARS), novel coronavirus SARS-CoV, in record time. Using cumulative skew diagrams, I found that mutational patterns in the SARS-CoV genome were strikingly different from other coronaviruses in terms of mutation rates, although they were in general agreement with the model of the coronavirus lifecycle. These findings might be relevant for the development of sequence-based diagnostics and the design of agents to treat SARS.",10.1016/j.tig.2004.01.009,g68g6xxu,"['Abstract', 'Focused', 'efforts', 'by', 'several', 'international', 'laboratories', 'have', 'resulted', 'in', 'the', 'sequencing', 'of', 'the', 'genome', 'of', 'the', 'causative', 'agent', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'novel', 'coronavirus', 'SARS', 'CoV', 'in', 'record', 'time', 'Using', 'cumulative', 'skew', 'diagrams', 'I', 'found', 'that', 'mutational', 'patterns', 'in', 'the', 'SARS', 'CoV', 'genome', 'were', 'strikingly', 'different', 'from', 'other', 'coronaviruses', 'in', 'terms', 'of', 'mutation', 'rates', 'although', 'they', 'were', 'in', 'general', 'agreement', 'with', 'the', 'model', 'of', 'the', 'coronavirus', 'lifecycle', 'These', 'findings', 'might', 'be', 'relevant', 'for', 'the', 'development', 'of', 'sequence', 'based', 'diagnostics', 'and', 'the', 'design', 'of', 'agents', 'to', 'treat', 'SARS', '']"
159346,Scalable Transcriptional Analysis Routine—Multiplexed Quantitative Real-Time Polymerase Chain Reaction Platform for Gene Expression Analysis and Molecular Diagnostics,2005-10-31,The Journal of molecular diagnostics : JMD,https://www.ncbi.nlm.nih.gov/pubmed/16237214/,"We report the development of a new technology for simultaneous quantitative detection of multiple targets in a single sample. Scalable transcriptional analysis routine (STAR) represents a novel integration of reverse transcriptase-polymerase chain reaction and capillary electrophoresis that allows detection of dozens of gene transcripts in a multiplexed format using amplicon size as an identifier for each target. STAR demonstrated similar or better sensitivity and precision compared to two commonly used methods, SYBR Green-based and TaqMan probe-based real-time reverse transcriptase-polymerase chain reaction. STAR can be used as a flexible platform for building a variety of applications to monitor gene expression, from single gene assays to assays analyzing the expression level of multiple genes. Using severe acute respiratory syndrome (SARS) corona virus as a model system, STAR technology detected single copies of the viral genome in a two-gene multiplex. Blinded studies using RNA extracted from various tissues of a SARS-infected individual showed that STAR correctly identified all samples containing SARS virus and yielded negative results for non-SARS control samples. Using alternate priming strategies, STAR technology can be adapted to transcriptional profiling studies without requiring a priori sequence information. Thus, STAR technology offers a flexible platform for development of highly multiplexed assays in gene expression analysis and molecular diagnostics.",,qhftb6d7,"['We', 'report', 'the', 'development', 'of', 'a', 'new', 'technology', 'for', 'simultaneous', 'quantitative', 'detection', 'of', 'multiple', 'targets', 'in', 'a', 'single', 'sample', 'Scalable', 'transcriptional', 'analysis', 'routine', 'STAR', 'represents', 'a', 'novel', 'integration', 'of', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'and', 'capillary', 'electrophoresis', 'that', 'allows', 'detection', 'of', 'dozens', 'of', 'gene', 'transcripts', 'in', 'a', 'multiplexed', 'format', 'using', 'amplicon', 'size', 'as', 'an', 'identifier', 'for', 'each', 'target', 'STAR', 'demonstrated', 'similar', 'or', 'better', 'sensitivity', 'and', 'precision', 'compared', 'to', 'two', 'commonly', 'used', 'methods', 'SYBR', 'Green', 'based', 'and', 'TaqMan', 'probe', 'based', 'real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'STAR', 'can', 'be', 'used', 'as', 'a', 'flexible', 'platform', 'for', 'building', 'a', 'variety', 'of', 'applications', 'to', 'monitor', 'gene', 'expression', 'from', 'single', 'gene', 'assays', 'to', 'assays', 'analyzing', 'the', 'expression', 'level', 'of', 'multiple', 'genes', 'Using', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'corona', 'virus', 'as', 'a', 'model', 'system', 'STAR', 'technology', 'detected', 'single', 'copies', 'of', 'the', 'viral', 'genome', 'in', 'a', 'two', 'gene', 'multiplex', 'Blinded', 'studies', 'using', 'RNA', 'extracted', 'from', 'various', 'tissues', 'of', 'a', 'SARS', 'infected', 'individual', 'showed', 'that', 'STAR', 'correctly', 'identified', 'all', 'samples', 'containing', 'SARS', 'virus', 'and', 'yielded', 'negative', 'results', 'for', 'non', 'SARS', 'control', 'samples', 'Using', 'alternate', 'priming', 'strategies', 'STAR', 'technology', 'can', 'be', 'adapted', 'to', 'transcriptional', 'profiling', 'studies', 'without', 'requiring', 'a', 'priori', 'sequence', 'information', 'Thus', 'STAR', 'technology', 'offers', 'a', 'flexible', 'platform', 'for', 'development', 'of', 'highly', 'multiplexed', 'assays', 'in', 'gene', 'expression', 'analysis', 'and', 'molecular', 'diagnostics', '']"
159350,Developing vaccines against epidemic-prone emerging infectious diseases,2019-11-27,Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz,https://doi.org/10.1007/s00103-019-03061-2; https://www.ncbi.nlm.nih.gov/pubmed/31776599/,"Today’s world is characterized by increasing population density, human mobility, urbanization, and climate and ecological change. This global dynamic has various effects, including the increased appearance of emerging infectious diseases (EIDs), which pose a growing threat to global health security. Outbreaks of EIDs, like the 2013–2016 Ebola outbreak in West Africa or the current Ebola outbreak in Democratic Republic of the Congo (DRC), have not only put populations in low- and middle-income countries (LMIC) at risk in terms of morbidity and mortality, but they also have had a significant impact on economic growth in affected regions and beyond. The Coalition for Epidemic Preparedness Innovation (CEPI) is an innovative global partnership between public, private, philanthropic, and civil society organizations that was launched as the result of a consensus that a coordinated, international, and intergovernmental plan was needed to develop and deploy new vaccines to prevent future epidemics. CEPI is focusing on supporting candidate vaccines against the World Health Organization (WHO) Blueprint priority pathogens MERS-CoV, Nipah virus, Lassa fever virus, and Rift Valley fever virus, as well as Chikungunya virus, which is on the WHO watch list. The current vaccine portfolio contains a wide variety of technologies, ranging across recombinant viral vectors, nucleic acids, and recombinant proteins. To support and accelerate vaccine development, CEPI will also support science projects related to the development of biological standards and assays, animal models, epidemiological studies, and diagnostics, as well as build capacities for future clinical trials in risk-prone contexts.",10.1007/s00103-019-03061-2,b6bm8do1,"['Today', 's', 'world', 'is', 'characterized', 'by', 'increasing', 'population', 'density', 'human', 'mobility', 'urbanization', 'and', 'climate', 'and', 'ecological', 'change', 'This', 'global', 'dynamic', 'has', 'various', 'effects', 'including', 'the', 'increased', 'appearance', 'of', 'emerging', 'infectious', 'diseases', 'EIDs', 'which', 'pose', 'a', 'growing', 'threat', 'to', 'global', 'health', 'security', 'Outbreaks', 'of', 'EIDs', 'like', 'the', '2013', '2016', 'Ebola', 'outbreak', 'in', 'West', 'Africa', 'or', 'the', 'current', 'Ebola', 'outbreak', 'in', 'Democratic', 'Republic', 'of', 'the', 'Congo', 'DRC', 'have', 'not', 'only', 'put', 'populations', 'in', 'low', 'and', 'middle', 'income', 'countries', 'LMIC', 'at', 'risk', 'in', 'terms', 'of', 'morbidity', 'and', 'mortality', 'but', 'they', 'also', 'have', 'had', 'a', 'significant', 'impact', 'on', 'economic', 'growth', 'in', 'affected', 'regions', 'and', 'beyond', 'The', 'Coalition', 'for', 'Epidemic', 'Preparedness', 'Innovation', 'CEPI', 'is', 'an', 'innovative', 'global', 'partnership', 'between', 'public', 'private', 'philanthropic', 'and', 'civil', 'society', 'organizations', 'that', 'was', 'launched', 'as', 'the', 'result', 'of', 'a', 'consensus', 'that', 'a', 'coordinated', 'international', 'and', 'intergovernmental', 'plan', 'was', 'needed', 'to', 'develop', 'and', 'deploy', 'new', 'vaccines', 'to', 'prevent', 'future', 'epidemics', 'CEPI', 'is', 'focusing', 'on', 'supporting', 'candidate', 'vaccines', 'against', 'the', 'World', 'Health', 'Organization', 'WHO', 'Blueprint', 'priority', 'pathogens', 'MERS', 'CoV', 'Nipah', 'virus', 'Lassa', 'fever', 'virus', 'and', 'Rift', 'Valley', 'fever', 'virus', 'as', 'well', 'as', 'Chikungunya', 'virus', 'which', 'is', 'on', 'the', 'WHO', 'watch', 'list', 'The', 'current', 'vaccine', 'portfolio', 'contains', 'a', 'wide', 'variety', 'of', 'technologies', 'ranging', 'across', 'recombinant', 'viral', 'vectors', 'nucleic', 'acids', 'and', 'recombinant', 'proteins', 'To', 'support', 'and', 'accelerate', 'vaccine', 'development', 'CEPI', 'will', 'also', 'support', 'science', 'projects', 'related', 'to', 'the', 'development', 'of', 'biological', 'standards', 'and', 'assays', 'animal', 'models', 'epidemiological', 'studies', 'and', 'diagnostics', 'as', 'well', 'as', 'build', 'capacities', 'for', 'future', 'clinical', 'trials', 'in', 'risk', 'prone', 'contexts', '']"
159604,STRATEGIES AND PERSPECTIVES TO DEVELOP SARS-CoV-2 DETECTION METHODS AND DIAGNOSTICS,2020-06-19,Biomed Pharmacother,https://www.sciencedirect.com/science/article/pii/S0753332220306399?v=s5; https://doi.org/10.1016/j.biopha.2020.110446; https://api.elsevier.com/content/article/pii/S0753332220306399,"To develop diagnostics and detection methods, current research is focussed on targeting the detection of coronavirus based on its RNA. Besides the RNA target, research reports are coming to develop diagnostics by targeting structure and other parts of coronavirus. PCR based detection system is widely used and various improvements in the PCR based detection system can be seen in the recent research reports. This review will discuss multiple detection methods for coronavirus for developing appropriate, reliable, and fast alternative detection methods. Considering the current scenario of COVID-19 diagnostics around the world and an urgent need for the development of reliable and cheap diagnostic, various techniques based on CRISPR technology, antibody, MIP, LAMP, microarray, etc. should be discussed and tried.",10.1016/j.biopha.2020.110446,zcmzpat5,"['To', 'develop', 'diagnostics', 'and', 'detection', 'methods', 'current', 'research', 'is', 'focussed', 'on', 'targeting', 'the', 'detection', 'of', 'coronavirus', 'based', 'on', 'its', 'RNA', 'Besides', 'the', 'RNA', 'target', 'research', 'reports', 'are', 'coming', 'to', 'develop', 'diagnostics', 'by', 'targeting', 'structure', 'and', 'other', 'parts', 'of', 'coronavirus', 'PCR', 'based', 'detection', 'system', 'is', 'widely', 'used', 'and', 'various', 'improvements', 'in', 'the', 'PCR', 'based', 'detection', 'system', 'can', 'be', 'seen', 'in', 'the', 'recent', 'research', 'reports', 'This', 'review', 'will', 'discuss', 'multiple', 'detection', 'methods', 'for', 'coronavirus', 'for', 'developing', 'appropriate', 'reliable', 'and', 'fast', 'alternative', 'detection', 'methods', 'Considering', 'the', 'current', 'scenario', 'of', 'COVID', '19', 'diagnostics', 'around', 'the', 'world', 'and', 'an', 'urgent', 'need', 'for', 'the', 'development', 'of', 'reliable', 'and', 'cheap', 'diagnostic', 'various', 'techniques', 'based', 'on', 'CRISPR', 'technology', 'antibody', 'MIP', 'LAMP', 'microarray', 'etc', 'should', 'be', 'discussed', 'and', 'tried', '']"
159717,Biosensors and rapid diagnostic tests on the frontier between analytical and clinical chemistry for biomolecular diagnosis of dengue disease: A review,2011-02-14,Anal Chim Acta,https://doi.org/10.1016/j.aca.2010.12.011; https://api.elsevier.com/content/article/pii/S0003267010015321; https://www.sciencedirect.com/science/article/pii/S0003267010015321; https://www.ncbi.nlm.nih.gov/pubmed/21241843/,"The past decades have witnessed enormous technological improvements towards the development of simple, cost-effective and accurate rapid diagnostic tests for detection and identification of infectious pathogens. Among them is dengue virus, the etiologic agent of the mosquito-borne dengue disease, one of the most important emerging infectious pathologies of nowadays. Dengue fever may cause potentially deadly hemorrhagic symptoms and is endemic in the tropical and sub-tropical world, being also a serious threat to temperate countries in the developed world. Effective diagnostics for dengue should be able to discriminate among the four antigenically related dengue serotypes and fulfill the requirements for successful decentralized (point-of-care) testing in the harsh environmental conditions found in most tropical regions. The accurate identification of circulating serotypes is crucial for the successful implementation of vector control programs based on reliable epidemiological predictions. This paper briefly summarizes the limitations of the main conventional techniques for biomolecular diagnosis of dengue disease and critically reviews some of the most relevant biosensors and rapid diagnostic tests developed, implemented and reported so far for point-of-care testing of dengue infections. The invaluable contributions of microfluidics and nanotechnology encompass the whole paper, while evaluation concerns of rapid diagnostic tests and foreseen technological improvements in this field are also overviewed for the diagnosis of dengue and other infectious and tropical diseases as well.",10.1016/j.aca.2010.12.011,uutap3da,"['The', 'past', 'decades', 'have', 'witnessed', 'enormous', 'technological', 'improvements', 'towards', 'the', 'development', 'of', 'simple', 'cost', 'effective', 'and', 'accurate', 'rapid', 'diagnostic', 'tests', 'for', 'detection', 'and', 'identification', 'of', 'infectious', 'pathogens', 'Among', 'them', 'is', 'dengue', 'virus', 'the', 'etiologic', 'agent', 'of', 'the', 'mosquito', 'borne', 'dengue', 'disease', 'one', 'of', 'the', 'most', 'important', 'emerging', 'infectious', 'pathologies', 'of', 'nowadays', 'Dengue', 'fever', 'may', 'cause', 'potentially', 'deadly', 'hemorrhagic', 'symptoms', 'and', 'is', 'endemic', 'in', 'the', 'tropical', 'and', 'sub', 'tropical', 'world', 'being', 'also', 'a', 'serious', 'threat', 'to', 'temperate', 'countries', 'in', 'the', 'developed', 'world', 'Effective', 'diagnostics', 'for', 'dengue', 'should', 'be', 'able', 'to', 'discriminate', 'among', 'the', 'four', 'antigenically', 'related', 'dengue', 'serotypes', 'and', 'fulfill', 'the', 'requirements', 'for', 'successful', 'decentralized', 'point', 'of', 'care', 'testing', 'in', 'the', 'harsh', 'environmental', 'conditions', 'found', 'in', 'most', 'tropical', 'regions', 'The', 'accurate', 'identification', 'of', 'circulating', 'serotypes', 'is', 'crucial', 'for', 'the', 'successful', 'implementation', 'of', 'vector', 'control', 'programs', 'based', 'on', 'reliable', 'epidemiological', 'predictions', 'This', 'paper', 'briefly', 'summarizes', 'the', 'limitations', 'of', 'the', 'main', 'conventional', 'techniques', 'for', 'biomolecular', 'diagnosis', 'of', 'dengue', 'disease', 'and', 'critically', 'reviews', 'some', 'of', 'the', 'most', 'relevant', 'biosensors', 'and', 'rapid', 'diagnostic', 'tests', 'developed', 'implemented', 'and', 'reported', 'so', 'far', 'for', 'point', 'of', 'care', 'testing', 'of', 'dengue', 'infections', 'The', 'invaluable', 'contributions', 'of', 'microfluidics', 'and', 'nanotechnology', 'encompass', 'the', 'whole', 'paper', 'while', 'evaluation', 'concerns', 'of', 'rapid', 'diagnostic', 'tests', 'and', 'foreseen', 'technological', 'improvements', 'in', 'this', 'field', 'are', 'also', 'overviewed', 'for', 'the', 'diagnosis', 'of', 'dengue', 'and', 'other', 'infectious', 'and', 'tropical', 'diseases', 'as', 'well', '']"
160366,SARS-CoV-2 Antibody Testing – Questions to be asked,2020-05-29,J Allergy Clin Immunol,https://www.ncbi.nlm.nih.gov/pubmed/32479758/; https://api.elsevier.com/content/article/pii/S0091674920307399; https://doi.org/10.1016/j.jaci.2020.05.020; https://www.sciencedirect.com/science/article/pii/S0091674920307399?v=s5,"ABSTRACT SARS-CoV-2 infection and development of COVID-19 disease presents a major healthcare challenge of global dimensions. Laboratory diagnostics of infected patients, and the assessment of immunity against the SARS-CoV-2 virus presents a major cornerstone in handling the pandemic. Currently there is an increase in demand of antibody testing and a large number of tests are already marketed or in the late stage of development. However, the interpretation of test results depends on many variables and factors, including sensitivity, specificity, potential cross-reactivity and cross-protectivity; the diagnostic value of antibodies of different isotypes, the use of antibody testing in identification of acutely ill patients or in epidemiological settings. In this article the recently established COVID-19 Task Force of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) addresses these issues based on the currently available datasets in this rapidly moving field.",10.1016/j.jaci.2020.05.020,tveeq4fj,"['ABSTRACT', 'SARS', 'CoV', '2', 'infection', 'and', 'development', 'of', 'COVID', '19', 'disease', 'presents', 'a', 'major', 'healthcare', 'challenge', 'of', 'global', 'dimensions', 'Laboratory', 'diagnostics', 'of', 'infected', 'patients', 'and', 'the', 'assessment', 'of', 'immunity', 'against', 'the', 'SARS', 'CoV', '2', 'virus', 'presents', 'a', 'major', 'cornerstone', 'in', 'handling', 'the', 'pandemic', 'Currently', 'there', 'is', 'an', 'increase', 'in', 'demand', 'of', 'antibody', 'testing', 'and', 'a', 'large', 'number', 'of', 'tests', 'are', 'already', 'marketed', 'or', 'in', 'the', 'late', 'stage', 'of', 'development', 'However', 'the', 'interpretation', 'of', 'test', 'results', 'depends', 'on', 'many', 'variables', 'and', 'factors', 'including', 'sensitivity', 'specificity', 'potential', 'cross', 'reactivity', 'and', 'cross', 'protectivity', 'the', 'diagnostic', 'value', 'of', 'antibodies', 'of', 'different', 'isotypes', 'the', 'use', 'of', 'antibody', 'testing', 'in', 'identification', 'of', 'acutely', 'ill', 'patients', 'or', 'in', 'epidemiological', 'settings', 'In', 'this', 'article', 'the', 'recently', 'established', 'COVID', '19', 'Task', 'Force', 'of', 'the', 'German', 'Society', 'for', 'Clinical', 'Chemistry', 'and', 'Laboratory', 'Medicine', 'DGKL', 'addresses', 'these', 'issues', 'based', 'on', 'the', 'currently', 'available', 'datasets', 'in', 'this', 'rapidly', 'moving', 'field', '']"
160770,Recent Advances in Diagnostic Microbiology,2009-07-31,Seminars in Hematology,https://www.ncbi.nlm.nih.gov/pubmed/19549577/; https://api.elsevier.com/content/article/pii/S003719630900064X; https://doi.org/10.1053/j.seminhematol.2009.03.009; https://www.sciencedirect.com/science/article/pii/S003719630900064X,"The past decade has seen a surge in the development of a variety of molecular diagnostics designed to rapidly identify or characterize medically important microorganisms. We briefly review important advances in molecular microbiology, and then discuss specific assays that have been implemented in clinical microbiology laboratories throughout the country. We also discuss emerging methods and technologies that will soon be more widely used for the prompt and accurate detection of the agents of infectious diseases.",10.1053/j.seminhematol.2009.03.009,22nilgvg,"['The', 'past', 'decade', 'has', 'seen', 'a', 'surge', 'in', 'the', 'development', 'of', 'a', 'variety', 'of', 'molecular', 'diagnostics', 'designed', 'to', 'rapidly', 'identify', 'or', 'characterize', 'medically', 'important', 'microorganisms', 'We', 'briefly', 'review', 'important', 'advances', 'in', 'molecular', 'microbiology', 'and', 'then', 'discuss', 'specific', 'assays', 'that', 'have', 'been', 'implemented', 'in', 'clinical', 'microbiology', 'laboratories', 'throughout', 'the', 'country', 'We', 'also', 'discuss', 'emerging', 'methods', 'and', 'technologies', 'that', 'will', 'soon', 'be', 'more', 'widely', 'used', 'for', 'the', 'prompt', 'and', 'accurate', 'detection', 'of', 'the', 'agents', 'of', 'infectious', 'diseases', '']"
160810,NTD Diagnostics for Disease Elimination: A Review,2020-06-05,Diagnostics (Basel),https://www.ncbi.nlm.nih.gov/pubmed/32517108/; https://doi.org/10.3390/diagnostics10060375,"Neglected Tropical Diseases (NTDs) marked out for disease elimination provide a lens through which to explore the changing status of diagnosis in global health. This paper reports on the findings of a scoping review, which set out to explore the main debates around diagnosis for the elimination of NTDs, including the multiple roles diagnostic technologies are being ascribed and the ideal characteristics of tests. It also attempts to summarise the state of diagnosis for three NTDs with elimination goals. The review places special emphasis on point-of-care testing in acknowledgement of the remote and underserved areas where NTDs proliferate. Early NTD campaigns were largely focused on attack phase planning, whereby a similar set of interventions could be transplanted anywhere. Now, with elimination goals in sight, strategies must be tailored to local settings if they are to attain and sustain success. Diagnostic data helps with local adaptation and is increasingly used for programmatic decision-making. The review finds that elimination goals reframe whom diagnosis is for and the myriad roles diagnostics can play. The exigencies of elimination also serve to highlight deficiencies in the current diagnostic arsenal and development pipeline for many NTDs. Moving forward, a guiding framework is needed to drive research and stimulate investment in diagnosis to support NTD goals.",10.3390/diagnostics10060375,u6mu11nl,"['Neglected', 'Tropical', 'Diseases', 'NTDs', 'marked', 'out', 'for', 'disease', 'elimination', 'provide', 'a', 'lens', 'through', 'which', 'to', 'explore', 'the', 'changing', 'status', 'of', 'diagnosis', 'in', 'global', 'health', 'This', 'paper', 'reports', 'on', 'the', 'findings', 'of', 'a', 'scoping', 'review', 'which', 'set', 'out', 'to', 'explore', 'the', 'main', 'debates', 'around', 'diagnosis', 'for', 'the', 'elimination', 'of', 'NTDs', 'including', 'the', 'multiple', 'roles', 'diagnostic', 'technologies', 'are', 'being', 'ascribed', 'and', 'the', 'ideal', 'characteristics', 'of', 'tests', 'It', 'also', 'attempts', 'to', 'summarise', 'the', 'state', 'of', 'diagnosis', 'for', 'three', 'NTDs', 'with', 'elimination', 'goals', 'The', 'review', 'places', 'special', 'emphasis', 'on', 'point', 'of', 'care', 'testing', 'in', 'acknowledgement', 'of', 'the', 'remote', 'and', 'underserved', 'areas', 'where', 'NTDs', 'proliferate', 'Early', 'NTD', 'campaigns', 'were', 'largely', 'focused', 'on', 'attack', 'phase', 'planning', 'whereby', 'a', 'similar', 'set', 'of', 'interventions', 'could', 'be', 'transplanted', 'anywhere', 'Now', 'with', 'elimination', 'goals', 'in', 'sight', 'strategies', 'must', 'be', 'tailored', 'to', 'local', 'settings', 'if', 'they', 'are', 'to', 'attain', 'and', 'sustain', 'success', 'Diagnostic', 'data', 'helps', 'with', 'local', 'adaptation', 'and', 'is', 'increasingly', 'used', 'for', 'programmatic', 'decision', 'making', 'The', 'review', 'finds', 'that', 'elimination', 'goals', 'reframe', 'whom', 'diagnosis', 'is', 'for', 'and', 'the', 'myriad', 'roles', 'diagnostics', 'can', 'play', 'The', 'exigencies', 'of', 'elimination', 'also', 'serve', 'to', 'highlight', 'deficiencies', 'in', 'the', 'current', 'diagnostic', 'arsenal', 'and', 'development', 'pipeline', 'for', 'many', 'NTDs', 'Moving', 'forward', 'a', 'guiding', 'framework', 'is', 'needed', 'to', 'drive', 'research', 'and', 'stimulate', 'investment', 'in', 'diagnosis', 'to', 'support', 'NTD', 'goals', '']"
161425,Diagnostics of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid antigen using chicken immunoglobulin Y,2012-03-01,Poultry Science,https://doi.org/10.3382/ps.2011-01916; https://api.elsevier.com/content/article/pii/S0032579119402265; https://www.sciencedirect.com/science/article/pii/S0032579119402265; https://www.ncbi.nlm.nih.gov/pubmed/22334738/,"Abstract The goal of this study was to develop a quantitative detection system for severe acute respiratory syndrome-associated coronavirus (SARS-CoV), targeting the nucleocapsid protein (NP), to determine the presence and degree of infection in suspected individuals. Because the NP is the viral protein shed during infection and its template mRNA is the most abundant subgenomic RNA, it is a suitable candidate for developing antibodies for diagnostic applications. In this study, we have prepared full-length SARS-CoV NP expressed in Escherichia coli and purified. Full-length NP was used for the preparation of mouse monoclonal antibody and chicken polyclonal IgY antibodies for the development of heterosandwich ELISA for early diagnostics of SARS-suspected individuals. The sensitivity of the developed heterosandwich ELISA can detect the viral antigen at 18.5 pg/mL of recombinant NP. This study describes ultrasensitive ELISA using 19B6 monoclonal antibody as the capture antibody and IgY as the detecting antibody against the most abundant SARS-CoV NP antigens. One of the most important findings was the use of inexpensive polyclonal IgY antibody to increase the sensitivity of the detection system for SARS-CoV at the picogram level. Furthermore, the immunoassay of SARS-CoV NP antigen developed could be an effective and sensitive method of diagnosing SARS-suspected individuals during a future SARS-CoV outbreak.",10.3382/ps.2011-01916,faymgnts,"['Abstract', 'The', 'goal', 'of', 'this', 'study', 'was', 'to', 'develop', 'a', 'quantitative', 'detection', 'system', 'for', 'severe', 'acute', 'respiratory', 'syndrome', 'associated', 'coronavirus', 'SARS', 'CoV', 'targeting', 'the', 'nucleocapsid', 'protein', 'NP', 'to', 'determine', 'the', 'presence', 'and', 'degree', 'of', 'infection', 'in', 'suspected', 'individuals', 'Because', 'the', 'NP', 'is', 'the', 'viral', 'protein', 'shed', 'during', 'infection', 'and', 'its', 'template', 'mRNA', 'is', 'the', 'most', 'abundant', 'subgenomic', 'RNA', 'it', 'is', 'a', 'suitable', 'candidate', 'for', 'developing', 'antibodies', 'for', 'diagnostic', 'applications', 'In', 'this', 'study', 'we', 'have', 'prepared', 'full', 'length', 'SARS', 'CoV', 'NP', 'expressed', 'in', 'Escherichia', 'coli', 'and', 'purified', 'Full', 'length', 'NP', 'was', 'used', 'for', 'the', 'preparation', 'of', 'mouse', 'monoclonal', 'antibody', 'and', 'chicken', 'polyclonal', 'IgY', 'antibodies', 'for', 'the', 'development', 'of', 'heterosandwich', 'ELISA', 'for', 'early', 'diagnostics', 'of', 'SARS', 'suspected', 'individuals', 'The', 'sensitivity', 'of', 'the', 'developed', 'heterosandwich', 'ELISA', 'can', 'detect', 'the', 'viral', 'antigen', 'at', '18', '5', 'pg', 'mL', 'of', 'recombinant', 'NP', 'This', 'study', 'describes', 'ultrasensitive', 'ELISA', 'using', '19B6', 'monoclonal', 'antibody', 'as', 'the', 'capture', 'antibody', 'and', 'IgY', 'as', 'the', 'detecting', 'antibody', 'against', 'the', 'most', 'abundant', 'SARS', 'CoV', 'NP', 'antigens', 'One', 'of', 'the', 'most', 'important', 'findings', 'was', 'the', 'use', 'of', 'inexpensive', 'polyclonal', 'IgY', 'antibody', 'to', 'increase', 'the', 'sensitivity', 'of', 'the', 'detection', 'system', 'for', 'SARS', 'CoV', 'at', 'the', 'picogram', 'level', 'Furthermore', 'the', 'immunoassay', 'of', 'SARS', 'CoV', 'NP', 'antigen', 'developed', 'could', 'be', 'an', 'effective', 'and', 'sensitive', 'method', 'of', 'diagnosing', 'SARS', 'suspected', 'individuals', 'during', 'a', 'future', 'SARS', 'CoV', 'outbreak', '']"
162420,CRISPR/cas systems redefine nucleic acid detection: Principles and methods,2020-07-08,Biosens Bioelectron,https://api.elsevier.com/content/article/pii/S0956566320304243; https://www.sciencedirect.com/science/article/pii/S0956566320304243?v=s5,"Methods that enable rapid, sensitive and specific analyses of nucleic acid sequences have positive effects on precise disease diagnostics and effective clinical treatments by providing direct insight into clinically relevant genetic information. Thus far, many CRISPR/Cas systems have been repurposed for diagnostic functions and are revolutionizing the accessibility of robust diagnostic tools due to their high flexibility, sensitivity and specificity. As RNA-guided targeted recognition effectors, Cas9 variants have been utilized for a variety of diagnostic applications, including biosensing assays, imaging assays and target enrichment for next-generation sequencing (NGS), thereby enabling the development of flexible and cost-effective tests. In addition, the ensuing discovery of Cas proteins (Cas12 and Cas13) with collateral cleavage activities has facilitated the development of numerous diagnostic tools for rapid and portable detection, and these tools have great potential for point-of-care settings. However, representative reviews proposed on this topic are mainly confined to classical biosensing applications; thus, a comprehensive and systematic description of this fast-developing field is required. In this review, based on the detection principle, we provide a detailed classification and comprehensive discussion of recent works that harness these CRISPR-based diagnostic tools from a new perspective. Furthermore, current challenges and future perspectives of CRISPR-based diagnostics are outlined.",10.1016/j.bios.2020.112430,nd7ub2u3,"['Methods', 'that', 'enable', 'rapid', 'sensitive', 'and', 'specific', 'analyses', 'of', 'nucleic', 'acid', 'sequences', 'have', 'positive', 'effects', 'on', 'precise', 'disease', 'diagnostics', 'and', 'effective', 'clinical', 'treatments', 'by', 'providing', 'direct', 'insight', 'into', 'clinically', 'relevant', 'genetic', 'information', 'Thus', 'far', 'many', 'CRISPR', 'Cas', 'systems', 'have', 'been', 'repurposed', 'for', 'diagnostic', 'functions', 'and', 'are', 'revolutionizing', 'the', 'accessibility', 'of', 'robust', 'diagnostic', 'tools', 'due', 'to', 'their', 'high', 'flexibility', 'sensitivity', 'and', 'specificity', 'As', 'RNA', 'guided', 'targeted', 'recognition', 'effectors', 'Cas9', 'variants', 'have', 'been', 'utilized', 'for', 'a', 'variety', 'of', 'diagnostic', 'applications', 'including', 'biosensing', 'assays', 'imaging', 'assays', 'and', 'target', 'enrichment', 'for', 'next', 'generation', 'sequencing', 'NGS', 'thereby', 'enabling', 'the', 'development', 'of', 'flexible', 'and', 'cost', 'effective', 'tests', 'In', 'addition', 'the', 'ensuing', 'discovery', 'of', 'Cas', 'proteins', 'Cas12', 'and', 'Cas13', 'with', 'collateral', 'cleavage', 'activities', 'has', 'facilitated', 'the', 'development', 'of', 'numerous', 'diagnostic', 'tools', 'for', 'rapid', 'and', 'portable', 'detection', 'and', 'these', 'tools', 'have', 'great', 'potential', 'for', 'point', 'of', 'care', 'settings', 'However', 'representative', 'reviews', 'proposed', 'on', 'this', 'topic', 'are', 'mainly', 'confined', 'to', 'classical', 'biosensing', 'applications', 'thus', 'a', 'comprehensive', 'and', 'systematic', 'description', 'of', 'this', 'fast', 'developing', 'field', 'is', 'required', 'In', 'this', 'review', 'based', 'on', 'the', 'detection', 'principle', 'we', 'provide', 'a', 'detailed', 'classification', 'and', 'comprehensive', 'discussion', 'of', 'recent', 'works', 'that', 'harness', 'these', 'CRISPR', 'based', 'diagnostic', 'tools', 'from', 'a', 'new', 'perspective', 'Furthermore', 'current', 'challenges', 'and', 'future', 'perspectives', 'of', 'CRISPR', 'based', 'diagnostics', 'are', 'outlined', '']"
162435,Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes,2020-02-02,bioRxiv,https://doi.org/10.1101/2020.01.31.928796; https://www.ncbi.nlm.nih.gov/pubmed/32511309/,"Genome Detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next generation sequencing datasets. This application allows the identification of phylogenetic clusters and genotypes from assembled genomes in FASTA format. Since its release in 2019, we have produced a number of typing tools for emergent viruses that have caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil. Here, we present The Genome Detective Coronavirus Typing Tool that can accurately identify novel coronavirus (2019-nCoV) sequences isolated in China and around the world. The tool can accept up to 2,000 sequences per submission and the analysis of a new whole genome sequence will take approximately one minute. The tool has been tested and validated with hundreds of whole genomes from ten coronavirus species, and correctly classified all of the SARS-related coronavirus (SARSr-CoV) and all of the available public data for 2019-nCoV. The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines.",10.1101/2020.01.31.928796,gxstlzuk,"['Genome', 'Detective', 'is', 'a', 'web', 'based', 'user', 'friendly', 'software', 'application', 'to', 'quickly', 'and', 'accurately', 'assemble', 'all', 'known', 'virus', 'genomes', 'from', 'next', 'generation', 'sequencing', 'datasets', 'This', 'application', 'allows', 'the', 'identification', 'of', 'phylogenetic', 'clusters', 'and', 'genotypes', 'from', 'assembled', 'genomes', 'in', 'FASTA', 'format', 'Since', 'its', 'release', 'in', '2019', 'we', 'have', 'produced', 'a', 'number', 'of', 'typing', 'tools', 'for', 'emergent', 'viruses', 'that', 'have', 'caused', 'large', 'outbreaks', 'such', 'as', 'Zika', 'and', 'Yellow', 'Fever', 'Virus', 'in', 'Brazil', 'Here', 'we', 'present', 'The', 'Genome', 'Detective', 'Coronavirus', 'Typing', 'Tool', 'that', 'can', 'accurately', 'identify', 'novel', 'coronavirus', '2019', 'nCoV', 'sequences', 'isolated', 'in', 'China', 'and', 'around', 'the', 'world', 'The', 'tool', 'can', 'accept', 'up', 'to', '2', '000', 'sequences', 'per', 'submission', 'and', 'the', 'analysis', 'of', 'a', 'new', 'whole', 'genome', 'sequence', 'will', 'take', 'approximately', 'one', 'minute', 'The', 'tool', 'has', 'been', 'tested', 'and', 'validated', 'with', 'hundreds', 'of', 'whole', 'genomes', 'from', 'ten', 'coronavirus', 'species', 'and', 'correctly', 'classified', 'all', 'of', 'the', 'SARS', 'related', 'coronavirus', 'SARSr', 'CoV', 'and', 'all', 'of', 'the', 'available', 'public', 'data', 'for', '2019', 'nCoV', 'The', 'tool', 'also', 'allows', 'tracking', 'of', 'new', 'viral', 'mutations', 'as', 'the', 'outbreak', 'expands', 'globally', 'which', 'may', 'help', 'to', 'accelerate', 'the', 'development', 'of', 'novel', 'diagnostics', 'drugs', 'and', 'vaccines', '']"
163390,"REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes",2018-12-13,Nat Microbiol,https://www.ncbi.nlm.nih.gov/pubmed/30546093/; https://doi.org/10.1038/s41564-018-0295-3,"Lack of access to quality diagnostics remains a major contributor to health burden in resource-limited settings. It has been more than 10 years since ASSURED (affordable, sensitive, specific, user-friendly, rapid, equipment-free, delivered) was coined to describe the ideal test to meet the needs of the developing world. Since its initial publication, technological innovations have led to the development of diagnostics that address the ASSURED criteria, but challenges remain. From this perspective, we assess factors contributing to the success and failure of ASSURED diagnostics, lessons learnt in the implementation of ASSURED tests over the past decade, and highlight additional conditions that should be considered in addressing point-of-care needs. With rapid advances in digital technology and mobile health (m-health), future diagnostics should incorporate these elements to give us REASSURED diagnostic systems that can inform disease control strategies in real-time, strengthen the efficiency of health care systems and improve patient outcomes.",10.1038/s41564-018-0295-3,xhpv783y,"['Lack', 'of', 'access', 'to', 'quality', 'diagnostics', 'remains', 'a', 'major', 'contributor', 'to', 'health', 'burden', 'in', 'resource', 'limited', 'settings', 'It', 'has', 'been', 'more', 'than', '10', 'years', 'since', 'ASSURED', 'affordable', 'sensitive', 'specific', 'user', 'friendly', 'rapid', 'equipment', 'free', 'delivered', 'was', 'coined', 'to', 'describe', 'the', 'ideal', 'test', 'to', 'meet', 'the', 'needs', 'of', 'the', 'developing', 'world', 'Since', 'its', 'initial', 'publication', 'technological', 'innovations', 'have', 'led', 'to', 'the', 'development', 'of', 'diagnostics', 'that', 'address', 'the', 'ASSURED', 'criteria', 'but', 'challenges', 'remain', 'From', 'this', 'perspective', 'we', 'assess', 'factors', 'contributing', 'to', 'the', 'success', 'and', 'failure', 'of', 'ASSURED', 'diagnostics', 'lessons', 'learnt', 'in', 'the', 'implementation', 'of', 'ASSURED', 'tests', 'over', 'the', 'past', 'decade', 'and', 'highlight', 'additional', 'conditions', 'that', 'should', 'be', 'considered', 'in', 'addressing', 'point', 'of', 'care', 'needs', 'With', 'rapid', 'advances', 'in', 'digital', 'technology', 'and', 'mobile', 'health', 'm', 'health', 'future', 'diagnostics', 'should', 'incorporate', 'these', 'elements', 'to', 'give', 'us', 'REASSURED', 'diagnostic', 'systems', 'that', 'can', 'inform', 'disease', 'control', 'strategies', 'in', 'real', 'time', 'strengthen', 'the', 'efficiency', 'of', 'health', 'care', 'systems', 'and', 'improve', 'patient', 'outcomes', '']"
163451,2016 International meeting of the Global Virus Network,2017-06-30,Antiviral Research,https://www.ncbi.nlm.nih.gov/pubmed/28315708/; https://doi.org/10.1016/j.antiviral.2017.03.005; https://www.sciencedirect.com/science/article/pii/S0166354217301341; https://api.elsevier.com/content/article/pii/S0166354217301341,"Abstract The Global Virus Network (GVN) was established in 2011 in order to strengthen research and responses to current viral causes of human disease and to prepare against new viral pandemic threats. There are now 38 GVN Centers of Excellence and 6 Affiliate laboratories in 24 countries. GVN scientists meet annually to learn about each other's current research, address collaborative priorities and plan future programs. The 2016 meeting was held from October 23–25 in Hokkaido, Japan, in partnership with the Japanese Society for Virology, the National Institute of Infectious Diseases of Japan and the Research Center for Zoonosis Control of Hokkaido University. This report highlights the accomplishments of GVN researchers in many priority areas of medical virology, including the current Zika epidemic, infections by human papillomavirus, influenza, Ebola, Lassa, dengue, HIV, hepatitis C, and chikungunya viruses, and the development of improved diagnostics and new vaccines.",10.1016/j.antiviral.2017.03.005,il7g78w1,"['Abstract', 'The', 'Global', 'Virus', 'Network', 'GVN', 'was', 'established', 'in', '2011', 'in', 'order', 'to', 'strengthen', 'research', 'and', 'responses', 'to', 'current', 'viral', 'causes', 'of', 'human', 'disease', 'and', 'to', 'prepare', 'against', 'new', 'viral', 'pandemic', 'threats', 'There', 'are', 'now', '38', 'GVN', 'Centers', 'of', 'Excellence', 'and', '6', 'Affiliate', 'laboratories', 'in', '24', 'countries', 'GVN', 'scientists', 'meet', 'annually', 'to', 'learn', 'about', 'each', 'other', 's', 'current', 'research', 'address', 'collaborative', 'priorities', 'and', 'plan', 'future', 'programs', 'The', '2016', 'meeting', 'was', 'held', 'from', 'October', '23', '25', 'in', 'Hokkaido', 'Japan', 'in', 'partnership', 'with', 'the', 'Japanese', 'Society', 'for', 'Virology', 'the', 'National', 'Institute', 'of', 'Infectious', 'Diseases', 'of', 'Japan', 'and', 'the', 'Research', 'Center', 'for', 'Zoonosis', 'Control', 'of', 'Hokkaido', 'University', 'This', 'report', 'highlights', 'the', 'accomplishments', 'of', 'GVN', 'researchers', 'in', 'many', 'priority', 'areas', 'of', 'medical', 'virology', 'including', 'the', 'current', 'Zika', 'epidemic', 'infections', 'by', 'human', 'papillomavirus', 'influenza', 'Ebola', 'Lassa', 'dengue', 'HIV', 'hepatitis', 'C', 'and', 'chikungunya', 'viruses', 'and', 'the', 'development', 'of', 'improved', 'diagnostics', 'and', 'new', 'vaccines', '']"
163465,Magnetic Lateral Flow Immunoassays,2020-05-08,Diagnostics (Basel),https://www.ncbi.nlm.nih.gov/pubmed/32397264/; https://doi.org/10.3390/diagnostics10050288,"A new generation of magnetic lateral flow immunoassays is emerging as powerful tool for diagnostics. They rely on the use of magnetic nanoparticles (MNP) as detecting label, replacing conventional gold or latex beads. MNPs can be sensed and quantified by means of external devices, allowing the development of immunochromatographic tests with a quantitative capability. Moreover, they have an added advantage because they can be used for immunomagnetic separation (IMS), with improvements in selectivity and sensitivity. In this paper, we have reviewed the current knowledge on magnetic-lateral flow immunoassay (LFIA), coupled with both research and commercially available instruments. The work in the literature has been classified in two categories: optical and magnetic sensing. We have analysed the type of magnetic nanoparticles used in each case, their size, coating, crystal structure and the functional groups for their conjugation with biomolecules. We have also taken into account the analytical characteristics and the type of transduction. Magnetic LFIA have been used for the determination of biomarkers, pathogens, toxins, allergens and drugs. Nanocomposites have been developed as alternative to MNP with the purpose of sensitivity enhancement. Moreover, IMS in combination with other detection principles could also improve sensitivity and limit of detection. The critical analysis in this review could have an impact for the future development of magnetic LFIA in fields requiring both rapid separation and quantification.",10.3390/diagnostics10050288,lyw3en42,"['A', 'new', 'generation', 'of', 'magnetic', 'lateral', 'flow', 'immunoassays', 'is', 'emerging', 'as', 'powerful', 'tool', 'for', 'diagnostics', 'They', 'rely', 'on', 'the', 'use', 'of', 'magnetic', 'nanoparticles', 'MNP', 'as', 'detecting', 'label', 'replacing', 'conventional', 'gold', 'or', 'latex', 'beads', 'MNPs', 'can', 'be', 'sensed', 'and', 'quantified', 'by', 'means', 'of', 'external', 'devices', 'allowing', 'the', 'development', 'of', 'immunochromatographic', 'tests', 'with', 'a', 'quantitative', 'capability', 'Moreover', 'they', 'have', 'an', 'added', 'advantage', 'because', 'they', 'can', 'be', 'used', 'for', 'immunomagnetic', 'separation', 'IMS', 'with', 'improvements', 'in', 'selectivity', 'and', 'sensitivity', 'In', 'this', 'paper', 'we', 'have', 'reviewed', 'the', 'current', 'knowledge', 'on', 'magnetic', 'lateral', 'flow', 'immunoassay', 'LFIA', 'coupled', 'with', 'both', 'research', 'and', 'commercially', 'available', 'instruments', 'The', 'work', 'in', 'the', 'literature', 'has', 'been', 'classified', 'in', 'two', 'categories', 'optical', 'and', 'magnetic', 'sensing', 'We', 'have', 'analysed', 'the', 'type', 'of', 'magnetic', 'nanoparticles', 'used', 'in', 'each', 'case', 'their', 'size', 'coating', 'crystal', 'structure', 'and', 'the', 'functional', 'groups', 'for', 'their', 'conjugation', 'with', 'biomolecules', 'We', 'have', 'also', 'taken', 'into', 'account', 'the', 'analytical', 'characteristics', 'and', 'the', 'type', 'of', 'transduction', 'Magnetic', 'LFIA', 'have', 'been', 'used', 'for', 'the', 'determination', 'of', 'biomarkers', 'pathogens', 'toxins', 'allergens', 'and', 'drugs', 'Nanocomposites', 'have', 'been', 'developed', 'as', 'alternative', 'to', 'MNP', 'with', 'the', 'purpose', 'of', 'sensitivity', 'enhancement', 'Moreover', 'IMS', 'in', 'combination', 'with', 'other', 'detection', 'principles', 'could', 'also', 'improve', 'sensitivity', 'and', 'limit', 'of', 'detection', 'The', 'critical', 'analysis', 'in', 'this', 'review', 'could', 'have', 'an', 'impact', 'for', 'the', 'future', 'development', 'of', 'magnetic', 'LFIA', 'in', 'fields', 'requiring', 'both', 'rapid', 'separation', 'and', 'quantification', '']"
164925,"Cryptosporidium Infection: Epidemiology, Pathogenesis, and Differential Diagnosis",2019-10-22,Eur J Microbiol Immunol (Bp),https://www.ncbi.nlm.nih.gov/pubmed/31934363/; https://doi.org/10.1556/1886.2019.00019,"Cryptosporidium is a protozoan that infects a wide variety of vertebrates, including humans, causing acute gastroenteritis. The disease manifests with abdominal pain and diarrhea similar to that of choleric infection. In the immunocompromised hosts, the parasite causes prolonged infections that can also be fatal. For this reason, cryptosporidiosis is considered one of riskiest opportunistic infections for patients with acquired immunodeficiency syndrome. The best way to control the infection in these patients is setting up sensitive and specific diagnostic tests for epidemiological surveillance and morbidity reduction. Here, we summarized the general aspects of Cryptosporidium infection focusing on available diagnostic tools used for the diagnosis of cryptosporidiosis. Molecular methods currently available for its detection and progress in the development of new diagnostics for cryptosporidiosis are also discussed.",10.1556/1886.2019.00019,9qj8d2f7,"['Cryptosporidium', 'is', 'a', 'protozoan', 'that', 'infects', 'a', 'wide', 'variety', 'of', 'vertebrates', 'including', 'humans', 'causing', 'acute', 'gastroenteritis', 'The', 'disease', 'manifests', 'with', 'abdominal', 'pain', 'and', 'diarrhea', 'similar', 'to', 'that', 'of', 'choleric', 'infection', 'In', 'the', 'immunocompromised', 'hosts', 'the', 'parasite', 'causes', 'prolonged', 'infections', 'that', 'can', 'also', 'be', 'fatal', 'For', 'this', 'reason', 'cryptosporidiosis', 'is', 'considered', 'one', 'of', 'riskiest', 'opportunistic', 'infections', 'for', 'patients', 'with', 'acquired', 'immunodeficiency', 'syndrome', 'The', 'best', 'way', 'to', 'control', 'the', 'infection', 'in', 'these', 'patients', 'is', 'setting', 'up', 'sensitive', 'and', 'specific', 'diagnostic', 'tests', 'for', 'epidemiological', 'surveillance', 'and', 'morbidity', 'reduction', 'Here', 'we', 'summarized', 'the', 'general', 'aspects', 'of', 'Cryptosporidium', 'infection', 'focusing', 'on', 'available', 'diagnostic', 'tools', 'used', 'for', 'the', 'diagnosis', 'of', 'cryptosporidiosis', 'Molecular', 'methods', 'currently', 'available', 'for', 'its', 'detection', 'and', 'progress', 'in', 'the', 'development', 'of', 'new', 'diagnostics', 'for', 'cryptosporidiosis', 'are', 'also', 'discussed', '']"
165429,Nanobioimaging and sensing of infectious diseases,2010-03-18,Advanced Drug Delivery Reviews,https://www.ncbi.nlm.nih.gov/pubmed/19931579/; https://api.elsevier.com/content/article/pii/S0169409X0900355X; https://www.sciencedirect.com/science/article/pii/S0169409X0900355X; https://doi.org/10.1016/j.addr.2009.11.014,"Abstract New methods to identify trace amount of infectious pathogens rapidly, accurately and with high sensitivity are in constant demand to prevent epidemics and loss of lives. Early detection of these pathogens to prevent, treat and contain the spread of infections is crucial. Therefore, there is a need and urgency for sensitive, specific, accurate, easy-to-use diagnostic tests. Versatile biofunctionalized engineered nanomaterials are proving to be promising in meeting these needs in diagnosing the pathogens in food, blood and clinical samples. The unique optical and magnetic properties of the nanoscale materials have been put to use for the diagnostics. In this review, we focus on the developments of the fluorescent nanoparticles, metallic nanostructures and superparamagnetic nanoparticles for bioimaging and detection of infectious microorganisms. The various nanodiagnostic assays developed to image, detect and capture infectious virus and bacteria in solutions, food or biological samples in vitro and in vivo are presented and their relevance to developing countries is discussed.",10.1016/j.addr.2009.11.014,hzs6y5lo,"['Abstract', 'New', 'methods', 'to', 'identify', 'trace', 'amount', 'of', 'infectious', 'pathogens', 'rapidly', 'accurately', 'and', 'with', 'high', 'sensitivity', 'are', 'in', 'constant', 'demand', 'to', 'prevent', 'epidemics', 'and', 'loss', 'of', 'lives', 'Early', 'detection', 'of', 'these', 'pathogens', 'to', 'prevent', 'treat', 'and', 'contain', 'the', 'spread', 'of', 'infections', 'is', 'crucial', 'Therefore', 'there', 'is', 'a', 'need', 'and', 'urgency', 'for', 'sensitive', 'specific', 'accurate', 'easy', 'to', 'use', 'diagnostic', 'tests', 'Versatile', 'biofunctionalized', 'engineered', 'nanomaterials', 'are', 'proving', 'to', 'be', 'promising', 'in', 'meeting', 'these', 'needs', 'in', 'diagnosing', 'the', 'pathogens', 'in', 'food', 'blood', 'and', 'clinical', 'samples', 'The', 'unique', 'optical', 'and', 'magnetic', 'properties', 'of', 'the', 'nanoscale', 'materials', 'have', 'been', 'put', 'to', 'use', 'for', 'the', 'diagnostics', 'In', 'this', 'review', 'we', 'focus', 'on', 'the', 'developments', 'of', 'the', 'fluorescent', 'nanoparticles', 'metallic', 'nanostructures', 'and', 'superparamagnetic', 'nanoparticles', 'for', 'bioimaging', 'and', 'detection', 'of', 'infectious', 'microorganisms', 'The', 'various', 'nanodiagnostic', 'assays', 'developed', 'to', 'image', 'detect', 'and', 'capture', 'infectious', 'virus', 'and', 'bacteria', 'in', 'solutions', 'food', 'or', 'biological', 'samples', 'in', 'vitro', 'and', 'in', 'vivo', 'are', 'presented', 'and', 'their', 'relevance', 'to', 'developing', 'countries', 'is', 'discussed', '']"
165464,Mechanisms of viral impact on asthma exacerbations,2004-02-29,Journal of Allergy and Clinical Immunology,https://api.elsevier.com/content/article/pii/S0091674904004245; https://www.sciencedirect.com/science/article/pii/S0091674904004245,"Abstract Rationale Respiratory viruses are a frequent cause of wheezing in infants and children. 60 - 85% of asthma exacerbations in children and up to 50% of asthma exacerbations in adults are attributed to respiratory viruses. Previous studies investigated the role of rhinoviruses, RS-viruses and adenoviruses in development of asthma exacerbations in children hospitalized in the clinic of the Institute of Immunology (Moscow, Russia). Rhinovirus was the most frequently detected – 33 samples (24.8% of all tested samples), adenovirus – 5 samples (3.8%), RSV– 4 samples (3.0%), and mixed infections (rhinovirus and RSV) – 1 sample (0.7%). Among positive samples rhinovirus accounted for 76.7%, adenovirus - 11.6%, RSV - 9.3%, and mixed infection - 2.3%. Methods Primers for PCR diagnostics of Parainfluenza viruses of 1, 2 and 3 type and coronaviruses OC43 and 229E were developed. Investigation of HLA-alleles and genotypes was conducted in patients with virus-induced bronchial asthma to reveal HLA-associated markers of susceptibility to viral-induced asthma. Results An increased frequency of HLA-DRB1∗13 specificity and reduced frequencies of HLA-DRB1∗04 and HLA-DRB1∗11 specificities were noted in the viral-induced asthmatics compared to the healthy control group. A minimal increase of HLA-DRB1 homozygotes - 21% was also noted in comparison with the control group - 14%. Conclusions Investigation of HLA-haplotype in patients with viral-induced outbreaks of asthma via HLA-genotyping may reveal more evident associations between HLA-haplotypes and individual respiratory viral infections.",10.1016/j.jaci.2004.01.419,d7nj2cdm,"['Abstract', 'Rationale', 'Respiratory', 'viruses', 'are', 'a', 'frequent', 'cause', 'of', 'wheezing', 'in', 'infants', 'and', 'children', '60', '85', 'of', 'asthma', 'exacerbations', 'in', 'children', 'and', 'up', 'to', '50', 'of', 'asthma', 'exacerbations', 'in', 'adults', 'are', 'attributed', 'to', 'respiratory', 'viruses', 'Previous', 'studies', 'investigated', 'the', 'role', 'of', 'rhinoviruses', 'RS', 'viruses', 'and', 'adenoviruses', 'in', 'development', 'of', 'asthma', 'exacerbations', 'in', 'children', 'hospitalized', 'in', 'the', 'clinic', 'of', 'the', 'Institute', 'of', 'Immunology', 'Moscow', 'Russia', 'Rhinovirus', 'was', 'the', 'most', 'frequently', 'detected', '33', 'samples', '24', '8', 'of', 'all', 'tested', 'samples', 'adenovirus', '5', 'samples', '3', '8', 'RSV', '4', 'samples', '3', '0', 'and', 'mixed', 'infections', 'rhinovirus', 'and', 'RSV', '1', 'sample', '0', '7', 'Among', 'positive', 'samples', 'rhinovirus', 'accounted', 'for', '76', '7', 'adenovirus', '11', '6', 'RSV', '9', '3', 'and', 'mixed', 'infection', '2', '3', 'Methods', 'Primers', 'for', 'PCR', 'diagnostics', 'of', 'Parainfluenza', 'viruses', 'of', '1', '2', 'and', '3', 'type', 'and', 'coronaviruses', 'OC43', 'and', '229E', 'were', 'developed', 'Investigation', 'of', 'HLA', 'alleles', 'and', 'genotypes', 'was', 'conducted', 'in', 'patients', 'with', 'virus', 'induced', 'bronchial', 'asthma', 'to', 'reveal', 'HLA', 'associated', 'markers', 'of', 'susceptibility', 'to', 'viral', 'induced', 'asthma', 'Results', 'An', 'increased', 'frequency', 'of', 'HLA', 'DRB1', '13', 'specificity', 'and', 'reduced', 'frequencies', 'of', 'HLA', 'DRB1', '04', 'and', 'HLA', 'DRB1', '11', 'specificities', 'were', 'noted', 'in', 'the', 'viral', 'induced', 'asthmatics', 'compared', 'to', 'the', 'healthy', 'control', 'group', 'A', 'minimal', 'increase', 'of', 'HLA', 'DRB1', 'homozygotes', '21', 'was', 'also', 'noted', 'in', 'comparison', 'with', 'the', 'control', 'group', '14', 'Conclusions', 'Investigation', 'of', 'HLA', 'haplotype', 'in', 'patients', 'with', 'viral', 'induced', 'outbreaks', 'of', 'asthma', 'via', 'HLA', 'genotyping', 'may', 'reveal', 'more', 'evident', 'associations', 'between', 'HLA', 'haplotypes', 'and', 'individual', 'respiratory', 'viral', 'infections', '']"
166631,Protein microarrays: high-throughput tools for proteomics,2014-01-09,Expert Rev Proteomics,https://www.ncbi.nlm.nih.gov/pubmed/19385942/; https://doi.org/10.1586/epr.09.2,"Protein microarrays are versatile tools for parallel, miniaturized screening of binding events involving large numbers of immobilized proteins in a time- and cost-effective manner. They are increasingly applied for high-throughput protein analyses in many research areas, such as protein interactions, expression profiling and target discovery. While conventionally made by the spotting of purified proteins, recent advances in technology have made it possible to produce protein microarrays through in situ cell-free synthesis directly from corresponding DNA arrays. This article reviews recent developments in the generation of protein microarrays and their applications in proteomics and diagnostics.",10.1586/epr.09.2,g0jiaenw,"['Protein', 'microarrays', 'are', 'versatile', 'tools', 'for', 'parallel', 'miniaturized', 'screening', 'of', 'binding', 'events', 'involving', 'large', 'numbers', 'of', 'immobilized', 'proteins', 'in', 'a', 'time', 'and', 'cost', 'effective', 'manner', 'They', 'are', 'increasingly', 'applied', 'for', 'high', 'throughput', 'protein', 'analyses', 'in', 'many', 'research', 'areas', 'such', 'as', 'protein', 'interactions', 'expression', 'profiling', 'and', 'target', 'discovery', 'While', 'conventionally', 'made', 'by', 'the', 'spotting', 'of', 'purified', 'proteins', 'recent', 'advances', 'in', 'technology', 'have', 'made', 'it', 'possible', 'to', 'produce', 'protein', 'microarrays', 'through', 'in', 'situ', 'cell', 'free', 'synthesis', 'directly', 'from', 'corresponding', 'DNA', 'arrays', 'This', 'article', 'reviews', 'recent', 'developments', 'in', 'the', 'generation', 'of', 'protein', 'microarrays', 'and', 'their', 'applications', 'in', 'proteomics', 'and', 'diagnostics', '']"
166782,Diarrhées aiguës virales : aspects cliniques et évolutifs,2007-10-31,Archives de Pédiatrie,https://api.elsevier.com/content/article/pii/S0929693X07800194; https://www.sciencedirect.com/science/article/pii/S0929693X07800194,"Abstract The molecular characterization of gastroenteritis viruses has led to advances both in our understanding of the pathogens themselves and in development of a new generation of diagnostics. In developing countries, gastroenteritis is a common cause of death in children under 5 years that can be linked to a wide variety of pathogens. In developed countries, while deaths from diarrhoea are less common, much illness leads to hospitalization or doctor visits. Much of the gastroenteritis in children is caused by viruses belonging to four distinct families: rotaviruses, caliciviruses, astroviruses and adenoviruses. Viral gastroenteritis occurs with two epidemiologic patterns, diarrhoea that is endemic in children and outbreaks that affect people of all ages. Rotavirus infection causes severe gastroenteritis, particularly in infants under six months of age.",10.1016/s0929-693x(07)80019-4,vuan5lch,"['Abstract', 'The', 'molecular', 'characterization', 'of', 'gastroenteritis', 'viruses', 'has', 'led', 'to', 'advances', 'both', 'in', 'our', 'understanding', 'of', 'the', 'pathogens', 'themselves', 'and', 'in', 'development', 'of', 'a', 'new', 'generation', 'of', 'diagnostics', 'In', 'developing', 'countries', 'gastroenteritis', 'is', 'a', 'common', 'cause', 'of', 'death', 'in', 'children', 'under', '5', 'years', 'that', 'can', 'be', 'linked', 'to', 'a', 'wide', 'variety', 'of', 'pathogens', 'In', 'developed', 'countries', 'while', 'deaths', 'from', 'diarrhoea', 'are', 'less', 'common', 'much', 'illness', 'leads', 'to', 'hospitalization', 'or', 'doctor', 'visits', 'Much', 'of', 'the', 'gastroenteritis', 'in', 'children', 'is', 'caused', 'by', 'viruses', 'belonging', 'to', 'four', 'distinct', 'families', 'rotaviruses', 'caliciviruses', 'astroviruses', 'and', 'adenoviruses', 'Viral', 'gastroenteritis', 'occurs', 'with', 'two', 'epidemiologic', 'patterns', 'diarrhoea', 'that', 'is', 'endemic', 'in', 'children', 'and', 'outbreaks', 'that', 'affect', 'people', 'of', 'all', 'ages', 'Rotavirus', 'infection', 'causes', 'severe', 'gastroenteritis', 'particularly', 'in', 'infants', 'under', 'six', 'months', 'of', 'age', '']"
167183,Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries,2014-08-05,Infect Dis Poverty,https://www.ncbi.nlm.nih.gov/pubmed/25120913/; https://doi.org/10.1186/2049-9957-3-29,"There is growing concern in Sub-Saharan Africa about the spread of the Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, and the public health burden that it ensues. Since 1976, there have been 885,343 suspected and laboratory confirmed cases of EVD and the disease has claimed 2,512 cases and 932 fatality in West Africa. There are certain requirements that must be met when responding to EVD outbreaks and this process could incur certain challenges. For the purposes of this paper, five have been identified: (i) the deficiency in the development and implementation of surveillance response systems against Ebola and others infectious disease outbreaks in Africa; (ii) the lack of education and knowledge resulting in an EVD outbreak triggering panic, anxiety, psychosocial trauma, isolation and dignity impounding, stigmatisation, community ostracism and resistance to associated socio-ecological and public health consequences; (iii) limited financial resources, human technical capacity and weak community and national health system operational plans for prevention and control responses, practices and management; (iv) inadequate leadership and coordination; and (v) the lack of development of new strategies, tools and approaches, such as improved diagnostics and novel therapies including vaccines which can assist in preventing, controlling and containing Ebola outbreaks as well as the spread of the disease. Hence, there is an urgent need to develop and implement an active early warning alert and surveillance response system for outbreak response and control of emerging infectious diseases. Understanding the unending risks of transmission dynamics and resurgence is essential in implementing rapid effective response interventions tailored to specific local settings and contexts. Therefore, the following actions are recommended: (i) national and regional inter-sectorial and trans-disciplinary surveillance response systems that include early warnings, as well as critical human resources development, must be quickly adopted by allied ministries and organisations in African countries in epidemic and pandemic responses; (ii) harnessing all stakeholders commitment and advocacy in sustained funding, collaboration, communication and networking including community participation to enhance a coordinated responses, as well as tracking and prompt case management to combat challenges; (iii) more research and development in new drug discovery and vaccines; and (iv) understanding the involvement of global health to promote the establishment of public health surveillance response systems with functions of early warning, as well as monitoring and evaluation in upholding research-action programmes and innovative interventions.",10.1186/2049-9957-3-29,8w5elfro,"['There', 'is', 'growing', 'concern', 'in', 'Sub', 'Saharan', 'Africa', 'about', 'the', 'spread', 'of', 'the', 'Ebola', 'virus', 'disease', 'EVD', 'formerly', 'known', 'as', 'Ebola', 'haemorrhagic', 'fever', 'and', 'the', 'public', 'health', 'burden', 'that', 'it', 'ensues', 'Since', '1976', 'there', 'have', 'been', '885', '343', 'suspected', 'and', 'laboratory', 'confirmed', 'cases', 'of', 'EVD', 'and', 'the', 'disease', 'has', 'claimed', '2', '512', 'cases', 'and', '932', 'fatality', 'in', 'West', 'Africa', 'There', 'are', 'certain', 'requirements', 'that', 'must', 'be', 'met', 'when', 'responding', 'to', 'EVD', 'outbreaks', 'and', 'this', 'process', 'could', 'incur', 'certain', 'challenges', 'For', 'the', 'purposes', 'of', 'this', 'paper', 'five', 'have', 'been', 'identified', 'i', 'the', 'deficiency', 'in', 'the', 'development', 'and', 'implementation', 'of', 'surveillance', 'response', 'systems', 'against', 'Ebola', 'and', 'others', 'infectious', 'disease', 'outbreaks', 'in', 'Africa', 'ii', 'the', 'lack', 'of', 'education', 'and', 'knowledge', 'resulting', 'in', 'an', 'EVD', 'outbreak', 'triggering', 'panic', 'anxiety', 'psychosocial', 'trauma', 'isolation', 'and', 'dignity', 'impounding', 'stigmatisation', 'community', 'ostracism', 'and', 'resistance', 'to', 'associated', 'socio', 'ecological', 'and', 'public', 'health', 'consequences', 'iii', 'limited', 'financial', 'resources', 'human', 'technical', 'capacity', 'and', 'weak', 'community', 'and', 'national', 'health', 'system', 'operational', 'plans', 'for', 'prevention', 'and', 'control', 'responses', 'practices', 'and', 'management', 'iv', 'inadequate', 'leadership', 'and', 'coordination', 'and', 'v', 'the', 'lack', 'of', 'development', 'of', 'new', 'strategies', 'tools', 'and', 'approaches', 'such', 'as', 'improved', 'diagnostics', 'and', 'novel', 'therapies', 'including', 'vaccines', 'which', 'can', 'assist', 'in', 'preventing', 'controlling', 'and', 'containing', 'Ebola', 'outbreaks', 'as', 'well', 'as', 'the', 'spread', 'of', 'the', 'disease', 'Hence', 'there', 'is', 'an', 'urgent', 'need', 'to', 'develop', 'and', 'implement', 'an', 'active', 'early', 'warning', 'alert', 'and', 'surveillance', 'response', 'system', 'for', 'outbreak', 'response', 'and', 'control', 'of', 'emerging', 'infectious', 'diseases', 'Understanding', 'the', 'unending', 'risks', 'of', 'transmission', 'dynamics', 'and', 'resurgence', 'is', 'essential', 'in', 'implementing', 'rapid', 'effective', 'response', 'interventions', 'tailored', 'to', 'specific', 'local', 'settings', 'and', 'contexts', 'Therefore', 'the', 'following', 'actions', 'are', 'recommended', 'i', 'national', 'and', 'regional', 'inter', 'sectorial', 'and', 'trans', 'disciplinary', 'surveillance', 'response', 'systems', 'that', 'include', 'early', 'warnings', 'as', 'well', 'as', 'critical', 'human', 'resources', 'development', 'must', 'be', 'quickly', 'adopted', 'by', 'allied', 'ministries', 'and', 'organisations', 'in', 'African', 'countries', 'in', 'epidemic', 'and', 'pandemic', 'responses', 'ii', 'harnessing', 'all', 'stakeholders', 'commitment', 'and', 'advocacy', 'in', 'sustained', 'funding', 'collaboration', 'communication', 'and', 'networking', 'including', 'community', 'participation', 'to', 'enhance', 'a', 'coordinated', 'responses', 'as', 'well', 'as', 'tracking', 'and', 'prompt', 'case', 'management', 'to', 'combat', 'challenges', 'iii', 'more', 'research', 'and', 'development', 'in', 'new', 'drug', 'discovery', 'and', 'vaccines', 'and', 'iv', 'understanding', 'the', 'involvement', 'of', 'global', 'health', 'to', 'promote', 'the', 'establishment', 'of', 'public', 'health', 'surveillance', 'response', 'systems', 'with', 'functions', 'of', 'early', 'warning', 'as', 'well', 'as', 'monitoring', 'and', 'evaluation', 'in', 'upholding', 'research', 'action', 'programmes', 'and', 'innovative', 'interventions', '']"
167221,Rapid Isothermal Amplification and Portable Detection System for SARS-CoV-2,2020-05-21,bioRxiv,https://www.ncbi.nlm.nih.gov/pubmed/32511358/; https://doi.org/10.1101/2020.05.21.108381,"The COVID-19 pandemic provides an urgent example where a gap exists between availability of state-of-the-art diagnostics and current needs. As assay details and primer sequences become widely known, many laboratories could perform diagnostic tests using methods such as RT-PCR or isothermal RT-LAMP amplification. A key advantage of RT-LAMP based approaches compared to RT-PCR is that RT-LAMP is known to be robust in detecting targets from unprocessed samples. In addition, RT-LAMP assays are performed at a constant temperature enabling speed, simplicity, and point-of-use testing. Here, we provide the details of an RT-LAMP isothermal assay for the detection of SARS-CoV-2 virus with performance comparable to currently approved tests using RT-PCR. We characterize the assay by introducing swabs in virus spiked synthetic nasal fluids, moving the swab to viral transport medium (VTM), and using a volume of that VTM for performing the amplification without an RNA extraction kit. The assay has a Limit-of-Detection (LOD) of 50 RNA copies/μL in the VTM solution within 20 minutes, and LOD of 5000 RNA copies/μL in the nasal solution. Additionally, we show the utility of this assay for real-time point-of-use testing by demonstrating detection of SARS-CoV-2 virus in less than 40 minutes using an additively manufactured cartridge and a smartphone-based reader. Finally, we explore the speed and cost advantages by comparing the required resources and workflows with RT-PCR. This work could accelerate the development and availability of SARS-CoV-2 diagnostics by proving alternatives to conventional laboratory benchtop tests.",10.1101/2020.05.21.108381,6epdh88j,"['The', 'COVID', '19', 'pandemic', 'provides', 'an', 'urgent', 'example', 'where', 'a', 'gap', 'exists', 'between', 'availability', 'of', 'state', 'of', 'the', 'art', 'diagnostics', 'and', 'current', 'needs', 'As', 'assay', 'details', 'and', 'primer', 'sequences', 'become', 'widely', 'known', 'many', 'laboratories', 'could', 'perform', 'diagnostic', 'tests', 'using', 'methods', 'such', 'as', 'RT', 'PCR', 'or', 'isothermal', 'RT', 'LAMP', 'amplification', 'A', 'key', 'advantage', 'of', 'RT', 'LAMP', 'based', 'approaches', 'compared', 'to', 'RT', 'PCR', 'is', 'that', 'RT', 'LAMP', 'is', 'known', 'to', 'be', 'robust', 'in', 'detecting', 'targets', 'from', 'unprocessed', 'samples', 'In', 'addition', 'RT', 'LAMP', 'assays', 'are', 'performed', 'at', 'a', 'constant', 'temperature', 'enabling', 'speed', 'simplicity', 'and', 'point', 'of', 'use', 'testing', 'Here', 'we', 'provide', 'the', 'details', 'of', 'an', 'RT', 'LAMP', 'isothermal', 'assay', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'virus', 'with', 'performance', 'comparable', 'to', 'currently', 'approved', 'tests', 'using', 'RT', 'PCR', 'We', 'characterize', 'the', 'assay', 'by', 'introducing', 'swabs', 'in', 'virus', 'spiked', 'synthetic', 'nasal', 'fluids', 'moving', 'the', 'swab', 'to', 'viral', 'transport', 'medium', 'VTM', 'and', 'using', 'a', 'volume', 'of', 'that', 'VTM', 'for', 'performing', 'the', 'amplification', 'without', 'an', 'RNA', 'extraction', 'kit', 'The', 'assay', 'has', 'a', 'Limit', 'of', 'Detection', 'LOD', 'of', '50', 'RNA', 'copies', 'μL', 'in', 'the', 'VTM', 'solution', 'within', '20', 'minutes', 'and', 'LOD', 'of', '5000', 'RNA', 'copies', 'μL', 'in', 'the', 'nasal', 'solution', 'Additionally', 'we', 'show', 'the', 'utility', 'of', 'this', 'assay', 'for', 'real', 'time', 'point', 'of', 'use', 'testing', 'by', 'demonstrating', 'detection', 'of', 'SARS', 'CoV', '2', 'virus', 'in', 'less', 'than', '40', 'minutes', 'using', 'an', 'additively', 'manufactured', 'cartridge', 'and', 'a', 'smartphone', 'based', 'reader', 'Finally', 'we', 'explore', 'the', 'speed', 'and', 'cost', 'advantages', 'by', 'comparing', 'the', 'required', 'resources', 'and', 'workflows', 'with', 'RT', 'PCR', 'This', 'work', 'could', 'accelerate', 'the', 'development', 'and', 'availability', 'of', 'SARS', 'CoV', '2', 'diagnostics', 'by', 'proving', 'alternatives', 'to', 'conventional', 'laboratory', 'benchtop', 'tests', '']"
167580,Enhancing preparation for large Nipah outbreaks beyond Bangladesh: Preventing a tragedy like Ebola in West Africa,2018-07-31,International Journal of Infectious Diseases,https://api.elsevier.com/content/article/pii/S1201971218344254; https://doi.org/10.1016/j.ijid.2018.05.015; https://www.sciencedirect.com/science/article/pii/S1201971218344254; https://www.ncbi.nlm.nih.gov/pubmed/29879523/,"Abstract The Nipah virus has been transmitted from person-to-person via close contact in non-urban parts of India (including Kerala May 2018), Bangladesh, and the Philippines. It can cause encephalitis and pneumonia, and has a high case fatality rate. Nipah is a One Health zoonotic infectious disease linked to fruit bats, and sometimes pigs or horses. We advocate anticipating and preparing for urban and larger rural outbreaks of Nipah. Immediate enhanced preparations would include standardized guidance on infection prevention and control, and personal protective equipment, from the World Health Organization (WHO) on their OpenWHO website and 2018 “Managing Epidemics” handbook, along with adding best clinical practices by experts in countries with multiple outbreaks such as Bangladesh and India. Longer-term enhanced preparations include accelerating development of field diagnostics, antiviral drugs, immune-based therapies, and vaccines. WHO-coordinated multi-partner protocols to test investigational treatments, diagnostics, and vaccines are needed, by analogy to such protocols for Ebola during the unanticipated pan-epidemic in Guinea, Liberia, and Sierra Leone. Anticipating and preparing now for urban and rural Nipah outbreaks in nations with no experience with Nipah will help avoid the potential for what the United Nations 2016 report on Ebola in West Africa called a “preventable tragedy”.",10.1016/j.ijid.2018.05.015,se5xtmul,"['Abstract', 'The', 'Nipah', 'virus', 'has', 'been', 'transmitted', 'from', 'person', 'to', 'person', 'via', 'close', 'contact', 'in', 'non', 'urban', 'parts', 'of', 'India', 'including', 'Kerala', 'May', '2018', 'Bangladesh', 'and', 'the', 'Philippines', 'It', 'can', 'cause', 'encephalitis', 'and', 'pneumonia', 'and', 'has', 'a', 'high', 'case', 'fatality', 'rate', 'Nipah', 'is', 'a', 'One', 'Health', 'zoonotic', 'infectious', 'disease', 'linked', 'to', 'fruit', 'bats', 'and', 'sometimes', 'pigs', 'or', 'horses', 'We', 'advocate', 'anticipating', 'and', 'preparing', 'for', 'urban', 'and', 'larger', 'rural', 'outbreaks', 'of', 'Nipah', 'Immediate', 'enhanced', 'preparations', 'would', 'include', 'standardized', 'guidance', 'on', 'infection', 'prevention', 'and', 'control', 'and', 'personal', 'protective', 'equipment', 'from', 'the', 'World', 'Health', 'Organization', 'WHO', 'on', 'their', 'OpenWHO', 'website', 'and', '2018', 'Managing', 'Epidemics', 'handbook', 'along', 'with', 'adding', 'best', 'clinical', 'practices', 'by', 'experts', 'in', 'countries', 'with', 'multiple', 'outbreaks', 'such', 'as', 'Bangladesh', 'and', 'India', 'Longer', 'term', 'enhanced', 'preparations', 'include', 'accelerating', 'development', 'of', 'field', 'diagnostics', 'antiviral', 'drugs', 'immune', 'based', 'therapies', 'and', 'vaccines', 'WHO', 'coordinated', 'multi', 'partner', 'protocols', 'to', 'test', 'investigational', 'treatments', 'diagnostics', 'and', 'vaccines', 'are', 'needed', 'by', 'analogy', 'to', 'such', 'protocols', 'for', 'Ebola', 'during', 'the', 'unanticipated', 'pan', 'epidemic', 'in', 'Guinea', 'Liberia', 'and', 'Sierra', 'Leone', 'Anticipating', 'and', 'preparing', 'now', 'for', 'urban', 'and', 'rural', 'Nipah', 'outbreaks', 'in', 'nations', 'with', 'no', 'experience', 'with', 'Nipah', 'will', 'help', 'avoid', 'the', 'potential', 'for', 'what', 'the', 'United', 'Nations', '2016', 'report', 'on', 'Ebola', 'in', 'West', 'Africa', 'called', 'a', 'preventable', 'tragedy', '']"
168247,Real-Time Sequence-Validated Loop-Mediated Isothermal Amplification Assays for Detection of Middle East Respiratory Syndrome Coronavirus (MERS-CoV),2015-04-09,PLoS One,https://doi.org/10.1371/journal.pone.0123126; https://www.ncbi.nlm.nih.gov/pubmed/25856093/,"The Middle East respiratory syndrome coronavirus (MERS-CoV), an emerging human coronavirus, causes severe acute respiratory illness with a 35% mortality rate. In light of the recent surge in reported infections we have developed asymmetric five-primer reverse transcription loop-mediated isothermal amplification (RT-LAMP) assays for detection of MERS-CoV. Isothermal amplification assays will facilitate the development of portable point-of-care diagnostics that are crucial for management of emerging infections. The RT-LAMP assays are designed to amplify MERS-CoV genomic loci located within the open reading frame (ORF)1a and ORF1b genes and upstream of the E gene. Additionally we applied one-step strand displacement probes (OSD) for real-time sequence-specific verification of LAMP amplicons. Asymmetric amplification effected by incorporating a single loop primer in each assay accelerated the time-to-result of the OSD-RT-LAMP assays. The resulting assays could detect 0.02 to 0.2 plaque forming units (PFU) (5 to 50 PFU/ml) of MERS-CoV in infected cell culture supernatants within 30 to 50 min and did not cross-react with common human respiratory pathogens.",10.1371/journal.pone.0123126,4jagpyyu,"['The', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'an', 'emerging', 'human', 'coronavirus', 'causes', 'severe', 'acute', 'respiratory', 'illness', 'with', 'a', '35', 'mortality', 'rate', 'In', 'light', 'of', 'the', 'recent', 'surge', 'in', 'reported', 'infections', 'we', 'have', 'developed', 'asymmetric', 'five', 'primer', 'reverse', 'transcription', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'assays', 'for', 'detection', 'of', 'MERS', 'CoV', 'Isothermal', 'amplification', 'assays', 'will', 'facilitate', 'the', 'development', 'of', 'portable', 'point', 'of', 'care', 'diagnostics', 'that', 'are', 'crucial', 'for', 'management', 'of', 'emerging', 'infections', 'The', 'RT', 'LAMP', 'assays', 'are', 'designed', 'to', 'amplify', 'MERS', 'CoV', 'genomic', 'loci', 'located', 'within', 'the', 'open', 'reading', 'frame', 'ORF', '1a', 'and', 'ORF1b', 'genes', 'and', 'upstream', 'of', 'the', 'E', 'gene', 'Additionally', 'we', 'applied', 'one', 'step', 'strand', 'displacement', 'probes', 'OSD', 'for', 'real', 'time', 'sequence', 'specific', 'verification', 'of', 'LAMP', 'amplicons', 'Asymmetric', 'amplification', 'effected', 'by', 'incorporating', 'a', 'single', 'loop', 'primer', 'in', 'each', 'assay', 'accelerated', 'the', 'time', 'to', 'result', 'of', 'the', 'OSD', 'RT', 'LAMP', 'assays', 'The', 'resulting', 'assays', 'could', 'detect', '0', '02', 'to', '0', '2', 'plaque', 'forming', 'units', 'PFU', '5', 'to', '50', 'PFU', 'ml', 'of', 'MERS', 'CoV', 'in', 'infected', 'cell', 'culture', 'supernatants', 'within', '30', 'to', '50', 'min', 'and', 'did', 'not', 'cross', 'react', 'with', 'common', 'human', 'respiratory', 'pathogens', '']"
168319,The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic,2017-02-28,J Microbiol,https://doi.org/10.1007/s12275-017-7026-y; https://www.ncbi.nlm.nih.gov/pubmed/28243939/,"Rapidly emerging infectious disease outbreaks place a great strain on laboratories to develop and implement sensitive and specific diagnostic tests for patient management and infection control in a timely manner. Furthermore, laboratories also play a role in real-time zoonotic, environmental, and epidemiological investigations to identify the ultimate source of the epidemic, facilitating measures to eventually control the outbreak. Each assay modality has unique pros and cons; therefore, incorporation of a battery of tests using traditional culture-based, molecular and serological diagnostics into diagnostic algorithms is often required. As such, laboratories face challenges in assay development, test evaluation, and subsequent quality assurance. In this review, we describe the different testing modalities available for the ongoing Middle East respiratory syndrome (MERS) epidemic including cell culture, nucleic acid amplification, antigen detection, and antibody detection assays. Applications of such tests in both acute clinical and epidemiological investigation settings are highlighted. Using the MERS epidemic as an example, we illustrate the various challenges faced by laboratories in test development and implementation in the setting of a rapidly emerging infectious disease. Future directions in the diagnosis of MERS and other emerging infectious disease investigations are also highlighted.",10.1007/s12275-017-7026-y,i0i5p4k7,"['Rapidly', 'emerging', 'infectious', 'disease', 'outbreaks', 'place', 'a', 'great', 'strain', 'on', 'laboratories', 'to', 'develop', 'and', 'implement', 'sensitive', 'and', 'specific', 'diagnostic', 'tests', 'for', 'patient', 'management', 'and', 'infection', 'control', 'in', 'a', 'timely', 'manner', 'Furthermore', 'laboratories', 'also', 'play', 'a', 'role', 'in', 'real', 'time', 'zoonotic', 'environmental', 'and', 'epidemiological', 'investigations', 'to', 'identify', 'the', 'ultimate', 'source', 'of', 'the', 'epidemic', 'facilitating', 'measures', 'to', 'eventually', 'control', 'the', 'outbreak', 'Each', 'assay', 'modality', 'has', 'unique', 'pros', 'and', 'cons', 'therefore', 'incorporation', 'of', 'a', 'battery', 'of', 'tests', 'using', 'traditional', 'culture', 'based', 'molecular', 'and', 'serological', 'diagnostics', 'into', 'diagnostic', 'algorithms', 'is', 'often', 'required', 'As', 'such', 'laboratories', 'face', 'challenges', 'in', 'assay', 'development', 'test', 'evaluation', 'and', 'subsequent', 'quality', 'assurance', 'In', 'this', 'review', 'we', 'describe', 'the', 'different', 'testing', 'modalities', 'available', 'for', 'the', 'ongoing', 'Middle', 'East', 'respiratory', 'syndrome', 'MERS', 'epidemic', 'including', 'cell', 'culture', 'nucleic', 'acid', 'amplification', 'antigen', 'detection', 'and', 'antibody', 'detection', 'assays', 'Applications', 'of', 'such', 'tests', 'in', 'both', 'acute', 'clinical', 'and', 'epidemiological', 'investigation', 'settings', 'are', 'highlighted', 'Using', 'the', 'MERS', 'epidemic', 'as', 'an', 'example', 'we', 'illustrate', 'the', 'various', 'challenges', 'faced', 'by', 'laboratories', 'in', 'test', 'development', 'and', 'implementation', 'in', 'the', 'setting', 'of', 'a', 'rapidly', 'emerging', 'infectious', 'disease', 'Future', 'directions', 'in', 'the', 'diagnosis', 'of', 'MERS', 'and', 'other', 'emerging', 'infectious', 'disease', 'investigations', 'are', 'also', 'highlighted', '']"
168418,Viral glycoproteins: biological role and application in diagnosis,2016-01-18,VirusDisease,https://doi.org/10.1007/s13337-015-0293-5; https://link.springer.com/content/pdf/10.1007/s13337-015-0293-5.pdf; https://www.ncbi.nlm.nih.gov/pubmed/26925438/,"The viruses that infect humans cause a huge global disease burden and produce immense challenge towards healthcare system. Glycoproteins are one of the major components of human pathogenic viruses. They have been demonstrated to have important role(s) in infection and immunity. Concomitantly high titres of antibodies against these antigenic viral glycoproteins have paved the way for development of novel diagnostics. Availability of appropriate biomarkers is necessary for advance diagnosis of infectious diseases especially in case of outbreaks. As human mobilization has increased manifold nowadays, dissemination of infectious agents became quicker that paves the need of rapid diagnostic system. In case of viral infection it is an emergency as virus spreads and mutates very fast. This review encircles the vast arena of viral glycoproteins, their importance in health and disease and their diagnostic applications.",10.1007/s13337-015-0293-5,gxu0refq,"['The', 'viruses', 'that', 'infect', 'humans', 'cause', 'a', 'huge', 'global', 'disease', 'burden', 'and', 'produce', 'immense', 'challenge', 'towards', 'healthcare', 'system', 'Glycoproteins', 'are', 'one', 'of', 'the', 'major', 'components', 'of', 'human', 'pathogenic', 'viruses', 'They', 'have', 'been', 'demonstrated', 'to', 'have', 'important', 'role', 's', 'in', 'infection', 'and', 'immunity', 'Concomitantly', 'high', 'titres', 'of', 'antibodies', 'against', 'these', 'antigenic', 'viral', 'glycoproteins', 'have', 'paved', 'the', 'way', 'for', 'development', 'of', 'novel', 'diagnostics', 'Availability', 'of', 'appropriate', 'biomarkers', 'is', 'necessary', 'for', 'advance', 'diagnosis', 'of', 'infectious', 'diseases', 'especially', 'in', 'case', 'of', 'outbreaks', 'As', 'human', 'mobilization', 'has', 'increased', 'manifold', 'nowadays', 'dissemination', 'of', 'infectious', 'agents', 'became', 'quicker', 'that', 'paves', 'the', 'need', 'of', 'rapid', 'diagnostic', 'system', 'In', 'case', 'of', 'viral', 'infection', 'it', 'is', 'an', 'emergency', 'as', 'virus', 'spreads', 'and', 'mutates', 'very', 'fast', 'This', 'review', 'encircles', 'the', 'vast', 'arena', 'of', 'viral', 'glycoproteins', 'their', 'importance', 'in', 'health', 'and', 'disease', 'and', 'their', 'diagnostic', 'applications', '']"
168962,Scanning the horizon: emerging hospital-wide technologies and their impact on critical care,2005-01-13,Crit Care,https://www.ncbi.nlm.nih.gov/pubmed/15693973/,"This commentary represents a selective survey of developments relevant to critical care. Selected themes include advances in point-of-care diagnostic testing, glucose control, novel microbiological diagnostics and infection control measures, and developments in information technology that have implications for intensive care. The latter encompasses an early example of an artificially intelligent clinical decision support mechanism, the introduction of a national health care information technology programme (UK NPfIT) and its implications, and exotic threats to patient safety due to emergent behaviour in complex information systems.",10.1186/cc3046,xiv9vxdp,"['This', 'commentary', 'represents', 'a', 'selective', 'survey', 'of', 'developments', 'relevant', 'to', 'critical', 'care', 'Selected', 'themes', 'include', 'advances', 'in', 'point', 'of', 'care', 'diagnostic', 'testing', 'glucose', 'control', 'novel', 'microbiological', 'diagnostics', 'and', 'infection', 'control', 'measures', 'and', 'developments', 'in', 'information', 'technology', 'that', 'have', 'implications', 'for', 'intensive', 'care', 'The', 'latter', 'encompasses', 'an', 'early', 'example', 'of', 'an', 'artificially', 'intelligent', 'clinical', 'decision', 'support', 'mechanism', 'the', 'introduction', 'of', 'a', 'national', 'health', 'care', 'information', 'technology', 'programme', 'UK', 'NPfIT', 'and', 'its', 'implications', 'and', 'exotic', 'threats', 'to', 'patient', 'safety', 'due', 'to', 'emergent', 'behaviour', 'in', 'complex', 'information', 'systems', '']"
169820,Chapter 1 Nanomaterials in Biosensors Fundamentals and Applications,2018-12-31,Nanomaterials for Biosensors,https://api.elsevier.com/content/article/pii/B9780323449236000017; https://www.sciencedirect.com/science/article/pii/B9780323449236000017,"Abstract With the recent advancement of nanomaterials and nanostructured materials, the point-of-care biosensor devices have shown a potential growth to revolutionize the future personalized health care diagnostics and therapy practices. This chapter deals with the fundamentals of nanomaterials-based biosensors. The first chapter covers the brief details of nanotechnology with its types and an introduction to the synthesis of nanomaterials and their importance to construct transducers. The different components of transducers such as electrochemical, optical, piezoelectric, thermal, surface plasmon resonance, and so on for biosensors have been explained in this chapter. Various principles utilized for development of enzymatic biosensors, immunosensors, DNA, and whole-cell biosensors have been included in this chapter. Immobilization of bioreceptors is a crucial step to fabricate biosensors and their stepwise demonstration and conjugation of nanomaterials with nanomaterials have been described.",10.1016/b978-0-323-44923-6.00001-7,vjyo2thc,"['Abstract', 'With', 'the', 'recent', 'advancement', 'of', 'nanomaterials', 'and', 'nanostructured', 'materials', 'the', 'point', 'of', 'care', 'biosensor', 'devices', 'have', 'shown', 'a', 'potential', 'growth', 'to', 'revolutionize', 'the', 'future', 'personalized', 'health', 'care', 'diagnostics', 'and', 'therapy', 'practices', 'This', 'chapter', 'deals', 'with', 'the', 'fundamentals', 'of', 'nanomaterials', 'based', 'biosensors', 'The', 'first', 'chapter', 'covers', 'the', 'brief', 'details', 'of', 'nanotechnology', 'with', 'its', 'types', 'and', 'an', 'introduction', 'to', 'the', 'synthesis', 'of', 'nanomaterials', 'and', 'their', 'importance', 'to', 'construct', 'transducers', 'The', 'different', 'components', 'of', 'transducers', 'such', 'as', 'electrochemical', 'optical', 'piezoelectric', 'thermal', 'surface', 'plasmon', 'resonance', 'and', 'so', 'on', 'for', 'biosensors', 'have', 'been', 'explained', 'in', 'this', 'chapter', 'Various', 'principles', 'utilized', 'for', 'development', 'of', 'enzymatic', 'biosensors', 'immunosensors', 'DNA', 'and', 'whole', 'cell', 'biosensors', 'have', 'been', 'included', 'in', 'this', 'chapter', 'Immobilization', 'of', 'bioreceptors', 'is', 'a', 'crucial', 'step', 'to', 'fabricate', 'biosensors', 'and', 'their', 'stepwise', 'demonstration', 'and', 'conjugation', 'of', 'nanomaterials', 'with', 'nanomaterials', 'have', 'been', 'described', '']"
170427,An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection,2020-07-29,Antiviral Res,https://api.elsevier.com/content/article/pii/S0166354220302965; https://www.sciencedirect.com/science/article/pii/S0166354220302965?v=s5; https://doi.org/10.1016/j.antiviral.2020.104882,"SARS-CoV-2 is a novel pandemic coronavirus that caused a global health and economic crisis. The development of efficient drugs and vaccines against COVID-19 requires detailed knowledge about SARS-CoV-2 biology. Several techniques to detect SARS-CoV-2 infection have been established, mainly based on counting infected cells by staining plaques or foci, or by quantifying the viral genome by PCR. These methods are laborious, time-consuming and expensive and therefore not suitable for a high sample throughput or rapid diagnostics. We here report a novel enzyme-based immunodetection assay that directly quantifies the amount of de novo synthesized viral spike protein within fixed and permeabilized cells. This in-cell ELISA enables a rapid and quantitative detection of SARS-CoV-2 infection in microtiter format, regardless of the virus isolate or target cell culture. It follows the established method of performing ELISA assays and does not require expensive instrumentation. Utilization of the in-cell ELISA allows to e.g. determine TCID(50) of virus stocks, antiviral efficiencies (IC(50) values) of drugs or neutralizing activity of sera. Thus, the in-cell spike ELISA represents a promising alternative to study SARS-CoV-2 infection and inhibition and may facilitate future research.",10.1016/j.antiviral.2020.104882,4bai2wg7,"['SARS', 'CoV', '2', 'is', 'a', 'novel', 'pandemic', 'coronavirus', 'that', 'caused', 'a', 'global', 'health', 'and', 'economic', 'crisis', 'The', 'development', 'of', 'efficient', 'drugs', 'and', 'vaccines', 'against', 'COVID', '19', 'requires', 'detailed', 'knowledge', 'about', 'SARS', 'CoV', '2', 'biology', 'Several', 'techniques', 'to', 'detect', 'SARS', 'CoV', '2', 'infection', 'have', 'been', 'established', 'mainly', 'based', 'on', 'counting', 'infected', 'cells', 'by', 'staining', 'plaques', 'or', 'foci', 'or', 'by', 'quantifying', 'the', 'viral', 'genome', 'by', 'PCR', 'These', 'methods', 'are', 'laborious', 'time', 'consuming', 'and', 'expensive', 'and', 'therefore', 'not', 'suitable', 'for', 'a', 'high', 'sample', 'throughput', 'or', 'rapid', 'diagnostics', 'We', 'here', 'report', 'a', 'novel', 'enzyme', 'based', 'immunodetection', 'assay', 'that', 'directly', 'quantifies', 'the', 'amount', 'of', 'de', 'novo', 'synthesized', 'viral', 'spike', 'protein', 'within', 'fixed', 'and', 'permeabilized', 'cells', 'This', 'in', 'cell', 'ELISA', 'enables', 'a', 'rapid', 'and', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'infection', 'in', 'microtiter', 'format', 'regardless', 'of', 'the', 'virus', 'isolate', 'or', 'target', 'cell', 'culture', 'It', 'follows', 'the', 'established', 'method', 'of', 'performing', 'ELISA', 'assays', 'and', 'does', 'not', 'require', 'expensive', 'instrumentation', 'Utilization', 'of', 'the', 'in', 'cell', 'ELISA', 'allows', 'to', 'e', 'g', 'determine', 'TCID', '50', 'of', 'virus', 'stocks', 'antiviral', 'efficiencies', 'IC', '50', 'values', 'of', 'drugs', 'or', 'neutralizing', 'activity', 'of', 'sera', 'Thus', 'the', 'in', 'cell', 'spike', 'ELISA', 'represents', 'a', 'promising', 'alternative', 'to', 'study', 'SARS', 'CoV', '2', 'infection', 'and', 'inhibition', 'and', 'may', 'facilitate', 'future', 'research', '']"
170494,Fighting COVID-19: Integrated Micro- and Nanosystems for Viral Infection Diagnostics,2020-07-09,Matter,https://api.elsevier.com/content/article/pii/S2590238520303052; https://doi.org/10.1016/j.matt.2020.06.015; https://www.sciencedirect.com/science/article/pii/S2590238520303052,"The pandemic of coronavirus disease 2019 (COVID-19) highlights the importance of rapid and sensitive diagnostics of viral infection that enables the efficient tracing of cases and the implementation of public health measures for disease containment. The immediate actions from both academia and industry have led to the development of many COVID-19 diagnostic systems that have secured fast-track regulatory approvals and have been serving our healthcare frontlines since the early stage of the pandemic. On diagnostic technologies, many of these clinically validated systems have significantly benefited from the recent advances in micro- and nanotechnologies in terms of platform design, analytical method, and system integration and miniaturization. The continued development of new diagnostic platforms integrating micro- and nanocomponents will address some of the shortcomings we have witnessed in the existing COVID-19 diagnostic systems. This Perspective reviews the previous and ongoing research efforts on developing integrated micro- and nanosystems for nucleic acid-based virus detection, and highlights promising technologies that could provide better solutions for the diagnosis of COVID-19 and other viral infectious diseases. With the summary and outlook of this rapidly evolving research field, we hope to inspire more research and development activities to better prepare our society for future public health crises.",10.1016/j.matt.2020.06.015,7v6rj65a,"['The', 'pandemic', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'highlights', 'the', 'importance', 'of', 'rapid', 'and', 'sensitive', 'diagnostics', 'of', 'viral', 'infection', 'that', 'enables', 'the', 'efficient', 'tracing', 'of', 'cases', 'and', 'the', 'implementation', 'of', 'public', 'health', 'measures', 'for', 'disease', 'containment', 'The', 'immediate', 'actions', 'from', 'both', 'academia', 'and', 'industry', 'have', 'led', 'to', 'the', 'development', 'of', 'many', 'COVID', '19', 'diagnostic', 'systems', 'that', 'have', 'secured', 'fast', 'track', 'regulatory', 'approvals', 'and', 'have', 'been', 'serving', 'our', 'healthcare', 'frontlines', 'since', 'the', 'early', 'stage', 'of', 'the', 'pandemic', 'On', 'diagnostic', 'technologies', 'many', 'of', 'these', 'clinically', 'validated', 'systems', 'have', 'significantly', 'benefited', 'from', 'the', 'recent', 'advances', 'in', 'micro', 'and', 'nanotechnologies', 'in', 'terms', 'of', 'platform', 'design', 'analytical', 'method', 'and', 'system', 'integration', 'and', 'miniaturization', 'The', 'continued', 'development', 'of', 'new', 'diagnostic', 'platforms', 'integrating', 'micro', 'and', 'nanocomponents', 'will', 'address', 'some', 'of', 'the', 'shortcomings', 'we', 'have', 'witnessed', 'in', 'the', 'existing', 'COVID', '19', 'diagnostic', 'systems', 'This', 'Perspective', 'reviews', 'the', 'previous', 'and', 'ongoing', 'research', 'efforts', 'on', 'developing', 'integrated', 'micro', 'and', 'nanosystems', 'for', 'nucleic', 'acid', 'based', 'virus', 'detection', 'and', 'highlights', 'promising', 'technologies', 'that', 'could', 'provide', 'better', 'solutions', 'for', 'the', 'diagnosis', 'of', 'COVID', '19', 'and', 'other', 'viral', 'infectious', 'diseases', 'With', 'the', 'summary', 'and', 'outlook', 'of', 'this', 'rapidly', 'evolving', 'research', 'field', 'we', 'hope', 'to', 'inspire', 'more', 'research', 'and', 'development', 'activities', 'to', 'better', 'prepare', 'our', 'society', 'for', 'future', 'public', 'health', 'crises', '']"
170563,Current applications and future trends of molecular diagnostics in clinical bacteriology,2009-04-18,Anal Bioanal Chem,https://www.ncbi.nlm.nih.gov/pubmed/19377839/; https://doi.org/10.1007/s00216-009-2779-8,"Molecular diagnostics of infectious diseases, in particular, nucleic-acid-based methods, are the fastest growing field in clinical laboratory diagnostics. These applications are stepwise replacing or complementing culture-based, biochemical, and immunological assays in microbiology laboratories. The first-generation nucleic acid assays were monoparametric such as conventional tests, determining only a single parameter. Improvements and new approaches in technology now open the possibility for the development of multiparameter assays using microarrays, multiplex nucleic acid amplification techniques, or mass spectrometry, while the introduction of closed-tube systems has resulted in rapid microbial diagnostics with a subsequently reduced contamination risk. Whereas the first assays were focused on the detection and identification of microbial pathogens, these new technologies paved the way for the parallel determination of multiple antibiotic resistance determinants or to perform microbial epidemiology and surveillance on a genetic level.",10.1007/s00216-009-2779-8,sxh2nqre,"['Molecular', 'diagnostics', 'of', 'infectious', 'diseases', 'in', 'particular', 'nucleic', 'acid', 'based', 'methods', 'are', 'the', 'fastest', 'growing', 'field', 'in', 'clinical', 'laboratory', 'diagnostics', 'These', 'applications', 'are', 'stepwise', 'replacing', 'or', 'complementing', 'culture', 'based', 'biochemical', 'and', 'immunological', 'assays', 'in', 'microbiology', 'laboratories', 'The', 'first', 'generation', 'nucleic', 'acid', 'assays', 'were', 'monoparametric', 'such', 'as', 'conventional', 'tests', 'determining', 'only', 'a', 'single', 'parameter', 'Improvements', 'and', 'new', 'approaches', 'in', 'technology', 'now', 'open', 'the', 'possibility', 'for', 'the', 'development', 'of', 'multiparameter', 'assays', 'using', 'microarrays', 'multiplex', 'nucleic', 'acid', 'amplification', 'techniques', 'or', 'mass', 'spectrometry', 'while', 'the', 'introduction', 'of', 'closed', 'tube', 'systems', 'has', 'resulted', 'in', 'rapid', 'microbial', 'diagnostics', 'with', 'a', 'subsequently', 'reduced', 'contamination', 'risk', 'Whereas', 'the', 'first', 'assays', 'were', 'focused', 'on', 'the', 'detection', 'and', 'identification', 'of', 'microbial', 'pathogens', 'these', 'new', 'technologies', 'paved', 'the', 'way', 'for', 'the', 'parallel', 'determination', 'of', 'multiple', 'antibiotic', 'resistance', 'determinants', 'or', 'to', 'perform', 'microbial', 'epidemiology', 'and', 'surveillance', 'on', 'a', 'genetic', 'level', '']"
170933,Applications of microarrays in pathogen detection and biodefence,2009-01-31,Trends in Biotechnology,https://doi.org/10.1016/j.tibtech.2008.09.004; https://www.ncbi.nlm.nih.gov/pubmed/19008003/; https://www.sciencedirect.com/science/article/pii/S0167779908002503; https://api.elsevier.com/content/article/pii/S0167779908002503,"The microarray is a platform with wide-ranging potential in biodefence. Owing to the high level of throughput attainable through miniaturization, microarrays have accelerated the ability to respond in an epidemic or crisis. Extending beyond diagnostics, recent studies have applied microarrays as a research tool towards understanding the etiology and pathogenicity of dangerous pathogens, as well as in vaccine development. The original emphasis was on DNA microarrays, but the range now includes protein, antibody and carbohydrate microarrays, and research groups have exploited this diversity to further extend microarray applications in the area of biodefence. Here, we discuss the impact and contributions of the growing range of microarrays and emphasize the concepts that might shape the future of biodefence research.",10.1016/j.tibtech.2008.09.004,vgizgq2y,"['The', 'microarray', 'is', 'a', 'platform', 'with', 'wide', 'ranging', 'potential', 'in', 'biodefence', 'Owing', 'to', 'the', 'high', 'level', 'of', 'throughput', 'attainable', 'through', 'miniaturization', 'microarrays', 'have', 'accelerated', 'the', 'ability', 'to', 'respond', 'in', 'an', 'epidemic', 'or', 'crisis', 'Extending', 'beyond', 'diagnostics', 'recent', 'studies', 'have', 'applied', 'microarrays', 'as', 'a', 'research', 'tool', 'towards', 'understanding', 'the', 'etiology', 'and', 'pathogenicity', 'of', 'dangerous', 'pathogens', 'as', 'well', 'as', 'in', 'vaccine', 'development', 'The', 'original', 'emphasis', 'was', 'on', 'DNA', 'microarrays', 'but', 'the', 'range', 'now', 'includes', 'protein', 'antibody', 'and', 'carbohydrate', 'microarrays', 'and', 'research', 'groups', 'have', 'exploited', 'this', 'diversity', 'to', 'further', 'extend', 'microarray', 'applications', 'in', 'the', 'area', 'of', 'biodefence', 'Here', 'we', 'discuss', 'the', 'impact', 'and', 'contributions', 'of', 'the', 'growing', 'range', 'of', 'microarrays', 'and', 'emphasize', 'the', 'concepts', 'that', 'might', 'shape', 'the', 'future', 'of', 'biodefence', 'research', '']"
171019,Importance of diagnostics in epidemic and pandemic preparedness,2019-01-29,BMJ Glob Health,https://www.ncbi.nlm.nih.gov/pubmed/30815287/; https://doi.org/10.1136/bmjgh-2018-001179,"Diagnostics are fundamental for successful outbreak containment. In this supplement, ‘Diagnostic preparedness for WHO Blueprint pathogens’, we describe specific diagnostic challenges presented by selected priority pathogens most likely to cause future epidemics. Some challenges to diagnostic preparedness are common to all outbreak situations, as highlighted by recent outbreaks of Ebola, Zika and yellow fever. In this article, we review these overarching challenges and explore potential solutions. Challenges include fragmented and unreliable funding pathways, limited access to specimens and reagents, inadequate diagnostic testing capacity at both national and community levels of healthcare and lack of incentives for companies to develop and manufacture diagnostics for priority pathogens during non-outbreak periods. Addressing these challenges in an efficient and effective way will require multiple stakeholders—public and private—coordinated in implementing a holistic approach to diagnostics preparedness. All require strengthening of healthcare system diagnostic capacity (including surveillance and education of healthcare workers), establishment of sustainable financing and market strategies and integration of diagnostics with existing mechanisms. Identifying overlaps in diagnostic development needs across different priority pathogens would allow more timely and cost-effective use of resources than a pathogen by pathogen approach; target product profiles for diagnostics should be refined accordingly. We recommend the establishment of a global forum to bring together representatives from all key stakeholders required for the response to develop a coordinated implementation plan. In addition, we should explore if and how existing mechanisms to address challenges to the vaccines sector, such as Coalition for Epidemic Preparedness Innovations and Gavi, could be expanded to cover diagnostics.",10.1136/bmjgh-2018-001179,mcyeyl4s,"['Diagnostics', 'are', 'fundamental', 'for', 'successful', 'outbreak', 'containment', 'In', 'this', 'supplement', 'Diagnostic', 'preparedness', 'for', 'WHO', 'Blueprint', 'pathogens', 'we', 'describe', 'specific', 'diagnostic', 'challenges', 'presented', 'by', 'selected', 'priority', 'pathogens', 'most', 'likely', 'to', 'cause', 'future', 'epidemics', 'Some', 'challenges', 'to', 'diagnostic', 'preparedness', 'are', 'common', 'to', 'all', 'outbreak', 'situations', 'as', 'highlighted', 'by', 'recent', 'outbreaks', 'of', 'Ebola', 'Zika', 'and', 'yellow', 'fever', 'In', 'this', 'article', 'we', 'review', 'these', 'overarching', 'challenges', 'and', 'explore', 'potential', 'solutions', 'Challenges', 'include', 'fragmented', 'and', 'unreliable', 'funding', 'pathways', 'limited', 'access', 'to', 'specimens', 'and', 'reagents', 'inadequate', 'diagnostic', 'testing', 'capacity', 'at', 'both', 'national', 'and', 'community', 'levels', 'of', 'healthcare', 'and', 'lack', 'of', 'incentives', 'for', 'companies', 'to', 'develop', 'and', 'manufacture', 'diagnostics', 'for', 'priority', 'pathogens', 'during', 'non', 'outbreak', 'periods', 'Addressing', 'these', 'challenges', 'in', 'an', 'efficient', 'and', 'effective', 'way', 'will', 'require', 'multiple', 'stakeholders', 'public', 'and', 'private', 'coordinated', 'in', 'implementing', 'a', 'holistic', 'approach', 'to', 'diagnostics', 'preparedness', 'All', 'require', 'strengthening', 'of', 'healthcare', 'system', 'diagnostic', 'capacity', 'including', 'surveillance', 'and', 'education', 'of', 'healthcare', 'workers', 'establishment', 'of', 'sustainable', 'financing', 'and', 'market', 'strategies', 'and', 'integration', 'of', 'diagnostics', 'with', 'existing', 'mechanisms', 'Identifying', 'overlaps', 'in', 'diagnostic', 'development', 'needs', 'across', 'different', 'priority', 'pathogens', 'would', 'allow', 'more', 'timely', 'and', 'cost', 'effective', 'use', 'of', 'resources', 'than', 'a', 'pathogen', 'by', 'pathogen', 'approach', 'target', 'product', 'profiles', 'for', 'diagnostics', 'should', 'be', 'refined', 'accordingly', 'We', 'recommend', 'the', 'establishment', 'of', 'a', 'global', 'forum', 'to', 'bring', 'together', 'representatives', 'from', 'all', 'key', 'stakeholders', 'required', 'for', 'the', 'response', 'to', 'develop', 'a', 'coordinated', 'implementation', 'plan', 'In', 'addition', 'we', 'should', 'explore', 'if', 'and', 'how', 'existing', 'mechanisms', 'to', 'address', 'challenges', 'to', 'the', 'vaccines', 'sector', 'such', 'as', 'Coalition', 'for', 'Epidemic', 'Preparedness', 'Innovations', 'and', 'Gavi', 'could', 'be', 'expanded', 'to', 'cover', 'diagnostics', '']"
171213,DNA markers and nano-biosensing approaches for tuberculosis diagnosis,2020-06-19,Nanotechnology Based Approaches for Tuberculosis Treatment,https://api.elsevier.com/content/article/pii/B9780128198117000138; https://www.sciencedirect.com/science/article/pii/B9780128198117000138,"According to WHO 2018 report, 10 million people developed tuberculosis and 1.3 million died from it making it 1 of 10 deadliest diseases worldwide. Tuberculosis is caused by infection with the bacillus Mycobacterium tuberculosis (Mtb). WHO recommends using a specific diagnostic kit Xpert MTB/RIF developed by Cepheid (California, United States). An alarming number of new cases (ca. 558,000) of rifampicin-resistant tuberculosis was diagnosticated in 2017. In recent years, new diagnosis tools targeting the Mtb DNA biomarkers have emerged using a plethora of nanomaterials capable of delivering new technological approaches for the rapid diagnostics of TB and rifampicin-resistant TB (RR-TB). In this chapter, we summarized the state-of-the-art of the current available DNA biomarkers and the potential applications for the development of new diagnosis nanotechnology-based devices. The latter use carbonaceous nanomaterials (graphene and carbon nanotubes), noble metals (silver and gold), semi-conducting (metal oxides, magnetic beads, and quantum dots) in order to reveal and/or to amplify the signal after the recognition of target DNA biomarker. The readout techniques such as colorimetry, fluorescence, surface plasmon resonance, and electrochemical methods were also reviewed. Future is bright for point-of-care diagnostics with a sample-in answer-out approach that hampers user-error through miniaturization of biochip technology to the nanoscale range, which will enable their use by nonspecialized personnel.",10.1016/b978-0-12-819811-7.00013-8,k751tehv,"['According', 'to', 'WHO', '2018', 'report', '10', 'million', 'people', 'developed', 'tuberculosis', 'and', '1', '3', 'million', 'died', 'from', 'it', 'making', 'it', '1', 'of', '10', 'deadliest', 'diseases', 'worldwide', 'Tuberculosis', 'is', 'caused', 'by', 'infection', 'with', 'the', 'bacillus', 'Mycobacterium', 'tuberculosis', 'Mtb', 'WHO', 'recommends', 'using', 'a', 'specific', 'diagnostic', 'kit', 'Xpert', 'MTB', 'RIF', 'developed', 'by', 'Cepheid', 'California', 'United', 'States', 'An', 'alarming', 'number', 'of', 'new', 'cases', 'ca', '558', '000', 'of', 'rifampicin', 'resistant', 'tuberculosis', 'was', 'diagnosticated', 'in', '2017', 'In', 'recent', 'years', 'new', 'diagnosis', 'tools', 'targeting', 'the', 'Mtb', 'DNA', 'biomarkers', 'have', 'emerged', 'using', 'a', 'plethora', 'of', 'nanomaterials', 'capable', 'of', 'delivering', 'new', 'technological', 'approaches', 'for', 'the', 'rapid', 'diagnostics', 'of', 'TB', 'and', 'rifampicin', 'resistant', 'TB', 'RR', 'TB', 'In', 'this', 'chapter', 'we', 'summarized', 'the', 'state', 'of', 'the', 'art', 'of', 'the', 'current', 'available', 'DNA', 'biomarkers', 'and', 'the', 'potential', 'applications', 'for', 'the', 'development', 'of', 'new', 'diagnosis', 'nanotechnology', 'based', 'devices', 'The', 'latter', 'use', 'carbonaceous', 'nanomaterials', 'graphene', 'and', 'carbon', 'nanotubes', 'noble', 'metals', 'silver', 'and', 'gold', 'semi', 'conducting', 'metal', 'oxides', 'magnetic', 'beads', 'and', 'quantum', 'dots', 'in', 'order', 'to', 'reveal', 'and', 'or', 'to', 'amplify', 'the', 'signal', 'after', 'the', 'recognition', 'of', 'target', 'DNA', 'biomarker', 'The', 'readout', 'techniques', 'such', 'as', 'colorimetry', 'fluorescence', 'surface', 'plasmon', 'resonance', 'and', 'electrochemical', 'methods', 'were', 'also', 'reviewed', 'Future', 'is', 'bright', 'for', 'point', 'of', 'care', 'diagnostics', 'with', 'a', 'sample', 'in', 'answer', 'out', 'approach', 'that', 'hampers', 'user', 'error', 'through', 'miniaturization', 'of', 'biochip', 'technology', 'to', 'the', 'nanoscale', 'range', 'which', 'will', 'enable', 'their', 'use', 'by', 'nonspecialized', 'personnel', '']"
171250,Cyprinid viral diseases and vaccine development,2018-12-31,Fish & Shellfish Immunology,https://doi.org/10.1016/j.fsi.2018.09.003; https://api.elsevier.com/content/article/pii/S1050464818305394; https://www.sciencedirect.com/science/article/pii/S1050464818305394; https://www.ncbi.nlm.nih.gov/pubmed/30195914/,"Abstract In the past decades, global freshwater fish production has been rapidly growing, while cyprinid takes the largest portion. Along with the rapid rise of novel forms of intensive aquaculture, increased global aquatic animal movement and various anthropogenic stress to aquatic ecosystems during the past century, freshwater fish farming industry encounter the emergence and breakout of many diseases, especially viral diseases. Because of the ability to safely and effectively prevent aquaculture diseases, vaccines have become the mainstream technology for prevention and control of aquatic diseases in the world. In this review, authors summarized six major cyprinid viral diseases, including koi herpesvirus disease (KHVD), spring viraemia of carp (SVC), grass carp hemorrhagic disease (GCHD), koi sleepy disease (KSD), carp pox disease (CPD) and herpesviral haematopoietic necrosis (HPHN). The present review described the characteristics of these diseases from epidemiology, pathology, etiology and diagnostics. Furthermore, the development of specific vaccines respective to these diseases is stated according to preparation methods and immunization approaches. It is hoped that the review could contribute to aquaculture in prevention and controlling of cyprinid viral diseases, and serve the healthy and sustainable development of aquaculture industry.",10.1016/j.fsi.2018.09.003,ew9cwiw0,"['Abstract', 'In', 'the', 'past', 'decades', 'global', 'freshwater', 'fish', 'production', 'has', 'been', 'rapidly', 'growing', 'while', 'cyprinid', 'takes', 'the', 'largest', 'portion', 'Along', 'with', 'the', 'rapid', 'rise', 'of', 'novel', 'forms', 'of', 'intensive', 'aquaculture', 'increased', 'global', 'aquatic', 'animal', 'movement', 'and', 'various', 'anthropogenic', 'stress', 'to', 'aquatic', 'ecosystems', 'during', 'the', 'past', 'century', 'freshwater', 'fish', 'farming', 'industry', 'encounter', 'the', 'emergence', 'and', 'breakout', 'of', 'many', 'diseases', 'especially', 'viral', 'diseases', 'Because', 'of', 'the', 'ability', 'to', 'safely', 'and', 'effectively', 'prevent', 'aquaculture', 'diseases', 'vaccines', 'have', 'become', 'the', 'mainstream', 'technology', 'for', 'prevention', 'and', 'control', 'of', 'aquatic', 'diseases', 'in', 'the', 'world', 'In', 'this', 'review', 'authors', 'summarized', 'six', 'major', 'cyprinid', 'viral', 'diseases', 'including', 'koi', 'herpesvirus', 'disease', 'KHVD', 'spring', 'viraemia', 'of', 'carp', 'SVC', 'grass', 'carp', 'hemorrhagic', 'disease', 'GCHD', 'koi', 'sleepy', 'disease', 'KSD', 'carp', 'pox', 'disease', 'CPD', 'and', 'herpesviral', 'haematopoietic', 'necrosis', 'HPHN', 'The', 'present', 'review', 'described', 'the', 'characteristics', 'of', 'these', 'diseases', 'from', 'epidemiology', 'pathology', 'etiology', 'and', 'diagnostics', 'Furthermore', 'the', 'development', 'of', 'specific', 'vaccines', 'respective', 'to', 'these', 'diseases', 'is', 'stated', 'according', 'to', 'preparation', 'methods', 'and', 'immunization', 'approaches', 'It', 'is', 'hoped', 'that', 'the', 'review', 'could', 'contribute', 'to', 'aquaculture', 'in', 'prevention', 'and', 'controlling', 'of', 'cyprinid', 'viral', 'diseases', 'and', 'serve', 'the', 'healthy', 'and', 'sustainable', 'development', 'of', 'aquaculture', 'industry', '']"
171498,A complete sequence and comparative analysis of a SARS-associated virus (Isolate BJ01),2003,Chin Sci Bull,https://doi.org/10.1007/bf03184203; https://www.ncbi.nlm.nih.gov/pubmed/32214698/,"The genome sequence of the Severe Acute Respiratory Syndrome (SARS)-associated virus provides essential information for the identification of pathogen(s), exploration of etiology and evolution, interpretation of transmission and pathogenesis, development of diagnostics, prevention by future vaccination, and treatment by developing new drugs. We report the complete genome sequence and comparative analysis of an isolate (BJ01) of the coronavirus that has been recognized as a pathogen for SARS. The genome is 29725 nt in size and has 11 ORFs (Open Reading Frames). It is composed of a stable region encoding an RNA-dependent RNA polymerase (composed of 2 ORFs) and a variable region representing 4 CDSs (coding sequences) for viral structural genes (the S, E, M, N proteins) and 5 PUPs (putative uncharacterized proteins). Its gene order is identical to that of other known coronaviruses. The sequence alignment with all known RNA viruses places this virus as a member in the family of Coronaviridae. Thirty putative substitutions have been identified by comparative analysis of the 5 SARS-associated virus genome sequences in GenBank. Fifteen of them lead to possible amino acid changes (non-synonymous mutations) in the proteins. Three amino acid changes, with predicted alteration of physical and chemical features, have been detected in the S protein that is postulated to be involved in the immunoreactions between the virus and its host. Two amino acid changes have been detected in the M protein, which could be related to viral envelope formation. Phylogenetic analysis suggests the possibility of non-human origin of the SARS-associated viruses but provides no evidence that they are man-made. Further efforts should focus on identifying the etiology of the SARS-associated virus and ruling out conclusively the existence of other possible SARS-related pathogen(s).",10.1007/bf03184203,t3t20wji,"['The', 'genome', 'sequence', 'of', 'the', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'SARS', 'associated', 'virus', 'provides', 'essential', 'information', 'for', 'the', 'identification', 'of', 'pathogen', 's', 'exploration', 'of', 'etiology', 'and', 'evolution', 'interpretation', 'of', 'transmission', 'and', 'pathogenesis', 'development', 'of', 'diagnostics', 'prevention', 'by', 'future', 'vaccination', 'and', 'treatment', 'by', 'developing', 'new', 'drugs', 'We', 'report', 'the', 'complete', 'genome', 'sequence', 'and', 'comparative', 'analysis', 'of', 'an', 'isolate', 'BJ01', 'of', 'the', 'coronavirus', 'that', 'has', 'been', 'recognized', 'as', 'a', 'pathogen', 'for', 'SARS', 'The', 'genome', 'is', '29725', 'nt', 'in', 'size', 'and', 'has', '11', 'ORFs', 'Open', 'Reading', 'Frames', 'It', 'is', 'composed', 'of', 'a', 'stable', 'region', 'encoding', 'an', 'RNA', 'dependent', 'RNA', 'polymerase', 'composed', 'of', '2', 'ORFs', 'and', 'a', 'variable', 'region', 'representing', '4', 'CDSs', 'coding', 'sequences', 'for', 'viral', 'structural', 'genes', 'the', 'S', 'E', 'M', 'N', 'proteins', 'and', '5', 'PUPs', 'putative', 'uncharacterized', 'proteins', 'Its', 'gene', 'order', 'is', 'identical', 'to', 'that', 'of', 'other', 'known', 'coronaviruses', 'The', 'sequence', 'alignment', 'with', 'all', 'known', 'RNA', 'viruses', 'places', 'this', 'virus', 'as', 'a', 'member', 'in', 'the', 'family', 'of', 'Coronaviridae', 'Thirty', 'putative', 'substitutions', 'have', 'been', 'identified', 'by', 'comparative', 'analysis', 'of', 'the', '5', 'SARS', 'associated', 'virus', 'genome', 'sequences', 'in', 'GenBank', 'Fifteen', 'of', 'them', 'lead', 'to', 'possible', 'amino', 'acid', 'changes', 'non', 'synonymous', 'mutations', 'in', 'the', 'proteins', 'Three', 'amino', 'acid', 'changes', 'with', 'predicted', 'alteration', 'of', 'physical', 'and', 'chemical', 'features', 'have', 'been', 'detected', 'in', 'the', 'S', 'protein', 'that', 'is', 'postulated', 'to', 'be', 'involved', 'in', 'the', 'immunoreactions', 'between', 'the', 'virus', 'and', 'its', 'host', 'Two', 'amino', 'acid', 'changes', 'have', 'been', 'detected', 'in', 'the', 'M', 'protein', 'which', 'could', 'be', 'related', 'to', 'viral', 'envelope', 'formation', 'Phylogenetic', 'analysis', 'suggests', 'the', 'possibility', 'of', 'non', 'human', 'origin', 'of', 'the', 'SARS', 'associated', 'viruses', 'but', 'provides', 'no', 'evidence', 'that', 'they', 'are', 'man', 'made', 'Further', 'efforts', 'should', 'focus', 'on', 'identifying', 'the', 'etiology', 'of', 'the', 'SARS', 'associated', 'virus', 'and', 'ruling', 'out', 'conclusively', 'the', 'existence', 'of', 'other', 'possible', 'SARS', 'related', 'pathogen', 's', '']"
171892,Implications of SARS-CoV-2 Genetic Diversity and Mutations on Pathogenicity of COVID-19 and Biomedical Interventions,2020-07-10,J Taibah Univ Med Sci,https://api.elsevier.com/content/article/pii/S1658361220300925; https://www.sciencedirect.com/science/article/pii/S1658361220300925?v=s5; https://doi.org/10.1016/j.jtumed.2020.06.005,"ABSTRACT Objective Coronavirus disease 2019 (COVID-19) has caused an unprecedented global health emergency. The COVID-19 pandemic has claimed over 350,000 human lives within five months of its emergence, especially in the USA and the European continent. This study analysed the implications of the genetic diversity and mutations in SARS-CoV-2 on its virulence diversity and investigated how these factors could affect the successful development and application of antiviral chemotherapy, immunotherapy, serodiagnosis, and vaccination. Methods All the suitable and eligible full text articles published between 31st December 2019 and 31st May 2020 were filtered and extracted from “PubMed”, “Scopus”, “Web of Science”, and “Hinari” and were critically reviewed. We used the Medical Subject Headings (MeSH) terms “COVID-19, “Mutation”, “Genetic diversity”, “SARS-CoV-2”, “Virulence”, “Pathogenicity”, “Evolution” and “SARS-CoV-2 transmission” for this search. Results Our search showed that SARS-CoV-2 has persistently undergone significant mutations in various parts of its non-structural proteins (NSPs), including NSP2 and NSP3, S protein, and RNA-dependent RNA polymerase (RdRp). In particular, the S protein was found to be the key determinant of evolution, transmission, and virulence of SARS-CoV-2, and could be a potential target for vaccine development. Additionally, RdRp could be a major target in the development of antivirals for the treatment of COVID-19. Conclusion Given the critical importance of mutations in the pathogenicity of SARS-CoV-2 and in the development of sero-diagnostics, antivirals, and vaccines, this study recommends continuous molecular surveillance of SARS-CoV-2. This approach would potentially prompt identification of new mutants and their impact on ongoing biomedical interventions and COVID-19 control measures.",10.1016/j.jtumed.2020.06.005,ajr7g7pm,"['ABSTRACT', 'Objective', 'Coronavirus', 'disease', '2019', 'COVID', '19', 'has', 'caused', 'an', 'unprecedented', 'global', 'health', 'emergency', 'The', 'COVID', '19', 'pandemic', 'has', 'claimed', 'over', '350', '000', 'human', 'lives', 'within', 'five', 'months', 'of', 'its', 'emergence', 'especially', 'in', 'the', 'USA', 'and', 'the', 'European', 'continent', 'This', 'study', 'analysed', 'the', 'implications', 'of', 'the', 'genetic', 'diversity', 'and', 'mutations', 'in', 'SARS', 'CoV', '2', 'on', 'its', 'virulence', 'diversity', 'and', 'investigated', 'how', 'these', 'factors', 'could', 'affect', 'the', 'successful', 'development', 'and', 'application', 'of', 'antiviral', 'chemotherapy', 'immunotherapy', 'serodiagnosis', 'and', 'vaccination', 'Methods', 'All', 'the', 'suitable', 'and', 'eligible', 'full', 'text', 'articles', 'published', 'between', '31st', 'December', '2019', 'and', '31st', 'May', '2020', 'were', 'filtered', 'and', 'extracted', 'from', 'PubMed', 'Scopus', 'Web', 'of', 'Science', 'and', 'Hinari', 'and', 'were', 'critically', 'reviewed', 'We', 'used', 'the', 'Medical', 'Subject', 'Headings', 'MeSH', 'terms', 'COVID', '19', 'Mutation', 'Genetic', 'diversity', 'SARS', 'CoV', '2', 'Virulence', 'Pathogenicity', 'Evolution', 'and', 'SARS', 'CoV', '2', 'transmission', 'for', 'this', 'search', 'Results', 'Our', 'search', 'showed', 'that', 'SARS', 'CoV', '2', 'has', 'persistently', 'undergone', 'significant', 'mutations', 'in', 'various', 'parts', 'of', 'its', 'non', 'structural', 'proteins', 'NSPs', 'including', 'NSP2', 'and', 'NSP3', 'S', 'protein', 'and', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'In', 'particular', 'the', 'S', 'protein', 'was', 'found', 'to', 'be', 'the', 'key', 'determinant', 'of', 'evolution', 'transmission', 'and', 'virulence', 'of', 'SARS', 'CoV', '2', 'and', 'could', 'be', 'a', 'potential', 'target', 'for', 'vaccine', 'development', 'Additionally', 'RdRp', 'could', 'be', 'a', 'major', 'target', 'in', 'the', 'development', 'of', 'antivirals', 'for', 'the', 'treatment', 'of', 'COVID', '19', 'Conclusion', 'Given', 'the', 'critical', 'importance', 'of', 'mutations', 'in', 'the', 'pathogenicity', 'of', 'SARS', 'CoV', '2', 'and', 'in', 'the', 'development', 'of', 'sero', 'diagnostics', 'antivirals', 'and', 'vaccines', 'this', 'study', 'recommends', 'continuous', 'molecular', 'surveillance', 'of', 'SARS', 'CoV', '2', 'This', 'approach', 'would', 'potentially', 'prompt', 'identification', 'of', 'new', 'mutants', 'and', 'their', 'impact', 'on', 'ongoing', 'biomedical', 'interventions', 'and', 'COVID', '19', 'control', 'measures', '']"
172434,"“Running the Gauntlet”: Formidable challenges in advancing neglected tropical diseases vaccines from development through licensure, and a “Call to Action”",2019-07-10,Hum Vaccin Immunother,https://www.ncbi.nlm.nih.gov/pubmed/31180271/; https://doi.org/10.1080/21645515.2019.1629254,"Translational science for new biotechnologies (e.g. drugs, vaccines, devices, or diagnostics) depend on the development of a robust ‘business case’. This is driven by complex scientific, technical, logistical, financial and operational elements to determine the feasibility and probability of traversing the “valleys of death” leading to licensure. The potential results in terms of profitability and financial realization, called ‘product value proposition’ play a crucial role in establishing incentives for investment during and after development. With this review, our goal is to summarize the challenges in taking vaccines against neglected tropical diseases (NTDs) from development through licensure and provide a perspective that these vaccines can have measurable public health and economic profitability and market success. Understanding these processes and its challenges would open the opportunity to accelerate and advance these essential NTD vaccines through the last mile towards licensure and for the delivery to afflicted populations in low- and middle-income countries.",10.1080/21645515.2019.1629254,i0gp9ehw,"['Translational', 'science', 'for', 'new', 'biotechnologies', 'e', 'g', 'drugs', 'vaccines', 'devices', 'or', 'diagnostics', 'depend', 'on', 'the', 'development', 'of', 'a', 'robust', 'business', 'case', 'This', 'is', 'driven', 'by', 'complex', 'scientific', 'technical', 'logistical', 'financial', 'and', 'operational', 'elements', 'to', 'determine', 'the', 'feasibility', 'and', 'probability', 'of', 'traversing', 'the', 'valleys', 'of', 'death', 'leading', 'to', 'licensure', 'The', 'potential', 'results', 'in', 'terms', 'of', 'profitability', 'and', 'financial', 'realization', 'called', 'product', 'value', 'proposition', 'play', 'a', 'crucial', 'role', 'in', 'establishing', 'incentives', 'for', 'investment', 'during', 'and', 'after', 'development', 'With', 'this', 'review', 'our', 'goal', 'is', 'to', 'summarize', 'the', 'challenges', 'in', 'taking', 'vaccines', 'against', 'neglected', 'tropical', 'diseases', 'NTDs', 'from', 'development', 'through', 'licensure', 'and', 'provide', 'a', 'perspective', 'that', 'these', 'vaccines', 'can', 'have', 'measurable', 'public', 'health', 'and', 'economic', 'profitability', 'and', 'market', 'success', 'Understanding', 'these', 'processes', 'and', 'its', 'challenges', 'would', 'open', 'the', 'opportunity', 'to', 'accelerate', 'and', 'advance', 'these', 'essential', 'NTD', 'vaccines', 'through', 'the', 'last', 'mile', 'towards', 'licensure', 'and', 'for', 'the', 'delivery', 'to', 'afflicted', 'populations', 'in', 'low', 'and', 'middle', 'income', 'countries', '']"
172506,The microarray revolution: Perspectives from educators,2006-11-03,Biochem Mol Biol Educ,https://doi.org/10.1002/bmb.2004.494032040362; https://www.ncbi.nlm.nih.gov/pubmed/21706728/,"In recent years, microarray analysis has become a key experimental tool, enabling the analysis of genome‐wide patterns of gene expression. This review approaches the microarray revolution with a focus upon four topics: 1) the early development of this technology and its application to cancer diagnostics; 2) a primer of microarray research, designed to guide the beginner; 3) a highlight of the Genome Consortium for Active Teaching (GCAT), a worldwide consortium of faculty who are integrating microarrays into the undergraduate teaching laboratory; and 4) the use of microarrays in the biotechnology industry with a look forward to future applications. A central theme within this review is the profound relevance of new, bioinformatics‐based, technologies to undergraduate students within the biosciences.",10.1002/bmb.2004.494032040362,rd7sv305,"['In', 'recent', 'years', 'microarray', 'analysis', 'has', 'become', 'a', 'key', 'experimental', 'tool', 'enabling', 'the', 'analysis', 'of', 'genome', 'wide', 'patterns', 'of', 'gene', 'expression', 'This', 'review', 'approaches', 'the', 'microarray', 'revolution', 'with', 'a', 'focus', 'upon', 'four', 'topics', '1', 'the', 'early', 'development', 'of', 'this', 'technology', 'and', 'its', 'application', 'to', 'cancer', 'diagnostics', '2', 'a', 'primer', 'of', 'microarray', 'research', 'designed', 'to', 'guide', 'the', 'beginner', '3', 'a', 'highlight', 'of', 'the', 'Genome', 'Consortium', 'for', 'Active', 'Teaching', 'GCAT', 'a', 'worldwide', 'consortium', 'of', 'faculty', 'who', 'are', 'integrating', 'microarrays', 'into', 'the', 'undergraduate', 'teaching', 'laboratory', 'and', '4', 'the', 'use', 'of', 'microarrays', 'in', 'the', 'biotechnology', 'industry', 'with', 'a', 'look', 'forward', 'to', 'future', 'applications', 'A', 'central', 'theme', 'within', 'this', 'review', 'is', 'the', 'profound', 'relevance', 'of', 'new', 'bioinformatics', 'based', 'technologies', 'to', 'undergraduate', 'students', 'within', 'the', 'biosciences', '']"
172726,Proteomics for biodefense applications: progress and opportunities,2014-01-09,Expert Rev Proteomics,https://www.ncbi.nlm.nih.gov/pubmed/15892565/,"The increasing threat of bioterrorism and continued emergence of new infectious diseases has driven a major resurgence in biomedical research efforts to develop improved treatments, diagnostics and vaccines, as well as increase the fundamental understanding of the host immune response to infectious agents. The availability of multiple mass spectrometry platforms combined with multidimensional separation technologies and microbial genomic databases provides an unprecedented opportunity to develop these much needed resources. An overview of current proteomic strategies applied to microbes and viruses considered potential bioterrorism agents is presented. The emerging area of immunoproteomics as applied to the development of new vaccine targets is also summarized. These powerful research approaches can generate a multitude of potential new protein targets; however, translating these proteomic discoveries to useful counter-bioterrorism products will require large collaborative research efforts across multiple basic science and clinical disciplines. A translational proteomic research paradigm illustrating this approach using influenza virus as an example is discussed.",10.1586/14789450.2.2.203,7xxcl2ug,"['The', 'increasing', 'threat', 'of', 'bioterrorism', 'and', 'continued', 'emergence', 'of', 'new', 'infectious', 'diseases', 'has', 'driven', 'a', 'major', 'resurgence', 'in', 'biomedical', 'research', 'efforts', 'to', 'develop', 'improved', 'treatments', 'diagnostics', 'and', 'vaccines', 'as', 'well', 'as', 'increase', 'the', 'fundamental', 'understanding', 'of', 'the', 'host', 'immune', 'response', 'to', 'infectious', 'agents', 'The', 'availability', 'of', 'multiple', 'mass', 'spectrometry', 'platforms', 'combined', 'with', 'multidimensional', 'separation', 'technologies', 'and', 'microbial', 'genomic', 'databases', 'provides', 'an', 'unprecedented', 'opportunity', 'to', 'develop', 'these', 'much', 'needed', 'resources', 'An', 'overview', 'of', 'current', 'proteomic', 'strategies', 'applied', 'to', 'microbes', 'and', 'viruses', 'considered', 'potential', 'bioterrorism', 'agents', 'is', 'presented', 'The', 'emerging', 'area', 'of', 'immunoproteomics', 'as', 'applied', 'to', 'the', 'development', 'of', 'new', 'vaccine', 'targets', 'is', 'also', 'summarized', 'These', 'powerful', 'research', 'approaches', 'can', 'generate', 'a', 'multitude', 'of', 'potential', 'new', 'protein', 'targets', 'however', 'translating', 'these', 'proteomic', 'discoveries', 'to', 'useful', 'counter', 'bioterrorism', 'products', 'will', 'require', 'large', 'collaborative', 'research', 'efforts', 'across', 'multiple', 'basic', 'science', 'and', 'clinical', 'disciplines', 'A', 'translational', 'proteomic', 'research', 'paradigm', 'illustrating', 'this', 'approach', 'using', 'influenza', 'virus', 'as', 'an', 'example', 'is', 'discussed', '']"
173292,Loop-mediated isothermal amplification (LAMP): recent progress in research and development,2013-03-29,J Infect Chemother,https://doi.org/10.1007/s10156-013-0590-0; https://api.elsevier.com/content/article/pii/S1341321X13701223; https://www.sciencedirect.com/science/article/pii/S1341321X13701223; https://www.ncbi.nlm.nih.gov/pubmed/23539453/,"Loop-mediated isothermal amplification (LAMP) is an established technology that continues to attract the attention of researchers in many fields. Research and development efforts on LAMP technology in recent years have focused on two major areas; first, the study of its clinical application as an approved in vitro diagnostics tool in Japan and certain other countries; and second, research aimed at further simplifying the LAMP test process. This review provides an overview of the status of LAMP on these two topics by summarizing research work conducted, in the main, after our previous review article.",10.1007/s10156-013-0590-0,8gbuoas6,"['Loop', 'mediated', 'isothermal', 'amplification', 'LAMP', 'is', 'an', 'established', 'technology', 'that', 'continues', 'to', 'attract', 'the', 'attention', 'of', 'researchers', 'in', 'many', 'fields', 'Research', 'and', 'development', 'efforts', 'on', 'LAMP', 'technology', 'in', 'recent', 'years', 'have', 'focused', 'on', 'two', 'major', 'areas', 'first', 'the', 'study', 'of', 'its', 'clinical', 'application', 'as', 'an', 'approved', 'in', 'vitro', 'diagnostics', 'tool', 'in', 'Japan', 'and', 'certain', 'other', 'countries', 'and', 'second', 'research', 'aimed', 'at', 'further', 'simplifying', 'the', 'LAMP', 'test', 'process', 'This', 'review', 'provides', 'an', 'overview', 'of', 'the', 'status', 'of', 'LAMP', 'on', 'these', 'two', 'topics', 'by', 'summarizing', 'research', 'work', 'conducted', 'in', 'the', 'main', 'after', 'our', 'previous', 'review', 'article', '']"
173388,Clinical Perspectives on Targeting Therapies for Personalized Medicine,2015-12-29,Adv Protein Chem Struct Biol,https://api.elsevier.com/content/article/pii/S1876162315000917; https://www.ncbi.nlm.nih.gov/pubmed/26827603/; https://doi.org/10.1016/bs.apcsb.2015.11.003; https://www.sciencedirect.com/science/article/pii/S1876162315000917,"Expected benefits from new technology include more efficient patient selection for clinical trials, more cost-effective treatment pathways for patients and health services and a more profitable accelerated approach for drug developers. Regulatory authorities expect the pharmaceutical and biotechnology industries to accelerate their development of companion diagnostics and companion therapeutics toward the goal of safer and more effective personalized medicine, and expect health services to fund and prescribers to adopt these new therapeutic technologies. This review discusses the importance of a range of new approaches to developing new and reprofiled medicines to treat common and serious diseases, and rare diseases: new network pharmacology approaches, adaptive trial designs with enriched populations more likely to respond safely to treatment, as assessed by companion diagnostics for response and toxicity risk and use of “real world” data. Case studies are described of single and multiple protein drug targets in several important therapeutic areas. These case studies also illustrate the value and complexity of use of selective biomarkers of clinical response and risk of adverse drug effects, either singly or in combination.",10.1016/bs.apcsb.2015.11.003,92xazjkb,"['Expected', 'benefits', 'from', 'new', 'technology', 'include', 'more', 'efficient', 'patient', 'selection', 'for', 'clinical', 'trials', 'more', 'cost', 'effective', 'treatment', 'pathways', 'for', 'patients', 'and', 'health', 'services', 'and', 'a', 'more', 'profitable', 'accelerated', 'approach', 'for', 'drug', 'developers', 'Regulatory', 'authorities', 'expect', 'the', 'pharmaceutical', 'and', 'biotechnology', 'industries', 'to', 'accelerate', 'their', 'development', 'of', 'companion', 'diagnostics', 'and', 'companion', 'therapeutics', 'toward', 'the', 'goal', 'of', 'safer', 'and', 'more', 'effective', 'personalized', 'medicine', 'and', 'expect', 'health', 'services', 'to', 'fund', 'and', 'prescribers', 'to', 'adopt', 'these', 'new', 'therapeutic', 'technologies', 'This', 'review', 'discusses', 'the', 'importance', 'of', 'a', 'range', 'of', 'new', 'approaches', 'to', 'developing', 'new', 'and', 'reprofiled', 'medicines', 'to', 'treat', 'common', 'and', 'serious', 'diseases', 'and', 'rare', 'diseases', 'new', 'network', 'pharmacology', 'approaches', 'adaptive', 'trial', 'designs', 'with', 'enriched', 'populations', 'more', 'likely', 'to', 'respond', 'safely', 'to', 'treatment', 'as', 'assessed', 'by', 'companion', 'diagnostics', 'for', 'response', 'and', 'toxicity', 'risk', 'and', 'use', 'of', 'real', 'world', 'data', 'Case', 'studies', 'are', 'described', 'of', 'single', 'and', 'multiple', 'protein', 'drug', 'targets', 'in', 'several', 'important', 'therapeutic', 'areas', 'These', 'case', 'studies', 'also', 'illustrate', 'the', 'value', 'and', 'complexity', 'of', 'use', 'of', 'selective', 'biomarkers', 'of', 'clinical', 'response', 'and', 'risk', 'of', 'adverse', 'drug', 'effects', 'either', 'singly', 'or', 'in', 'combination', '']"
173399,Molecular and diagnostic clinical virology in real time,2014-12-12,Clin Microbiol Infect,https://www.ncbi.nlm.nih.gov/pubmed/14706081/,"During the last decade, the application of both qualitative and quantitative nucleic acid detection techniques has had a major impact on diagnostics in clinical virology. Both signal and target amplification-based systems are currently used routinely in most if not all virology laboratories. However, commercial assays are only available for a very limited number of targets, and this has resulted in the development and introduction of assays developed in-house for most viral targets. With improved and automated nucleic acid sample isolation techniques, as well as real-time detection methods, a new generation of assays for most clinically important viruses is being developed. These technological improvements also make it possible to generate results with a very short turnaround time. As an example of a more individual-patient disease-management concept, we have introduced in our clinical setting the quantitative detection of Epstein–Barr virus (EBV) in T-cell-depleted allogeneic stem cell transplant patients. This has enabled us to develop models for pre-emptive anti-B-cell immunotherapy for EBV reactivation, and for reducing not only the incidence of EBV lymphoproliferative disease (EBV-LPD), but the virus-related mortality. It is now also feasible to introduce molecular testing for those viruses that can easily be detected using classical virological methods, such as culture techniques or antigen detection. Prospective studies are needed to evaluate the clinical importance of the additional positive samples detected. It should, however, be clear that a complete exchange of technology is unlikely to occur, and that complementary methods should stay operational, making possible the discovery of new viruses. Furthermore, the ability to characterise viruses more easily by sequencing opens new possibilities for epidemiological studies. There is also an urgent need, with regard to molecular diagnostic methods, for the introduction and use of standardised materials and participation in international quality control programmes. Finally, with the introduction of a universal internal control throughout the whole procedure, the accuracy of the results generated is warranted.",10.1111/j.1469-0691.2004.00699.x,oscbagdq,"['During', 'the', 'last', 'decade', 'the', 'application', 'of', 'both', 'qualitative', 'and', 'quantitative', 'nucleic', 'acid', 'detection', 'techniques', 'has', 'had', 'a', 'major', 'impact', 'on', 'diagnostics', 'in', 'clinical', 'virology', 'Both', 'signal', 'and', 'target', 'amplification', 'based', 'systems', 'are', 'currently', 'used', 'routinely', 'in', 'most', 'if', 'not', 'all', 'virology', 'laboratories', 'However', 'commercial', 'assays', 'are', 'only', 'available', 'for', 'a', 'very', 'limited', 'number', 'of', 'targets', 'and', 'this', 'has', 'resulted', 'in', 'the', 'development', 'and', 'introduction', 'of', 'assays', 'developed', 'in', 'house', 'for', 'most', 'viral', 'targets', 'With', 'improved', 'and', 'automated', 'nucleic', 'acid', 'sample', 'isolation', 'techniques', 'as', 'well', 'as', 'real', 'time', 'detection', 'methods', 'a', 'new', 'generation', 'of', 'assays', 'for', 'most', 'clinically', 'important', 'viruses', 'is', 'being', 'developed', 'These', 'technological', 'improvements', 'also', 'make', 'it', 'possible', 'to', 'generate', 'results', 'with', 'a', 'very', 'short', 'turnaround', 'time', 'As', 'an', 'example', 'of', 'a', 'more', 'individual', 'patient', 'disease', 'management', 'concept', 'we', 'have', 'introduced', 'in', 'our', 'clinical', 'setting', 'the', 'quantitative', 'detection', 'of', 'Epstein', 'Barr', 'virus', 'EBV', 'in', 'T', 'cell', 'depleted', 'allogeneic', 'stem', 'cell', 'transplant', 'patients', 'This', 'has', 'enabled', 'us', 'to', 'develop', 'models', 'for', 'pre', 'emptive', 'anti', 'B', 'cell', 'immunotherapy', 'for', 'EBV', 'reactivation', 'and', 'for', 'reducing', 'not', 'only', 'the', 'incidence', 'of', 'EBV', 'lymphoproliferative', 'disease', 'EBV', 'LPD', 'but', 'the', 'virus', 'related', 'mortality', 'It', 'is', 'now', 'also', 'feasible', 'to', 'introduce', 'molecular', 'testing', 'for', 'those', 'viruses', 'that', 'can', 'easily', 'be', 'detected', 'using', 'classical', 'virological', 'methods', 'such', 'as', 'culture', 'techniques', 'or', 'antigen', 'detection', 'Prospective', 'studies', 'are', 'needed', 'to', 'evaluate', 'the', 'clinical', 'importance', 'of', 'the', 'additional', 'positive', 'samples', 'detected', 'It', 'should', 'however', 'be', 'clear', 'that', 'a', 'complete', 'exchange', 'of', 'technology', 'is', 'unlikely', 'to', 'occur', 'and', 'that', 'complementary', 'methods', 'should', 'stay', 'operational', 'making', 'possible', 'the', 'discovery', 'of', 'new', 'viruses', 'Furthermore', 'the', 'ability', 'to', 'characterise', 'viruses', 'more', 'easily', 'by', 'sequencing', 'opens', 'new', 'possibilities', 'for', 'epidemiological', 'studies', 'There', 'is', 'also', 'an', 'urgent', 'need', 'with', 'regard', 'to', 'molecular', 'diagnostic', 'methods', 'for', 'the', 'introduction', 'and', 'use', 'of', 'standardised', 'materials', 'and', 'participation', 'in', 'international', 'quality', 'control', 'programmes', 'Finally', 'with', 'the', 'introduction', 'of', 'a', 'universal', 'internal', 'control', 'throughout', 'the', 'whole', 'procedure', 'the', 'accuracy', 'of', 'the', 'results', 'generated', 'is', 'warranted', '']"
174091,The role of respiratory virus infections in childhood asthma inception,2010-11-01,Immunology and Allergy Clinics of North America,https://doi.org/10.1016/j.iac.2010.08.004; http://europepmc.org/articles/pmc2966844?pdf=render; https://www.sciencedirect.com/science/article/pii/S0889856110000688; https://api.elsevier.com/content/article/pii/S0889856110000688; https://www.ncbi.nlm.nih.gov/pubmed/21029935/,"Viral respiratory illnesses associated with wheezing are extremely common during early life and remain a frequent cause of morbidity and hospitalization in young children. Although many children who wheeze with respiratory viruses during infancy outgrow the problem, most children with asthma and reductions in lung function at school age begin wheezing during the first several years of life. Whether symptomatic viral infections of the lower respiratory tract are causal in asthma development or simply identify predisposed children remains a controversial issue. Wheezing illnesses caused by respiratory syncytial virus (RSV), particularly those severe enough to lead to hospitalization, have historically been associated with an increased risk of asthma at school age. However, with the development of molecular diagnostics, human rhinovirus (HRV) wheezing illnesses have been recognized more recently as a stronger predictor of school-age asthma than RSV. In this article, the authors review the impact of virus infections during early life, focusing primarily on RSV and HRV, and their potential roles in asthma inception.",10.1016/j.iac.2010.08.004,daaenmo9,"['Viral', 'respiratory', 'illnesses', 'associated', 'with', 'wheezing', 'are', 'extremely', 'common', 'during', 'early', 'life', 'and', 'remain', 'a', 'frequent', 'cause', 'of', 'morbidity', 'and', 'hospitalization', 'in', 'young', 'children', 'Although', 'many', 'children', 'who', 'wheeze', 'with', 'respiratory', 'viruses', 'during', 'infancy', 'outgrow', 'the', 'problem', 'most', 'children', 'with', 'asthma', 'and', 'reductions', 'in', 'lung', 'function', 'at', 'school', 'age', 'begin', 'wheezing', 'during', 'the', 'first', 'several', 'years', 'of', 'life', 'Whether', 'symptomatic', 'viral', 'infections', 'of', 'the', 'lower', 'respiratory', 'tract', 'are', 'causal', 'in', 'asthma', 'development', 'or', 'simply', 'identify', 'predisposed', 'children', 'remains', 'a', 'controversial', 'issue', 'Wheezing', 'illnesses', 'caused', 'by', 'respiratory', 'syncytial', 'virus', 'RSV', 'particularly', 'those', 'severe', 'enough', 'to', 'lead', 'to', 'hospitalization', 'have', 'historically', 'been', 'associated', 'with', 'an', 'increased', 'risk', 'of', 'asthma', 'at', 'school', 'age', 'However', 'with', 'the', 'development', 'of', 'molecular', 'diagnostics', 'human', 'rhinovirus', 'HRV', 'wheezing', 'illnesses', 'have', 'been', 'recognized', 'more', 'recently', 'as', 'a', 'stronger', 'predictor', 'of', 'school', 'age', 'asthma', 'than', 'RSV', 'In', 'this', 'article', 'the', 'authors', 'review', 'the', 'impact', 'of', 'virus', 'infections', 'during', 'early', 'life', 'focusing', 'primarily', 'on', 'RSV', 'and', 'HRV', 'and', 'their', 'potential', 'roles', 'in', 'asthma', 'inception', '']"
174337,New Respiratory Viruses and the Elderly,2011-07-06,Open Respir Med J,https://doi.org/10.2174/1874306401105010061; https://www.ncbi.nlm.nih.gov/pubmed/21760867/,"The diagnostics of respiratory viral infections has improved markedly during the last 15 years with the development of PCR techniques. Since 1997, several new respiratory viruses and their subgroups have been discovered: influenza A viruses H5N1 and H1N1, human metapneumovirus, coronaviruses SARS, NL63 and HKU1, human bocavirus, human rhinoviruses C and D and potential respiratory pathogens, the KI and WU polyomaviruses and the torque teno virus. The detection of previously known viruses has also improved. Currently, a viral cause of respiratory illness is almost exclusively identifiable in children, but in the elderly, the detection rates of a viral etiology are below 40%, and this holds also true for exacerbations of chronic respiratory illnesses. The new viruses cause respiratory symptoms like the common cold, cough, bronchitis, bronchiolitis, exacerbations of asthma and chronic obstructive pulmonary disease and pneumonia. Acute respiratory failure may occur. These viruses are distributed throughout the globe and affect people of all ages. Data regarding these viruses and the elderly are scarce. This review introduces these new viruses and reviews their clinical significance, especially with regard to the elderly population.",10.2174/1874306401105010061,7fwzohmu,"['The', 'diagnostics', 'of', 'respiratory', 'viral', 'infections', 'has', 'improved', 'markedly', 'during', 'the', 'last', '15', 'years', 'with', 'the', 'development', 'of', 'PCR', 'techniques', 'Since', '1997', 'several', 'new', 'respiratory', 'viruses', 'and', 'their', 'subgroups', 'have', 'been', 'discovered', 'influenza', 'A', 'viruses', 'H5N1', 'and', 'H1N1', 'human', 'metapneumovirus', 'coronaviruses', 'SARS', 'NL63', 'and', 'HKU1', 'human', 'bocavirus', 'human', 'rhinoviruses', 'C', 'and', 'D', 'and', 'potential', 'respiratory', 'pathogens', 'the', 'KI', 'and', 'WU', 'polyomaviruses', 'and', 'the', 'torque', 'teno', 'virus', 'The', 'detection', 'of', 'previously', 'known', 'viruses', 'has', 'also', 'improved', 'Currently', 'a', 'viral', 'cause', 'of', 'respiratory', 'illness', 'is', 'almost', 'exclusively', 'identifiable', 'in', 'children', 'but', 'in', 'the', 'elderly', 'the', 'detection', 'rates', 'of', 'a', 'viral', 'etiology', 'are', 'below', '40', 'and', 'this', 'holds', 'also', 'true', 'for', 'exacerbations', 'of', 'chronic', 'respiratory', 'illnesses', 'The', 'new', 'viruses', 'cause', 'respiratory', 'symptoms', 'like', 'the', 'common', 'cold', 'cough', 'bronchitis', 'bronchiolitis', 'exacerbations', 'of', 'asthma', 'and', 'chronic', 'obstructive', 'pulmonary', 'disease', 'and', 'pneumonia', 'Acute', 'respiratory', 'failure', 'may', 'occur', 'These', 'viruses', 'are', 'distributed', 'throughout', 'the', 'globe', 'and', 'affect', 'people', 'of', 'all', 'ages', 'Data', 'regarding', 'these', 'viruses', 'and', 'the', 'elderly', 'are', 'scarce', 'This', 'review', 'introduces', 'these', 'new', 'viruses', 'and', 'reviews', 'their', 'clinical', 'significance', 'especially', 'with', 'regard', 'to', 'the', 'elderly', 'population', '']"
174703,Protein Microarrays for Personalized Medicine,2010-03-01,Clin Chem,https://www.ncbi.nlm.nih.gov/pubmed/20075183/; https://doi.org/10.1373/clinchem.2009.137158,"Background: Over the last 10 years, DNA microarrays have achieved a robust analytical performance, enabling their use for analyzing the whole transcriptome or for screening thousands of single-nucleotide polymorphisms in a single experiment. DNA microarrays allow scientists to correlate gene expression signatures with disease progression, to screen for disease-specific mutations, and to treat patients according to their individual genetic profiles; however, the real key is proteins and their manifold functions. It is necessary to achieve a greater understanding of not only protein function and abundance but also their role in the development of diseases. Protein concentrations have been shown to reflect the physiological and pathologic state of an organ, tissue, or cells far more directly than DNA, and proteins can be profiled effectively with protein microarrays, which require only a small amount of sample material. Content: Protein microarrays have become well-established tools in basic and applied research, and the first products have already entered the in vitro diagnostics market. This review focuses on protein microarray applications for biomarker discovery and validation, disease diagnosis, and use within the area of personalized medicine. Summary: Protein microarrays have proved to be reliable research tools in screening for a multitude of parameters with only a minimal quantity of sample and have enormous potential in applications for diagnostic and personalized medicine.",10.1373/clinchem.2009.137158,ba7m0l16,"['Background', 'Over', 'the', 'last', '10', 'years', 'DNA', 'microarrays', 'have', 'achieved', 'a', 'robust', 'analytical', 'performance', 'enabling', 'their', 'use', 'for', 'analyzing', 'the', 'whole', 'transcriptome', 'or', 'for', 'screening', 'thousands', 'of', 'single', 'nucleotide', 'polymorphisms', 'in', 'a', 'single', 'experiment', 'DNA', 'microarrays', 'allow', 'scientists', 'to', 'correlate', 'gene', 'expression', 'signatures', 'with', 'disease', 'progression', 'to', 'screen', 'for', 'disease', 'specific', 'mutations', 'and', 'to', 'treat', 'patients', 'according', 'to', 'their', 'individual', 'genetic', 'profiles', 'however', 'the', 'real', 'key', 'is', 'proteins', 'and', 'their', 'manifold', 'functions', 'It', 'is', 'necessary', 'to', 'achieve', 'a', 'greater', 'understanding', 'of', 'not', 'only', 'protein', 'function', 'and', 'abundance', 'but', 'also', 'their', 'role', 'in', 'the', 'development', 'of', 'diseases', 'Protein', 'concentrations', 'have', 'been', 'shown', 'to', 'reflect', 'the', 'physiological', 'and', 'pathologic', 'state', 'of', 'an', 'organ', 'tissue', 'or', 'cells', 'far', 'more', 'directly', 'than', 'DNA', 'and', 'proteins', 'can', 'be', 'profiled', 'effectively', 'with', 'protein', 'microarrays', 'which', 'require', 'only', 'a', 'small', 'amount', 'of', 'sample', 'material', 'Content', 'Protein', 'microarrays', 'have', 'become', 'well', 'established', 'tools', 'in', 'basic', 'and', 'applied', 'research', 'and', 'the', 'first', 'products', 'have', 'already', 'entered', 'the', 'in', 'vitro', 'diagnostics', 'market', 'This', 'review', 'focuses', 'on', 'protein', 'microarray', 'applications', 'for', 'biomarker', 'discovery', 'and', 'validation', 'disease', 'diagnosis', 'and', 'use', 'within', 'the', 'area', 'of', 'personalized', 'medicine', 'Summary', 'Protein', 'microarrays', 'have', 'proved', 'to', 'be', 'reliable', 'research', 'tools', 'in', 'screening', 'for', 'a', 'multitude', 'of', 'parameters', 'with', 'only', 'a', 'minimal', 'quantity', 'of', 'sample', 'and', 'have', 'enormous', 'potential', 'in', 'applications', 'for', 'diagnostic', 'and', 'personalized', 'medicine', '']"
175320,"Novel Coronavirus: Current Understanding of Clinical Features, Diagnosis, Pathogenesis, and Treatment Options",2020-04-17,Pathogens,https://doi.org/10.3390/pathogens9040297; https://www.ncbi.nlm.nih.gov/pubmed/32316618/,"Since December 2019, coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in devastating consequences worldwide and infected more than 350,000 individuals and killed more than 16,000 people. SARS-CoV-2 is the seventh member of the coronavirus family to affect humans. Symptoms of COVID-19 include fever (88%), cough (68%), vomiting (5%) and diarrhoea (3.7%), and transmission of SARS-CoV-2 is thought to occur from human to human via respiratory secretions released by the infected individuals when coughing and sneezing. COVID-19 can be detected through computed tomography scans and confirmed through molecular diagnostics tools such as polymerase chain reaction. Currently, there are no effective treatments against SARS-CoV-2, hence antiviral drugs have been used to reduce the development of respiratory complications by reducing viral load. The purpose of this review is to provide a comprehensive update on the pathogenesis, clinical aspects, diagnosis, challenges and treatment of SARS-CoV-2 infections.",10.3390/pathogens9040297,oyr03uw1,"['Since', 'December', '2019', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'resulted', 'in', 'devastating', 'consequences', 'worldwide', 'and', 'infected', 'more', 'than', '350', '000', 'individuals', 'and', 'killed', 'more', 'than', '16', '000', 'people', 'SARS', 'CoV', '2', 'is', 'the', 'seventh', 'member', 'of', 'the', 'coronavirus', 'family', 'to', 'affect', 'humans', 'Symptoms', 'of', 'COVID', '19', 'include', 'fever', '88', 'cough', '68', 'vomiting', '5', 'and', 'diarrhoea', '3', '7', 'and', 'transmission', 'of', 'SARS', 'CoV', '2', 'is', 'thought', 'to', 'occur', 'from', 'human', 'to', 'human', 'via', 'respiratory', 'secretions', 'released', 'by', 'the', 'infected', 'individuals', 'when', 'coughing', 'and', 'sneezing', 'COVID', '19', 'can', 'be', 'detected', 'through', 'computed', 'tomography', 'scans', 'and', 'confirmed', 'through', 'molecular', 'diagnostics', 'tools', 'such', 'as', 'polymerase', 'chain', 'reaction', 'Currently', 'there', 'are', 'no', 'effective', 'treatments', 'against', 'SARS', 'CoV', '2', 'hence', 'antiviral', 'drugs', 'have', 'been', 'used', 'to', 'reduce', 'the', 'development', 'of', 'respiratory', 'complications', 'by', 'reducing', 'viral', 'load', 'The', 'purpose', 'of', 'this', 'review', 'is', 'to', 'provide', 'a', 'comprehensive', 'update', 'on', 'the', 'pathogenesis', 'clinical', 'aspects', 'diagnosis', 'challenges', 'and', 'treatment', 'of', 'SARS', 'CoV', '2', 'infections', '']"
175419,"Oncocardiology: new challenges, new opportunities",2020-06-08,Herz,https://www.ncbi.nlm.nih.gov/pubmed/32514587/; https://doi.org/10.1007/s00059-020-04951-x,"Patients with cancer are at a higher risk of cardiovascular disease, which contributes to significant morbidity and mortality. The rapid progress in the field of oncological treatments has led to a steady increase in long-term cancer survivors. Care for cardiovascular complications is therefore becoming increasingly important. In addition, the establishment of new oncological therapies has resulted in the identification of previously unknown cardiovascular side effects. Oncocardiology aims to detect and treat cardiovascular diseases associated with cancer and cancer therapy. Continuous scientific, clinical, and structural developments are necessary as the basis for the best care of the growing number of affected patients. This review summarizes current developments in the field of oncocardiology with regard to advances in cancer therapy and challenges in clinical oncocardiology work. Cardiovascular side effects by targeted cancer therapies are characterized and recent advances in the field of cardiovascular diagnostics are outlined. Developments to better integrate oncocardiology into the medical care system and perspectives for modern, patient-oriented care are shown. In light of the coronavirus disease 2019 (COVID-19) pandemic, current challenges and opportunities are highlighted. The relevance of profitable further advances in oncocardiology including standardized guidelines and educational programs is delineated as a mandatory requirement for the successful development of oncocardiology.",10.1007/s00059-020-04951-x,m1o0wszu,"['Patients', 'with', 'cancer', 'are', 'at', 'a', 'higher', 'risk', 'of', 'cardiovascular', 'disease', 'which', 'contributes', 'to', 'significant', 'morbidity', 'and', 'mortality', 'The', 'rapid', 'progress', 'in', 'the', 'field', 'of', 'oncological', 'treatments', 'has', 'led', 'to', 'a', 'steady', 'increase', 'in', 'long', 'term', 'cancer', 'survivors', 'Care', 'for', 'cardiovascular', 'complications', 'is', 'therefore', 'becoming', 'increasingly', 'important', 'In', 'addition', 'the', 'establishment', 'of', 'new', 'oncological', 'therapies', 'has', 'resulted', 'in', 'the', 'identification', 'of', 'previously', 'unknown', 'cardiovascular', 'side', 'effects', 'Oncocardiology', 'aims', 'to', 'detect', 'and', 'treat', 'cardiovascular', 'diseases', 'associated', 'with', 'cancer', 'and', 'cancer', 'therapy', 'Continuous', 'scientific', 'clinical', 'and', 'structural', 'developments', 'are', 'necessary', 'as', 'the', 'basis', 'for', 'the', 'best', 'care', 'of', 'the', 'growing', 'number', 'of', 'affected', 'patients', 'This', 'review', 'summarizes', 'current', 'developments', 'in', 'the', 'field', 'of', 'oncocardiology', 'with', 'regard', 'to', 'advances', 'in', 'cancer', 'therapy', 'and', 'challenges', 'in', 'clinical', 'oncocardiology', 'work', 'Cardiovascular', 'side', 'effects', 'by', 'targeted', 'cancer', 'therapies', 'are', 'characterized', 'and', 'recent', 'advances', 'in', 'the', 'field', 'of', 'cardiovascular', 'diagnostics', 'are', 'outlined', 'Developments', 'to', 'better', 'integrate', 'oncocardiology', 'into', 'the', 'medical', 'care', 'system', 'and', 'perspectives', 'for', 'modern', 'patient', 'oriented', 'care', 'are', 'shown', 'In', 'light', 'of', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'pandemic', 'current', 'challenges', 'and', 'opportunities', 'are', 'highlighted', 'The', 'relevance', 'of', 'profitable', 'further', 'advances', 'in', 'oncocardiology', 'including', 'standardized', 'guidelines', 'and', 'educational', 'programs', 'is', 'delineated', 'as', 'a', 'mandatory', 'requirement', 'for', 'the', 'successful', 'development', 'of', 'oncocardiology', '']"
175698,"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing",2019-04-23,Sensors (Basel),https://doi.org/10.3390/s19081917; https://www.ncbi.nlm.nih.gov/pubmed/31018573/,"We review some emerging trends in transduction, connectivity and data analytics for Point-of-Care Testing (POCT) of infectious and non-communicable diseases. The patient need for POCT is described along with developments in portable diagnostics, specifically in respect of Lab-on-chip and microfluidic systems. We describe some novel electrochemical and photonic systems and the use of mobile phones in terms of hardware components and device connectivity for POCT. Developments in data analytics that are applicable for POCT are described with an overview of data structures and recent AI/Machine learning trends. The most important methodologies of machine learning, including deep learning methods, are summarised. The potential value of trends within POCT systems for clinical diagnostics within Lower Middle Income Countries (LMICs) and the Least Developed Countries (LDCs) are highlighted.",10.3390/s19081917,wi4hv57b,"['We', 'review', 'some', 'emerging', 'trends', 'in', 'transduction', 'connectivity', 'and', 'data', 'analytics', 'for', 'Point', 'of', 'Care', 'Testing', 'POCT', 'of', 'infectious', 'and', 'non', 'communicable', 'diseases', 'The', 'patient', 'need', 'for', 'POCT', 'is', 'described', 'along', 'with', 'developments', 'in', 'portable', 'diagnostics', 'specifically', 'in', 'respect', 'of', 'Lab', 'on', 'chip', 'and', 'microfluidic', 'systems', 'We', 'describe', 'some', 'novel', 'electrochemical', 'and', 'photonic', 'systems', 'and', 'the', 'use', 'of', 'mobile', 'phones', 'in', 'terms', 'of', 'hardware', 'components', 'and', 'device', 'connectivity', 'for', 'POCT', 'Developments', 'in', 'data', 'analytics', 'that', 'are', 'applicable', 'for', 'POCT', 'are', 'described', 'with', 'an', 'overview', 'of', 'data', 'structures', 'and', 'recent', 'AI', 'Machine', 'learning', 'trends', 'The', 'most', 'important', 'methodologies', 'of', 'machine', 'learning', 'including', 'deep', 'learning', 'methods', 'are', 'summarised', 'The', 'potential', 'value', 'of', 'trends', 'within', 'POCT', 'systems', 'for', 'clinical', 'diagnostics', 'within', 'Lower', 'Middle', 'Income', 'Countries', 'LMICs', 'and', 'the', 'Least', 'Developed', 'Countries', 'LDCs', 'are', 'highlighted', '']"
176138,A novel method to produce armored double-stranded DNA by encapsulation of MS2 viral capsids,2015-05-19,Appl Microbiol Biotechnol,https://www.ncbi.nlm.nih.gov/pubmed/25981999/; https://doi.org/10.1007/s00253-015-6664-4,"With the rapid development of molecular diagnostic techniques, there is a growing need for quality controls and standards with favorable properties to monitor the entire detection process. In this study, we describe a novel method to produce armored hepatitis B virus (HBV) and human papillomavirus (HPV) DNA for use in nucleic acid tests, which was confirmed to be stable, homogeneous, noninfectious, nuclease resistant, and safe for shipping. We demonstrated that MS2 bacteriophage could successfully package double-stranded DNA of 1.3-, 3-, 3.5-, and 6.5-kb length into viral capsids with high reassembly efficiency. This is the first application of RNA bacteriophage MS2 as a platform to encapsulate double-stranded DNA, forming virus-like particles (VLPs) which were indistinguishable from native MS2 capsids in size and morphology. Moreover, by analyzing the interaction mechanism of pac site and the MS2 coat protein (CP), we found that in addition to the recognized initiation signal TR-RNA, TR-DNA can also trigger spontaneous reassembly of CP dimers, providing a more convenient and feasible method of assembly. In conclusion, this straightforward and reliable manufacturing approach makes armored DNA an ideal control and standard for use in clinical laboratory tests and diagnostics, possessing prospects for broad application, especially providing a new platform for the production of quality controls for DNA viruses. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00253-015-6664-4) contains supplementary material, which is available to authorized users.",10.1007/s00253-015-6664-4,ou2cilvp,"['With', 'the', 'rapid', 'development', 'of', 'molecular', 'diagnostic', 'techniques', 'there', 'is', 'a', 'growing', 'need', 'for', 'quality', 'controls', 'and', 'standards', 'with', 'favorable', 'properties', 'to', 'monitor', 'the', 'entire', 'detection', 'process', 'In', 'this', 'study', 'we', 'describe', 'a', 'novel', 'method', 'to', 'produce', 'armored', 'hepatitis', 'B', 'virus', 'HBV', 'and', 'human', 'papillomavirus', 'HPV', 'DNA', 'for', 'use', 'in', 'nucleic', 'acid', 'tests', 'which', 'was', 'confirmed', 'to', 'be', 'stable', 'homogeneous', 'noninfectious', 'nuclease', 'resistant', 'and', 'safe', 'for', 'shipping', 'We', 'demonstrated', 'that', 'MS2', 'bacteriophage', 'could', 'successfully', 'package', 'double', 'stranded', 'DNA', 'of', '1', '3', '3', '3', '5', 'and', '6', '5', 'kb', 'length', 'into', 'viral', 'capsids', 'with', 'high', 'reassembly', 'efficiency', 'This', 'is', 'the', 'first', 'application', 'of', 'RNA', 'bacteriophage', 'MS2', 'as', 'a', 'platform', 'to', 'encapsulate', 'double', 'stranded', 'DNA', 'forming', 'virus', 'like', 'particles', 'VLPs', 'which', 'were', 'indistinguishable', 'from', 'native', 'MS2', 'capsids', 'in', 'size', 'and', 'morphology', 'Moreover', 'by', 'analyzing', 'the', 'interaction', 'mechanism', 'of', 'pac', 'site', 'and', 'the', 'MS2', 'coat', 'protein', 'CP', 'we', 'found', 'that', 'in', 'addition', 'to', 'the', 'recognized', 'initiation', 'signal', 'TR', 'RNA', 'TR', 'DNA', 'can', 'also', 'trigger', 'spontaneous', 'reassembly', 'of', 'CP', 'dimers', 'providing', 'a', 'more', 'convenient', 'and', 'feasible', 'method', 'of', 'assembly', 'In', 'conclusion', 'this', 'straightforward', 'and', 'reliable', 'manufacturing', 'approach', 'makes', 'armored', 'DNA', 'an', 'ideal', 'control', 'and', 'standard', 'for', 'use', 'in', 'clinical', 'laboratory', 'tests', 'and', 'diagnostics', 'possessing', 'prospects', 'for', 'broad', 'application', 'especially', 'providing', 'a', 'new', 'platform', 'for', 'the', 'production', 'of', 'quality', 'controls', 'for', 'DNA', 'viruses', 'ELECTRONIC', 'SUPPLEMENTARY', 'MATERIAL', 'The', 'online', 'version', 'of', 'this', 'article', 'doi', '10', '1007', 's00253', '015', '6664', '4', 'contains', 'supplementary', 'material', 'which', 'is', 'available', 'to', 'authorized', 'users', '']"
177963,FDA Perspectives on Diagnostic Device Clinical Studies for Respiratory Infections,2011-05-01,Clin Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/21460289/; https://doi.org/10.1093/cid/cir056,"Two pathways are described for submission to FDA for clearance of a diagnostic device: a Premarket Application (PMA), which can lead to approval of a diagnostic device, and a Premarket Notification, which can lead to clearance. The latter is often called a 510(k), named for the statute providing for this path. Recent FDA clearance of molecular-based multiplex panels represents the beginning of a new era for the diagnosis of respiratory infections. The ability to test for multiple pathogens simultaneously, accompanied by the increasing availability of molecular-based assays for newly recognized respiratory pathogens will likely have a major impact on patient care, drug development, and public health epidemiology. We provide a general overview of how FDA evaluates new diagnostics for respiratory tract infections and the agency’s expectations for sponsors developing new tests in this area.",10.1093/cid/cir056,uijwq8gx,"['Two', 'pathways', 'are', 'described', 'for', 'submission', 'to', 'FDA', 'for', 'clearance', 'of', 'a', 'diagnostic', 'device', 'a', 'Premarket', 'Application', 'PMA', 'which', 'can', 'lead', 'to', 'approval', 'of', 'a', 'diagnostic', 'device', 'and', 'a', 'Premarket', 'Notification', 'which', 'can', 'lead', 'to', 'clearance', 'The', 'latter', 'is', 'often', 'called', 'a', '510', 'k', 'named', 'for', 'the', 'statute', 'providing', 'for', 'this', 'path', 'Recent', 'FDA', 'clearance', 'of', 'molecular', 'based', 'multiplex', 'panels', 'represents', 'the', 'beginning', 'of', 'a', 'new', 'era', 'for', 'the', 'diagnosis', 'of', 'respiratory', 'infections', 'The', 'ability', 'to', 'test', 'for', 'multiple', 'pathogens', 'simultaneously', 'accompanied', 'by', 'the', 'increasing', 'availability', 'of', 'molecular', 'based', 'assays', 'for', 'newly', 'recognized', 'respiratory', 'pathogens', 'will', 'likely', 'have', 'a', 'major', 'impact', 'on', 'patient', 'care', 'drug', 'development', 'and', 'public', 'health', 'epidemiology', 'We', 'provide', 'a', 'general', 'overview', 'of', 'how', 'FDA', 'evaluates', 'new', 'diagnostics', 'for', 'respiratory', 'tract', 'infections', 'and', 'the', 'agency', 's', 'expectations', 'for', 'sponsors', 'developing', 'new', 'tests', 'in', 'this', 'area', '']"
178021,COVID-19 diagnostic approaches: different roads to the same destination,2020-06-13,Virusdisease,https://www.ncbi.nlm.nih.gov/pubmed/32656306/; https://doi.org/10.1007/s13337-020-00599-7,"“SARS-CoV2”, a previously unknown strain of coronaviruses caused a severe respiratory disease called Coronavirus disease (COVID-19) which emerged from Wuhan city of China on 30 December 2019, and declared as Global health problem by World Health Organisation within a month. In less than two and half months (11 March, 2020) it was declared as a pandemic disease due to its rapid spreading ability, it covered more than 211 countries infecting around 1.7 million persons and claiming around 1.1 lakhs lives within merely 100 days of its emergence. Containment of the infection of this virus is the only available measure to control the disease as no vaccine or specific antiviral treatment is available. Confirmed detection of the virus followed by isolation of the infected person at the earliest possible is the only measure to prevent this disease. Although there are number of methods available for detection of virus and to combat this disease in the present pandemic situation, but these available diagnostic methods have their own limitations. The speedy and exponential global spread of this disease strongly urges the fast and economic diagnostics tools. Additional to the available diagnostic methods, there is a sudden surge for development of various of methods and platforms to diagnose the COVID-19. The review summarized the advantage and disadvantage of various diagnostic approaches being used presently for COVID-19, newer detection methods in developmental stage and the feasibility of advanced platforms like newer nano-sensor based on-the-spot detection technologies.",10.1007/s13337-020-00599-7,xjzhilgm,"['', 'SARS', 'CoV2', 'a', 'previously', 'unknown', 'strain', 'of', 'coronaviruses', 'caused', 'a', 'severe', 'respiratory', 'disease', 'called', 'Coronavirus', 'disease', 'COVID', '19', 'which', 'emerged', 'from', 'Wuhan', 'city', 'of', 'China', 'on', '30', 'December', '2019', 'and', 'declared', 'as', 'Global', 'health', 'problem', 'by', 'World', 'Health', 'Organisation', 'within', 'a', 'month', 'In', 'less', 'than', 'two', 'and', 'half', 'months', '11', 'March', '2020', 'it', 'was', 'declared', 'as', 'a', 'pandemic', 'disease', 'due', 'to', 'its', 'rapid', 'spreading', 'ability', 'it', 'covered', 'more', 'than', '211', 'countries', 'infecting', 'around', '1', '7', 'million', 'persons', 'and', 'claiming', 'around', '1', '1', 'lakhs', 'lives', 'within', 'merely', '100', 'days', 'of', 'its', 'emergence', 'Containment', 'of', 'the', 'infection', 'of', 'this', 'virus', 'is', 'the', 'only', 'available', 'measure', 'to', 'control', 'the', 'disease', 'as', 'no', 'vaccine', 'or', 'specific', 'antiviral', 'treatment', 'is', 'available', 'Confirmed', 'detection', 'of', 'the', 'virus', 'followed', 'by', 'isolation', 'of', 'the', 'infected', 'person', 'at', 'the', 'earliest', 'possible', 'is', 'the', 'only', 'measure', 'to', 'prevent', 'this', 'disease', 'Although', 'there', 'are', 'number', 'of', 'methods', 'available', 'for', 'detection', 'of', 'virus', 'and', 'to', 'combat', 'this', 'disease', 'in', 'the', 'present', 'pandemic', 'situation', 'but', 'these', 'available', 'diagnostic', 'methods', 'have', 'their', 'own', 'limitations', 'The', 'speedy', 'and', 'exponential', 'global', 'spread', 'of', 'this', 'disease', 'strongly', 'urges', 'the', 'fast', 'and', 'economic', 'diagnostics', 'tools', 'Additional', 'to', 'the', 'available', 'diagnostic', 'methods', 'there', 'is', 'a', 'sudden', 'surge', 'for', 'development', 'of', 'various', 'of', 'methods', 'and', 'platforms', 'to', 'diagnose', 'the', 'COVID', '19', 'The', 'review', 'summarized', 'the', 'advantage', 'and', 'disadvantage', 'of', 'various', 'diagnostic', 'approaches', 'being', 'used', 'presently', 'for', 'COVID', '19', 'newer', 'detection', 'methods', 'in', 'developmental', 'stage', 'and', 'the', 'feasibility', 'of', 'advanced', 'platforms', 'like', 'newer', 'nano', 'sensor', 'based', 'on', 'the', 'spot', 'detection', 'technologies', '']"
178044,Development and Implementation of Multiplex TaqMan Array Cards for Specimen Testing at Child Health and Mortality Prevention Surveillance Site Laboratories,2019-10-15,Clin Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/31598666/; https://doi.org/10.1093/cid/ciz571,"Child Health and Mortality Prevention Surveillance (CHAMPS) laboratories are employing a variety of laboratory methods to identify infectious agents contributing to deaths of children <5 years old and stillbirths in sub-Saharan Africa and South Asia. In support of this long-term objective, our team developed TaqMan Array Cards (TACs) for testing postmortem specimens (blood, cerebrospinal fluid, lung tissue, respiratory tract swabs, and rectal swabs) for >100 real-time polymerase chain reaction (PCR) targets in total (30–45 per card depending on configuration). Multipathogen panels were configured by syndrome and customized to include pathogens of significance in young children within the regions where CHAMPS is conducted, including bacteria (57 targets covering 30 genera), viruses (48 targets covering 40 viruses), parasites (8 targets covering 8 organisms), and fungi (3 targets covering 3 organisms). The development and application of multiplex real-time PCR reactions to the TAC microfluidic platform increased the number of targets in each panel while maintaining assay efficiency and replicates for heightened sensitivity. These advances represent a substantial improvement in the utility of this technology for infectious disease diagnostics and surveillance. We optimized all aspects of the CHAMPS molecular laboratory testing workflow including nucleic acid extraction, quality assurance, and data management to ensure comprehensive molecular testing of specimens and high-quality data. Here we describe the development and implementation of multiplex TACs and associated laboratory protocols for specimen processing, testing, and data management at CHAMPS site laboratories.",10.1093/cid/ciz571,8zfss1ox,"['Child', 'Health', 'and', 'Mortality', 'Prevention', 'Surveillance', 'CHAMPS', 'laboratories', 'are', 'employing', 'a', 'variety', 'of', 'laboratory', 'methods', 'to', 'identify', 'infectious', 'agents', 'contributing', 'to', 'deaths', 'of', 'children', '5', 'years', 'old', 'and', 'stillbirths', 'in', 'sub', 'Saharan', 'Africa', 'and', 'South', 'Asia', 'In', 'support', 'of', 'this', 'long', 'term', 'objective', 'our', 'team', 'developed', 'TaqMan', 'Array', 'Cards', 'TACs', 'for', 'testing', 'postmortem', 'specimens', 'blood', 'cerebrospinal', 'fluid', 'lung', 'tissue', 'respiratory', 'tract', 'swabs', 'and', 'rectal', 'swabs', 'for', '100', 'real', 'time', 'polymerase', 'chain', 'reaction', 'PCR', 'targets', 'in', 'total', '30', '45', 'per', 'card', 'depending', 'on', 'configuration', 'Multipathogen', 'panels', 'were', 'configured', 'by', 'syndrome', 'and', 'customized', 'to', 'include', 'pathogens', 'of', 'significance', 'in', 'young', 'children', 'within', 'the', 'regions', 'where', 'CHAMPS', 'is', 'conducted', 'including', 'bacteria', '57', 'targets', 'covering', '30', 'genera', 'viruses', '48', 'targets', 'covering', '40', 'viruses', 'parasites', '8', 'targets', 'covering', '8', 'organisms', 'and', 'fungi', '3', 'targets', 'covering', '3', 'organisms', 'The', 'development', 'and', 'application', 'of', 'multiplex', 'real', 'time', 'PCR', 'reactions', 'to', 'the', 'TAC', 'microfluidic', 'platform', 'increased', 'the', 'number', 'of', 'targets', 'in', 'each', 'panel', 'while', 'maintaining', 'assay', 'efficiency', 'and', 'replicates', 'for', 'heightened', 'sensitivity', 'These', 'advances', 'represent', 'a', 'substantial', 'improvement', 'in', 'the', 'utility', 'of', 'this', 'technology', 'for', 'infectious', 'disease', 'diagnostics', 'and', 'surveillance', 'We', 'optimized', 'all', 'aspects', 'of', 'the', 'CHAMPS', 'molecular', 'laboratory', 'testing', 'workflow', 'including', 'nucleic', 'acid', 'extraction', 'quality', 'assurance', 'and', 'data', 'management', 'to', 'ensure', 'comprehensive', 'molecular', 'testing', 'of', 'specimens', 'and', 'high', 'quality', 'data', 'Here', 'we', 'describe', 'the', 'development', 'and', 'implementation', 'of', 'multiplex', 'TACs', 'and', 'associated', 'laboratory', 'protocols', 'for', 'specimen', 'processing', 'testing', 'and', 'data', 'management', 'at', 'CHAMPS', 'site', 'laboratories', '']"
178095,Integrated Polymerase Chain Reaction Technologies (Sample-to-Answer Technologies),2016-11-04,Molecular Diagnostics,https://www.sciencedirect.com/science/article/pii/B9780128029718000055; https://api.elsevier.com/content/article/pii/B9780128029718000055,"The tools available for both infectious disease diagnostics and human identity testing have benefitted from major technological advances in the automation of nucleic acid purification, amplification, and detection methods. The seamless integration of these processes into a fully automated microscale format has led to the development of rapid, user-friendly sample-to-answer assay systems. The application of these systems for human identity testing allows for DNA profiles to be generated in a field-forward environment where they can be used to generate investigative leads in crimes or other actionable intelligence. When used for infectious disease diagnostics, the sensitivity and specificity of these assay systems meets or exceeds that of more conventional strategies for the detection of respiratory, gastrointestinal, nervous system, and sexually transmitted pathogens. The anticipated medical benefits of this technology include shorter hospital stays, the elimination of unnecessary or ineffectual treatment, improved patient outcomes, and an overall quantifiable reduction in healthcare costs.",10.1016/b978-0-12-802971-8.00005-5,x821kf2c,"['The', 'tools', 'available', 'for', 'both', 'infectious', 'disease', 'diagnostics', 'and', 'human', 'identity', 'testing', 'have', 'benefitted', 'from', 'major', 'technological', 'advances', 'in', 'the', 'automation', 'of', 'nucleic', 'acid', 'purification', 'amplification', 'and', 'detection', 'methods', 'The', 'seamless', 'integration', 'of', 'these', 'processes', 'into', 'a', 'fully', 'automated', 'microscale', 'format', 'has', 'led', 'to', 'the', 'development', 'of', 'rapid', 'user', 'friendly', 'sample', 'to', 'answer', 'assay', 'systems', 'The', 'application', 'of', 'these', 'systems', 'for', 'human', 'identity', 'testing', 'allows', 'for', 'DNA', 'profiles', 'to', 'be', 'generated', 'in', 'a', 'field', 'forward', 'environment', 'where', 'they', 'can', 'be', 'used', 'to', 'generate', 'investigative', 'leads', 'in', 'crimes', 'or', 'other', 'actionable', 'intelligence', 'When', 'used', 'for', 'infectious', 'disease', 'diagnostics', 'the', 'sensitivity', 'and', 'specificity', 'of', 'these', 'assay', 'systems', 'meets', 'or', 'exceeds', 'that', 'of', 'more', 'conventional', 'strategies', 'for', 'the', 'detection', 'of', 'respiratory', 'gastrointestinal', 'nervous', 'system', 'and', 'sexually', 'transmitted', 'pathogens', 'The', 'anticipated', 'medical', 'benefits', 'of', 'this', 'technology', 'include', 'shorter', 'hospital', 'stays', 'the', 'elimination', 'of', 'unnecessary', 'or', 'ineffectual', 'treatment', 'improved', 'patient', 'outcomes', 'and', 'an', 'overall', 'quantifiable', 'reduction', 'in', 'healthcare', 'costs', '']"
178628,8 Electrospinning and microfluidics An integrated approach for tissue engineering and cancer,2018-12-31,Electrofluidodynamic Technologies (EFDTs) for Biomaterials and Medical Devices,https://api.elsevier.com/content/article/pii/B9780081017456000086; https://www.sciencedirect.com/science/article/pii/B9780081017456000086,"Abstract Progress in microfluidic technology has enabled precise manipulation of small volumes of fluids, leading to the development of low-cost and portable systems that have shown considerable promise in biomedicine. Although these functional devices have gained a great deal of attention over the past decades, a new fascinating trend concerns the integration of microfluidics with other fabrication techniques, with particular regard to electrospinning and additive manufacturing.In this chapter, the attention will be focused on integrative approaches obtained combining microfluidics and electrospinning, highlighting the recent advances and challenges in the tissue-engineering framework. Indeed, although this innovative trend is still at its beginning, significant results have been achieved both in the microfluidic-aided fabrication of novel microstructured materials and in the development of new biosensors and analytical devices for point-of-care diagnostics.",10.1016/b978-0-08-101745-6.00008-6,txdlgghh,"['Abstract', 'Progress', 'in', 'microfluidic', 'technology', 'has', 'enabled', 'precise', 'manipulation', 'of', 'small', 'volumes', 'of', 'fluids', 'leading', 'to', 'the', 'development', 'of', 'low', 'cost', 'and', 'portable', 'systems', 'that', 'have', 'shown', 'considerable', 'promise', 'in', 'biomedicine', 'Although', 'these', 'functional', 'devices', 'have', 'gained', 'a', 'great', 'deal', 'of', 'attention', 'over', 'the', 'past', 'decades', 'a', 'new', 'fascinating', 'trend', 'concerns', 'the', 'integration', 'of', 'microfluidics', 'with', 'other', 'fabrication', 'techniques', 'with', 'particular', 'regard', 'to', 'electrospinning', 'and', 'additive', 'manufacturing', 'In', 'this', 'chapter', 'the', 'attention', 'will', 'be', 'focused', 'on', 'integrative', 'approaches', 'obtained', 'combining', 'microfluidics', 'and', 'electrospinning', 'highlighting', 'the', 'recent', 'advances', 'and', 'challenges', 'in', 'the', 'tissue', 'engineering', 'framework', 'Indeed', 'although', 'this', 'innovative', 'trend', 'is', 'still', 'at', 'its', 'beginning', 'significant', 'results', 'have', 'been', 'achieved', 'both', 'in', 'the', 'microfluidic', 'aided', 'fabrication', 'of', 'novel', 'microstructured', 'materials', 'and', 'in', 'the', 'development', 'of', 'new', 'biosensors', 'and', 'analytical', 'devices', 'for', 'point', 'of', 'care', 'diagnostics', '']"
178643,"Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities",2020-07-26,Biosens Bioelectron,https://www.sciencedirect.com/science/article/pii/S0956566320304395?v=s5; https://api.elsevier.com/content/article/pii/S0956566320304395,"With the trend of moving genomic test from (medical) laboratories to on-site testing, there is a need for nucleic acid based diagnostic tools combining the sensitivity, specificity and flexibility of established genomic diagnostics with the ease, cost effectiveness and speed of isothermal amplification methods. A promising new genomic sensing method is Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated nuclease (Cas)-based sensing. In this method Cas effector proteins are used as highly specific sequence recognition elements that can be combined with many different read-out methods for on-site point-of-care testing. This review covers the technical aspects of integrating CRISPR/Cas technology in miniaturized sensors for analysis on-site. We start with a short introduction to CRISPR/Cas systems and the different effector proteins and continue with reviewing the recent developments of integrating CRISPR sensing in miniaturized sensors for point-of-care applications. Finally, we discuss the challenges of point-of-care CRISPR sensing and describe future research perspectives.",10.1016/j.bios.2020.112445,muy75w79,"['With', 'the', 'trend', 'of', 'moving', 'genomic', 'test', 'from', 'medical', 'laboratories', 'to', 'on', 'site', 'testing', 'there', 'is', 'a', 'need', 'for', 'nucleic', 'acid', 'based', 'diagnostic', 'tools', 'combining', 'the', 'sensitivity', 'specificity', 'and', 'flexibility', 'of', 'established', 'genomic', 'diagnostics', 'with', 'the', 'ease', 'cost', 'effectiveness', 'and', 'speed', 'of', 'isothermal', 'amplification', 'methods', 'A', 'promising', 'new', 'genomic', 'sensing', 'method', 'is', 'Clustered', 'Regularly', 'Interspaced', 'Short', 'Palindromic', 'Repeats', 'CRISPR', 'associated', 'nuclease', 'Cas', 'based', 'sensing', 'In', 'this', 'method', 'Cas', 'effector', 'proteins', 'are', 'used', 'as', 'highly', 'specific', 'sequence', 'recognition', 'elements', 'that', 'can', 'be', 'combined', 'with', 'many', 'different', 'read', 'out', 'methods', 'for', 'on', 'site', 'point', 'of', 'care', 'testing', 'This', 'review', 'covers', 'the', 'technical', 'aspects', 'of', 'integrating', 'CRISPR', 'Cas', 'technology', 'in', 'miniaturized', 'sensors', 'for', 'analysis', 'on', 'site', 'We', 'start', 'with', 'a', 'short', 'introduction', 'to', 'CRISPR', 'Cas', 'systems', 'and', 'the', 'different', 'effector', 'proteins', 'and', 'continue', 'with', 'reviewing', 'the', 'recent', 'developments', 'of', 'integrating', 'CRISPR', 'sensing', 'in', 'miniaturized', 'sensors', 'for', 'point', 'of', 'care', 'applications', 'Finally', 'we', 'discuss', 'the', 'challenges', 'of', 'point', 'of', 'care', 'CRISPR', 'sensing', 'and', 'describe', 'future', 'research', 'perspectives', '']"
178774,RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses,2020-04-06,bioRxiv,https://doi.org/10.1101/2020.03.27.012906; https://www.ncbi.nlm.nih.gov/pubmed/32511306/,"As the COVID-19 outbreak spreads, there is a growing need for a compilation of conserved RNA genome regions in the SARS-CoV-2 virus along with their structural propensities to guide development of antivirals and diagnostics. Using sequence alignments spanning a range of betacoronaviruses, we rank genomic regions by RNA sequence conservation, identifying 79 regions of length at least 15 nucleotides as exactly conserved over SARS-related complete genome sequences available near the beginning of the COVID-19 outbreak. We then confirm the conservation of the majority of these genome regions across 739 SARS-CoV-2 sequences reported to date from the current COVID-19 outbreak, and we present a curated list of 30 ‘SARS-related-conserved’ regions. We find that known RNA structured elements curated as Rfam families and in prior literature are enriched in these conserved genome regions, and we predict additional conserved, stable secondary structures across the viral genome. We provide 106 ‘SARS-CoV-2-conserved-structured’ regions as potential targets for antivirals that bind to structured RNA. We further provide detailed secondary structure models for the 5’ UTR, frame-shifting element, and 3’ UTR. Last, we predict regions of the SARS-CoV-2 viral genome have low propensity for RNA secondary structure and are conserved within SARS-CoV-2 strains. These 59 ‘SARS-CoV-2-conserved-unstructured’ genomic regions may be most easily targeted in primer-based diagnostic and oligonucleotide-based therapeutic strategies.",10.1101/2020.03.27.012906,c8f7a9bq,"['As', 'the', 'COVID', '19', 'outbreak', 'spreads', 'there', 'is', 'a', 'growing', 'need', 'for', 'a', 'compilation', 'of', 'conserved', 'RNA', 'genome', 'regions', 'in', 'the', 'SARS', 'CoV', '2', 'virus', 'along', 'with', 'their', 'structural', 'propensities', 'to', 'guide', 'development', 'of', 'antivirals', 'and', 'diagnostics', 'Using', 'sequence', 'alignments', 'spanning', 'a', 'range', 'of', 'betacoronaviruses', 'we', 'rank', 'genomic', 'regions', 'by', 'RNA', 'sequence', 'conservation', 'identifying', '79', 'regions', 'of', 'length', 'at', 'least', '15', 'nucleotides', 'as', 'exactly', 'conserved', 'over', 'SARS', 'related', 'complete', 'genome', 'sequences', 'available', 'near', 'the', 'beginning', 'of', 'the', 'COVID', '19', 'outbreak', 'We', 'then', 'confirm', 'the', 'conservation', 'of', 'the', 'majority', 'of', 'these', 'genome', 'regions', 'across', '739', 'SARS', 'CoV', '2', 'sequences', 'reported', 'to', 'date', 'from', 'the', 'current', 'COVID', '19', 'outbreak', 'and', 'we', 'present', 'a', 'curated', 'list', 'of', '30', 'SARS', 'related', 'conserved', 'regions', 'We', 'find', 'that', 'known', 'RNA', 'structured', 'elements', 'curated', 'as', 'Rfam', 'families', 'and', 'in', 'prior', 'literature', 'are', 'enriched', 'in', 'these', 'conserved', 'genome', 'regions', 'and', 'we', 'predict', 'additional', 'conserved', 'stable', 'secondary', 'structures', 'across', 'the', 'viral', 'genome', 'We', 'provide', '106', 'SARS', 'CoV', '2', 'conserved', 'structured', 'regions', 'as', 'potential', 'targets', 'for', 'antivirals', 'that', 'bind', 'to', 'structured', 'RNA', 'We', 'further', 'provide', 'detailed', 'secondary', 'structure', 'models', 'for', 'the', '5', 'UTR', 'frame', 'shifting', 'element', 'and', '3', 'UTR', 'Last', 'we', 'predict', 'regions', 'of', 'the', 'SARS', 'CoV', '2', 'viral', 'genome', 'have', 'low', 'propensity', 'for', 'RNA', 'secondary', 'structure', 'and', 'are', 'conserved', 'within', 'SARS', 'CoV', '2', 'strains', 'These', '59', 'SARS', 'CoV', '2', 'conserved', 'unstructured', 'genomic', 'regions', 'may', 'be', 'most', 'easily', 'targeted', 'in', 'primer', 'based', 'diagnostic', 'and', 'oligonucleotide', 'based', 'therapeutic', 'strategies', '']"
179904,"Update: Public Health Response to the Coronavirus Disease 2019 Outbreak — United States, February 24, 2020",2020-02-28,MMWR Morb Mortal Wkly Rep,https://doi.org/10.15585/mmwr.mm6908e1; https://www.ncbi.nlm.nih.gov/pubmed/32106216/,"An outbreak of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) began in Wuhan, Hubei Province, China in December 2019, and has spread throughout China and to 31 other countries and territories, including the United States (1). As of February 23, 2020, there were 76,936 reported cases in mainland China and 1,875 cases in locations outside mainland China (1). There have been 2,462 associated deaths worldwide; no deaths have been reported in the United States. Fourteen cases have been diagnosed in the United States, and an additional 39 cases have occurred among repatriated persons from high-risk settings, for a current total of 53 cases within the United States. This report summarizes the aggressive measures (2,3) that CDC, state and local health departments, multiple other federal agencies, and other partners are implementing to slow and try to contain transmission of COVID-19 in the United States. These measures require the identification of cases and contacts of persons with COVID-19 in the United States and the recommended assessment, monitoring, and care of travelers arriving from areas with substantial COVID-19 transmission. Although these measures might not prevent widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare state and local health departments, health care systems, businesses, educational organizations, and the general public in the event that widespread transmission occurs; and 3) better characterize COVID-19 to guide public health recommendations and the development and deployment of medical countermeasures, including diagnostics, therapeutics, and vaccines. U.S. public health authorities are monitoring the situation closely, and CDC is coordinating efforts with the World Health Organization (WHO) and other global partners. Interim guidance is available at https://www.cdc.gov/coronavirus/index.html. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC, state and local health departments, health care providers, and communities.",10.15585/mmwr.mm6908e1,l4o7nicc,"['An', 'outbreak', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'the', '2019', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'began', 'in', 'Wuhan', 'Hubei', 'Province', 'China', 'in', 'December', '2019', 'and', 'has', 'spread', 'throughout', 'China', 'and', 'to', '31', 'other', 'countries', 'and', 'territories', 'including', 'the', 'United', 'States', '1', 'As', 'of', 'February', '23', '2020', 'there', 'were', '76', '936', 'reported', 'cases', 'in', 'mainland', 'China', 'and', '1', '875', 'cases', 'in', 'locations', 'outside', 'mainland', 'China', '1', 'There', 'have', 'been', '2', '462', 'associated', 'deaths', 'worldwide', 'no', 'deaths', 'have', 'been', 'reported', 'in', 'the', 'United', 'States', 'Fourteen', 'cases', 'have', 'been', 'diagnosed', 'in', 'the', 'United', 'States', 'and', 'an', 'additional', '39', 'cases', 'have', 'occurred', 'among', 'repatriated', 'persons', 'from', 'high', 'risk', 'settings', 'for', 'a', 'current', 'total', 'of', '53', 'cases', 'within', 'the', 'United', 'States', 'This', 'report', 'summarizes', 'the', 'aggressive', 'measures', '2', '3', 'that', 'CDC', 'state', 'and', 'local', 'health', 'departments', 'multiple', 'other', 'federal', 'agencies', 'and', 'other', 'partners', 'are', 'implementing', 'to', 'slow', 'and', 'try', 'to', 'contain', 'transmission', 'of', 'COVID', '19', 'in', 'the', 'United', 'States', 'These', 'measures', 'require', 'the', 'identification', 'of', 'cases', 'and', 'contacts', 'of', 'persons', 'with', 'COVID', '19', 'in', 'the', 'United', 'States', 'and', 'the', 'recommended', 'assessment', 'monitoring', 'and', 'care', 'of', 'travelers', 'arriving', 'from', 'areas', 'with', 'substantial', 'COVID', '19', 'transmission', 'Although', 'these', 'measures', 'might', 'not', 'prevent', 'widespread', 'transmission', 'of', 'the', 'virus', 'in', 'the', 'United', 'States', 'they', 'are', 'being', 'implemented', 'to', '1', 'slow', 'the', 'spread', 'of', 'illness', '2', 'provide', 'time', 'to', 'better', 'prepare', 'state', 'and', 'local', 'health', 'departments', 'health', 'care', 'systems', 'businesses', 'educational', 'organizations', 'and', 'the', 'general', 'public', 'in', 'the', 'event', 'that', 'widespread', 'transmission', 'occurs', 'and', '3', 'better', 'characterize', 'COVID', '19', 'to', 'guide', 'public', 'health', 'recommendations', 'and', 'the', 'development', 'and', 'deployment', 'of', 'medical', 'countermeasures', 'including', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'U', 'S', 'public', 'health', 'authorities', 'are', 'monitoring', 'the', 'situation', 'closely', 'and', 'CDC', 'is', 'coordinating', 'efforts', 'with', 'the', 'World', 'Health', 'Organization', 'WHO', 'and', 'other', 'global', 'partners', 'Interim', 'guidance', 'is', 'available', 'at', 'https', 'www', 'cdc', 'gov', 'coronavirus', 'index', 'html', 'As', 'more', 'is', 'learned', 'about', 'this', 'novel', 'virus', 'and', 'this', 'outbreak', 'CDC', 'will', 'rapidly', 'incorporate', 'new', 'knowledge', 'into', 'guidance', 'for', 'action', 'by', 'CDC', 'state', 'and', 'local', 'health', 'departments', 'health', 'care', 'providers', 'and', 'communities', '']"
180216,In silico approach toward the identification of unique peptides from viral protein infection: Application to COVID-19,2020-04-10,bioRxiv,https://doi.org/10.1101/2020.03.08.980383,"We describe a method for rapid in silico selection of diagnostic peptides from newly described viral pathogens and applied this approach to SARS-CoV-2/COVID-19. This approach is multi-tiered, beginning with compiling the theoretical protein sequences from genomic derived data. In the case of SARS-CoV-2 we begin with 496 peptides that would be produced by proteolytic digestion of the viral proteins. To eliminate peptides that would cause cross-reactivity and false positives we remove peptides from consideration that have sequence homology or similar chemical characteristics using a progressively larger database of background peptides. Using this pipeline, we can remove 47 peptides from consideration as diagnostic due to the presence of peptides derived from the human proteome. To address the complexity of the human microbiome, we describe a method to create a database of all proteins of relevant abundance in the saliva microbiome. By utilizing a protein-based approach to the microbiome we can more accurately identify peptides that will be problematic in COVID-19 studies which removes 12 peptides from consideration. To identify diagnostic peptides, another 7 peptides are flagged for removal following comparison to the proteome backgrounds of viral and bacterial pathogens of similar clinical presentation. By aligning the protein sequences of SARS-CoV-2 field isolates deposited to date we can identify peptides for removal due to their presence in highly variable regions that may lead to false negatives as the pathogen evolves. We provide maps of these regions and highlight 3 peptides that should be avoided as potential diagnostic or vaccine targets. Finally, we leverage publicly deposited proteomics data from human cells infected with SARS-CoV-2, as well as a second study with the closely related MERS-CoV to identify the two proteins of highest abundance in human infections. The resulting final list contains the 24 peptides most unique and diagnostic of SARS-CoV-2 infections. These peptides represent the best targets for the development of antibodies are clinical diagnostics. To demonstrate one application of this we model peptide fragmentation using a deep learning tool to rapidly generate targeted LCMS assays and data processing method for detecting CoVID-19 infected patient samples. Graphical Abstract",10.1101/2020.03.08.980383,te049lxh,"['We', 'describe', 'a', 'method', 'for', 'rapid', 'in', 'silico', 'selection', 'of', 'diagnostic', 'peptides', 'from', 'newly', 'described', 'viral', 'pathogens', 'and', 'applied', 'this', 'approach', 'to', 'SARS', 'CoV', '2', 'COVID', '19', 'This', 'approach', 'is', 'multi', 'tiered', 'beginning', 'with', 'compiling', 'the', 'theoretical', 'protein', 'sequences', 'from', 'genomic', 'derived', 'data', 'In', 'the', 'case', 'of', 'SARS', 'CoV', '2', 'we', 'begin', 'with', '496', 'peptides', 'that', 'would', 'be', 'produced', 'by', 'proteolytic', 'digestion', 'of', 'the', 'viral', 'proteins', 'To', 'eliminate', 'peptides', 'that', 'would', 'cause', 'cross', 'reactivity', 'and', 'false', 'positives', 'we', 'remove', 'peptides', 'from', 'consideration', 'that', 'have', 'sequence', 'homology', 'or', 'similar', 'chemical', 'characteristics', 'using', 'a', 'progressively', 'larger', 'database', 'of', 'background', 'peptides', 'Using', 'this', 'pipeline', 'we', 'can', 'remove', '47', 'peptides', 'from', 'consideration', 'as', 'diagnostic', 'due', 'to', 'the', 'presence', 'of', 'peptides', 'derived', 'from', 'the', 'human', 'proteome', 'To', 'address', 'the', 'complexity', 'of', 'the', 'human', 'microbiome', 'we', 'describe', 'a', 'method', 'to', 'create', 'a', 'database', 'of', 'all', 'proteins', 'of', 'relevant', 'abundance', 'in', 'the', 'saliva', 'microbiome', 'By', 'utilizing', 'a', 'protein', 'based', 'approach', 'to', 'the', 'microbiome', 'we', 'can', 'more', 'accurately', 'identify', 'peptides', 'that', 'will', 'be', 'problematic', 'in', 'COVID', '19', 'studies', 'which', 'removes', '12', 'peptides', 'from', 'consideration', 'To', 'identify', 'diagnostic', 'peptides', 'another', '7', 'peptides', 'are', 'flagged', 'for', 'removal', 'following', 'comparison', 'to', 'the', 'proteome', 'backgrounds', 'of', 'viral', 'and', 'bacterial', 'pathogens', 'of', 'similar', 'clinical', 'presentation', 'By', 'aligning', 'the', 'protein', 'sequences', 'of', 'SARS', 'CoV', '2', 'field', 'isolates', 'deposited', 'to', 'date', 'we', 'can', 'identify', 'peptides', 'for', 'removal', 'due', 'to', 'their', 'presence', 'in', 'highly', 'variable', 'regions', 'that', 'may', 'lead', 'to', 'false', 'negatives', 'as', 'the', 'pathogen', 'evolves', 'We', 'provide', 'maps', 'of', 'these', 'regions', 'and', 'highlight', '3', 'peptides', 'that', 'should', 'be', 'avoided', 'as', 'potential', 'diagnostic', 'or', 'vaccine', 'targets', 'Finally', 'we', 'leverage', 'publicly', 'deposited', 'proteomics', 'data', 'from', 'human', 'cells', 'infected', 'with', 'SARS', 'CoV', '2', 'as', 'well', 'as', 'a', 'second', 'study', 'with', 'the', 'closely', 'related', 'MERS', 'CoV', 'to', 'identify', 'the', 'two', 'proteins', 'of', 'highest', 'abundance', 'in', 'human', 'infections', 'The', 'resulting', 'final', 'list', 'contains', 'the', '24', 'peptides', 'most', 'unique', 'and', 'diagnostic', 'of', 'SARS', 'CoV', '2', 'infections', 'These', 'peptides', 'represent', 'the', 'best', 'targets', 'for', 'the', 'development', 'of', 'antibodies', 'are', 'clinical', 'diagnostics', 'To', 'demonstrate', 'one', 'application', 'of', 'this', 'we', 'model', 'peptide', 'fragmentation', 'using', 'a', 'deep', 'learning', 'tool', 'to', 'rapidly', 'generate', 'targeted', 'LCMS', 'assays', 'and', 'data', 'processing', 'method', 'for', 'detecting', 'CoVID', '19', 'infected', 'patient', 'samples', 'Graphical', 'Abstract']"
180407,Fifty-Five Years of International Epidemic-Assistance Investigations Conducted by CDC’s Disease Detectives,2011-12-01,Am J Epidemiol,https://www.ncbi.nlm.nih.gov/pubmed/22135398/; https://doi.org/10.1093/aje/kwr312,"For more than 60 years, the Centers for Disease Control and Prevention (CDC) has used its scientific expertise to help people throughout the world live healthier, safer, longer lives through science-based health action. In 1951, CDC officially established the Epidemic Intelligence Service to help build public health capacity. During 1950–2005, CDC’s Epidemic Intelligence Service officers conducted 462 international epidemiologic field investigations in 131 foreign countries and 7 territories. Investigations have included responding to emerging infectious and noninfectious disease outbreaks, assisting in disaster response, and evaluating core components of public health programs worldwide. Approximately 81% of investigations were responses to infectious disease outbreaks, but the proportion of investigations related to chronic and other noninfectious conditions increased 7-fold (6%–45%). These investigations have contributed to detecting and characterizing new pathogens (e.g., severe acute respiratory syndrome–associated coronavirus) and conditions, provided insights regarding factors that cause or contribute to disease acquisition (e.g., Ebola hemorrhagic fever), led to development of new diagnostics and surveillance technologies, and provided information upon which global health policies and regulations can be based. CDC’s disease detectives will undoubtedly continue to play a critical role in global health and in responding to emerging global disease threats.",10.1093/aje/kwr312,0u6idk0m,"['For', 'more', 'than', '60', 'years', 'the', 'Centers', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'has', 'used', 'its', 'scientific', 'expertise', 'to', 'help', 'people', 'throughout', 'the', 'world', 'live', 'healthier', 'safer', 'longer', 'lives', 'through', 'science', 'based', 'health', 'action', 'In', '1951', 'CDC', 'officially', 'established', 'the', 'Epidemic', 'Intelligence', 'Service', 'to', 'help', 'build', 'public', 'health', 'capacity', 'During', '1950', '2005', 'CDC', 's', 'Epidemic', 'Intelligence', 'Service', 'officers', 'conducted', '462', 'international', 'epidemiologic', 'field', 'investigations', 'in', '131', 'foreign', 'countries', 'and', '7', 'territories', 'Investigations', 'have', 'included', 'responding', 'to', 'emerging', 'infectious', 'and', 'noninfectious', 'disease', 'outbreaks', 'assisting', 'in', 'disaster', 'response', 'and', 'evaluating', 'core', 'components', 'of', 'public', 'health', 'programs', 'worldwide', 'Approximately', '81', 'of', 'investigations', 'were', 'responses', 'to', 'infectious', 'disease', 'outbreaks', 'but', 'the', 'proportion', 'of', 'investigations', 'related', 'to', 'chronic', 'and', 'other', 'noninfectious', 'conditions', 'increased', '7', 'fold', '6', '45', 'These', 'investigations', 'have', 'contributed', 'to', 'detecting', 'and', 'characterizing', 'new', 'pathogens', 'e', 'g', 'severe', 'acute', 'respiratory', 'syndrome', 'associated', 'coronavirus', 'and', 'conditions', 'provided', 'insights', 'regarding', 'factors', 'that', 'cause', 'or', 'contribute', 'to', 'disease', 'acquisition', 'e', 'g', 'Ebola', 'hemorrhagic', 'fever', 'led', 'to', 'development', 'of', 'new', 'diagnostics', 'and', 'surveillance', 'technologies', 'and', 'provided', 'information', 'upon', 'which', 'global', 'health', 'policies', 'and', 'regulations', 'can', 'be', 'based', 'CDC', 's', 'disease', 'detectives', 'will', 'undoubtedly', 'continue', 'to', 'play', 'a', 'critical', 'role', 'in', 'global', 'health', 'and', 'in', 'responding', 'to', 'emerging', 'global', 'disease', 'threats', '']"
180679,The rise of artificial intelligence in healthcare applications,2020-06-26,Artificial Intelligence in Healthcare,https://www.sciencedirect.com/science/article/pii/B9780128184387000022; https://api.elsevier.com/content/article/pii/B9780128184387000022,"Big data and machine learning are having an impact on most aspects of modern life, from entertainment, commerce, and healthcare. Netflix knows which films and series people prefer to watch, Amazon knows which items people like to buy when and where, and Google knows which symptoms and conditions people are searching for. All this data can be used for very detailed personal profiling, which may be of great value for behavioral understanding and targeting but also has potential for predicting healthcare trends. There is great optimism that the application of artificial intelligence (AI) can provide substantial improvements in all areas of healthcare from diagnostics to treatment. It is generally believed that AI tools will facilitate and enhance human work and not replace the work of physicians and other healthcare staff as such. AI is ready to support healthcare personnel with a variety of tasks from administrative workflow to clinical documentation and patient outreach as well as specialized support such as in image analysis, medical device automation, and patient monitoring. In this chapter, some of the major applications of AI in healthcare will be discussed covering both the applications that are directly associated with healthcare and those in the healthcare value chain such as drug development and ambient assisted living.",10.1016/b978-0-12-818438-7.00002-2,iiahpjod,"['Big', 'data', 'and', 'machine', 'learning', 'are', 'having', 'an', 'impact', 'on', 'most', 'aspects', 'of', 'modern', 'life', 'from', 'entertainment', 'commerce', 'and', 'healthcare', 'Netflix', 'knows', 'which', 'films', 'and', 'series', 'people', 'prefer', 'to', 'watch', 'Amazon', 'knows', 'which', 'items', 'people', 'like', 'to', 'buy', 'when', 'and', 'where', 'and', 'Google', 'knows', 'which', 'symptoms', 'and', 'conditions', 'people', 'are', 'searching', 'for', 'All', 'this', 'data', 'can', 'be', 'used', 'for', 'very', 'detailed', 'personal', 'profiling', 'which', 'may', 'be', 'of', 'great', 'value', 'for', 'behavioral', 'understanding', 'and', 'targeting', 'but', 'also', 'has', 'potential', 'for', 'predicting', 'healthcare', 'trends', 'There', 'is', 'great', 'optimism', 'that', 'the', 'application', 'of', 'artificial', 'intelligence', 'AI', 'can', 'provide', 'substantial', 'improvements', 'in', 'all', 'areas', 'of', 'healthcare', 'from', 'diagnostics', 'to', 'treatment', 'It', 'is', 'generally', 'believed', 'that', 'AI', 'tools', 'will', 'facilitate', 'and', 'enhance', 'human', 'work', 'and', 'not', 'replace', 'the', 'work', 'of', 'physicians', 'and', 'other', 'healthcare', 'staff', 'as', 'such', 'AI', 'is', 'ready', 'to', 'support', 'healthcare', 'personnel', 'with', 'a', 'variety', 'of', 'tasks', 'from', 'administrative', 'workflow', 'to', 'clinical', 'documentation', 'and', 'patient', 'outreach', 'as', 'well', 'as', 'specialized', 'support', 'such', 'as', 'in', 'image', 'analysis', 'medical', 'device', 'automation', 'and', 'patient', 'monitoring', 'In', 'this', 'chapter', 'some', 'of', 'the', 'major', 'applications', 'of', 'AI', 'in', 'healthcare', 'will', 'be', 'discussed', 'covering', 'both', 'the', 'applications', 'that', 'are', 'directly', 'associated', 'with', 'healthcare', 'and', 'those', 'in', 'the', 'healthcare', 'value', 'chain', 'such', 'as', 'drug', 'development', 'and', 'ambient', 'assisted', 'living', '']"
183023,"COVID-19: Progress in diagnostics, therapy and vaccination",2020-06-19,Theranostics,https://doi.org/10.7150/thno.47987; https://www.ncbi.nlm.nih.gov/pubmed/32685022/,"Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently become a pandemic. As the sudden emergence and rapid spread of SARS-CoV-2 is endangering global health and the economy, the development of strategies to contain the virus's spread are urgently needed. At present, various diagnostic kits to test for SARS-CoV-2 are available for use to initiate appropriate treatment faster and to limit further spread of the virus. Several drugs have demonstrated in vitro activity against SARS-CoV-2 or potential clinical benefits. In addition, institutions and companies worldwide are working tirelessly to develop treatments and vaccines against COVID-19. However, no drug or vaccine has yet been specifically approved for COVID-19. Given the urgency of the outbreak, we focus here on recent advances in the diagnostics, treatment, and vaccine development for SARS-CoV-2 infection, helping to guide strategies to address the current COVID-19 pandemic.",10.7150/thno.47987,q7d0ysbo,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'recently', 'become', 'a', 'pandemic', 'As', 'the', 'sudden', 'emergence', 'and', 'rapid', 'spread', 'of', 'SARS', 'CoV', '2', 'is', 'endangering', 'global', 'health', 'and', 'the', 'economy', 'the', 'development', 'of', 'strategies', 'to', 'contain', 'the', 'virus', 's', 'spread', 'are', 'urgently', 'needed', 'At', 'present', 'various', 'diagnostic', 'kits', 'to', 'test', 'for', 'SARS', 'CoV', '2', 'are', 'available', 'for', 'use', 'to', 'initiate', 'appropriate', 'treatment', 'faster', 'and', 'to', 'limit', 'further', 'spread', 'of', 'the', 'virus', 'Several', 'drugs', 'have', 'demonstrated', 'in', 'vitro', 'activity', 'against', 'SARS', 'CoV', '2', 'or', 'potential', 'clinical', 'benefits', 'In', 'addition', 'institutions', 'and', 'companies', 'worldwide', 'are', 'working', 'tirelessly', 'to', 'develop', 'treatments', 'and', 'vaccines', 'against', 'COVID', '19', 'However', 'no', 'drug', 'or', 'vaccine', 'has', 'yet', 'been', 'specifically', 'approved', 'for', 'COVID', '19', 'Given', 'the', 'urgency', 'of', 'the', 'outbreak', 'we', 'focus', 'here', 'on', 'recent', 'advances', 'in', 'the', 'diagnostics', 'treatment', 'and', 'vaccine', 'development', 'for', 'SARS', 'CoV', '2', 'infection', 'helping', 'to', 'guide', 'strategies', 'to', 'address', 'the', 'current', 'COVID', '19', 'pandemic', '']"
183497,"SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions",2020-05-10,Viruses,https://doi.org/10.3390/v12050526; https://www.ncbi.nlm.nih.gov/pubmed/32397688/,"The COVID-19 pandemic is due to infection caused by the novel SARS-CoV-2 virus that impacts the lower respiratory tract. The spectrum of symptoms ranges from asymptomatic infections to mild respiratory symptoms to the lethal form of COVID-19 which is associated with severe pneumonia, acute respiratory distress, and fatality. To address this global crisis, up-to-date information on viral genomics and transcriptomics is crucial for understanding the origins and global dispersion of the virus, providing insights into viral pathogenicity, transmission, and epidemiology, and enabling strategies for therapeutic interventions, drug discovery, and vaccine development. Therefore, this review provides a comprehensive overview of COVID-19 epidemiology, genomic etiology, findings from recent transcriptomic map analysis, viral-human protein interactions, molecular diagnostics, and the current status of vaccine and novel therapeutic intervention development. Moreover, we provide an extensive list of resources that will help the scientific community access numerous types of databases related to SARS-CoV-2 OMICs and approaches to therapeutics related to COVID-19 treatment.",10.3390/v12050526,m2tpue3y,"['The', 'COVID', '19', 'pandemic', 'is', 'due', 'to', 'infection', 'caused', 'by', 'the', 'novel', 'SARS', 'CoV', '2', 'virus', 'that', 'impacts', 'the', 'lower', 'respiratory', 'tract', 'The', 'spectrum', 'of', 'symptoms', 'ranges', 'from', 'asymptomatic', 'infections', 'to', 'mild', 'respiratory', 'symptoms', 'to', 'the', 'lethal', 'form', 'of', 'COVID', '19', 'which', 'is', 'associated', 'with', 'severe', 'pneumonia', 'acute', 'respiratory', 'distress', 'and', 'fatality', 'To', 'address', 'this', 'global', 'crisis', 'up', 'to', 'date', 'information', 'on', 'viral', 'genomics', 'and', 'transcriptomics', 'is', 'crucial', 'for', 'understanding', 'the', 'origins', 'and', 'global', 'dispersion', 'of', 'the', 'virus', 'providing', 'insights', 'into', 'viral', 'pathogenicity', 'transmission', 'and', 'epidemiology', 'and', 'enabling', 'strategies', 'for', 'therapeutic', 'interventions', 'drug', 'discovery', 'and', 'vaccine', 'development', 'Therefore', 'this', 'review', 'provides', 'a', 'comprehensive', 'overview', 'of', 'COVID', '19', 'epidemiology', 'genomic', 'etiology', 'findings', 'from', 'recent', 'transcriptomic', 'map', 'analysis', 'viral', 'human', 'protein', 'interactions', 'molecular', 'diagnostics', 'and', 'the', 'current', 'status', 'of', 'vaccine', 'and', 'novel', 'therapeutic', 'intervention', 'development', 'Moreover', 'we', 'provide', 'an', 'extensive', 'list', 'of', 'resources', 'that', 'will', 'help', 'the', 'scientific', 'community', 'access', 'numerous', 'types', 'of', 'databases', 'related', 'to', 'SARS', 'CoV', '2', 'OMICs', 'and', 'approaches', 'to', 'therapeutics', 'related', 'to', 'COVID', '19', 'treatment', '']"
183780,"Fighting COVID-19: a quick review of diagnoses, therapies, and vaccines",2020-05-30,Biomed J,https://www.sciencedirect.com/science/article/pii/S2319417020300858?v=s5; https://doi.org/10.1016/j.bj.2020.05.021; https://api.elsevier.com/content/article/pii/S2319417020300858; https://www.ncbi.nlm.nih.gov/pubmed/32532623/,"The COVID-19 pandemic caused by a novel coronavirus, SARS-CoV-2, has infected more than 4.9 million individuals and resulted in over 300,000 deaths globally. The rapid spread of the virus and the precipitously increasing numbers of cases necessitate the urgent development of accurate diagnostic methods, effective treatments, and vaccines. Here, we review the progress of developing diagnostic methods, therapies, and vaccines for SARS-CoV-2 with a focus on current clinical trials and their challenges. For diagnosis, nucleic acid amplification tests remain the mainstay diagnostics for laboratory confirmation of SARS-CoV-2 infection, while serological antibody tests are used to aid contact tracing, epidemiological, and vaccine evaluation studies. Viral isolation is not recommended for routine diagnostic procedures due to safety concerns. Currently, no single effective drug or specific vaccine is available against SARS-CoV-2. Some candidate drugs targeting different levels and stages of human responses against COVID-19 such as cell membrane fusion, RNA-dependent RNA polymerase, viral protease inhibitor, interleukin 6 blocker, and convalescent plasma may improve the clinical outcomes of critical COVID-19 patients. Other supportive care measures for critical patients are still necessary. Advances in genetic sequencing and other technological developments have sped up the establishment of a variety of vaccine platforms. Accordingly, numerous vaccines are under development. Vaccine candidates against SARS-CoV-2 are mainly based upon the viral spike protein due to its vital role in viral infectivity, and most of these candidates have recently moved into clinical trials. Before the efficacy of such vaccines in humans is demonstrated, strong international coordination and collaboration among studies, pharmaceutical companies, regulators, and governments are needed to limit further damage due the emerging SARS-CoV-2 virus.",10.1016/j.bj.2020.05.021,0g7a9s5z,"['The', 'COVID', '19', 'pandemic', 'caused', 'by', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'has', 'infected', 'more', 'than', '4', '9', 'million', 'individuals', 'and', 'resulted', 'in', 'over', '300', '000', 'deaths', 'globally', 'The', 'rapid', 'spread', 'of', 'the', 'virus', 'and', 'the', 'precipitously', 'increasing', 'numbers', 'of', 'cases', 'necessitate', 'the', 'urgent', 'development', 'of', 'accurate', 'diagnostic', 'methods', 'effective', 'treatments', 'and', 'vaccines', 'Here', 'we', 'review', 'the', 'progress', 'of', 'developing', 'diagnostic', 'methods', 'therapies', 'and', 'vaccines', 'for', 'SARS', 'CoV', '2', 'with', 'a', 'focus', 'on', 'current', 'clinical', 'trials', 'and', 'their', 'challenges', 'For', 'diagnosis', 'nucleic', 'acid', 'amplification', 'tests', 'remain', 'the', 'mainstay', 'diagnostics', 'for', 'laboratory', 'confirmation', 'of', 'SARS', 'CoV', '2', 'infection', 'while', 'serological', 'antibody', 'tests', 'are', 'used', 'to', 'aid', 'contact', 'tracing', 'epidemiological', 'and', 'vaccine', 'evaluation', 'studies', 'Viral', 'isolation', 'is', 'not', 'recommended', 'for', 'routine', 'diagnostic', 'procedures', 'due', 'to', 'safety', 'concerns', 'Currently', 'no', 'single', 'effective', 'drug', 'or', 'specific', 'vaccine', 'is', 'available', 'against', 'SARS', 'CoV', '2', 'Some', 'candidate', 'drugs', 'targeting', 'different', 'levels', 'and', 'stages', 'of', 'human', 'responses', 'against', 'COVID', '19', 'such', 'as', 'cell', 'membrane', 'fusion', 'RNA', 'dependent', 'RNA', 'polymerase', 'viral', 'protease', 'inhibitor', 'interleukin', '6', 'blocker', 'and', 'convalescent', 'plasma', 'may', 'improve', 'the', 'clinical', 'outcomes', 'of', 'critical', 'COVID', '19', 'patients', 'Other', 'supportive', 'care', 'measures', 'for', 'critical', 'patients', 'are', 'still', 'necessary', 'Advances', 'in', 'genetic', 'sequencing', 'and', 'other', 'technological', 'developments', 'have', 'sped', 'up', 'the', 'establishment', 'of', 'a', 'variety', 'of', 'vaccine', 'platforms', 'Accordingly', 'numerous', 'vaccines', 'are', 'under', 'development', 'Vaccine', 'candidates', 'against', 'SARS', 'CoV', '2', 'are', 'mainly', 'based', 'upon', 'the', 'viral', 'spike', 'protein', 'due', 'to', 'its', 'vital', 'role', 'in', 'viral', 'infectivity', 'and', 'most', 'of', 'these', 'candidates', 'have', 'recently', 'moved', 'into', 'clinical', 'trials', 'Before', 'the', 'efficacy', 'of', 'such', 'vaccines', 'in', 'humans', 'is', 'demonstrated', 'strong', 'international', 'coordination', 'and', 'collaboration', 'among', 'studies', 'pharmaceutical', 'companies', 'regulators', 'and', 'governments', 'are', 'needed', 'to', 'limit', 'further', 'damage', 'due', 'the', 'emerging', 'SARS', 'CoV', '2', 'virus', '']"
184004,Selection of SARS-Coronavirus-specific B cell epitopes by phage peptide library screening and evaluation of the immunological effect of epitope-based peptides on mice(),2007-03-15,Virology,https://api.elsevier.com/content/article/pii/S0042682206006696; https://www.sciencedirect.com/science/article/pii/S0042682206006696; https://www.ncbi.nlm.nih.gov/pubmed/17055022/,"Antibodies to SARS-Coronavirus (SARS-CoV)-specific B cell epitopes might recognize the pathogen and interrupt its adherence to and penetration of host cells. Hence, these epitopes could be useful for diagnosis and as vaccine constituents. Using the phage-displayed peptide library screening method and purified Fab fragments of immunoglobulin G (IgG Fab) from normal human sera and convalescent sera from SARS-CoV-infected patients as targets, 11 B cell epitopes of SARS-CoV spike glycoprotein (S protein) and membrane protein (M protein) were screened. After a bioinformatics tool was used to analyze these epitopes, four epitope-based S protein dodecapeptides corresponding to the predominant epitopes were chosen for synthesis. Their antigenic specificities and immunogenicities were studied in vitro and in vivo. Flow cytometry and ELISPOT analysis of lymphocytes as well as a serologic analysis of antibody showed that these peptides could trigger a rapid, highly effective, and relatively safe immune response in BALB/c mice. These findings might aid development of SARS diagnostics and vaccines. Moreover, the role of S and M proteins as important surface antigens is confirmed.",10.1016/j.virol.2006.09.016,djfj4262,"['Antibodies', 'to', 'SARS', 'Coronavirus', 'SARS', 'CoV', 'specific', 'B', 'cell', 'epitopes', 'might', 'recognize', 'the', 'pathogen', 'and', 'interrupt', 'its', 'adherence', 'to', 'and', 'penetration', 'of', 'host', 'cells', 'Hence', 'these', 'epitopes', 'could', 'be', 'useful', 'for', 'diagnosis', 'and', 'as', 'vaccine', 'constituents', 'Using', 'the', 'phage', 'displayed', 'peptide', 'library', 'screening', 'method', 'and', 'purified', 'Fab', 'fragments', 'of', 'immunoglobulin', 'G', 'IgG', 'Fab', 'from', 'normal', 'human', 'sera', 'and', 'convalescent', 'sera', 'from', 'SARS', 'CoV', 'infected', 'patients', 'as', 'targets', '11', 'B', 'cell', 'epitopes', 'of', 'SARS', 'CoV', 'spike', 'glycoprotein', 'S', 'protein', 'and', 'membrane', 'protein', 'M', 'protein', 'were', 'screened', 'After', 'a', 'bioinformatics', 'tool', 'was', 'used', 'to', 'analyze', 'these', 'epitopes', 'four', 'epitope', 'based', 'S', 'protein', 'dodecapeptides', 'corresponding', 'to', 'the', 'predominant', 'epitopes', 'were', 'chosen', 'for', 'synthesis', 'Their', 'antigenic', 'specificities', 'and', 'immunogenicities', 'were', 'studied', 'in', 'vitro', 'and', 'in', 'vivo', 'Flow', 'cytometry', 'and', 'ELISPOT', 'analysis', 'of', 'lymphocytes', 'as', 'well', 'as', 'a', 'serologic', 'analysis', 'of', 'antibody', 'showed', 'that', 'these', 'peptides', 'could', 'trigger', 'a', 'rapid', 'highly', 'effective', 'and', 'relatively', 'safe', 'immune', 'response', 'in', 'BALB', 'c', 'mice', 'These', 'findings', 'might', 'aid', 'development', 'of', 'SARS', 'diagnostics', 'and', 'vaccines', 'Moreover', 'the', 'role', 'of', 'S', 'and', 'M', 'proteins', 'as', 'important', 'surface', 'antigens', 'is', 'confirmed', '']"
184092,Serology testing in the COVID-19 pandemic response,2020-07-17,Lancet Infect Dis,https://api.elsevier.com/content/article/pii/S147330992030517X; https://www.sciencedirect.com/science/article/pii/S147330992030517X; https://www.ncbi.nlm.nih.gov/pubmed/32687805/; https://doi.org/10.1016/s1473-3099(20)30517-x,"The collapse of global cooperation and a failure of international solidarity have led to many low-income and middle-income countries being denied access to molecular diagnostics in the COVID-19 pandemic response. Yet the scarcity of knowledge on the dynamics of the immune response to infection has led to hesitation on recommending the use of rapid immunodiagnostic tests, even though rapid serology tests are commercially available and scalable. On the basis of our knowledge and understanding of viral infectivity and host response, we urge countries without the capacity to do molecular testing at scale to research the use of serology tests to triage symptomatic patients in community settings, to test contacts of confirmed cases, and in situational analysis and surveillance. The WHO R&D Blue Print expert group identified eight priorities for research and development, of which the highest is to mobilise research on rapid point-of-care diagnostics for use at the community level. This research should inform control programmes of the required performance and utility of rapid serology tests, which, when applied specifically for appropriate public health measures to then be put in place, can make a huge difference.",10.1016/s1473-3099(20)30517-x,ru2iw0py,"['The', 'collapse', 'of', 'global', 'cooperation', 'and', 'a', 'failure', 'of', 'international', 'solidarity', 'have', 'led', 'to', 'many', 'low', 'income', 'and', 'middle', 'income', 'countries', 'being', 'denied', 'access', 'to', 'molecular', 'diagnostics', 'in', 'the', 'COVID', '19', 'pandemic', 'response', 'Yet', 'the', 'scarcity', 'of', 'knowledge', 'on', 'the', 'dynamics', 'of', 'the', 'immune', 'response', 'to', 'infection', 'has', 'led', 'to', 'hesitation', 'on', 'recommending', 'the', 'use', 'of', 'rapid', 'immunodiagnostic', 'tests', 'even', 'though', 'rapid', 'serology', 'tests', 'are', 'commercially', 'available', 'and', 'scalable', 'On', 'the', 'basis', 'of', 'our', 'knowledge', 'and', 'understanding', 'of', 'viral', 'infectivity', 'and', 'host', 'response', 'we', 'urge', 'countries', 'without', 'the', 'capacity', 'to', 'do', 'molecular', 'testing', 'at', 'scale', 'to', 'research', 'the', 'use', 'of', 'serology', 'tests', 'to', 'triage', 'symptomatic', 'patients', 'in', 'community', 'settings', 'to', 'test', 'contacts', 'of', 'confirmed', 'cases', 'and', 'in', 'situational', 'analysis', 'and', 'surveillance', 'The', 'WHO', 'R', 'D', 'Blue', 'Print', 'expert', 'group', 'identified', 'eight', 'priorities', 'for', 'research', 'and', 'development', 'of', 'which', 'the', 'highest', 'is', 'to', 'mobilise', 'research', 'on', 'rapid', 'point', 'of', 'care', 'diagnostics', 'for', 'use', 'at', 'the', 'community', 'level', 'This', 'research', 'should', 'inform', 'control', 'programmes', 'of', 'the', 'required', 'performance', 'and', 'utility', 'of', 'rapid', 'serology', 'tests', 'which', 'when', 'applied', 'specifically', 'for', 'appropriate', 'public', 'health', 'measures', 'to', 'then', 'be', 'put', 'in', 'place', 'can', 'make', 'a', 'huge', 'difference', '']"
184720,Antibody-profiling technologies for studying humoral responses to infectious agents,2010-06-01,Expert Review of Vaccines,http://europepmc.org/articles/pmc3417761?pdf=render; https://www.ncbi.nlm.nih.gov/pubmed/20518713/; https://doi.org/10.1586/erv.10.50,"Analyses of humoral responses against different infectious agents are critical for infectious disease diagnostics, understanding pathogenic mechanisms, and the development and monitoring of vaccines. While ELISAs are often used to measure antibody responses to one or several targets, new antibody-profiling technologies, such as protein microarrays, can now evaluate antibody responses to hundreds, or even thousands, of recombinant antigens at one time. These large-scale studies have uncovered new antigenic targets, provided new insights into vaccine research and yielded an overview of immunoreactivity against almost the entire proteome of certain pathogens. However, solid-phase antigen arrays also have drawbacks that limit the type of information obtained, including suboptimal detection of conformational epitopes, high backgrounds due to impure antigens and a narrow dynamic range of detection. We have developed a solution-phase antibody-profiling technology, luciferase immunoprecipitation systems (LIPS), which harnesses light-emitting recombinant antigen fusion proteins to quantitatively measure patient antibody titers. Owing to the highly linear light output of the luciferase reporter, some antibodies can be detected without serum dilution in a dynamic range of detection often spanning seven orders of magnitude. When LIPS is applied iteratively with multiple target antigens, a high-definition antibody profile is obtained. Here, we discuss the application of these different antibody-profiling technologies and their associated limitations with particular emphasis on protein microarrays. We also describe LIPS in detail and discuss several clinically relevant uses of the technology. Together, these new technologies offer new tools for understanding humoral responses to known and emerging infectious agents.",10.1586/erv.10.50,1evsmqw6,"['Analyses', 'of', 'humoral', 'responses', 'against', 'different', 'infectious', 'agents', 'are', 'critical', 'for', 'infectious', 'disease', 'diagnostics', 'understanding', 'pathogenic', 'mechanisms', 'and', 'the', 'development', 'and', 'monitoring', 'of', 'vaccines', 'While', 'ELISAs', 'are', 'often', 'used', 'to', 'measure', 'antibody', 'responses', 'to', 'one', 'or', 'several', 'targets', 'new', 'antibody', 'profiling', 'technologies', 'such', 'as', 'protein', 'microarrays', 'can', 'now', 'evaluate', 'antibody', 'responses', 'to', 'hundreds', 'or', 'even', 'thousands', 'of', 'recombinant', 'antigens', 'at', 'one', 'time', 'These', 'large', 'scale', 'studies', 'have', 'uncovered', 'new', 'antigenic', 'targets', 'provided', 'new', 'insights', 'into', 'vaccine', 'research', 'and', 'yielded', 'an', 'overview', 'of', 'immunoreactivity', 'against', 'almost', 'the', 'entire', 'proteome', 'of', 'certain', 'pathogens', 'However', 'solid', 'phase', 'antigen', 'arrays', 'also', 'have', 'drawbacks', 'that', 'limit', 'the', 'type', 'of', 'information', 'obtained', 'including', 'suboptimal', 'detection', 'of', 'conformational', 'epitopes', 'high', 'backgrounds', 'due', 'to', 'impure', 'antigens', 'and', 'a', 'narrow', 'dynamic', 'range', 'of', 'detection', 'We', 'have', 'developed', 'a', 'solution', 'phase', 'antibody', 'profiling', 'technology', 'luciferase', 'immunoprecipitation', 'systems', 'LIPS', 'which', 'harnesses', 'light', 'emitting', 'recombinant', 'antigen', 'fusion', 'proteins', 'to', 'quantitatively', 'measure', 'patient', 'antibody', 'titers', 'Owing', 'to', 'the', 'highly', 'linear', 'light', 'output', 'of', 'the', 'luciferase', 'reporter', 'some', 'antibodies', 'can', 'be', 'detected', 'without', 'serum', 'dilution', 'in', 'a', 'dynamic', 'range', 'of', 'detection', 'often', 'spanning', 'seven', 'orders', 'of', 'magnitude', 'When', 'LIPS', 'is', 'applied', 'iteratively', 'with', 'multiple', 'target', 'antigens', 'a', 'high', 'definition', 'antibody', 'profile', 'is', 'obtained', 'Here', 'we', 'discuss', 'the', 'application', 'of', 'these', 'different', 'antibody', 'profiling', 'technologies', 'and', 'their', 'associated', 'limitations', 'with', 'particular', 'emphasis', 'on', 'protein', 'microarrays', 'We', 'also', 'describe', 'LIPS', 'in', 'detail', 'and', 'discuss', 'several', 'clinically', 'relevant', 'uses', 'of', 'the', 'technology', 'Together', 'these', 'new', 'technologies', 'offer', 'new', 'tools', 'for', 'understanding', 'humoral', 'responses', 'to', 'known', 'and', 'emerging', 'infectious', 'agents', '']"
185013,Advances of multiplex and high throughput biomolecular detection technologies based on encoding microparticles,2011-08-20,Sci China Chem,https://www.ncbi.nlm.nih.gov/pubmed/32214998/; https://doi.org/10.1007/s11426-011-4343-6,"The rapid developments of genomics and proteomics have driven the demand for multiplex and high throughput analysis of large numbers of biomolecules in the fields of medical diagnostics, drug discovery, and environmental monitoring. Encoding the biomolecular binding events is the key technique to fulfill this demand, in which microparticles play the most important roles. This review outlines the development of multiplex and high throughput biodetections, and highlights the most recent advances in the field of encoding microparticles, together with problems that need to be resolved.",10.1007/s11426-011-4343-6,1yvkyel6,"['The', 'rapid', 'developments', 'of', 'genomics', 'and', 'proteomics', 'have', 'driven', 'the', 'demand', 'for', 'multiplex', 'and', 'high', 'throughput', 'analysis', 'of', 'large', 'numbers', 'of', 'biomolecules', 'in', 'the', 'fields', 'of', 'medical', 'diagnostics', 'drug', 'discovery', 'and', 'environmental', 'monitoring', 'Encoding', 'the', 'biomolecular', 'binding', 'events', 'is', 'the', 'key', 'technique', 'to', 'fulfill', 'this', 'demand', 'in', 'which', 'microparticles', 'play', 'the', 'most', 'important', 'roles', 'This', 'review', 'outlines', 'the', 'development', 'of', 'multiplex', 'and', 'high', 'throughput', 'biodetections', 'and', 'highlights', 'the', 'most', 'recent', 'advances', 'in', 'the', 'field', 'of', 'encoding', 'microparticles', 'together', 'with', 'problems', 'that', 'need', 'to', 'be', 'resolved', '']"
185355,Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay,2006-03-02,BMC Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/16512903/,"BACKGROUND: Continuous outbreaks of the highly pathogenic H5N1 avian influenza A in Asia has resulted in an urgent effort to improve current diagnostics to aid containment of the virus and lower the threat of a influenza pandemic. We report here the development of a PCR-based assay that is highly specific for the H5N1 avian influenza A virus. METHODS: A one-step reverse-transcription PCR assay was developed to detect the H5N1 avian influenza A virus. The specificity of the assay was shown by testing sub-types of influenza A virus and other viral and bacterial pathogens; and on field samples. RESULTS: Validation on 145 field specimens from Vietnam and Malaysia showed that the assay was specific without cross reactivity to a number of other infuenza strains as well as human respiratory related pathogens. Detection was 100% from allantoic fluid in H5N1 positive samples, suggesting it to be a reliable sampling source for accurate detection. CONCLUSION: The assay developed from this study indicates that the primers are specific for the H5N1 influenza virus. As shown by the field tested results, this assay would be highly useful as a diagnostic tool to help identify and control influenza epidemics.",10.1186/1471-2334-6-40,vip4jtlv,"['BACKGROUND', 'Continuous', 'outbreaks', 'of', 'the', 'highly', 'pathogenic', 'H5N1', 'avian', 'influenza', 'A', 'in', 'Asia', 'has', 'resulted', 'in', 'an', 'urgent', 'effort', 'to', 'improve', 'current', 'diagnostics', 'to', 'aid', 'containment', 'of', 'the', 'virus', 'and', 'lower', 'the', 'threat', 'of', 'a', 'influenza', 'pandemic', 'We', 'report', 'here', 'the', 'development', 'of', 'a', 'PCR', 'based', 'assay', 'that', 'is', 'highly', 'specific', 'for', 'the', 'H5N1', 'avian', 'influenza', 'A', 'virus', 'METHODS', 'A', 'one', 'step', 'reverse', 'transcription', 'PCR', 'assay', 'was', 'developed', 'to', 'detect', 'the', 'H5N1', 'avian', 'influenza', 'A', 'virus', 'The', 'specificity', 'of', 'the', 'assay', 'was', 'shown', 'by', 'testing', 'sub', 'types', 'of', 'influenza', 'A', 'virus', 'and', 'other', 'viral', 'and', 'bacterial', 'pathogens', 'and', 'on', 'field', 'samples', 'RESULTS', 'Validation', 'on', '145', 'field', 'specimens', 'from', 'Vietnam', 'and', 'Malaysia', 'showed', 'that', 'the', 'assay', 'was', 'specific', 'without', 'cross', 'reactivity', 'to', 'a', 'number', 'of', 'other', 'infuenza', 'strains', 'as', 'well', 'as', 'human', 'respiratory', 'related', 'pathogens', 'Detection', 'was', '100', 'from', 'allantoic', 'fluid', 'in', 'H5N1', 'positive', 'samples', 'suggesting', 'it', 'to', 'be', 'a', 'reliable', 'sampling', 'source', 'for', 'accurate', 'detection', 'CONCLUSION', 'The', 'assay', 'developed', 'from', 'this', 'study', 'indicates', 'that', 'the', 'primers', 'are', 'specific', 'for', 'the', 'H5N1', 'influenza', 'virus', 'As', 'shown', 'by', 'the', 'field', 'tested', 'results', 'this', 'assay', 'would', 'be', 'highly', 'useful', 'as', 'a', 'diagnostic', 'tool', 'to', 'help', 'identify', 'and', 'control', 'influenza', 'epidemics', '']"
185638,Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex,2019-06-30,BMB Rep,https://www.ncbi.nlm.nih.gov/pubmed/30355437/,"Middle East respiratory syndrome coronavirus (MERS-CoV) uses the spike (S) glycoprotein to recognize and enter target cells. In this study, we selected two epitope peptide sequences within the receptor binding domain (RBD) of the MERS-CoV S protein. We used a complex consisting of the epitope peptide of the MERS-CoV S protein and CpG-DNA encapsulated in liposome complex to immunize mice, and produced the monoclonal antibodies 506-2G10G5 and 492-1G10E4E2. The western blotting data showed that both monoclonal antibodies detected the S protein and immunoprecipitated the native form of the S protein. Indirect immunofluorescence and confocal analysis suggested strong reactivity of the antibodies towards the S protein of MERS-CoV virus infected Vero cells. Furthermore, the 506-2G10G5 monoclonal antibody significantly reduced plaque formation in MERS-CoV infected Vero cells compared to normal mouse IgG and 492-1G10E4E2. Thus, we successfully produced a monoclonal antibody directed against the RBD domain of the S protein which could be used in the development of diagnostics and therapeutic applications in the future.",10.5483/bmbrep.2019.52.6.185,n7ehxulc,"['Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'uses', 'the', 'spike', 'S', 'glycoprotein', 'to', 'recognize', 'and', 'enter', 'target', 'cells', 'In', 'this', 'study', 'we', 'selected', 'two', 'epitope', 'peptide', 'sequences', 'within', 'the', 'receptor', 'binding', 'domain', 'RBD', 'of', 'the', 'MERS', 'CoV', 'S', 'protein', 'We', 'used', 'a', 'complex', 'consisting', 'of', 'the', 'epitope', 'peptide', 'of', 'the', 'MERS', 'CoV', 'S', 'protein', 'and', 'CpG', 'DNA', 'encapsulated', 'in', 'liposome', 'complex', 'to', 'immunize', 'mice', 'and', 'produced', 'the', 'monoclonal', 'antibodies', '506', '2G10G5', 'and', '492', '1G10E4E2', 'The', 'western', 'blotting', 'data', 'showed', 'that', 'both', 'monoclonal', 'antibodies', 'detected', 'the', 'S', 'protein', 'and', 'immunoprecipitated', 'the', 'native', 'form', 'of', 'the', 'S', 'protein', 'Indirect', 'immunofluorescence', 'and', 'confocal', 'analysis', 'suggested', 'strong', 'reactivity', 'of', 'the', 'antibodies', 'towards', 'the', 'S', 'protein', 'of', 'MERS', 'CoV', 'virus', 'infected', 'Vero', 'cells', 'Furthermore', 'the', '506', '2G10G5', 'monoclonal', 'antibody', 'significantly', 'reduced', 'plaque', 'formation', 'in', 'MERS', 'CoV', 'infected', 'Vero', 'cells', 'compared', 'to', 'normal', 'mouse', 'IgG', 'and', '492', '1G10E4E2', 'Thus', 'we', 'successfully', 'produced', 'a', 'monoclonal', 'antibody', 'directed', 'against', 'the', 'RBD', 'domain', 'of', 'the', 'S', 'protein', 'which', 'could', 'be', 'used', 'in', 'the', 'development', 'of', 'diagnostics', 'and', 'therapeutic', 'applications', 'in', 'the', 'future', '']"
185952,"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review",2020-02-26,J Clin Med,https://doi.org/10.3390/jcm9030623; https://www.ncbi.nlm.nih.gov/pubmed/32110875/,"Rapid diagnostics, vaccines and therapeutics are important interventions for the management of the 2019 novel coronavirus (2019-nCoV) outbreak. It is timely to systematically review the potential of these interventions, including those for Middle East respiratory syndrome-Coronavirus (MERS-CoV) and severe acute respiratory syndrome (SARS)-CoV, to guide policymakers globally on their prioritization of resources for research and development. A systematic search was carried out in three major electronic databases (PubMed, Embase and Cochrane Library) to identify published studies in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Supplementary strategies through Google Search and personal communications were used. A total of 27 studies fulfilled the criteria for review. Several laboratory protocols for confirmation of suspected 2019-nCoV cases using real-time reverse transcription polymerase chain reaction (RT-PCR) have been published. A commercial RT-PCR kit developed by the Beijing Genomic Institute is currently widely used in China and likely in Asia. However, serological assays as well as point-of-care testing kits have not been developed but are likely in the near future. Several vaccine candidates are in the pipeline. The likely earliest Phase 1 vaccine trial is a synthetic DNA-based candidate. A number of novel compounds as well as therapeutics licensed for other conditions appear to have in vitro efficacy against the 2019-nCoV. Some are being tested in clinical trials against MERS-CoV and SARS-CoV, while others have been listed for clinical trials against 2019-nCoV. However, there are currently no effective specific antivirals or drug combinations supported by high-level evidence.",10.3390/jcm9030623,8gncbgot,"['Rapid', 'diagnostics', 'vaccines', 'and', 'therapeutics', 'are', 'important', 'interventions', 'for', 'the', 'management', 'of', 'the', '2019', 'novel', 'coronavirus', '2019', 'nCoV', 'outbreak', 'It', 'is', 'timely', 'to', 'systematically', 'review', 'the', 'potential', 'of', 'these', 'interventions', 'including', 'those', 'for', 'Middle', 'East', 'respiratory', 'syndrome', 'Coronavirus', 'MERS', 'CoV', 'and', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'to', 'guide', 'policymakers', 'globally', 'on', 'their', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'A', 'systematic', 'search', 'was', 'carried', 'out', 'in', 'three', 'major', 'electronic', 'databases', 'PubMed', 'Embase', 'and', 'Cochrane', 'Library', 'to', 'identify', 'published', 'studies', 'in', 'accordance', 'with', 'the', 'Preferred', 'Reporting', 'Items', 'for', 'Systematic', 'Reviews', 'and', 'Meta', 'Analyses', 'PRISMA', 'guidelines', 'Supplementary', 'strategies', 'through', 'Google', 'Search', 'and', 'personal', 'communications', 'were', 'used', 'A', 'total', 'of', '27', 'studies', 'fulfilled', 'the', 'criteria', 'for', 'review', 'Several', 'laboratory', 'protocols', 'for', 'confirmation', 'of', 'suspected', '2019', 'nCoV', 'cases', 'using', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'have', 'been', 'published', 'A', 'commercial', 'RT', 'PCR', 'kit', 'developed', 'by', 'the', 'Beijing', 'Genomic', 'Institute', 'is', 'currently', 'widely', 'used', 'in', 'China', 'and', 'likely', 'in', 'Asia', 'However', 'serological', 'assays', 'as', 'well', 'as', 'point', 'of', 'care', 'testing', 'kits', 'have', 'not', 'been', 'developed', 'but', 'are', 'likely', 'in', 'the', 'near', 'future', 'Several', 'vaccine', 'candidates', 'are', 'in', 'the', 'pipeline', 'The', 'likely', 'earliest', 'Phase', '1', 'vaccine', 'trial', 'is', 'a', 'synthetic', 'DNA', 'based', 'candidate', 'A', 'number', 'of', 'novel', 'compounds', 'as', 'well', 'as', 'therapeutics', 'licensed', 'for', 'other', 'conditions', 'appear', 'to', 'have', 'in', 'vitro', 'efficacy', 'against', 'the', '2019', 'nCoV', 'Some', 'are', 'being', 'tested', 'in', 'clinical', 'trials', 'against', 'MERS', 'CoV', 'and', 'SARS', 'CoV', 'while', 'others', 'have', 'been', 'listed', 'for', 'clinical', 'trials', 'against', '2019', 'nCoV', 'However', 'there', 'are', 'currently', 'no', 'effective', 'specific', 'antivirals', 'or', 'drug', 'combinations', 'supported', 'by', 'high', 'level', 'evidence', '']"
186363,Recent advances in lab-on-a-chip technologies for viral diagnosis,2020-04-01,Biosensors and Bioelectronics,https://api.elsevier.com/content/article/pii/S0956566320300385; https://www.ncbi.nlm.nih.gov/pubmed/31999560/; https://doi.org/10.1016/j.bios.2020.112041; https://www.sciencedirect.com/science/article/pii/S0956566320300385,"Abstract The global risk of viral disease outbreaks emphasizes the need for rapid, accurate, and sensitive detection techniques to speed up diagnostics allowing early intervention. An emerging field of microfluidics also known as the lab-on-a-chip (LOC) or micro total analysis system includes a wide range of diagnostic devices. This review briefly covers both conventional and microfluidics-based techniques for rapid viral detection. We first describe conventional detection methods such as cell culturing, immunofluorescence or enzyme-linked immunosorbent assay (ELISA), or reverse transcription polymerase chain reaction (RT-PCR). These methods often have limited speed, sensitivity, or specificity and are performed with typically bulky equipment. Here, we discuss some of the LOC technologies that can overcome these demerits, highlighting the latest advances in LOC devices for viral disease diagnosis. We also discuss the fabrication of LOC systems to produce devices for performing either individual steps or virus detection in samples with the sample to answer method. The complete system consists of sample preparation, and ELISA and RT-PCR for viral-antibody and nucleic acid detection, respectively. Finally, we formulate our opinions on these areas for the future development of LOC systems for viral diagnostics.",10.1016/j.bios.2020.112041,zwbn44gz,"['Abstract', 'The', 'global', 'risk', 'of', 'viral', 'disease', 'outbreaks', 'emphasizes', 'the', 'need', 'for', 'rapid', 'accurate', 'and', 'sensitive', 'detection', 'techniques', 'to', 'speed', 'up', 'diagnostics', 'allowing', 'early', 'intervention', 'An', 'emerging', 'field', 'of', 'microfluidics', 'also', 'known', 'as', 'the', 'lab', 'on', 'a', 'chip', 'LOC', 'or', 'micro', 'total', 'analysis', 'system', 'includes', 'a', 'wide', 'range', 'of', 'diagnostic', 'devices', 'This', 'review', 'briefly', 'covers', 'both', 'conventional', 'and', 'microfluidics', 'based', 'techniques', 'for', 'rapid', 'viral', 'detection', 'We', 'first', 'describe', 'conventional', 'detection', 'methods', 'such', 'as', 'cell', 'culturing', 'immunofluorescence', 'or', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'or', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'These', 'methods', 'often', 'have', 'limited', 'speed', 'sensitivity', 'or', 'specificity', 'and', 'are', 'performed', 'with', 'typically', 'bulky', 'equipment', 'Here', 'we', 'discuss', 'some', 'of', 'the', 'LOC', 'technologies', 'that', 'can', 'overcome', 'these', 'demerits', 'highlighting', 'the', 'latest', 'advances', 'in', 'LOC', 'devices', 'for', 'viral', 'disease', 'diagnosis', 'We', 'also', 'discuss', 'the', 'fabrication', 'of', 'LOC', 'systems', 'to', 'produce', 'devices', 'for', 'performing', 'either', 'individual', 'steps', 'or', 'virus', 'detection', 'in', 'samples', 'with', 'the', 'sample', 'to', 'answer', 'method', 'The', 'complete', 'system', 'consists', 'of', 'sample', 'preparation', 'and', 'ELISA', 'and', 'RT', 'PCR', 'for', 'viral', 'antibody', 'and', 'nucleic', 'acid', 'detection', 'respectively', 'Finally', 'we', 'formulate', 'our', 'opinions', 'on', 'these', 'areas', 'for', 'the', 'future', 'development', 'of', 'LOC', 'systems', 'for', 'viral', 'diagnostics', '']"
186873,Emerging Viral Infections,2012-11-05,Genomic and Personalized Medicine,https://www.sciencedirect.com/science/article/pii/B9780123822277000975; https://api.elsevier.com/content/article/pii/B9780123822277000975,"Emerging and re-emerging viral diseases pose a continuous health threat and disease burden to humans. Research efforts to mitigate the effects of infectious threats, focusing on improved surveillance and diagnostic capabilities, but also on the development of intervention strategies like the use of vaccines and antiviral agents, are crucial. We describe how genomic approaches may aid in mitigating viral threats, by highlighting potential roles and limitations of genomics approaches in virus surveillance and diagnostics, and development of vaccines and antivirals. Keywords antiviral, diagnostics, (emerging) infectious disease, evolution and diversity, gene expression profiling, genome-wide association studies, genome-wide functional screens, host genomics, prevention, surveillance, treatment, viral genomics, virus discovery, vaccine",10.1016/b978-0-12-382227-7.00097-5,m0xlnm6n,"['Emerging', 'and', 're', 'emerging', 'viral', 'diseases', 'pose', 'a', 'continuous', 'health', 'threat', 'and', 'disease', 'burden', 'to', 'humans', 'Research', 'efforts', 'to', 'mitigate', 'the', 'effects', 'of', 'infectious', 'threats', 'focusing', 'on', 'improved', 'surveillance', 'and', 'diagnostic', 'capabilities', 'but', 'also', 'on', 'the', 'development', 'of', 'intervention', 'strategies', 'like', 'the', 'use', 'of', 'vaccines', 'and', 'antiviral', 'agents', 'are', 'crucial', 'We', 'describe', 'how', 'genomic', 'approaches', 'may', 'aid', 'in', 'mitigating', 'viral', 'threats', 'by', 'highlighting', 'potential', 'roles', 'and', 'limitations', 'of', 'genomics', 'approaches', 'in', 'virus', 'surveillance', 'and', 'diagnostics', 'and', 'development', 'of', 'vaccines', 'and', 'antivirals', 'Keywords', 'antiviral', 'diagnostics', 'emerging', 'infectious', 'disease', 'evolution', 'and', 'diversity', 'gene', 'expression', 'profiling', 'genome', 'wide', 'association', 'studies', 'genome', 'wide', 'functional', 'screens', 'host', 'genomics', 'prevention', 'surveillance', 'treatment', 'viral', 'genomics', 'virus', 'discovery', 'vaccine']"
187878,Re-imagining the future of diagnosis of Neglected Tropical Diseases,2017-02-21,Comput Struct Biotechnol J,https://api.elsevier.com/content/article/pii/S2001037016301015; https://www.ncbi.nlm.nih.gov/pubmed/28352456/; https://www.sciencedirect.com/science/article/pii/S2001037016301015; https://doi.org/10.1016/j.csbj.2017.02.003,"Neglected Tropical Diseases (NTDs) affect an estimated 1 billion people in 149 countries. The World Health Organization (WHO) prioritised 17 NTDs for control and elimination by 2020 and defined a Road Map to help countries reach these goals. Improved diagnostics for NTDs are essential for guiding treatment strategies at different thresholds of control, interruption of transmission, elimination and post-elimination surveillance. While substantial progress has been made in the last decade with chemotherapy, the same cannot be said of diagnostics, largely due to the perceived lack of a commercially viable market for NTD diagnostics. New sample in-answer out nucleic acid amplification technologies that can be performed at the point-of-care offer improved performance over current technologies and the potential to test for multiple pathogens using a single specimen. Finding commonalities for different NTDs in terms of geographic overlap, sentinel populations and treatment strategy will allow NTD programs to leverage these innovations to build cost-effective multiplex surveillance platforms. Connectivity solutions linking data from diagnostic laboratories and POC test readers/devices provide opportunities for automated surveillance systems to make health systems more efficient, improving patient outcomes and assessing impact of interventions in real time. New models of public–private product development partnerships are critical in leveraging diagnostic innovation in other priority area for better diagnosis, control and elimination of NTDs.",10.1016/j.csbj.2017.02.003,5lusy98x,"['Neglected', 'Tropical', 'Diseases', 'NTDs', 'affect', 'an', 'estimated', '1', 'billion', 'people', 'in', '149', 'countries', 'The', 'World', 'Health', 'Organization', 'WHO', 'prioritised', '17', 'NTDs', 'for', 'control', 'and', 'elimination', 'by', '2020', 'and', 'defined', 'a', 'Road', 'Map', 'to', 'help', 'countries', 'reach', 'these', 'goals', 'Improved', 'diagnostics', 'for', 'NTDs', 'are', 'essential', 'for', 'guiding', 'treatment', 'strategies', 'at', 'different', 'thresholds', 'of', 'control', 'interruption', 'of', 'transmission', 'elimination', 'and', 'post', 'elimination', 'surveillance', 'While', 'substantial', 'progress', 'has', 'been', 'made', 'in', 'the', 'last', 'decade', 'with', 'chemotherapy', 'the', 'same', 'cannot', 'be', 'said', 'of', 'diagnostics', 'largely', 'due', 'to', 'the', 'perceived', 'lack', 'of', 'a', 'commercially', 'viable', 'market', 'for', 'NTD', 'diagnostics', 'New', 'sample', 'in', 'answer', 'out', 'nucleic', 'acid', 'amplification', 'technologies', 'that', 'can', 'be', 'performed', 'at', 'the', 'point', 'of', 'care', 'offer', 'improved', 'performance', 'over', 'current', 'technologies', 'and', 'the', 'potential', 'to', 'test', 'for', 'multiple', 'pathogens', 'using', 'a', 'single', 'specimen', 'Finding', 'commonalities', 'for', 'different', 'NTDs', 'in', 'terms', 'of', 'geographic', 'overlap', 'sentinel', 'populations', 'and', 'treatment', 'strategy', 'will', 'allow', 'NTD', 'programs', 'to', 'leverage', 'these', 'innovations', 'to', 'build', 'cost', 'effective', 'multiplex', 'surveillance', 'platforms', 'Connectivity', 'solutions', 'linking', 'data', 'from', 'diagnostic', 'laboratories', 'and', 'POC', 'test', 'readers', 'devices', 'provide', 'opportunities', 'for', 'automated', 'surveillance', 'systems', 'to', 'make', 'health', 'systems', 'more', 'efficient', 'improving', 'patient', 'outcomes', 'and', 'assessing', 'impact', 'of', 'interventions', 'in', 'real', 'time', 'New', 'models', 'of', 'public', 'private', 'product', 'development', 'partnerships', 'are', 'critical', 'in', 'leveraging', 'diagnostic', 'innovation', 'in', 'other', 'priority', 'area', 'for', 'better', 'diagnosis', 'control', 'and', 'elimination', 'of', 'NTDs', '']"
188199,ViPR: an open bioinformatics database and analysis resource for virology research,2011-10-17,Nucleic Acids Res,https://doi.org/10.1093/nar/gkr859; https://www.ncbi.nlm.nih.gov/pubmed/22006842/,"The Virus Pathogen Database and Analysis Resource (ViPR, www.ViPRbrc.org) is an integrated repository of data and analysis tools for multiple virus families, supported by the National Institute of Allergy and Infectious Diseases (NIAID) Bioinformatics Resource Centers (BRC) program. ViPR contains information for human pathogenic viruses belonging to the Arenaviridae, Bunyaviridae, Caliciviridae, Coronaviridae, Flaviviridae, Filoviridae, Hepeviridae, Herpesviridae, Paramyxoviridae, Picornaviridae, Poxviridae, Reoviridae, Rhabdoviridae and Togaviridae families, with plans to support additional virus families in the future. ViPR captures various types of information, including sequence records, gene and protein annotations, 3D protein structures, immune epitope locations, clinical and surveillance metadata and novel data derived from comparative genomics analysis. Analytical and visualization tools for metadata-driven statistical sequence analysis, multiple sequence alignment, phylogenetic tree construction, BLAST comparison and sequence variation determination are also provided. Data filtering and analysis workflows can be combined and the results saved in personal ‘Workbenches’ for future use. ViPR tools and data are available without charge as a service to the virology research community to help facilitate the development of diagnostics, prophylactics and therapeutics for priority pathogens and other viruses.",10.1093/nar/gkr859,48ym7eti,"['The', 'Virus', 'Pathogen', 'Database', 'and', 'Analysis', 'Resource', 'ViPR', 'www', 'ViPRbrc', 'org', 'is', 'an', 'integrated', 'repository', 'of', 'data', 'and', 'analysis', 'tools', 'for', 'multiple', 'virus', 'families', 'supported', 'by', 'the', 'National', 'Institute', 'of', 'Allergy', 'and', 'Infectious', 'Diseases', 'NIAID', 'Bioinformatics', 'Resource', 'Centers', 'BRC', 'program', 'ViPR', 'contains', 'information', 'for', 'human', 'pathogenic', 'viruses', 'belonging', 'to', 'the', 'Arenaviridae', 'Bunyaviridae', 'Caliciviridae', 'Coronaviridae', 'Flaviviridae', 'Filoviridae', 'Hepeviridae', 'Herpesviridae', 'Paramyxoviridae', 'Picornaviridae', 'Poxviridae', 'Reoviridae', 'Rhabdoviridae', 'and', 'Togaviridae', 'families', 'with', 'plans', 'to', 'support', 'additional', 'virus', 'families', 'in', 'the', 'future', 'ViPR', 'captures', 'various', 'types', 'of', 'information', 'including', 'sequence', 'records', 'gene', 'and', 'protein', 'annotations', '3D', 'protein', 'structures', 'immune', 'epitope', 'locations', 'clinical', 'and', 'surveillance', 'metadata', 'and', 'novel', 'data', 'derived', 'from', 'comparative', 'genomics', 'analysis', 'Analytical', 'and', 'visualization', 'tools', 'for', 'metadata', 'driven', 'statistical', 'sequence', 'analysis', 'multiple', 'sequence', 'alignment', 'phylogenetic', 'tree', 'construction', 'BLAST', 'comparison', 'and', 'sequence', 'variation', 'determination', 'are', 'also', 'provided', 'Data', 'filtering', 'and', 'analysis', 'workflows', 'can', 'be', 'combined', 'and', 'the', 'results', 'saved', 'in', 'personal', 'Workbenches', 'for', 'future', 'use', 'ViPR', 'tools', 'and', 'data', 'are', 'available', 'without', 'charge', 'as', 'a', 'service', 'to', 'the', 'virology', 'research', 'community', 'to', 'help', 'facilitate', 'the', 'development', 'of', 'diagnostics', 'prophylactics', 'and', 'therapeutics', 'for', 'priority', 'pathogens', 'and', 'other', 'viruses', '']"
188270,"An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies",2020-05-30,Travel Med Infect Dis,https://www.sciencedirect.com/science/article/pii/S1477893920302349?v=s5; https://www.ncbi.nlm.nih.gov/pubmed/32479816/; https://api.elsevier.com/content/article/pii/S1477893920302349; https://doi.org/10.1016/j.tmaid.2020.101755,"Coronavirus Disease 2019 (COVID-19), emerged in early December 2019 in China and became a pandemic situation worldwide by its rapid spread to nearly 190 countries. Bats are considered as the reservoir host, and the search of a probable intermediate host is still going on. The severe form of the infection is associated with death is mainly reported in older and immune-compromised patients with pre-existing disease history. Death in severe cases is attributed to respiratory failure associated with hyperinflammation. Cytokine storm syndrome associated with inflammation in response to SARS-CoV-2 infection is considered as the leading cause of mortality in COVID-19 patients. COVID-19 patients have thus higher levels of many proinflammatory cytokines and chemokines. The blood lab profile of the COVID-19 patients exhibits lymphopenia, leukopenia, thrombocytopenia, and RNAaemia, along with increased levels of aspartate aminotransferase. SARS-CoV-2 infection in pregnant women does not lead to fetus mortality, unlike other zoonotic coronaviruses such as SARS-CoV and MERS-CoV, and there is, to date, no evidence of intrauterine transmission to neonates. Rapid diagnostics have been developed, and significant efforts are being made to develop effective vaccines and therapeutics. In the absence of any virus-specific therapy, internationally, health care authorities are recommending the adoption of effective community mitigation measures to counter and contain this pandemic virus. This paper is an overview of this virus and the disease with a particular focus on SARS-CoV-2/COVID-19 clinical pathology, pathogenesis, and immunopathology, along with recent research developments.",10.1016/j.tmaid.2020.101755,7rh07bii,"['Coronavirus', 'Disease', '2019', 'COVID', '19', 'emerged', 'in', 'early', 'December', '2019', 'in', 'China', 'and', 'became', 'a', 'pandemic', 'situation', 'worldwide', 'by', 'its', 'rapid', 'spread', 'to', 'nearly', '190', 'countries', 'Bats', 'are', 'considered', 'as', 'the', 'reservoir', 'host', 'and', 'the', 'search', 'of', 'a', 'probable', 'intermediate', 'host', 'is', 'still', 'going', 'on', 'The', 'severe', 'form', 'of', 'the', 'infection', 'is', 'associated', 'with', 'death', 'is', 'mainly', 'reported', 'in', 'older', 'and', 'immune', 'compromised', 'patients', 'with', 'pre', 'existing', 'disease', 'history', 'Death', 'in', 'severe', 'cases', 'is', 'attributed', 'to', 'respiratory', 'failure', 'associated', 'with', 'hyperinflammation', 'Cytokine', 'storm', 'syndrome', 'associated', 'with', 'inflammation', 'in', 'response', 'to', 'SARS', 'CoV', '2', 'infection', 'is', 'considered', 'as', 'the', 'leading', 'cause', 'of', 'mortality', 'in', 'COVID', '19', 'patients', 'COVID', '19', 'patients', 'have', 'thus', 'higher', 'levels', 'of', 'many', 'proinflammatory', 'cytokines', 'and', 'chemokines', 'The', 'blood', 'lab', 'profile', 'of', 'the', 'COVID', '19', 'patients', 'exhibits', 'lymphopenia', 'leukopenia', 'thrombocytopenia', 'and', 'RNAaemia', 'along', 'with', 'increased', 'levels', 'of', 'aspartate', 'aminotransferase', 'SARS', 'CoV', '2', 'infection', 'in', 'pregnant', 'women', 'does', 'not', 'lead', 'to', 'fetus', 'mortality', 'unlike', 'other', 'zoonotic', 'coronaviruses', 'such', 'as', 'SARS', 'CoV', 'and', 'MERS', 'CoV', 'and', 'there', 'is', 'to', 'date', 'no', 'evidence', 'of', 'intrauterine', 'transmission', 'to', 'neonates', 'Rapid', 'diagnostics', 'have', 'been', 'developed', 'and', 'significant', 'efforts', 'are', 'being', 'made', 'to', 'develop', 'effective', 'vaccines', 'and', 'therapeutics', 'In', 'the', 'absence', 'of', 'any', 'virus', 'specific', 'therapy', 'internationally', 'health', 'care', 'authorities', 'are', 'recommending', 'the', 'adoption', 'of', 'effective', 'community', 'mitigation', 'measures', 'to', 'counter', 'and', 'contain', 'this', 'pandemic', 'virus', 'This', 'paper', 'is', 'an', 'overview', 'of', 'this', 'virus', 'and', 'the', 'disease', 'with', 'a', 'particular', 'focus', 'on', 'SARS', 'CoV', '2', 'COVID', '19', 'clinical', 'pathology', 'pathogenesis', 'and', 'immunopathology', 'along', 'with', 'recent', 'research', 'developments', '']"
189043,CRISPR/dCas9-mediated biosensor for detection of tick-borne diseases,2018-11-10,Sensors and Actuators B: Chemical,https://www.ncbi.nlm.nih.gov/pubmed/32288252/; https://doi.org/10.1016/j.snb.2018.06.069; https://www.sciencedirect.com/science/article/pii/S0925400518311742; https://api.elsevier.com/content/article/pii/S0925400518311742,"Abstract Rapid and highly sensitive detection of biomolecules is greatly needed for pathogen diagnosis in clinical samples, but the method needs to be significantly improved in terms of sensitivity and specificity for actual use in clinical settings. Here, we report the development of an improved molecular diagnostics tool that utilizes CRISPR/dCas9-mediated biosensor that couples a nuclease inactivated Cas9 (dCas9) and single microring resonator biosensor, enables label-free and real-time detection of pathogenic DNA and RNA. We addressed the clinical utility of this CRISPR/dCas9-mediated biosensor in tick-borne illnesses including scrub typhus (ST) and severe fever with thrombocytopenia syndrome (SFTS), whose clinical presentations are too similar to be easily differentiated. By using CRISPR/dCas9-mediated biosensor, we achieved single molecule sensitivity for the detection of ST (0.54 aM) and SFTS (0.63 aM); this detection sensitivity is 100 times more sensitive than that of RT-PCR assay. Finally, CRISPR/dCas9-mediated biosensor was able to clearly distinguish between ST and SFTS in serum samples within 20 min. We believe that CRISPR/dCas9-mediated biosensor will be useful for rapid and accurate molecular diagnostic tool that is suitable for immediate clinical applications.",10.1016/j.snb.2018.06.069,kgzbd6w3,"['Abstract', 'Rapid', 'and', 'highly', 'sensitive', 'detection', 'of', 'biomolecules', 'is', 'greatly', 'needed', 'for', 'pathogen', 'diagnosis', 'in', 'clinical', 'samples', 'but', 'the', 'method', 'needs', 'to', 'be', 'significantly', 'improved', 'in', 'terms', 'of', 'sensitivity', 'and', 'specificity', 'for', 'actual', 'use', 'in', 'clinical', 'settings', 'Here', 'we', 'report', 'the', 'development', 'of', 'an', 'improved', 'molecular', 'diagnostics', 'tool', 'that', 'utilizes', 'CRISPR', 'dCas9', 'mediated', 'biosensor', 'that', 'couples', 'a', 'nuclease', 'inactivated', 'Cas9', 'dCas9', 'and', 'single', 'microring', 'resonator', 'biosensor', 'enables', 'label', 'free', 'and', 'real', 'time', 'detection', 'of', 'pathogenic', 'DNA', 'and', 'RNA', 'We', 'addressed', 'the', 'clinical', 'utility', 'of', 'this', 'CRISPR', 'dCas9', 'mediated', 'biosensor', 'in', 'tick', 'borne', 'illnesses', 'including', 'scrub', 'typhus', 'ST', 'and', 'severe', 'fever', 'with', 'thrombocytopenia', 'syndrome', 'SFTS', 'whose', 'clinical', 'presentations', 'are', 'too', 'similar', 'to', 'be', 'easily', 'differentiated', 'By', 'using', 'CRISPR', 'dCas9', 'mediated', 'biosensor', 'we', 'achieved', 'single', 'molecule', 'sensitivity', 'for', 'the', 'detection', 'of', 'ST', '0', '54', 'aM', 'and', 'SFTS', '0', '63', 'aM', 'this', 'detection', 'sensitivity', 'is', '100', 'times', 'more', 'sensitive', 'than', 'that', 'of', 'RT', 'PCR', 'assay', 'Finally', 'CRISPR', 'dCas9', 'mediated', 'biosensor', 'was', 'able', 'to', 'clearly', 'distinguish', 'between', 'ST', 'and', 'SFTS', 'in', 'serum', 'samples', 'within', '20', 'min', 'We', 'believe', 'that', 'CRISPR', 'dCas9', 'mediated', 'biosensor', 'will', 'be', 'useful', 'for', 'rapid', 'and', 'accurate', 'molecular', 'diagnostic', 'tool', 'that', 'is', 'suitable', 'for', 'immediate', 'clinical', 'applications', '']"
189132,"COVID-19 Diagnostics, Tools, and Prevention",2020-06-16,Diagnostics (Basel),https://www.ncbi.nlm.nih.gov/pubmed/32560091/; https://doi.org/10.3390/diagnostics10060409,"The Coronavirus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), outbreak from Wuhan City, Hubei province, China in 2019 has become an ongoing global health emergency. The emerging virus, SARS-CoV-2, causes coughing, fever, muscle ache, and shortness of breath or dyspnea in symptomatic patients. The pathogenic particles that are generated by coughing and sneezing remain suspended in the air or attach to a surface to facilitate transmission in an aerosol form. This review focuses on the recent trends in pandemic biology, diagnostics methods, prevention tools, and policies for COVID-19 management. To meet the growing demand for medical supplies during the COVID-19 era, a variety of personal protective equipment (PPE) and ventilators have been developed using do-it-yourself (DIY) manufacturing. COVID-19 diagnosis and the prediction of virus transmission are analyzed by machine learning algorithms, simulations, and digital monitoring. Until the discovery of a clinically approved vaccine for COVID-19, pandemics remain a public concern. Therefore, technological developments, biomedical research, and policy development are needed to decipher the coronavirus mechanism and epidemiological characteristics, prevent transmission, and develop therapeutic drugs.",10.3390/diagnostics10060409,lx5jhpnc,"['The', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'caused', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'outbreak', 'from', 'Wuhan', 'City', 'Hubei', 'province', 'China', 'in', '2019', 'has', 'become', 'an', 'ongoing', 'global', 'health', 'emergency', 'The', 'emerging', 'virus', 'SARS', 'CoV', '2', 'causes', 'coughing', 'fever', 'muscle', 'ache', 'and', 'shortness', 'of', 'breath', 'or', 'dyspnea', 'in', 'symptomatic', 'patients', 'The', 'pathogenic', 'particles', 'that', 'are', 'generated', 'by', 'coughing', 'and', 'sneezing', 'remain', 'suspended', 'in', 'the', 'air', 'or', 'attach', 'to', 'a', 'surface', 'to', 'facilitate', 'transmission', 'in', 'an', 'aerosol', 'form', 'This', 'review', 'focuses', 'on', 'the', 'recent', 'trends', 'in', 'pandemic', 'biology', 'diagnostics', 'methods', 'prevention', 'tools', 'and', 'policies', 'for', 'COVID', '19', 'management', 'To', 'meet', 'the', 'growing', 'demand', 'for', 'medical', 'supplies', 'during', 'the', 'COVID', '19', 'era', 'a', 'variety', 'of', 'personal', 'protective', 'equipment', 'PPE', 'and', 'ventilators', 'have', 'been', 'developed', 'using', 'do', 'it', 'yourself', 'DIY', 'manufacturing', 'COVID', '19', 'diagnosis', 'and', 'the', 'prediction', 'of', 'virus', 'transmission', 'are', 'analyzed', 'by', 'machine', 'learning', 'algorithms', 'simulations', 'and', 'digital', 'monitoring', 'Until', 'the', 'discovery', 'of', 'a', 'clinically', 'approved', 'vaccine', 'for', 'COVID', '19', 'pandemics', 'remain', 'a', 'public', 'concern', 'Therefore', 'technological', 'developments', 'biomedical', 'research', 'and', 'policy', 'development', 'are', 'needed', 'to', 'decipher', 'the', 'coronavirus', 'mechanism', 'and', 'epidemiological', 'characteristics', 'prevent', 'transmission', 'and', 'develop', 'therapeutic', 'drugs', '']"
191425,Rapid and generic identification of influenza A and other respiratory viruses with mass spectrometry,2015-03-01,Journal of Virological Methods,https://doi.org/10.1016/j.jviromet.2014.11.014; https://www.ncbi.nlm.nih.gov/pubmed/25500183/; https://api.elsevier.com/content/article/pii/S0166093414004443; https://www.sciencedirect.com/science/article/pii/S0166093414004443,"Abstract The rapid identification of existing and emerging respiratory viruses is crucial in combating outbreaks and epidemics. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is a rapid and reliable identification method in bacterial diagnostics, but has not been used in virological diagnostics. Mass spectrometry systems have been investigated for the identification of respiratory viruses. However, sample preparation methods were laborious and time-consuming. In this study, a reliable and rapid sample preparation method was developed allowing identification of cultured respiratory viruses. Tenfold serial dilutions of ten cultures influenza A strains, mixed samples of influenza A virus with human metapneumovirus or respiratory syncytial virus, and reconstituted clinical samples were treated with the developed sample preparation method. Subsequently, peptides were subjected to MALDI-TOF MS and liquid chromatography tandem mass spectrometry (LC–MS/MS). The influenza A strains were identified to the subtype level within 3h with MALDI-TOF MS and 6h with LC–MS/MS, excluding the culturing time. The sensitivity of LC–MS/MS was higher compared to MALDI-TOF MS. In addition, LC–MS/MS was able to discriminate between two viruses in mixed samples and was able to identify virus from reconstituted clinical samples. The development of an improved and rapid sample preparation method allowed generic and rapid identification of cultured respiratory viruses by mass spectrometry.",10.1016/j.jviromet.2014.11.014,x7qtxaum,"['Abstract', 'The', 'rapid', 'identification', 'of', 'existing', 'and', 'emerging', 'respiratory', 'viruses', 'is', 'crucial', 'in', 'combating', 'outbreaks', 'and', 'epidemics', 'Matrix', 'assisted', 'laser', 'desorption', 'ionization', 'time', 'of', 'flight', 'mass', 'spectrometry', 'MALDI', 'TOF', 'MS', 'is', 'a', 'rapid', 'and', 'reliable', 'identification', 'method', 'in', 'bacterial', 'diagnostics', 'but', 'has', 'not', 'been', 'used', 'in', 'virological', 'diagnostics', 'Mass', 'spectrometry', 'systems', 'have', 'been', 'investigated', 'for', 'the', 'identification', 'of', 'respiratory', 'viruses', 'However', 'sample', 'preparation', 'methods', 'were', 'laborious', 'and', 'time', 'consuming', 'In', 'this', 'study', 'a', 'reliable', 'and', 'rapid', 'sample', 'preparation', 'method', 'was', 'developed', 'allowing', 'identification', 'of', 'cultured', 'respiratory', 'viruses', 'Tenfold', 'serial', 'dilutions', 'of', 'ten', 'cultures', 'influenza', 'A', 'strains', 'mixed', 'samples', 'of', 'influenza', 'A', 'virus', 'with', 'human', 'metapneumovirus', 'or', 'respiratory', 'syncytial', 'virus', 'and', 'reconstituted', 'clinical', 'samples', 'were', 'treated', 'with', 'the', 'developed', 'sample', 'preparation', 'method', 'Subsequently', 'peptides', 'were', 'subjected', 'to', 'MALDI', 'TOF', 'MS', 'and', 'liquid', 'chromatography', 'tandem', 'mass', 'spectrometry', 'LC', 'MS', 'MS', 'The', 'influenza', 'A', 'strains', 'were', 'identified', 'to', 'the', 'subtype', 'level', 'within', '3h', 'with', 'MALDI', 'TOF', 'MS', 'and', '6h', 'with', 'LC', 'MS', 'MS', 'excluding', 'the', 'culturing', 'time', 'The', 'sensitivity', 'of', 'LC', 'MS', 'MS', 'was', 'higher', 'compared', 'to', 'MALDI', 'TOF', 'MS', 'In', 'addition', 'LC', 'MS', 'MS', 'was', 'able', 'to', 'discriminate', 'between', 'two', 'viruses', 'in', 'mixed', 'samples', 'and', 'was', 'able', 'to', 'identify', 'virus', 'from', 'reconstituted', 'clinical', 'samples', 'The', 'development', 'of', 'an', 'improved', 'and', 'rapid', 'sample', 'preparation', 'method', 'allowed', 'generic', 'and', 'rapid', 'identification', 'of', 'cultured', 'respiratory', 'viruses', 'by', 'mass', 'spectrometry', '']"
191649,LightUp® probes in clinical diagnostics,2006-06-30,Molecular Aspects of Medicine,https://api.elsevier.com/content/article/pii/S0098299705000968; https://www.ncbi.nlm.nih.gov/pubmed/16466783/; https://www.sciencedirect.com/science/article/pii/S0098299705000968,"Abstract The LightUp® Probe technology has now matured and reached the phase where it has been implemented in commercial reagent kits, i.e. the ReSSQ® product line. Several properties of the LightUp® probes make them particularly suitable for clinical settings. For instance, extraordinary shelf life and a chemical stability that allows convenient fridge storage. The origin of the higher stability of LightUp® probe kits compared to others, based on alternative probe technologies, is partly the relatively good stability of cyanine dyes but also the resistance towards nucleases and proteases of the synthetic DNA analogue peptide nucleic acid that is used as the sequence recognizing element in LightUp probes. It is clear from recent trends in the PCR amplification hardware technology that the instrumentation is becoming more flexible and less adapted for dedicated probe chemistries. This will pave the way for increased standardization in the field of DNA diagnostics and the development of cross-platform assays. In the present review the LightUp technology will briefly be presented and discussed. The utility of the technology will be illustrated by examples from cytomegalovirus quantification and monitoring of the viral load of the SARS Coronavirus. An example of cancer diagnostics by detection of altered gene expression patterns will also be shown.",10.1016/j.mam.2005.12.005,39jdxj93,"['Abstract', 'The', 'LightUp', 'Probe', 'technology', 'has', 'now', 'matured', 'and', 'reached', 'the', 'phase', 'where', 'it', 'has', 'been', 'implemented', 'in', 'commercial', 'reagent', 'kits', 'i', 'e', 'the', 'ReSSQ', 'product', 'line', 'Several', 'properties', 'of', 'the', 'LightUp', 'probes', 'make', 'them', 'particularly', 'suitable', 'for', 'clinical', 'settings', 'For', 'instance', 'extraordinary', 'shelf', 'life', 'and', 'a', 'chemical', 'stability', 'that', 'allows', 'convenient', 'fridge', 'storage', 'The', 'origin', 'of', 'the', 'higher', 'stability', 'of', 'LightUp', 'probe', 'kits', 'compared', 'to', 'others', 'based', 'on', 'alternative', 'probe', 'technologies', 'is', 'partly', 'the', 'relatively', 'good', 'stability', 'of', 'cyanine', 'dyes', 'but', 'also', 'the', 'resistance', 'towards', 'nucleases', 'and', 'proteases', 'of', 'the', 'synthetic', 'DNA', 'analogue', 'peptide', 'nucleic', 'acid', 'that', 'is', 'used', 'as', 'the', 'sequence', 'recognizing', 'element', 'in', 'LightUp', 'probes', 'It', 'is', 'clear', 'from', 'recent', 'trends', 'in', 'the', 'PCR', 'amplification', 'hardware', 'technology', 'that', 'the', 'instrumentation', 'is', 'becoming', 'more', 'flexible', 'and', 'less', 'adapted', 'for', 'dedicated', 'probe', 'chemistries', 'This', 'will', 'pave', 'the', 'way', 'for', 'increased', 'standardization', 'in', 'the', 'field', 'of', 'DNA', 'diagnostics', 'and', 'the', 'development', 'of', 'cross', 'platform', 'assays', 'In', 'the', 'present', 'review', 'the', 'LightUp', 'technology', 'will', 'briefly', 'be', 'presented', 'and', 'discussed', 'The', 'utility', 'of', 'the', 'technology', 'will', 'be', 'illustrated', 'by', 'examples', 'from', 'cytomegalovirus', 'quantification', 'and', 'monitoring', 'of', 'the', 'viral', 'load', 'of', 'the', 'SARS', 'Coronavirus', 'An', 'example', 'of', 'cancer', 'diagnostics', 'by', 'detection', 'of', 'altered', 'gene', 'expression', 'patterns', 'will', 'also', 'be', 'shown', '']"
192644,ISHLT CONSENSUS STATEMENT FOR THE STANDARDIZATION OF BRONCHOALVEOLAR LAVAGE IN LUNG TRANSPLANTATION,2020-07-15,J Heart Lung Transplant,https://api.elsevier.com/content/article/pii/S1053249820316533; https://www.sciencedirect.com/science/article/pii/S1053249820316533?v=s5,"ABSTRACT Bronchoalveolar lavage (BAL) is a key clinical and research tool in lung transplantation (LTx). However, BAL collection and processing are not standardized across LTx centers. This ISHLT-supported consensus document on BAL standardization aims to clarify definitions and propose common approaches to improve clinical and research practice standards. Nine areas are covered: 1) bronchoscopy procedure and BAL collection, 2) sample handling, 3) sample processing for microbiology, 4) cytology, 5) research and 6) microbiome, 7) sample inventory/tracking, 8) donor bronchoscopy and 9) pediatric considerations. This consensus document aims to harmonize clinical and research practices for BAL collection and processing in LTx. The overarching goal is to enhance standardization and multi-center collaboration within the international LTx community and enable improvement and development of new BAL-based diagnostics.",10.1016/j.healun.2020.07.006,ueig940p,"['ABSTRACT', 'Bronchoalveolar', 'lavage', 'BAL', 'is', 'a', 'key', 'clinical', 'and', 'research', 'tool', 'in', 'lung', 'transplantation', 'LTx', 'However', 'BAL', 'collection', 'and', 'processing', 'are', 'not', 'standardized', 'across', 'LTx', 'centers', 'This', 'ISHLT', 'supported', 'consensus', 'document', 'on', 'BAL', 'standardization', 'aims', 'to', 'clarify', 'definitions', 'and', 'propose', 'common', 'approaches', 'to', 'improve', 'clinical', 'and', 'research', 'practice', 'standards', 'Nine', 'areas', 'are', 'covered', '1', 'bronchoscopy', 'procedure', 'and', 'BAL', 'collection', '2', 'sample', 'handling', '3', 'sample', 'processing', 'for', 'microbiology', '4', 'cytology', '5', 'research', 'and', '6', 'microbiome', '7', 'sample', 'inventory', 'tracking', '8', 'donor', 'bronchoscopy', 'and', '9', 'pediatric', 'considerations', 'This', 'consensus', 'document', 'aims', 'to', 'harmonize', 'clinical', 'and', 'research', 'practices', 'for', 'BAL', 'collection', 'and', 'processing', 'in', 'LTx', 'The', 'overarching', 'goal', 'is', 'to', 'enhance', 'standardization', 'and', 'multi', 'center', 'collaboration', 'within', 'the', 'international', 'LTx', 'community', 'and', 'enable', 'improvement', 'and', 'development', 'of', 'new', 'BAL', 'based', 'diagnostics', '']"
193494,Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic,2020-06-10,ACS Nano,https://www.ncbi.nlm.nih.gov/pubmed/32519842/; https://doi.org/10.1021/acsnano.0c03697,"[Image: see text] The COVID-19 outbreak has fueled a global demand for effective diagnosis and treatment as well as mitigation of the spread of infection, all through large-scale approaches such as specific alternative antiviral methods and classical disinfection protocols. Based on an abundance of engineered materials identifiable by their useful physicochemical properties through versatile chemical functionalization, nanotechnology offers a number of approaches to cope with this emergency. Here, through a multidisciplinary Perspective encompassing diverse fields such as virology, biology, medicine, engineering, chemistry, materials science, and computational science, we outline how nanotechnology-based strategies can support the fight against COVID-19, as well as infectious diseases in general, including future pandemics. Considering what we know so far about the life cycle of the virus, we envision key steps where nanotechnology could counter the disease. First, nanoparticles (NPs) can offer alternative methods to classical disinfection protocols used in healthcare settings, thanks to their intrinsic antipathogenic properties and/or their ability to inactivate viruses, bacteria, fungi, or yeasts either photothermally or via photocatalysis-induced reactive oxygen species (ROS) generation. Nanotechnology tools to inactivate SARS-CoV-2 in patients could also be explored. In this case, nanomaterials could be used to deliver drugs to the pulmonary system to inhibit interaction between angiotensin-converting enzyme 2 (ACE2) receptors and viral S protein. Moreover, the concept of “nanoimmunity by design” can help us to design materials for immune modulation, either stimulating or suppressing the immune response, which would find applications in the context of vaccine development for SARS-CoV-2 or in counteracting the cytokine storm, respectively. In addition to disease prevention and therapeutic potential, nanotechnology has important roles in diagnostics, with potential to support the development of simple, fast, and cost-effective nanotechnology-based assays to monitor the presence of SARS-CoV-2 and related biomarkers. In summary, nanotechnology is critical in counteracting COVID-19 and will be vital when preparing for future pandemics.",10.1021/acsnano.0c03697,kuvfdl4q,"['', 'Image', 'see', 'text', 'The', 'COVID', '19', 'outbreak', 'has', 'fueled', 'a', 'global', 'demand', 'for', 'effective', 'diagnosis', 'and', 'treatment', 'as', 'well', 'as', 'mitigation', 'of', 'the', 'spread', 'of', 'infection', 'all', 'through', 'large', 'scale', 'approaches', 'such', 'as', 'specific', 'alternative', 'antiviral', 'methods', 'and', 'classical', 'disinfection', 'protocols', 'Based', 'on', 'an', 'abundance', 'of', 'engineered', 'materials', 'identifiable', 'by', 'their', 'useful', 'physicochemical', 'properties', 'through', 'versatile', 'chemical', 'functionalization', 'nanotechnology', 'offers', 'a', 'number', 'of', 'approaches', 'to', 'cope', 'with', 'this', 'emergency', 'Here', 'through', 'a', 'multidisciplinary', 'Perspective', 'encompassing', 'diverse', 'fields', 'such', 'as', 'virology', 'biology', 'medicine', 'engineering', 'chemistry', 'materials', 'science', 'and', 'computational', 'science', 'we', 'outline', 'how', 'nanotechnology', 'based', 'strategies', 'can', 'support', 'the', 'fight', 'against', 'COVID', '19', 'as', 'well', 'as', 'infectious', 'diseases', 'in', 'general', 'including', 'future', 'pandemics', 'Considering', 'what', 'we', 'know', 'so', 'far', 'about', 'the', 'life', 'cycle', 'of', 'the', 'virus', 'we', 'envision', 'key', 'steps', 'where', 'nanotechnology', 'could', 'counter', 'the', 'disease', 'First', 'nanoparticles', 'NPs', 'can', 'offer', 'alternative', 'methods', 'to', 'classical', 'disinfection', 'protocols', 'used', 'in', 'healthcare', 'settings', 'thanks', 'to', 'their', 'intrinsic', 'antipathogenic', 'properties', 'and', 'or', 'their', 'ability', 'to', 'inactivate', 'viruses', 'bacteria', 'fungi', 'or', 'yeasts', 'either', 'photothermally', 'or', 'via', 'photocatalysis', 'induced', 'reactive', 'oxygen', 'species', 'ROS', 'generation', 'Nanotechnology', 'tools', 'to', 'inactivate', 'SARS', 'CoV', '2', 'in', 'patients', 'could', 'also', 'be', 'explored', 'In', 'this', 'case', 'nanomaterials', 'could', 'be', 'used', 'to', 'deliver', 'drugs', 'to', 'the', 'pulmonary', 'system', 'to', 'inhibit', 'interaction', 'between', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'receptors', 'and', 'viral', 'S', 'protein', 'Moreover', 'the', 'concept', 'of', 'nanoimmunity', 'by', 'design', 'can', 'help', 'us', 'to', 'design', 'materials', 'for', 'immune', 'modulation', 'either', 'stimulating', 'or', 'suppressing', 'the', 'immune', 'response', 'which', 'would', 'find', 'applications', 'in', 'the', 'context', 'of', 'vaccine', 'development', 'for', 'SARS', 'CoV', '2', 'or', 'in', 'counteracting', 'the', 'cytokine', 'storm', 'respectively', 'In', 'addition', 'to', 'disease', 'prevention', 'and', 'therapeutic', 'potential', 'nanotechnology', 'has', 'important', 'roles', 'in', 'diagnostics', 'with', 'potential', 'to', 'support', 'the', 'development', 'of', 'simple', 'fast', 'and', 'cost', 'effective', 'nanotechnology', 'based', 'assays', 'to', 'monitor', 'the', 'presence', 'of', 'SARS', 'CoV', '2', 'and', 'related', 'biomarkers', 'In', 'summary', 'nanotechnology', 'is', 'critical', 'in', 'counteracting', 'COVID', '19', 'and', 'will', 'be', 'vital', 'when', 'preparing', 'for', 'future', 'pandemics', '']"
193659,A line immunoassay utilizing recombinant nucleocapsid proteins for detection of antibodies to human coronaviruses,2008-05-31,Diagnostic Microbiology and Infectious Disease,https://www.sciencedirect.com/science/article/pii/S0732889307005883; https://api.elsevier.com/content/article/pii/S0732889307005883; https://www.ncbi.nlm.nih.gov/pubmed/18191362/; https://doi.org/10.1016/j.diagmicrobio.2007.12.002,"Abstract Most coronaviruses infecting humans cause mild diseases, whereas severe acute respiratory syndrome (SARS)-associated coronavirus is an extremely dangerous pathogen. Here, we report the development of a serologic assay for detection of antibodies to human coronaviruses (HCoVs) based on recombinant nucleocapsid (N) proteins of all known pathogenic strains (229E, NL63, OC43, HKU1, SARS). The novel immunoassay is highly useful for epidemiologic surveys, where use of nucleic acid diagnostics often is limited. Purified recombinant antigens were immobilized on nitrocellulose membranes and applied in a line immunoassay, which allows rapid detection of antibodies to 5 different HCoVs in a single experiment. For assay evaluation, serum samples from persons infected with 229E or OC43 (acute/convalescent), recovered SARS patients and healthy donors were analyzed. Screening for nucleocapsid (N)-specific immunoglobulin G (IgG) in convalescent sera reached 100% sensitivity. With this new technique, we found that recently identified NL63 and HKU1 contribute significantly to the overall spectrum of coronavirus infections. Possibly, cross-reactive antibody responses were observed using 229E and OC43 serum pairs. However, the potential of this assay could clearly be demonstrated employing SARS-positive serum samples, where nonspecific binding to nucleocapsids of other HCoVs was not observed. This coronavirus strain-specific line immunoassay represents a powerful tool for serologic diagnostics.",10.1016/j.diagmicrobio.2007.12.002,m400cal3,"['Abstract', 'Most', 'coronaviruses', 'infecting', 'humans', 'cause', 'mild', 'diseases', 'whereas', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'associated', 'coronavirus', 'is', 'an', 'extremely', 'dangerous', 'pathogen', 'Here', 'we', 'report', 'the', 'development', 'of', 'a', 'serologic', 'assay', 'for', 'detection', 'of', 'antibodies', 'to', 'human', 'coronaviruses', 'HCoVs', 'based', 'on', 'recombinant', 'nucleocapsid', 'N', 'proteins', 'of', 'all', 'known', 'pathogenic', 'strains', '229E', 'NL63', 'OC43', 'HKU1', 'SARS', 'The', 'novel', 'immunoassay', 'is', 'highly', 'useful', 'for', 'epidemiologic', 'surveys', 'where', 'use', 'of', 'nucleic', 'acid', 'diagnostics', 'often', 'is', 'limited', 'Purified', 'recombinant', 'antigens', 'were', 'immobilized', 'on', 'nitrocellulose', 'membranes', 'and', 'applied', 'in', 'a', 'line', 'immunoassay', 'which', 'allows', 'rapid', 'detection', 'of', 'antibodies', 'to', '5', 'different', 'HCoVs', 'in', 'a', 'single', 'experiment', 'For', 'assay', 'evaluation', 'serum', 'samples', 'from', 'persons', 'infected', 'with', '229E', 'or', 'OC43', 'acute', 'convalescent', 'recovered', 'SARS', 'patients', 'and', 'healthy', 'donors', 'were', 'analyzed', 'Screening', 'for', 'nucleocapsid', 'N', 'specific', 'immunoglobulin', 'G', 'IgG', 'in', 'convalescent', 'sera', 'reached', '100', 'sensitivity', 'With', 'this', 'new', 'technique', 'we', 'found', 'that', 'recently', 'identified', 'NL63', 'and', 'HKU1', 'contribute', 'significantly', 'to', 'the', 'overall', 'spectrum', 'of', 'coronavirus', 'infections', 'Possibly', 'cross', 'reactive', 'antibody', 'responses', 'were', 'observed', 'using', '229E', 'and', 'OC43', 'serum', 'pairs', 'However', 'the', 'potential', 'of', 'this', 'assay', 'could', 'clearly', 'be', 'demonstrated', 'employing', 'SARS', 'positive', 'serum', 'samples', 'where', 'nonspecific', 'binding', 'to', 'nucleocapsids', 'of', 'other', 'HCoVs', 'was', 'not', 'observed', 'This', 'coronavirus', 'strain', 'specific', 'line', 'immunoassay', 'represents', 'a', 'powerful', 'tool', 'for', 'serologic', 'diagnostics', '']"
193681,Diagnostic microbiologique : du diagnostic par étiologie au diagnostic par syndrome,2009-02-28,Antibiotiques,https://www.sciencedirect.com/science/article/pii/S129455010800109X; https://api.elsevier.com/content/article/pii/S129455010800109X,"Résumé Objectifs Depuis les dix dernières années, l’introduction de la biologie moléculaire et l’automatisation ont radicalement changé les pratiques dans les laboratoires de microbiologie clinique. L’amélioration de la communication entre les microbiologistes et les cliniciens ainsi que les évolutions technologiques telles que la standardisation et le développement de tests diagnostics plus rapides ont conduit à une réorganisation des laboratoires de microbiologie. Méthodes Jusqu’à présent la prescription des examens ciblait un diagnostic étiologique précis, actuellement l’évolution se fait vers le diagnostic par syndrome incluant un panel de tests regroupant les étiologies responsables d’un syndrome donné y compris les pathogènes émergents. Résultats et conclusions Dans cette revue, nous avons résumé les développements technologiques les plus récents en matière de diagnostic microbiologique adapté au diagnostic par syndrome incluant les stratégies de diagnostic exhaustif, les DNA microarray et les microarray antigéniques. Summary Objectives Over the past decade, the introduction of techniques of molecular biology and the automation have undergone important changes in the practice of clinical microbiological laboratories. Methods Commonly, physician prescriptions are etiology driven for emerging infectious agent. The improving in test standardization and rapidity and the best communication between physician and clinical microbiologist lead to profound changes in microbiology laboratories. Results and conclusion The present review summarizes the recent development in multiplexed microbiological technology adapted to syndrome driven diagnosis, including sampling strategy, DNA microarray and antigenic microarray.",10.1016/j.antib.2008.10.002,sgtw5lxt,"['Résumé', 'Objectifs', 'Depuis', 'les', 'dix', 'dernières', 'années', 'l', 'introduction', 'de', 'la', 'biologie', 'moléculaire', 'et', 'l', 'automatisation', 'ont', 'radicalement', 'changé', 'les', 'pratiques', 'dans', 'les', 'laboratoires', 'de', 'microbiologie', 'clinique', 'L', 'amélioration', 'de', 'la', 'communication', 'entre', 'les', 'microbiologistes', 'et', 'les', 'cliniciens', 'ainsi', 'que', 'les', 'évolutions', 'technologiques', 'telles', 'que', 'la', 'standardisation', 'et', 'le', 'développement', 'de', 'tests', 'diagnostics', 'plus', 'rapides', 'ont', 'conduit', 'à', 'une', 'réorganisation', 'des', 'laboratoires', 'de', 'microbiologie', 'Méthodes', 'Jusqu', 'à', 'présent', 'la', 'prescription', 'des', 'examens', 'ciblait', 'un', 'diagnostic', 'étiologique', 'précis', 'actuellement', 'l', 'évolution', 'se', 'fait', 'vers', 'le', 'diagnostic', 'par', 'syndrome', 'incluant', 'un', 'panel', 'de', 'tests', 'regroupant', 'les', 'étiologies', 'responsables', 'd', 'un', 'syndrome', 'donné', 'y', 'compris', 'les', 'pathogènes', 'émergents', 'Résultats', 'et', 'conclusions', 'Dans', 'cette', 'revue', 'nous', 'avons', 'résumé', 'les', 'développements', 'technologiques', 'les', 'plus', 'récents', 'en', 'matière', 'de', 'diagnostic', 'microbiologique', 'adapté', 'au', 'diagnostic', 'par', 'syndrome', 'incluant', 'les', 'stratégies', 'de', 'diagnostic', 'exhaustif', 'les', 'DNA', 'microarray', 'et', 'les', 'microarray', 'antigéniques', 'Summary', 'Objectives', 'Over', 'the', 'past', 'decade', 'the', 'introduction', 'of', 'techniques', 'of', 'molecular', 'biology', 'and', 'the', 'automation', 'have', 'undergone', 'important', 'changes', 'in', 'the', 'practice', 'of', 'clinical', 'microbiological', 'laboratories', 'Methods', 'Commonly', 'physician', 'prescriptions', 'are', 'etiology', 'driven', 'for', 'emerging', 'infectious', 'agent', 'The', 'improving', 'in', 'test', 'standardization', 'and', 'rapidity', 'and', 'the', 'best', 'communication', 'between', 'physician', 'and', 'clinical', 'microbiologist', 'lead', 'to', 'profound', 'changes', 'in', 'microbiology', 'laboratories', 'Results', 'and', 'conclusion', 'The', 'present', 'review', 'summarizes', 'the', 'recent', 'development', 'in', 'multiplexed', 'microbiological', 'technology', 'adapted', 'to', 'syndrome', 'driven', 'diagnosis', 'including', 'sampling', 'strategy', 'DNA', 'microarray', 'and', 'antigenic', 'microarray', '']"
194174,Using Artificial Intelligence in Infection Prevention,2020-03-19,Curr Treat Options Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/32218708/; https://doi.org/10.1007/s40506-020-00216-7,"PURPOSE OF REVIEW: Artificial intelligence (AI) offers huge potential in infection prevention and control (IPC). We explore its potential IPC benefits in epidemiology, laboratory infection diagnosis, and hand hygiene. RECENT FINDINGS: AI has the potential to detect transmission events during outbreaks or predict high-risk patients, enabling development of tailored IPC interventions. AI offers opportunities to enhance diagnostics with objective pattern recognition, standardize the diagnosis of infections with IPC implications, and facilitate the dissemination of IPC expertise. AI hand hygiene applications can deliver behavior change, though it requires further evaluation in different clinical settings. However, staff can become dependent on automatic reminders, and performance returns to baseline if feedback is removed. SUMMARY: Advantages for IPC include speed, consistency, and capability of handling infinitely large datasets. However, many challenges remain; improving the availability of high-quality representative datasets and consideration of biases within preexisting databases are important challenges for future developments. AI in itself will not improve IPC; this requires culture and behavior change. Most studies to date assess performance retrospectively so there is a need for prospective evaluation in the real-life, often chaotic, clinical setting. Close collaboration with IPC experts to interpret outputs and ensure clinical relevance is essential.",10.1007/s40506-020-00216-7,jp66ptzy,"['PURPOSE', 'OF', 'REVIEW', 'Artificial', 'intelligence', 'AI', 'offers', 'huge', 'potential', 'in', 'infection', 'prevention', 'and', 'control', 'IPC', 'We', 'explore', 'its', 'potential', 'IPC', 'benefits', 'in', 'epidemiology', 'laboratory', 'infection', 'diagnosis', 'and', 'hand', 'hygiene', 'RECENT', 'FINDINGS', 'AI', 'has', 'the', 'potential', 'to', 'detect', 'transmission', 'events', 'during', 'outbreaks', 'or', 'predict', 'high', 'risk', 'patients', 'enabling', 'development', 'of', 'tailored', 'IPC', 'interventions', 'AI', 'offers', 'opportunities', 'to', 'enhance', 'diagnostics', 'with', 'objective', 'pattern', 'recognition', 'standardize', 'the', 'diagnosis', 'of', 'infections', 'with', 'IPC', 'implications', 'and', 'facilitate', 'the', 'dissemination', 'of', 'IPC', 'expertise', 'AI', 'hand', 'hygiene', 'applications', 'can', 'deliver', 'behavior', 'change', 'though', 'it', 'requires', 'further', 'evaluation', 'in', 'different', 'clinical', 'settings', 'However', 'staff', 'can', 'become', 'dependent', 'on', 'automatic', 'reminders', 'and', 'performance', 'returns', 'to', 'baseline', 'if', 'feedback', 'is', 'removed', 'SUMMARY', 'Advantages', 'for', 'IPC', 'include', 'speed', 'consistency', 'and', 'capability', 'of', 'handling', 'infinitely', 'large', 'datasets', 'However', 'many', 'challenges', 'remain', 'improving', 'the', 'availability', 'of', 'high', 'quality', 'representative', 'datasets', 'and', 'consideration', 'of', 'biases', 'within', 'preexisting', 'databases', 'are', 'important', 'challenges', 'for', 'future', 'developments', 'AI', 'in', 'itself', 'will', 'not', 'improve', 'IPC', 'this', 'requires', 'culture', 'and', 'behavior', 'change', 'Most', 'studies', 'to', 'date', 'assess', 'performance', 'retrospectively', 'so', 'there', 'is', 'a', 'need', 'for', 'prospective', 'evaluation', 'in', 'the', 'real', 'life', 'often', 'chaotic', 'clinical', 'setting', 'Close', 'collaboration', 'with', 'IPC', 'experts', 'to', 'interpret', 'outputs', 'and', 'ensure', 'clinical', 'relevance', 'is', 'essential', '']"
194221,International Biological Reference Preparations for Epidemic Infectious Diseases,2019-02-28,Emerg Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/30666925/; https://doi.org/10.3201/eid2502.180798,"Recent years have seen unprecedented investment in research and development for countermeasures for high-threat pathogens, including specific and ambitious objectives for development of diagnostics, therapeutics, and vaccines. The inadequate availability of biological reference materials for these pathogens poses a genuine obstacle in pursuit of these objectives, and the lack of a comprehensive and equitable framework for developing reference materials is a weakness. We outline the need for internationally standardized biological materials for high-threat pathogens as a core element of global health security. We also outline the key components of a framework for addressing this deficiency.",10.3201/eid2502.180798,4nchg95h,"['Recent', 'years', 'have', 'seen', 'unprecedented', 'investment', 'in', 'research', 'and', 'development', 'for', 'countermeasures', 'for', 'high', 'threat', 'pathogens', 'including', 'specific', 'and', 'ambitious', 'objectives', 'for', 'development', 'of', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'The', 'inadequate', 'availability', 'of', 'biological', 'reference', 'materials', 'for', 'these', 'pathogens', 'poses', 'a', 'genuine', 'obstacle', 'in', 'pursuit', 'of', 'these', 'objectives', 'and', 'the', 'lack', 'of', 'a', 'comprehensive', 'and', 'equitable', 'framework', 'for', 'developing', 'reference', 'materials', 'is', 'a', 'weakness', 'We', 'outline', 'the', 'need', 'for', 'internationally', 'standardized', 'biological', 'materials', 'for', 'high', 'threat', 'pathogens', 'as', 'a', 'core', 'element', 'of', 'global', 'health', 'security', 'We', 'also', 'outline', 'the', 'key', 'components', 'of', 'a', 'framework', 'for', 'addressing', 'this', 'deficiency', '']"
195083,Immobilization Techniques for Aptamers on Gold Electrodes for the Electrochemical Detection of Proteins: A Review,2020-04-28,Biosensors (Basel),https://doi.org/10.3390/bios10050045; https://www.ncbi.nlm.nih.gov/pubmed/32354207/,"The development of reliable biosensing platforms plays a key role in the detection of proteins in clinically and environmentally derived samples for diagnostics, as well as for process monitoring in biotechnological productions. For this purpose, the biosensor has to be stable and reproducible, and highly sensitive to detect potentially extremely low concentrations and prevent the nonspecific binding of interfering compounds. In this review, we present an overview of recently published (2017–2019) immobilization techniques for aptamers on gold electrodes for the electrochemical detection of proteins. These include the direct immobilization of thiolated aptamers and the utilization of short linkers, streptavidin/biotin interaction, as well as DNA nanostructures and reduced graphene oxide as immobilization platforms. Applied strategies for signal amplification and the prevention of biofouling are additionally discussed, as they play a crucial role in the design of biosensors. While a wide variety of amplification strategies are already available, future investigations should aim to establish suitable antifouling strategies that are compatible with electrochemical measurements. The focus of our review lies on the detailed discussion of the underlying principles and the presentation of utilized chemical protocols in order to provide the reader with promising ideas and profound knowledge of the subject, as well as an update on recent discoveries and achievements.",10.3390/bios10050045,sa7rbifx,"['The', 'development', 'of', 'reliable', 'biosensing', 'platforms', 'plays', 'a', 'key', 'role', 'in', 'the', 'detection', 'of', 'proteins', 'in', 'clinically', 'and', 'environmentally', 'derived', 'samples', 'for', 'diagnostics', 'as', 'well', 'as', 'for', 'process', 'monitoring', 'in', 'biotechnological', 'productions', 'For', 'this', 'purpose', 'the', 'biosensor', 'has', 'to', 'be', 'stable', 'and', 'reproducible', 'and', 'highly', 'sensitive', 'to', 'detect', 'potentially', 'extremely', 'low', 'concentrations', 'and', 'prevent', 'the', 'nonspecific', 'binding', 'of', 'interfering', 'compounds', 'In', 'this', 'review', 'we', 'present', 'an', 'overview', 'of', 'recently', 'published', '2017', '2019', 'immobilization', 'techniques', 'for', 'aptamers', 'on', 'gold', 'electrodes', 'for', 'the', 'electrochemical', 'detection', 'of', 'proteins', 'These', 'include', 'the', 'direct', 'immobilization', 'of', 'thiolated', 'aptamers', 'and', 'the', 'utilization', 'of', 'short', 'linkers', 'streptavidin', 'biotin', 'interaction', 'as', 'well', 'as', 'DNA', 'nanostructures', 'and', 'reduced', 'graphene', 'oxide', 'as', 'immobilization', 'platforms', 'Applied', 'strategies', 'for', 'signal', 'amplification', 'and', 'the', 'prevention', 'of', 'biofouling', 'are', 'additionally', 'discussed', 'as', 'they', 'play', 'a', 'crucial', 'role', 'in', 'the', 'design', 'of', 'biosensors', 'While', 'a', 'wide', 'variety', 'of', 'amplification', 'strategies', 'are', 'already', 'available', 'future', 'investigations', 'should', 'aim', 'to', 'establish', 'suitable', 'antifouling', 'strategies', 'that', 'are', 'compatible', 'with', 'electrochemical', 'measurements', 'The', 'focus', 'of', 'our', 'review', 'lies', 'on', 'the', 'detailed', 'discussion', 'of', 'the', 'underlying', 'principles', 'and', 'the', 'presentation', 'of', 'utilized', 'chemical', 'protocols', 'in', 'order', 'to', 'provide', 'the', 'reader', 'with', 'promising', 'ideas', 'and', 'profound', 'knowledge', 'of', 'the', 'subject', 'as', 'well', 'as', 'an', 'update', 'on', 'recent', 'discoveries', 'and', 'achievements', '']"
195264,"Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020",2020-02-07,MMWR Morb Mortal Wkly Rep,https://www.ncbi.nlm.nih.gov/pubmed/32027631/; https://doi.org/10.15585/mmwr.mm6905e1,"On December 31, 2019, Chinese health officials reported a cluster of cases of acute respiratory illness in persons associated with the Hunan seafood and animal market in the city of Wuhan, Hubei Province, in central China. On January 7, 2020, Chinese health officials confirmed that a novel coronavirus (2019-nCoV) was associated with this initial cluster (1). As of February 4, 2020, a total of 20,471 confirmed cases, including 2,788 (13.6%) with severe illness,* and 425 deaths (2.1%) had been reported by the National Health Commission of China (2). Cases have also been reported in 26 locations outside of mainland China, including documentation of some person-to-person transmission and one death (2). As of February 4, 11 cases had been reported in the United States. On January 30, the World Health Organization (WHO) Director-General declared that the 2019-nCoV outbreak constitutes a Public Health Emergency of International Concern.† On January 31, the U.S. Department of Health and Human Services (HHS) Secretary declared a U.S. public health emergency to respond to 2019-nCoV.§ Also on January 31, the president of the United States signed a ""Proclamation on Suspension of Entry as Immigrants and Nonimmigrants of Persons who Pose a Risk of Transmitting 2019 Novel Coronavirus,"" which limits entry into the United States of persons who traveled to mainland China to U.S. citizens and lawful permanent residents and their families (3). CDC, multiple other federal agencies, state and local health departments, and other partners are implementing aggressive measures to slow transmission of 2019-nCoV in the United States (4,5). These measures require the identification of cases and their contacts in the United States and the appropriate assessment and care of travelers arriving from mainland China to the United States. These measures are being implemented in anticipation of additional 2019-nCoV cases in the United States. Although these measures might not prevent the eventual establishment of ongoing, widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare health care systems and the general public to be ready if widespread transmission with substantial associated illness occurs; and 3) better characterize 2019-nCoV infection to guide public health recommendations and the development of medical countermeasures including diagnostics, therapeutics, and vaccines. Public health authorities are monitoring the situation closely. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC and state and local health departments.",10.15585/mmwr.mm6905e1,vj2z52vg,"['On', 'December', '31', '2019', 'Chinese', 'health', 'officials', 'reported', 'a', 'cluster', 'of', 'cases', 'of', 'acute', 'respiratory', 'illness', 'in', 'persons', 'associated', 'with', 'the', 'Hunan', 'seafood', 'and', 'animal', 'market', 'in', 'the', 'city', 'of', 'Wuhan', 'Hubei', 'Province', 'in', 'central', 'China', 'On', 'January', '7', '2020', 'Chinese', 'health', 'officials', 'confirmed', 'that', 'a', 'novel', 'coronavirus', '2019', 'nCoV', 'was', 'associated', 'with', 'this', 'initial', 'cluster', '1', 'As', 'of', 'February', '4', '2020', 'a', 'total', 'of', '20', '471', 'confirmed', 'cases', 'including', '2', '788', '13', '6', 'with', 'severe', 'illness', 'and', '425', 'deaths', '2', '1', 'had', 'been', 'reported', 'by', 'the', 'National', 'Health', 'Commission', 'of', 'China', '2', 'Cases', 'have', 'also', 'been', 'reported', 'in', '26', 'locations', 'outside', 'of', 'mainland', 'China', 'including', 'documentation', 'of', 'some', 'person', 'to', 'person', 'transmission', 'and', 'one', 'death', '2', 'As', 'of', 'February', '4', '11', 'cases', 'had', 'been', 'reported', 'in', 'the', 'United', 'States', 'On', 'January', '30', 'the', 'World', 'Health', 'Organization', 'WHO', 'Director', 'General', 'declared', 'that', 'the', '2019', 'nCoV', 'outbreak', 'constitutes', 'a', 'Public', 'Health', 'Emergency', 'of', 'International', 'Concern', 'On', 'January', '31', 'the', 'U', 'S', 'Department', 'of', 'Health', 'and', 'Human', 'Services', 'HHS', 'Secretary', 'declared', 'a', 'U', 'S', 'public', 'health', 'emergency', 'to', 'respond', 'to', '2019', 'nCoV', 'Also', 'on', 'January', '31', 'the', 'president', 'of', 'the', 'United', 'States', 'signed', 'a', 'Proclamation', 'on', 'Suspension', 'of', 'Entry', 'as', 'Immigrants', 'and', 'Nonimmigrants', 'of', 'Persons', 'who', 'Pose', 'a', 'Risk', 'of', 'Transmitting', '2019', 'Novel', 'Coronavirus', 'which', 'limits', 'entry', 'into', 'the', 'United', 'States', 'of', 'persons', 'who', 'traveled', 'to', 'mainland', 'China', 'to', 'U', 'S', 'citizens', 'and', 'lawful', 'permanent', 'residents', 'and', 'their', 'families', '3', 'CDC', 'multiple', 'other', 'federal', 'agencies', 'state', 'and', 'local', 'health', 'departments', 'and', 'other', 'partners', 'are', 'implementing', 'aggressive', 'measures', 'to', 'slow', 'transmission', 'of', '2019', 'nCoV', 'in', 'the', 'United', 'States', '4', '5', 'These', 'measures', 'require', 'the', 'identification', 'of', 'cases', 'and', 'their', 'contacts', 'in', 'the', 'United', 'States', 'and', 'the', 'appropriate', 'assessment', 'and', 'care', 'of', 'travelers', 'arriving', 'from', 'mainland', 'China', 'to', 'the', 'United', 'States', 'These', 'measures', 'are', 'being', 'implemented', 'in', 'anticipation', 'of', 'additional', '2019', 'nCoV', 'cases', 'in', 'the', 'United', 'States', 'Although', 'these', 'measures', 'might', 'not', 'prevent', 'the', 'eventual', 'establishment', 'of', 'ongoing', 'widespread', 'transmission', 'of', 'the', 'virus', 'in', 'the', 'United', 'States', 'they', 'are', 'being', 'implemented', 'to', '1', 'slow', 'the', 'spread', 'of', 'illness', '2', 'provide', 'time', 'to', 'better', 'prepare', 'health', 'care', 'systems', 'and', 'the', 'general', 'public', 'to', 'be', 'ready', 'if', 'widespread', 'transmission', 'with', 'substantial', 'associated', 'illness', 'occurs', 'and', '3', 'better', 'characterize', '2019', 'nCoV', 'infection', 'to', 'guide', 'public', 'health', 'recommendations', 'and', 'the', 'development', 'of', 'medical', 'countermeasures', 'including', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'Public', 'health', 'authorities', 'are', 'monitoring', 'the', 'situation', 'closely', 'As', 'more', 'is', 'learned', 'about', 'this', 'novel', 'virus', 'and', 'this', 'outbreak', 'CDC', 'will', 'rapidly', 'incorporate', 'new', 'knowledge', 'into', 'guidance', 'for', 'action', 'by', 'CDC', 'and', 'state', 'and', 'local', 'health', 'departments', '']"
195444,Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art,2018-10-18,Front Microbiol,https://doi.org/10.3389/fmicb.2018.02478; https://www.ncbi.nlm.nih.gov/pubmed/30405553/,"In the pediatric population, respiratory infections are the most common cause of physician visits. Although many respiratory illnesses are self-limiting viral infections that resolve with time and supportive care, it can be critical to identify the causative pathogen at an early stage of the disease in order to implement effective antimicrobial therapy and infection control. Over the last few years, diagnostics for respiratory infections have evolved substantially, with the development of novel assays and the availability of updated tests for newer strains of pathogens. Newer laboratory methods are rapid, highly sensitive and specific, and are gradually replacing the conventional gold standards, although the clinical utility of these assays is still under evaluation. This article reviews the current laboratory methods available for testing for respiratory pathogens and discusses the advantages and disadvantages of each approach.",10.3389/fmicb.2018.02478,avjw4kx1,"['In', 'the', 'pediatric', 'population', 'respiratory', 'infections', 'are', 'the', 'most', 'common', 'cause', 'of', 'physician', 'visits', 'Although', 'many', 'respiratory', 'illnesses', 'are', 'self', 'limiting', 'viral', 'infections', 'that', 'resolve', 'with', 'time', 'and', 'supportive', 'care', 'it', 'can', 'be', 'critical', 'to', 'identify', 'the', 'causative', 'pathogen', 'at', 'an', 'early', 'stage', 'of', 'the', 'disease', 'in', 'order', 'to', 'implement', 'effective', 'antimicrobial', 'therapy', 'and', 'infection', 'control', 'Over', 'the', 'last', 'few', 'years', 'diagnostics', 'for', 'respiratory', 'infections', 'have', 'evolved', 'substantially', 'with', 'the', 'development', 'of', 'novel', 'assays', 'and', 'the', 'availability', 'of', 'updated', 'tests', 'for', 'newer', 'strains', 'of', 'pathogens', 'Newer', 'laboratory', 'methods', 'are', 'rapid', 'highly', 'sensitive', 'and', 'specific', 'and', 'are', 'gradually', 'replacing', 'the', 'conventional', 'gold', 'standards', 'although', 'the', 'clinical', 'utility', 'of', 'these', 'assays', 'is', 'still', 'under', 'evaluation', 'This', 'article', 'reviews', 'the', 'current', 'laboratory', 'methods', 'available', 'for', 'testing', 'for', 'respiratory', 'pathogens', 'and', 'discusses', 'the', 'advantages', 'and', 'disadvantages', 'of', 'each', 'approach', '']"
195542,Synthetic long oligonucleotides to generate artificial templates for use as positive controls in molecular assays: drug resistance mutations in influenza virus as an example,2011-08-16,Virol J,https://www.ncbi.nlm.nih.gov/pubmed/21843374/; https://doi.org/10.1186/1743-422x-8-405,"BACKGROUND: Positive controls are an integral component of any sensitive molecular diagnostic tool, but this can be affected, if several mutations are being screened in a scenario of a pandemic or newly emerging disease where it can be difficult to acquire all the necessary positive controls from the host. This work describes the development of a synthetic oligo-cassette for positive controls for accurate and highly sensitive diagnosis of several mutations relevant to influenza virus drug resistance. RESULTS: Using influenza antiviral drug resistance mutations as an example by employing the utility of synthetic paired long oligonucleotides containing complementary sequences at their 3' ends and utilizing the formation of oligonucleotide dimers and DNA polymerization, we generated ~170bp dsDNA containing several known specific neuraminidase inhibitor (NAI) resistance mutations. These templates were further cloned and successfully applied as positive controls in downstream assays. CONCLUSION: This approach significantly improved the development of diagnosis of resistance mutations in terms of time, accuracy, efficiency and sensitivity, which are paramount to monitoring the emergence and spread of antiviral drug resistant influenza strains. Thus, this may have a significantly broader application in molecular diagnostics along with its application in rapid molecular testing of all relevant mutations in an event of pandemic.",10.1186/1743-422x-8-405,r7m7gfi4,"['BACKGROUND', 'Positive', 'controls', 'are', 'an', 'integral', 'component', 'of', 'any', 'sensitive', 'molecular', 'diagnostic', 'tool', 'but', 'this', 'can', 'be', 'affected', 'if', 'several', 'mutations', 'are', 'being', 'screened', 'in', 'a', 'scenario', 'of', 'a', 'pandemic', 'or', 'newly', 'emerging', 'disease', 'where', 'it', 'can', 'be', 'difficult', 'to', 'acquire', 'all', 'the', 'necessary', 'positive', 'controls', 'from', 'the', 'host', 'This', 'work', 'describes', 'the', 'development', 'of', 'a', 'synthetic', 'oligo', 'cassette', 'for', 'positive', 'controls', 'for', 'accurate', 'and', 'highly', 'sensitive', 'diagnosis', 'of', 'several', 'mutations', 'relevant', 'to', 'influenza', 'virus', 'drug', 'resistance', 'RESULTS', 'Using', 'influenza', 'antiviral', 'drug', 'resistance', 'mutations', 'as', 'an', 'example', 'by', 'employing', 'the', 'utility', 'of', 'synthetic', 'paired', 'long', 'oligonucleotides', 'containing', 'complementary', 'sequences', 'at', 'their', '3', 'ends', 'and', 'utilizing', 'the', 'formation', 'of', 'oligonucleotide', 'dimers', 'and', 'DNA', 'polymerization', 'we', 'generated', '170bp', 'dsDNA', 'containing', 'several', 'known', 'specific', 'neuraminidase', 'inhibitor', 'NAI', 'resistance', 'mutations', 'These', 'templates', 'were', 'further', 'cloned', 'and', 'successfully', 'applied', 'as', 'positive', 'controls', 'in', 'downstream', 'assays', 'CONCLUSION', 'This', 'approach', 'significantly', 'improved', 'the', 'development', 'of', 'diagnosis', 'of', 'resistance', 'mutations', 'in', 'terms', 'of', 'time', 'accuracy', 'efficiency', 'and', 'sensitivity', 'which', 'are', 'paramount', 'to', 'monitoring', 'the', 'emergence', 'and', 'spread', 'of', 'antiviral', 'drug', 'resistant', 'influenza', 'strains', 'Thus', 'this', 'may', 'have', 'a', 'significantly', 'broader', 'application', 'in', 'molecular', 'diagnostics', 'along', 'with', 'its', 'application', 'in', 'rapid', 'molecular', 'testing', 'of', 'all', 'relevant', 'mutations', 'in', 'an', 'event', 'of', 'pandemic', '']"
195716,Navigating the Diagnostics of COVID-19,2020-07-25,SN Compr Clin Med,https://doi.org/10.1007/s42399-020-00408-8,"The recent outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in Hubei province, China, in December 2019 and has spread worldwide at an alarming rate. With over eight million individuals infected and exceeding 400,000 deaths globally, the necessity to develop fast and efficient diagnostic methods is of high importance. This paper reports on currently available diagnostic screening methods for patients infected with SARS-CoV-2 to guide frontline healthcare workers involved with the diagnosis of 2019 novel coronavirus disease (COVID-19) patient. An electronic literature search was performed for peer-reviewed articles published from January 1, 2020, until June 19, 2020. Published articles were then reviewed and included based on the applicability to the topic. The preferred diagnostic approach is the reverse transcription (RT) of the virus’ ribonucleic acid (RNA) followed by polymerase chain reaction (PCR) amplification (RT-PCR). However, this method has been proven to be time-consuming. In improving the speed and efficiency of diagnostics, newer rapid diagnostic serological tests are in development for testing SARS-CoV-2, each with its unique advantages and disadvantages. They could potentially be used as triage tests to rapidly identify patients who are very likely to have COVID-19 in combination with other accurate diagnostic methods, such as diagnostic imaging. A combination of the disease history, clinical manifestations, laboratory diagnostic testing, and diagnostic imaging is crucial for making an accurate and useful diagnosis for COVID-19. Hopefully, the continuous development and use of rapid diagnostic tests and the implementation of public health measures will help control the spread of the disease.",10.1007/s42399-020-00408-8,bqibelvc,"['The', 'recent', 'outbreak', 'of', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'began', 'in', 'Hubei', 'province', 'China', 'in', 'December', '2019', 'and', 'has', 'spread', 'worldwide', 'at', 'an', 'alarming', 'rate', 'With', 'over', 'eight', 'million', 'individuals', 'infected', 'and', 'exceeding', '400', '000', 'deaths', 'globally', 'the', 'necessity', 'to', 'develop', 'fast', 'and', 'efficient', 'diagnostic', 'methods', 'is', 'of', 'high', 'importance', 'This', 'paper', 'reports', 'on', 'currently', 'available', 'diagnostic', 'screening', 'methods', 'for', 'patients', 'infected', 'with', 'SARS', 'CoV', '2', 'to', 'guide', 'frontline', 'healthcare', 'workers', 'involved', 'with', 'the', 'diagnosis', 'of', '2019', 'novel', 'coronavirus', 'disease', 'COVID', '19', 'patient', 'An', 'electronic', 'literature', 'search', 'was', 'performed', 'for', 'peer', 'reviewed', 'articles', 'published', 'from', 'January', '1', '2020', 'until', 'June', '19', '2020', 'Published', 'articles', 'were', 'then', 'reviewed', 'and', 'included', 'based', 'on', 'the', 'applicability', 'to', 'the', 'topic', 'The', 'preferred', 'diagnostic', 'approach', 'is', 'the', 'reverse', 'transcription', 'RT', 'of', 'the', 'virus', 'ribonucleic', 'acid', 'RNA', 'followed', 'by', 'polymerase', 'chain', 'reaction', 'PCR', 'amplification', 'RT', 'PCR', 'However', 'this', 'method', 'has', 'been', 'proven', 'to', 'be', 'time', 'consuming', 'In', 'improving', 'the', 'speed', 'and', 'efficiency', 'of', 'diagnostics', 'newer', 'rapid', 'diagnostic', 'serological', 'tests', 'are', 'in', 'development', 'for', 'testing', 'SARS', 'CoV', '2', 'each', 'with', 'its', 'unique', 'advantages', 'and', 'disadvantages', 'They', 'could', 'potentially', 'be', 'used', 'as', 'triage', 'tests', 'to', 'rapidly', 'identify', 'patients', 'who', 'are', 'very', 'likely', 'to', 'have', 'COVID', '19', 'in', 'combination', 'with', 'other', 'accurate', 'diagnostic', 'methods', 'such', 'as', 'diagnostic', 'imaging', 'A', 'combination', 'of', 'the', 'disease', 'history', 'clinical', 'manifestations', 'laboratory', 'diagnostic', 'testing', 'and', 'diagnostic', 'imaging', 'is', 'crucial', 'for', 'making', 'an', 'accurate', 'and', 'useful', 'diagnosis', 'for', 'COVID', '19', 'Hopefully', 'the', 'continuous', 'development', 'and', 'use', 'of', 'rapid', 'diagnostic', 'tests', 'and', 'the', 'implementation', 'of', 'public', 'health', 'measures', 'will', 'help', 'control', 'the', 'spread', 'of', 'the', 'disease', '']"
196123,Overview of the CSIRO Australian Animal Health Laboratory,2016-04-24,J Infect Public Health,https://www.sciencedirect.com/science/article/pii/S1876034116300247; https://www.ncbi.nlm.nih.gov/pubmed/27118215/; https://api.elsevier.com/content/article/pii/S1876034116300247; https://doi.org/10.1016/j.jiph.2016.04.007,"Emerging infectious diseases arising from livestock and wildlife pose serious threats to global human health, as shown by a series of continuous outbreaks involving highly pathogenic influenza, SARS, Ebola and MERS. The risk of pandemics and bioterrorism threats is ever present and growing, but our ability to combat them is limited by the lack of available vaccines, therapeutics and rapid diagnostics. The use of high bio-containment facilities, such as the CSIRO Australian Animal Health Laboratory, plays a key role studying these dangerous pathogens and facilitates the development of countermeasures. To combat diseases like MERS, we must take a holistic approach that involves the development of early biomarkers of infection, a suite of treatment options (vaccines, anti-viral drugs and antibody therapeutics) and appropriate animal models to test the safety and efficacy of candidate treatments.",10.1016/j.jiph.2016.04.007,13adnvav,"['Emerging', 'infectious', 'diseases', 'arising', 'from', 'livestock', 'and', 'wildlife', 'pose', 'serious', 'threats', 'to', 'global', 'human', 'health', 'as', 'shown', 'by', 'a', 'series', 'of', 'continuous', 'outbreaks', 'involving', 'highly', 'pathogenic', 'influenza', 'SARS', 'Ebola', 'and', 'MERS', 'The', 'risk', 'of', 'pandemics', 'and', 'bioterrorism', 'threats', 'is', 'ever', 'present', 'and', 'growing', 'but', 'our', 'ability', 'to', 'combat', 'them', 'is', 'limited', 'by', 'the', 'lack', 'of', 'available', 'vaccines', 'therapeutics', 'and', 'rapid', 'diagnostics', 'The', 'use', 'of', 'high', 'bio', 'containment', 'facilities', 'such', 'as', 'the', 'CSIRO', 'Australian', 'Animal', 'Health', 'Laboratory', 'plays', 'a', 'key', 'role', 'studying', 'these', 'dangerous', 'pathogens', 'and', 'facilitates', 'the', 'development', 'of', 'countermeasures', 'To', 'combat', 'diseases', 'like', 'MERS', 'we', 'must', 'take', 'a', 'holistic', 'approach', 'that', 'involves', 'the', 'development', 'of', 'early', 'biomarkers', 'of', 'infection', 'a', 'suite', 'of', 'treatment', 'options', 'vaccines', 'anti', 'viral', 'drugs', 'and', 'antibody', 'therapeutics', 'and', 'appropriate', 'animal', 'models', 'to', 'test', 'the', 'safety', 'and', 'efficacy', 'of', 'candidate', 'treatments', '']"
196338,Building an Intelligent Hospital to Fight Contagion,2017-08-15,Clin Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/28859348/; https://doi.org/10.1093/cid/cix402,"The idea of building hospitals to fight contagion was born with the lazarettos. At the time when the microorganisms were not yet known, the mechanisms of transmission of contagion were already well apprehended. Based on the same knowledge but thanks to new technologies, such hospitals have now been built downtown, next to the most highly performing technological plateau. Regrouping patient care, diagnostics, research, and development, the University Hospital Institute Méditerranée Infection building offers a wonderful tool to contain and understand contagion, in a well-designed setting, creating excellent working conditions that are attractive for interested scientists.",10.1093/cid/cix402,e95en2q4,"['The', 'idea', 'of', 'building', 'hospitals', 'to', 'fight', 'contagion', 'was', 'born', 'with', 'the', 'lazarettos', 'At', 'the', 'time', 'when', 'the', 'microorganisms', 'were', 'not', 'yet', 'known', 'the', 'mechanisms', 'of', 'transmission', 'of', 'contagion', 'were', 'already', 'well', 'apprehended', 'Based', 'on', 'the', 'same', 'knowledge', 'but', 'thanks', 'to', 'new', 'technologies', 'such', 'hospitals', 'have', 'now', 'been', 'built', 'downtown', 'next', 'to', 'the', 'most', 'highly', 'performing', 'technological', 'plateau', 'Regrouping', 'patient', 'care', 'diagnostics', 'research', 'and', 'development', 'the', 'University', 'Hospital', 'Institute', 'Méditerranée', 'Infection', 'building', 'offers', 'a', 'wonderful', 'tool', 'to', 'contain', 'and', 'understand', 'contagion', 'in', 'a', 'well', 'designed', 'setting', 'creating', 'excellent', 'working', 'conditions', 'that', 'are', 'attractive', 'for', 'interested', 'scientists', '']"
196831,"The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics",2018-06-22,Respir Res,https://www.ncbi.nlm.nih.gov/pubmed/29929556/; https://doi.org/10.1186/s12931-018-0784-1,"The Human Viral Challenge (HVC) model has, for many decades, helped in the understanding of respiratory viruses and their role in disease pathogenesis. In a controlled setting using small numbers of volunteers removed from community exposure to other infections, this experimental model enables proof of concept work to be undertaken on novel therapeutics, including vaccines, immunomodulators and antivirals, as well as new diagnostics. Crucially, unlike conventional phase 1 studies, challenge studies include evaluable efficacy endpoints that then guide decisions on how to optimise subsequent field studies, as recommended by the FDA and thus licensing studies that follow. Such a strategy optimises the benefit of the studies and identifies possible threats early on, minimising the risk to subsequent volunteers but also maximising the benefit of scarce resources available to the research group investing in the research. Inspired by the principles of the 3Rs (Replacement, Reduction and Refinement) now commonly applied in the preclinical phase, HVC studies allow refinement and reduction of the subsequent development phase, accelerating progress towards further statistically powered phase 2b studies. The breadth of data generated from challenge studies allows for exploration of a wide range of variables and endpoints that can then be taken through to pivotal phase 3 studies. We describe the disease burden for acute respiratory viral infections for which current conventional development strategies have failed to produce therapeutics that meet clinical need. The Authors describe the HVC model’s utility in increasing scientific understanding and in progressing promising therapeutics through development. The contribution of the model to the elucidation of the virus-host interaction, both regarding viral pathogenicity and the body’s immunological response is discussed, along with its utility to assist in the development of novel diagnostics. Future applications of the model are also explored. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-018-0784-1) contains supplementary material, which is available to authorized users.",10.1186/s12931-018-0784-1,n026zwp8,"['The', 'Human', 'Viral', 'Challenge', 'HVC', 'model', 'has', 'for', 'many', 'decades', 'helped', 'in', 'the', 'understanding', 'of', 'respiratory', 'viruses', 'and', 'their', 'role', 'in', 'disease', 'pathogenesis', 'In', 'a', 'controlled', 'setting', 'using', 'small', 'numbers', 'of', 'volunteers', 'removed', 'from', 'community', 'exposure', 'to', 'other', 'infections', 'this', 'experimental', 'model', 'enables', 'proof', 'of', 'concept', 'work', 'to', 'be', 'undertaken', 'on', 'novel', 'therapeutics', 'including', 'vaccines', 'immunomodulators', 'and', 'antivirals', 'as', 'well', 'as', 'new', 'diagnostics', 'Crucially', 'unlike', 'conventional', 'phase', '1', 'studies', 'challenge', 'studies', 'include', 'evaluable', 'efficacy', 'endpoints', 'that', 'then', 'guide', 'decisions', 'on', 'how', 'to', 'optimise', 'subsequent', 'field', 'studies', 'as', 'recommended', 'by', 'the', 'FDA', 'and', 'thus', 'licensing', 'studies', 'that', 'follow', 'Such', 'a', 'strategy', 'optimises', 'the', 'benefit', 'of', 'the', 'studies', 'and', 'identifies', 'possible', 'threats', 'early', 'on', 'minimising', 'the', 'risk', 'to', 'subsequent', 'volunteers', 'but', 'also', 'maximising', 'the', 'benefit', 'of', 'scarce', 'resources', 'available', 'to', 'the', 'research', 'group', 'investing', 'in', 'the', 'research', 'Inspired', 'by', 'the', 'principles', 'of', 'the', '3Rs', 'Replacement', 'Reduction', 'and', 'Refinement', 'now', 'commonly', 'applied', 'in', 'the', 'preclinical', 'phase', 'HVC', 'studies', 'allow', 'refinement', 'and', 'reduction', 'of', 'the', 'subsequent', 'development', 'phase', 'accelerating', 'progress', 'towards', 'further', 'statistically', 'powered', 'phase', '2b', 'studies', 'The', 'breadth', 'of', 'data', 'generated', 'from', 'challenge', 'studies', 'allows', 'for', 'exploration', 'of', 'a', 'wide', 'range', 'of', 'variables', 'and', 'endpoints', 'that', 'can', 'then', 'be', 'taken', 'through', 'to', 'pivotal', 'phase', '3', 'studies', 'We', 'describe', 'the', 'disease', 'burden', 'for', 'acute', 'respiratory', 'viral', 'infections', 'for', 'which', 'current', 'conventional', 'development', 'strategies', 'have', 'failed', 'to', 'produce', 'therapeutics', 'that', 'meet', 'clinical', 'need', 'The', 'Authors', 'describe', 'the', 'HVC', 'model', 's', 'utility', 'in', 'increasing', 'scientific', 'understanding', 'and', 'in', 'progressing', 'promising', 'therapeutics', 'through', 'development', 'The', 'contribution', 'of', 'the', 'model', 'to', 'the', 'elucidation', 'of', 'the', 'virus', 'host', 'interaction', 'both', 'regarding', 'viral', 'pathogenicity', 'and', 'the', 'body', 's', 'immunological', 'response', 'is', 'discussed', 'along', 'with', 'its', 'utility', 'to', 'assist', 'in', 'the', 'development', 'of', 'novel', 'diagnostics', 'Future', 'applications', 'of', 'the', 'model', 'are', 'also', 'explored', 'ELECTRONIC', 'SUPPLEMENTARY', 'MATERIAL', 'The', 'online', 'version', 'of', 'this', 'article', '10', '1186', 's12931', '018', '0784', '1', 'contains', 'supplementary', 'material', 'which', 'is', 'available', 'to', 'authorized', 'users', '']"
197065,36 Viral Febrile Illnesses and Emerging Pathogens,2020-12-31,Hunter's Tropical Medicine and Emerging Infectious Diseases,https://www.sciencedirect.com/science/article/pii/B9780323555128000363; https://api.elsevier.com/content/article/pii/B9780323555128000363,"Abstract Emerging or emerged diseases and viral pathogens are responsible historically and currently for large epidemics, global pandemics, and significant morbidity and mortality. Our civilization will continue to face the emergence of new pathogens and viruses: viruses will continue to evolve and adapt to new environments at a high rate; our population continues to grow through birth rate, land development, and migration; climate change will continue to increase the vector burden and spread and change the migratory pattern of animals; and our societal mobility will continue to increase through rapid transportation. The clinical evaluation of the febrile patient with a potential emerging viral pathogen involves documenting the likelihood for an infection by a detailed travel history, calculation of an incubation time by exposure, and an understanding of the disease progression though the clinical illness, which drives the differential diagnosis and the type of diagnostics ordered. Ultimately, the proper identification and diagnosis of a patient with a viral febrile illness due to an emerging pathogen will elicit the appropriate precautions to protect health care providers and communities, deliver appropriate therapeutic interventions, and initiate a targeted public health response.",10.1016/b978-0-323-55512-8.00036-3,oja9rqcn,"['Abstract', 'Emerging', 'or', 'emerged', 'diseases', 'and', 'viral', 'pathogens', 'are', 'responsible', 'historically', 'and', 'currently', 'for', 'large', 'epidemics', 'global', 'pandemics', 'and', 'significant', 'morbidity', 'and', 'mortality', 'Our', 'civilization', 'will', 'continue', 'to', 'face', 'the', 'emergence', 'of', 'new', 'pathogens', 'and', 'viruses', 'viruses', 'will', 'continue', 'to', 'evolve', 'and', 'adapt', 'to', 'new', 'environments', 'at', 'a', 'high', 'rate', 'our', 'population', 'continues', 'to', 'grow', 'through', 'birth', 'rate', 'land', 'development', 'and', 'migration', 'climate', 'change', 'will', 'continue', 'to', 'increase', 'the', 'vector', 'burden', 'and', 'spread', 'and', 'change', 'the', 'migratory', 'pattern', 'of', 'animals', 'and', 'our', 'societal', 'mobility', 'will', 'continue', 'to', 'increase', 'through', 'rapid', 'transportation', 'The', 'clinical', 'evaluation', 'of', 'the', 'febrile', 'patient', 'with', 'a', 'potential', 'emerging', 'viral', 'pathogen', 'involves', 'documenting', 'the', 'likelihood', 'for', 'an', 'infection', 'by', 'a', 'detailed', 'travel', 'history', 'calculation', 'of', 'an', 'incubation', 'time', 'by', 'exposure', 'and', 'an', 'understanding', 'of', 'the', 'disease', 'progression', 'though', 'the', 'clinical', 'illness', 'which', 'drives', 'the', 'differential', 'diagnosis', 'and', 'the', 'type', 'of', 'diagnostics', 'ordered', 'Ultimately', 'the', 'proper', 'identification', 'and', 'diagnosis', 'of', 'a', 'patient', 'with', 'a', 'viral', 'febrile', 'illness', 'due', 'to', 'an', 'emerging', 'pathogen', 'will', 'elicit', 'the', 'appropriate', 'precautions', 'to', 'protect', 'health', 'care', 'providers', 'and', 'communities', 'deliver', 'appropriate', 'therapeutic', 'interventions', 'and', 'initiate', 'a', 'targeted', 'public', 'health', 'response', '']"
197129,Electrospun nanomaterials for ultrasensitive sensors,2010-11-30,Materials Today,https://api.elsevier.com/content/article/pii/S1369702110702005; https://www.sciencedirect.com/science/article/pii/S1369702110702005; https://doi.org/10.1016/s1369-7021(10)70200-5; https://www.ncbi.nlm.nih.gov/pubmed/32362770/,"Increasing demands for ever more sensitive sensors for global environmental monitoring, food inspection and medical diagnostics have led to an upsurge of interests in nanostructured materials such as nanofibers and nanowebs. Electrospinning exhibits the unique ability to produce diverse forms of fibrous assemblies. The remarkable specific surface area and high porosity bring electrospun nanomaterials highly attractive to ultrasensitive sensors and increasing importance in other nanotechnological applications. In this review, we summarize recent progress in developments of the electrospun nanomaterials with applications in some predominant sensing approaches such as acoustic wave, resistive, photoelectric, optical, amperometric, and so on, illustrate with examples how they work, and discuss their intrinsic fundamentals and optimization designs. We are expecting the review to pave the way for developing more sensitive and selective nanosensors.",10.1016/s1369-7021(10)70200-5,oxoi9t1m,"['Increasing', 'demands', 'for', 'ever', 'more', 'sensitive', 'sensors', 'for', 'global', 'environmental', 'monitoring', 'food', 'inspection', 'and', 'medical', 'diagnostics', 'have', 'led', 'to', 'an', 'upsurge', 'of', 'interests', 'in', 'nanostructured', 'materials', 'such', 'as', 'nanofibers', 'and', 'nanowebs', 'Electrospinning', 'exhibits', 'the', 'unique', 'ability', 'to', 'produce', 'diverse', 'forms', 'of', 'fibrous', 'assemblies', 'The', 'remarkable', 'specific', 'surface', 'area', 'and', 'high', 'porosity', 'bring', 'electrospun', 'nanomaterials', 'highly', 'attractive', 'to', 'ultrasensitive', 'sensors', 'and', 'increasing', 'importance', 'in', 'other', 'nanotechnological', 'applications', 'In', 'this', 'review', 'we', 'summarize', 'recent', 'progress', 'in', 'developments', 'of', 'the', 'electrospun', 'nanomaterials', 'with', 'applications', 'in', 'some', 'predominant', 'sensing', 'approaches', 'such', 'as', 'acoustic', 'wave', 'resistive', 'photoelectric', 'optical', 'amperometric', 'and', 'so', 'on', 'illustrate', 'with', 'examples', 'how', 'they', 'work', 'and', 'discuss', 'their', 'intrinsic', 'fundamentals', 'and', 'optimization', 'designs', 'We', 'are', 'expecting', 'the', 'review', 'to', 'pave', 'the', 'way', 'for', 'developing', 'more', 'sensitive', 'and', 'selective', 'nanosensors', '']"
198074,Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes,2020-02-28,Bioinformatics,https://doi.org/10.1093/bioinformatics/btaa145; https://www.ncbi.nlm.nih.gov/pubmed/32108862/,"SUMMARY: Genome Detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next generation sequencing datasets. This application allows the identification of phylogenetic clusters and genotypes from assembled genomes in FASTA format. Since its release in 2019, we have produced a number of typing tools for emergent viruses that have caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil. Here, we present The Genome Detective Coronavirus Typing Tool that can accurately identify the novel severe acute respiratory syndrome (SARS) related coronavirus (SARS-CoV-2) sequences isolated in China and around the world. The tool can accept up to 2,000 sequences per submission and the analysis of a new whole genome sequence will take approximately one minute. The tool has been tested and validated with hundreds of whole genomes from ten coronavirus species, and correctly classified all of the SARS-related coronavirus (SARSr-CoV) and all of the available public data for SARS-CoV-2. The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines to stop the COVID-19 disease. AVAILABILITY: https://www.genomedetective.com/app/typingtool/cov SUPPLEMENTARY INFORMATION:",10.1093/bioinformatics/btaa145,st5idleq,"['SUMMARY', 'Genome', 'Detective', 'is', 'a', 'web', 'based', 'user', 'friendly', 'software', 'application', 'to', 'quickly', 'and', 'accurately', 'assemble', 'all', 'known', 'virus', 'genomes', 'from', 'next', 'generation', 'sequencing', 'datasets', 'This', 'application', 'allows', 'the', 'identification', 'of', 'phylogenetic', 'clusters', 'and', 'genotypes', 'from', 'assembled', 'genomes', 'in', 'FASTA', 'format', 'Since', 'its', 'release', 'in', '2019', 'we', 'have', 'produced', 'a', 'number', 'of', 'typing', 'tools', 'for', 'emergent', 'viruses', 'that', 'have', 'caused', 'large', 'outbreaks', 'such', 'as', 'Zika', 'and', 'Yellow', 'Fever', 'Virus', 'in', 'Brazil', 'Here', 'we', 'present', 'The', 'Genome', 'Detective', 'Coronavirus', 'Typing', 'Tool', 'that', 'can', 'accurately', 'identify', 'the', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'related', 'coronavirus', 'SARS', 'CoV', '2', 'sequences', 'isolated', 'in', 'China', 'and', 'around', 'the', 'world', 'The', 'tool', 'can', 'accept', 'up', 'to', '2', '000', 'sequences', 'per', 'submission', 'and', 'the', 'analysis', 'of', 'a', 'new', 'whole', 'genome', 'sequence', 'will', 'take', 'approximately', 'one', 'minute', 'The', 'tool', 'has', 'been', 'tested', 'and', 'validated', 'with', 'hundreds', 'of', 'whole', 'genomes', 'from', 'ten', 'coronavirus', 'species', 'and', 'correctly', 'classified', 'all', 'of', 'the', 'SARS', 'related', 'coronavirus', 'SARSr', 'CoV', 'and', 'all', 'of', 'the', 'available', 'public', 'data', 'for', 'SARS', 'CoV', '2', 'The', 'tool', 'also', 'allows', 'tracking', 'of', 'new', 'viral', 'mutations', 'as', 'the', 'outbreak', 'expands', 'globally', 'which', 'may', 'help', 'to', 'accelerate', 'the', 'development', 'of', 'novel', 'diagnostics', 'drugs', 'and', 'vaccines', 'to', 'stop', 'the', 'COVID', '19', 'disease', 'AVAILABILITY', 'https', 'www', 'genomedetective', 'com', 'app', 'typingtool', 'cov', 'SUPPLEMENTARY', 'INFORMATION', '']"
198387,Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks,2020-05-01,Tissue Eng Part A,https://doi.org/10.1089/ten.tea.2020.0094; https://www.ncbi.nlm.nih.gov/pubmed/32272857/,"In light of the current novel coronavirus (COVID-19) pandemic, as well as other viral outbreaks in the 21st century, there is a dire need for new diagnostic and therapeutic strategies to combat infectious diseases worldwide. As a convergence science, tissue engineering has traditionally focused on the application of engineering principles to biological systems, collaboration across disciplines, and rapid translation of technologies from the benchtop to the bedside. Given these strengths, tissue engineers are particularly well suited to apply their skill set to the current crisis and viral outbreaks in general. This work introduces the basics of virology and epidemiology for tissue engineers, and highlights important developments in the field of tissue engineering relevant to the current pandemic, including in vitro model systems, vaccine technology, and small-molecule drug delivery. COVID-19 serves as a call to arms for scientists across all disciplines, and tissue engineers are well trained to be leaders and contributors in this time of need. IMPACT STATEMENT: Given the steep mortality caused by the recent novel coronavirus (COVID-19) pandemic, there is clear need for advances in diagnostics and therapeutics for viral outbreaks. Tissue engineering has the potential for critical impact on clinical outcomes in viral outbreaks. Tissue engineers, if mobilized, could play key roles as leaders in the outbreak, given their ability to apply engineering principles to biological processes, experience in collaborative environments, and penchant for technological translation from benchtop to bedside. In this work, three areas pioneered by tissue engineers that could be applied to the current COVID-19 crisis and future viral outbreaks are highlighted.",10.1089/ten.tea.2020.0094,b16i6uot,"['In', 'light', 'of', 'the', 'current', 'novel', 'coronavirus', 'COVID', '19', 'pandemic', 'as', 'well', 'as', 'other', 'viral', 'outbreaks', 'in', 'the', '21st', 'century', 'there', 'is', 'a', 'dire', 'need', 'for', 'new', 'diagnostic', 'and', 'therapeutic', 'strategies', 'to', 'combat', 'infectious', 'diseases', 'worldwide', 'As', 'a', 'convergence', 'science', 'tissue', 'engineering', 'has', 'traditionally', 'focused', 'on', 'the', 'application', 'of', 'engineering', 'principles', 'to', 'biological', 'systems', 'collaboration', 'across', 'disciplines', 'and', 'rapid', 'translation', 'of', 'technologies', 'from', 'the', 'benchtop', 'to', 'the', 'bedside', 'Given', 'these', 'strengths', 'tissue', 'engineers', 'are', 'particularly', 'well', 'suited', 'to', 'apply', 'their', 'skill', 'set', 'to', 'the', 'current', 'crisis', 'and', 'viral', 'outbreaks', 'in', 'general', 'This', 'work', 'introduces', 'the', 'basics', 'of', 'virology', 'and', 'epidemiology', 'for', 'tissue', 'engineers', 'and', 'highlights', 'important', 'developments', 'in', 'the', 'field', 'of', 'tissue', 'engineering', 'relevant', 'to', 'the', 'current', 'pandemic', 'including', 'in', 'vitro', 'model', 'systems', 'vaccine', 'technology', 'and', 'small', 'molecule', 'drug', 'delivery', 'COVID', '19', 'serves', 'as', 'a', 'call', 'to', 'arms', 'for', 'scientists', 'across', 'all', 'disciplines', 'and', 'tissue', 'engineers', 'are', 'well', 'trained', 'to', 'be', 'leaders', 'and', 'contributors', 'in', 'this', 'time', 'of', 'need', 'IMPACT', 'STATEMENT', 'Given', 'the', 'steep', 'mortality', 'caused', 'by', 'the', 'recent', 'novel', 'coronavirus', 'COVID', '19', 'pandemic', 'there', 'is', 'clear', 'need', 'for', 'advances', 'in', 'diagnostics', 'and', 'therapeutics', 'for', 'viral', 'outbreaks', 'Tissue', 'engineering', 'has', 'the', 'potential', 'for', 'critical', 'impact', 'on', 'clinical', 'outcomes', 'in', 'viral', 'outbreaks', 'Tissue', 'engineers', 'if', 'mobilized', 'could', 'play', 'key', 'roles', 'as', 'leaders', 'in', 'the', 'outbreak', 'given', 'their', 'ability', 'to', 'apply', 'engineering', 'principles', 'to', 'biological', 'processes', 'experience', 'in', 'collaborative', 'environments', 'and', 'penchant', 'for', 'technological', 'translation', 'from', 'benchtop', 'to', 'bedside', 'In', 'this', 'work', 'three', 'areas', 'pioneered', 'by', 'tissue', 'engineers', 'that', 'could', 'be', 'applied', 'to', 'the', 'current', 'COVID', '19', 'crisis', 'and', 'future', 'viral', 'outbreaks', 'are', 'highlighted', '']"
198968,Role of viral and bacterial pathogens in causing pneumonia among Western Australian children: a case–control study protocol,2018-03-16,BMJ Open,https://doi.org/10.1136/bmjopen-2017-020646; https://www.ncbi.nlm.nih.gov/pubmed/29549211/,"INTRODUCTION: Pneumonia is the leading cause of childhood morbidity and mortality globally. Introduction of the conjugate Haemophilus influenzae B and multivalent pneumococcal vaccines in developed countries including Australia has significantly reduced the overall burden of bacterial pneumonia. With the availability of molecular diagnostics, viruses are frequently detected in children with pneumonia either as primary pathogens or predispose to secondary bacterial infection. Many respiratory pathogens that are known to cause pneumonia are also identified in asymptomatic children, so the true contribution of these pathogens to childhood community-acquired pneumonia (CAP) remains unclear. Since the introduction of pneumococcal vaccines, very few comprehensive studies from developed countries have attempted to determine the bacterial and viral aetiology of pneumonia. We aim to determine the contribution of bacteria and viruses to childhood CAP to inform further development of effective diagnosis, treatment and preventive strategies. METHODS AND ANALYSIS: We are conducting a prospective case–control study (PneumoWA) where cases are children with radiologically confirmed pneumonia admitted to Princess Margaret Hospital for Children (PMH) and controls are healthy children identified from PMH outpatient clinics and from local community immunisation clinics. The case–control ratio is 1:1 with 250 children to be recruited in each arm. Nasopharyngeal swabs are collected from both cases and controls to detect the presence of viruses and bacteria by PCR; pathogen load will be assessed by quantitative PCR. The prevalence of pathogens detected in cases and controls will be compared, the OR of detection and population attributable fraction to CAP for each pathogen will be determined; relationships between pathogen load and disease status and severity will be explored. ETHICS AND DISSEMINATION: This study has been approved by the human research ethics committees of PMH, Perth, Australia (PMH HREC REF 2014117EP). Findings will be disseminated at research conferences and in peer-reviewed journals.",10.1136/bmjopen-2017-020646,w3rxdaii,"['INTRODUCTION', 'Pneumonia', 'is', 'the', 'leading', 'cause', 'of', 'childhood', 'morbidity', 'and', 'mortality', 'globally', 'Introduction', 'of', 'the', 'conjugate', 'Haemophilus', 'influenzae', 'B', 'and', 'multivalent', 'pneumococcal', 'vaccines', 'in', 'developed', 'countries', 'including', 'Australia', 'has', 'significantly', 'reduced', 'the', 'overall', 'burden', 'of', 'bacterial', 'pneumonia', 'With', 'the', 'availability', 'of', 'molecular', 'diagnostics', 'viruses', 'are', 'frequently', 'detected', 'in', 'children', 'with', 'pneumonia', 'either', 'as', 'primary', 'pathogens', 'or', 'predispose', 'to', 'secondary', 'bacterial', 'infection', 'Many', 'respiratory', 'pathogens', 'that', 'are', 'known', 'to', 'cause', 'pneumonia', 'are', 'also', 'identified', 'in', 'asymptomatic', 'children', 'so', 'the', 'true', 'contribution', 'of', 'these', 'pathogens', 'to', 'childhood', 'community', 'acquired', 'pneumonia', 'CAP', 'remains', 'unclear', 'Since', 'the', 'introduction', 'of', 'pneumococcal', 'vaccines', 'very', 'few', 'comprehensive', 'studies', 'from', 'developed', 'countries', 'have', 'attempted', 'to', 'determine', 'the', 'bacterial', 'and', 'viral', 'aetiology', 'of', 'pneumonia', 'We', 'aim', 'to', 'determine', 'the', 'contribution', 'of', 'bacteria', 'and', 'viruses', 'to', 'childhood', 'CAP', 'to', 'inform', 'further', 'development', 'of', 'effective', 'diagnosis', 'treatment', 'and', 'preventive', 'strategies', 'METHODS', 'AND', 'ANALYSIS', 'We', 'are', 'conducting', 'a', 'prospective', 'case', 'control', 'study', 'PneumoWA', 'where', 'cases', 'are', 'children', 'with', 'radiologically', 'confirmed', 'pneumonia', 'admitted', 'to', 'Princess', 'Margaret', 'Hospital', 'for', 'Children', 'PMH', 'and', 'controls', 'are', 'healthy', 'children', 'identified', 'from', 'PMH', 'outpatient', 'clinics', 'and', 'from', 'local', 'community', 'immunisation', 'clinics', 'The', 'case', 'control', 'ratio', 'is', '1', '1', 'with', '250', 'children', 'to', 'be', 'recruited', 'in', 'each', 'arm', 'Nasopharyngeal', 'swabs', 'are', 'collected', 'from', 'both', 'cases', 'and', 'controls', 'to', 'detect', 'the', 'presence', 'of', 'viruses', 'and', 'bacteria', 'by', 'PCR', 'pathogen', 'load', 'will', 'be', 'assessed', 'by', 'quantitative', 'PCR', 'The', 'prevalence', 'of', 'pathogens', 'detected', 'in', 'cases', 'and', 'controls', 'will', 'be', 'compared', 'the', 'OR', 'of', 'detection', 'and', 'population', 'attributable', 'fraction', 'to', 'CAP', 'for', 'each', 'pathogen', 'will', 'be', 'determined', 'relationships', 'between', 'pathogen', 'load', 'and', 'disease', 'status', 'and', 'severity', 'will', 'be', 'explored', 'ETHICS', 'AND', 'DISSEMINATION', 'This', 'study', 'has', 'been', 'approved', 'by', 'the', 'human', 'research', 'ethics', 'committees', 'of', 'PMH', 'Perth', 'Australia', 'PMH', 'HREC', 'REF', '2014117EP', 'Findings', 'will', 'be', 'disseminated', 'at', 'research', 'conferences', 'and', 'in', 'peer', 'reviewed', 'journals', '']"
199355,COVID‐19 Clinical Diagnostics and Testing Technology,2020-07-08,Pharmacotherapy,https://doi.org/10.1002/phar.2439; https://www.ncbi.nlm.nih.gov/pubmed/32643218/,"Given the global nature of the COVID‐19 pandemic, the need for disease detection and expanding testing capacity remains a critical priority. This review discusses the technological advances in testing capability and methodology that are currently employed or in development for detecting the novel coronavirus. We describe the current clinical diagnostics and technology, including molecular and serological testing approaches, for SARS‐CoV‐2 testing as well as address their advantages and limitations. Nucleic acid amplification technology for molecular diagnostics remains the gold standard for virus detection. We highlight alternative molecular detection techniques used for developing novel COVID‐19 diagnostics on the horizon. Antibody response against SARS‐CoV‐2 remains poorly understood and proper validation of serology tests is necessary to demonstrate their accuracy and clinical utility. In order to bring the pandemic under control, we must speed up the development of rapid and widespread testing through improvements in clinical diagnostics and testing technology as well as access to these tools.",10.1002/phar.2439,5mf1r24m,"['Given', 'the', 'global', 'nature', 'of', 'the', 'COVID', '19', 'pandemic', 'the', 'need', 'for', 'disease', 'detection', 'and', 'expanding', 'testing', 'capacity', 'remains', 'a', 'critical', 'priority', 'This', 'review', 'discusses', 'the', 'technological', 'advances', 'in', 'testing', 'capability', 'and', 'methodology', 'that', 'are', 'currently', 'employed', 'or', 'in', 'development', 'for', 'detecting', 'the', 'novel', 'coronavirus', 'We', 'describe', 'the', 'current', 'clinical', 'diagnostics', 'and', 'technology', 'including', 'molecular', 'and', 'serological', 'testing', 'approaches', 'for', 'SARS', 'CoV', '2', 'testing', 'as', 'well', 'as', 'address', 'their', 'advantages', 'and', 'limitations', 'Nucleic', 'acid', 'amplification', 'technology', 'for', 'molecular', 'diagnostics', 'remains', 'the', 'gold', 'standard', 'for', 'virus', 'detection', 'We', 'highlight', 'alternative', 'molecular', 'detection', 'techniques', 'used', 'for', 'developing', 'novel', 'COVID', '19', 'diagnostics', 'on', 'the', 'horizon', 'Antibody', 'response', 'against', 'SARS', 'CoV', '2', 'remains', 'poorly', 'understood', 'and', 'proper', 'validation', 'of', 'serology', 'tests', 'is', 'necessary', 'to', 'demonstrate', 'their', 'accuracy', 'and', 'clinical', 'utility', 'In', 'order', 'to', 'bring', 'the', 'pandemic', 'under', 'control', 'we', 'must', 'speed', 'up', 'the', 'development', 'of', 'rapid', 'and', 'widespread', 'testing', 'through', 'improvements', 'in', 'clinical', 'diagnostics', 'and', 'testing', 'technology', 'as', 'well', 'as', 'access', 'to', 'these', 'tools', '']"
199613,Point-of-Care Diagnostic Services as an Integral Part of Health Services during the Novel Coronavirus 2019 Era,2020,Diagnostics,https://www.ncbi.nlm.nih.gov/pubmed/32635234/; https://doi.org/10.3390/diagnostics10070449,"Point-of-care (POC) diagnostic services are commonly associated with pathology laboratory services This issue presents a holistic approach to POC diagnostics services from a variety of disciplines including pathology, radiological and information technology as well as mobile technology and artificial intelligence This highlights the need for transdisciplinary collaboration to ensure the efficient development and implementation of point-of-care diagnostics The advent of the novel coronavirus 2019 (COVID-19) pandemic has prompted rapid advances in the development of new POC diagnostics Global private and public sector agencies have significantly increased their investment in the development of POC diagnostics There is no longer a question about the availability and accessibility of POC diagnostics The question is ""how can POC diagnostic services be integrated into health services in way that is useful and acceptable in the COVID-19 era?""",10.3390/diagnostics10070449,jtce7jpi,"['Point', 'of', 'care', 'POC', 'diagnostic', 'services', 'are', 'commonly', 'associated', 'with', 'pathology', 'laboratory', 'services', 'This', 'issue', 'presents', 'a', 'holistic', 'approach', 'to', 'POC', 'diagnostics', 'services', 'from', 'a', 'variety', 'of', 'disciplines', 'including', 'pathology', 'radiological', 'and', 'information', 'technology', 'as', 'well', 'as', 'mobile', 'technology', 'and', 'artificial', 'intelligence', 'This', 'highlights', 'the', 'need', 'for', 'transdisciplinary', 'collaboration', 'to', 'ensure', 'the', 'efficient', 'development', 'and', 'implementation', 'of', 'point', 'of', 'care', 'diagnostics', 'The', 'advent', 'of', 'the', 'novel', 'coronavirus', '2019', 'COVID', '19', 'pandemic', 'has', 'prompted', 'rapid', 'advances', 'in', 'the', 'development', 'of', 'new', 'POC', 'diagnostics', 'Global', 'private', 'and', 'public', 'sector', 'agencies', 'have', 'significantly', 'increased', 'their', 'investment', 'in', 'the', 'development', 'of', 'POC', 'diagnostics', 'There', 'is', 'no', 'longer', 'a', 'question', 'about', 'the', 'availability', 'and', 'accessibility', 'of', 'POC', 'diagnostics', 'The', 'question', 'is', 'how', 'can', 'POC', 'diagnostic', 'services', 'be', 'integrated', 'into', 'health', 'services', 'in', 'way', 'that', 'is', 'useful', 'and', 'acceptable', 'in', 'the', 'COVID', '19', 'era', '']"
199639,A Decentralized Molecular Diagnostic Testing Plan for Pandemic Influenza in the Ontario Public Health Laboratory System,2008-09-01,Canadian Journal of Public Health,https://www.ncbi.nlm.nih.gov/pubmed/19009922/,"The Ontario Public Health Laboratories system (OPHL) is in the midst of a six-year plan to implement molecular tools for pandemic influenza diagnostics in one central and three regional public health laboratories. This plan has been formulated as a consequence of: 1) experiences gained through severe acute respiratory syndrome (SARS), and comments of the members of the Expert Panel on SARS and Infectious Disease Control (i.e., the Walker report); 2) a review of pandemic preparedness literature; 3) historical and epidemiologic discussions about previous pandemics; and 4) suggestions made by various pandemic working committees. The OPHL plan includes: 1) an aggressive restructuring of the overall molecular microbiology testing capacity of the OPHL; 2) the ability to shift influenza testing of samples between designated OPHL laboratories; and 3) the development of screening tools for pandemic influenza diagnostic tests. The authors believe that investing in increased molecular testing capacity for regional laboratories outside the greater Toronto area will be beneficial to the OPHL system whether or not an influenza pandemic occurs. Well-trained technologists and microbiologists, and the introduction of new technologies, will facilitate the development of a wide variety of molecular tests for other infectious diseases at public health laboratories geographically distant from Toronto, thus enhancing overall laboratory testing capacity in the province of Ontario.",10.1007/bf03405247,wq7p3116,"['The', 'Ontario', 'Public', 'Health', 'Laboratories', 'system', 'OPHL', 'is', 'in', 'the', 'midst', 'of', 'a', 'six', 'year', 'plan', 'to', 'implement', 'molecular', 'tools', 'for', 'pandemic', 'influenza', 'diagnostics', 'in', 'one', 'central', 'and', 'three', 'regional', 'public', 'health', 'laboratories', 'This', 'plan', 'has', 'been', 'formulated', 'as', 'a', 'consequence', 'of', '1', 'experiences', 'gained', 'through', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'and', 'comments', 'of', 'the', 'members', 'of', 'the', 'Expert', 'Panel', 'on', 'SARS', 'and', 'Infectious', 'Disease', 'Control', 'i', 'e', 'the', 'Walker', 'report', '2', 'a', 'review', 'of', 'pandemic', 'preparedness', 'literature', '3', 'historical', 'and', 'epidemiologic', 'discussions', 'about', 'previous', 'pandemics', 'and', '4', 'suggestions', 'made', 'by', 'various', 'pandemic', 'working', 'committees', 'The', 'OPHL', 'plan', 'includes', '1', 'an', 'aggressive', 'restructuring', 'of', 'the', 'overall', 'molecular', 'microbiology', 'testing', 'capacity', 'of', 'the', 'OPHL', '2', 'the', 'ability', 'to', 'shift', 'influenza', 'testing', 'of', 'samples', 'between', 'designated', 'OPHL', 'laboratories', 'and', '3', 'the', 'development', 'of', 'screening', 'tools', 'for', 'pandemic', 'influenza', 'diagnostic', 'tests', 'The', 'authors', 'believe', 'that', 'investing', 'in', 'increased', 'molecular', 'testing', 'capacity', 'for', 'regional', 'laboratories', 'outside', 'the', 'greater', 'Toronto', 'area', 'will', 'be', 'beneficial', 'to', 'the', 'OPHL', 'system', 'whether', 'or', 'not', 'an', 'influenza', 'pandemic', 'occurs', 'Well', 'trained', 'technologists', 'and', 'microbiologists', 'and', 'the', 'introduction', 'of', 'new', 'technologies', 'will', 'facilitate', 'the', 'development', 'of', 'a', 'wide', 'variety', 'of', 'molecular', 'tests', 'for', 'other', 'infectious', 'diseases', 'at', 'public', 'health', 'laboratories', 'geographically', 'distant', 'from', 'Toronto', 'thus', 'enhancing', 'overall', 'laboratory', 'testing', 'capacity', 'in', 'the', 'province', 'of', 'Ontario', '']"
199740,A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19,2020-04-17,Cureus,https://doi.org/10.7759/cureus.7708; https://www.ncbi.nlm.nih.gov/pubmed/32313785/,"Saliva is an exocrine secretion produced from the salivary glands and has numerous functions, such as cleansing and protection of the oral cavity, antimicrobial effects and aids in digestion. Due to the speedy development in the field of salivaomics, saliva is now well accepted as a pool of biological markers that vary from changes in biochemicals, nucleic acids and proteins to the microflora. Saliva has an immense potential as a diagnostic fluid and offers an edge over other biological fluids as its collection method does not require invasive procedure, economical and is useful for monitoring systemic health. Development of sensitive and precise salivary diagnostic tools and the formulation of defined guidelines following meticulous testing will allow salivary diagnostics to be utilised as chair side tests for various oral and systemic diseases in the near future. The coronavirus disease (Covid-19) pandemic is the biggest challenge and global health crisis for the world since World War Two. Rapid and accurate diagnosis of Covid-19 is crucial in controlling the outbreak in the community and in hospitals. Nasopharyngeal and oropharyngeal swabs are the recommended specimen types for Covid-19 diagnostic testing. The collection of these specimen types requires close contact between healthcare workers and patients and poses a risk of transmission of the virus, causes discomfort and may cause bleeding, especially in patients with condition such as thrombocytopenia. Hence, nasopharyngeal or oropharyngeal swabs are not desirable for sequential monitoring of viral load. Saliva specimens can be obtained easily as the patient is asked to spit into a sterile bottle. The collection of saliva is non-invasive and greatly minimizes the exposure of healthcare workers to Covid-19. Saliva has a high consistency rate of greater than 90% with nasopharyngeal specimens in the detection of respiratory viruses, including coronaviruses. Saliva has also been used in screening respiratory viruses among hospitalized patients without pyrexia or respiratory symptoms. SARS-CoV can be detected in saliva at high titers. Salivary diagnostics is a dynamic field that is being incorporated as part of disease diagnosis, clinical monitoring of systemic health and to make significant clinical decisions for patient care. More research is required to analyze the potential diagnostic of Covid-19 in saliva to develop rapid chair side tests for the detection of Covid-19 and it is also pivotal to improve and develop successful strategies for prevention, especially for dentists and healthcare professionals who are involved in performing aerosol-generating procedures.",10.7759/cureus.7708,awy3aans,"['Saliva', 'is', 'an', 'exocrine', 'secretion', 'produced', 'from', 'the', 'salivary', 'glands', 'and', 'has', 'numerous', 'functions', 'such', 'as', 'cleansing', 'and', 'protection', 'of', 'the', 'oral', 'cavity', 'antimicrobial', 'effects', 'and', 'aids', 'in', 'digestion', 'Due', 'to', 'the', 'speedy', 'development', 'in', 'the', 'field', 'of', 'salivaomics', 'saliva', 'is', 'now', 'well', 'accepted', 'as', 'a', 'pool', 'of', 'biological', 'markers', 'that', 'vary', 'from', 'changes', 'in', 'biochemicals', 'nucleic', 'acids', 'and', 'proteins', 'to', 'the', 'microflora', 'Saliva', 'has', 'an', 'immense', 'potential', 'as', 'a', 'diagnostic', 'fluid', 'and', 'offers', 'an', 'edge', 'over', 'other', 'biological', 'fluids', 'as', 'its', 'collection', 'method', 'does', 'not', 'require', 'invasive', 'procedure', 'economical', 'and', 'is', 'useful', 'for', 'monitoring', 'systemic', 'health', 'Development', 'of', 'sensitive', 'and', 'precise', 'salivary', 'diagnostic', 'tools', 'and', 'the', 'formulation', 'of', 'defined', 'guidelines', 'following', 'meticulous', 'testing', 'will', 'allow', 'salivary', 'diagnostics', 'to', 'be', 'utilised', 'as', 'chair', 'side', 'tests', 'for', 'various', 'oral', 'and', 'systemic', 'diseases', 'in', 'the', 'near', 'future', 'The', 'coronavirus', 'disease', 'Covid', '19', 'pandemic', 'is', 'the', 'biggest', 'challenge', 'and', 'global', 'health', 'crisis', 'for', 'the', 'world', 'since', 'World', 'War', 'Two', 'Rapid', 'and', 'accurate', 'diagnosis', 'of', 'Covid', '19', 'is', 'crucial', 'in', 'controlling', 'the', 'outbreak', 'in', 'the', 'community', 'and', 'in', 'hospitals', 'Nasopharyngeal', 'and', 'oropharyngeal', 'swabs', 'are', 'the', 'recommended', 'specimen', 'types', 'for', 'Covid', '19', 'diagnostic', 'testing', 'The', 'collection', 'of', 'these', 'specimen', 'types', 'requires', 'close', 'contact', 'between', 'healthcare', 'workers', 'and', 'patients', 'and', 'poses', 'a', 'risk', 'of', 'transmission', 'of', 'the', 'virus', 'causes', 'discomfort', 'and', 'may', 'cause', 'bleeding', 'especially', 'in', 'patients', 'with', 'condition', 'such', 'as', 'thrombocytopenia', 'Hence', 'nasopharyngeal', 'or', 'oropharyngeal', 'swabs', 'are', 'not', 'desirable', 'for', 'sequential', 'monitoring', 'of', 'viral', 'load', 'Saliva', 'specimens', 'can', 'be', 'obtained', 'easily', 'as', 'the', 'patient', 'is', 'asked', 'to', 'spit', 'into', 'a', 'sterile', 'bottle', 'The', 'collection', 'of', 'saliva', 'is', 'non', 'invasive', 'and', 'greatly', 'minimizes', 'the', 'exposure', 'of', 'healthcare', 'workers', 'to', 'Covid', '19', 'Saliva', 'has', 'a', 'high', 'consistency', 'rate', 'of', 'greater', 'than', '90', 'with', 'nasopharyngeal', 'specimens', 'in', 'the', 'detection', 'of', 'respiratory', 'viruses', 'including', 'coronaviruses', 'Saliva', 'has', 'also', 'been', 'used', 'in', 'screening', 'respiratory', 'viruses', 'among', 'hospitalized', 'patients', 'without', 'pyrexia', 'or', 'respiratory', 'symptoms', 'SARS', 'CoV', 'can', 'be', 'detected', 'in', 'saliva', 'at', 'high', 'titers', 'Salivary', 'diagnostics', 'is', 'a', 'dynamic', 'field', 'that', 'is', 'being', 'incorporated', 'as', 'part', 'of', 'disease', 'diagnosis', 'clinical', 'monitoring', 'of', 'systemic', 'health', 'and', 'to', 'make', 'significant', 'clinical', 'decisions', 'for', 'patient', 'care', 'More', 'research', 'is', 'required', 'to', 'analyze', 'the', 'potential', 'diagnostic', 'of', 'Covid', '19', 'in', 'saliva', 'to', 'develop', 'rapid', 'chair', 'side', 'tests', 'for', 'the', 'detection', 'of', 'Covid', '19', 'and', 'it', 'is', 'also', 'pivotal', 'to', 'improve', 'and', 'develop', 'successful', 'strategies', 'for', 'prevention', 'especially', 'for', 'dentists', 'and', 'healthcare', 'professionals', 'who', 'are', 'involved', 'in', 'performing', 'aerosol', 'generating', 'procedures', '']"
200471,Rapid detection of infectious bovine Rhinotracheitis virus using recombinase polymerase amplification assays,2017-12-13,BMC Vet Res,https://www.ncbi.nlm.nih.gov/pubmed/29237466/; https://doi.org/10.1186/s12917-017-1284-0,"BACKGROUND: Infectious bovine rhinotracheitis virus (IBRV) is a major pathogen in cattle and has led to significant economic losses to the dairy industry worldwide, and therefore a more optimal method for the rapid diagnosis of IBRV infection is highly needed. In this study, we described the development of a lateral flow dipstrip (LFD) of isothermal recombinase polymerase amplification (RPA) method for rapid detection of IBRV. METHODS: Distinct regions were selected as a candidate target for designing the LFD-RPA primers and probes. The analytical sensitivity of the RPA assay was determined using ten-fold serially diluted IBRV DNA. The specificity of the assay was assessed with other viral pathogens of cattle with similar clinic and other herpesviruses. The clinical performance was evaluated by testing 106 acute-phase high fever clinical specimens. RESULTS: RPA primers and probe were designed to target the specific conserved UL52 region fragment of IBRV. The detection could be completed at a constant temperature of 38 °C for 25 min, and the amplification products were easily visualized on a simple LFD. The detection limit of this assay was 5 copies per reaction of IBRV DNA and there was no cross-reactivity with other viruses causing bovine gastrointestinal and respiratory infections or other herpesviruses. The assay performance on acute-phase high fever clinical samples collected from cattle with no vaccine against IBRV, which were suspected to be infected with IBRV, was validated by detecting 24 fecal, 36 blood, 38 nasal swab and 8 tissue specimens, and compared with SYBR Green I based real-time PCR. The coincidence between IBRV LFD-RPA and real-time PCR was 100%. CONCLUSION: IBRV LFD-RPA was fast and much easier to serve as an alternative to the common measures used for IBRV diagnosis, as there is reduction in the use of instruments for identification of the infected animals. In addition, this assay may be the potential candidate to be used as point-of-care diagnostics in the field.",10.1186/s12917-017-1284-0,bgrgzfoo,"['BACKGROUND', 'Infectious', 'bovine', 'rhinotracheitis', 'virus', 'IBRV', 'is', 'a', 'major', 'pathogen', 'in', 'cattle', 'and', 'has', 'led', 'to', 'significant', 'economic', 'losses', 'to', 'the', 'dairy', 'industry', 'worldwide', 'and', 'therefore', 'a', 'more', 'optimal', 'method', 'for', 'the', 'rapid', 'diagnosis', 'of', 'IBRV', 'infection', 'is', 'highly', 'needed', 'In', 'this', 'study', 'we', 'described', 'the', 'development', 'of', 'a', 'lateral', 'flow', 'dipstrip', 'LFD', 'of', 'isothermal', 'recombinase', 'polymerase', 'amplification', 'RPA', 'method', 'for', 'rapid', 'detection', 'of', 'IBRV', 'METHODS', 'Distinct', 'regions', 'were', 'selected', 'as', 'a', 'candidate', 'target', 'for', 'designing', 'the', 'LFD', 'RPA', 'primers', 'and', 'probes', 'The', 'analytical', 'sensitivity', 'of', 'the', 'RPA', 'assay', 'was', 'determined', 'using', 'ten', 'fold', 'serially', 'diluted', 'IBRV', 'DNA', 'The', 'specificity', 'of', 'the', 'assay', 'was', 'assessed', 'with', 'other', 'viral', 'pathogens', 'of', 'cattle', 'with', 'similar', 'clinic', 'and', 'other', 'herpesviruses', 'The', 'clinical', 'performance', 'was', 'evaluated', 'by', 'testing', '106', 'acute', 'phase', 'high', 'fever', 'clinical', 'specimens', 'RESULTS', 'RPA', 'primers', 'and', 'probe', 'were', 'designed', 'to', 'target', 'the', 'specific', 'conserved', 'UL52', 'region', 'fragment', 'of', 'IBRV', 'The', 'detection', 'could', 'be', 'completed', 'at', 'a', 'constant', 'temperature', 'of', '38', 'C', 'for', '25', 'min', 'and', 'the', 'amplification', 'products', 'were', 'easily', 'visualized', 'on', 'a', 'simple', 'LFD', 'The', 'detection', 'limit', 'of', 'this', 'assay', 'was', '5', 'copies', 'per', 'reaction', 'of', 'IBRV', 'DNA', 'and', 'there', 'was', 'no', 'cross', 'reactivity', 'with', 'other', 'viruses', 'causing', 'bovine', 'gastrointestinal', 'and', 'respiratory', 'infections', 'or', 'other', 'herpesviruses', 'The', 'assay', 'performance', 'on', 'acute', 'phase', 'high', 'fever', 'clinical', 'samples', 'collected', 'from', 'cattle', 'with', 'no', 'vaccine', 'against', 'IBRV', 'which', 'were', 'suspected', 'to', 'be', 'infected', 'with', 'IBRV', 'was', 'validated', 'by', 'detecting', '24', 'fecal', '36', 'blood', '38', 'nasal', 'swab', 'and', '8', 'tissue', 'specimens', 'and', 'compared', 'with', 'SYBR', 'Green', 'I', 'based', 'real', 'time', 'PCR', 'The', 'coincidence', 'between', 'IBRV', 'LFD', 'RPA', 'and', 'real', 'time', 'PCR', 'was', '100', 'CONCLUSION', 'IBRV', 'LFD', 'RPA', 'was', 'fast', 'and', 'much', 'easier', 'to', 'serve', 'as', 'an', 'alternative', 'to', 'the', 'common', 'measures', 'used', 'for', 'IBRV', 'diagnosis', 'as', 'there', 'is', 'reduction', 'in', 'the', 'use', 'of', 'instruments', 'for', 'identification', 'of', 'the', 'infected', 'animals', 'In', 'addition', 'this', 'assay', 'may', 'be', 'the', 'potential', 'candidate', 'to', 'be', 'used', 'as', 'point', 'of', 'care', 'diagnostics', 'in', 'the', 'field', '']"
200705,Chapter 20 The potential of exosomes as theragnostics in various clinical situations,2020-12-31,Exosomes,https://api.elsevier.com/content/article/pii/B9780128160534000201; https://www.sciencedirect.com/science/article/pii/B9780128160534000201,"Abstract Exosomes are membrane-bound cargo measuring 30–140nm comprised of a lipid bilayer containing various proteins, RNAs, DNAs, and bioactive lipids that can be transferred between cells. They have been shown to be produced and released by many different types of healthy and diseased cells. Exosomes are secreted by all types of cells in culture, and are also found in various body fluids including blood, saliva, urine, and breast milk. Exosomes are essential for healthy physiological as well as pathological processes. In addition to their normal function, exosomes are involved in the development and progression of various diseases, potentiating cellular stress and damage. Pathogens take advantage of exosome release from infected host cells by manipulating host-derived exosomes to evade the immune system responses. Exosomes are involved in other pathological conditions such as neurodegenerative diseases, liver diseases, heart failure, cancer, diabetes, kidney diseases, osteoporosis and atherosclerotic cardiovascular disease. Hence, we can exploit exosomes as biomarkers and vaccines and modify them rationally for therapeutic interventions including tissue engineering. Further studies on exosomes will explore their potential and provide new methodology for effective clinical diagnostics and therapeutic strategies: such uses can be called exosome theragnostics. This chapter reviews the potential theragnostic (diagnostic and therapeutic) application of exosomes in major organ systems in clinical fields.",10.1016/b978-0-12-816053-4.00020-1,ru8xqqj4,"['Abstract', 'Exosomes', 'are', 'membrane', 'bound', 'cargo', 'measuring', '30', '140nm', 'comprised', 'of', 'a', 'lipid', 'bilayer', 'containing', 'various', 'proteins', 'RNAs', 'DNAs', 'and', 'bioactive', 'lipids', 'that', 'can', 'be', 'transferred', 'between', 'cells', 'They', 'have', 'been', 'shown', 'to', 'be', 'produced', 'and', 'released', 'by', 'many', 'different', 'types', 'of', 'healthy', 'and', 'diseased', 'cells', 'Exosomes', 'are', 'secreted', 'by', 'all', 'types', 'of', 'cells', 'in', 'culture', 'and', 'are', 'also', 'found', 'in', 'various', 'body', 'fluids', 'including', 'blood', 'saliva', 'urine', 'and', 'breast', 'milk', 'Exosomes', 'are', 'essential', 'for', 'healthy', 'physiological', 'as', 'well', 'as', 'pathological', 'processes', 'In', 'addition', 'to', 'their', 'normal', 'function', 'exosomes', 'are', 'involved', 'in', 'the', 'development', 'and', 'progression', 'of', 'various', 'diseases', 'potentiating', 'cellular', 'stress', 'and', 'damage', 'Pathogens', 'take', 'advantage', 'of', 'exosome', 'release', 'from', 'infected', 'host', 'cells', 'by', 'manipulating', 'host', 'derived', 'exosomes', 'to', 'evade', 'the', 'immune', 'system', 'responses', 'Exosomes', 'are', 'involved', 'in', 'other', 'pathological', 'conditions', 'such', 'as', 'neurodegenerative', 'diseases', 'liver', 'diseases', 'heart', 'failure', 'cancer', 'diabetes', 'kidney', 'diseases', 'osteoporosis', 'and', 'atherosclerotic', 'cardiovascular', 'disease', 'Hence', 'we', 'can', 'exploit', 'exosomes', 'as', 'biomarkers', 'and', 'vaccines', 'and', 'modify', 'them', 'rationally', 'for', 'therapeutic', 'interventions', 'including', 'tissue', 'engineering', 'Further', 'studies', 'on', 'exosomes', 'will', 'explore', 'their', 'potential', 'and', 'provide', 'new', 'methodology', 'for', 'effective', 'clinical', 'diagnostics', 'and', 'therapeutic', 'strategies', 'such', 'uses', 'can', 'be', 'called', 'exosome', 'theragnostics', 'This', 'chapter', 'reviews', 'the', 'potential', 'theragnostic', 'diagnostic', 'and', 'therapeutic', 'application', 'of', 'exosomes', 'in', 'major', 'organ', 'systems', 'in', 'clinical', 'fields', '']"
200837,Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients,2020-06-01,Nat Commun,https://www.ncbi.nlm.nih.gov/pubmed/32483236/; https://doi.org/10.1038/s41467-020-16638-2,"Given the ongoing SARS-CoV-2 pandemic, identification of immunogenic targets against the coronavirus spike glycoprotein will provide crucial advances towards the development of sensitive diagnostic tools and potential vaccine candidate targets. In this study, using pools of overlapping linear B-cell peptides, we report two IgG immunodominant regions on SARS-CoV-2 spike glycoprotein that are recognised by sera from COVID-19 convalescent patients. Notably, one is specific to SARS-CoV-2, which is located in close proximity to the receptor binding domain. The other region, which is localised at the fusion peptide, could potentially function as a pan-SARS target. Functionally, antibody depletion assays demonstrate that antibodies targeting these immunodominant regions significantly alter virus neutralisation capacities. Taken together, identification and validation of these neutralising B-cell epitopes will provide insights towards the design of diagnostics and vaccine candidates against this high priority coronavirus.",10.1038/s41467-020-16638-2,p9u6rlue,"['Given', 'the', 'ongoing', 'SARS', 'CoV', '2', 'pandemic', 'identification', 'of', 'immunogenic', 'targets', 'against', 'the', 'coronavirus', 'spike', 'glycoprotein', 'will', 'provide', 'crucial', 'advances', 'towards', 'the', 'development', 'of', 'sensitive', 'diagnostic', 'tools', 'and', 'potential', 'vaccine', 'candidate', 'targets', 'In', 'this', 'study', 'using', 'pools', 'of', 'overlapping', 'linear', 'B', 'cell', 'peptides', 'we', 'report', 'two', 'IgG', 'immunodominant', 'regions', 'on', 'SARS', 'CoV', '2', 'spike', 'glycoprotein', 'that', 'are', 'recognised', 'by', 'sera', 'from', 'COVID', '19', 'convalescent', 'patients', 'Notably', 'one', 'is', 'specific', 'to', 'SARS', 'CoV', '2', 'which', 'is', 'located', 'in', 'close', 'proximity', 'to', 'the', 'receptor', 'binding', 'domain', 'The', 'other', 'region', 'which', 'is', 'localised', 'at', 'the', 'fusion', 'peptide', 'could', 'potentially', 'function', 'as', 'a', 'pan', 'SARS', 'target', 'Functionally', 'antibody', 'depletion', 'assays', 'demonstrate', 'that', 'antibodies', 'targeting', 'these', 'immunodominant', 'regions', 'significantly', 'alter', 'virus', 'neutralisation', 'capacities', 'Taken', 'together', 'identification', 'and', 'validation', 'of', 'these', 'neutralising', 'B', 'cell', 'epitopes', 'will', 'provide', 'insights', 'towards', 'the', 'design', 'of', 'diagnostics', 'and', 'vaccine', 'candidates', 'against', 'this', 'high', 'priority', 'coronavirus', '']"
201523,Picobirnavirus detection in bovine and buffalo calves from foothills of Himalaya and Central India,2011-04-10,Trop Anim Health Prod,https://doi.org/10.1007/s11250-011-9834-0; https://www.ncbi.nlm.nih.gov/pubmed/21479844/,"The present study describes detection of picobirnavirus (PBV) in faecal samples from bovine and buffalo calves employing the polyacrylamide gel electrophoresis (PAGE). A total of 136 faecal samples from buffalo (n = 122) and cow calves (n = 14) exhibiting clinical signs of diarrhoea and from healthy calves were collected during 2007–2010 from subtropical (central India) and tarai area of western temperate Himalayan foothills (Uttarakhand). The dsRNA nature of the virus was confirmed by nuclease treatment (RNase A, RNaseT1 and DNase 1). PAGE results confirmed 3.67% (5/136) positivity for PBV, showing a typical genomic migration pattern with two discrete bands with size of approximately 2.4 and 1.7 kbps for the larger and smaller segments, respectively. Among the five PBV samples identified, three were from buffalo calves and one from cow calf exhibiting clinical signs of acute diarrhoea, while one sample from non-diarrhoeic buffalo calf also showed the presence of PBV. None of the samples showed dual infection of rotavirus and PBV. The preliminary findings indicate sporadic incidences of PBV in bovine calves and emphasize the need for the development of better diagnostics for early detection and genetic characterization of these emerging isolates of farm animals of economic significance.",10.1007/s11250-011-9834-0,72syeejs,"['The', 'present', 'study', 'describes', 'detection', 'of', 'picobirnavirus', 'PBV', 'in', 'faecal', 'samples', 'from', 'bovine', 'and', 'buffalo', 'calves', 'employing', 'the', 'polyacrylamide', 'gel', 'electrophoresis', 'PAGE', 'A', 'total', 'of', '136', 'faecal', 'samples', 'from', 'buffalo', 'n', '122', 'and', 'cow', 'calves', 'n', '14', 'exhibiting', 'clinical', 'signs', 'of', 'diarrhoea', 'and', 'from', 'healthy', 'calves', 'were', 'collected', 'during', '2007', '2010', 'from', 'subtropical', 'central', 'India', 'and', 'tarai', 'area', 'of', 'western', 'temperate', 'Himalayan', 'foothills', 'Uttarakhand', 'The', 'dsRNA', 'nature', 'of', 'the', 'virus', 'was', 'confirmed', 'by', 'nuclease', 'treatment', 'RNase', 'A', 'RNaseT1', 'and', 'DNase', '1', 'PAGE', 'results', 'confirmed', '3', '67', '5', '136', 'positivity', 'for', 'PBV', 'showing', 'a', 'typical', 'genomic', 'migration', 'pattern', 'with', 'two', 'discrete', 'bands', 'with', 'size', 'of', 'approximately', '2', '4', 'and', '1', '7', 'kbps', 'for', 'the', 'larger', 'and', 'smaller', 'segments', 'respectively', 'Among', 'the', 'five', 'PBV', 'samples', 'identified', 'three', 'were', 'from', 'buffalo', 'calves', 'and', 'one', 'from', 'cow', 'calf', 'exhibiting', 'clinical', 'signs', 'of', 'acute', 'diarrhoea', 'while', 'one', 'sample', 'from', 'non', 'diarrhoeic', 'buffalo', 'calf', 'also', 'showed', 'the', 'presence', 'of', 'PBV', 'None', 'of', 'the', 'samples', 'showed', 'dual', 'infection', 'of', 'rotavirus', 'and', 'PBV', 'The', 'preliminary', 'findings', 'indicate', 'sporadic', 'incidences', 'of', 'PBV', 'in', 'bovine', 'calves', 'and', 'emphasize', 'the', 'need', 'for', 'the', 'development', 'of', 'better', 'diagnostics', 'for', 'early', 'detection', 'and', 'genetic', 'characterization', 'of', 'these', 'emerging', 'isolates', 'of', 'farm', 'animals', 'of', 'economic', 'significance', '']"
201734,Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections,2014-07-28,ISBT Sci Ser,https://www.ncbi.nlm.nih.gov/pubmed/25210533/,"BACKGROUND: In August 2009, a group from the AABB (Stramer et al., Transfusion 2009;99:1S–29S, Emerging Infectious Disease Agents and their Potential Threat to Transfusion Safety; http://www.aabb.org/resources/bct/eid/Pages/default.aspx) published a Supplement to Transfusion that reviewed emerging infectious disease (EID) agents that pose a real or theoretical threat to transfusion safety, but for which an existing effective intervention is lacking. The necessary attributes for transfusion transmission were outlined including: presence of the agent in blood during the donor's asymptomatic phase, the agent's survival/persistence in blood during processing/storage, and lastly that the agent must be recognized as responsible for a clinically apparent outcome in at least a proportion of recipients who become infected. Without these attributes, agents are not considered as a transfusion-transmission threat and were excluded. Sixty-eight such agents were identified with enough evidence/likelihood of transfusion transmission (e.g., blood phase) and potential for clinical disease to warrant further consideration. In the Supplement, Fact Sheets (FS) were published providing information on: agent classification; disease agent's importance; clinical syndromes/diseases caused; transmission modes (including vectors/reservoirs); likelihood of transfusion transmission, and if proven to be transfusion-transmitted, information on known cases; the feasibility/predicted success of interventions for donor screening (questioning) and tests available for diagnostics/ adapted for donor screening; and finally, the efficacy, if known, of inactivation methods for plasma-derived products. The Supplement included a separate section on pathogen reduction using published data. Agents were prioritized relative to their scientific/epidemiologic threat and their perceived threat to the community including concerns expressed by the regulators of blood. Agents given the highest priority due to a known transfusion-transmission threat and severe/fatal disease in recipients were the vCJD prion, dengue viruses and the obligate red-cell parasite that causes babesiosis (B. microti and related Babesia). Although the focus of the Supplement was towards the United States and Canada, many of the agents (and the process) are applicable worldwide. NEXT STEPS: Since the publication of the Supplement, six new FSs (yellow fever viruses-including vaccine breakthrough infections, miscellaneous arboviruses, XMRV, human parvoviruses/bocaviruses other than B19, and most recently the Middle East respiratory syndrome coronavirus, MERS-CoV) were added and 14 existing FSs updated (Anaplasma, Babesia, Bartonella, Erhlichia, chronic wasting disease-CWD, human prions other than vCJD, vCJD, Coxiella burnetii-the agent of Q fever, dengue viruses, HAV, HEV, Japanese encephalitis-JE complex, tick-borne encephalitis viruses-TBEV, and human parvovirus B19). Also, tables were released outlining pathogen reduction clinical trials/results (published) and availability/commercial routine use of such technologies by country. Of necessity, the list of EID agents is not, and can never be, complete due to the nature of emergence. We recognized that a system of assessing the risk/threat of EIDs for their potential impact on blood safety and availability must include processes for monitoring, identifying, evaluating, estimating severity, assessing risk and developing interventions. Thus, a ‘toolkit’ containing the necessary ‘tools’ from EID monitoring (horizon scanning) to validation/effectiveness evaluations of interventions is being developed. The goal is, to develop a systematic approach to risk assessment and intervention development for the impact of emerging infectious upon blood safety intended to educate and provide advise about risks/interventions in a timely/accurate fashion. CONCLUSIONS: The process and final product (toolkit) including methods to monitor EID agent emergence, identification/recognition of a transfusion-transmission threat, methods for quantitative risk assessments, and the appropriate management of such threats should be considered for implementation by all blood systems.",10.1111/voxs.12070,nyocnvvj,"['BACKGROUND', 'In', 'August', '2009', 'a', 'group', 'from', 'the', 'AABB', 'Stramer', 'et', 'al', 'Transfusion', '2009', '99', '1S', '29S', 'Emerging', 'Infectious', 'Disease', 'Agents', 'and', 'their', 'Potential', 'Threat', 'to', 'Transfusion', 'Safety', 'http', 'www', 'aabb', 'org', 'resources', 'bct', 'eid', 'Pages', 'default', 'aspx', 'published', 'a', 'Supplement', 'to', 'Transfusion', 'that', 'reviewed', 'emerging', 'infectious', 'disease', 'EID', 'agents', 'that', 'pose', 'a', 'real', 'or', 'theoretical', 'threat', 'to', 'transfusion', 'safety', 'but', 'for', 'which', 'an', 'existing', 'effective', 'intervention', 'is', 'lacking', 'The', 'necessary', 'attributes', 'for', 'transfusion', 'transmission', 'were', 'outlined', 'including', 'presence', 'of', 'the', 'agent', 'in', 'blood', 'during', 'the', 'donor', 's', 'asymptomatic', 'phase', 'the', 'agent', 's', 'survival', 'persistence', 'in', 'blood', 'during', 'processing', 'storage', 'and', 'lastly', 'that', 'the', 'agent', 'must', 'be', 'recognized', 'as', 'responsible', 'for', 'a', 'clinically', 'apparent', 'outcome', 'in', 'at', 'least', 'a', 'proportion', 'of', 'recipients', 'who', 'become', 'infected', 'Without', 'these', 'attributes', 'agents', 'are', 'not', 'considered', 'as', 'a', 'transfusion', 'transmission', 'threat', 'and', 'were', 'excluded', 'Sixty', 'eight', 'such', 'agents', 'were', 'identified', 'with', 'enough', 'evidence', 'likelihood', 'of', 'transfusion', 'transmission', 'e', 'g', 'blood', 'phase', 'and', 'potential', 'for', 'clinical', 'disease', 'to', 'warrant', 'further', 'consideration', 'In', 'the', 'Supplement', 'Fact', 'Sheets', 'FS', 'were', 'published', 'providing', 'information', 'on', 'agent', 'classification', 'disease', 'agent', 's', 'importance', 'clinical', 'syndromes', 'diseases', 'caused', 'transmission', 'modes', 'including', 'vectors', 'reservoirs', 'likelihood', 'of', 'transfusion', 'transmission', 'and', 'if', 'proven', 'to', 'be', 'transfusion', 'transmitted', 'information', 'on', 'known', 'cases', 'the', 'feasibility', 'predicted', 'success', 'of', 'interventions', 'for', 'donor', 'screening', 'questioning', 'and', 'tests', 'available', 'for', 'diagnostics', 'adapted', 'for', 'donor', 'screening', 'and', 'finally', 'the', 'efficacy', 'if', 'known', 'of', 'inactivation', 'methods', 'for', 'plasma', 'derived', 'products', 'The', 'Supplement', 'included', 'a', 'separate', 'section', 'on', 'pathogen', 'reduction', 'using', 'published', 'data', 'Agents', 'were', 'prioritized', 'relative', 'to', 'their', 'scientific', 'epidemiologic', 'threat', 'and', 'their', 'perceived', 'threat', 'to', 'the', 'community', 'including', 'concerns', 'expressed', 'by', 'the', 'regulators', 'of', 'blood', 'Agents', 'given', 'the', 'highest', 'priority', 'due', 'to', 'a', 'known', 'transfusion', 'transmission', 'threat', 'and', 'severe', 'fatal', 'disease', 'in', 'recipients', 'were', 'the', 'vCJD', 'prion', 'dengue', 'viruses', 'and', 'the', 'obligate', 'red', 'cell', 'parasite', 'that', 'causes', 'babesiosis', 'B', 'microti', 'and', 'related', 'Babesia', 'Although', 'the', 'focus', 'of', 'the', 'Supplement', 'was', 'towards', 'the', 'United', 'States', 'and', 'Canada', 'many', 'of', 'the', 'agents', 'and', 'the', 'process', 'are', 'applicable', 'worldwide', 'NEXT', 'STEPS', 'Since', 'the', 'publication', 'of', 'the', 'Supplement', 'six', 'new', 'FSs', 'yellow', 'fever', 'viruses', 'including', 'vaccine', 'breakthrough', 'infections', 'miscellaneous', 'arboviruses', 'XMRV', 'human', 'parvoviruses', 'bocaviruses', 'other', 'than', 'B19', 'and', 'most', 'recently', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'were', 'added', 'and', '14', 'existing', 'FSs', 'updated', 'Anaplasma', 'Babesia', 'Bartonella', 'Erhlichia', 'chronic', 'wasting', 'disease', 'CWD', 'human', 'prions', 'other', 'than', 'vCJD', 'vCJD', 'Coxiella', 'burnetii', 'the', 'agent', 'of', 'Q', 'fever', 'dengue', 'viruses', 'HAV', 'HEV', 'Japanese', 'encephalitis', 'JE', 'complex', 'tick', 'borne', 'encephalitis', 'viruses', 'TBEV', 'and', 'human', 'parvovirus', 'B19', 'Also', 'tables', 'were', 'released', 'outlining', 'pathogen', 'reduction', 'clinical', 'trials', 'results', 'published', 'and', 'availability', 'commercial', 'routine', 'use', 'of', 'such', 'technologies', 'by', 'country', 'Of', 'necessity', 'the', 'list', 'of', 'EID', 'agents', 'is', 'not', 'and', 'can', 'never', 'be', 'complete', 'due', 'to', 'the', 'nature', 'of', 'emergence', 'We', 'recognized', 'that', 'a', 'system', 'of', 'assessing', 'the', 'risk', 'threat', 'of', 'EIDs', 'for', 'their', 'potential', 'impact', 'on', 'blood', 'safety', 'and', 'availability', 'must', 'include', 'processes', 'for', 'monitoring', 'identifying', 'evaluating', 'estimating', 'severity', 'assessing', 'risk', 'and', 'developing', 'interventions', 'Thus', 'a', 'toolkit', 'containing', 'the', 'necessary', 'tools', 'from', 'EID', 'monitoring', 'horizon', 'scanning', 'to', 'validation', 'effectiveness', 'evaluations', 'of', 'interventions', 'is', 'being', 'developed', 'The', 'goal', 'is', 'to', 'develop', 'a', 'systematic', 'approach', 'to', 'risk', 'assessment', 'and', 'intervention', 'development', 'for', 'the', 'impact', 'of', 'emerging', 'infectious', 'upon', 'blood', 'safety', 'intended', 'to', 'educate', 'and', 'provide', 'advise', 'about', 'risks', 'interventions', 'in', 'a', 'timely', 'accurate', 'fashion', 'CONCLUSIONS', 'The', 'process', 'and', 'final', 'product', 'toolkit', 'including', 'methods', 'to', 'monitor', 'EID', 'agent', 'emergence', 'identification', 'recognition', 'of', 'a', 'transfusion', 'transmission', 'threat', 'methods', 'for', 'quantitative', 'risk', 'assessments', 'and', 'the', 'appropriate', 'management', 'of', 'such', 'threats', 'should', 'be', 'considered', 'for', 'implementation', 'by', 'all', 'blood', 'systems', '']"
201890,Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus,2016-07-31,Emerg Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/27191188/; https://doi.org/10.3201/eid2207.160022,"Preclinical development of and research on potential Middle East respiratory syndrome coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are needed before most countermeasures are ready to be tested in human clinical trials. Research priorities include standardization of animal models and virus stocks for studying disease pathogenesis and efficacy of medical countermeasures; development of MERS-CoV diagnostics; improved access to nonhuman primates to support preclinical research; studies to better understand and control MERS-CoV disease, including vaccination studies in camels; and development of a standardized clinical trial protocol. Partnering with clinical trial networks in affected countries to evaluate safety and efficacy of investigational therapeutics will strengthen efforts to identify successful medical countermeasures.",10.3201/eid2207.160022,jtx7ni9b,"['Preclinical', 'development', 'of', 'and', 'research', 'on', 'potential', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'medical', 'countermeasures', 'remain', 'preliminary', 'advancements', 'are', 'needed', 'before', 'most', 'countermeasures', 'are', 'ready', 'to', 'be', 'tested', 'in', 'human', 'clinical', 'trials', 'Research', 'priorities', 'include', 'standardization', 'of', 'animal', 'models', 'and', 'virus', 'stocks', 'for', 'studying', 'disease', 'pathogenesis', 'and', 'efficacy', 'of', 'medical', 'countermeasures', 'development', 'of', 'MERS', 'CoV', 'diagnostics', 'improved', 'access', 'to', 'nonhuman', 'primates', 'to', 'support', 'preclinical', 'research', 'studies', 'to', 'better', 'understand', 'and', 'control', 'MERS', 'CoV', 'disease', 'including', 'vaccination', 'studies', 'in', 'camels', 'and', 'development', 'of', 'a', 'standardized', 'clinical', 'trial', 'protocol', 'Partnering', 'with', 'clinical', 'trial', 'networks', 'in', 'affected', 'countries', 'to', 'evaluate', 'safety', 'and', 'efficacy', 'of', 'investigational', 'therapeutics', 'will', 'strengthen', 'efforts', 'to', 'identify', 'successful', 'medical', 'countermeasures', '']"
201895,Plasmon-Enhanced Fluorescence Biosensors: a Review,2013-12-28,Plasmonics,https://www.ncbi.nlm.nih.gov/pubmed/27330521/,"Surfaces of metallic films and metallic nanoparticles can strongly confine electromagnetic field through its coupling to propagating or localized surface plasmons. This interaction is associated with large enhancement of the field intensity and local optical density of states which provides means to increase excitation rate, raise quantum yield, and control far field angular distribution of fluorescence light emitted by organic dyes and quantum dots. Such emitters are commonly used as labels in assays for detection of chemical and biological species. Their interaction with surface plasmons allows amplifying fluorescence signal (brightness) that accompanies molecular binding events by several orders of magnitude. In conjunction with interfacial architectures for the specific capture of target analyte on a metallic surface, plasmon-enhanced fluorescence (PEF) that is also referred to as metal-enhanced fluorescence (MEF) represents an attractive method for shortening detection times and increasing sensitivity of various fluorescence-based analytical technologies. This review provides an introduction to fundamentals of PEF, illustrates current developments in design of metallic nanostructures for efficient fluorescence signal amplification that utilizes propagating and localized surface plasmons, and summarizes current implementations to biosensors for detection of trace amounts of biomarkers, toxins, and pathogens that are relevant to medical diagnostics and food control.",10.1007/s11468-013-9660-5,pntezzct,"['Surfaces', 'of', 'metallic', 'films', 'and', 'metallic', 'nanoparticles', 'can', 'strongly', 'confine', 'electromagnetic', 'field', 'through', 'its', 'coupling', 'to', 'propagating', 'or', 'localized', 'surface', 'plasmons', 'This', 'interaction', 'is', 'associated', 'with', 'large', 'enhancement', 'of', 'the', 'field', 'intensity', 'and', 'local', 'optical', 'density', 'of', 'states', 'which', 'provides', 'means', 'to', 'increase', 'excitation', 'rate', 'raise', 'quantum', 'yield', 'and', 'control', 'far', 'field', 'angular', 'distribution', 'of', 'fluorescence', 'light', 'emitted', 'by', 'organic', 'dyes', 'and', 'quantum', 'dots', 'Such', 'emitters', 'are', 'commonly', 'used', 'as', 'labels', 'in', 'assays', 'for', 'detection', 'of', 'chemical', 'and', 'biological', 'species', 'Their', 'interaction', 'with', 'surface', 'plasmons', 'allows', 'amplifying', 'fluorescence', 'signal', 'brightness', 'that', 'accompanies', 'molecular', 'binding', 'events', 'by', 'several', 'orders', 'of', 'magnitude', 'In', 'conjunction', 'with', 'interfacial', 'architectures', 'for', 'the', 'specific', 'capture', 'of', 'target', 'analyte', 'on', 'a', 'metallic', 'surface', 'plasmon', 'enhanced', 'fluorescence', 'PEF', 'that', 'is', 'also', 'referred', 'to', 'as', 'metal', 'enhanced', 'fluorescence', 'MEF', 'represents', 'an', 'attractive', 'method', 'for', 'shortening', 'detection', 'times', 'and', 'increasing', 'sensitivity', 'of', 'various', 'fluorescence', 'based', 'analytical', 'technologies', 'This', 'review', 'provides', 'an', 'introduction', 'to', 'fundamentals', 'of', 'PEF', 'illustrates', 'current', 'developments', 'in', 'design', 'of', 'metallic', 'nanostructures', 'for', 'efficient', 'fluorescence', 'signal', 'amplification', 'that', 'utilizes', 'propagating', 'and', 'localized', 'surface', 'plasmons', 'and', 'summarizes', 'current', 'implementations', 'to', 'biosensors', 'for', 'detection', 'of', 'trace', 'amounts', 'of', 'biomarkers', 'toxins', 'and', 'pathogens', 'that', 'are', 'relevant', 'to', 'medical', 'diagnostics', 'and', 'food', 'control', '']"
202443,Development of a RT Real-Time PCR for the Detection and Quantification of Human Rhinoviruses,2009-03-17,Mol Biotechnol,https://www.ncbi.nlm.nih.gov/pubmed/19291427/; https://doi.org/10.1007/s12033-009-9164-x,"Human Rhinoviruses (HRV) are the most common viral agents, being responsible for upper as well as lower respiratory tract infections. Evidence demonstrating that HRV disease is not exclusively limited to the upper airways and may cause lower respiratory complications, together with the frequency of HRV infections and the increasing number of immunocompromised patients underline the need for including HRV in virological diagnostics of acute lower respiratory tract illness. This article describes the development and optimization of a reverse transcription (RT) real-time PCR assay for quantification of HRV RNA in clinical samples. Efficiency, sensitivity, specificity, inter- and intra-assay variability, and dynamic range have been determined. Subsequently, the assay has been validated on bronchoalveolar lavage (BAL) specimens obtained from immunocompetent and immunocompromised patients.",10.1007/s12033-009-9164-x,8gi1wb76,"['Human', 'Rhinoviruses', 'HRV', 'are', 'the', 'most', 'common', 'viral', 'agents', 'being', 'responsible', 'for', 'upper', 'as', 'well', 'as', 'lower', 'respiratory', 'tract', 'infections', 'Evidence', 'demonstrating', 'that', 'HRV', 'disease', 'is', 'not', 'exclusively', 'limited', 'to', 'the', 'upper', 'airways', 'and', 'may', 'cause', 'lower', 'respiratory', 'complications', 'together', 'with', 'the', 'frequency', 'of', 'HRV', 'infections', 'and', 'the', 'increasing', 'number', 'of', 'immunocompromised', 'patients', 'underline', 'the', 'need', 'for', 'including', 'HRV', 'in', 'virological', 'diagnostics', 'of', 'acute', 'lower', 'respiratory', 'tract', 'illness', 'This', 'article', 'describes', 'the', 'development', 'and', 'optimization', 'of', 'a', 'reverse', 'transcription', 'RT', 'real', 'time', 'PCR', 'assay', 'for', 'quantification', 'of', 'HRV', 'RNA', 'in', 'clinical', 'samples', 'Efficiency', 'sensitivity', 'specificity', 'inter', 'and', 'intra', 'assay', 'variability', 'and', 'dynamic', 'range', 'have', 'been', 'determined', 'Subsequently', 'the', 'assay', 'has', 'been', 'validated', 'on', 'bronchoalveolar', 'lavage', 'BAL', 'specimens', 'obtained', 'from', 'immunocompetent', 'and', 'immunocompromised', 'patients', '']"
202459,Rapid Optical Cavity PCR,2016-01-07,Adv Healthc Mater,https://doi.org/10.1002/adhm.201500708; https://www.ncbi.nlm.nih.gov/pubmed/26592501/,"Recent outbreaks of deadly infectious diseases, such as Ebola and Middle East respiratory syndrome coronavirus, have motivated the research for accurate, rapid diagnostics that can be administered at the point of care. Nucleic acid biomarkers for these diseases can be amplified and quantified via polymerase chain reaction (PCR). In order to solve the problems of conventional PCR—speed, uniform heating and cooling, and massive metal heating blocks—an innovative optofluidic cavity PCR method using light‐emitting diodes (LEDs) is accomplished. Using this device, 30 thermal cycles between 94 °C and 68 °C can be accomplished in 4 min for 1.3 μL (10 min for 10 μL). Simulation results show that temperature differences across the 750 μm thick cavity are less than 2 °C and 0.2 °C, respectively, at 94 °C and 68 °C. Nucleic acid concentrations as low as 10(–8) ng μL(–1) (2 DNA copies per μL) can be amplified with 40 PCR thermal cycles. This simple, ultrafast, precise, robust, and low‐cost optofluidic cavity PCR is favorable for advanced molecular diagnostics and precision medicine. It is especially important for the development of lightweight, point‐of‐care devices for use in both developing and developed countries.",10.1002/adhm.201500708,czb8luhk,"['Recent', 'outbreaks', 'of', 'deadly', 'infectious', 'diseases', 'such', 'as', 'Ebola', 'and', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'have', 'motivated', 'the', 'research', 'for', 'accurate', 'rapid', 'diagnostics', 'that', 'can', 'be', 'administered', 'at', 'the', 'point', 'of', 'care', 'Nucleic', 'acid', 'biomarkers', 'for', 'these', 'diseases', 'can', 'be', 'amplified', 'and', 'quantified', 'via', 'polymerase', 'chain', 'reaction', 'PCR', 'In', 'order', 'to', 'solve', 'the', 'problems', 'of', 'conventional', 'PCR', 'speed', 'uniform', 'heating', 'and', 'cooling', 'and', 'massive', 'metal', 'heating', 'blocks', 'an', 'innovative', 'optofluidic', 'cavity', 'PCR', 'method', 'using', 'light', 'emitting', 'diodes', 'LEDs', 'is', 'accomplished', 'Using', 'this', 'device', '30', 'thermal', 'cycles', 'between', '94', 'C', 'and', '68', 'C', 'can', 'be', 'accomplished', 'in', '4', 'min', 'for', '1', '3', 'μL', '10', 'min', 'for', '10', 'μL', 'Simulation', 'results', 'show', 'that', 'temperature', 'differences', 'across', 'the', '750', 'μm', 'thick', 'cavity', 'are', 'less', 'than', '2', 'C', 'and', '0', '2', 'C', 'respectively', 'at', '94', 'C', 'and', '68', 'C', 'Nucleic', 'acid', 'concentrations', 'as', 'low', 'as', '10', '8', 'ng', 'μL', '1', '2', 'DNA', 'copies', 'per', 'μL', 'can', 'be', 'amplified', 'with', '40', 'PCR', 'thermal', 'cycles', 'This', 'simple', 'ultrafast', 'precise', 'robust', 'and', 'low', 'cost', 'optofluidic', 'cavity', 'PCR', 'is', 'favorable', 'for', 'advanced', 'molecular', 'diagnostics', 'and', 'precision', 'medicine', 'It', 'is', 'especially', 'important', 'for', 'the', 'development', 'of', 'lightweight', 'point', 'of', 'care', 'devices', 'for', 'use', 'in', 'both', 'developing', 'and', 'developed', 'countries', '']"
203119,Chapter 57 Genomic Approaches to the Host Response to Pathogens,2010-12-31,Essentials of Genomic and Personalized Medicine,https://api.elsevier.com/content/article/pii/B978012374934500057X; https://www.sciencedirect.com/science/article/pii/B978012374934500057X,"Publisher Summary The need to better understand host–pathogen interactions has risen with the expansion in genomics and related technologies. This chapter focuses on two aspects of the host response to pathogens where major advances are being made using genomic approaches. The availability of complete genomic sequences of an expanding number of pathogens, the human and mouse genome sequences, and the advent of genome-wide genotyping and gene expression profiling has opened up new avenues of investigation in the field. The genotype of the pathogen plays a major role in the response of the host to infection with more virulent pathogenic strains possessing the capability to interfere with the host immune response. In addition, different individuals in a population can have very different responses to a genetically identical pathogen. Part of the differential response is governed by the underlying genetic differences between individuals. The advent of genome-wide genotyping using single nucleotide polymorphisms or microsatellite markers is leading to major advances in molecular epidemiology. The future impact of genomic approaches on the development of diagnostics and therapeutics is discussed for infectious diseases. This includes defining the basis of genetic susceptibility to infection and system-wide molecular response to a pathogen.",10.1016/b978-0-12-374934-5.00057-x,dbe5o8gl,"['Publisher', 'Summary', 'The', 'need', 'to', 'better', 'understand', 'host', 'pathogen', 'interactions', 'has', 'risen', 'with', 'the', 'expansion', 'in', 'genomics', 'and', 'related', 'technologies', 'This', 'chapter', 'focuses', 'on', 'two', 'aspects', 'of', 'the', 'host', 'response', 'to', 'pathogens', 'where', 'major', 'advances', 'are', 'being', 'made', 'using', 'genomic', 'approaches', 'The', 'availability', 'of', 'complete', 'genomic', 'sequences', 'of', 'an', 'expanding', 'number', 'of', 'pathogens', 'the', 'human', 'and', 'mouse', 'genome', 'sequences', 'and', 'the', 'advent', 'of', 'genome', 'wide', 'genotyping', 'and', 'gene', 'expression', 'profiling', 'has', 'opened', 'up', 'new', 'avenues', 'of', 'investigation', 'in', 'the', 'field', 'The', 'genotype', 'of', 'the', 'pathogen', 'plays', 'a', 'major', 'role', 'in', 'the', 'response', 'of', 'the', 'host', 'to', 'infection', 'with', 'more', 'virulent', 'pathogenic', 'strains', 'possessing', 'the', 'capability', 'to', 'interfere', 'with', 'the', 'host', 'immune', 'response', 'In', 'addition', 'different', 'individuals', 'in', 'a', 'population', 'can', 'have', 'very', 'different', 'responses', 'to', 'a', 'genetically', 'identical', 'pathogen', 'Part', 'of', 'the', 'differential', 'response', 'is', 'governed', 'by', 'the', 'underlying', 'genetic', 'differences', 'between', 'individuals', 'The', 'advent', 'of', 'genome', 'wide', 'genotyping', 'using', 'single', 'nucleotide', 'polymorphisms', 'or', 'microsatellite', 'markers', 'is', 'leading', 'to', 'major', 'advances', 'in', 'molecular', 'epidemiology', 'The', 'future', 'impact', 'of', 'genomic', 'approaches', 'on', 'the', 'development', 'of', 'diagnostics', 'and', 'therapeutics', 'is', 'discussed', 'for', 'infectious', 'diseases', 'This', 'includes', 'defining', 'the', 'basis', 'of', 'genetic', 'susceptibility', 'to', 'infection', 'and', 'system', 'wide', 'molecular', 'response', 'to', 'a', 'pathogen', '']"
203502,Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential,2020-07-24,Lancet Infect Dis,https://api.elsevier.com/content/article/pii/S1473309920304618; https://doi.org/10.1016/s1473-3099(20)30461-8; https://www.sciencedirect.com/science/article/pii/S1473309920304618; https://www.ncbi.nlm.nih.gov/pubmed/32717208/,"Outbreaks of infectious diseases are occurring with increasing frequency and unpredictability. The rapid development and deployment of diagnostics that can accurately and quickly identify pathogens as part of epidemic preparedness is needed now for the COVID-19 pandemic. WHO has developed a global research and innovation forum to facilitate, accelerate, and deepen research collaboration among countries and funders. Great progress has been made in the past decade, but access to specimens remains a major barrier for the development and evaluation of needed quality diagnostics. We present a sustainable model for a global network of country-owned biobanks with standardised methods for collection, characterisation, and archiving of specimens and pathogens to facilitate and accelerate diagnostics development and evaluation for COVID-19 and other diseases of epidemic potential. The biobanking network should be run on the guiding principles of transparency, equitable access, ethics, and respect for national laws that support country ownership and sustainability. Adapting the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits, sharing of specimens from national biobanks can be rewarded through mechanisms such as equitable access to diagnostics at negotiated prices. Such networks should be prepared for any pathogen of epidemic potential.",10.1016/s1473-3099(20)30461-8,spdu4lem,"['Outbreaks', 'of', 'infectious', 'diseases', 'are', 'occurring', 'with', 'increasing', 'frequency', 'and', 'unpredictability', 'The', 'rapid', 'development', 'and', 'deployment', 'of', 'diagnostics', 'that', 'can', 'accurately', 'and', 'quickly', 'identify', 'pathogens', 'as', 'part', 'of', 'epidemic', 'preparedness', 'is', 'needed', 'now', 'for', 'the', 'COVID', '19', 'pandemic', 'WHO', 'has', 'developed', 'a', 'global', 'research', 'and', 'innovation', 'forum', 'to', 'facilitate', 'accelerate', 'and', 'deepen', 'research', 'collaboration', 'among', 'countries', 'and', 'funders', 'Great', 'progress', 'has', 'been', 'made', 'in', 'the', 'past', 'decade', 'but', 'access', 'to', 'specimens', 'remains', 'a', 'major', 'barrier', 'for', 'the', 'development', 'and', 'evaluation', 'of', 'needed', 'quality', 'diagnostics', 'We', 'present', 'a', 'sustainable', 'model', 'for', 'a', 'global', 'network', 'of', 'country', 'owned', 'biobanks', 'with', 'standardised', 'methods', 'for', 'collection', 'characterisation', 'and', 'archiving', 'of', 'specimens', 'and', 'pathogens', 'to', 'facilitate', 'and', 'accelerate', 'diagnostics', 'development', 'and', 'evaluation', 'for', 'COVID', '19', 'and', 'other', 'diseases', 'of', 'epidemic', 'potential', 'The', 'biobanking', 'network', 'should', 'be', 'run', 'on', 'the', 'guiding', 'principles', 'of', 'transparency', 'equitable', 'access', 'ethics', 'and', 'respect', 'for', 'national', 'laws', 'that', 'support', 'country', 'ownership', 'and', 'sustainability', 'Adapting', 'the', 'Nagoya', 'Protocol', 'on', 'Access', 'to', 'Genetic', 'Resources', 'and', 'the', 'Fair', 'and', 'Equitable', 'Sharing', 'of', 'Benefits', 'sharing', 'of', 'specimens', 'from', 'national', 'biobanks', 'can', 'be', 'rewarded', 'through', 'mechanisms', 'such', 'as', 'equitable', 'access', 'to', 'diagnostics', 'at', 'negotiated', 'prices', 'Such', 'networks', 'should', 'be', 'prepared', 'for', 'any', 'pathogen', 'of', 'epidemic', 'potential', '']"
204163,Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape,2020-07-18,Biosens Bioelectron,https://www.sciencedirect.com/science/article/pii/S0956566320304486?v=s5; https://doi.org/10.1016/j.bios.2020.112454; https://api.elsevier.com/content/article/pii/S0956566320304486,"The rapidly spreading outbreak of COVID-19 disease is caused by the SARS-CoV-2 virus, first reported in December 2019 in Wuhan, China. As of June 17, 2020, this virus has infected over 8.2 million people but ranges in symptom severity, making it difficult to assess its overall infection rate. There is a need for rapid and accurate diagnostics to better monitor and prevent the spread of COVID-19. In this review, we present and evaluate two main types of diagnostics with FDA-EUA status for COVID-19: nucleic acid testing for detection of SARS-CoV-2 RNA, and serological assays for detection of SARS-CoV-2 specific IgG and IgM patient antibodies, along with the necessary sample preparation for accurate diagnoses. In particular, we cover and compare tests such as the CDC 2019-nCoV RT-PCR Diagnostic Panel, Cellex's qSARS-CoV-2 IgG/IgM Rapid Test, and point-of-care tests such as Abbott's ID NOW COVID-19 Test. Antibody testing is especially important in understanding the prevalence of the virus in the community and to identify those who have gained immunity. We conclude by highlighting the future of COVID-19 diagnostics, which include the need for quantitative testing and the development of emerging biosensors as point-of-care tests.",10.1016/j.bios.2020.112454,3ejychjf,"['The', 'rapidly', 'spreading', 'outbreak', 'of', 'COVID', '19', 'disease', 'is', 'caused', 'by', 'the', 'SARS', 'CoV', '2', 'virus', 'first', 'reported', 'in', 'December', '2019', 'in', 'Wuhan', 'China', 'As', 'of', 'June', '17', '2020', 'this', 'virus', 'has', 'infected', 'over', '8', '2', 'million', 'people', 'but', 'ranges', 'in', 'symptom', 'severity', 'making', 'it', 'difficult', 'to', 'assess', 'its', 'overall', 'infection', 'rate', 'There', 'is', 'a', 'need', 'for', 'rapid', 'and', 'accurate', 'diagnostics', 'to', 'better', 'monitor', 'and', 'prevent', 'the', 'spread', 'of', 'COVID', '19', 'In', 'this', 'review', 'we', 'present', 'and', 'evaluate', 'two', 'main', 'types', 'of', 'diagnostics', 'with', 'FDA', 'EUA', 'status', 'for', 'COVID', '19', 'nucleic', 'acid', 'testing', 'for', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'and', 'serological', 'assays', 'for', 'detection', 'of', 'SARS', 'CoV', '2', 'specific', 'IgG', 'and', 'IgM', 'patient', 'antibodies', 'along', 'with', 'the', 'necessary', 'sample', 'preparation', 'for', 'accurate', 'diagnoses', 'In', 'particular', 'we', 'cover', 'and', 'compare', 'tests', 'such', 'as', 'the', 'CDC', '2019', 'nCoV', 'RT', 'PCR', 'Diagnostic', 'Panel', 'Cellex', 's', 'qSARS', 'CoV', '2', 'IgG', 'IgM', 'Rapid', 'Test', 'and', 'point', 'of', 'care', 'tests', 'such', 'as', 'Abbott', 's', 'ID', 'NOW', 'COVID', '19', 'Test', 'Antibody', 'testing', 'is', 'especially', 'important', 'in', 'understanding', 'the', 'prevalence', 'of', 'the', 'virus', 'in', 'the', 'community', 'and', 'to', 'identify', 'those', 'who', 'have', 'gained', 'immunity', 'We', 'conclude', 'by', 'highlighting', 'the', 'future', 'of', 'COVID', '19', 'diagnostics', 'which', 'include', 'the', 'need', 'for', 'quantitative', 'testing', 'and', 'the', 'development', 'of', 'emerging', 'biosensors', 'as', 'point', 'of', 'care', 'tests', '']"
204787,Aptamers in Diagnostics and Treatment of Viral Infections,2015-02-16,Viruses,https://www.ncbi.nlm.nih.gov/pubmed/25690797/; https://doi.org/10.3390/v7020751,"Aptamers are in vitro selected DNA or RNA molecules that are capable of binding a wide range of nucleic and non-nucleic acid molecules with high affinity and specificity. They have been conducted through the process known as SELEX (Systematic Evolution of Ligands by Exponential Enrichment). It serves to reach specificity and considerable affinity to target molecules, including those of viral origin, both proteins and nucleic acids. Properties of aptamers allow detecting virus infected cells or viruses themselves and make them competitive to monoclonal antibodies. Specific aptamers can be used to interfere in each stage of the viral replication cycle and also inhibit its penetration into cells. Many current studies have reported possible application of aptamers as a treatment or diagnostic tool in viral infections, e.g., HIV (Human Immunodeficiency Virus), HBV (Hepatitis B Virus), HCV (Hepatitis C Virus), SARS (Severe Acute Respiratory Syndrome), H5N1 avian influenza and recently spread Ebola. This review presents current developments of using aptamers in the diagnostics and treatment of viral diseases.",10.3390/v7020751,2hj8zzdh,"['Aptamers', 'are', 'in', 'vitro', 'selected', 'DNA', 'or', 'RNA', 'molecules', 'that', 'are', 'capable', 'of', 'binding', 'a', 'wide', 'range', 'of', 'nucleic', 'and', 'non', 'nucleic', 'acid', 'molecules', 'with', 'high', 'affinity', 'and', 'specificity', 'They', 'have', 'been', 'conducted', 'through', 'the', 'process', 'known', 'as', 'SELEX', 'Systematic', 'Evolution', 'of', 'Ligands', 'by', 'Exponential', 'Enrichment', 'It', 'serves', 'to', 'reach', 'specificity', 'and', 'considerable', 'affinity', 'to', 'target', 'molecules', 'including', 'those', 'of', 'viral', 'origin', 'both', 'proteins', 'and', 'nucleic', 'acids', 'Properties', 'of', 'aptamers', 'allow', 'detecting', 'virus', 'infected', 'cells', 'or', 'viruses', 'themselves', 'and', 'make', 'them', 'competitive', 'to', 'monoclonal', 'antibodies', 'Specific', 'aptamers', 'can', 'be', 'used', 'to', 'interfere', 'in', 'each', 'stage', 'of', 'the', 'viral', 'replication', 'cycle', 'and', 'also', 'inhibit', 'its', 'penetration', 'into', 'cells', 'Many', 'current', 'studies', 'have', 'reported', 'possible', 'application', 'of', 'aptamers', 'as', 'a', 'treatment', 'or', 'diagnostic', 'tool', 'in', 'viral', 'infections', 'e', 'g', 'HIV', 'Human', 'Immunodeficiency', 'Virus', 'HBV', 'Hepatitis', 'B', 'Virus', 'HCV', 'Hepatitis', 'C', 'Virus', 'SARS', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'H5N1', 'avian', 'influenza', 'and', 'recently', 'spread', 'Ebola', 'This', 'review', 'presents', 'current', 'developments', 'of', 'using', 'aptamers', 'in', 'the', 'diagnostics', 'and', 'treatment', 'of', 'viral', 'diseases', '']"
